PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Greenfield, LK; Richards, MR; Li, JJ; Wakarchuk, WW; Lowary, TL; Whitfield, C				Greenfield, Laura K.; Richards, Michele R.; Li, Jianjun; Wakarchuk, Warren W.; Lowary, Todd L.; Whitfield, Chris			Biosynthesis of the Polymannose Lipopolysaccharide O-antigens from Escherichia coli Serotypes O8 and O9a Requires a Unique Combination of Single- and Multiple-active Site Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; BINDING CASSETTE TRANSPORTER; ACID-SEQUENCE SIMILARITIES; S-LAYER GLYCOPROTEIN; GENE-CLUSTER; GEOBACILLUS-STEAROTHERMOPHILUS; ABC TRANSPORTER; BIOCHEMICAL-CHARACTERIZATION; BAND LIPOPOLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA	The Escherichia coli O9a and O8 O-antigen serotypes represent model systems for the ABC transporter-dependent synthesis of bacterial polysaccharides. The O9a and O8 antigens are linear mannose homopolymers containing conserved reducing termini (the primer-adaptor), a serotype-specific repeat unit domain, and a terminator. Synthesis of these glycans occurs on the polyisoprenoid lipid-linked primer, undecaprenol pyrophosphoryl-GlcpNAc, by two conserved mannosyltransferases, WbdC and WbdB, and a serotype-specific mannosyltransferase, WbdA. The glycan structure and pattern of conservation in the O9a and O8 mannosyltransferases are not consistent with the existing model of O9a biosynthesis. Here we establish a revised pathway using a combination of in vivo (mutant complementation) experiments and in vitro strategies with purified enzymes and synthetic acceptors. WbdC and WbdB synthesize the adaptor region, where they transfer one and two alpha-(1 -> 3)-linked mannose residues, respectively. The WbdA enzymes are solely responsible for forming the repeat unit domains of these O-antigens. WbdA(O9a) has two predicted active sites and polymerizes a tetrasaccharide repeat unit containing two alpha-(1 -> 3)-and two alpha-(1 -> 2)-linked mannopyranose residues. In contrast, WbdA(O8) polymerizes trisaccharide repeat units containing single alpha-(1 -> 3)-, alpha-(1 -> 2)-, and beta-(1 -> 2)-mannopyranoses. These studies illustrate assembly systems exploiting several mannosyltransferases with flexible active sites, arranged in single-and multiple-domain formats.	[Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Li, Jianjun; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Alberta; University of Alberta; National Research Council Canada	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019; Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Li, Jianjun/0000-0002-6531-3687	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alberta Innovates Health Solutions	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alberta Innovates Health Solutions	This work was supported by grants from the Natural Sciences and Engineering Research Council (awarded to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.).; Recipient of an Alberta Innovates Health Solutions Ph.D. studentship.	Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; ARSENAULT TL, 1991, CAN J CHEM, V69, P1273, DOI 10.1139/v91-190; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Blixt O, 2005, CARBOHYD RES, V340, P1963, DOI 10.1016/j.carres.2005.06.008; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; FITZGERA.DK, 1971, EUR J BIOCHEM, V24, P222, DOI 10.1111/j.1432-1033.1971.tb19674.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hodson N, 2000, J BIOL CHEM, V275, P27311; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; KANEGASAKI S, 1979, EUR J BIOCHEM, V95, P287, DOI 10.1111/j.1432-1033.1979.tb12964.x; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; Kido N, 1997, MICROBIOL IMMUNOL, V41, P519, DOI 10.1111/j.1348-0421.1997.tb01887.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CJ, 2007, CARBOHYD RES, V342, P2818, DOI 10.1016/j.carres.2007.08.020; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Miller J. H., 1972, EXPT MOL GENETICS, P432; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Perepelov AV, 2009, FEMS IMMUNOL MED MIC, V57, P80, DOI 10.1111/j.1574-695X.2009.00584.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rocchetta HL, 1998, MOL MICROBIOL, V28, P1103, DOI 10.1046/j.1365-2958.1998.00871.x; SAEKI A, 1993, MICROBIOL IMMUNOL, V37, P601, DOI 10.1111/j.1348-0421.1993.tb01682.x; Sambrook J., 1989, MOL CLONING LAB MANU; Schaffer C, 2002, J BIOL CHEM, V277, P6230, DOI 10.1074/jbc.M108873200; Shatzman A. R., 2001, CURRENT PROTOCOLS MO, V11; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Sugiyama T, 1997, GENE, V198, P111, DOI 10.1016/S0378-1119(97)00300-4; Sugiyama T, 1998, J BACTERIOL, V180, P2775, DOI 10.1128/JB.180.10.2775-2778.1998; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wakarchuk Warren W, 2003, Methods Mol Biol, V213, P263	70	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35078	35091		10.1074/jbc.M112.401000	http://dx.doi.org/10.1074/jbc.M112.401000			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22875852	Green Published, hybrid			2022-12-25	WOS:000309968000019
J	Kadurin, I; Alvarez-Laviada, A; Ng, SFJ; Walker-Gray, R; D'Arco, M; Fadel, MG; Pratt, WS; Dolphin, AC				Kadurin, Ivan; Alvarez-Laviada, Anita; Ng, Shu Fun Josephine; Walker-Gray, Ryan; D'Arco, Marianna; Fadel, Michael G.; Pratt, Wendy S.; Dolphin, Annette C.			Calcium Currents Are Enhanced by alpha(2)delta-1 Lacking Its Membrane Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNEL ALPHA(2)DELTA; LIPID RAFTS; ENDOPLASMIC-RETICULUM; SUBUNIT INTERACTION; BETA-SUBUNITS; ALPHA 1A; EXPRESSION; PROTEIN; SITE; FORM	The accessory alpha(2)delta subunits of voltage-gated calcium channels are membrane-anchored proteins, which are highly glycosylated, possess multiple disulfide bonds, and are post-translationally cleaved into alpha(2) and delta. All alpha(2)delta subunits have a C-terminal hydrophobic, potentially trans-membrane domain and were described as type I transmembrane proteins, but we found evidence that they can be glycosylphosphatidylinositol-anchored. To probe further the function of membrane anchoring in alpha(2)delta subunits, we have now examined the properties of alpha(2)delta-1 constructs truncated at their putative glycosylphosphatidylinositol anchor site, located before the C-terminal hydrophobic domain (alpha(2)delta-1 Delta C-term). We find that the majority of alpha(2)delta-1 Delta C-term is soluble and secreted into the medium, but unexpectedly, some of the protein remains associated with detergent-resistant membranes, also termed lipid rafts, and is extrinsically bound to the plasma membrane. Furthermore, heterologous co-expression of alpha(2)delta-1 Delta C-term with Ca(V)2.1/beta 1b results in a substantial enhancement of the calcium channel currents, albeit less than that produced by wild-type alpha(2)delta-1. These results call into question the role of membrane anchoring of alpha(2)delta subunits for calcium current enhancement.	[Kadurin, Ivan; Alvarez-Laviada, Anita; Ng, Shu Fun Josephine; Walker-Gray, Ryan; D'Arco, Marianna; Fadel, Michael G.; Pratt, Wendy S.; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Kadurin, I (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	i.kadurin@ucl.ac.uk; a.dolphin@ucl.ac.uk	Ng, Shu Fun Josephine/AAH-4384-2021; Kadurin, Ivan/F-7759-2012; Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856; Ng, Shu Fun Josephine/0000-0003-4567-1409; Kadurin, Ivan/0000-0002-7720-367X	Medical Research Council [G0700368, G0801756]; Medical Research Council [G0901758] Funding Source: researchfish; MRC [G0901758, G0801756, G0700368] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Grants G0700368 and G0801756.	Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown JP, 1998, J BIOL CHEM, V273, P25458, DOI 10.1074/jbc.273.39.25458; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; CAMPBELL V, 1995, J PHYSIOL-LONDON, V485, P365, DOI 10.1113/jphysiol.1995.sp020735; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti Carles, 2003, Current Neuropharmacology, V1, P209, DOI 10.2174/1570159033477116; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DELAHUNTY MD, 1993, J BIOL CHEM, V268, P12017; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Douglas L, 2006, BIOCHEM SOC T, V34, P894, DOI 10.1042/BST0340894; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Felix R, 1997, J NEUROSCI, V17, P6884; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hobom M, 2000, EUR J NEUROSCI, V12, P1217, DOI 10.1046/j.1460-9568.2000.01009.x; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; JAY SD, 1991, J BIOL CHEM, V266, P3287; Klugbauer N, 1999, J NEUROSCI, V19, P684; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Robinson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019802; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9	41	24	24	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33554	33566		10.1074/jbc.M112.378554	http://dx.doi.org/10.1074/jbc.M112.378554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869375	Green Published, hybrid			2022-12-25	WOS:000309602100041
J	Potkin, KT; Bunney, WE				Potkin, Katya Trudeau; Bunney, William E., Jr.			Sleep Improves Memory: The Effect of Sleep on Long Term Memory in Early Adolescence	PLOS ONE			English	Article							CONSOLIDATION; CHILDREN; DECLINE; AGE; NAP	Sleep plays an important role in the consolidation of memory. This has been most clearly shown in adults for procedural memory (i.e. skills and procedures) and declarative memory (e.g. recall of facts). The effects of sleep and memory are relatively unstudied in adolescents. Declarative memory is important in school performance and consequent social functioning in adolescents. This is the first study to specifically examine the effects of normal sleep on auditory declarative memory in an early adolescent sample. Given that the majority of adolescents do not obtain the recommended amount of sleep, it is critical to study the cognitive effects of normal sleep. Forty male and female normal, healthy adolescents between the ages of ten and fourteen years old were randomly assigned to sleep and no sleep conditions. Subjects were trained on a paired-associate declarative memory task and a control working memory task at 9am, and tested at night (12 hours later) without sleep. The same number of subjects was trained at 9pm and tested 9am following sleep. An increase of 20.6% in declarative memory, as measured by the number correct in a paired-associate test, following sleep was observed compared to the group which was tested at the same time interval without sleep (p < 0.03). The performance on the control working memory task that involved encoding and memoranda manipulation was not affected by time of day or relationship to sleep. Declarative memory is significantly improved by sleep in a sample of normal adolescents.	[Potkin, Katya Trudeau] Brown Univ, Dept Human Biol, Providence, RI 02912 USA; [Bunney, William E., Jr.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	Brown University; University of California System; University of California Irvine	Potkin, KT (corresponding author), Brown Univ, Dept Human Biol, Providence, RI 02912 USA.	katya_potkin@brown.edu; webunney@uci.edu						Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Berkman Julia M, 2006, Med Health R I, V89, P94; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; Carskadon MA, 2011, PROG BRAIN RES, V190, P137, DOI 10.1016/B978-0-444-53817-8.00008-6; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Meltzer LJ, 2006, PSYCHIAT CLIN N AM, V29, P1059, DOI 10.1016/j.psc.2006.08.004; Moore M, 2008, PAEDIATR RESPIR REV, V9, P114, DOI 10.1016/j.prrv.2008.01.001; Moroni F, 2008, NEUROIMAGE, V42, P911, DOI 10.1016/j.neuroimage.2008.05.027; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pace-Schott EF, 2011, PROG BRAIN RES, V191, P75, DOI 10.1016/B978-0-444-53752-2.00012-6; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Voderholzer U, 2011, SLEEP MED, V12, P170, DOI 10.1016/j.sleep.2010.07.017; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; WILSON RS, 1982, J CONSULT CLIN PSYCH, V50, P154, DOI 10.1037/0022-006X.50.1.154	24	37	37	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42191	10.1371/journal.pone.0042191	http://dx.doi.org/10.1371/journal.pone.0042191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22879917	Green Published, gold			2022-12-25	WOS:000307437900024
J	Rishishwar, L; Varghese, N; Tyagi, E; Harvey, SC; Jordan, IK; McCarty, NA				Rishishwar, Lavanya; Varghese, Neha; Tyagi, Eishita; Harvey, Stephen C.; Jordan, I. King; McCarty, Nael A.			Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; R-DOMAIN; SERVER; IDENTIFICATION; CONSERVATION; MUSCLE; GENE	Cystic fibrosis (CF) is the most common genetic disease among Caucasians, and accordingly the cystic fibrosis transmembrane conductance regulator (CFTR) protein has perhaps the best characterized disease mutation spectrum with more than 1,500 causative mutations having been identified. In this study, we took advantage of that wealth of mutational information in an effort to relate site-specific evolutionary parameters with the propensity and severity of CFTR disease-causing mutations. To do this, we devised a scoring scheme for known CFTR disease-causing mutations based on the Grantham amino acid chemical difference matrix. CFTR site-specific evolutionary constraint values were then computed for seven different evolutionary metrics across a range of increasing evolutionary depths. The CFTR mutational scores and the various site-specific evolutionary constraint values were compared in order to evaluate which evolutionary measures best reflect the disease-causing mutation spectrum. Site-specific evolutionary constraint values from the widely used comparative method PolyPhen2 show the best correlation with the CFTR mutation score spectrum, whereas more straightforward conservation based measures (ConSurf and ScoreCons) show the greatest ability to predict individual CFTR disease-causing mutations. While far greater than could be expected by chance alone, the fraction of the variability in mutation scores explained by the PolyPhen2 metric (3.6%), along with the best set of paired sensitivity (58%) and specificity (60%) values for the prediction of disease-causing residues, were marginal. These data indicate that evolutionary constraint levels are informative but far from determinant with respect to disease-causing mutations in CFTR. Nevertheless, this work shows that, when combined with additional lines of evidence, information on site-specific evolutionary conservation can and should be used to guide site-directed mutagenesis experiments by more narrowly defining the set of target residues, resulting in a potential savings of both time and money.	[Rishishwar, Lavanya; Varghese, Neha; Tyagi, Eishita; Harvey, Stephen C.; Jordan, I. King] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Jordan, I. King] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [McCarty, Nael A.] Emory Univ, Sch Med, Dept Pediat, Ctr Cyst Fibrosis Res,Childrens Healthcare Atlant, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Children's Healthcare of Atlanta (CHOA); Emory University	Rishishwar, L (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	namccar@emory.edu	Rishishwar, Lavanya/H-5587-2013	Rishishwar, Lavanya/0000-0002-2055-9392; Varghese, Neha/0000-0003-0580-0675	NIH [5R01DK075016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the NIH, 5R01DK075016 to N.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaucher EA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-44; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Miller MP, 2003, ANN HUM GENET, V67, P567, DOI 10.1046/j.1529-8817.2003.00072.x; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Notaro R, 2000, FASEB J, V14, P485, DOI 10.1096/fasebj.14.3.485; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Schaner P, 2001, NAT GENET, V27, P318, DOI 10.1038/85893; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valdar WSJ, 2001, PROTEINS, V42, P108; Zieve D, 2011, CYSTIC FIBROSIS	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42336	10.1371/journal.pone.0042336	http://dx.doi.org/10.1371/journal.pone.0042336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879944	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900029
J	Liu, WJ; Schat, H; Bliek, M; Chen, Y; McGrath, SP; George, G; Salt, DE; Zhao, FJ				Liu, Wenju; Schat, Henk; Bliek, Mathijs; Chen, Yi; McGrath, Steve P.; George, Graham; Salt, David E.; Zhao, Fang-Jie			Knocking Out ACR2 Does Not Affect Arsenic Redox Status in Arabidopsis thaliana: Implications for As Detoxification and Accumulation in Plants	PLOS ONE			English	Article							PHOSPHOROLYTIC-ARSENOLYTIC ENZYMES; HYPERACCUMULATOR PTERIS-VITTATA; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASE; REDUCTION; RICE; TOLERANCE; PHYTOCHELATINS; PHOSPHORYLASE; BANGLADESH	Many plant species are able to reduce arsenate to arsenite efficiently, which is an important step allowing detoxification of As through either efflux of arsenite or complexation with thiol compounds. It has been suggested that this reduction is catalyzed by ACR2, a plant homologue of the yeast arsenate reductase ScACR2. Silencing of AtACR2 was reported to result in As hyperaccumulation in the shoots of Arabidopsis thaliana. However, no information of the in vivo As speciation has been reported. Here, we investigated the effect of AtACR2 knockout or overexpression on As speciation, arsenite efflux from roots and As accumulation in shoots. T-DNA insertion lines, overexpression lines and wild-type (WT) plants were exposed to different concentrations of arsenate for different periods, and As speciation in plants and arsenite efflux were determined using HPLC-ICP-MS. There were no significant differences in As speciation between different lines, with arsenite accounting for >90% of the total extractable As in both roots and shoots. Arsenite efflux to the external medium represented on average 77% of the arsenate taken up during 6 h exposure, but there were no significant differences between WT and mutants or overexpression lines. Accumulation of As in the shoots was also unaffected by AtACR2 knockout or overexpression. Additionally, after exposure to arsenate, the yeast (Saccharomyces cerevisiae) strain with ScACR2 deleted showed similar As speciation as the WT with arsenite-thiol complexes being the predominant species. Our results suggest the existence of multiple pathways of arsenate reduction in plants and yeast.	[Liu, Wenju; Chen, Yi; McGrath, Steve P.] Rothamsted Res, Harpenden, Herts, England; [Liu, Wenju] Hebei Agr Univ, Coll Resources & Environm Sci, Baoding, Hebei Province, Peoples R China; [Schat, Henk; Bliek, Mathijs] Vrije Univ Amsterdam, Dept Genet, Fac Earth & Life Sci, Amsterdam, Netherlands; [George, Graham] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 0W0, Canada; [Salt, David E.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Zhao, Fang-Jie] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Hebei Agricultural University; Vrije Universiteit Amsterdam; University of Saskatchewan; University of Aberdeen; Nanjing Agricultural University	Zhao, FJ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	Fangjie.Zhao@njau.edu.cn	George, Graham N/E-3290-2013; Zhao, Fang-Jie/A-8339-2008; McGrath, Steve P/B-5127-2008; Schat, Henk/AAB-8723-2019; Zhao, Fang-Jie/A-8339-2008	Zhao, Fang-Jie/0000-0002-0164-169X; McGrath, Steve P/0000-0003-0952-8947; Chen, Yi/0000-0001-7146-3975; George, Graham/0000-0002-0420-7493; Zhao, Fang-Jie/0000-0002-1252-1079	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; Biotechnology and Biological Sciences Research Council of the UK; Rothamsted International Fellowship; National Science Foundation [IOS 0844413]; Canada Research Chair; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; BBSRC [BBS/E/C/00005206, BBS/E/C/00004981] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rothamsted International Fellowship; National Science Foundation(National Science Foundation (NSF)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was financially supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and by the 111 project (B12009). Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences Research Council of the UK. W.J.L. was supported by a Rothamsted International Fellowship. This work was supported by a grant to D.E.S. from the National Science Foundation (IOS 0844413). G.N.G. was supported by a Canada Research Chair, the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; Bleeker PM, 2006, PLANT J, V45, P917, DOI 10.1111/j.1365-313X.2005.02651.x; Bolle C, 2011, CURR GENOMICS, V12, P1, DOI 10.2174/138920211794520187; Brammer H, 2009, ENVIRON INT, V35, P647, DOI 10.1016/j.envint.2008.10.004; Chen WH, 2010, PLANT PHYSIOL, V153, P1385, DOI 10.1104/pp.110.153452; DELNOMDEDIEU M, 1994, CHEM-BIOL INTERACT, V90, P139, DOI 10.1016/0009-2797(94)90099-X; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Dhankher OP, 2006, P NATL ACAD SCI USA, V103, P5413, DOI 10.1073/pnas.0509770102; Dhankher OP, 2003, NEW PHYTOL, V159, P431, DOI 10.1046/j.1469-8137.2003.00827.x; Dissmeyer N, 2009, PLANT CELL, V21, P3641, DOI 10.1105/tpc.109.070417; Duan GL, 2007, NEW PHYTOL, V174, P311, DOI 10.1111/j.1469-8137.2007.02009.x; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gregus Z, 2005, TOXICOL SCI, V85, P859, DOI 10.1093/toxsci/kfi158; Gregus Z, 2002, TOXICOL SCI, V70, P13, DOI 10.1093/toxsci/70.1.13; Gregus Z, 2009, TOXICOL SCI, V110, P282, DOI 10.1093/toxsci/kfp113; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Indriolo E, 2010, PLANT CELL, V22, P2045, DOI 10.1105/tpc.109.069773; Landrieu I, 2004, BIOCHEM BIOPH RES CO, V322, P734, DOI 10.1016/j.bbrc.2004.07.182; Liu WJ, 2010, PLANT PHYSIOL, V152, P2211, DOI 10.1104/pp.109.150862; Lombi E, 2002, NEW PHYTOL, V156, P195, DOI 10.1046/j.1469-8137.2002.00512.x; Moore KL, 2011, PLANT PHYSIOL, V156, P913, DOI 10.1104/pp.111.173088; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Nemeti B, 2007, TOXICOL SCI, V100, P36, DOI 10.1093/toxsci/kfm211; Nemeti B, 2010, TOXICOL SCI, V117, P270, DOI 10.1093/toxsci/kfq141; Nemeti B, 2009, TOXICOL SCI, V110, P270, DOI 10.1093/toxsci/kfp112; Panaullah GM, 2009, PLANT SOIL, V317, P31, DOI 10.1007/s11104-008-9786-y; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Pickering IJ, 2006, ENVIRON SCI TECHNOL, V40, P5010, DOI 10.1021/es052559a; Raab A, 2005, NEW PHYTOL, V168, P551, DOI 10.1111/j.1469-8137.2005.01519.x; Rathinasabapathi B, 2006, PLANT MOL BIOL, V62, P845, DOI 10.1007/s11103-006-9060-8; Schmoger MEV, 2000, PLANT PHYSIOL, V122, P793, DOI 10.1104/pp.122.3.793; Sneller FEC, 1999, NEW PHYTOL, V144, P223, DOI 10.1046/j.1469-8137.1999.00512.x; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Spadafora ND, 2011, ANN BOT-LONDON, V107, P1183, DOI 10.1093/aob/mcq142; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Wu ZC, 2011, PLANT PHYSIOL, V157, P498, DOI 10.1104/pp.111.178921; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Xu XY, 2007, NEW PHYTOL, V176, P590, DOI 10.1111/j.1469-8137.2007.02195.x; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhao FJ, 2003, NEW PHYTOL, V159, P403, DOI 10.1046/j.1469-8137.2003.00784.x	46	41	47	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42408	10.1371/journal.pone.0042408	http://dx.doi.org/10.1371/journal.pone.0042408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879969	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000032
J	Foo, SA; Dworjanyn, SA; Poore, AGB; Byrne, M				Foo, Shawna A.; Dworjanyn, Symon A.; Poore, Alistair G. B.; Byrne, Maria			Adaptive Capacity of the Habitat Modifying Sea Urchin Centrostephanus rodgersii to Ocean Warming and Ocean Acidification: Performance of Early Embryos	PLOS ONE			English	Article							CLIMATE-CHANGE; STRONGYLOCENTROTUS-PURPURATUS; THERMAL TOLERANCE; CARBONIC-ACID; MARINE; SEAWATER; FERTILIZATION; DISSOCIATION; ADAPTATION; MECHANISMS	Background: Predicting effects of rapid climate change on populations depends on measuring the effects of climate stressors on performance, and potential for adaptation. Adaptation to stressful climatic conditions requires heritable genetic variance for stress tolerance present in populations. Methodology/Principal Findings: We quantified genetic variation in tolerance of early development of the ecologically important sea urchin Centrostephanus rodgersii to near-future (2100) ocean conditions projected for the southeast Australian global change hot spot. Multiple dam-sire crosses were used to quantify the interactive effects of warming (+2-4 degrees C) and acidification (-0.3-0.5 pH units) across twenty-seven family lines. Acidification, but not temperature, decreased the percentage of cleavage stage embryos. In contrast, temperature, but not acidification decreased the percentage of gastrulation. Cleavage success in response to both stressors was strongly affected by sire identity. Sire and dam identity significantly affected gastrulation and both interacted with temperature to determine developmental success. Positive genetic correlations for gastrulation indicated that genotypes that did well at lower pH also did well in higher temperatures. Conclusions/Significance: Significant genotype (sire) by environment interactions for both stressors at gastrulation indicated the presence of heritable variation in thermal tolerance and the ability of embryos to respond to changing environments. The significant influence of dam may be due to maternal provisioning (maternal genotype or environment) and/or offspring genotype. It appears that early development in this ecologically important sea urchin is not constrained in adapting to the multiple stressors of ocean warming and acidification. The presence of tolerant genotypes indicates the potential to adapt to concurrent warming and acidification, contributing to the resilience of C. rodgersii in a changing ocean.	[Foo, Shawna A.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Poore, Alistair G. B.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of New South Wales Sydney; University of Sydney; University of Sydney	Foo, SA (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	shawna@anatomy.usyd.edu.au	Byrne, Maria/K-6355-2016; Poore, Alistair/C-2934-2008; Dworjanyn, Symon A/O-5633-2017	Byrne, Maria/0000-0002-8902-9808; Poore, Alistair/0000-0002-3560-3659; Dworjanyn, Symon A/0000-0002-6690-8033; Foo, Shawna/0000-0002-7083-2377	Australian Research Council; New South Wales Environment Research trust; National Climate Change Adaptation Research Facility	Australian Research Council(Australian Research Council); New South Wales Environment Research trust; National Climate Change Adaptation Research Facility	This research was supported by grants from the Australian Research Council (http://www.arc.gov.au/), New South Wales Environment Research trust (http://www.environment.nsw.gov.au/grants/research.htm) and the National Climate Change Adaptation Research Facility (http://www.nccarf.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrew N. L., 2007, BIOL ECOLOGY EDIBLE, p[191, xxv]; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Astles PA, 2006, J EVOLUTION BIOL, V19, P114, DOI 10.1111/j.1420-9101.2005.00997.x; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2011, DEEP-SEA RES PT II, V58, P712, DOI 10.1016/j.dsr2.2010.06.010; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Darwin C., 1877, DIFFERENT FORMS FLOW; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doo SS, 2012, ICES J MAR SCI, V69, P460, DOI 10.1093/icesjms/fsr123; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; EISEN EJ, 1983, THEOR APPL GENET, V67, P75, DOI 10.1007/BF00303929; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Evans JP, 2012, P ROY SOC B-BIOL SCI, V279, P2855, DOI 10.1098/rspb.2012.0181; Galletly BC, 2007, ECOL APPL, V17, P2290, DOI 10.1890/06-2079.1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hammond LM, 2010, MAR BIOL, V157, P2677, DOI 10.1007/s00227-010-1528-z; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; IPCC (Intergovernmental Panel on Climate Change), 2007, 4 ASS REP IPCC; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall DJ, 2000, MAR ECOL PROG SER, V195, P305, DOI 10.3354/meps195305; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Nguyen H, 2012, GLOBAL CHAN IN PRESS; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pease CJ, 2010, AQUAT TOXICOL, V99, P10, DOI 10.1016/j.aquatox.2010.03.014; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pierrot D., 2006, ORNLCDIAC105A US DEP; Pistevos JCA, 2011, OIKOS, V120, P675, DOI 10.1111/j.1600-0706.2010.19470.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCONZO G, 1986, CELL DIFFER DEV, V19, P173, DOI 10.1016/0045-6039(86)90093-X; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825	60	102	102	1	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42497	10.1371/journal.pone.0042497	http://dx.doi.org/10.1371/journal.pone.0042497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880005	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100110
J	Furtado, C; Kunrath-Lima, M; Rajao, MA; Mendes, IC; de Moura, MB; Campos, PC; Macedo, AM; Franco, GR; Pena, SDJ; Teixeira, SMR; Van Houten, B; Machado, CR				Furtado, Carolina; Kunrath-Lima, Marianna; Rajao, Matheus Andrade; Mendes, Isabela Cecilia; de Moura, Michelle Barbi; Campos, Priscila Carneiro; Macedo, Andrea Mara; Franco, Gloria Regina; Junho Pena, Sergio Danilo; Ribeiro Teixeira, Santuza Maria; Van Houten, Bennett; Machado, Carlos Renato			Functional Characterization of 8-Oxoguanine DNA Glycosylase of Trypanosoma cruzi	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MITOCHONDRIAL-DNA; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; OGG1 GENE; CLONING; DAMAGE; PROTEIN; EXPRESSION	The oxidative lesion 8-oxoguanine (8-oxoG) is removed during base excision repair by the 8-oxoguanine DNA glycosylase 1 (Ogg1). This lesion can erroneously pair with adenine, and the excision of this damaged base by Ogg1 enables the insertion of a guanine and prevents DNA mutation. In this report, we identified and characterized Ogg1 from the protozoan parasite Trypanosoma cruzi (TcOgg1), the causative agent of Chagas disease. Like most living organisms, T. cruzi is susceptible to oxidative stress, hence DNA repair is essential for its survival and improvement of infection. We verified that the TcOGG1 gene encodes an 8-oxoG DNA glycosylase by complementing an Ogg1-defective Saccharomyces cerevisiae strain. Heterologous expression of TcOGG1 reestablished the mutation frequency of the yeast mutant ogg1(-/-) (CD138) to wild type levels. We also demonstrate that the overexpression of TcOGG1 increases T. cruzi sensitivity to hydrogen peroxide (H2O2). Analysis of DNA lesions using quantitative PCR suggests that the increased susceptibility to H2O2 of TcOGG1-overexpressor could be a consequence of uncoupled BER in abasic sites and/or strand breaks generated after TcOgg1 removes 8-oxoG, which are not rapidly repaired by the subsequent BER enzymes. This hypothesis is supported by the observation that TcOGG1-overexpressors have reduced levels of 8-oxoG both in the nucleus and in the parasite mitochondrion. The localization of TcOgg1 was examined in parasite transfected with a TcOgg1-GFP fusion, which confirmed that this enzyme is in both organelles. Taken together, our data indicate that T. cruzi has a functional Ogg1 ortholog that participates in nuclear and mitochondrial BER.	[Furtado, Carolina; Kunrath-Lima, Marianna; Rajao, Matheus Andrade; Mendes, Isabela Cecilia; Campos, Priscila Carneiro; Macedo, Andrea Mara; Franco, Gloria Regina; Junho Pena, Sergio Danilo; Ribeiro Teixeira, Santuza Maria; Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA	Universidade Federal de Minas Gerais; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Furtado, C (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	crmachad@icb.ufmg.br	TEIXEIRA, SANTUZA MR/I-8137-2013; Van Houten, Bennett/K-2284-2019; Franco, Glória/I-3654-2013; Machado, Carlos Renato/H-1043-2015; Macedo, Andréa M/C-1506-2013; MACHADO, CARLOS/AAW-1492-2020	Franco, Glória/0000-0001-5245-2365; Machado, Carlos Renato/0000-0002-8724-3165; Campos, Priscila/0000-0003-1789-3290	CNPq [474865/2010-0]; FAPEMIG [PPM-00284-11]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by CNPq Grant Process number 474865/2010-0 (www.cnpq.br) and FAPEMIG grant Process number PPM-00284-11 (www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Augusto-Pinto L, 2001, GENE, V272, P323, DOI 10.1016/S0378-1119(01)00549-2; Augusto-Pinto Luiz, 2003, Genet Mol Res, V2, P77; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Belousova EA, 2006, BBA-PROTEINS PROTEOM, V1764, P97, DOI 10.1016/j.bbapap.2005.11.001; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; BOITEUX S, 1989, MOL GEN GENET, V215, P300, DOI 10.1007/BF00339732; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cabrera G, 2011, J CELL BIOCHEM, V112, P2189, DOI 10.1002/jcb.23138; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; de Moura MB, 2009, ENVIRON MOL MUTAGEN, V50, P375, DOI 10.1002/em.20450; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P89, DOI 10.1590/S0074-02762009000900014; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Eot-Houllier G, 2007, NUCLEIC ACIDS RES, V35, P3355, DOI 10.1093/nar/gkm190; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Guibourt N, 2000, BIOCHIMIE, V82, P59, DOI 10.1016/S0300-9084(00)00357-6; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hollenbach S, 1999, CARCINOGENESIS, V20, P1863, DOI 10.1093/carcin/20.9.1863; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Jin G, 2006, INT J RADIAT BIOL, V82, P241, DOI 10.1080/09553000600649216; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Krokan HE, 1997, BIOCHEM J, V325, P1; Li WQ, 2009, CARCINOGENESIS, V30, P500, DOI 10.1093/carcin/bgp018; Lopes DD, 2008, DNA REPAIR, V7, P1882, DOI 10.1016/j.dnarep.2008.07.018; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Nakabeppu Y, 2001, PROG NUCLEIC ACID RE, V68, P75; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Nussbaum K, 2010, CURR MED CHEM, V17, P1594, DOI 10.2174/092986710790979953; Pfeifer GP, 1996, TECHNOLOGIES DETECTI, pxxv; Pires SF, 2008, INT J PARASITOL, V38, P289, DOI 10.1016/j.ijpara.2007.08.013; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x; Regis-Da-Silva CG, 2006, MOL BIOCHEM PARASIT, V149, P191, DOI 10.1016/j.molbiopara.2006.05.012; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sambrook J, 2001, MOL CLONING LAB MANU; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Thomas S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-133; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Zhang Y., 2011, INT J COLORECTAL DIS	73	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42484	10.1371/journal.pone.0042484	http://dx.doi.org/10.1371/journal.pone.0042484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876325	Green Published, Green Accepted, gold			2022-12-25	WOS:000307184700053
J	Jazbutyte, V; Stumpner, J; Redel, A; Lorenzen, JM; Roewer, N; Thum, T; Kehl, F				Jazbutyte, Virginija; Stumpner, Jan; Redel, Andreas; Lorenzen, Johan M.; Roewer, Norbert; Thum, Thomas; Kehl, Franz			Aromatase Inhibition Attenuates Desflurane-Induced Preconditioning against Acute Myocardial Infarction in Male Mouse Heart In Vivo	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FUNCTIONAL ESTROGEN-RECEPTORS; NITRIC-OXIDE; VOLATILE ANESTHETICS; CARDIAC-HYPERTROPHY; BLOOD-PRESSURE; ISCHEMIA; REPERFUSION; RABBITS; ISOFLURANE	The volatile anesthetic desflurane (DES) effectively reduces cardiac infarct size following experimental ischemia/reperfusion injury in the mouse heart. We hypothesized that endogenous estrogens play a role as mediators of desflurane-induced preconditioning against myocardial infarction. In this study, we tested the hypothesis that desflurane effects local estrogen synthesis by modulating enzyme aromatase expression and activity in the mouse heart. Aromatase metabolizes testosterone to 17 beta-estradiol (E2) and thereby significantly contributes to local estrogen synthesis. We tested aromatase effects in acute myocardial infarction model in male mice. The animals were randomized and subjected to four groups which were pre-treated with the selective aromatase inhibitor anastrozole (A group) and DES alone (DES group) or in combination (A+DES group) for 15 minutes prior to surgical intervention whereas the control group received 0.9% NaCl (CON group). All animals were subjected to 45 minutes ischemia following 180 minutes reperfusion. Anastrozole blocked DES induced preconditioning and increased infarct size compared to DES alone (37.94 +/- 15.5% vs. 17.1 +/- 3.62%) without affecting area at risk and systemic hemodynamic parameters following ischemia/reperfusion. Protein localization studies revealed that aromatase was abundant in the murine cardiovascular system with the highest expression levels in endothelial and smooth muscle cells. Desflurane application at pharmacological concentrations efficiently upregulated aromatase expression in vivo and in vitro. We conclude that desflurane efficiently regulates aromatase expression and activity which might lead to increased local estrogen synthesis and thus preserve cellular integrity and reduce cardiac damage in an acute myocardial infarction model.	[Jazbutyte, Virginija; Lorenzen, Johan M.; Thum, Thomas] Hannover Med Sch MHH, Inst Mol & Translat Therapeut Strategies IMTTS, Hannover, Germany; [Stumpner, Jan; Roewer, Norbert] Univ Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany; [Redel, Andreas] Univ Regensburg, Dept Anesthesia, Regensburg, Germany; [Kehl, Franz] Klinikum Karlsruhe, Dept Anesthesiol & Crit Care, Karslruhe, Germany	Hannover Medical School; University of Wurzburg; University of Regensburg; Municipal Hospital Karlsruhe	Jazbutyte, V (corresponding author), Hannover Med Sch MHH, Inst Mol & Translat Therapeut Strategies IMTTS, Hannover, Germany.	vjazbutyte@hotmail.com		Lorenzen, Johan/0000-0002-9132-948X; Thum, Thomas/0000-0003-4360-1511	University Clinics of Wurzburg, Germany; Else-Kroner-Fresenius Foundation; German Ministry for Education and Research (IFB-Tx) [01EO0802]	University Clinics of Wurzburg, Germany; Else-Kroner-Fresenius Foundation; German Ministry for Education and Research (IFB-Tx)	The study was supported by the University Clinics of Wurzburg, Germany, by Else-Kroner-Fresenius Foundation (FK) and by the German Ministry for Education and Research (IFB-Tx, grant 01EO0802 for TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYARD F, 1995, ENDOCRINOLOGY, V136, P1523, DOI 10.1210/en.136.4.1523; Bayard F, 1995, CIBA F SYMP, V191, P122; Bignami E, 2009, J CARDIOTHOR VASC AN, V23, P594, DOI 10.1053/j.jvca.2009.01.022; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Head GA, 2004, ENDOCRINOLOGY, V145, P4286, DOI 10.1210/en.2004-0421; Jazbutyte V, 2008, CARDIOVASC RES, V77, P774, DOI 10.1093/cvr/cvm081; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Kolodgie FD, 1997, J MOL CELL CARDIOL, V29, P2403, DOI 10.1006/jmcc.1997.0476; Landoni G, 2009, CURR DRUG TARGETS, V10, P858, DOI 10.2174/138945009789108837; Lange M, 2006, ANESTHESIOLOGY, V105, P503, DOI 10.1097/00000542-200609000-00014; Lew R, 2003, CIRC RES, V93, P1127, DOI 10.1161/01.RES.0000103633.57225.BC; Meco M, 2007, EUR J CARDIO-THORAC, V32, P319, DOI 10.1016/j.ejcts.2007.05.005; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Node K, 1997, CIRCULATION, V96, P1953, DOI 10.1161/01.CIR.96.6.1953; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; PLOURDE PV, 1994, BREAST CANCER RES TR, V30, P103, DOI 10.1007/BF00682745; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Sbarouni E, 1998, CARDIOVASC DRUG THER, V12, P457, DOI 10.1023/A:1007750015372; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Smul TM, 2006, ANESTHESIOLOGY, V105, P719, DOI 10.1097/00000542-200610000-00018; Stadnicka A, 2007, J ANESTH, V21, P212, DOI 10.1007/s00540-006-0486-6; Tanaka K, 2002, ANESTHESIOLOGY, V97, P1485, DOI 10.1097/00000542-200212000-00021; Tritapepe L, 2007, EUR J ANAESTH, V24, P323, DOI 10.1017/S0265021506001931; Tsai SK, 2004, LIFE SCI, V76, P651, DOI 10.1016/j.lfs.2004.05.025; Wang C, 2006, ANESTH ANALG, V103, P274, DOI 10.1213/01.ANE.0000230389.76351.0C; Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834; Zangrillo A, 2011, J CARDIOTHOR VASC AN, V25, P902, DOI 10.1053/j.jvca.2011.06.016	33	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42032	10.1371/journal.pone.0042032	http://dx.doi.org/10.1371/journal.pone.0042032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876297	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700025
J	Britta, EA; Silva, APB; Ueda-Nakamura, T; Dias-Filho, BP; Silva, CC; Sernaglia, RL; Nakamura, CV				Britta, Elizandra Aparecida; Barbosa Silva, Ana Paula; Ueda-Nakamura, Tania; Dias-Filho, Benedito Prado; Silva, Cleuza Conceicao; Sernaglia, Rosana Lazara; Nakamura, Celso Vataru			Benzaldehyde Thiosemicarbazone Derived from Limonene Complexed with Copper Induced Mitochondrial Dysfunction in Leishmania amazonensis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IN-VITRO ACTIVITY; TRYPANOSOMA-CRUZI; SEMICARBAZONES; ORGANELLES	Background: Leishmaniasis is a major health problem that affects more than 12 million people. Treatment presents several problems, including high toxicity and many adverse effects, leading to the discontinuation of treatment and emergence of resistant strains. Methodology/Principal Findings: We evaluated the in vitro antileishmanial activity of benzaldehyde thiosemicarbazone derived from limonene complexed with copper, termed BenzCo, against Leishmania amazonensis. BenzCo inhibited the growth of the promastigote and axenic amastigote forms, with IC50 concentrations of 3.8 and 9.5 mu M, respectively, with 72 h of incubation. Intracellular amastigotes were inhibited by the compound, with an IC50 of 10.7 mu M. BenzCo altered the shape, size, and ultrastructure of the parasites. Mitochondrial membrane depolarization was observed in protozoa treated with BenzCo but caused no alterations in the plasma membrane. Additionally, BenzCo induced lipoperoxidation and the production of mitochondrial superoxide anion radicals in promastigotes and axenic amastigotes of Leishmania amazonensis. Conclusion/Significance: Our studies indicated that the antileishmania activity of BenzCo might be associated with mitochondrial dysfunction and oxidative damage, leading to parasite death.	[Britta, Elizandra Aparecida; Ueda-Nakamura, Tania; Dias-Filho, Benedito Prado; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil; [Barbosa Silva, Ana Paula; Silva, Cleuza Conceicao; Sernaglia, Rosana Lazara] Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Britta, EA (corresponding author), Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil.	cvnakamura@uem.br	Nakamura, Celso Vataru/AAA-5620-2019; Ueda-Nakamura, Tania/P-8250-2015	Ueda-Nakamura, Tania/0000-0001-5057-3518	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria); INCT_if; Complexo de Centrais de Apoio a Pesquisa (COMCAP); Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); INCT_if; Complexo de Centrais de Apoio a Pesquisa (COMCAP); Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	This study was supported through grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria), INCT_if, Complexo de Centrais de Apoio a Pesquisa (COMCAP), and Programa de Pos-graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa. EAB has a Master fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriolli AC, 2007, J ENV HLTH, V8, P19; Aponte JC, 2010, BIOORG MED CHEM LETT, V20, P100, DOI 10.1016/j.bmcl.2009.11.033; Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004; Belicchi-Ferrari M, 2007, POLYHEDRON, V26, P5150, DOI 10.1016/j.poly.2007.07.014; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Beraldo H, 2004, QUIM NOVA, V27, P461, DOI 10.1590/S0100-40422004000300017; Da Silva APB, 2010, THESIS U ESTADUAL MA; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; de Souza W, 2002, PARASITOL RES, V88, P1013, DOI 10.1007/s00436-002-0696-2; Diaz A, 1999, INORG CHEM COMMUN, V2, P358, DOI 10.1016/S1387-7003(99)00093-3; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Fonseca-Silva F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014666; Foroumadi A, 2005, BIOORG MED CHEM LETT, V15, P1983, DOI 10.1016/j.bmcl.2005.02.073; Gadelha FR, 1997, ARCH BIOCHEM BIOPHYS, V345, P243, DOI 10.1006/abbi.1997.0259; Graebin CS, 2010, EUR J MED CHEM, V45, P1524, DOI 10.1016/j.ejmech.2009.12.061; Khan SA, 2009, EUR J MED CHEM, V44, P2270, DOI 10.1016/j.ejmech.2008.06.008; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Mandelker L, 2008, VET CLIN N AM-SMALL, V38, P1, DOI 10.1016/j.cvsm.2007.10.005; Menna-Barreto RFS, 2005, J ANTIMICROB CHEMOTH, V56, P1034, DOI 10.1093/jac/dki403; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Moreno D, 2011, PARASITOL RES, V108, P233, DOI 10.1007/s00436-010-2073-x; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ngure PK., 2009, REV J NANJING MEDICA, V23, P79, DOI [10.1016/S1007-4376(09)60032-0, DOI 10.1016/S1007-4376(09)60032-0]; Pelizzaro-Rocha KJ, 2011, MICROBES INFECT, V13, P1018, DOI 10.1016/j.micinf.2011.05.011; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Santa-Rita RM, 2004, J ANTIMICROB CHEMOTH, V54, P704, DOI 10.1093/jac/dkh380; Santin MR, 2009, PARASITOL RES, V105, P1489, DOI 10.1007/s00436-009-1578-7; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; SHIPMAN C, 1986, ANTIVIR RES, V6, P197, DOI 10.1016/0166-3542(86)90002-1; Soares ROA, 2011, EXP PARASITOL, V129, P381, DOI 10.1016/j.exppara.2011.08.019; Ueda-Nakamura T, 2001, PARASITOL RES, V87, P89, DOI 10.1007/s004360000319; Valdez RH, 2009, ACTA TROP, V110, P7, DOI 10.1016/j.actatropica.2008.11.008; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; World Health Organization, PAR DIS; Yamaguchi MU, 2009, MOLECULES, V14, P1796, DOI 10.3390/molecules14051796	37	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41440	10.1371/journal.pone.0041440	http://dx.doi.org/10.1371/journal.pone.0041440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870222	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800019
J	Nguyen, QC; Villaveces, A; Marshall, SW; Hussey, JM; Halpern, CT; Poole, C				Nguyen, Quynh C.; Villaveces, Andres; Marshall, Stephen W.; Hussey, Jon M.; Halpern, Carolyn T.; Poole, Charles			Adolescent Expectations of Early Death Predict Adult Risk Behaviors	PLOS ONE			English	Article							SUBSTANCE USE; HOPELESSNESS SCALE; YOUNG ADULTHOOD; SUICIDE RISK; SELF-HARM; DRUG-USE; YOUTH; PERCEPTION; DEPRESSION; DEPENDENCE	Only a handful of public health studies have investigated expectations of early death among adolescents. Associations have been found between these expectations and risk behaviors in adolescence. However, these beliefs may not only predict worse adolescent outcomes, but worse trajectories in health with ties to negative outcomes that endure into young adulthood. The objectives of this study were to investigate perceived chances of living to age 35 (Perceived Survival Expectations, PSE) as a predictor of suicidal ideation, suicide attempt and substance use in young adulthood. We examined the predictive capacity of PSE on future suicidal ideation/attempt after accounting for sociodemographics, depressive symptoms, and history of suicide among family and friends to more fully assess its unique contribution to suicide risk. We investigated the influence of PSE on legal and illegal substance use and varying levels of substance use. We utilized the National Longitudinal Study of Adolescent Health (Add Health) initiated in 1994-95 among 20,745 adolescents in grades 7-12 with follow-up interviews in 1996 (Wave II), 2001-02 (Wave III) and 2008 (Wave IV; ages 24-32). Compared to those who were almost certain of living to age 35, perceiving a 50-50 or less chance of living to age 35 at Waves I or III predicted suicide attempt and ideation as well as regular substance use (i.e., exceeding daily limits for moderate drinking; smoking >= a pack/day; and using illicit substances other than marijuana at least weekly) at Wave IV. Associations between PSE and detrimental adult outcomes were particularly strong for those reporting persistently low PSE at both Waves I and III. Low PSE at Wave I or Wave III was also related to a doubling and tripling, respectively, of death rates in young adulthood. Long-term and wide-ranging ties between PSE and detrimental outcomes suggest these expectations may contribute to identifying at-risk youth.	[Nguyen, Quynh C.; Villaveces, Andres; Marshall, Stephen W.; Poole, Charles] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Villaveces, Andres; Marshall, Stephen W.] Univ N Carolina, UNC Injury Prevent Res Ctr, Chapel Hill, NC USA; [Hussey, Jon M.; Halpern, Carolyn T.] UNC Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; [Hussey, Jon M.; Halpern, Carolyn T.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nguyen, QC (corresponding author), Northeastern Univ, Inst Urban Hlth Res, Bouve Coll Hlth Sci, Boston, MA 02115 USA.	qu.nguyen@neu.edu	Hussey, Jon/A-9352-2009	Hussey, Jon/0000-0003-1799-9845; Villaveces, Andres/0000-0002-3725-2741; Marshall, Stephen/0000-0002-2664-9233	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD050924] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill. Add Health was funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design of Add Health. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth).	[Anonymous], J PRIMARY PREVENTION, DOI DOI 10.1023/A:1021302302085; Arias E., 2002, US LIFE TABLES 2000; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bolland JM, 2003, J ADOLESCENCE, V26, P145, DOI 10.1016/S0140-1971(02)00136-7; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Borowsky IW, 2009, PEDIATRICS, V124, pE81, DOI 10.1542/peds.2008-3425; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Centers for Disease Control and Prevention, 2009, SUICIDE; Cooper M.L., 1992, PSYCHOL ASSESS J CON, V4, P123, DOI DOI 10.1037/1040-3590.4.2.123; Crosby RA, 1996, J SCHOOL HEALTH, V66, P186, DOI 10.1111/j.1746-1561.1996.tb06273.x; de Bruin WB, 2000, ORGAN BEHAV HUM DEC, V81, P115, DOI 10.1006/obhd.1999.2868; Department of Health and Human Services/Department of Agriculture, 2005, DIET GUID AM; DuBois DL, 2002, AM J COMMUN PSYCHOL, V30, P157, DOI 10.1023/A:1014628810714; Duke NN, 2011, J PEDIATR HEALTH CAR, V25, P224, DOI 10.1016/j.pedhc.2010.03.004; Duke NN, 2011, CLIN PEDIATR, V50, P21, DOI 10.1177/0009922810379041; Duke NN, 2009, ACAD PEDIATR, V9, P256, DOI 10.1016/j.acap.2009.02.004; Ezzati M., 2004, COMP QUANTIFICATION; Flannery DJ, 2001, J AM ACAD CHILD PSY, V40, P435, DOI 10.1097/00004583-200104000-00012; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Harris K. M., 2009, NATL LONGITUDINAL ST; Jaffee WB, 2009, BEHAV THER, V40, P93, DOI 10.1016/j.beth.2008.03.001; Jamieson PE, 2008, J ADOLESCENT HEALTH, V42, P154, DOI 10.1016/j.jadohealth.2007.07.010; Johnston LD, 2008, MONITORING FUTURE NA, VII; Marshall MM, 2011, ADDICT BEHAV, V36, P61, DOI 10.1016/j.addbeh.2010.08.022; McDade TW, 2011, SOC SCI MED, V73, P391, DOI 10.1016/j.socscimed.2011.06.005; McLauchlin JA, 1996, J ADOLESCENCE, V19, P523, DOI 10.1006/jado.1996.0051; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Millstein SG, 2002, J RES ADOLESCENCE, V12, P399, DOI 10.1111/1532-7795.00039; National Institute of Mental Health, 2010, SUIC US STAT PREV; Nguyen QC, 2012, SOC SCI MED, V74, P1452, DOI 10.1016/j.socscimed.2012.01.006; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Palmer RHC, 2009, DRUG ALCOHOL DEPEN, V102, P78, DOI 10.1016/j.drugalcdep.2009.01.012; Panzarella C, 2006, COGNITIVE THER RES, V30, P307, DOI 10.1007/s10608-006-9048-3; Patrick ME, 2011, J STUD ALCOHOL DRUGS, V72, P106, DOI 10.15288/jsad.2011.72.106; PETERSON C, 1987, J PERS SOC PSYCHOL, V53, P603, DOI 10.1037/0022-3514.53.3.603; PETRAITIS J, 1995, PSYCHOL BULL, V117, P67, DOI 10.1037/0033-2909.117.1.67; QUADREL MJ, 1993, AM PSYCHOL, V48, P102, DOI 10.1037/0003-066X.48.2.102; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Stone AL, 2012, ADDICT BEHAV, V37, P747, DOI 10.1016/j.addbeh.2012.02.014; *SUBST AB MENT HLT, 2005, RES 2004 NAT SURV DR; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Valadez-Meltzer A, 2005, PEDIATRICS, V116, P24, DOI 10.1542/peds.2004-0892; Vartanian LR, 2000, ADOLESCENCE, V35, P639	46	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41905	10.1371/journal.pone.0041905	http://dx.doi.org/10.1371/journal.pone.0041905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984SU	22870260	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800042
J	Zhang, C; Niu, WB; Wang, ZP; Wang, XX; Xia, GL				Zhang, Cheng; Niu, Wanbao; Wang, Zhengpin; Wang, Xiaoxia; Xia, Guoliang			The Effect of Gonadotropin on Glucose Transport and Apoptosis in Rat Ovary	PLOS ONE			English	Article							FOLLICULAR DEVELOPMENT; GENE-EXPRESSION; GNRH RECEPTOR; GLUT-4; GRANULOSA; INSULIN; MUSCLE; CELLS; ACID	Although the effects of Gonadotropin on ovarian physiology have been known for many decades, its action on glucose uptake in the rat ovary remained poorly understood. Evidence also suggests that glucose uptake is mediated by a number of glucose transporter proteins (Glut). Therefore, we examined the rat ovary for the presence of Glut1-4 and blood glucose level after eCG (equine chorionic gonadotropin) and anti-eCG antiserum treatment. All of the glucose transports were present in the ovarian oocyte, granulosa cells and theca cells in different stage follicles. The expression of Glut in ovary was up-regulated by eCG, however, anti-eCG antiserum reversed eCG action. Western blot analysis also demonstrated the content of Glut1 was higher in eCG treatment group compared with anti-eCG antiserum and control group. The same tendency was shown in other glut isoforms. Moreover, there were no significant difference between the anti-eCG antiserum and control group. In additional, the level of serum glucose in eCG treatment group was significantly higher than others, which is similar with glut expression pattern. High glucose level in blood is correlated with increased expression of glucose transporter proteins in rat ovary. Meanwhile, anti-eCG antiserum increased granulosa cell apoptosis in antral follicle compared with those in eCG group. Our observations provide potential explanation for the effects of Glut on follicular development in rat ovary and a role for eCG in the regulation of ovarian glucose uptake.	[Zhang, Cheng; Wang, Xiaoxia] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Niu, Wanbao; Wang, Zhengpin; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	Capital Normal University; China Agricultural University	Zhang, C (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	wxx@mail.cnu.edu.cn; glxiachina@sohu.com	Wang, Zhengpin/AAM-3021-2020	Xia, Guoliang/0000-0003-3674-0142; Wang, Zhengpin/0000-0001-5388-1516	China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research; National Natural Science Foundation of China [81061120522]	China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the China-Canada Joint Health Research Initiative of the Canadian Institutes of Health Research and the National Natural Science Foundation of China (Project number: 81061120522 to GLX and BKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanderson C, 2010, J STEROID BIOCHEM, V122, P82, DOI 10.1016/j.jsbmb.2009.10.006; ASANO T, 1991, CANCER RES, V51, P4450; Bartlewski PM, 2000, ANIM REPROD SCI, V58, P273, DOI 10.1016/S0378-4320(99)00092-5; Berry GT, 2005, MOL GENET METAB, V86, P473, DOI 10.1016/j.ymgme.2005.09.010; BILL CH, 1981, BIOL REPROD, V24, P913, DOI 10.1095/biolreprod24.4.913; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Fujimoto E, 2010, J PHYSIOL SCI, V60, P95, DOI 10.1007/s12576-009-0072-4; Hagi Akifumi, 2000, Journal of Medical Investigation, V47, P19; Harris VM, 2012, J ENDOCRINOL, V212, P139, DOI 10.1530/JOE-11-0359; Hirshfield AN, 1997, ENVIRON MOL MUTAGEN, V29, P10; Kato H, 2002, ANTICANCER RES, V22, P2635; Kim JM, 1998, BIOL REPROD, V58, P1170, DOI 10.1095/biolreprod58.5.1170; Kind KL, 2005, MOL REPROD DEV, V70, P37, DOI 10.1002/mrd.20183; Kodaman PH, 1999, ENDOCRINOLOGY, V140, P3659, DOI 10.1210/en.140.8.3659; Kol S, 1997, J CLIN INVEST, V99, P2274, DOI 10.1172/JCI119403; Kuo CH, 2004, J APPL PHYSIOL, V96, P621, DOI 10.1152/japplphysiol.00830.2003; Lee AD, 1997, AM J PHYSIOL-CELL PH, V273, pC1082, DOI 10.1152/ajpcell.1997.273.3.C1082; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; Nishimoto H, 2006, J ENDOCRINOL, V188, P111, DOI 10.1677/joe.1.06210; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Peyron-Caso E, 2002, HORM METAB RES, V34, P360, DOI 10.1055/s-2002-33467; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Schirman-Hildesheim TD, 2005, ENDOCRINOLOGY, V146, P3401, DOI 10.1210/en.2005-0240; Stokkel MPM, 2002, J CANCER RES CLIN, V128, P393, DOI 10.1007/s00432-002-0350-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wang L, 2009, ENDOCR PATHOL, V20, P227, DOI 10.1007/s12022-009-9086-y; Weissman A, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2007.01.119; WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2525, DOI 10.1073/pnas.88.6.2525; Williams SA, 2001, REPRODUCTION, V122, P947, DOI 10.1530/rep.0.1220947; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Zhan T, 2011, J CELL BIOCH; Zhang Cheng, 2011, Front Biosci (Elite Ed), V3, P1401; Zhou J, 2000, GROWTH HORM IGF RES, V10, P111, DOI 10.1054/ghir.2000.0147; Zhou Shui-hong, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P623	38	19	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42406	10.1371/journal.pone.0042406	http://dx.doi.org/10.1371/journal.pone.0042406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870326	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800089
J	Schowalter, RM; Reinhold, WC; Buck, CB				Schowalter, Rachel M.; Reinhold, William C.; Buck, Christopher B.			Entry Tropism of BK and Merkel Cell Polyomaviruses in Cell Culture	PLOS ONE			English	Article							JC-VIRUS; PAPILLOMAVIRUS CAPSIDS; HEPARAN-SULFATE; GROWTH-FACTOR; IN-VITRO; CARCINOMA; RECEPTOR; DNA; LINE; IDENTIFICATION	Merkel Cell Polyomavirus (MCV or MCPyV) was recently discovered in an aggressive form of skin cancer known as Merkel cell carcinoma (MCC). Integration of MCV DNA into the host genome likely contributes to the development of MCC in humans. MCV infection is common and many healthy people shed MCV virions from the surface of their skin. MCV DNA has also been detected in samples from a variety of other tissues. Although MCC tumors serve as a record that MCV can infect the Merkel cell lineage, the true tissue tropism and natural reservoirs of MCV infection in the host are not known. In an effort to gain insight into the tissue tropism of MCV, and to possibly identify cellular factors responsible for mediating infectious entry of the virus, the infection potential of human cells derived from a variety of tissues was evaluated. MCV gene transfer vectors (pseudoviruses) carrying reporter plasmid DNA encoding GFP or luciferase genes were used to transduce keratinocytes and melanocytes, as well as lines derived from MCC tumors and the NCI-60 panel of human tumor cell lines. MCV transduction was compared to transduction with pseudoviruses based on the better-studied human BK polyomavirus (BKV). The efficiency of MCV and BKV transduction of various cell types occasionally overlapped, but often differed greatly, and no clear tissue type preference emerged. Application of native MCV virions to a subset of highly transducible cell types suggested that the lines do not support robust replication of MCV, consistent with recent proposals that the MCV late phase may be governed by cellular differentiation in vivo. The availability of carefully curated gene expression data for the NCI-60 panel should make the MCV and BKV transduction data for these lines a useful reference for future studies aimed at elucidation of the infectious entry pathways of these viruses.	[Schowalter, Rachel M.; Buck, Christopher B.] NCI, Tumor Virus Mol Biol Sect, Cellular Oncol Lab, Bethesda, MD 20892 USA; [Reinhold, William C.] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schowalter, RM (corresponding author), NCI, Tumor Virus Mol Biol Sect, Cellular Oncol Lab, Bethesda, MD 20892 USA.	buckc@mail.nih.gov	Buck, Christopher/G-8358-2017; Reinhold, William/J-6704-2017	Buck, Christopher/0000-0003-3165-8094; Reinhold, William/0000-0001-5513-9323	Intramural Research Program of National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011090, ZIABC011460] Funding Source: NIH RePORTER	Intramural Research Program of National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bluemn EG, 2009, J CLIN VIROL, V44, P164, DOI 10.1016/j.jcv.2008.11.008; Boldorini R, 2005, ARCH PATHOL LAB MED, V129, P69; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Broekema NM, 2012, VIROLOGY, V422, P235, DOI 10.1016/j.virol.2011.10.026; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022468; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; GARDNER SD, 1971, LANCET, V1, P1253; Ghez D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-99; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105; HOGAN TF, 1980, J CLIN MICROBIOL, V11, P178, DOI 10.1128/JCM.11.2.178-183.1980; HOLTHOFER H, 1994, KIDNEY INT, V45, P123, DOI 10.1038/ki.1994.14; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Husseiny MI, 2010, J CLIN VIROL, V49, P137, DOI 10.1016/j.jcv.2010.06.017; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kiasari BA, 2011, J MED VIROL, V83, P2220, DOI 10.1002/jmv.22222; KNOWLES WA, 1989, J MED VIROL, V28, P118, DOI 10.1002/jmv.1890280212; Low JA, 2006, J VIROL, V80, P1361, DOI 10.1128/JVI.80.3.1361-1366.2006; Margolis L, 1998, FEBS LETT, V433, P5, DOI 10.1016/S0014-5793(98)00858-8; Mertz KD, 2010, J INVEST DERMATOL, V130, P1146, DOI 10.1038/jid.2009.392; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Pastrana DV, 2010, VIROLOGY, V405, P20, DOI 10.1016/j.virol.2010.06.022; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Ramos E, 2009, TRANSPLANTATION, V87, P621, DOI 10.1097/TP.0b013e318197c17d; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; ROSEN ST, 1987, LAB INVEST, V56, P302; Rubin J, 2011, ANTICANCER RES, V31, P3489; Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Singh HK, 2006, ADV EXP MED BIOL, V577, P201; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Wang TS, 2011, SEMIN CUTAN MED SURG, V30, P48, DOI 10.1016/j.sder.2011.02.001; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575; WINTERBOURNE DJ, 1981, J BIOL CHEM, V256, P4310; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317	59	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42181	10.1371/journal.pone.0042181	http://dx.doi.org/10.1371/journal.pone.0042181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860078	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600069
J	Stebbing, J; Filipovic, A; Lit, LC; Blighe, K; Grothey, A; Xu, Y; Miki, Y; Chow, LW; Coombes, RC; Sasano, H; Shaw, JA; Giamas, G				Stebbing, J.; Filipovic, A.; Lit, L. C.; Blighe, K.; Grothey, A.; Xu, Y.; Miki, Y.; Chow, L. W.; Coombes, R. C.; Sasano, H.; Shaw, J. A.; Giamas, G.			LMTK3 is implicated in endocrine resistance via multiple signaling pathways	ONCOGENE			English	Article						LMTK3; breast cancer; estrogen receptor; endocrine resistance; HSPB8; oncogene	BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; CYCLIN D1; IN-VITRO; EXPRESSION; KINASE; TUMORIGENESIS; RECURRENCE; ACTIVATION; TAMOXIFEN	Resistance to endocrine therapy in breast cancer is common. With the aim of discovering new molecular targets for breast cancer therapy, we have recently identified LMTK3 as a regulator of the estrogen receptor-alpha (ER alpha) and wished to understand its role in endocrine resistance. We find that inhibition of LMTK3 in a xenograft tamoxifen (Tam)-resistant (BT474) breast cancer mouse model results in re-sensitization to Tam as demonstrated by a reduction in tumor volume. A whole genome microarray analysis, using a BT474 cell line, reveals genes significantly modulated (positively or negatively) after LMTK3 silencing, including some that are known to be implicated in Tam resistance, notably c-MYC, HSPB8 and SIAH2. We show that LMTK3 is able to increase the levels of HSPB8 at a transcriptional and translational level thereby protecting MCF7 cells from Tam-induced cell death, by reducing autophagy. Finally, high LMTK3 levels at baseline in tumors are predictive for endocrine resistance; therapy does not lead to alteration in levels, whereas in patient's plasma samples, acquired LMTK3 gene amplification (copy number variation) was associated with relapse while receiving Tam. In aggregate, these data support a role for LMTK3 in both innate (intrinsic) and acquired (adaptive) endocrine resistance in breast cancer.	[Stebbing, J.; Filipovic, A.; Lit, L. C.; Grothey, A.; Xu, Y.; Coombes, R. C.; Giamas, G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus, London W12 0NN, England; [Blighe, K.; Shaw, J. A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Miki, Y.; Chow, L. W.; Sasano, H.] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Chow, L. W.] Comprehens Ctr Breast Dis, UNIMED Med Inst, Hong Kong, Hong Kong, Peoples R China	Imperial College London; University of Leicester; Tohoku University	Giamas, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England.	g.giamas@imperial.ac.uk	LIT, LEI CHENG/B-8875-2010; Giamas, Georgios/AAP-3487-2021; Lit, Lei Cheng/AAS-9778-2021	LIT, LEI CHENG/0000-0002-3210-4491; Lit, Lei Cheng/0000-0002-3210-4491; Coombes, Raoul Charles/0000-0002-4811-1100; Blighe, Kevin/0000-0002-6322-6571; Shaw, Jacqui/0000-0003-4227-503X; Giamas, Georgios/0000-0002-4417-2707; Stebbing, Justin/0000-0002-1117-6947	Grants for Targets (G4T) program of Bayer Healthcare; Cancer Research UK; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; R & E Girling and friends; Pink Ribbon Foundation; Imperial BRC; ECMC; MRC [MR/L000172/1] Funding Source: UKRI; Cancer Research UK [13462, 14549, 12011] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Grants for Targets (G4T) program of Bayer Healthcare; Cancer Research UK(Cancer Research UK); UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; R & E Girling and friends; Pink Ribbon Foundation; Imperial BRC; ECMC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank Champions Biotechnology, in particular David Sidransky and Elizabeth Bruckheimer for their expertise and help with the mouse xenograft model (Johns Hopkins, Baltimore, USA), P Trivedi for performing the immunohistochemistry staining (Imperial College) and Katsuhiko Ono for technical assistance (Tohoku University). We are grateful to Richard Szydlo (Imperial College) for statistical advice. We thank Martina Sperling for performing the Illumina microarray hybridizations. We thank Luisella Toschi, Anette Sommer, and Georg Beckmann (Bayer, Berlin, Germany) for their significant input in both the experimental design and analysis of the gene expression profiling experiments and the selection of cell lines, without which this work could not have been undertaken. The project was supported by a grant from the Grants for Targets (G4T) program of Bayer Healthcare. JS, JAS, RCC and GG are supported by grants from Cancer Research UK. This work has been supported by a UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant to GG. We thank R & E Girling and friends, Cancer Research UK and the Pink Ribbon Foundation for their support. This work was also supported by the Imperial BRC and ECMC.	Agoulnik IU, 2011, ONCOTARGET, V2, P321; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Chanplakorn N, BREAST CANC RES TREA, V120, P639; Chow LWC, 2008, J STEROID BIOCHEM, V111, P13, DOI 10.1016/j.jsbmb.2008.04.004; Cook KL, 2011, EXPERT REV ANTICANC, V11, P1283, DOI [10.1586/ERA.11.111, 10.1586/era.11.111]; Cordera F, 2006, SEMIN ONCOL, V33, P631, DOI 10.1053/j.seminoncol.2006.08.020; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Dixon JM, 2005, CLIN EVID, p[13, 2226]; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Giamas G, 2007, PHARMACOGENOMICS, V8, P1005, DOI 10.2217/14622416.8.8.1005; Giamas G, 2011, NAT MED, V17, P715, DOI 10.1038/nm.2351; Giamas G, 2010, CELL SIGNAL, V22, P984, DOI 10.1016/j.cellsig.2010.01.011; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Guo SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021467; Harrington WR, 2006, ENDOCRINOLOGY, V147, P3843, DOI 10.1210/en.2006-0358; Hu DG, 2009, MOL PHARMACOL, V76, P425, DOI 10.1124/mol.109.057380; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liguori L, 2012, CELL CYCLE, V11, P569, DOI 10.4161/cc.11.3.19063; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller TW, CLIN CANC RES, V17, P2024; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Oshima T, 2011, BIOL PHARM BULL, V34, P54, DOI 10.1248/bpb.34.54; Paroni G, 2011, ONCOGENE; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Schafer JM, 2006, METH MOLEC MED, V120, P453; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Stebbing J, 2007, CLIN EVID, V2007; Stebbing J, 2007, PHARMACOGENOMICS, V8, P1, DOI 10.2217/14622416.8.1.1; Stebbing J, 2012, BREAST CANCER RES TR, V132, P537, DOI 10.1007/s10549-011-1622-z; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Sun X, 2007, CELL STRESS CHAPERON, V12, P307, DOI 10.1379/CSC-276.1; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Wilson CG, 2011, FEBS LETT, V585, P2137, DOI 10.1016/j.febslet.2011.05.059; Xu J, 2012, BREAST CANC RES TREA; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	46	34	38	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 11	2013	32	28					3371	3380		10.1038/onc.2012.343	http://dx.doi.org/10.1038/onc.2012.343			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22869149				2022-12-25	WOS:000321620200007
J	Maamary, PG; Ben Zakour, NL; Cole, JN; Hollands, A; Aziz, RK; Barnett, TC; Cork, AJ; Henningham, A; Sanderson-Smith, M; McArthur, JD; Venturini, C; Gillen, CM; Kirk, JK; Johnson, DR; Taylor, WL; Kaplan, EL; Kotb, M; Nizet, V; Beatson, SA; Walker, MJ				Maamary, Peter G.; Ben Zakour, Nouri L.; Cole, Jason N.; Hollands, Andrew; Aziz, Ramy K.; Barnett, Timothy C.; Cork, Amanda J.; Henningham, Anna; Sanderson-Smith, Martina; McArthur, Jason D.; Venturini, Carola; Gillen, Christine M.; Kirk, Joshua K.; Johnson, Dwight R.; Taylor, William L.; Kaplan, Edward L.; Kotb, Malak; Nizet, Victor; Beatson, Scott A.; Walker, Mark J.			Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone	FASEB JOURNAL			English	Article						Streptococcus pyogenes; virulence factors; reemergent pathogens	PYROGENIC EXOTOXIN; PLASMINOGEN BINDING; MOLECULAR ANALYSIS; M-PROTEIN; IN-VIVO; VIRULENCE; PYOGENES; INFECTIONS; EXPRESSION; SEQUENCE	The past 50 years has witnessed the emergence of new viral and bacterial pathogens with global effect on human health. The hyperinvasive group A Streptococcus (GAS) M1T1 clone, first detected in the mid-1980s in the United States, has since disseminated worldwide and remains a major cause of severe invasive human infections. Although much is understood regarding the capacity of this pathogen to cause disease, much less is known of the precise evolutionary events selecting for its emergence. We used high-throughput technologies to sequence a World Health Organization strain collection of serotype M1 GAS and reconstructed its phylogeny based on the analysis of core genome single-nucleotide polymorphisms. We demonstrate that acquisition of a 36-kb genome segment from serotype M12 GAS and the bacteriophage-encoded DNase Sda1 led to increased virulence of the M1T1 precursor and occurred relatively early in the molecular evolutionary history of this strain. The more recent acquisition of the phage-encoded superantigen SpeA is likely to have provided selection advantage for the global dissemination of the M1T1 clone. This study provides an exemplar for the evolution and emergence of virulent clones from microbial populations existing commensally or causing only superficial infection.-Maamary, P. G., Ben Zakour, N. L., Cole, J. N., Hollands, A., Aziz, R. K., Barnett, T. C., Cork, A. J., Henningham, A., Sanderson-Smith, M., McArthur, J. D., Venturini, C., Gillen, C. M., Kirk, J. K., Johnson, D. R., Taylor, W. L., Kaplan, E. L., Kotb, M., Nizet, V., Beatson, S. A., Walker, M. J. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. FASEB J. 26, 4675-4684 (2012). www.fasebj.org	[Maamary, Peter G.; Ben Zakour, Nouri L.; Hollands, Andrew; Barnett, Timothy C.; Cork, Amanda J.; Henningham, Anna; Venturini, Carola; Gillen, Christine M.; Beatson, Scott A.; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Maamary, Peter G.; Ben Zakour, Nouri L.; Cole, Jason N.; Hollands, Andrew; Barnett, Timothy C.; Cork, Amanda J.; Henningham, Anna; Venturini, Carola; Gillen, Christine M.; Beatson, Scott A.; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Maamary, Peter G.; Cole, Jason N.; Hollands, Andrew; Cork, Amanda J.; Henningham, Anna; Sanderson-Smith, Martina; McArthur, Jason D.; Kirk, Joshua K.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Hollands, Andrew] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Aziz, Ramy K.] San Diego State Univ, San Diego, CA 92182 USA; [Johnson, Dwight R.; Kaplan, Edward L.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Johnson, Dwight R.; Kaplan, Edward L.] Univ Minnesota, World Hlth Org Collaborating Ctr Reference & Res, Minneapolis, MN 55455 USA; [Taylor, William L.; Kotb, Malak] Univ Tennessee, Mol Resource Ctr, Memphis, TN USA; [Kotb, Malak] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA; [Kotb, Malak] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA	University of Queensland; University of Queensland; University of Wollongong; University of California System; University of California San Diego; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Cairo University; California State University System; San Diego State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; World Health Organization; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Cooper Rd, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Nizet, Victor/AAF-3190-2019; Venturini, Carola/G-6642-2018; Barnett, Timothy/G-2155-2011; Gillen, Christine M/A-2717-2014; Cork, Amanda/C-3830-2012; Walker, Mark J./F-6940-2011; Sanderson-Smith, Martina L/H-9614-2013; Henningham, Anna/C-7355-2017; Sanderson-Smith, Martina/O-9387-2019; ZAKOUR, Nouri L BEN/B-9338-2011; Beatson, Scott/B-6985-2013; Aziz, Ramy/B-2918-2009	Venturini, Carola/0000-0003-2370-8661; Barnett, Timothy/0000-0002-3346-5117; Cork, Amanda/0000-0003-2207-6877; Sanderson-Smith, Martina L/0000-0002-6366-4993; Henningham, Anna/0000-0002-0554-6593; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Beatson, Scott/0000-0002-1806-3283; Duplancic, Christine/0000-0002-1775-3055; Aziz, Ramy/0000-0002-4448-7100; Walker, Mark/0000-0001-7423-2769; Nizet, Victor/0000-0003-3847-0422	Australian postgraduate award; Australian National Health and Medical Research Council (NHMRC); NHMRC; Medical Research Service, Department of Veterans Affairs; U.S. National Institutes of Health [AI077780]; NHMRC of Australia [573401]; Australian International Science Linkages grant [CG110095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	Australian postgraduate award(Australian Government); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian International Science Linkages grant(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	P.M. is the recipient of an Australian postgraduate award. J.C. and A. H. are recipients of Australian National Health and Medical Research Council (NHMRC) Overseas Biomedical Training Fellowships. M. S. S. is the recipient of an NHMRC Career Development Fellowship. This work was funded by Medical Research Service, Department of Veterans Affairs (M. K.), U.S. National Institutes of Health grant AI077780 (V.N., M. W.), NHMRC of Australia grant 573401 (M. W.), and Australian International Science Linkages grant CG110095 (M. W., M. K., V.N.).	Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Baquero F, 2011, J ANTIMICROB CHEMOTH, V66, P1659, DOI 10.1093/jac/dkr214; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; IMANISHI K, 1992, INFECT IMMUN, V60, P5025, DOI 10.1128/IAI.60.12.5025-5029.1992; Johnson DR, 2002, J INFECT DIS, V185, P1586, DOI 10.1086/340576; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; KOTB M, 1995, CLIN MICROBIOL REV, V8, P411, DOI 10.1128/CMR.8.3.411; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maamary PG, 2010, J INNATE IMMUN, V2, P596, DOI 10.1159/000317640; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NELSON K, 1991, J EXP MED, V174, P1271, DOI 10.1084/jem.174.5.1271; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Ramachandran V, 2004, J BACTERIOL, V186, P7601, DOI 10.1128/JB.186.22.7601-7609.2004; Rogers S, 2007, J INFECT DIS, V195, P1625, DOI 10.1086/513875; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sriskandan S, 1999, MOL MICROBIOL, V33, P778, DOI 10.1046/j.1365-2958.1999.01525.x; Sriskandan S, 2001, J INFECT DIS, V184, P166, DOI 10.1086/322018; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; TOMAI MA, 1992, INFECT IMMUN, V60, P701, DOI 10.1128/IAI.60.2.701-705.1992; Unnikrishnan M, 2001, MICROB PATHOGENESIS, V31, P109, DOI 10.1006/mpat.2001.0453; Vlaminckx BJM, 2007, INFECT IMMUN, V75, P3673, DOI 10.1128/IAI.01695-06; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	50	42	42	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4675	4684		10.1096/fj.12-212142	http://dx.doi.org/10.1096/fj.12-212142			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22878963	Green Published			2022-12-25	WOS:000310574200028
J	Onarheim, KH; Tessema, S; Johansson, KA; Eide, KT; Norheim, OF; Miljeteig, I				Onarheim, Kristine Husoy; Tessema, Solomon; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid			Prioritizing Child Health Interventions in Ethiopia: Modeling Impact on Child Mortality, Life Expectancy and Inequality in Age at Death	PLOS ONE			English	Article							LIVES SAVED TOOL; MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; PUBLIC-HEALTH; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; NEWBORN; COUNTDOWN; SURVIVAL; AFRICA	Background: The fourth Millennium Development Goal calls for a two-thirds reduction in under-5 mortality between 1990 and 2015. Under-5 mortality rate is declining, but many countries are still far from achieving the goal. Effective child health interventions that could reduce child mortality exist, but national decision-makers lack contextual information for priority setting in their respective resource-constrained settings. We estimate the potential health impact of increasing coverage of 14 selected health interventions on child mortality in Ethiopia (2011-2015). We also explore the impact on life expectancy and inequality in the age of death (Gini(health)). Methods and Findings: We used the Lives Saved Tool to estimate potential impact of scaling-up 14 health interventions in Ethiopia (2011-2015). Interventions are scaled-up to 1) government target levels, 2) 90% coverage and 3) 90% coverage of the five interventions with the highest impact. Under-5 mortality rate, neonatal mortality rate and deaths averted are primary outcome measures. We used modified life tables to estimate impact on life expectancy at birth and inequality in the age of death (Gini(health)). Under-5 mortality rate declines from 101.0 in 2011 to 68.8, 42.1 and 56.7 per 1000 live births under these three scenarios. Prioritizing child health would also increase life expectancy at birth from expected 60.5 years in 2015 to 62.5, 64.2 and 63.4 years and reduce inequality in age of death (Gini(health)) substantially from 0.24 to 0.21, 0.18 and 0.19. Conclusions: The Millennium Development Goal for child health is reachable in Ethiopia. Prioritizing child health would also increase total life expectancy at birth and reduce inequality in age of death substantially (Gini(health)).	[Onarheim, Kristine Husoy; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid] Univ Bergen, Res Grp Global Hlth, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Onarheim, Kristine Husoy; Johansson, Kjell Arne; Eide, Kristiane Tislevoll; Norheim, Ole Frithjof; Miljeteig, Ingrid] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Tessema, Solomon] Int Ctr AIDS Care & Treatment Programs ICAP Ethio, Addis Ababa, Ethiopia	University of Bergen; University of Bergen	Onarheim, KH (corresponding author), Univ Bergen, Res Grp Global Hlth, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	kristine.onarheim@isf.uib.no	Johansson, Kjell Arne/ABE-3628-2020; Miljeteig, Ingrid/AAW-8728-2020; Norheim, Ole Frithjof/AAC-8771-2020	Johansson, Kjell Arne/0000-0001-8912-8710; Norheim, Ole Frithjof/0000-0002-5748-5956; Onarheim, Kristine Husoy/0000-0001-8796-4782	Medical Students Research Program/Norwegian Research Council; NORAD/Norwegian Research Council [218694]; University of Bergen	Medical Students Research Program/Norwegian Research Council; NORAD/Norwegian Research Council; University of Bergen	This study was funded through the Medical Students Research Program/the Norwegian Research Council, a NORAD/Norwegian Research Council grant (#218694) and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; [Anonymous], 2011, WORLD HLTH STAT; Baeza C, 2011, ACCOUNTABILITY IMPAC; Baltussen R, 2011, TROP MED INT HEALTH, V16, P838, DOI 10.1111/j.1365-3156.2011.02780.x; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bill and Melinda Gates Foundation, DEC VACC; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Brock DW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P259; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chiang CL, 1968, LIFE TABLE ITS CONST, P189; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Daniels N., 2007, JUST HLTH M HLTH NEE; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; EPGDC, 2019, ENV PROT GREEN DEV C; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, HLTH SECT DEV PROGR; Foster J., 2007, EC INEQUALITY; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Futures Institute, ONEHEALTH TOOL; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jimenez J, 2007, HEALTH AFFAIR, V26, P458, DOI 10.1377/hlthaff.26.2.458; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; KNIPPENBERG R, 2004, MARGINAL BUDGETING B; LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4; Ministry of Finance and Economic Development Ethiopia, 2006, PLAN ACC SUST DEV EN; Norheim OF, 1999, BRIT MED J, V319, P1426, DOI 10.1136/bmj.319.7222.1426; Norheim OF, 2010, GINI IMPACT ANAL MEA; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Robberstad B, 2011, SOC SCI MED, V72, P1711, DOI 10.1016/j.socscimed.2011.03.032; Rudan I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000308; Smits J, 2009, SOC SCI MED, V68, P1114, DOI 10.1016/j.socscimed.2008.12.034; Steinglass R, 2011, INT J EPIDEMIOL, V40, P519, DOI 10.1093/ije/dyq173; UNAIDS/WHO, 2008, EP FACT SHEET HIV AI; UNDP, 2011, HUM DEV REP; Wagstaff A, 2002, J HEALTH ECON, V21, P627, DOI 10.1016/S0167-6296(02)00006-1; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; WHO, 2010, WOR HEALT REP, P1; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization, WHO CHOICE POPMOD	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41521	10.1371/journal.pone.0041521	http://dx.doi.org/10.1371/journal.pone.0041521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22879890	Green Published, gold			2022-12-25	WOS:000307437900011
J	Ormsby, CE; SenGupta, D; Tandon, R; Deeks, SG; Martin, JN; Jones, RB; Ostrowski, MA; Garrison, KE; Vazquez-Perez, JA; Reyes-Teran, G; Nixon, DF				Ormsby, Christopher E.; SenGupta, Devi; Tandon, Ravi; Deeks, Steven G.; Martin, Jeffrey N.; Jones, R. Brad; Ostrowski, Mario A.; Garrison, Keith E.; Vazquez-Perez, Joel A.; Reyes-Teran, Gustavo; Nixon, Douglas F.			Human Endogenous Retrovirus Expression Is Inversely Associated with Chronic Immune Activation in HIV-1 Infection	PLOS ONE			English	Article							T-CELL-ACTIVATION; VIRAL LOAD; ANTIRETROVIRAL TREATMENT; HERV-K; VIRUS; INDIVIDUALS; RESPONSES; THERAPY; FAMILY; RNA	Human endogenous retroviruses (HERV) are remnants of ancestral retroviral infections integrated into the germ line, and constitute approximately 8% of the genome. Several autoimmune disorders, malignancies, and infectious diseases such as HIV-1 are associated with higher HERV expression. The degree to which HERV expression in vivo results in persistent inflammation is not known. We studied the association of immune activation and HERV-K expression in 20 subjects with chronic, untreated progressive HIV-1 infection and 10 HIV-1 negative controls. The mean HERV-K gag and env RNA expression level in the HIV-1 infected cohort was higher than in the control group (p = 0.0003), and was negatively correlated with the frequency of activated CD38+HLA-DR+CD4+ T cells (Rho = -0.61; p = 0.01) and activated CD38+HLA-DR+CD8+ T cells (Rho = -0.51; p = 0.03). Although HIV-infected persons had higher levels of HERV-K RNA expression (as expected), the level of RNA expression was negatively associated with level of T cell activation. The mechanism for this unexpected association remains to be defined.	[Ormsby, Christopher E.; Vazquez-Perez, Joel A.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [SenGupta, Devi; Tandon, Ravi; Garrison, Keith E.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Deeks, Steven G.] San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA 94110 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Toronto	Ormsby, CE (corresponding author), Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico.	christopher.ormsby@cieni.org.mx	Nixon, Douglas/AAU-5734-2020; Vazquez-Perez, Joel/F-3476-2019	Nixon, Douglas/0000-0002-2801-1786; Vazquez-Perez, Joel/0000-0002-8508-3698; Reyes-Teran, Gustavo/0000-0002-4115-4888	Consejo Nacional de Ciencia y Tecnologia, Mexico [SALUD-2009-01-115265]; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); National Institutes of Health (NIH) [P30 AI027763]; University of California San Francisco (UCSF) Clinical and Translational Science Institute [UL1 RR024131]; National Institute of Allergy and Infectious Diseases (NIAID) [AI087145, AI76059, AI84113, K24AI069994]; American Foundation for AIDS Research [106710-40-RGRL]; NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS) [1 R24 AI067039-1]; Peter and Shelagh Godsoe Family Foundation; UCSF AIDS Research Institute (ARI); UC Mexus grant; Ragon Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076059, R01AI087145, P30AI027763, R56AI084113, K24AI069994, R24AI067039] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Foundation for AIDS Research; NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS); Peter and Shelagh Godsoe Family Foundation; UCSF AIDS Research Institute (ARI); UC Mexus grant; Ragon Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Ormsby was funded by Consejo Nacional de Ciencia y Tecnologia, Mexico, SALUD-2009-01-115265 and grants from the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), an National Institutes of Health (NIH) funded program (P30 AI027763) and the University of California San Francisco (UCSF) Clinical and Translational Science Institute (UL1 RR024131); Additional support was provided by National Institute of Allergy and Infectious Diseases (NIAID) (AI087145, AI76059; AI84113; K24AI069994), the American Foundation for AIDS Research (106710-40-RGRL), the NIH/NIAID CFAR Network of Integrated Clinical Systems (CNICS; grant 1 R24 AI067039-1), the Peter and Shelagh Godsoe Family Foundation, the UCSF AIDS Research Institute (ARI) the Ragon Institute, and a UC Mexus grant to Dr. Nixon, Dr. Ormsby and Dr. Reyes-Teran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arens R, 2005, J IMMUNOL, V174, P5915, DOI 10.4049/jimmunol.174.10.5915; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; Chen DY, 2011, J VIROL, V85, P2474, DOI 10.1128/JVI.01726-10; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Contreras-Galindo RA, 2011, J VIROLOGY; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Douek Daniel, 2007, Top HIV Med, V15, P114; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Esnault C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-75; Espinosa E, 2010, JAIDS-J ACQ IMM DEF, V55, P439, DOI 10.1097/QAI.0b013e3181ef991d; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Freimanis G, 2010, CLIN EXP IMMUNOL, V160, P340, DOI 10.1111/j.1365-2249.2010.04110.x; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gasser O, 2009, AM J TRANSPLANT, V9, P794, DOI 10.1111/j.1600-6143.2008.02539.x; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Harrer T, 1996, J IMMUNOL, V156, P2616; Huang W, 2010, SCHIZOPHR B; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; HUNT PW, 2011, 17 INT AIDS C MEX CI, V25, P2123, DOI DOI 10.1097/QAD.0B013E32834C4AC1; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nellaker C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44; Paiardini M, 2008, AIDS REV, V10, P36; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Ramos-Lopez E, 2006, TISSUE ANTIGENS, V68, P147, DOI 10.1111/j.1399-0039.2006.00637.x; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Stauffer Yves, 2004, Cancer Immun, V4, P2; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Tonjes RR, 1996, J ACQ IMMUN DEF SYND, V13, pS261; Tsibris AMN, 2010, J VIROL, V84, P5458, DOI 10.1128/JVI.02524-09; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Weissman D, 1996, J EXP MED, V183, P687, DOI 10.1084/jem.183.2.687; World Health Organization, 2006, WHO CAS DEF HIV SURV	55	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41021	10.1371/journal.pone.0041021	http://dx.doi.org/10.1371/journal.pone.0041021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879884	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900007
J	Bidaud, P; Hebert, L; Barbey, C; Appourchaux, AC; Torelli, R; Sanguinetti, M; Laugier, C; Petry, S				Bidaud, Pauline; Hebert, Laurent; Barbey, Corinne; Appourchaux, Anne-Cecile; Torelli, Riccardo; Sanguinetti, Maurizio; Laugier, Claire; Petry, Sandrine			Rhodococcus equi's Extreme Resistance to Hydrogen Peroxide Is Mainly Conferred by One of Its Four Catalase Genes	PLOS ONE			English	Article							OXIDATIVE STRESS; LEGIONELLA-PNEUMOPHILA; PERITONEAL-MACROPHAGES; ENTEROCOCCUS-FAECALIS; SALMONELLA VIRULENCE; IN-VITRO; SURVIVAL; EXPRESSION; INFECTION; KATA	Rhodococcus equi is one of the most widespread causes of disease in foals aged from 1 to 6 months. R. equi possesses antioxidant defense mechanisms to protect it from reactive oxygen metabolites such as hydrogen peroxide (H2O2) generated during the respiratory burst of phagocytic cells. These defense mechanisms include enzymes such as catalase, which detoxify hydrogen peroxide. Recently, an analysis of the R. equi 103 genome sequence revealed the presence of four potential catalase genes. We first constructed Delta katA-, Delta katB-, Delta katC-and Delta katD-deficient mutants to study the ability of R. equi to survive exposure to H2O2 in vitro and within mouse peritoneal macrophages. Results showed that Delta katA and, to a lesser extent Delta katC, were affected by 80 mM H2O2. Moreover, katA deletion seems to significantly affect the ability of R. equi to survive within murine macrophages. We finally investigated the expression of the four catalases in response to H2O2 assays with a real time PCR technique. Results showed that katA is overexpressed 367.9 times (+/- 122.6) in response to exposure to 50 mM of H2O2 added in the stationary phase, and 3.11 times (+/- 0.59) when treatment was administered in the exponential phase. In untreated bacteria, katB, katC and katD were overexpressed from 4.3 to 17.5 times in the stationary compared to the exponential phase. Taken together, our results show that KatA is the major catalase involved in the extreme H2O2 resistance capability of R. equi.	[Bidaud, Pauline; Hebert, Laurent; Barbey, Corinne; Appourchaux, Anne-Cecile; Laugier, Claire; Petry, Sandrine] ANSES, Unit Bacteriol & Parasitol, Dozule Lab Equine Dis, Goustranville, France; [Torelli, Riccardo; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bidaud, P (corresponding author), ANSES, Unit Bacteriol & Parasitol, Dozule Lab Equine Dis, Goustranville, France.	sandrine.petry@anses.fr	Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019; Hébert, Laurent/AAQ-1949-2021; Hébert, Laurent/GLV-5872-2022; Torelli, Riccardo/K-8822-2018	Sanguinetti, Maurizio/0000-0002-9780-7059; Hébert, Laurent/0000-0002-5738-9913; Torelli, Riccardo/0000-0001-7927-4343; PETRY, Sandrine/0000-0002-3091-575X	Regional Council of Low-Normandy; Research and Higher Education Ministry [R25_p3 (CPER 2007-2013)]; Anses and Regional Council of Low-Normandy; Institut Francais du Cheval et de l'Equitation	Regional Council of Low-Normandy(Region Normandie); Research and Higher Education Ministry; Anses and Regional Council of Low-Normandy(Region Normandie); Institut Francais du Cheval et de l'Equitation	P. Bidaud and L. Hebert were funded by a grant awarded by Regional Council of Low-Normandy and by Research and Higher Education Ministry, within the project R25_p3 (CPER 2007-2013). C. Barbey was supported by a thesis grant awarded by Anses and Regional Council of Low-Normandy. Financial support was obtained from Institut Francais du Cheval et de l'Equitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2002, J BACTERIOL, V184, P3305, DOI 10.1128/JB.184.12.3305-3312.2002; Bandyopadhyay P, 1998, J BACTERIOL, V180, P5369, DOI 10.1128/JB.180.20.5369-5374.1998; Bandyopadhyay P, 2000, J BACTERIOL, V182, P6679, DOI 10.1128/JB.182.23.6679-6686.2000; Benoit S, 2002, INFECT IMMUN, V70, P3768, DOI 10.1128/IAI.70.7.3768-3776.2002; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; DeLaPenaMoctezuma A, 1996, CAN J VET RES, V60, P29; DEMPLE B, 1983, J BACTERIOL, V153, P1079, DOI 10.1128/JB.153.2.1079-1082.1983; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devi P, 2011, INDIAN J MED MICROBI, V29, P65, DOI 10.4103/0255-0857.76529; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Frederick JR, 2001, APPL ENVIRON MICROB, V67, P1375, DOI 10.1128/AEM.67.3.1375-1379.2001; Gentry-Weeks CR, 1999, INFECT IMMUN, V67, P2160, DOI 10.1128/IAI.67.5.2160-2165.1999; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hirose I, 2000, MICROBIOL-SGM, V146, P65, DOI 10.1099/00221287-146-1-65; HONDALUS MK, 1994, INFECT IMMUN, V62, P4167, DOI 10.1128/IAI.62.10.4167-4175.1994; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Janssen R, 2003, MICROBES INFECT, V5, P527, DOI 10.1016/S1286-4579(03)00069-8; Kedlaya I, 2001, CLIN INFECT DIS, V32, pE39, DOI 10.1086/318520; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewen PC, 2000, ASM NEWS, V66, P76; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Navas J, 2001, J BACTERIOL, V183, P4796, DOI 10.1128/JB.183.16.4796-4805.2001; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; SHA ZY, 1994, J BACTERIOL, V176, P7375, DOI 10.1128/JB.176.23.7375-7377.1994; Soler-Garcia AA, 2007, INFECT IMMUN, V75, P2225, DOI 10.1128/IAI.01513-06; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P8303; Topino S, 2010, AIDS PATIENT CARE ST, V24, P211, DOI 10.1089/apc.2009.0248; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verneuil N, 2006, MICROBIOL-SGM, V152, P2579, DOI 10.1099/mic.0.28922-0; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42396	10.1371/journal.pone.0042396	http://dx.doi.org/10.1371/journal.pone.0042396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879963	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000031
J	Guyader, C; Ceraline, J; Gravier, E; Morin, A; Michel, S; Erdmann, E; de Pinieux, G; Cabon, F; Bergerat, JP; Poupon, MF; Oudard, S				Guyader, Charlotte; Ceraline, Jocelyn; Gravier, Eleonore; Morin, Aurelie; Michel, Sandrine; Erdmann, Eva; de Pinieux, Gonzague; Cabon, Florence; Bergerat, Jean-Pierre; Poupon, Marie-France; Oudard, Stephane			Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							ANDROGEN-RECEPTOR; CELL-PROLIFERATION; BREAST-CANCER; PROGRESSION; SURVIVAL; GROWTH; PHOSPHORYLATION; XENOGRAFTS; ACTIVATION; EXPRESSION	Almost all prostate cancers respond to androgen deprivation treatment but many recur. We postulated that risk of hormone escape -frequency and delay- are influenced by hormone therapy modalities. More, hormone therapies induce crucial biological changes involving androgen receptors; some might be targets for escape prevention. We investigated the relationship between the androgen deprivation treatment and the risk of recurrence using nude mice bearing the high grade, hormone-dependent human prostate cancer xenograft PAC120. Tumor-bearing mice were treated by Luteinizing-Hormone Releasing Hormone (LHRH) antagonist alone, continuous or intermittent regimen, or combined with androgen receptor (AR) antagonists (bicalutamide or flutamide). Tumor growth was monitored. Biological changes were studied as for genomic alterations, AR mutations and protein expression in a large series of recurrent tumors according to hormone therapy modalities. Therapies targeting Her-2 or AKT were tested in combination with castration. All statistical tests were two-sided. Tumor growth was inhibited by continuous administration of the LH-RH antagonist degarelix (castration), but 40% of tumors recurred. Intermittent castration or complete blockade induced by degarelix and antiandrogens combination, inhibited tumor growth but increased the risk of recurrence (RR) as compared to continuous castration (RRintermittent: 14.5, RRcomplete blockade: 6.5 and 1.35). All recurrent tumors displayed new quantitative genetic alterations and AR mutations, whatever the treatment modalities. AR amplification was found after complete blockade. Increased expression of Her-2/neu with frequent ERK/AKT activation was detected in all variants. Combination of castration with a Her2/neu inhibitor decreased recurrence risk (0.17) and combination with an mTOR inhibitor prevented it. Anti-hormone treatments influence risk of recurrence although tumor growth inhibition was initially similar. Recurrent tumors displayed genetic instability, AR mutations, and alterations of phosphorylation pathways. We postulated that Her-2/AKT pathways allowed salvage of tumor cells under castration and we demonstrated that their inhibition prevented tumor recurrence in our model.	[Guyader, Charlotte; Gravier, Eleonore; Poupon, Marie-France] Inst Curie, Translat Res Dept, Paris, France; [Ceraline, Jocelyn; Erdmann, Eva; Bergerat, Jean-Pierre] Univ Strasbourg, Signaling & Prostate Canc Grp, Strasbourg, France; [Gravier, Eleonore] Inst Curie, Dept Biostat, Paris, France; [Gravier, Eleonore] INSERM, U900, Paris, France; [Gravier, Eleonore] ParisTech, Ecole Mines Paris, Fontainebleau, France; [Morin, Aurelie; Cabon, Florence] CNRS, FRE2944, Villejuif, France; [Michel, Sandrine] BioMerieux, Biomarker Res & Validat Dept, Marcy Letoile, France; [de Pinieux, Gonzague] Hop Trousseau, Tours, France; [Oudard, Stephane] Hop Europeen Georges Pompidou, Paris, France; [Oudard, Stephane] Univ Paris 05, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); bioMerieux; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Guyader, C (corresponding author), Inst Curie, Translat Res Dept, Paris, France.	stephane.oudard@egp.aphp.fr	Cabon, Florence/B-3284-2013	Cabon, Florence/0000-0002-6149-082X; CERALINE, Jocelyn/0000-0001-6476-8797; OUDARD, Stephane/0000-0003-0893-285X	ARC; Ligue contre le cancer (Paris, France)	ARC(Australian Research Council); Ligue contre le cancer (Paris, France)	This work was supported by the ARC and the Ligue contre le cancer (Paris, France). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ARTIC funded the English editing.	[Anonymous], 1995, LANCET, V346, P265; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Ceraline J, 2003, EUR J ENDOCRINOL, V148, P99, DOI 10.1530/eje.0.1480099; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Craft N, 1999, CANCER RES, V59, P5030; Crook J. M, 2011, ASCO ANN M; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; CULIG Z, 1994, CANCER RES, V54, P5474; D'Antonio JM, 2008, PROSTATE, V68, P698, DOI 10.1002/pros.20677; DASILVA FEC, 2009, EUR UROL; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Pinieux G, 2001, AM J PATHOL, V159, P753, DOI 10.1016/S0002-9440(10)61746-4; Doehn C, 2006, IDRUGS, V9, P565; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Festuccia C, 2007, ENDOCR-RELAT CANCER, V14, P601, DOI 10.1677/ERC-07-0118; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Nupponen NN, 2000, MICROSC RES TECHNIQ, V51, P456, DOI 10.1002/1097-0029(20001201)51:5<456::AID-JEMT8>3.0.CO;2-H; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shi Y, 2006, BJU INT, V97, P170, DOI 10.1111/j.1464-410X.2006.05857.x; Steinkamp MP, 2009, CANC RES; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wen Y, 2000, CANCER RES, V60, P6841; Ye CJ, 2009, J CELL PHYSIOL, V219, P288, DOI 10.1002/jcp.21663; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458	43	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42252	10.1371/journal.pone.0042252	http://dx.doi.org/10.1371/journal.pone.0042252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879924	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000021
J	Readhead, AC; Gordon, DE; Wang, ZY; Anderson, BJ; Brousseau, KS; Kouznetsova, MA; Forgione, LA; Smith, LC; Torian, LV				Readhead, Adam C.; Gordon, Daniel E.; Wang, Zhengyan; Anderson, Bridget J.; Brousseau, Kathleen S.; Kouznetsova, Maria A.; Forgione, Lisa A.; Smith, Lou C.; Torian, Lucia V.			Transmitted Antiretroviral Drug Resistance in New York State, 2006-2008: Results from a New Surveillance System	PLOS ONE			English	Article							RECENT HIV-INFECTIONS; DUAL-TROPIC HIV-1; MULTIDRUG-RESISTANT; VIROLOGICAL FAILURE; RAPID PROGRESSION; PREVALENCE; MUTATIONS; RISK; EPIDEMIOLOGY; TRANSMISSION	Background: HIV transmitted drug resistance (TDR) is a public health concern because it has the potential to compromise antiretroviral therapy (ART) at the population level. In New York State, high prevalence of TDR in a local cohort and a multiclass resistant case cluster led to the development and implementation of a statewide resistance surveillance system. Methodology: We conducted a cross-sectional analysis of the 13,109 cases of HIV infection that were newly diagnosed and reported in New York State between 2006 and 2008, including 4,155 with HIV genotypes drawn within 3 months of initial diagnosis and electronically reported to the new resistance surveillance system. We assessed compliance with DHHS recommendations for genotypic resistance testing and estimated TDR among new HIV diagnoses. Principal Findings: Of 13,109 new HIV diagnoses, 9,785 (75%) had laboratory evidence of utilization of HIV-related medical care, and 4,155 (43%) had a genotype performed within 3 months of initial diagnosis. Of these, 11.2% (95% confidence interval [CI], 10.2%-12.1%) had any evidence of TDR. The proportion with mutations associated with any antiretroviral agent in the NNRTI, NRTI or PI class was 6.3% (5.5%-7.0%), 4.3% (3.6%-4.9%) and 2.9% (2.4%-3.4%), respectively. Multiclass resistance was observed in <1%. TDR did not increase significantly over time (p for trend = 0.204). Men who have sex with men were not more likely to have TDR than persons with heterosexual risk factor (OR 1.0 (0.77-1.30)). TDR to EFV+TDF+FTC and LPV/r+TDF+FTC regimens was 7.1% (6.3%-7.9%) and 1.4% (1.0%-1.8%), respectively. Conclusions/Significance: TDR appears to be evenly distributed and stable among new HIV diagnoses in New York State; multiclass TDR is rare. Less than half of new diagnoses initiating care received a genotype per DHHS guidelines.	[Readhead, Adam C.; Forgione, Lisa A.; Torian, Lucia V.] New York City Dept Hlth & Mental Hyg, HIV Epidemiol & Field Serv Program, New York, NY USA; [Gordon, Daniel E.; Wang, Zhengyan; Anderson, Bridget J.; Brousseau, Kathleen S.; Kouznetsova, Maria A.; Smith, Lou C.] New York State Dept Hlth, Bur HIV AIDS Epidemiol, Albany, NY USA	New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System	Readhead, AC (corresponding author), New York City Dept Hlth & Mental Hyg, HIV Epidemiol & Field Serv Program, New York, NY USA.	ltorian@health.nyc.gov	Readhead, Adam/AAK-3511-2021		Centers for Disease Control and Prevention [PS08-80202, UC62/CCU223595]; New York City government; New York state government	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); New York City government; New York state government	The analysis was supported in part by a cooperative agreement with the Centers for Disease Control and Prevention, PS08-80202, #UC62/CCU223595, and in part by New York City and New York state government funding for HIV/AIDS surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT HIV AIDS STRAT U; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Blick G, 2007, J INFECT DIS, V195, P1250, DOI 10.1086/512240; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Centers for Disease Control, 2007, ANN REP 2007; *DEP HLTH HUM SERV, 2006, GUID US ANT AG HIV 1; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Grant ECG, 2002, JAMA-J AM MED ASSOC, V287, P2360, DOI 10.1001/jama.287.18.2360; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hurt CB, 2009, ANTIVIR THER, V14, P673; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Jayaraman GC, 2006, JAIDS-J ACQ IMM DEF, V42, P86, DOI 10.1097/01.qai.0000196666.16616.fe; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; McDavid K, 2006, AIDS PATIENT CARE ST, V20, P285, DOI 10.1089/apc.2006.20.285; Mimiaga MJ, 2009, AIDS PATIENT CARE ST, V23, P825, DOI 10.1089/apc.2009.0086; New York State Department of Health, 2008, NEW YORK STAT HIV AI; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Ross L, 2007, HIV CLIN TRIALS, V8, P1, DOI 10.1310/hct0801-1; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Sohler NL, 2009, AIDS PATIENT CARE ST, V23, P775, DOI 10.1089/apc.2009.0041; SPREAD Programme, 2008, 17 INT AIDS C MEX CI, V22, P625; Torian L. V., 2006, Morbidity and Mortality Weekly Report, V55, P793; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2007, PUBLIC HEALTH REP, V122, P4, DOI 10.1177/00333549071220S102; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Youmans E, 2011, SOUTH MED J, V104, P95, DOI 10.1097/SMJ.0b013e3181fcd75b	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40533	10.1371/journal.pone.0040533	http://dx.doi.org/10.1371/journal.pone.0040533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879878	Green Published, gold			2022-12-25	WOS:000307810000005
J	Zhang, L; Ding, QY; Wang, Z				Zhang, Lang; Ding, Qingyang; Wang, Zhao			Nuclear Respiratory Factor 1 Mediates the Transcription Initiation of Insulin-Degrading Enzyme in a TATA Box-Binding Protein-Independent Manner	PLOS ONE			English	Article							RNA-POLYMERASE-II; AMYLOID BETA-PROTEIN; GENOME-WIDE ANALYSIS; DNA METHYLATION; CPG ISLANDS; GENE; PROMOTER; ASSOCIATION; NRF-1; TBP	CpG island promoters often lack canonical core promoter elements such as the TATA box, and have dispersed transcription initiation sites. Despite the prevalence of CpG islands associated with mammalian genes, the mechanism of transcription initiation from CpG island promoters remains to be clarified. Here we investigate the mechanism of transcription initiation of the CpG island-associated gene, insulin-degrading enzyme (IDE). IDE is ubiquitously expressed, and has dispersed transcription initiation sites. The IDE core promoter locates within a 32-bp region, which contains three CGGCG repeats and a nuclear respiratory factor 1 (NRF-1) binding motif. Sequential mutation analysis indicates that the NRF-1 binding motif is critical for IDE transcription initiation. The NRF-1 binding motif is functional, because NRF-1 binds to this motif in vivo and this motif is required for the regulation of IDE promoter activity by NRF-1. Furthermore, the NRF-1 binding site in the IDE promoter is conserved among different species, and dominant negative NRF-1 represses endogenous IDE expression. Finally, TATA-box binding protein (TBP) is not associated with the IDE promoter, and inactivation of TBP does not abolish IDE transcription, suggesting that TBP is not essential for IDE transcription initiation. Our studies indicate that NRF-1 mediates IDE transcription initiation in a TBP-independent manner, and provide insights into the potential mechanism of transcription initiation for other CpG island-associated genes.	[Zhang, Lang; Ding, Qingyang; Wang, Zhao] Tsinghua Univ, Prot Sci Key Lab, Minist Educ, Dept Biol Sci & Biotechnol,Sch Med, Beijing 100084, Peoples R China	Tsinghua University	Zhang, L (corresponding author), Tsinghua Univ, Prot Sci Key Lab, Minist Educ, Dept Biol Sci & Biotechnol,Sch Med, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn			National Basic Research Program (973 Project) of China [2007CB507406]; Tsinghua University Initiative Scientific Research Program [20111081143]	National Basic Research Program (973 Project) of China(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program	This work was financially supported by the National Basic Research Program (973 Project) of China (No. 2007CB507406), and the Tsinghua University Initiative Scientific Research Program (20111081143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Authier F, 1996, CLIN INVEST MED, V19, P149; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Blesa JR, 2008, BIOCHEM CELL BIOL, V86, P46, DOI [10.1139/O07-151, 10.1139/o07-151]; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; COOPER DN, 1983, HUM GENET, V64, P315, DOI 10.1007/BF00292363; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; GOMEZCUADRADO A, 1995, MOL CELL BIOL, V15, P6670; GRIPPO P, 1968, J MOL BIOL, V36, P195, DOI 10.1016/0022-2836(68)90375-6; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Liu Y, 2008, DIABETES, V57, P777, DOI 10.2337/db07-0008; Mahishi L, 2006, BIOCHEM J, V400, P327, DOI 10.1042/BJ20060734; Martianov I, 2002, SCIENCE, V298, P1036, DOI 10.1126/science.1076327; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; PECH M, 1979, CELL, V18, P883, DOI 10.1016/0092-8674(79)90140-5; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; SWARTZ MN, 1962, J BIOL CHEM, V237, P1961; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42035	10.1371/journal.pone.0042035	http://dx.doi.org/10.1371/journal.pone.0042035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870279	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100042
J	Roti, ECR; Leisman, SK; Abbott, DH; Salih, SM				Roti, Elon C. Roti; Leisman, Scott K.; Abbott, David H.; Salih, Sana M.			Acute Doxorubicin Insult in the Mouse Ovary Is Cell- and Follicle-Type Dependent	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; MULTIDRUG-RESISTANT; P-GLYCOPROTEIN; EXTRACELLULAR-MATRIX; CANCER-CELLS; INTRACELLULAR-LOCALIZATION; ENCAPSULATED DOXORUBICIN; CYTOPLASMIC ORGANELLES; DRUG SEQUESTRATION; INDUCED APOPTOSIS	Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemotherapy faced by the growing number of female cancer survivors. While ovarian repercussions of chemotherapy have long been recognized, the acute insult phase and primary sites of damage are not well-studied, hampering efforts to design effective intervention therapies to protect the ovary. Utilizing doxorubicin (DXR) as a model chemotherapy agent, we defined the acute timeline for drug accumulation, induced DNA damage, and subsequent cellular and follicular demise in the mouse ovary. DXR accumulated first in the core ovarian stroma cells, then redistributed outwards into the cortex and follicles in a time-dependent manner, without further increase in total ovarian drug levels after four hours post-injection. Consistent with early drug accumulation and intimate interactions with the blood supply, stroma cell-enriched populations exhibited an earlier DNA damage response (measurable at 2 hours) than granulosa cells (measurable at 4 hours), as quantified by the comet assay. Granulosa cell-enriched populations were more sensitive however, responding with greater levels of DNA damage. The oocyte DNA damage response was delayed, and not measurable above background until 10-12 hours post-DXR injection. By 8 hours post-DXR injection and prior to the oocyte DNA damage response, the number of primary, secondary, and antral follicles exhibiting TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling)-positive granulosa cells plateaued, indicating late-stage apoptosis and suggesting damage to the oocytes is subsequent to somatic cell failure. Primordial follicles accumulate significant DXR by 4 hours post-injection, but do not exhibit TUNEL-positive granulosa cells until 48 hours post-injection, indicating delayed demise. Taken together, the data suggest effective intervention therapies designed to protect the ovary from chemotherapy accumulation and induced insult in the ovary must act almost immediately to prevent acute insult as significant damage was seen in stroma cells within the first two hours.	[Roti, Elon C. Roti; Leisman, Scott K.; Abbott, David H.; Salih, Sana M.] Univ Wisconsin Madison, Dept Obstet & Gynecol, Reprod Endocrinol & Infertil Div, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Roti, ECR (corresponding author), Univ Wisconsin Madison, Dept Obstet & Gynecol, Reprod Endocrinol & Infertil Div, Madison, WI 53706 USA.	salih@wisc.edu			University of Wisconsin-Madison; National Institutes of Health (NIH) [K12HD0558941]; UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI) [P30 CA014520]; Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources [UL1RR025011]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI); Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by startup funds from the University of Wisconsin-Madison and National Institutes of Health (NIH) training grant K12HD0558941 to SMS, and by the UW-Madison Comprehensive Cancer Center grant National Institutes of Health (NIH)/National Cancer Institute (NCI) P30 CA014520 and UL1RR025011 grant from the Clinical and Translational Science Award (CTSA) Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAI E, 1990, CANCER CHEMOTH PHARM, V25, P295, DOI 10.1007/BF00684889; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Altan N, 1999, P NATL ACAD SCI USA, V96, P4432, DOI 10.1073/pnas.96.8.4432; American Cancer Society, 2011, CANC FACTS FIG 2011; Anderson D, 1997, MUTAT RES-GEN TOX EN, V390, P69, DOI 10.1016/S0165-1218(96)00167-X; Andreu-Vieyra C, 2008, MOL ENDOCRINOL, V22, P2141, DOI 10.1210/me.2008-0033; ATAYA K, 1989, STEROIDS, V54, P607, DOI 10.1016/0039-128X(89)90084-6; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bath LE, 2002, BJOG-INT J OBSTET GY, V109, P107, DOI 10.1111/j.1471-0528.2002.t01-1-01007.x; Bath LE, 2001, HUM REPROD, V16, P1838, DOI 10.1093/humrep/16.9.1838; BECK WT, 1987, BIOCHEM PHARMACOL, V36, P2879, DOI 10.1016/0006-2952(87)90198-5; Belhoussine R, 1998, J HISTOCHEM CYTOCHEM, V46, P1369, DOI 10.1177/002215549804601205; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; BENNIS S, 1995, INT J CANCER, V62, P283, DOI 10.1002/ijc.2910620309; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Bonilla E, 2003, BIOCHEM PHARMACOL, V65, P1701, DOI 10.1016/S0006-2952(03)00119-9; Bour-Dill C, 2000, CYTOMETRY, V39, P16, DOI 10.1002/(SICI)1097-0320(20000101)39:1<16::AID-CYTO4>3.0.CO;2-I; BREUNINGER LM, 1995, CANCER RES, V55, P5342; Brougham MFH, 2005, BRIT J HAEMATOL, V131, P143, DOI 10.1111/j.1365-2141.2005.05740.x; Burton KA, 2002, HOSP MED, V63, P522, DOI 10.12968/hosp.2002.63.9.1946; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cleary I, 1997, BIOCHEM PHARMACOL, V53, P1493; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Dai XW, 2008, NANOMED-NANOTECHNOL, V4, P49, DOI 10.1016/j.nano.2007.12.002; DELANGE JHM, 1992, CYTOMETRY, V13, P571, DOI 10.1002/cyto.990130604; DURAND RE, 1981, CANCER RES, V41, P3489; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Ferrao P, 2001, LEUKEMIA RES, V25, P827, DOI 10.1016/S0145-2126(01)00120-5; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Gallois L, 1996, EUR J BIOCHEM, V241, P879, DOI 10.1111/j.1432-1033.1996.00879.x; GERVASONI JE, 1991, CANCER RES, V51, P4955; GOLDMAN R, 1978, BIOCHIM BIOPHYS ACTA, V512, P254, DOI 10.1016/0005-2736(78)90251-1; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong YP, 2000, LEUKEMIA RES, V24, P769, DOI 10.1016/S0145-2126(00)00048-5; Gong YP, 2003, J BIOL CHEM, V278, P50234, DOI 10.1074/jbc.M306606200; Herlevsen M, 2007, MOL CANCER THER, V6, P1804, DOI 10.1158/1535-7163.MCT-06-0372; Hewitt M, 1999, J NATL CANCER I, V91, P1480, DOI 10.1093/jnci/91.17.1480; HINDENBURG AA, 1989, CANCER RES, V49, P4607; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; HUXHAM IM, 1994, INT J CANCER, V59, P94, DOI 10.1002/ijc.2910590118; Irving-Rodgers HF, 2006, SEMIN REPROD MED, V24, P195, DOI 10.1055/s-2006-948549; Irving-Rodgers HF, 2010, CELL TISSUE RES, V339, P613, DOI 10.1007/s00441-009-0905-8; Johnston RJ, 2009, PEDIATR BLOOD CANCER, V53, P296, DOI 10.1002/pbc.22012; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Karukstis KK, 1998, BIOPHYS CHEM, V73, P249, DOI 10.1016/S0301-4622(98)00150-1; KEIZER HG, 1989, CANCER RES, V49, P2988; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kirchmeier MJ, 2001, J LIPOSOME RES, V11, P15, DOI 10.1081/LPR-100103167; KLOHS WD, 1988, MOL PHARMACOL, V34, P180; Kramer DL, 1998, CANCER RES, V58, P3883; LANKELMA J, 1991, BIOCHIM BIOPHYS ACTA, V1093, P147, DOI 10.1016/0167-4889(91)90116-F; Lautier D, 1997, INT J CANCER, V71, P292; Loetchutinat C, 2001, EUR J BIOCHEM, V268, P4459, DOI 10.1046/j.1432-1327.2001.02370.x; Meirow D, 1999, LEUKEMIA LYMPHOMA, V33, P65, DOI 10.3109/10428199909093726; Meirow D, 2010, FERTIL STERIL, V94, pS10, DOI 10.1016/j.fertnstert.2010.07.038; Meirow D, 1996, HUM REPROD UPDATE, V2, P63, DOI 10.1093/humupd/2.1.63; Meirow D, 1999, HUM REPROD, V14, P1903, DOI 10.1093/humrep/14.7.1903; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Merlin JL, 2000, CYTOMETRY, V41, P62, DOI 10.1002/1097-0320(20000901)41:1<62::AID-CYTO9>3.0.CO;2-7; MILLER JJ, 1971, AM J MED, V50, P530, DOI 10.1016/0002-9343(71)90341-X; Millot C, 1997, J HISTOCHEM CYTOCHEM, V45, P1255, DOI 10.1177/002215549704500909; MORGENFELD MC, 1972, SURG GYNECOL OBSTETR, V134, P826; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nakano K, 2007, ARCH HISTOL CYTOL, V70, P243, DOI 10.1679/aohc.70.243; Oktay K, 2006, J CLIN ONCOL, V24, P4044, DOI 10.1200/JCO.2006.06.9823; Oktay K, 2009, PEDIATR BLOOD CANCER, V53, P267, DOI 10.1002/pbc.22003; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; PASCHOUD N, 1985, J HISTOCHEM CYTOCHEM, V33, P73, DOI 10.1177/33.1.2578145; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez-Ruiz T, 2001, ELECTROPHORESIS, V22, P134, DOI 10.1002/1522-2683(200101)22:1<134::AID-ELPS134>3.3.CO;2-O; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Rodgers RJ, 2001, MOL CELL ENDOCRINOL, V171, P41, DOI 10.1016/S0303-7207(00)00430-5; RUTHERFORD AV, 1993, J HISTOCHEM CYTOCHEM, V41, P1573, DOI 10.1177/41.10.7902372; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; SCHUURHUIS GJ, 1991, BRIT J CANCER, V64, P857, DOI 10.1038/bjc.1991.413; SCHUURHUIS GJ, 1993, BRIT J CANCER, V68, P898, DOI 10.1038/bjc.1993.452; SEIDEL A, 1995, VIRCHOWS ARCH, V426, P249; Shapiro AB, 1998, INT J CANCER, V76, P857, DOI 10.1002/(SICI)1097-0215(19980610)76:6<857::AID-IJC15>3.0.CO;2-#; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shinoda K, 1999, ARCH TOXICOL, V73, P274, DOI 10.1007/s002040050617; SIMON S, 1994, P NATL ACAD SCI USA, V91, P4101, DOI 10.1073/pnas.91.9.4101; SLAPAK CA, 1994, BLOOD, V84, P3113, DOI 10.1182/blood.V84.9.3113.bloodjournal8493113; Smith MA, 1999, J NATL CANCER I, V91, P973; SOGNIER MA, 1994, BIOCHEM PHARMACOL, V48, P391, DOI 10.1016/0006-2952(94)90112-0; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Wang E, 2000, J CELL PHYSIOL, V184, P263, DOI 10.1002/1097-4652(200008)184:2<263::AID-JCP15>3.0.CO;2-F; WARREN L, 1991, CANCER RES, V51, P1996; Wei GL, 2008, BIOMED CHROMATOGR, V22, P1252, DOI 10.1002/bmc.1054; Wientjes MG, 2005, CLIN CANCER RES, V11, P4204, DOI 10.1158/1078-0432.CCR-04-1969; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; Wood DJT, 1996, CANCER LETT, V108, P41, DOI 10.1016/S0304-3835(96)04368-6	98	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42293	10.1371/journal.pone.0042293	http://dx.doi.org/10.1371/journal.pone.0042293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876313	gold, Green Published, Green Submitted			2022-12-25	WOS:000307184700041
J	Henson, MA; Larsen, RS; Lawson, SN; Perez-Otano, I; Nakanishi, N; Lipton, SA; Philpot, BD				Henson, Maile A.; Larsen, Rylan S.; Lawson, Shelikha N.; Perez-Otano, Isabel; Nakanishi, Nobuki; Lipton, Stuart A.; Philpot, Benjamin D.			Genetic Deletion of NR3A Accelerates Glutamatergic Synapse Maturation	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNITS; LONG-TERM POTENTIATION; D-ASPARTATE-RECEPTORS; DEVELOPING RAT-BRAIN; POSTNATAL-DEVELOPMENT; DIFFERENTIAL EXPRESSION; REGIONAL EXPRESSION; AMPA RECEPTORS; NR3A-CONTAINING NMDARS; HIPPOCAMPAL SYNAPSES	Glutamatergic synapse maturation is critically dependent upon activation of NMDA-type glutamate receptors (NMDARs); however, the contributions of NR3A subunit-containing NMDARs to this process have only begun to be considered. Here we characterized the expression of NR3A in the developing mouse forebrain and examined the consequences of NR3A deletion on excitatory synapse maturation. We found that NR3A is expressed in many subcellular compartments, and during early development, NR3A subunits are particularly concentrated in the postsynaptic density (PSD). NR3A levels dramatically decline with age and are no longer enriched at PSDs in juveniles and adults. Genetic deletion of NR3A accelerates glutamatergic synaptic transmission, as measured by AMPAR-mediated postsynaptic currents recorded in hippocampal CA1. Consistent with the functional observations, we observed that the deletion of NR3A accelerated the expression of the glutamate receptor subunits NR1, NR2A, and GluR1 in the PSD in postnatal day (P) 8 mice. These data support the idea that glutamate receptors concentrate at synapses earlier in NR3A-knockout (NR3A-KO) mice. The precocious maturation of both AMPAR function and glutamate receptor expression are transient in NR3A-KO mice, as AMPAR currents and glutamate receptor protein levels are similar in NR3A-KO and wildtype mice by P16, an age when endogenous NR3A levels are normally declining. Taken together, our data support a model whereby NR3A negatively regulates the developmental stabilization of glutamate receptors involved in excitatory neurotransmission, synaptogenesis, and spine growth.	[Henson, Maile A.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Larsen, Rylan S.; Lawson, Shelikha N.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Perez-Otano, Isabel] CIMA, Dept Neurociencias, Pamplona, Spain; [Perez-Otano, Isabel] Univ Navarra, E-31080 Pamplona, Spain; [Nakanishi, Nobuki; Lipton, Stuart A.] Del E Webb Ctr Neurosci Aging & Stem Cell Res, Sanford Burnham Med Res Inst, La Jolla, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Navarra; Sanford Burnham Prebys Medical Discovery Institute	Henson, MA (corresponding author), Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC USA.	maile.henson@nih.gov	Perez-Otano, Isabel/S-9613-2017	Perez-Otano, Isabel/0000-0002-7222-8202; Lipton, Stuart/0000-0002-3490-1259; Larsen, Rylan/0000-0002-7136-1175	NARSAD; Marie Curie International Reintegration Program; UTE project CIMA; MEC [SAF2006-10025]; National Eye Institute [R01 EY018323, R01 EY05477]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD29687]; UNC Charles Lee Raper Dissertation Fellowship; Society for Neuroscience/NINDS Neuroscience Scholars Program; NATIONAL EYE INSTITUTE [R01EY005477, R01EY018323] Funding Source: NIH RePORTER	NARSAD(NARSAD); Marie Curie International Reintegration Program; UTE project CIMA; MEC(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UNC Charles Lee Raper Dissertation Fellowship; Society for Neuroscience/NINDS Neuroscience Scholars Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NARSAD (BDP, IPO; bbrfoundation.org), Marie Curie International Reintegration Program (http://cordis.europa.eu), UTE project CIMA and MEC (IPO; SAF2006-10025), National Eye Institute (BDP, R01 EY018323; SAL, R01 EY05477), Eunice Kennedy Shriver National Institute of Child Health and Human Development (SAL, P01 HD29687), UNC Charles Lee Raper Dissertation Fellowship (MAH), and the Society for Neuroscience/NINDS Neuroscience Scholars Program (MAH; http://www.sfn.org/index.aspx?pagename = NeuroscienceScholars_Main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Al-Hallaq RA, 2001, J NEUROCHEM, V77, P110, DOI 10.1046/j.1471-4159.2001.t01-1-00210.x; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Awobuluyi M, 2007, MOL PHARMACOL, V71, P112, DOI 10.1124/mol.106.03070; Brody SA, 2005, BIOL PSYCHIAT, V57, P1147, DOI 10.1016/j.biopsych.2005.01.024; Chan WS, 2003, NEUROSIGNALS, V12, P302, DOI 10.1159/000075312; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eriksson M, 2007, PHYSIOL BEHAV, V92, P54, DOI 10.1016/j.physbeh.2007.05.026; Flint AC, 1997, J NEUROSCI, V17, P2469; Friedman LK, 2007, DEV NEUROSCI-BASEL, V29, P427, DOI 10.1159/000100078; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lau WK, 2003, NEUROCHEM INT, V43, P47, DOI 10.1016/S0197-0186(02)00191-2; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martin LJ, 1998, NEUROSCIENCE, V83, P917, DOI 10.1016/S0306-4522(97)00411-9; Matsuda K, 2003, J NEUROSCI, V23, P10064; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Park HT, 1999, DEV BRAIN RES, V115, P83, DOI 10.1016/S0165-3806(99)00049-8; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; RIVA MA, 1994, MOL BRAIN RES, V25, P209, DOI 10.1016/0169-328X(94)90155-4; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Suen P, 1998, MOL BRAIN RES, V59, P215, DOI 10.1016/S0169-328X(98)00157-0; Tong G, 2008, J NEUROPHYSIOL, V99, P122, DOI 10.1152/jn.01044.2006; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Tu SC, 2007, NEURON, V55, P69, DOI 10.1016/j.neuron.2007.06.021; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; VanDongen AMJ, 2004, NEUROSIGNALS, V13, P194, DOI 10.1159/000077526; Wada A, 2006, J NEUROSCI, V26, P13156, DOI 10.1523/JNEUROSCI.2552-06.2006; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; ZHONG J, 1995, J NEUROCHEM, V64, P531	75	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42327	10.1371/journal.pone.0042327	http://dx.doi.org/10.1371/journal.pone.0042327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870318	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800081
J	Schreiber, KJ; Ye, D; Fich, E; Jian, A; Lo, T; Desveaux, D				Schreiber, Karl J.; Ye, David; Fich, Eric; Jian, Allen; Lo, Timothy; Desveaux, Darrell			A High-Throughput Forward Genetic Screen Identifies Genes Required for Virulence of Pseudomonas syringae pv. maculicola ES4326 on Arabidopsis	PLOS ONE			English	Article							REDUCED VIRULENCE; SECRETION SYSTEM; TRANSPOSON TN5; TOMATO; MUTANTS; CBRAB; BIOSYNTHESIS; SPECIFICITY; GLUTAMINE; APOPLAST	Successful pathogenesis requires a number of coordinated processes whose genetic bases remain to be fully characterized. We utilized a high-throughput, liquid media-based assay to screen transposon disruptants of the phytopathogen Pseudomonas syringae pv. maculicola ES4326 to identify genes required for virulence on Arabidopsis. Many genes identified through this screen were involved in processes such as type III secretion, periplasmic glucan biosynthesis, flagellar motility, and amino acid biosynthesis. A small set of genes did not fall into any of these functional groups, and their disruption resulted in context-specific effects on in planta bacterial growth.	[Schreiber, Karl J.; Ye, David; Fich, Eric; Jian, Allen; Lo, Timothy; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Schreiber, KJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	darrell.desveaux@utoronto.ca		Fich, Eric/0000-0002-8948-7112	Natural Science and Engineering Research Council (NSERC) of Canada; NSERC; Canadian Foundation for Innovation; Ontario Ministry of Research and Innovation	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	KS was supported by the Natural Science and Engineering Research Council (NSERC) of Canada. DD is a Canada Research Chair in Plant-Microbe Systems Biology. This work was supported by an NSERC Discovery Grant and awards from the Canadian Foundation for Innovation and the Ontario Ministry of Research and Innovation to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELBERG EA, 1956, ANNU REV BIOCHEM, V25, P349, DOI 10.1146/annurev.bi.25.070156.002025; ALEXEYEV MF, 1995, CAN J MICROBIOL, V41, P1053, DOI 10.1139/m95-147; Arnold C, 1991, PCR Methods Appl, V1, P39; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; BERG DE, 1983, GENETICS, V105, P813; BOYD LA, 1993, PLASMID, V30, P155, DOI 10.1006/plas.1993.1043; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chand NS, 2011, J BACTERIOL, V193, P2989, DOI 10.1128/JB.01546-10; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Deng WL, 2010, MOL PLANT MICROBE IN, V23, P1184, DOI 10.1094/MPMI-23-9-1184; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282; Hirano SS, 1999, P NATL ACAD SCI USA, V96, P9851, DOI 10.1073/pnas.96.17.9851; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hojo H, 2008, MICROBIOL-SGM, V154, P2920, DOI 10.1099/mic.0.2008/021097-0; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Katagiri F., 2002, ARABIDOPSIS BOOK; KING EO, 1954, J LAB CLIN MED, V44, P301; Kloek AP, 2000, MOL PLANT PATHOL, V1, P139, DOI 10.1046/j.1364-3703.2000.00016.x; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Penaloza-Vazquez A, 2010, ENVIRON MICROBIOL, V12, P1452, DOI 10.1111/j.1462-2920.2010.02160.x; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Preiter K, 2005, J BACTERIOL, V187, P7805, DOI 10.1128/JB.187.22.7805-7814.2005; Rainey PB, 1997, MOL GEN GENET, V256, P84, DOI 10.1007/s004380050548; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P683, DOI 10.1104/pp.103.024802; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; SCHULMAN H, 1977, J BIOL CHEM, V252, P6299; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; SOMLYAI G, 1986, PHYSIOL MOL PLANT P, V29, P369, DOI 10.1016/S0048-4059(86)80053-4; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zhang XX, 2008, GENETICS, V178, P185, DOI 10.1534/genetics.107.081984; Zhang XX, 2010, ENVIRON MICROBIOL, V12, P1674, DOI 10.1111/j.1462-2920.2010.02228.x	49	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41461	10.1371/journal.pone.0041461	http://dx.doi.org/10.1371/journal.pone.0041461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870224	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800021
J	Yan, R; Ji, HL; Wu, YH; Kerr, PG; Fang, YM; Yang, LZ				Yan, Rong; Ji, Hongli; Wu, Yonghong; Kerr, Philip G.; Fang, Yanming; Yang, Linzhang			An Investigation into the Kinetics and Mechanism of the Removal of Cyanobacteria by Extract of Ephedra equisetina Root	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; GREEN-ALGAE; GENE; EXPOSURE; STRAINS; BLOOMS; GROWTH; STATE; FLAA	An aqueous extract of Ephedra equisetina root was found to induce cyanobacterial cell death. The extract displayed no negative effects on the fish populations but instead, improved the habitat conditions for the growth of macrophytes, zooplankton and bacteria because the inhibiting effects of the extracts on cyanobacteria helped clear up the water column. The removal kinetics of cyanobacteria by E. equisetina extract appears to be a first order process with the rate constant being extract-dose-dependent. Compounds including the flavonoids found in E. equisetina root kill the cyanobacteria in vitro at a dose of 5.0 mu g extract per 100 mL water or above. The extract constituents act to disrupt the thylakoid membrane, interrupt the electronic transport, decrease the effective quantum yield, and eventually lead to the failure of photosynthesis in Microcystis aeruginosa. This study presents an easily-deployed, natural and promising approach for controlling cyanobacterial blooms as an emergency measure, and also provides insight into the dynamics and mechanism of the extract consisting of multiple compounds synergistically removing algae.	[Yan, Rong; Ji, Hongli; Fang, Yanming] Nanjing Forestry Univ, Coll Forest Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Yan, Rong; Wu, Yonghong; Yang, Linzhang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Kerr, Philip G.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Nanjing Forestry University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Charles Sturt University	Yan, R (corresponding author), Nanjing Forestry Univ, Coll Forest Resource & Environm Sci, Nanjing, Jiangsu, Peoples R China.	yhwu@issas.ac.cn; jwu4@njfu.edu.cn	Kerr, Philip/B-4212-2013; Wu, Yonghong/B-4501-2010	Kerr, Philip/0000-0002-6406-0593; Wu, Yonghong/0000-0002-2985-219X	Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University; Innovative Project of Graduate Students in University, Jiangsu, China	Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University; Innovative Project of Graduate Students in University, Jiangsu, China	This work was jointly supported by the Priority Academic Program Development of Jiangsu High Education Institutions (PAPD), the Doctorate Fellowship Foundation of Nanjing Forestry University and the Innovative Project of Graduate Students in University, Jiangsu, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta G, 2005, J CHEM ECOL, V16, P9; [Anonymous], 2017, STANDARD METHODS EXA; Assmy P., 2009, ENCY MICROBIOLOGY, P27, DOI DOI 10.1016/B978-012373944-5.00001-8; Bagheri-Gavkosh S, 2009, MYCOPATHOLOGIA, V168, P249, DOI 10.1007/s11046-009-9220-x; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; del Pozo R, 2010, AQUAT BOT, V92, P55, DOI 10.1016/j.aquabot.2009.10.003; DeNobel WT, 1997, FEMS MICROBIOL ECOL, V24, P259, DOI 10.1111/j.1574-6941.1997.tb00443.x; Di Giovanni GD, 1999, CURR MICROBIOL, V38, P217, DOI 10.1007/PL00006790; Diaz M, 2007, LIMNOLOGICA, V37, P17, DOI 10.1016/j.limno.2006.08.006; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Dziga D, 2007, ENVIRON TOXICOL, V22, P341, DOI 10.1002/tox.20276; Ferrier MD, 2005, BIORESOURCE TECHNOL, V96, P1788, DOI 10.1016/j.biortech.2005.01.021; Gobler CJ, 2008, HARMFUL ALGAE, V7, P293, DOI 10.1016/j.hal.2007.12.006; Golterman H. L., 1969, IBP HDB, V8; GRAY DI, 1995, LETT APPL MICROBIOL, V20, P65, DOI 10.1111/j.1472-765X.1995.tb00409.x; HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X; Jersek B, 1999, J CLIN MICROBIOL, V37, P103; Jin Q, 2003, J EXP MAR BIOL ECOL, V293, P41, DOI 10.1016/S0022-0981(03)00214-4; Kim IS, 2010, INT IMMUNOPHARMACOL, V10, P1616, DOI 10.1016/j.intimp.2010.09.019; Kuhnau J, 1976, WORLD REV NUTR DIET, V24, P8; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Miao SY, 2006, SCI TOTAL ENVIRON, V371, P334, DOI 10.1016/j.scitotenv.2006.07.027; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Nakai S, 2005, HYDROBIOLOGIA, V543, P71, DOI 10.1007/s10750-004-6822-7; NAWWAR MAM, 1984, PHYTOCHEMISTRY, V23, P2937, DOI 10.1016/0031-9422(84)83045-9; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; RIPPKA R., 1992, PASTEUR CULTURE COLL, V1; Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145; Sekizuka T, 2007, J BASIC MICROB, V47, P63, DOI 10.1002/jobm.200610194; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith GJ, 2000, J PHOTOCH PHOTOBIO A, V136, P87, DOI 10.1016/S1010-6030(00)00320-8; SPENCER CM, 1988, PHYTOCHEMISTRY, V27, P2397, DOI 10.1016/0031-9422(88)87004-3; Svrcek C, 2004, J ENVIRON ENG SCI, V3, P155, DOI 10.1139/S04-010; Weaver Warren, 1949, DROP CITATION; Wu Y, 2008, ALLELOPATHY J, V22; Wu YH, 2010, BIORESOURCE TECHNOL, V101, P3903, DOI 10.1016/j.biortech.2009.12.144; Yang W.D., 2005, CHIN ENV SCI, V25, P1	40	12	16	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42285	10.1371/journal.pone.0042285	http://dx.doi.org/10.1371/journal.pone.0042285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870313	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800076
J	Benavente, CA; Schnell, SA; Jacobson, EL				Benavente, Claudia A.; Schnell, Stephanie A.; Jacobson, Elaine L.			Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin	PLOS ONE			English	Article							RAT BONE-MARROW; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; XERODERMA-PIGMENTOSUM; DEFICIENCY INCREASES; HUMAN KERATINOCYTES; MAMMALIAN-CELLS; NAD; APOPTOSIS	Sirtuins (SIRTs) and poly(ADP-ribose) polymerases (PARPs), NAD(+)-dependent enzymes, link cellular energy status with responses to environmental stresses. Skin is frequently exposed to the DNA damaging effects of UV irradiation, a known etiology in skin cancer. Thus, understanding the defense mechanisms in response to UV, including the role of SIRTs and PARPs, may be important in developing skin cancer prevention strategies. Here, we report expression of the seven SIRT family members in human skin. SIRTs gene expressions are progressively upregulated in A431 epidermoid carcinoma cells (SIRTs1 and 3), actinic keratoses (SIRTs 2, 3, 5, 6, and 7) and squamous cell carcinoma (SIRTs 1-7). Photodamage induces dynamic changes in SIRT expression with upregulation of both SIRT1 and SIRT4 mRNAs. Specific losses of SIRT proteins occur early after photodamage followed by accumulation later, especially for SIRT4. Niacin restriction, which decreases NAD(+), the sirtuin substrate, results in an increase in acetylated proteins, upregulation of SIRTs 2 and 4, increased inherent DNA damage, alterations in SIRT responses to photodamage, abrogation of PARP activation following photodamage, and increased sensitivity to photodamage that is completely reversed by repleting niacin. These data support the hypothesis that SIRTs and PARPs play important roles in resistance to photodamage and identify specific SIRTs that respond to photodamage and may be targets for skin cancer prevention.	[Benavente, Claudia A.] Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; University of Arizona	Benavente, CA (corresponding author), Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA.	elaine.jacobson@pharmacy.arizona.edu		Benavente, Claudia/0000-0002-6875-3186	National Institute of Health [CA43894, CA106677, CA27502, ES06694]; NATIONAL CANCER INSTITUTE [R01CA043894, R01CA106677, P01CA027502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institute of Health grants CA43894, CA106677, CA27502 and ES06694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; BASUMODAK S, 1993, CANCER RES, V53, P4505; Benavente CA, 2008, FREE RADICAL BIO MED, V44, P527, DOI 10.1016/j.freeradbiomed.2007.10.006; BERGER NA, 1980, BIOCHEMISTRY-US, V19, P289, DOI 10.1021/bi00543a006; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyonoski AC, 1999, MOL CELL BIOCHEM, V193, P83, DOI 10.1023/A:1006964227277; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Chang H, 2002, BIOL CHEM, V383, P703, DOI 10.1515/BC.2002.072; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dal Farra C, 2006, J COSMET SCI, V57, P187; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Halappanavar SS, 1999, J BIOL CHEM, V274, P37097, DOI 10.1074/jbc.274.52.37097; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; JACOBSON EL, 1993, J AM COLL NUTR, V12, P412, DOI 10.1080/07315724.1993.10718330; Jacobson EL, 1997, METHOD ENZYMOL, V280, P221; JACOBSON EL, 1983, J BIOL CHEM, V258, P103; Jacobson EL, 1999, MOL CELL BIOCHEM, V193, P69, DOI 10.1023/A:1006960126369; Jacobson EL, 2001, J PHOTOCH PHOTOBIO B, V63, P141, DOI 10.1016/S1011-1344(01)00211-1; JACOBSON EL, 1979, J CELL PHYSIOL, V99, P417, DOI 10.1002/jcp.1040990316; Jacobson EL, 2007, EXP DERMATOL, V16, P490, DOI 10.1111/j.1600-0625.2007.00553.x; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kubilus J, 1996, IN VITRO TOXICOL, V9, P157; Lee JS, 2010, EXP DERMATOL, V19, P1060, DOI 10.1111/j.1600-0625.2010.01129.x; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Ohguchi K, 2010, BRIT J DERMATOL, V163, P689, DOI 10.1111/j.1365-2133.2010.09825.x; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; SHAH GM, 2002, CANCER RES, V131, pS3150; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Spronck JC, 2003, NUTR CANCER, V45, P124, DOI 10.1207/S15327914NC4501_14; Spronck JC, 2002, MUTAT RES-FUND MOL M, V508, P83, DOI 10.1016/S0027-5107(02)00188-4; Spronck JC, 2007, NUTR CANCER, V57, P88, DOI 10.1080/01635580701268337; STEVNSNER T, 1994, NUCLEIC ACIDS RES, V22, P4620, DOI 10.1093/nar/22.22.4620; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wondrak GT, 2005, J PHARMACOL EXP THER, V312, P482, DOI 10.1124/jpet.104.075101; Wondrak GT, 2003, J INVEST DERMATOL, V121, P578, DOI 10.1046/j.1523-1747.2003.12414.x; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG JZ, 1993, J NUTR, V123, P1349	57	48	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42276	10.1371/journal.pone.0042276	http://dx.doi.org/10.1371/journal.pone.0042276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860104	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600084
J	Gladigau, G; Haselmayer, P; Scharrer, I; Munder, M; Prinz, N; Lackner, K; Schild, H; Stein, P; Radsak, MP				Gladigau, Gerd; Haselmayer, Philipp; Scharrer, Inge; Munder, Markus; Prinz, Nadine; Lackner, Karl; Schild, Hansjoerg; Stein, Pamela; Radsak, Markus P.			A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; TISSUE FACTOR; FETAL INJURY; ANTIBODIES; ACTIVATION; THROMBOSIS; C5A; MONOCYTES; RESPONSES; MICROBES	The anti-phospholipid syndrome (APS) is characterized by recurrent thrombosis and occurrence of anti-phospholipid antibodies (aPL). aPL are necessary, but not sufficient for the clinical manifestations of APS. Growing evidence suggests a role of innate immune cells, in particular polymorphonuclear neutrophils (PMN) and Toll-like receptors (TLR) to be additionally involved. aPL activate endothelial cells and monocytes through a TLR4-dependent signalling pathway. Whether this is also relevant for PMN in a similar way is currently not known. To address this issue, we used purified PMN from healthy donors and stimulated them in the presence or absence of human monoclonal aPL and the TLR4 agonist LPS monitoring neutrophil effector functions, namely the oxidative burst, phagocytosis, L-Selectin shedding and IL-8 production. aPL alone were only able to induce minor activation of PMN effector functions at high concentrations. However, in the additional presence of LPS the activation threshold was markedly lower indicating a synergistic activation pathway of aPL and TLR in PMN. In summary, our results indicate that PMN effector functions are directly activated by aPL and boosted by the additional presence of microbial products. This highlights a role for PMN as important innate immune effector cells that contribute to the pathophysiology of APS.	[Gladigau, Gerd; Haselmayer, Philipp; Schild, Hansjoerg; Stein, Pamela; Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, D-6500 Mainz, Germany; [Scharrer, Inge; Munder, Markus; Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 3, Mainz, Germany; [Prinz, Nadine; Lackner, Karl] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Gladigau, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, Obere Zahlbacher Str 67, D-6500 Mainz, Germany.	pamela.stein@uni-mainz.de; radsak@uni-mainz.de	Scharrer, Inge/N-2999-2013; Munder, Markus/K-6737-2013; Radsak, Markus P/L-3651-2013	Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft KFO 183 [Ra 988/4-2]; University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention''); Federal Ministry of Education and Research [BMBF 01EO1003]	Deutsche Forschungsgemeinschaft KFO 183; University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention''); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft KFO 183 (Ra 988/4-2 to H. S. and M. P. R.), University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention'' to M. P. R.) and by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherson RA, 1996, LUPUS, V5, P414, DOI 10.1177/096120339600500516; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cervera R, 2004, ANN RHEUM DIS, V63, P1312, DOI 10.1136/ard.2003.014175; Doring Y, 2010, IMMUNOBIOLOGY, V215, P230, DOI 10.1016/j.imbio.2009.03.002; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Giron-Gonzalez JA, 2004, J RHEUMATOL, V31, P1560; Haselmayer P, 2006, IMMUNOLOGY, V119, P404, DOI 10.1111/j.1365-2567.2006.02449.x; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lackner KJ, 2000, THROMB HAEMOSTASIS, V83, P583; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 2000, J AUTOIMMUN, V15, P241, DOI 10.1006/jaut.2000.0420; Prinz N, 2011, BLOOD, V118, P2322, DOI 10.1182/blood-2011-01-330639; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shovinan O, 2007, CLIN REV ALLERG IMMU, V32, P145, DOI 10.1007/s12016-007-0001-3; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Tripodi A, 2001, BRIT J HAEMATOL, V115, P672, DOI 10.1046/j.1365-2141.2001.03178.x; von Landenberg C, 1999, J AUTOIMMUN, V13, P215, DOI 10.1006/jaut.1999.0316; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yetman DL, 1996, FERTIL STERIL, V66, P540, DOI 10.1016/S0015-0282(16)58565-3	35	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42176	10.1371/journal.pone.0042176	http://dx.doi.org/10.1371/journal.pone.0042176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860075	Green Submitted, Green Published, gold			2022-12-25	WOS:000307045600066
J	Stamps, JA; Yang, LH; Morales, VM; Boundy-Mills, KL				Stamps, Judy A.; Yang, Louie H.; Morales, Vanessa M.; Boundy-Mills, Kyria L.			Drosophila Regulate Yeast Density and Increase Yeast Community Similarity in a Natural Substrate	PLOS ONE			English	Article							MELANOGASTER; BEHAVIOR; EVOLUTION; LARVAL; IDENTIFICATION; ORGANIZATION; AGRICULTURE; SELECTION; ANTS; FOOD	Drosophila melanogaster adults and larvae, but especially larvae, had profound effects on the densities and community structure of yeasts that developed in banana fruits. Pieces of fruit exposed to adult female flies previously fed fly-conditioned bananas developed higher yeast densities than pieces of the same fruits that were not exposed to flies, supporting previous suggestions that adult Drosophila vector yeasts to new substrates. However, larvae alone had dramatic effects on yeast density and species composition. When yeast densities were compared in pieces of the same fruits assigned to different treatments, fruits that developed low yeast densities in the absence of flies developed significantly higher yeast densities when exposed to larvae. Across all of the fruits, larvae regulated yeast densities within narrow limits, as compared to a much wider range of yeast densities that developed in pieces of the same fruits not exposed to flies. Larvae also affected yeast species composition, dramatically reducing species diversity across fruits, reducing variation in yeast communities from one fruit to the next (beta diversity), and encouraging the consistent development of a yeast community composed of three species of yeast (Candida californica, C. zemplinina, and Pichia kluvyeri), all of which were palatable to larvae. Larvae excreted viable cells of these three yeast species in their fecal pools, and discouraged the growth of filamentous fungi, processes which may have contributed to their effects on the yeast communities in banana fruits. These and other findings suggest that D. melanogaster adults and their larval offspring together engage in 'niche construction', facilitating a predictable microbial environment in the fruit substrates in which the larvae live and develop.	[Stamps, Judy A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morales, Vanessa M.; Boundy-Mills, Kyria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Stamps, JA (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	jastamps@ucdavis.edu	Stamps, Judy A/A-5142-2010	Yang, Louie/0000-0002-9237-5357				Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anagnostou C, 2010, OIKOS, V119, P533, DOI 10.1111/j.1600-0706.2009.18001.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Begon M., 1982, Genetics and Biology of Drosophila, V3b, P345; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; BUDNIK M, 1981, REV BRAS GENET, V4, P513; Carroll G. C., 1992, The fungal community: its organization and role in the ecosystem., P327; CASTRO JA, 1986, ARCH INSECT BIOCHEM, V3, P485, DOI 10.1002/arch.940030508; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Davis JM, 2007, ANIM BEHAV, V74, P111, DOI 10.1016/j.anbehav.2006.11.014; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Ganter PF, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P303, DOI 10.1007/3-540-30985-3_14; GANTER PF, 1988, OECOLOGIA, V75, P400, DOI 10.1007/BF00376943; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; GODOYHERRERA R, 1986, HEREDITY, V56, P33, DOI 10.1038/hdy.1986.6; Gowen JW, 1919, GENETICS, V4, P205; GREEN CH, 1983, ANIM BEHAV, V31, P282, DOI 10.1016/S0003-3472(83)80198-5; Harlan JR, 1992, CROPS MAN; Hata H, 2004, J EXP MAR BIOL ECOL, V313, P285, DOI 10.1016/j.jembe.2004.08.009; Hoffmann AA, 2006, EVOL ECOL RES, V8, P813; Janzen D.H., 1985, P40; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LACHANCE MA, 1989, YEAST, V5, P501; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Laland KN, 2006, EVOLUTION, V60, P1751; LARUE TA, 1968, CAN J MICROBIOL, V14, P79, DOI 10.1139/m68-012; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; MORAIS PB, 1994, ANTON LEEUW INT J G, V66, P313, DOI 10.1007/BF00882766; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Oksanen J., 2013, R PACKAGE VERSION 2, P292; ONISHI H, 1978, J AGR CHEM SOC JPN, V52, P317, DOI 10.1271/nogeikagaku1924.52.8_317; Pearce T, 2011, BIOL PHILOS, V26, P793, DOI 10.1007/s10539-011-9282-2; Phaff H. J., 1987, YEASTS, V1, P123; Rohlfs M, 2005, MYCOLOGIA, V97, P996, DOI 10.3852/mycologia.97.5.996; Rohlfs M, 2010, J APPL ENTOMOL, V134, P667, DOI 10.1111/j.1439-0418.2009.01458.x; SEWELL D, 1974, GENET RES, V24, P163, DOI 10.1017/S0016672300015196; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Smith B. D., 1998, EMERGENCE AGR; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; Stamps JA, 2006, ANIM BEHAV, V71, P663, DOI 10.1016/j.anbehav.2005.07.015; Starmer WT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P65, DOI 10.1016/B978-0-444-52149-1.00006-9; STARMER WT, 1986, J CHEM ECOL, V12, P1037, DOI 10.1007/BF01638995; Starmer WT, 1990, ECOLOGICAL EVOLUTION; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x	57	86	88	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42238	10.1371/journal.pone.0042238	http://dx.doi.org/10.1371/journal.pone.0042238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860093	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600079
J	Ayyanathan, K; Kesaraju, S; Dawson-Scully, K; Weissbach, H				Ayyanathan, Kasirajan; Kesaraju, Shailaja; Dawson-Scully, Ken; Weissbach, Herbert			Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage	PLOS ONE			English	Article							CONGENITAL LACTIC-ACIDOSIS; CYCLOOXYGENASE-2 INHIBITORS; HYDROGEN-PEROXIDE; ARSENIC TRIOXIDE; IN-VITRO; APOPTOSIS; STRESS; INDUCTION; GROWTH; DEHYDROGENASE	Sulindac is an FDA-approved non-steroidal anti-inflammatory drug with documented anticancer activities. Our recent studies showed that sulindac selectively enhanced the killing of cancer cells exposed to oxidizing agents via production of reactive oxygen species (ROS) resulting in mitochondrial dysfunction. This effect of sulindac and oxidative stress on cancer cells could be related to the defect in respiration in cancer cells, first described by Warburg 50 years ago, known as the Warburg effect. We postulated that sulindac might enhance the selective killing of cancer cells when combined with any compound that alters mitochondrial respiration. To test this hypothesis we have used dichloroacetate (DCA), which is known to shift pyruvate metabolism away from lactic acid formation to respiration. One might expect that DCA, since it stimulates aerobic metabolism, could stress mitochondrial respiration in cancer cells, which would result in enhanced killing in the presence of sulindac. In this study, we have shown that the combination of sulindac and DCA enhances the selective killing of A549 and SCC25 cancer cells under the conditions used. As predicted, the mechanism of killing involves ROS production, mitochondrial dysfunction, JNK signaling and death by apoptosis. Our results suggest that the sulindac-DCA drug combination may provide an effective cancer therapy.	[Ayyanathan, Kasirajan; Kesaraju, Shailaja; Dawson-Scully, Ken; Weissbach, Herbert] Florida Atlantic Univ, Charles E Schmidt Coll Sci, Ctr Mol Biol & Biotechnol, Jupiter, FL USA; [Ayyanathan, Kasirajan; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Charles E Schmidt Coll Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Ayyanathan, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Sci, Ctr Mol Biol & Biotechnol, Jupiter, FL USA.	kayyanat@fau.edu			National Institutes of Health [5K01CA95620, R15 CA122001]; State of Florida (SURECAG) [R94007]; NATIONAL CANCER INSTITUTE [K01CA095620, R15CA122001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida (SURECAG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding assistance from the National Institutes of Health to KA (grant 5K01CA95620) and HW (grant R15 CA122001) and from the State of Florida to HW (SURECAG grant R94007) to carry out this work is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boolbol SK, 1996, CANCER RES, V56, P2556; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heshe D, 2011, CANCER CHEMOTH PHARM, V67, P647, DOI 10.1007/s00280-010-1361-6; Jiang TT, 2004, J EXP CLIN CANC RES, V23, P259; Jin HO, 2006, BIOCHEM PHARMACOL, V72, P1228, DOI 10.1016/j.bcp.2006.07.026; Jina HO, 2008, LUNG CANCER, V61, P317, DOI 10.1016/j.lungcan.2008.01.002; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Marchetti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005804; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Minami T, 2005, CLIN CANCER RES, V11, P5248, DOI 10.1158/1078-0432.CCR-05-0085; Moench I, 2009, P NATL ACAD SCI USA, V106, P19611, DOI 10.1073/pnas.0911046106; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Papandreou I, 2011, INT J CANCER, V128, P1001, DOI 10.1002/ijc.25728; RAO CV, 1995, CANCER RES, V55, P1464; Resnick L, 2009, J DRUGS DERMATOL, V8, P29; Richter M, 2001, CARCINOGENESIS, V22, P17, DOI 10.1093/carcin/22.1.17; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Seo SK, 2008, MOL PHARMACOL, V73, P1005, DOI 10.1124/mol.107.041293; Soriano AF, 1999, CANCER RES, V59, P6178; Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062; Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535; STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702; Staley K, 1997, CELL DEATH DIFFER, V4, P66, DOI 10.1038/sj.cdd.4400207; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Vogt T, 2001, MELANOMA RES, V11, P587, DOI 10.1097/00008390-200112000-00005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	42	43	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39949	10.1371/journal.pone.0039949	http://dx.doi.org/10.1371/journal.pone.0039949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22866174	Green Published, Green Submitted, gold			2022-12-25	WOS:000306507000010
J	Dieudonne, A; Torres, D; Blanchard, S; Taront, S; Jeannin, P; Delneste, Y; Pichavant, M; Trottein, F; Gosset, P				Dieudonne, Audrey; Torres, David; Blanchard, Simon; Taront, Solenne; Jeannin, Pascale; Delneste, Yves; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe			Scavenger Receptors in Human Airway Epithelial Cells: Role in Response to Double-Stranded RNA	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; THYMIC STROMAL LYMPHOPOIETIN; MEMBRANE PROTEIN-A; NF-KAPPA-B; DENDRITIC CELLS; TNF-ALPHA; NEUTROPHIL RECRUITMENT; IMMUNE RECOGNITION; ENDOTHELIAL-CELLS; INNATE IMMUNITY	Scavenger receptors and Toll-like receptors (TLRs) cooperate in response to danger signals to adjust the host immune response. The TLR3 agonist double stranded (ds) RNA is an efficient activator of innate signalling in bronchial epithelial cells. In this study, we aimed at defining the role played by scavenger receptors expressed by bronchial epithelial cells in the control of the innate response to dsRNA both in vitro and in vivo. Expression of several scavenger receptor involved in pathogen recognition was first evaluated in human bronchial epithelial cells in steady-state and inflammatory conditions. Their implication in the uptake of dsRNA and the subsequent cell activation was evaluated in vitro by competition with ligand of scavenger receptors including maleylated ovalbumin and by RNA silencing. The capacity of maleylated ovalbumin to modulate lung inflammation induced by dsRNA was also investigated in mice. Exposure to tumor necrosis factor-a increased expression of the scavenger receptors LOX-1 and CXCL16 and the capacity to internalize maleylated ovalbumin, whereas activation by TLR ligands did not. In contrast, the expression of SR-B1 was not modulated in these conditions. Interestingly, supplementation with maleylated ovalbumin limited dsRNA uptake and inhibited subsequent activation of bronchial epithelial cells. RNA silencing of LOX-1 and SR-B1 strongly blocked the dsRNA-induced cytokine production. Finally, administration of maleylated ovalbumin in mice inhibited the dsRNA-induced infiltration and activation of inflammatory cells in bronchoalveolar spaces and lung draining lymph nodes. Together, our data characterize the function of SR-B1 and LOX-1 in bronchial epithelial cells and their implication in dsRNA-induced responses, a finding that might be relevant during respiratory viral infections.	[Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Dieudonne, Audrey; Torres, David; Taront, Solenne; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Univ Lille Nord France, Lille, France; [Dieudonne, Audrey; Torres, David; Taront, Solenne; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Natl Sante & Rech Med, U1019, Lille, France; [Dieudonne, Audrey; Torres, David; Pichavant, Muriel; Trottein, Francois; Gosset, Philippe] Inst Federatif Rech 142, Lille, France; [Dieudonne, Audrey] CH Valenciennes, Serv Hematol Immunol Cytogenet, Valenciennes, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Univ Angers, LUNAM Univ, Angers, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Ctr Rech Cancerol Nantes Angers, U892, INSERM, Nantes, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] CNRS, Unit 6299, Angers, France; [Blanchard, Simon; Jeannin, Pascale; Delneste, Yves] Univ Angers, CHU Angers, Lab Immunol & Allergol, Angers, France; [Taront, Solenne] IBL, CNRS, UMR8199, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; CH de Valenciennes; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Dieudonne, A (corresponding author), Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France.	Philippe.Gosset@pasteur-lille.fr	DELNESTE, Yves/K-7367-2015; JEANNIN, Pascale/K-8656-2015; TROTTEIN, Francois/C-2405-2018; Gosset, Philippe/C-6174-2018; Blanchard, Simon/L-1417-2015; Pichavant, Muriel/B-9036-2018; Delneste, Yves/O-3956-2016; DEZITTER, Solenne/N-5219-2018	DELNESTE, Yves/0000-0002-2142-596X; TROTTEIN, Francois/0000-0003-3373-1814; Gosset, Philippe/0000-0002-4043-6429; Pichavant, Muriel/0000-0002-1315-4397; JEANNIN, Pascale/0000-0002-3666-3856; DEZITTER, Solenne/0000-0001-5850-7291	Agence de l'Environnement et de la Maitrise de l'Energie (ADEME); Conseil Regional Nord-Pas-De-Calais; FRM; fondation pour la recherche medicale (FRM) (Paris, France); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre national de recherche scientifique (CNRS); University of Lille Nord de France; Pasteur Institute of Lille; University of Angers (France)	Agence de l'Environnement et de la Maitrise de l'Energie (ADEME); Conseil Regional Nord-Pas-De-Calais(Region Hauts-de-France); FRM(Fondation pour la Recherche Medicale); fondation pour la recherche medicale (FRM) (Paris, France)(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Lille Nord de France; Pasteur Institute of Lille; University of Angers (France)	ST was supported by a grant from Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) and Conseil Regional Nord-Pas-De-Calais. DT received a grant from the FRM. This study was supported by a grant from the fondation pour la recherche medicale (FRM) (Paris, France). This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the Centre national de recherche scientifique (CNRS), the University of Lille Nord de France, the Pasteur Institute of Lille. PJ is supported by the University of Angers (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; ABRAHAM R, 1995, J IMMUNOL, V154, P1; Ahmed RAM, 2009, ENDOCRINE, V35, P233, DOI 10.1007/s12020-008-9142-2; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Chiba Y, 2001, BIOCHEM BIOPH RES CO, V286, P541, DOI 10.1006/bbrc.2001.5361; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Fujimoto C, 2004, INT IMMUNOL, V16, P55, DOI 10.1093/intimm/dxh025; Ganesan S, 2012, AM J PATHOL, V180, P61, DOI 10.1016/j.ajpath.2011.09.029; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HABERLAND ME, 1989, J IMMUNOL, V142, P855; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Park HS, 2000, ANN ALLERG ASTHMA IM, V84, P623, DOI 10.1016/S1081-1206(10)62414-3; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Pichavant M, 2003, J IMMUNOL, V171, P6697, DOI 10.4049/jimmunol.171.12.6697; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Takizawa H, 1998, INT J MOL MED, V1, P367; Taront S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-9; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200	46	36	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41952	10.1371/journal.pone.0041952	http://dx.doi.org/10.1371/journal.pone.0041952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879901	Green Submitted, gold, Green Published			2022-12-25	WOS:000307437900017
J	Hsu, JC; Chien, TY; Hu, CC; Chen, MJM; Wu, WJ; Feng, HT; Haymer, DS; Chen, CY				Hsu, Ju-Chun; Chien, Ting-Ying; Hu, Chia-Cheng; Chen, Mei-Ju May; Wu, Wen-Jer; Feng, Hai-Tung; Haymer, David S.; Chen, Chien-Yu			Discovery of Genes Related to Insecticide Resistance in Bactrocera dorsalis by Functional Genomic Analysis of a De Novo Assembled Transcriptome	PLOS ONE			English	Article							DETOXIFICATION ENZYMES; KNOCKDOWN RESISTANCE; FRUIT-FLIES; DROSOPHILA; EVOLUTION; FAMILY; GENERATION; DIPTERA; P450; IDENTIFICATION	Insecticide resistance has recently become a critical concern for control of many insect pest species. Genome sequencing and global quantization of gene expression through analysis of the transcriptome can provide useful information relevant to this challenging problem. The oriental fruit fly, Bactrocera dorsalis, is one of the world's most destructive agricultural pests, and recently it has been used as a target for studies of genetic mechanisms related to insecticide resistance. However, prior to this study, the molecular data available for this species was largely limited to genes identified through homology. To provide a broader pool of gene sequences of potential interest with regard to insecticide resistance, this study uses whole transcriptome analysis developed through de novo assembly of short reads generated by next-generation sequencing (NGS). The transcriptome of B. dorsalis was initially constructed using Illumina's Solexa sequencing technology. Qualified reads were assembled into contigs and potential splicing variants (isotigs). A total of 29,067 isotigs have putative homologues in the non-redundant (nr) protein database from NCBI, and 11,073 of these correspond to distinct D. melanogaster proteins in the RefSeq database. Approximately 5,546 isotigs contain coding sequences that are at least 80% complete and appear to represent B. dorsalis genes. We observed a strong correlation between the completeness of the assembled sequences and the expression intensity of the transcripts. The assembled sequences were also used to identify large numbers of genes potentially belonging to families related to insecticide resistance. A total of 90 P450-, 42 GST-and 37 COE-related genes, representing three major enzyme families involved in insecticide metabolism and resistance, were identified. In addition, 36 isotigs were discovered to contain target site sequences related to four classes of resistance genes. Identified sequence motifs were also analyzed to characterize putative polypeptide translational products and associate them with specific genes and protein functions.	[Hsu, Ju-Chun; Wu, Wen-Jer] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Hsu, Ju-Chun; Wu, Wen-Jer] Natl Taiwan Univ, Res Ctr Plant Med, Taipei 10764, Taiwan; [Chien, Ting-Ying] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Hu, Chia-Cheng; Chen, Chien-Yu] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Chen, Mei-Ju May; Chen, Chien-Yu] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Feng, Hai-Tung] Council Agr, Taiwan Agr Chem & Tox Subst Res Inst, Taichung, Taiwan; [Haymer, David S.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; University of Hawaii System; University of Hawaii Manoa	Hsu, JC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	cychen@mars.csie.ntu.edu.tw	Hsu, Ju-Chun/K-2917-2012; Chu, Shu-Chuan/AFQ-6798-2022	Hsu, Ju-Chun/0000-0002-8058-5090; Chu, Shu-Chuan/0000-0003-2117-0618; CHEN, CHIEN-YU/0000-0002-6940-6389	National Science Council of Republic of China, Taiwan [96-2313-B-225-001-MY3, 98-2221-E-002-137-MY2, 99-2627-B-002-004]	National Science Council of Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank National Science Council of Republic of China, Taiwan, for the financial support under the contracts: 96-2313-B-225-001-MY3, 98-2221-E-002-137-MY2 and 99-2627-B-002-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Beverley SM, 1984, J MOL EVOL, V21, P139; Chien TY, 2008, NUCLEIC ACIDS RES, V36, pW291, DOI 10.1093/nar/gkn324; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Fletcher B.S., 1989, FRUIT FLIES THEIR B, P195; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; HE M, 1995, J MOL EVOL, V41, P141, DOI 10.1007/BF00170665; HOSIE AM, 1995, BRIT J PHARMACOL, V115, P909, DOI 10.1111/j.1476-5381.1995.tb15896.x; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Hsu CM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-6; Hsu JC, 2004, J ECON ENTOMOL, V97, P1682, DOI 10.1603/0022-0493-97.5.1682; Hsu JC, 2008, INSECT BIOCHEM MOLEC, V38, P146, DOI 10.1016/j.ibmb.2007.10.002; Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002; Jones AK, 2005, GENOMICS, V85, P176, DOI 10.1016/j.ygeno.2004.09.001; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P2604, DOI 10.1016/S0028-3908(00)00111-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rinkevich FD, 2009, INSECT MOL BIOL, V18, P233, DOI 10.1111/j.1365-2583.2009.00873.x; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roessler Y, 1989, INSECTICIDAL BAIT CO, P329; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Vontas J, 2011, PESTIC BIOCHEM PHYS, V100, P199, DOI 10.1016/j.pestbp.2011.04.004; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; White I.M., 1992, FRUIT FLIES EC SIGNI; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	38	45	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40950	10.1371/journal.pone.0040950	http://dx.doi.org/10.1371/journal.pone.0040950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879883	Green Submitted, gold, Green Published			2022-12-25	WOS:000307437900006
J	Huang, YN; Zhang, YL; Wu, Y; Wang, J; Liu, XG; Dai, LS; Wang, LS; Yu, M; Mo, W				Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Jue; Liu, Xingang; Dai, Linsen; Wang, Longsheng; Yu, Min; Mo, Wei			Expression, Purification, and Mass Spectrometric Analysis of N-15, C-13-Labeled RGD-Hirudin, Expressed in Pichia pastoris, for NMR Studies	PLOS ONE			English	Article							SPECTROSCOPY; PROTEIN; THROMBOCYTOPENIA; SENSITIVITY; HEPARIN	A novel recombinant hirudin, RGD-hirudin, inhibits the activity of thrombin and the aggregation of platelets. Here, we successfully expressed N-15, C-13-labeled RGD-hirudin in Pichia pastoris in a fermenter. The protein was subsequently purified to yield sufficient quantities for structural and functional studies. The purified protein was characterized by HPLC and MALDI-TOF mass spectroscopy. Analysis revealed that the protein was pure and uniformly labeled with N-15 and C-13. A bioassay showed that the anti-thrombin activity and the anti-platelet aggregation ability of the labeled protein were the same as those of unlabeled RGD-hirudin. Multidimensional heteronuclear NMR spectroscopy has been used to determine almost complete backbone N-15, C-13 and H-1 resonance assignments of the r-RGD-Hirudin. The N-15-H-1 HSQC spectrum of uniformly N-15, C-13-labeled RGD-hirudin allowed successful assignment of the signals. Examples of the quality of the data are provided for the N-15-H-1 correlation spectrum, and by selected planes of the CBCA(CO)NH, CBCANH, and HNCO experiments. These results provide a basis for further studies on the structure-function relationship of RGD-hirudin with thrombin and platelets.	[Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Longsheng; Yu, Min; Mo, Wei] Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China; [Huang, Yinong; Zhang, Yanling; Wu, Yi; Wang, Longsheng; Yu, Min; Mo, Wei] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Jue; Liu, Xingang; Dai, Linsen] Fudan Univ, Ctr Anal & Measurement, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Huang, YN (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China.	minyu@shmu.edu.cn; weimo1025@shmu.edu.cn			Foundation of Ministry of Science and Technology of the People's Republic of China [2009ZX09503-006]	Foundation of Ministry of Science and Technology of the People's Republic of China	This study was supported by the Foundation of Ministry of Science and Technology of the People's Republic of China (2009ZX09503-006). The funders had no role in study design, data collection and analysis, decision to publish, or praparation of the manuscript.	AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Cubeddu L, 2000, PROTEIN EXPRES PURIF, V19, P335, DOI 10.1006/prep.2000.1269; Denton H, 1998, PROTEIN EXPRES PURIF, V14, P97, DOI 10.1006/prep.1998.0924; ERNST JF, 1988, TRENDS BIOTECHNOL, V6, P196, DOI 10.1016/0167-7799(88)90046-7; GARRETT DS, 1994, BIOCHEMISTRY-US, V33, P2852, DOI 10.1021/bi00176a015; GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kay LE, 1990, J MAGN RESON, V213, P423, DOI DOI 10.1016/J.JMR.2011.09.004; MARKWARDT F, 1992, CARDIOVASC DRUG REV, V10, P211, DOI 10.1111/j.1527-3466.1992.tb00247.x; MARKWARDT F, 1967, H-S Z PHYSIOL CHEM, V348, P1381, DOI 10.1515/bchm2.1967.348.1.1381; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Mo Wei, 2004, Sheng Wu Gong Cheng Xue Bao, V20, P126; Mo W, 2009, J THROMB THROMBOLYS, V28, P230, DOI 10.1007/s11239-008-0251-9; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Song X, 2007, BIOCHEM BIOPH RES CO, V360, P103, DOI 10.1016/j.bbrc.2007.06.014; Sun Z, 2009, MOL BIOL REP, V36, P1119, DOI 10.1007/s11033-008-9287-3; Wallis RB, 1996, SEMIN THROMB HEMOST, V22, P185, DOI 10.1055/s-2007-999007; Wang J, 2010, PROTEIN PEPTIDE LETT, V17, P1228, DOI 10.2174/092986610792231465; Warkentin TE, 2004, BEST PRACT RES CL HA, V17, P105, DOI 10.1016/j.beha.2004.02.002; Wendeler M, 2004, PROTEIN EXPRES PURIF, V34, P147, DOI 10.1016/j.pep.2003.11.010; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood MJ, 1999, J BIOMOL NMR, V13, P149, DOI 10.1023/A:1008398313350	25	10	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42207	10.1371/journal.pone.0042207	http://dx.doi.org/10.1371/journal.pone.0042207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879918	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900025
J	Joucla, S; Branchereau, P; Cattaert, D; Yvert, B				Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise			Extracellular Neural Microstimulation May Activate Much Larger Regions than Expected by Simulations: A Combined Experimental and Modeling Study	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; DEEP BRAIN-STIMULATION; NERVOUS-SYSTEM NEURONS; ELECTRICAL MICROSTIMULATION; CORTICAL-NEURONS; RHYTHMIC ACTIVITY; CEREBRAL-CORTEX; MOTOR CORTEX; SPREAD; EXCITATION	Electrical stimulation of the central nervous system has been widely used for decades for either fundamental research purposes or clinical treatment applications. Yet, very little is known regarding the spatial extent of an electrical stimulation. If pioneering experimental studies reported that activation threshold currents (TCs) increase with the square of the neuron-to-electrode distance over a few hundreds of microns, there is no evidence that this quadratic law remains valid for larger distances. Moreover, nowadays, numerical simulation approaches have supplanted experimental studies for estimating TCs. However, model predictions have not yet been validated directly with experiments within a common paradigm. Here, we present a direct comparison between experimental determination and modeling prediction of TCs up to distances of several millimeters. First, we combined patch-clamp recording and microelectrode array stimulation in whole embryonic mouse spinal cords to determine TCs. Experimental thresholds did not follow a quadratic law beyond 1 millimeter, but rather tended to remain constant for distances larger than 1 millimeter. We next built a combined finite element - compartment model of the same experimental paradigm to predict TCs. While theoretical TCs closely matched experimental TCs for distances <250 microns, they were highly overestimated for larger distances. This discrepancy remained even after modifications of the finite element model of the potential field, taking into account anisotropic, heterogeneous or dielectric properties of the tissue. In conclusion, these results show that quadratic evolution of TCs does not always hold for large distances between the electrode and the neuron and that classical models may underestimate volumes of tissue activated by electrical stimulation.	[Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France; [Joucla, Sebastien; Branchereau, Pascal; Cattaert, Daniel; Yvert, Blaise] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Joucla, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, UMR5287, Talence, France.	blaise.yvert@u-bordeaux1.fr	Cattaert, Daniel/D-8630-2014; Branchereau, Pascal/B-9206-2011; Yvert, Blaise/E-9052-2016	Branchereau, Pascal/0000-0003-3972-8229; Yvert, Blaise/0000-0002-8850-7935	French ministry for research and technology (RMNT Neurocom project) [03J489]; French ministry for research and technology (ACI Neurosciences Integratives et Computationnelles) [2003541]; French National Research Agency (ANR) [ANR06BLAN035601, ANR07TECSAN01404]; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine [20030301201A, 20040301202A]; European Union (EU)	French ministry for research and technology (RMNT Neurocom project); French ministry for research and technology (ACI Neurosciences Integratives et Computationnelles); French National Research Agency (ANR)(French National Research Agency (ANR)); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Region Aquitaine(Region Nouvelle-Aquitaine); European Union (EU)(CGIAREuropean Commission)	This work was supported by the French ministry for research and technology (RMNT Neurocom project No 03J489 and ACI Neurosciences Integratives et Computationnelles No 2003541), the French National Research Agency (ANR - Programme Blanc No ANR06BLAN035601 and Programme TecSan No ANR07TECSAN01404), the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME), the Region Aquitaine (No 20030301201A and 20040301202A), and the European Union (EU) FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG C, 1974, J PHYSIOL-LONDON, V243, P499, DOI 10.1113/jphysiol.1974.sp010764; Adrian ED, 1936, J PHYSIOL-LONDON, V88, P127, DOI 10.1113/jphysiol.1936.sp003427; BAGSHAW EV, 1976, EXP BRAIN RES, V25, P391; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bossetti CA, 2008, J NEURAL ENG, V5, P44, DOI 10.1088/1741-2560/5/1/005; Branchereau P, 2002, J NEUROSCI, V22, P2598, DOI 10.1523/JNEUROSCI.22-07-02598.2002; BROOKS VB, 1959, J GEN PHYSIOL, V42, P761, DOI 10.1085/jgp.42.4.761; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; CLARK GM, 1977, J LARYNGOL OTOL, V91, P935, DOI 10.1017/S0022215100084607; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020; Eytan D, 2003, J NEUROSCI, V23, P9349; GUSTAFSSON B, 1976, J PHYSIOL-LONDON, V258, P33, DOI 10.1113/jphysiol.1976.sp011405; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Joucla S, 2012, J PHYSIOL-PARIS, V106, P146, DOI 10.1016/j.jphysparis.2011.10.003; Joucla S, 2009, BIOPHYS J, V96, P3495, DOI 10.1016/j.bpj.2008.12.3961; Joucla S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004828; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; McIntyre CC, 2001, ANN BIOMED ENG, V29, P227, DOI 10.1114/1.1352640; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nowak LG, 1996, J NEUROSCI METH, V67, P237, DOI 10.1016/0165-0270(96)00065-9; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Plonsey R, 1998, IEEE ENG MED BIOL, V17, P130, DOI 10.1109/51.715497; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Struijk J. J., 1993, IEEE Transactions on Rehabilitation Engineering, V1, P101, DOI 10.1109/86.242424; STRUIJK JJ, 1993, IEEE T BIO-MED ENG, V40, P632, DOI 10.1109/10.237693; STRUIJK JJ, 1992, IEEE T BIO-MED ENG, V39, P903, DOI 10.1109/10.256423; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Weiss G., 1901, ARCH ITAL BIOL, V35, P416; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Winfree Christopher J, 2005, Curr Surg, V62, P476; Yvert B, 2004, J NEUROPHYSIOL, V91, P2101, DOI 10.1152/jn.01095.2003; Yvert B, 2011, J NEUROSCI, V31, P8832, DOI 10.1523/JNEUROSCI.1354-11.2011	50	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41324	10.1371/journal.pone.0041324	http://dx.doi.org/10.1371/journal.pone.0041324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879886	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900009
J	Vas, V; Senger, K; Dorr, K; Niebel, A; Geiger, H				Vas, Virag; Senger, Katharina; Doerr, Karin; Niebel, Anja; Geiger, Hartmut			Aging of the Microenvironment Influences Clonality in Hematopoiesis	PLOS ONE			English	Article							STEM-CELL NICHE; PROGENITOR CELLS; LEUKEMIA; AGE	The mechanisms of the age-associated exponential increase in the incidence of leukemia are not known in detail. Leukemia as well as aging are initiated and regulated in multi-factorial fashion by cell-intrinsic and extrinsic factors. The role of aging of the microenvironment for leukemia initiation/progression has not been investigated in great detail so far. Clonality in hematopoiesis is tightly linked to the initiation of leukemia. Based on a retroviral-insertion mutagenesis approach to generate primitive hematopoietic cells with an intrinsic potential for clonal expansion, we determined clonality of transduced hematopoietic progenitor cells (HPCs) exposed to a young or aged microenvironment in vivo. While HPCs displayed primarily oligo-clonality within a young microenvironment, aged animals transplanted with identical pool of cells displayed reduced clonality within transduced HPCs. Our data show that an aged niche exerts a distinct selection pressure on dominant HPC-clones thus facilitating the transition to mono-clonality, which might be one underlying cause for the increased age-associated incidence of leukemia.	[Vas, Virag; Senger, Katharina; Doerr, Karin; Niebel, Anja; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Geiger, Hartmut] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Vas, V (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	hartmut.geiger@uni-ulm.de	Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022	Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Vas, Virag/0000-0002-9722-8188	Deutsche Forschungsgemeinschaft [SFB497, TP10, KFO142, GE2063/1]; National Institute of Health [HL076604, DK077762, AG040118]; Tierforschungszentrum of University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tierforschungszentrum of University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB497, TP10 and KFO142, GE2063/1 and from National Institute of Health, HL076604, DK077762 and AG040118 to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tierforschungszentrum of University of Ulm for supporting our animal work.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bagby Grover C, 2011, Front Biosci (Schol Ed), V3, P487, DOI 10.2741/s167; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Freemont AJ, 2007, J PATHOL, V211, P252, DOI 10.1002/path.2097; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020	26	63	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42080	10.1371/journal.pone.0042080	http://dx.doi.org/10.1371/journal.pone.0042080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879906	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000014
J	Chen, J; Wang, M; Xi, B; Xue, J; He, D; Zhang, J; Zhao, YR				Chen, Jie; Wang, Mei; Xi, Bo; Xue, Jian; He, Dan; Zhang, Jie; Zhao, Yueran			SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer	PLOS ONE			English	Article							PROTEIN EXPRESSION; DOWN-REGULATION; E-CADHERIN; CELL; BREAST; RICH; ACTIVATION; GROWTH; OSTEONECTIN/SPARC; IDENTIFICATION	Background: Secreted protein acidic and rich in cysteine (SPARC), a calcium-binding matricellular glycoprotein, is implicated in the progression of many cancers. In this study, we investigated the expression and function of SPARC in ovarian cancer. Methods: cDNA microarray analysis was performed to compare gene expression profiles of the highly invasive and the low invasive subclones derived from the SKOV3 human ovarian cancer cell line. Immunohistochemistry (IHC) staining was performed to investigate SPARC expression in a total of 140 ovarian tissue specimens. In functional assays, effects of SPARC knockdown on the biological behavior of ovarian cancer cells were investigated. The mechanisms of SPARC in ovarian cancer proliferation, apoptosis and invasion were also researched. Results: SPARC was overexpressed in the highly invasive subclone compared with the low invasive subclone. High SPARC expression was associated with high stage, low differentiation, lymph node metastasis and poor prognosis of ovarian cancer. Knockdown of SPARC expression significantly suppressed ovarian cancer cell proliferation, induced cell apoptosis and inhibited cell invasion and metastasis. Conclusion: SPARC is overexpressed in highly invasive subclone and ovarian cancer tissues and plays an important role in ovarian cancer growth, apoptosis and metastasis.	[Chen, Jie; Xi, Bo; Xue, Jian; He, Dan] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wang, Mei] Shandong Univ, Shandong Prov Hosp, Dept Pharm, Jinan 250100, Peoples R China; [Zhang, Jie; Zhao, Yueran] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Chen, J (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China.	zhangjie19630711@163.com; yrzhao@sdu.edu.cn			Shandong University [2012TS088]	Shandong University	This study was supported by a grant-in-aid for scientific research (2012TS088) from the Shandong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Atorrasagasti C, 2010, INT J CANCER, V126, P2726, DOI 10.1002/ijc.24966; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brown TJ, 1999, GYNECOL ONCOL, V75, P25, DOI 10.1006/gyno.1999.5552; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen J, 2009, J CANCER RES CLIN, V135, P909, DOI 10.1007/s00432-008-0526-8; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Greenaway JB, 2012, BIOCHEM CELL BIOL, V90, P96, DOI [10.1139/o11-047, 10.1139/O11-047]; Horie K, 2010, CANCER SCI, V101, P913, DOI 10.1111/j.1349-7006.2009.01476.x; Hsiao YH, 2010, BREAST J, V16, P305, DOI 10.1111/j.1524-4741.2009.00899.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kunigal S, 2006, INT J ONCOL, V29, P1349; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Le Bail B, 1999, J PATHOL, V189, P46; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Paley PJ, 2000, GYNECOL ONCOL, V78, P336, DOI 10.1006/gyno.2000.5894; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; Shenhua X, 1999, J EXP CLIN CANC RES, V18, P233; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706; Yin J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-59; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zhang LQ, 2011, CLIN LUNG CANC	43	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42413	10.1371/journal.pone.0042413	http://dx.doi.org/10.1371/journal.pone.0042413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879971	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100084
J	Ferrario, CR; Goussakov, I; Stutzmann, GE; Wolf, ME				Ferrario, Carrie R.; Goussakov, Ivan; Stutzmann, Grace E.; Wolf, Marina E.			Withdrawal from Cocaine Self-Administration Alters NMDA Receptor-Mediated Ca2+ Entry in Nucleus Accumbens Dendritic Spines	PLOS ONE			English	Article							PERMEABLE AMPA RECEPTORS; SYNAPTIC PLASTICITY; STRUCTURAL PLASTICITY; PREFRONTAL CORTEX; HIPPOCAMPAL; NEURONS; ACTIVATION; CHANNELS; MORPHOLOGY; INCUBATION	We previously showed that the time-dependent intensification ("incubation'') of cue-induced cocaine seeking after withdrawal from extended-access cocaine self-administration is accompanied by accumulation of Ca2+-permeable AMPA receptors (CP-AMPARs) in the rat nucleus accumbens (NAc). These results suggest an enduring change in Ca2+ signaling in NAc dendritic spines. The purpose of the present study was to determine if Ca2+ signaling via NMDA receptors (NMDARs) is also altered after incubation. Rats self-administered cocaine or saline for 10 days (6 h/day). After 45-47 days of withdrawal, NMDAR-mediated Ca2+ entry elicited by glutamate uncaging was monitored in individual NAc dendritic spines. NMDAR currents were simultaneously recorded using whole cell patch clamp recordings. We also measured NMDAR subunit levels in a postsynaptic density (PSD) fraction prepared from the NAc of identically treated rats. NMDAR currents did not differ between groups, but a smaller percentage of spines in the cocaine group responded to glutamate uncaging with NMDAR-mediated Ca2+ entry. No significant group differences in NMDAR subunit protein levels were found. The decrease in the proportion of spines showing NMDAR-mediated Ca2+ entry suggests that NAc neurons in the cocaine group contain more spines which lack NMDARs (non-responding spines). The fact that cocaine and saline groups did not differ in NMDAR currents or NMDAR subunit levels suggests that the number of NMDARs on responding spines is not significantly altered by cocaine exposure. These findings are discussed in light of increases in dendritic spine density in the NAc observed after withdrawal from repeated cocaine exposure.	[Ferrario, Carrie R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Goussakov, Ivan] Univ Chicago, Dept Pediat, Neurol Sect, Chicago, IL 60637 USA; [Stutzmann, Grace E.; Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA	University of Michigan System; University of Michigan; University of Chicago; Rosalind Franklin University Medical & Science	Ferrario, CR (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	marina.wolf@rosalindfranklin.edu	Ferrario, Carrie R/L-7372-2016	Ferrario, Carrie R/0000-0002-9673-7028	National Research Service Award [DA024502];  [DA015835];  [DA029099]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015835, K05DA029099, R01DA015835, F32DA024502] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by DA015835 and DA029099 (MEW), and National Research Service Award DA024502 (CRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara AA, 2011, SYNAPSE, V65, P309, DOI 10.1002/syn.20849; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Finch DM, 1996, HIPPOCAMPUS, V6, P495; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Higley MJ, 2012, COLD SPRING HARBOR P, V4; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Johnston D, 1994, FDN CELLULAR NEUROPH; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kim Y, 2009, P NATL ACAD SCI USA, V106, P2915, DOI 10.1073/pnas.0813179106; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Majewska A, 2000, J NEUROSCI, V20, P1722; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Reimers JM, 2011, BRAIN RES, V1367, P223, DOI 10.1016/j.brainres.2010.10.016; Ren Z, 2010, NEUROSCIENCE, V168, P48, DOI 10.1016/j.neuroscience.2010.03.034; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	59	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40898	10.1371/journal.pone.0040898	http://dx.doi.org/10.1371/journal.pone.0040898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870207	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100011
J	Heyerdahl, H; Abbas, N; Brevik, EM; Mollatt, C; Dahle, J				Heyerdahl, Helen; Abbas, Nasir; Brevik, Ellen Mengshoel; Mollatt, Camilla; Dahle, Jostein			Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting Th-227-DOTA-p-benzyl-trastuzumab	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROSTATE-CANCER; TRASTUZUMAB; BINDING; RADIOIMMUNOTHERAPY; MULTICENTER; RADIUM-223; EFFICACY; TUMORS	Background: The aim of this study was to investigate therapeutic efficacy and normal tissue toxicity of single dosage and fractionated targeted alpha therapy (TAT) in mice with HER2-expressing breast and ovarian cancer xenografts using the low dose rate radioimmunoconjugate Th-227-DOTA-p-benzyl-trastuzumab. Methodology/Principal Findings: Nude mice carrying HER2-overexpressing subcutaneous SKOV-3 or SKBR-3 xenografts were treated with 1000 kBq/kg Th-227-trastuzumab as single injection or four injections of 250 kBq/kg with intervals of 4-5 days, 2 weeks, or 4 weeks. Control animals were treated with normal saline or unlabeled trastuzumab. In SKOV-3 xenografts tumor growth to 10-fold size was delayed (p<0.01) and survival with tumor diameter less than 16 mm was prolonged (p<0.05) in all TAT groups compared to the control groups. No statistically significant differences were seen among the treated groups. In SKBR-3 xenografts tumor growth to 10-fold size was delayed in the single injection and 4-5 days interval groups (p<0.001) and all except the 4 weeks interval TAT group showed improved survival to the control groups (p<0.05). Toxicity was assessed by blood cell counts, clinical chemistry measurements and body weight. Transient reduction in white blood cells was seen for the single injection and 4-5 days interval groups (p<0.05). No significant changes were seen in red blood cells, platelets or clinical chemistry parameters. Survival without life threatening loss of body weight was significantly prolonged in 4 weeks interval group compared to single injection group (p<0.05) for SKOV-3 animals and in 2 weeks interval group compared with the 4-5 days interval groups (p<0.05) for SKBR-3 animals. Conclusions/Significance: The same concentration of radioactivity split into several fractions may improve toxicity of Th-227-radioimmunotherapy while the therapeutic effect is maintained. Thus, it might be possible to increase the cumulative absorbed radiation dose to tumor with acceptable toxicity by fractionation of the dosage.	[Heyerdahl, Helen; Abbas, Nasir; Mollatt, Camilla; Dahle, Jostein] Univ Oslo, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Brevik, Ellen Mengshoel] Algeta ASA, Dept Res & Dev, Oslo, Norway; [Dahle, Jostein] Nord Nanovector AS, Dept Res & Dev, Oslo, Norway	University of Oslo	Heyerdahl, H (corresponding author), Univ Oslo, Inst Canc Res, Dept Radiat Biol, Oslo, Norway.	Helen.Heyerdahl@rr-research.no	Dahle, Jostein/AAE-7776-2020	Dahle, Jostein/0000-0002-1447-6005	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	Research support was granted by the Norwegian Cancer Society (http://www.kreftforeningen.no) (graduate student salary for HH), South-Eastern Norway Regional Health Authority (http://www. helse-sorost.no) (graduate student salary for NA). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas N, 2012, NUCL MED CO IN PRESS; Abbas N, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-18; Dahle J, 2008, INT J RADIAT ONCOL, V72, P186, DOI 10.1016/j.ijrobp.2008.05.029; Dahle J, 2007, BLOOD, V110, P2049, DOI 10.1182/blood-2007-01-066803; Dahle J, 2010, EUR J NUCL MED MOL I, V37, P93, DOI 10.1007/s00259-009-1197-7; DeNardo GL, 2002, CANCER-AM CANCER SOC, V94, P1332, DOI 10.1002/cncr.10304; Elgqvist J, 2010, J ONCOL, V2010, DOI 10.1155/2010/394913; Elgqvist J, 2006, NUCL MED BIOL, V33, P1065, DOI 10.1016/j.nucmedbio.2006.07.009; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FUJIMORI K, 1990, J NUCL MED, V31, P1191; Heyerdahl H, 2011, INT J RADIAT ONCOL, V79, P563, DOI 10.1016/j.ijrobp.2010.08.038; Illidge TM, 2009, BLOOD, V113, P1412, DOI 10.1182/blood-2008-08-175653; KENNEL SJ, 1992, CANCER RES, V52, P1284; Larsen RH, 2007, CANCER BIOTHER RADIO, V22, P431, DOI 10.1089/cbr.2006.321; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Milenic DE, 2010, MABS-AUSTIN, V2, P550, DOI 10.4161/mabs.2.5.13054; Morschhauser F, 2010, J CLIN ONCOL, V28, P3709, DOI 10.1200/JCO.2009.27.7863; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nilsson S, 2007, LANCET ONCOL, V8, P587, DOI 10.1016/S1470-2045(07)70147-X; Palm S, 2007, INT J RADIAT ONCOL, V69, P572, DOI 10.1016/j.ijrobp.2007.06.023; Parker C, 2011, EUR J CANCER, V47, P3, DOI 10.1016/S0959-8049(11)70100-9; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; SCHLOM J, 1990, JNCI-J NATL CANCER I, V82, P763, DOI 10.1093/jnci/82.9.763; Sgouros G, 1999, J NUCL MED, V40, P1935; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steger GG, 2010, WIEN KLIN WOCHENSCHR, V122, P368, DOI 10.1007/s00508-010-1373-6; Verri E, 2005, ONCOLOGY-BASEL, V68, P154, DOI 10.1159/000086958; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	29	41	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42345	10.1371/journal.pone.0042345	http://dx.doi.org/10.1371/journal.pone.0042345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879947	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100072
J	Huang, WC; Sala-Newby, GB; Susana, A; Johnson, JL; Newby, AC				Huang, Wei-Chun; Sala-Newby, Graciela B.; Susana, Angela; Johnson, Jason L.; Newby, Andrew C.			Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-kappa B	PLOS ONE			English	Article							INTERFERON-GAMMA; EXPRESSION; MONOCYTE; CELLS; INFLAMMATION; MODULATORS; INHIBITOR; MOLECULES; ARTHRITIS; GENES	Remodelling of the extracellular matrix (ECM) and cell surface by matrix metalloproteinases (MMPs) is an important function of monocytes and macrophages. Recent work has emphasised the diverse roles of classically and alternatively activated macrophages but the consequent regulation of MMPs and their inhibitors has not been studied comprehensively. Classical activation of macrophages derived in vitro from un-fractionated CD16(+/-) or negatively-selected CD16(-) macrophages up-regulated MMP-1, -3, -7, -10, -12, -14 and -25 and decreased TIMP-3 steady-state mRNA levels. Bacterial lipopolysaccharide, IL-1 and TNF alpha were more effective than interferon gamma except for the effects on MMP-25, and TIMP-3. By contrast, alternative activation decreased MMP-2, -8 and -19 but increased MMP -11, -12, -25 and TIMP-3 steady-state mRNA levels. Up-regulation of MMPs during classical activation depended on mitogen activated protein kinases, phosphoinositide-3-kinase and inhibitor of kappa B kinase-2. Effects of interferonc depended on janus kinase-2. Where investigated, similar effects were seen on protein concentrations and collagenase activity. Moreover, activity of MMP-1 and -10 co-localised with markers of classical activation in human atherosclerotic plaques in vivo. In conclusion, classical macrophage activation selectively up-regulates several MMPs in vitro and in vivo and down-regulates TIMP-3, whereas alternative activation up-regulates a distinct group of MMPs and TIMP-3. The signalling pathways defined here suggest targets for selective modulation of MMP activity.	[Huang, Wei-Chun; Sala-Newby, Graciela B.; Susana, Angela; Johnson, Jason L.; Newby, Andrew C.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Huang, Wei-Chun] Kaohsiung Vet Gen Hosp, Ctr Cardiovasc, Kaohsiung, Taiwan; [Huang, Wei-Chun] Natl Yang Ming Univ, Taiwan Sch Med, Taipei 112, Taiwan	University of Bristol; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, WC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	a.newby@bris.ac.uk	Johnson, Jason/AAC-3124-2019	Johnson, Jason/0000-0003-0630-9183	British Heart Foundation [CH95/001, RG04/009]; National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine; Yen Tjing Ling Medical Foundation; Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan; British Heart Foundation [FS/07/053/24069, RG/09/006/27918] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine(National Health Research Institutes - Taiwan); Yen Tjing Ling Medical Foundation; Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation CH95/001 and RG04/009 and the National Health Research Institute (UK) Bristol Biomedical Research Unit in Cardiovascular Medicine. W-C Huang held Fellowships from the Yen Tjing Ling Medical Foundation and Medical Foundation in Memory of Dr. Deh-Lin Cheng, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2358; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Bond M, 1999, BIOCHEM BIOPH RES CO, V264, P561, DOI 10.1006/bbrc.1999.1551; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gueders MM, 2010, AM J RESP CELL MOL, V43, P286, DOI 10.1165/rcmb.2008-0426OC; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Montero I, 2006, J AM COLL CARDIOL, V47, P1369, DOI 10.1016/j.jacc.2005.10.070; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	40	53	57	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42507	10.1371/journal.pone.0042507	http://dx.doi.org/10.1371/journal.pone.0042507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880008	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100113
J	Imamura, Y; Sakamoto, S; Endo, T; Utsumi, T; Fuse, M; Suyama, T; Kawamura, K; Imamoto, T; Yano, K; Uzawa, K; Nihei, N; Suzuki, H; Mizokami, A; Ueda, T; Seki, N; Tanzawa, H; Ichikawa, T				Imamura, Yusuke; Sakamoto, Shinichi; Endo, Takumi; Utsumi, Takanobu; Fuse, Miki; Suyama, Takahito; Kawamura, Koji; Imamoto, Takashi; Yano, Kojiro; Uzawa, Katsuhiro; Nihei, Naoki; Suzuki, Hiroyoshi; Mizokami, Atsushi; Ueda, Takeshi; Seki, Naohiko; Tanzawa, Hideki; Ichikawa, Tomohiko			FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway	PLOS ONE			English	Article							FORKHEAD BOX A1; LARGE GENE LISTS; ANDROGEN RECEPTOR; TRANSCRIPTION FACTORS; LUMINAL SUBTYPE; BREAST-CANCER; STROMAL CELLS; HIGH-LEVEL; EXPRESSION; LNCAP	Fork-head box protein A1 (FOXA1) is a "pioneer factor" that is known to bind to the androgen receptor (AR) and regulate the transcription of AR-specific genes. However, the precise role of FOXA1 in prostate cancer (PC) remains unknown. In this study, we report that FOXA1 plays a critical role in PC cell proliferation. The expression of FOXA1 was higher in PC than in normal prostate tissues (P = 0.0002), and, using immunohistochemical analysis, we found that FOXA1 was localized in the nucleus. FOXA1 expression levels were significantly correlated with both PSA and Gleason scores (P = 0.016 and P = 0.031, respectively). Moreover, FOXA1 up-regulation was a significant factor in PSA failure (P = 0.011). Depletion of FOXA1 in a prostate cancer cell line (LNCaP) using small interfering RNA (siRNA) significantly inhibited AR activity, led to cell-growth suppression, and induced G0/G1 arrest. The anti-proliferative effect of FOXA1 siRNA was mediated through insulin-like growth factor binding protein 3 (IGFBP-3). An increase in IGFBP-3, mediated by depletion of FOXA1, inhibited phosphorylation of MAPK and Akt, and increased expression of the cell cycle regulators p21 and p27. We also found that the anti-proliferative effect of FOXA1 depletion was significantly reversed by simultaneous siRNA depletion of IGFBP-3. These findings provide direct physiological and molecular evidence for a role of FOXA1 in controlling cell proliferation through the regulation of IGFBP-3 expression in PC.	[Imamura, Yusuke; Sakamoto, Shinichi; Utsumi, Takanobu; Fuse, Miki; Suyama, Takahito; Kawamura, Koji; Imamoto, Takashi; Nihei, Naoki; Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; [Endo, Takumi; Suzuki, Hiroyoshi] Toho Univ, Med Ctr, Sakura Hosp, Dept Urol, Chiba 2748510, Japan; [Yano, Kojiro] Osaka Inst Technol, Fac Informat Sci & Technol, Osaka 535, Japan; [Uzawa, Katsuhiro; Tanzawa, Hideki] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Mizokami, Atsushi] Kanazawa Univ, Dept Urol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Ueda, Takeshi] Chiba Canc Ctr, Div Urol, Chiba 2608717, Japan; [Ueda, Takeshi] Chiba Canc Ctr, Prostate Ctr, Chiba 2608717, Japan; [Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	Chiba University; Toho University; Osaka Institute of Technology; Chiba University; Kanazawa University; Chiba Cancer Center; Chiba Cancer Center; Chiba University	Imamura, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan.	rbatbat1@yahoo.co.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Science, Sports and Culture of Japan [20390420, 22791469]; Grants-in-Aid for Scientific Research [22591761] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (no. 20390420, no. 22791469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Lima GAB, 2009, ARQ BRAS ENDOCRINOL, V53, P969, DOI 10.1590/S0004-27302009000800010; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; DeGraff DJ, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P587, DOI 10.1007/978-0-387-69179-4_25; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Endo T, 2009, INT J ONCOL, V35, P499, DOI 10.3892/ijo_00000361; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ichikawa T, 2005, CANCER CHEMOTH PHARM, V56, pS58, DOI 10.1007/s00280-005-0100-x; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kojima S, 2006, PROSTATE, V66, P971, DOI 10.1002/pros.20420; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Lin L, 2002, CANCER RES, V62, P5273; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Mizokami A, 2009, ENDOCR-RELAT CANCER, V16, P1139, DOI 10.1677/ERC-09-0070; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Silha JV, 2006, ENDOCRINOLOGY, V147, P2112, DOI 10.1210/en.2005-1270; Sun Q, 2009, MOL ENDOCRINOL, V23, P2038, DOI 10.1210/me.2009-0092; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yamatoji M, 2010, ONCOL REP, V23, P61, DOI 10.3892/or_00000606; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	46	41	43	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42456	10.1371/journal.pone.0042456	http://dx.doi.org/10.1371/journal.pone.0042456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879989	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100098
J	Leimu, R; Kloss, L; Fischer, M				Leimu, Roosa; Kloss, Lena; Fischer, Markus			Inbreeding Alters Activities of the Stress-Related Enzymes Chitinases and beta-1,3-Glucanases	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; LYCHNIS-FLOS-CUCULI; PLANT CHITINASES; MIMULUS-GUTTATUS; HSP70 EXPRESSION; RESISTANCE; HERBIVORY; POPULATION; DEPRESSION; DEFENSE	Pathogenesis-related proteins, chitinases (CHT) and beta-1,3-glucanases (GLU), are stress proteins up-regulated as response to extrinsic environmental stress in plants. It is unknown whether these PR proteins are also influenced by inbreeding, which has been suggested to constitute intrinsic genetic stress, and which is also known to affect the ability of plants to cope with environmental stress. We investigated activities of CHT and GLU in response to inbreeding in plants from 13 Ragged Robin (Lychnis flos-cuculi) populations. We also studied whether activities of these enzymes were associated with levels of herbivore damage and pathogen infection in the populations from which the plants originated. We found an increase in pathogenesis-related protein activity in inbred plants from five out of the 13 investigated populations, which suggests that these proteins may play a role in how plants respond to intrinsic genetic stress brought about by inbreeding in some populations depending on the allele frequencies of loci affecting the expression of CHT and the past levels of inbreeding. More importantly, we found that CHT activities were higher in plants from populations with higher levels of herbivore or pathogen damage, but inbreeding reduced CHT activity in these populations disrupting the increased activities of this resistance-related enzyme in populations where high resistance is beneficial. These results provide novel information on the effects of plant inbreeding on plant-enemy interactions on a biochemical level.	[Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England; [Leimu, Roosa; Kloss, Lena; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Kloss, Lena] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Oxford; University of Potsdam; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bern	Leimu, R (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	roosa.leimu@plants.ox.ac.uk	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	Marie Curie Intra-European Fellowship of the Academy of Finland [108784]; Swiss National Science Foundation [31-56809.99, 31-67876.02]	Marie Curie Intra-European Fellowship of the Academy of Finland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by a Marie Curie Intra-European Fellowship for RL, grant 108784 of the Academy of Finland to RL, and grants 31-56809.99 and 31-67876.02 of the Swiss National Science Foundation to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Bello-Bedoy R, 2011, EVOL ECOL, V25, P815, DOI 10.1007/s10682-010-9448-4; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; Delphia CM, 2009, INT J PLANT SCI, V170, P12, DOI 10.1086/593039; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dudash MR, 1997, EVOLUTION, V51, P54, DOI [10.2307/2410960, 10.1111/j.1558-5646.1997.tb02388.x]; DUDASH MR, 1990, EVOLUTION, V44, P1129, DOI 10.1111/j.1558-5646.1990.tb05220.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Ferrari MJ, 2006, AM J BOT, V93, P1768, DOI 10.3732/ajb.93.12.1768; Galeuchet DJ, 2005, ECOLOGY, V86, P1002, DOI 10.1890/03-0762; Galeuchet DJ, 2005, MOL ECOL, V14, P991, DOI 10.1111/j.1365-294X.2005.02485.x; GALEUCHET DJ, 2003, THESIS U ZURICH; Hayes CN, 2005, J EVOLUTION BIOL, V18, P147, DOI 10.1111/j.1420-9101.2004.00785.x; HOEHN S, 2006, THESIS U ZURICH; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Kariyat RR, 2012, ECOL LETT, V15, P301, DOI 10.1111/j.1461-0248.2011.01738.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Krishnaveni S, 1999, PLANT SCI, V144, P9, DOI 10.1016/S0168-9452(99)00049-7; Kristensen TN, 2002, EVOL ECOL RES, V4, P1209; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Lawrence CB, 2000, PHYSIOL MOL PLANT P, V57, P211, DOI 10.1006/pmpp.2000.0298; LEGRAND M, 1987, P NATL ACAD SCI USA, V84, P6750, DOI 10.1073/pnas.84.19.6750; Leimu R, 2008, ECOL LETT, V11, P1101, DOI 10.1111/j.1461-0248.2008.01222.x; Metwally A, 2005, J EXP BOT, V56, P167; Ouborg NJ, 2000, ECOLOGY, V81, P520, DOI 10.2307/177445; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Pedersen KS, 2005, J EVOLUTION BIOL, V18, P756, DOI 10.1111/j.1420-9101.2005.00884.x; Ridley CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024762; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; TRONSMO AM, 1993, DEV PLANT PATHOL, V2, P369; Tuzun S, 2001, EUR J PLANT PATHOL, V107, P85, DOI 10.1023/A:1008784417222; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Waller DM, 2008, EVOLUTION, V62, P917, DOI 10.1111/j.1558-5646.2008.00325.x; Wirooks Ludger, 1999, Melanargia, V11, P93; WIRTH SJ, 1992, SOIL BIOL BIOCHEM, V24, P511, DOI 10.1016/0038-0717(92)90074-8	41	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42326	10.1371/journal.pone.0042326	http://dx.doi.org/10.1371/journal.pone.0042326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879940	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100067
J	Simon-Vazquez, R; Dominguez, M; Lorenz-Fonfria, VA; Alvarez, S; Bourdelande, JL; de Lera, AR; Padros, E; Peralvarez-Marin, A				Simon-Vazquez, Rosana; Dominguez, Marta; Lorenz-Fonfria, Victor A.; Alvarez, Susana; Bourdelande, Jose-Luis; de Lera, Angel R.; Padros, Esteve; Peralvarez-Marin, Alex			Probing a Polar Cluster in the Retinal Binding Pocket of Bacteriorhodopsin by a Chemical Design Approach	PLOS ONE			English	Article							HALOBACTERIUM-HALOBIUM; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; PURPLE MEMBRANE; O-INTERMEDIATE; PROTON; PHOTOCYCLE; 13-CIS; ISOMERIZATION; ADAPTATION	Bacteriorhodopsin has a polar cluster of amino acids surrounding the retinal molecule, which is responsible for light harvesting to fuel proton pumping. From our previous studies, we have shown that threonine 90 is the pivotal amino acid in this polar cluster, both functionally and structurally. In an attempt to perform a phenotype rescue, we have chemically designed a retinal analogue molecule to compensate the drastic effects of the T90A mutation in bacteriorhodopsin. This analogue substitutes the methyl group at position C-13 of the retinal hydrocarbon chain by and ethyl group (20-methyl retinal). We have analyzed the effect of reconstituting the wild-type and the T90A mutant apoproteins with all-trans-retinal and its 20-methyl derivative (hereafter, 13-ethyl retinal). Biophysical characterization indicates that recovering the steric interaction between the residue 90 and retinal, eases the accommodation of the chromophore, however it is not enough for a complete phenotype rescue. The characterization of these chemically engineered chromoproteins provides further insight into the role of the hydrogen bond network and the steric interactions involving the retinal binding pocket in bacteriorhodopsin and other microbial sensory rhodopsins.	[Simon-Vazquez, Rosana; Lorenz-Fonfria, Victor A.; Padros, Esteve; Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Spain; [Simon-Vazquez, Rosana; Lorenz-Fonfria, Victor A.; Padros, Esteve; Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Dominguez, Marta; Alvarez, Susana; de Lera, Angel R.] Univ Vigo, Fac Quim, Dept Quim Organ, Vigo 36310, Spain; [Bourdelande, Jose-Luis] Univ Autonoma Barcelona, Dept Quim Quim Organ, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidade de Vigo; Autonomous University of Barcelona	Simon-Vazquez, R (corresponding author), Univ Vigo, Fac Ciencias, Lab Inmunol, Campus Lagoas Marcosende, Vigo 36310, Spain.	Alex.Peralvarez@uab.cat	Peralvarez-Marin, Alex/AAH-4305-2020; Fonfria, Victor A Lorenz/B-3754-2018; Fonfria, Victor A. Lorenz/AAU-9034-2021; Dominguez, Marta/AAA-2084-2019; Peralvarez-Marin, Alex/A-8958-2017; Simón, Rosana/K-6130-2014; Simón-Vázquez, Rosana/AER-4378-2022	Fonfria, Victor A Lorenz/0000-0002-8859-8347; Fonfria, Victor A. Lorenz/0000-0002-8859-8347; Peralvarez-Marin, Alex/0000-0002-3457-0875; Simón, Rosana/0000-0001-8963-6547; Dominguez Seoane, Marta/0000-0003-4569-8011; Rodriguez de Lera, Angel/0000-0001-6896-9078	Spanish Ministry of Science and Innovation [BES-2004-5542, BFU2009-08758/BMC, SAF2010-21385, SAF2010-17935-FEDER]; Xunta de Galicia (from DXI+D+i) [08CSA052383PR]; European Commission [PIOF-GA-2009-237120]; Xunta de Galicia (from DXPCTSUG) [Consolidacion 2006/15]; Xunta de Galicia (from INBIOMED); Xunta de Galicia (from Parga Pondal)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (from DXI+D+i)(Xunta de Galicia); European Commission(European CommissionEuropean Commission Joint Research Centre); Xunta de Galicia (from DXPCTSUG)(Xunta de Galicia); Xunta de Galicia (from INBIOMED)(Xunta de Galicia); Xunta de Galicia (from Parga Pondal)(Xunta de Galicia)	The authors want to thank the following sources of funding: the Spanish Ministry of Science and Innovation (BES-2004-5542 to RS-V, BFU2009-08758/BMC to EP, SAF2010-21385 to AP-M, SAF2010-17935-FEDER to ARdL), Xunta de Galicia (Grant 08CSA052383PR from DXI+D+i; Consolidacion 2006/15 from DXPCTSUG; INBIOMED; Parga Pondal Contract to MD), and European Commission (Marie Curie Action PIOF-GA-2009-237120 to AP-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, BIOCHEMISTRY-US, V40, P13310, DOI 10.1021/bi011438u; Alvarez R, 1999, TETRAHEDRON, V55, P13779, DOI 10.1016/S0040-4020(99)00861-3; BALASHOV SP, 1993, BIOCHEMISTRY-US, V32, P10331, DOI 10.1021/bi00090a008; Brown MF, 2007, BBA-BIOMEMBRANES, V1768, P2979, DOI 10.1016/j.bbamem.2007.10.014; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CORRIU RJP, 1972, J CHEM SOC CHEM COMM, P144; Curran AR, 2003, CURRENT OPINION STRU, P13; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Gartner W, 1988, BIOCHEMISTRY-US, V27, P6; GERGELY C, 1994, BIOPHYS J, V67, P855, DOI 10.1016/S0006-3495(94)80545-4; Gillespie NB, 2005, J PHYS CHEM B, V109, P16142, DOI 10.1021/jp052124+; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Hiraki K, 2002, BIOPHYS J, V83, P3460, DOI 10.1016/S0006-3495(02)75345-9; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kato HE, 2012, NATURE; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lazarova T, 2009, PHOTOCHEM PHOTOBIOL, V85, P617, DOI 10.1111/j.1751-1097.2008.00534.x; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Lopez S, 2005, CHEMBIOCHEM, V6, P2078, DOI 10.1002/cbic.200500148; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MOWERY PC, 1979, BIOCHEMISTRY-US, V18, P4100, DOI 10.1021/bi00586a007; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OESTERHELT D, 1974, FEBS LETT, V44, P262, DOI 10.1016/0014-5793(74)81153-1; OHNO K, 1977, BIOCHIM BIOPHYS ACTA, V462, P575, DOI 10.1016/0005-2728(77)90102-5; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; Peralvarez A, 2001, FEBS LETT, V508, P399, DOI 10.1016/S0014-5793(01)03080-0; Peralvarez-Marin A, 2008, BIOPHYS J, V95, P4384, DOI 10.1529/biophysj.108.136747; Peralvarez-Marin A, 2007, J MOL BIOL, V368, P666, DOI 10.1016/j.jmb.2007.02.021; Ritter E, 2009, CURR ORG CHEM, V13, P241, DOI 10.2174/138527209787314805; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sanz C, 2001, J BIOL CHEM, V276, P40788, DOI 10.1074/jbc.M104836200; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; SUBRAMANIAM S, 1992, J BIOL CHEM, V267, P25730; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; TAMAO K, 1972, J AM CHEM SOC, V94, P4374, DOI 10.1021/ja00767a075; Toth-Boconadi R, 2003, BIOPHYS J, V84, P3857, DOI 10.1016/S0006-3495(03)75113-3; TRISSL HW, 1987, BIOCHEMISTRY-US, V26, P751, DOI 10.1021/bi00377a015; Walz T, 1998, J STRUCT BIOL, V121, P142, DOI 10.1006/jsbi.1998.3945; ZHANG HZ, 1994, J AM CHEM SOC, V116, P6823, DOI 10.1021/ja00094a041	42	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42447	10.1371/journal.pone.0042447	http://dx.doi.org/10.1371/journal.pone.0042447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879987	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100096
J	Holland, D; Desikan, RS; Dale, AM; McEvoy, LK				Holland, Dominic; Desikan, Rahul S.; Dale, Anders M.; McEvoy, Linda K.		Alzheimers Dis Neuroimaging Initia	Rates of Decline in Alzheimer Disease Decrease with Age	PLOS ONE			English	Article							NEUROFIBRILLARY PATHOLOGY; BRAIN ATROPHY; OLDEST-OLD; DEMENTIA; NEUROPATHOLOGY; PREVALENCE; BIOMARKER; MODEL; DIAGNOSIS; ADULTS	Age is the strongest risk factor for sporadic Alzheimer disease (AD), yet the effects of age on rates of clinical decline and brain atrophy in AD have been largely unexplored. Here, we examined longitudinal rates of change as a function of baseline age for measures of clinical decline and structural MRI-based regional brain atrophy, in cohorts of AD, mild cognitive impairment (MCI), and cognitively healthy (HC) individuals aged 65 to 90 years (total n = 723). The effect of age was modeled using mixed effects linear regression. There was pronounced reduction in rates of clinical decline and atrophy with age for AD and MCI individuals, whereas HCs showed increased rates of clinical decline and atrophy with age. This resulted in convergence in rates of change for HCs and patients with advancing age for several measures. Baseline cerebrospinal fluid densities of AD-relevant proteins, A beta(1-42), tau, and phospho-tau(181p) (ptau), showed a similar pattern of convergence with advanced age across cohorts, particularly for ptau. In contrast, baseline clinical measures did not differ by age, indicating uniformity of clinical severity at baseline. These results imply that the phenotypic expression of AD is relatively mild in individuals older than approximately 85 years, and this may affect the ability to distinguish AD from normal aging in the very old. Our findings show that inclusion of older individuals in clinical trials will substantially reduce the power to detect disease-modifying therapeutic effects, leading to dramatic increases in required clinical trial sample sizes with age of study sample.	[Holland, Dominic; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Desikan, Rahul S.; Dale, Anders M.; McEvoy, Linda K.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, D (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	dominic.holland@gmail.com	Levey, Allan/F-2104-2011; Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021	Levey, Allan/0000-0002-3153-502X; Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856	NIH [R01AG031224, R01AG22381, U54NS056883, P50NS22343, P50MH081755, P30 AG010129, K01 AG030514]; NIA [K01AG029218]; NIH-NIBIB [T32 EB005970]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS022343, U54NS056883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG013846, P30AG010129, K01AG029218, R01AG031224, U19AG010483, K01AG030514, R01AG022381, P30AG019610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH grants R01AG031224, R01AG22381, U54NS056883, P50NS22343, and P50MH081755 (A. M. D.); NIA K01AG029218 (LKM); NIH-NIBIB T32 EB005970 (RSD). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Bernick C, 2012, ARCH NEUROL; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Brumback-Peltz C, 2011, MATURITAS, V70, P164, DOI 10.1016/j.maturitas.2011.07.008; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Caroli A, 2010, NEUROBIOL AGING, V31, P1263, DOI 10.1016/j.neurobiolaging.2010.04.024; Clarke G, 2001, HUM MOL GENET, V10, P2269, DOI 10.1093/hmg/10.20.2269; Coley N, 2011, ALZHEIMERS DEMENT, V7, P602, DOI 10.1016/j.jalz.2011.01.005; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2012, ARCH NEUROL; Desikan RS, 2011, ANN NEUROL; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V25; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gold G, 2007, BRAIN, V130, P2830, DOI 10.1093/brain/awm228; Hastie T, 1990, GEN ADDITIVE MODELS, pxv; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Holland D., 2011, HUM BRAIN MAPP; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack Jr CR, 2012, ARCH NEUROL; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kovari E, 2007, NEUROLOGY, V68, P927, DOI 10.1212/01.wnl.0000257094.10655.9a; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lee GJ, 2012, BIOL PSYCHIAT, V71, P814, DOI 10.1016/j.biopsych.2011.12.024; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Lomasko T, 2009, J THEOR BIOL, V256, P104, DOI 10.1016/j.jtbi.2008.08.025; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Reuter M, 2012, NEUROIMAGE; Rosner B, 2006, FUNDAMENTALS BIOSTAT, pxix; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schuff N, 2012, NEUROBIOL AGING, V33, P845, DOI 10.1016/j.neurobiolaging.2010.07.012; Sinka L, 2010, J NEUROPATH EXP NEUR, V69, P1247, DOI 10.1097/NEN.0b013e3181ffc3b9; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Stricker NH, 2011, NEUROLOGY, V77, P713, DOI 10.1212/WNL.0b013e31822b0004; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; van der Flier WM, 2011, LANCET NEUROL, V10, P280, DOI 10.1016/S1474-4422(10)70306-9; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wan H, 2005, 65 US 2005; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]	71	74	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42325	10.1371/journal.pone.0042325	http://dx.doi.org/10.1371/journal.pone.0042325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876315	Green Published, gold			2022-12-25	WOS:000307184700043
J	Eriksson, ME; Terfelt, F; Elofsson, R; Marone, F				Eriksson, Mats E.; Terfelt, Fredrik; Elofsson, Rolf; Marone, Federica			Internal Soft-Tissue Anatomy of Cambrian 'Orsten' Arthropods as Revealed by Synchrotron X-Ray Tomographic Microscopy	PLOS ONE			English	Article							CRUSTACEA; SCANDINAVIA; LABRUM	The world-famous 'Orsten' Konservat-Lagerstatte has yielded detailed information about Cambrian arthropods and their morphology. Internal organs or soft tissues have, however, rarely been reported, an obvious palaeobiological drawback. In this study, we employed synchrotron radiation X-ray tomographic microscopy (SRXTM) to study microscopic 'Orsten' arthropods from the Cambrian of Sweden: Skara minuta and two phosphatocopine species, Hesslandona sp. and Hesslandona trituberculata. This exceptionally high-resolution technique reveals internal organs or soft tissues that allow detailed comparison with equivalent structures in extant crustaceans and functional inferences to be made. The S. minuta specimen shows the digestive system and muscles that extend to the extremities. The slanting anterior portion of the head and anterior position of the mouth with a straight oesophagus suggest a primarily brushing and scraping way of feeding. The prominent head appendage muscles indicate muscle strength and good capacity for food manipulation. In the phosphatocopines the bulbous labrum is one of the most prominent morphological structures of the body. All specimens analysed reveal pairs of muscle bundles within the labrum. Based on comparisons with extant crustacean relatives, these muscles would fulfil the function of moving the labrum up and down in order to open the buccal cavity. The results of this pilot study demonstrate that there is still much to be learned about the 'Orsten' taxa.	[Eriksson, Mats E.] Lund Univ, Dept Geol, Lund, Sweden; [Terfelt, Fredrik] Lund Univ, Dept Phys, Lund, Sweden; [Elofsson, Rolf] Lund Univ, Dept Biol, Lund, Sweden; [Marone, Federica] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	Lund University; Lund University; Lund University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Eriksson, ME (corresponding author), Lund Univ, Dept Geol, Lund, Sweden.	mats.eriksson@geol.lu.se	Marone, Federica/J-4420-2013		Swedish Research Council; Royal Physiographic Society, Lund; Faculty of Science, Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society, Lund; Faculty of Science, Lund University	This research was financed by grants to MEE and FT from the Swedish Research Council, the Royal Physiographic Society, Lund, and the Faculty of Science, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwmark C, 2011, METEORIT PLANET SCI, V46, P1071, DOI 10.1111/j.1945-5100.2011.01214.x; Andersson A., 1985, SVERIGES GEOLOGISKA, V56, P1; Bengtson S, 2004, SCIENCE, V306; Bitsch C, 2002, ARTHROPOD STRUCT DEV, V30, P159, DOI 10.1016/S1467-8039(01)00032-9; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Cunningham JA, 2012, P ROY SOC B-BIOL SCI, V279, P2369, DOI 10.1098/rspb.2011.2280; Dahl E., 1956, Acta Zoologica Stockholm, V37, P123; ELOFSSON R, 1992, J CRUSTACEAN BIOL, V12, P571, DOI 10.2307/1548838; Elofsson R, 2008, ARTHROPOD STRUCT DEV, V37, P522, DOI 10.1016/j.asd.2008.05.002; Elofsson R, 2010, ARTHROPOD STRUCT DEV, V39, P242, DOI 10.1016/j.asd.2010.01.002; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Henningsmoen G., 1957, SKRIFTER UTGITT N MN, V1957, P1; HerreraAlvarez L, 1996, J MORPHOL, V230, P199, DOI 10.1002/(SICI)1097-4687(199611)230:2<199::AID-JMOR7>3.0.CO;2-C; Hessler R. R., 1964, Mem Con Acad Sci, V16, P1; Jeppsson L, 1999, J PALEONTOL, V73, P964, DOI 10.1017/S0022336000040798; LARINK O, 1972, Z MORPHOL TIERE, V72, P341, DOI 10.1007/BF00283128; Maas A, 2005, HYDROBIOLOGIA, V538, P139, DOI 10.1007/s10750-004-4944-6; Maas Andreas, 2003, Fossils and Strata, V49, P1; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Maeda H, 2011, PALAIOS, V26, P225, DOI 10.2110/palo.2010.p10-042r; Marone F, 2010, PROC SPIE, V7804, DOI 10.1117/12.859703; Martinsson A., 1974, P185; Muller K.J., 1991, Fossils and Strata, P1; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Muller KJ, 1985, FOSSILS STRATA, V17, P1; Siveter DJ, 2003, SPEC PAP PALAEONTOL, P9; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Terfelt F, 2008, NORW J GEOL, V88, P73; Terfelt F, 2011, LETHAIA, V44, P8, DOI 10.1111/j.1502-3931.2009.00211.x; Walossek D, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P185; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Waloszek Dieter, 2003, Paleontological Research, V7, P71, DOI 10.2517/prpsj.7.71; WESTERGARD A. H., 1947, SVERIGES GEOL UNDERSOKN SER C, V489, P1; Westergard A. H., 1922, Sveriges geol Unders Ser Ca, V18, P1	35	19	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42582	10.1371/journal.pone.0042582	http://dx.doi.org/10.1371/journal.pone.0042582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870334	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800097
J	Madireddi, S; Schabowsky, RH; Srivastava, AK; Sharma, RK; Yolcu, ES; Shirwan, H				Madireddi, Shravan; Schabowsky, Rich-Henry; Srivastava, Abhishek K.; Sharma, Rajesh K.; Yolcu, Esma S.; Shirwan, Haval			SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-gamma	PLOS ONE			English	Article							TGF-BETA; IN-VIVO; ESTABLISHED TUMORS; FOXP3 INDUCTION; 4-1BB LIGAND; RESPONSES; OX40; PROLIFERATION; EXPANSION; DEPLETION	Tumors convert conventional CD4(+) T cells into induced CD4(+)CD25(+)FoxP3(+) T regulatory (iTreg) cells that serve as an effective means of immune evasion. Therefore, the blockade of conventional CD4(+) T cell conversion into iTreg cells represents an attractive target for improving the efficacy of various immunotherapeutic approaches. Using a novel form of 4-1BBL molecule, SA-4-1BBL, we previously demonstrated that costimulation via 4-1BB receptor renders both CD4(+) and CD8(+) T effector (Teff) cells refractory to inhibition by Treg cells and increased intratumoral Teff/Treg cell ratio that correlated with therapeutic efficacy in various preclinical tumor models. Building on these studies, we herein show for the first time, to our knowledge, that signaling through 4-1BB inhibits antigen-and TGF-beta-driven conversion of naive CD4(+)FoxP3(-) T cells into iTreg cells via stimulation of IFN-gamma production by CD4(+)FoxP3(-) T cells. Importantly, treatment with SA-4-1BBL blocked the conversion of CD4(+)FoxP3(-) T cells into Treg cells by EG.7 tumors. Taken together with our previous studies, these results show that 4-1BB signaling negatively modulate Treg cells by two distinct mechanisms: i) inhibiting the conversion of CD4(+)FoxP3(-) T cells into iTreg cells and ii) endowing Teff cells refractory to inhibition by Treg cells. Given the dominant role of Treg cells in tumor immune evasion mechanisms, 4-1BB signaling represents an attractive target for favorably tipping the Teff: Treg balance toward Teff cells with important implications for cancer immunotherapy.	[Madireddi, Shravan] Univ Louisville, Dept Microbiol & Immunol, Inst Cellular Therapeut, Louisville, KY 40292 USA; Univ Louisville, James Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Madireddi, S (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Inst Cellular Therapeut, Louisville, KY 40292 USA.	esma.yolcu@louisville.edu; haval.shirwan@louisville.edu	Srivastava, Abhishek/M-7577-2014	MADIREDDI, SHRAVAN/0000-0002-7069-1252	NIH [2R44 AI071618-02]; Kentucky Lung Cancer Research Program; W.M. Keck Foundation; Commonwealth of Kentucky Research Challenge Trust Fund;  [R43 AI074176];  [R41 CA121665]; NATIONAL CANCER INSTITUTE [R41CA121665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI074176, R44AI071618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; W.M. Keck Foundation(W.M. Keck Foundation); Commonwealth of Kentucky Research Challenge Trust Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH 2R44 AI071618-02, R43 AI074176, R41 CA121665, Kentucky Lung Cancer Research Program, the W.M. Keck Foundation, and the Commonwealth of Kentucky Research Challenge Trust Fund (HS and ESY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawicki W, 2004, J IMMUNOL, V173, P5944, DOI 10.4049/jimmunol.173.10.5944; Duan W, 2008, J IMMUNOL, V181, P8650, DOI 10.4049/jimmunol.181.12.8650; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Lee SW, 2009, J IMMUNOL, V182, P6753, DOI 10.4049/jimmunol.0803241; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2010, VACCINE, V28, P5794, DOI 10.1016/j.vaccine.2010.06.073; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang P, 2007, SCAND J IMMUNOL, V66, P435, DOI 10.1111/j.1365-3083.2007.01994.x; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	39	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42459	10.1371/journal.pone.0042459	http://dx.doi.org/10.1371/journal.pone.0042459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870329	gold, Green Submitted, Green Published			2022-12-25	WOS:000307212800093
J	Matallana-Surget, S; Joux, F; Wattiez, R; Lebaron, P				Matallana-Surget, Sabine; Joux, Fabien; Wattiez, Ruddy; Lebaron, Philippe			Proteome Analysis of the UVB-Resistant Marine Bacterium Photobacterium angustum S14	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; DEINOCOCCUS-RADIODURANS; SPHINGOPYXIS-ALASKENSIS; CELLULAR-RESPONSE; OXIDATIVE STRESS; RNA; HFQ; GENES; ULTRAMICROBACTERIUM	The proteome of the marine bacterium Photobacterium angustum S14 was exposed to UVB and analyzed by the implementation of both the post-digest ICPL labeling method and 2D-DIGE technique using exponentially growing cells. A total of 40 and 23 proteins were quantified in all replicates using either the ICPL or 2D-DIGE methods, respectively. By combining both datasets from 8 biological replicates (4 biological replicates for each proteomics technique), 55 proteins were found to respond significantly to UVB radiation in P. angustum. A total of 8 UVB biomarkers of P. angustum were quantified in all replicates using both methods. Among them, the protein found to present the highest increase in abundance (almost a 3-fold change) was RecA, which is known to play a crucial role in the so-called recombinational repair process. We also observed a high number of antioxidants, transport proteins, metabolism-related proteins, transcription/ translation regulators, chaperonins and proteases. We also discuss and compare the UVB response and global protein expression profiles obtained for two different marine bacteria with trophic lifestyles: the copiotroph P. angustum and oligotroph Sphingopyxis alaskensis.	[Matallana-Surget, Sabine; Joux, Fabien; Lebaron, Philippe] UPMC Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France; [Matallana-Surget, Sabine; Joux, Fabien; Lebaron, Philippe] CNRS, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France; [Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Interdisciplinary Mass Spectrometry Ctr CISMa, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Mons	Matallana-Surget, S (corresponding author), UPMC Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France.	sabine.matallana@obs-banyuls.fr	Joux, Fabien/F-8107-2010; Surget, Sabine Matallana/AAM-1004-2020	Surget, Sabine Matallana/0000-0002-6023-3215; wattiez, ruddy/0000-0003-2071-4310; Joux, Fabien/0000-0001-8089-2771	European community [FP7-KBBE-2008-226977]	European community(European Commission)	This work was supported by the European community project MAMBA (FP7-KBBE-2008-226977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi M, 2008, CURR MICROBIOL, V57, P412, DOI 10.1007/s00284-008-9214-9; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; [Богачев А.В. Bogachev A.V.], 2005, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V70, P177; Booth MG, 2001, MICROB ECOL, V42, P531, DOI 10.1007/s00248-001-1009-5; Cavicchioli R, 2003, MICROB ECOL, V45, P203, DOI 10.1007/s00248-002-3008-6; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deuerling E, 1997, MOL MICROBIOL, V23, P921, DOI 10.1046/j.1365-2958.1997.2721636.x; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; Ehling-Schulz M, 2002, MOL MICROBIOL, V46, P827, DOI 10.1046/j.1365-2958.2002.03209.x; Epp RG, 2007, PHOTOCH PHOTOBIO SCI, V6, P286, DOI 10.1039/b700021a; Fegatella F, 1999, ELECTROPHORESIS, V20, P2094, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2094::AID-ELPS2094>3.0.CO;2-E; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HECK HD, 1990, CRIT REV TOXICOL, V20, P397; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kovacs D, 2009, FEBS LETT, V583, P88, DOI 10.1016/j.febslet.2008.11.049; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; KRUEGER JH, 1984, P NATL ACAD SCI-BIOL, V81, P1499, DOI 10.1073/pnas.81.5.1499; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lease RA, 2000, P NATL ACAD SCI USA, V97, P9919, DOI 10.1073/pnas.170281497; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MA TH, 1988, MUTAT RES, V196, P37, DOI 10.1016/0165-1110(88)90027-9; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Matallana-Surget S, 2009, ENVIRON MICROBIOL, V11, P2660, DOI 10.1111/j.1462-2920.2009.01992.x; Matallana-Surget S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1313, DOI 10.1039/b902715g; Mitchell D. L., 1995, MOL BIOL BIOTECHNOLO, P939; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Pandhal J, 2007, J PROTEOME RES, V6, P996, DOI 10.1021/pr060460c; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Shangari N, 2003, BIOCHEM SOC T, V31, P1390, DOI 10.1042/BST0311390; Srinivasan S, 1998, J BIOSCIENCE, V23, P501, DOI 10.1007/BF02936144; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; TOMOYASU T, 1993, J BACTERIOL, V175, P1344, DOI 10.1128/JB.175.5.1344-1351.1993; Trautinger F, 1996, J PHOTOCH PHOTOBIO B, V35, P141, DOI 10.1016/S1011-1344(96)07344-7; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Welch TJ, 1996, J BACTERIOL, V178, P5027, DOI 10.1128/jb.178.16.5027-5031.1996; Williams T, 2011, EXTREMOPHILES HDB, P1179; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875	65	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42299	10.1371/journal.pone.0042299	http://dx.doi.org/10.1371/journal.pone.0042299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870314	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800077
J	Chen, LJ; Su, JG; Yang, CR; Peng, LM; Wan, QY; Wang, L				Chen, Lijun; Su, Jianguo; Yang, Chunrong; Peng, Limin; Wan, Quanyuan; Wang, Lan			Functional Characterizations of RIG-I to GCRV and Viral/Bacterial PAMPs in Grass Carp Ctenopharyngodon idella	PLOS ONE			English	Article							INDUCIBLE GENE-I; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR; NF-KAPPA-B; RECOGNITION RECEPTORS; PATHOGEN RECOGNITION; GENOMIC STRUCTURE; RNA; EXPRESSION; DOMAIN	Background: RIG-I (retinoic acid inducible gene-I) is one of the key cytosolic pattern recognition receptors (PRRs) for detecting nucleotide pathogen associated molecular patterns (PAMPs) and mediating the induction of type I interferon and inflammatory cytokines in innate immune response. Though the mechanism is well characterized in mammals, the study of the accurate function of RIG-I in teleosts is still in its infancy. Methodology/Principal Findings: To clarify the functional characterizations of RIG-I in grass carp Ctenopharyngodon idella (CiRIG-I), six representative overexpression plasmids were constructed and transfected into C. idella kidney (CIK) cell lines to obtain stably expressing recombinant proteins, respectively. A virus titer test and 96-well plate staining assay showed that all constructs exhibited the antiviral activity somewhat. The quantitative real-time RT-PCR (qRT-PCR) demonstrated that mRNA expressions of CiIPS-1, CiIFN-I and CiMx2 were regulated by not only virus (GCRV) or viral PAMP (poly(IC)) challenge but also bacterial PAMPs (LPS and PGN) stimulation in the steadily transfected cells. The results showed that the full-length CiRIG-I played a key role in RLR pathway. The repressor domain (RD) exerted an inhibitory function of the signaling channel under all utilized challenges. Caspase activation and recruitment domains (CARDs) showed a positive role in GCRV and poly(I: C) challenge. Helicase motifs were crucial for the signaling pathway upon LPS and PGN stimulation. Interestingly, DCARDs (CARDs deleted) showed postive modulation in RIG-I signal transduction. Conclusions/Significance: The results provided some novel insights into RIG-I sensing with a strikingly broad regulation in teleosts, responding not only to the dsRNA virus or synthetic dsRNA but also bacterial PAMPs.	[Chen, Lijun; Su, Jianguo; Yang, Chunrong; Peng, Limin; Wan, Quanyuan; Wang, Lan] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Peoples R China	Northwest A&F University - China	Su, JG (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Peoples R China.	su.jianguo@gmail.com	Su, Jianguo/A-7444-2015; Wan, Quanyuan/AAD-5810-2022; Wan, Quanyuan/D-1149-2015; Su, Jianguo/G-9277-2012	Su, Jianguo/0000-0002-9083-0715; Wan, Quanyuan/0000-0003-4227-1530; Wan, Quanyuan/0000-0003-4227-1530; Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-1340-6144	Program for New Century Excellent Talents in University [NCET-08-0466]; Chinese Universities Scientific Fund [QN2009022]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Universities Scientific Fund	The study was supported by Program for New Century Excellent Talents in University (NCET-08-0466) and Chinese Universities Scientific Fund (QN2009022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Huang T, 2010, FISH SHELLFISH IMMUN, V29, P349, DOI 10.1016/j.fsi.2010.04.001; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kubota K, 2006, ORAL MICROBIOL IMMUN, V21, P399, DOI 10.1111/j.1399-302X.2006.00326.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Rajendran KV, 2012, DEV COMP IMMUNOL, V37, P381, DOI 10.1016/j.dci.2012.02.004; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Su JG, 2008, MAR BIOTECHNOL, V10, P262, DOI 10.1007/s10126-007-9059-4; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Su JG, 2009, AQUACULTURE, V289, P1, DOI [10.1016/j.aquaculture.2008.12.027, 10.1016/j.aquaculture.2008.10.025]; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Wang L, 2011, MOL IMMUNOL, V49, P359, DOI 10.1016/j.molimm.2011.09.010; Yang CR, 2011, FISH SHELLFISH IMMUN, V30, P936, DOI 10.1016/j.fsi.2011.01.020; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	52	31	32	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42182	10.1371/journal.pone.0042182	http://dx.doi.org/10.1371/journal.pone.0042182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860079	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600070
J	Li, B; Yi, Y; Wang, Q; Woo, PCY; Tan, L; Jing, H; Gao, GF; Liu, CH				Li, Bin; Yi, Yong; Wang, Qi; Woo, Patrick C. Y.; Tan, Lin; Jing, Hua; Gao, George F.; Liu, Cui Hua			Analysis of Drug Resistance Determinants in Klebsiella pneumoniae Isolates from a Tertiary-Care Hospital in Beijing, China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; TEL-AVIV; MOLECULAR CHARACTERIZATION; QUINOLONE RESISTANCE; MEDIATED RESISTANCE; GLOBAL SPREAD; RISK-FACTORS; EMERGENCE; ENTEROBACTERIACEAE	Background: The rates of multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) isolates among Enterobacteriaceae isolates, particularly Klebsiella pneumoniae, have risen substantially worldwide. Methodology/Principal Findings: To better understand the molecular mechanisms of drug resistance in K. pneumoniae, we analyzed the drug resistance determinants for K. pneumoniae isolates collected from the 306 Hospital, a tertiary-care hospital in Beijing, China, for the period of September 1, 2010-October 31, 2011. Drug susceptibility testing, PCR amplification and sequencing of the drug resistance determinants were performed. Conjugation experiments were conducted to examine the natural ability of drug resistance to disseminate among Enterobacteriaceae strains using a sodium azide-resistant Escherichia coli J53 strain as a recipient. Among the 223 consecutive non-repetitive K. pneumoniae isolates included in this study, 101 (45.3%) were extended-spectrum beta-lactamases (ESBLs) positive. The rates of MDR, XDR, and PDR isolates were 61.4% (n = 137), 22.0% (n = 49), and 1.8% (n = 4), respectively. Among the tested drug resistance-associated genes, the following ones were detected at relatively high rates bla(CTX-M-10) (80, 35.9%), aacC2 (73, 32.7%), dhfr (62, 27.8%), qnrS (58, 26.0%), aacA4 (57, 25.6%), aadA1 (56, 25.1%). Results from conjugation experiments indicate that many of the drug resistance genes were transmissible. Conclusions/Significance: Our data give a "snapshot" of the complex genetic background responsible for drug resistance in K. pneumoniae in China and demonstrate that a high degree of awareness and monitoring of those drug resistance determinants are urgently needed in order to better control the emergence and transmission of drug-resistant K. pneumoniae isolates in hospital settings.	[Li, Bin; Wang, Qi; Tan, Lin; Gao, George F.; Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Li, Bin] Shandong Univ, State Key Lab Microbial Technol, Jinan, Peoples R China; [Yi, Yong; Jing, Hua] 306 Hosp, Beijing, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong University; University of Hong Kong	Li, B (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn; liucuihua@im.ac.cn	Gao, George Fu/ABD-5229-2021; Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Basic Research Program of China [2012CB518700]; Chinese Academy of Sciences [KSCX2-EW-J-6]; National Natural Science Foundation of China [30700975]; Merieux Research Grant program	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Merieux Research Grant program	This work was supported by the National Basic Research Program of China (2012CB518700), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6), the National Natural Science Foundation of China (grant No. 30700975), and the Merieux Research Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2010, INT J ANTIMICROB AG, V36, P239, DOI 10.1016/j.ijantimicag.2010.04.010; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P509, DOI 10.1128/AAC.40.2.509; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Bogaerts P, 2007, J ANTIMICROB CHEMOTH, V59, P459, DOI 10.1093/jac/dkl527; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Chudackova E, 2010, FEMS MICROBIOL LETT, V309, P62, DOI 10.1111/j.1574-6968.2010.02016.x; Clinical and Laboratory Standards Institute (CLSI), 2019, M100S21 CLSI; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Giakkoupi P, 2003, J CLIN MICROBIOL, V41, P3893, DOI 10.1128/JCM.41.8.3893-3896.2003; Goren MG, 2011, J ANTIMICROB CHEMOTH, V66, P672, DOI 10.1093/jac/dkq467; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jean SS, 2009, EUR J CLIN MICROBIOL, V28, P215, DOI 10.1007/s10096-008-0610-7; Jemima SA, 2008, INDIAN J MED MICROBI, V26, P365, DOI 10.4103/0255-0857.43581; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Ko KS, 2008, DIAGN MICR INFEC DIS, V61, P453, DOI 10.1016/j.diagmicrobio.2008.03.005; Kohlenberg A, 2012, EPIDEMIOL INFECT, V140, P528, DOI 10.1017/S0950268811000781; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Lee H, 2006, DIAGN MICR INFEC DIS, V56, P305, DOI 10.1016/j.diagmicrobio.2006.05.002; Lee YH, 2006, J ANTIMICROB CHEMOTH, V57, P1259, DOI 10.1093/jac/dkl115; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Marchaim D, 2010, ANTIMICROB AGENTS CH, V54, P5099, DOI 10.1128/AAC.00565-10; Mokracka J, 2011, J MED MICROBIOL, V60, P737, DOI 10.1099/jmm.0.027979-0; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2008, EXPERT REV ANTI-INFE, V6, P657, DOI 10.1586/14787210.6.5.657; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poulou A, 2010, J ANTIMICROB CHEMOTH, V65, P2538, DOI 10.1093/jac/dkq363; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Reinert RR, 2007, J ANTIMICROB CHEMOTH, V60, P1018, DOI 10.1093/jac/dkm310; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Sabate M, 2000, ANTIMICROB AGENTS CH, V44, P1970, DOI 10.1128/AAC.44.7.1970-1973.2000; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Schultsz C, 2012, DRUGS, V72, P1, DOI 10.2165/11597960-000000000-00000; Tato M, 2010, J CLIN MICROBIOL, V48, P4089, DOI 10.1128/JCM.01130-10; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Veras DL, 2011, CURR MICROBIOL, V62, P1610, DOI 10.1007/s00284-011-9899-z; Wang XR, 2012, CHINESE MED J-PEKING, V125, P894, DOI 10.3760/cma.j.issn.0366-6999.2012.05.029; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	65	29	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42280	10.1371/journal.pone.0042280	http://dx.doi.org/10.1371/journal.pone.0042280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860106	gold, Green Published			2022-12-25	WOS:000307045600086
J	Shih, KS; Wang, JH; Wu, YW; Teng, CM; Chen, CC; Yang, CR				Shih, Kao-Shang; Wang, Jyh-Horng; Wu, Yi-Wen; Teng, Che-Ming; Chen, Chien-Chih; Yang, Chia-Ron			Aciculatin Inhibits Granulocyte Colony-Stimulating Factor Production by Human Interleukin 1 beta-Stimulated Fibroblast-Like Synoviocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; HUMAN SYNOVIAL FIBROBLASTS; G-CSF; INFLAMMATORY ARTHRITIS; CYTOKINE REGULATION; IL-8 EXPRESSION; MACROPHAGE CSF; IN-VITRO; GM-CSF; NEUTROPHIL	The expression of granulocyte colony-stimulating factor (G-CSF), the major regulator of neutrophil maturation, by human fibroblast-like synoviocytes (FLS) can be stimulated by the inflammatory cytokine interleukin-1 beta (IL-1 beta). G-CSF is known to contribute to the pathologic processes of destructive arthritis, but the induction mechanism remains unknown. The aims of this study were to identify the signaling pathways involved in IL-1 beta-stimulated G-CSF production and to determine whether this process was inhibited by aciculatin (8-((2R,4S,5S,6R)-tetrahydro-4,5-dihydroxy-6-methyl-2H-pyran-2-yl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one), the major bioactive component of Chrysopogon aciculatus. IL-1 beta-induced cytokine expression was evaluated by measuring mRNA and protein levels by RT-PCR, ELISA, and Milliplex (R) assay. Whether aciculatin inhibited IL-1 beta-stimulated G-CSF expression, and if so, how, were evaluated using western blot assay, an electrophoretic mobility shift assay, and a reporter gene assay. Neutrophil differentiation was determined by Wright-Giemsa staining and flow cytometry. Aciculatin markedly inhibited G-CSF expression induced by IL-1 beta (10 ng/mL) in a concentration-dependent manner (1-10 mu M). In clarifying the mechanisms involved, aciculatin was found to inhibit the IL-1 beta-induced activation of the IkB kinase (IKK)/I kappa B/nuclear factor-kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) pathways by suppressing the DNA binding activity of the transcription factors NF-kappa B and activator protein (AP)-1. Furthermore, aciculatin significantly inhibited the G-CSF-mediated phosphorylation of Janus kinase-signal transducer and activator of transcription (JAK-STAT) and Akt and neutrophil differentiation from precursor cells. Our results show that aciculatin inhibits IL-1 beta-stimulated G-CSF expression and the subsequent neutrophil differentiation, suggesting that it might have therapeutic potential for inflammatory arthritis.	[Shih, Kao-Shang] Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan; [Shih, Kao-Shang] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shih, Kao-Shang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Wang, Jyh-Horng; Wu, Yi-Wen] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Chen, Chien-Chih] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan; [Yang, Chia-Ron] Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei 10764, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Hungkuang University; National Taiwan University	Shih, KS (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan.	cryang@ntu.edu.tw	Huang, James/ADK-6342-2022	TENG, CHE-MING/0000-0002-9719-7334; YANG, CHIA-RON/0000-0001-5990-1346; Wang, Jyh- Horng/0000-0002-1531-5297	National Science Council of Taiwan [NSC100-2320-B-002-004-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work received grant support from National Science Council of Taiwan (NSC100-2320-B-002-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2001, FEBS LETT, V487, P318, DOI 10.1016/S0014-5793(00)02324-3; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Chakraborty A, 2003, AM J PHYSIOL-CELL PH, V284, pC103, DOI 10.1152/ajpcell.00165.2002; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; GUERNE PA, 1990, J IMMUNOL, V144, P499; HAMILTON JA, 1992, BLOOD, V79, P1413; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Huebner JL, 2007, OSTEOARTHR CARTILAGE, V15, P354, DOI 10.1016/j.joca.2006.10.014; Huebner JL, 2006, OSTEOARTHR CARTILAGE, V14, P923, DOI 10.1016/j.joca.2006.03.007; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; KAWAKAMI M, 1990, BLOOD, V76, P1962; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; Kojima H, 2011, BLOOD, V117, P1091, DOI 10.1182/blood-2010-05-286963; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; LEIZER T, 1990, BLOOD, V76, P1989, DOI 10.1182/blood.V76.10.1989.1989; LORD BI, 1991, BLOOD, V77, P2154; LOTZ M, 1992, J IMMUNOL, V148, P466; Mangan JK, 2005, LEUKEMIA LYMPHOMA, V46, P21, DOI 10.1080/10428190400005320; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Nakamae-Akahori M, 2006, IMMUNOLOGY, V119, P393, DOI 10.1111/j.1365-2567.2006.02448.x; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Shen CC, 2012, J NAT PROD, V75, P198, DOI 10.1021/np2007796; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; TIAN SS, 1994, BLOOD, V84, P1760; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42389	10.1371/journal.pone.0042389	http://dx.doi.org/10.1371/journal.pone.0042389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860122	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600098
J	Uijen, AA; Heinst, CW; Schellevis, FG; van den Bosch, WJHM; van de Laar, FA; Terwee, CB; Schers, HJ				Uijen, Annemarie A.; Heinst, Claire W.; Schellevis, Francois G.; van den Bosch, Wil J. H. M.; van de Laar, Floris A.; Terwee, Caroline B.; Schers, Henk J.			Measurement Properties of Questionnaires Measuring Continuity of Care: A Systematic Review	PLOS ONE			English	Review							UPDATED METHOD GUIDELINES; SELF-REPORT MEASURE; CARDIAC PATIENTS; HEALTH OUTCOMES; CANCER CARE; VALIDATION; COORDINATION; PERCEPTIONS; QUALITY; RELIABILITY	Background: Continuity of care is widely acknowledged as a core value in family medicine. In this systematic review, we aimed to identify the instruments measuring continuity of care and to assess the quality of their measurement properties. Methods: We did a systematic review using the PubMed, Embase and PsycINFO databases, with an extensive search strategy including 'continuity of care', 'coordination of care', 'integration of care', 'patient centered care', 'case management' and its linguistic variations. We searched from 1995 to October 2011 and included articles describing the development and/or evaluation of the measurement properties of instruments measuring one or more dimensions of continuity of care (1) care from the same provider who knows and follows the patient (personal continuity), (2) communication and cooperation between care providers in one care setting (team continuity), and (3) communication and cooperation between care providers in different care settings (cross-boundary continuity). We assessed the methodological quality of the measurement properties of each instrument using the COSMIN checklist. Results: We included 24 articles describing the development and/or evaluation of 21 instruments. Ten instruments measured all three dimensions of continuity of care. Instruments were developed for different groups of patients or providers. For most instruments, three or four of the six measurement properties were assessed (mostly internal consistency, content validity, structural validity and construct validity). Six instruments scored positive on the quality of at least three of six measurement properties. Conclusions: Most included instruments have problems with either the number or quality of its assessed measurement properties or the ability to measure all three dimensions of continuity of care. Based on the results of this review, we recommend the use of one of the four most promising instruments, depending on the target population Diabetes Continuity of Care Questionnaire, Alberta Continuity of Services Scale-Mental Health, Heart Continuity of Care Questionnaire, and Nijmegen Continuity Questionnaire.	[Uijen, Annemarie A.; Heinst, Claire W.; van den Bosch, Wil J. H. M.; van de Laar, Floris A.; Schers, Henk J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Schellevis, Francois G.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Schellevis, Francois G.; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Radboud University Nijmegen; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Uijen, AA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	A.Uijen@elg.umcn.nl	van de Laar, Floris/CAI-2875-2022; Bosch, W.J.H.M./H-8016-2014; Schers, H.J./L-4631-2015; van de Laar, F.A./L-4467-2015; Uijen, A.A./L-4701-2015	van de Laar, Floris/0000-0001-7373-8864; Schers, H.J./0000-0002-9362-9451; Terwee, Caroline/0000-0003-4570-2826	Frans Huygen Stichting	Frans Huygen Stichting	The source of funding: Frans Huygen Stichting. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CE, 2005, PSYCHIAT SERV, V56, P1061, DOI 10.1176/appi.ps.56.9.1061; Adair CE, 2003, PSYCHIAT SERV, V54, P1351, DOI 10.1176/appi.ps.54.10.1351; Adair CE, 2004, CONTINUITY MENTAL HL; Ahgren Bengt, 2009, Int J Integr Care, V9, pe03; [Anonymous], 2002, HEALTH CARE; Bull M J, 2000, J Nurs Meas, V8, P41; Casparie AF, 1998, ONDERZOEKSPROGRAMMA; Dobrow Mark J, 2009, Healthc Policy, V5, P35; Dolovich LR, 2004, HEALTH SOC CARE COMM, V12, P475, DOI 10.1111/j.1365-2524.2004.00517.x; Durbin J, 2004, J BEHAV HEALTH SER R, V31, P279; Flocke SA, 1997, J FAM PRACTICE, V45, P64; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gulliford M, 2011, J HEALTH SERV RES PO, V16, P67, DOI 10.1258/jhsrp.2010.010015; Gulliford MC, 2006, ANN FAM MED, V4, P548, DOI 10.1370/afm.578; Hadjistavropoulos HD, 2004, CAN J CARDIOL, V20, P883; Hadjistavropoulos H, 2008, INT J QUAL HEALTH C, V20, P314, DOI 10.1093/intqhc/mzn030; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hanninen J, 2001, DIABETES RES CLIN PR, V51, P21, DOI 10.1016/S0168-8227(00)00198-4; Hess BJ, 2009, ACAD MED, V84, pS109, DOI 10.1097/ACM.0b013e3181b37ac7; Hudon C, 2011, ANN FAM MED, V9, P155, DOI 10.1370/afm.1226; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Joyce AS, 2010, COMMUNITY MENT HLT J, V46, P192, DOI 10.1007/s10597-009-9215-6; King M, 2008, BRIT J CANCER, V98, P529, DOI 10.1038/sj.bjc.6604164; Kowalyk KM, 2004, CAN J CARDIOL, V20, P205; Lawrence M, 2012, HEALTH EXPECT, V15, P295, DOI 10.1111/j.1369-7625.2011.00683.x; McGuiness C, 2003, INT J QUAL HEALTH C, V15, P309, DOI 10.1093/intqhc/mzg043; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Rose D, 2009, ACTA PSYCHIAT SCAND, V119, P320, DOI 10.1111/j.1600-0447.2008.01296.x; Schaefer JA, 2004, J STUD ALCOHOL, V65, P513, DOI 10.15288/jsa.2004.65.513; Stange KC, 2009, ANN FAM MED, V7, P293, DOI 10.1370/afm.1023; Strandberg-Larsen Martin, 2009, Int J Integr Care, V9, pe01; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Terwee CB, 2011, QUAL LIFE RES; Uijen AA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652364; Uijen AA, 2012, FAM PRACT, V29, P264, DOI 10.1093/fampra/cmr104; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Ware Norma C, 2003, Ment Health Serv Res, V5, P209, DOI 10.1023/A:1026276918081; Wei XL, 2008, J CLIN EPIDEMIOL, V61, P925, DOI 10.1016/j.jclinepi.2007.12.010; Young JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-298	45	62	63	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42256	10.1371/journal.pone.0042256	http://dx.doi.org/10.1371/journal.pone.0042256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860100	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600082
J	Wyllie, DH; Sogaard, KC; Holland, K; Xu, YB; Bregu, M; Hill, AVS; Kiss-Toth, E				Wyllie, David H.; Sogaard, Karen C.; Holland, Karen; Xu Yaobo; Bregu, Migena; Hill, Adrian V. S.; Kiss-Toth, Endre			Identification of 34 Novel Proinflammatory Proteins in a Genome-Wide Macrophage Functional Screen	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; CONTAINING ADAPTER; EXPRESSION; RECEPTOR; KINASE; FAMILY; ACTIVATION; POLYMORPHISM; REGULATOR	Signal transduction pathways activated by Toll-like Receptors and the IL-1 family of cytokines are fundamental to mounting an innate immune response and thus to clearing pathogens and promoting wound healing. Whilst mechanistic understanding of the regulation of innate signalling pathways has advanced considerably in recent years, there are still a number of critical controllers to be discovered. In order to characterise novel regulators of macrophage inflammation, we have carried out an extensive, cDNA-based forward genetic screen and identified 34 novel activators, based on their ability to induce the expression of cxcl2. Many are physiologically expressed in macrophages, although the majority of genes uncovered in our screen have not previously been linked to innate immunity. We show that expression of particular activators has profound but distinct impacts on LPS-induced inflammatory gene expression, including switch-type, amplifier and sensitiser behaviours. Furthermore, the novel genes identified here interact with the canonical inflammatory signalling network via specific mechanisms, as demonstrated by the use of dominant negative forms of IL1/TLR signalling mediators.	[Wyllie, David H.; Sogaard, Karen C.; Bregu, Migena; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Holland, Karen; Kiss-Toth, Endre] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Xu Yaobo] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	University of Oxford; Jenner Institute; University of Sheffield; Newcastle University - UK	Wyllie, DH (corresponding author), Univ Oxford, Jenner Inst, Old Rd,Campus Res Bldg, Oxford, England.	e.kiss-toth@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation; Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation; Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit	This work was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation. Support to fund KH was received from the Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Eder K, 2008, INT IMMUNOL, V20, P1543, DOI 10.1093/intimm/dxn116; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gordon A, 2010, J ORTHOP RES, V28, P1127, DOI 10.1002/jor.21135; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Guan HT, 2008, J IMMUNOL METHODS, V330, P96, DOI 10.1016/j.jim.2007.11.002; Guan HT, 2006, CELL IMMUNOL, V244, P158, DOI 10.1016/j.cellimm.2007.02.011; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hemmerich S, 2001, DRUG DISCOV TODAY, V6, P27, DOI 10.1016/S1359-6446(00)01581-6; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Kawashima H, 2012, ANN NY ACAD SCI, V1253, P112, DOI 10.1111/j.1749-6632.2011.06356.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kiss-Toth E, 2005, BIOCHEM SOC T, V33, P1405, DOI 10.1042/BST0331405; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2000, J IMMUNOL METHODS, V239, P125, DOI 10.1016/S0022-1759(00)00151-4; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kiss-Toth E, 2004, CYTOKINE GROWTH F R, V15, P97, DOI 10.1016/j.cytogfr.2004.02.002; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Ozen S, 2006, J RHEUMATOL, V33, P2498; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Smith SM, 2011, J IMMUNOL; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42388	10.1371/journal.pone.0042388	http://dx.doi.org/10.1371/journal.pone.0042388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860121	gold, Green Published, Green Accepted			2022-12-25	WOS:000307045600097
J	Zhang, WC; Wang, J; Shu, YW; Tang, TT; Zhu, ZF; Xia, N; Nie, SF; Liu, J; Zhou, SF; Li, JJ; Xiao, H; Yuan, J; Liao, MY; Cheng, LX; Liao, YH; Cheng, X				Zhang, Wen-cai; Wang, Jun; Shu, Yan-wen; Tang, Ting-ting; Zhu, Zheng-feng; Xia, Ni; Nie, Shao-fang; Liu, Juan; Zhou, Su-feng; Li, Jing-jing; Xiao, Hong; Yuan, Jing; Liao, Meng-yang; Cheng, Long-xian; Liao, Yu-hua; Cheng, Xiang			Impaired Thymic Export and Increased Apoptosis Account for Regulatory T Cell Defects in Patients with Non-ST Segment Elevation Acute Coronary Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SUPPRESSIVE FUNCTION; NERVOUS-SYSTEM; TNF-ALPHA; ATHEROSCLEROSIS; INTERLEUKIN-10; INFLAMMATION; IMMUNITY; MECHANISMS; EXPRESSION	Regulatory T (Treg) cells play a protective role against the development of atherosclerosis. Previous studies have revealed Treg cell defects in patients with non-ST elevation acute coronary syndrome (NSTACS), but the mechanisms underlying these defects remain unclear. In this study, we found that the numbers of peripheral blood CD4(+)CD25(+)CD127(low) Treg cells and CD4(+)CD25(+)CD127(low)CD45RA(+)CD45RO(-) naive Treg cells were lower in the NSTACS patients than in the chronic stable angina (CSA) and the chest pain syndrome (CPS) patients. However, the number of CD4(+)CD25(+)CD127(low)CD45RA(-) CD45RO(+) memory Treg cells was comparable in all of the groups. The frequency of CD4(+)CD25(+)CD127(low)CD45RO(-) CD45RA(+)CD31(+) recent thymic emigrant Treg cells and the T cell receptor excision circle content of purified Treg cells were lower in the NSTACS patients than in the CSA patients and the CPS controls. The spontaneous apoptosis of Treg cells (defined as CD4(+)CD25(+)CD127(low)annexinV(+)7-AAD(-)) was increased in the NSTACS patients compared with the CSA and CPS groups. Furthermore, oxidized LDL could induce Treg cell apoptosis, and the oxidized LDL levels were significantly higher in the NSTACS patients than in the CSA and CPS groups. In accordance with the altered Treg cell levels, the concentration of TNF-alpha was increased in the NSTACS patients, resulting in a decreased IL-10/TNF-alpha ratio. These findings indicate that the impaired thymic output of Treg cells and their enhanced susceptibility to apoptosis in the periphery were responsible for Treg cell defects observed in the NSTACS patients.	[Zhang, Wen-cai; Wang, Jun; Shu, Yan-wen; Tang, Ting-ting; Zhu, Zheng-feng; Xia, Ni; Nie, Shao-fang; Liu, Juan; Zhou, Su-feng; Li, Jing-jing; Yuan, Jing; Liao, Meng-yang; Cheng, Long-xian; Liao, Yu-hua; Cheng, Xiang] Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol, Inst Cardiol,Union Hosp,Tongji Med Coll,Minist Ed, Wuhan 430022, Peoples R China; [Wang, Jun] NO1 Peoples Hosp Yangzhou, Dept Cardiol, Yangzhou 225000, Peoples R China; [Xiao, Hong] NO1 Hosp Wuhan, Wuhan 430000, Peoples R China	Huazhong University of Science & Technology	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol, Inst Cardiol,Union Hosp,Tongji Med Coll,Minist Ed, Wuhan 430022, Peoples R China.	nathancx@mail.hust.edu.cn	Cheng, Xiang/K-2190-2012; Wu, yanxia/HGA-0318-2022	yan, wei/0000-0001-5575-7017	National Basic Research Program of China 973 Program [2012CB517805]; National Natural Science Foundation of China [81170303, 81222002, 81200177]; Program for New Century Excellent Talents in University of China [NCET-09-0380]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB517805 (to X. C.), National Natural Science Foundation of China Grants 81170303 and 81222002 (to X. C.) and 81200177 (to T.-T. T.), and Program for New Century Excellent Talents in University of China Grant NCET-09-0380 (to X. C.).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ehara S, 2002, J DIABETES COMPLICAT, V16, P60, DOI 10.1016/S1056-8727(01)00210-0; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Fritzsching B, 2006, J NEUROL SCI, V251, P91, DOI 10.1016/j.jns.2006.09.006; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gossl M, 2010, JACC-CARDIOVASC IMAG, V3, P32, DOI 10.1016/j.jcmg.2009.10.009; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Holven KB, 2002, ARTERIOSCL THROM VAS, V22, P699, DOI 10.1161/01.ATV.0000013288.35930.90; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Kinscherf R, 1998, FASEB J, V12, P461, DOI 10.1096/fasebj.12.6.461; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Livak F, 1996, MOL CELL BIOL, V16, P609; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Meier P, 2007, J AM SOC NEPHROL, V18, P331, DOI 10.1681/ASN.2006050514; Meilhac O, 1999, FASEB J, V13, P485, DOI 10.1096/fasebj.13.3.485; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Nakano A, 2007, THYROID, V17, P25, DOI 10.1089/thy.2006.0231; Naruko T, 2006, ARTERIOSCL THROM VAS, V26, P877, DOI 10.1161/01.ATV.0000209886.31510.7f; Patel KD, 2009, CLIN IMMUNOL, V133, P251, DOI 10.1016/j.clim.2009.07.007; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Stanzer S, 2008, J CLIN IMMUNOL, V28, P107, DOI 10.1007/s10875-007-9139-2; Steffens S, 2006, CIRCULATION, V114, P1977, DOI 10.1161/CIRCULATIONAHA.106.627430; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Tziakas DN, 2006, J AM COLL CARDIOL, V48, P2471, DOI 10.1016/j.jacc.2006.08.032; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Es T, 2010, ATHEROSCLEROSIS, V209, P74, DOI 10.1016/j.atherosclerosis.2009.08.041; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955	65	46	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34157	34166		10.1074/jbc.M112.382978	http://dx.doi.org/10.1074/jbc.M112.382978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872639	hybrid, Green Published			2022-12-25	WOS:000309654200021
J	Faingold, O; Cohen, T; Shai, Y				Faingold, Omri; Cohen, Tomer; Shai, Yechiel			A GxxxG-like Motif within HIV-1 Fusion Peptide Is Critical to Its Immunosuppressant Activity, Structure, and Interaction with the Transmembrane Domain of the T-cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-SPANNING DOMAIN; PROTEIN-KINASE-C; SYNTHETIC PEPTIDE; ENVELOPE GLYCOPROTEIN; SEQUENCE IDENTITY; DENDRITIC CELLS; IN-VIVO; GP41; INHIBITION	To thrive in the human body, HIV fuses to its target cell and evades the immune response via several mechanisms. The fusion cascade is initiated by the fusion peptide (FP), which is located at the N-terminal of gp41, the transmembrane protein of HIV. Recently, it has been shown that the HIV-1 FP, particularly its 5-13 amino acid region (FP5-13), suppresses T-cell activation and interacts with the transmembrane domain (TMD) of the T-cell receptor (TCR) complex. Specific amino acid motifs often contribute to such interactions in TMDs of membrane proteins. Using bioinformatics and experimental studies, we report on a GxxxG-like motif (AxxxG), which is conserved in the FP throughout different clades and strains of HIV-1. Biological activity studies and FTIR spectroscopy revealed that HIV FP5-13-derived peptides, in which the motif was altered either by randomization or by a single amino acid shift, lost their immunosuppressive activity concomitant with a loss of the beta-sheet structure in a membranous environment. Furthermore, fluorescence studies revealed that the inactive mutants lost their ability to interact with their target site, namely, the TMD of TCR alpha, designated CP. Importantly, lipotechoic acid activated macrophages (lacking TCR) were not affected by FP, further demonstrating the specificity of the immunosuppressant activity of CP. Finally, although the AxxxG WT and the GxxxG analog both associated with the CP and immunosuppressed T-cells, the AxxxG WT but not the GxxxG analog induced lipid mixing. Overall, the data support an important role for the AxxxG motif in the function of FP and might explain the natural selection of the AxxxG motif rather than the classical GxxxG motif in FP.	[Faingold, Omri; Cohen, Tomer; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.jac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bloch I, 2007, FASEB J, V21, P393, DOI 10.1096/fj.06-7061com; BLUMENTHAL R, 1991, ANN NY ACAD SCI, V635, P285, DOI 10.1111/j.1749-6632.1991.tb36499.x; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; CHIRMULE N, 1995, J IMMUNOL, V155, P917; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cohen T, 2008, BIOCHEMISTRY-US, V47, P4826, DOI 10.1021/bi800100p; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; Donaghy H, 2004, CURR OPIN INFECT DIS, V17, P1, DOI 10.1097/00001432-200402000-00002; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fernando K, 2007, BLOOD, V109, P2538, DOI 10.1182/blood-2006-08-038661; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; GABUZDA D, 1991, J ACQ IMMUN DEF SYND, V4, P34; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Grasnick D, 2011, EUR BIOPHYS J BIOPHY, V40, P529, DOI 10.1007/s00249-011-0676-5; HAYNES BF, 1993, J EXP MED, V177, P717, DOI 10.1084/jem.177.3.717; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Manolios N, 2008, ADV EXP MED BIOL, V640, P208, DOI 10.1007/978-0-387-09789-3_16; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Masci AM, 2003, J LEUKOCYTE BIOL, V74, P1117, DOI 10.1189/jlb.0503239; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; Oren Z, 1999, EUR J BIOCHEM, V259, P360, DOI 10.1046/j.1432-1327.1999.00047.x; Peisajovich SG, 2003, BBA-BIOMEMBRANES, V1614, P122, DOI 10.1016/S0005-2736(03)00170-6; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sigalov AB, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000404; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang XM, 2002, CELL IMMUNOL, V215, P12, DOI 10.1016/S0008-8749(02)00002-3; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731	64	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33503	33511		10.1074/jbc.M112.370817	http://dx.doi.org/10.1074/jbc.M112.370817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872636	Green Published, hybrid			2022-12-25	WOS:000309602100036
J	Dave, B; Landis, MD; Dobrolecki, LE; Wu, MF; Zhang, XM; Westbrook, TF; Hilsenbeck, SG; Liu, D; Lewis, MT; Tweardy, DJ; Chang, JC				Dave, Bhuvanesh; Landis, Melissa D.; Dobrolecki, Lacey E.; Wu, Meng-Fen; Zhang, Xiaomei; Westbrook, Thomas F.; Hilsenbeck, Susan G.; Liu, Dan; Lewis, Michael T.; Tweardy, David J.; Chang, Jenny C.			Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model	PLOS ONE			English	Article							STEM-CELLS; ACTIVATOR; DYNAMICS; THERAPY; TARGETS; GROWTH; ALPHA	Metastasis and disease relapse are hypothesized to result from tumor initiating cells (TICs). Previously, we have defined a CD44+/CD24-/low mammosphere-forming tumorigenic 493-gene signature in breast cancer. Stat3 was identified as a critical node in self-renewal based on an ongoing lentiviral shRNA screen being conducted in two breast cancer cell lines SUM159 and BT549. In corroborating work, targeting the SH2 domain of Stat3 with a novel small molecule decreased the percentage of cells expressing TIC markers (CD44+/CD24-/low and ALDH+) and mammosphere formation in p-Stat3 overexpressing human breast cancer xenografts in SCID-beige mice. Importantly, we observed a four-fold improvement in the 30-day recurrence-free survival relative to docetaxel alone with the addition of the Stat3 inhibitor in the chemoresistant tumor model. Thus, these findings provide a strong impetus for the development of selective Stat3 inhibitors in order to improve survival in patients with p-Stat3 overexpressing tumors.	[Dave, Bhuvanesh; Landis, Melissa D.; Dobrolecki, Lacey E.; Chang, Jenny C.] Methodist Canc Ctr, Houston, TX USA; [Tweardy, David J.] Baylor Coll Med, Dept Infect Dis, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Radiol, Dept Infect Dis, Houston, TX 77030 USA; [Westbrook, Thomas F.; Liu, Dan] Baylor Coll Med, Dept Radiol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Westbrook, Thomas F.; Liu, Dan] Baylor Coll Med, Dept Mol & Cellular Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wu, Meng-Fen; Zhang, Xiaomei; Hilsenbeck, Susan G.; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wu, Meng-Fen; Zhang, Xiaomei; Hilsenbeck, Susan G.; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Radiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dave, B (corresponding author), Methodist Canc Ctr, Houston, TX USA.	jcchang@tmhs.org	Lewis, Michael T/A-9572-2009; Dave, Bhuvanesh/ABF-8334-2020; Tweardy, David/L-3929-2019; chang, jenny/G-7614-2015	Dave, Bhuvanesh/0000-0001-6741-1363; chang, jenny/0000-0002-0890-9302	Breast Cancer Research Foundation; National Cancer Institute [1 R01 CA112305-01]; Komen Promise grant [KG 081694]; US Army Medical Research and Material Command [W81XWH-04-1-0468]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA112305] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Promise grant(Susan G. Komen Breast Cancer Foundation); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Breast Cancer Research Foundation, 1 R01 CA112305-01 from the National Cancer Institute (JCC, MTL), the Breast Cancer Research Foundation (JC), Komen Promise grant KG 081694 (JCC), and US Army Medical Research and Material Command W81XWH-04-1-0468 (JCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Villalva C, 2010, INT J CANC; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783	22	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e30207	10.1371/journal.pone.0030207	http://dx.doi.org/10.1371/journal.pone.0030207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879872	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000001
J	Chen, MH; Ha, EH; Wen, TW; Su, YN; Lien, GW; Chen, CY; Chen, PC; Hsieh, WS				Chen, Mei-Huei; Ha, Eun-Hee; Wen, Ting-Wen; Su, Yi-Ning; Lien, Guang-Wen; Chen, Chia-Yang; Chen, Pau-Chung; Hsieh, Wu-Shiun			Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE; PERFLUOROALKYL ACIDS; NEONATAL-MORTALITY; GESTATIONAL-AGE; FETAL-GROWTH; SERUM-LEVELS; CHEMICALS; EXPOSURE; WEIGHT; PREGNANCY	Background: Previous animal studies have shown that perfluorinated compounds (PFCs) have adverse impacts on birth outcomes, but the results have been inconclusive in humans. We investigated associations between prenatal exposure to perfluorooctanoic acid (PFOA), perfluorooctyl sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA) and birth outcomes. Methods: In total, 429 mother-infant pairs were recruited from the Taiwan Birth Panel Study (TBPS). Demographic data were obtained by interviewing mothers using a structured questionnaire and birth outcomes were extracted from medical records. Cord blood was collected for PFOA, PFOS, PFNA, and PFUA analysis by ultra-high-performance liquid chromatography/tandem mass spectrometry. Results: The geometric mean (standard deviation) levels of PFOA, PFOS, PFNA, and PFUA in cord blood plasma were 1.84 (2.23), 5.94 (1.95), 2.36(4.74), and 10.26 (3.07) ng/mL, respectively. Only PFOS levels were found to be inversely associated with gestational age, birth weight, and head circumference [per ln unit: adjusted beta (95% confidence interval, CI) = -0.37 (-0.60, -0.13) wks, -110.2 (-176.0, -44.5) gm and -0.25 (-0.46, -0.05) cm]. Additionally, the odds ratio of preterm birth, low birth weight, and small for gestational age increased with PFOS exposure [ per ln unit: adjusted odds ratio (OR) (95% CI) = 2.45 (1.47, 4.08), 2.61(0.85, 8.03) and 2.27 (1.25, 4.15)]. When PFOS levels were divided into quartiles, a dose-response relation was observed. However, PFOA, PFNA, and PFUA were not observed to have any convincing impact on birth outcomes. Conclusions: An adverse dose-dependent association was observed between prenatal PFOS exposure and birth outcomes. However, no associations were found for the other examined PFCs.	[Chen, Mei-Huei; Wen, Ting-Wen; Lien, Guang-Wen; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Chen, Mei-Huei] Cardinal Tien Hosp, Yonghe Branch, Dept Pediat, New Taipei, Taiwan; [Ha, Eun-Hee] Ewha Womans Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Su, Yi-Ning] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Su, Yi-Ning] Natl Taiwan Univ, Coll Med, Inst Clin Genom, Taipei 10764, Taiwan; [Chen, Chia-Yang] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 10764, Taiwan; [Chen, Chia-Yang; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	National Taiwan University; Ewha Womans University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chen, MH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan.	pchen@ntu.edu.tw; hsiehws@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; Chen, Chia-Yang/AAT-6155-2021; Chen, Chia Yang/C-5466-2019	Chen, Pau-Chung/0000-0002-6242-5974; Chen, Chia-Yang/0000-0001-5301-1609; Chen, Chia Yang/0000-0001-5301-1609; HSIEH, WU-SHIUN/0000-0002-0609-3311	National Science Council, Taiwan [NSC98-2621-M-002-017, NSC98-2621-M-002-018, NSC99-2621-M-002-003, NSC99-2621-M-002-005, NSC100-2621-M-002-003, NSC100-2621-M-002-004, NSC101-2621-M-002-005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council (NSC98-2621-M-002-017, NSC98-2621-M-002-018, NSC99-2621-M-002-003, NSC99-2621-M-002-005, NSC100-2621-M-002-003, NSC100-2621-M-002-004 and NSC101-2621-M-002-005), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; BARKER DJP, 1986, LANCET, V1, P1077; Bartell SM, 2010, ENVIRON HEALTH PERSP, V118, P222, DOI 10.1289/ehp.0901252; Begley TH, 2005, FOOD ADDIT CONTAM A, V22, P1023, DOI 10.1080/02652030500183474; Chang YC, 2012, ANAL BIOANAL CHEM, V402, P1315, DOI 10.1007/s00216-011-5519-9; Fei CY, 2008, AM J EPIDEMIOL, V168, P66, DOI 10.1093/aje/kwn095; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Grasty RC, 2003, BIRTH DEFECTS RES B, V68, P465, DOI 10.1002/bdrb.10046; Grice MM, 2007, J OCCUP ENVIRON MED, V49, P722, DOI 10.1097/JOM.0b013e3180582043; Hamm MP, 2010, J EXPO SCI ENV EPID, V20, P589, DOI 10.1038/jes.2009.57; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Inoue K, 2004, ENVIRON HEALTH PERSP, V112, P1204, DOI 10.1289/ehp.6864; Kudo N, 2006, BIOL PHARM BULL, V29, P1952, DOI 10.1248/bpb.29.1952; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lien GW, 2011, J CHROMATOGR B, V879, P641, DOI 10.1016/j.jchromb.2011.01.037; Lin AYC, 2010, CHEMOSPHERE, V80, P1167, DOI 10.1016/j.chemosphere.2010.06.018; Luebker DJ, 2005, TOXICOLOGY, V215, P149, DOI 10.1016/j.tox.2005.07.019; Monroy R, 2008, ENVIRON RES, V108, P56, DOI 10.1016/j.envres.2008.06.001; Nolan LA, 2009, REPROD TOXICOL, V27, P231, DOI 10.1016/j.reprotox.2008.11.001; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2009, REPROD TOXICOL, V27, P212, DOI 10.1016/j.reprotox.2009.02.001; Olsen GW, 2004, J OCCUP ENVIRON MED, V46, P837, DOI 10.1097/01.jom.0000135546.70469.87; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Sinclair E, 2007, ENVIRON SCI TECHNOL, V41, P1180, DOI 10.1021/es062377w; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; U.S. Environmental Protection Agency, 2010 2015 PFOA STEW; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459; Wolf CJ, 2008, TOXICOL SCI, V106, P162, DOI 10.1093/toxsci/kfn166; Wolf CJ, 2012, REPROD TOXICOL, V33, P546, DOI 10.1016/j.reprotox.2011.09.009; Wolf CJ, 2010, PPAR RES, V2010, DOI 10.1155/2010/282896	34	111	114	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42474	10.1371/journal.pone.0042474	http://dx.doi.org/10.1371/journal.pone.0042474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879996	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100102
J	Verger, EO; Mariotti, F; Holmes, BA; Paineau, D; Huneau, JF				Verger, Eric O.; Mariotti, Francois; Holmes, Bridget A.; Paineau, Damien; Huneau, Jean-Francois			Evaluation of a Diet Quality Index Based on the Probability of Adequate Nutrient Intake (PANDiet) Using National French and US Dietary Surveys	PLOS ONE			English	Article							LOW-ENERGY-DENSITY; HEALTHY EATING INDEX-2005; UNITED-STATES; NUTRITIONAL-STATUS; ADULTS; FOOD; PATTERNS; WOMEN; ADHERENCE; POPULATION	Background: Existing diet quality indices often show theoretical and methodological limitations, especially with regard to validation. Objective: To develop a diet quality index based on the probability of adequate nutrient intake (PANDiet) and evaluate its validity using data from French and US populations. Material and Methods: The PANDiet is composed of adequacy probabilities for 24 nutrients grouped into two sub-scores. The relationship between the PANDiet score and energy intake were investigated. We evaluated the construct validity of the index by comparing scores for population sub-groups with 'a priori' differences in diet quality, according to smoking status, energy density, food intakes, plasma folate and carotenoid concentrations. French and US implementations of the PANDiet were developed and evaluated using national nutritional recommendations and dietary surveys. Results: The PANDiet was not correlated with energy for the French implementation (r = -0.02, P>0.05) and correlated at a low level for the US implementation (r = -0.11, P<0.0001). In both implementations, a higher PANDiet score (i.e. a better diet quality) was associated with not smoking, having a lower-energy-dense diet, consuming higher amounts of fruits, vegetables, fish, milk and other dairy products and lower amounts of cheese, pizza, eggs, meat and processed meat, and having higher plasma folate and carotenoid concentrations after controlling for appropriate factors (all P<0.05, carotenoid data for US not available). Conclusions: The PANDiet provides a single score that measures the adequacy of nutrient intake and reflects diet quality. This index is adaptable for use in different countries and relevant at the individual and population levels.	[Verger, Eric O.; Mariotti, Francois; Huneau, Jean-Francois] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Verger, Eric O.; Mariotti, Francois; Huneau, Jean-Francois] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Verger, Eric O.; Holmes, Bridget A.; Paineau, Damien] Danone Res, Dept Nutr, Palaiseau, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Danone Nutricia	Verger, EO (corresponding author), AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	eric.verger@agroparistech.fr	Verger, Eric/J-9163-2016; Mariotti, François/F-9651-2017	Verger, Eric/0000-0002-8689-8290; Mariotti, François/0000-0002-4516-3853	Danone Research; Association nationale de la recherche et de la technologie [CIFRE 474/2010]	Danone Research(Danone Nutricia); Association nationale de la recherche et de la technologie(French National Research Agency (ANR))	EOV was supported by Danone Research and a grant from the Association nationale de la recherche et de la technologie (CIFRE 474/2010). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSSA, 2007, APP PROT CONS QUAL B; [Anonymous], APPORTS NUTR CONSEIL; Arambepola C, 2008, PUBLIC HEALTH NUTR, V11, P371, DOI 10.1017/S1368980007000377; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bland JM, 2002, BRIT MED J, V324, P606, DOI 10.1136/bmj.324.7337.606; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Commission of the European Communities, 1993, NUTR EN INT EUR COMM; Dallongeville J, 1998, J NUTR, V128, P1450; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Drake I, 2011, PUBLIC HEALTH NUTR, V7, P1; EFSA Panel on Dietetic Products NaA, 2010, SCI OP DIET REF VAL; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Fogli-Cawley JJ, 2006, J NUTR, V136, P2908, DOI 10.1093/jn/136.11.2908; Food and Nutrition Board Institute of Medicine, 2000, DIET REF INT VIT C V; Foote JA, 2004, J NUTR, V134, P1779; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Golley RK, 2011, J NUTR, V141, P1340, DOI 10.3945/jn.110.136879; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Guenther PM, 2008, J AM DIET ASSOC, V108, P1854, DOI 10.1016/j.jada.2008.08.011; Hercberg S, 2005, TABLE COMPOSITION AL; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; *I MED FOOD NUTR B, 2000, DIET REF INT APPL DI; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Institute of Medicine, 1997, DIETARY REFERENCE IN; Institute of Medicine Food and Nutrition Board, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2010, DIET REF INT VIT D C; Institute of Medicine Food and Nutrition Board Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Panel on Micronutrients., 2002, DIET REF INT EN CARB; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kourlaba G, 2009, MATURITAS, V62, P1, DOI 10.1016/j.maturitas.2008.11.021; Ledikwe JH, 2006, J AM DIET ASSOC, V106, P1172, DOI 10.1016/j.jada.2006.05.013; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; MADDEN JP, 1972, PENN AGR EXP STA B, V78, P1; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Maillot M, 2010, AM J CLIN NUTR, V91, P421, DOI 10.3945/ajcn.2009.28426; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McNaughton SA, 2008, J NUTR, V138, P86, DOI 10.1093/jn/138.1.86; Murphy MM, 2011, J AM DIET ASSOC, V112, P222; National Center for Health Statistics, 2011, 2007 2008 NAT HLTH N; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; OMS, 2018, TOP 10 CAUS DEATH; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Panagiotakos D, 2009, OPEN CARDIOVASC MED, V3, P160, DOI 10.2174/1874192400903010160; Park JY, 2011, BR J NUTR, V1, P1; Pietinen P, 2008, PUBLIC HEALTH NUTR, V11, P335, DOI 10.1017/S1368980007000249; Schroder H, 2008, J NUTR, V138, P1476, DOI 10.1093/jn/138.8.1476; Shatenstein B, 2005, J AM DIET ASSOC, V105, P1251, DOI 10.1016/j.jada.2005.05.008; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; Taechangam S, 2008, ASIA PAC J CLIN NUTR, V17, P365; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X	56	73	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42155	10.1371/journal.pone.0042155	http://dx.doi.org/10.1371/journal.pone.0042155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870293	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100048
J	Yu, LN; Zhou, XL; Yu, J; Huang, H; Jiang, LS; Zhang, FJ; Cao, JL; Yan, M				Yu, Li-Na; Zhou, Xue-Long; Yu, Jing; Huang, Hao; Jiang, Li-Shan; Zhang, Feng-Jiang; Cao, Jun-Li; Yan, Min			PI3K Contributed to Modulation of Spinal Nociceptive Information Related to ephrinBs/EphBs	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROPATHIC PAIN; DORSAL-HORN; CENTRAL SENSITIZATION; SYNAPTIC PLASTICITY; PATHOLOGICAL PAIN; SENSITIVE METHOD; EPH RECEPTORS; UP-REGULATION	There is accumulating evidence to implicate the importance of EphBs receptors and ephrinBs ligands were involved in modulation of spinal nociceptive information. However, the downstream mechanisms that control this process are not well understood. In the present study, we investigated whether phosphatidylinositol 3-kinase (PI3K), as the downstream effectors, participates in modulation of spinal nociceptive information related to ephrinBs/EphBs. Intrathecal injection of ephrinB1-Fc produced a dose- and time-dependent thermal and mechanical hyperalgesia, accompanied by the increase of spinal PI3K-p110 gamma, phosphorylation of AKT (p-AKT) and c-Fos expression. Pre-treatment with PI3K inhibitor wortmannin or LY294002 prevented activation of spinal AKT induced by ephrinB1-Fc. Inhibition of spinal PI3K signaling dose-dependently prevented and reversed pain behaviors and spinal c-Fos protein expression induced by intrathecal injection of ephrinB1-Fc. Inhibition of EphBs receptors by intrathecal injection of EphB1-Fc reduced formalin-induced inflammation and chronic constrictive injury-induced neuropathic pain behaviors accompanied by decreased expression of spinal PI3K,p-AKT and c-Fos protein. Furthermore, pre-treatment with PI3K inhibitor wortmannin or LY294002 prevented ephrinB1-Fc-induced ERK activation in spinal. These data demonstrated that PI3K and PI3K crosstalk to ERK signaling contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.	[Yu, Li-Na; Yu, Jing; Huang, Hao; Zhang, Feng-Jiang; Yan, Min] Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xue-Long; Jiang, Li-Shan; Cao, Jun-Li; Yan, Min] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Zhou, Xue-Long; Jiang, Li-Shan; Cao, Jun-Li; Yan, Min] Xuzhou Med Coll, Ctr Pain Res & Treatment, Xuzhou, Jiangsu, Peoples R China	Zhejiang University; Xuzhou Medical University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	yanminnina@hotmail.com	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165; Cao, Jun-Li/0000-0002-8932-4743	medicine health project of Zhejiang province [2008A088]	medicine health project of Zhejiang province	This work was supported by a grant from the medicine health project of Zhejiang province (No. 2008A088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bogen O, 2008, EUR J NEUROSCI, V28, P12, DOI 10.1111/j.1460-9568.2008.06308.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cao JL, 2008, PAIN, V139, P617, DOI 10.1016/j.pain.2008.06.023; Carvalho TT, 2011, PHARMACOL BIOCHEM BE, V98, P188, DOI 10.1016/j.pbb.2010.12.027; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Cirillo G, 2010, CELL MOL NEUROBIOL, V30, P51, DOI 10.1007/s10571-009-9430-2; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Guan XH, 2010, PHARMACOL BIOCHEM BE, V95, P315, DOI 10.1016/j.pbb.2010.02.007; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Haugan F, 2008, NEUROSCIENCE, V154, P1568, DOI 10.1016/j.neuroscience.2008.05.010; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jongen JLM, 2005, EXP NEUROL, V194, P255, DOI 10.1016/j.expneurol.2005.02.019; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kobayashi H, 2007, SPINE, V32, P1592, DOI 10.1097/BRS.0b013e318074d46a; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Liu S, 2011, CANCER RES, V71, P4392, DOI 10.1158/0008-5472.CAN-10-3870; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Melzack R, 2001, ANN NY ACAD SCI, V933, P157; Munglani R, 1996, BRIT J ANAESTH, V76, P1; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pezet S, 2008, J NEUROSCI, V28, P4261, DOI 10.1523/JNEUROSCI.5392-07.2008; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; Sanchez-Perez AM, 2006, NEUROCHEM INT, V49, P351, DOI 10.1016/j.neuint.2006.02.005; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Song XJ, 2008, EUR J PAIN, V12, P1031, DOI 10.1016/j.ejpain.2008.01.011; Steinle JJ, 2003, CELL SIGNAL, V15, P1011, DOI 10.1016/S0898-6568(03)00072-X; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Sun R, 2007, NEUROSCIENCE, V144, P286, DOI 10.1016/j.neuroscience.2006.08.084; Sun RQ, 2006, PAIN, V120, P86, DOI 10.1016/j.pain.2005.10.017; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; Villarreal CF, 2009, LIFE SCI, V85, P822, DOI 10.1016/j.lfs.2009.10.018; Wang ZY, 2006, NEUROPHARMACOLOGY, V51, P764, DOI 10.1016/j.neuropharm.2006.05.024; Willson CA, 2003, CELL TRANSPLANT, V12, P279, DOI 10.3727/000000003108746830; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Zhang X, 2011, J NEURAL TRANSM; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77	54	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40930	10.1371/journal.pone.0040930	http://dx.doi.org/10.1371/journal.pone.0040930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879882	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100012
J	Majesky, L; Vasut, RJ; Kitner, M; Travnicek, B				Majesky, Lubos; Vasut, Radim J.; Kitner, Miloslav; Travnicek, Bohumil			The Pattern of Genetic Variability in Apomictic Clones of Taraxacum officinale Indicates the Alternation of Asexual and Sexual Histories of Apomicts	PLOS ONE			English	Article							DANDELIONS TARAXACUM; POPULATION-STRUCTURE; RANUNCULUS-CARPATICOLA; MICROSATELLITE MARKERS; SECT. ERYTHROSPERMA; AFLP; EVOLUTION; ASTERACEAE; DIVERSITY; SECTIONS	Dandelions (genus Taraxacum) comprise a group of sexual diploids and apomictic polyploids with a complicated reticular evolution. Apomixis (clonal reproduction through seeds) in this genus is considered to be obligate, and therefore represent a good model for studying the role of asexual reproduction in microevolutionary processes of apomictic genera. In our study, a total of 187 apomictic individuals composing a set of nine microspecies (sampled across wide geographic area in Europe) were genotyped for six microsatellite loci and for 162 amplified fragment length polymorphism (AFLP) markers. Our results indicated that significant genetic similarity existed within accessions with low numbers of genotypes. Genotypic variability was high among accessions but low within accessions. Clustering methods discriminated individuals into nine groups corresponding to their phenotypes. Furthermore, two groups of apomictic genotypes were observed, which suggests that they had different asexual histories. A matrix compatibility test suggests that most of the variability within accession groups was mutational in origin. However, the presence of recombination was also detected. The accumulation of mutations in asexual clones leads to the establishment of a network of clone mates. However, this study suggests that the clones primarily originated from the hybridisation between sexual and apomicts.	[Majesky, Lubos; Vasut, Radim J.; Kitner, Miloslav; Travnicek, Bohumil] Palacky Univ, Dept Bot, Fac Sci, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Majesky, L (corresponding author), Palacky Univ, Dept Bot, Fac Sci, CR-77147 Olomouc, Czech Republic.	radim.vasut@upol.cz	Kitner, Miloslav/I-1223-2012; Vasut, Radim/J-8983-2012	Kitner, Miloslav/0000-0002-3762-8067; Vasut, Radim/0000-0001-6882-5509; Majesky, Lubos/0000-0002-8860-5703	Czech Science Foundation [206/09/P356]; Palacky University [IGA PrF 2010/1, 2011/3, 2012/1]; GACR [206/09/1126]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959215]	Czech Science Foundation(Grant Agency of the Czech Republic); Palacky University; GACR(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the Czech Science Foundation (GACR: http://www.gacr.cz/), Grant no. 206/09/P356. In addition, LM was supported by the Palacky University fundings (www.upol.cz), nos. IGA PrF 2010/1 and 2011/3 and 2012/1; RJV by GACR 206/09/1126 (www.gacr.cz) and MK by grant by the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz), no. MSM 6198959215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asker S. E., 1992, APOMIXIS PLANTS; Battjes Johannes, 1992, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V114, P315; Bell G., 1982, MASTERPIECE NATURE E; Bendiksby M, 2011, NEW PHYTOL, V191, P1150, DOI 10.1111/j.1469-8137.2011.03753.x; Brookfield JFY, 1992, MOL ECOL, V1, P21, DOI 10.1111/j.1365-294X.1992.tb00151.x; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Corander J, 2006, FISH B-NOAA, V104, P550; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond EBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030314; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falque M, 1998, THEOR APPL GENET, V97, P283, DOI 10.1007/s001220050897; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fehrer J, 2005, REGNUM VEG, V143, P175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heuertz M, 2004, EVOLUTION, V58, P976; Horandl E, 2006, NEW PHYTOL, V171, P525, DOI 10.1111/j.1469-8137.2006.01769.x; HUGHES J, 1988, HEREDITY, V60, P161, DOI 10.1038/hdy.1988.28; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kirschner J, 1996, FOLIA GEOBOT PHYTOTX, V31, P415, DOI 10.1007/BF02815386; KIRSCHNER J, 1987, TAXON, V36, P608, DOI 10.2307/1221855; Kirschner J, 2011, TAXON, V60, P216, DOI 10.1002/tax.601021; Kitner M, 2012, PRESLIA, V84, P97; Kitner M, 2008, ISR J PLANT SCI, V56, P185, DOI 10.1560/IJPS.56.3.185; Kolarcik V, 2010, PLANT SYST EVOL, V290, P21, DOI 10.1007/s00606-010-0346-6; Lo EYY, 2009, MOL ECOL, V18, P1145, DOI 10.1111/j.1365-294X.2009.04091.x; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Mariette S, 2002, SILVAE GENET, V51, P72; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Mariette S, 2002, MOL ECOL, V11, P1145, DOI 10.1046/j.1365-294X.2002.01519.x; Martonfiova L, 2006, FOLIA GEOBOT, V41, P183, DOI 10.1007/BF02806478; Martonfiova L, 2007, ACTA BIOL CRACOV BOT, V49, P47; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; Meirmans PG, 2003, J EVOLUTION BIOL, V16, P343, DOI 10.1046/j.1420-9101.2003.00515.x; MENKEN S B J, 1989, Plant Species Biology, V4, P29, DOI 10.1111/j.1442-1984.1989.tb00045.x; Menken SBJ, 1995, EVOLUTION, V49, P1108, DOI 10.2307/2410435; Mes THM, 2002, MOL ECOL, V11, P253, DOI 10.1046/j.1365-294X.2002.01427.x; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paule J, 2011, TAXON, V60, P721, DOI 10.1002/tax.603008; Paun O, 2006, MOL ECOL, V15, P897, DOI 10.1111/j.1365-294X.2006.02800.x; Paun O, 2006, GENETICS, V174, P387, DOI 10.1534/genetics.105.052761; Paun O, 2006, NEW PHYTOL, V171, P223, DOI 10.1111/j.1469-8137.2006.01738.x; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Reisch C, 2004, BOT J LINN SOC, V145, P109, DOI 10.1111/j.1095-8339.2004.00283.x; RICHARDS AJ, 1973, BOT J LINN SOC, V66, P189, DOI 10.1111/j.1095-8339.1973.tb02169.x; Richards AJ, 1996, FOLIA GEOBOT PHYTOTX, V31, P405, DOI 10.1007/BF02815385; Rogstad SH, 2002, PLANT ECOL, V161, P111, DOI 10.1023/A:1020301011283; Rohlf F. J., 1998, NTSYS PC NUMERICAL T; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; SMITH JM, 1978, EVOLUTION SEX; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tas ICQ, 1999, HEREDITY, V83, P707, DOI 10.1038/sj.hdy.6886190; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; van Baarlen P, 2000, GENOME, V43, P827, DOI 10.1139/gen-43-5-827; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Van Dijk P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P475, DOI 10.1007/978-90-481-2770-2_22; van Dijk PJ, 2008, NATURE, V451, P1063, DOI 10.1038/4511063a; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483; van Dijk PJ, 2003, PHILOS T R SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; Vasut RJ, 2004, MOL ECOL NOTES, V4, P645, DOI 10.1111/j.1471-8286.2004.00760.x; Vasut RJ, 2003, PRESLIA, V75, P311; Vijverberg K, 2004, THEOR APPL GENET, V108, P725, DOI 10.1007/s00122-003-1474-y; Vijverberg K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-154; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; Whitton J, 2008, INT J PLANT SCI, V169, P169, DOI 10.1086/523369; Wilkinson M., 2001, PICA 4 0 SOFTWARE DO; Wittzell H, 1999, MOL ECOL, V8, P2023, DOI 10.1046/j.1365-294x.1999.00807.x; Zaveska Drabkova L, 2009, PLANT SYST EVOL, V278, P67, DOI 10.1007/s00606-008-0134-8	87	48	50	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41868	10.1371/journal.pone.0041868	http://dx.doi.org/10.1371/journal.pone.0041868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870257	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800040
J	Hennebelle, M; Balasse, L; Latour, A; Champeil-Potokar, G; Denis, S; Lavialle, M; Gisquet-Verrier, P; Denis, I; Vancassel, S				Hennebelle, Marie; Balasse, Laure; Latour, Alizee; Champeil-Potokar, Gaelle; Denis, Stephanie; Lavialle, Monique; Gisquet-Verrier, Pascale; Denis, Isabelle; Vancassel, Sylvie			Influence of Omega-3 Fatty Acid Status on the Way Rats Adapt to Chronic Restraint Stress	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLUCOCORTICOID NEGATIVE FEEDBACK; RECEPTOR GENE-TRANSCRIPTION; MESSENGER-RNA EXPRESSION; N-3 PUFA; MATERNAL-DEPRIVATION; SPATIAL MEMORY; TIME-COURSE; ADULT RATS; BRAIN	Omega-3 fatty acids are important for several neuronal and cognitive functions. Altered omega-3 fatty acid status has been implicated in reduced resistance to stress and mood disorders. We therefore evaluated the effects of repeated restraint stress (6 h/day for 21 days) on adult rats fed omega-3 deficient, control or omega-3 enriched diets from conception. We measured body weight, plasma corticosterone and hippocampus glucocorticoid receptors and correlated these data with emotional and depression-like behaviour assessed by their open-field (OF) activity, anxiety in the elevated-plus maze (EPM), the sucrose preference test and the startle response. We also determined their plasma and brain membrane lipid profiles by gas chromatography. Repeated restraint stress caused rats fed a control diet to lose weight. Their plasma corticosterone increased and they showed moderate behavioural changes, with increases only in grooming (OF test) and entries into the open arms (EPM). Rats fed the omega-3 enriched diet had a lower stress-induced weight loss and plasma corticosterone peak, and reduced grooming. Rats chronically lacking omega-3 fatty acid exhibited an increased startle response, a stress-induced decrease in locomotor activity and exaggerated grooming. The brain omega-3 fatty acids increased as the dietary omega-3 fatty acids increased; diets containing preformed long-chain omega-3 fatty acid were better than diets containing the precursor alpha-linolenic acid. However, the restraint stress reduced the amounts of omega-3 incorporated. These data showed that the response to chronic restraint stress was modulated by the omega-3 fatty acid supply, a dietary deficiency was deleterious while enrichment protecting against stress.	[Hennebelle, Marie; Latour, Alizee; Champeil-Potokar, Gaelle; Denis, Stephanie; Lavialle, Monique; Denis, Isabelle; Vancassel, Sylvie] INRA, Unite Nutr & Regulat Lipid Fonct Cerebrales, NuReLiCe, UR909, Jouy En Josas, France; [Balasse, Laure; Gisquet-Verrier, Pascale] Univ Paris 11, CNRS, UMR 8195, Ctr Neurosci Paris Sud, Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Hennebelle, M (corresponding author), INRA, Unite Nutr & Regulat Lipid Fonct Cerebrales, NuReLiCe, UR909, Jouy En Josas, France.	sylvie.vancassel@jouy.inra.fr	Hennebelle, Marie/AAC-7730-2020; Vancassel, sylvie/GXG-5187-2022	Balasse, Laure/0000-0003-2057-7408; DENIS, Stephanie/0000-0001-7761-8843; Hennebelle, Marie/0000-0002-2279-1400	Institut National de la Recherche Agronomique, Paris, France; Agence Nationale pour la Recherche, France [ANR-09-ALIA-006 Neuromega3]; Unilever, Netherlands; Unilever	Institut National de la Recherche Agronomique, Paris, France; Agence Nationale pour la Recherche, France(French National Research Agency (ANR)); Unilever, Netherlands(Unilever); Unilever(Unilever)	This work was supported by the Institut National de la Recherche Agronomique, Paris, France, by the Agence Nationale pour la Recherche, France, ANR-09-ALIA-006 Neuromega3, and by Unilever, Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Unilever provided funding for supplying research reagents and a grant for Marie Hennebelle, graduate student. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aid S, 2003, J LIPID RES, V44, P1545, DOI 10.1194/jlr.M300079-JLR200; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Alessandri JM, 2001, LIPIDS, V36, P1141, DOI 10.1007/s11745-001-0825-2; Alessandri JM, 2004, REPROD NUTR DEV, V44, P1; Anuradha H, 2008, J NEURAL TRANSM, V115, P35, DOI 10.1007/s00702-007-0821-6; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Barnum CJ, 2007, J NEUROENDOCRINOL, V19, P632, DOI 10.1111/j.1365-2826.2007.01571.x; Beck KD, 2002, PHYSIOL BEHAV, V75, P661, DOI 10.1016/S0031-9384(02)00670-4; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Borcela E, 2008, BEHAV PHARMACOL, V19, P41, DOI 10.1097/FBP.0b013e3282f3fca9; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; Cunnane SC, 2000, LIPIDS, V35, P105, DOI 10.1007/s11745-000-0501-6; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fedorova I, 2009, BEHAV NEUROSCI, V123, P1218, DOI 10.1037/a0017446; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Gomez F, 1996, NEUROENDOCRINOLOGY, V63, P327, DOI 10.1159/000126973; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Hamazaki K, 2005, NUTRITION, V21, P705, DOI 10.1016/j.nut.2004.07.020; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; Herman JP, 1998, J NEUROSCI, V18, P7462; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/138161209789909683; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lucas M, 2010, J AM COLL NUTR, V29, P211, DOI 10.1080/07315724.2010.10719836; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McEwen BS, 2010, EUR J PHARMACOL, V583, P174; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; Paskitti ME, 2000, MOL BRAIN RES, V80, P142, DOI 10.1016/S0169-328X(00)00121-2; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Romeo RD, 2008, NEUROENDOCRINOLOGY, V87, P160, DOI 10.1159/000109710; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Rybkin II, 1997, AM J PHYSIOL-REG I, V273, pR1612, DOI 10.1152/ajpregu.1997.273.5.R1612; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Talahalli RR, 2010, LIPIDS, V45, P799, DOI 10.1007/s11745-010-3464-6; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; VANERP AMM, 1994, BEHAV BRAIN RES, V65, P47, DOI 10.1016/0166-4328(94)90072-8; Vazquez V, 2005, PSYCHOPHARMACOLOGY, V181, P706, DOI 10.1007/s00213-005-0029-0; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53	70	56	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42142	10.1371/journal.pone.0042142	http://dx.doi.org/10.1371/journal.pone.0042142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860066	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900072
J	McGowan, EM; Tran, N; Alling, N; Yagoub, D; Sedger, LM; Martiniello-Wilks, R				McGowan, Eileen M.; Nham Tran; Alling, Nikki; Yagoub, Daniel; Sedger, Lisa M.; Martiniello-Wilks, Rosetta			p14ARF Post-Transcriptional Regulation of Nuclear Cyclin D1 in MCF-7 Breast Cancer Cells: Discrimination between a Good and Bad Prognosis?	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; TRANSCRIPTIONAL ACTIVITY; DEPENDENT KINASES; IN-VIVO; P53; MDM2; P21	As part of a cell's inherent protection against carcinogenesis, p14ARF is upregulated in response to hyperproliferative signalling to induce cell cycle arrest. This property makes p14ARF a leading candidate for cancer therapy. This study explores the consequences of reactivating p14ARF in breast cancer and the potential of targeting p14ARF in breast cancer treatment. Our results show that activation of the p14ARF-p53-p21-Rb pathway in the estrogen sensitive MCF-7 breast cancer cells induces many hallmarks of senescence including a large flat cell morphology, multinucleation, senescence-associated-beta-gal staining, and rapid G1 and G2/M phase cell cycle arrest. P14ARF also induces the expression of the proto-oncogene cyclin D1, which is most often associated with a transition from G1-S phase and is highly expressed in breast cancers with poor clinical prognosis. In this study, siRNA knockdown of cyclin D1, p21 and p53 show p21 plays a pivotal role in the maintenance of high cyclin D1 expression, cell cycle and growth arrest post-p14ARF induction. High p53 and p14ARF expression and low p21/cyclin D1 did not cause cell-cycle arrest. Knockdown of cyclin D1 stops proliferation but does not reverse senescence-associated cell growth. Furthermore, cyclin D1 accumulation in the nucleus post-p14ARF activation correlated with a rapid loss of nucleolar Ki-67 protein and inhibition of DNA synthesis. Latent effects of the p14ARF-induced cellular processes resulting from high nuclear cyclin D1 accumulation included a redistribution of Ki-67 into the nucleoli, aberrant nuclear growth (multinucleation), and cell proliferation. Lastly, downregulation of cyclin D1 through inhibition of ER abrogated latent recurrence. The mediation of these latent effects by continuous expression of p14ARF further suggests a novel mechanism whereby dysregulation of cyclin D1 could have a double-edged effect. Our results suggest that p14ARF induced-senescence is related to late-onset breast cancer in estrogen responsive breast cancers and/or the recurrence of more aggressive breast cancer post-therapy.	[McGowan, Eileen M.; Nham Tran; Sedger, Lisa M.; Martiniello-Wilks, Rosetta] Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Nham Tran; Sedger, Lisa M.; Martiniello-Wilks, Rosetta] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Nham Tran] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Alling, Nikki] Garvan Inst Med Res, Flow Cytometry Unit, Sydney, NSW, Australia; [Yagoub, Daniel] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Technology Sydney; University of Technology Sydney; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney	McGowan, EM (corresponding author), Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia.	Eileen.Mcgowan@uts.edu.au		Martiniello-Wilks, Rosetta/0000-0002-0038-3430; Tran, Nham/0000-0001-7747-2530; Sedger, Lisa/0000-0003-1009-5683; McGowan, Eileen/0000-0001-6371-3751	Cancer Institute of NSW Fellowship; University of Technology Sydney, Vice Chancellor's Research Fellowship; Prostate Cancer Foundation of Australia; Sydney Cancer Centre Foundation; Cancer Institute NSW; Rebecca L Cooper Foundation	Cancer Institute of NSW Fellowship; University of Technology Sydney, Vice Chancellor's Research Fellowship; Prostate Cancer Foundation of Australia; Sydney Cancer Centre Foundation; Cancer Institute NSW; Rebecca L Cooper Foundation	EMM is a recipient of a Cancer Institute of NSW Fellowship; NT is a recipient of a University of Technology Sydney, Vice Chancellor's Research Fellowship. RMW is supported by the Prostate Cancer Foundation of Australia, Sydney Cancer Centre Foundation, Cancer Institute NSW & the Rebecca L Cooper Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsafadi S, 2009, CURR MED CHEM, V16, P4328, DOI 10.2174/092986709789578196; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Berns A, 2002, CANCER CELL, V1, P309, DOI 10.1016/S1535-6108(02)00063-6; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; CHEN XB, 1995, CANCER RES, V55, P4257; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; D'Amico M, 2003, CANCER RES, V63, P3395; de Jong JS, 1999, J CLIN PATHOL-MOL PA, V52, P78, DOI 10.1136/mp.52.2.78; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Gallagher S, 2005, CELL CYCLE, V4, P465, DOI 10.4161/cc.4.3.1526; Gosselin K, 2009, CANCER RES, V69, P7917, DOI 10.1158/0008-5472.CAN-08-2510; HARPER JW, 1993, CELL, V75, P805; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Konduri SD, 2010, P NATL ACAD SCI USA, V107, P15081, DOI 10.1073/pnas.1009575107; Kurokawa K, 1999, ONCOGENE, V18, P2718, DOI 10.1038/sj.onc.1202628; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Matsuoka M, 2003, BIOCHEM BIOPH RES CO, V301, P1000, DOI 10.1016/S0006-291X(03)00080-9; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2000, CANCER RES, V60, P3689; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sutherland R.L., 1999, HUMAN CELL CULTURE, P79; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Wilcken NRC, 1997, CLIN CANCER RES, V3, P849; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yu SH, 2009, J MED CHEM, V52, P7970, DOI 10.1021/jm901400z; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42246	10.1371/journal.pone.0042246	http://dx.doi.org/10.1371/journal.pone.0042246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860097	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900082
J	Gunnaiah, R; Kushalappa, AC; Duggavathi, R; Fox, S; Somers, DJ				Gunnaiah, Raghavendra; Kushalappa, Ajjamada C.; Duggavathi, Raj; Fox, Stephen; Somers, Daryl J.			Integrated Metabolo-Proteomic Approach to Decipher the Mechanisms by Which Wheat QTL (Fhb1) Contributes to Resistance against Fusarium graminearum	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; QUANTITATIVE TRAIT LOCUS; MYCOTOXIN DEOXYNIVALENOL; TRANSCRIPTOME ANALYSIS; PEROXIDASE-ACTIVITY; IDENTIFICATION; BARLEY; LIGNIN; GENE; INFECTION	Background: Resistance in plants to pathogen attack can be qualitative or quantitative. For the latter, hundreds of quantitative trait loci (QTLs) have been identified, but the mechanisms of resistance are largely unknown. Integrated nontarget metabolomics and proteomics, using high resolution hybrid mass spectrometry, were applied to identify the mechanisms of resistance governed by the fusarium head blight resistance locus, Fhb1, in the near isogenic lines derived from wheat genotype Nyubai. Findings: The metabolomic and proteomic profiles were compared between the near isogenic lines (NIL) with resistant and susceptible alleles of Fhb1 upon F. graminearum or mock-inoculation. The resistance-related metabolites and proteins identified were mapped to metabolic pathways. Metabolites of the shunt phenylpropanoid pathway such as hydroxycinnamic acid amides, phenolic glucosides and flavonoids were induced only in the resistant NIL, or induced at higher abundances in resistant than in susceptible NIL, following pathogen inoculation. The identities of these metabolites were confirmed, with fragmentation patterns, using the high resolution LC-LTQ-Orbitrap. Concurrently, the enzymes of phenylpropanoid biosynthesis such as cinnamyl alcohol dehydrogenase, caffeoyl-CoA O-methyltransferase, caffeic acid O-methyltransferase, flavonoid O-methyltransferase, agmatine coumaroyltransferase and peroxidase were also up-regulated. Increased cell wall thickening due to deposition of hydroxycinnamic acid amides and flavonoids was confirmed by histochemical localization of the metabolites using confocal microscopy. Conclusion: The present study demonstrates that the resistance in Fhb1 derived from the wheat genotype Nyubai is mainly associated with cell wall thickening due to deposition of hydroxycinnamic acid amides, phenolic glucosides and flavonoids, but not with the conversion of deoxynivalenol to less toxic deoxynivalenol 3-O-glucoside.	[Gunnaiah, Raghavendra; Kushalappa, Ajjamada C.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Duggavathi, Raj] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Fox, Stephen] Agr & Agri Food Canada, Winnipeg, MB, Canada; [Somers, Daryl J.] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada	McGill University; McGill University; Agriculture & Agri Food Canada	Gunnaiah, R (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	ajjamada.kushalappa@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022	Gunnaiah, Raghavendra/0000-0001-8479-3164	Natural Sciences and Engineering Research Council of Canada; Indian Council of Agricultural Research, New Delhi, India	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	This project was funded by the Natural Sciences and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mr. Raghavendra Gunnaiah would like to thank the Indian Council of Agricultural Research, New Delhi, India for the ICAR-International Ph.D. fellowship.	Aldini G, 2011, J CHROMATOGR A, V1218, P2856, DOI 10.1016/j.chroma.2011.02.065; Alemanno L, 2003, ANN BOT-LONDON, V92, P613, DOI 10.1093/aob/mcg177; [Anonymous], 2004, SAS V 9 2; Bai GH, 1999, PHYTOPATHOLOGY, V89, P343, DOI 10.1094/PHYTO.1999.89.4.343; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bassard JE, 2010, PHYTOCHEMISTRY, V71, P1808, DOI 10.1016/j.phytochem.2010.08.003; Bhuiyan NH, 2007, PLANT MOL BIOL, V64, P305, DOI 10.1007/s11103-007-9155-x; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Cerretani L, 2010, EUR J LIPID SCI TECH, V112, P1150, DOI 10.1002/ejlt.201000356; Chen LiFeng, 1997, Acta Phytopathologica Sinica, V27, P209; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Edreva AM, 2007, RUSS J PLANT PHYSL+, V54, P287, DOI 10.1134/S1021443707030016; Facchini PJ, 2002, CAN J BOT, V80, P577, DOI [10.1139/B02-065, 10.1139/b02-065]; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Geddes J, 2008, PROTEOMICS, V8, P545, DOI 10.1002/pmic.200700115; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; Hamzehzarghani H, 2008, CAN J PLANT PATHOL, V30, P24, DOI 10.1080/07060660809507493; Hamzehzarghani H, 2005, PHYSIOL MOL PLANT P, V66, P119, DOI 10.1016/j.pmpp.2005.05.005; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Kuhl C, 2009, LC MS PEAK ANNOTATIO; Kumaraswamy GK, 2012, PLANT PATHOL, V61, P509, DOI 10.1111/j.1365-3059.2011.02528.x; Kumaraswamy GK, 2011, EUR J PLANT PATHOL, V130, P29, DOI 10.1007/s10658-010-9729-3; Kumaraswamy KG, 2011, J CHEM ECOL, V37, P846, DOI 10.1007/s10886-011-9989-1; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; Lim EK, 2005, FEBS LETT, V579, P2802, DOI 10.1016/j.febslet.2005.04.016; Lloyd AJ, 2011, PLANT J, V67, P852, DOI 10.1111/j.1365-313X.2011.04639.x; MATERN U, 1995, CAN J BOT, V73, pS511, DOI 10.1139/b95-290; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; McLusky SR, 1999, PLANT J, V17, P523, DOI 10.1046/j.1365-313X.1999.00403.x; Menden B, 2007, PHYTOCHEMISTRY, V68, P513, DOI 10.1016/j.phytochem.2006.11.011; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; MILLER JD, 1985, PHYTOPATHOL Z, V113, P359; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Somers DJ, 2005, THEOR APPL GENET, V111, P1623, DOI 10.1007/s00122-005-0094-0; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Suzuki S, 2010, J WOOD SCI, V56, P71, DOI 10.1007/s10086-009-1059-8; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wang Y, 2005, PROTEOMICS, V5, P4496, DOI 10.1002/pmic.200401317; Wei S, 2010, PLANT GROWTH REGUL, V61, P243, DOI 10.1007/s10725-010-9468-7; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yang F, 2010, PROTEOMICS, V10, P3748, DOI 10.1002/pmic.201000243; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; Zhang CY, 2008, J AGR FOOD CHEM, V56, P8268, DOI 10.1021/jf801830z; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041	69	180	188	7	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40695	10.1371/journal.pone.0040695	http://dx.doi.org/10.1371/journal.pone.0040695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22866179	Green Submitted, Green Published, gold			2022-12-25	WOS:000306366400048
J	Ashkenazi, A; Viard, M; Unger, L; Blumenthal, R; Shai, Y				Ashkenazi, Avraham; Viard, Mathias; Unger, Linor; Blumenthal, Robert; Shai, Yechiel			Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1	FASEB JOURNAL			English	Article						viral envelope protein; sphingolipids	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; CELL-CELL FUSION; ENVELOPE GLYCOPROTEIN; MEDIATED FUSION; COILED-COIL; LIPID RAFTS; GP41; CHOLESTEROL; PEPTIDE	Understanding the structural organization of lipids in the cell and viral membranes is essential for elucidating mechanisms of viral fusion that lead to entry of enveloped viruses into their host cells. The HIV lipidome shows a remarkable enrichment in dihydrosphingomyelin, an unusual sphingolipid formed by a dihydrosphingosine backbone. Here we investigated the ability of dihydrosphingosine to incorporate into the site of membrane fusion mediated by the HIV envelope (Env) protein. Dihydrosphingosine as well as cholesterol, fatty acid, and tocopherol was conjugated to highly conserved, short HIV-1 Env-derived peptides with no antiviral activity otherwise. We showed that dihydrosphingosine exclusively endowed nanomolar antiviral activity to the peptides (IC50 as low as 120 nM) in HIV-1 infection on TZM-bl cells and on Jurkat T cells, as well as in the cell-cell fusion assay. These sphingopeptides were active against enfuvirtide-resistant and wild-type CXCR4 and CCR5 tropic HIV strains. The anti-HIV activity was determined by both the peptides and their dihydrosphingosine conjugate. Moreover, their mode of action involved accumulation in the cells and viruses and binding to membranes enriched in sphingomyelin and cholesterol. The data suggest that sphingopeptides are recruited to the HIV membrane fusion site and provide a general concept in developing inhibitors of sphingolipid-mediated biological systems.-Ashkenazi, A., Viard, M., Unger, L., Blumenthal, R., Shai, Y. Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. FASEB J. 26, 4628-4636 (2012). www.fasebj.org	[Ashkenazi, Avraham; Unger, Linor; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Viard, Mathias; Blumenthal, Robert] NCI, Nanobiol Program, Ctr Canc Res, Frederick Natl Lab, Frederick, MD 21701 USA; [Viard, Mathias] SAIC Frederick Inc, Basic Sci Program, Ctr Canc Res Nanobiol Program, Frederick Natl Lab, Frederick, MD USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X	Israel Science Foundation; Frederick National Laboratory; National Cancer Institute; U.S. National Institutes of Health [HHSN26120080001E]; NATIONAL CANCER INSTITUTE [ZIABC008303] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Frederick National Laboratory(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Batya Zarmi for her valuable help with peptide purification and Winfried Weissenhorn for providing the recent 3-dimensional structure of gp41. This study was supported by the Israel Science Foundation (to Y. S.) and in part by federal funds (to R. B.) from the Frederick National Laboratory, National Cancer Institute, U.S. National Institutes of Health (contract HHSN26120080001E). The content of this publication does not necessarily reflect the views or policies of the U. S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. Y. S. is the incumbent of the Harold S. and Harriet B. Brady Professorial Chair in Cancer Research.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; BENEFRAIM I, 1993, BIOCHEMISTRY-US, V32, P2371, DOI 10.1021/bi00060a031; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chien MP, 2008, FASEB J, V22, P1179, DOI 10.1096/fj.07-9576com; Choi KS, 2005, J VIROL, V79, P9862, DOI 10.1128/JVI.79.15.9862-9871.2005; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Epand RM, 2003, BIOPHYS J, V84, P3102, DOI 10.1016/S0006-3495(03)70035-6; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; Hetru C, 2000, BIOCHEM J, V345, P653, DOI 10.1042/0264-6021:3450653; Holguin A, 2007, AIDS RES HUM RETROV, V23, P1067, DOI 10.1089/aid.2006.0256; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kuikka M, 2001, BIOPHYS J, V80, P2327, DOI 10.1016/S0006-3495(01)76203-0; Lev N, 2007, J MOL BIOL, V374, P220, DOI 10.1016/j.jmb.2007.09.008; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Melikyan GB, 2006, J VIROL, V80, P3249, DOI 10.1128/JVI.80.7.3249-3258.2006; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Rawat SS, 2005, BIOSCIENCE REP, V25, P329, DOI 10.1007/s10540-005-2894-5; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Viard M, 2003, GLYCOCONJUGATE J, V20, P213, DOI 10.1023/B:GLYC.0000024253.48791.d9; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331	56	32	33	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4628	4636		10.1096/fj.12-215111	http://dx.doi.org/10.1096/fj.12-215111			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872679	Green Published			2022-12-25	WOS:000310574200024
J	Herrera-Cruz, M; Cruz, G; Valadez-Graham, V; Fregoso-Lomas, M; Villicana, C; Vazquez, M; Reynaud, E; Zurita, M				Herrera-Cruz, Mariana; Cruz, Grisel; Valadez-Graham, Viviana; Fregoso-Lomas, Mariana; Villicana, Claudia; Vazquez, Martha; Reynaud, Enrique; Zurita, Mario			Physical and Functional Interactions between Drosophila Homologue of Swc6/p18(Hamlet) Subunit of the SWR1/SRCAP Chromatin-remodeling Complex with the DNA Repair/Transcription Factor TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; BICISTRONIC TRANSCRIPT; HISTONE H2A.Z; HUMAN SRCAP; PROTEIN; MUTATIONS; ENCODES; DAMAGE; DISSOCIATION; BIOLOGY	The multisubunit DNA repair and transcription factor TFIIH maintains an intricate cross-talk with different factors to achieve its functions. The p8 subunit of TFIIH maintains the basal levels of the complex by interacting with the p52 subunit. Here, we report that in Drosophila, the homolog of the p8 subunit (Dmp8) is encoded in a bicistronic transcript with the homolog of the Swc6/p18(Hamlet) subunit (Dmp18) of the SWR1/SRCAP chromatin remodeling complex. The SWR1 and SRCAP complexes catalyze the exchange of the canonical histone H2A with the H2AZ histone variant. In eukaryotic cells, bicistronic transcripts are not common, and in some cases, the two encoded proteins are functionally related. We found that Dmp18 physically interacts with the Dmp52 subunit of TFIIH and co-localizes with TFIIH in the chromatin. We also demonstrated that Dmp18 genetically interacts with Dmp8, suggesting that a crosstalk might exist between TFIIH and a component of a chromatin remodeler complex involved in histone exchange. Interestingly, our results also show that when the level of one of the two proteins is decreased and the other maintained, a specific defect in the fly is observed, suggesting that the organization of these two genes in a bicistronic locus has been selected during evolution to allow co-regulation of both genes.	[Herrera-Cruz, Mariana; Cruz, Grisel; Valadez-Graham, Viviana; Fregoso-Lomas, Mariana; Villicana, Claudia; Vazquez, Martha; Reynaud, Enrique; Zurita, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet, Av Univ 2001, Cuernavaca 62250, Morelos, Mexico.	marioz@ibt.unam.mx	Villicaña, Claudia/AAB-8767-2022; Herrera-Cruz, Mariana/F-6971-2018	Villicaña, Claudia/0000-0002-3737-8416; Herrera-Cruz, Mariana/0000-0001-7821-9924; Valadez, Viviana/0000-0002-2556-7375; Cruz Becerra, Grisel/0000-0001-6297-4132; Vazquez, Martha/0000-0003-0329-8802	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico [IN 20109-3]; Consejo Nacional de Ciencia y Tecnologia Grant [127440]; IXTLI/Universidad Nacional Autonoma de Mexico; Fundacion Miguel Aleman; Howard Hughes Medical Institute	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Grant; IXTLI/Universidad Nacional Autonoma de Mexico; Fundacion Miguel Aleman; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by funds from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico IN 20109-3, Consejo Nacional de Ciencia y Tecnologia Grant 127440, IXTLI/Universidad Nacional Autonoma de Mexico, Fundacion Miguel Aleman, and the Howard Hughes Medical Institute (to M. Z.).	Aguilar-Fuentes J, 2006, J CELL SCI, V119, P3866, DOI 10.1242/jcs.03150; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; Bao YH, 2011, CELL, V144, P158, DOI 10.1016/j.cell.2010.12.024; Betran E, 2000, MOL BIOL EVOL, V17, P1344, DOI 10.1093/oxfordjournals.molbev.a026418; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Jawhari A, 2002, J BIOL CHEM, V277, P31761, DOI 10.1074/jbc.M203792200; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafarga V, 2007, CELL CYCLE, V6, P2319, DOI 10.4161/cc.6.19.4741; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Merino C, 2002, MOL BIOL CELL, V13, P3246, DOI 10.1091/mbc.E02-02-0087; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Reynaud E, 1999, MOL BIOL CELL, V10, P1191, DOI 10.1091/mbc.10.4.1191; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; Sloan J, 1999, NUCLEIC ACIDS RES, V27, P854, DOI 10.1093/nar/27.3.854; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Valadez-Graham V, 2012, NUCLEIC ACIDS RES, V40, P1460, DOI 10.1093/nar/gkr865; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, P861, DOI 10.1093/nar/gkl1085; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	54	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33567	33580		10.1074/jbc.M112.383505	http://dx.doi.org/10.1074/jbc.M112.383505			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865882	Green Published, hybrid			2022-12-25	WOS:000309602100042
J	Dechorgnat, J; Patrit, O; Krapp, A; Fagard, M; Daniel-Vedele, F				Dechorgnat, Julie; Patrit, Oriane; Krapp, Anne; Fagard, Mathilde; Daniel-Vedele, Francoise			Characterization of the Nrt2.6 Gene in Arabidopsis thaliana: A Link with Plant Response to Biotic and Abiotic Stress	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; NITRIC-OXIDE; DEFENSE RESPONSES; NITROGEN; EXPRESSION; IDENTIFICATION; RESISTANCE; ATNRT2.1; CLONING; ROOTS	The high affinity nitrate transport system in Arabidopsis thaliana involves one gene and potentially seven genes from the NRT1 and NRT2 family, respectively. Among them, NRT2.1, NRT2.2, NRT2.4 and NRT2.7 proteins have been shown to transport nitrate and are localized on the plasmalemma or the tonoplast membranes. NRT2.1, NRT2.2 and NRT2.4 play a role in nitrate uptake from soil solution by root cells while NRT2.7 is responsible for nitrate loading in the seed vacuole. We have undertaken the functional characterization of a third member of the family, the NRT2.6 gene. NRT2.6 was weakly expressed in most plant organs and its expression was higher in vegetative organs than in reproductive organs. Contrary to other NRT2 members, NRT2.6 expression was not induced by limiting but rather by high nitrogen levels, and no nitrate-related phenotype was found in the nrt2.6-1 mutant. Consistently, the over-expression of the gene failed to complement the nitrate uptake defect of an nrt2.1-nrt2.2 double mutant. The NRT2.6 expression is induced after inoculation of Arabidopsis thaliana by the phytopathogenic bacterium Erwinia amylovora. Interestingly, plants with a decreased NRT2.6 expression showed a lower tolerance to pathogen attack. A correlation was found between NRT2.6 expression and ROS species accumulation in response to infection by E. amylovora and treatment with the redox-active herbicide methyl viologen, suggesting a probable link between NRT2.6 activity and the production of ROS in response to biotic and abiotic stress.	[Dechorgnat, Julie; Krapp, Anne; Daniel-Vedele, Francoise] Saclay Plant Sci, AgroParisTech, INRA, Inst Jean Pierre Bourgin,UMR 1318, Versailles, France; [Patrit, Oriane] AgroParisTech, UMR217, Lab Interact Plantes Pathogenes, Paris, France; [Fagard, Mathilde] INRA, UMR217, Lab Interact Plantes Pathogenes, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE	Dechorgnat, J (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Urrbrae, Australia.	fancoise.vedele@versailles.inra.fr	Fagard, Mathilde/K-7998-2012; Krapp, Anne/E-8372-2013	Krapp, Anne/0000-0003-2034-5615	French Ministry; French ANR (Agence Nationale pour la Recherche) [ANR08-Blan-008]; doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante)	French Ministry; French ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante)	J Dechorgnat was funded by the French Ministry and the doctoral school, ABIES (Agriculture, Alimentation, Environnement et Sante). This project was supported by a French ANR (Agence Nationale pour la Recherche, http://www.agence-nationale-recherche.fr/) program (Nitrapool, ANR08-Blan-008). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Besson-Bard A, 2008, J EXP BOT, V59, P3407, DOI 10.1093/jxb/ern189; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Bonasera JM, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-23; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Chardon F, 2010, J EXP BOT, V61, P2293, DOI 10.1093/jxb/erq059; Chopin F, 2007, PLANT PHYSIOL BIOCH, V45, P630, DOI 10.1016/j.plaphy.2007.04.007; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DANIELVEDELE F, 1993, MOL GEN GENET, V240, P365, DOI 10.1007/BF00280388; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Deeken R, 2006, PLANT CELL, V18, P3617, DOI 10.1105/tpc.106.044743; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; DODGE AD, 1994, CAUSES PHOTOOXIDATIV, P219; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Filleur S, 1999, PLANTA, V207, P461, DOI 10.1007/s004250050505; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; Glass ADM, 1995, NITROGEN NUTR HIGHER, P21; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; HUBER DM, 1974, ANNU REV PHYTOPATHOL, V12, P139, DOI 10.1146/annurev.py.12.090174.001035; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jouannic S, 2011, ANN BOT-LONDON, V108, P1477, DOI 10.1093/aob/mcr019; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Krapp A, 1998, PLANT J, V14, P723, DOI 10.1046/j.1365-313x.1998.00181.x; Lejay L, 2008, PLANT PHYSIOL, V146, P2036, DOI 10.1104/pp.107.114710; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Merigout P, 2008, PLANT PHYSIOL, V147, P1225, DOI 10.1104/pp.108.119339; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Modolo LV, 2006, PLANT SCI, V171, P34, DOI 10.1016/j.plantsci.2006.02.010; Moreau M, 2012, MOL PLANT MICROBE IN, V25, P421, DOI 10.1094/MPMI-05-11-0111; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Oliveira HC, 2009, PLANT SCI, V176, P105, DOI 10.1016/j.plantsci.2008.09.017; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; PAULIN J-P, 1973, Annales de Phytopathologie, V5, P389; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Segonzac C, 2007, PLANT CELL, V19, P3760, DOI 10.1105/tpc.106.048173; Snoeijers SS, 2000, EUR J PLANT PATHOL, V106, P493, DOI 10.1023/A:1008720704105; Song W, 1996, PLANT PHYSIOL, V110, P171, DOI 10.1104/pp.110.1.171; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yong ZH, 2010, PLANT J, V63, P739, DOI 10.1111/j.1365-313X.2010.04278.x; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhang C, 2004, MOL PLANT MICROBE IN, V17, P357, DOI 10.1094/MPMI.2004.17.4.357	61	50	51	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42491	10.1371/journal.pone.0042491	http://dx.doi.org/10.1371/journal.pone.0042491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880003	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900042
J	Fearnley, LG; Nielsen, LK				Fearnley, Liam G.; Nielsen, Lars K.			PATHLOGIC-S: A Scalable Boolean Framework for Modelling Cellular Signalling	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; ACTIVATION; PATHWAYS; RECEPTOR; NETWORKS	Curated databases of signal transduction have grown to describe several thousand reactions, and efficient use of these data requires the development of modelling tools to elucidate and explore system properties. We present PATHLOGIC-S, a Boolean specification for a signalling model, with its associated GPL-licensed implementation using integer programming techniques. The PATHLOGIC-S specification has been designed to function on current desktop workstations, and is capable of providing analyses on some of the largest currently available datasets through use of Boolean modelling techniques to generate predictions of stable and semi-stable network states from data in community file formats. PATHLOGIC-S also addresses major problems associated with the presence and modelling of inhibition in Boolean systems, and reduces logical incoherence due to common inhibitory mechanisms in signalling systems. We apply this approach to signal transduction networks including Reactome and two pathways from the Panther Pathways database, and present the results of computations on each along with a discussion of execution time. A software implementation of the framework and model is freely available under a GPL license.	[Fearnley, Liam G.; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland	Fearnley, LG (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	lars.nielsen@uq.edu.au	Nielsen, Lars K/A-5519-2011	Nielsen, Lars K/0000-0001-8191-3511	Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government; Australian Research Council [DP110103384]	Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	LGF was funded by an Australian Postgraduate Award from the Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian Government, and through Australian Research Council Discovery Grant DP110103384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; [Anonymous], 2011, BIOPAX BIOL PATHW EX; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Berkelaar M, 2010, LP SOLV VERS 5 5 2 0; Bertsimas D, 2005, ATHENA SCI, VI-X, P1; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fliss AE, 1999, J BIOL CHEM, V274, P34045, DOI 10.1074/jbc.274.48.34045; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gosling J, 2005, JAVATMLANGUAGE SPECI; Graves JD, 2004, IMMUNOL REV, V197, P129, DOI 10.1111/j.0105-2896.2004.0110.x; Handorf T, 2012, BIOINFORMATICS, V28, P557, DOI 10.1093/bioinformatics/btr697; Harlin H, 2002, J IMMUNOL, V169, P2451, DOI 10.4049/jimmunol.169.5.2451; Haus UU, 2009, J COMPUT BIOL, V16, P725, DOI 10.1089/cmb.2008.0163; Haus UU, 2008, J SATISF BOOLEAN MOD, V6, P13; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Himsolt M, 1996, A8 U FLOR; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Joshi-Tope G, 2003, COLD SPRING HARB SYM, V68, P237, DOI 10.1101/sqb.2003.68.237; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Matthews L, 2007, BIOINFORMATICS PRIME, DOI [10.1038/pid.2007.3, DOI 10.1038/PID.2007.3]; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Nielsen LK, 2011, NAT CHEM BIOL, V7, P407, DOI 10.1038/nchembio.601; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Rivas FV, 2001, J IMMUNOL, V167, P3123, DOI 10.4049/jimmunol.167.6.3123; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Tarjan Robert, 1971, P 12 ANN S SWITCH AU, P114, DOI [DOI 10.1109/SWAT.1971.10, 10.1109/SWAT.1971.10]; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Zhang YQ, 2004, MOL CELL BIOL, V24, P1044, DOI 10.1128/MCB.24.3.1044-1057.2004	38	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41977	10.1371/journal.pone.0041977	http://dx.doi.org/10.1371/journal.pone.0041977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879903	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900018
J	Milanesi, A; Lee, JW; Li, ZH; Da Sacco, S; Villani, V; Cervantes, V; Perin, L; Yu, JS				Milanesi, Anna; Lee, Jang-Won; Li, Zhenhua; Da Sacco, Stefano; Villani, Valentina; Cervantes, Vanessa; Perin, Laura; Yu, John S.			beta-Cell Regeneration Mediated by Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INSULIN-PRODUCING CELLS; PANCREATIC-ISLETS; STROMAL CELLS; IN-VIVO; FACTOR-A; DIFFERENTIATION; EXPRESSION; PDX1; TRANSPLANTATION	Bone marrow mesenchymal stem cells (BMSCs) have been shown to ameliorate diabetes in animal models. The mechanism, however, remains largely unknown. An unanswered question is whether BMSCs are able to differentiate into beta-cells in vivo, or whether BMSCs are able to mediate recovery and/or regeneration of endogenous beta-cells. Here we examined these questions by testing the ability of hBMSCs genetically modified to transiently express vascular endothelial growth factor (VEGF) or pancreatic-duodenal homeobox 1 (PDX1) to reverse diabetes and whether these cells were differentiated into beta-cells or mediated recovery through alternative mechanisms. Human BMSCs expressing VEGF and PDX1 reversed hyperglycemia in more than half of the diabetic mice and induced overall improved survival and weight maintenance in all mice. Recovery was sustained only in the mice treated with hBMSCs-VEGF. However, de novo beta-cell differentiation from human cells was observed in mice in both cases, treated with either hBMSCs-VEGF or hBMSCs-PDX1, confirmed by detectable level of serum human insulin. Sustained reversion of diabetes mediated by hBMSCs-VEGF was secondary to endogenous beta-cell regeneration and correlated with activation of the insulin/IGF receptor signaling pathway involved in maintaining beta-cell mass and function. Our study demonstrated the possible benefit of hBMSCs for the treatment of insulin-dependent diabetes and gives new insight into the mechanism of beta-cell recovery after injury mediated by hBMSC therapy.	[Milanesi, Anna] Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA; [Milanesi, Anna] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Lee, Jang-Won; Li, Zhenhua; Cervantes, Vanessa; Yu, John S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Da Sacco, Stefano; Villani, Valentina; Perin, Laura] Univ So Calif, Dept Urol, Childrens Hosp Los Angeles, Los Angeles, CA USA	Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; Children's Hospital Los Angeles; University of Southern California	Milanesi, A (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA.	john.yu@cshs.org	Da Sacco, Stefano/G-6346-2011; Villani, Valentina/ABB-8016-2020	Da Sacco, Stefano/0000-0001-9654-6822; Yu, John/0000-0003-1230-8494	Endocrine Fellow Foundation; Cedars-Sinai Clinical Scholar Program	Endocrine Fellow Foundation; Cedars-Sinai Clinical Scholar Program	Funding source: Endocrine Fellow Foundation, and Cedars-Sinai Clinical Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Banerjee M, 2005, BIOCHEM BIOPH RES CO, V328, P318, DOI 10.1016/j.bbrc.2004.12.176; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Chae HY, 2005, EXP MOL MED, V37, P513, DOI 10.1038/emm.2005.64; Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Ezquer F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016566; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Forte A, 2008, J CELL PHYSIOL, V217, P789, DOI 10.1002/jcp.21559; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414; Malek A, 2010, CLIN EXP METASTAS, V27, P261, DOI 10.1007/s10585-010-9324-1; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Milanesi A, 2011, J ENDOCRINOL, V209, P193, DOI 10.1530/JOE-10-0344; Nakayama S, 2009, DIABETOLOGIA, V52, P115, DOI 10.1007/s00125-008-1172-z; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nicholson JM, 2010, EXP BIOL MED, V235, P189, DOI 10.1258/ebm.2009.009316; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Alvarez SS, 2006, MICROSURG, V26, P539, DOI 10.1002/micr.20283; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Wang QH, 2009, ISLETS, V1, P95, DOI 10.4161/isl.1.2.9263; Yue WM, 2008, STEM CELLS DEV, V17, P785, DOI 10.1089/scd.2007.0243; Zeng ZH, 2007, J NEUROSCI RES, V85, P310, DOI 10.1002/jnr.21131; Zhao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002666	54	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42177	10.1371/journal.pone.0042177	http://dx.doi.org/10.1371/journal.pone.0042177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879915	gold, Green Submitted, Green Published			2022-12-25	WOS:000307437900023
J	Tiemann, I; Rehkamper, G				Tiemann, Inga; Rehkaemper, Gerd			Evolutionary Pets: Offspring Numbers Reveal Speciation Process in Domesticated Chickens	PLOS ONE			English	Article							GALLUS-GALLUS; ISOLATING MECHANISMS; SEXUAL SELECTION; FOWL; HYBRIDIZATION; PREFERENCES; JUNGLEFOWL; HOMOGAMY; PIGEONS; CHOICE	Since Darwin, the nature of the relationship between evolution and domestication has been debated. Evolution offers different mechanisms of selection that lead to adaptation and may end in the origin of new species as defined by the biological species concept. Domestication has given rise to numerous breeds in almost every domesticated species, including chickens. At the same time, so-called artificial selection seems to exclude mechanisms of sexual selection by the animals themselves. We want to forward the question to the animal itself: With whom do you reproduce successfully? This study focused on the sexual behavior of the domestic chicken Gallus gallus f.dom., particularly the White Crested Polish breed. Experiments on mate choice and the observation of fertilization and hatching rates of mixed-breeding groups revealed breed-specific preferences. In breeding groups containing White Crested Polish and a comparative breed, more purebred chicks hatched than hybrids (number of eggs collected: 1059). Mating was possible in equal shares, but in relation to the number of eggs collected, purebred offspring (62.75%+/-67.10%, M+/-SE) hatched to a greater extend compared to hybrid offspring (28.75%+/-15.32%, M+/-SE). These data demonstrate that the mechanism of sexual selection is still present in domestic chicken breeds, which includes the alteration of gene frequencies typical for domestication and evolutionary speciation. Due to selection and mate choice we state that breeding in principle can generate new species. Therefore, we see domestication as an evolutionary process that integrates human interests of animal breeding with innate mate choice by the animal.	[Tiemann, Inga] Poultry Res Ctr, Bruno Durigen Inst, Rommerskirchen, Germany; [Tiemann, Inga; Rehkaemper, Gerd] Univ Dusseldorf, Inst Anat, Res Grp Comparat Neurobiol & Evolutionary Res, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Tiemann, I (corresponding author), Poultry Res Ctr, Bruno Durigen Inst, Rommerskirchen, Germany.	tiemanni@uni-duesseldorf.de	Tiemann, Inga/AAF-8365-2021	Tiemann, Inga/0000-0002-3607-4453	German Research Foundation [RE 635/6 2]	German Research Foundation(German Research Foundation (DFG))	The project was supported by the German Research Foundation, RE 635/6 2 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SEXUAL SELECTION; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bateson P., 1983, MATE CHOICE; Birkhead TR, 1992, SPERM COMPETITION BI; Bleed P, 2006, EVOL ANTHROPOL, V15, P8, DOI 10.1002/evan.20084; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; BROTHWELL D, 1979, J ARCHAEOL SCI, V6, P291, DOI 10.1016/0305-4403(79)90007-4; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; Cooke F., 1983, P279; Coyne JA, 2004, SPECIATION, V37; Crawford R.D, 1990, POULTRY BREEDING GEN; d'Udine B., 1983, P311; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dytham C, 2003, CHOOSING USING STAT; Fisher A. E., 1957, Behaviour, V10, P309; Fisher R.A., 1930, GEN THEORY NATURAL S; Frahm HD, 1998, BRAIN BEHAV EVOLUT, V52, P292, DOI 10.1159/000006574; Freeman S., 2007, EVOLUTIONARY ANAL; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Gleason JM, 1998, EVOLUTION, V52, P1093, DOI [10.1111/j.1558-5646.1998.tb01836.x, 10.2307/2411239]; Gulick JT, 1890, NATURE, V42, P28; Hartl :D. L, 2000, PRIMER POPULATION GE; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hauffe HC, 2004, CYTOGENET GENOME RES, V105, P395, DOI 10.1159/000078212; Herre W., 1990, HAUSTIERE ZOOLOGISCH, V2nd ed.; Holveck MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023974; Kirk RE, 1995, EXPT DESIGN; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; LILL A, 1968, Behaviour, V30, P127; LILL A, 1968, BEHAVIOUR, V30, P107, DOI 10.1163/156853967X00280; LILL A, 1965, BEHAVIOUR, V25, P16, DOI 10.1163/156853965X00101; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MOREJOHN GV, 1968, EVOLUTION, V22, P576, DOI 10.1111/j.1558-5646.1968.tb03993.x; Noor MAF, 2002, TRENDS ECOL EVOL, V17, P153, DOI 10.1016/S0169-5347(02)02452-7; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Price E.O., 2002, ANIMAL DOMESTICATION; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Provine W. B., 1986, SEWALL WRIGHT EVOLUT; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAMBRAUS HH, 1980, ARCH GEFLUGELKD, V44, P200; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Schutz F., 1965, Zeitschrift fuer Tierpsychologie, V22, P50; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SMITH JM, 1978, EVOLUTION SEX; ten Cate C, 2006, CURR BIOL, V16, P1128, DOI 10.1016/j.cub.2006.03.068; TENCATE C, 1988, EVOLUTION, V42, P1355, DOI 10.1111/j.1558-5646.1988.tb04196.x; Tiemann I, 2009, POULTRY SCI, V88, P1948, DOI 10.3382/ps.2008-00250; Tiemann I, 2008, BRAIN RES BULL, V76, P300, DOI 10.1016/j.brainresbull.2008.03.013; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Turner GF, 1999, REV FISH BIOL FISHER, V9, P281, DOI 10.1023/A:1008903228512; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Westneat D.F., 2010, EVOLUTIONARY BEHAV E; Williams D.M., 1983, P297; WRIGHT S, 1978, J ANIM SCI, V46, P1192, DOI 10.2527/jas1978.4651192x; Wright S., 1978, EVOLUTION GENETICS P; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	63	4	4	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41453	10.1371/journal.pone.0041453	http://dx.doi.org/10.1371/journal.pone.0041453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879889	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000007
J	Yanovsky, Y; Schubring, SR; Yao, QL; Zhao, Y; Li, S; May, A; Haas, HL; Lin, JS; Sergeeva, OA				Yanovsky, Yevgenij; Schubring, Stephan R.; Yao, Quiaoling; Zhao, Yan; Li, Sha; May, Andrea; Haas, Helmut L.; Lin, Jian-Sheng; Sergeeva, Olga A.			Waking Action of Ursodeoxycholic Acid (UDCA) Involves Histamine and GABA(A) Receptor Block	PLOS ONE			English	Article							BILE-ACIDS; TAUROURSODEOXYCHOLIC ACID; POSTERIOR HYPOTHALAMUS; BILIARY ENRICHMENT; NERVOUS-SYSTEM; NEURONS; SLEEP; MODULATION; APOPTOSIS; SUBUNIT	Since ancient times ursodeoxycholic acid (UDCA), a constituent of bile, is used against gallstone formation and cholestasis. A neuroprotective action of UDCA was demonstrated recently in models of Alzheimer's disease and retinal degeneration. The mechanisms of UDCA action in the nervous system are poorly understood. We show now that UDCA promotes wakefulness during the active period of the day, lacking this activity in histamine-deficient mice. In cultured hypothalamic neurons UDCA did not affect firing rate but synchronized the firing, an effect abolished by the GABA(A)R antagonist gabazine. In histaminergic neurons recorded in slices UDCA reduced amplitude and duration of spontaneous and evoked IPSCs. In acutely isolated histaminergic neurons UDCA inhibited GABA-evoked currents and sIPSCs starting at 10 mu M (IC50 = 70 mu M) and did not affect NMDA- and AMPA-receptor mediated currents at 100 mu M. Recombinant GABA(A) receptors composed of alpha 1, beta 1-3 and gamma 2L subunits expressed in HEK293 cells displayed a sensitivity to UDCA similar to that of native GABA(A) receptors. The mutation alpha 1V256S, known to reduce the inhibitory action of pregnenolone sulphate, reduced the potency of UDCA. The mutation alpha 1Q241L, which abolishes GABA(A)R potentiation by several neurosteroids, had no effect on GABA(A)R inhibition by UDCA. In conclusion, UDCA enhances alertness through disinhibition, at least partially of the histaminergic system via GABA(A) receptors.	[Yanovsky, Yevgenij; Schubring, Stephan R.; Li, Sha; May, Andrea; Haas, Helmut L.; Sergeeva, Olga A.] Univ Dusseldorf, Dept Neurophysiol, Fac Med, D-40225 Dusseldorf, Germany; [Yao, Quiaoling; Zhao, Yan; Li, Sha; Lin, Jian-Sheng] Univ Lyon 1, INSERM, U1028, Lyon Neurosci Res Ctr,Fac Med,CNRS,UMR 5292, F-69365 Lyon, France	Heinrich Heine University Dusseldorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Yanovsky, Y (corresponding author), Univ Dusseldorf, Dept Neurophysiol, Fac Med, D-40225 Dusseldorf, Germany.	olga.sergeeva@uni-duesseldorf.de	Lin, Jian-Sheng/G-4395-2013; Sergeeva, Olga/AAE-1869-2019	Lin, Jian-Sheng/0000-0002-2004-6079; 	Deutsche Forschungsgemeinschaft [DFG SE 1767, SFB 575/3, INSERM U628]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft DFG SE 1767, SFB 575/3 and 8 to OAS, INSERM U628 to J-SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2001, J PHYSIOL-LONDON, V532, P673, DOI 10.1111/j.1469-7793.2001.0673e.x; Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Bergasa NV, 2008, CLIN LIVER DIS, V12, P219, DOI 10.1016/j.cld.2007.11.009; Boatright JH, 2006, MOL VIS, V12, P1706; Cauli O, 2009, GASTROENTEROLOGY, V136, P1359, DOI 10.1053/j.gastro.2008.12.057; Chepkova AN, 2008, NEUROPHARMACOLOGY, V55, P139, DOI 10.1016/j.neuropharm.2008.05.001; Dalpiaz A, 2012, MOL PHARMACEUT, V9, P957, DOI 10.1021/mp200565g; Festi D, 2007, CURR CLIN PHARMACOL, V2, P155, DOI 10.2174/157488407780598171; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jimenez-Anguiano A, 2009, WORLD J GASTROENTERO, V15, P5176, DOI 10.3748/wjg.15.5176; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Lin JS, 2011, CELL MOL LIFE SCI, V68, P2499, DOI 10.1007/s00018-011-0631-8; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu JW, 2007, J PHYSIOL-LONDON, V582, P553, DOI 10.1113/jphysiol.2007.127613; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Nobilis M, 2001, J PHARMACEUT BIOMED, V24, P937, DOI 10.1016/S0731-7085(00)00563-X; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Parmentier R, 2009, J NEUROSCI, V29, P4471, DOI 10.1523/JNEUROSCI.2976-08.2009; Perret P, 1999, J BIOL CHEM, V274, P25350, DOI 10.1074/jbc.274.36.25350; Ramalho RM, 2008, TRENDS MOL MED, V14, P54, DOI 10.1016/j.molmed.2007.12.001; Roda E, 2002, DIGEST LIVER DIS, V34, P523, DOI 10.1016/S1590-8658(02)80112-8; Rost D, 2004, HEPATOLOGY, V40, P693, DOI 10.1002/hep.20370; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; Sergeeva OA, 2006, EUR J NEUROSCI, V24, P1413, DOI 10.1111/j.1460-9568.2006.05027.x; Sergeeva OA, 2010, J BIOL CHEM, V285, P23985, DOI 10.1074/jbc.M110.103309; Shen WX, 2000, J NEUROSCI, V20, P3571, DOI 10.1523/JNEUROSCI.20-10-03571.2000; Sola S, 2005, HEPATOLOGY, V42, P925, DOI 10.1002/hep.20870; Sola S, 2006, MOL ENDOCRINOL, V20, P2292, DOI 10.1210/me.2006-0063; Vorobjev VS, 1996, J NEUROSCI METH, V68, P303, DOI 10.1016/0165-0270(96)00097-0; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yanovsky Y, 2012, PFLUG ARCH EUR J PHY, V463, P187, DOI 10.1007/s00424-011-0988-4; Yanovsky Y, 2011, J PHYSIOL-LONDON, V589, P1349, DOI 10.1113/jphysiol.2010.203257	44	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42512	10.1371/journal.pone.0042512	http://dx.doi.org/10.1371/journal.pone.0042512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880010	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000037
J	Magosso, E; Cuppini, C; Ursino, M				Magosso, Elisa; Cuppini, Cristiano; Ursino, Mauro			A Neural Network Model of Ventriloquism Effect and Aftereffect	PLOS ONE			English	Article							AUDITORY SPATIAL PERCEPTION; CROSS-MODAL BIAS; MULTISENSORY INTEGRATION; MACAQUE MONKEY; SUPERIOR COLLICULUS; BAYESIAN-INFERENCE; POPULATION CODES; MOTOR CORTEX; LOCALIZATION; PLASTICITY	Presenting simultaneous but spatially discrepant visual and auditory stimuli induces a perceptual translocation of the sound towards the visual input, the ventriloquism effect. General explanation is that vision tends to dominate over audition because of its higher spatial reliability. The underlying neural mechanisms remain unclear. We address this question via a biologically inspired neural network. The model contains two layers of unimodal visual and auditory neurons, with visual neurons having higher spatial resolution than auditory ones. Neurons within each layer communicate via lateral intra-layer synapses; neurons across layers are connected via inter-layer connections. The network accounts for the ventriloquism effect, ascribing it to a positive feedback between the visual and auditory neurons, triggered by residual auditory activity at the position of the visual stimulus. Main results are: i) the less localized stimulus is strongly biased toward the most localized stimulus and not vice versa; ii) amount of the ventriloquism effect changes with visual-auditory spatial disparity; iii) ventriloquism is a robust behavior of the network with respect to parameter value changes. Moreover, the model implements Hebbian rules for potentiation and depression of lateral synapses, to explain ventriloquism aftereffect (that is, the enduring sound shift after exposure to spatially disparate audio-visual stimuli). By adaptively changing the weights of lateral synapses during cross-modal stimulation, the model produces post-adaptive shifts of auditory localization that agree with in-vivo observations. The model demonstrates that two unimodal layers reciprocally interconnected may explain ventriloquism effect and aftereffect, even without the presence of any convergent multimodal area. The proposed study may provide advancement in understanding neural architecture and mechanisms at the basis of visual-auditory integration in the spatial realm.	[Magosso, Elisa; Cuppini, Cristiano; Ursino, Mauro] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy	University of Bologna	Magosso, E (corresponding author), Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy.	elisa.magosso@unibo.it	Ursino, Mauro/AAE-7389-2020; Cuppini, Cristiano/K-7814-2018	Ursino, Mauro/0000-0002-0911-0308; Cuppini, Cristiano/0000-0002-6529-2599; Magosso, Elisa/0000-0002-4673-2974				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1998, NEURAL NETWORKS BRAI; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bertelson P, 2006, PERCEPT PSYCHOPHYS, V68, P428, DOI 10.3758/BF03193687; Bertini C, 2010, EUR J NEUROSCI, V31, P1791, DOI 10.1111/j.1460-9568.2010.07200.x; Bolognini N, 2007, PERCEPTION, V36, P1477, DOI 10.1068/p5846; Bonath B, 2007, CURR BIOL, V17, P1697, DOI 10.1016/j.cub.2007.08.050; Bruns P, 2011, EXP BRAIN RES, V209, P333, DOI 10.1007/s00221-011-2543-0; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; CRICK F, 1989, NATURE, V337, P129, DOI 10.1038/337129a0; Cuppini C, 2011, EXP BRAIN RES, V213, P341, DOI 10.1007/s00221-011-2714-z; Cuppini C, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00006; Dayan P, 2001, PLASTICITY LEARNING, P153; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Frissen I, 2005, ACTA PSYCHOL, V118, P93, DOI 10.1016/j.actpsy.2004.10.004; Frissen I, 2003, ACTA PSYCHOL, V113, P315, DOI 10.1016/S0001-6918(03)00043-X; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lewald J, 2002, LEARN MEMORY, V9, P268, DOI 10.1101/lm.51402; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; Magosso E, 2010, IEEE T INF TECHNOL B, V14, P598, DOI 10.1109/TITB.2010.2040750; Magosso E, 2010, NEUROPSYCHOLOGIA, V48, P812, DOI 10.1016/j.neuropsychologia.2009.09.037; Magosso E, 2010, NEURAL COMPUT, V22, P190, DOI 10.1162/neco.2009.01-08-694; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Passamonti C, 2009, EUR J NEUROSCI, V30, P1141, DOI 10.1111/j.1460-9568.2009.06910.x; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; RADEAU M, 1977, PERCEPT PSYCHOPHYS, V22, P137, DOI 10.3758/BF03198746; RAJAN R, 1990, J NEUROPHYSIOL, V64, P888, DOI 10.1152/jn.1990.64.3.888; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Recanzone GH, 2008, ANNU REV PSYCHOL, V59, P119, DOI 10.1146/annurev.psych.59.103006.093544; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Rolls ET, 2002, COMPUTATIONAL NEUROS; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Stein BE., 1993, MERGING SENSES; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Ursino M, 2009, J COMPUT NEUROSCI, V26, P55, DOI 10.1007/s10827-008-0096-4; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; Weisswange TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021575; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020; Witten IB, 2008, J NEUROPHYSIOL, V100, P1067, DOI 10.1152/jn.00013.2008; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Woods TM, 2004, CURR BIOL, V14, P1559, DOI 10.1016/j.cub.2004.08.059; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075	58	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42503	10.1371/journal.pone.0042503	http://dx.doi.org/10.1371/journal.pone.0042503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880007	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100112
J	Singh, RR; Jefferies, AJ; Lankadeva, YR; Lombardo, P; Schneider-Kolsky, M; Hilliard, L; Denton, KM; Moritz, KM				Singh, Reetu R.; Jefferies, Andrew J.; Lankadeva, Yugeesh R.; Lombardo, Paul; Schneider-Kolsky, Michal; Hilliard, Lucinda; Denton, Kate M.; Moritz, Karen M.			Increased Cardiovascular and Renal Risk Is Associated with Low Nephron Endowment in Aged Females: An Ovine Model of Fetal Unilateral Nephrectomy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; NITRIC-OXIDE SYSTEM; BLOOD-PRESSURE; PRENATAL DEXAMETHASONE; ANGIOTENSIN-II; MALE SHEEP; FUNCTIONAL RESERVE; ARTERIAL-PRESSURE; HYPERTENSIVE-RATS; SEXUAL-DIMORPHISM	Previously we have shown that ovariectomised (OVX) female sheep have reduced renal function and elevated blood pressure from 6 months of age following fetal uninephrectomy (uni-x) at 100 days of gestation (term = 150 days). In the current study we examined if in intact female sheep the onset of decline in renal function and elevation in blood pressure was prevented. Studies were performed at 1 year, 2 and 5 years of age. Following fetal uni-x at 100 days, intact female sheep had similar to 30% reduction in glomerular filtration rate (GFR) at 1 year, which did not exacerbate with age (P-treatment = 0.0001, P-age = 0.7). In contrast renal blood flow was similar between the treatment groups at 1 year of age but had declined in the uni-x animals at 5 years of age (P-treatment (x) (age) = 0.046). Interestingly, intact uni-x sheep did not develop elevations in arterial pressure until 2 years of age. Furthermore, uni-x animals had a similar capacity to respond to a cardiac challenge at 1 year and 2 years of age, however, cardiac functional reserve was significantly reduced compared to sham group at 5 years of age. Uni-x animals exhibited an increase in left ventricular dimensions at 5 years of age compared to the sham animals and compared to 2 years of age (P-treatment <0.001, P-treatment (x age) <0.001). In conclusion, the onset of renal dysfunction preceded the onset of hypertension in intact female uni-x sheep. Furthermore, this study showed that the intact females are protected from the impact of a reduced nephron endowment on cardiovascular health early in life as opposed to our findings in young male sheep and OVX uni-x female sheep. However, with ageing this protection is lost as evidenced by presence of left ventricular hypertrophy and impaired cardiac function in 5 year old uni-x female sheep.	[Singh, Reetu R.; Jefferies, Andrew J.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Lankadeva, Yugeesh R.; Hilliard, Lucinda; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Lombardo, Paul; Schneider-Kolsky, Michal] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	Monash University; Monash University; Monash University; University of Queensland	Singh, RR (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	r.singh7@uq.edu.au	Lankadeva, Yugeesh/R-9253-2019; Moritz, Karen/G-2508-2015; Denton, Kate/AAG-2423-2019	Lankadeva, Yugeesh/0000-0002-3589-9111; Moritz, Karen/0000-0002-8085-0034; Lombardo, Paul/0000-0003-2519-3358; Schneider, Michal/0000-0002-5521-3455; Krause, Lucinda/0000-0002-8634-6568; Denton, Kate/0000-0002-5929-4387	National Heart Foundation Grant [G 05M 2110]; Monash University Research Fund; Australian Postgraduate Award; Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)	National Heart Foundation Grant(National Heart Foundation of Australia); Monash University Research Fund(Monash University); Australian Postgraduate Award(Australian Government); Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by a National Heart Foundation Grant (G 05M 2110) and Monash University Research Fund. RS was supported by an Australian Postgraduate Award and Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship. KM was supported by an National Health and Medical Research Council (NHMRC) Career Development Award and by an (NHMRC) Senior Research Fellowship and KD was supported by an NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; [Anonymous], 2011, BAS INF SHEEP, P1; Bagby SP, 2007, J NUTR, V137, P1066, DOI 10.1093/jn/137.4.1066; Baylis C, 2005, EXP GERONTOL, V40, P271, DOI 10.1016/j.exger.2005.01.008; BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531; Baylis C, 2009, NAT REV NEPHROL, V5, P384, DOI 10.1038/nrneph.2009.90; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Blantz RC, 2002, KIDNEY INT, V61, P782, DOI 10.1046/j.1523-1755.2002.00220.x; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brenner BM, 1997, KIDNEY INT, pS124; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dalshaug GB, 2000, AM J PHYSIOL-HEART C, V282, pH1359; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; Fliser D, 1997, KIDNEY INT, V51, P1196, DOI 10.1038/ki.1997.163; Fontanet HL, 1996, AM J CARDIOL, V78, P1029, DOI 10.1016/S0002-9149(96)00592-9; Gades MD, 1998, KIDNEY INT, V53, P130, DOI 10.1046/j.1523-1755.1998.00746.x; Gava AL, 2011, BRAZ J MED BIOL RES, V44, P905, DOI 10.1590/S0100-879X2011000900012; Gibson KJ, 1999, CLIN EXP PHARMACOL P, V26, P765, DOI 10.1046/j.1440-1681.1999.03127.x; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hamilton CA, 2006, AM J HYPERTENS, V19, P859, DOI 10.1016/j.amjhyper.2006.01.008; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Huang A, 2004, MICROCIRCULATION, V11, P9, DOI 10.1080/10739680490266162; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Kett MM, 2011, AM J PHYSL REGUL INT; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; Mitchell Kenneth D., 1995, P1437; Moritz KM, 2005, KIDNEY INT, V67, P822, DOI 10.1111/j.1523-1755.2005.00147.x; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Mulatero P, 2007, CLIN ENDOCRINOL, V67, P324, DOI 10.1111/j.1365-2265.2007.02898.x; Nielsen CB, 2003, J AM SOC NEPHROL, V14, P3102, DOI 10.1097/01.ASN.0000096262.18679.25; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Okuniewski R, 1998, CLIN SCI, V95, P445, DOI 10.1042/CS19970303; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; PecinsThompson M, 1997, AM J PHYSIOL-REG I, V272, pR377, DOI 10.1152/ajpregu.1997.272.1.R377; Reckelhoff JF, 2008, GENDER MED, V5, pS1, DOI 10.1016/j.genm.2008.03.001; Rumball CWH, 2008, PLACENTA, V29, P89, DOI 10.1016/j.placenta.2007.09.004; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Silbiger SR, 2011, KIDNEY INT, V79, P382, DOI 10.1038/ki.2010.474; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF1168, DOI 10.1152/ajprenal.00463.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2010, CLIN SCI, V118, P669, DOI 10.1042/CS20090479; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Stefanelli CB, 2004, MOL GENET METAB, V83, P188, DOI 10.1016/j.ymgme.2004.04.013; Stier CT, 2003, AM J PHYSIOL-ENDOC M, V285, pE232, DOI 10.1152/ajpendo.00029.2003; THOMAS GB, 1988, AUST J BIOL SCI, V41, P303, DOI 10.1071/BI9880303; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wlodek ME, 2007, J AM SOC NEPHROL, V18, P1688, DOI 10.1681/ASN.2007010015; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR955, DOI 10.1152/ajpregu.00455.2004; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Yamaleyeva LM, 2007, AM J PHYSIOL-HEART C, V293, pH2064, DOI 10.1152/ajpheart.00427.2007	67	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42400	10.1371/journal.pone.0042400	http://dx.doi.org/10.1371/journal.pone.0042400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879965	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100079
J	Buczkowski, G; Richmond, DS				Buczkowski, Grzegorz; Richmond, Douglas S.			The Effect of Urbanization on Ant Abundance and Diversity: A Temporal Examination of Factors Affecting Biodiversity	PLOS ONE			English	Article							ODOROUS HOUSE ANT; TAPINOMA-SESSILE; BIOTIC HOMOGENIZATION; HYMENOPTERA-FORMICIDAE; URBAN-ENVIRONMENT; SPECIES RICHNESS; UNITED-STATES; COMMUNITIES; HABITAT; CONSERVATION	Numerous studies have examined the effect of urbanization on species richness and most studies implicate urbanization as the major cause of biodiversity loss. However, no study has identified an explicit connection between urbanization and biodiversity loss as the impact of urbanization is typically inferred indirectly by comparing species diversity along urban-rural gradients at a single time point. A different approach is to focus on the temporal rather than the spatial aspect and perform "before and after" studies where species diversity is cataloged over time in the same sites. The current study examined changes in ant abundance and diversity associated with the conversion of natural habitats into urban habitats. Ant abundance and diversity were tracked in forested sites that became urbanized through construction and were examined at 3 time points - before, during, and after construction. On average, 4.3 +/- 1.2 unique species were detected in undisturbed plots prior to construction. Ant diversity decreased to 0.7 +/- 0.8 species in plots undergoing construction and 1.5 +/- 1.1 species in plots 1 year after construction was completed. With regard to species richness, urbanization resulted in the permanent loss of 17 of the 20 species initially present in the study plots. Recovery was slow and only 3 species were present right after construction was completed and 4 species were present 1 year after construction was completed. The second objective examined ant fauna recovery in developed residential lots based on time since construction, neighboring habitat quality, pesticide inputs, and the presence of invasive ants. Ant diversity was positively correlated with factors that promoted ecological recovery and negatively correlated with factors that promoted ecological degradation. Taken together, these results address a critical gap in our knowledge by characterizing the short-and long-term the effects of urbanization on the loss of ant biodiversity.	[Buczkowski, Grzegorz; Richmond, Douglas S.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Buczkowski, G (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	gbuczkow@purdue.edu			Purdue University	Purdue University	Grzegorz Buczkowski was supported by the Industrial Affiliates Program at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LW, 1994, URBAN WILDLIFE HABIT; ALBERTI M, 2001, AVIAN ECOLOGY URBANI, P68; Alonso Leeanne E., 2000, P1; Andersen AN, 2002, J APPL ECOL, V39, P8, DOI 10.1046/j.1365-2664.2002.00704.x; Angilletta MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000258; Buczkowski G, 2006, INSECT SOC, V53, P282, DOI 10.1007/s00040-006-0870-0; Buczkowski G, 2012, INSECT SOC, V59, P241, DOI 10.1007/s00040-011-0211-9; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Buczkowski G, 2012, MYRMECOL NEWS, V16, P61; Buczkowski G, 2011, ECOL ENTOMOL, V36, P62, DOI 10.1111/j.1365-2311.2010.01245.x; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Coovert GA., 2005, ANTS OHIO HYMENOPTER; Cover, 2007, ANTS N AM GUIDE GENE, P145; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Kremen C, 1993, ECOGRAPHY, V27, P57; Lassau SA, 2004, BIOL CONSERV, V106, P91; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Marzluff John M., 2001, P19; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McKinney ML, 2004, GLOBAL ECOL BIOGEOGR, V13, P47, DOI 10.1111/j.1466-882X.2004.00059.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McKinney ML, 2001, BIOTIC HOMOGENIZATION, P1; Meissner HE, 2001, J ECON ENTOMOL, V94, P1526, DOI 10.1603/0022-0493-94.6.1526; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; PASSERA L, 1994, WESTV STUD, P23; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Peck DC, 2009, PEDOBIOLOGIA, V52, P287, DOI 10.1016/j.pedobi.2008.10.003; Philpott SM, 2006, BIODIVERS CONSERV, V15, P139, DOI 10.1007/s10531-004-4247-2; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; SAS Institute, 2008, SAS STAT GUID PERS C; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Stringer Lloyd D., 2009, Urban Ecosystems, V12, P503, DOI 10.1007/s11252-009-0100-4; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; THOMPSON CR, 1990, WESTV STUD, P51; Toennisson TA, 2011, ENVIRON ENTOMOL, V40, P1397, DOI 10.1603/EN11110; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Uno Shinsuke, 2010, Urban Ecosystems, V13, P425, DOI 10.1007/s11252-010-0136-5; Vitousek P., 2007, SCIENCE, V277, P494; Wang CL, 2001, ENVIRON ENTOMOL, V30, P842, DOI 10.1603/0046-225X-30.5.842; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1; Wilson JM, 2006, MANAGING GRASSLANDS, P51; Yasuda M, 2009, LANDSCAPE URBAN PLAN, V92, P276, DOI 10.1016/j.landurbplan.2009.05.008; Zipperer WC, 2000, ECOL APPL, V10, P685, DOI 10.2307/2641038	62	71	89	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41729	10.1371/journal.pone.0041729	http://dx.doi.org/10.1371/journal.pone.0041729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876291	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700019
J	Cummings, DO; Buhl, J; Lee, RW; Simpson, SJ; Holmes, SP				Cummings, David O.; Buhl, Jerome; Lee, Raymond W.; Simpson, Stephen J.; Holmes, Sebastian P.			Estimating Niche Width Using Stable Isotopes in the Face of Habitat Variability: A Modelling Case Study in the Marine Environment	PLOS ONE			English	Article							TROPHIC POSITION; SERIOLA-DUMERILI; MIXING MODELS; FOOD-WEB; DIET; DELTA-C-13; MIGRATION; PREY; SEA; INFORMATION	Distributions of stable isotopes have been used to infer an organism's trophic niche width, the 'isotopic niche', and examine resource partitioning. Spatial variation in the isotopic composition of prey may however confound the interpretation of isotopic signatures especially when foragers exploit resources across numerous locations. In this study the isotopic compositions from marine assemblages are modelled to determine the role of variation in the signature of prey items and the effect of dietary breadth and foraging strategies on predator signatures. Outputs from the models reveal that isotopic niche widths can be greater for populations of dietary specialists rather than for generalists, which contravenes what is generally accepted in the literature. When a range of different mixing models are applied to determine if the conversion from delta to p-space can be used to improve model accuracy, predator signature variation is increased rather than model precision. Furthermore the mixing models applied failed to correctly identify dietary specialists and/or to accurately estimate diet contributions that may identify resource partitioning. The results presented illustrate the need to collect sufficiently large sample sizes, in excess of what is collected under most current studies, across the complete distribution of a species and its prey, before attempts to use stable isotopes to make inferences about niche width can be made.	[Cummings, David O.; Buhl, Jerome; Simpson, Stephen J.; Holmes, Sebastian P.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lee, Raymond W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Holmes, Sebastian P.] Univ Western Sydney, Sch Nat Sci, Penrith, NSW 1797, Australia; [Cummings, David O.] Cardno NSW ACT Pty Ltd, Cardno Ecol Lab, St Leonards, NSW, Australia	University of Sydney; Washington State University; Western Sydney University	Cummings, DO (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	davidocummings@hotmail.com	Buhl, Jerome/AAE-1687-2020	Buhl, Jerome/0000-0002-7506-6835; Holmes, Sebastian/0000-0003-2101-376X; Simpson, Stephen J./0000-0003-0256-7687	Australian Research Council (ARC) [ARC LP0775183]; ARC	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council)	This research was funded by the Australian Research Council (ARC) linkage grant ARC LP0775183 and constitutes a portion of the Ph.D. thesis of DOC. SJS was funded by an ARC Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaloro F, 1997, CAH BIOL MAR, V38, P91; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Aurioles-Gamboa D, 2009, J MAMMAL, V90, P1410, DOI 10.1644/08-MAMM-A-209R2.1; Barnes C, 2008, OECOLOGIA, V155, P227, DOI 10.1007/s00442-007-0904-y; Barreiros JP, 2003, CYBIUM, V27, P37; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Behmer ST, 2003, ANIM BEHAV, V66, P665, DOI 10.1006/anbe.2003.2243; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chen G, 2011, LIMNOLOGY, V12, P151, DOI 10.1007/s10201-010-0332-2; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Costa GC, 2009, ECOLOGY, V90, P2014, DOI 10.1890/08-1150.1; Cummings DO, 2011, J EXP MAR BIOL ECOL, V409, P186, DOI 10.1016/j.jembe.2011.08.021; Cummings DO, 2010, MAR ECOL PROG SER, V419, P211, DOI 10.3354/meps08827; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Doi H, 2010, LIMNOLOGY, V11, P185, DOI 10.1007/s10201-009-0297-1; Erhardt EB, 2010, SISUS STABLE ISOTOPE; Feranec RS, 2000, PALAEOGEOGR PALAEOCL, V162, P155, DOI 10.1016/S0031-0182(00)00110-3; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; Flaherty EA, 2010, J MAMMAL, V91, P79, DOI 10.1644/09-MAMM-A-014R.1; Frederich B, 2009, ICHTHYOL RES, V56, P10, DOI 10.1007/s10228-008-0053-2; Gillanders BM, 2001, MAR FRESHWATER RES, V52, P179, DOI 10.1071/MF99153; Gross A, 2009, ESTUAR COAST SHELF S, V84, P367, DOI 10.1016/j.ecss.2009.05.017; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; MATALLANAS J, 1995, J MAR BIOL ASSOC UK, V75, P257, DOI 10.1017/S0025315400015356; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mooney KA, 2005, ECOLOGY, V86, P1225, DOI 10.1890/04-0938; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; OBRIEN RG, 1981, PSYCHOL BULL, V89, P570, DOI 10.1037/0033-2909.89.3.570; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semmens BX, 2009, ECOL LETT, V12, pE6, DOI 10.1111/j.1461-0248.2009.01283.x; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SOULE M, 1970, American Naturalist, V104, P85, DOI 10.1086/282642; TANAKA S, 1972, B JPN SOC SCI FISH, V38, P93; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1998, T AM FISH SOC, V127, P729, DOI 10.1577/1548-8659(1998)127<0729:AOSITT>2.0.CO;2; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wilson RM, 2009, ESTUAR COAST, V32, P999, DOI 10.1007/s12237-009-9183-7; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3; ZOHARY T, 1994, LIMNOL OCEANOGR, V39, P1030, DOI 10.4319/lo.1994.39.5.1030	65	27	28	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40539	10.1371/journal.pone.0040539	http://dx.doi.org/10.1371/journal.pone.0040539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876280	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700008
J	Hashimoto, S				Hashimoto, Shoji			A New Estimation of Global Soil Greenhouse Gas Fluxes Using a Simple Data-Oriented Model	PLOS ONE			English	Article							ATMOSPHERIC METHANE; INTERANNUAL VARIABILITY; TERRESTRIAL ECOSYSTEMS; NITROUS-OXIDE; FOREST SOILS; EMISSIONS; N2O; RESPIRATION; TEMPERATURE; UNCERTAINTIES	Soil greenhouse gas fluxes (particularly CO2, CH4, and N2O) play important roles in climate change. However, despite the importance of these soil greenhouse gases, the number of reports on global soil greenhouse gas fluxes is limited. Here, new estimates are presented for global soil CO2 emission (total soil respiration), CH4 uptake, and N2O emission fluxes, using a simple data-oriented model. The estimated global fluxes for CO2 emission, CH4 uptake, and N2O emission were 78 Pg C yr(-1) (Monte Carlo 95% confidence interval, 64-95 Pg C yr(-1)), 18 Tg C yr(-1) (11-23 Tg C yr(-1)), and 4.4 Tg N yr(-1) (1.4-11.1 Tg N yr(-1)), respectively. Tropical regions were the largest contributor of all of the gases, particularly the CO2 and N2O fluxes. The soil CO2 and N2O fluxes had more pronounced seasonal patterns than the soil CH4 flux. The collected estimates, including both the previous and the present estimates, demonstrate that the means of the best estimates from each study were 79 Pg C yr(-1) (291 Pg CO2 yr(-1); coefficient of variation, CV = 13%, N = 6) for CO2, 21 Tg C yr(-1) (29 Tg CH4 yr(-1); CV = 24%, N = 24) for CH4, and 7.8 Tg N yr(-1) (12.2 Tg N2O yr(-1); CV = 38%, N = 11) for N2O. For N2O, the mean of the estimates that was calculated by excluding the earliest two estimates was 6.6 Tg N yr(-1) (10.4 Tg N2O yr(-1); CV = 22%, N = 9). The reported estimates vary and have large degrees of uncertainty but their overall magnitudes are in general agreement. To further minimize the uncertainty of soil greenhouse gas flux estimates, it is necessary to build global databases and identify key processes in describing global soil greenhouse gas fluxes.	Forestry & Forest Prod Res Inst, Dept Forest Site Environm, Tsukuba, Ibaraki 305, Japan	Forestry & Forest Products Research Institute - Japan	Hashimoto, S (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Site Environm, 1 Matsunosato, Tsukuba, Ibaraki 305, Japan.	shojih@ffpri.affrc.go.jp	Hashimoto, Shoji/C-5785-2011	Hashimoto, Shoji/0000-0003-3022-7495	Forestry and Forest Products Research Institute, Japan; Japan Society for the Promotion of Science KAKENHI [24510025]	Forestry and Forest Products Research Institute, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Forestry and Forest Products Research Institute, Japan. Also, this work was supported by a grant from the Japan Society for the Promotion of Science KAKENHI (grant number 24510025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Banin A, 1984, Adv Space Res, V4, P207, DOI 10.1016/0273-1177(84)90564-7; BANIN A, 1986, SCI TOTAL ENVIRON, V55, P27, DOI 10.1016/0048-9697(86)90166-X; Batjes N., 2005, ISRIC WISE GLOBAL DA; Batjes N. H., 1995, HOMOGENIZED SOIL DAT; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; BORN M, 1990, Tellus Series B Chemical and Physical Meteorology, V42, P2, DOI 10.1034/j.1600-0889.1990.00002.x; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; BOWDEN WB, 1986, BIOGEOCHEMISTRY, V2, P249, DOI 10.1007/BF02180161; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Curry CL, 2009, BIOGEOSCIENCES, V6, P2355, DOI 10.5194/bg-6-2355-2009; Curry CL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002818; Del Grosso SJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P999, DOI 10.1029/1999GB001226; DORR H, 1993, CHEMOSPHERE, V26, P697, DOI 10.1016/0045-6535(93)90454-D; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; [FAO IFA], 2001, GLOB EST GAS EM NH4; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; GLOBALVIEW-CH4, 2009, COOP ATM DAT INT PRO; Hashimoto S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00116; Hashimoto S, 2011, ECOL MODEL, V222, P1283, DOI 10.1016/j.ecolmodel.2011.01.013; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; IPCC, 2007, CLIM CHANG 2007 PHYS; Ito A, 2012, BIOGEOSCIENCES, V9, P759, DOI 10.5194/bg-9-759-2012; KING GM, 1994, NATURE, V370, P282, DOI 10.1038/370282a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; KREILEMAN GJJ, 1994, WATER AIR SOIL POLL, V76, P231, DOI 10.1007/BF00478341; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morishita T, 2007, SOIL SCI PLANT NUTR, V53, P678, DOI 10.1111/j.1747-0765.2007.00181.x; Mosier AR, 1998, CLIMATIC CHANGE, V40, P39, DOI 10.1023/A:1005338731269; Nevison CD, 1996, CLIMATIC CHANGE, V32, P327, DOI 10.1007/BF00142468; Olivier JGJ, 1998, ENVIRON POLLUT, V102, P135, DOI 10.1016/S0269-7491(98)80026-2; Potter CS, 1996, J GEOPHYS RES-ATMOS, V101, P1361, DOI 10.1029/95JD02028; Potter CS, 1996, CHEMOSPHERE, V32, P2219, DOI 10.1016/0045-6535(96)00119-1; Potter CS, 1998, GLOBAL BIOGEOCHEM CY, V12, P621, DOI 10.1029/98GB02425; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Ridgwell AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P59, DOI 10.1029/1998GB900004; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; SCHMIDT J, 1988, J ATMOS CHEM, V6, P95, DOI 10.1007/BF00048334; Seiler W., 1987, GEOPHYSIOLOGY AMAZON, P133; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Spahni R, 2011, BIOGEOSCIENCES, V8, P1643, DOI 10.5194/bg-8-1643-2011; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180	52	34	37	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41962	10.1371/journal.pone.0041962	http://dx.doi.org/10.1371/journal.pone.0041962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876295	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700023
J	Stevens, JR; Nicholas, G				Stevens, John R.; Nicholas, Gabriel			Assessing Numerical Dependence in Gene Expression Summaries with the Jackknife Expression Difference	PLOS ONE			English	Article							PREFERRED ANALYSIS-METHODS; MODEL	Statistical methods to test for differential expression traditionally assume that each gene's expression summaries are independent across arrays. When certain preprocessing methods are used to obtain those summaries, this assumption is not necessarily true. In general, the erroneous assumption of dependence results in a loss of statistical power. We introduce a diagnostic measure of numerical dependence for gene expression summaries from any preprocessing method and discuss the relative performance of several common preprocessing methods with respect to this measure. Some common preprocessing methods introduce non-trivial levels of numerical dependence. The issue of (between-array) dependence has received little if any attention in the literature, and researchers working with gene expression data should not take such properties for granted, or they risk unnecessarily losing statistical power.	[Stevens, John R.] Utah State Univ, Ctr Integrated Biosyst, Dept Math & Stat, Logan, UT 84322 USA; [Nicholas, Gabriel] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Utah System of Higher Education; Utah State University; University of Wisconsin System; University of Wisconsin Madison	Stevens, JR (corresponding author), Utah State Univ, Ctr Integrated Biosyst, Dept Math & Stat, Logan, UT 84322 USA.	john.r.stevens@usu.edu			Utah Agricultural Experiment Station (UAES), Utah State University; UAES [W1112/W2112]; College of Science at Utah State University	Utah Agricultural Experiment Station (UAES), Utah State University; UAES; College of Science at Utah State University	This research was supported by the Utah Agricultural Experiment Station (UAES), Utah State University, and approved as journal paper number 8430. This UAES funding was in association with the Multistate Research Project W1112/W2112, Reproductive Performance in Domestic Ruminants. This work was also supported by start-up funding from the College of Science at Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2001, AFF MICR SUIT US GUI; Affymetrix, 2005, TECHN NOT GUID PROB; Affymetrix, 2002, STAT ALG DESCR DOC; Affymetrix, 2000, LAT SQUAR DAT EXPR A; Auer PL, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1627; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BOLSTAD B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2004, THESIS U CALIFORNIA; CARR DB, 1987, J AM STAT ASSOC, V82, P424, DOI 10.2307/2289444; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Craig BA, 2003, J AGRIC BIOL ENVIR S, V8, P1, DOI 10.1198/1085711031256; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hevel JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-376; Hoy M, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P261; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C., 2003, ANAL GENE EXPRESSION; Liu X, 2007, BMC BIOINFORMATICS, V8; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lockhart DJ, 1996, NATURE BIOTECHNOLOGY, V14; Nicholas G, 2007, THESIS UTAH STAT U; Qiu X, 2005, STAT APPL GENET MOL, V4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rey W., 1983, INTRO ROBUST QUASI R; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Seber G.A., 1977, LINEAR REGRESSION AN; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stevens JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-281; Therneau TM, 2008, CANCER INFORM, V6, P423; Tukey JW, 1977, EXPLORATORY DATA ANA; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhu DX, 2007, BIOINFORMATICS, V23, P2298, DOI 10.1093/bioinformatics/btm328; Zhu QQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-285	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39570	10.1371/journal.pone.0039570	http://dx.doi.org/10.1371/journal.pone.0039570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876276	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700004
J	van Hoorn, F; Campian, ME; Spijkerboer, A; Blom, MT; Planken, RN; van Rossum, AC; de Bakker, JMT; Wilde, AAM; Groenink, M; Tan, HL				van Hoorn, Frans; Campian, Maria E.; Spijkerboer, Anje; Blom, Marieke T.; Planken, R. Nils; van Rossum, Albert C.; de Bakker, Jacques M. T.; Wilde, Arthur A. M.; Groenink, Maarten; Tan, Hanno L.			SCN5A Mutations in Brugada Syndrome Are Associated with Increased Cardiac Dimensions and Reduced Contractility	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; SICK SINUS SYNDROME; CONDUCTION DISEASE; LONG-QT; FAILURE; ABNORMALITIES; CONTRIBUTES; ACTIVATION; MECHANISM; DELAY	Background: The cardiac sodium channel (Na(v)1.5) controls cardiac excitability. Accordingly, SCN5A mutations that result in loss-of-function of Na(v)1.5 are associated with various inherited arrhythmia syndromes that revolve around reduced cardiac excitability, most notably Brugada syndrome (BrS). Experimental studies have indicated that Na(v)1.5 interacts with the cytoskeleton and may also be involved in maintaining structural integrity of the heart. We aimed to determine whether clinical evidence may be obtained that Na(v)1.5 is involved in maintaining cardiac structural integrity. Methods: Using cardiac magnetic resonance (CMR) imaging, we compared right ventricular (RV) and left ventricular (LV) dimensions and ejection fractions between 40 BrS patients with SCN5A mutations (SCN5a-mut-positive) and 98 BrS patients without SCN5A mutations (SCN5a-mut-negative). We also studied 18 age/sex-matched healthy volunteers. Results: SCN5a-mut-positive patients had significantly larger end-diastolic and end-systolic RV and LV volumes, and lower LV ejection fractions, than SCN5a-mut-negative patients or volunteers. Conclusions: Loss-of-function SCN5A mutations are associated with dilatation and impairment in contractile function of both ventricles that can be detected by CMR analysis.	[van Hoorn, Frans; Spijkerboer, Anje; Planken, R. Nils; Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Campian, Maria E.; Blom, Marieke T.; de Bakker, Jacques M. T.; Wilde, Arthur A. M.; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Dept Heart Failure, Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Rossum, Albert C.] Vrije Univ Amsterdam, Med Ctr, Cardiol, Amsterdam, Netherlands; [Wilde, Arthur A. M.; Groenink, Maarten; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Hoorn, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.nl	Planken, RN/GMX-0438-2022	Blom, Marieke Tabo/0000-0002-8088-1105; van Rossum, Albert C./0000-0003-1714-4652; Planken, R. Nils/0000-0003-3940-4670	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Dr. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Alfakih K, 2003, J MAGN RESON IMAGING, V18, P25, DOI 10.1002/jmri.10329; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Antzelevitch C, 2005, HEART RHYTHM, V2, P429, DOI 10.1016/jhrthm.2005.01.005; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bezzina C, 1999, CIRC RES, V85, P1206; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; CASE MT, 1984, TOXICOL APPL PHARM, V73, P232, DOI 10.1016/0041-008X(84)90328-4; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; Hardziyenka M, 2011, EUROPACE, V13, P1753, DOI 10.1093/europace/eur189; Hoogendijk MG, 2010, HEART RHYTHM, V7, P238, DOI 10.1016/j.hrthm.2009.10.007; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Papavassiliu T, 2010, HEART RHYTHM, V7, P1790, DOI 10.1016/j.hrthm.2010.09.004; Postema PG, 2010, J AM COLL CARDIOL, V55, P789, DOI 10.1016/j.jacc.2009.11.033; Postema PG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P379, DOI 10.1161/CIRCEP.108.790543; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Smits JPP, 2005, J MOL CELL CARDIOL, V38, P969, DOI 10.1016/j.yjmcc.2005.02.024; Takagi M, 2003, HEART, V89, P169, DOI 10.1136/heart.89.2.169; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Tukkie R, 2004, CIRCULATION, V109, P1272, DOI 10.1161/01.CIR.0000118467.53182.D1; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Zumhagen S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P16, DOI 10.1161/CIRCEP.107.737882	39	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42037	10.1371/journal.pone.0042037	http://dx.doi.org/10.1371/journal.pone.0042037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876298	gold, Green Published, Green Submitted			2022-12-25	WOS:000307184700026
J	Fukushi, M; Yamashita, M; Miyoshi-Akiyama, T; Kubo, S; Yamamoto, K; Kudo, K				Fukushi, Masaya; Yamashita, Makoto; Miyoshi-Akiyama, Tohru; Kubo, Shuku; Yamamoto, Kenji; Kudo, Koichiro			Laninamivir Octanoate and Artificial Surfactant Combination Therapy Significantly Increases Survival of Mice Infected with Lethal Influenza H1N1 Virus	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; NEURAMINIDASE INHIBITOR LANINAMIVIR; B-IMMOBILIZED FIBER; ACUTE LUNG INJURY; PROTEIN-D; A H1N1; PULMONARY SURFACTANT; DIRECT HEMOPERFUSION; CLINICAL-TRIAL; IN-VIVO	Background: Patients with influenza virus infection can develop severe pneumonia and acute respiratory distress syndrome (ARDS) which have a high mortality. Influenza virus infection is treated worldwide mainly by neuraminidase inhibitors (NAIs). However, monotherapy with NAIs is insufficient for severe pneumonia secondary to influenza virus infection. We previously demonstrated that mice infected with a lethal dose of influenza virus develop diffuse alveolar damage (DAD) with alveolar collapse similar to that seen in ARDS in humans. Additionally, pulmonary surfactant proteins were gradually increased in mouse serum, suggesting a decrease in pulmonary surfactant in the lung. Therefore, the present study examined whether combination therapy of NAI with exogenous artificial surfactant affects mortality of influenza virus-infected mice. Methodology/Principal Findings: BALB/c mice were inoculated with several viral doses of influenza A/Puerto Rico/8/34 (PR8) virus (H1N1). The mice were additionally administered exogenous artificial surfactant in the presence or absence of a new NAI, laninamivir octanoate. Mouse survival, body weight and general condition were observed for up to 20 days after inoculation. Viral titer and cytokine/chemokine levels in the lungs, lung weight, pathological analysis, and blood O-2 and CO2 pressures were evaluated. Infected mice treated with combination therapy of laninamivir octanoate with artificial surfactant showed a significantly higher survival rate compared with those that received laninamivir octanoate monotherapy (p = 0.003). However, virus titer, lung weight and cytokine/chemokine responses were not different between the groups. Histopathological examination, a hydrostatic lung test and blood gas analysis showed positive results in the combination therapy group. Conclusions/Significance: Combination therapy of laninamivir octanoate with artificial surfactant reduces lethality in mice infected with influenza virus, and eventually suppresses DAD formation and preserves lung function. This combination could be effective for prevention of severe pneumonia secondary to influenza virus infection in humans, which is not improved by NAI monotherapy.	[Fukushi, Masaya; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Fukushi, Masaya; Yamamoto, Kenji] Natl Ctr Global Hlth & Med, Res Inst, Deputy Director Gen Lab, Tokyo, Japan; [Fukushi, Masaya] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan; [Yamashita, Makoto; Kubo, Shuku] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Hiroshima University; Daiichi Sankyo Company Limited; National Center for Global Health & Medicine - Japan	Fukushi, M (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	mfukushi@hiroshima-u.ac.jp	YAMAMOTO, Kenji/I-1758-2013		Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	The Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBAUGH DG, 1967, LANCET, V2, P319; Baudouin SV, 2004, NEW ENGL J MED, V351, P853, DOI 10.1056/NEJMp048172; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Confalonieri Marco, 2010, Ther Adv Respir Dis, V4, P233, DOI 10.1177/1753465810376951; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Gingrich JR, 1996, CANCER RES, V56, P4096; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Hartl D, 2006, EUR J CLIN INVEST, V36, P423, DOI 10.1111/j.1365-2362.2006.01648.x; Hasleton P. S., 1996, SPENCERS PATHOLOGY L; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Inoue T., 2010, Kawasaki Medical Journal, V36, P295; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwasaki T, 1999, ARCH VIROL, V144, P675, DOI 10.1007/s007050050535; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Katzenstein A., 2006, SURG PATHOLOGY NONNE; Kesecioglu J, 2009, AM J RESP CRIT CARE, V180, P989, DOI 10.1164/rccm.200812-1955OC; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000786; Kliegman RM, 2020, NELSON TXB PEDIAT; Koyama K, 2010, XENOBIOTICA, V40, P207, DOI 10.3109/00498250903447691; Koyama K, 2009, ANTIMICROB AGENTS CH, V53, P4845, DOI 10.1128/AAC.00731-09; Kubo S, 2010, ANTIMICROB AGENTS CH, V54, P1256, DOI 10.1128/AAC.01311-09; Lucattelli M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-83; Martin R.J, 2011, FANAROFF MARTINS NEO, V9th; Matthay MA, 2010, AM J RESP CRIT CARE, V181, P1027, DOI 10.1164/rccm.201001-0074UP; Murata M, 2010, EXP LUNG RES, V36, P463, DOI 10.3109/01902141003746371; Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125; Namendys-Silva SA, 2010, INTENS CARE MED, V36, P1102, DOI 10.1007/s00134-010-1865-x; Namendys-Silva SA, 2010, INTENS CARE MED, V36, P1097, DOI 10.1007/s00134-010-1814-8; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Ottolini M, 2003, PEDIATR PULM, V36, P290, DOI 10.1002/ppul.10320; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Skokic F, 2010, PEDIATR INFECT DIS J, V29, P387, DOI [10.1097/INF.0b013e3181cf2eaa, 10.1097/INF.0b013e3181ce8e81]; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; THURLBECK W, 1995, PATHOLOGY LUNG; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Turner DA, 2011, RESP CARE, V56, P941, DOI 10.4187/respcare.01066; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watanabe A, 2010, CLIN INFECT DIS, V51, P1167, DOI 10.1086/656802; White MR, 2005, AM J PHYSIOL-LUNG C, V288, pL831, DOI 10.1152/ajplung.00365.2004; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamashita Makoto, 2010, Antiviral Chemistry & Chemotherapy, V21, P71, DOI 10.3851/IMP1688; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Yatera K, 2011, INTERNAL MED, V50, P601, DOI 10.2169/internalmedicine.50.4604; Yokoyama T, 2010, J CLIN APHERESIS, V25, P350, DOI 10.1002/jca.20252; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	65	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42419	10.1371/journal.pone.0042419	http://dx.doi.org/10.1371/journal.pone.0042419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22879974	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800090
J	Lague, MN; Romieu-Mourez, R; Bonneil, E; Boyer, A; Pouletty, N; Mes-Masson, AM; Thibault, P; Nadeau, ME; Boerboom, D				Lague, Marie-Noelle; Romieu-Mourez, Raphaelle; Bonneil, Eric; Boyer, Alexandre; Pouletty, Nicolas; Mes-Masson, Anne-Marie; Thibault, Pierre; Nadeau, Marie-Eve; Boerboom, Derek			Proteomic Profiling of a Mouse Model for Ovarian Granulosa Cell Tumor Identifies VCP as a Highly Sensitive Serum Tumor Marker in Several Human Cancers	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; INCREASED EXPRESSION; ELEVATED EXPRESSION; DISEASE RECURRENCE; P97; PROGNOSIS; CARCINOMA; PROGRESSION; PROSTATE; HORMONE	The initial aim of this study was to identify novel serum diagnostic markers for the human ovarian granulosa cell tumor (GCT), a tumor that represents up to 5% of all ovarian cancers. To circumvent the paucity of human tissues available for analyses, we used the Ctnnb1(tm1Mmt/+); Pten(tm1Hwu/tmiHwu); Amhr2(tm3(cre)Bhr/+) transgenic mouse model, which features the constitutive activation of CTNNB1 signaling combined with the loss of Pten in granulosa cells and develops GCTs that mimic aggressive forms of the human disease. Proteomic profiling by mass spectrometry showed that vinculin, enolase 1, several heat shock proteins, and valosin containing protein (VCP) were more abundantly secreted by cultured mouse GCT cells compared to primary cultured GC. Among these proteins, only VCP was present in significantly increased levels in the preoperative serum of GCT cancer patients compared to normal subjects. To determine the specificity of VCP, serum levels were also measured in ovarian carcinoma, non-Hodgkin's lymphoma and breast, colon, pancreatic, lung, and prostate cancer patients. Increased serum VCP levels were observed in the majority of cancer cases, with the exception of patients with lung or prostate cancer. Moreover, serum VCP levels were increased in some GCT, ovarian carcinoma, breast cancer, and colon cancer patients who did not otherwise display increased levels of widely used serum tumor markers for their cancer type (e. g. inhibin A, inhibin B, CA125, CEA, or CA15.3). These results demonstrate the potential use of VCP as highly sensitive serum marker for GCT as well as several other human cancers.	[Lague, Marie-Noelle; Boyer, Alexandre; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, Montreal, PQ, Canada; [Romieu-Mourez, Raphaelle] Lady Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; [Romieu-Mourez, Raphaelle] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Rech Canc & Immunol, Montreal, PQ, Canada; [Pouletty, Nicolas] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ, Canada; [Nadeau, Marie-Eve] Univ Montreal, Fac Med Vet, Dept Sci Clin, Montreal, PQ, Canada	Universite de Montreal; Lady Davis Institute; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lague, MN (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, Montreal, PQ, Canada.	derek.boerboom@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes of Health Research [MOP-102508]; Canada Research Chair in Ovarian Molecular Biology and Functional Genomics; National Institutes of Health NICHD (SCCPRR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Ovarian Molecular Biology and Functional Genomics(Canada Research Chairs); National Institutes of Health NICHD (SCCPRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by operating grant MOP-102508 from the Canadian Institutes of Health Research and the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the National Institutes of Health NICHD (SCCPRR) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiya A, 2005, J PROTEOME RES, V4, P1213, DOI 10.1021/pr050149f; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; CARLSON KJ, 1994, ANN INTERN MED, V121, P124, DOI 10.7326/0003-4819-121-2-199407150-00009; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Geerts I, 2009, INT J GYNECOL CANCER, V19, P847, DOI 10.1111/IGC.0b013e3181a702d1; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Perkins GL, 2003, AM FAM PHYSICIAN, V68, P1075; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wei BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007670; Weihl CC, 2011, J CLIN INVEST, V121, P4627, DOI 10.1172/JCI61126; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, ONCOLOGY-BASEL, V66, P468, DOI 10.1159/000079501; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42470	10.1371/journal.pone.0042470	http://dx.doi.org/10.1371/journal.pone.0042470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870330	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800094
J	Li, FX; Jo, MS; Curry, TE; Liu, J				Li, Feixue; Jo, Misung; Curry, Thomas E., Jr.; Liu, Jing			Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary	PLOS ONE			English	Article							PROTEIN-SERINE/THREONINE KINASE; FOLLICLE-STIMULATING-HORMONE; GRANULOSA-CELLS; LUTEINIZING-HORMONE; GENE-EXPRESSION; PROLIFERATION; GONADOTROPIN; FAMILY; GROWTH; FERTILIZATION	The highly conserved polo-like kinases (Plks) are potent regulators of multiple functions in the cell cycle before and during mitotic cell division. We investigated the expression pattern of Plk genes and their potential role(s) in the rat ovary during the periovulatory period. Plk2 and Plk3 were highly induced both in intact ovaries and granulosa cells in vivo after treatment with the luteinizing hormone (LH) agonist, human chorionic gonadotropin (hCG). In vitro, hCG stimulated the expression of Plk2 in granulosa cells, but not Plk3. This induction of Plk2 expression was mimicked by both forskolin and phorbol 12 myristate 13-acetate (PMA). Moreover, Plk2 expression was reduced by inhibitors of prostaglandin synthesis or the EGF pathway, but not by progesterone receptor antagonist (RU486) treatment. At the promoter level, mutation of the Sp1 binding sequence abolished the transcriptional activity of the Plk2 gene. ChIP assays also revealed the interaction of endogenous Sp1 protein in the Plk2 promoter region. Functionally, the over-expression of Plk2 and Plk3 arrested granulosa cells at the G0/G1 phase of the cell cycle. In contrast, the knockdown of Plk2 expression in granulosa cells decreased the number of cells in the G0/G1 stage of the cell cycle, but increased granulosa cell viability. In summary, hCG induced Plk2 and Plk3 expression in the rat ovary. Prostaglandins and the EGF signaling pathway are involved in regulating Plk2 expression. The transcription factor Sp1 is important for Plk2 transcriptional up-regulation. Our findings suggest that the increase in Plk2 and Plk3 expression contributes to the cell cycle arrest of granulosa cells which is important for the luteinization of granulosa cells during the periovulatory period.	[Li, Feixue] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Jo, Misung; Curry, Thomas E., Jr.] Univ Kentucky, Albert B Chandler Med Ctr, Dept Obstet & Gynecol, Lexington, KY 40536 USA; [Liu, Jing] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; University of Kentucky; Zhejiang University	Liu, J (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	jliue@zju.edu.cn	Jing, Liu/K-8655-2014; Li, Feixue/M-2126-2014	Jing, Liu/0000-0001-8892-036X; 	National Natural Science Foundation of China [21007056, 31100845]; Scientific Research Foundation of Hangzhou Normal University [2011QPL15]; National Institutes of Health grants [HD057446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057446] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Hangzhou Normal University; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The present study was supported by the National Natural Science Foundation of China (21007056 to J.L., and 31100845 to F.L.), Scientific Research Foundation of Hangzhou Normal University (2011QPL15 to F.L.), and National Institutes of Health grants (HD057446 to M.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Espey LL, 2000, ENDOCRINOLOGY, V141, P2385, DOI 10.1210/en.141.7.2385; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Karn T, 1997, ONCOL REP, V4, P505; LAKE RJ, 1993, MOL CELL BIOL, V13, P7793, DOI 10.1128/MCB.13.12.7793; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li F, 2012, BIOL REPROD; Li FX, 2011, MOL ENDOCRINOL, V25, P445, DOI 10.1210/me.2010-0250; Li FX, 2009, ENDOCRINOLOGY, V150, P3894, DOI 10.1210/en.2008-1650; Li FX, 2009, ENDOCRINOLOGY, V150, P3903, DOI 10.1210/en.2008-1141; Liu J, 2011, TOXICOLOGY, V290, P42, DOI 10.1016/j.tox.2011.08.016; Liu J, 2011, TOXICOLOGY, V282, P47, DOI 10.1016/j.tox.2011.01.007; Liu J, 2010, MOL ENDOCRINOL, V24, P1203, DOI 10.1210/me.2009-0325; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Liu J, 2009, ENDOCRINOLOGY, V150, P3291, DOI 10.1210/en.2008-1527; Liu Z, 1997, MOL ENDOCRINOL, V11, P127, DOI 10.1210/me.11.2.127; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Seo YM, 2009, LIFE SCI, V85, P153, DOI 10.1016/j.lfs.2009.05.005; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sriraman V, 2003, MOL ENDOCRINOL, V17, P436, DOI 10.1210/me.2002-0252; SUNKEL CE, 1988, J CELL SCI, V89, P25; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002	40	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41844	10.1371/journal.pone.0041844	http://dx.doi.org/10.1371/journal.pone.0041844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870256	Green Published, gold			2022-12-25	WOS:000307212800039
J	Miao, YY; Dong, LD; Chen, J; Hu, XC; Yang, XL; Wang, ZF				Miao, Yanying; Dong, Ling-Dan; Chen, Jie; Hu, Xiao-Chen; Yang, Xiong-Li; Wang, Zhongfeng			Involvement of Calpain/p35-p25/Cdk5/NMDAR Signaling Pathway in Glutamate-Induced Neurotoxicity in Cultured Rat Retinal Neurons	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; GANGLION-CELL DEATH; EXPERIMENTAL GLAUCOMA; NMDA RECEPTORS; NEURITE OUTGROWTH; DOWN-REGULATION; CDK5 ACTIVITY; UP-REGULATION; IN-VITRO; CALPAIN	We investigated possible involvement of a calpain/p35-p25/cyclin-dependent kinase 5 (Cdk5) signaling pathway in modifying NMDA receptors (NMDARs) in glutamate-induced injury of cultured rat retinal neurons. Glutamate treatment decreased cell viability and induced cell apoptosis, which was accompanied by an increase in Cdk5 and p-Cdk5(T15) protein levels. The Cdk5 inhibitor roscovitine rescued the cell viability and inhibited the cell apoptosis. In addition, the protein levels of both calpain 2 and calpain-specific alpha-spectrin breakdown products (SBDPs), which are both Ca2+-dependent, were elevated in glutamate-induced cell injury. The protein levels of Cdk5, p-Cdk5(T15), calpain 2 and SBDPs tended to decline with glutamate treatments of more than 9 h. Furthermore, the elevation of SBDPs was attenuated by either D-APV, a NMDAR antagonist, or CNQX, a non-NMDAR antagonist, but was hardly changed by the inhibitors of intracellular calcium stores dantrolene and xestospongin. Moreover, the Cdk5 co-activator p35 was significantly up-regulated, whereas its cleaved product p25 expression showed a transient increase. Glutamate treatment for less than 9 h also considerably enhanced the ratio of the Cdk5-phosphorylated NMDAR subunit NR2A at Ser1232 site (p-NR2A(S1232)) and NR2A (p-NR2A(S1232)/NR2A), and caused a translocation of p-NR2A(S1232) from the cytosol to the plasma membrane. The enhanced p-NR2A(S1232) was inhibited by roscovitine, but augmented by over-expression of Cdk5. Calcium imaging experiments further showed that intracellular Ca2+ concentrations ([Ca2+](i)) of retinal cells were steadily increased following glutamate treatments of 2 h, 6 h and 9 h. All these results suggest that the activation of the calpain/p35-p25/Cdk5 signaling pathway may contribute to glutamate neurotoxicity in the retina by up-regulating p-NR2A(S1232) expression.	[Miao, Yanying] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Miao, YY (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China.	yymiao@fudan.edu.cn; zfwang@fudan.edu.cn	Chen, Jie/J-4852-2015	Chen, Jie/0000-0003-0906-0416	National Program of Basic Research; Ministry of Science and Technology of China [2011CB504602]; Natural Science Foundation of China [30900427, 31070966, 30930034]; Key Research Program of Science and Technology Commissions of Shanghai Municipality [11JC1401200]; Research Fund for the Doctoral Program of Higher Education of China [20110071110031]; SRF for ROCS, SEM	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Science and Technology Commissions of Shanghai Municipality; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2011CB504602), the Natural Science Foundation of China (30900427; 31070966; 30930034), the Key Research Program of Science and Technology Commissions of Shanghai Municipality (11JC1401200), Research Fund for the Doctoral Program of Higher Education of China (20110071110031), and SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Barisic Karmela, 2003, Acta Pharmaceutica (Zagreb), V53, P151; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bu BT, 2002, J NEUROSCI, V22, P6515; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Calzada JI, 2002, NEUROCHEM RES, V27, P79, DOI 10.1023/A:1014854606309; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Caudle WM, 2009, EXP NEUROL, V220, P230, DOI 10.1016/j.expneurol.2009.09.027; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen J, 2011, NEUROBIOL DIS, V43, P455, DOI 10.1016/j.nbd.2011.04.019; Chen Jie, 2010, Shengli Xuebao, V62, P295; Cheng Q, 2003, MOL CELL NEUROSCI, V24, P632, DOI 10.1016/S1044-7431(03)00220-3; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chiu K, 2005, BRAIN RES, V1046, P207, DOI 10.1016/j.brainres.2005.04.016; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Das A, 2006, BRAIN RES, V1084, P146, DOI 10.1016/j.brainres.2006.02.051; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dingledine R, 1999, PHARMACOL REV, V51, P7; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guo L, 2006, INVEST OPHTH VIS SCI, V47, P626, DOI 10.1167/iovs.05-0754; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Huang W, 2010, INVEST OPHTH VIS SCI, V51, P3049, DOI 10.1167/iovs.09-4364; Humbert S, 2000, J CELL SCI, V113, P975; Ikiz B, 2008, NEURON, V60, P731, DOI 10.1016/j.neuron.2008.11.020; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kerokoski P, 2002, MOL BRAIN RES, V106, P50, DOI 10.1016/S0169-328X(02)00409-6; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Kerrison JB, 2007, METH MOL B, V356, P427; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lagreze WA, 1998, INVEST OPHTH VIS SCI, V39, P1063; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lefevre K, 2002, J COMP NEUROL, V447, P72, DOI 10.1002/cne.10215; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Lipton S A, 2001, Prog Brain Res, V131, P712; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Luo XG, 2009, CELL MOL NEUROBIOL, V29, P1143, DOI 10.1007/s10571-009-9407-1; McKernan DP, 2007, INVEST OPHTH VIS SCI, V48, P5420, DOI 10.1167/iovs.07-0287; Miao YY, 2010, J NEUROSCI RES, V88, P102, DOI 10.1002/jnr.22188; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Ohshima T, 2002, J NEUROSCI, V22, P4036, DOI 10.1523/JNEUROSCI.22-10-04036.2002; Oka T, 2006, J NEUROSCI RES, V83, P1342, DOI 10.1002/jnr.20827; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Rothman Steven M., 1995, Trends in Neurosciences, V18, P57, DOI 10.1016/0166-2236(95)93869-Y; Russo R, 2008, J NEUROCHEM, V107, P1347, DOI 10.1111/j.1471-4159.2008.05694.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Skaper SD, 2001, ANN NY ACAD SCI, V939, P11; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Sukharev SA, 1997, CELL DEATH DIFFER, V4, P457, DOI 10.1038/sj.cdd.4400263; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; WoldeMussie E, 2002, J GLAUCOMA, V11, P474, DOI 10.1097/00061198-200212000-00003; Yang XF, 2011, NEUROSCIENCE, V173, P19, DOI 10.1016/j.neuroscience.2010.11.028; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883; Zhao PW, 2008, EUR J NEUROSCI, V27, P572, DOI 10.1111/j.1460-9568.2008.06041.x; Zhao WJ, 2010, J PHYSIOL-LONDON, V588, P2605, DOI 10.1113/jphysiol.2010.187641; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	95	43	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42318	10.1371/journal.pone.0042318	http://dx.doi.org/10.1371/journal.pone.0042318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870316	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800079
J	Ryvkin, A; Ashkenazy, H; Smelyanski, L; Kaplan, G; Penn, O; Weiss-Ottolenghi, Y; Privman, E; Ngam, PB; Woodward, JE; May, GD; Bell, C; Pupko, T; Gershoni, JM				Ryvkin, Arie; Ashkenazy, Haim; Smelyanski, Larisa; Kaplan, Gilad; Penn, Osnat; Weiss-Ottolenghi, Yael; Privman, Eyal; Ngam, Peter B.; Woodward, James E.; May, Gregory D.; Bell, Callum; Pupko, Tal; Gershoni, Jonathan M.			Deep Panning: Steps towards Probing the IgOme	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; B-CELL EPITOPES; PHAGE DISPLAY; PEPTIDE LIBRARIES; PROTEIN; GENERATION; ANTIBODIES; REPERTOIRE; DIVERSITY; BACTERIOPHAGE	Background: Polyclonal serum consists of vast collections of antibodies, products of differentiated B-cells. The spectrum of antibody specificities is dynamic and varies with age, physiology, and exposure to pathological insults. The complete repertoire of antibody specificities in blood, the IgOme, is therefore an extraordinarily rich source of information-a molecular record of previous encounters as well as a status report of current immune activity. The ability to profile antibody specificities of polyclonal serum at exceptionally high resolution has been an important and serious challenge which can now be overcome. Methodology/Principal Findings: Here we illustrate the application of Deep Panning, a method that combines the flexibility of combinatorial phage display of random peptides with the power of high-throughput deep sequencing. Deep Panning is first applied to evaluate the quality and diversity of naive random peptide libraries. The production of very large data sets, hundreds of thousands of peptides, has revealed unexpected properties of combinatorial random peptide libraries and indicates correctives to ensure the quality of the libraries generated. Next, Deep Panning is used to analyze a model monoclonal antibody in addition to allowing one to follow the dynamics of biopanning and peptide selection. Finally Deep Panning is applied to profile polyclonal sera derived from HIV infected individuals. Conclusions/Significance: The ability to generate and characterize hundreds of thousands of affinity-selected peptides creates an effective means towards the interrogation of the IgOme and understanding of the humoral response to disease. Deep Panning should open the door to new possibilities for serological diagnostics, vaccine design and the discovery of the correlates of immunity to emerging infectious agents.	[Ryvkin, Arie; Ashkenazy, Haim; Smelyanski, Larisa; Kaplan, Gilad; Penn, Osnat; Weiss-Ottolenghi, Yael; Privman, Eyal; Pupko, Tal; Gershoni, Jonathan M.] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Ngam, Peter B.; Woodward, James E.; May, Gregory D.; Bell, Callum] Natl Ctr Genome Resources, Santa Fe, NM USA	Tel Aviv University; National Center for Genome Resources (NCGR)	Ryvkin, A (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gershoni@tauex.tau.ac.il	Pupko, Tal/HGF-1353-2022; Ashkenazy, Haim/AAX-6285-2021	Kaplan, Gilad/0000-0003-1374-305X; Pupko, Tal/0000-0001-9463-2575; Ashkenazy, Haim/0000-0002-5079-4684	The United States - Israel Binational Agricultural Research and Development Fund (BARD) [IS-4287-10]; Marian Gertner Institute for Nanomedical Systems Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Jakov, Miriana, and Jorge Saia Doctoral Fellowship	The United States - Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Marian Gertner Institute for Nanomedical Systems Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Jakov, Miriana, and Jorge Saia Doctoral Fellowship	This research was supported by the The United States - Israel Binational Agricultural Research and Development Fund (BARD) [Research Grant No. IS-4287-10 to TP and JMG]. AR is the recipient of the Marian Gertner Institute for Nanomedical Systems Fellowship. This study was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University to HA and OP. GK is the recipient of the Jakov, Miriana, and Jorge Saia Doctoral Fellowship. We thank the Frankel Foundation for generous support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; COHEN D, 1994, EUR J EPIDEMIOL, V10, P267, DOI 10.1007/BF01719348; Denisova G, 1996, AIDS RES HUM RETROV, V12, P901, DOI 10.1089/aid.1996.12.901; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Dunn-Walters DK, 2010, CURR OPIN IMMUNOL, V22, P514, DOI 10.1016/j.coi.2010.04.009; Enshell-Seijffers D, 2001, Nucleic Acids Res, V29, pE50, DOI 10.1093/nar/29.10.e50; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Freund NT, 2009, CURR PROTOC IMMUNOL; Georgieva Y, 2011, MOLECULES, V16, P1667, DOI 10.3390/molecules16021667; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; IANNOLO G, 1995, J MOL BIOL, V248, P835, DOI 10.1006/jmbi.1995.0264; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; KRETZSCHMAR T, 1995, GENE, V155, P61, DOI 10.1016/0378-1119(94)00897-2; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lynch RM, 2012, J VIROLOGY; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; PAIGE CJ, 1989, FASEB J, V3, P1818, DOI 10.1096/fasebj.3.7.2497040; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH GP, 1993, GENE, V128, P1, DOI 10.1016/0378-1119(93)90145-S; Smith-Norowitz TA, 2011, INT J MED SCI, V8, P239, DOI 10.7150/ijms.8.239; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	51	38	41	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41469	10.1371/journal.pone.0041469	http://dx.doi.org/10.1371/journal.pone.0041469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870226	Green Submitted, gold, Green Published			2022-12-25	WOS:000307212800022
J	Van Belleghem, SM; Roelofs, D; Van Houdt, J; Hendrickx, F				Van Belleghem, Steven M.; Roelofs, Dick; Van Houdt, Jeroen; Hendrickx, Frederik			De novo Transcriptome Assembly and SNP Discovery in the Wing Polymorphic Salt Marsh Beetle Pogonus chalceus (Coleoptera, Carabidae)	PLOS ONE			English	Article							HABITAT PERSISTENCE; JUVENILE-HORMONE; GENOME SEQUENCE; GENE-EXPRESSION; PEA APHID; EVOLUTION; DISPERSAL; DIMORPHISM; ADAPTATION; DIFFERENTIATION	Background: The salt marsh beetle Pogonus chalceus represents a unique opportunity to understand and study the origin and evolution of dispersal polymorphisms as remarkable inter-population divergence in dispersal related traits (e. g. wing development, body size and metabolism) has been shown to persist in face of strong homogenizing gene flow. Sequencing and assembling the transcriptome of P. chalceus is a first step in developing large scale genetic information that will allow us to further study the recurrent phenotypic evolution in dispersal traits in these natural populations. Methodology/Results: We used the Illumina HiSeq2000 to sequence 37 Gbases of the transcriptome and performed de novo transcriptome assembly with the Trinity short read assembler. This resulted in 65,766 contigs, clustering into 39,393 unique transcripts (unigenes). A subset of 12,987 show similarity (BLAST) to known proteins in the NCBI database and 7,589 are assigned Gene Ontology (GO). Using homology searches we identified all reported genes involved in wing development, juvenile- and ecdysteroid hormone pathways in Tribolium castaneum. About half (56.7%) of the unique assembled genes are shared among three life stages (third-instar larva, pupa, and imago). We identified 38,141 single nucleotide polymorphisms (SNPs) in these unigenes. Of these SNPs, 26,823 (70.3%) were found in a predicted open reading frame (ORF) and 6,998 (18.3%) were nonsynonymous. Conclusions: The assembled transcriptome and SNP data are essential genomic resources for further study of the developmental pathways, genetic mechanisms and metabolic consequences of adaptive divergence in dispersal power in natural populations.	[Van Belleghem, Steven M.; Hendrickx, Frederik] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Van Belleghem, Steven M.; Hendrickx, Frederik] Royal Belgian Inst Nat Sci, Dept Entomol, Brussels, Belgium; [Roelofs, Dick] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Van Houdt, Jeroen] Lab Cytogenet & Genome Res, Louvain, Belgium	Ghent University; Royal Belgian Institute of Natural Sciences; Vrije Universiteit Amsterdam	Van Belleghem, SM (corresponding author), Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium.	Steven.VanBelleghem@UGent.be	Van Belleghem, Steven/J-2270-2019; Hendrickx, Frederik/F-3149-2013	Van Belleghem, Steven/0000-0001-9399-1007; Roelofs, Dick/0000-0003-3954-3590	FWO-Flanders; Belgian Science Policy [MO/36/025]; Ghent University; Hercules Foundation; Flemish Government - department EWI	FWO-Flanders(FWO); Belgian Science Policy(Belgian Federal Science Policy Office); Ghent University(Ghent University); Hercules Foundation; Flemish Government - department EWI	Funding was received from the FWO-Flanders (PhD grant to Steven Van Belleghem) and the Belgian Science Policy (MO/36/025) and partly conducted within the framework of the Interuniversity Attraction Poles programme IAP (SPEEDY) - Belgian Science Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janine Marien, affiliated to the Vrije Universiteit Amsterdam, for her help in preparation of the samples. This work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government - department EWI and we are grateful to the ICT Department of Ghent University for assistance with our computations. Sequencing was performed by the Genomics Core of the University Hospital of Leuven, Belgium.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020714; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; DENBOER PJ, 1980, ENTOMOL GEN, V6, P107; Denno RF, 1996, ECOL MONOGR, V66, P389, DOI 10.2307/2963487; DESENDER K, 1988, ANN SOC ROY ZOOL BEL, V118, P78; DESENDER K, 1987, ACTA PHYTOPATHOL HUN, V22, P85; DESENDER K, 1985, Biologisch Jaarboek, V53, P89; Desender K, 1998, OECOLOGIA, V114, P503, DOI 10.1007/s004420050474; Dhuyvetter H, 2004, MOL ECOL, V13, P1065, DOI 10.1111/j.1365-294X.2004.02134.x; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gustavson E, 1996, GENETICS, V142, P893; Hendrickx F, 2009, GLOBAL ECOL BIOGEOGR, V18, P607, DOI 10.1111/j.1466-8238.2009.00473.x; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Holt RD, 1996, AM NAT, V148, P709, DOI 10.1086/285949; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ishikawa A, 2012, INSECT MOL BIOL, V21, P49, DOI 10.1111/j.1365-2583.2011.01111.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Michel AP, 2010, P NATL ACAD SCI USA, V107, P9724, DOI 10.1073/pnas.1000939107; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; MITTAPALLI O, 2010, PLOS ONE, V5; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SERRANO J, 1981, GENETICA, V57, P119, DOI 10.1007/BF00131237; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theodorides K, 2002, INSECT MOL BIOL, V11, P467, DOI 10.1046/j.1365-2583.2002.00355.x; Turin H, 2000, NEDERLANDSE LOOPKEVE; Van Dyck H, 1999, TRENDS ECOL EVOL, V14, P172, DOI 10.1016/S0169-5347(99)01610-9; VANSTRAALEN NM, 2006, INTRO ECOLOGICAL GEN; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Weihe U, 2005, INSECT DEV MORPHOGEN, P730; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xue J, 2011, PLOS ONE, V5; Zera AJ, 2003, INTEGR COMP BIOL, V43, P607, DOI 10.1093/icb/43.5.607; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2007, EVOL DEV, V9, P499, DOI 10.1111/j.1525-142X.2007.00181.x	87	45	48	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42605	10.1371/journal.pone.0042605	http://dx.doi.org/10.1371/journal.pone.0042605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870338	Green Published, gold			2022-12-25	WOS:000307212800101
J	Godeke, J; Binnenkade, L; Thormann, KM				Goedeke, Julia; Binnenkade, Lucas; Thormann, Kai M.			Transcriptome Analysis of Early Surface-Associated Growth of Shewanella oneidensis MR-1	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; SWARMER CELL-DIFFERENTIATION; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; VIBRIO-PARAHAEMOLYTICUS; BACTERIAL BIOFILMS; SIGNALING PATHWAY; DI-GMP; IRON	Bacterial biofilm formation starts with single cells attaching to a surface, however, little is known about the initial attachment steps and the adaptation to the surface-associated life style. Here, we describe a hydrodynamic system that allows easy harvest of cells at very early biofilm stages. Using the metal ion-reducing gammaproteobacterium Shewanella oneidensis MR-1 as a model organism, we analyzed the transcriptional changes occurring during surface-associated growth between 15 and 60 minutes after attachment. 230 genes were significantly upregulated and 333 were downregulated by a factor of >= 2. Main functional categories of the corresponding gene products comprise metabolism, uptake and transport, regulation, and hypothetical proteins. Among the genes highly upregulated those implicated in iron uptake are highly overrepresented, strongly indicating that S. oneidensis MR-1 has a high demand for iron during surface attachment and initial biofilm stages. Subsequent microscopic analysis of biofilm formation under hydrodynamic conditions revealed that addition of Fe(II) significantly stimulated biofilm formation of S. oneidensis MR-1 while planktonic growth was not affected. Our approach to harvest cells for transcriptional analysis of early biofilm stages is expected to be easily adapted to other bacterial species.	[Goedeke, Julia; Binnenkade, Lucas; Thormann, Kai M.] Max Planck Inst Terr Mikrobiol, Dept Ecophysiol, Marburg, Germany	Max Planck Society	Godeke, J (corresponding author), TWINCORE Zentrum Expt & Klin Infekt Forsch GmbH, Feodor Lynen Str 7-9, Hannover, Germany.	thormann@mpi-marburg.mpg.de			Deutsche Forschungsgemeinschaft (DFG) [831/3-1]; Max-Planck-Gesellschaft (MPG); International Max Planck Research School (IMPRS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max-Planck-Gesellschaft (MPG)(Max Planck Society); International Max Planck Research School (IMPRS)	The work was funded by the Deutsche Forschungsgemeinschaft (DFG, grant 831/3-1), the Max-Planck-Gesellschaft (MPG), and the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; AIBA H, 1981, J BIOL CHEM, V256, P1905; An DD, 2007, CURR OPIN MICROBIOL, V10, P292, DOI 10.1016/j.mib.2007.05.011; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Baum M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng151; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Chourey K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-395; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Dorel C, 1999, FEMS MICROBIOL LETT, V178, P169, DOI 10.1111/j.1574-6968.1999.tb13774.x; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Glick R, 2010, J BACTERIOL, V192, P2973, DOI 10.1128/JB.01601-09; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; GRISHIN SI, 1988, APPL ENVIRON MICROB, V54, P3092, DOI 10.1128/AEM.54.12.3092-3100.1988; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Heun M, 2012, APPL ENVIRON MICROB, V78, P4400, DOI 10.1128/AEM.07895-11; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Learman DR, 2009, APPL ENVIRON MICROB, V75, P1301, DOI 10.1128/AEM.01393-08; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Liang YL, 2012, ARCH MICROBIOL, V194, P473, DOI 10.1007/s00203-011-0782-x; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; MCCARTER L, 1989, J BACTERIOL, V171, P731, DOI 10.1128/jb.171.2.731-736.1989; MCCARTER L, 1990, MOL MICROBIOL, V4, P1057, DOI 10.1111/j.1365-2958.1990.tb00678.x; McLean JS, 2008, J MICROBIOL METH, V74, P47, DOI 10.1016/j.mimet.2008.02.015; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Rakshe S, 2011, APPL ENVIRON MICROB, V77, P2196, DOI 10.1128/AEM.01985-10; Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004; Rosenbaum MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030827; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Saville RM, 2011, J BACTERIOL, V193, P3257, DOI 10.1128/JB.00251-11; Saville RM, 2010, FEMS MICROBIOL LETT, V308, P76, DOI 10.1111/j.1574-6968.2010.01995.x; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2004, BIOMETALS, V17, P267, DOI 10.1023/B:BIOM.0000027703.77456.27; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Theunissen S, 2010, RES MICROBIOL, V161, P144, DOI 10.1016/j.resmic.2009.12.002; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131	78	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42160	10.1371/journal.pone.0042160	http://dx.doi.org/10.1371/journal.pone.0042160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860070	Green Submitted, Green Published, gold			2022-12-25	WOS:000307045600063
J	Irimia, JM; Rovira, J; Nielsen, JN; Guerrero, M; Wojtaszewski, JFP; Cusso, R				Irimia, Jose M.; Rovira, Jordi; Nielsen, Jakob N.; Guerrero, Mario; Wojtaszewski, Jorgen F. P.; Cusso, Roser			Hexokinase 2, Glycogen Synthase and Phosphorylase Play a Key Role in Muscle Glycogen Supercompensation	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; RAT SKELETAL-MUSCLE; ACTIVATED PROTEIN-KINASE; II MESSENGER-RNA; GLUCOSE; EXPRESSION; EXERCISE; INSULIN; TRANSLOCATION; RESYNTHESIS	Background: Glycogen-depleting exercise can lead to supercompensation of muscle glycogen stores, but the biochemical mechanisms of this phenomenon are still not completely understood. Methods: Using chronic low-frequency stimulation (CLFS) as an exercise model, the tibialis anterior muscle of rabbits was stimulated for either 1 or 24 hours, inducing a reduction in glycogen of 90% and 50% respectively. Glycogen recovery was subsequently monitored during 24 hours of rest. Results: In muscles stimulated for 1 hour, glycogen recovered basal levels during the rest period. However, in those stimulated for 24 hours, glycogen was supercompensated and its levels remained 50% higher than basal levels after 6 hours of rest, although the newly synthesized glycogen had fewer branches. This increase in glycogen correlated with an increase in hexokinase-2 expression and activity, a reduction in the glycogen phosphorylase activity ratio and an increase in the glycogen synthase activity ratio, due to dephosphorylation of site 3a, even in the presence of elevated glycogen stores. During supercompensation there was also an increase in 5'-AMP-activated protein kinase phosphorylation, correlating with a stable reduction in ATP and total purine nucleotide levels. Conclusions: Glycogen supercompensation requires a coordinated chain of events at two levels in the context of decreased cell energy balance: First, an increase in the glucose phosphorylation capacity of the muscle and secondly, control of the enzymes directly involved in the synthesis and degradation of the glycogen molecule. However, supercompensated glycogen has fewer branches.	[Irimia, Jose M.; Rovira, Jordi; Guerrero, Mario; Cusso, Roser] Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Nielsen, Jakob N.; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Mol Physiol Grp, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen	Irimia, JM (corresponding author), Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	mcusso@ub.edu	Rovira, Jordi/A-9603-2017; Wojtaszewski, Jørgen FP/P-6583-2014	Rovira, Jordi/0000-0001-8737-5005; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Guerrero, Mario/0000-0002-9912-661X; wojtaszewski, jorgen/0000-0001-8185-3408	Ministerio Espanol de Ciencia y Tecnologia [BFI2002-00218, BFU2005-08506]; FISS of the Instituto Carlos III (Red de Centros) [RCMN-C03708]; Agencia Espanola de Cooperacion Internacional; Danish Medical Reseach council; Novo Nordisk foundation; Danish Diabetes Association; European Union [LSHM-CT-2004-005272]; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain	Ministerio Espanol de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FISS of the Instituto Carlos III (Red de Centros); Agencia Espanola de Cooperacion Internacional; Danish Medical Reseach council; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; European Union(European Commission); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain	This study was supported by the Ministerio Espanol de Ciencia y Tecnologia (BFI2002-00218 and BFU2005-08506), the FISS of the Instituto Carlos III (Red de Centros RCMN-C03708); and the Agencia Espanola de Cooperacion Internacional. JFPW and JNN were supported by the Danish Medical Reseach council, Novo Nordisk foundation, The Danish Diabetes Association and by an integrated project (LSHM-CT-2004-005272) from the European Union. JMI was supported by a predoctoral fellowship from Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain. JR was supported by a predoctoral fellowship from Universitat de Barcelona, Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Baque S, 1996, J BIOL CHEM, V271, P2594, DOI 10.1074/jbc.271.5.2594; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNO C, 1993, ANN NEUROL, V33, P88, DOI 10.1002/ana.410330114; Cadefau JA, 1999, J BIOL CHEM, V274, P31961, DOI 10.1074/jbc.274.45.31961; CADEFAU JA, 1993, PFLUG ARCH EUR J PHY, V424, P529, DOI 10.1007/BF00374918; CALDER PC, 1992, INT J BIOCHEM, V24, P71, DOI 10.1016/0020-711X(92)90231-O; CAO YJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P293, DOI 10.1006/abbi.1995.1295; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Fueger PT, 2005, CLIN EXP PHARMACOL P, V32, P314, DOI 10.1111/j.1440-1681.2005.04190.x; Fueger PT, 2004, AM J PHYSIOL-ENDOC M, V286, pE77, DOI 10.1152/ajpendo.00309.2003; Garcia-Roves P, 2003, AM J PHYSIOL-ENDOC M, V285, pE729, DOI 10.1152/ajpendo.00216.2003; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Greiwe JS, 1999, J APPL PHYSIOL, V87, P222, DOI 10.1152/jappl.1999.87.1.222; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hatfield DL, 2006, J STRENGTH COND RES, V20, P167; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; HOFMANN S, 1994, EUR J BIOCHEM, V219, P307, DOI 10.1111/j.1432-1033.1994.tb19942.x; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Koval JA, 1998, AM J PHYSIOL-ENDOC M, V274, pE304, DOI 10.1152/ajpendo.1998.274.2.E304; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Lai YC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1622, DOI 10.1152/ajpendo.00113.2007; Laurent D, 2000, AM J PHYSIOL-ENDOC M, V278, pE663, DOI 10.1152/ajpendo.2000.278.4.E663; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; Nielsen JN, 2004, P NUTR SOC, V63, P233, DOI 10.1079/PNS2004348; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; ODOHERTY RM, 1994, AM J PHYSIOL, V266, pE171; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PETTE D, 1975, PFLUG ARCH EUR J PHY, V361, P1, DOI 10.1007/BF00587333; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prats C, 2005, J BIOL CHEM, V280, P23165, DOI 10.1074/jbc.M502713200; Prats C, 2002, BBA-GEN SUBJECTS, V1573, P68, DOI 10.1016/S0304-4165(02)00332-X; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; Putman CT, 2007, AM J PHYSIOL-REG I, V293, pR1325, DOI 10.1152/ajpregu.00609.2006; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Sandstrom ME, 2004, PFLUG ARCH EUR J PHY, V448, P533, DOI 10.1007/s00424-004-1280-7; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V289, pE508, DOI 10.1152/ajpendo.00100.2005; Skein M, 2011, EUR J APPL PHYSL; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; TAN AWH, 1979, BIOCHIM BIOPHYS ACTA, V582, P543, DOI 10.1016/0304-4165(79)90146-6; TULLSON PC, 1990, AM J PHYSIOL, V258, pC258, DOI 10.1152/ajpcell.1990.258.2.C258; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Wilson RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1815, DOI 10.1152/ajpendo.00598.2006; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	57	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42453	10.1371/journal.pone.0042453	http://dx.doi.org/10.1371/journal.pone.0042453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860128	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600102
J	Chen, CC; Balaban, E; Jarvis, ED				Chen, Chun-Chun; Balaban, Evan; Jarvis, Erich D.			Interspecies Avian Brain Chimeras Reveal That Large Brain Size Differences Are Influenced by Cell-Interdependent Processes	PLOS ONE			English	Article							QUAIL-CHICK CHIMERAS; SPECIES-DIFFERENCES; MELOPSITTACUS-UNDULATUS; SUBVENTRICULAR ZONES; BOBWHITE QUAIL; BIGGER BRAINS; EVOLUTION; BIRDS; TELENCEPHALON; NEUROGENESIS	Like humans, birds that exhibit vocal learning have relatively delayed telencephalon maturation, resulting in a disproportionately smaller brain prenatally but enlarged telencephalon in adulthood relative to vocal non-learning birds. To determine if this size difference results from evolutionary changes in cell-autonomous or cell-interdependent developmental processes, we transplanted telencephala from zebra finch donors (a vocal-learning species) into Japanese quail hosts (a vocal non-learning species) during the early neural tube stage (day 2 of incubation), and harvested the chimeras at later embryonic stages (between 9-12 days of incubation). The donor and host tissues fused well with each other, with known major fiber pathways connecting the zebra finch and quail parts of the brain. However, the overall sizes of chimeric finch telencephala were larger than non-transplanted finch telencephala at the same developmental stages, even though the proportional sizes of telencephalic subregions and fiber tracts were similar to normal finches. There were no significant changes in the size of chimeric quail host midbrains, even though they were innervated by the physically smaller zebra finch brain, including the smaller retinae of the finch eyes. Chimeric zebra finch telencephala had a decreased cell density relative to normal finches. However, cell nucleus size differences between each species were maintained as in normal birds. These results suggest that telencephalic size development is partially cell-interdependent, and that the mechanisms controlling the size of different brain regions may be functionally independent.	[Chen, Chun-Chun; Jarvis, Erich D.] Duke Univ, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27706 USA; [Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada	Duke University; Howard Hughes Medical Institute; McGill University	Chen, CC (corresponding author), Duke Univ, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27706 USA.	cc229@duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Balaban, Evan/AAV-2353-2020	Jarvis, Erich D/0000-0001-8931-5049; Balaban, Evan/0000-0002-0391-3433	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The funding source is from Howard Hughes Medical Institute to the investigator, Dr. Erich Jarvis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2010, J COMP NEUROL, V518, P3512, DOI 10.1002/cne.22410; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; Apanius V., 1998, AVIAN GROWTH DEV EVO; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Balaban E, 2005, INT J DEV BIOL, V49, P117, DOI 10.1387/ijdb.041934eb; BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Boire Denis, 1994, Journal of Brain Research, V35, P49; Bronner-Fraser M, 2008, METHOD CELL BIOL, V87, P75, DOI 10.1016/S0091-679X(08)00204-5; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Castellan NJ, 1988, NONPARAMETRIC STAT B; Charvet CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00004; Charvet CJ, 2010, P ROY SOC B-BIOL SCI, V277, P3469, DOI 10.1098/rspb.2010.0811; Charvet CJ, 2009, P R SOC B, V276, P3421, DOI 10.1098/rspb.2009.0888; Charvet CJ, 2009, BRAIN BEHAV EVOLUT, V73, P285, DOI 10.1159/000230673; Charvet CJ, 2008, BRAIN BEHAV EVOLUT, V72, P295, DOI 10.1159/000184744; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eames BF, 2005, DEVELOPMENT, V132, P1499, DOI 10.1242/dev.01719; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Finlay BL, 2010, BRAIN BEHAV EVOLUT, V75, P4, DOI 10.1159/000295350; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LeDouarin NM, 1997, INT REV CYTOL, V175, P241, DOI 10.1016/S0074-7696(08)62128-2; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; Long KD, 2001, P NATL ACAD SCI USA, V98, P5862, DOI 10.1073/pnas.091080098; McGowan L, 2011, EVOLUTION, V65, P907, DOI 10.1111/j.1558-5646.2010.01126.x; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; Nikolakopoulou AM, 2006, BRAIN RES BULL, V70, P107, DOI 10.1016/j.brainresbull.2006.04.005; Nobrega-Pereira S, 2009, CEREB CORTEX, V19, pI107, DOI 10.1093/cercor/bhp044; NOTTEBOH.F, 1970, SCIENCE, V167, P950, DOI 10.1126/science.167.3920.950; Nottebohm F, 2010, BRAIN LANG, V115, P3, DOI 10.1016/j.bandl.2010.05.002; Osmon, 2005, ATLAS CHICK DEV; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Pombero A, 2009, J COMP NEUROL, V512, P784, DOI 10.1002/cne.21933; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Scharff C, 2004, ANN NY ACAD SCI, V1016, P325, DOI 10.1196/annals.1298.032; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; SENUT MC, 1986, DEV BRAIN RES, V29, P123, DOI 10.1016/0165-3806(86)90088-X; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; SOHAL GS, 1991, INT J DEV NEUROSCI, V9, P563, DOI 10.1016/0736-5748(91)90017-G; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Striedter GF, 2008, J COMP NEUROL, V507, P1663, DOI 10.1002/cne.21640; Striedter GF, 2009, BIOL LETTERS, V5, P134, DOI 10.1098/rsbl.2008.0439; TANAKA H, 1990, DEVELOPMENT, V110, P565; Teillet Marie-Aimee, 2008, V461, P337, DOI 10.1007/978-1-60327-483-8_24; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; White SA, 2010, BRAIN LANG, V115, P21, DOI 10.1016/j.bandl.2009.10.002; Windle WF, 1936, J COMP NEUROL, V63, P431, DOI 10.1002/cne.900630304	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42477	10.1371/journal.pone.0042477	http://dx.doi.org/10.1371/journal.pone.0042477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860132	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900093
J	Poisbleau, M; Muller, W; Carslake, D; Demongin, L; Groothuis, TGG; Van Camp, J; Eens, M				Poisbleau, Maud; Mueller, Wendt; Carslake, David; Demongin, Laurent; Groothuis, Ton G. G.; Van Camp, Jeff; Eens, Marcel			Penguin Chicks Benefit from Elevated Yolk Androgen Levels under Sibling Competition	PLOS ONE			English	Article							ROCKHOPPER PENGUINS; HATCHING ASYNCHRONY; TESTOSTERONE LEVELS; MATERNAL ANDROGENS; BEGGING BEHAVIOR; LAYING ORDER; EGGS; GROWTH; HORMONES; SEX	Crested penguins (genus Eudyptes) have a peculiar hatching pattern, with the first-laid egg (A-egg) hatching after the second-laid egg (B-egg) and chicks from A-eggs typically having a much lower survival probability. Maternal yolk androgens have been suggested to contribute to the competitive superiority of the B-chick in southern rockhopper penguins Eudyptes chrysocome, given their important role in mediating sibling competition in other species. We therefore increased the yolk androgen levels in freshly-laid eggs and examined the consequences for sibling competition - via effects on embryonic developmental times, chick growth and early survival. We placed one androgen-treated egg and one control egg into each foster nest, matching them for mass, laying date and laying order. The androgen treatment did not significantly affect embryonic developmental times or chick measurements at hatching. However, elevated yolk androgen levels benefitted chick growth in interaction with the number of siblings in a brood. Chicks from androgen-treated eggs had faster growth in the presence of a sibling than chicks from control eggs. Under these circumstances they also had a higher survival probability. Thus maternal androgens appear to reinforce the observed hatching pattern, facilitating brood reduction. This contrasts to most previous studies in other species where yolk androgens have been shown to compensate for the negative consequences of delayed hatching within the brood hierarchy.	[Poisbleau, Maud; Mueller, Wendt; Demongin, Laurent; Van Camp, Jeff; Eens, Marcel] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Carslake, David] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England; [Groothuis, Ton G. G.] Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands	University of Antwerp; University of Bristol; University of Groningen	Poisbleau, M (corresponding author), Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium.	maud.poisbleau@ua.ac.be	Eens, Marcel/AAC-8466-2020; Poisbleau, Maud/B-9968-2014	Poisbleau, Maud/0000-0002-0729-3251; Muller, Wendt/0000-0001-7273-4095	University of Antwerp; FWO-Flanders [1.2.619.10.N.00, 1.5.020.11.N.00]	University of Antwerp; FWO-Flanders(FWO)	Financial support was provided by the University of Antwerp and FWO-Flanders (Application numbers 1.2.619.10.N.00 and 1.5.020.11.N.00) to ME and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T., 1991, P1707; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; Barnett CA, 2011, ANIM BEHAV, V81, P113, DOI 10.1016/j.anbehav.2010.09.019; Boncoraglio G, 2006, HORM BEHAV, V50, P442, DOI 10.1016/j.yhbeh.2006.05.005; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Bonisoli-Alquati A, 2011, HORM BEHAV, V59, P75, DOI 10.1016/j.yhbeh.2010.10.013; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; Demongin L, 2010, POLAR BIOL, V33, P469, DOI 10.1007/s00300-009-0722-2; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Gil D, 2004, HORM BEHAV, V45, P64, DOI 10.1016/j.yhbeh.2003.08.005; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Griffiths R, 1998, MOL ECOL, V7, P1701; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; HOWE HF, 1978, ECOLOGY, V59, P1109, DOI 10.2307/1938226; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; Lack D., 1954, P343; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lamey T.C., 1990, P399; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; Massaro M, 2004, BEHAV ECOL SOCIOBIOL, V56, P426, DOI 10.1007/s00265-004-0803-8; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Moreno J, 1997, AUK, V114, P47, DOI 10.2307/4089064; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Muller W, 2009, BIOL LETTERS, V5, P586, DOI 10.1098/rsbl.2009.0283; Muller W, 2009, BEHAV ECOL SOCIOBIOL, V63, P809, DOI 10.1007/s00265-009-0714-9; Muller W, 2009, HORM BEHAV, V55, P175, DOI 10.1016/j.yhbeh.2008.09.012; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Poisbleau M, 2011, GEN COMP ENDOCR, V170, P622, DOI 10.1016/j.ygcen.2010.11.027; Poisbleau M, 2009, GEN COMP ENDOCR, V162, P139, DOI 10.1016/j.ygcen.2009.03.022; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Poisbleau M, 2009, HORM BEHAV, V55, P500, DOI 10.1016/j.yhbeh.2009.02.002; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rutkowska J, 2007, BEHAV ECOL SOCIOBIOL, V61, P1211, DOI 10.1007/s00265-007-0351-0; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Sockman KW, 2008, BEHAV ECOL SOCIOBIOL, V62, P617, DOI 10.1007/s00265-007-0486-z; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; St Clair CC, 1998, AUK, V115, P478, DOI 10.2307/4089208; St Clair CC, 1996, J ANIM ECOL, V65, P485; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warham J., 1975, P189; Williams T.D., 1995, PENGUINS; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243	58	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42174	10.1371/journal.pone.0042174	http://dx.doi.org/10.1371/journal.pone.0042174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860073	gold, Green Published			2022-12-25	WOS:000306950900074
J	Ioannidis, NE; Lopera, O; Santos, M; Torne, JM; Kotzabasis, K				Ioannidis, Nikolaos E.; Lopera, Oriol; Santos, Mireya; Torne, Josep M.; Kotzabasis, Kiriakos			Role of Plastid Transglutaminase in LHCII Polyamination and Thylakoid Electron and Proton Flow	PLOS ONE			English	Article							CROSS-LINKING ENZYMES; PHOTOSYSTEM-II; IN-VIVO; PHOTOSYNTHETIC APPARATUS; ENERGY-DISSIPATION; XANTHOPHYLL CYCLE; ANTENNA PROTEINS; FLUORESCENCE; STRESS; PHOTOPROTECTION	Transglutaminases function as biological glues in animal cells, plant cells and microbes. In energy producing organelles such as chloroplasts the presence of transglutaminases was recently confirmed. Furthermore, a plastidial transglutaminase has been cloned from maize and the first plants overexpressing tgz are available (Nicotiana tabacum TGZ OE). Our hypothesis is that the overexpression of plastidal transglutaminase will alter photosynthesis via increased polyamination of the antenna of photosystem II. We have used standard analytical tools to separate the antenna from photosystem II in wild type and modified plants, 6 specific antibodies against LHCbs to confirm their presence and sensitive HPLC method to quantify the polyamination level of these proteins. We report that bound spermidine and spermine were significantly increased (similar to 80%) in overexpressors. Moreover, we used recent advances in in vivo probing to study simultaneously the proton and electron circuit of thylakoids. Under physiological conditions overexpressors show a 3-fold higher sensitivity of the antenna down regulation loop (qE) to the elicitor (luminal protons) which is estimated as the Delta pH component of thylakoidal proton motive force. In addition, photosystem (hyper-PSII alpha) with an exceptionally high antenna (large absorption cross section), accumulate in transglutaminase over expressers doubling the rate constant of light energy utilization (K alpha) and promoting thylakoid membrane stacking. Polyamination of antenna proteins is a previously unrecognized mechanism for the modulation of the size (antenna absorption cross section) and sensitivity of photosystem II to down regulation. Future research will reveal which peptides and which residues of the antenna are responsible for such effects.	[Ioannidis, Nikolaos E.; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Ioannidis, Nikolaos E.; Lopera, Oriol; Santos, Mireya; Torne, Josep M.] CRAG CSIC IRTA UAB UB, Ctr Res Agr Genom, Dept Mol Genet, Barcelona, Spain	University of Crete; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA	Ioannidis, NE (corresponding author), Univ Crete, Dept Biol, Voutes Univ Campus, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365	Greek Scholarship Foundation (IKY); Spanish projects MEC (Ministerio de Educacion y Ciencia) [BFU2006-15115-01/BMC, BFU2009-08575]	Greek Scholarship Foundation (IKY); Spanish projects MEC (Ministerio de Educacion y Ciencia)	N.E.I. acknowledges Greek Scholarship Foundation (IKY) for a post doctoral research fellowship. This study was supported by the Spanish projects MEC (Ministerio de Educacion y Ciencia) BFU2006-15115-01/BMC and BFU2009-08575. The authors would also like to thank the Spanish Ministry of Science and Innovation, Consolider-Ingenio 2010 Programme, CSD2007-00036 "CRAG'' (Centre for Research in Agricultural Genomics) and the Xarxa de Referencia en Biotecnologia de la Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BAKER GM, 1981, BIOCHEMISTRY-US, V20, P2307, DOI 10.1021/bi00511a037; Bernet E, 1999, PLANT PHYSIOL BIOCH, V37, P899, DOI 10.1016/S0981-9428(99)00104-7; Bernet E, 1997, THESIS U BARCELONA B; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Campos A, 2010, PLANT BIOLOGY, V12, P708, DOI 10.1111/j.1438-8677.2009.00280.x; Carvajal P, 2011, BIOTECHNOL PROGR, V27, P232, DOI 10.1002/btpr.538; Carvajal-Vallejos PK, 2007, BIOTECHNOL LETT, V29, P1255, DOI 10.1007/s10529-007-9377-7; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; DELDUCA S, 1994, PLANTA, V193, P283, DOI 10.1007/BF00192542; Della Mea M, 2004, PLANTA, V219, P754, DOI 10.1007/s00425-004-1278-6; Dilley RA, 2004, PHOTOSYNTH RES, V80, P245, DOI 10.1023/B:PRES.0000030436.32486.aa; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Huber CG, 2001, J BIOL CHEM, V276, P45755, DOI 10.1074/jbc.M106700200; Ioannidis NE, 2007, BBA-BIOENERGETICS, V1767, P1372, DOI 10.1016/j.bbabio.2007.10.002; Ioannidis NE, 2006, BBA-BIOENERGETICS, V1757, P821, DOI 10.1016/j.bbabio.2006.05.034; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Ioannidis NE, 2011, PHOTOSYNTH RES, V107, P169, DOI 10.1007/s11120-010-9617-x; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; KOTZABASIS K, 1993, ANAL BIOCHEM, V214, P484, DOI 10.1006/abio.1993.1526; KOTZABASIS K, 1993, PHOTOSYNTH RES, V38, P83, DOI 10.1007/BF00015064; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Kramer DM, 1998, PHOTOSYNTH RES, V56, P103, DOI 10.1023/A:1005968211506; Labate MTV, 2004, PLANT MOL BIOL, V55, P701, DOI 10.1007/s11103-004-1963-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASZLO JA, 1984, BIOCHIM BIOPHYS ACTA, V764, P160, DOI 10.1016/0005-2728(84)90025-2; LASZLO JA, 1984, J BIOENERG BIOMEMBR, V16, P37, DOI 10.1007/BF00744144; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; Logothetis K, 2004, J PLANT PHYSIOL, V161, P715, DOI 10.1078/0176-1617-00942; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P261, DOI 10.1016/j.bbabio.2007.02.008; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Ortigosa SM, 2010, PLANTA, V232, P593, DOI 10.1007/s00425-010-1185-y; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pinto-Marijuan M, 2007, PHYSIOL PLANTARUM, V131, P159, DOI 10.1111/j.1399-3054.2007.00939.x; Santos M, 2007, MODERN RES ED TOPICS, P212; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Sfichi-Duke L, 2008, PLANTA, V228, P341, DOI 10.1007/s00425-008-0741-1; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Torne JM, 2003, Patent, Patent No. [1535992, EP1535992]; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsiavos T, 2012, BBA-BIOENERGETICS, V1817, P735, DOI 10.1016/j.bbabio.2012.01.007; Villalobos E, 2004, GENE, V336, P93, DOI 10.1016/j.gene.2004.03.025; Villalobos E, 2001, PROTOPLASMA, V216, P155, DOI 10.1007/BF02673867; Villalobos E, 2007, THESIS U BARCELONA S; Villar-Pique A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013625; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200	62	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41979	10.1371/journal.pone.0041979	http://dx.doi.org/10.1371/journal.pone.0041979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22870182	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200141
J	Savkovic, B; Symonds, G; Murray, JM				Savkovic, Borislav; Symonds, Geoff; Murray, John M.			Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; STRUCTURED TREATMENT INTERRUPTIONS; SYNCYTIUM-INDUCING PHENOTYPE; CORECEPTOR SWITCH; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; HEMATOPOIETIC STEM; CXCR4-USING HIV-1; LYMPHOID-TISSUE	The emergence of X4 tropic viral strains throughout the course of HIV infection is associated with poorer prognostic outcomes and faster progressions to AIDS than for patients in whom R5 viral strains predominate. Here we investigate a stochastic model to account for the emergence of X4 virus via mutational intermediates of lower fitness that exhibit dual/mixed (D/M) tropism, and employ the model to investigate whether the administration of CCR5 blockers in-vivo is likely to promote a shift towards X4 tropism. We show that the proposed stochastic model can account for X4 emergence with a median time of approximately 4 years post-infection as a result of: 1.) random stochastic mutations in the V3 region of env during the reverse transcription step of infection; 2.) increasing numbers of CXCR4-expressing activated naive CD4+ T cells with declining total CD4+ T cell counts, thereby providing increased numbers of activated target cells for productive infection by X4 virus. Our model indicates that administration of the CCR5 blocker maraviroc does not promote a shift towards X4 tropism, assuming sufficient efficacy of background therapy (BT). However our modelling also indicates that administration of maraviroc as a monotherapy or with BT of suboptimal efficacy can promote emergence of X4 tropic virus, resulting in accelerated progression to AIDS. Taken together, our results demonstrate that maraviroc is safe and effective if co-administered with sufficiently potent BT, but that suboptimal BT may promote X4 emergence and accelerated progression to AIDS. These results underscore the clinical importance for careful selection of BT when CCR5 blockers are administered in-vivo.	[Savkovic, Borislav; Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Symonds, Geoff] St Vincents Ctr Appl Med Res, Darlinghurst, NSW, Australia; [Murray, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute	Savkovic, B (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	b.savkovic@unsw.edu.au	Murray, John/B-5481-2009	Murray, John/0000-0001-9314-2283	Australian Research Council (ARC) [LP100100242]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC) under an ARC Linkage grant held by GS and JMM (LP100100242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007387; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Corbeau P, 2009, AIDS, V23, P1931, DOI 10.1097/QAD.0b013e32832e71cd; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Del Prete GQ, 2010, J VIROL, V84, P8777, DOI 10.1128/JVI.00333-10; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; ESSUNGER P, 1994, J THEOR BIOL, V170, P367, DOI 10.1006/jtbi.1994.1199; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Frost SDW, 2002, J VIROL, V76, P968, DOI 10.1128/JVI.76.3.968-979.2002; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Huenecke S, 2008, EUR J HAEMATOL, V80, P532, DOI 10.1111/j.1600-0609.2008.01052.x; Igarashi T, 2002, J VIROL, V76, P379, DOI 10.1128/JVI.76.1.379-391.2002; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; KLEIN J, 1990, IMMUNOLOGY; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lee S, 2000, J VIROL, V74, P5016, DOI 10.1128/JVI.74.11.5016-5023.2000; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lewin SR, 2008, JAIDS-J ACQ IMM DEF, V47, P140, DOI 10.1097/QAI.0b013e31815dbf7f; Lewin SR, 1996, AIDS RES HUM RETROV, V12, P877, DOI 10.1089/aid.1996.12.877; Lewis M, 2007, ANTIVIR THER, V12, pS65; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; Murray JM, 1998, MATH BIOSCI, V154, P57, DOI 10.1016/S0025-5564(98)10046-9; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Murray JM, 2012, AIDS, V26, P543, DOI 10.1097/QAD.0b013e328350fb3c; Murray JM, 2009, J GENE MED, V11, P1077, DOI 10.1002/jgm.1401; Nazari R, 2008, J GEN VIROL, V89, P2252, DOI 10.1099/vir.0.2008/001222-0; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Notermans DW, 1999, J INFECT DIS, V180, P1050, DOI 10.1086/315013; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Poizot-Martin I, 2010, MED MALADIES INFECT, V40, P245, DOI 10.1016/j.medmal.2010.03.007; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Ribeiro RM, 1999, AIDS, V13, P351, DOI 10.1097/00002030-199902250-00007; Shakirzyanova M, 2010, J VIROL, V84, P12862, DOI 10.1128/JVI.01478-10; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Svicher V, 2011, ANTIVIR RES, V90, P42, DOI 10.1016/j.antiviral.2011.02.005; Symons J, 2011, J ANTIMICROB CHEMOTH, V66, P890, DOI 10.1093/jac/dkq535; Tasca S, 2008, J VIROL, V82, P7089, DOI 10.1128/JVI.00570-08; Tebit DM, 2007, AIDS REV, V9, P75; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Troia-Cancio P, 2011, EXPERT REV ANTI-INFE, V9, P649, DOI [10.1586/eri.11.52, 10.1586/ERI.11.52]; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Weinberger AD, 2011, MATH BIOSCI ENG, V8, P605, DOI 10.3934/mbe.2011.8.605; Weinberger Ariel D, 2009, PLoS Comput Biol, V5, pe1000467, DOI 10.1371/journal.pcbi.1000467; Westby Mike, 2010, Antiviral Chemistry & Chemotherapy, V20, P179, DOI 10.3851/IMP1507; Wolinsky SM, 2004, VIROLOGY, V328, P19, DOI 10.1016/j.virol.2004.07.021; ZAUNDERS J, 1995, AIDS, V9, P561, DOI 10.1097/00002030-199506000-00005; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	72	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e38755	10.1371/journal.pone.0038755	http://dx.doi.org/10.1371/journal.pone.0038755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22866173	gold, Green Published, Green Submitted			2022-12-25	WOS:000306507000004
J	Oba, S; Noda, M; Waki, K; Nanri, A; Kato, M; Takahashi, Y; Poudel-Tandukar, K; Matsushita, Y; Inoue, M; Mizoue, T; Tsugane, S				Oba, Shino; Noda, Mitsuhiko; Waki, Kayo; Nanri, Akiko; Kato, Masayuki; Takahashi, Yoshihiko; Poudel-Tandukar, Kalpana; Matsushita, Yumi; Inoue, Manami; Mizoue, Tetsaya; Tsugane, Shoichiro		Japan Public Hlth Ctr Based Prospe	Smoking Cessation Increases Short-Term Risk of Type 2 Diabetes Irrespective of Weight Gain: The Japan Public Health Center-Based Prospective Study	PLOS ONE			English	Article							MIDDLE-AGED JAPANESE; SELF-REPORTED HEIGHT; BETA-CELL FUNCTION; BODY-WEIGHT; FOLLOW-UP; COHORT-I; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; PLASMA-INSULIN; POPULATION	Objective: The effect of smoking cessation on the risk of diabetes has been reported previously. However, it is unknown whether the association is influenced by weight gain and other potential risk factors. Methods: The Japan Public Health Center-Based Prospective Study established in 1990 for Cohort I and in 1993 for Cohort II provided data, and 25,875 men and 33,959 women were analyzed. The response rate to the baseline questionnaire was 80.9%, and 68.4% of the respondents participated both the 5- and 10-year follow-up surveys. Smoking cessation was noted during the initial five years and the development of diabetes was reported in the subsequent five years. Results: An increased risk was observed among individuals who newly quit smoking compared with never smokers among men (odds ratio (OR) = 1.42, 95% CI = 1.03-1.94) and women (OR = 2.84, CI = 1.53-5.29). The risk of developing diabetes among male new quitters who gained 3 kg or more during the 5-year follow-up did not substantially differ from the risk among male never smokers with less than 3 kg of weight gain or no weight gain, while an increased risk was observed among male new quitters with less or no weight gain (OR = 1.46, 95% CI 1.00-2.14). An insignificant increased risk was observed among male new quitters with a family history of diabetes compared with male never smokers with a family history of diabetes. The risk was more than twice as high for male new quitters who used to smoke 25 or more cigarettes per day compared with never smokers (OR = 2.15, 95% CI: 1.34-3.47). Discussion: An increased risk of diabetes was implied among individuals who quit smoking. However, the increased risk was not implied among those who gained weight over the 5-years of follow-up. Those who had major risk factors for diabetes or who smoked heavier had a higher risk.	[Oba, Shino] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Noda, Mitsuhiko; Takahashi, Yoshihiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet & Metab Med, Tokyo, Japan; [Waki, Kayo] Tokyo Univ Hosp, Dept Ubiquitous Hlth Informat, Tokyo 113, Japan; [Waki, Kayo; Takahashi, Yoshihiko] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Nanri, Akiko; Mizoue, Tetsaya] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Kato, Masayuki] Japan Fdn Promot Int Med Res Cooperat, Tokyo, Japan; [Poudel-Tandukar, Kalpana] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Clin Res Coordinat, Tokyo, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan	National Institute of Public Health - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan; Waseda University; National Center for Global Health & Medicine - Japan; National Cancer Center - Japan	Oba, S (corresponding author), Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan.	oba@niph.go.jp	Waki, Kayo/AAS-9523-2021; Oba, Shino/AAC-5473-2021; Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015; wang, YA XING/K-9671-2016	Oba, Shino/0000-0002-7388-5861; Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; wang, YA XING/0000-0003-2749-7793; Waki, Kayo/0000-0003-0046-2523	Ministry of Health, Labour and Welfare of Japan [19shi-2, H19-016]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid for Cancer Research (19shi-2) and a Health Sciences Research Grant (Research on Comprehensive Research on Cardiovascular Diseases H19-016) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Ministry of Health and Welfare, 1988, KOK EIYO GENJ; Ministry of Health Labour and Welfare in Japan, 2010, NAT HLTH NUTR SURV J; Mizoue T, 1998, INT J EPIDEMIOL, V27, P984, DOI 10.1093/ije/27.6.984; MOFFATT RJ, 1991, METABOLISM, V40, P465, DOI 10.1016/0026-0495(91)90225-L; Nanri A, 2010, J EPIDEMIOL COMMUNIT; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; PYORALA K, 1985, ACTA MED SCAND, P38; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Sakurai Y, 1997, DIABETES CARE, V20, P978, DOI 10.2337/diacare.20.6.978; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; STAMFORD BA, 1986, AM J CLIN NUTR, V43, P486, DOI 10.1093/ajcn/43.4.486; Tsugane S, 1999, AM J EPIDEMIOL, V150, P1201, DOI 10.1093/oxfordjournals.aje.a009946; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	29	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e17061	10.1371/journal.pone.0017061	http://dx.doi.org/10.1371/journal.pone.0017061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22879858	Green Published, gold			2022-12-25	WOS:000302733900001
J	Benned-Jensen, T; Norn, C; Laurent, S; Madsen, CM; Larsen, HM; Arfelt, KN; Wolf, RM; Frimurer, T; Sailer, AW; Rosenkilde, MM				Benned-Jensen, Tau; Norn, Christoffer; Laurent, Stephane; Madsen, Christian M.; Larsen, Hjalte M.; Arfelt, Kristine N.; Wolf, Romain M.; Frimurer, Thomas; Sailer, Andreas W.; Rosenkilde, Mette M.			Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CONSTITUTIVE ACTIVITY; 7-TRANSMEMBRANE RECEPTOR; CRYSTAL-STRUCTURE; SIGNALING PATHWAY; STRUCTURAL BASIS; ROR-GAMMA; ACTIVATION; LIGAND; EBI2	Oxysterols are oxygenated cholesterol derivates that are emerging as a physiologically important group of molecules. Although they regulate a range of cellular processes, only few oxysterol-binding effector proteins have been identified, and the knowledge of their binding mode is limited. Recently, the family of G protein-coupled seven transmembrane-spanning receptors (7TM receptors) was added to this group. Specifically, the Epstein-Barr virus-induced gene 2 (EBI2 or GPR183) was shown to be activated by several oxysterols, most potently by 7 alpha,25-dihydroxycholesterol (7 alpha,25-OHC). Nothing is known about the binding mode, however. Using mutational analysis, we identify here four key residues for 7 alpha,25-OHC binding: Arg-87 in TM-II (position II: 20/2.60), Tyr-112 and Tyr-116 (positions III: 09/3.33 and III: 13/3.37) in TM-III, and Tyr-260 in TM-VI (position VI: 16/6.51). Substituting these residues with Ala and/or Phe results in a severe decrease in agonist binding and receptor activation. Docking simulations suggest that Tyr-116 interacts with the 3 beta-OH group in the agonist, Tyr-260 with the 7 alpha-OH group, and Arg-87, either directly or indirectly, with the 25-OH group, although nearby residues likely also contribute. In addition, Tyr-112 is involved in 7 alpha,25-OHC binding but via hydrophobic interactions. Finally, we show that II: 20/2.60 constitutes an important residue for ligand binding in receptors carrying a positively charged residue at this position. This group is dominated by lipid-and nucleotide-activated receptors, here exemplified by the CysLTs, P2Y12, and P2Y14. In conclusion, we present the first molecular characterization of oxysterol binding to a 7TM receptor and identify position II: 20/2.60 as a generally important residue for ligand binding in certain 7TM receptors.	[Benned-Jensen, Tau; Madsen, Christian M.; Arfelt, Kristine N.; Rosenkilde, Mette M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen N, Denmark; [Norn, Christoffer; Larsen, Hjalte M.; Frimurer, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark; [Laurent, Stephane; Wolf, Romain M.; Sailer, Andreas W.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Frimurer, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Laurent, Stephane; Wolf, Romain M.; Sailer, Andreas W.] Novartis Pharma AG, Basel, Switzerland	University of Copenhagen; University of Copenhagen; Novartis; Novo Nordisk Foundation; University of Copenhagen; Novartis	Rosenkilde, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	rosenkilde@sund.ku.dk	; Sailer, Andreas/M-9913-2016	Rosenkilde, Mette Marie/0000-0001-9600-3254; Norn, Christoffer/0000-0002-1450-4651; Sailer, Andreas/0000-0002-9015-7946; Frimruer, Thomas/0000-0002-9682-8245				Alexander Nathan, 2011, IEEE Int Conf Comput Adv Bio Med Sci, V2011, P13, DOI 10.1109/ICCABS.2011.5729867; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Benned-Jensen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024644; Benned-Jensen T, 2011, J BIOL CHEM, V286, P29292, DOI 10.1074/jbc.M110.196345; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lu DS, 1998, MOL ENDOCRINOL, V12, P592, DOI 10.1210/me.12.4.592; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Panini SR, 2001, J LIPID RES, V42, P1678; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu LY, 2010, LIPIDS, V45, P821, DOI 10.1007/s11745-010-3451-y	45	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35470	35483		10.1074/jbc.M112.387894	http://dx.doi.org/10.1074/jbc.M112.387894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22875855	Green Published, hybrid			2022-12-25	WOS:000309968000056
J	Gundimeda, U; McNeill, TH; Elhiani, AA; Schiffman, JE; Hinton, DR; Gopalakrishna, R				Gundimeda, Usha; McNeill, Thomas H.; Elhiani, Albert A.; Schiffman, Jason E.; Hinton, David R.; Gopalakrishna, Rayudu			Green Tea Polyphenols Precondition against Cell Death Induced by Oxygen-Glucose Deprivation via Stimulation of Laminin Receptor, Generation of Reactive Oxygen Species, and Activation of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; RAT PHEOCHROMOCYTOMA CELLS; (-)-EPIGALLOCATECHIN GALLATE; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; CEREBRAL-ISCHEMIA; IN-VITRO; TYROSINE PHOSPHORYLATION; HYDROGEN-PEROXIDE; REGULATED KINASE	As the development of synthetic drugs for the prevention of stroke has proven challenging, utilization of natural products capable of preconditioning neuronal cells against ischemia-induced cell death would be a highly useful complementary approach. In this study using an oxygen-glucose deprivation and reoxygenation (OGD/R) model in PC12 cells, we show that 2-day pretreatment with green tea polyphenols (GTPP) and their active ingredient, epigallocatechin-3-gallate (EGCG), protects cells from subsequent OGD/R-induced cell death. A synergistic interaction was observed between GTPP constituents, with unfractionated GTPP more potently preconditioning cells than EGCG. GTPP-induced preconditioning required the 67-kDa laminin receptor (67LR), to which EGCG binds with high affinity. 67LR also mediated the generation of reactive oxygen species (ROS) via activation of NADPH oxidase. An exogenous ROS-generating system bypassed 67LR to induce preconditioning, suggesting that sublethal levels of ROS are indeed an important mediator in GTPP-induced preconditioning. This role for ROS was further supported by the fact that antioxidants blocked GTPP-induced preconditioning. Additionally, ROS induced an activation and translocation of protein kinase C (PKC), particularly PKC epsilon from the cytosol to the membrane/mitochondria, which was also blocked by antioxidants. The crucial role of PKC in GTPP-induced preconditioning was supported by use of its specific inhibitors. Preconditioning was increased by conditional overexpression of PKC epsilon and decreased by its knock-out with siRNA. Collectively, these results suggest that GTPP stimulates 67LR and thereby induces NADPH oxidase-dependent generation of ROS, which in turn induces activation of PKC, particularly prosurvival isoenzyme PKC epsilon, resulting in preconditioning against cell death induced by OGD/R.	[Gundimeda, Usha; McNeill, Thomas H.; Elhiani, Albert A.; Schiffman, Jason E.; Gopalakrishna, Rayudu] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [McNeill, Thomas H.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90089 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Gopalakrishna, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA.	rgopalak@usc.edu						Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470; Ardehali H, 2006, CIRC RES, V99, P798, DOI 10.1161/01.RES.0000247029.31997.a4; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Barth BM, 2009, MOL CELL NEUROSCI, V41, P274, DOI 10.1016/j.mcn.2009.03.007; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BLUMBERG PM, 1994, PROG CLIN BIOL RES, V387, P3; Bode AM, 2009, CANCER PREV RES, V2, P514, DOI 10.1158/1940-6207.CAPR-09-0083; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Bright R, 2008, NEUROSCI LETT, V441, P120, DOI 10.1016/j.neulet.2008.05.080; Choi YB, 2004, BRAIN RES, V1019, P47, DOI 10.1016/j.brainres.2004.05.079; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; GONZALEZ A, 1993, ANAL BIOCHEM, V215, P184, DOI 10.1006/abio.1993.1574; GOPALAKRISHNA R, 1992, FEBS LETT, V314, P149, DOI 10.1016/0014-5793(92)80962-G; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gundimeda U, 2010, J NEUROSCI RES, V88, P3644, DOI 10.1002/jnr.22519; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Hong J, 2002, CANCER RES, V62, P7241; Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Kanthasamy AG, 2003, ANN NY ACAD SCI, V1010, P683, DOI 10.1196/annals.1299.125; Keller JN, 1998, J NEUROSCI, V18, P687; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Lange-Asschenfeldt C, 2004, J CEREBR BLOOD F MET, V24, P636, DOI 10.1097/01.WCB.0000121235.42748.BF; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Lee SY, 2003, BRAIN RES BULL, V61, P399, DOI 10.1016/S0361-9230(03)00139-4; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Lu QY, 2005, CLIN CANCER RES, V11, P1675, DOI 10.1158/1078-0432.CCR-04-1608; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morre DJ, 2003, PHARMACOL TOXICOL, V92, P234, DOI 10.1034/j.1600-0773.2003.920506.x; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Murakami K, 1998, J NEUROSCI, V18, P205; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Natarajan V, 1996, AM J PHYSIOL-LUNG C, V271, pL400, DOI 10.1152/ajplung.1996.271.3.L400; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Park JW, 2009, J NEUROSCI RES, V87, P567, DOI 10.1002/jnr.21847; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Rahman RMA, 2005, NEUROSCI LETT, V382, P227, DOI 10.1016/j.neulet.2005.03.018; Raval AP, 2007, BRAIN RES, V1184, P345, DOI 10.1016/j.brainres.2007.09.073; Raval AP, 2005, J CEREBR BLOOD F MET, V25, P730, DOI 10.1038/sj.jcbfm.9600071; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Salmeen A, 2010, ONCOGENE, V29, P4473, DOI 10.1038/onc.2010.200; Sang SM, 2007, FREE RADICAL BIO MED, V43, P362, DOI 10.1016/j.freeradbiomed.2007.04.008; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Suganuma M, 1999, CANCER RES, V59, P44; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Tabakman R, 2004, J MOL NEUROSCI, V22, P237, DOI 10.1385/JMN:22:3:237; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang J, 2004, NEUROPHARMACOLOGY, V47, P136, DOI 10.1016/j.neuropharm.2004.03.009; Wang ZF, 2002, ACTA PHARMACOL SIN, V23, P1193; Wang Z, 2008, NEUROL RES, V30, P106, DOI 10.1179/016164107X229894; Xu W, 2007, ACTA PHARMACOL SIN, V28, P1573, DOI 10.1111/j.1745-7254.2007.00502.x; Wise-Faberowski L, 2001, ANESTH ANALG, V93, P1281, DOI 10.1097/00000539-200111000-00051; Xie J, 2000, MOL BRAIN RES, V82, P107, DOI 10.1016/S0169-328X(00)00187-X; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yang CS, 2004, J NUTR, V134, p3181S, DOI 10.1093/jn/134.11.3181S; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608; Zabouri N, 2002, NEUROSCI LETT, V329, P257, DOI 10.1016/S0304-3940(02)00686-9; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	101	47	48	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34694	34708		10.1074/jbc.M112.356899	http://dx.doi.org/10.1074/jbc.M112.356899			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879598	hybrid, Green Published			2022-12-25	WOS:000309654200070
J	Liu, GQ; Myers, S; Chen, XM; Bissler, JJ; Sinden, RR; Leffak, M				Liu, Guoqi; Myers, Shere; Chen, Xiaomi; Bissler, John J.; Sinden, Richard R.; Leffak, Michael			Replication Fork Stalling and Checkpoint Activation by a PKD1 Locus Mirror Repeat Polypurine-Polypyrimidine (Pu-Py) Tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE CHECKPOINT; C-MYC REPLICATOR; GROSS CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; INTRAMOLECULAR TRIPLEX DNA; SYNTHESIS IN-VITRO; PROTEIN DUE-B; HUMAN-CELLS; MAMMALIAN-CELLS	DNA sequences prone to forming noncanonical structures ( hairpins, triplexes, G-quadruplexes) cause DNA replication fork stalling, activate DNA damage responses, and represent hotspots of genomic instability associated with human disease. The 88-bp asymmetric polypurine-polypyrimidine (Pu-Py) mirror repeat tract from the human polycystic kidney disease (PKD1) intron 21 forms non-B DNA secondary structures in vitro. We show that the PKD1 mirror repeat also causes orientation-dependent fork stalling during replication in vitro and in vivo. When integrated alongside the c-myc replicator at an ectopic chromosomal site in the HeLa genome, the Pu-Py mirror repeat tract elicits a polar replication fork barrier. Increased replication protein A (RPA), Rad9, and ataxia telangiectasia- and Rad3-related (ATR) checkpoint protein binding near the mirror repeat sequence suggests that the DNA damage response is activated upon replication fork stalling. Moreover, the proximal c-myc origin of replication was not required to cause orientation-dependent checkpoint activation. Cells expressing the replication fork barrier display constitutive Chk1 phosphorylation and continued growth, i.e. checkpoint adaptation. Excision of the Pu-Py mirror repeat tract abrogates the DNA damage response. Adaptation to Chk1 phosphorylation in cells expressing the replication fork barrier may allow the accumulation of mutations that would otherwise be remediated by the DNA damage response.	[Liu, Guoqi; Myers, Shere; Chen, Xiaomi; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Bissler, John J.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Sinden, Richard R.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	University System of Ohio; Wright State University Dayton; Cincinnati Children's Hospital Medical Center; Florida Institute of Technology	Liu, GQ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Guoqi.Liu@yahoo.com; Michael.Leffak@wright.edu	Sinden, Richard/AAE-3086-2019	Bissler, John/0000-0001-9685-9183	National Institutes of Health [DK016458, GM53819]; WSU Boonshoft School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819, R01GM099874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WSU Boonshoft School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK016458 (to J. J. B.) and GM53819 (to M. L.). This work was also supported by a grant from the WSU Boonshoft School of Medicine (to G. L.).	Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; BERBERICH S, 1995, J MOL BIOL, V245, P92, DOI 10.1006/jmbi.1994.0010; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Blaszak RT, 1999, NUCLEIC ACIDS RES, V27, P2610, DOI 10.1093/nar/27.13.2610; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Bucek P, 2009, CHEM-EUR J, V15, P12663, DOI 10.1002/chem.200901631; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; CARTY MP, 1993, MOL CELL BIOL, V13, P533, DOI 10.1128/MCB.13.1.533; Carty MP, 1996, J BIOL CHEM, V271, P9637, DOI 10.1074/jbc.271.16.9637; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Chowdhury A, 2010, MOL CELL BIOL, V30, P1495, DOI 10.1128/MCB.00710-09; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Entezam A, 2008, NUCLEIC ACIDS RES, V36, P1050, DOI 10.1093/nar/gkm1136; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Ghosh M, 2004, MOL CELL BIOL, V24, P10193, DOI 10.1128/MCB.24.23.10193-10207.2004; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Inoue Mamiko, 2005, Nucleic Acids Symp Ser (Oxf), P243, DOI 10.1093/nass/49.1.243; Jackson JR, 2000, CANCER RES, V60, P566; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Kendrick S, 2009, J AM CHEM SOC, V131, P17667, DOI 10.1021/ja9076292; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; Krasilnikova Maria M., 2004, V277, P19; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Lahiri M, 2004, MOL CELL, V15, P287, DOI 10.1016/j.molcel.2004.06.034; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2012, MOL CELL BIOL, V32, P1618, DOI 10.1128/MCB.06727-11; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; Malott M, 1999, MOL CELL BIOL, V19, P5685; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; O'Callaghan FJK, 2000, J MED GENET, V37, P156, DOI 10.1136/jmg.37.2.156; Patel HP, 2004, NUCLEIC ACIDS RES, V32, P1460, DOI 10.1093/nar/gkh312; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Prindle MJ, 2010, CURR DRUG TARGETS, V11, P1296; Rao BS, 1996, MOL CELL BIOCHEM, V156, P163; Razidlo DF, 2008, DNA REPAIR, V7, P633, DOI 10.1016/j.dnarep.2008.01.009; Rodriguez-Bravo V, 2006, CANCER RES, V66, P8672, DOI 10.1158/0008-5472.CAN-05-4443; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tiner WJ, 2001, J MOL BIOL, V314, P353, DOI 10.1006/jmbi.2001.5174; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; USSERY DW, 1993, BIOCHEMISTRY-US, V32, P6206, DOI 10.1021/bi00075a013; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Voineagu I, 2009, MOL CARCINOGEN, V48, P309, DOI 10.1002/mc.20512; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Xu YJ, 2010, P NATL ACAD SCI USA, V107, P13561, DOI 10.1073/pnas.1008909107; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	93	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33412	33423		10.1074/jbc.M112.402503	http://dx.doi.org/10.1074/jbc.M112.402503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872635	Green Published, hybrid			2022-12-25	WOS:000309602100028
J	Samanta, S; Anderson, K; Moran, S; Hawke, D; Gorenstein, D; Fornage, M				Samanta, Susmita; Anderson, Kurtis; Moran, Sean; Hawke, David; Gorenstein, David; Fornage, Myriam			Characterization of a Human 12/15-Lipoxygenase Promoter Variant Associated with Atherosclerosis Identifies Vimentin as a Promoter Binding Protein	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; CORONARY-ARTERY-DISEASE; IN-VITRO; CELLS; EXPRESSION; LDL; MACROPHAGES; PLAQUES; DNA; TRANSCRIPTION	Background: Sequence variation in the human 12/15 lipoxygenase (ALOX15) has been associated with atherosclerotic disease. We functionally characterized an ALOX15 promoter polymorphism, rs2255888, previously associated with carotid plaque burden. Methodology/Principal Findings: We demonstrate specific in vitro and in vivo binding of the cytoskeletal protein, vimentin, to the ALOX15 promoter. We show that the two promoter haplotypes carrying alternate alleles at rs2255888 exhibit significant differences in promoter activity by luciferase reporter assay in two cell lines. Differences in in-vitro vimentin-binding to and formation of DNA secondary structures in the polymorphic promoter sequence are also detected by electrophoretic mobility shift assay and biophysical analysis, respectively. We show regulation of ALOX15 protein by vimentin. Conclusions/Significance: This study suggests that vimentin binds the ALOX15 promoter and regulates its promoter activity and protein expression. Sequence variation that results in changes in DNA conformation and vimentin binding to the promoter may be relevant to ALOX15 gene regulation.	[Samanta, Susmita; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Res Ctr Human Genet, Brown Fdn Inst Mol Med, Houston, TX USA; [Anderson, Kurtis; Gorenstein, David] Univ Texas Hlth Sci Ctr Houston, Ctr Prote & Syst Biol, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX USA; [Anderson, Kurtis] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Moran, Sean] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Medical Branch Galveston; Rice University; University of Texas System; UTMD Anderson Cancer Center	Samanta, S (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	Susmita.Samanta@bcm.edu		Hawke, David/0000-0002-6102-7843	National Heart Lung and Blood Institute [HL084099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084099] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant HL084099 from the National Heart Lung and Blood Institute to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Colio LM, 2006, CARDIOVASC RES, V72, P18, DOI 10.1016/j.cardiores.2006.05.017; DARTSCH PC, 1989, ATHEROSCLEROSIS, V80, P149, DOI 10.1016/0021-9150(89)90023-3; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Hartig R, 1998, J CELL SCI, V111, P3573; Heidenthal AK, 2000, BIOCHEM BIOPH RES CO, V267, P49, DOI 10.1006/bbrc.1999.1940; Hersberger M, 2009, ATHEROSCLEROSIS, V205, P192, DOI 10.1016/j.atherosclerosis.2008.11.017; Holwell TA, 1999, J LIPID RES, V40, P1440; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kuhn H, 2005, MOL NUTR FOOD RES, V49, P1014, DOI 10.1002/mnfr.200500131; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; McCaskie PA, 2008, HUM GENET, V123, P445, DOI 10.1007/s00439-008-0496-6; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Mergui X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-473; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Nagatoishi S, 2007, ANAL CHIM ACTA, V581, P125, DOI 10.1016/j.aca.2006.08.010; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; OSBORN M, 1987, VIRCHOWS ARCH A, V411, P449, DOI 10.1007/BF00735226; Poduri A, 2012, MOL CELL BIOCHEM, V360, P181, DOI 10.1007/s11010-011-1055-3; Qin Z, 2011, J MOL MODEL, V17, P37, DOI 10.1007/s00894-010-0696-6; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Reimann I, 2002, J MOL BIOL, V315, P965, DOI 10.1006/jmbi.2001.5315; RIUS C, 1990, EXP CELL RES, V188, P129, DOI 10.1016/0014-4827(90)90287-K; RIUS C, 1992, J CELL SCI, V101, P395; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Schurmann K, 2011, J BIOL CHEM, V286, P23920, DOI 10.1074/jbc.M110.211821; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; Takahashi Y, 2005, ANTIOXID REDOX SIGN, V7, P425, DOI 10.1089/ars.2005.7.425; Tolstonog GV, 2005, DNA CELL BIOL, V24, P85, DOI 10.1089/dna.2005.24.85; TRAUB P, 1994, INT REV CYTOL, V154, P1, DOI 10.1016/S0074-7696(08)62198-1; Tuntiwechapikul W, 2006, BIOORG MED CHEM LETT, V16, P4120, DOI 10.1016/j.bmcl.2006.04.078; Vivanco F, 2008, BIOMARK INSIGHTS, V3, P101; Wang Q, 2000, BIOCHEMISTRY-US, V39, P6645, DOI 10.1021/bi000199s; Weibel GL, 2009, ARTERIOSCL THROM VAS, V29, P837, DOI 10.1161/ATVBAHA.109.186163; Wittwer J, 2006, HUM MUTAT, V27, P78, DOI 10.1002/humu.20273; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zhang K, 2010, HEART VESSELS, V25, P368, DOI 10.1007/s00380-009-1223-5; Zuo X, 2009, ONCOGENE, V28, P1496, DOI 10.1038/onc.2008.494	41	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42417	10.1371/journal.pone.0042417	http://dx.doi.org/10.1371/journal.pone.0042417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879973	Green Submitted, gold, Green Published			2022-12-25	WOS:000307437900038
J	Schallenberg, S; Petzold, C; Tsai, PY; Sparwasser, T; Kretschmer, K				Schallenberg, Sonja; Petzold, Cathleen; Tsai, Pei-Yun; Sparwasser, Tim; Kretschmer, Karsten			Vagaries of Fluorochrome Reporter Gene Expression in Foxp3(+) Regulatory T Cells	PLOS ONE			English	Article							FOREIGN ANTIGEN; DENDRITIC CELLS; TARGET GENES; IN-VIVO; DIFFERENTIATION; TOLERANCE; AUTOIMMUNITY; THYMOCYTES; INDUCTION; ABSENCE	CD4(+)CD25(+) regulatory T (Treg) cell lineage commitment and expression of the transcription factor Foxp3 can be induced at the CD4(+)CD8(+) double-positive (DP) and CD4(+)CD8(?) single-positive stages of thymic development, as well as in postthymic CD4(+) T cells in peripheral lymphoid tissues. The availability of transgenic mice with Foxp3-dependent fluorochrome reporter gene expression has greatly facilitated studies on the intra-and extrathymic generation of murine Foxp3(+) Treg cells. Here, we performed a comparative analysis of thymic Treg cell development and peripheral compartments of mature Treg cells in various transgenic strains with gene targeted and bacterial artificial chromosome (BAC)-driven Foxp3-fluorochrome expression. These studies revealed a relative deficiency of Foxp3(+) DP thymocytes selectively in mice with targeted insertion of the fluorochrome reporter gene coding sequence into the endogenous Foxp3 gene. While Foxp3 BAC-driven fluorochrome expression in ex vivo CD4(+) T cells was found to faithfully reflect Foxp3 protein expression, we provide evidence that Foxp3 BAC transgenesis can result in sizable populations of Foxp3(+) Treg cells that lack fluorochrome reporter expression. This could be attributed to both timely delayed up-regulation of BAC expression in developing Treg cells and the accumulation of peripheral Foxp3(+) Treg cells with continuous transcriptional inactivity of the Foxp3 BAC transgene.	[Schallenberg, Sonja; Petzold, Cathleen; Tsai, Pei-Yun; Kretschmer, Karsten] Tech Univ Dresden, CRTD DFG Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Sparwasser, Tim] TWINCORE Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center for Infection Research	Schallenberg, S (corresponding author), Tech Univ Dresden, CRTD DFG Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.	Karsten.Kretschmer@crt-dresden.de	Tsai, Pei-Yun/L-9386-2013; Sparwasser, Tim/AAF-7085-2019; Kretschmer, Karsten/E-8174-2010; Sparwasser, Tim D/AAA-4306-2022; Schallenberg, Sonja/F-6220-2012	Sparwasser, Tim/0000-0001-5645-902X; Kretschmer, Karsten/0000-0001-6770-4078; 	German Federal Ministry of education and Research (BMBF) [FKZ 01GI1102]; Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]	German Federal Ministry of education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence(German Research Foundation (DFG))	This work was supported by a grant from the German Federal Ministry of education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.); by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the BMBF (FKZ 01GI1102); and by the FZT 111 (DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kretschmer K, 2006, NAT PROTOC, V1, P653, DOI 10.1038/nprot.2006.105; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Petzold Cathleen, 2010, Rev Diabet Stud, V7, P47, DOI 10.1900/RDS.2010.7.47; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41971	10.1371/journal.pone.0041971	http://dx.doi.org/10.1371/journal.pone.0041971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879902	Green Submitted, gold, Green Published			2022-12-25	WOS:000307810000012
J	Jacquemyn, H; Deja, A; De Hert, K; Bailarote, BC; Lievens, B				Jacquemyn, Hans; Deja, Agnieszka; De Hert, Koen; Bailarote, Bruno Cachapa; Lievens, Bart			Variation in Mycorrhizal Associations with Tulasnelloid Fungi among Populations of Five Dactylorhiza Species	PLOS ONE			English	Article							MYCOHETEROTROPHIC ORCHIDS; DIVERSITY; SPECIFICITY; RARITY; IDENTIFICATION; CONSERVATION; GERMINATION; SEQUENCES; SYMBIOSIS; INSIGHTS	Background: Orchid species rely on mycorrhizal symbioses with fungi to complete their life cycle. Although there is mounting evidence that orchids can associate with several fungi from different clades or families, less is known about the actual geographic distribution of these fungi and how they are distributed across different orchid species within a genus. Methodology/Principal Findings: We investigated among-population variation in mycorrhizal associations in five species of the genus Dactylorhiza (D. fuchsii, D. incarnata, D. maculata, D. majalis and D. praetermissa) using culture-independent detection and identification techniques enabling simultaneous detection of multiple fungi in a single individual. Mycorrhizal specificity, determined as the number of fungal operational taxonomic units (OTUs), and phylogenetic diversity of fungi were compared between species, whereas discriminant analysis was used to compare mycorrhizal spectra across populations and species. Based on a 95% cut-off value in internal transcribed spacer (ITS) sequence similarity, a total of ten OTUs was identified belonging to three different clades within the Tulasnellaceae. Most OTUs were found in two or more Dactylorhiza species, and some of them were common and widespread, occurring in more than 50% of all sampled populations. Each orchid species associated with at least five different OTUs, whereas most individuals also associated with two or more fungal OTUs at the same time. Phylogenetic diversity, corrected for species richness, was not significantly different between species, confirming the generality of the observed orchid mycorrhizal associations. Conclusions/Significance: We found that the investigated species of the genus Dactylorhiza associated with a wide range of fungal OTUs from the Tulasnellaceae, some of which were widespread and common. These findings challenge the idea that orchid rarity is related to mycorrhizal specificity and fungal distribution.	[Jacquemyn, Hans; Deja, Agnieszka; De Hert, Koen; Bailarote, Bruno Cachapa] Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium; [Lievens, Bart] Scientia Terrae Res Inst, St Katelijne Waver, Belgium; [Lievens, Bart] KU Leuven Assoc, Dept Microbial & Mol Syst, CIMB,Lessius Univ Coll, Lab Proc Microbial Ecol & Bioinspirat Management, St Katelijne Waver, Belgium	KU Leuven; KU Leuven	Jacquemyn, H (corresponding author), Katholieke Univ Leuven, Dept Biol, Div Plant Ecol & Systemat, Heverlee, Belgium.	hans.jacquemyn@bio.kuleuven.be	Jacquemyn, Hans/AAC-4875-2019; Lievens, Bart/B-3339-2019	Jacquemyn, Hans/0000-0001-9600-5794; 	European Research Council (ERC) [260601 - MYCASOR]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was funded by the European Research Council (ERC starting grant 260601 - MYCASOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie JC, 2006, CAN J BOT, V84, P1462, DOI 10.1139/B06-101; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bidartondo MI, 2003, P ROY SOC B-BIOL SCI, V270, P835, DOI 10.1098/rspb.2002.2299; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gebauer G, 2003, NEW PHYTOL, V160, P209, DOI 10.1046/j.1469-8137.2003.00872.x; Girlanda M, 2006, MOL ECOL, V15, P491, DOI 10.1111/j.1365-294X.2005.02770.x; Girlanda M, 2011, AM J BOT, V98, P1148, DOI 10.3732/ajb.1000486; Govaerts R., 2011, WORLD CHECKLIST ORCH; Gura-Tsujita Y, 2008, AM J BOT, V95, P93, DOI 10.3732/ajb.95.1.93; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jacquemyn H, 2005, BIOL CONSERV, V121, P257, DOI 10.1016/j.biocon.2004.05.002; Jacquemyn H, 2011, NEW PHYTOL, V192, P518, DOI 10.1111/j.1469-8137.2011.03796.x; Jacquemyn H, 2010, MOL ECOL, V19, P4086, DOI 10.1111/j.1365-294X.2010.04785.x; Julou T, 2005, NEW PHYTOL, V166, P639, DOI 10.1111/j.1469-8137.2005.01364.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kristiansen KA, 2001, MOL ECOL, V10, P2089, DOI 10.1046/j.0962-1083.2001.01324.x; Kull T, 2006, BIOL CONSERV, V129, P31, DOI 10.1016/j.biocon.2005.09.046; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leake JR, 2010, NEW PHYTOL, V185, P601, DOI 10.1111/j.1469-8137.2009.03153.x; Liebel HT, 2010, AM J BOT, V97, P903, DOI 10.3732/ajb.0900354; Lievens B, 2003, FEMS MICROBIOL LETT, V223, P113, DOI 10.1016/S0378-1097(03)00352-5; Lievens B, 2010, J MICROBIOL METH, V80, P76, DOI 10.1016/j.mimet.2009.11.004; Martos F, 2009, NEW PHYTOL, V184, P668, DOI 10.1111/j.1469-8137.2009.02987.x; McCormick MK, 2004, NEW PHYTOL, V163, P425, DOI 10.1111/j.1469-8137.2004.01114.x; McCormick MK, 2006, ECOLOGY, V87, P903, DOI 10.1890/0012-9658(2006)87[903:OFAMMT]2.0.CO;2; McKendrick SL, 2002, NEW PHYTOL, V154, P233, DOI 10.1046/j.1469-8137.2002.00372.x; Otero JT, 2006, TRENDS ECOL EVOL, V21, P64, DOI 10.1016/j.tree.2005.11.016; Phillips RD, 2011, J ECOL, V99, P858, DOI 10.1111/j.1365-2745.2011.01797.x; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Rasmussen HN, 1995, TERRESTRIAL ORCHIDS; Roche SA, 2010, AM J BOT, V97, P1313, DOI 10.3732/ajb.1000049; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shefferson RP, 2008, AM J BOT, V95, P156, DOI 10.3732/ajb.95.2.156; Shefferson RP, 2007, EVOLUTION, V61, P1380, DOI 10.1111/j.1558-5646.2007.00112.x; Shefferson RP, 2005, MOL ECOL, V14, P613, DOI 10.1111/j.1365-294X.2005.02424.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stark C, 2009, MYCOL RES, V113, P952, DOI 10.1016/j.mycres.2009.05.002; Suarez JP, 2006, MYCOL RES, V110, P1257, DOI 10.1016/j.mycres.2006.08.004; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Taylor DL, 1997, P NATL ACAD SCI USA, V94, P4510, DOI 10.1073/pnas.94.9.4510; Waterman RJ, 2008, J EXP BOT, V59, P1085, DOI 10.1093/jxb/erm366; Waterman RJ, 2011, AM NAT, V177, pE54, DOI 10.1086/657955; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zettler LW, 2012, AM MIDL NAT, V166, P29	55	49	54	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42212	10.1371/journal.pone.0042212	http://dx.doi.org/10.1371/journal.pone.0042212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870305	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100055
J	Pardoux, R; Sauge-Merle, S; Lemaire, D; Delangle, P; Guilloreau, L; Adriano, JM; Berthomieu, C				Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Delangle, Pascale; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine			Modulating Uranium Binding Affinity in Engineered Calmodulin EF-Hand Peptides: Effect of Phosphorylation	PLOS ONE			English	Article							PROTEIN-KINASE CK2; AQUEOUS-SOLUTION; AMINO-ACIDS; URANYL-ION; GAS-PHASE; SPECTROSCOPY; COORDINATION; COMPLEXES; CALCIUM; SPECTRA	To improve our understanding of uranium toxicity, the determinants of uranyl affinity in proteins must be better characterized. In this work, we analyzed the contribution of a phosphoryl group on uranium binding affinity in a protein binding site, using the site 1 EF-hand motif of calmodulin. The recombinant domain 1 of calmodulin from A. thaliana was engineered to impair metal binding at site 2 and was used as a structured template. Threonine at position 9 of the loop was phosphorylated in vitro, using the recombinant catalytic subunit of protein kinase CK2. Hence, the T9TKE12 sequence was substituted by the CK2 recognition sequence TAAE. A tyrosine was introduced at position 7, so that uranyl and calcium binding affinities could be determined by following tyrosine fluorescence. Phosphorylation was characterized by ESI-MS spectrometry, and the phosphorylated peptide was purified to homogeneity using ion-exchange chromatography. The binding constants for uranyl were determined by competition experiments with iminodiacetate. At pH 6, phosphorylation increased the affinity for uranyl by a factor of similar to 5, from K-d = 25 +/- 6 nM to K-d = 5 +/- 1 nM. The phosphorylated peptide exhibited a much larger affinity at pH 7, with a dissociation constant in the subnanomolar range (K-d = 0.25 +/- 0.06 nM). FTIR analyses showed that the phosphothreonine side chain is partly protonated at pH 6, while it is fully deprotonated at pH 7. Moreover, formation of the uranyl-peptide complex at pH 7 resulted in significant frequency shifts of the v(as)(P-O) and v(s)(P-O) IR modes of phosphothreonine, supporting its direct interaction with uranyl. Accordingly, a bathochromic shift in v(as)(UO2)(2+) vibration (from 923 cm(-1) to 908 cm(-1)) was observed upon uranyl coordination to the phosphorylated peptide. Together, our data demonstrate that the phosphoryl group plays a determining role in uranyl binding affinity to proteins at physiological pH.	[Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Berthomieu, Catherine] CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine] CNRS, UMR Biol Vegetale & Microbiol Environm, St Paul Les Durance, France; [Pardoux, Romain; Sauge-Merle, Sandrine; Lemaire, David; Guilloreau, Luc; Adriano, Jean-Marc; Berthomieu, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Delangle, Pascale] CEA, INAC, Serv Chim Inorgan & Biol, UMR E CEA UJF 3, Grenoble, France; [Adriano, Jean-Marc] CEA, DSV IBEB, Lab Bioenerget & Biotechnol Bacteries & Microalg, Grenoble, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Pardoux, R (corresponding author), CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France.	catherine.berthomieu@cea.fr	Berthomieu, Catherine/AAX-9559-2021	Berthomieu, Catherine/0000-0001-8784-5396; Sauge-Merle, Sandrine/0000-0003-2721-3885; Lemaire, David/0000-0001-6874-3685	"Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo); CEA international program IRTELIS	"Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo); CEA international program IRTELIS	This work was funded in part by the "Toxicologie'' program of the Commissariat a l'energie atomique et aux energies alternatives (CEA) (CalUMo). RP acknowledges a PhD grant from the CEA international program IRTELIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananyev GM, 1999, BIOCHEMISTRY-US, V38, P7200, DOI 10.1021/bi990023u; Ansoborlo E, 2006, BIOCHIMIE, V88, P1605, DOI 10.1016/j.biochi.2006.06.011; Averseng O, 2010, ANAL CHEM, V82, P9797, DOI 10.1021/ac102578y; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Barkleit A, 2011, DALTON T, V40, P9868, DOI 10.1039/c1dt10546a; Binstead R. A., 2003, SPECFIT GLOBAL ANAL; Blake RC, 2004, BIOCONJUGATE CHEM, V15, P1125, DOI 10.1021/bc049889p; Brugge Doug, 2005, Reviews on Environmental Health, V20, P177; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Correia CF, 2008, J AM CHEM SOC, V130, P3359, DOI 10.1021/ja073868z; Dedieu A, 2009, J CHROMATOGR A, V1216, P5365, DOI 10.1016/j.chroma.2009.05.023; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; Duff MR, 2006, ANGEW CHEM INT EDIT, V45, P137, DOI 10.1002/anie.200502344; Hartsock WJ, 2007, CHEM RES TOXICOL, V20, P784, DOI 10.1021/tx600347k; Hillson NJ, 2007, APPL ENVIRON MICROB, V73, P7615, DOI 10.1128/AEM.01566-07; HOFFMANN R, 1994, INT J PEPT PROT RES, V44, P193; Huang H, 2005, INORG CHEM, V44, P813, DOI 10.1021/ic049528l; Jiang J, 2003, INORG CHEM, V42, P1233, DOI 10.1021/ic020460o; KAKIHANA M, 1987, J PHYS CHEM-US, V91, P6128, DOI 10.1021/j100308a015; Koban A, 2007, J INORG BIOCHEM, V101, P750, DOI 10.1016/j.jinorgbio.2007.01.001; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Le Clainche L, 2006, ENVIRON CHEM LETT, V4, P45, DOI 10.1007/s10311-005-0033-y; Le Clainche L, 2003, J BIOL INORG CHEM, V8, P334, DOI 10.1007/s00775-002-0419-2; Li B, 2010, J INORG BIOCHEM, V104, P718, DOI 10.1016/j.jinorgbio.2010.03.004; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; Marin O, 1997, BIOCHEMISTRY-US, V36, P7192, DOI 10.1021/bi962885q; MCGLYNN SP, 1961, J CHEM PHYS, V35, P105, DOI 10.1063/1.1731876; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Melton SJ, 2009, ENVIRON SCI TECHNOL, V43, P6703, DOI 10.1021/es9007239; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Michon J, 2010, J FLUORESC, V20, P581, DOI 10.1007/s10895-009-0587-3; Montavon G, 2009, J INORG BIOCHEM, V103, P1609, DOI 10.1016/j.jinorgbio.2009.08.010; Muller K, 2008, INORG CHEM, V47, P10127, DOI 10.1021/ic8005103; Muller K, 2009, J PHYS CHEM A, V113, P6626, DOI 10.1021/jp9008948; Pible O, 2006, BIOCHIMIE, V88, P1631, DOI 10.1016/j.biochi.2006.05.015; Pible O, 2010, PROTEIN SCI, V19, P2219, DOI 10.1002/pro.501; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Quadroni M, 1998, BIOCHEMISTRY-US, V37, P6523, DOI 10.1021/bi972930+; Quiles F, 2000, VIB SPECTROSC, V23, P231, DOI 10.1016/S0924-2031(00)00067-9; Reisser-Rubrecht L, 2008, CHEM RES TOXICOL, V21, P349, DOI 10.1021/tx700215e; Sawicki M, 2005, CHEM-EUR J, V11, P3689, DOI 10.1002/chem.200401056; Scapolan S, 1998, RADIAT PROT DOSIM, V79, P505, DOI 10.1093/oxfordjournals.rpd.a032462; Scuderi D, 2009, CHEMPHYSCHEM, V10, P1630, DOI 10.1002/cphc.200800856; Taylor David M., 1997, Reviews on Environmental Health, V12, P147; Van Horn JD, 2006, COORDIN CHEM REV, V250, P765, DOI 10.1016/j.ccr.2005.09.010; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vidaud C, 2007, BIOCHEMISTRY-US, V46, P2215, DOI 10.1021/bi061945h; Wegner SV, 2009, ANGEW CHEM INT EDIT, V48, P2339, DOI 10.1002/anie.200805262; Xie Y, 2005, ANAL BIOCHEM, V343, P223, DOI 10.1016/j.ab.2005.05.038; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x	52	50	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41922	10.1371/journal.pone.0041922	http://dx.doi.org/10.1371/journal.pone.0041922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870263	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100037
J	Rangiani, A; Cao, ZG; Sun, Y; Lu, YB; Gao, T; Yuan, BZ; Rodgers, A; Qin, CL; Kuro-o, M; Feng, JQ				Rangiani, Afsaneh; Cao, Zhengguo; Sun, Yao; Lu, Yongbo; Gao, Tian; Yuan, Baozhi; Rodgers, Anika; Qin, Chunlin; Kuro-o, Makoto; Feng, Jian Q.			Protective Roles of DMP1 in High Phosphate Homeostasis	PLOS ONE			English	Article							MATRIX PROTEIN-1 DMP1; SOFT-TISSUE CALCIFICATION; CHRONIC KIDNEY-DISEASE; HYPOPHOSPHATEMIC RICKETS; COMPUTED-TOMOGRAPHY; DMP1-DEFICIENT MICE; PATHOGENIC ROLE; DEFICIENT MICE; MOUSE MODEL; IN-VIVO	Purpose: Dmp1 (dentin matrix protein1) null mice (Dmp1(-/-)) display hypophosphatemic rickets with a sharp increase in fibroblast growth factor 23 (FGF23). Disruption of Klotho (the obligatory co-receptor of FGF23) results in hyperphosphatemia with ectopic calcifications formed in blood vessels and kidneys. To determine the role of DMP1 in both a hyperphosphatemic environment and within the ectopic calcifications, we created Dmp1/Klotho compound deficient (Dmp1(-/-)kl/kl) mice. Procedures: A combination of TUNEL, immunohistochemistry, TRAP, von Kossa, micro CT, bone histomorphometry, serum biochemistry and Scanning Electron Microscopy techniques were used to analyze the changes in blood vessels, kidney and bone for wild type control, Dmp1(-/-), Klotho deficient (kl/kl) and Dmp1(-/-)kl/kl animals. Findings: Interestingly, Dmp1(-/-)kl/kl mice show a dramatic improvement of rickets and an identical serum biochemical phenotype to kl/kl mice (extremely high FGF23, hyperphosphatemia and reduced parathyroid hormone (PTH) levels). Unexpectedly, Dmp1(-/-)kl/kl mice presented elevated levels of apoptosis in osteocytes, endothelial and vascular smooth muscle cells in small and large blood vessels, and within the kidney as well as dramatic increase in ectopic calcification in all these tissues, as compared to kl/kl. Conclusion: These findings suggest that DMP1 has an anti-apoptotic role in hyperphosphatemia. Discovering this novel protective role of DMP1 may have clinical relevance in protecting the cells from apoptosis in high-phosphate environments as observed in chronic kidney disease (CKD).	[Rangiani, Afsaneh; Cao, Zhengguo; Sun, Yao; Lu, Yongbo; Gao, Tian; Rodgers, Anika; Qin, Chunlin; Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX USA; [Yuan, Baozhi] Univ Wisconsin, Madison, WI USA; [Yuan, Baozhi] GRECC, Madison, WI USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cao, Zhengguo] Wuhan Univ, Dept Periodontol, Sch & Hosp Stomatol,Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Cao, Zhengguo] Wuhan Univ, Dept Periodontol, Sch & Hosp Stomatol,Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wuhan University; Wuhan University	Rangiani, A (corresponding author), Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX USA.	arangiani@bcd.tamhsc.edu		Lu, Yongbo/0000-0003-3692-1736; Cao, Zhengguo/0000-0002-4261-9034	NIH [DE018486, DE005092]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018486, R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was partly supported by NIH Grant DE018486 (to JQF) and DE005092 (to CQ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Foster Brian L., 2008, Birth Defects Research, V84, P281, DOI 10.1002/bdrc.20136; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Kestenbaum B, 2007, SEMIN DIALYSIS, V20, P286, DOI 10.1111/j.1525-139X.2007.00303.x; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lv K, 2010, INT J BIOL SCI, V6, P537; Maciejewska I, 2009, J HISTOCHEM CYTOCHEM, V57, P155, DOI 10.1369/jhc.2008.952630; Maekawa Y, 2011, GERIATR GERONTOL INT; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Memon F, 2008, KIDNEY INT, V74, P566, DOI 10.1038/ki.2008.218; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Schiavi SC, 2004, KIDNEY INT, V65, P1, DOI 10.1111/j.1523-1755.2004.00355.x; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Terasawa M, 2004, J BONE MINER METAB, V22, P430, DOI 10.1007/s00774-004-0504-4; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	51	18	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42329	10.1371/journal.pone.0042329	http://dx.doi.org/10.1371/journal.pone.0042329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879941	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100068
J	Maxwell, EE; Fernandez, MS; Schoch, RR				Maxwell, Erin E.; Fernandez, Marta S.; Schoch, Rainer R.			First Diagnostic Marine Reptile Remains from the Aalenian (Middle Jurassic): A New Ichthyosaur from Southwestern Germany	PLOS ONE			English	Article							GENUS; STENOPTERYGIUS; TENUIROSTRIS; BAJOCIAN; BASIN	Background: The Middle Jurassic was a critical time in the evolutionary history of ichthyosaurs. During this time interval, the diverse, well-studied faunas of the Lower Jurassic were entirely replaced by ophthalmosaurids, a new group that arose sometime prior to the Aalenian-Bajocian boundary and by the latest middle Jurassic comprised the only surviving group of ichthyosaurs. Thus, the Middle Jurassic Aalenian-Bathonian interval (176-165 million years ago) comprises the time frame during which ophthalmosaurids not only originated but also achieved taxonomic dominance. However, diagnostic ichthyosaur remains have been described previously from only a single locality from this interval, from the Bajocian of Argentina. Methodology/Principal Findings: In this paper, we describe a new species of ichthyosaur based on a partial articulated specimen from the Middle Jurassic of southwestern Germany. This specimen was recovered from the Opalinuston Formation (early Aalenian) and is referable to Stenopterygius aaleniensis sp. nov. reflecting features of the skull and forefin. The genus Stenopterygius is diverse and abundant in the Lower Jurassic of Europe, but its presence has not previously been confirmed in younger (Middle Jurassic) rocks from the northern hemisphere. Conclusions/Significance: This specimen represents the only diagnostic ichthyosaur remains reported from the Aalenian. It bears numerous similarities in size and in morphology to the Lower Jurassic species of the genus Stenopterygius and provides additional evidence that the major ecological changes hypothesized to have occurred at the end of the Toarcian took place sometime after this point and most likely did not occur suddenly. There is currently no evidence for the presence of ophthalmosaurids in the northern hemisphere during the Aalenian-Bathonian interval.	[Maxwell, Erin E.; Schoch, Rainer R.] Staatliches Museum Nat Kunde, Stuttgart, Germany; [Maxwell, Erin E.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Fernandez, Marta S.] Museo La Plata, Dept Paleontol Vertebrados, La Plata, Buenos Aires, Argentina	Leibniz Institut fur Evolutions und Biodiversitatsforschung; National University of La Plata; Museo La Plata	Maxwell, EE (corresponding author), Staatliches Museum Nat Kunde, Stuttgart, Germany.	emaxwell@ualberta.ca		Maxwell, Erin/0000-0002-6032-6251; Fernandez, Marta/0000-0001-6935-7575	Natural Sciences and Engineering Research Council of Canada; Alexander von Humboldt postdoctoral fellowships; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina;  [PIP 0426]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander von Humboldt postdoctoral fellowships; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	This project was funded through Natural Sciences and Engineering Research Council of Canada and Alexander von Humboldt postdoctoral fellowships to EM, and PIP 0426, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CW., 1910, DESCRIPTIVE CATALOGU; Arkhangel'skii M.S., 2002, IZV VYSSH UCHEBN ZAV, P14; Arnaud M., 1976, Bulletin du Museum d'Histoire Naturelle de Marseille, V36, P17; Bardet Nathalie, 1994, Historical Biology, V7, P313; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Buchholtz EA, 2001, J VERTEBR PALEONTOL, V21, P61, DOI 10.1671/0272-4634(2001)021[0061:SSIJI]2.0.CO;2; Cabrera xC., 1939, Notas del Museo de La Plata Paleontologia, V4, P485; Caine H, 2011, PALAEONTOLOGY, V54, P1069, DOI 10.1111/j.1475-4983.2011.01093.x; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Fernandez Marta, 1994, Ameghiniana, V31, P291; Fernandez MS, 2005, J VERTEBR PALEONTOL, V25, P330, DOI 10.1671/0272-4634(2005)025[0330:IEPICI]2.0.CO;2; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fernandez MS, 2003, J VERTEBR PALEONTOL, V23, P691, DOI 10.1671/1864; Fernandez MS, 2007, PATAGONIAN MESOZOIC, P271; Fischer V, 2012, WILEY BLACKWELL  SEP, V7; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Fischer V, 2011, NEUES JAHRB GEOL P-A, V261, P111, DOI 10.1127/0077-7749/2011/0155; Fraas E.E., 1891, ICHTHYOSAURIER SUDDE; Geyer M., 2011, GEOLOGIE BADEN WURTT; Godefroit Pascal, 1994, Memoires pour Servir a l'Explication des Cartes Geologiques et Minieres de la Belgique, V39, P1; Godefroit Pascal, 1994, Revue de Paleobiologie Volume Special, V7, P67; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hegele A., 1995, KLASSISCHE FUNDSTELL, V3, P92; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Johnson R., 1979, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V159, P41; Kirton A.M., 1983, THESIS NEWSCASTLE UP; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Maddison, 2019, MESQUITE MODULAR SYS; Maisch MW, 2006, GEOBIOS-LYON, V39, P491, DOI 10.1016/j.geobios.2005.04.005; Maisch Michael W., 2004, Palaeontologische Zeitschrift, V78, P161; Maisch Michael W., 2008, Palaeodiversity, P227; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch Michael W., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V209, P401; Maisch MW, 2003, J VERTEBR PALEONTOL, V23, P116, DOI 10.1671/0272-4634(2003)23[116:TCOOTI]2.0.CO;2; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2012, J PALEONTOL, V86, P105, DOI 10.1666/11-038.1; Mazin J.M., 1988, B SOC LINNEENNE NORM, V112, P121; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY; Motani R, 2005, J VERTEBR PALEONTOL, V25, P338, DOI 10.1671/0272-4634(2005)025[0338:TSRCOI]2.0.CO;2; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Ohmert W, 1993, GEOLOGISCHE BLATTER, V43, P143; PHILLIPS J., 1871, GEOLOGY OXFORD VALLE; QUENSTEDT F.A., 1856, JURA; Sander P. Martin, 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1993, P631; Storrs Glenn W., 2000, P187; Vincent P, 2007, NEUES JAHRB GEOL P-A, V243, P363, DOI 10.1127/0077-7749/2007/0243-0363; Von Huene F, 1922, MONOGRAPHIEN GEOLOGI	51	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41692	10.1371/journal.pone.0041692	http://dx.doi.org/10.1371/journal.pone.0041692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870244	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800031
J	Martinez-Mora, C; Mrowiec, A; Garcia-Vizcaino, EM; Alcaraz, A; Cenis, JL; Nicolas, FJ				Martinez-Mora, Celia; Mrowiec, Anna; Maria Garcia-Vizcaino, Eva; Alcaraz, Antonia; Luis Cenis, Jose; Jose Nicolas, Francisco			Fibroin and Sericin from Bombyx mori Silk Stimulate Cell Migration through Upregulation and Phosphorylation of c-Jun	PLOS ONE			English	Article							N-TERMINAL KINASE; WOUND CLOSURE; GROWTH; EXPRESSION; PROLIFERATION; ACTIVATION; ATTACHMENT; FILM; DISRUPTION; MECHANISMS	Wound healing is a biological process directed to the restoration of tissue that has suffered an injury. An important phase of wound healing is the generation of a basal epithelium able to wholly replace the epidermis of the wound. A broad range of products derived from fibroin and sericin from Bombyx mori silk are used to stimulate wound healing. However, so far the molecular mechanism underlying this phenomenon has not been elucidated. The aim of this work was to determine the molecular basis underlying wound healing properties of silk proteins using a cell model. For this purpose, we assayed fibroin and sericin in a wound healing scratch assay using MDA-MB-231 and Mv1Lu cells. Both proteins stimulated cell migration. Furthermore, treatment with sericin and fibroin involved key factors of the wound healing process such as upregulation of c-Jun and c-Jun protein phosphorylation. Moreover, fibroin and sericin stimulated the phosphorylation of ERK 1/2 and JNK 1/2 kinases. All these experiments were done in the presence of specific inhibitors for some of the cell signalling pathways referred above. The obtained results revealed that MEK, JNK and PI3K pathways are involved in fibroin and sericin stimulated cells migration. Inhibition of these three kinases prevented c-Jun upregulation and phosphorylation by fibroin or sericin. Fibroin and sericin were tested in the human keratinocyte cell line, HaCaT, with similar results. Altogether, our results showed that fibroin and sericin initiate cell migration by activating the MEK, JNK and PI3K signalling pathways ending in c-Jun activation.	[Martinez-Mora, Celia; Luis Cenis, Jose] Inst Murciano Invest & Desarrollo Agr & Alimentar, Murcia, Spain; [Mrowiec, Anna; Maria Garcia-Vizcaino, Eva; Alcaraz, Antonia; Jose Nicolas, Francisco] Hosp Univ Virgen Arrixaca, Lab Oncol Mol & TGF, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca	Martinez-Mora, C (corresponding author), Inst Murciano Invest & Desarrollo Agr & Alimentar, Murcia, Spain.	franciscoj.nicolas2@carm.es	Cenis, Jose Luis/G-8363-2015; Martínez-Mora, Celia/AAS-4254-2020; Nicolás, Francisco José/H-9422-2019	Cenis, Jose Luis/0000-0003-3925-7842; Nicolás, Francisco José/0000-0002-3969-1430; Mrowiec, Anna/0000-0001-8745-5494	Fundacion Seneca de la Region de Murcia [12035/PI/09]; FEDER Operative Program of the Region of Murcia; Spanish Ministry of Science and Innovation; Spanish Ministry for Education and Science; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Hospital Universitario Virgen de la Arrixaca	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); FEDER Operative Program of the Region of Murcia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry for Education and Science(Spanish Government); Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Hospital Universitario Virgen de la Arrixaca	This work was supported by a grant from the Fundacion Seneca de la Region de Murcia, grant number 12035/PI/09 (http://www.f-seneca.org/seneca2) and the FEDER Operative Program of the Region of Murcia 2007-2013. CMM was recipient of a grant by the FEDER Operative Program of the Region of Murcia 2007-2013. EMGV was recipient of a fellowship from Fundacion Seneca de la Region de Murcia. AA was recipient of a fellowship of the Spanish Ministry of Science and Innovation. FJN was supported by the Ramon y Cajal program of the Spanish Ministry for Education and Science and the Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The authors are indebted to the Hospital Universitario Virgen de la Arrixaca that strongly supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Czekay R. P., 2011, INT J CELL BIOL, V2011; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Desai LP, 2010, J BIOL CHEM, V285, P4511, DOI 10.1074/jbc.M109.084335; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Geh E, 2011, P NATL ACAD SCI; Ghosh AK, 2011, J CELLULAR PHYSL; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Insausti CL, 2010, WOUND REPAIR REGEN, V18, P368, DOI 10.1111/j.1524-475X.2010.00604.x; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Kimura T., 2007, Journal of Applied Sciences Research, P1306; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163; Manes S, 2000, IUBMB LIFE, V49, P89; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Providence KM, 2004, J CELL PHYSIOL, V200, P297, DOI 10.1002/jcp.20016; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rodriguez Luis G., 2004, V294, P23; Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x; TAO WH, 1995, INVEST OPHTH VIS SCI, V36, P2614; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375; Tetreault MP, 2008, J CELL BIOCHEM, V105, P1240, DOI 10.1002/jcb.21924; Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403; Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	66	75	76	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42271	10.1371/journal.pone.0042271	http://dx.doi.org/10.1371/journal.pone.0042271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860103	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600083
J	Arcipowski, KM; Bishop, GA				Arcipowski, Kelly M.; Bishop, Gail A.			Roles of the Kinase TAK1 in TRAF6-Dependent Signaling by CD40 and Its Oncogenic Viral Mimic, LMP1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; CRITICAL MEDIATOR; TERMINAL KINASE; FACTORS TRAFS; BINDING-SITE; MAPK KINASE	The Epstein-Barr virus (EBV)-encoded protein latent membrane protein 1 (LMP1) is essential for EBV-mediated B cell transformation and plays a critical role in the development of post-transplant B cell lymphomas. LMP1 also contributes to the exacerbation of autoimmune diseases such as systemic lupus erythematosus (SLE). LMP1 is a functional mimic of the tumor necrosis factor receptor (TNFR) superfamily member CD40, and relies on TNFR-associated factor (TRAF) adaptor proteins to mediate signaling. However, LMP1 activation signals to the B cell are amplified and sustained compared to CD40 signals. We previously demonstrated that LMP1 and CD40 use TRAF molecules differently. Although associating with CD40 and LMP1 via separate mechanisms, TRAF6 plays a significant role in signal transduction by both. It is unknown whether TRAF6 mediates CD40 versus LMP1 functions via distinct or shared pathways. In this study, we tested the hypothesis that TRAF6 uses the kinase TAK1 to trigger important signaling pathways following both CD40 and LMP1 stimulation. We determined that TAK1 was required for JNK activation and interleukin-6 (IL-6) production mediated by CD40 and LMP1, in both mouse and human B cells. Additionally, TRAF3 negatively regulated TRAF6-dependent, CD40-mediated TAK1 activation by limiting TRAF6 recruitment. This mode of regulation was not observed for LMP1 and may contribute to the dysregulation of LMP1 compared to CD40 signals.	[Arcipowski, Kelly M.; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Bishop, Gail A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Arcipowski, KM (corresponding author), Univ Iowa, Dept Microbiol, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [NIH R01 CA099997]; American Heart Association Predoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA099997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from National Institutes of Health NIH R01 CA099997 to GAB and the American Heart Association Predoctoral fellowship to KMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006; Adam P, 2011, ADV ANAT PATHOL, V18, P349, DOI 10.1097/PAP.0b013e318229bf08; Arcipowski KM, 2011, J BIOL CHEM, V286, P9948, DOI 10.1074/jbc.M110.185983; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; BISHOP GA, 1991, J IMMUNOL, V147, P1107; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Graham JP, 2009, J IMMUNOL, V183, P2966, DOI 10.4049/jimmunol.0900442; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hammaker DR, 2004, J IMMUNOL, V172, P1612, DOI 10.4049/jimmunol.172.3.1612; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KIM KJ, 1979, J IMMUNOL, V122, P549; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Martin SE, 2011, CURR CANCER DRUG TAR, V11, P976; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2010, CANCER RES, V70, P8417, DOI 10.1158/0008-5472.CAN-10-1227; Pai S, 2001, SEMIN CANCER BIOL, V11, P455, DOI 10.1006/scbi.2001.0412; Peters AL, 2010, J IMMUNOL, V185, P6555, DOI 10.4049/jimmunol.1000135; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Safina A, 2011, MOL CANCER RES, V9, P1042, DOI 10.1158/1541-7786.MCR-10-0196; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schubert S, 2009, PEDIATR TRANSPLANT, V13, P54, DOI 10.1111/j.1399-3046.2008.00969.x; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Stunz LL, 2004, IMMUNITY, V21, P255, DOI 10.1016/j.immuni.2004.07.008; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Vanden Bush T.J., 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019468; WARREN WD, 1995, J IMMUNOL, V155, P5637; Wu LM, 2006, J BIOL CHEM, V281, P2162, DOI 10.1074/jbc.M505903200; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Xie P, 2011, J LEUKOCYTE BIOL, V90, P1149, DOI 10.1189/jlb.0111044; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	71	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42478	10.1371/journal.pone.0042478	http://dx.doi.org/10.1371/journal.pone.0042478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860133	gold, Green Submitted, Green Published			2022-12-25	WOS:000306950900094
J	He, M; Wang, Y; Hua, WP; Zhang, Y; Wang, ZZ				He, Miao; Wang, Ying; Hua, Wenping; Zhang, Yuan; Wang, Zhezhi			De Novo Sequencing of Hypericum perforatum Transcriptome to Identify Potential Genes Involved in the Biosynthesis of Active Metabolites	PLOS ONE			English	Article							ST-JOHNS-WORT; III POLYKETIDE SYNTHASE; MOLECULAR-CLONING; EXPRESSION; TRYPTOPHAN; MELATONIN; L.; HYPERFORIN; IDENTIFICATION; REPEATS	Background: Hypericum perforatum L. (St. John's wort) is a medicinal plant with pharmacological properties that are antidepressant, anti-inflammatory, antiviral, anti-cancer, and antibacterial. Its major active metabolites are hypericins, hyperforins, and melatonin. However, little genetic information is available for this species, especially that concerning the biosynthetic pathways for active ingredients. Methodology/Principal Findings: Using de novo transcriptome analysis, we obtained 59,184 unigenes covering the entire life cycle of these plants. In all, 40,813 unigenes (68.86%) were annotated and 2,359 were assigned to secondary metabolic pathways. Among them, 260 unigenes are involved in the production of hypericin, hyperforin, and melatonin. Another 2,291 unigenes are classified as potential Type III polyketide synthase. Our BlastX search against the AGRIS database reveals 1,772 unigenes that are homologous to 47 known Arabidopsis transcription factor families. Further analysis shows that 10.61% (6,277) of these unigenes contain 7,643 SSRs. Conclusion: We have identified a set of putative genes involved in several secondary metabolism pathways, especially those related to the synthesis of its active ingredients. Our results will serve as an important platform for public information about gene expression, genomics, and functional genomics in H. perforatum.	[He, Miao; Zhang, Yuan; Wang, Zhezhi] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian, Shaanxi, Peoples R China; [Wang, Ying] Northwest Univ, Inst Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Shaanxi, Peoples R China; [Hua, Wenping] Shaanxi Inst Educ, Dept Life Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Northwest University Xi'an	He, M (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian, Shaanxi, Peoples R China.	zzwang@snnu.edu.cn		Hua, wenping/0000-0003-3692-4953	"Twelve-Five technology support program funding [2011BAI06B06]; Graduate student Innovation Fund of Shaanxi Normal University, Shaanxi, P. R. China [2008CXB014]	"Twelve-Five technology support program funding; Graduate student Innovation Fund of Shaanxi Normal University, Shaanxi, P. R. China	This work benefited from financial support from the "Twelve-Five technology support program funding (2011BAI06B06)" and the "Graduate student Innovation Fund of Shaanxi Normal University (2008CXB014), Shaanxi, P. R. China". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adam P, 2002, J MED CHEM, V45, P4786, DOI 10.1021/jm0209782; Altun A, 2007, INT J CLIN PRACT, V61, P835, DOI 10.1111/j.1742-1241.2006.01191.x; Bais HP, 2003, J BIOL CHEM, V278, P32413, DOI 10.1074/jbc.M301681200; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Boubakir Z, 2005, PHYTOCHEMISTRY, V66, P51, DOI 10.1016/j.phytochem.2004.10.020; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Caraci F, 2011, CURR DRUG METAB, V12, P570; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Flores-Sanchez IJ, 2009, PLANT PHYSIOL BIOCH, V47, P167, DOI 10.1016/j.plaphy.2008.11.005; Franklin G, 2009, PHYTOCHEMISTRY, V70, P60, DOI 10.1016/j.phytochem.2008.10.016; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Germ M, 2010, FOOD CHEM, V122, P471, DOI 10.1016/j.foodchem.2010.03.008; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Karppinen K, 2008, FEBS J, V275, P4329, DOI 10.1111/j.1742-4658.2008.06576.x; Karppinen K, 2008, J PLANT PHYSIOL, V165, P1079, DOI 10.1016/j.jplph.2007.04.008; Klingauf P, 2005, PHYTOCHEMISTRY, V66, P139, DOI 10.1016/j.phytochem.2004.11.003; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; LI JY, 1995, PLANT PHYSIOL, V108, P877, DOI 10.1104/pp.108.2.877; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; Mallika V, 2011, EVOL BIOINFORM, V7, P41, DOI 10.4137/EBO.S6854; Murch SJ, 1997, LANCET, V350, P1598, DOI 10.1016/S0140-6736(05)64014-7; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; NORMANLY J, 2010, COLD SPRING HARB PER, V2, P1; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Palombella AL, 1998, PLANT PHYSIOL, V117, P455, DOI 10.1104/pp.117.2.455; Paredes SD, 2009, J EXP BOT, V60, P57, DOI 10.1093/jxb/ern284; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Smelcerovic A, 2006, PHARMAZIE, V61, P251; Smolen GA, 2002, GENETICS, V161, P1235; Song J, 2009, MOL BIOL REP, V36, P939, DOI 10.1007/s11033-008-9266-8; Umek A, 1999, PLANTA MED, V65, P388, DOI 10.1055/s-2006-960798; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayan M, 2011, BIOINFORMATION, V6, P125, DOI 10.6026/97320630006125; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043	47	41	51	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42081	10.1371/journal.pone.0042081	http://dx.doi.org/10.1371/journal.pone.0042081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860059	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900065
J	McDonald, TJ; Perry, MH; Peake, RWA; Pullan, NJ; O'Connor, J; Shields, BM; Knight, BA; Hattersley, AT				McDonald, Timothy J.; Perry, Mandy H.; Peake, Roy W. A.; Pullan, Nicola J.; O'Connor, John; Shields, Beverley M.; Knight, Beatrice A.; Hattersley, Andrew T.			EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature	PLOS ONE			English	Article							BETA-CELL FUNCTION; DIABETES-MELLITUS; PLASMA; STANDARDIZATION; IMMUNOASSAYS; HORMONE; STORAGE	Introduction: C-peptide and insulin measurements in blood provide useful information regarding endogenous insulin secretion. Conflicting evidence on sample stability and handling procedures continue to limit the widespread clinical use of these tests. We assessed the factors that altered the stability of insulin and C-peptide in blood. Methods: We investigated the impact of preservative type, time to centrifugation, storage conditions and duration of storage on the stability of C-peptide and insulin on three different analytical platforms. Results: C-peptide was stable for at least 24 hours at room temperature in both centrifuged and whole blood collected in K+-EDTA and serum gel tubes, with the exception of whole blood serum gel, which decreased to 78% of baseline at 24 hours, (p = 0.008). Insulin was stable at room temperature for 24 hours in both centrifuged and whole blood collected in K+-EDTA tubes. In contrast insulin levels decreased in serum gel tubes both centrifuged and whole blood (66% of baseline, p = 0.01 and 76% of baseline p = 0.01, by 24 hours respectively). C-peptide and insulin remained stable after 6 freeze-thaw cycles. Conclusions: The stability of C-peptide and insulin in whole blood K+-EDTA tubes negates the need to conform to strict sample handling procedures for these assays, greatly increasing their clinical utility.	[McDonald, Timothy J.; Perry, Mandy H.; O'Connor, John] Royal Devon & Exeter NHS Fdn Trust, Dept Clin Chem, Exeter, Devon, England; [McDonald, Timothy J.; Shields, Beverley M.; Knight, Beatrice A.; Hattersley, Andrew T.] Univ Exeter, NIHR Clin Res Facil, Peninsula Coll Med & Dent, Exeter, Devon, England; [Peake, Roy W. A.] NHS Grampian Hlth Board, Dept Clin Biochem, Aberdeen, Scotland; [Pullan, Nicola J.] Nottingham Univ Hosp NHS Trust, Nottingham, England	University of Exeter; University of Exeter; University of Plymouth; University of Aberdeen; Nottingham University Hospital NHS Trust	McDonald, TJ (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Dept Clin Chem, Exeter, Devon, England.	Timothy.McDonald@nhs.net		Hattersley, Andrew/0000-0001-5620-473X; McDonald, Timothy James/0000-0003-3559-6660	National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bolner A, 2005, CLIN LAB, V51, P153; BRISTOW AF, 1988, J BIOL STAND, V16, P179, DOI 10.1016/0092-1157(88)90005-4; Ellis MJ, 2003, CLIN BIOCHEM, V36, P109, DOI 10.1016/S0009-9120(02)00440-X; Evans MJ, 2001, CLIN BIOCHEM, V34, P107, DOI 10.1016/S0009-9120(01)00196-5; Jermendy G, 1996, J DIABETES COMPLICAT, V10, P223, DOI 10.1016/1056-8727(95)00006-2; KOSKINEN PJ, 1988, DIABETES CARE, V11, P318, DOI 10.2337/diacare.11.4.318; KUBASIK NP, 1982, CLIN CHEM, V28, P164; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P1664, DOI 10.1210/jc.2002-021018; Little RR, 2008, CLIN CHEM, V54, P1023, DOI 10.1373/clinchem.2007.101287; LIVESEY JH, 1980, CLIN BIOCHEM, V13, P151, DOI 10.1016/S0009-9120(80)91040-1; MADSBAD S, 1981, ACTA MED SCAND, V210, P153; Marcovina S, 2007, CLIN CHEM, V53, P711, DOI 10.1373/clinchem.2006.082214; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller WG, 2009, CLIN CHEM, V55, P1011, DOI 10.1373/clinchem.2008.118380; Prando R, 1996, DIABETES METAB, V22, P185; Saddig Christiane, 2002, JOP, V3, P16; Smith S., 1996, Journal of Endocrinology, V151, pP20; Van Uytfanghe K, 2010, MED NUCL, V34, P566, DOI 10.1016/j.mednuc.2010.07.005; WALTERS E, 1986, CLIN CHEM, V32, P224; Wiedmeyer HM, 2007, CLIN CHEM, V53, P784, DOI 10.1373/clinchem.2006.081570	20	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42084	10.1371/journal.pone.0042084	http://dx.doi.org/10.1371/journal.pone.0042084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860060	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900066
J	Zubiaurre-Elorza, L; Soria-Pastor, S; Junque, C; Sala-Llonch, R; Segarra, D; Bargallo, N; Macaya, A				Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors; Bargallo, Nuria; Macaya, Alfons			Cortical Thickness and Behavior Abnormalities in Children Born Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; HUMAN CEREBRAL-CORTEX; REGIONAL BRAIN VOLUME; PERIVENTRICULAR LEUKOMALACIA; NEUROBEHAVIORAL OUTCOMES; GEOMETRICALLY ACCURATE; ADOLESCENTS; MRI; AGE; AUTISM	Aim: To identify long-term effects of preterm birth and of periventricular leukomalacia (PVL) on cortical thickness (CTh). To study the relationship between CTh and cognitive-behavioral abnormalities. Methods: We performed brain magnetic resonance imaging on 22 preterm children with PVL, 14 preterm children with no evidence of PVL and 22 full-term peers. T1-weighted images were analyzed with FreeSurfer software. All participants underwent cognitive and behavioral assessments by means of the Wechsler Intelligence Scales for Children-Fourth Edition (WISC-IV) and the Child Behavior Checklist (CBCL). Results: We did not find global CTh differences between the groups. However, a thinner cortex was found in left postcentral, supramarginal, and caudal middle rostral gyri in preterm children with no evidence of PVL than in the full-term controls, while PVL preterm children showed thicker cortex in right pericalcarine and left rostral middle frontal areas than in preterm children with no evidence of PVL. In the PVL group, internalizing and externalizing scores correlated mainly with CTh in frontal areas. Attentional scores were found to be higher in PVL and correlated with CTh increments in right frontal areas. Interpretation: The preterm group with no evidence of PVL, when compared with full-term children, showed evidence of a different pattern of regional thinning in the cortical gray matter. In turn, PVL preterm children exhibited atypical increases in CTh that may underlie their prevalent behavioral problems.	[Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors] Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, Barcelona 7, Spain; [Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Soria-Pastor, Sara] Hosp Clin Barcelona, Clin Inst Neurosci, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge CDIC, Dept Radiol, Neuroradiol Sect, Barcelona, Spain; [Macaya, Alfons] Autonomous Univ Barcelona, Grp Recerca Neurol Pediat, Inst Recerca Vall dHebron, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Zubiaurre-Elorza, L (corresponding author), Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, Barcelona 7, Spain.	cjunque@ub.edu	Junque, Carme/B-4400-2011; Bargallo, Nuria/G-6854-2016; Sala-Llonch, Roser/L-4135-2015; Sala-Llonch, Roser/E-7882-2012; Zubiaurre-Elorza, Leire/F-2431-2016; Soria Pastor, Sara/L-5103-2017	Junque, Carme/0000-0002-6381-3063; Bargallo, Nuria/0000-0001-6284-5402; Sala-Llonch, Roser/0000-0003-3576-0475; Sala-Llonch, Roser/0000-0003-3576-0475; Zubiaurre-Elorza, Leire/0000-0001-9830-3939; Soria Pastor, Sara/0000-0001-7275-7166; Macaya Ruiz, Alfons/0000-0001-7998-4185	Ministerio de Ciencia y Tecnologia [SAF2005-007340]; Generalitat de Catalunya [2009 SGR 00941, 2009 SGR 0078]; Ministerio de Educacion y Ciencia [AP2005-0047, BES-2011-047053, AP2008-0935]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	This study was supported by grants from the Ministerio de Ciencia y Tecnologia (SAF2005-007340), and the Generalitat de Catalunya (2009 SGR 00941, 2009 SGR 0078). S. Soria-Pastor, R. Sala-Llonch, and L. Zubiaurre-Elorza hold fellowships from the Ministerio de Educacion y Ciencia (AP2005-0047), (BES-2011-047053) and (AP2008-0935) respectively. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FLODMARK O, 1987, RADIOLOGY, V162, P119, DOI 10.1148/radiology.162.1.3538143; Gray RF, 2004, PEDIATRICS, V114, P736, DOI 10.1542/peds.2003-1150-L; Gurka MJ, 2010, ARCH PEDIAT ADOL MED, V164, P525, DOI 10.1001/archpediatrics.2010.83; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Kulseng S, 2006, ACTA PAEDIATR, V95, P224, DOI 10.1080/08035250500421568; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Mak-Fan KM, 2012, J AUTISM DEV DISORD, V42, P419, DOI 10.1007/s10803-011-1261-6; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2005, BIOL PSYCHIAT, V57, P661, DOI 10.1016/j.biopsych.2004.12.003; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raznahan A, 2010, CEREB CORTEX, V20, P1332, DOI 10.1093/cercor/bhp198; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Samara M, 2008, PEDIATRICS, V122, P562, DOI 10.1542/peds.2007-3231; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Soria-Pastor S, 2009, PEDIATRICS, V124, pE1161, DOI 10.1542/peds.2009-0244; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tosun D, 2011, HUM BRAIN MAPP, V32, P580, DOI 10.1002/hbm.21045; Tzarouchi LC, 2009, PEDIATR RADIOL, V39, P1327, DOI 10.1007/s00247-009-1389-0; Wechsler, 2007, ESCALA WECHSLER INTE; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Zubiaurre-Elorza L, 2012, PEDIATR RES, V71, P354, DOI 10.1038/pr.2011.70; Zubiaurre-Elorza L, 2011, PEDIATR RES, V69, P554, DOI 10.1203/PDR.0b013e3182182366	48	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42148	10.1371/journal.pone.0042148	http://dx.doi.org/10.1371/journal.pone.0042148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860067	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900073
J	Greibe, E; Fedosov, S; Sorensen, BS; Hojrup, P; Poulsen, SS; Nexo, E				Greibe, Eva; Fedosov, Sergey; Sorensen, Boe S.; Hojrup, Peter; Poulsen, Steen S.; Nexo, Ebba			A Single Rainbow Trout Cobalamin-binding Protein Stands in for Three Human Binders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTRINSIC-FACTOR; TRANSCOBALAMIN; VITAMIN-B12; HAPTOCORRIN; CHROMATOGRAPHY; AQUOCOBALAMIN; SERUM; B-12	Cobalamin uptake and transport in mammals are mediated by three cobalamin-binding proteins: haptocorrin, intrinsic factor, and transcobalamin. The nature of cobalamin-binding proteins in lower vertebrates remains to be elucidated. The aim of this study was to characterize the cobalamin-binding proteins of the rainbow trout (Oncorhynchus mykiss) and to compare their properties with those of the three human cobalamin-binding proteins. High cobalamin-binding capacity was found in trout stomach (210 pmol/g), roe (400 pmol/g), roe fluid (390 nmol/liter), and plasma (2500 nmol/liter). In all cases, it appeared to be the same protein based on analysis of partial sequences and immunological responses. The trout cobalamin-binding protein was purified from roe fluid, sequenced, and further characterized. Like haptocorrin, the trout cobalamin-binding protein was stable at low pH and had a high binding affinity for the cobalamin analog cobinamide. Like haptocorrin and transcobalamin, the trout cobalamin-binding protein was present in plasma and recognized ligands with altered nucleotide moiety. Like intrinsic factors, the trout cobalamin-binding protein was present in the stomach and resisted degradation by trypsin and chymotrypsin. It also resembled intrinsic factor in the composition of conserved residues in the primary cobalamin-binding site in the C terminus. The trout cobalamin-binding protein was glycosylated and displayed spectral properties comparable with those of haptocorrin and intrinsic factor. In conclusion, only one soluble cobalamin-binding protein was identified in the rainbow trout, a protein that structurally behaves like an intermediate between the three human cobalamin-binding proteins.	[Greibe, Eva; Sorensen, Boe S.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; [Fedosov, Sergey] Aarhus Univ, Dept Engn Sci, DK-8000 Aarhus, Denmark; [Hojrup, Peter] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Poulsen, Steen S.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; University of Copenhagen	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Norrebrogade 44,Bldg 9, DK-8000 Aarhus C, Denmark.	evagreibe@gmail.com	Fedosov, Sergey N./J-2340-2019; Greibe, Eva/E-3375-2018; Højrup, Peter/ABG-8477-2020	Fedosov, Sergey N./0000-0002-7016-2959; Greibe, Eva/0000-0002-0417-1195; Nexo, Ebba/0000-0001-9406-9081; Hojrup, Peter/0000-0002-7838-6180; Poulsen, Steen Seier/0000-0003-4419-4911; Sorensen, Boe/0000-0002-9472-8099				ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Bledsoe GE, 2003, CRIT REV FOOD SCI, V43, P317, DOI 10.1080/10408690390826545; DOSCHERHOLMEN A, 1981, P SOC EXP BIOL MED, V167, P480, DOI 10.3181/00379727-167-41201; Fedosov SN, 2000, J BIOL CHEM, V275, P11791, DOI 10.1074/jbc.275.16.11791; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; Fieber W, 2002, HELV CHIM ACTA, V85, P927, DOI 10.1002/1522-2675(200203)85:3<927::AID-HLCA927>3.0.CO;2-A; Furger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037421; Galfre G, 1981, Methods Enzymol, V73, P3; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Greibe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035660; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; HEWITT JE, 1991, GENOMICS, V10, P432, DOI 10.1016/0888-7543(91)90329-D; HIPPE E, 1970, BIOCHIM BIOPHYS ACTA, V208, P337, DOI 10.1016/0304-4165(70)90255-2; HIPPE E, 1977, COMP BIOCHEM PHYS B, V56, P305, DOI 10.1016/0305-0491(77)90021-9; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Kalra S, 2004, ARCH BIOCHEM BIOPHYS, V431, P189, DOI 10.1016/j.abb.2004.08.011; LINNELL JC, 1975, COBALAMIN BIOCH PATH, P287; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO BA, 1982, BIOCHIM BIOPHYS ACTA, V708, P178, DOI 10.1016/0167-4838(82)90218-7; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1976, BIOCHIM BIOPHYS ACTA, V446, P143, DOI 10.1016/0005-2795(76)90106-9; Nielsen R, 2001, J AM SOC NEPHROL, V12, P1099, DOI 10.1681/ASN.V1261099; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; TAN CH, 1975, COMP BIOCHEM PHYS B, V50, P541, DOI 10.1016/0305-0491(75)90086-3; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	32	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33917	33925		10.1074/jbc.M112.398016	http://dx.doi.org/10.1074/jbc.M112.398016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872637	Green Published, hybrid			2022-12-25	WOS:000309602100072
J	Jarmalavicius, S; Welte, Y; Walden, P				Jarmalavicius, Saulius; Welte, Yvonne; Walden, Peter			High Immunogenicity of the Human Leukocyte Antigen Peptidomes of Melanoma Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYTIC T-LYMPHOCYTES; LUNG-CARCINOMA; POINT MUTATION; IDENTIFICATION; EPITOPES; MOTIFS; GENE; STIMULATION; DEFINITION; TURNOVER	Human leukocyte antigens (HLA) bind peptides generated by limited proteolysis in cells and present them at the cell surfaces for recognition by T cells. Through this antigen presentation function they control the specificity of T cell responses and thereby adaptive immune responses. Knowledge of HLA-bound peptides is thus key to understanding adaptive immunity and to the development of vaccines and other specific immune intervention strategies. To gain insight into the antigenicity of melanomas, peptides were extracted from HLA isolated from the tumor cells, separated by two-dimensional HPLC, and sequenced by mass spectrometry. The spectra were analyzed by database-dependent MASCOT searches and database-independent de novo sequencing and, where required, confirmed with synthetic peptides, which were also used to determine their immunogenicity. Comparing four different melanoma cell lines, little overlap of the HLA-bound peptides was found, suggesting a high degree of individualization of the HLA peptidomes. This notwithstanding, the peptidomes were highly immunogenic in the patients from whom the tumor cells had been established and in unrelated patients. This broad cross-patient immunogenicity was only exceptionally related to individual peptides. The majority of the identified epitopes were derived from low to medium abundance proteins, mostly involved in sensitive cellular processes such as cell cycle control, DNA replication, control of gene expression, tumor suppressor function, and protein metabolism. The peptidomes thus provide insights into processes potentially related to tumorigenesis. Furthermore, analyses of the peptide sequences yield information on the specificity of peptide selection by HLA applicable to the developing prediction algorithms for T cell epitopes.	[Jarmalavicius, Saulius; Welte, Yvonne; Walden, Peter] Charite Univ Med Berlin, Dept Dermatol Venerol & Allergol, Clin Res Grp Tumor Immunol, D-10098 Berlin, Germany; [Jarmalavicius, Saulius] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Walden, P (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, Charitepl 1, D-10117 Berlin, Germany.	peter.walden@charite.de			German Research Council (Deutsche Forschungsgemeinschaft) [KFO50]; German Ministry for Research and Education [13N9197]; Berlin Cancer Society [WAFF200824]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry for Research and Education(Federal Ministry of Education & Research (BMBF)); Berlin Cancer Society	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft Grant KFO50), German Ministry for Research and Education (Grant 13N9197), and Berlin Cancer Society (Grant WAFF200824).	Arnett KL, 1998, IMMUNOGENETICS, V48, P56, DOI 10.1007/s002510050400; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bredenbeck A, 2005, J IMMUNOL, V174, P6716, DOI 10.4049/jimmunol.174.11.6716; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chaux P, 1999, J IMMUNOL, V163, P2928; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Demine R, 2005, J BIOL CHEM, V280, P17573, DOI 10.1074/jbc.M501233200; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Demine R, 2003, MOL BIOTECHNOL, V25, P71, DOI 10.1385/MB:25:1:71; Echchakir H, 2001, CANCER RES, V61, P4078; FALK K, 1994, IMMUNOGENETICS, V40, P238, DOI 10.1007/BF00167086; Gaudin C, 1999, J IMMUNOL, V162, P1730; Harada M, 2001, CANCER RES, V61, P1089; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hogan KT, 1998, CANCER RES, V58, P5144; Jarmalavicius S, 2010, FASEB J, V24, P937, DOI 10.1096/fj.09-136283; KUBO RT, 1994, J IMMUNOL, V152, P3913; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Liu YF, 2011, CLIN EXP METASTAS, V28, P413, DOI 10.1007/s10585-011-9380-1; Matsumoto T, 2009, INT J BIOL MARKER, V24, P282, DOI 10.1177/172460080902400411; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reynolds SR, 2000, J IMMUNOL METHODS, V244, P59, DOI 10.1016/S0022-1759(00)00254-4; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522	30	23	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33401	33411		10.1074/jbc.M112.358903	http://dx.doi.org/10.1074/jbc.M112.358903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869377	Green Published, hybrid			2022-12-25	WOS:000309602100027
J	Wiedner, SD; Burnum, KE; Pederson, LM; Anderson, LN; Fortuin, S; Chauvigne-Hines, LM; Shukla, AK; Ansong, C; Panisko, EA; Smith, RD; Wright, AT				Wiedner, Susan D.; Burnum, Kristin E.; Pederson, LeeAnna M.; Anderson, Lindsey N.; Fortuin, Suereta; Chauvigne-Hines, Lacie M.; Shukla, Anil K.; Ansong, Charles; Panisko, Ellen A.; Smith, Richard D.; Wright, Aaron T.			Multiplexed Activity-based Protein Profiling of the Human Pathogen Aspergillus fumigatus Reveals Large Functional Changes upon Exposure to Human Serum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; OXIDATIVE STRESS-RESPONSE; TANDEM MASS-SPECTRA; KINASE MPKA; BIOSYNTHESIS; GROWTH; GENE; METABOLISM; PROTEOMICS; PATHWAY	Environmental adaptability is critical for survival of the fungal human pathogen Aspergillus fumigatus in the immunocompromised host lung. We hypothesized that exposure of the fungal pathogen to human serum would lead to significant alterations to the organism's physiology, including metabolic activity and stress response. Shifts in functional pathway and corresponding enzyme reactivity of A. fumigatus upon exposure to the human host may represent much needed prognostic indicators of fungal infection. To address this, we employed a multiplexed activity-based protein profiling (ABPP) approach coupled to quantitative mass spectrometry-based proteomics to measure broad enzyme reactivity of the fungus cultured with and without human serum. ABPP showed a shift from aerobic respiration to ethanol fermentation and utilization over time in the presence of human serum, which was not observed in serum-free culture. Our approach provides direct insight into this pathogen's ability to survive, adapt, and proliferate. Additionally, our multiplexed ABPP approach captured a broad swath of enzyme reactivity and functional pathways and provides a method for rapid assessment of the A. fumigatus response to external stimuli.	[Wiedner, Susan D.; Burnum, Kristin E.; Pederson, LeeAnna M.; Anderson, Lindsey N.; Fortuin, Suereta; Chauvigne-Hines, Lacie M.; Shukla, Anil K.; Ansong, Charles; Smith, Richard D.; Wright, Aaron T.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Panisko, Ellen A.] Pacific NW Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wright, AT (corresponding author), Pacific NW Natl Lab, Div Biol Sci, 902 Battelle Blvd, Richland, WA 99352 USA.	aaron.wright@pnnl.gov	Smith, Richard D/J-3664-2012; Fortuin, Suereta/AAV-5804-2021; Burnum, Kristin E/B-1308-2011; Fortuin, Suereta/AAX-8725-2020; Anderson, Lindsey N/S-6375-2016	Smith, Richard D/0000-0002-2381-2349; Fortuin, Suereta/0000-0001-8148-7807; Burnum, Kristin E/0000-0002-2722-4149; Anderson, Lindsey N/0000-0002-8741-7823; Wright, Aaron/0000-0002-3172-5253	National Institutes of Health Grant (NIH), NCRR [5P41RR018522-10]; NIH, NIGMS [8 P41 GM103493-10]; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL); Battelle for the United States Department of Energy [DE-AC05-76RL01830]; National Institutes of Health [P41 GM103493-10]; United States Department of Energy Office of Biological and Environmental Research (DOE/BER); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH), NCRR; NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL); Battelle for the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Office of Biological and Environmental Research (DOE/BER)(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (NIH), NCRR, Grant 5P41RR018522-10 and NIH, NIGMS, Grant 8 P41 GM103493-10. This work was also supported in part by the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), a multiprogram national laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830. This work used instrumentation and capabilities developed under support from the National Institutes of Health (Grant P41 GM103493-10) and the United States Department of Energy Office of Biological and Environmental Research (DOE/BER). Work was performed in the Environmental Molecular Sciences Laboratory, a DOE/BER national scientific user facility at PNNL.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Barglow KT, 2004, CHEM BIOL, V11, P1523, DOI 10.1016/j.chembiol.2004.08.023; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Cagas SE, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010108, 10.1074/mcp.M110.004606]; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Dorr P. K., 2003, U.S. Patent, Patent No. 6514726B; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Gifford AHT, 2002, INFECT IMMUN, V70, P19, DOI 10.1128/IAI.70.1.19-26.2002; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hummel M, 2007, MYCOSES, V50, P18, DOI 10.1111/j.1439-0507.2007.01376.x; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; KAGI JHR, 1960, J BIOL CHEM, V235, P3188; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Kniemeyer O, 2011, PROTEOMICS, V11, P3232, DOI 10.1002/pmic.201100087; Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039; Krappmann S., 2003, ASPERGILLUS FUMIGATU, P63; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lenz T, 2011, J PROTEOMICS, V75, P100, DOI 10.1016/j.jprot.2011.07.017; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Lodeiro S, 2009, ORG LETT, V11, P1241, DOI 10.1021/ol802696a; Luo JJ, 2010, MOL CELL BIOL, V30, P537, DOI 10.1128/MCB.00980-09; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Morrice J, 1998, CURR GENET, V34, P379, DOI 10.1007/s002940050410; Mousavi SAA, 2003, FUNGAL GENET BIOL, V39, P221, DOI 10.1016/S1087-1845(03)00047-1; Oliver BG, 2002, MICROBIOL-SGM, V148, P2627, DOI 10.1099/00221287-148-8-2627; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Palmer GE, 2008, AUTOPHAGY, V4, P982, DOI 10.4161/auto.7075; Papagianni M, 2004, BIOTECHNOL ADV, V22, P189, DOI 10.1016/j.biotechadv.2003.09.005; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; Rhodes JC, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P697; Rodrigues AG, 2005, MED MYCOL, V43, P711, DOI 10.1080/13693780500129814; Roush WR, 1998, J AM CHEM SOC, V120, P10994, DOI 10.1021/ja981792o; Sami L, 2001, MYCOL RES, V105, P1246, DOI 10.1016/S0953-7562(08)61996-6; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Schoberle T, 2007, ADV GENET, V57, P263, DOI 10.1016/S0065-2660(06)57007-5; Shimizu K, 2001, GENETICS, V157, P591; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Taubitz A, 2007, CURR MICROBIOL, V54, P354, DOI 10.1007/s00284-006-0413-y; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Toyotome T, 2012, INT J MED MICROBIOL, V302, P108, DOI 10.1016/j.ijmm.2011.12.001; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Wallwey C, 2010, ORG BIOMOL CHEM, V8, P3500, DOI 10.1039/c003823g; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	75	18	18	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33447	33459		10.1074/jbc.M112.394106	http://dx.doi.org/10.1074/jbc.M112.394106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865858	hybrid, Green Published			2022-12-25	WOS:000309602100031
J	Gong, R; Wang, YP; Ying, TL; Dimitrov, DS				Gong, Rui; Wang, Yanping; Ying, Tianlei; Dimitrov, Dimiter S.			Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn	PLOS ONE			English	Article							INTERNATIONAL IMMUNOGENETICS DATABASE; BINDING-SITE; CH2 DOMAINS; HUMAN IGG1; THERAPEUTIC ANTIBODIES; MOLECULAR RECOGNITION; INCREASED-STABILITY; PROTEIN SCAFFOLDS; CRYSTAL-STRUCTURE; RECEPTOR	Libraries based on an isolated human immunoglobulin G1 (IgG1) constant domain 2 (CH2) have been previously diversified by random mutagenesis. However, native isolated CH2 is not very stable and the generation of many mutations could lead to an increase in immunogenicity. Recently, we demonstrated that engineering an additional disulfide bond and removing seven N-terminal residues results in an engineered antibody domain (eAd) (m01s) with highly increased stability and enhanced binding to human neonatal Fc receptor (FcRn) (Gong et al, JBC, 2009 and 2011). We and others have also previously shown that grafting of the heavy chain complementarity region 3 (CDR-H3 (H3)) onto cognate positions of the variable domain leads to highly diversified libraries from which a number of binders to various antigens have been selected. However, grafting of H3s to non-cognate positions in constant domains results in additional residues at the junctions of H3s and the CH2 framework. Here we describe a new method based on multi-step PCR that allows the precise replacement of loop FG (no changes in its flanking sequences) by human H3s from another library. Using this method and limited mutagenesis of loops BC and DE we generated an eAd phage-displayed library. Panning of this library against an HIV-1 gp41 MPER peptide resulted in selection of a binder, m2a1, which neutralized HIV-1 isolates from different clades with modest activity and retained the m01s capability of binding to FcRn. This result provides a proof of concept that CH2-based antigen binders that also mimic to certain extent other functions of full-size antibodies (binding to FcRn) can be generated; we have previously hypothesized that such binders can be made and coined the term nanoantibodies (nAbs). Further studies in animal models and in humans will show how useful nAbs could be as therapeutics and diagnostics.	[Gong, Rui; Wang, Yanping; Ying, Tianlei; Dimitrov, Dimiter S.] NIH, Prot Interact Grp, Frederick Natl Lab Canc Res, Frederick, MD USA; [Wang, Yanping] SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Gong, R (corresponding author), NIH, Prot Interact Grp, Frederick Natl Lab Canc Res, Frederick, MD USA.	gongr@mail.nih.gov	应, 天雷/P-5396-2019	应, 天雷/0000-0002-9597-2843	National Institutes of Health (NIH); NIH, National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH [N01-CO-12400]; U.S. Government; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health (NIH) to DSD, and by the Intramural Research Program of the NIH, National Cancer Institute (NCI), Center for Cancer Research. This project has been funded in whole or in part with federal funds from the NCI, NIH, under contract N01-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SAIC-Frederick, Inc. is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the National Cancer Institute, part of the U.S. National Institutes of Health. All funding is derived from the U.S. Government. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Caravella J, 2010, CURR OPIN CHEM BIOL, V14, P520, DOI 10.1016/j.cbpa.2010.06.175; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Chen WZ, 2008, J MOL BIOL, V382, P779, DOI 10.1016/j.jmb.2008.07.054; Chen WZ, 2010, MOL IMMUNOL, V47, P912, DOI 10.1016/j.molimm.2009.09.039; Chen Weizao, 2009, V525, P81, DOI 10.1007/978-1-59745-554-1_4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gehlsen KR, 2012, MABS-AUSTIN, V4, P466, DOI 10.4161/mabs.20652; Gill DS, 2006, CURR OPIN BIOTECH, V17, P653, DOI 10.1016/j.copbio.2006.10.003; Gong R, 2012, BIODRUGS, V26, P143, DOI 10.2165/11631400-000000000-00000; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lefranc Marie-Paule, 2005, In Silico Biology, V5, P45; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Regan L, 2003, P NATL ACAD SCI USA, V100, P3553, DOI 10.1073/pnas.0830651100; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Skerra A, 2000, J MOL RECOGNIT, V13, P167, DOI 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.3.CO;2-0; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; von Minckwitz G, 2005, BREAST CANCER RES, V7, pR617, DOI 10.1186/bcr1264; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V387, P387, DOI 10.1016/j.bbrc.2009.07.044; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	54	20	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42288	10.1371/journal.pone.0042288	http://dx.doi.org/10.1371/journal.pone.0042288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879932	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900027
J	Canducci, F; Saita, D; Foglieni, C; Piscopiello, MR; Chiesa, R; Colombo, A; Cianflone, D; Maseri, A; Clementi, M; Burioni, R				Canducci, Filippo; Saita, Diego; Foglieni, Chiara; Piscopiello, Maria Rosaria; Chiesa, Roberto; Colombo, Antonio; Cianflone, Domenico; Maseri, Attilio; Clementi, Massimo; Burioni, Roberto			Cross-Reacting Antibacterial Auto-Antibodies Are Produced within Coronary Atherosclerotic Plaques of Acute Coronary Syndrome Patients	PLOS ONE			English	Article							CELLS; INFECTION; INFLAMMATION; PROTEIN; RISK; DIFFERENTIATE; MECHANISMS; EXPRESSION; GENERATION; MICROBIOTA	Coronary atherosclerosis, the main condition predisposing to acute myocardial infarction, has an inflammatory component caused by stimuli that are yet unknown. We molecularly investigated the nature of the immune response within human coronary lesion in four coronary plaques obtained by endoluminal atherectomy from four patients. We constructed phage-display libraries containing the IgG1/kappa antibody fragments produced by B-lymphocytes present in each plaque. By immunoaffinity, we selected from these libraries a monoclonal antibody, arbitrarily named Fab7816, able to react both with coronary and carotid atherosclerotic tissue samples. We also demonstrated by confocal microscopy that this monoclonal antibody recognized human transgelin type 1, a cytoskeleton protein involved in atherogenesis, and that it co-localized with fibrocyte-like cells transgelin+, CD68+, CD45+ in human sections of coronary and carotid plaques. In vitro fibrocytes obtained by differentiating CD14+ cells isolated from peripheral blood mononuclear cells also interacted with Fab7816, thus supporting the hypothesis of a specific recognition of fibrocytes into the atherosclerotic lesions. Interestingly, the same antibody, cross-reacted with the outer membrane proteins of Proteus mirabilis and Klebsiella pneumoniae (and possibly with homologous proteins of other enterobacteriaceae present in the microbiota). From all the other three libraries, we were able to clone, by immunoaffinity selection, human monoclonal antibodies cross-reacting with bacterial outer membrane proteins and with transgelin. These findings demonstrated that in human atherosclerotic plaques a local cross-reactive immune response takes place.	[Canducci, Filippo; Saita, Diego; Clementi, Massimo; Burioni, Roberto] Univ Milan, Osped San Raffaele, Lab Microbiol & Virol, I-20127 Milan, Italy; [Canducci, Filippo; Saita, Diego; Foglieni, Chiara; Piscopiello, Maria Rosaria; Chiesa, Roberto; Colombo, Antonio; Cianflone, Domenico; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Milan, Italy; [Foglieni, Chiara; Cianflone, Domenico] Univ Milan, Osped San Raffaele, Clin Cardiovasc Biol Ctr, I-20127 Milan, Italy; [Piscopiello, Maria Rosaria] Univ Milan, Osped San Raffaele, Ist Neurol Sperimentale, I-20127 Milan, Italy; [Chiesa, Roberto] Univ Milan, Osped San Raffaele, Div Vasc Surg, I-20127 Milan, Italy; [Colombo, Antonio] Univ Milan, Osped San Raffaele, Intervent Cardiol Unit, Dept Cardiothorac & Vasc Dis, I-20127 Milan, Italy; [Maseri, Attilio] ONLUS, Heart Care Fdn, Florence, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Canducci, F (corresponding author), Univ Milan, Osped San Raffaele, Lab Microbiol & Virol, Via Prinetti 29, I-20127 Milan, Italy.	Canducci.filippo@hsr.it; Burioni.roberto@hsr.it	Roberto, Chiesa/AAV-6476-2021; Clementi, Massimo/F-6646-2013; Colombo, Antonio/N-2960-2015; Foglieni, Chiara/O-2339-2015; Burioni, Roberto/F-2396-2012	Colombo, Antonio/0000-0002-2940-2455; Foglieni, Chiara/0000-0002-5155-6426; Canducci, Filippo/0000-0002-5637-6205; Clementi, Massimo/0000-0002-7461-5898; Grandi, Alessandro/0000-0002-2770-8266	Bracco Imaging SpA; Young Investigators Grant of the Italian Ministry of Health [GR08-41]	Bracco Imaging SpA; Young Investigators Grant of the Italian Ministry of Health	This work was partially supported by a grant from Bracco Imaging SpA, and by the Young Investigators Grant GR08-41 of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Angiolillo DJ, 2003, J AM COLL CARDIOL, V41, P546, DOI 10.1016/S0735-1097(02)02899-1; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Burioni R, 1998, J IMMUNOL METHODS, V217, P195, DOI 10.1016/S0022-1759(98)00102-1; Burioni R, 1998, HEPATOLOGY, V28, P810, DOI 10.1002/hep.510280331; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, J IMMUNOL, V183, P2537, DOI 10.4049/jimmunol.0901076; Camoretti-Mercado B, 1998, GENOMICS, V49, P452, DOI 10.1006/geno.1998.5267; Clayton TC, 2008, EUR HEART J, V29, P96, DOI 10.1093/eurheartj/ehm516; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; De Palma R, 2006, CIRCULATION, V113, P640, DOI 10.1161/CIRCULATIONAHA.105.537712; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Espinola-Klein C, 2007, ATHEROSCLEROSIS, V195, pE126, DOI 10.1016/j.atherosclerosis.2007.01.021; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Ford PJ, 2006, ORAL MICROBIOL IMMUN, V21, P206, DOI 10.1111/j.1399-302X.2006.00276.x; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Honda T, 2005, ORAL MICROBIOL IMMUN, V20, P82, DOI 10.1111/j.1399-302X.2004.00193.x; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Iwata H, 2010, CIRCULATION, V122, P2048, DOI 10.1161/CIRCULATIONAHA.110.965202; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5; Mandal K, 2005, HANDB EXP PHARM, V170, P723; Paju S, 2007, ATHEROSCLEROSIS, V193, P193, DOI 10.1016/j.atherosclerosis.2006.06.015; Rao J, 2008, MICROBIOL-SGM, V154, P654, DOI 10.1099/mic.0.2007/011429-0; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stassen FR, 2008, PHARMACOL REP, V60, P85; Stow NW, 2010, OTOLARYNG CLIN N AM, V43, P489, DOI 10.1016/j.otc.2010.02.008; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Watanabe M, 2007, J ATHEROSCLER THROMB, V14, P325, DOI 10.5551/jat.E489; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538	46	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42283	10.1371/journal.pone.0042283	http://dx.doi.org/10.1371/journal.pone.0042283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879930	Green Submitted, gold, Green Published			2022-12-25	WOS:000307810000025
J	Lim, J; Maher, GJ; Turner, GDH; Dudka-Ruszkowska, W; Taylor, S; Meyts, ERD; Goriely, A; Wilkie, AOM				Lim, Jasmine; Maher, Geoffrey J.; Turner, Gareth D. H.; Dudka-Ruszkowska, Wioleta; Taylor, Stephen; Meyts, Ewa Rajpert-De; Goriely, Anne; Wilkie, Andrew O. M.			Selfish Spermatogonial Selection: Evidence from an Immunohistochemical Screen in Testes of Elderly Men	PLOS ONE			English	Article							HUMAN SEMINIFEROUS TUBULES; SPERMATOCYTIC SEMINOMA; STEM-CELLS; BREAST-CANCER; GERM-LINE; CANCER/TESTIS ANTIGENS; MUTATION FREQUENCY; TESTICULAR-TUMORS; FGFR2 MUTATIONS; GROWTH-FACTORS	The dominant congenital disorders Apert syndrome, achondroplasia and multiple endocrine neoplasia-caused by specific missense mutations in the FGFR2, FGFR3 and RET proteins respectively-represent classical examples of paternal age-effect mutation, a class that arises at particularly high frequencies in the sperm of older men. Previous analyses of DNA from randomly selected cadaveric testes showed that the levels of the corresponding FGFR2, FGFR3 and RET mutations exhibit very uneven spatial distributions, with localised hotspots surrounded by large mutation-negative areas. These studies imply that normal testes are mosaic for clusters of mutant cells: these clusters are predicted to have altered growth and signalling properties leading to their clonal expansion (selfish spermatogonial selection), but DNA extraction eliminates the possibility to study such processes at a tissue level. Using a panel of antibodies optimised for the detection of spermatocytic seminoma, a rare tumour of spermatogonial origin, we demonstrate that putative clonal events are frequent within normal testes of elderly men (mean age: 73.3 yrs) and can be classed into two broad categories. We found numerous small (less than 200 cells) cellular aggregations with distinct immunohistochemical characteristics, localised to a portion of the seminiferous tubule, which are of uncertain significance. However more infrequently we identified additional regions where entire seminiferous tubules had a circumferentially altered immunohistochemical appearance that extended through multiple serial sections that were physically contiguous (up to 1 mm in length), and exhibited enhanced staining for antibodies both to FGFR3 and a marker of downstream signal activation, pAKT. These findings support the concept that populations of spermatogonia in individual seminiferous tubules in the testes of older men are clonal mosaics with regard to their signalling properties and activation, thus fulfilling one of the specific predictions of selfish spermatogonial selection.	[Lim, Jasmine; Maher, Geoffrey J.; Dudka-Ruszkowska, Wioleta; Goriely, Anne; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England; [Turner, Gareth D. H.] Univ Oxford Hosp NHS Trust, NIHR Biomed Res Ctr, Dept Cellular Pathol, Oxford, England; [Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England; [Meyts, Ewa Rajpert-De] Rigshosp, Copenhagen Univ Hosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Rigshospitalet; University of Copenhagen	Lim, J (corresponding author), Univ Malaya, Kuala Lumpur, Malaysia.	andrew.wilkie@imm.ox.ac.uk	JASMINE, LIM/F-7404-2015; Goriely, Anne/AAR-1133-2020; Wilkie, Andrew/AAC-3820-2020; Rajpert-De Meyts, Ewa/H-6526-2019	JASMINE, LIM/0000-0002-7501-1834; Wilkie, Andrew/0000-0002-2972-5481; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Goriely, Anne/0000-0001-9229-7216; Dudka, Wioleta/0000-0002-7637-6480	Wellcome Trust [091182]; National Institute for Health Research Biomedical Research Centre Programme, Oxford; Danish Cancer Society [DP08147]; Malaysian Ministry of Higher Education Fellowship; NIHR Biomedical Research Centre Programme	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre Programme, Oxford(National Institute for Health Research (NIHR)); Danish Cancer Society(Danish Cancer Society); Malaysian Ministry of Higher Education Fellowship; NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust (091182 to AG and AOMW); the National Institute for Health Research Biomedical Research Centre Programme, Oxford (GDHT); and the Danish Cancer Society (DP08147 to ERDM). JL was funded by a Malaysian Ministry of Higher Education Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Giulio Spagnoli (University of Basel, Basel, Switzerland) and Ad Geurts van Kessel (Department of Human Genetics, University Hospital, Nijmegen, The Netherlands) for the MAGEA4 and SSX antibodies, respectively. For sourcing samples used in this study, we thank Mark Sullivan, David Cranston, Helen Hemsworth, Gemma Crane, Ian Roberts, and Freddie Hamdy, as well as Divija Jatavallabhula, Linda Godfrey and the Oxford Radcliffe Biobank, which is supported by the NIHR Biomedical Research Centre Programme. We are grateful to Russell Leek and Graham Steers for assistance with digital microscopy.	Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655; Aubry F, 2001, CANCER, V92, P2778, DOI 10.1002/1097-0142(20011201)92:11<2778::AID-CNCR10125>3.0.CO;2-S; BEHRE HM, 1989, INT J ANDROL, V12, P395, DOI 10.1111/j.1365-2605.1989.tb01328.x; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; BERGMANN M, 1989, CELL TISSUE RES, V256, P183; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Chang H, 2005, BLOOD, V106, P353, DOI 10.1182/blood-2005-01-0033; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Choi SK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002420; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; dos Santos NR, 2000, CANCER RES, V60, P1654; EBLE JN, 1994, HUM PATHOL, V25, P1035, DOI 10.1016/0046-8177(94)90062-0; GERDES J, 1984, J IMMUNOL, V133, P1710; Giudicelli MD, 2008, FERTIL STERIL, V89, P1651, DOI 10.1016/j.fertnstert.2007.04.037; Glass J, 2005, GRAYS ANATOMY ANATOM, P1304; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2011, 12 INT C HUM GEN ICH, P44; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; HOLSTEIN AF, 1984, CELL TISSUE RES, V236, P35, DOI 10.1007/BF00216510; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; JOHNSON L, 1986, J ANDROL, V7, P331; Johnston CL, 1995, J BIOL CHEM, V270, P30643, DOI 10.1074/jbc.270.51.30643; Khnykin D, 2006, J PATHOL, V208, P431, DOI 10.1002/path.1900; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Landry C, 2000, INT J CANCER, V86, P835, DOI 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; LINDNER SG, 1982, ANDROLOGIA, V14, P352; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meyts ERD, 2007, INT J ANDROL, V30, P192, DOI 10.1111/j.1365-2605.2007.00810.x; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MULLER J, 1987, INT J ANDROL, V10, P147, DOI 10.1111/j.1365-2605.1987.tb00176.x; NISTAL M, 1987, J ANDROL, V8, P64; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; PANIAGUA R, 1991, J ELECTRON MICR TECH, V19, P241, DOI 10.1002/jemt.1060190209; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pop OT, 2011, ROM J MORPHOL EMBRYO, V52, P241; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Ren ZP, 1996, ONCOGENE, V12, P765; Ren ZP, 1997, AM J PATHOL, V150, P1791; Rimoldi D, 2000, INT J CANCER, V86, P749; Sato Y, 2008, FERTIL STERIL, V90, P1310, DOI 10.1016/j.fertnstert.2007.10.019; Sol-Church K, 2006, HUM MUTAT, V27, P736, DOI 10.1002/humu.20381; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; TAN K H, 1991, SMJ Singapore Medical Journal, V32, P41; Tan PH, 2005, MODERN PATHOL, V18, P374, DOI 10.1038/modpathol.3800254; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Ventela ST, 2012, STEM CELLS; Waheeb R, 2011, INT J ANDROL, V34, pE296, DOI 10.1111/j.1365-2605.2011.01199.x; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Zhu XG, 2010, AM J PATHOL, V176, P2333, DOI 10.2353/ajpath.2010.091049	66	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42382	10.1371/journal.pone.0042382	http://dx.doi.org/10.1371/journal.pone.0042382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879958	Green Published, gold			2022-12-25	WOS:000307810000030
J	Hung, YP; Tsai, PJ; Hung, KH; Liu, HC; Lee, CI; Lin, HJ; Wu, YH; Wu, JJ; Ko, WC				Hung, Yuan-Pin; Tsai, Pei-Jane; Hung, Kuei-Hsiang; Liu, Hsiu-Chuan; Lee, Chih-I; Lin, Hsiao-Ju; Wu, Yi-Hui; Wu, Jiunn-Jong; Ko, Wen-Chien			Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan	PLOS ONE			English	Article							RISK-FACTORS; HEMATOLOGICAL MALIGNANCY; NOSOCOMIAL ACQUISITION; DIARRHEA; PREVALENCE; PCR; COHORT; EPIDEMIOLOGY; ADMISSION; RESIDENTS	Background: The impact of toxigenic Clostridium difficile colonization (tCDC) in hospitalized patients is not clear. Aim: To study the significance of tCDC in hospitalized patients. Methods: A prospective study in the medical wards of a regional hospital was performed from January to June 2011. Fecal samples collected from patients at the time of admission were tested for tcdB by real-time polymerase chain reaction (PCR) and cultured for C. difficile. The patients were followed up weekly or when they developed diarrhea during hospitalization. If C. difficile was isolated, tcdA and tcdB would be tested by multiplex PCR. The primary outcome was the development of C. difficile-associated diarrhea (CDAD). Findings: Of 168 patients enrolled, females predominated (87, 51.8%), and the mean patient age was 75.4 years old. Approximately 70% of the patients were nursing home residents, and one third had a recent hospitalization within the prior three months. Twenty-eight (16.7%) patients had tCDC, including 16 (9.5%) patients with tCDC at the time of admission and 12 (7.2%) with tCDC during the follow-up period. With regard to the medications taken during hospitalization, the patients were more likely to have tCDC if they had received more than one class of antibiotics than if they had received monotherapy (odds ratio [OR] 6.67, 95% confidence interval [CI] 1.41-31.56, P = 0.01), particularly if they received a glycopeptide in combination with a cephalosporin or penicillin or a cephalosporin and a carbapenem. More patients with tCDC developed CDAD than those without tCDC (17.9%, 5/28 vs. 1.4%, 2/140, P = 0.002). Overall 7 (4.2%) of the 168 patients developed CDAD, and crude mortality rate of those with and without tCDC was similar (21.4%, 6/28 vs. 19.4%, 27/140, P = 0.79). Conclusion: Recent use of glycopeptides and beta-lactam antibiotics is associated with toxigenic C. difficile colonization, which is a risk factor for developing C. difficile-associated diarrhea.	[Hung, Yuan-Pin; Lee, Chih-I; Lin, Hsiao-Ju] Tainan Hosp, Dept Hlth, Dept Internal Med, Tainan, Taiwan; [Liu, Hsiu-Chuan] Tainan Hosp, Dept Hlth, Dept Expt & Diag, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju; Wu, Yi-Hui; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Hung, Yuan-Pin] Natl Hlth Res Inst, Grad Inst Clin Med, Tainan, Taiwan; [Tsai, Pei-Jane; Hung, Kuei-Hsiang; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan 70428, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Hung, YP (corresponding author), Tainan Hosp, Dept Hlth, Dept Internal Med, Tainan, Taiwan.	jjwu@mail.ncku.edu.tw; winston3415@gmail.com	Ko, Wen-Chien/ABG-4316-2020; hong, hesse/EUM-0179-2022; Tsai, Pei-Jane/G-3563-2011; Wu, Jiunn-Jong/E-6075-2011	Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X; 	National Science Council, Taiwan [NSC 99-2628-B-006-014-MY3]; Department of Health, Executive Yuan, Taiwan [DOH100-TD-B-111-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan	This work was supported by the grants from the National Science Council, Taiwan (NSC 99-2628-B-006-014-MY3) and Department of Health, Executive Yuan, Taiwan (DOH100-TD-B-111-002) for the consumables in the real-time PCR and multiplex PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulou E, 2011, EUR J ONCOL NURS, V15, P404, DOI 10.1016/j.ejon.2010.11.002; Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Chang VT, 2000, CLIN INFECT DIS, V31, P717, DOI 10.1086/314030; Chopra T, 2011, CLIN TRANSPLANT, V25, pE82, DOI 10.1111/j.1399-0012.2010.01331.x; Chopra T, 2010, EXPERT REV ANTI-INFE, V8, P1113, DOI [10.1586/eri.10.95, 10.1586/ERI.10.95]; Chung CH, 2010, J MICROBIOL IMMUNOL, V43, P119, DOI 10.1016/S1684-1182(10)60019-9; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Hornbuckle K, 1998, ANN ONCOL, V9, P307, DOI 10.1023/A:1008295500932; Hutin Y, 1997, CLIN INFECT DIS, V24, P920, DOI 10.1093/clinids/24.5.920; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kent KC, 1998, ANN SURG, V227, P296, DOI 10.1097/00000658-199802000-00021; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kvach EJ, 2010, J CLIN MICROBIOL, V48, P109, DOI 10.1128/JCM.01630-09; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Lin YC, 2011, ANTIMICROB AGENTS CH; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Marciniak C, 2006, ARCH PHYS MED REHAB, V87, P1086, DOI 10.1016/j.apmr.2006.03.020; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McGowan AP, 2011, J HOSP INFECT, V77, P11, DOI 10.1016/j.jhin.2010.09.017; Pant Chaitanya, 2011, J La State Med Soc, V163, P91; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; RAMPLING A, 1985, J CLIN PATHOL, V38, P445, DOI 10.1136/jcp.38.4.445; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; RUDENSKY B, 1993, POSTGRAD MED J, V69, P45, DOI 10.1136/pgmj.69.807.45; Sakai C, 1993, Gan To Kagaku Ryoho, V20, P2413; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Schaier M, 2004, NEPHROL DIAL TRANSPL, V19, P2432, DOI 10.1093/ndt/gfh428; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Spencer RC, 1998, J ANTIMICROB CHEMOTH, V41, P21, DOI 10.1093/jac/41.suppl_3.21; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Winkeljohn D, 2011, CLIN J ONCOL NURS, V15, P215, DOI 10.1188/11.CJON.215-217	39	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42415	10.1371/journal.pone.0042415	http://dx.doi.org/10.1371/journal.pone.0042415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876321	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700049
J	Kengne, AP; Czernichow, S; Hamer, M; Batty, GD; Stamatakis, E				Kengne, Andre Pascal; Czernichow, Sebastien; Hamer, Mark; Batty, G. David; Stamatakis, Emmanuel			Anaemia, Haemoglobin Level and Cause-Specific Mortality in People with and without Diabetes	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK-FACTOR; METAANALYSIS; ASSOCIATION; HEMATOCRIT; EQUIVALENT	Background: Both anaemia and cardiovascular disease (CVD) are common in people with diabetes. While individually both characteristics are known to raise mortality risk, their combined influence has yet to be quantified. In this pooling project, we examined the combined impact of baseline haemoglobin levels and existing CVD on all-cause and CVD mortality in people with diabetes. We draw comparison of these effects with those apparent in diabetes-free individuals. Methods/Principal Findings: A combined analyses of 7 UK population-based cohorts resulted in 26,480 study members. There were 946 participants with physician-diagnosed diabetes, 2227 with anaemia [haemoglobin<13 g/dl (men) or <12 (women)], 2592 with existing CVD (stroke, ischaemic heart disease), and 21,396 with none of the conditions. Across diabetes and anaemia subgroups, and using diabetes-free, non-anaemic participants as the referent group, the adjusted hazard ratios (HR) were 1.46 (95% CI: 1.30-1.63) for anaemia, 1.67 (1.45-1.92) for diabetes, and 2.10 (1.55-2.85) for diabetes and anaemia combined. Across combined diabetes, anaemia and CVD subgroups, and compared with non-anaemic, diabetes-free and CVD-free participants, HR (95% CI) for all-cause mortality were 1.49 (1.32-1.69) anaemia, 1.60 (1.46-1.76) for existing CVD, and 1.66 (1.39-1.97) for diabetes alone. Equivalents were 2.13 (1.48-3.07) for anaemia and diabetes, 2.68 (2.14-3.36) for diabetes and existing CVD, and 3.25 (1.88-5.62) for the three combined. Patterns were similar for CVD mortality. Conclusions/Significance: Individually, anaemia and CVD confer similar mortality risks in people with diabetes, and are excessively fatal in combination. Screening for anaemia would identify vulnerable diabetic patients whose outcomes can potentially be improved.	[Kengne, Andre Pascal] S African MRC, Natl Collaborat Res Programme Cardiovasc & Metab, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Kengne, Andre Pascal] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kengne, Andre Pascal] George Inst Global Hlth, Cardiovasc Div, Sydney, NSW, Australia; [Czernichow, Sebastien] Ambroise Pare Hosp AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles St Quentin, Dept Nutr, Boulogne, France; [Hamer, Mark; Batty, G. David; Stamatakis, Emmanuel] UCL, Dept Epidemiol & Publ Hlth, London, England	South African Medical Research Council; University of Cape Town; Utrecht University; Utrecht University Medical Center; George Institute for Global Health; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	Kengne, AP (corresponding author), S African MRC, Natl Collaborat Res Programme Cardiovasc & Metab, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Batty, GD/Y-4401-2018; Hamer, Mark/AAJ-6814-2021; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/C-1602-2008; Kengne, Andre Pascal/ABB-3696-2020	Batty, GD/0000-0003-1822-5753; Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992; Kengne, Andre Pascal/0000-0002-5183-131X	Wellcome Trust; UK MRC; Chief Scientist Office at Scottish Government Health Directorates	Wellcome Trust(Wellcome TrustEuropean Commission); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office at Scottish Government Health Directorates	GD Batty is supported by a Wellcome Trust Career Development Fellowship. The Medical Research Council (MRC) Social and Public Health Sciences Unit receives funding from the UK MRC and the Chief Scientist Office at the Scottish Government Health Directorates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Bhatia V, 2006, DIABETES CARE, V29, P2289, DOI 10.2337/dc06-0637; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Bulugahapitiya U, 2009, DIABETIC MED, V26, P142, DOI 10.1111/j.1464-5491.2008.02640.x; Chonchol M, 2008, AM HEART J, V155, P494, DOI 10.1016/j.ahj.2007.10.031; Collett D, 2003, MODELLING SURVIVAL D; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Deray G, 2004, AM J NEPHROL, V24, P522, DOI 10.1159/000081058; Dong W, 1997, SCOTTISH HLTH SURVEY; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Erens B, 1999, HLTH SURVEY ENGLAND; Fishbane Steven, 2008, Heart Fail Clin, V4, P401, DOI 10.1016/j.hfc.2008.03.005; Gonzalez-Clemente JM, 2007, REV ESP CARDIOL, V60, P1167, DOI 10.1157/13111789; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kengne AP, 2012, DIABETES CARE, V35, P396, DOI 10.2337/dc11-1588; Lipsic E, 2005, INT J CARDIOL, V100, P289, DOI 10.1016/j.ijcard.2004.10.043; McFarlane Samy I, 2006, Curr Diab Rep, V6, P213, DOI 10.1007/s11892-006-0037-4; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pereira AA, 2003, KIDNEY INT, V64, pS32, DOI 10.1046/j.1523-1755.64.s87.6.x; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Qiao Q, 1997, J CLIN EPIDEMIOL, V50, P153, DOI 10.1016/S0895-4356(96)00335-6; Redondo-Bermejo B, 2007, REV ESP CARDIOL, V60, P597, DOI 10.1157/13107116; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Shaw A., 2000, SCOTTISH HLTH SURVEY; Tong PCY, 2006, DIABETES CARE, V29, P2439, DOI 10.2337/dc06-0887; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; *WHO, 1972, WHO TECHN REP SER, V503; Zoppini G, 2010, ATHEROSCLEROSIS, V210, P575, DOI 10.1016/j.atherosclerosis.2009.12.008	35	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41875	10.1371/journal.pone.0041875	http://dx.doi.org/10.1371/journal.pone.0041875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876293	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700021
J	Corney, DPA; Tang, HLL; Clark, JY; Hu, Y; Jin, J				Corney, David P. A.; Tang, H. Lilian; Clark, Jonathan Y.; Hu, Yin; Jin, Jing			Automating Digital Leaf Measurement: The Tooth, the Whole Tooth, and Nothing but the Tooth	PLOS ONE			English	Article							ACER-RUBRUM; SEED PLANTS; CLIMATE; LEAVES; SHAPE; SIZE; IDENTIFICATION; SENSITIVITY	Many species of plants produce leaves with distinct teeth around their margins. The presence and nature of these teeth can often help botanists to identify species. Moreover, it has long been known that more species native to colder regions have teeth than species native to warmer regions. It has therefore been suggested that fossilized remains of leaves can be used as a proxy for ancient climate reconstruction. Similar studies on living plants can help our understanding of the relationships. The required analysis of leaves typically involves considerable manual effort, which in practice limits the number of leaves that are analyzed, potentially reducing the power of the results. In this work, we describe a novel algorithm to automate the marginal tooth analysis of leaves found in digital images. We demonstrate our methods on a large set of images of whole herbarium specimens collected from Tilia trees (also known as lime, linden or basswood). We chose the genus Tilia as its constituent species have toothed leaves of varied size and shape. In a previous study we extracted c: 1600 leaves automatically from a set of c: 1100 images. Our new algorithm locates teeth on the margins of such leaves and extracts features such as each tooth's area, perimeter and internal angles, as well as counting them. We evaluate an implementation of our algorithm's performance against a manually analyzed subset of the images. We found that the algorithm achieves an accuracy of 85% for counting teeth and 75% for estimating tooth area. We also demonstrate that the automatically extracted features are sufficient to identify different species of Tilia using a simple linear discriminant analysis, and that the features relating to teeth are the most useful.	[Corney, David P. A.; Tang, H. Lilian; Clark, Jonathan Y.; Hu, Yin; Jin, Jing] Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England	University of Surrey	Corney, DPA (corresponding author), Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England.	David.Corney.1@city.ac.uk	Corney, David/C-1601-2008	Corney, David/0000-0002-0651-9028	Leverhulme Trust, MORPHIDAS: the Morphological Herbarium Image Data Analysis research project [F/00 242/H]	Leverhulme Trust, MORPHIDAS: the Morphological Herbarium Image Data Analysis research project	This work was partly funded by the Leverhulme Trust (grant F/00 242/H) as part of MORPHIDAS: the Morphological Herbarium Image Data Analysis research project, and the authors express their gratitude to them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1106 US GEOL SURV; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Belhumeur PN, 2008, LECT NOTES COMPUT SC, V5305, P116, DOI 10.1007/978-3-540-88693-8_9; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Clark J. Y., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P343, DOI 10.1109/CIBCB.2012.6217250; Clark JY, 2009, BOT J LINN SOC, V159, P300, DOI 10.1111/j.1095-8339.2008.00891.x; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Green WA, 2006, PALAEONTOL ELECTRON, V9; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Pigott C.D., 1997, EUROPEAN GARDEN FLOR, V5, P205; Pigott CD, 2012, LIME TREES IN PRESS; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Scotland RW, 2003, TAXON, V52, P101, DOI 10.2307/3647306; Thiers B, 2019, INDEX HERBARIORUM GL; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wolfe JA, 1993, US GEOL SURVEY B, V2040	26	28	28	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42112	10.1371/journal.pone.0042112	http://dx.doi.org/10.1371/journal.pone.0042112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870286	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800059
J	De Houwer, S; Demeulemeester, J; Thys, W; Taltynov, O; Zmajkovicova, K; Christ, F; Debyser, Z				De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Taltynov, Oliver; Zmajkovicova, Katarina; Christ, Frauke; Debyser, Zeger			Identification of Residues in the C-terminal Domain of HIV-1 Integrase That Mediate Binding to the Transportin-SR2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 REPLICATION; NUCLEAR IMPORT RECEPTOR; SR PROTEINS; PREINTEGRATION COMPLEXES; NONDIVIDING CELLS; LENTIVIRAL VECTOR; DNA INTEGRATION; CATALYTIC CORE; IN-VIVO; INFECTION	Transportin-SR2 (TRN-SR2 and TNPO3) is a cellular cofactor of HIV replication that has been implicated in the nuclear import of HIV. TRN-SR2 was originally identified in a yeast two-hybrid screen as an interaction partner of HIV integrase (IN) and in two independent siRNA screens as a cofactor of viral replication. We have now studied the interaction of TRN-SR2 and HIV IN in molecular detail and identified the TRN-SR2 interacting regions of IN. A weak interaction with the catalytic core domain (CCD) and a strong interaction with the C-terminal domain (CTD) of IN were detected. By dissecting the catalytic core domain (CCD) of IN into short structural fragments, we identified a peptide (INIP1, amino acids (170)EHLKTAVQMAVFIHNFKRKGGI(191)) retaining the ability to interact with TRN-SR2. By dissecting the C-terminal domain (CTD) of IN, we could identify two interacting peptides (amino acids (214)QKQITKIQNFRVYYR(228) and (262)RRKVKIIRDYGK(273)) that come together in the CTD tertiary structure to form an exposed antiparallel beta-sheet. Through site-specific mutagenesis, we defined the following sets of amino acids in IN as important for the interaction with TRN-SR2: Phe-185/Lys-186/Arg-187/Lys-188 in the CCD and Arg-262/Arg-263/Lys-264 and Lys-266/Arg-269 in the CTD. An HIV-1 strain carrying K266A/R269A in IN was replication-defective due to a block in reverse transcription, confounding the study of nuclear import. Insight into the IN/TRN-SR2 interaction interface is necessary to guide drug discovery efforts targeting the nuclear entry step of replication.	[De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Taltynov, Oliver; Zmajkovicova, Katarina; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium.	zeger.debyser@med.kuleuven.be	Christ, Frauke/H-7513-2018; Demeulemeester, Jonas/J-6130-2014; debyser, zeger/H-1310-2013	Demeulemeester, Jonas/0000-0002-2660-2478; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	Fonds Wetenschappelijk Onderzoek [G.0487.10N]; European Union; CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie	Fonds Wetenschappelijk Onderzoek(FWO); European Union(European Commission); CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie	This work was supported in part by Fonds Wetenschappelijk Onderzoek Grant G.0487.10N, European Union FP7 Program Grants THINC and CHAARM, and the CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cribier A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-104; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Piller SC, 2003, CURR DRUG TARGETS, V4, P409, DOI 10.2174/1389450033490984; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Van Maele B, 2003, J VIROL, V77, P4685, DOI 10.1128/JVI.77.8.4685-4694.2003; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	54	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34059	34068		10.1074/jbc.M112.387944	http://dx.doi.org/10.1074/jbc.M112.387944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872638	hybrid, Green Published			2022-12-25	WOS:000309654200012
J	Ligons, DL; Tuncer, C; Linowes, BA; Akcay, IM; Kurtulus, S; Deniz, E; Arslan, BA; Cevik, SI; Keller, HR; Luckey, MA; Feigenbaum, L; Moroy, T; Ersahin, T; Atalay, R; Erman, B; Park, JH				Ligons, Davinna L.; Tuncer, Ceren; Linowes, Brett A.; Akcay, Izzet Mehmet; Kurtulus, Sema; Deniz, Emre; Arslan, Belkis Atasever; Cevik, Safak Isil; Keller, Hilary R.; Luckey, Megan A.; Feigenbaum, Lionel; Moeroey, Tarik; Ersahin, Tulin; Atalay, Rengul; Erman, Batu; Park, Jung-Hyun			CD8 Lineage-specific Regulation of Interleukin-7 Receptor Expression by the Transcriptional Repressor Gfi1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DEVELOPMENT; ZINC-FINGER PROTEIN; GA-BINDING-PROTEIN; IL-7 RECEPTOR; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; IL-7R-ALPHA EXPRESSION; THYMOCYTE DEVELOPMENT; ALPHA EXPRESSION; UP-REGULATION	Interleukin-7 receptor alpha (IL-7R alpha) is essential for T cell survival and differentiation. Glucocorticoids are potent enhancers of IL-7R alpha expression with diverse roles in T cell biology. Here we identify the transcriptional repressor, growth factor independent-1 (Gfi1), as a novel intermediary in glucocorticoid-induced IL-7R alpha up-regulation. We found Gfi1 to be a major inhibitory target of dexamethasone by microarray expression profiling of 3B4.15 T-hybridoma cells. Concordantly, retroviral transduction of Gfi1 significantly blunted IL-7R alpha up-regulation by dexamethasone. To further assess the role of Gfi1 in vivo, we generated bacterial artificial chromosome (BAC) transgenic mice, in which a modified Il7r locus expresses GFP to report Il7r gene transcription. By introducing this BAC reporter transgene into either Gfi1-deficient or Gfi1-transgenic mice, we document in vivo that IL-7R alpha transcription is up-regulated in the absence of Gfi1 and down-regulated when Gfi1 is overexpressed. Strikingly, the in vivo regulatory role of Gfi1 was specific for CD8(+), and not CD4(+) T cells or immature thymocytes. These results identify Gfi1 as a specific transcriptional repressor of the Il7r gene in CD8 T lymphocytes in vivo.	[Tuncer, Ceren; Akcay, Izzet Mehmet; Kurtulus, Sema; Deniz, Emre; Arslan, Belkis Atasever; Cevik, Safak Isil; Erman, Batu] Sabanci Univ, FENS, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Ligons, Davinna L.; Linowes, Brett A.; Keller, Hilary R.; Luckey, Megan A.; Park, Jung-Hyun] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Sci Applicat Int Corp Frederick, Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Moeroey, Tarik] Univ Montreal, Dept Microbiol & Immunol, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Ersahin, Tulin; Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Erman, Batu] Sabanci Univ, Nanotechnol Res & Applicat Ctr, SUNUM, TR-34956 Istanbul, Turkey	Sabanci University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Ihsan Dogramaci Bilkent University; Sabanci University	Erman, B (corresponding author), Sabanci Univ, FENS, Biol Sci & Bioengn Program, Univ Caddesi 27, TR-34956 Istanbul, Turkey.	batu@sabanciuniv.edu; parkhy@mail.nih.gov	Davis, Megan/F-5339-2015; CEVIK, ISIL/K-1320-2012; TUNCER, CEREN/AAM-2353-2021; Ersahin, Tulin/M-5721-2013; Cetin-Atalay, Rengul/O-9826-2014; erman, batu/AAE-1963-2020; Cetin-Atalay, Rengul/F-5780-2013; Park, Jung Hyun/B-5712-2015	Ersahin, Tulin/0000-0002-7474-7890; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Park, Jung Hyun/0000-0002-9547-9055; DENIZ, EMRE/0000-0002-9635-983X; , Hilary/0000-0002-6510-5685; Atasever Arslan, Belkis/0000-0001-5827-8484; Davis, Megan/0000-0002-9674-0753; Akcay, Izzet Mehmet/0000-0001-6364-0062	National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research; Scientific and Technological Research Council of Turkey; Turkish National Academy of Science; TUBITAK 1001 [109T315]; National Institutes of Health-FIRCA [1R03TW008208]; National Institutes of Health-GRIP [1R01TW007270]; FOGARTY INTERNATIONAL CENTER [R03TW008208, R01TW007270] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011214] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish National Academy of Science(Turkish Academy of Sciences); TUBITAK 1001(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); National Institutes of Health-FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health-GRIP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research.; Supported by the Scientific and Technological Research Council of Turkey scholarships.; Supported by the Turkish National Academy of Science post-doctoral fellowship.; Supported by TUBITAK 1001 Grant 109T315, National Institutes of Health-FIRCA Grant 1R03TW008208, and National Institutes of Health-GRIP Grant 1R01TW007270.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Brewer JA, 2002, J IMMUNOL, V169, P1309, DOI 10.4049/jimmunol.169.3.1309; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Kim HR, 2007, J IMMUNOL, V178, P5473, DOI 10.4049/jimmunol.178.9.5473; Kim HR, 2006, BLOOD, V107, P2855, DOI 10.1182/blood-2005-09-3560; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pargmann D, 2007, EUR J IMMUNOL, V37, P3551, DOI 10.1002/eji.200737130; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purton JF, 2000, IMMUNITY, V13, P179, DOI 10.1016/S1074-7613(00)00018-2; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Shibata H, 2007, IMMUNOL LETT, V111, P45, DOI 10.1016/j.imlet.2007.04.012; Simon A, 2010, BIOINFORMATICS, V26, P2468, DOI 10.1093/bioinformatics/btq410; Sinclair C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002246; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Vacchio MS, 1999, J IMMUNOL, V163, P1327; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang ZF, 2011, BLOOD, V118, P2243, DOI 10.1182/blood-2010-07-298802; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu SY, 2012, TRANSGENIC RES, V21, P201, DOI 10.1007/s11248-011-9508-8; Zhan YF, 2004, INT IMMUNOL, V16, P1315, DOI 10.1093/intimm/dxh134; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	60	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34386	34399		10.1074/jbc.M112.378687	http://dx.doi.org/10.1074/jbc.M112.378687			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865857	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000309654200041
J	Munoz, IM; MacArtney, T; Sanchez-Pulido, L; Ponting, CP; Rocha, S; Rouse, J				Munoz, Ivan M.; MacArtney, Thomas; Sanchez-Pulido, Luis; Ponting, Chris P.; Rocha, Sonia; Rouse, John			Family with Sequence Similarity 60A (FAM60A) Protein Is a Cell Cycle-fluctuating Regulator of the SIN3-HDAC1 Histone Deacetylase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; D1; EXPRESSION; REPRESSION; CHROMATIN; GROWTH; MICE; SIN3	The SIN3A-HDAC complex deacetylates histones thereby repressing gene transcription. Here we describe family with sequence similarity 60A (FAM60A), a cell cycle-regulated protein that binds to the SIN3-HDAC complex. FAM60A expression peaks during G(1) and S phases of the cell cycle in U2OS cells, in a manner similar to the G(1) regulator cyclin D1, which is a known target of SIN3-HDAC. In this light we found that FAM60A binds to SIN3-HDAC-regulated promoters such as cyclin D1 in G(1) and S phases. Cells depleted of FAM60A show increased histone acetylation at the cyclin D1 promoter and elevated levels of cyclin D1 mRNA and protein. Furthermore, depletion of FAM60A altered the periodic association of HDAC1 with the cyclin D1 promoter, increased cyclin D1 expression at all cell cycle phases, and caused premature S phase entry. The data in this study introduce FAM60A as a novel regulator of SIN3-HDAC function and gene expression.	[Rocha, Sonia] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Munoz, Ivan M.; MacArtney, Thomas; Rouse, John] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England	University of Dundee; University of Dundee; University of Oxford	Rocha, S (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	s.rocha@dundee.ac.uk; j.rouse@dundee.ac.uk	Ponting, Chris/AAV-2621-2021	Rocha, Sonia/0000-0002-2413-4981; Sanchez Pulido, Luis/0000-0002-2300-8502; Munoz Munoz, Ivan/0000-0002-1606-5445; Ponting, Chris/0000-0003-0202-7816	Medical Research Council; Division of Signal Transduction Therapy, University of Dundee; Cancer Research UK; Wellcome Trust; Cancer Research UK [12918] Funding Source: researchfish; Medical Research Council [MC_U137761446, MC_U127070192] Funding Source: researchfish; MRC [MC_U137761446, MC_U127070192] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Signal Transduction Therapy, University of Dundee; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to C.C.P. and J.R.), the Division of Signal Transduction Therapy, University of Dundee (to I.M.M., T.M., and J.R.), Cancer Research UK, and the Wellcome Trust (to S.R.).	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BARTKOVA J, 1995, ONCOGENE, V10, P775; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Han EKH, 1998, PROSTATE, V35, P95, DOI 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Resnitzky D, 1997, MOL CELL BIOL, V17, P5640, DOI 10.1128/MCB.17.9.5640; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	21	26	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32346	32353		10.1074/jbc.M112.382499	http://dx.doi.org/10.1074/jbc.M112.382499			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865885	Green Published, hybrid			2022-12-25	WOS:000309168300006
J	Duenas, M; Santos, M; Aranda, JF; Bielza, C; Martinez-Cruz, AB; Lorz, C; Taron, M; Ciruelos, EM; Rodriguez-Peralto, JL; Martin, M; Larranaga, P; Dahabreh, J; Stathopoulos, GP; Rosell, R; Paramio, JM; Garcia-Escudero, R				Duenas, Marta; Santos, Mirentxu; Aranda, Juan F.; Bielza, Concha; Martinez-Cruz, Ana B.; Lorz, Corina; Taron, Miquel; Ciruelos, Eva M.; Rodriguez-Peralto, Jose L.; Martin, Miguel; Larranaga, Pedro; Dahabreh, Jubrail; Stathopoulos, George P.; Rosell, Rafael; Paramio, Jesus M.; Garcia-Escudero, Ramon			Mouse p53-Deficient Cancer Models as Platforms for Obtaining Genomic Predictors of Human Cancer Clinical Outcomes	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; ESTROGEN-RECEPTOR-ALPHA; HUMAN BREAST; LUNG-CANCER; MOLECULAR SUBTYPES; P53; IDENTIFICATION; MAMMARY; SENSITIVITY; METASTASIS	Mutations in the TP53 gene are very common in human cancers, and are associated with poor clinical outcome. Transgenic mouse models lacking the Trp53 gene or that express mutant Trp53 transgenes produce tumours with malignant features in many organs. We previously showed the transcriptome of a p53-deficient mouse skin carcinoma model to be similar to those of human cancers with TP53 mutations and associated with poor clinical outcomes. This report shows that much of the 682-gene signature of this murine skin carcinoma transcriptome is also present in breast and lung cancer mouse models in which p53 is inhibited. Further, we report validated gene-expression-based tests for predicting the clinical outcome of human breast and lung adenocarcinoma. It was found that human patients with cancer could be stratified based on the similarity of their transcriptome with the mouse skin carcinoma 682-gene signature. The results also provide new targets for the treatment of p53-defective tumours.	[Duenas, Marta; Santos, Mirentxu; Aranda, Juan F.; Martinez-Cruz, Ana B.; Lorz, Corina; Paramio, Jesus M.; Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Bielza, Concha; Larranaga, Pedro] Univ Politecn Madrid, Dept Inteligencia Artificial, Madrid, Spain; [Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain; [Ciruelos, Eva M.] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Hosp Univ 12 Octubre, Dept Pathol, Madrid, Spain; [Rodriguez-Peralto, Jose L.] Univ Complutense Madrid, Inst Invest Hosp Octubre I 12 12, Madrid, Spain; [Martin, Miguel] Univ Complutense Madrid, Hosp Gen Gregorio Maranon, Madrid, Spain; [Dahabreh, Jubrail] Athens Med Ctr, Dept Surg, Athens, Greece; [Stathopoulos, George P.] Errikos Dunant Hosp, Dept Oncol, Athens, Greece	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidad Politecnica de Madrid; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; General University Gregorio Maranon Hospital; Henry Dunant Hospital	Duenas, M (corresponding author), CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain.	jesusm.paramio@ciemat.es; ramon.garcia@ciemat.es	Paramio, Jesus M/M-8482-2014; Santos, Mirentxu/AAA-1727-2020; Martin, Miguel/V-6589-2019; Bielza, Concha/F-9277-2013; Lorz, Corina/E-3651-2016; Martin, Miguel/AAJ-9242-2020; Garcia-Escudero, Ramon/A-2735-2012; Aranda, Juan Francisco/S-6388-2018; Larranaga, Pedro/F-9293-2013	Paramio, Jesus M/0000-0001-7520-3177; Bielza, Concha/0000-0001-7109-2668; Lorz, Corina/0000-0001-8214-9076; Martin, Miguel/0000-0001-9237-3231; Garcia-Escudero, Ramon/0000-0001-5640-6542; Aranda, Juan Francisco/0000-0002-5598-2465; Larranaga, Pedro/0000-0003-0652-9872; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Duenas, Marta/0000-0003-0857-9726; Ciruelos, Eva/0000-0002-2796-1042	CAM [Oncocycle S2006/BIO-0232]; MICINN [ISCIII-RETIC RD06/0020, SAF2008-00121]; Fundacion Sandra Ibarra	CAM; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Sandra Ibarra	Oncocycle S2006/BIO-0232 (CAM), ISCIII-RETIC RD06/0020 (MICINN), and SAF2008-00121 (MICINN). J.M.P. was the recipient of a grant from the Fundacion Sandra Ibarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bornachea O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00434; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Degenhardt Y, 2010, MOL CANCER THER, V9, P2079, DOI 10.1158/1535-7163.MCT-10-0095; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eilon T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-231; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Garcia-Escudero R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-193; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hurd C, 1999, ONCOGENE, V18, P1067, DOI 10.1038/sj.onc.1202398; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schoenherr RM, 2011, PROTEOM CLIN APPL, V5, P179, DOI 10.1002/prca.201000037; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; SILVEY SD, 1959, ANN MATH STAT, V30, P389, DOI 10.1214/aoms/1177706259; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Toussaint J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-424; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	70	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42494	10.1371/journal.pone.0042494	http://dx.doi.org/10.1371/journal.pone.0042494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880004	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000307437900043
J	Hidalgo, J; Seoane, LF; Cortes, JM; Munoz, MA				Hidalgo, Jorge; Seoane, Luis F.; Cortes, Jesus M.; Munoz, Miguel A.			Stochastic Amplification of Fluctuations in Cortical Up-States	PLOS ONE			English	Article							SLOW-WAVE SLEEP; NETWORK MECHANISMS; NEURONAL NETWORKS; DYNAMIC SYNAPSES; CEREBRAL-CORTEX; IN-VITRO; OSCILLATIONS; POPULATION; HZ; TRANSITIONS	Cortical neurons are bistable; as a consequence their local field potentials can fluctuate between quiescent and active states, generating slow 0.5-2 Hz oscillations which are widely known as transitions between Up and Down States. Despite a large number of studies on Up-Down transitions, deciphering its nature, mechanisms and function are still today challenging tasks. In this paper we focus on recent experimental evidence, showing that a class of spontaneous oscillations can emerge within the Up states. In particular, a non-trivial peak around 20 Hz appears in their associated power-spectra, what produces an enhancement of the activity power for higher frequencies ( in the 30{90 Hz band). Moreover, this rhythm within Ups seems to be an emergent or collective phenomenon given that individual neurons do not lock to it as they remain mostly unsynchronized. Remarkably, similar oscillations ( and the concomitant peak in the spectrum) do not appear in the Down states. Here we shed light on these findings by using different computational models for the dynamics of cortical networks in presence of different levels of physiological complexity. Our conclusion, supported by both theory and simulations, is that the collective phenomenon of "stochastic amplification of fluctuations'' - previously described in other contexts such as Ecology and Epidemiology - explains in an elegant and parsimonious manner, beyond model-dependent details, this extra-rhythm emerging only in the Up states but not in the Downs.	[Hidalgo, Jorge; Munoz, Miguel A.] Univ Granada, Dept Electromagnetism & Fis Mat, Granada, Spain; [Hidalgo, Jorge; Munoz, Miguel A.] Univ Granada, Inst Fis Teor & Computac Carlos 1, Granada, Spain; [Seoane, Luis F.] Tech Univ Berlin, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Seoane, Luis F.] UPF CSIC, Inst Biol Evolutiva, Barcelona, Spain; [Cortes, Jesus M.] Univ Granada, Dept Ciencias Computac & Inteligencia Artificial, Granada, Spain	University of Granada; University of Granada; Technical University of Berlin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Granada	Hidalgo, J (corresponding author), Univ Granada, Dept Electromagnetism & Fis Mat, Granada, Spain.	mamunoz@onsager.ugr.es	Munoz, Miguel A/J-9627-2012; Cortes, Jesus/D-9949-2012; MUÑOZ, MIGUEL A/M-4099-2015; , Ivan/D-6804-2012	Munoz, Miguel A/0000-0002-0529-6221; Cortes, Jesus/0000-0002-9059-8194; MUÑOZ, MIGUEL A/0000-0003-0152-9080; Hidalgo, Jorge/0000-0001-7433-5602; , Ivan/0000-0002-3108-058X	Spanish MICINN-FEDER [FIS2009-08451]; Junta de Andalucia Proyecto de Excelencia [P09FQM-4682]; Fundacion P. Barrie de la Maza;  [01GQ1001A]	Spanish MICINN-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); Fundacion P. Barrie de la Maza; 	Funding provided by Spanish MICINN-FEDER under project FIS2009-08451 and Junta de Andalucia Proyecto de Excelencia P09FQM-4682. L.S. acknowledges the financial support of Fundacion P. Barrie de la Maza and funding grant 01GQ1001A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buzsaki G., 2006, RHYTHMS BRAIN; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Fujisawa S, 2006, CEREB CORTEX, V16, P639, DOI 10.1093/cercor/bhj010; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang K, 2010, J COMPUT NEUROSCI, V29, P495, DOI 10.1007/s10827-009-0190-2; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; McCarthy MM, 2011, P NATL ACAD SCI USA, V108, P11620, DOI 10.1073/pnas.1107748108; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Mejias JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013651; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; NISBET RM, 1976, NATURE, V263, P319, DOI 10.1038/263319a0; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Spiridon M, 1999, NETWORK-COMP NEURAL, V10, P257, DOI 10.1088/0954-898X/10/3/304; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wallace E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014804; Wilson Charles, 2008, Scholarpedia J, V3, P1410; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40710	10.1371/journal.pone.0040710	http://dx.doi.org/10.1371/journal.pone.0040710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879879	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900003
J	Peuser, V; Remes, B; Klug, G				Peuser, Verena; Remes, Bernhard; Klug, Gabriele			Role of the Irr Protein in the Regulation of Iron Metabolism in Rhodobacter sphaeroides	PLOS ONE			English	Article							DEPENDENT GENE-EXPRESSION; OXIDATIVE STRESS-RESPONSE; HYDROGEN-PEROXIDE; SINGLET OXYGEN; DESULFOVIBRIO-VULGARIS; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; FUR; RUBRERYTHRIN; RIRA	In Rhizobia the Irr protein is an important regulator for iron-dependent gene expression. We studied the role of the Irr homolog RSP_3179 in the photosynthetic alpha-proteobacterium Rhodobacter sphaeroides. While Irr had little effect on growth under iron-limiting or non-limiting conditions its deletion resulted in increased resistance to hydrogen peroxide and singlet oxygen. This correlates with an elevated expression of katE for catalase in the Irr mutant compared to the wild type under non-stress conditions. Transcriptome studies revealed that Irr affects the expression of genes for iron metabolism, but also has some influence on genes involved in stress response, citric acid cycle, oxidative phosphorylation, transport, and photosynthesis. Most genes showed higher expression levels in the wild type than in the mutant under normal growth conditions indicating an activator function of Irr. Irr was however not required to activate genes of the iron metabolism in response to iron limitation, which showed even stronger induction in the absence of Irr. This was also true for genes mbfA and ccpA, which were verified as direct targets for Irr. Our results suggest that in R. sphaeroides Irr diminishes the strong induction of genes for iron metabolism under iron starvation.	[Peuser, Verena; Remes, Bernhard; Klug, Gabriele] Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany	Justus Liebig University Giessen	Peuser, V (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093; Gluschak, Verena/0000-0001-8612-954X	Deutsche Forschungsgemeinschaft [Kl563/25]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Kl563/25) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Chao TC, 2004, J BACTERIOL, V186, P3609, DOI 10.1128/JB.186.11.3609-3620.2004; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Drews G, 1983, MIKROBIOLOGISCHES PR; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2007, J PROTEOME RES, V6, P2460, DOI 10.1021/pr060624p; Gomelsky L, 2003, MICROBIOL-SGM, V149, P377, DOI 10.1099/mic.0.25972-0; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hibbing ME, 2011, J BACTERIOL, V193, P3461, DOI 10.1128/JB.00317-11; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; Jean D, 2004, MICROBIOL-SGM, V150, P1649, DOI 10.1099/mic.0.27017-0; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Li KY, 2003, ARCH MICROBIOL, V180, P484, DOI 10.1007/s00203-003-0620-x; Li M, 2003, J BIOL INORG CHEM, V8, P149, DOI 10.1007/s00775-002-0400-0; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Martinez M, 2006, MICROBIOL-SGM, V152, P2591, DOI 10.1099/mic.0.28782-0; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Peuser V, 2011, ENV MICROBIOL REP, V3, P397, DOI 10.1111/j.1758-2229.2011.00245.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platero R, 2004, APPL ENVIRON MICROB, V70, P4349, DOI 10.1128/AEM.70.7.4349-4355.2004; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Viguier C, 2005, FEMS MICROBIOL LETT, V246, P235, DOI 10.1016/j.femsle.2005.04.012; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; Wexler M, 2003, MICROBIOL-SGM, V149, P1357, DOI 10.1099/mic.0.26130-0; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Zeilstra-Ryalls JH, 2004, CELL MOL LIFE SCI, V61, P417, DOI 10.1007/s00018-003-3242-1; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zeller T, 2004, MICROBIOL-SGM, V150, P3451, DOI 10.1099/mic.0.27308-0; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06	54	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42231	10.1371/journal.pone.0042231	http://dx.doi.org/10.1371/journal.pone.0042231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879920	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900026
J	Schauble, S; Klement, K; Marthandan, S; Munch, S; Heiland, I; Schuster, S; Hemmerich, P; Diekmann, S				Schaeuble, Sascha; Klement, Karolin; Marthandan, Shiva; Muench, Sandra; Heiland, Ines; Schuster, Stefan; Hemmerich, Peter; Diekmann, Stephan			Quantitative Model of Cell Cycle Arrest and Cellular Senescence in Primary Human Fibroblasts	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; INDUCED PREMATURE SENESCENCE; HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE; REPLICATIVE SENESCENCE; LIFE-SPAN; IN-VIVO; INTRACLONAL VARIATION; STOCHASTIC MECHANISM; CHECKPOINT RESPONSE	Primary human fibroblasts in tissue culture undergo a limited number of cell divisions before entering a non-replicative "senescent'' state. At early population doublings (PD), fibroblasts are proliferation-competent displaying exponential growth. During further cell passaging, an increasing number of cells become cell cycle arrested and finally senescent. This transition from proliferating to senescent cells is driven by a number of endogenous and exogenous stress factors. Here, we have developed a new quantitative model for the stepwise transition from proliferating human fibroblasts (P) via reversibly cell cycle arrested (C) to irreversibly arrested senescent cells (S). In this model, the transition from P to C and to S is driven by a stress function gamma and a cellular stress response function F which describes the time-delayed cellular response to experimentally induced irradiation stress. The application of this model based on senescence marker quantification at the single-cell level allowed to discriminate between the cellular states P, C, and S and delivers the transition rates between the P, C and S states for different human fibroblast cell types. Model-derived quantification unexpectedly revealed significant differences in the stress response of different fibroblast cell lines. Evaluating marker specificity, we found that SA-beta-Gal is a good quantitative marker for cellular senescence in WI-38 and BJ cells, however much less so in MRC-5 cells. Furthermore we found that WI-38 cells are more sensitive to stress than BJ and MRC-5 cells. Thus, the explicit separation of stress induction from the cellular stress response, and the differentiation between three cellular states P, C and S allows for the first time to quantitatively assess the response of primary human fibroblasts towards endogenous and exogenous stress during cellular ageing.	[Schaeuble, Sascha] Univ Jena, Res Grp Theoret Syst Biol, Jena, Germany; [Schaeuble, Sascha; Heiland, Ines; Schuster, Stefan] Univ Jena, Dept Bioinformat, Jena, Germany; [Klement, Karolin; Marthandan, Shiva; Muench, Sandra; Hemmerich, Peter; Diekmann, Stephan] FLI, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schauble, S (corresponding author), Univ Jena, Res Grp Theoret Syst Biol, Jena, Germany.	diekmann@fli-leibniz.de	Heiland, Ines/B-9212-2014; Schäuble, Sascha/AAF-7809-2021	Heiland, Ines/0000-0002-9124-5112; 	Bundesministerium fuer Bildung und Forschung (BMBF) [0315581D]	Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from Bundesministerium fuer Bildung und Forschung (BMBF) (grant no. 0315581D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Golubev A, 2003, J THEOR BIOL, V225, P153, DOI 10.1016/S0022-5193(03)00229-7; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Havelka AM, 2007, MINI-REV MED CHEM, V7, P1035, DOI 10.2174/138955707782110196; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KILL IR, 1994, J CELL SCI, V107, P571; Kim CS, 2007, MOL CELLS, V24, P424; Klement K, 2012, MECH AGEING IN PRESS; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Kronschnabl M, 2003, J GEN VIROL, V84, P61, DOI 10.1099/vir.0.18703-0; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Munch S, 2011, THESIS F SCHILLER U; Nakamura AJ, 2009, AGING-US, V1, P212, DOI 10.18632/aging.100019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; PENNINGDEVRIES FWT, 1975, ANN BOT-LONDON, V39, P77; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Portugal RD, 2008, BIOSYSTEMS, V91, P262, DOI 10.1016/j.biosystems.2007.10.003; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Seluanov A, 2008, AGING CELL, V7, P813, DOI 10.1111/j.1474-9726.2008.00431.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shin JS, 2006, PATHOLOGY, V38, P103, DOI 10.1080/00313020600580468; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; SMITH JR, 1980, SCIENCE, V207, P82; Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tan Z, 1999, J THEOR BIOL, V198, P259, DOI 10.1006/jtbi.1999.0914; THORNLEY JH, 1970, NATURE, V227, P304, DOI 10.1038/227304b0; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Toussaint O, 2002, BIOGERONTOLOGY, V3, P13, DOI 10.1023/A:1015226524335; Toussaint O, 2011, J CELL PHYSIOL, V226, P315, DOI 10.1002/jcp.22416; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Zhao W, 2004, CELL RES, V14, P60, DOI 10.1038/sj.cr.7290203	78	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42150	10.1371/journal.pone.0042150	http://dx.doi.org/10.1371/journal.pone.0042150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879912	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900022
J	Zhou, Q; Bett, GCL; Rasmusson, RL				Zhou, Qinlian; Bett, Glenna C. L.; Rasmusson, Randall L.			Markov Models of Use-Dependence and Reverse Use-Dependence during the Mouse Cardiac Action Potential	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; HUMAN ATRIAL MYOCYTES; LONG QT; K+ CURRENTS; HUMAN HEART; INACTIVATION; CHANNELS; BLOCK; PROLONGATION; DRUGS	The fast component of the cardiac transient outward current, I-Ktof, is blocked by a number of drugs. The major molecular bases of I-Ktof are Kv4.2/Kv4.3 voltage-gated potassium channels. Drugs with similar potencies but different blocking mechanisms have differing effects on action potential duration (APD). We used in silico analysis to determine the effect of I-Ktof-blocking drugs with different blocking mechanisms on mouse ventricular myocytes. We used our existing mouse model of the action potential, and developed 4 new Markov formulations for I-Ktof, I-Ktos, I-Kur, I-Ks. We compared effects of theoretical I-Ktof-specific channel blockers: (1) a closed state, and (2) an open channel blocker. At concentrations lower or close to IC50, the drug which bound to the open state always had a much greater effect on APD than the drug which bound to the closed state. At concentrations much higher than IC50, both mechanisms had similar effects at very low pacing rates. However, an open state binding drug had a greater effect on APD at faster pacing rates, particularly around 10 Hz. In summary, our data indicate that drug effects on APD are strongly dependent not only on IC50, but also on the drug binding state.	[Zhou, Qinlian; Bett, Glenna C. L.; Rasmusson, Randall L.] SUNY Buffalo, Ctr Cellular & Syst Elect, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhou, Q (corresponding author), SUNY Buffalo, Ctr Cellular & Syst Elect, Buffalo, NY USA.	rr32@buffalo.edu	Bett, Glenna/I-8074-2012	Bett, Glenna/0000-0003-2405-6562	NIH [HL062465, HL088058, HL093631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062465, R21HL093631, R21HL088058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the following grants from the NIH: HL062465, HL088058 (RR) and HL093631 (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS ZS, 1991, AM J PHYSIOL, V261, pC310, DOI 10.1152/ajpcell.1991.261.2.C310; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bett GCL, 2004, J PHYSIOL-LONDON, V556, P109, DOI 10.1113/jphysiol.2003.055012; Bett GCL, 2011, BIOPHYS J, V100, P11, DOI 10.1016/j.bpj.2010.11.011; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bondarenko VE, 2007, AM J PHYSIOL-HEART C, V293, pH1816, DOI 10.1152/ajpheart.00471.2007; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burashnikov A, 2011, PHARMACOL THERAPEUT, V132, P300, DOI 10.1016/j.pharmthera.2011.08.002; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P571, DOI 10.1085/jgp.101.4.571; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; Das MK, 2010, J CARDIOVASC PHARM, V55, P438, DOI 10.1097/FJC.0b013e3181d64dde; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Ehrlich JR, 2007, CURR VASC PHARMACOL, V5, P185; Feng JL, 1998, AM J PHYSIOL-HEART C, V275, pH1717, DOI 10.1152/ajpheart.1998.275.5.H1717; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Ich, 2002, SAF PHARM STUD ASS P; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Knollmann BC, 2007, AM J PHYSIOL-HEART C, V292, pH614, DOI 10.1152/ajpheart.01085.2005; Liu SG, 1997, AM J PHYSIOL-HEART C, V272, pH2013, DOI 10.1152/ajpheart.1997.272.4.H2013; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; McEwen DP, 2009, MOL INTERV, V9, P79, DOI 10.1124/mi.9.2.7; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Riera Andres Ricardo Perez, 2008, Cardiol J, V15, P209; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; SNYDERS DJ, 1995, CIRC RES, V77, P575, DOI 10.1161/01.RES.77.3.575; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wang SM, 2005, BIOPHYS J, V89, P3026, DOI 10.1529/biophysj.105.059378; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42295	10.1371/journal.pone.0042295	http://dx.doi.org/10.1371/journal.pone.0042295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879935	gold, Green Submitted, Green Published			2022-12-25	WOS:000307810000027
J	Mangieri, RA; Cofresi, RU; Gonzales, RA				Mangieri, Regina A.; Cofresi, Roberto U.; Gonzales, Rueben A.			Ethanol Seeking by Long Evans Rats Is Not Always a Goal-Directed Behavior	PLOS ONE			English	Article							ACCUMBAL DOPAMINE CONCENTRATION; NUCLEUS-ACCUMBENS; BASAL GANGLIA; 10-PERCENT SUCROSE; COCAINE SEEKING; DEVALUATION; EXPOSURE; PARALLEL	Background: Two parallel and interacting processes are said to underlie animal behavior, whereby learning and performance of a behavior is at first via conscious and deliberate (goal-directed) processes, but after initial acquisition, the behavior can become automatic and stimulus-elicited (habitual). With respect to instrumental behaviors, animal learning studies suggest that the duration of training and the action-outcome contingency are two factors involved in the emergence of habitual seeking of "natural" reinforcers (e. g., sweet solutions, food or sucrose pellets). To rigorously test whether behaviors reinforced by abused substances such as ethanol, in particular, similarly become habitual was the primary aim of this study. Methodology/Principal Findings: Male Long Evans rats underwent extended or limited operant lever press training with 10% sucrose/10% ethanol (10S10E) reinforcement (variable interval (VI) or (VR) ratio schedule of reinforcement), or with 10% sucrose (10S) reinforcement (VI schedule only). Once training and pretesting were complete, the impact of outcome devaluation on operant behavior was evaluated after lithium chloride injections were paired with the reinforcer, or unpaired 24 hours later. After limited, but not extended instrumental training, lever pressing by groups trained under VR with 10S10E and under VI with 10S was sensitive to outcome devaluation. In contrast, responding by both the extended and limited training 10S10E VI groups was not sensitive to ethanol devaluation during the test for habitual behavior. Conclusions/Significance: Operant behavior by rats trained to self-administer an ethanol-sucrose solution showed variable sensitivity to a change in the value of ethanol, with relative insensitivity developing sooner in animals that received time-variable ethanol reinforcement during training sessions. One important implication, with respect to substance abuse in humans, is that initial learning about the relationship between instrumental actions and the opportunity to consume ethanol-containing drinks can influence the time course for the development or expression of habitual ethanol seeking behavior.	[Mangieri, Regina A.; Cofresi, Roberto U.; Gonzales, Rueben A.] Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mangieri, RA (corresponding author), Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA.	reginamangieri@austin.utexas.edu	Mangieri, Regina/N-1602-2019	Mangieri, Regina/0000-0002-4499-6183; Cofresi Bonilla, Roberto Ulises/0000-0003-1131-6142	National Institute on Alcohol and Alcohol Abuse [T32AA007471, F32AA018252, R37AA011852]; National Science Foundation [HRD-0703584]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007471, R37AA011852, F32AA018252] Funding Source: NIH RePORTER	National Institute on Alcohol and Alcohol Abuse; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research support was provided by awards T32AA007471, F32AA018252, and R37AA011852 from the National Institute on Alcohol and Alcohol Abuse (http://www.niaaa.nih.gov) and HRD-0703584 from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Carrillo J, 2008, ALCOHOL, V42, P171, DOI 10.1016/j.alcohol.2008.01.005; Carrillo J, 2011, ALCOHOL, V45, P559, DOI 10.1016/j.alcohol.2011.01.003; Corbit LH, 2012, BIOL PSYCHIAT; DeRusso AL, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00017; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; Donahoe JW, 2000, J EXP ANAL BEHAV, V74, P331, DOI 10.1901/jeab.2000.74-331; Doyon WM, 2006, NEUROPHARMACOLOGY, V51, P487, DOI 10.1016/j.neuropharm.2006.04.005; Doyon WM, 2005, J NEUROCHEM, V93, P1469, DOI 10.1111/j.1471-4159.2005.03137.x; Doyon WM, 2004, ALCOHOL, V34, P261, DOI 10.1016/j.alcohol.2004.10.004; Doyon WM, 2003, ALCOHOL CLIN EXP RES, V27, P1573, DOI 10.1097/01.ALC.0000089959.66222.B8; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hogarth L, 2011, J EXP PSYCHOL-ANIM B, V37, P261, DOI 10.1037/a0022913; Howard EC, 2009, ALCOHOL CLIN EXP RES, V33, P1355, DOI 10.1111/j.1530-0277.2009.00965.x; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jonkman S, 2010, BEHAV PROCESS, V83, P276, DOI 10.1016/j.beproc.2009.12.017; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Ostlund SB, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00019; Redgrave P, 2011, NEUROSCIENCE, V198, P138, DOI 10.1016/j.neuroscience.2011.07.060; Rescorla RA, 1996, ANIM LEARN BEHAV, V24, P450, DOI 10.3758/BF03199016; RESCORLA RA, 1995, Q J EXP PSYCHOL-B, V48, P252; Roberts AJ, 1999, ALCOHOL CLIN EXP RES, V23, P1151, DOI 10.1097/00000374-199907000-00003; Robinson DL, 2009, ALCOHOL CLIN EXP RES, V33, P1187, DOI 10.1111/j.1530-0277.2009.00942.x; Root DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007170; Samson HH, 1999, PSYCHOPHARMACOLOGY, V147, P274, DOI 10.1007/s002130051167; Samson HH, 2004, ALCOHOL, V32, P203, DOI 10.1016/j.alcohol.2004.02.002; Seger CA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00066; Shahan TA, 2004, BEHAV PHARMACOL, V15, P279, DOI 10.1097/01.fbp.0000135706.93950.1a; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010	38	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42886	10.1371/journal.pone.0042886	http://dx.doi.org/10.1371/journal.pone.0042886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870342	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100178
J	Pham, NT; Jewell, WT; Morin, D; Jones, AD; Buckpitt, AR				Pham, Nathalie T.; Jewell, William T.; Morin, Dexter; Jones, A. Daniel; Buckpitt, Alan R.			Characterization of Model Peptide Adducts with Reactive Metabolites of Naphthalene by Mass Spectrometry	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; COVALENT BINDING; PROTEIN TARGETS; IN-VIVO; LIVER; 1,4-NAPHTHOQUINONE; HEMOGLOBIN; LYSINE; MICE; 1,2-NAPHTHOQUINONE	Naphthalene is a volatile polycyclic aromatic hydrocarbon generated during combustion and is a ubiquitous chemical in the environment. Short term exposures of rodents to air concentrations less than the current OSHA standard yielded necrotic lesions in the airways and nasal epithelium of the mouse, and in the nasal epithelium of the rat. The cytotoxic effects of naphthalene have been correlated with the formation of covalent protein adducts after the generation of reactive metabolites, but there is little information about the specific sites of adduction or on the amino acid targets of these metabolites. To better understand the chemical species produced when naphthalene metabolites react with proteins and peptides, we studied the formation and structure of the resulting adducts from the incubation of model peptides with naphthalene epoxide, naphthalene diol epoxide, 1,2-naphthoquinone, and 1,4-naphthoquinone using high resolution mass spectrometry. Identification of the binding sites, relative rates of depletion of the unadducted peptide, and selectivity of binding to amino acid residues were determined. Adduction occurred on the cysteine, lysine, and histidine residues, and on the N-terminus. Monoadduct formation occurred in 39 of the 48 reactions. In reactions with the naphthoquinones, diadducts were observed, and in one case, a triadduct was detected. The results from this model peptide study will assist in data interpretation from ongoing work to detect peptide adducts in vivo as markers of biologic effect.	[Pham, Nathalie T.; Morin, Dexter; Buckpitt, Alan R.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Jewell, William T.] Univ Calif Davis, Mol Struct Facil, Davis, CA 95616 USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of California System; University of California Davis; University of California System; University of California Davis; Michigan State University; Michigan State University	Pham, NT (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	natpham@ucdavis.edu	Jones, Arthur D/C-2670-2013	Jones, A. Daniel/0000-0002-7408-6690	National Institutes of Environmental Health [ES 04311, ES 04699]; Floyd and Mary Schwall Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004311, P42ES004699] Funding Source: NIH RePORTER	National Institutes of Environmental Health; Floyd and Mary Schwall Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Environmental Health [Grant ES 04311, ES 04699]. NP was supported by a fellowship from the Floyd and Mary Schwall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBAL RB, 1995, CHEM RES TOXICOL, V8, P729, DOI 10.1021/tx00047a013; Booth ED, 2004, CHEM-BIOL INTERACT, V147, P213, DOI 10.1016/j.cbi.2004.01.002; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Chao YCE, 2006, ENVIRON HEALTH PERSP, V114, P182, DOI 10.1289/ehp.8288; CHO M, 1994, J PHARMACOL EXP THER, V269, P881; COLES B, 1985, DRUG METAB REV, V15, P1307, DOI 10.3109/03602538409029962; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; DeStefano-Shields C, 2010, ENVIRON HEALTH PERSP, V118, P647, DOI 10.1289/ehp.0901333; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Hanzlik RP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-95; Hettick JM, 2011, ANAL BIOCHEM, V414, P232, DOI 10.1016/j.ab.2011.03.035; Humphreys WG, 2011, CHEM-BIOL INTERACT, V192, P56, DOI 10.1016/j.cbi.2011.01.005; Ikehata K, 2008, CHEM RES TOXICOL, V21, P1432, DOI 10.1021/tx800093k; Jagr M, 2007, CHEM RES TOXICOL, V20, P1442, DOI 10.1021/tx700057t; Kristiansson MH, 2003, BIOMARKERS, V8, P343, DOI 10.1080/13547500310001607836; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Lin CY, 2006, PROTEOMICS, V6, P972, DOI 10.1002/pmic.200500170; Liu J, 2005, CHEM RES TOXICOL, V18, P1485, DOI 10.1021/tx0501738; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; National Toxicology Program, 2000, 500 NTP; Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s; Pham N, 2012, CHEM BIOL INTERACTIO; Pham N, 2011, TOXICOLOGIST, V120; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; ROBERTS SA, 1990, TOXICOL APPL PHARM, V105, P195, DOI 10.1016/0041-008X(90)90181-S; Stamper BD, 2011, CHEM RES TOXICOL, V24, P549, DOI 10.1021/tx1004198; Tang W, 2010, DRUG METAB REV, V42, P225, DOI 10.3109/03602530903401658; TSANG WS, 1982, J ORG CHEM, V47, P5339, DOI 10.1021/jo00148a021; TSURUDA LS, 1995, DRUG METAB DISPOS, V23, P129; TSURUDA LS, 1995, ARCH TOXICOL, V69, P362, DOI 10.1007/s002040050185; Waidyanatha S, 2002, CHEM-BIOL INTERACT, V141, P189, DOI 10.1016/S0009-2797(02)00048-0; Waidyanatha S, 2008, CHEM-BIOL INTERACT, V172, P105, DOI 10.1016/j.cbi.2008.01.004; YAGI H, 1975, J AM CHEM SOC, V97, P3185, DOI 10.1021/ja00844a044; ZHANG MJ, 1993, J BIOL CHEM, V268, P22420; Zheng J, 1997, CHEM RES TOXICOL, V10, P1008, DOI 10.1021/tx970061j	36	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42053	10.1371/journal.pone.0042053	http://dx.doi.org/10.1371/journal.pone.0042053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870282	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100044
J	Smith, CR; Mutti, NS; Jasper, WC; Naidu, A; Smith, CD; Gadau, J				Smith, Chris R.; Mutti, Navdeep S.; Jasper, W. Cameron; Naidu, Agni; Smith, Christopher D.; Gadau, Juergen			Patterns of DNA Methylation in Development, Division of Labor and Hybridization in an Ant with Genetic Caste Determination	PLOS ONE			English	Article							RED HARVESTER ANT; HYBRID ORIGIN; DRAFT GENOME; EVOLUTION; WIDESPREAD; INSECT; SYSTEM; AMPLIFICATION; METHYLOME; FREQUENCY	Background: DNA methylation is a common regulator of gene expression, including acting as a regulator of developmental events and behavioral changes in adults. Using the unique system of genetic caste determination in Pogonomyrmex barbatus, we were able to document changes in DNA methylation during development, and also across both ancient and contemporary hybridization events. Methodology/Principal Findings: Sodium bisulfite sequencing demonstrated in vivo methylation of symmetric CG dinucleotides in P. barbatus. We also found methylation of non-CpG sequences. This validated two bioinformatics methods for predicting gene methylation, the bias in observed to expected ratio of CpG dinucleotides and the density of CpG/TpG single nucleotide polymorphisms (SNP). Frequencies of genomic DNA methylation were determined for different developmental stages and castes using ms-AFLP assays. The genetic caste determination system (GCD) is probably the product of an ancestral hybridization event between P. barbatus and P. rugosus. Two lineages obligately co-occur within a GCD population, and queens are derived from intra-lineage matings whereas workers are produced from inter-lineage matings. Relative DNA methylation levels of queens and workers from GCD lineages (contemporary hybrids) were not significantly different until adulthood. Virgin queens had significantly higher relative levels of DNA methylation compared to workers. Worker DNA methylation did not vary among developmental stages within each lineage, but was significantly different between the currently hybridizing lineages. Finally, workers of the two genetic caste determination lineages had half as many methylated cytosines as workers from the putative parental species, which have environmental caste determination. Conclusions/Significance: These results suggest that DNA methylation may be a conserved regulatory mechanism moderating division of labor in both bees and ants. Current and historic hybridization appear to have altered genomic methylation levels suggesting a possible link between changes in overall DNA methylation and the origin and regulation of genetic caste determination in P. barbatus.	[Smith, Chris R.; Mutti, Navdeep S.; Gadau, Juergen] Earlham Coll, Dept Biol, Richmond, IN 47374 USA; [Smith, Chris R.] Arizona State Univ, Sch Life Sci, Ctr Social Dynam & Complex, Tempe, AZ USA; [Jasper, W. Cameron; Naidu, Agni; Smith, Christopher D.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Earlham College; Arizona State University; Arizona State University-Tempe; California State University System; San Francisco State University	Smith, CR (corresponding author), Earlham Coll, Dept Biol, Richmond, IN 47374 USA.	crsmith.ant@gmail.com		Smith, Chris/0000-0003-4667-9509	Arizona State University; National Science Foundation [IOS-0920732]; Division Of Integrative Organismal Systems [0920732] Funding Source: National Science Foundation	Arizona State University; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded primarily by a Post-doctoral Interdisciplinary Research in the Life Sciences (PIRLS) grant from Arizona State University to C. R. Smith and N. S. Mutti. Additional funding was provided by a grant from the National Science Foundation (IOS-0920732) to J. Gadau and C. R. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Kirk E., 2008, Myrmecological News, V11, P119; Anderson KE, 2006, ECOLOGY, V87, P2171, DOI 10.1890/0012-9658(2006)87[2171:DAEOGC]2.0.CO;2; Anderson KE, 2009, EVOLUTION, V63, P2142, DOI 10.1111/j.1558-5646.2009.00696.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Cahan SH, 2004, CURR BIOL, V14, P2277, DOI 10.1016/j.cub.2004.12.027; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; EVANS JD, 1993, MOL ECOL, V2, P393, DOI 10.1111/j.1365-294X.1993.tb00032.x; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Flores KB, 2011, J EXP BIOL, V214, P3155, DOI 10.1242/jeb.059741; Foitzik S, 1997, INSECT SOC, V44, P219, DOI 10.1007/s000400050043; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hahn DA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P100, DOI 10.1086/380214; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Kim SH, 2006, PLOS GENET, V2, P1527, DOI 10.1371/journal.pgen.0020163; Krauss V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007223; Kronforst MR, 2008, CURR BIOL, V18, pR287, DOI 10.1016/j.cub.2008.02.015; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lewis S.E., 2002, GENOME BIOL, V3; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lockett GA, 2012, GENES BRAIN BEHAV, V11, P235, DOI 10.1111/j.1601-183X.2011.00751.x; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Park J, 2011, MOL BIOL EVOL, V28, P3345, DOI 10.1093/molbev/msr168; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schutt S, 2003, GENETICS, V165, P223; Schwander T, 2008, EVOLUTION, V62, P1635, DOI 10.1111/j.1558-5646.2008.00387.x; Schwander T, 2008, CURR BIOL, V18, P265, DOI 10.1016/j.cub.2008.01.024; Schwander T, 2007, MOL ECOL, V16, P367, DOI 10.1111/j.1365-294X.2006.03124.x; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Sirvio A, 2011, EVOLUTION, V65, P869, DOI 10.1111/j.1558-5646.2010.01170.x; Smith CR, 2008, AM NAT, V172, P497, DOI 10.1086/590961; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Volny VP, 2002, MOL ECOL NOTES, V2, P302, DOI 10.1046/j.1471-8286.2002.00243.x; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao Y, 2008, MOL BIOL+, V42, P169, DOI 10.1134/S0026893308020015; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	58	47	48	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42433	10.1371/journal.pone.0042433	http://dx.doi.org/10.1371/journal.pone.0042433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879983	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100093
J	Lee, JJ; Kim, YM; Jeong, J; Bae, DS; Lee, KJ				Lee, Jae-Jin; Kim, Young Mee; Jeong, Jaeho; Bae, Duk Soo; Lee, Kong-Joo			Ubiquitin-Associated (UBA) Domain in Human Fas Associated Factor 1 Inhibits Tumor Formation by Promoting Hsp70 Degradation	PLOS ONE			English	Article							NF-KAPPA-B; POSTTRANSLATIONAL MODIFICATIONS; LIGASE ACTIVITY; PAGETS-DISEASE; PROTEINS; PROTEASOME; BINDING; IDENTIFICATION; SUPPRESSOR; APOPTOSIS	Human Fas associated factor 1 (hFAF1) is a pro-apoptotic scaffolding protein containing ubiquitin-associating (UBA), ubiquitin like 1 and 2 (UBL1, UBL2), and ubiquitin regulatory X (UBX) domains. hFAF1 interacts with polyubiquitinated proteins via its N-terminal UBA domain and with valosin containing protein (VCP) via its C-terminal UBX domain. Overexpression of hFAF1 or its N-terminal UBA domain significantly increases cell death by increasing the degradation of polyubiquitinated proteins. In this study, we investigated whether hFAF1, whose expression level is reduced in cervical cancer, plays a role in tumor formation. We found that HeLa cells overexpressing full-length hFAF1 or the hFAF1 UBA domain alone, significantly suppressed the anchorage independent tumor growth in soft agar colony formation, increased cell death, and activated JNK and caspase 3. Employing UBA-specific tandem immunoprecipitation, we identified moieties specifically interacting with UBA domain of hFAF1, and found that polyubiquitinated Hsp70s are recruited to UBA domain. We also demonstrated that hFAF1 overexpression promotes Hsp70 degradation via the proteasome. We further found that mutating the UBA domain (I41N), as well as knocking down hFAF1 with specific RNAi, abolishs its ability to increase the proteasomal degradation of Hsp70. These findings suggest that hFAF1 inhibits tumor formation by increasing the degradation of Hsp70 mediated via its UBA domain.	[Lee, Jae-Jin; Kim, Young Mee; Jeong, Jaeho; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling, Div Life & Pharmaceut Sci,Dept Bioinspired Sci, Seoul, South Korea; [Bae, Duk Soo] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JJ (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling, Div Life & Pharmaceut Sci,Dept Bioinspired Sci, Seoul, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University from National Core Research Center (NCRC) [R15-2006-020]; WCU (World Class University) [R31-2008-000-10010-0]; Brain Korea 21 project	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University from National Core Research Center (NCRC); WCU (World Class University); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported through the Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University from the National Core Research Center (NCRC) program and by WCU (World Class University) project R31-2008-000-10010-0). Lee JJ and Kim YM were supported by the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Daniel DC, 2002, MICROSC RES TECHNIQ, V59, P68, DOI 10.1002/jemt.10178; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	38	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40361	10.1371/journal.pone.0040361	http://dx.doi.org/10.1371/journal.pone.0040361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876279	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700007
J	Shepherd, LD; Worthy, TH; Tennyson, AJD; Scofield, RP; Ramstad, KM; Lambert, DM				Shepherd, Lara D.; Worthy, Trevor H.; Tennyson, Alan J. D.; Scofield, R. Paul; Ramstad, Kristina M.; Lambert, David M.			Ancient DNA Analyses Reveal Contrasting Phylogeographic Patterns amongst Kiwi (Apteryx spp.) and a Recently Extinct Lineage of Spotted Kiwi	PLOS ONE			English	Article							QUATERNARY FOSSIL FAUNAS; NEW-ZEALAND; SOUTH-ISLAND; HYBRIDIZATION; CONSERVATION; CANTERBURY; DIVERGENCE; HISTORY; MAXIMUM; CAVES	The little spotted kiwi (Apteryx owenii) is a flightless ratite formerly found throughout New Zealand but now greatly reduced in distribution. Previous phylogeographic studies of the related brown kiwi (A. mantelli, A. rowi and A. australis), with which little spotted kiwi was once sympatric, revealed extremely high levels of genetic structuring, with mitochondrial DNA haplotypes often restricted to populations. We surveyed genetic variation throughout the present and pre-human range of little spotted kiwi by obtaining mitochondrial DNA sequences from contemporary and ancient samples. Little spotted kiwi and great spotted kiwi (A. haastii) formed a monophyletic clade sister to brown kiwi. Ancient samples of little spotted kiwi from the northern North Island, where it is now extinct, formed a lineage that was distinct from remaining little spotted kiwi and great spotted kiwi lineages, potentially indicating unrecognized taxonomic diversity. Overall, little spotted kiwi exhibited much lower levels of genetic diversity and structuring than brown kiwi, particularly through the South Island. Our results also indicate that little spotted kiwi (or at least hybrids involving this species) survived on the South Island mainland until more recently than previously thought.	[Shepherd, Lara D.; Lambert, David M.] Massey Univ, Allan Wilson Ctr, Auckland, New Zealand; [Shepherd, Lara D.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Shepherd, Lara D.; Tennyson, Alan J. D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Scofield, R. Paul] Canterbury Museum, Christchurch, New Zealand; [Ramstad, Kristina M.] Victoria Univ Wellington, Sch Biol Sci, Allan Wilson Ctr, Wellington, New Zealand; [Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Massey University; Massey University; University of New South Wales Sydney; Victoria University Wellington; Griffith University; Griffith University	Shepherd, LD (corresponding author), Massey Univ, Allan Wilson Ctr, Auckland, New Zealand.	Lara.Shepherd@tepapa.govt.nz	Ramstad, Kristina/AAC-1103-2019; Scofield, R. Paul/A-4271-2011; Ramstad, Kristina/AAV-7517-2021; Worthy, Trevor/B-3781-2012; Ramstad, Kristina/G-3728-2014	Scofield, R. Paul/0000-0002-7510-6980; Ramstad, Kristina/0000-0002-4979-6543; Worthy, Trevor/0000-0001-7047-4680; Shepherd, Lara/0000-0002-7136-0017; Lambert, David/0000-0002-5821-3637	Massey University Doctoral Scholarship; New Zealand Federation of University Women; Marsden Fund grant [MAU302]	Massey University Doctoral Scholarship; New Zealand Federation of University Women; Marsden Fund grant(Royal Society of New ZealandMarsden Fund (NZ))	L.D.S. acknowledges financial support from a Massey University Doctoral Scholarship and the New Zealand Federation of University Women. This research was supported by a Marsden Fund grant (MAU302) to D. M. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BAKER AJ, 1995, P NATL ACAD SCI USA, V92, P8254, DOI 10.1073/pnas.92.18.8254; Barrell DJA, 2005, 20057 I GEOL NUCL SC; Basse B, 2003, NEW ZEAL J ECOL, V27, P95; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; Brochu CA, 2004, EVOLUTION, V58, P1375; Buller WL, 1888, HIST BIRDS NZ, V2; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Butler D, 1991, KIWI RECOVERY PLAN; Colbourne R. M., 2005, DEP CONSERVATION RES, V208; Drost F, 2007, QUATERNARY SCI REV, V26, P2505, DOI 10.1016/j.quascirev.2007.06.005; Drummond AJ, 2010, GENEIOUS V5 3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fleming C.A., 1986, Notornis, V33, P245; Forbes Y, 2009, THESIS AUCKLAND U TE; Garcia-Moreno J, 2004, J AVIAN BIOL, V35, P465, DOI 10.1111/j.0908-8857.2004.03316.x; Gardner RC, 2004, BIOL J LINN SOC, V83, P399, DOI 10.1111/j.1095-8312.2004.00398.x; Gibb J. G., 1986, R SOC NZ B, V24, P377; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEATHER BD, 2000, FIELD GUIDE BIRDS NZ; Herbert J., 2002, SOME EARLY 1990S STU, P11; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Holzapfel S, 2008, KIWI APTERYX SPP REC; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutching G., 2004, BACK BRINK FIGHT SAV; IUCN, 2019, IUCN RED LIST THREAT; Jolly Jim N., 2002, New Zealand Department of Conservation Science & Research Internal Report, V191, P57; Jolly JN, 1992, GREAT SPOTTED UNPUB; Jolly JN, 1990, KIWIS, P86; Jolly JN, 1983, 2 NZ WILDL SERV; Lambert DM, 1993, MORPHOLOGICAL RESEMB, P63; Leschen RAB, 2008, MOL ECOL, V17, P1256, DOI 10.1111/j.1365-294X.2007.03630.x; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Marsh S, 2005, KIWI HUNTER; Marske KA, 2009, MOL ECOL, V18, P5126, DOI 10.1111/j.1365-294X.2009.04418.x; MATHEWS G. M., 1935, BULL BRIT ORNITH CLUB, V55, P179; McGlone MS, 2010, TERRA AUSTRALIS, V32, P49; MCGLONE MS, 1985, NEW ZEAL J BOT, V23, P723, DOI 10.1080/0028825X.1985.10434240; McLennan J, 2002, SOME EARLY 1990S STU, P35; MCLENNAN JA, 1987, NEW ZEAL J ECOL, V10, P97; McLennan JA, 1990, MONOGRAPH APTERYGIDA, P72; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miskelly Colin M., 2008, Notornis, V55, P117; Morgan-Richards M, 2009, J ROY SOC NEW ZEAL, V39, P15, DOI 10.1080/03014220909510561; Newnham RM, 2004, PALAEOGEOGR PALAEOCL, V207, P165, DOI 10.1016/j.palaeo.2004.02.007; PEAT N, 1990, INCREDIBLE KIWI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Ramstad KM, 2010, CONSERV GENET RESOUR, V2, P333, DOI 10.1007/s12686-010-9233-2; Reid B, 1975, BIOGEOGRAPHY ECOLOGY, P301; Reischek A, 1930, YESTERDAYS MAORILAND; Robertson H., 2004, SCI CONSERVATION, V241; Rothschild W, 1899, NOVITATES ZOOLOGICAE, V6, P361; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shepherd LD, 2008, MOL ECOL, V17, P2174, DOI 10.1111/j.1365-294X.2008.03749.x; Shepherd LD, 2007, MOL ECOL, V16, P4536, DOI 10.1111/j.1365-294X.2007.03451.x; Shepherd LD, 2011, MOL ECOL, V20, P1389, DOI 10.1111/j.1365-294X.2011.05017.x; Shepherd LD, 2006, MOL ECOL NOTES, V6, P227, DOI 10.1111/j.1471-8286.2005.01201.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taborsky B, 1999, J AVIAN BIOL, V30, P143, DOI 10.2307/3677123; Tennyson Alan J. D., 2003, Records of the Auckland Museum, V40, P55; Trewick Steven A., 2011, Insects, V2, P297, DOI 10.3390/insects2030297; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; WILKINSON AS, 1952, KAPITI BIRD SANCTUAR; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY; Worthy T. H., 1998, Records of the Canterbury Museum, V12, P49; Worthy TH, 1997, J ROY SOC NEW ZEAL, V27, P67, DOI 10.1080/03014223.1997.9517528; WORTHY TH, 1994, J ROY SOC NEW ZEAL, V24, P297, DOI 10.1080/03014223.1994.9517474; Worthy TH, 1998, J ROY SOC NEW ZEAL, V28, P537, DOI 10.1080/03014223.1998.9517575; WORTHY TH, 1995, J ROY SOC NEW ZEAL, V25, P333, DOI 10.1080/03014223.1995.9517494; Worthy TH, 1998, J ROYAL SOC NZ, V28, P42; WORTHY TH, 2002, LOST WORLD MOA; Worthy Trevor H., 2002, Tuhinga Records of the Museum of New Zealand Te Papa Tongarewa, V13, P1	77	32	35	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42384	10.1371/journal.pone.0042384	http://dx.doi.org/10.1371/journal.pone.0042384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876319	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700047
J	Valles, I; Pajares, MJ; Segura, V; Guruceaga, E; Gomez-Roman, J; Blanco, D; Tamura, A; Montuenga, LM; Pio, R				Valles, Inaki; Pajares, Maria J.; Segura, Victor; Guruceaga, Elisabet; Gomez-Roman, Javier; Blanco, David; Tamura, Akiko; Montuenga, Luis M.; Pio, Ruben			Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; NUCLEAR RIBONUCLEOPROTEIN A2/B1; TUMOR-SUPPRESSOR GENE; MESSENGER-RNA; LONG ARM; EXPRESSION PROFILES; PROSTATE-CANCER; DIFFERENTIAL EXPRESSION; SPLICING MACHINERY; MALIGNANT GLIOMAS	Lung cancer is a leading cause of cancer death worldwide. Several alterations in RNA metabolism have been found in lung cancer cells; this suggests that RNA metabolism-related molecules are involved in the development of this pathology. In this study, we searched for RNA metabolism-related genes that exhibit different expression levels between normal and tumor lung tissues. We identified eight genes differentially expressed in lung adenocarcinoma microarray datasets. Of these, seven were up-regulated whereas one was down-regulated. Interestingly, most of these genes had not previously been associated with lung cancer. These genes play diverse roles in mRNA metabolism: three are associated with the spliceosome (ASCL3L1, SNRPB and SNRPE), whereas others participate in RNA-related processes such as translation (MARS and MRPL3), mRNA stability (PCBPC1), mRNA transport (RAE), or mRNA editing (ADAR2, also known as ADARB1). Moreover, we found a high incidence of loss of heterozygosity at chromosome 21q22.3, where the ADAR2 locus is located, in NSCLC cell lines and primary tissues, suggesting that the downregulation of ADAR2 in lung cancer is associated with specific genetic losses. Finally, in a series of adenocarcinoma patients, the expression of five of the deregulated genes (ADAR2, MARS, RAE, SNRPB and SNRPE) correlated with prognosis. Taken together, these results support the hypothesis that changes in RNA metabolism are involved in the pathogenesis of lung cancer, and identify new potential targets for the treatment of this disease.	[Valles, Inaki; Pajares, Maria J.; Blanco, David; Montuenga, Luis M.; Pio, Ruben] Ctr Appl Med Res, Div Oncol, Pamplona, Spain; [Pajares, Maria J.; Blanco, David; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Segura, Victor; Guruceaga, Elisabet] Ctr Appl Med Res, Genom & Bioinformat Unit, Pamplona, Spain; [Gomez-Roman, Javier] Univ Cantabria, Dept Pathol, Marques de Valdecilla Univ Hosp, Sch Med, E-39005 Santander, Spain; [Tamura, Akiko] Univ Navarra Clin, Dept Thorac Surg, Pamplona, Spain; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Navarra; University of Navarra	Valles, I (corresponding author), Ctr Appl Med Res, Div Oncol, Pamplona, Spain.	lmontuenga@unav.es; rpio@unav.es	Montuenga, Luis M/AAF-7783-2020; José Javier, Gómez-Román/AAC-8156-2021; Pio, Ruben/F-5353-2017; Segura, Victor/E-4531-2010; Guruceaga, Elizabeth/B-1796-2008	Montuenga, Luis M/0000-0002-8739-1387; José Javier, Gómez-Román/0000-0002-2849-9435; Pio, Ruben/0000-0002-6831-6111; Segura, Victor/0000-0002-7740-6290; Guruceaga, Elizabeth/0000-0003-0547-681X	UTE project CIMA; Spanish Government [ISCIII452RTICC RD06/0020/0066, PI02/1116, PI10/00166]; European Regional Development Fund (ERDF) "Una manera de hacer Europa"	UTE project CIMA; Spanish Government(Spanish GovernmentEuropean Commission); European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission)	This work has been supported by "UTE project CIMA"; Spanish Government (ISCIII452RTICC RD06/0020/0066, PI02/1116 and PI10/00166), European Regional Development Fund (ERDF) "Una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2011, CANCER CELL, V20, P420, DOI 10.1016/j.ccr.2011.10.004; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Castano Z, 2008, INT J CANCER, V122, P1512, DOI 10.1002/ijc.23236; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen R, 2011, J INT MED RES, V39, P533, DOI 10.1177/147323001103900222; CLIBY W, 1993, CANCER RES, V53, P2393; Comtesse N, 2007, INT J CANCER, V120, P2538, DOI 10.1002/ijc.22585; Cuende J, 2008, ONCOGENE, V27, P3339, DOI 10.1038/sj.onc.1210987; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Ebert B, 2011, NEW ENGL J MED, V365, P2534, DOI 10.1056/NEJMe1111584; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Flanagan JM, 2009, MOL CANCER THER, V8, P249, DOI 10.1158/1535-7163.MCT-08-0636; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jia D, 2011, HEPATOLOGY; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Katzenellenbogen RA, 2010, J VIROL, V84, P12934, DOI 10.1128/JVI.01377-10; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kuo WP, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P415; KUSHNER JP, 1976, P SOC EXP BIOL MED, V153, P273; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Lee EB, 2003, ANN THORAC SURG, V75, P1597, DOI 10.1016/S0003-4975(02)04902-0; Li Z, 2008, J CELL MOL MED, V12, P2427, DOI 10.1111/j.1582-4934.2008.00244.x; Liu YF, 2007, ONCOL REP, V18, P943; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Mayama T, 2000, INT J ONCOL, V17, P245; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Miura K, 2011, CANCER SCI, V102, P309, DOI 10.1111/j.1349-7006.2010.01797.x; Ohgaki K, 1998, GENE CHROMOSOME CANC, V23, P244, DOI 10.1002/(SICI)1098-2264(199811)23:3<244::AID-GCC6>3.3.CO;2-#; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Park SW, 2010, GUT LIVER, V4, P430, DOI 10.5009/gnl.2010.4.3.430; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peebles KA, 2007, MOL CARCINOGEN, V46, P887, DOI 10.1002/mc.20321; Petersen S, 2000, BRIT J CANCER, V82, P65; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Pio R, 2004, CANCER RES, V64, P4171, DOI 10.1158/0008-5472.CAN-03-2982; Pio R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-352; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Sakata K, 1997, GENE CHROMOSOME CANC, V18, P318, DOI 10.1002/(SICI)1098-2264(199704)18:4<318::AID-GCC12>3.3.CO;2-#; SATO S, 1994, CANCER RES, V54, P5652; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Sueoka E, 2005, LUNG CANCER, V48, P77, DOI 10.1016/j.lungcan.2004.10.007; Takashima N, 2006, ONCOL REP, V15, P667; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; Travis WD., 2004, TRAVIS WB WHO CLASSI; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang XS, 2010, HUM MOL GENET, V19, P2886, DOI 10.1093/hmg/ddq174; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Wong RW, 2010, CELL CYCLE, V9, P198, DOI 10.4161/cc.9.1.10431; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yamamoto N, 1999, ONCOL REP, V6, P1223; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Yi YJ, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-18; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053	77	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42086	10.1371/journal.pone.0042086	http://dx.doi.org/10.1371/journal.pone.0042086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876301	gold, Green Published, Green Submitted			2022-12-25	WOS:000307184700029
J	Idei, M; Osada, K; Sato, S; Toyoda, K; Nagumo, T; Mann, DG				Idei, Masahiko; Osada, Keigo; Sato, Shinya; Toyoda, Kensuke; Nagumo, Tamotsu; Mann, David G.			Gametogenesis and Auxospore Development in Actinocyclus (Bacillariophyta)	PLOS ONE			English	Article							CENTRIC DIATOM; FINE-STRUCTURE; ENTWICKLUNGSGESCHICHTLICHE UNTERSUCHUNGEN; CYCLOTELLA-MENEGHINIANA; SPECIES IDENTIFICATION; ZENTRISCHEN DIATOMEEN; SEXUAL REPRODUCTION; LIFE-HISTORY; INITIAL CELL; EVOLUTION	cGametogenesis and auxospore development have been studied in detail in surprisingly few centric diatoms. We studied the development of sperm, eggs and auxospores in Actinocyclus sp., a radially symmetrical freshwater diatom collected from Japan, using LM and electron microscopy of living cultures and thin sections. Actinocyclus represents a deep branch of the 'radial centric' diatoms and should therefore contribute useful insights into the evolution of sexual reproduction in diatoms. Spermatogenesis was examined by LM and SEM and involved the formation of two spermatogonia (sperm mother-cells) in each spermatogonangium through an equal mitotic division. The spermatogonia produced a reduced 'lid' valve, resembling a large flat scale with irregular radial thickenings. Sperm formation was merogenous, producing four sperm per spermatogonium, which were released by dehiscence of the 'lid' valve. The sperm were spindle-shaped with numerous surface globules and, as usual for diatoms, the single anterior flagellum bore mastigonemes. One egg cell was produced per oogonium. Immature eggs produced a thin layer of circular silica scales before fertilization, while the eggs were still contained within the oogonium. Sperm were attracted in large numbers to each egg and were apparently able to contact the egg surface via a gap formed between the long hypotheca and shorter epitheca of the oogonium and a small underlying hole in the scale-case. Auxospores expanded isodiametrically and many new scales were added to its envelope during expansion. Finally, new slightly-domed initial valves were produced at right angles to the oogonium axis, after a strong contraction of the cell away from the auxospore wall. At different stages, Golgi bodies were associated with chloroplasts or mitochondria, contrasting with the constancy of Golgi-ER-mitochondrion (G-ER-M) units in some other centric diatoms, which has been suggested to have phylogenetic significance. Electron-dense bodies in the vacuole of Actinocyclus are probably acidocalcisomes containing polyphosphate.	[Idei, Masahiko] Bunkyo Univ, Dept Biol, Saitama, Japan; [Osada, Keigo] Nippon Dent Univ, Dept Biol, Sch Life Dent Niigata, Niigata, Japan; [Sato, Shinya; Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Toyoda, Kensuke] Keio Univ, Dept Biol, Tokyo, Kanagawa 108, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Dept Biol, Tokyo, Japan	Nippon Dental University; Keio University; Nippon Dental University	Idei, M (corresponding author), Bunkyo Univ, Dept Biol, Saitama, Japan.	idei@koshigaya.bunkyo.ac.jp	Toyoda, Kensuke/AAB-7875-2021; Mann, David G/I-9018-2014	Mann, David G/0000-0003-0522-6802				Bergon P, 1907, B SOC BOT FRANCE 4, V7, P327; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2006, J PHYCOL, V42, P845, DOI 10.1111/j.1529-8817.2006.00244.x; CRAWFORD R M, 1974, British Phycological Journal, V9, P9; DAWSON PA, 1973, J PHYCOL, V9, P165, DOI 10.1111/j.0022-3646.1973.00165.x; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DREBES G, 1966, HELGOLAND WISS MEER, V13, P101, DOI 10.1007/BF01612659; Drebes G., 1977, BIOL DIATOMS, P250; DREBES G., 1974, MARINES PHYTOPLANKTO; DREBES G, 1977, NOVA HEDWIGIA S, V54, P167; Drebes G, 1972, NOVA HEDWIGIA S, V39, P95; Drum RW, 1966, DIATOMEEN ELEKTRONEN, V6; EHRLICH A, 1982, BRIT PHYCOL J, V17, P205, DOI 10.1080/00071618200650221; FRITSCH F.E., 1935, STRUCTURE REPROD ALG, V1; Geitler L, 1952, OSTERR BOT Z, V99, P507; GEITLER L, 1963, BER DEUT BOT GES, V75, P393; GEITLER LOTHAR, 1932, ARCH PROTISTENK, V78, P1; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hasle G.R., 1983, BACILLARIA, V6, P9; HEATH IB, 1971, Z ZELLFORSCH MIK ANA, V112, P371; HEATH IB, 1972, J PHYCOL, V8, P51, DOI 10.1111/j.1529-8817.1972.tb04001.x; Heinzerling O., 1908, BIBL BOT, V69, P1; HOFKER J., 1928, ANN PROTISTOL, V1, P167; HOOPS HJ, 1979, PHYCOLOGIA, V18, P424, DOI 10.2216/i0031-8884-18-4-424.1; Hoppenrath M., 2009, SCHWEIZERBART SCHE V; Hori T, 1993, ILLUSTRATED ATLAS LI, V3; Ichinomiya M, 2011, J PHYCOL, V47, P144, DOI 10.1111/j.1529-8817.2010.00926.x; IDEI M, 1992, BOT MAG TOKYO, V105, P649, DOI 10.1007/BF02489438; Jensen KG, 2003, PHYCOLOGIA, V42, P98, DOI 10.2216/i0031-8884-42-1-98.1; Kaczmarska I, 2000, NOVA HEDWIGIA, V71, P337; Kaczmarska I, 2007, PHYCOLOGIA, V46, P726, DOI 10.2216/07-04.1; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; KUROIWA T, 1980, CELL STRUCT FUNCT, V5, P195, DOI 10.1247/csf.5.195; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Mann DG, 2010, CRYPTOGAMIE ALGOL, V31, P557; Mann DG, 1984, P 7 INT DIAT S PHIL, V982, P47; Manton I., 1966, J ROY MICROSC SOC, V85, P119, DOI DOI 10.1111/J.1365-2818.1966.TB02174.X; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Medeiros LCS, 2011, J EUKARYOT MICROBIOL, V58, P416, DOI 10.1111/j.1550-7408.2011.00565.x; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Migita S., 1967, B JPN SOC SCI FISH, V33, P392, DOI [10.2331/suisan.33.392, DOI 10.2331/SUISAN.33.392)]; Mizuno M., 1977, B JAP SOC PHYCOL, V25, P149; Mizuno M, 2008, PHYCOL RES, V56, P156, DOI 10.1111/j.1440-1835.2008.00497.x; OTT D W, 1974, British Phycological Journal, V9, P111; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; PICKETTHEAPS JD, 1988, J PHYCOL, V24, P35; PICKETTHEAPS JD, 1986, J PHYCOL, V22, P334, DOI 10.1111/j.1529-8817.1986.tb00032.x; REIMANN B, 1960, NOVA HEDWIGIA, V2, P349; ROUND FE, 1981, PROC R SOC SER B-BIO, V211, P237, DOI 10.1098/rspb.1981.0004; Ruiz FA, 2004, MICROSC MICROANAL, V10, P563, DOI 10.1017/S1431927604040875; Schmid A. M.-M., 2000, ORIGIN EARLY EVOLUTI, P13; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Schmid AMM, 1995, PROCEEDINGS OF THE THIRTEENTH INTERNATIONAL DIATOM SYMPOSIUM, P139; SCHMID AMM, 1988, PLANT SYST EVOL, V158, P211; SCHMID AMM, 1989, PLANT SYST EVOL, V164, P239, DOI 10.1007/BF00940440; Schmid AMM, 2001, EUR J PHYCOL, V36, P307, DOI 10.1080/09670260110001735468; Schmid Anna-Maria M., 1994, Diatom Research, V9, P371; SCHULTZ ME, 1968, J PHYCOL, V4, P85, DOI 10.1111/j.1529-8817.1968.tb04681.x; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STOERMER EF, 1965, AM J BOT, V52, P1067, DOI 10.2307/2440138; STOSCH HAV, 1973, HELGOLAND WISS MEER, V25, P384, DOI 10.1007/BF01611205; Subrahmanyan R., 1946, JOUR INDIAN BOT SOC, V25, P61; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Toyoda Kensuke, 2010, Plankton & Benthos Research, V5, P56; Trobajo R, 2010, EUR J PHYCOL, V45, P413, DOI 10.1080/09670262.2010.498586; von Stosch H. A., 1982, BACILLARIA, V5, P127; VON STOSCH HANS A., 1964, HELGOLANDER WISSENSCHAFTLICHE MEERESUNTERSUCH, V11, P209; VONSTOSCH HA, 1950, NATURE, V165, P531, DOI 10.1038/165531a0; VONSTOSCH HA, 1956, ARCH MIKROBIOL, V23, P327; VONSTOSCH HA, 1951, ARCH MIKROBIOL, V16, P101; VONSTOSCH HA, 1958, ARCH MIKROBIOL, V31, P274; Went FW, 1925, NEDERLANDSCH KRUIDKU, V1924, P75	76	21	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41890	10.1371/journal.pone.0041890	http://dx.doi.org/10.1371/journal.pone.0041890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870259	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800041
J	Smidt, MP; von Oerthel, L; Hoekstra, EJ; Schellevis, RD; Hoekman, MFM				Smidt, Marten P.; von Oerthel, Lars; Hoekstra, Elisa J.; Schellevis, Raymond D.; Hoekman, Marco F. M.			Spatial and Temporal Lineage Analysis of a Pitx3-Driven Cre-Recombinase Knock-In Mouse Model	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GABAERGIC NEURON DIFFERENTIATION; DIENCEPHALIC DOPAMINE NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; ELEGANS UNC-30; PITX3; MICE; IDENTIFICATION; PROGENITORS	Development and function of mesodiencephalic dopaminergic (mdDA) neurons has received a lot of scientific interest since these neurons are critically involved in neurological diseases as Parkinson and psychiatric diseases as schizophrenia, depression and attention deficit hyperactivity disorder (ADHD). The understanding of the molecular processes that lead to normal development and function of mdDA neurons has provided insight in the pathology and provided critical information on new treatment paradigms. In order to be able to study specific genetic ablation in mdDA neurons a new tools was developed that drives Cre-recombinase under the control of the Pitx3 locus. The Pitx3 gene is well known for its specific expression in mdDA neurons and is present at the onset of terminal differentiation. Analysis of newly generated Pitx3-Cre knock-in mice shows that Cre expression, measured through the activation of eYfp by removal of a "Stop'' signal (LoxP-Stop-LoxP-eYfp reporter mouse), is present at the onset of terminal differentiation and mimics closely the native Pitx3 expression domain. In conclusion, we present here a new Cre-driver mouse model to be used in the restricted ablation of interesting genes in mdDA neurons in order to improve our understanding of the underlying molecular programming.	[Smidt, Marten P.; von Oerthel, Lars; Hoekstra, Elisa J.; Hoekman, Marco F. M.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smidt, Marten P.; Hoekstra, Elisa J.; Schellevis, Raymond D.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	VICI-grant [865.09.002]	VICI-grant	This work was supported by a VICI-grant (no. 865.09.002 to M.P. Smidt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; Ferrari D, 2006, EUR J NEUROSCI, V24, P1885, DOI 10.1111/j.1460-9568.2006.05093.x; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Maxwell SL, 2005, J ANAT, V207, P209, DOI 10.1111/j.1469-7580.2005.00453.x; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Westmoreland JJ, 2001, J NEUROSCI, V21, P6810, DOI 10.1523/JNEUROSCI.21-17-06810.2001; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	23	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42641	10.1371/journal.pone.0042641	http://dx.doi.org/10.1371/journal.pone.0042641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870339	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800102
J	Starkey, MR; Kim, RY; Beckett, EL; Schilter, HC; Shim, D; Essilfie, AT; Nguyen, DH; Beagley, KW; Mattes, J; Mackay, CR; Horvat, JC; Hansbro, PM				Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Schilter, Heidi C.; Shim, Doris; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Beagley, Kenneth W.; Mattes, Joerg; Mackay, Charles R.; Horvat, Jay C.; Hansbro, Philip M.			Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; IFN-GAMMA; STREPTOCOCCUS-PNEUMONIAE; PROTECTIVE IMMUNITY; ASTHMA; THERAPY; INFLAMMATION; INDUCTION; TWAR	Background: Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway inflammation and asthma. However, the mechanisms involved are not well understood. We have previously shown that neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hypersecretion and airway hyper-responsiveness. This occurred through different mechanisms with infection at different ages. Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell: T-cell IL-13 release and induced permanent alterations in lung structure (i.e., increased the size of alveoli). Infant infection enhanced inflammatory responses but had no effect on lung structure. Here we investigated the role of hematopoietic cells in these processes using bone marrow chimera studies. Methodology/Principal Findings: Neonatal (<24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were infected with C. muridarum. Nine weeks after infection bone marrow was collected and transferred into recipient age-matched irradiated naive mice. Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and challenge with ovalbumin. Reconstitution of irradiated naive mice with bone marrow from mice infected as neonates resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway hyper-responsiveness, which was associated with decreased IL-13 levels in the lung. In stark contrast, reconstitution with bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung. Reconstitution with bone marrow from infected adult mice had no effects. Conclusions: These results suggest that an infant chlamydial lung infection results in long lasting alterations in hematopoietic cells that increases the severity of allergic airway disease in later-life.	[Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Mattes, Joerg; Horvat, Jay C.; Hansbro, Philip M.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Starkey, Malcolm R.; Kim, Richard Y.; Beckett, Emma L.; Essilfie, Ama-Tawiah; Nguyen, Duc H.; Mattes, Joerg; Horvat, Jay C.; Hansbro, Philip M.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Schilter, Heidi C.; Shim, Doris] Garvan Inst Med Res, Program Immunol, Sydney, NSW, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Australia; [Mattes, Joerg] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Expt & Translat Resp Grp, Callaghan, NSW 2308, Australia; [Mackay, Charles R.] Monash Univ, Fac Med Nursing & Hlth Serv, Clayton, Vic, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Garvan Institute of Medical Research; Queensland University of Technology (QUT); University of Newcastle; Monash University	Starkey, MR (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Philip.Hansbro@newcastle.edu.au	MATTES, JOERG/M-5179-2019; Hansbro, Phil/G-7486-2013; Beckett, Emma/AAU-8537-2021; Beagley, Kenneth/J-1129-2012; Mackay, Charles R/A-9673-2008	Hansbro, Phil/0000-0002-4741-3035; Beckett, Emma/0000-0002-8888-3789; Beagley, Kenneth/0000-0003-3112-6557; Mackay, Charles R/0000-0002-6338-7340; Schilter, Heidi/0000-0003-3709-1631; Horvat, Jay/0000-0002-8526-0631; Essilfie, Ama-Tawiah/0000-0003-0443-9005; Kim, Richard/0000-0002-8709-5270; Starkey, Malcolm/0000-0002-7359-7464	National Health and Medical Research Council of Australia (NHMRC) [569219]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by National Health and Medical Research Council of Australia (NHMRC) grant #569219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Blasi F, 2004, EUR RESPIR J, V24, P171, DOI 10.1183/09031936.04.00135703; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Essilfie AT, 2012, THORAX; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Hansbro PM, 2012, J DEV ORIGI IN PRESS; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Jupelli M, 2008, J IMMUNOL, V180, P4148, DOI 10.4049/jimmunol.180.6.4148; Jupelli M, 2011, LAB INVEST, V91, P1530, DOI 10.1038/labinvest.2011.103; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Patel KK, 2010, PEDIATR INFECT DIS J, V29, P1093, DOI 10.1097/INF.0b013e3181eaebdc; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; SAETTA M, 1994, EUR RESPIR J, V7, P1505, DOI 10.1183/09031936.94.07081505; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Thorburn AN, 2009, EXPERT OPIN BIOL TH, V9, P621, DOI [10.1517/14712590902916999, 10.1517/14712590902916999 ]; Thorburn AN, 2012, J IMMUNOL IN PRESS, V188; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vila-Corcoles A, 2009, RESP MED, V103, P309, DOI 10.1016/j.rmed.2008.08.006; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	38	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42588	10.1371/journal.pone.0042588	http://dx.doi.org/10.1371/journal.pone.0042588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870337	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800100
J	Walter, WJ; Beranek, V; Fischermeier, E; Diez, S				Walter, Wilhelm J.; Beranek, Vaclav; Fischermeier, Elisabeth; Diez, Stefan			Tubulin Acetylation Alone Does Not Affect Kinesin-1 Velocity and Run Length In Vitro	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; MOTOR DOMAIN; TRANSPORT; MICROTUBULES; BINDING; ACETYLTRANSFERASE; PROCESSIVITY; DEACETYLASE; MICROSCOPY; MOLECULES	Kinesin-1 plays a major role in anterograde transport of intracellular cargo along microtubules. Currently, there is an ongoing debate of whether alpha-tubulin K40 acetylation directly enhances the velocity of kinesin-1 and its affinity to the microtubule track. We compared motor motility on microtubules reconstituted from acetylated and deacetylated tubulin. For both, single- and multi-motor in vitro motility assays, we demonstrate that tubulin acetylation alone does not affect kinesin-1 velocity and run length.	[Walter, Wilhelm J.; Beranek, Vaclav; Fischermeier, Elisabeth; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany; [Diez, Stefan] Max Planck Insitute Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Walter, WJ (corresponding author), Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany.	diez@bcube-dresden.de	Diez, Stefan/E-8172-2010	Diez, Stefan/0000-0002-0750-8515	Volkswagen Foundation [I/84 087-090]; Deutsche Forschungsgemeinschaft (DFG Heisenberg Program); Max-Planck-Society; Technische Universitat Dresden; European Research Council (ERC) [242933]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft (DFG Heisenberg Program)(German Research Foundation (DFG)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden; European Research Council (ERC)(European Research Council (ERC))	This work has been supported by funding from the Volkswagen Foundation (grant I/84 087-090), the Deutsche Forschungsgemeinschaft (DFG Heisenberg Program), the Max-Planck-Society, the Technische Universitat Dresden and the European Research Council (ERC starting grant 242933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; [Anonymous], FREE STAT SOFTWARE; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Press W. H., 1992, ART SCI COMPUTING; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032	30	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42218	10.1371/journal.pone.0042218	http://dx.doi.org/10.1371/journal.pone.0042218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870307	gold, Green Submitted, Green Published			2022-12-25	WOS:000307212800070
J	Kassambara, A; Hose, D; Moreaux, J; Reme, T; Torrent, J; Rossi, JF; Goldschmidt, H; Klein, B				Kassambara, Alboukadel; Hose, Dirk; Moreaux, Jerome; Reme, Thierry; Torrent, Jennifer; Rossi, Jean Francois; Goldschmidt, Hartmut; Klein, Bernard			Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma	PLOS ONE			English	Article							RISK-ADAPTED TREATMENT; MOLECULAR CLASSIFICATION; TUMOR ANGIOGENESIS; SELF-RENEWAL; B-CELL; EXPRESSION; MODEL; CANCER; GROWTH; INDUCTION	Gene expression-based scores used to predict risk in cancer frequently include genes coding for DNA replication, repair or recombination. Using two independent cohorts of 206 and 345 previously-untreated patients with Multiple Myeloma (MM), we identified 50 cell cycle-unrelated genes overexpressed in multiple myeloma cells (MMCs) compared to normal human proliferating plasmablasts and non-proliferating bone marrow plasma cells and which have prognostic value for overall survival. Thirty-seven of these 50 myeloma genes (74%) were enriched in genes overexpressed in one of 3 normal human stem cell populations - pluripotent (18), hematopoietic (10) or mesenchymal stem cells (9) - and only three genes were enriched in one of 5 populations of differentiated cells (memory B lymphocytes, T lymphocytes, polymorphonuclear cells, monocytes, osteoclasts). These 37 genes shared by MMCs and adult or pluripotent stem cells were used to build a stem cell score ((SC)score), which proved to be strongly prognostic in the 2 independent cohorts of patients compared to other gene expression-based risk scores or usual clinical scores using multivariate Cox analysis. This finding highlights cell cycleun-related prognostic genes shared by myeloma cells and normal stem cells, whose products might be important for normal and malignant stem cell biology.	[Moreaux, Jerome; Reme, Thierry; Torrent, Jennifer; Rossi, Jean Francois; Klein, Bernard] CHU Montpellier, Inst Res Biotherapy, Montpellier, France; [Kassambara, Alboukadel; Moreaux, Jerome; Reme, Thierry; Klein, Bernard] INSERM, U1040, Montpellier, France; [Klein, Bernard] Univ Montpellier I, UFR Med, Montpellier, France; [Hose, Dirk; Goldschmidt, Hartmut] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany; [Hose, Dirk; Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kassambara, A (corresponding author), CHU Montpellier, Inst Res Biotherapy, Montpellier, France.	bernard.klein@inserm.fr	Xiao, Yang/B-5668-2012; Goldschmidt, Hartmut/AAL-8069-2021; moreaux, jerome/HGA-5649-2022; J, Moreaux/ABA-2974-2021	J, Moreaux/0000-0002-5717-3207	ARC "Association pour la Recherche sur le 355 Cancer'' (Paris, France) [SL220110603450]; European Community; Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany; Deutsche Forschungsgemeinschaft, Bonn, Germany [Transregio TRR 79]	ARC "Association pour la Recherche sur le 355 Cancer'' (Paris, France); European Community(European Commission); Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported by grants from ARC "Association pour la Recherche sur le 355 Cancer'' (SL220110603450, Paris, France), the European Community (FP7- OVERMYR), the Tumorzentrum Heidelberg/Mannheim, Germany, and the Deutsche Krebshilfe, Bonn, Germany, the Deutsche Forschungsgemeinschaft (Transregio TRR 79), Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber KE, 2007, GENE CHROMOSOME CANC, V46, P478, DOI 10.1002/gcc.20431; Barlogie B, 2006, BLOOD, V107, P2633, DOI 10.1182/blood-2005-10-4084; Bjerke GA, 2011, MOL CELL BIOL, V31, P3723, DOI 10.1128/MCB.01456-10; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chiron D, 2011, BR J HAEMATOL; Chiron D, 2012, BRIT J HAEMATOL, V156, P679, DOI 10.1111/j.1365-2141.2011.08904.x; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Groen RWJ, 2011, HAEMATOL-HEMATOL J, V96, P1653, DOI 10.3324/haematol.2010.038133; Gu ZJ, 2000, LEUKEMIA, V14, P188, DOI 10.1038/sj.leu.2401632; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Moreaux J, 2005, BLOOD, V106, P1021, DOI 10.1182/blood-2004-11-4512; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; Moreaux J, 2011, BLOOD, V117, P1280, DOI 10.1182/blood-2010-04-279760; Paraoanu LE, 2007, LIFE SCI, V80, P2375, DOI 10.1016/j.lfs.2007.03.008; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reme T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-16; Rickelt S, 2009, INT J CANCER, V125, P2036, DOI 10.1002/ijc.24552; Schmid BC, 2007, BREAST CANCER RES TR, V106, P333, DOI 10.1007/s10549-007-9504-0; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Sperling LE, 2008, CHEM-BIOL INTERACT, V175, P156, DOI 10.1016/j.cbi.2008.05.034; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Szymanski P, 2011, PHARMAZIE, V66, P399, DOI 10.1691/ph.2011.0815; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Team RDC, 2019, R LANG ENV STAT COMP; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Wessler I, 1999, CLIN EXP PHARMACOL P, V26, P198, DOI 10.1046/j.1440-1681.1999.03016.x; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Xiong W, 2008, BLOOD, V112, P4235, DOI 10.1182/blood-2007-10-119123; ZHANG XG, 1994, BLOOD, V83, P3654	51	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42161	10.1371/journal.pone.0042161	http://dx.doi.org/10.1371/journal.pone.0042161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860071	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600064
J	Robinson, MW; Alvarado, R; To, J; Hutchinson, AT; Dowdell, SN; Lund, M; Turnbull, L; Whitchurch, CB; O'Brien, BA; Dalton, JP; Donnelly, S				Robinson, Mark W.; Alvarado, Raquel; To, Joyce; Hutchinson, Andrew T.; Dowdell, Stephanie N.; Lund, Maria; Turnbull, Lynne; Whitchurch, Cynthia B.; O'Brien, Bronwyn A.; Dalton, John P.; Donnelly, Sheila			A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase	FASEB JOURNAL			English	Article						trematode; Fasciola hepatica; lysosomal acidification; host defense peptides	ANTIMICROBIAL PEPTIDE LL-37; LIPID RAFTS; CELLS; MEMBRANES; BINDING; CHOLESTEROL; TRAFFICKING; ACTIVATION; PHAGOSOMES; VIRULENCE	We previously reported the identification of a novel family of immunomodulatory proteins, termed helminth defense molecules (HDMs), that are secreted by medically important trematode parasites. Since HDMs share biochemical, structural, and functional characteristics with mammalian cathelicidin-like host defense peptides (HDPs), we proposed that HDMs modulate the immune response via molecular mimicry of host molecules. In the present study, we report the mechanism by which HDMs influence the function of macrophages. We show that the HDM secreted by Fasciola hepatica (FhHDM-1) binds to macrophage plasma membrane lipid rafts via selective interaction with phospholipids and/or cholesterol before being internalized by endocytosis. Following internalization, FhHDM-1 is rapidly processed by lysosomal cathepsin L to release a short C-terminal peptide (containing a conserved amphipathic helix that is a key to HDM function), which then prevents the acidification of the endolysosomal compartments by inhibiting vacuolar ATPase activity. The resulting endolysosomal alkalization impedes macrophage antigen processing and prevents the transport of peptides to the cell surface in conjunction with MHC class II for presentation to CD4(+) T cells. Thus, we have elucidated a novel mechanism by which helminth pathogens alter innate immune cell function to assist their survival in the host.-Robinson, M. W., Alvarado, R., To, J., Hutchinson, A. T., Dowdell, S. N., Lund, M., Turnbull, L., Whitchurch, C. B., O'Brien, B. A., Dalton, J. P., Donnelly, S. A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J. 26, 4614-4627 (2012). www.fasebj.org	[Robinson, Mark W.; Alvarado, Raquel; To, Joyce; Lund, Maria; Turnbull, Lynne; Whitchurch, Cynthia B.; Donnelly, Sheila] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Hutchinson, Andrew T.; Dowdell, Stephanie N.; O'Brien, Bronwyn A.] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Dalton, John P.] McGill Univ, Inst Parasitol, Quebec City, PQ, Canada	University of Technology Sydney; University of Technology Sydney; McGill University	Robinson, MW (corresponding author), Queens Univ Belfast, Sch Biol Sci, 97 Lisburn Rd, Belfast, Antrim, North Ireland.	mark.robinson@qub.ac.uk	Alvarado, Raquel/J-5073-2019; Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Whitchurch, Cynthia/A-5954-2008; Turnbull, Lynne/A-2605-2012	Alvarado, Raquel/0000-0001-7250-2200; Whitchurch, Cynthia/0000-0003-2296-3791; Robinson, Mark/0000-0001-7191-0034; Donnelly, Sheila/0000-0003-2005-3698; To, Joyce/0000-0003-3482-4369; Turnbull, Lynne/0000-0002-9255-9033; Lund, Maria/0000-0001-7360-5041	National Health and Medical Research Council [APP1010197, APP513111]; Tier 1 Canada Research Chair; National Science and Engineering Council (NSERC) Canada	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Tier 1 Canada Research Chair(Canada Research Chairs); National Science and Engineering Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Health and Medical Research Council Grants APP1010197 and APP513111. J. P. D is supported by a Tier 1 Canada Research Chair and a grant from the National Science and Engineering Council (NSERC) Canada.	Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Garcia-Marcos M, 2006, BBA-BIOMEMBRANES, V1758, P796, DOI 10.1016/j.bbamem.2006.05.008; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hirsch T, 2008, SHOCK, V30, P117, DOI 10.1097/SHK.0b013e318160de11; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Hutchinson AT, 2010, J IMMUNOL, V185, P4179, DOI 10.4049/jimmunol.1001956; Jenssen H, 2010, METHODS MOL BIOL, V618, P329, DOI 10.1007/978-1-60761-594-1_20; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kirikae T, 1998, INFECT IMMUN, V66, P1861, DOI 10.1128/IAI.66.5.1861-1868.1998; Klotz C, 2011, ADV EXP MED BIOL, V712, P208, DOI 10.1007/978-1-4419-8414-2_13; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Min CK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000209; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y; Risso A, 2000, J LEUKOCYTE BIOL, V68, P785; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Robinson MW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001012; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Seil M, 2010, PHARMACEUTICALS, V3, P3435, DOI 10.3390/ph3113435; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P1460, DOI 10.1016/j.bbamem.2008.02.014; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; WANG R, 1993, J IMMUNOL, V150, P3832	54	63	63	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4614	4627		10.1096/fj.12-213876	http://dx.doi.org/10.1096/fj.12-213876			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872675	Green Submitted, hybrid			2022-12-25	WOS:000310574200023
J	Bien, J; Jefferson, T; Causevic, M; Jumpertz, T; Munter, L; Multhaup, G; Weggen, S; Becker-Pauly, C; Pietrzik, CU				Bien, Jessica; Jefferson, Tamara; Causevic, Mirsada; Jumpertz, Thorsten; Munter, Lisa; Multhaup, Gerd; Weggen, Sascha; Becker-Pauly, Christoph; Pietrzik, Claus U.			The Metalloprotease Meprin beta Generates Amino Terminal-truncated Amyloid beta Peptide Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; SECRETASE; CLEAVAGE; BACE; MODULATION; DEMENTIA; ALPHA	The amyloid beta (A beta) peptide, which is abundantly found in the brains of patients suffering from Alzheimer disease, is central in the pathogenesis of this disease. Therefore, to understand the processing of the amyloid precursor protein (APP) is of critical importance. Recently, we demonstrated that the metalloprotease meprin beta cleaves APP and liberates soluble N-terminal APP (N-APP) fragments. In this work, we present evidence that meprin beta can also process APP in a manner reminiscent of beta-secretase. We identified cleavage sites of meprin beta in the amyloid beta sequence of the wild type and Swedish mutant of APP at positions p1 and p2, thereby generating A beta variants starting at the first or second amino acid residue. We observed even higher kinetic values for meprin beta than BACE1 for both the wild type and the Swedish mutant APP form. This enzymatic activity of meprin beta on APP and A beta generation was also observed in the absence of BACE1/2 activity using a beta-secretase inhibitor and BACE knock-out cells, indicating that meprin beta acts independently of beta-secretase.	[Jefferson, Tamara; Becker-Pauly, Christoph] Univ Kiel, Unit Degrad Protease Web, Inst Biochem, D-24118 Kiel, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Dept Mol Neurodegenerat, D-55128 Mainz, Germany; [Jumpertz, Thorsten; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Munter, Lisa; Multhaup, Gerd] Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	University of Kiel; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Free University of Berlin	Becker-Pauly, C (corresponding author), Univ Kiel, Unit Degrad Protease Web, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de; pietrzik@uni-mainz.de	Causevic, Mirsada/AAM-7423-2020; Becker-Pauly, Christoph/B-7569-2011	Causevic, Mirsada/0000-0002-6099-6415; Munter, Lisa/0000-0001-5736-1462	Deutsche Forschungsgemeinschaft [DFG PI 379/5-1, DFG BE 4086/1-2, SFB877 (project A9)]; Cluster of Excellence "Inflammation at Interfaces"; Federal Ministry of Education and Research [01EW1009, 01GI1004D]; European Community's Seventh Framework Program (FP7) [200931]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Program (FP7)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG PI 379/5-1 (to C. U. P.), DFG BE 4086/1-2, and SFB877 (project A9), by the Cluster of Excellence "Inflammation at Interfaces" (to C. B.-P.), and Federal Ministry of Education and Research Grants 01EW1009 and 01GI1004D (to C. U. P.). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7) under Grant Agreement 200931 (project IBDase).	Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lewczuk P, 2004, ELECTROPHORESIS, V25, P3336, DOI 10.1002/elps.200406068; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Schechter I, 2008, BIOL CHEM, V389, P313, DOI 10.1515/BC.2008.025; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Wiltfang J, 2001, J BIOL CHEM, V276, P42645, DOI 10.1074/jbc.M102790200	38	91	94	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33304	33313		10.1074/jbc.M112.395608	http://dx.doi.org/10.1074/jbc.M112.395608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879596	Green Published, hybrid			2022-12-25	WOS:000309602100019
J	Kihira, S; Yu, EJ; Cunningham, J; Cram, EJ; Lee, M				Kihira, Shingo; Yu, Eun Jeong; Cunningham, Jessica; Cram, Erin J.; Lee, Myeongwoo			A Novel Mutation in beta Integrin Reveals an Integrin-Mediated Interaction between the Extracellular Matrix and cki-1/p27(KIP1)	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; LINKED KINASE ILK; F-BOX PROTEIN; CAENORHABDITIS-ELEGANS; C-ELEGANS; CYTOPLASMIC DOMAIN; DEVELOPMENTAL REGULATION; PROSTATE CARCINOMA; ADHESION COMPLEXES; SPLICE VARIANTS	The cell-extracellular matrix (ECM) interaction plays an essential role in maintaining tissue shapes and regulates cell behaviors such as cell adhesion, differentiation and proliferation. The mechanism by which the ECM influences the cell cycle in vivo is poorly understood. Here we demonstrate that the beta integrin PAT-3 regulates the localization and expression of CKI-1, a C. elegans homologue of the cyclin dependent kinase inhibitor p27(KIP1). In nematodes expressing wild type PAT-3, CKI-1::GFP localizes primarily to nucleoli in hypodermal cells, whereas in animals expressing mutant pat-3 with a defective splice junction, CKI-1::GFP appears clumped and disorganized in nucleoplasm. RNAi analysis links cell adhesion genes to the regulation of CKI-1. RNAi of unc-52/perlecan, ina-1/alpha integrin, pat-4/ILK, and unc-97/PINCH resulted in abnormal CKI-1::GFP localization. Additional RNAi experiments revealed that the SCF E3 ubiquitin-ligase complex genes, skpt-1/SKP2, cul-1/CUL1 and lin-23/F-box, are required for the proper localization and expression of CKI-1, suggesting that integrin signaling and SCF E3 ligase work together to regulate the cellular distribution of CKI-1. These data also suggest that integrin plays a major role in maintaining proper CKI-1/p27(KIP1) levels in the cell. Perturbed integrin signaling may lead to the inhibition of SCF ligase activity, mislocalization and elevation of CKI-1/p27(KIP1). These results suggest that adhesion signaling is crucial for cell cycle regulation in vivo.	[Kihira, Shingo; Yu, Eun Jeong; Cunningham, Jessica; Lee, Myeongwoo] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Cram, Erin J.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Baylor University; Northeastern University	Kihira, S (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	myeongwoo_lee@baylor.edu		lee, myeongwoo/0000-0003-2652-3646; Kihira, Shingo/0000-0003-1001-8741	National Institutes of Health [GM077156]; University Research Council (URC) at Baylor University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM077156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Council (URC) at Baylor University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.K. was a business fellow at Baylor University. M. L. was funded by the National Institutes of Health (GM077156) and the University Research Council (URC) at Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTRUDA F, 1990, GENE, V95, P261, DOI 10.1016/0378-1119(90)90369-3; Ambros V, 1999, DEVELOPMENT, V126, P1947; Armulik A, 2002, FRONT BIOSCI-LANDMRK, V7, pD219, DOI 10.2741/armulik; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Baudoin C, 1996, CELL ADHES COMMUN, V4, P1, DOI 10.3109/15419069609010759; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Boxem M, 2001, DEVELOPMENT, V128, P4349; BRENNER S, 1974, GENETICS, V77, P71; Buck SH, 2009, CELL CYCLE, V8, P2613, DOI 10.4161/cc.8.16.9354; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Del Pizzo JJ, 1999, AM J PATHOL, V155, P1129, DOI 10.1016/S0002-9440(10)65216-9; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fornaro M, 1996, AM J PATHOL, V149, P765; Fornaro M, 1999, J CLIN INVEST, V103, P321, DOI 10.1172/JCI4585; Fornaro M, 1998, AM J PATHOL, V153, P1079, DOI 10.1016/S0002-9440(10)65652-0; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; HEDGECOCK EM, 1995, GENETICS, V141, P989; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hong Y, 1998, DEVELOPMENT, V125, P3585; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jonason JH, 2007, CELL CYCLE, V6, P951, DOI 10.4161/cc.6.8.4104; Kamai T, 2001, BRIT J CANCER, V84, P1242, DOI 10.1054/bjoc.2000.1736; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Kostic I, 2002, DEVELOPMENT, V129, P2155; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MEREDITH J, 1995, SCIENCE, V269, P1570, DOI 10.1126/science.7545312; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Moerman Donald G, 2006, WormBook, P1; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Moro L, 2004, J BIOL CHEM, V279, P1692, DOI 10.1074/jbc.M307857200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Pleasance ED, 2003, GENOME RES, V13, P1203, DOI 10.1101/gr.873003; Qadota H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864749; ROGALSKI TM, 1995, GENETICS, V139, P159; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wang-Rodriguez J, 2002, CANCER-AM CANCER SOC, V95, P1387, DOI 10.1002/cncr.10878; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wood WB, 1988, NEMATODE CAENORHABDI; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Xu XJ, 2006, EXP CELL RES, V312, P1475, DOI 10.1016/j.yexcr.2006.01.006; Xu XJ, 2010, DEV DYNAM, V239, P763, DOI 10.1002/dvdy.22205; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	89	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42425	10.1371/journal.pone.0042425	http://dx.doi.org/10.1371/journal.pone.0042425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879977	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000033
J	Songane, M; Kleinnijenhuis, J; Alisjahbana, B; Sahiratmadja, E; Parwati, I; Oosting, M; Plantinga, TS; Joosten, LAB; Netea, MG; Ottenhoff, THM; van de Vosse, E; van Crevel, R				Songane, Mario; Kleinnijenhuis, Johanneke; Alisjahbana, Bachti; Sahiratmadja, Edhyana; Parwati, Ida; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; Ottenhoff, Tom H. M.; van de Vosse, Esther; van Crevel, Reinout			Polymorphisms in Autophagy Genes and Susceptibility to Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HUMAN MACROPHAGES; HUMAN MONOCYTES/MACROPHAGES; INTRACELLULAR MYCOBACTERIA; CONTAINING PHAGOSOMES; CROHNS-DISEASE; P2X(7) GENE; ASSOCIATION; RECEPTOR	Recent data suggest that autophagy is important for intracellular killing of Mycobacterium tuberculosis, and polymorphisms in the autophagy gene IRGM have been linked with susceptibility to tuberculosis (TB) among African-Americans, and with TB caused by particular M. tuberculosis genotypes in Ghana. We compared 22 polymorphisms of 14 autophagy genes between 1022 Indonesian TB patients and 952 matched controls, and between patients infected with different M. tuberculosis genotypes, as determined by spoligotyping. The same autophagy polymorphisms were studied in correlation with ex-vivo production of TNF, IL-1 beta, IL-6, IL-8, IFN-gamma and IL-17 in healthy volunteers. No association was found between TB and polymorphisms in the genes ATG10, ATG16L2, ATG2B, ATG5, ATG9B, IRGM, LAMP1, LAMP3, P2RX7, WIPI1, MTOR and ATG4C. Associations were found between polymorphisms in LAMP1 (p = 0.02) and MTOR (p = 0.02) and infection with the successful M. tuberculosis Beijing genotype. The polymorphisms examined were not associated with M. tuberculosis induced cytokines, except for a polymorphism in ATG10, which was linked with IL-8 production (p = 0.04). All associations found lost statistical significance after correction for multiple testing. This first examination of a broad set of polymorphisms in autophagy genes fails to show a clear association with TB, with M. tuberculosis Beijing genotype infection or with ex-vivo pro-inflammatory cytokine production.	[Songane, Mario; Kleinnijenhuis, Johanneke; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Songane, Mario; Kleinnijenhuis, Johanneke; Oosting, Marije; Plantinga, Theo S.; Joosten, Leo A. B.; Netea, Mihai G.; van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, Dept Internal Med, Bandung, Indonesia; [Alisjahbana, Bachti; Sahiratmadja, Edhyana] Padjadjaran State Univ, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Sahiratmadja, Edhyana] Padjadjaran State Univ, Fac Med, Dept Biochem, Bandung, Indonesia; [Parwati, Ida] Padjadjaran State Univ, Fac Med, Dept Clin Pathol, Bandung, Indonesia; [Ottenhoff, Tom H. M.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Universitas Padjadjaran; Universitas Padjadjaran; Universitas Padjadjaran; Universitas Padjadjaran; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Songane, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	r.vancrevel@aig.umcn.nl	Oosting, Marije/H-7437-2015; van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009; kleinnijenhuis, johanneke/G-7978-2016; Netea, Mihai/N-5155-2014; Kleinnijenhuis, Johanneke/P-6309-2015; van Crevel, reinout/A-6636-2010; Plantinga, Theo S./A-6895-2015; Joosten, Leo AB/H-3138-2015	van de Vosse, Esther/0000-0001-5199-3426; van Crevel, reinout/0000-0002-6233-6410; Plantinga, Theo S./0000-0003-4990-6084; Joosten, Leo AB/0000-0001-6166-9830; Sahiratmadja, Edhyana/0000-0001-9092-5848; Parwati, Ida/0000-0002-9700-589X	Netherlands Organization of Scientific Research; Royal Netherlands Academy of Arts and Sciences (KNAW) [KNAW99MED01]; Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO)	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO)	R.v.C. was supported by a Vidi grant from the Netherlands Organization of Scientific Research. M.G.N. was supported by a Vici grant from the Netherlands Organization of Scientific Research. This study was supported by the Royal Netherlands Academy of Arts and Sciences (KNAW; KNAW99MED01) and the Netherlands Organization for Scientific Research-Netherlands Foundation for the Advancement of Tropical Research (NWOWOTRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Che NY, 2010, CLIN CHIM ACTA, V411, P1645, DOI 10.1016/j.cca.2010.06.009; Cheng JF, 2010, WORLD J GASTROENTERO, V16, P1258, DOI 10.3748/wjg.v16.i10.1258; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fernando SL, 2005, J INFECT DIS, V192, P149, DOI 10.1086/430622; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lacher M, 2009, ACTA PAEDIATR, V98, P1835, DOI 10.1111/j.1651-2227.2009.01438.x; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Moon CM, 2012, INFLAMM BOWEL DIS; Myers AJ, 2005, INFECT IMMUN, V73, P3192, DOI 10.1128/IAI.73.5.3192-3195.2005; Parwati I, 2008, J CLIN MICROBIOL, V46, P3639, DOI 10.1128/JCM.00605-08; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Sehgal R, 2012, DIS COLON RECTUM, V55, P115, DOI 10.1097/DCR.0b013e31823ccea8; Selvaraj P., 1999, Tubercle and Lung Disease, V79, P221, DOI 10.1054/tuld.1999.0204; Shepard EM, 2005, HUM BIOL, V77, P825, DOI 10.1353/hub.2006.0019; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stober CB, 2001, J IMMUNOL, V166, P6276, DOI 10.4049/jimmunol.166.10.6276; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004	49	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41618	10.1371/journal.pone.0041618	http://dx.doi.org/10.1371/journal.pone.0041618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879892	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000008
J	Zamostna, B; Novak, J; Vopalensky, V; Masek, T; Burysek, L; Pospisek, M				Zamostna, Blanka; Novak, Josef; Vopalensky, Vaclav; Masek, Tomas; Burysek, Ladislav; Pospisek, Martin			N-Terminal Domain of Nuclear IL-1 alpha Shows Structural Similarity to the C-Terminal Domain of Snf1 and Binds to the HAT/Core Module of the SAGA Complex	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NUCLEOSOME ACETYLATION; ALZHEIMERS-DISEASE; ADA-COMPLEX; YEAST SAGA; INTERLEUKIN-1-ALPHA; TRANSCRIPTION	Interleukin-1 alpha (IL-1 alpha) is a proinflammatory cytokine and a key player in host immune responses in higher eukaryotes. IL-1 alpha has pleiotropic effects on a wide range of cell types, and it has been extensively studied for its ability to contribute to various autoimmune and inflammation-linked disorders, including rheumatoid arthritis, Alzheimer's disease, systemic sclerosis and cardiovascular disorders. Interestingly, a significant proportion of IL-1 alpha is translocated to the cell nucleus, in which it interacts with histone acetyltransferase complexes. Despite the importance of IL-1 alpha, little is known regarding its binding targets and functions in the nucleus. We took advantage of the histone acetyltransferase (HAT) complexes being evolutionarily conserved from yeast to humans and the yeast SAGA complex serving as an epitome of the eukaryotic HAT complexes. Using gene knock-out technique and co-immunoprecipitation of the IL-1 alpha precursor with TAP-tagged subunits of the yeast HAT complexes, we mapped the IL-1 alpha-binding site to the HAT/Core module of the SAGA complex. We also predicted the 3-D structure of the IL-1 alpha N-terminal domain, and by employing structure similarity searches, we found a similar structure in the C-terminal regulatory region of the catalytic subunit of the AMP-activated/Snf1 protein kinases, which interact with HAT complexes both in mammals and yeast, respectively. This finding is further supported with the ability of the IL-1 alpha precursor to partially rescue growth defects of snf1 Delta yeast strains on media containing 3-Amino-1,2,4-triazole (3-AT), a competitive inhibitor of His3. Finally, the careful evaluation of our data together with other published data in the field allows us to hypothesize a new function for the ADA complex in SAGA complex assembly.	[Zamostna, Blanka; Novak, Josef; Vopalensky, Vaclav; Masek, Tomas; Pospisek, Martin] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic; [Burysek, Ladislav] Protean Sro, Dobra Voda, Czech Republic	Charles University Prague	Zamostna, B (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic.	martin@natur.cuni.cz	Pospisek, Martin/A-9100-2008; Zamostna, Blanka/AAK-6526-2020; Vopalensky, Vaclav/Q-6418-2017; Burýšek, Ladislav/M-7369-2019; Masek, Tomas/Q-4636-2017	Vopalensky, Vaclav/0000-0002-4858-4645; Novak, Josef/0000-0002-9764-6195; Masek, Tomas/0000-0001-8732-0565; Pospisek, Martin/0000-0002-9490-8911	Ministry of Health of the Czech Republic, IGA [NS/9819]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620858]; Charles University [SVV-2012-265202]	Ministry of Health of the Czech Republic, IGA; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University	This project was supported by the Ministry of Health of the Czech Republic, IGA (grant NS/9819) and also partially supported by the Ministry of Education, Youth and Sports of the Czech Republic (grant MSM0021620858) and by the Charles University institutional grant SVV-2012-265202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; GAO G, 1995, BBA-MOL CELL RES, V1266, P73, DOI 10.1016/0167-4889(94)00222-Z; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Gueldener Ullrich, 1996, Nucleic Acids Research, V24, P2519; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Hu B, 2003, P NATL ACAD SCI USA, V100, P10008, DOI 10.1073/pnas.1737765100; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; KAWAGUCHI Y, 1994, CLIN EXP IMMUNOL, V97, P445; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Liu Y, 2005, MOL CELL BIOL, V25, P10566, DOI 10.1128/MCB.25.23.10566-10579.2005; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Orlova M, 2010, EUKARYOT CELL, V9, P208, DOI 10.1128/EC.00216-09; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Slovackova J, 2010, CELL CYCLE, V9, P2141, DOI 10.4161/cc.9.11.11808; Smardova J, 2005, DIFFERENTIATION, V73, P261, DOI 10.1111/j.1432-0436.2005.00028.x; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vicenova B, 2009, PHYSIOL RES, V58, P481, DOI 10.33549/physiolres.931673; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Yin HL, 2001, CYTOKINE, V15, P122, DOI 10.1006/cyto.2001.0891; Yousef AF, 2008, INT J CANCER, V122, P942, DOI 10.1002/ijc.23174	65	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41801	10.1371/journal.pone.0041801	http://dx.doi.org/10.1371/journal.pone.0041801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879895	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000010
J	Balakrishnan, SK; Witcher, M; Berggren, TW; Emerson, BM				Balakrishnan, Sri Kripa; Witcher, Michael; Berggren, Travis W.; Emerson, Beverly M.			Functional and Molecular Characterization of the Role of CTCF in Human Embryonic Stem Cell Biology	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; TRANSCRIPTIONAL NETWORK; PROTEIN CTCF; ES CELLS; HUMAN GENOME; H19 GENE; CHROMATIN; BINDING; INSULATOR; PLURIPOTENCY	The CCCTC-binding factor CTCF is the only known vertebrate insulator protein and has been shown to regulate important developmental processes such as imprinting, X-chromosome inactivation and genomic architecture. In this study, we examined the role of CTCF in human embryonic stem cell (hESC) biology. We demonstrate that CTCF associates with several important pluripotency genes, including NANOG, SOX2, cMYC and LIN28 and is critical for hESC proliferation. CTCF depletion impacts expression of pluripotency genes and accelerates loss of pluripotency upon BMP4 induced differentiation, but does not result in spontaneous differentiation. We find that CTCF associates with the distal ends and internal sites of the coregulated 160 kb NANOG-DPPA3-GDF3 locus. Each of these sites can function as a CTCF-dependent enhancer-blocking insulator in heterologous assays. In hESCs, CTCF exists in multisubunit protein complexes and can be poly(ADP) ribosylated. Known CTCF cofactors, such as Cohesin, differentially co-localize in the vicinity of specific CTCF binding sites within the NANOG locus. Importantly, the association of some cofactors and protein PARlation selectively changes upon differentiation although CTCF binding remains constant. Understanding how unique cofactors may impart specialized functions to CTCF at specific genomic locations will further illuminate its role in stem cell biology.	[Balakrishnan, Sri Kripa; Witcher, Michael; Emerson, Beverly M.] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Berggren, Travis W.] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Balakrishnan, SK (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	emerson@salk.edu			California Institute of Regenerative Medicine SEED grant [RS1-00195]	California Institute of Regenerative Medicine SEED grant	This work was supported by a California Institute of Regenerative Medicine SEED grant (RS1-00195) to BME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Gombert WM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006109; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; NG YK, 1994, DEVELOPMENT, V120, P3257; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	50	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42424	10.1371/journal.pone.0042424	http://dx.doi.org/10.1371/journal.pone.0042424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879976	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100087
J	Hao, JL; Madigan, MC; Khatri, A; Power, CA; Hung, TT; Beretov, J; Chang, L; Xiao, WW; Cozzi, PJ; Graham, PH; Kearsley, JH; Li, Y				Hao, Jingli; Madigan, Michele C.; Khatri, Aparajita; Power, Carl A.; Hung, Tzong-Tyng; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Cozzi, Paul J.; Graham, Peter H.; Kearsley, John H.; Li, Yong			In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147	PLOS ONE			English	Article							DRUG-RESISTANCE; MONOCARBOXYLATE TRANSPORTERS; MULTIDRUG-RESISTANCE; CELL-LINE; HYALURONAN-CD44 INTERACTION; P-GLYCOPROTEIN; OVARIAN-CANCER; INVASION; EMMPRIN; GROWTH	CD44 and CD147 are associated with cancer metastasis and progression. Our purpose in the study was to investigate the effects of down-regulation of CD44 or CD147 on the metastatic ability of prostate cancer (CaP) cells, their docetaxel (DTX) responsiveness and potential mechanisms involved in vitro and in vivo. CD44 and CD147 were knocked down (KD) in PC-3M-luc CaP cells using short hairpin RNA (shRNA). Expression of CD44, CD147, MRP2 (multi-drug resistance protein-2) and MCT4 (monocarboxylate tranporter-4) was evaluated using immunofluorescence and Western blotting. The DTX dose-response and proliferation was measured by MTT and colony assays, respectively. The invasive potential was assessed using a matrigel chamber assay. Signal transduction proteins in PI3K/Akt and MAPK/Erk pathways were assessed by Western blotting. An in vivo subcutaneous (s.c.) xenograft model was established to assess CaP tumorigenecity, lymph node metastases and DTX response. Our results indicated that KD of CD44 or CD147 decreased MCT4 and MRP2 expression, reduced CaP proliferation and invasive potential and enhanced DTX sensitivity; and KD of CD44 or CD147 down-regulated p-Akt and p-Erk, the main signal modulators associated with cell growth and survival. In vivo, CD44 or CD147-KD PC-3M-luc xenografts displayed suppressed tumor growth with increased DTX responsiveness compared to control xenografts. Both CD44 and CD147 enhance metastatic capacity and chemoresistance of CaP cells, potentially mediated by activation of the PI3K and MAPK pathways. Selective targeting of CD44/CD147 alone or combined with DTX may limit CaP metastasis and increase chemosensitivity, with promise for future CaP treatment.	[Hao, Jingli; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Cozzi, Paul J.; Graham, Peter H.; Kearsley, John H.; Li, Yong] Univ New S Wales, St George Clin Sch, Kensington, NSW 2033, Australia; [Hao, Jingli; Beretov, Julia; Chang, Lei; Xiao, Weiwei; Graham, Peter H.; Kearsley, John H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Madigan, Michele C.] Univ Sydney, Sydney Med Sch, Save Sight Inst, Sydney, NSW 2006, Australia; [Khatri, Aparajita; Hung, Tzong-Tyng] Univ New S Wales, Prince Wales Clin Sch, Kensington, NSW 2033, Australia; [Power, Carl A.; Hung, Tzong-Tyng] Univ New S Wales, Biol Resources Imaging Lab, Kensington, NSW 2033, Australia; [Beretov, Julia] St George Hosp, Dept Anat Pathol, Kogarah, NSW, Australia; [Cozzi, Paul J.] St George Hosp, Dept Surg, Kogarah, NSW, Australia	University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St George Hospital; St George Hospital	Hao, JL (corresponding author), Univ New S Wales, St George Clin Sch, POB 1, Kensington, NSW 2033, Australia.	y.li@unsw.edu.au		Li, Yong/0000-0002-8910-9787; Hung, Tzong/0000-0002-2904-2664; Xiao, WeiWei/0000-0002-9922-640X; Beretov, Julia/0000-0001-5582-0020	National Health & Medical Research Council (NHMRC); St George Medical Research Foundation; Urology Research Fund; St George Hospital Trust Fund	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); St George Medical Research Foundation; Urology Research Fund; St George Hospital Trust Fund	This work was supported by National Health & Medical Research Council (NH&MRC) (YL), St George Medical Research Foundation (YL), Urology Research Fund (PJC) and St George Hospital Trust Fund (PHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Calabro F, 2007, EUR UROL, V51, P17, DOI 10.1016/j.eururo.2006.08.013; Chang SS, 2009, BJU INT, V103, P8, DOI 10.1111/j.1464-410X.2008.08256.x; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Chen HC, 2010, INTEGR SER INFORM SY, V21, P147, DOI 10.1007/978-1-4419-1278-7_10; Cozzi PJ, 2005, CLIN EXP METASTAS, V22, P565, DOI 10.1007/s10585-005-5376-z; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Gao AC, 1998, CANCER RES, V58, P2350; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gilg AG, 2008, CLIN CANCER RES, V14, P1804, DOI 10.1158/1078-0432.CCR-07-1228; GLEAVE M, 1991, CANCER RES, V51, P3753; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hao JL, 2010, CURR CANCER DRUG TAR, V10, P287, DOI 10.2174/156800910791190193; Ide H, 2010, JPN J CLIN ONCOL, V40, P79, DOI 10.1093/jjco/hyp126; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Li Y, 2002, BRIT J CANCER, V86, P1197, DOI 10.1038/sj/bjc/6600179; Ma JJ, 2009, ARCH GYNECOL OBSTET, V279, P149, DOI 10.1007/s00404-008-0690-8; Madigan MC, 2008, CANCER IMMUNOL IMMUN, V57, P1367, DOI 10.1007/s00262-008-0473-x; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Nishida N, 2004, CANCER, V101, P364; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Petrylak DP, 2005, UROLOGY, V65, P8, DOI 10.1016/j.urology.2005.04.020; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Schneiderhan W, 2009, GUT, V58, P1391, DOI 10.1136/gut.2009.181412; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024405; Wang L, 2011, CANCER LETT, V300, P122, DOI 10.1016/j.canlet.2010.09.013; Wang LG, 2006, CANCER BIOL THER, V5, P608, DOI 10.4161/cbt.5.6.2661; Wang WJ, 2008, CHEMOTHERAPY, V54, P291, DOI 10.1159/000151225; WARE JL, 1982, J UROLOGY, V128, P1064, DOI 10.1016/S0022-5347(17)53345-5; Wegiel B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007953; Yamasaki M, 2011, BRIT J CANCER, V104, P707, DOI 10.1038/sj.bjc.6606071; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yang K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-16; Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982; Zhu HN, 2012, PROSTATE, V72, P72, DOI 10.1002/pros.21408	62	69	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40716	10.1371/journal.pone.0040716	http://dx.doi.org/10.1371/journal.pone.0040716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870202	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100010
J	Lai, A; Simonetti, FR; Zehender, G; De Luca, A; Micheli, V; Meraviglia, P; Corsi, P; Bagnarelli, P; Almi, P; Zoncada, A; Paolucci, S; Gonnelli, A; Colao, G; Tacconi, D; Franzetti, M; Ciccozzi, M; Zazzi, M; Balotta, C				Lai, Alessia; Simonetti, Francesco R.; Zehender, Gianguglielmo; De Luca, Andrea; Micheli, Valeria; Meraviglia, Paola; Corsi, Paola; Bagnarelli, Patrizia; Almi, Paolo; Zoncada, Alessia; Paolucci, Stefania; Gonnelli, Angela; Colao, Grazia; Tacconi, Danilo; Franzetti, Marco; Ciccozzi, Massimo; Zazzi, Maurizio; Balotta, Claudia			HIV-1 Subtype F1 Epidemiological Networks among Italian Heterosexual Males Are Associated with Introduction Events from South America	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NON-B SUBTYPES; DRUG-RESISTANCE; PREVALENCE; TRANSMISSION; DIVERSITY; STRAINS	About 40% of the Italian HIV-1 epidemic due to non-B variants is sustained by F1 clade, which circulates at high prevalence in South America and Eastern Europe. Aim of this study was to define clade F1 origin, population dynamics and epidemiological networks through phylogenetic approaches. We analyzed pol sequences of 343 patients carrying F1 subtype stored in the ARCA database from 1998 to 2009. Citizenship of patients was as follows: 72.6% Italians, 9.3% South Americans and 7.3% Rumanians. Heterosexuals, Homo-bisexuals, Intravenous Drug Users accounted for 58.1%, 24.0% and 8.8% of patients, respectively. Phylogenetic analysis indicated that 70% of sequences clustered in 27 transmission networks. Two distinct groups were identified; the first clade, encompassing 56 sequences, included all Rumanian patients. The second group involved the remaining clusters and included 10 South American Homo-bisexuals in 9 distinct clusters. Heterosexual modality of infection was significantly associated with the probability to be detected in transmission networks. Heterosexuals were prevalent either among Italians (67.2%) or Rumanians (50%); by contrast, Homo-bisexuals accounted for 71.4% of South Americans. Among patients with resistant strains the proportion of clustering sequences was 57.1%, involving 14 clusters (51.8%). Resistance in clusters tended to be higher in South Americans (28.6%) compared to Italian (17.7%) and Rumanian patients (14.3%). A striking proportion of epidemiological networks could be identified in heterosexuals carrying F1 subtype residing in Italy. Italian Heterosexual males predominated within epidemiological clusters while foreign patients were mainly Heterosexual Rumanians, both males and females, and South American Homo-bisexuals. Tree topology suggested that F1 variant from South America gave rise to the Italian F1 epidemic through multiple introduction events. The contact tracing also revealed an unexpected burden of resistance in epidemiological clusters underlying the need of public interventions to limit the spread of non-B subtypes and transmitted drug resistance.	[Lai, Alessia; Simonetti, Francesco R.; Zehender, Gianguglielmo; Franzetti, Marco; Balotta, Claudia] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy; [De Luca, Andrea] Univ Siena, Infect Dis Unit 2, I-53100 Siena, Italy; [Micheli, Valeria] L Sacco Hosp Vialba, Microbiol Lab, Milan, Italy; [Meraviglia, Paola] L Sacco Hosp Vialba, Div Infect Dis 2, Milan, Italy; [Corsi, Paola] Unita Operat Complessa Infect Dis Careggi, Florence, Italy; [Bagnarelli, Patrizia] Univ Politecn Marche, Virol Lab, Microbiol Sect, Dept Biomed Sci, Ancona, Italy; [Almi, Paolo; Gonnelli, Angela] Azienda Osped Univ Senese, Unita Operat Complessa Infect Dis & Hepatol, Siena, Italy; [Zoncada, Alessia] Infect Dis Sect, Cremona, Italy; [Paolucci, Stefania] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Colao, Grazia] Sect Virol Careggi, Florence, Italy; [Tacconi, Danilo] Infect Dis Sect, Arezzo, Italy; [Ciccozzi, Massimo] Italian Inst Hlth, Dept Infect, Epidemiol Unit, Rome, Italy; [Zazzi, Maurizio] Univ Siena, Dept Biotechnol, Microbiol Sect, I-53100 Siena, Italy	University of Milan; Luigi Sacco Hospital; University of Siena; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Marche Polytechnic University; University of Siena; University Hospital of Siena; IRCCS Fondazione San Matteo; University of Siena	Lai, A (corresponding author), Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy.	alessia.lai@unimi.it	Paolucci, Stefania/J-4055-2018; LAI, ALESSIA/AAR-1300-2021; Micheli, Valeria/G-4927-2018; Bagnarelli, Patrizia/AAL-2750-2020; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016; Zazzi, Maurizio/K-3422-2018; De Luca, Andrea/G-8810-2011; Balotta, Claudia/L-7295-2017	Paolucci, Stefania/0000-0001-8447-8586; LAI, ALESSIA/0000-0002-3174-5721; Micheli, Valeria/0000-0001-5629-3875; Bagnarelli, Patrizia/0000-0001-5231-9660; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; Zazzi, Maurizio/0000-0002-0344-6281; De Luca, Andrea/0000-0002-9561-9193; meraviglia, paola/0000-0002-3356-7199; Balotta, Claudia/0000-0002-1107-9119; Simonetti, Francesco Roberto/0000-0002-4165-660X	Ministry of Health, Rome, Italy [40H63, 40H64]; VI AIDS Research Program of the Ministry of Health, Rome, Italy [30G.58]; Italian PRIN [200887SYZ5]; Anti-HIV Drug Resistance Network (CHAIN) [223131]	Ministry of Health, Rome, Italy(Ministry of Health, Italy); VI AIDS Research Program of the Ministry of Health, Rome, Italy; Italian PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Anti-HIV Drug Resistance Network (CHAIN)	This work was supported by grants from the Ministry of Health, Rome, Italy (grant 40H63 and grant 40H64) to CB; from the VI AIDS Research Program of the Ministry of Health, Rome, Italy (grant 30G.58), the Italian PRIN 2008 (grant 200887SYZ5) and Anti-HIV Drug Resistance Network (CHAIN) (grant agreement 223131) to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanti F, 2008, J MED VIROL, V80, P947, DOI 10.1002/jmv.21163; Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; Ciccozzi M, 2010, NEW MICROBIOL, V33, P179; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUMITRESCU O, 1994, J INFECT DIS, V169, P281, DOI 10.1093/infdis/169.2.281; Franzetti M, 2012, J ANTIMICROB CHEMOTH, V67, P1250, DOI 10.1093/jac/dks013; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Guimaraes ML, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-39; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lai A, 2011, AIDS RES HU IN PRESS; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Riva C, 2010, AIDS RES HUM RETROV, V26, P41, DOI 10.1089/aid.2009.0057; Snoeck J, 2004, JAIDS-J ACQ IMM DEF, V35, P279, DOI 10.1097/00126334-200403010-00009; Suligoi B., 2009, NOTIZIARIO I SUPERIO, V22, P3; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Zaccarelli M, 2004, SEX TRANSM INFECT, V80, P541, DOI 10.1136/sti.2004.010769	25	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42223	10.1371/journal.pone.0042223	http://dx.doi.org/10.1371/journal.pone.0042223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876310	gold, Green Published, Green Submitted			2022-12-25	WOS:000307184700038
J	Mountrakis, G; Zhuang, W				Mountrakis, Giorgos; Zhuang, Wei			Integrating Local and Global Error Statistics for Multi-Scale RBF Network Training: An Assessment on Remote Sensing Data	PLOS ONE			English	Article							FUNCTION NEURAL-NETWORKS; RESOLUTION SATELLITE IMAGERY; RADIAL BASIS FUNCTIONS; IMPERVIOUS SURFACES; LASER ALTIMETER; CLASSIFICATION; ALGORITHM; SYSTEM; CLASSIFIERS; LIDAR	Background: This study discusses the theoretical underpinnings of a novel multi-scale radial basis function (MSRBF) neural network along with its application to classification and regression tasks in remote sensing. The novelty of the proposed MSRBF network relies on the integration of both local and global error statistics in the node selection process. Methodology and Principal Findings: The method was tested on a binary classification task, detection of impervious surfaces using a Landsat satellite image, and a regression problem, simulation of waveform LiDAR data. In the classification scenario, results indicate that the MSRBF is superior to existing radial basis function and back propagation neural networks in terms of obtained classification accuracy and training-testing consistency, especially for smaller datasets. The latter is especially important as reference data acquisition is always an issue in remote sensing applications. In the regression case, MSRBF provided improved accuracy and consistency when contrasted with a multi kernel RBF network. Conclusion and Significance: Results highlight the potential of a novel training methodology that is not restricted to a specific algorithmic type, therefore significantly advancing machine learning algorithms for classification and regression tasks. The MSRBF is expected to find numerous applications within and outside the remote sensing field.	[Mountrakis, Giorgos; Zhuang, Wei] SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Mountrakis, G (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA.	gmountrakis@esf.edu	Beckley, Matthew/D-4547-2013; Mountrakis, Giorgos/I-9612-2014	Mountrakis, Giorgos/0000-0001-5958-8134	NASA [NNX09AK16G, NNX08AR11G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported NASA's Biodiversity and New Investigator Progams (awards NNX09AK16G, NNX08AR11G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Bauer M. E., 2004, ASPRS ANN C P DENV C; BENEDIKTSSON JA, 1990, IEEE T GEOSCI REMOTE, V28, P540, DOI 10.1109/TGRS.1990.572944; Bhattacharya D, 1997, IEEE T GEOSCI REMOTE, V35, P699, DOI 10.1109/36.581990; Bhattacharya D, 1996, P IEEE INT S CIRCUIT, V3, P309; BILLINGS SA, 1989, INT J CONTROL, V49, P2157, DOI 10.1080/00207178908559767; Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; Bruzzone L., 2002, Information Fusion, V3, P289, DOI 10.1016/S1566-2535(02)00091-X; Bruzzone L, 2004, PATTERN RECOGN LETT, V25, P1491, DOI 10.1016/j.patrec.2004.06.002; Bruzzone L, 2004, IEEE T GEOSCI REMOTE, V42, P1321, DOI 10.1109/TGRS.2004.826821; Bruzzone L, 2003, INT J REMOTE SENS, V24, P1709, DOI 10.1080/01431160210144714; Bruzzone L, 1999, IEEE T GEOSCI REMOTE, V37, P1179, DOI 10.1109/36.752239; Bruzzone L, 2002, IEEE T GEOSCI REMOTE, V40, P1984, DOI 10.1109/TGRS.2002.803794; Bruzzone L, 2001, P SPIE INT SOC OPTIC, V4541, P223; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; CHEN S, 1991, IEEE T NEURAL NETWOR, V2, P302, DOI 10.1109/72.80341; Constantinopoulos C, 2006, IEEE T NEURAL NETWOR, V17, P966, DOI 10.1109/TNN.2006.875982; Dell'Acqua F, 2003, IEEE T GEOSCI REMOTE, V41, P853, DOI 10.1109/TGRS.2003.811077; Ferrari S, 2004, IEEE T NEURAL NETWOR, V15, P178, DOI 10.1109/TNN.2003.811355; Fischer MM, 1997, GEOGRAPHICAL SYSTEMS, V4, P195; Foody GM, 2007, INT J REMOTE SENS, V28, P1733, DOI 10.1080/01431160600962566; Foody G.M., 2001, J GEOGR SYST, V3, P217; Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Gamba P, 2003, INT J REMOTE SENS, V24, P827, DOI 10.1080/01431160210154001; Grebby S, 2010, REMOTE SENS ENVIRON, V114, P713, DOI 10.1016/j.rse.2009.11.006; Harding DJ, 2001, REMOTE SENS ENVIRON, V76, P283, DOI 10.1016/S0034-4257(00)00210-8; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Hyde P, 2005, REMOTE SENS ENVIRON, V96, P427, DOI 10.1016/j.rse.2005.03.005; Jena B, 2010, IEEE GEOSCI REMOTE S, V7, P567, DOI 10.1109/LGRS.2010.2041632; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Kalra R, 2005, MAR STRUCT, V18, P289, DOI 10.1016/j.marstruc.2005.09.003; Kalra R, 2005, OCEAN ENG, V32, P1917, DOI 10.1016/j.oceaneng.2005.01.007; Karayiannis NB, 2006, IEEE T NEURAL NETWOR, V17, P1222, DOI 10.1109/TNN.2006.877538; Keramitsoglou I, 2005, INT J REMOTE SENS, V26, P1861, DOI 10.1080/01431160512331326594; Keramitsoglou I, 2006, ISPRS J PHOTOGRAMM, V60, P225, DOI 10.1016/j.isprsjprs.2006.01.002; Le Gia QT, 2012, APPL COMPUT HARMON A, V32, P401, DOI 10.1016/j.acha.2011.07.007; Lee S, 2006, IEEE T GEOSCI REMOTE, V44, P1642, DOI 10.1109/TGRS.2006.869984; Li Q, 2011, PROC SPIE, V8286, DOI 10.1117/12.913031; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P1053, DOI 10.14358/PERS.70.9.1053; Luo H, 2005, P SPIE INT SOC OPTIC; Luo L, 2010, REMOTE SENS ENVIRON, V114, P1220, DOI 10.1016/j.rse.2010.01.008; McCauley S, 2004, INT J REMOTE SENS, V25, P1077, DOI 10.1080/0143116031000115102; Means JE, 1999, REMOTE SENS ENVIRON, V67, P298, DOI 10.1016/S0034-4257(98)00091-1; Mountrakis G, 2011, REMOTE SENSING ENV; Mountrakis G, 2009, MULTISCALE RADIAL BA; Mountrakis G, 2009, PHOTOGRAMM ENG REM S, V75, P831, DOI 10.14358/PERS.75.7.831; Perry DA, 2008, FOREST ECOSYSTEMS; Rollet R, 1998, INT J REMOTE SENS, V19, P3003, DOI 10.1080/014311698214398; ROY A, 1995, NEURAL NETWORKS, V8, P179, DOI 10.1016/0893-6080(94)00064-S; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; SHIOTANI S, 1995, NEUROCOMPUTING, V9, P111, DOI 10.1016/0925-2312(94)00061-V; Sing JK, 2009, NEURAL COMPUT APPL, V18, P979, DOI 10.1007/s00521-009-0242-6; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Suresh S, 2008, NEUROCOMPUTING, V71, P1345, DOI 10.1016/j.neucom.2007.06.003; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; Wei HL, 2007, ADV SPACE RES, V40, P1863, DOI 10.1016/j.asr.2007.02.080; Weng Q., 2011, REMOTE SENSING ENV; Weng QH, 2008, IEEE T GEOSCI REMOTE, V46, P2397, DOI 10.1109/TGRS.2008.917601; Weng QH, 2009, INT J REMOTE SENS, V30, P4807, DOI 10.1080/01431160802665926; Weng QH, 2009, INT J REMOTE SENS, V30, P2547, DOI 10.1080/01431160802552777; West D.C., 1981, FOREST SUCCESSION CO, DOI 10.1007/978-1-4612-5950-3; Xiao RR, 1998, IEEE T GEOSCI REMOTE, V36, P716, DOI 10.1109/36.673664; Xie N, 2003, IEEE T GEOSCI REMOTE, V41, P1491, DOI 10.1109/TGRS.2003.811690; Yang LM, 2003, CAN J REMOTE SENS, V29, P230, DOI 10.5589/m02-098; Yang XJ, 2006, IEEE GEOSCI REMOTE S, V3, P6, DOI 10.1109/LGRS.2005.853929	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e40093	10.1371/journal.pone.0040093	http://dx.doi.org/10.1371/journal.pone.0040093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876278	gold, Green Submitted, Green Published			2022-12-25	WOS:000307184700006
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi	PLOS ONE			English	Article							K-ATP CHANNELS; ANTIFUNGAL ANTIBIOTIC CLOTRIMAZOLE; RECTIFYING POTASSIUM CHANNEL; RECEPTOR POTENTIAL CHANNELS; 2 PORE DOMAINS; NEUROSPORA-CRASSA; PLASMA-MEMBRANE; ION CHANNELS; CANDIDA-ALBICANS; CA2+ CHANNEL	Fungi are major causes of human, animal and plant disease. Human fungal infections can be fatal, but there are limited options for therapy, and resistance to commonly used anti-fungal drugs is widespread. The genomes of many fungi have recently been sequenced, allowing identification of proteins that may become targets for novel therapies. We examined the genomes of human fungal pathogens for genes encoding homologues of cation channels, which are prominent drug targets. Many of the fungal genomes examined contain genes encoding homologues of potassium (K+), calcium (Ca2+) and transient receptor potential (Trp) channels, but not sodium (Na+) channels or ligand-gated channels. Some fungal genomes contain multiple genes encoding homologues of K+ and Trp channel subunits, and genes encoding novel homologues of voltage-gated K-v channel subunits are found in Cryptococcus spp. Only a single gene encoding a homologue of a plasma membrane Ca2+ channel was identified in the genome of each pathogenic fungus examined. These homologues are similar to the Cch1 Ca2+ channel of Saccharomyces cerevisiae. The genomes of Aspergillus spp. and Cryptococcus spp., but not those of S. cerevisiae or the other pathogenic fungi examined, also encode homologues of the mitochondrial Ca2+ uniporter (MCU). In contrast to humans, which express many K+, Ca2+ and Trp channels, the genomes of pathogenic fungi encode only very small numbers of K+, Ca2+ and Trp channel homologues. Furthermore, the sequences of fungal K+, Ca2+, Trp and MCU channels differ from those of human channels in regions that suggest differences in regulation and susceptibility to drugs.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	; Taylor, Colin/G-2447-2010	Prole, David/0000-0003-2782-6665; Taylor, Colin/0000-0001-7771-1044	St. John's College, Cambridge; Wellcome Trust [085295]	St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres senior research associateship from St. John's College, Cambridge (to DLP), and by the Wellcome Trust (grant number 085295, to CWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Aide MA, 2009, J BRAS PNEUMOL, V35, P1145, DOI 10.1590/S1806-37132009001100013; Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; [Anonymous], 2012, OR MULT SEQ PROJ FUN; Baev D, 2003, INFECT IMMUN, V71, P3251, DOI 10.1128/IAI.71.6.3251-3260.2003; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Bencina M, 2009, FUNGAL GENET BIOL, V46, pS93, DOI 10.1016/j.fgb.2008.07.019; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bertl A, 2003, MOL MICROBIOL, V47, P767, DOI 10.1046/j.1365-2958.2003.03335.x; Bertl A, 1998, J MEMBRANE BIOL, V162, P67, DOI 10.1007/s002329900343; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Borchers AT, 2010, AUTOIMMUN REV, V10, P94, DOI 10.1016/j.autrev.2010.08.010; Bormann J, 2009, MICROBIOL-SGM, V155, P3922, DOI 10.1099/mic.0.030825-0; Brand A, 2009, MOL MICROBIOL, V71, P1155, DOI 10.1111/j.1365-2958.2008.06592.x; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Cai XJ, 2012, PURINERG SIGNAL, V8, P11, DOI 10.1007/s11302-011-9261-8; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; CALVERT CM, 1995, J BIOL CHEM, V270, P7272, DOI 10.1074/jbc.270.13.7272; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavinder B, 2011, EUKARYOT CELL, V10, P832, DOI 10.1128/EC.00235-10; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CORNELIUS G, 1989, BIOCHEM BIOPH RES CO, V162, P852, DOI 10.1016/0006-291X(89)92388-7; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; de Deus A, 2009, J BRAS PNEUMOL, V35, P920, DOI 10.1590/S1806-37132009000900014; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; ERMOLAYEVA E, 1995, APPL ENVIRON MICROB, V61, P3385, DOI 10.1128/AEM.61.9.3385-3390.1995; Faguy David M, 2011, Radiol Technol, V82, P321; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gajdanowicz P, 2011, P NATL ACAD SCI USA, V108, P864, DOI 10.1073/pnas.1009777108; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Gullo A, 2009, DRUGS, V69, P65, DOI 10.2165/11315530-000000000-00000; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Haynes WJ, 2008, FEBS LETT, V582, P1514, DOI 10.1016/j.febslet.2008.03.046; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Inoue I, 1996, J DERMATOL SCI, V12, P156, DOI 10.1016/0923-1811(95)00475-0; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiselyov K, 2011, CELL CALCIUM, V50, P288, DOI 10.1016/j.ceca.2011.04.009; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2012, FEMS MICROBIOL REV, V36, P78, DOI 10.1111/j.1574-6976.2011.00286.x; Kraus R, 1996, J BIOL CHEM, V271, P20113, DOI 10.1074/jbc.271.33.20113; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; Lesage F, 1996, J BIOL CHEM, V271, P4183; Lew RR, 2009, MICROBIOL-SGM, V155, P903, DOI 10.1099/mic.0.023507-0; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Lupetti A, 2004, J ANTIMICROB CHEMOTH, V54, P603, DOI 10.1093/jac/dkh385; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; McDonough SI, 2002, J GEN PHYSIOL, V119, P313, DOI 10.1085/jgp.20028560; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00021; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Patterson Karen, 2010, Proc Am Thorac Soc, V7, P237, DOI 10.1513/pats.200908-086AL; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Quesada I, 2002, P NATL ACAD SCI USA, V99, P9544, DOI 10.1073/pnas.142039299; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rodrigues AAG, 2000, CURR MICROBIOL, V40, P145, DOI 10.1007/s002849910030; Roller A, 2005, PFLUG ARCH EUR J PHY, V451, P362, DOI 10.1007/s00424-005-1418-2; SALKOFF L, 1995, NEURON, V15, P489, DOI 10.1016/0896-6273(95)90137-X; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; SLAYMAN CL, 1962, SCIENCE, V136, P876, DOI 10.1126/science.136.3519.876; SLAYMAN CL, 1965, J GEN PHYSIOL, V49, P69, DOI 10.1085/jgp.49.1.69; SLAYMAN CL, 1976, BIOCHIM BIOPHYS ACTA, V426, P732, DOI 10.1016/0005-2736(76)90138-3; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; Su ZW, 2011, J GEN PHYSIOL, V138, P627, DOI 10.1085/jgp.201110693; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; Thomas GP, 1999, BRIT J PHARMACOL, V126, P1531, DOI 10.1038/sj.bjp.0702475; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Tian M, 2006, BRIT J PHARMACOL, V147, P289, DOI 10.1038/sj.bjp.0706590; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; VACATA V, 1981, BIOCHIM BIOPHYS ACTA, V643, P265, DOI 10.1016/0005-2736(81)90241-8; VanderHeyden N, 2000, FEMS MICROBIOL LETT, V183, P327, DOI 10.1111/j.1574-6968.2000.tb08979.x; Verret F, 2010, NEW PHYTOL, V187, P23, DOI 10.1111/j.1469-8137.2010.03271.x; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu T, 2011, ANTIMICROB AGENTS CH, V55, P1611, DOI 10.1128/AAC.01022-10; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	155	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42404	10.1371/journal.pone.0042404	http://dx.doi.org/10.1371/journal.pone.0042404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876320	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700048
J	Xu, Q; Xiong, GJ; Li, PB; He, F; Huang, Y; Wang, KB; Li, ZH; Hua, JP				Xu, Qin; Xiong, Guanjun; Li, Pengbo; He, Fei; Huang, Yi; Wang, Kunbo; Li, Zhaohu; Hua, Jinping			Analysis of Complete Nucleotide Sequences of 12 Gossypium Chloroplast Genomes: Origin and Evolution of Allotetraploids	PLOS ONE			English	Article							DISTINCT PLASTID GENOMES; PHYLOGENETIC-RELATIONSHIPS; SUBSECTION OENOTHERA; SUBSTITUTION RATES; COTTON; DIVERGENCE; NUCLEAR; GENE; DIVERSIFICATION; POLYPLOIDY	Background: Cotton (Gossypium spp.) is a model system for the analysis of polyploidization. Although ascertaining the donor species of allotetraploid cotton has been intensively studied, sequence comparison of Gossypium chloroplast genomes is still of interest to understand the mechanisms underlining the evolution of Gossypium allotetraploids, while it is generally accepted that the parents were A-and D-genome containing species. Here we performed a comparative analysis of 13 Gossypium chloroplast genomes, twelve of which are presented here for the first time. Methodology/Principal Findings: The size of 12 chloroplast genomes under study varied from 159,959 bp to 160,433 bp. The chromosomes were highly similar having >98% sequence identity. They encoded the same set of 112 unique genes which occurred in a uniform order with only slightly different boundary junctions. Divergence due to indels as well as substitutions was examined separately for genome, coding and noncoding sequences. The genome divergence was estimated as 0.374% to 0.583% between allotetraploid species and A-genome, and 0.159% to 0.454% within allotetraploids. Forty protein-coding genes were completely identical at the protein level, and 20 intergenic sequences were completely conserved. The 9 allotetraploids shared 5 insertions and 9 deletions in whole genome, and 7-bp substitutions in protein-coding genes. The phylogenetic tree confirmed a close relationship between allotetraploids and the ancestor of A-genome, and the allotetraploids were divided into four separate groups. Progenitor allotetraploid cotton originated 0.43-0.68 million years ago (MYA). Conclusion: Despite high degree of conservation between the Gossypium chloroplast genomes, sequence variations among species could still be detected. Gossypium chloroplast genomes preferred for 5-bp indels and 1-3-bp indels are mainly attributed to the SSR polymorphisms. This study supports that the common ancestor of diploid A-genome species in Gossypium is the maternal source of extant allotetraploid species and allotetraploids have a monophyletic origin. G. hirsutum AD1 lineages have experienced more sequence variations than other allotetraploids in intergenic regions. The available complete nucleotide sequences of 12 Gossypium chloroplast genomes should facilitate studies to uncover the molecular mechanisms of compartmental co-evolution and speciation of Gossypium allotetraploids.	[Xu, Qin; Xiong, Guanjun; Li, Pengbo; Li, Zhaohu; Hua, Jinping] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Li, Pengbo] Shanxi Acad Agr Sci, Inst Cotton, Yuncheng, Peoples R China; [He, Fei] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Huang, Yi] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Wang, Kunbo] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University; China Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Xu, Q (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	jinping_hua@cau.edu.cn	FEI, HE/C-5912-2015; Hua, Jinping/L-3221-2019; li, zh/HII-5698-2022	FEI, HE/0000-0002-1165-3248; 	Training Program Foundation for the New Century Excellent Talents in University [NCET-06-0106]; National Natural Science Foundation of China [31171591]	Training Program Foundation for the New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Training Program Foundation for the New Century Excellent Talents in University (NCET-06-0106) and National Natural Science Foundation of China (Grant No. 31171591) to J. Hua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; BALDAUF SL, 1990, NATURE, V344, P262, DOI 10.1038/344262a0; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Chan CX, 2011, PLANT PHYSIOL, V155, P1552, DOI 10.1104/pp.111.173500; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fryxell P.A, 1979, NATURAL HIST COTTON; Gaut BS, 1998, EVOL BIOL, V30, P93; Gong X, 1991, CHINESE SCI BULL, V36, P467; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Grover CE, 2007, PLANT J, V50, P995, DOI 10.1111/j.1365-313X.2007.03102.x; GU X, 1995, J MOL EVOL, V40, P464, DOI 10.1007/BF00164032; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; McCluskey K, 2011, G3-GENES GENOM GENET, V1, P303, DOI 10.1534/g3.111.000307; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Stoletzki N, 2011, MOL BIOL EVOL, V28, P1371, DOI 10.1093/molbev/msq320; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turmel M, 2009, MOL BIOL EVOL, V26, P2317, DOI 10.1093/molbev/msp138; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Vallender EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-168; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WENDEL JF, 1994, PLANT SYST EVOL, V192, P49, DOI 10.1007/BF00985907; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	69	54	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e37128	10.1371/journal.pone.0037128	http://dx.doi.org/10.1371/journal.pone.0037128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876273	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700001
J	Gallo, ND; Jeffery, WR				Gallo, Natalya D.; Jeffery, William R.			Evolution of Space Dependent Growth in the Teleost Astyanax mexicanus	PLOS ONE			English	Article							JUVENILE RAINBOW-TROUT; CAVE FISH; REGRESSIVE EVOLUTION; EYE DEGENERATION; STOCKING DENSITY; STRESS-RESPONSE; CORTISOL; COMPENSATION; CONSEQUENCES; POPULATIONS	The relationship between growth rate and environmental space is an unresolved issue in teleosts. While it is known from aquaculture studies that stocking density has a negative relationship to growth, the underlying mechanisms have not been elucidated, primarily because the growth rate of populations rather than individual fish were the subject of all previous studies. Here we investigate this problem in the teleost Astyanax mexicanus, which consists of a sighted surface-dwelling form (surface fish) and several blind cave-dwelling (cavefish) forms. Surface fish and cavefish are distinguished by living in spatially contrasting environments and therefore are excellent models to study the effects of environmental size on growth. Multiple controlled growth experiments with individual fish raised in confined or unconfined spaces showed that environmental size has a major impact on growth rate in surface fish, a trait we have termed space dependent growth (SDG). In contrast, SDG has regressed to different degrees in the Pachon and Tinaja populations of cavefish. Mating experiments between surface and Pachon cavefish show that SDG is inherited as a dominant trait and is controlled by multiple genetic factors. Despite its regression in blind cavefish, SDG is not affected when sighted surface fish are raised in darkness, indicating that vision is not required to perceive and react to environmental space. Analysis of plasma cortisol levels showed that an elevation above basal levels occurred soon after surface fish were exposed to confined space. This initial cortisol peak was absent in Pachon cavefish, suggesting that the effects of confined space on growth may be mediated partly through a stress response. We conclude that Astyanax reacts to confined spaces by exhibiting SDG, which has a genetic component and shows evolutionary regression during adaptation of cavefish to confined environments.	[Gallo, Natalya D.; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Gallo, ND (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	Jeffery@umd.edu	Gallo, Natalya/V-7734-2019		National Science Foundation [IBN-052384]; National Institutes of Health [R01-EYE014619]; Udall Fellowship; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Science Foundation (IBN-052384) and National Institutes of Health (R01-EYE014619) grants to WRJ supported the research. NDG acknowledges support by a Udall Fellowship while conducting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad TA, 2000, AQUAC RES, V31, P603, DOI 10.1046/j.1365-2109.2000.00479.x; BARTON BA, 1987, DIS AQUAT ORGAN, V2, P173; Bernier NJ, 2001, COMP BIOCHEM PHYS B, V129, P639, DOI 10.1016/S1096-4959(01)00360-8; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Costas B, 2008, AQUAC RES, V39, P1, DOI 10.1111/j.1365-2109.2007.01845.x; Dorn LD, 2007, ANN CLIN BIOCHEM, V44, P281, DOI 10.1258/000456307780480954; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Herrera M, 2009, AQUAC RES, V40, P790, DOI 10.1111/j.1365-2109.2008.02162.x; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Huang WB, 1997, AQUAC RES, V28, P165; Iguchi K, 2003, AQUACULTURE, V220, P515, DOI 10.1016/S0044-8486(02)00626-9; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 2000, DEV GENES EVOL, V210, P223, DOI 10.1007/s004270050308; JOBLING M, 1986, J FISH BIOL, V28, P379, DOI 10.1111/j.1095-8649.1986.tb05174.x; Langecker T.G., 1991, Ichthyological Exploration of Freshwaters, V2, P209; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Montgomery JC, 2001, ENVIRON BIOL FISH, V62, P87, DOI 10.1023/A:1011873111454; Pankhurst NW, 2000, GEN COMP ENDOCR, V117, P225, DOI 10.1006/gcen.1999.7401; Porter ML, 2007, ACTA CARSOLOGICA, V36, P173; Protas M, WIRES DEV B IN PRESS; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Ruane NM, 2003, AQUACULTURE, V218, P685, DOI 10.1016/S0044-8486(02)00422-2; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; SIDDIQUI A Q, 1989, Aquaculture and Fisheries Management, V20, P49, DOI 10.1111/j.1365-2109.1989.tb00440.x; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; SUMPTER JP, 1986, GEN COMP ENDOCR, V62, P377, DOI 10.1016/0016-6480(86)90047-X; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Varatharasan N, 2009, DEV DYNAM, V238, P3056, DOI 10.1002/dvdy.22144; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Yoshizawa M, 2012, EVOLUTION, V66, P2975, DOI 10.1111/j.1558-5646.2012.01651.x; Yoshizawa Masato, 2011, Communicative & Integrative Biology, V4, P89, DOI 10.4161/cib.4.1.14118; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	43	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41443	10.1371/journal.pone.0041443	http://dx.doi.org/10.1371/journal.pone.0041443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870223	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800020
J	Heinrichsen, ET; Haddad, GG				Heinrichsen, Erilynn T.; Haddad, Gabriel G.			Role of High-Fat Diet in Stress Response of Drosophila	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; CONSTANT HYPOXIA; O-2 DEPRIVATION; COLD STRESS; OBESITY; MELANOGASTER; TOLERANCE; INSECTS; METABOLISM	Obesity is associated with many diseases, one of the most common being obstructive sleep apnea (OSA), which in turn leads to blood gas disturbances, including intermittent hypoxia (IH). Obesity, OSA and IH are associated with metabolic changes, and while much mammalian work has been done, mechanisms underlying the response to IH, the role of obesity and the interaction of obesity and hypoxia remain unknown. As a model organism, Drosophila offers tremendous power to study a specific phenotype and, at a subsequent stage, to uncover and study fundamental mechanisms, given the conservation of molecular pathways. Herein, we characterize the phenotype of Drosophila on a high-fat diet in normoxia, IH and constant hypoxia (CH) using triglyceride and glucose levels, response to stress and lifespan. We found that female flies on a high-fat diet show increased triglyceride levels (p<0.001) and a shortened lifespan in normoxia, IH and CH. Furthermore, flies on a high-fat diet in normoxia and CH show diminished tolerance to stress, with decreased survival after exposure to extreme cold or anoxia (p<0.001). Of interest, IH seems to rescue this decreased cold tolerance, as flies on a high-fat diet almost completely recovered from cold stress following IH. We conclude that the cross talk between hypoxia and a high-fat diet can be either deleterious or compensatory, depending on the nature of the hypoxic treatment.	[Heinrichsen, Erilynn T.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Heinrichsen, Erilynn T.; Haddad, Gabriel G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Heinrichsen, ET (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu			National Institutes of Health (NIH) [PO1 HL098053]; National Institute of General Medical Sciences [T32 GM008666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health (NIH) grant PO1 HL098053 and in part by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences, T32 GM008666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora RN, 2007, SLEEP MED CLIN, V2, P237, DOI 10.1016/j.jsmc.2007.03.006; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Colinet H, 2010, INSECT BIOCHEM MOLEC, V40, P425, DOI 10.1016/j.ibmb.2010.03.002; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson TE, 1996, J GERONTOL A-BIOL, V51, pB392, DOI 10.1093/gerona/51A.6.B392; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; O'Brien PE, 2002, AM J SURG, V184, p4S, DOI 10.1016/S0002-9610(02)01172-8; Oltmanns KM, 2004, AM J RESP CRIT CARE, V169, P1231, DOI 10.1164/rccm.200308-1200OC; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Prabhakar NR, 2001, AM J PHYSIOL-LUNG C, V281, pL524, DOI 10.1152/ajplung.2001.281.3.L524; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Shuldiner AR, 2001, NEW ENGL J MED, V345, P1345, DOI 10.1056/NEJM200111013451814; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	39	41	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42587	10.1371/journal.pone.0042587	http://dx.doi.org/10.1371/journal.pone.0042587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870336	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800099
J	Wu, XH; Zhang, QF; Wang, XJ; Zhu, JY; Xu, KF; Okada, H; Wang, RN; Woo, M				Wu, Xiaohong; Zhang, Qinfeng; Wang, Xiaojing; Zhu, Jiayu; Xu, Kuangfeng; Okada, Hitoshi; Wang, Rennian; Woo, Minna			Survivin Is Required for Beta-Cell Mass Expansion in the Pancreatic Duct-Ligated Mouse Model	PLOS ONE			English	Article							DEVELOPMENTALLY-REGULATED EXPRESSION; FOXM1 TRANSCRIPTION FACTOR; ANTI-APOPTOSIS GENE; DIFFERENTIATION; CANCER; GROWTH; MICE; PROLIFERATION; MAINTENANCE; PROGENITORS	Aims/Hypothesis: Pancreatic beta-cell mass expands through adulthood under certain conditions. The related molecular mechanisms are elusive. This study was designed to determine whether surviving (also known as Birc5), which is transiently expressed perinatally in islets, was required for beta-cell mass expansion in the pancreatic duct-ligated mouse model. Methods: Mice with beta cell-specific deletion of survivin (RIPCre(+) survivin(fl/fl)) and their control littermates (RIPCre(+) survivin(+/+)) were examined to determine the essential role of survivin in partial pancreatic duct ligation (PDL)-induced beta-cell proliferation, function and survival. Results: Resurgence of survivin expression occurred as early as day 3 post-PDL. By day 7 post-PDL, control mice showed significant expansion of beta-cell mass and increase in beta-cell proliferation and islet number in the ligated tail of the pancreas. However, mice deficient in beta-cell survivin showed a defect in beta-cell mass expansion and proliferation with a marked attenuation in the increase of total islet number, largely due to an impairment in the increase in number of larger islets while sparing the increase in number of small islets in the ligated tail of pancreas, resulting in insufficient insulin secretion and glucose intolerance. Importantly however, beta cell neogenesis and apoptosis were not affected by the absence of survivin in beta cells after PDL. Conclusions/Interpretation: Our results indicate that survivin is essential for beta-cell mass expansion after PDL. Survivin appears to exhibit a preferential requirement for proliferation of preexisting beta cells.	[Wu, Xiaohong; Zhang, Qinfeng; Wang, Xiaojing; Zhu, Jiayu; Xu, Kuangfeng] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Okada, Hitoshi] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada; [Woo, Minna] Toronto Gen Res Inst, Toronto, ON, Canada; [Woo, Minna] Univ Toronto, Dept Med & Med Biophys, Toronto, ON, Canada; [Woo, Minna] St Michaels Hosp, Div Endocrinol, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Keenan Res Ctr, Li KaShing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Nanjing Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wu, XH (corresponding author), Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	drxhwu@njmu.edu.cn	Wang, Rennian/N-3879-2015	Wu, Xiaohong/0000-0001-5984-3342	National Natural Science Foundation of China [30971404/C140406, 81070621/H0704]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Human Resource Ministry; State Education Ministry; International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects [BZ2011042]; Jiangsu Government Scholarship for Overseas Studies; Canadian Institutes of Health Research [MOP-201188, MOP-191501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Human Resource Ministry; State Education Ministry; International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects; Jiangsu Government Scholarship for Overseas Studies; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to X. Wu from the National Natural Science Foundation of China (30971404/C140406 and 81070621/H0704), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Human Resource Ministry and State Education Ministry, International Science and Technology Cooperation Plan - the Key National and Regional Research and Development Cooperation Projects (BZ2011042) and the Jiangsu Government Scholarship for Overseas Studies. MW was supported by grants from the Canadian Institutes of Health Research (MOP-201188 and MOP-191501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; EFRAT S, 1991, ENDOCRINOLOGY, V128, P897, DOI 10.1210/endo-128-2-897; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Geisler JG, 2002, DIABETES, V51, P2158, DOI 10.2337/diabetes.51.7.2158; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Hasel C, 2005, LAB INVEST, V85, P1263, DOI 10.1038/labinvest.3700323; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Liggins C, 2003, PEDIATR DEVEL PATHOL, V6, P392, DOI 10.1007/s10024-003-2014-0; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wu X, 2009, DIABETOLOGIA, V52, P2130, DOI 10.1007/s00125-009-1469-6; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41976	10.1371/journal.pone.0041976	http://dx.doi.org/10.1371/journal.pone.0041976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870272	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800048
J	Zeidan, A; Ziv, NE				Zeidan, Adel; Ziv, Noam E.			Neuroligin-1 Loss Is Associated with Reduced Tenacity of Excitatory Synapses	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; AMPA RECEPTORS; SYNAPTIC PLASTICITY; NMDA RECEPTORS; IN-VIVO; PRESYNAPTIC TERMINALS; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; NEUREXINS; PSD-95	Neuroligins (Nlgns) are postsynaptic, integral membrane cell adhesion molecules that play important roles in the formation, validation, and maturation of synapses in the mammalian central nervous system. Given their prominent roles in the life cycle of synapses, it might be expected that the loss of neuroligin family members would affect the stability of synaptic organization, and ultimately, affect the tenacity and persistence of individual synaptic junctions. Here we examined whether and to what extent the loss of Nlgn-1 affects the dynamics of several key synaptic molecules and the constancy of their contents at individual synapses over time. Fluorescently tagged versions of the postsynaptic scaffold molecule PSD-95, the AMPA-type glutamate receptor subunit GluA2 and the presynaptic vesicle molecule SV2A were expressed in primary cortical cultures from Nlgn-1 KO mice and wild-type (WT) littermates, and live imaging was used to follow the constancy of their contents at individual synapses over periods of 8-12 hours. We found that the loss of Nlgn-1 was associated with larger fluctuations in the synaptic contents of these molecules and a poorer preservation of their contents at individual synapses. Furthermore, rates of synaptic turnover were somewhat greater in neurons from Nlgn-1 knockout mice. Finally, the increased GluA2 redistribution rates observed in neurons from Nlgn-1 knockout mice were negated by suppressing spontaneous network activity. These findings suggest that the loss of Nlgn-1 is associated with some use-dependent destabilization of excitatory synapse organization, and indicate that in the absence of Nlgn-1, the tenacity of excitatory synapses might be somewhat impaired.	[Zeidan, Adel] Technion Fac Med, Dept Physiol & Biophys, Haifa, Israel; Technion Fac Med, Rappaport Inst, Haifa, Israel; Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Zeidan, A (corresponding author), Technion Fac Med, Dept Physiol & Biophys, Haifa, Israel.	noamz@netvision.net.il	Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X	European Union [HEALTH-F2-2009-241498]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement no HEALTH-F2-2009-241498 ("EUROSPIN" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fisher-Lavie A, 2011, J NEUROSCI, V31, P16770, DOI 10.1523/JNEUROSCI.3384-11.2011; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Khosravani H, 2005, FEBS LETT, V579, P6587, DOI 10.1016/j.febslet.2005.10.051; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lee H, 2010, J NEUROSCI, V30, P11435, DOI 10.1523/JNEUROSCI.2946-10.2010; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; McMahon SA, 2011, CURR OPIN NEUROBIOL, V21, P221, DOI 10.1016/j.conb.2010.12.005; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; SNYDER M, 1982, CELL, V29, P1027, DOI 10.1016/0092-8674(82)90466-4; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Staras Kevin, 2010, Front Synaptic Neurosci, V2, P20, DOI 10.3389/fnsyn.2010.00020; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001	75	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42314	10.1371/journal.pone.0042314	http://dx.doi.org/10.1371/journal.pone.0042314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860111	gold, Green Submitted, Green Published			2022-12-25	WOS:000307045600089
J	Bye, A; Vettukattil, R; Aspenes, ST; Giskeodegard, GF; Gribbestad, IS; Wisloff, U; Bathen, TF				Bye, Anja; Vettukattil, Riyas; Aspenes, Stian T.; Giskeodegard, Guro F.; Gribbestad, Ingrid S.; Wisloff, Ulrik; Bathen, Tone F.			Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; WHOLE-BLOOD CHOLINE; CARDIORESPIRATORY FITNESS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PLASMA CHOLINE; MEN; CAPACITY; EXERCISE; INDIVIDUALS	Background: Cardiovascular disease (CVD) is a leading cause of death worldwide, and the number of people at risk is continuously growing. New methods for early risk prediction are therefore needed to actuate prevention strategies before the individuals are diagnosed with CVD. Several studies report that aerobic fitness level, measured as maximal oxygen uptake (VO2max), is the single best predictor of future CVD mortality in healthy people. Based on this, we wanted to study differences between healthy individuals with a large difference in VO2max-level to identify new biomarkers of low aerobic fitness that may also have potential as early biomarkers of CVD risk. Methodology/Principal Findings: Serum samples from 218 healthy individuals with a low VO2max (n = 108, 63 women) or high VO2max (n = 110, 64 women) were analysed with MR metabolomics. In addition, standard clinical-chemical analyses for glucose, lipids, liver enzymes, micro-CRP, and colorimetric analysis on circulating choline were performed. Individuals in the low VO2max-group had increased serum levels of free choline, decreased phosphatidylcholine, increased glucose, and decreased unsaturated fatty acids compared to the individuals in the high VO2max-group. Conclusions/Significance: Aerobic fitness dependent differences in serum levels of free choline and phosphatidylcholine are observed. They should be further studied as potential early markers of CVD risk.	[Bye, Anja; Vettukattil, Riyas; Aspenes, Stian T.; Giskeodegard, Guro F.; Gribbestad, Ingrid S.; Wisloff, Ulrik; Bathen, Tone F.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Bye, Anja; Aspenes, Stian T.; Wisloff, Ulrik] KG Jebsen Ctr Exercise Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bye, A (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.	muhammad.r.vettukattil@ntnu.no	Bye, Anja/K-8041-2019; Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587; Vettukattil, Riyas/0000-0002-2152-4933; Bye, Anja/0000-0003-1259-5542	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Liaison Committee; Faculty of Medicine, Norwegian University of Science and Technology (NTNU); Norwegian Research Council Funding for Outstanding Young Investigators; Royal Norwegian Society of Sciences and Letters (DKNVS); Foundation for Cardiovascular Research at St. Olavs Hospital; NTNU	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Liaison Committee; Faculty of Medicine, Norwegian University of Science and Technology (NTNU); Norwegian Research Council Funding for Outstanding Young Investigators; Royal Norwegian Society of Sciences and Letters (DKNVS); Foundation for Cardiovascular Research at St. Olavs Hospital; NTNU	The study was supported by grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, St. Olavs Hospital and the Liaison Committee between the St. Olavs Hospital and the Faculty of Medicine, Norwegian University of Science and Technology (NTNU), the Norwegian Research Council Funding for Outstanding Young Investigators, the Royal Norwegian Society of Sciences and Letters (DKNVS) and the Foundation for Cardiovascular Research at St. Olavs Hospital and NTNU. There are no disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Barba I, 2008, MAGN RESON MED, V60, P27, DOI 10.1002/mrm.21632; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Bougle D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/580897; Buchman AL, 1999, J AM COLL NUTR, V18, P598, DOI 10.1080/07315724.1999.10718894; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Danne O, 2003, AM J CARDIOL, V91, P1060, DOI 10.1016/S0002-9149(03)00149-8; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; Dhalla NS, 1997, J MOL CELL CARDIOL, V29, P2865, DOI 10.1006/jmcc.1997.0522; Dvorak RV, 2000, J CLIN ENDOCR METAB, V85, P957, DOI 10.1210/jc.85.3.957; Farrell SW, 2004, OBES RES, V12, P824, DOI 10.1038/oby.2004.99; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kuo HK, 2007, INT J CARDIOL, V114, P28, DOI 10.1016/j.ijcard.2005.11.110; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Laukkanen JA, 2001, ARCH INTERN MED, V161, P825, DOI 10.1001/archinte.161.6.825; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Maxwell Mark S., 2008, Metabolic Syndrome and Related Disorders, V6, P8, DOI 10.1089/met.2007.0013; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Meyer T, 2005, INT J SPORTS MED, V26, pS19, DOI 10.1055/s-2004-830507; MIETTINEN TA, 1982, BRIT MED J, V285, P993, DOI 10.1136/bmj.285.6347.993; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sassen B, 2009, EUR J CARDIOV PREV R, V16, P677, DOI 10.1097/HJR.0b013e3283312e94; Shephard RJ, 2000, ENDURANCE SPORT, P301; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; WHO, 1999, REP WHO CONS DEF MET, P1; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413	39	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42330	10.1371/journal.pone.0042330	http://dx.doi.org/10.1371/journal.pone.0042330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860113	gold, Green Published, Green Submitted			2022-12-25	WOS:000306950900089
J	Rines, AK; Burke, MA; Fernandez, RP; Volpert, OV; Ardehali, H				Rines, Amy K.; Burke, Michael A.; Fernandez, Richard P.; Volpert, Olga V.; Ardehali, Hossein			Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of beta-catenin	FASEB JOURNAL			English	Article						SNRK; CacyBP	MOLECULAR-CLONING; EXPRESSION; PATHWAY; TARGET; SNRK; AMPK; IDENTIFICATION; CARCINOMA; SUBFAMILY; FAMILY	Sucrose nonfermenting 1 (Snf1)-related kinase (SNRK) is a serine/threonine kinase with sequence similarity to AMP-activated protein kinase (AMPK); however, its function is not well characterized. We conducted a gene array to determine which genes are regulated by SNRK. The array demonstrated that SNRK overexpression increased the levels of genes involved in cell proliferation, including calcyclin-binding protein (CacyBP), a member of the ubiquitin ligase complex that targets nonphosphorylated beta-catenin for degradation. We confirmed that SNRK increased CacyBP mRNA and protein, and decreased beta-catenin protein in HCT116 and RKO colon cancer cells. Furthermore, SNRK inhibited colon cancer cell proliferation, and CacyBP down-regulation reversed the SNRK-mediated decrease in proliferation and beta-catenin. SNRK overexpression also decreased beta-catenin nuclear localization and target gene transcription, and beta-catenin down-regulation reversed the effects of SNRK knockdown on proliferation. SNRK transcript levels were reduced in human colon tumors compared to normal tissue by 35.82%, and stable knockdown of SNRK increased colon cancer cell tumorigenicity. Our results demonstrate that SNRK is down-regulated in colon cancer and inhibits colon cancer cell proliferation through CacyBP up-regulation and beta-catenin degradation, resulting in reduced proliferation signaling. These findings reveal a novel function for SNRK in the regulation of colon cancer cell proliferation and beta-catenin signaling.-Rines, A. K., Burke, M. A., Fernandez, R. P., Volpert, O. V., Ardehali, H. Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin binding protein-dependent reduction of beta-catenin. FASEB J. 26, 4685-4695 (2012). www.fasebj.org	[Rines, Amy K.; Burke, Michael A.; Fernandez, Richard P.; Ardehali, Hossein] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Volpert, Olga V.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Ardehali, H (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Tarry 14-733,303 E Chicago Ave, Chicago, IL 60611 USA.	h-ardehali@northwestern.edu	Burke, Michael/GSN-3331-2022	Burke, Michael/0000-0003-1491-1131	U.S. National Institutes of Health [K02 HL107448, R01 HL087149, R01 HL104181, P01 HL108795]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087149, K02HL107448, P01HL108795, R01HL104181] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	H.A. is supported by U.S. National Institutes of Health grants K02 HL107448, R01 HL087149, R01 HL104181, P01 HL108795, and the American Heart Association. The authors report no conflicts of interest.	Becker W, 1996, EUR J BIOCHEM, V235, P736, DOI 10.1111/j.1432-1033.1996.00736.x; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; CELENZA JL, 1984, MOL CELL BIOL, V4, P49, DOI 10.1128/MCB.4.1.49; Chen X, 2011, MOL CARCINOGEN, V50, P804, DOI 10.1002/mc.20737; Chun CZ, 2009, BLOOD, V113, P1192, DOI 10.1182/blood-2008-06-162156; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Kertesz N, 2002, GENE, V294, P13, DOI 10.1016/S0378-1119(02)00829-6; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nie F, 2010, INT J ONCOL, V37, P1261, DOI 10.3892/ijo_00000777; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Yoshida K, 2000, BRAIN RES, V873, P274, DOI 10.1016/S0006-8993(00)02548-8; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519	29	17	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2012	26	11					4685	4695		10.1096/fj.12-212282	http://dx.doi.org/10.1096/fj.12-212282			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22874833	Green Published			2022-12-25	WOS:000310574200029
J	Cook, DC; Liu, S; Edwards, J; Villalta, ON; Aurambout, JP; Kriticos, DJ; Drenth, A; De Barro, PJ				Cook, David C.; Liu, Shuang; Edwards, Jacqueline; Villalta, Oscar N.; Aurambout, Jean-Philippe; Kriticos, Darren J.; Drenth, Andre; De Barro, Paul J.			Predicting the Benefits of Banana Bunchy Top Virus Exclusion from Commercial Plantations in Australia	PLOS ONE			English	Article							DISEASE; SPREAD; ERADICATION	Benefit cost analysis is a tried and tested analytical framework that can clearly communicate likely net changes in producer welfare from investment decisions to diverse stakeholder audiences. However, in a plant biosecurity context, it is often difficult to predict policy benefits over time due to complex biophysical interactions between invasive species, their hosts, and the environment. In this paper, we demonstrate how a break-even style benefit cost analysis remains highly relevant to biosecurity decision-makers using the example of banana bunchy top virus, a plant pathogen targeted for eradication from banana growing regions of Australia. We develop an analytical approach using a stratified diffusion spread model to simulate the likely benefits of exclusion of this virus from commercial banana plantations over time relative to a nil management scenario in which no surveillance or containment activities take place. Using Monte Carlo simulation to generate a range of possible future incursion scenarios, we predict the exclusion benefits of the disease will avoid Aus$15.9-27.0 million in annual losses for the banana industry. For these exclusion benefits to be reduced to zero would require a bunchy top re-establishment event in commercial banana plantations three years in every four. Sensitivity analysis indicates that exclusion benefits can be greatly enhanced through improvements in disease surveillance and incursion response.	[Cook, David C.] Dept Agr & Food, Bunbury, WA, Australia; [Cook, David C.; Liu, Shuang; Edwards, Jacqueline; Villalta, Oscar N.; Aurambout, Jean-Philippe; Kriticos, Darren J.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Cook, David C.] Univ Western Australia, Crawley, WA, Australia; [Cook, David C.; Liu, Shuang] Australian Ctr Biosecur & Environm Econ, Canberra, ACT, Australia; [Liu, Shuang; Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Edwards, Jacqueline; Villalta, Oscar N.] Dept Primary Ind, Knoxfield, Vic, Australia; [Aurambout, Jean-Philippe] Dept Primary Ind, Parkville, Vic, Australia; [Kriticos, Darren J.] Charles Sturt Univ, Barton, ACT, Australia; [Kriticos, Darren J.] Univ Minnesota, Minneapolis, MN USA; [Drenth, Andre] Univ Queensland, Dutton Pk, Qld, Australia; [De Barro, Paul J.] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cook, DC (corresponding author), Dept Agr & Food, Bunbury, WA, Australia.	david.cook@agric.wa.gov.au	Drenth, Andre/A-4915-2008; Liu, Shuang/C-1951-2008; Cook, David C/C-1064-2009; De Barro, Paul J/C-1724-2008; Kriticos, Darren J/A-4170-2008	Drenth, Andre/0000-0002-8510-1534; Liu, Shuang/0000-0002-8749-3607; Cook, David C/0000-0002-2954-7697; Kriticos, Darren J/0000-0003-2599-8105; Edwards, Jacqueline/0000-0003-0310-7236	Cooperative Research Centre for National Plant Biosecurity under Australian Government [CRC10162]	Cooperative Research Centre for National Plant Biosecurity under Australian Government	This research was supported by the Cooperative Research Centre for National Plant Biosecurity (Project No. CRC10162), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS A.B.o.S., 2013, AGR COMM; ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; [Anonymous], 1966, BANANAS; Biosecurity Australia, 2001, GUID IMP RISK AN; Boardman A, 2006, COST BENEFIT ANAL CO; Carrasco LR, 2012, ECOL ECON, V76, P95, DOI 10.1016/j.ecolecon.2012.02.009; COOK D, 2003, PRIORITISING EXOTIC; Cook D, 2010, POTENTIAL METHODS TO; Cook D. C., 2011, AUSTR J AGR RESOURCE, V55, P1; Cook DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026084; DALE JL, 1987, ADV VIRUS RES, V33, P301, DOI 10.1016/S0065-3527(08)60321-8; *DEP FIN, 1991, HDB COST BEN AN; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; FAO, 2010, FAOSTAT DAT; FISH S, 1970, ANNU REV PHYTOPATHOL, V8, P13, DOI 10.1146/annurev.py.08.090170.000305; Fisher R A, 1937, ANN EUGEN, V7, P353, DOI DOI 10.1111/J.1469-1809.1937.TB02153.X; Henderson J, 2006, AUSTRALAS PLANT PATH, V35, P181, DOI 10.1071/AP06017; Hengeveld B., 1989, DYNAMICS BIOL INVASI; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hinchy M. D., 1991, COST BENEFIT ANAL QU; HOLMES EE, 1993, AM NAT, V142, P779, DOI 10.1086/285572; Hooks CRR, 2008, ANN APPL BIOL, V153, P1, DOI 10.1111/j.1744-7348.2008.00233.x; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; MAGEE CJP, 1927, COUNCIL SCI IND RES, V30, P1; McCann K, 2000, THEOR POPUL BIOL, V57, P97, DOI 10.1006/tpbi.1999.1444; MOODY ME, 1988, J APPL ECOL, V25, P1009, DOI 10.2307/2403762; MORAN P. A. P., 1984, INTRO PROBABILITY TH; Okubo A., 2002, DIFFUSION ECOLOGICAL; Perrings C, 1998, ENVIRON RESOUR ECON, V11, P503, DOI 10.1023/A:1008255614276; Peterson R., 2005, Infomusa, V14, P7; Ploetz R., 2000, Pesticide Outlook, V11, P19, DOI 10.1039/b006308h; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Shigesada N, 1997, BIOL INVASIONS THEOR; Sosnowski MR, 2009, PLANT PATHOL, V58, P621, DOI 10.1111/j.1365-3059.2009.02042.x; Thomas JE, 1996, DEV DETECTION METHOD; Ulubasoglu M, 2011, PRICE AFFECTS DEMAND; Wilby, 2005, NEW AGENDA BIOSECURI; Wittwer G, 2005, AUST J AGR RESOUR EC, V49, P75, DOI 10.1111/j.1467-8489.2005.00276.x	38	13	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42391	10.1371/journal.pone.0042391	http://dx.doi.org/10.1371/journal.pone.0042391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879960	Green Published, gold			2022-12-25	WOS:000307437900036
J	Mahan, VL; Zurakowski, D; Otterbein, LE; Pigula, FA				Mahan, Vicki L.; Zurakowski, David; Otterbein, Leo E.; Pigula, Frank A.			Inhaled Carbon Monoxide Provides Cerebral Cytoprotection in Pigs	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HYPOTHERMIC CARDIOPULMONARY BYPASS; HEME OXYGENASE-1; LIVER-TRANSPLANTATION; LACTATE METABOLISM; CIRCULATORY ARREST; SIGNALING PATHWAY; BRAIN ISCHEMIA; UP-REGULATION; BLOOD-FLOW	Carbon monoxide (CO) at low concentrations imparts protective effects in numerous preclinical small animal models of brain injury. Evidence of protection in large animal models of cerebral injury, however, has not been tested. Neurologic deficits following open heart surgery are likely related in part to ischemia reperfusion injury that occurs during cardiopulmonary bypass surgery. Using a model of deep hypothermic circulatory arrest (DHCA) in piglets, we evaluated the effects of CO to reduce cerebral injury. DHCA and cardiopulmonary bypass (CPB) induced significant alterations in metabolic demands, including a decrease in the oxygen/glucose index (OGI), an increase in lactate/glucose index (LGI) and a rise in cerebral blood pressure that ultimately resulted in increased cell death in the neocortex and hippocampus that was completely abrogated in piglets preconditioned with a low, safe dose of CO. Moreover CO-treated animals maintained normal, pre-CPB OGI and LGI and corresponding cerebral sinus pressures with no change in systemic hemodynamics or metabolic intermediates. Collectively, our data demonstrate that inhaled CO may be beneficial in preventing cerebral injury resulting from DHCA and offer important therapeutic options in newborns undergoing DHCA for open heart surgery.	[Mahan, Vicki L.; Otterbein, Leo E.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Zurakowski, David; Pigula, Frank A.] Boston Childrens Hosp, Dept Pediat Cardiothorac Surg, Boston, MA USA; [Mahan, Vicki L.; Otterbein, Leo E.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mahan, VL (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	vmahan@bidmc.harvard.edu			Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center); National Institutes of Health [5R01GM088666, R56AI092272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088666] Funding Source: NIH RePORTER	Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the Julie Henry Fund at the Transplant Center of the BIDMC (Beth Israel Deaconess Medical Center) for their support. LEO is supported by National Institutes of Health grants 5R01GM088666 and R56AI092272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2011, LIVER TRANSPLANT, V17, P610, DOI 10.1002/lt.22272; Andreani P, 2010, HPB, V12, P439, DOI 10.1111/j.1477-2574.2010.00194.x; Bach FH, 2002, WIEN KLIN WOCHENSCHR, V114, P1; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Daley ML, 2007, J NEUROTRAUM, V24, P559, DOI 10.1089/neu.2006.0129; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Deshane J, 2005, ACTA BIOCHIM POL, V52, P273; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P176, DOI 10.1038/jcbfm.2008.109; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hanto DW, 2010, AM J TRANSPLANT, V10, P2421, DOI 10.1111/j.1600-6143.2010.03289.x; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Katori M, 2002, TRANSPL IMMUNOL, V9, P227, DOI 10.1016/S0966-3274(02)00043-6; Khaladj N, 2006, EUR J CARDIO-THORAC, V30, P492, DOI 10.1016/j.ejcts.2006.05.031; Lango Romuald, 2010, Anestezjol Intens Ter, V42, P206; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QH, 2011, BASIC RES CARDIOL, V106, P1367, DOI 10.1007/s00395-011-0208-6; Li QF, 2008, ACTA BIOCH BIOPH SIN, V40, P803, DOI 10.1111/j.1745-7270.2008.00461.x; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; MEZROW CK, 1995, J THORAC CARDIOV SUR, V109, P959, DOI 10.1016/S0022-5223(95)70322-5; Mo L, 2012, INT J MOL MED, V30, P314, DOI 10.3892/ijmm.2012.1002; Montalvo-Jave Eduardo Esteban, 2011, Cir Cir, V79, P132; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Moxon-Lester L, 2007, BRAIN RES, V1179, P79, DOI 10.1016/j.brainres.2007.08.037; Nie J, 2011, J SURG RES, V168, P281, DOI 10.1016/j.jss.2009.10.020; Occhipinti R, 2009, J NEUROPHYSIOL, V101, P2528, DOI 10.1152/jn.90377.2008; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pigula FA, 2001, J THORAC CARDIOV SUR, V121, P366, DOI 10.1067/mtc.2001.112207; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Raza A, LIVER TRANSPLANTATIO, V16, P588; Rieger A, 1997, NEUROSURGERY, V41, P462, DOI 10.1097/00006123-199708000-00027; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Rox PT, 1986, P NATL ACAD SCI USA, V83, P1140; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; Saeki I, 2011, PEDIATR SURG INT, V27, P857, DOI 10.1007/s00383-010-2810-3; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Siesjo BK, 1978, BRAIN ENERGY METABOL, P101; Simon T, 2011, IMMUNOTHERAPY-UK, V3, P15, DOI [10.2217/IMT.11.43, 10.2217/imt.11.43]; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Soares MP, 2007, FRONT BIOSCI, V12, P4932, DOI 10.2741/2439; Song XY, 2012, INT J BIOL SCI, V8, P707, DOI 10.7150/ijbs.4231; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Strauch JT, 2003, EUR J CARDIO-THORAC, V24, P807, DOI 10.1016/S1010-7940(03)00517-7; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Tsuchihashi Sei-ichiro, 2004, Ann Transplant, V9, P84; van der Woude FJ, 2004, J INVEST MED, V52, P323, DOI 10.1136/jim-52-05-32; Varga J, 2011, EUR SURG RES, V46, P207, DOI 10.1159/000327396; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang Z, 2011, PEDIATR TRANSPLANT, V15, P65, DOI 10.1111/j.1399-3046.2010.01362.x; Weerateerangkul P, 2011, MED SCI MONITOR, V17, pRA44, DOI 10.12659/MSM.881385; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Yan S, 2010, HEPATOB PANCREAT DIS, V9, P346; Zapletal C, 2010, MICROVASC RES, V80, P365, DOI 10.1016/j.mvr.2010.05.005; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007	69	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41982	10.1371/journal.pone.0041982	http://dx.doi.org/10.1371/journal.pone.0041982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879904	Green Submitted, gold, Green Published			2022-12-25	WOS:000307437900019
J	Schulz-Mirbach, T; Metscher, B; Ladich, F				Schulz-Mirbach, Tanja; Metscher, Brian; Ladich, Friedrich			Relationship between Swim Bladder Morphology and Hearing Abilities-A Case Study on Asian and African Cichlids	PLOS ONE			English	Article							INNER-EAR; AMBIENT NOISE; ACOUSTIC COMMUNICATION; AUDITORY-SENSITIVITY; SOUND PRODUCTION; FISHES; BUTTERFLYFISHES; THRESHOLDS; AUDIOGRAMS; DIVERSITY	Background: Several teleost species have evolved anterior extensions of the swim bladder which come close to or directly contact the inner ears. A few comparative studies have shown that these morphological specializations may enhance hearing abilities. This study investigates the diversity of swim bladder morphology in four Asian and African cichlid species and analyzes how this diversity affects their hearing sensitivity. Methodology/Principal Findings: We studied swim bladder morphology by dissections and by making 3D reconstructions from high-resolution microCT scans. The auditory sensitivity was determined in terms of sound pressure levels (SPL) and particle acceleration levels (PAL) using the auditory evoked potential (AEP) recording technique. The swim bladders in Hemichromis guttatus and Steatocranus tinanti lacked anterior extensions and the swim bladder was considerably small in the latter species. In contrast, Paratilapia polleni and especially Etroplus maculatus possessed anterior extensions bringing the swim bladder close to the inner ears. All species were able to detect frequencies up to 3 kHz (SPL) except S. tinanti which only responded to frequencies up to 0.7 kHz. P. polleni and E. maculatus showed significantly higher auditory sensitivities at 0.5 and 1 kHz than the two species lacking anterior swim bladder extensions. The highest auditory sensitivities were found in E. maculatus, which possessed the most intimate swim bladder-inner ear relationship (maximum sensitivity 66 dB re 1 mu Pa at 0.5 kHz). Conclusions: Our results indicate that anterior swim bladder extensions seem to improve mean absolute auditory sensitivities by 21-42 dB (SPLs) and 21-36 dB (PALs) between 0.5 and 1 kHz. Besides anterior extensions, the size of the swim bladder appears to be an important factor for extending the detectable frequency range (up to 3 kHz).	[Schulz-Mirbach, Tanja; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Metscher, Brian] Univ Vienna, Dept Theoret Biol, Vienna, Austria	University of Vienna; University of Vienna	Schulz-Mirbach, T (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	tanja.schulz-mirbach@univie.ac.at	Metscher, Brian/I-1238-2019	Metscher, Brian/0000-0002-6514-4406	German Academic Exchange Service (DAAD) [D/10/51727]; Austrian Science Fund (FWF) [22319]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support came from the German Academic Exchange Service (DAAD) (Postdoctoral fellowship D/10/51727 to TSM) and the Austrian Science Fund (FWF grant 22319 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Blaxter JHS, 1981, HEARING SOUND COMMUN, P39; Braun Christopher B., 2008, V32, P99; Casper BM, 2006, ENVIRON BIOL FISH, V76, P101, DOI 10.1007/s10641-006-9012-9; COOMBS S, 1979, J COMP PHYSIOL, V132, P203, DOI 10.1007/BF00614491; Corwin J.T., 1981, HEARING SOUND COMMUN, P81; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dehadrai P. V., 1959, Proceedings of the National Institute of Sciences of India, V25B, P254; Deng XH, 2011, DEEP-SEA RES PT I, V58, P27, DOI 10.1016/j.dsr.2010.11.001; Fay R. R., 1988, HEARING VERTEBRATES; FINE ML, 1995, MAR BIOL, V123, P401, DOI 10.1007/BF00349218; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; *ISO, 1983, 1683 ISO; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P321; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2000, PHILOS T ROY SOC B, V355, P1285, DOI 10.1098/rstb.2000.0685; Ladich Friedrich, 2006, P3; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Longrie N, 2009, J EXP BIOL, V212, P3395, DOI 10.1242/jeb.032946; Lugli M, 2003, J COMP PHYSIOL A, V189, P309, DOI 10.1007/s00359-003-0404-4; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MYRBERG AA, 1980, J COMP PHYSIOL, V140, P135, DOI 10.1007/BF00606305; NELSON EDWARD M., 1955, FIELDIANA ZOOL, V37, P121; Papes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026479; Parmentier E, 2011, J EXP BIOL, V214, P2697, DOI 10.1242/jeb.058750; Parmentier E, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-12; PAULIN CD, 1988, COPEIA, P450, DOI 10.2307/1445886; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Ramcharitar J, 2001, BRAIN BEHAV EVOLUT, V58, P152, DOI 10.1159/000047269; Ramcharitar JU, 2006, J ACOUST SOC AM, V119, P439, DOI 10.1121/1.2139068; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Ripley Jennifer L., 2002, Bioacoustics, V12, P238; SCHELLART NAM, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P295; Schwarzer J, 2012, J EVOLUTION BIOL, V25, P138, DOI 10.1111/j.1420-9101.2011.02409.x; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Sparks JS, 2008, B AM MUS NAT HIST, P5; Tavolga W. N., 1963, Bulletin of the American Museum of Natural History, V126, P177; Webb JF, 2010, J FISH BIOL, V77, P1406, DOI 10.1111/j.1095-8649.2010.02765.x; Webb JF, 2006, J MORPHOL, V267, P1338, DOI 10.1002/jmor.10480; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; Wysocki LE, 2007, J ACOUST SOC AM, V121, P2559, DOI 10.1121/1.2713661; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; YAN HY, 1992, J COMP PHYSIOL A, V171, P105; Yan HY, 2000, J COMP PHYSIOL A, V187, P371, DOI DOI 10.1007/S003590050443	52	47	47	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42292	10.1371/journal.pone.0042292	http://dx.doi.org/10.1371/journal.pone.0042292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879934	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900028
J	Cabal, B; Cafini, F; Esteban-Tejeda, L; Alou, L; Bartolome, JF; Sevillano, D; Lopez-Piriz, R; Torrecillas, R; Moya, JS				Cabal, Belen; Cafini, Fabio; Esteban-Tejeda, Leticia; Alou, Luis; Bartolome, Jose F.; Sevillano, David; Lopez-Piriz, Roberto; Torrecillas, Ramon; Serafin Moya, Jose			Inhibitory Effect on In Vitro Streptococcus oralis Biofilm of a Soda-Lime Glass Containing Silver Nanoparticles Coating on Titanium Alloy	PLOS ONE			English	Article							6 BACTERIA; IMPLANTS	This paper reports the effect of soda-lime-glass-nAg coating on the viability of an in vitro biofilm of Streptococcus oralis. Three strains (ATCC 35037 and two clinical isolates from periodontitis patients) were grown on coated with glass, glass containing silver nanoparticles, and uncoated titanium alloy disks. Two different methods were used to quantify biofilm formation abilities: crystal violet staining and determination of viable counts. The influence of the surface morphology on the cell attachment was studied. The surface morphology was characterized by scanning electron microscopy (SEM) and using a profilometer. SEM was also used to study the formation and the development of biofilm on the coated and uncoated disks. At least a >99.7% inocula reduction of biofilm respect to titanium disks and also to glass coated disks was observed in the glass-nAg coated disks for all the studied strains. A quantitative evaluation of the release of silver was conducted in vitro to test whether and to what extend the biocidal agent (silver) could leach from the coating. These findings suggest that the biofilm formation of S. oralis strains is highly inhibited by the glass-nAg and may be useful for materials which require durable antibacterial effect on their surfaces, as it is the case of dental implants.	[Cabal, Belen; Lopez-Piriz, Roberto; Torrecillas, Ramon] Univ Oviedo Principado Asturias, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, Llanera, Spain; [Cabal, Belen; Esteban-Tejeda, Leticia; Bartolome, Jose F.; Serafin Moya, Jose] CSIC, Inst Mat Sci Madrid, Dept Biomat & Bioinspired Mat, Madrid, Spain; [Cafini, Fabio; Alou, Luis; Sevillano, David] Univ Complutense Madrid, Sch Med, Dept Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Complutense University of Madrid	Cabal, B (corresponding author), Univ Oviedo Principado Asturias, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, Parque Tecnol Asturias, Llanera, Spain.	b.cabal@cinn.es	Torrecillas, Ramón/G-7851-2011; Cafini, Fabio/AAA-7938-2020; Cabal, Belén/G-2694-2019; Sevillano, David/G-5661-2010; Moya, Jose/I-5841-2013; Bartolomé, José/B-1977-2010; López-Píriz, Roberto/W-8146-2019; Alou, Luis/B-8170-2011	Torrecillas, Ramón/0000-0003-3856-0217; Cafini, Fabio/0000-0002-5442-1674; Cabal, Belén/0000-0002-4102-3810; Bartolomé, José/0000-0002-7515-4202; López-Píriz, Roberto/0000-0003-2431-6950; Alou, Luis/0000-0002-0859-008X; Sevillano Fernandez, David/0000-0003-0212-2194	Spanish Ministry of Science and Innovation [MAT2009-14542-C02-01]; CSIC JAE-Doc Program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC JAE-Doc Program	This work was supported by the Spanish Ministry of Science and Innovation under the project MAT2009-14542-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Juan Ramon Maestre for the supply of the S. oralis strains. B. Cabal thanks the CSIC JAE-Doc Program for a postdoctoral contract.	Ahmed AA, 2011, J BIOMED MATER RES A, V98A, P132, DOI 10.1002/jbm.a.33101; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; da Silva AC, 2008, J AM CERAM SOC, V91, P1300; Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125; Davey ME, 2006, PERIODONTOL 2000, V42, P13, DOI 10.1111/j.1600-0757.2006.00052.x; Esteban-Tejeda L, 2012, J EUR CERAM SOC, V32, P2723, DOI 10.1016/j.jeurceramsoc.2012.02.053; Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Maestre JR, 2007, REV ESP QUIM, V20, P61; Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1	21	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42393	10.1371/journal.pone.0042393	http://dx.doi.org/10.1371/journal.pone.0042393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879961	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100077
J	Dinkla, S; Novotny, VMJ; Joosten, I; Bosman, GJCGM				Dinkla, Sip; Novotny, Vera M. J.; Joosten, Irma; Bosman, Giel J. C. G. M.			Storage-Induced Changes in Erythrocyte Membrane Proteins Promote Recognition by Autoantibodies	PLOS ONE			English	Article							AUTOIMMUNE HEMOLYTIC-ANEMIA; BLOOD-BANK CONDITIONS; IN-VIVO; AGED ERYTHROCYTES; RED-CELLS; TRANSFUSION; INFLAMMATION; VESICLES; BAND-3; SILVER	Physiological erythrocyte removal is associated with a selective increase in expression of neoantigens on erythrocytes and their vesicles, and subsequent autologous antibody binding and phagocytosis. Chronic erythrocyte transfusion often leads to immunization and the formation of alloantibodies and autoantibodies. We investigated whether erythrocyte storage leads to the increased expression of non-physiological antigens. Immunoprecipitations were performed with erythrocytes and vesicles from blood bank erythrocyte concentrates of increasing storage periods, using patient plasma containing erythrocyte autoantibodies. Immunoprecipitate composition was identified using proteomics. Patient plasma antibody binding increased with erythrocyte storage time, while the opposite was observed for healthy volunteer plasma, showing that pathology-associated antigenicity changes during erythrocyte storage. Several membrane proteins were identified as candidate antigens. The protein complexes that were precipitated by the patient antibodies in erythrocytes were different from the ones in the vesicles formed during erythrocyte storage, indicating that the storage-associated vesicles have a different immunization potential. Soluble immune mediators including complement factors were present in the patient plasma immunoprecipitates, but not in the allogeneic control immunoprecipitates. The results support the theory that disturbed erythrocyte aging during storage of erythrocyte concentrates contributes to transfusion-induced alloantibody and autoantibody formation.	[Dinkla, Sip; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Lab Med,Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Novotny, Vera M. J.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [Bosman, Giel J. C. G. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Dinkla, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Lab Med,Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands.	G.Bosman@ncmls.ru.nl	Joosten, Irma/N-4418-2013; Bosman, G.J.C.G.M./L-4221-2015	Joosten, Irma/0000-0003-2950-4977; 				Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; BARKER RN, 1992, BRIT J HAEMATOL, V82, P126, DOI 10.1111/j.1365-2141.1992.tb04604.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; BOSMAN GJCGM, 1993, NEUROBIOL AGING, V14, P223, DOI 10.1016/0197-4580(93)90004-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE LJ, 1995, BLOOD, V85, P541; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Fossati-Jimack L, 2002, J AUTOIMMUN, V18, P17, DOI 10.1006/jaut.2001.0563; Galletti J, 2008, J IMMUNOL, V181, P3674, DOI 10.4049/jimmunol.181.5.3674; Grove H, 2009, ELECTROPHORESIS, V30, P1856, DOI 10.1002/elps.200800568; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; LEDDY JP, 1993, J CLIN INVEST, V91, P1672, DOI 10.1172/JCI116376; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Luten M, 2008, TRANSFUSION, V48, P1478, DOI 10.1111/j.1537-2995.2008.01734.x; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Messana I, 2000, TRANSFUSION, V40, P353, DOI 10.1046/j.1537-2995.2000.40030353.x; Racanelli V, 2011, AUTOIMMUN REV, V10, P503, DOI 10.1016/j.autrev.2011.03.001; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Sawasdee N, 2010, BIOCHEM BIOPH RES CO, V401, P85, DOI 10.1016/j.bbrc.2010.09.015; Shen CR, 2003, BLOOD, V102, P3800, DOI 10.1182/blood-2002-07-2125; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25; Willekens FLA, 2003, BLOOD, V101, P747, DOI 10.1182/blood-2002-02-0500; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Xiong ZY, 2011, TRANSFUSION, V51, P610, DOI 10.1111/j.1537-2995.2010.02861.x; Young PP, 2004, TRANSFUSION, V44, P67, DOI 10.1046/j.0041-1132.2003.00589.x	37	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42250	10.1371/journal.pone.0042250	http://dx.doi.org/10.1371/journal.pone.0042250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879923	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100059
J	Edqvist, PHD; Niklasson, M; Vidal-Sanz, M; Hallbook, F; Forsberg-Nilsson, K				Edqvist, Per-Henrik D.; Niklasson, Mia; Vidal-Sanz, Manuel; Hallbook, Finn; Forsberg-Nilsson, Karin			Platelet-Derived Growth Factor Over-Expression in Retinal Progenitors Results in Abnormal Retinal Vessel Formation	PLOS ONE			English	Article							PERSISTENT FETAL VASCULATURE; OVEREXPRESSING PDGF-B; PRECURSOR CELLS APCS; DEVELOPING MOUSE EYE; OPTIC-NERVE; GLIAL-CELLS; IN-VIVO; MICE; DIFFERENTIATION; ASTROCYTES	Platelet-derived growth factor (PDGF) plays an important role in development of the central nervous system, including the retina. Excessive PDGF signaling is associated with proliferative retinal disorders. We reported previously that transgenic mice in which PDGF-B was over-expressed under control of the nestin enhancer, nes/tk-PdgfB-lacZ, exhibited enhanced apoptosis in the developing corpus striatum. These animals display enlarged lateral ventricles after birth as well as behavioral aberrations as adults. Here, we report that in contrast to the relatively mild central nervous system phenotype, development of the retina is severely disturbed in nes/tk-PdgfB-lacZ mice. In transgenic retinas all nuclear layers were disorganized and photoreceptor segments failed to develop properly. Since astrocyte precursor cells did not populate the retina, retinal vascular progenitors could not form a network of vessels. With time, randomly distributed vessels resembling capillaries formed, but there were no large trunk vessels and the intraocular pressure was reduced. In addition, we observed a delayed regression of the hyaloid vasculature. The prolonged presence of this structure may contribute to the other abnormalities observed in the retina, including the defective lamination.	[Edqvist, Per-Henrik D.; Niklasson, Mia; Forsberg-Nilsson, Karin] Dept Immunol Genet & Pathol, Uppsala, Sweden; [Edqvist, Per-Henrik D.; Niklasson, Mia; Forsberg-Nilsson, Karin] Sci Life Lab, Uppsala, Sweden; [Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Vidal-Sanz, Manuel] Univ Murcia, Dept Ophthalmol, Murcia, Spain	Uppsala University; University of Murcia	Edqvist, PHD (corresponding author), Dept Immunol Genet & Pathol, Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Vidal-Sanz, Manuel/J-6989-2016	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Vidal-Sanz, Manuel/0000-0002-9216-1615; Hallbook, Finn/0000-0001-7552-187X	Swedish Cancer Society [070079]; Swedish Research Council [319-2008-2557]; Swedish Childhood Cancer Foundation [PROJ07/017]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission)	This study was supported by grants to KFN from the Swedish Cancer Society (www.cancerfonden.se Grant 070079), Swedish Research Council (www.vr.se 319-2008-2557) and Swedish Childhood Cancer Foundation (www.barncancerfonden.se PROJ07/017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1068, DOI 10.1016/S0161-6420(00)00100-7; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Forsberg-Nilsson K, 2003, GLIA, V41, P276, DOI 10.1002/glia.10191; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Goldberg MF, 1997, AM J OPHTHALMOL, V124, P587, DOI 10.1016/S0002-9394(14)70899-2; Guidry C, 2003, INVEST OPHTH VIS SCI, V44, P1355, DOI 10.1167/iovs.02-0046; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Homsi Jade, 2007, Cancer Control, V14, P285; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johansson CB, 2002, J NEUROSCI RES, V69, P784, DOI 10.1002/jnr.10376; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lindsey JD, 2005, J GLAUCOMA, V14, P318, DOI 10.1097/01.ijg.0000169411.09258.f6; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Niklasson M, 2010, EXP CELL RES, V316, P2779, DOI 10.1016/j.yexcr.2010.07.009; Peichl L, 1998, NATO ADV SCI I A-LIF, V299, P147; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; Reichel MB, 1998, CELL DEATH DIFFER, V5, P156, DOI 10.1038/sj.cdd.4400326; Reneker LW, 1996, INVEST OPHTH VIS SCI, V37, P2455; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Savinova OV, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-12; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Vinores SA, 2003, DEV BRAIN RES, V140, P169, DOI 10.1016/S0165-3806(02)00581-3; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Xue LP, 2006, NEUROSCIENCE, V139, P723, DOI 10.1016/j.neuroscience.2005.12.032; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226	41	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42488	10.1371/journal.pone.0042488	http://dx.doi.org/10.1371/journal.pone.0042488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880002	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100109
J	Formella, I; Scott, EK; Burne, THJ; Harms, LR; Liu, PY; Turner, KM; Cui, X; Eyles, DW				Formella, Isabel; Scott, Ethan K.; Burne, Tom H. J.; Harms, Lauren R.; Liu, Pei-Yun; Turner, Karly M.; Cui, Xiaoying; Eyles, Darryl W.			Transient Knockdown of Tyrosine Hydroxylase during Development Has Persistent Effects on Behaviour in Adult Zebrafish (Danio rerio)	PLOS ONE			English	Article							DOPAMINE-RECEPTOR GENES; D DEFICIENCY ALTERS; LARVAL ZEBRAFISH; CATECHOLAMINERGIC SYSTEMS; LOCUS-COERULEUS; SCHIZOPHRENIA; BRAIN; EXPRESSION; NEURONS; ANXIETY	Abnormal dopamine (DA) signaling is often suggested as causative in schizophrenia. The other prominent hypothesis for this disorder, largely driven by epidemiological data, is that certain adverse events during the early stages of brain development increase an individual's risk of developing schizophrenia later in life. However, the clinical and preclinical literature consistently implicates behavioural, cognitive, and pharmacological abnormalities, implying that DA signaling is abnormal in the adult brain. How can we reconcile these two major hypotheses underlying much of the clinical and basic research into schizophrenia? In this study we have transiently knocked down tyrosine hydroxylase (TH, the rate limiting enzyme in DA synthesis) gene expression in the early stages of brain development in zebrafish using morpholinos. We show that by adulthood, TH and DA levels have returned to normal and basic DA-mediated behaviours, such as locomotion, are also normal. However, when they were exposed to a novel environment the levels of freezing and immediate positioning in deeper zones were significantly reduced in these adult fish. The neurochemistry underlying these behaviours is complex, and the exact mechanisms for these abnormal behaviours remains unknown. This study demonstrates that early transient alterations in DA ontogeny can produce persistent alterations in adult brain function and suggests that the zebrafish may be a promising model animal for future studies directed at clarifying the basic neurodevelopmental mechanisms behind complex psychiatric disease.	[Formella, Isabel; Scott, Ethan K.; Burne, Tom H. J.; Harms, Lauren R.; Liu, Pei-Yun; Turner, Karly M.; Cui, Xiaoying; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Scott, Ethan K.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Burne, Tom H. J.; Eyles, Darryl W.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Queensland Centre for Mental Health Research	Formella, I (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	eyles@uq.edu.au	Burne, Thomas H/C-5656-2009; Harms, Lauren R/J-8698-2012; Turner, Karly/F-4607-2012; Eyles, Darryl W/X-3386-2018	Burne, Thomas H/0000-0003-3502-9789; Turner, Karly/0000-0003-3714-5118; Eyles, Darryl W/0000-0002-5023-7095; Scott, Ethan/0000-0003-3150-9216; Harms, Lauren/0000-0003-2268-8654	National Health and Medical Research Council, Australia; Queensland Centre for Mental Health Research, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Centre for Mental Health Research, Australia	This study was supported by the National Health and Medical Research Council, Australia, and the Queensland Centre for Mental Health Research, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LJG, 2007, AQUACULTURE, V272, P774, DOI 10.1016/j.aquaculture.2007.09.002; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Burne T, 2011, MOL PSYCHIATR, V16, P7, DOI 10.1038/mp.2010.35; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Cui XY, 2010, NEUROSCI LETT, V486, P220, DOI 10.1016/j.neulet.2010.09.057; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Eyles D, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.6; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Giacomini NJ, 2006, NEUROTOXICOL TERATOL, V28, P245, DOI 10.1016/j.ntt.2006.01.013; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Holzschuh J, 2003, J NEUROSCI, V23, P5507; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Kandel ER., 2012, PRINCIPLES NEURAL SC, V5; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kesby JP, 2009, NEUROSCI LETT, V461, P155, DOI 10.1016/j.neulet.2009.05.070; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lange M, 2012, MOL PSYCHIATR, V17, P946, DOI 10.1038/mp.2012.29; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LEWIS SW, 1987, J PSYCHIAT RES, V21, P413, DOI 10.1016/0022-3956(87)90088-4; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; MA PM, 1994, J COMP NEUROL, V344, P242, DOI 10.1002/cne.903440206; MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Mirnics K, 2001, AM J PSYCHIAT, V158, P1384, DOI 10.1176/appi.ajp.158.9.1384; Murray RM, 2008, EUR NEUROPSYCHOPHARM, V18, pS129, DOI 10.1016/j.euroneuro.2008.04.002; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Ruediger T, 2007, ADV EXP MED BIOL, V621, P104, DOI 10.1007/978-0-387-76715-4_8; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Schweitzer J, 2009, ADV EXP MED BIOL, V651, P1; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Souza BR, 2011, J NEUROSCI, V31, P5512, DOI 10.1523/JNEUROSCI.5548-10.2011; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006	62	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42482	10.1371/journal.pone.0042482	http://dx.doi.org/10.1371/journal.pone.0042482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879998	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100104
J	Thean, LF; Li, HH; Teo, YY; Koh, WP; Yuan, JM; Teoh, ML; Koh, PK; Tang, CL; Cheah, PY				Thean, Lai Fun; Li, Hui Hua; Teo, Yik Ying; Koh, Woon-Puay; Yuan, Jian-Min; Teoh, Mei Lin; Koh, Poh Koon; Tang, Choong Leong; Cheah, Peh Yean			Association of Caucasian-Identified Variants with Colorectal Cancer Risk in Singapore Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; MIXED POLYPOSIS SYNDROME; SUSCEPTIBILITY LOCI; C-MYC; 8Q24; SCAN; POPULATION; 8Q23.3; 18Q21	Background: Genome-wide association studies (GWAS) in Caucasians have identified fourteen index single nucleotide polymorphisms (iSNPs) that influence colorectal cancer (CRC) risk. Methods: We investigated the role of eleven iSNPs or surrogate SNPs (sSNPs), in high linkage disequilibrium (LD, r(2)>= 0.8) and within 100 kb vicinity of iSNPs, in 2,000 age-and gender-matched Singapore Chinese (SCH) cases and controls. Results: Only iSNP rs6983267 at 8q24.21 and sSNPs rs6695584, rs11986063, rs3087967, rs2059254, and rs7226855 at 1q41, 8q23.3, 11q23.1, 16q22.1 and 18q21.1 respectively showed evidence of association with CRC risk, with odds ratios (OR) ranging from 1.13 to 1.40. sSNP rs827401 at 10p14 was associated with rectal cancer risk (OR = 0.74, 95% CI 0.63-0.88) but not disease prognosis (OR = 0.91, 95% CI 0.69-1.20). Interestingly, sSNP rs3087967 at 11q23.1 was associated with CRC risk in men (OR = 1.34, 95% CI 1.14-1.58) but not women (OR = 1.07, 95% CI: 0.88-1.29), suggesting a gender-specific role. Half of the Caucasian-identified variants, including the recently fine-mapped BMP pathway loci, BMP4, GREM1, BMP2 and LAMA 5, did not show any evidence for association with CRC in SCH (OR similar to 1; p-value >0.1). Comparing the results of this study with that of the Northern and Hong Kong Chinese, only variants at chromosomes 8q24.21, 10p14, 11q23.1 and 18q21.1 were replicated in at least two out of the three Chinese studies. Conclusions: The contrasting results between Caucasians and Chinese could be due to different LD patterns and allelic frequencies or genetic heterogeneity. The results suggest that additional common variants contributing to CRC predisposition remained to be identified.	[Thean, Lai Fun; Koh, Poh Koon; Tang, Choong Leong; Cheah, Peh Yean] Singapore Gen Hosp, Dept Colorectal Surg, Singapore 0316, Singapore; [Li, Hui Hua] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; [Teo, Yik Ying; Koh, Woon-Puay; Cheah, Peh Yean] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Inst Canc, Pittsburgh, PA USA; [Teoh, Mei Lin] Singapore Gen Hosp, Hlth Screening Unit, Singapore 0316, Singapore; [Cheah, Peh Yean] Natl Univ Singapore, Grad Sch Med, Duke Natl Univ Singapore, Singapore 117548, Singapore	Singapore General Hospital; Singapore General Hospital; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Singapore General Hospital; National University of Singapore	Thean, LF (corresponding author), Singapore Gen Hosp, Dept Colorectal Surg, Singapore 0316, Singapore.	cheah.peh.yean@sgh.com.sg		Yuan, Jian-Min/0000-0002-4620-3108	National Medical Research Council of Singapore [NMRC/1193/2008]; National Institutes of Health [R01-CA55069, R35-CA53890, R01-CA80205, R01-CA98497, R01-CA144034]; NATIONAL CANCER INSTITUTE [R01CA098497, R01CA055069, R35CA053890, R01CA080205, R01CA144034] Funding Source: NIH RePORTER	National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by a grant from the National Medical Research Council of Singapore (NMRC/1193/2008) to PYC and grants from the National Institutes of Health (grant numbers R01-CA55069, R35-CA53890, R01-CA80205, R01-CA98497 and R01-CA144034) to WPK and JMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Cao X, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034827; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chia KS, 2000, 5 SING CANC REG; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lubbe SJ, 2012, CARCINOGENESIS, V33, P108, DOI 10.1093/carcin/bgr243; Matsuo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-379; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Xu S, 2009, AM J HUM GENET, V85, P1; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42407	10.1371/journal.pone.0042407	http://dx.doi.org/10.1371/journal.pone.0042407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879968	Green Published, Green Accepted, gold			2022-12-25	WOS:000307284100082
J	Verger, P; Flicoteaux, R; Schwarzinger, M; Sagaon-Teyssier, L; Peretti-Watel, P; Launay, O; Sebbah, R; Moatti, JP				Verger, Pierre; Flicoteaux, Remi; Schwarzinger, Michael; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Launay, Odile; Sebbah, Remy; Moatti, Jean-Paul			Pandemic Influenza (A/H1N1) Vaccine Uptake among French Private General Practitioners: A Cross Sectional Study in 2010	PLOS ONE			English	Article							HEALTH-CARE WORKERS; H1N1 INFLUENZA; WILLINGNESS; ACCEPTANCE; ATTITUDES; SELECTION; FRANCE	Background: In July, 2009, French health authorities, like those in many other countries, decided to embark on a mass vaccination campaign against the pandemic A(H1N1) influenza. Private general practitioners (GPs) were not involved in this campaign. We studied GPs' pandemic vaccine (pvaccine) uptake, quantified the relative contribution of its potential explanatory factors and studied whether their own vaccination choice was correlated with their recommendations to patients about pvaccination. Methodology/Principal Findings: In this cross-sectional telephone survey, professional investigators interviewed an existing panel of randomly selected private GPs (N = 1431; response rate at inclusion in the panel: 36.8%; participation rate in the survey: 100%). The main outcome variable was GPs' own pvaccine uptake. We used an averaging multi-model approach to quantify the relative contribution of factors associated with their vaccination. The pvaccine uptake rate was 61% (95% CI = 58.3-63.3). Four independent factors contributed the most to this rate (partial Nagelkerke's R-2): history of previous vaccination against seasonal influenza (14.5%), perception of risks and efficacy of the pvaccine (10.8%), opinions regarding the organization of the vaccination campaign (7.1%), and perception of the pandemic's severity (5.2%). Overall, 71.3% (95% CI = 69.0-73.6) of the participants recommended pvaccination to young adults at risk and 40.1% (95% CI = 37.6-42.7) to other young adults. GPs' own pvaccination was strongly predictive of their recommendation to both young adults at risk (OR = 9.6; 95% CI = 7.2-12.6) and those not at risk (OR = 8.5; 95% CI = 6.4-11.4). Conclusions/Significance: These results suggest that around 60% of French private GPs followed French authorities' recommendations about vaccination of health care professionals against the A(H1N1) influenza. They pinpoint priority levers for improving preparedness for future influenza pandemics. Besides encouraging GPs' own uptake of regular vaccination against seasonal influenza, providing GPs with clear information about the risks and efficacy of any new pvaccine and involving them in the organization of any future vaccine campaign may improve their pvaccine uptake.	[Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] INSERM, Sci Econ & Sociales Sante & Traitement Informat M, Marseilles, France; [Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] Aix Marseille Univ, UMR S912, Inst Rech & Dev, Marseilles, France; [Verger, Pierre; Sagaon-Teyssier, Luis; Peretti-Watel, Patrick; Moatti, Jean-Paul] Observ Reg Sante Provence Alpes Cote dAzur, Marseilles, France; [Flicoteaux, Remi] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France; [Schwarzinger, Michael] INSERM, Act Themat & Incitat Programme AVENIR U738, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, UMR S738, Paris, France; [Launay, Odile] INSERM, Ctr Invest Clin BT505, Paris, France; [Sebbah, Remy] Union Reg Profess Sante, Marseilles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Verger, P (corresponding author), INSERM, Sci Econ & Sociales Sante & Traitement Informat M, Marseilles, France.	pierre.verger@inserm.fr	Schwarzinger, Michael/F-7367-2011; Peretti-Watel, Patrick/P-4535-2017	Schwarzinger, Michael/0000-0002-0573-6856; Sagaon-Teyssier, Luis/0000-0001-7318-6596	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur	The French Regional Panel of General Practices received funding from the Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports as part of the 2010-2012 contract with the Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuwari MG, 2011, VACCINE, V29, P2206, DOI 10.1016/j.vaccine.2010.08.093; Barriere J, 2010, VACCINE, V28, P7030, DOI 10.1016/j.vaccine.2010.08.021; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chan M, 2009, WORDL NOW START 2009; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Dube Eve, 2010, BMC Res Notes, V3, P102, DOI 10.1186/1756-0500-3-102; Esteves-Jaramillo A, 2009, ARCH MED RES, V40, P705, DOI 10.1016/j.arcmed.2010.01.004; Fantino B, 2004, Sante Publique, V16, P551; Gautier A, 2011, 2009 HLTH BAROMETER; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; HCSP, 2010, B EP HEBD, V14-15; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Inoue Yusuke, 2011, Environmental Health and Preventive Medicine, V16, P320, DOI 10.1007/s12199-010-0202-x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Joyce CM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-50; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kraut A, 2011, VACCINE, V29, P8357, DOI 10.1016/j.vaccine.2011.08.084; La Torre G, 2009, EUROSURVEILLANCE, V14, P7; Lavoue J, 2009, ANN OCCUP HYG, V53, P173, DOI 10.1093/annhyg/men085; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Michiels B, 2006, VACCINE, V24, P3145, DOI 10.1016/j.vaccine.2006.01.040; Opstelten W, 2010, VACCINE, V28, P6164, DOI 10.1016/j.vaccine.2010.07.031; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; POTTHOFF RF, 1994, AM J EPIDEMIOL, V139, P967, DOI 10.1093/oxfordjournals.aje.a116946; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Raude Jocelyn, 2010, PLoS Curr, V2, pRRN1188, DOI 10.1371/currents.RRN1188; Savas E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-281; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Seale H, 2011, VACCINE, V29, P1605, DOI 10.1016/j.vaccine.2010.12.077; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sicart D, 2008, 127 MIN SANT JEUN SP, P127; Thoon KC, 2010, ANN ACAD MED SINGAP, V39, P307; Torun SD, 2010, VACCINE, V28, P5703, DOI 10.1016/j.vaccine.2010.06.049; Turkheimer FE, 2003, J CEREBR BLOOD F MET, V23, P490, DOI 10.1097/01.WCB.0000050065.57184.BB; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Woo TM, 2010, J PEDIATR HEALTH CAR, V24, P258, DOI 10.1016/j.pedhc.2010.05.001; Wright DB, 2010, LEGAL CRIMINOL PSYCH, V15, P195, DOI 10.1348/135532508X400347; Yassi A, 1994, Can J Infect Control, V9, P103	45	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41837	10.1371/journal.pone.0041837	http://dx.doi.org/10.1371/journal.pone.0041837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879896	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100034
J	Wu, YC; Zhu, MF; Robertson, DM				Wu, Yu-Chieh; Zhu, Meifang; Robertson, Danielle M.			Novel Nuclear Localization and Potential Function of Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Hybrid in Corneal Epithelial Cells	PLOS ONE			English	Article							PATHWAY MEDIATES ACTIVATION; FGFR1 SIGNALING INFS; LARGE GENE LISTS; TUMOR-CELLS; DIABETES-MELLITUS; IGF-1 RECEPTOR; ANGIOTENSIN-II; PROTEIN-KINASE; TYPE-1; DIFFERENTIATION	Background: Type I insulin-like growth factor receptor (IGF-1R) and insulin receptor (INSR) are highly homologous molecules, which can heterodimerize to form an IGF-1R/INSR hybrid (Hybrid-R). The presence and biological significance of the Hybrid-R in human corneal epithelium has not yet been established. In addition, while nuclear localization of IGF-1R was recently reported in cancer cells and human corneal epithelial cells, the function and profile of nuclear IGF-1R is unknown. In this study, we characterized the nuclear localization and function of the Hybrid-R and the role of IGF-1/IGF-1R and Hybrid-R signaling in the human corneal epithelium. Methodology/Principle Findings: IGF-1-mediated signaling and cell growth were examined in a human telomerized corneal epithelial (hTCEpi) cell line using co-immunoprecipitation, immunoblotting and cell proliferation assays. The presence of Hybrid-R in hTCEpi and primary cultured human corneal epithelial cells was confirmed by immunofluorescence and reciprocal immunoprecipitation of whole cell lysates. We found that IGF-1 stimulated Akt and promoted cell growth through IGF-1R activation, which was independent of the Hybrid-R. The presence of Hybrid-R, but not IGF-1R/IGF-1R, was detected in nuclear extracts. Knockdown of INSR by small interfering RNA resulted in depletion of the INSR/INSR and preferential formation of Hybrid-R. Chromatin-immunoprecipitation sequencing assay with anti-IGF-1R or anti-INSR was subsequently performed to identify potential genomic targets responsible for critical homeostatic regulatory pathways. Conclusion/Significance: In contrast to previous reports on nuclear localized IGF-1R, this is the first report identifying the nuclear localization of Hybrid-R in an epithelial cell line. The identification of a nuclear Hybrid-R and novel genomic targets suggests that IGF-1R traffics to the nucleus as an IGF-1R/INSR heterotetrameric complex to regulate corneal epithelial homeostatic pathways. The development of novel therapeutic strategies designed to target the IGF-1/IGF-1R pathway must take into account the modulatory roles IGF-1R/INSR play in the epithelial cell nucleus.	[Wu, Yu-Chieh; Zhu, Meifang; Robertson, Danielle M.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, YC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.	Danielle.Robertson@utsouthwestern.edu			National Institutes of Health [R01 EY018219, P30 EY020799]; OneSight Research Foundation; Research to Prevent Blindness Career Development Award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018219, P30EY020799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OneSight Research Foundation; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01 EY018219 (DMR), P30 EY020799; OneSight Research Foundation (DMR); a Research to Prevent Blindness Career Development Award (DMR); and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader H, 2011, CLIN EXP OPHTHALMOL, V39, P259, DOI 10.1111/j.1442-9071.2010.02435.x; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dunn SE, 1998, CANCER RES, V58, P3353; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V135, P41, DOI 10.1016/S0303-7207(97)00185-8; Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139; FORSAYETH JR, 1987, J BIOL CHEM, V262, P4134; GAROFALO RS, 1992, J BIOL CHEM, V267, P11470; Hailey J, 2002, MOL CANCER THER, V1, P1349; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RADULESCU RT, 1995, MED HYPOTHESES, V45, P107, DOI 10.1016/0306-9877(95)90055-1; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Robertson DM, 2012, EXP EYE RES, V94, P179, DOI 10.1016/j.exer.2011.12.006; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rocha EM, 2002, INVEST OPHTH VIS SCI, V43, P963; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42483	10.1371/journal.pone.0042483	http://dx.doi.org/10.1371/journal.pone.0042483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879999	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100105
J	Henesy, MB; Britain, AL; Zhu, B; Amable, L; Honkanen, RE; Corbin, JD; Francis, SH; Rich, TC				Henesy, Michelle B.; Britain, Andrea L.; Zhu, Bing; Amable, Lauren; Honkanen, Richard E.; Corbin, Jackie D.; Francis, Sharron H.; Rich, Thomas C.			Calcineurin Regulates Homologous Desensitization of Natriuretic Peptide Receptor-A and Inhibits ANP-Induced Testosterone Production in MA-10 Cells	PLOS ONE			English	Article							PARTICULATE GUANYLATE-CYCLASE; SALAMANDER ROD PHOTORESPONSE; VASCULAR SMOOTH-MUSCLE; MOUSE LEYDIG-CELLS; CYCLIC-GMP; RAT TESTIS; PROTEIN PHOSPHATASES; NUCLEAR FACTOR; CAMP SIGNALS; PHOSPHORYLATION	Receptor desensitization is a ubiquitous regulatory mechanism that defines the activatable pool of receptors, and thus, the ability of cells to respond to environmental stimuli. In recent years, the molecular mechanisms controlling the desensitization of a variety of receptors have been established. However, little is known about the molecular mechanisms that underlie desensitization of natriuretic peptide receptors, including natriuretic peptide receptor-A (NPR-A). Here we report that calcineurin (protein phosphatase 2B, PP2B, PPP3C) regulates homologous desensitization of NPR-A in murine Leydig tumor (MA-10) cells. We demonstrate that both pharmacological inhibition of calcineurin activity and siRNA-mediated suppression of calcineurin expression potentiate atrial natriuretic peptide (ANP)-induced cGMP synthesis. Treatment of MA-10 cells with inhibitors of other phosphoprotein phosphatases had little or no effect on ANP-induced cGMP accumulation. In addition, overexpression of calcineurin blunts ANP-induced cGMP synthesis. We also present data indicating that the inhibition of calcineurin potentiates ANP-induced testosterone production. To better understand the contribution of calcineurin in the regulation of NPR-A activity, we examined the kinetics of ANP-induced cGMP signals. We observed transient ANP-induced cGMP signals, even in the presence of phosphodiesterase inhibitors. Inhibition of both calcineurin and phosphodiesterase dramatically slowed the decay in the response. These observations are consistent with a model in which calcineurin mediated dephosphorylation and desensitization of NPR-A is associated with significant inhibition of cGMP synthesis. PDE activity hydrolyzes cGMP, thus lowering intracellular cGMP toward the basal level. Taken together, these data suggest that calcineurin plays a previously unrecognized role in the desensitization of NPR-A and, thereby, inhibits ANP-mediated increases in testosterone production.	[Henesy, Michelle B.; Britain, Andrea L.; Zhu, Bing; Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Zhu, Bing; Rich, Thomas C.] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Amable, Lauren; Honkanen, Richard E.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Corbin, Jackie D.; Francis, Sharron H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	University of South Alabama; University of South Alabama; University of South Alabama; Vanderbilt University	Henesy, MB (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	trich@jaguar1.usouthal.edu			National Institutes of Health [R01HL094455, P01H066299, R01DK40029]; American Heart Association [0715101B, 0335084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01HL094455, P01H066299, and R01DK40029, and American Heart Association grants 0715101B and 0335084N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Saraiva KLA, 2009, INT J EXP PATHOL, V90, P454, DOI 10.1111/j.1365-2613.2009.00660.x; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bonness K, 2006, MOL CANCER THER, V5, P2727, DOI 10.1158/1535-7163.MCT-06-0273; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; DEBOLD AJ, 1982, CAN J PHYSIOL PHARM, V60, P324, DOI 10.1139/y82-045; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; El-Gehani F, 2001, BIOL REPROD, V65, P595, DOI 10.1095/biolreprod65.2.595; FORESTA C, 1987, ARCH ANDROLOGY, V19, P253, DOI 10.3109/01485018708986825; FORESTA C, 1993, ACTA ENDOCRINOL-COP, V128, P274, DOI 10.1530/acta.0.1280274; Fortin Y, 2006, CAN J PHYSIOL PHARM, V84, P539, DOI 10.1139/Y05-163; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; GARBERS DL, 1993, ADV SEC MESS PHOSPH, V28, P91; Golden TA, 2003, METHOD ENZYMOL, V366, P372; Gross KL, 2004, IN VITRO CELL DEV-AN, V40, P57; HALL PF, 1981, ENDOCRINOLOGY, V109, P1677, DOI 10.1210/endo-109-5-1677; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Kapasi AA, 1996, HYPERTENSION, V28, P847, DOI 10.1161/01.HYP.28.5.847; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; KUNO T, 1986, J BIOL CHEM, V261, P5817; Lucas KA, 2000, PHARMACOL REV, V52, P375; Middendorff R, 2000, ANDROLOGIA, V32, P55; MOGER WH, 1983, BIOL REPROD, V28, P528, DOI 10.1095/biolreprod28.3.528; MUKHOPADHYAY AK, 1986, FEBS LETT, V202, P111, DOI 10.1016/0014-5793(86)80659-7; Muller D, 2004, ENDOCRINOLOGY, V145, P1392, DOI 10.1210/en.2003-0706; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PANDEY KN, 1986, BIOCHEM BIOPH RES CO, V138, P399, DOI 10.1016/0006-291X(86)90295-0; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pereira VM, 2008, PEPTIDES, V29, P2024, DOI 10.1016/j.peptides.2008.08.005; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 2005, FRONT BIOSCI-LANDMRK, V10, P1205, DOI 10.2741/1613; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Potthast R, 2005, PEPTIDES, V26, P1001, DOI 10.1016/j.peptides.2004.08.033; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Scipioni A, 2005, HISTOCHEM CELL BIOL, V124, P401, DOI 10.1007/s00418-005-0057-1; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Terada H, 2003, J NEUROCHEM, V87, P1145, DOI 10.1046/j.1471-4159.2003.02098.x; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Tsai LCL, 2011, CURR OPIN PHARMACOL, V11, P670, DOI 10.1016/j.coph.2011.09.003; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	57	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41711	10.1371/journal.pone.0041711	http://dx.doi.org/10.1371/journal.pone.0041711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876290	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700018
J	Lee, P; Taghavi, F; Yan, P; Ewart, P; Ashley, EA; Loew, LM; Kohl, P; Bollensdorff, C; Woods, CE				Lee, Peter; Taghavi, Fouad; Yan, Ping; Ewart, Paul; Ashley, Euan A.; Loew, Leslie M.; Kohl, Peter; Bollensdorff, Christian; Woods, Christopher E.			In Situ Optical Mapping of Voltage and Calcium in the Heart	PLOS ONE			English	Article							ENDOCARDIAL VISUALIZATION CATHETER; RABBIT HEARTS; CARDIAC-CELLS; ABLATION; SYSTEM; IMPLANTATION; MOTION; MODEL; VITRO; DYES	Electroanatomic mapping the interrelation of intracardiac electrical activation with anatomic locations has become an important tool for clinical assessment of complex arrhythmias. Optical mapping of cardiac electrophysiology combines high spatiotemporal resolution of anatomy and physiological function with fast and simultaneous data acquisition. If applied to the clinical setting, this could improve both diagnostic potential and therapeutic efficacy of clinical arrhythmia interventions. The aim of this study was to explore this utility in vivo using a rat model. To this aim, we present a single-camera imaging and multiple light-emitting-diode illumination system that reduces economic and technical implementation hurdles to cardiac optical mapping. Combined with a red-shifted calcium dye and a new near-infrared voltage-sensitive dye, both suitable for use in blood-perfused tissue, we demonstrate the feasibility of in vivo multi-parametric imaging of the mammalian heart. Our approach combines recording of electrophysiologically-relevant parameters with observation of structural substrates and is adaptable, in principle, to trans-catheter percutaneous approaches.	[Lee, Peter; Ewart, Paul] Univ Oxford, Dept Phys, Oxford, England; [Taghavi, Fouad] Papworth Hosptial, Div Cardiothorac Surg, Cambridge, England; [Yan, Ping; Loew, Leslie M.] Univ Connecticut, Ctr Hlth, Richard D Berlin Ctr Cell Anal & Modeling, Farmington, CT USA; [Ashley, Euan A.; Woods, Christopher E.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Kohl, Peter; Bollensdorff, Christian] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kohl, Peter] Univ Oxford, Dept Comp Sci, Oxford, England	University of Oxford; Papworth Hospital; University of Connecticut; Stanford University; Imperial College London; University of Oxford	Lee, P (corresponding author), Univ Oxford, Dept Phys, Oxford, England.	c.bollensdorff@imperial.ac.uk; cwoods1@stanford.edu	Bollensdorff, Christian/AAQ-6961-2020	Bollensdorff, Christian/0000-0002-6333-4791; Yan, Ping/0000-0001-6472-150X; Loew, Leslie/0000-0002-1851-4646; Kohl, Peter/0000-0003-0416-6270	Clarendon Fund Scholarship; Papsworth Hospital National Health Service Foundation Trust [175-2009-MD398]; National Institutes of Health (NIH) [OD004613]; National Institute of Biomedical Imaging and Bioengineering [R01EB001963NIH]; British Heart Foundation; NIH [HL094274-01A2]; BBSRC [BB/I012117/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012117/1] Funding Source: researchfish; British Heart Foundation [FS/12/17/29532, PG/09/031/27221] Funding Source: researchfish	Clarendon Fund Scholarship; Papsworth Hospital National Health Service Foundation Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); British Heart Foundation(British Heart Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Clarendon Fund Scholarship (to PL), Papsworth Hospital National Health Service Foundation Trust (Gledhill Fellowship Reference 175-2009-MD398 to FT), National Institutes of Health (NIH) New Investigator DP2 award (OD004613 to EAA), National Institute of Biomedical Imaging and Bioengineering (R01EB001963NIH to PY and LML), and the British Heart Foundation (to PK and CB), and NIH T32 award (HL094274-01A2 to CEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DJ, 2008, PACE, V31, P78, DOI 10.1111/j.1540-8159.2007.00928.x; Anh DJ, 2006, HEART RHYTHM, V3, P875, DOI 10.1016/j.hrthm.2006.04.029; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bhakta Deepak, 2008, Indian Pacing Electrophysiol J, V8, P32; Cribier A, 2009, HERZ, V34, P347, DOI 10.1007/s00059-009-3264-z; Dillon SM, 1998, IEEE ENG MED BIOL, V17, P95, DOI 10.1109/51.646226; Ding CH, 2010, PACE, V33, P687, DOI [10.1111/J.1540-8159.2010.02704.x, 10.1111/j.1540-8159.2010.02704.x]; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; Entcheva E, 2004, IEEE T BIO-MED ENG, V51, P333, DOI 10.1109/TBME.2003.820376; Eversull CS, 2009, J CARDIOVASC TRANSL, V2, P198, DOI 10.1007/s12265-009-9094-9; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Gepstein L, 1997, CIRCULATION, V95, P1611; Gerstenfeld EP, 2010, J INTERV CARD ELECTR, V29, P1, DOI 10.1007/s10840-010-9501-9; Gunzinger R, 2007, BASIC RES CARDIOL, V102, P508, DOI 10.1007/s00395-007-0668-x; Hameedullah I, 2009, HEART RHYTHM, V6, P1249, DOI 10.1016/j.hrthm.2009.04.032; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Irani AR, 2009, J INTERV CARD ELECTR, V25, P107, DOI 10.1007/s10840-008-9338-7; Kong W, 2003, J CARDIOVASC ELECTR, V14, P76, DOI 10.1046/j.1540-8167.2003.02077.x; LaPage MJ, 2011, CURR OPIN CARDIOL, V26, P79, DOI 10.1097/HCO.0b013e3283437d48; Lee P, 2011, HEART RHYTHM, V8, P1482, DOI 10.1016/j.hrthm.2011.03.061; Matiukas A, 2007, HEART RHYTHM, V4, P1441, DOI 10.1016/j.hrthm.2007.07.012; Metzner A, 2011, HEART RHYTHM, V8, P988, DOI 10.1016/j.hrthm.2011.02.030; Phillips KP, 2008, J CARDIOVASC ELECTR, V19, P14, DOI 10.1111/j.1540-8167.2007.00964.x; Qian YW, 2001, CIRCULATION, V104, P2082, DOI 10.1161/hc4201.097136; Rohde GK, 2005, IEEE T BIO-MED ENG, V52, P338, DOI 10.1109/TBME.2004.840464; Salama Guy, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1217s49; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Waggoner A S, 2001, Curr Protoc Cytom, VChapter 2, DOI 10.1002/0471142956.cy0204s15	28	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42562	10.1371/journal.pone.0042562	http://dx.doi.org/10.1371/journal.pone.0042562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876327	gold, Green Published			2022-12-25	WOS:000307184700055
J	Taulet, N; Delorme-Walker, VD; DerMardirossian, C				Taulet, Nicolas; Delorme-Walker, Violaine D.; DerMardirossian, Celine			Reactive Oxygen Species Regulate Protrusion Efficiency by Controlling Actin Dynamics	PLOS ONE			English	Article							FLUORESCENT SPECKLE MICROSCOPY; VASCULAR SMOOTH-MUSCLE; CELL-MIGRATION; ARP2/3 COMPLEX; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; FILAMENT TURNOVER; ENDOTHELIAL-CELLS; XANTHINE-OXIDASE; COFILIN ACTIVITY	Productive protrusions allowing motile cells to sense and migrate toward a chemotactic gradient of reactive oxygen species (ROS) require a tight control of the actin cytoskeleton. However, the mechanisms of how ROS affect cell protrusion and actin dynamics are not well elucidated yet. We show here that ROS induce the formation of a persistent protrusion. In migrating epithelial cells, protrusion of the leading edge requires the precise regulation of the lamellipodium and lamella F-actin networks. Using fluorescent speckle microscopy, we showed that, upon ROS stimulation, the F-actin retrograde flow is enhanced in the lamellipodium. This event coincides with an increase of cofilin activity, free barbed ends formation, Arp2/3 recruitment, and ERK activity at the cell edge. In addition, we observed an acceleration of the F-actin flow in the lamella of ROS-stimulated cells, which correlates with an enhancement of the cell contractility. Thus, this study demonstrates that ROS modulate both the lamellipodium and the lamella networks to control protrusion efficiency.	[Taulet, Nicolas; Delorme-Walker, Violaine D.; DerMardirossian, Celine] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Taulet, N (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	dmceline@scripps.edu	DerMardirossian, Celine/P-1020-2015		National Institutes of Health [HL48008]; Fondation pour la Recherche Medicale (FRM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant (HL48008) to GMB and CDM. NT was supported in part by a postdoctoral fellowship from Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanc A, 2004, ANTIOXID REDOX SIGN, V6, P353, DOI 10.1089/152308604322899422; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; DalleDonne I, 1995, BIOPHYS J, V69, P2710, DOI 10.1016/S0006-3495(95)80142-6; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; FAGGIONI R, 1994, J LAB CLIN MED, V123, P394; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; JAESCHKE H, 1989, BIOCHEM BIOPH RES CO, V160, P140, DOI 10.1016/0006-291X(89)91632-X; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Sadok A, 2009, MOL CELL BIOL, V29, P3915, DOI 10.1128/MCB.01199-08; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632	71	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41342	10.1371/journal.pone.0041342	http://dx.doi.org/10.1371/journal.pone.0041342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876286	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700014
J	Bexfield, NH; Watson, PJ; Aguirre-Hernandez, J; Sargan, DR; Tiley, L; Heeney, JL; Kennedy, LJ				Bexfield, Nicholas H.; Watson, Penny J.; Aguirre-Hernandez, Jesus; Sargan, David R.; Tiley, Laurence; Heeney, Jonathan L.; Kennedy, Lorna J.			DLA Class II Alleles and Haplotypes Are Associated with Risk for and Protection from Chronic Hepatitis in the English Springer Spaniel	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER-DISEASE; C VIRUS; NOMENCLATURE COMMITTEE; PEPTIDE PRESENTATION; INFECTIOUS-DISEASES; DOBERMAN HEPATITIS; SYSTEM DLA; 1ST REPORT	Chronic hepatitis (CH) is common in dogs in the United Kingdom. An increased prevalence of the disease is seen in the English Springer spaniel (ESS), and this breed suffer from a severe form with young to middle aged female dogs being predisposed. The disease shares histological features with those of human viral hepatitis, although the specific aetiological agent has not yet been identified. The aim of the current study was to investigate whether dog leucocyte antigen (DLA) class II alleles and haplotypes are associated with susceptibility/resistance to CH in the ESS. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1 and -DQB1 class II loci were performed in 66 ESSs with CH and 84 healthy controls. There was a significant difference in the distribution of the protective alleles DRB1*00501 (3.0% vs. 12.0%, odds ratio [OR] = 0.23, 95% confidence interval [CI] = 0.06-0.74) and DQB1*00501 (3.8% vs. 12.0%, OR = 0.29, 95% CI = 0.09-0.85) between cases and controls. The haplotype DLA-DRB1*00501/DQA1*00301/DQB1*00501 was present in 11.9% of controls and 3.0% of cases and was significantly associated with protection against disease development (OR = 0.26, 95% CI = 0.08-0.80). There was a significant difference in the distribution of the risk alleles DRB1*00601 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) and DQB1*00701 (14.4% vs. 6.5%, OR = 2.40, 95% CI = 1.10-5.63) between cases and controls. A risk haplotype (DLA-DRB1*00601/DQA1*005011/DQB1*00701) was present in 14.4% of cases and 6.5% of controls and conferred an elevated risk of developing CH with an OR of 3.13 (95% CI = 1.20-8.26). These results demonstrate that DLA class II is significantly associated with risk and protection from developing CH in ESSs.	[Bexfield, Nicholas H.; Watson, Penny J.; Aguirre-Hernandez, Jesus; Sargan, David R.; Tiley, Laurence; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Kennedy, Lorna J.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England	University of Cambridge; University of Manchester	Bexfield, NH (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	nb289@cam.ac.uk	Aguirre-Hernandez, Jesus/M-7955-2018; Kennedy, Lorna/AAK-8767-2020	Aguirre-Hernandez, Jesus/0000-0002-2715-6422; Kennedy, Lorna/0000-0002-3087-4548; Sargan, David Richard/0000-0001-9897-2489; Watson, Penelope Jayne/0000-0002-7241-9412; Heeney, Jonathan/0000-0003-2702-1621; Bexfield, Nicholas/0000-0001-6830-8296	Wellcome Trust [WT088619MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Wellcome Trust (grant number WT088619MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Hernandez J, 2010, TISSUE ANTIGENS, V76, P476, DOI 10.1111/j.1399-0039.2010.01554.x; ALMARRI A, 1994, LANCET, V344, P1194, DOI 10.1016/S0140-6736(94)90510-X; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; ANDERSSON M, 1992, J SMALL ANIM PRACT, V33, P389, DOI 10.1111/j.1748-5827.1992.tb01182.x; Bateman AC, 2007, HISTOPATHOLOGY, V51, P585, DOI 10.1111/j.1365-2559.2007.02765.x; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665; Bexfield NH, 2012, VET J, DOI [10.1016/j.tvjl.2011.1011.1024, DOI 10.1016/J.TVJL.2011.1011.1024]; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; BISHOP L, 1979, AM J VET RES, V40, P839; Boomkens SY, 2005, VET MICROBIOL, V108, P49, DOI 10.1016/j.vetmic.2005.03.003; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BUNCH SE, 1993, VET CLIN N AM-SMALL, V23, P659, DOI 10.1016/S0195-5616(93)50311-X; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Clements DN, 2010, J HERED, V101, P54, DOI 10.1093/jhered/esp088; DIENES HP, 1987, HEPATOLOGY, V7, P1317, DOI 10.1002/hep.1840070623; Donaldson PT, 2004, GUT, V53, P599, DOI 10.1136/gut.2003.031732; DONALDSON PT, 1991, HEPATOLOGY, V13, P701, DOI 10.1016/0270-9139(91)92567-R; Dyggve H, 2011, TISSUE ANTIGENS, V77, P30, DOI 10.1111/j.1399-0039.2010.01575.x; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; FRANCO A, 1988, HEPATOLOGY, V8, P449, DOI 10.1002/hep.1840080302; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; FUJISAWA T, 1995, DIABETOLOGIA, V38, P1493; Gao J, 1999, J VIROL, V73, P1411, DOI 10.1128/JVI.73.2.1411-1418.1999; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOCKE DJ, 1967, J CLIN INVEST, V46, P1506, DOI 10.1172/JCI105642; GUARDIOLA J, 1993, CRIT REV IMMUNOL, V13, P247; HANKE T, 1994, REV MED VIROL, V4, P47, DOI 10.1002/rmv.1980040109; Herkel J, 2003, HEPATOLOGY, V37, P1079, DOI 10.1053/jhep.2003.50191; Ishak KG, 2000, AM J CLIN PATHOL, V113, P40, DOI 10.1309/42D6-W7PL-FX0A-LBXF; It V, 2010, TISSUE ANTIGENS, V76, P67, DOI 10.1111/j.1399-0039.2010.01463.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P292, DOI 10.1111/j.1399-0039.2006.00781.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P272, DOI 10.1111/j.1399-0039.2006.00779.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 1999, TISSUE ANTIGENS, V54, P312, DOI 10.1034/j.1399-0039.1999.540319.x; Kennedy LJ, 1998, IMMUNOGENETICS, V48, P296, DOI 10.1007/s002510050435; Kennedy LJ, 2002, TISSUE ANTIGENS, V60, P43, DOI 10.1034/j.1399-0039.2002.600106.x; Kennedy LJ, 2002, TISSUE ANTIGENS, V59, P194, DOI 10.1034/j.1399-0039.2002.590303.x; Kennedy LJ, 2000, ANIM GENET, V31, P52, DOI 10.1046/j.1365-2052.2000.00492.x; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Mieli-Vergani G, 2011, NAT REV GASTRO HEPAT, V8, P320, DOI 10.1038/nrgastro.2011.69; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; SEVELIUS E, 1994, J COMP PATHOL, V111, P401, DOI 10.1016/S0021-9975(05)80098-2; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shawcroft A., 2010, BSAVA 53rd Annual Congress 2010, Scientific Proceedings, Veterinary Programme, Birmingham, UK, 8-11 April 2010, P458; Speeti M, 2003, VET IMMUNOL IMMUNOP, V96, P1, DOI 10.1016/S0165-2427(03)00134-X; STEEL CM, 1988, LANCET, V1, P1185; STROMBECK DR, 1988, J AM VET MED ASSOC, V193, P1109; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van den Ingh T. S. G. A. M., 2006, WSAVA STANDARDS CLIN, P85; Venkataraman GM, 2007, TISSUE ANTIGENS, V70, P53, DOI 10.1111/j.1399-0039.2007.00839.x; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Watson PJ, 2004, VET J, V167, P228, DOI 10.1016/S1090-0233(03)00118-7; WEISS DJ, 1995, J VET INTERN MED, V9, P267, DOI 10.1111/j.1939-1676.1995.tb01078.x; Wilbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012332; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6; Zavaglia C, 1998, J HEPATOL, V28, P1, DOI 10.1016/S0168-8278(98)80195-5	66	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42584	10.1371/journal.pone.0042584	http://dx.doi.org/10.1371/journal.pone.0042584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870335	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800098
J	Chen, YF; Pottala, JV; Weltman, NY; Ge, XJ; Savinova, OV; Gerdes, AM				Chen, Yue-Feng; Pottala, James V.; Weltman, Nathan Y.; Ge, Xijin; Savinova, Olga V.; Gerdes, A. Martin			Regulation of Gene Expression with Thyroid Hormone in Rats with Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; ILLUMINA MICROARRAY; CARDIAC MYOCYTE; HEART; ANGIOGENESIS; MODEL; BIOINFORMATICS; ANGIOPOIETIN-2; HYPERTROPHY; APOPTOSIS	Introduction: The expression of hundreds of genes is altered in response to left ventricular (LV) remodeling following large transmural myocardial infarction (MI). Thyroid hormone (TH) improves LV remodeling and cardiac performance after MI. However, the molecular basis is unknown. Methods: MI was produced by ligation of the left anterior descending coronary artery in female SD rats. Rats were divided into the following groups: (1) Sham MI, (2) MI, and (3) MI+T4 treatment (T4 pellet 3.3 mg, 60 days release, implanted subcutaneously immediately following MI). Four weeks after surgery, total RNA was isolated from LV non-infarcted areas for microarray analysis using the Illumina RatRef-12 Expression BeadChip Platform. Results: Signals were detected in 13,188 genes (out of 22,523), of which the expression of 154 genes were decreased and the expression of 200 genes were increased in MI rats compared with Sham MI rats (false discovery rate (FDR) < 0.05). Compared to MI rats, T4 treatment decreased expression of 27 genes and increased expression of 28 genes. In particular, 6 genes down- regulated by MI and 12 genes up-regulated by MI were reversed by T4. Most of the 55 genes altered by T4 treatment are in the category of molecular function under binding (24) and biological processes which includes immune system process (9), multi-organism process (5) and biological regulation (19) nonexclusively. Conclusions: These results suggest that altered expression of genes for molecular function and biological process may be involved in the beneficial effects of thyroid hormone treatment following MI in rats.	[Chen, Yue-Feng; Gerdes, A. Martin] New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Pottala, James V.; Weltman, Nathan Y.; Savinova, Olga V.] Univ S Dakota, Sioux Falls, SD USA; [Ge, Xijin] S Dakota State Univ, Dept Math & Stat, Brookings, SD 57007 USA	New York Institute Technology; University of South Dakota; South Dakota State University	Chen, YF (corresponding author), New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA.	ychen33@nyit.edu	Ge, Xijin/AAP-6237-2021; Ge, Steven/ABF-1186-2021	Ge, Steven/0000-0001-7406-3782; Chen, Yuefeng/0000-0002-5925-2291	National Institutes of Health (NIH) [RO1 HL093160-01A1, RO1 HL103671-01A1]; American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship [10POST2650057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103671, R01HL093160] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (NIH) RO1 HL093160-01A1 and RO1 HL103671-01A1, as well as American Heart Association (AHA) MWA Fall 09 Postdoctoral Fellowship 10POST2650057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2004, J PHARMACOL EXP THER, V311, P164, DOI 10.1124/jpet.104.069153; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BREISCH EA, 1989, BASIC RES CARDIOL, V84, P345, DOI 10.1007/BF02650869; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Deacon DC, 2010, DEVELOPMENT, V137, P1887, DOI 10.1242/dev.050526; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Forini F, 2011, J CELL MOL MED, V15, P514, DOI 10.1111/j.1582-4934.2010.01014.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; Henderson KK, 2009, CIRC-HEART FAIL, V2, P243, DOI 10.1161/CIRCHEARTFAILURE.108.810747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kalofoutis C, 2010, MOL CELL BIOCHEM, V345, P161, DOI 10.1007/s11010-010-0569-4; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu GY, 2009, J APPL GENET, V50, P47, DOI 10.1007/BF03195651; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; Ojamaa K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1319, DOI 10.1152/ajpendo.2000.279.6.E1319; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Sandhu R, 2004, CARDIOVASC RES, V64, P115, DOI 10.1016/j.cardiores.2004.05.013; Sasaki H, 2001, J MOL CELL CARDIOL, V33, P283, DOI 10.1006/jmcc.2000.1299; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; ZIMMER HG, 1990, J MOL CELL CARDIOL, V22, P1231, DOI 10.1016/0022-2828(90)90060-F	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40161	10.1371/journal.pone.0040161	http://dx.doi.org/10.1371/journal.pone.0040161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870193	gold, Green Published			2022-12-25	WOS:000307212800004
J	Chong-Seng, KM; Mannering, TD; Pratchett, MS; Bellwood, DR; Graham, NAJ				Chong-Seng, Karen M.; Mannering, Thomas D.; Pratchett, Morgan S.; Bellwood, David R.; Graham, Nicholas A. J.			The Influence of Coral Reef Benthic Condition on Associated Fish Assemblages	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; PHASE-SHIFTS; CLIMATE-CHANGE; RESILIENCE; HERBIVORY; DEGRADATION; DECLINE; IMPACTS; STATES	Accumulative disturbances can erode a coral reef's resilience, often leading to replacement of scleractinian corals by macroalgae or other non-coral organisms. These degraded reef systems have been mostly described based on changes in the composition of the reef benthos, and there is little understanding of how such changes are influenced by, and in turn influence, other components of the reef ecosystem. This study investigated the spatial variation in benthic communities on fringing reefs around the inner Seychelles islands. Specifically, relationships between benthic composition and the underlying substrata, as well as the associated fish assemblages were assessed. High variability in benthic composition was found among reefs, with a gradient from high coral cover (up to 58%) and high structural complexity to high macroalgae cover (up to 95%) and low structural complexity at the extremes. This gradient was associated with declining species richness of fishes, reduced diversity of fish functional groups, and lower abundance of corallivorous fishes. There were no reciprocal increases in herbivorous fish abundances, and relationships with other fish functional groups and total fish abundance were weak. Reefs grouping at the extremes of complex coral habitats or low-complexity macroalgal habitats displayed markedly different fish communities, with only two species of benthic invertebrate feeding fishes in greater abundance in the macroalgal habitat. These results have negative implications for the continuation of many coral reef ecosystem processes and services if more reefs shift to extreme degraded conditions dominated by macroalgae.	[Chong-Seng, Karen M.; Mannering, Thomas D.; Pratchett, Morgan S.; Bellwood, David R.; Graham, Nicholas A. J.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Mannering, Thomas D.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Chong-Seng, KM (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	karen.chongseng@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Graham, Nicholas AJ/C-8360-2014; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Graham, Nicholas AJ/0000-0002-0304-7467; Pratchett, Morgan S/0000-0002-1862-8459; Chong-Seng, Karen/0000-0001-9178-5891	Australian Research Council; Seychelles Fishing Authority; Western Indian Ocean Marine Science Association Marine Research Grant	Australian Research Council(Australian Research Council); Seychelles Fishing Authority; Western Indian Ocean Marine Science Association Marine Research Grant	This study was funded by the Australian Research Council, the Seychelles Fishing Authority, and a Western Indian Ocean Marine Science Association Marine Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamada S., 2008, STATUS CORAL REEFS W, V2008, P105; Arthur R, 2006, CORAL REEFS, V25, P427, DOI 10.1007/s00338-006-0127-4; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02306-z, DOI 10.1007/S00442-00012-02306-Z]; Brown Barbara E., 1997, P354; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daw TM, 2011, ENVIRON CONSERV, V38, P75, DOI 10.1017/S0376892910000901; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Duckworth AR, 2011, J EXP MAR BIOL ECOL, V402, P49, DOI 10.1016/j.jembe.2011.03.017; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2003, HYDROBIOLOGIA, V498, P191, DOI 10.1023/A:1026217201408; Goreau T.J., 1998, CORAL RECOVERY BLEAC; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grandcourt EM, 2003, FISH RES, V60, P539, DOI 10.1016/S0165-7836(02)00173-X; GRANDCOURT EM, 1999, POPULATION BIOL SELE; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lecchini D, 2012, ENVIRON BIOL FISH, V94, P421, DOI 10.1007/s10641-011-9958-0; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; Maina J., 2011, SPATIAL BEHAV ARTISA; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nogueira C, 2009, AUSTRAL ECOL, V34, P83, DOI 10.1111/j.1442-9993.2008.01887.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Neill RV., 1998, J AQUATIC ECOSYSTEM, V6, P181, DOI [10.1023/A:1009996332614, DOI 10.1023/A:1009996332614]; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Payet R, 2006, AMBIO, V35, P182, DOI 10.1579/0044-7447(2006)35[182:CCITSI]2.0.CO;2; Petraitis PS, 2009, OECOLOGIA, V161, P139, DOI 10.1007/s00442-009-1350-9; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Shafer CS, 2000, ENVIRON MANAGE, V26, P73, DOI 10.1007/s002670010072; Stoddart DR, 1984, BIOGEOGRAPHY ECOLOGY; Syms C, 2001, OECOLOGIA, V127, P560, DOI 10.1007/s004420000617; TAYLOR JD, 1968, PHILOS T ROY SOC B, V254, P129, DOI 10.1098/rstb.1968.0015; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Uyarra MC, 2005, ENVIRON CONSERV, V32, P11, DOI 10.1017/S0376892904001808; Victor S, 2008, ESTUAR COAST SHELF S, V77, P175, DOI 10.1016/j.ecss.2007.09.009; WALKER BH, 1993, AMBIO, V22, P80; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; Williams ID, 2000, ENVIRON CONSERV, V27, P382, DOI 10.1017/S0376892900000436; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185; Wilson SK, 2012, CONSERV BIO IN PRESS; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	84	72	73	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42167	10.1371/journal.pone.0042167	http://dx.doi.org/10.1371/journal.pone.0042167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870294	Green Published, gold, Green Accepted			2022-12-25	WOS:000307212800064
J	Jiang, H; He, CZ; Geng, SS; Sheng, HH; Shen, XY; Zhang, XY; Li, H; Zhu, SZ; Chen, XM; Yang, CQ; Gao, HJ				Jiang, Hua; He, Chengzhi; Geng, Shasha; Sheng, Haihui; Shen, Xiaoying; Zhang, Xiaoyan; Li, Hang; Zhu, Shizhang; Chen, Ximei; Yang, Changqing; Gao, HengJun			RhoT1 and Smad4 Are Correlated with Lymph Node Metastasis and Overall Survival in Pancreatic Cancer	PLOS ONE			English	Article							GTPASES; EXPRESSION; INVASION; PROTEIN; P16; PROGNOSIS; CARCINOMA; MARKER; ROLES	Cancer cell invasion and metastasis are the most important adverse prognostic factors for pancreatic cancer. Identification of biomarkers associated with outcome of pancreatic cancer may provide new approaches and targets for anticancer therapy. The aim of this study is to examine the relationship between the expression of RhoT1, Smad4 and p16 and metastasis and survival in patients with pancreatic cancer. The analysis showed that the high cytoplasmic expression levels of RhoT1, Smad4 and p16 in pancreatic cancer tissues had significantly negative correlation with lymph node metastasis (LNM) (P = 0.017, P = 0.032, P = 0.042, respectively). However, no significant association was observed between perineural invasion (PNI) and the expression of above three proteins (all P > 0.05). Additionally, the survival analysis showed that the low expression levels of RhoT1 and Smad4 were significantly associated with worse survival (P = 0.034, P = 0.047, respectively). In conclusion, these results indicated that the low-expression levels of RhoT1 and Smad4 were significantly associated with LNM and shorter survival. RhoT1 may be considered as a potential novel marker for predicting the outcome in patients with pancreatic cancer.	[Jiang, Hua; Geng, Shasha] Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai E Hosp, Shanghai 200092, Peoples R China; [He, Chengzhi; Chen, Ximei; Yang, Changqing; Gao, HengJun] Tongji Univ, Sch Med, Dept Gastroenterol, Inst Digest Dis,Tongji Hosp, Shanghai 200092, Peoples R China; [Sheng, Haihui; Shen, Xiaoying; Zhang, Xiaoyan; Li, Hang; Zhu, Shizhang; Gao, HengJun] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China	Tongji University; Tongji University	Jiang, H (corresponding author), Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai E Hosp, Shanghai 200092, Peoples R China.	huajiang666@yahoo.com.cn; hengjun_gao@shbiochip.com			Pudong Health Bureau of Shanghai, China [PWZxkq2010-05]; China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics) [1006AA02A302]	Pudong Health Bureau of Shanghai, China; China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics)	HJ is supported by Key Discipline Construction Project of Pudong Health Bureau of Shanghai, China (Grant No: PWZxkq2010-05). HG is supported by China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics) (Grant No: 1006AA02A302), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Fu ZJ, 2008, CLIN EXP METASTAS, V25, P887, DOI 10.1007/s10585-008-9207-x; Gerdes B, 2002, ANN SURG, V235, P51, DOI 10.1097/00000658-200201000-00007; He SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-70; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hua J, 2009, CHINESE J PANCREATOL, V9, P187; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Liu F, 2001, CLIN CANCER RES, V7, P3853; Maitra A, 2000, AM J PATHOL, V157, P1105, DOI 10.1016/S0002-9440(10)64625-1; Mihic-Probst D, 2006, INT J CANCER, V118, P2262, DOI 10.1002/ijc.21608; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Ohtsubo K, 2003, J GASTROENTEROL, V38, P663, DOI 10.1007/s00535-003-1119-6; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Schulz P, 2008, BRIT J CANCER, V99, P110, DOI 10.1038/sj.bjc.6604457; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tanaka T, 2008, J SURG ONCOL, V97, P69, DOI 10.1002/jso.20896; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42234	10.1371/journal.pone.0042234	http://dx.doi.org/10.1371/journal.pone.0042234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860091	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600077
J	Delaby, C; Rondeau, C; Pouzet, C; Willemetz, A; Pilard, N; Desjardins, M; Canonne-Hergaux, F				Delaby, Constance; Rondeau, Christiane; Pouzet, Cecile; Willemetz, Alexandra; Pilard, Nathalie; Desjardins, Michel; Canonne-Hergaux, Francois			Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; NATURAL-RESISTANCE; INTRACELLULAR INFECTIONS; MEDIATED PHAGOCYTOSIS; PHAGOSOME MATURATION; PLASMA-MEMBRANE; FORMERLY NRAMP1; CELL-DEATH; IN-VIVO	Background: Senescent red blood cells (RBC) are recognized, phagocytosed and cleared by tissue macrophages. During this erythrophagocytosis (EP), RBC are engulfed and processed in special compartments called erythrophagosomes. We previously described that following EP, heme is rapidly degraded through the catabolic activity of heme oxygenase (HO). Extracted heme iron is then either exported or stored by macrophages. However, the cellular localization of the early steps of heme processing and iron extraction during EP remains to be clearly defined. Methodology/Principal Findings: We took advantage of our previously described cellular model of EP, using bone marrow-derived macrophages (BMDM). The subcellular localization of both inducible and constitutive isoforms of HO (HO-1 and HO-2), of the divalent metal transporters (Nramp1, Nramp2/DMT1, Fpn), and of the recently identified heme transporter HRG-1, was followed by fluorescence and electron microscopy during the earliest steps of EP. We also looked at some ER [calnexin, glucose-6-phosphatase (G6Pase) activity] and lysosomes (Lamp1) markers during EP. In both quiescent and LPS-activated BMDM, Nramp1 and Lamp1 were shown to be strong markers of the erythrophagolysosomal membrane. HRG-1 was also recruited to the erythrophagosome. Furthermore, we observed calnexin labeling and G6Pase activity at the erythrophagosomal membrane, indicating the contribution of ER in this phagocytosis model. In contrast, Nramp2/DMT1, Fpn, HO-1 and HO-2 were not detected at the membrane of erythrophagosomes. Conclusions/Significance: Our study highlights the subcellular localization of various heme- and iron-related proteins during early steps of EP, thereby suggesting a model for heme catabolism occurring outside the phagosome, with heme likely being transported into the cytosol through HRG1. The precise function of Nramp1 at the phagosomal membrane in this model remains to be determined.	[Delaby, Constance; Pilard, Nathalie; Canonne-Hergaux, Francois] Ctr Rech Bichat Beaujon, INSERM, U773, CRB3, Paris, France; [Delaby, Constance] Hop St Eloi, CHU Montpellier, IRB, Biochim Prote Clin, Montpellier, France; [Rondeau, Christiane; Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Pouzet, Cecile] Inst Federatif Rech 02, UFR Med Paris, Paris, France; [Willemetz, Alexandra; Canonne-Hergaux, Francois] CNRS, Inst Chim Subst Nat, UPR 2301, Ctr Rech Gif Sur Yvette, Gif Sur Yvette, France; [Canonne-Hergaux, Francois] CPTP, INSERM, U1043, Toulouse, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse, UPS, CPTP, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Delaby, C (corresponding author), Ctr Rech Bichat Beaujon, INSERM, U773, CRB3, Paris, France.	francois.canonne-Hergaux@inserm.fr	CANONNE-HERGAUX, François/AAC-2073-2020; Canonne-Hergaux, Francois/L-5363-2016	CANONNE-HERGAUX, François/0000-0002-0621-2157; Canonne-Hergaux, Francois/0000-0002-0621-2157; DELABY, Constance/0000-0002-8606-6814; Desjardins, Michel/0000-0002-5684-5980	INSERM (Institut National de la Sante et de la Recherche Medicale); CNRS (Centre National de la Recherche Scientifique); France Canada Research Fund (FCRF)	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); France Canada Research Fund (FCRF)	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale), CNRS (Centre National de la Recherche Scientifique), and by a research grant to FCH and MD from the France Canada Research Fund (FCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont C, 2005, TRANSFUS CLIN BIOL, V12, P123, DOI 10.1016/j.tracli.2005.04.017; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Deiss A, 1999, DESTRUCTION ERYTHROC; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Delaby C, 2008, BIOCHEM J, V411, P123, DOI 10.1042/BJ20071474; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2007, IMMUNOBIOLOGY, V212, P751, DOI 10.1016/j.imbio.2007.09.014; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gottlieb Y, 2012, HAEMATOLOGICA; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Huynh KK, 2007, PHYSIOLOGY, V22, P366, DOI 10.1152/physiol.00028.2007; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jabado N, 2003, P NATL ACAD SCI USA, V100, P6127, DOI 10.1073/pnas.0937287100; Jabado N, 2002, BLOOD, V100, P2617, DOI 10.1182/blood-2002-04-1182; Khan AA, 2011, BIOCH BIOPHYS ACTA; Kim HP, 2011, BIOCHEM BIOPH RES CO, V404, P1, DOI 10.1016/j.bbrc.2010.11.067; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rogers LD, 2008, CELL MICROBIOL, V10, P1405, DOI 10.1111/j.1462-5822.2008.01140.x; Schaer CA, 2008, J LEUKOCYTE BIOL, V83, P325, DOI 10.1189/jlb.0407226; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Soe-Lin S, 2010, EXP HEMATOL, V38, P609, DOI 10.1016/j.exphem.2010.04.003; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Touret N, 2005, J LEUKOCYTE BIOL, V77, P878, DOI 10.1189/jlb.1104630; VERSIECK J, 1974, CLIN CHEM, V20, P1141; Vidal SM, 1996, J IMMUNOL, V157, P3559; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	62	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42199	10.1371/journal.pone.0042199	http://dx.doi.org/10.1371/journal.pone.0042199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860081	gold, Green Submitted, Green Published			2022-12-25	WOS:000306950900076
J	Monahan, WB; Tingley, MW				Monahan, William B.; Tingley, Morgan W.			Niche Tracking and Rapid Establishment of Distributional Equilibrium in the House Sparrow Show Potential Responsiveness of Species to Climate Change	PLOS ONE			English	Article							DISTRIBUTION MODELS; CHANGE PROJECTIONS; RESPONSES; HABITAT; TEMPERATURE; POPULATIONS; ECOLOGY; SHIFTS; RANGE; SPACE	The ability of species to respond to novel future climates is determined in part by their physiological capacity to tolerate climate change and the degree to which they have reached and continue to maintain distributional equilibrium with the environment. While broad-scale correlative climatic measurements of a species' niche are often described as estimating the fundamental niche, it is unclear how well these occupied portions actually approximate the fundamental niche per se, versus the fundamental niche that exists in environmental space, and what fitness values bounding the niche are necessary to maintain distributional equilibrium. Here, we investigate these questions by comparing physiological and correlative estimates of the thermal niche in the introduced North American house sparrow (Passer domesticus). Our results indicate that occupied portions of the fundamental niche derived from temperature correlations closely approximate the centroid of the existing fundamental niche calculated on a fitness threshold of 50% population mortality. Using these niche measures, a 75-year time series analysis (1930-2004) further shows that: (i) existing fundamental and occupied niche centroids did not undergo directional change, (ii) interannual changes in the two niche centroids were correlated, (iii) temperatures in North America moved through niche space in a net centripetal fashion, and consequently, (iv) most areas throughout the range of the house sparrow tracked the existing fundamental niche centroid with respect to at least one temperature gradient. Following introduction to a new continent, the house sparrow rapidly tracked its thermal niche and established continent-wide distributional equilibrium with respect to major temperature gradients. These dynamics were mediated in large part by the species' broad thermal physiological tolerances, high dispersal potential, competitive advantage in human-dominated landscapes, and climatically induced changes to the realized environmental space. Such insights may be used to conceptualize mechanistic climatic niche models in birds and other taxa.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA; [Tingley, Morgan W.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	United States Department of the Interior; Princeton University	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA.	Bill_Monahan@nps.gov	Tingley, Morgan W/F-8519-2011	Tingley, Morgan W/0000-0002-1477-2218				Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barrows WB, 1889, USDA B, V1, P1; Blem C.R., 1973, Ornithological Monographs, VNo. 14, P96; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cassini MH, 2011, J BIOGEOGR, V38, P2057, DOI 10.1111/j.1365-2699.2011.02552.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KENDEIGH SC, 1969, WILSON BULL, V81, P441; Long J.L., 1981, INTRO BIRDS WORLD WO; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Moulton MP, 2010, BIOL INVASIONS, V12, P2955, DOI 10.1007/s10530-010-9692-0; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson R, 2010, LESSONS CONSERVATION, V3, P56; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2011, ECOLOGICAL NICHES GE; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Stankowski PA, 2011, ECOL MODEL, V222, P567, DOI 10.1016/j.ecolmodel.2010.10.018; Summers-Smith JD, 1988, SPARROWS; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; ZAR JH, 1977, COMP BIOCHEM PHYS A, V57, P127, DOI 10.1016/0300-9629(77)90362-0; Zurell D, 2009, ECOGRAPHY, V32, P733, DOI 10.1111/j.1600-0587.2009.05810.x	49	22	26	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42097	10.1371/journal.pone.0042097	http://dx.doi.org/10.1371/journal.pone.0042097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860062	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950900068
J	Exeter, HJ; Folkersen, L; Palmen, J; Franco-Cereceda, A; Cooper, JA; Kalea, AZ; van't Hooft, F; Eriksson, P; Humphries, SE; Talmud, PJ				Exeter, Holly J.; Folkersen, Lasse; Palmen, Jutta; Franco-Cereceda, Anders; Cooper, Jackie A.; Kalea, Anastasia Z.; van't Hooft, Ferdinand; Eriksson, Per; Humphries, Steve E.; Talmud, Philippa J.			Functional Analysis of Two PLA2G2A Variants Associated with Secretory Phospholipase A2-IIA Levels	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BINDING-PROTEINS; EPIC-NORFOLK; SERUM-LEVELS; HEALTHY-MEN; A(2); LIPOPROTEIN; RISK; EVENTS; WOMEN	Background: Secretory phospholipase A2 group IIA (sPLA2-IIA) has been identified as a biomarker of atherosclerosis in observational and animal studies. The protein is encoded by the PLA2G2A gene and the aim of this study was to test the functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alleles have been previously associated with higher and lower sPLA2-IIA levels respectively. Methodology/Principal Findings: Luciferase assays, electrophoretic mobility shift assays (EMSA), and RNA expression by RT-PCR were used to examine allelic differences. For rs3767221 the G allele showed similar to 55% lower luciferase activity compared to the T allele (T = 62.1 (95% CI 59.1 to 65.1) G = 27.8 (95% CI 25.0 to 30.6), p = 1.22x10(-35), and stronger EMSA binding of a nuclear protein compared to the T-allele. For rs11573156 C>G there were no luciferase or EMSA allelic differences seen. In lymphocyte cell RNA, from individuals of known rs11573156 genotype, there was no allelic RNA expression difference for exons 5 and 6, but G allele carriers (n = 7) showed a trend to lower exon 1-2 expression compared to CC individuals. To take this further, in the ASAP study (n = 223), an rs11573156 proxy (r(2) = 0.91) showed similar to 25% higher liver expression of PLA2G2A (1.67x10(-17)) associated with the G allele. However, considering exon specific expression, the association was greatly reduced for exon 2 (4.5x10(-5)) compared to exons 3-6 (10(-10) to 10(-20)), suggesting rs11573156 G allele-specific exon 2 skipping. Conclusion: Both SNPs are functional and provide useful tools for Mendelian Randomisation to determine whether the relationship between sPLA2-IIA and coronary heart disease is causal.	[Exeter, Holly J.; Palmen, Jutta; Cooper, Jackie A.; Kalea, Anastasia Z.; Humphries, Steve E.; Talmud, Philippa J.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Folkersen, Lasse; van't Hooft, Ferdinand; Eriksson, Per] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden	University of London; University College London; Karolinska Institutet; Karolinska Institutet	Exeter, HJ (corresponding author), UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England.	h.exeter@ucl.ac.uk; p.talmud@ucl.ac.uk	Kalea, Anastasia Z./G-4053-2010	Talmud, Philippa/0000-0002-5560-1933; Eriksson, Per/0000-0002-5635-2692; Kalea, Anastasia Z./0000-0001-5775-3984; Folkersen, Lasse/0000-0003-0708-9530; Humphries, Stephen E/0000-0002-8221-6547	British Heart Foundation [FS08/048/25628, RG008/014]; Swedish Research Council; Swedish Heart-Lung foundation; Fredrik Lundberg; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Fredrik Lundberg; British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation PhD studentship FS08/048/25628 supporting HJE. The ASAP study was supported by the Swedish Research Council, the Swedish Heart-Lung foundation, and a donation by Fredrik Lundberg. SEH and PJT are supported by the British Heart Foundation RG008/014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekholdt SM, 2005, ARTERIOSCL THROM VAS, V25, P839, DOI 10.1161/01.ATV.0000157933.19424.b7; Fan QS, 1997, MOL CELL BIOL, V17, P4238, DOI 10.1128/MCB.17.8.4238; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Folkersen L, 2009, BIOINFORMATICS, V25, P1978, DOI 10.1093/bioinformatics/btp279; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004; Jonsson-Rylander AC, 2008, CURR ATHEROSCLER REP, V10, P252, DOI 10.1007/s11883-008-0039-6; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Leonarduzzi G, 2011, FREE RADIC BIOL MED; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Oorni K, 2009, CURR OPIN LIPIDOL, V20, P421, DOI 10.1097/MOL.0b013e32832fa14d; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Touqui Lhousseine, 2001, Current Molecular Medicine (Hilversum), V1, P739, DOI 10.2174/1566524013363258; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Wootton PTE, 2006, HUM MOL GENET, V15, P355, DOI 10.1093/hmg/ddi453	25	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41139	10.1371/journal.pone.0041139	http://dx.doi.org/10.1371/journal.pone.0041139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22879865	Green Published, gold, Green Submitted			2022-12-25	WOS:000306507000073
J	Mitani, T; Harada, N; Nakano, Y; Inui, H; Yamaji, R				Mitani, Takakazu; Harada, Naoki; Nakano, Yoshihisa; Inui, Hiroshi; Yamaji, Ryoichi			Coordinated Action of Hypoxia-inducible Factor-1 alpha and beta-Catenin in Androgen Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH; WNT; TRANSCRIPTION; ACTIVATION; ENVIRONMENT; INHIBITION; MUTATIONS; PATHWAYS; THERAPY	The androgen receptor (AR) acts as a ligand-dependent transcriptional factor and plays a critical role in the development and progression of androgen-dependent and castration-resistant prostate cancer. Castration results in hypoxia in prostate cancer cells, and hypoxia enhances transcriptional activity of AR through hypoxia-inducible factor (HIF)-1 alpha at low serum androgen levels mimicking the castration-resistant stage. However, HIF-1 alpha is necessary but not sufficient for hypoxia-activated AR transactivation, and the molecular mechanism that regulates AR function in castration-resistant prostate cancer remains unclear. Here, we report that beta-catenin is required for HIF-1 alpha mediated AR transactivation in hypoxic LNCaP prostate cancer cells under low androgen conditions. HIF-1 alpha and beta-catenin coordinately enhanced AR N-terminal and C-terminal interaction. beta-Catenin accumulated in the nucleus in the HIF-1 alpha protein-positive cells of LNCaP xenografts in castrated mice. In LNCaP cells, when HIF-1 alpha was knocked down or was exogenously expressed in the cytoplasm, hypoxia-induced nuclear localization of beta-catenin was inhibited. beta-Catenin formed a complex with HIF-1 alpha both in the nucleus and in the cytoplasm. Hypoxia increased the amount of a complex composed of AR and beta-catenin, and knockdown of HIF-1 alpha attenuated the recruitment of AR and beta-catenin to the androgen response elements (AREs) of androgen-responsive genes. Furthermore, together with beta-catenin, HIF-1 alpha bound to the AREs in the presence of androgen. These results demonstrate that (i) HIF-1 alpha and beta-catenin coordinately enhance AR transactivation by accelerating N-terminal and C-terminal interaction; (ii) HIF-1 alpha promotes nuclear translocation of beta-catenin in hypoxia; and (iii) AR, HIF-1 alpha, and beta-catenin form a ternary complex on AREs.	[Mitani, Takakazu; Harada, Naoki; Inui, Hiroshi; Yamaji, Ryoichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Nakano, Yoshihisa] Osaka Womens Jr Coll, Osaka 5838558, Japan	Osaka Metropolitan University	Yamaji, R (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	yamaji@biochem.osakafu-u.ac.jp	Mitani, Takakazu/AAL-8251-2020; Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X; Mitani, Takakazu/0000-0002-2272-9228	Japan Society for the Promotion of Science [20580141, 6913]; Grants-in-Aid for Scientific Research [22580152, 11J06913] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research 20580141 (to R. Y.) and Research Fellowship 6913 (to T. M.) from the Japan Society for the Promotion of Science.	Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gobinet J, 2002, MOL CELL ENDOCRINOL, V198, P15, DOI 10.1016/S0303-7207(02)00364-7; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Horii K, 2007, MOL CANCER RES, V5, P383, DOI 10.1158/1541-7786.MCR-06-0226; Hsu CL, 2005, MOL ENDOCRINOL, V19, P350, DOI 10.1210/me.2004-0190; Jang KL, 2005, P NATL ACAD SCI USA, V102, P18431, DOI 10.1073/pnas.0504054102; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Ki H, 2006, CELL BIOL INT, V30, P253, DOI 10.1016/j.cellbi.2005.11.005; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Mostaghel EA, 2009, UROL ONCOL-SEMIN ORI, V27, P251, DOI 10.1016/j.urolonc.2009.03.016; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nishiyama T, 2007, J UROLOGY, V178, P1282, DOI 10.1016/j.juro.2007.05.138; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Parker C, 2004, INT J RADIAT ONCOL, V58, P750, DOI 10.1016/S0360-3016(03)01621-3; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shabsigh A, 2001, J CELL BIOCHEM, V81, P437, DOI 10.1002/1097-4644(20010601)81:3<437::AID-JCB1057>3.3.CO;2-Y; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	42	43	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33594	33606		10.1074/jbc.M112.388298	http://dx.doi.org/10.1074/jbc.M112.388298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865883	Green Published, hybrid			2022-12-25	WOS:000309602100044
J	Auzmendi, J; Do Porto, DF; Pallavicini, C; Moffatt, L				Auzmendi, Jeronimo; Fernandez Do Porto, Dario; Pallavicini, Carla; Moffatt, Luciano			Achieving Maximal Speed of Solution Exchange for Patch Clamp Experiments	PLOS ONE			English	Article							LASER-PULSE PHOTOLYSIS; ACETYLCHOLINE-RECEPTOR KINETICS; CHANNEL-OPENING KINETICS; GATED ION CHANNELS; END-PLATE; CONFORMATIONAL-CHANGE; MACROSCOPIC CURRENTS; GLYCINE RECEPTORS; GABA(A) RECEPTORS; AMPA RECEPTOR	Background: Resolving the kinetics of agonist binding events separately from the subsequent channel gating processes requires the ability of applying and removing the agonist before channel gating occurs. No reported system has yet achieved pulses shorter than 100 m mu, necessary to study nicotinic ACh receptor or AMPA receptor activation. Methodology/Principal Findings: Solution exchange systems deliver short agonist pulses by moving a sharp interface between a control and an experimental solution across a channel preparation. We achieved shorter pulses by means of an exchange system that combines a faster flow velocity, narrower partition between the two streams, and increased velocity and bandwidth of the movement of the interface. The measured response of the entire system was fed back to optimize the voltage signal applied to the piezoelectric actuator overcoming the spurious oscillations arising from the mechanical resonances when a high bandwidth driving function was applied. Optimization was accomplished by analyzing the transfer function of the solution exchange system. When driven by optimized command pulses the enhanced system provided pulses lasting 26 +/- 1 mu s and exchanging 93 +/- 1% of the solution, as measured in the open tip of a patch pipette. Conclusions/Significance: Pulses of this duration open the experimental study of the molecular events that occur between the agonist binding and the opening of the channel.	[Auzmendi, Jeronimo; Fernandez Do Porto, Dario; Pallavicini, Carla; Moffatt, Luciano] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina	University of Buenos Aires	Auzmendi, J (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina.	lmoffatt@qi.fcen.uba.ar	Moffatt, Luciano/E-9805-2012	Auzmendi, Jeronimo/0000-0002-4819-2713; Moffatt, Luciano/0000-0003-4994-4304; Fernandez Do Porto, Dario Augusto/0000-0002-3622-4052	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1902/2006]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1902/2006 to L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzmendi JA, 2010, J NEUROSCI METH, V185, P280, DOI 10.1016/j.jneumeth.2009.10.002; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; Botzolakis EJ, 2009, J NEUROSCI METH, V177, P294, DOI 10.1016/j.jneumeth.2008.10.014; Breitinger HG, 2001, NEUROSCIENTIST, V7, P95, DOI 10.1177/107385840100700204; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DIONNE VE, 1982, BIOPHYS J, V39, P253, DOI 10.1016/S0006-3495(82)84515-3; Elenes S, 2009, J GEN PHYSIOL, V133, P151, DOI 10.1085/jgp.200810089; FRANKE C, 1992, J PHYSIOL-LONDON, V451, P145, DOI 10.1113/jphysiol.1992.sp019158; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Hamill OP, 1995, PATCH CLAMP TECHNIQU, P75; Jonas Peter, 1995, P231; Komal P, 2011, J NEUROSCI METH, V198, P246, DOI 10.1016/j.jneumeth.2011.04.024; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LEIBOWITZ MD, 1984, BIOPHYS J, V45, P153, DOI 10.1016/S0006-3495(84)84144-2; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; Li HY, 2002, BIOCHEMISTRY-US, V41, P4753, DOI 10.1021/bi0118916; Li XS, 2000, J NEUROSCI, V20, P899, DOI 10.1523/JNEUROSCI.20-03-00899.2000; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MACONOCHIE DJ, 1995, J GEN PHYSIOL, V106, P113, DOI 10.1085/jgp.106.1.113; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MATSUBARA N, 1992, BIOCHEMISTRY-US, V31, P5507, DOI 10.1021/bi00139a012; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Moffatt L, 2007, BIOPHYS J, V93, P74, DOI 10.1529/biophysj.106.101212; Moffatt L, 2007, J GEN PHYSIOL, V130, P183, DOI 10.1085/jgp.200709779; Robert A, 2003, J NEUROSCI, V23, P847; Sachs F, 1999, BIOPHYS J, V77, P682, DOI 10.1016/S0006-3495(99)76923-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sigworth FJ, 1983, SINGLE CHANNEL RECOR, P3; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Stiles JR, 1999, BIOPHYS J, V77, P1177, DOI 10.1016/S0006-3495(99)76969-9; Stilson S, 2001, IEEE T BIO-MED ENG, V48, P806, DOI 10.1109/10.930905; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026	41	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42275	10.1371/journal.pone.0042275	http://dx.doi.org/10.1371/journal.pone.0042275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879927	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100060
J	Chen, TT; Hedman, L; Mattila, PS; Jartti, L; Jartti, T; Ruuskanen, O; Soderlund-Venermo, M; Hedman, K				Chen, Tingting; Hedman, Lea; Mattila, Petri S.; Jartti, Laura; Jartti, Tuomas; Ruuskanen, Olli; Soderlund-Venermo, Maria; Hedman, Klaus			Biotin IgM Antibodies in Human Blood: A Previously Unknown Factor Eliciting False Results in Biotinylation-Based Immunoassays	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOREACTIVE HIGH-AFFINITY; BINDING IMMUNOGLOBULIN-G; B-CELL REPERTOIRE; EGG-WHITE POWDER; RHEUMATOID-FACTOR; AUTOANTIBODIES; DEFICIENCY; SERA; QUANTITATION	Biotin is an essential vitamin that binds streptavidin or avidin with high affinity and specificity. As biotin is a small molecule that can be linked to proteins without affecting their biological activity, biotinylation is applied widely in biochemical assays. In our laboratory, IgM enzyme immuno assays (EIAs) of mu-capture format have been set up against many viruses, using as antigen biotinylated virus like particles (VLPs) detected by horseradish peroxidase-conjugated streptavidin. We recently encountered one serum sample reacting with the biotinylated VLP but not with the unbiotinylated one, suggesting in human sera the occurrence of biotin-reactive antibodies. In the present study, we search the general population (612 serum samples from adults and 678 from children) for IgM antibodies reactive with biotin and develop an indirect EIA for quantification of their levels and assessment of their seroprevalence. These IgM antibodies were present in 3% adults regardless of age, but were rarely found in children. The adverse effects of the biotin IgM on biotinylation-based immunoassays were assessed, including four inhouse and one commercial virus IgM EIAs, showing that biotin IgM do cause false positivities. The biotin can not bind IgM and streptavidin or avidin simultaneously, suggesting that these biotin-interactive compounds compete for the common binding site. In competitive inhibition assays, the affinities of biotin IgM antibodies ranged from 2.1x10(-3) to 1.7x10(-4) mol/L. This is the first report on biotin antibodies found in humans, providing new information on biotinylation-based immunoassays as well as new insights into the biomedical effects of vitamins.	[Chen, Tingting; Hedman, Lea; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Mattila, Petri S.] Univ Helsinki, Dept Otorhinolaryngol, Helsinki, Finland; [Jartti, Laura] Turku City Hosp, Dept Geriatr, Turku, Finland; [Jartti, Tuomas; Ruuskanen, Olli] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Hedman, Klaus] Univ Helsinki, Cent Hosp, Dept Virol & Immunol, Lab Div, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Chen, TT (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	klaus.hedman@helsinki.fi	Chen, Tingting/I-8274-2019; Söderlund-Venermo, Maria/AAX-2112-2020; Hedman, Klaus/D-5379-2009	Chen, Tingting/0000-0002-2227-3208; Mattila, Petri/0000-0003-1911-1811; Hedman, Klaus/0000-0003-1779-7960	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation; Medical Society of Finland; Academy of Finland [1122539]; Orion-Farmos Research Foundation Grant	Helsinki University Central Hospital Research and Education Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation Grant	This study was supported by the Helsinki University Central Hospital Research and Education Fund, the Sigrid Juselius Foundation, the Medical Society of Finland, the Academy of Finland (project 1122539), and the Orion-Farmos Research Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILUS K, 1991, CLIN CHEM, V37, P1766; BALNAVE D, 1977, AM J CLIN NUTR, V30, P1408, DOI 10.1093/ajcn/30.9.1408; Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P257, DOI 10.1007/978-1-59745-324-0_26; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; Carvalho JF, 2007, ANN NY ACAD SCI, V1109, P550, DOI 10.1196/annals.1398.061; CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513; Chatterjee NS, 1999, AM J PHYSIOL-CELL PH, V277, pC605, DOI 10.1152/ajpcell.1999.277.4.C605; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; DAKSHINAMURTI K, 1990, METHOD ENZYMOL, V184, P93; DEVEY ME, 1989, CLIN EXP IMMUNOL, V77, P191; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GRIER RE, 1990, CLIN CHIM ACTA, V186, P397, DOI 10.1016/0009-8981(90)90326-N; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Korpilahde T, 2003, ANN RHEUM DIS, V62, P353, DOI 10.1136/ard.62.4.353; Lahtinen A, 2011, EMERG INFECT DIS, V17, P79, DOI 10.3201/eid1701.100750; McMahon RJ, 2002, ANNU REV NUTR, V22, P221, DOI 10.1146/annurev.nutr.22.121101.112819; Mock DM, 1999, J NUTR, V129, p498S, DOI 10.1093/jn/129.2.498S; MOCK DM, 1995, J NUTR, V125, P941; Muratsugu M, 2003, BIOL PHARM BULL, V26, P1605, DOI 10.1248/bpb.26.1605; Muratsugu M, 2008, BIOL PHARM BULL, V31, P507, DOI 10.1248/bpb.31.507; NAKAMURA M, 1988, J IMMUNOL, V141, P4165; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Pengo P, 2010, J MOL RECOGNIT, V23, P551, DOI 10.1002/jmr.1095; PETERS JM, 1967, BRIT J NUTR, V21, P801, DOI 10.1079/BJN19670082; PETERS JM, 1969, FOOD COSMET TOXICOL, V7, P197, DOI 10.1016/S0015-6264(69)80323-8; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Shim CN, 2012, MOD RHEUMATOL, V22, P885, DOI 10.1007/s10165-012-0603-3; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; SUTTON A, 1985, J IMMUNOL METHODS, V82, P215, DOI 10.1016/0022-1759(85)90353-9; SYDENSTRICKER V. P., 1942, SCIENCE, V95, P176, DOI 10.1126/science.95.2459.176; TERNYNCK T, 1986, IMMUNOL REV, V94, P99; Wolf B, 2010, MOL GENET METAB, V100, P6, DOI 10.1016/j.ymgme.2010.01.003; Zempleni J, 1999, J NUTR BIOCHEM, V10, P128, DOI 10.1016/S0955-2863(98)00095-3	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42376	10.1371/journal.pone.0042376	http://dx.doi.org/10.1371/journal.pone.0042376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879954	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100074
J	Kohn, C; Schleifenbaum, J; Szijarto, IA; Marko, L; Dubrovska, G; Huang, Y; Gollasch, M				Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Huang, Yu; Gollasch, Maik			Differential Effects of Cystathionine-gamma-lyase-Dependent Vasodilatory H2S in Periadventitial Vasoregulation of Rat and Mouse Aortas	PLOS ONE			English	Article							PERIVASCULAR ADIPOSE-TISSUE; SPONTANEOUSLY HYPERTENSIVE-RATS; SMOOTH-MUSCLE-CELLS; HYDROGEN-SULFIDE; VASCULAR FUNCTION; ARTERIAL TONE; MICE; VASORELAXANT; INFLAMMATION; ENDOTHELIUM	Background: Hydrogen sulfide (H2S) is a potent vasodilator. However, the complex mechanisms of vasoregulation by H2S are not fully understood. We tested the hypotheses that (1) H2S exerts vasodilatory effects by opening KCNQ-type voltage-dependent (K-v) K+ channels and (2) that H2S-producing cystathionine-gamma-lyase (CSE) in perivascular adipose tissue plays a major role in this pathway. Methodology/Principal Findings: Wire myography of rat and mouse aortas was used. NaHS and 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADTOH) were used as H2S donors. KCNQ-type K-v channels were blocked by XE991. 4-Propargylglycine (PPG) and beta-cyano-l-alanine (BCA), or 2-(aminooxy)-acetic acid (AOAA) were used as inhibitors of CSE or cystathionine-beta-synthase (CBS), respectively. NaHS and ADTOH produced strong vasorelaxation in rat and mouse aortas, which were abolished by KCNQ channel inhibition with XE991. Perivascular adipose tissue (PVAT) exerted an anticontractile effect in these arteries. CSE inhibition by PPG and BCA reduced this effect in aortas from rats but not from mice. CBS inhibition with AOAA did not inhibit the anticontractile effects of PVAT. XE991, however, almost completely suppressed the anticontractile effects of PVAT in both species. Exogenous l-cysteine, substrate for the endogenous production of H2S, induced vasorelaxation only at concentrations >5 mmol/l, an effect unchanged by CSE inhibition. Conclusions/Signficance: Our results demonstrate potent vasorelaxant effects of H2S donors in large arteries of both rats and mice, in which XE991-sensitive KCNQ-type channel opening play a pivotal role. CSE-H2S seems to modulate the effect of adipocyte-derived relaxing factor in rat but not in mouse aorta. The present study provides novel insight into the interaction of CSE-H2S and perivascular adipose tissue. Furthermore, with additional technical advances, a future clinical approach targeting vascular H2S/KCNQ pathways to influence states of vascular dysfunction may be possible.	[Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Gollasch, Maik] Charite Campus Virchow Klinikum, Med Clin Nephrol & Internal Intens Care, Berlin, Germany; [Koehn, Carolin; Schleifenbaum, Johanna; Szijarto, Istvan Andras; Marko, Lajos; Dubrovska, Galyna; Gollasch, Maik] Max Delbruck Ctr Mol Med, ECRC, Berlin, Germany; [Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Li Ka Shing Inst Hlth Sci, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chinese University of Hong Kong	Kohn, C (corresponding author), Charite Campus Virchow Klinikum, Med Clin Nephrol & Internal Intens Care, Berlin, Germany.	maik.gollasch@charite.de	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; Schleifenbaum, Johanna/0000-0002-3195-1517; Marko, Lajos/0000-0003-1888-5575; Szijarto, Istvan/0000-0002-0796-9450	Deutsche Forschungsgemeinschaft (DFG); Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme)	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG) and Deutsche Akademische Austauschdienst (Germany/Hong Kong Joint Research Scheme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Magableh MR, 2011, N-S ARCH PHARMACOL, V383, P403, DOI 10.1007/s00210-011-0608-z; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Dubrovska G, 2004, AM J PHYSIOL-HEART C, V286, pH1107, DOI 10.1152/ajpheart.00656.2003; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Galvez B, 2006, ARTERIOSCL THROM VAS, V26, P1297, DOI 10.1161/01.ATV.0000220381.40739.dd; Galvez-Prieto B, 2008, HYPERTENS RES, V31, P1415, DOI 10.1291/hypres.31.1415; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; Gao YJ, 2005, J THORAC CARDIOV SUR, V130, P1130, DOI 10.1016/j.jtcvs.2005.05.028; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Givvimani S, 2011, J APPL PHYSIOL, V110, P1093, DOI 10.1152/japplphysiol.01064.2010; Gollasch M, 2004, TRENDS PHARMACOL SCI, V25, P647, DOI 10.1016/j.tips.2004.10.005; Gollasch M, 2012, BRIT J PHARMACOL, V165, P633, DOI 10.1111/j.1476-5381.2011.01430.x; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Jin Hong-fang, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P541; Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661; Kiss L, 2008, LIFE SCI, V83, P589, DOI 10.1016/j.lfs.2008.08.006; Koenitzer JR, 2007, AM J PHYSIOL-HEART C, V292, pH1953, DOI 10.1152/ajpheart.01193.2006; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lee RMKW, 2009, CAN J PHYSIOL PHARM, V87, P944, DOI [10.1139/Y09-088, 10.1139/y09-088]; Lee SW, 2007, BIOCHEM BIOPH RES CO, V358, P1142, DOI 10.1016/j.bbrc.2007.05.063; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Liang GH, 2011, AM J PHYSIOL-HEART C, V300, pH2088, DOI 10.1152/ajpheart.01290.2010; Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Monjok EM, 2008, EXP EYE RES, V87, P612, DOI 10.1016/j.exer.2008.09.011; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Schleifenbaum J, 2010, J HYPERTENS, V28, P1875, DOI 10.1097/HJH.0b013e32833c20d5; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Sun Yan, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P161, DOI 10.3760/cma.j.issn.0253-3758.2009.02.018; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151; Verlohren S, 2004, HYPERTENSION, V44, P271, DOI 10.1161/01.HYP.0000140058.28994.ec; Wagner CA, 2009, J NEPHROL, V22, P173; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Withers SB, 2011, ARTERIOSCL THROM VAS, V31, P908, DOI 10.1161/ATVBAHA.110.221705; Wojcicka G, 2011, PHARMACOL RES, V63, P68, DOI 10.1016/j.phrs.2010.10.011; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao Jing, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P449	45	72	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41951	10.1371/journal.pone.0041951	http://dx.doi.org/10.1371/journal.pone.0041951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870268	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100039
J	Li, HZ; Mani, S; Cao, W; Yang, GD; Lai, C; Wu, LY; Wang, R				Li, Hongzhu; Mani, Sarathi; Cao, Wei; Yang, Guangdong; Lai, Christopher; Wu, Lingyun; Wang, Rui			Interaction of Hydrogen Sulfide and Estrogen on the Proliferation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							H2S; APOPTOSIS; BETA; VASORELAXANT; MECHANISMS; ESTRADIOL; P38	Hydrogen sulfide (H2S) can be endogenously generated from cystathionine gamma-lyase (CSE) in cardiovascular system, offering a cardiovascular protection. It is also known that the lower risk of cardiovascular diseases in female is partially attributed to the protective effect of estrogen. The current study explores the interaction of H2S and estrogen on smooth muscle cell (SMC) growth. In the present study, we found that the proliferation of cultured vascular SMCs isolated from wildtype mice (WT-SMCs) was inhibited, but that from CSE gene knockout mice (CSE-KO-SMCs) increased, by estrogen treatments. The expression of estrogen receptor alpha (ER alpha), but not ER beta, was significantly decreased in CSE-KO-SMCs compared with that in WT-SMCs. Exogenously applied H2S markedly increased ER alpha but not ER beta expression. In addition, the inhibition of ER activation and knockdown of ER alpha expression in WT-SMCs or the overexpression of ER alpha in CSE-KO-SMCs reversed the respective effects of estrogen on cell proliferation. The expression of cyclin D1 was reduced in WT-SMCs but increased in CSE-KO-SMCs after estrogen treatments, which was reversed by knockdown of ER alpha in WT-SMCs or overexpression of ER alpha in CSE-KO-SMCs, respectively. The overexpression of cyclin D1 in WT-SMCs or knockdown of cyclin D1 expression in CSE-KO-SMCs reversed the effects of estrogen on cell proliferation. These results suggest that H2S mediates estrogen-inhibited proliferation of SMCs via selective activation of ER alpha/cyclin D1 pathways.	[Li, Hongzhu; Mani, Sarathi; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Li, Hongzhu; Wang, Rui] Harbin Med Univ, Dept Pathophysiol, Harbin, Peoples R China; [Cao, Wei; Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Lai, Christopher] Lakehead Univ, No Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada	Lakehead University; Harbin Medical University; Lakehead University; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Li, HZ (corresponding author), Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada.	rwang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011	Wang, Rui/0000-0003-3825-3620; MANI, SARATHI/0000-0001-8383-4788	Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (HSFC); HSFC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); HSFC(Heart & Stroke Foundation of Canada)	This study was supported by a Discovery Grant from Natural Sciences and Engineering Research Council of Canada. SM was supported by a research fellowship award from Heart and Stroke Foundation of Canada (HSFC). GY was supported by a New Investigator Award from HSFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal JF, 2004, EUR J ENDOCRINOL, V150, P113, DOI 10.1530/eje.0.1500113; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Cheng B, 2009, INT J CARDIOL, V134, P356, DOI 10.1016/j.ijcard.2008.02.017; Geraldes P, 2002, ARTERIOSCL THROM VAS, V22, P1585, DOI 10.1161/01.ATV.0000035393.11854.6A; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hodges YK, 2000, CIRCULATION, V101, P1792, DOI 10.1161/01.CIR.101.15.1792; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Li HZ, 2008, BASIC CLIN PHARMACOL, V102, P329, DOI 10.1111/j.1742-7843.2007.00177.x; Li HZ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-18; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Stamatiou R, 2011, STEROIDS, V76, P400, DOI 10.1016/j.steroids.2010.12.010; Takahashi K, 2003, J ENDOCRINOL, V178, P319, DOI 10.1677/joe.0.1780319; Waladali W, 2009, WORLD J UROL, V27, P241, DOI 10.1007/s00345-008-0333-5; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Watanabe T, 2003, CARDIOVASC RES, V59, P734, DOI 10.1016/S0008-6363(03)00496-6; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	31	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41614	10.1371/journal.pone.0041614	http://dx.doi.org/10.1371/journal.pone.0041614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870237	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100024
J	Maddi, A; Dettman, A; Fu, C; Seiler, S; Free, SJ				Maddi, Abhiram; Dettman, Anne; Fu, Ci; Seiler, Stephan; Free, Stephen J.			WSC-1 and HAM-7 Are MAK-1 MAP Kinase Pathway Sensors Required for Cell Wall Integrity and Hyphal Fusion in Neurospora crassa	PLOS ONE			English	Article							FILAMENTOUS FUNGUS; SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; PROTEIN-KINASES; STRESS SENSORS; GROWTH; IDENTIFICATION; BIOSYNTHESIS; BIOGENESIS; BEHAVIOR	A large number of cell wall proteins are encoded in the Neurospora crassa genome. Strains carrying gene deletions of 65 predicted cell wall proteins were characterized. Deletion mutations in two of these genes (wsc-1 and ham-7) have easily identified morphological and inhibitor-based defects. Their phenotypic characterization indicates that HAM-7 and WSC-1 function during cell-to-cell hyphal fusion and in cell wall integrity maintenance, respectively. wsc-1 encodes a transmembrane protein with extensive homology to the yeast Wsc family of sensor proteins. In N. crassa, WSC-1 (and its homolog WSC-2) activates the cell wall integrity MAK-1 MAP kinase pathway. The GPI-anchored cell wall protein HAM-7 is required for cell-to-cell fusion and the sexual stages of the N. crassa life cycle. Like WSC-1, HAM-7 is required for activating MAK-1. A Delta wsc-1; Delta ham-7 double mutant fully phenocopies mutants lacking components of the MAK-1 MAP kinase cascade. The data identify WSC-1 and HAM-7 as the major cell wall sensors that regulate two distinct MAK-1-dependent cellular activities, cell wall integrity and hyphal anastomosis, respectively.	[Maddi, Abhiram; Fu, Ci; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Maddi, Abhiram] SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA; [Dettman, Anne; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Gottingen	Maddi, A (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sseiler@gwdg.de; free@buffalo.edu	Maddi, Abhiram/B-3895-2018; Maddi, Abhiram/L-1696-2019	Maddi, Abhiram/0000-0001-9565-408X; Maddi, Abhiram/0000-0001-9565-408X	National Institutes of Health [R01 GM078589]; Deutsche Forschungsgesellschaft [SE1054/4-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R01 GM078589 from the National Institutes of Health (to SF) and SE1054/4-1 from the Deutsche Forschungsgesellschaft (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Bowman SM, 2005, MYCOLOGIA, V97, P872, DOI 10.3852/mycologia.97.4.872; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dupres V, 2009, NAT CHEM BIOL, V5, P857, DOI 10.1038/nchembio.220; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fleissner Andre, 2008, V475, P21, DOI 10.1007/978-1-59745-250-2_2; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Futagami T, 2011, EUKARYOT CELL, V10, P1504, DOI 10.1128/EC.05080-11; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Goryachev AB, 2012, BIOESSAYS, V34, P259, DOI 10.1002/bies.201100135; Heinisch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011104; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kothe GO, 1998, GENETICS, V149, P117; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Maerz S, 2008, GENETICS, V179, P1313, DOI 10.1534/genetics.108.089425; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Richthammer C, 2012, MOL MICROBI IN PRESS; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Xiang QJ, 2002, GENETICS, V160, P169	53	45	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42374	10.1371/journal.pone.0042374	http://dx.doi.org/10.1371/journal.pone.0042374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879952	gold, Green Published			2022-12-25	WOS:000307284100073
J	Peng, RH; Tian, YS; Xiong, AS; Zhao, W; Fu, XY; Han, HJ; Chen, C; Jin, XF; Yao, QH				Peng, Ri-He; Tian, Yong-Sheng; Xiong, Ai-Sheng; Zhao, Wei; Fu, Xiao-Yan; Han, Hong-Juan; Chen, Chen; Jin, Xiao-Fen; Yao, Quan-Hong			A Novel 5-Enolpyruvylshikimate-3-Phosphate Synthase from Rahnella aquatilis with Significantly Reduced Glyphosate Sensitivity	PLOS ONE			English	Article							3-PHOSPHATE SYNTHASE; 5-ENOPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; SHIKIMATE 3-PHOSPHATE; HERBICIDE GLYPHOSATE; CATALYTIC RESIDUES; STRUCTURAL BASIS; HIGH TOLERANCE; RESISTANCE; GENE; AROA	The 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS; EC 2.5.1.19) is a key enzyme in the shikimate pathway for the production of aromatic amino acids and chorismate-derived secondary metabolites in plants, fungi, and microorganisms. It is also the target of the broad-spectrum herbicide glyphosate. Natural glyphosate resistance is generally thought to occur within microorganisms in a strong selective pressure condition. Rahnella aquatilis strain GR20, an antagonist against pathogenic agrobacterial strains of grape crown gall, was isolated from the rhizosphere of grape in glyphosate-contaminated vineyards. A novel gene encoding EPSPS was identified from the isolated bacterium by complementation of an Escherichia coli auxotrophic aroA mutant. The EPSPS, named AroA(R.aquatilis), was expressed and purified from E. coli, and key kinetic values were determined. The full-length enzyme exhibited higher tolerance to glyphosate than the E. coli EPSPS (AroA(E.coli)), while retaining high affinity for the substrate phosphoenolpyruvate. Transgenic plants of AroA(R.aquatilis) were also observed to be more resistant to glyphosate at a concentration of 5 mM than that of AroA(E.coli). To probe the sites contributing to increased tolerance to glyphosate, mutant R. aquatilis EPSPS enzymes were produced with the c-strand of subdomain 3 and the f-strand of subdomain 5 (Thr38Lys, Arg40Val, Arg222Gln, Ser224Val, Ile225Val, and Gln226Lys) substituted by the corresponding region of the E. coli EPSPS. The mutant enzyme exhibited greater sensitivity to glyphosate than the wild type R. aquatilis EPSPS with little change of affinity for its first substrate, shikimate-3-phosphate (S3P) and phosphoenolpyruvate (PEP). The effect of the residues on subdomain 5 on glyphosate resistance was more obvious.	[Peng, Ri-He; Tian, Yong-Sheng; Xiong, Ai-Sheng; Zhao, Wei; Fu, Xiao-Yan; Han, Hong-Juan; Chen, Chen; Jin, Xiao-Fen; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Peng, RH (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China.	yaoquanhong_sh@yahoo.com.cn		Xiong, Ai-Sheng/0000-0002-7900-5001	Key Project Fund of the Shanghai Municipal Committee of Agriculture [2009-6-4, 2011-1-8]; International Scientific and Technological Cooperation [2010DFA62320, 11230705900]; National Natural Science Foundation [31071486]	Key Project Fund of the Shanghai Municipal Committee of Agriculture; International Scientific and Technological Cooperation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The research was supported by the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2009-6-4) and The Key Project Fund of the Shanghai Municipal Committee of Agriculture (No. 2011-1-8) and International Scientific and Technological Cooperation (2010DFA62320, 11230705900) and National Natural Science Foundation (31071486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel F, 1997, SHORT PROTOCOLS MOL; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Berti PJ, 2009, BIOCHEMISTRY-US, V48, P3699, DOI 10.1021/bi802251s; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Farmer JJ, 1986, BERGEYS MANUAL SYSTE, V1, P506; Franz JE, 1997, AM CHEM SOC MONOGRAP, V189; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; He M, 2001, BBA-GEN SUBJECTS, V1568, P1, DOI 10.1016/S0304-4165(01)00181-7; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li L, 2009, J BIOTECHNOL, V144, P330, DOI 10.1016/j.jbiotec.2009.09.014; Marzabadi MR, 1996, BIOCHEMISTRY-US, V35, P4199, DOI 10.1021/bi9521349; McDowell LM, 1996, J MOL BIOL, V256, P160, DOI 10.1006/jmbi.1996.0074; Mizyed S, 2003, BIOCHEMISTRY-US, V42, P6986, DOI 10.1021/bi027217l; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OPHEL K, 1990, INT J SYST BACTERIOL, V40, P236, DOI 10.1099/00207713-40-3-236; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; STALLINGS WC, 1991, P NATL ACAD SCI USA, V88, P5046, DOI 10.1073/pnas.88.11.5046; Stauffer ME, 2001, FEBS LETT, V499, P182, DOI 10.1016/S0014-5793(01)02555-8; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sun YC, 2005, APPL ENVIRON MICROB, V71, P4771, DOI 10.1128/AEM.71.8.4771-4776.2005; Tian YS, 2012, APPL MICROBIOL BIOT, V93, P241, DOI 10.1007/s00253-011-3443-8; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Xie X. M., 1993, Acta Phytopathologica Sinica, V23, P137; Xue Y, 2009, J PLANT PHYSIOL, V166, P844, DOI 10.1016/j.jplph.2008.11.013; [No title captured], Patent No. 6040497	36	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39579	10.1371/journal.pone.0039579	http://dx.doi.org/10.1371/journal.pone.0039579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870190	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100004
J	Gates, TA; Prieto-Marquez, A; Zanno, LE				Gates, Terry A.; Prieto-Marquez, Albert; Zanno, Lindsay E.			Mountain Building Triggered Late Cretaceous North American Megaherbivore Dinosaur Radiation	PLOS ONE			English	Article							KAIPAROWITS FORMATION; HADROSAURIAN DINOSAUR; PARK FORMATION; SOUTHERN UTAH; BIOGEOGRAPHY; DIVERSITY; HISTORY; DYNAMICS; PLANT; ORNITHISCHIA	Prior studies of Mesozoic biodiversity document a diversity peak for dinosaur species in the Campanian stage of the Late Cretaceous, yet have failed to provide explicit causal mechanisms. We provide evidence that a marked increase in North American dinosaur biodiversity can be attributed to dynamic orogenic episodes within the Western Interior Basin (WIB). Detailed fossil occurrences document an association between the shift from Sevier-style, latitudinally arrayed basins to smaller Laramide-style, longitudinally arrayed basins and a well substantiated decreased geographic range/increased taxonomic diversity of megaherbivorous dinosaur species. Dispersal-vicariance analysis demonstrates that the nearly identical biogeographic histories of the megaherbivorous dinosaur clades Ceratopsidae and Hadrosauridae are attributable to rapid diversification events within restricted basins and that isolation events are contemporaneous with known tectonic activity in the region. SYMMETREE analysis indicates that megaherbivorous dinosaur clades exhibited significant variation in diversification rates throughout the Late Cretaceous. Phylogenetic divergence estimates of fossil clades offer a new lower boundary on Laramide surficial deformation that precedes estimates based on sedimentological data alone.	[Gates, Terry A.] Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA; [Gates, Terry A.; Zanno, Lindsay E.] N Carolina State Univ, Raleigh, NC 27695 USA; [Prieto-Marquez, Albert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Zanno, Lindsay E.] N Carolina Museum Nat, Nat Res Ctr, Raleigh, NC USA	University System of Ohio; Ohio University; University of North Carolina; North Carolina State University	Gates, TA (corresponding author), Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA.	terryagates@gmail.com	Prieto-Marquez, Albert/AAA-1470-2019	Prieto-Marquez, Albert/0000-0002-4836-4052	Alexander von Humboldt Foundation; National Science Foundation [EAR0959029]; Ministry of Education and Science of Spain [CGL2005-07878-C02-01]; North Carolina State University	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); Ministry of Education and Science of Spain(Spanish Government); North Carolina State University	The Alexander von Humboldt Foundation, the National Science Foundation (grant #EAR0959029 presented to G. Erickson and M. Norell), the Ministry of Education and Science of Spain (CGL2005-07878-C02-01 grant presented to A. Galobart), and North Carolina State University provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Butler RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1165, DOI 10.1098/rspb.2010.1754; Campione N, 2010, J VERTEBRATE PALE S3, V30, p69A; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Cather SM., 2004, GEOLOGY NEW MEXICO G, P203; CERVENY PF, 1993, TECTONICS, V12, P77, DOI 10.1029/92TC01567; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Crowley PD, 2002, GEOLOGY, V30, P27, DOI 10.1130/0091-7613(2002)030<0027:LEOTBM>2.0.CO;2; DECELLES PG, 1986, GEOL SOC AM BULL, V97, P911, DOI 10.1130/0016-7606(1986)97<911:SIATPN>2.0.CO;2; Dickinson W.R., 1978, LARAMIDE FOLDING ASS, V151, P355, DOI DOI 10.1130/MEM151-P355; Dickinson W.R., 1989, GEOLOGIC EVOLUTION A, V17, P447; DODSON P, 1990, P NATL ACAD SCI USA, V87, P7608, DOI 10.1073/pnas.87.19.7608; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2009, CAN J EARTH SCI, V46, P791, DOI 10.1139/E09-050; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Finarelli JA, 2010, P ROY SOC B-BIOL SCI, V277, P2721, DOI 10.1098/rspb.2010.0348; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, ADV LATE CR IN PRESS; Gates T, 2009, J VERTEBR PALEONTOL, V29, p103A; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Horner J.R., 1989, Montana Geological Society Field Conference Guidebook, V1, P153; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Horton BK, 2004, GEOLOGY, V32, P637, DOI 10.1130/G20407.1; Hunt Adrian P., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P383; Jacques-Ayala C, 1999, REV MEXICANA CIENCIA, V16, P97; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Johnson KR, 2002, GEOL S AM S, P503; Kirkland James I., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P299; Lawton T.F., 1986, PALEOTECTONICS SEDIM, V41, P423; Lawton T.F., 1983, LATE CRETACEOUS FLUV; Lawton TF, 2011, J SEDIMENT RES, V81, P495, DOI 10.2110/jsr.2011.45; Lawton TF, 2008, SEDIMENT BASIN WORLD, V5, P429, DOI 10.1016/S1874-5997(08)00012-9; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; Liu LJ, 2010, GEOLOGY, V38, P663, DOI 10.1130/G30624.1; Lomolino M. V., 2005, BIOGEOGRAPHY; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Lucas SG, 1990, CRETACEOUS RES, V11, P1; Lucas Spencer G., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P293; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; McMillan NJ, 2000, NEW MEX GEOL SOC GUI, P149; Mederos S., 2005, ROCKY MOUNTAIN GEOLO, V40, P167, DOI [10.2113/40.2.167, DOI 10.2113/40.2.167]; MILLER AI, 1995, GEOLOGY, V23, P305, DOI 10.1130/0091-7613(1995)023<0305:AOOAWT>2.3.CO;2; NEILSON RP, 1986, SCIENCE, V232, P27, DOI 10.1126/science.232.4746.27; NORELL MA, 1993, AM J SCI, V293A, P407, DOI 10.2475/ajs.293.A.407; OSTROM JH, 1961, J PALEONTOL, V35, P575; Perry Jr W. J., 1988, INTERACTION ROCKY MO, V171, P267, DOI [10.1130/MEM171-p267, DOI 10.1130/MEM171-P267]; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; RENNE PR, 1991, GEOPHYS RES LETT, V18, P459, DOI 10.1029/91GL00464; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Ryan MJ, 2005, LIFE O PAST, P312; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Sullivan RM, 1999, NEW SKULL PARASAUROL; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; URBAN DL, 1987, BIOSCIENCE, V37, P119, DOI 10.2307/1310366; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Wagner JR, 2001, THESIS TEXAS TU; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487	88	58	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42135	10.1371/journal.pone.0042135	http://dx.doi.org/10.1371/journal.pone.0042135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876302	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700030
J	Ockinger, E; Van Dyck, H				Ockinger, Erik; Van Dyck, Hans			Landscape Structure Shapes Habitat Finding Ability in a Butterfly	PLOS ONE			English	Article							LEVEL PERCEPTUAL ABILITIES; LIFE-HISTORY TRAITS; FRAGMENTATION; CONNECTIVITY; MOVEMENTS; BEHAVIOR; RANGE; ORIENTATION; DISPERSAL; EVOLUTION	Land-use intensification and habitat fragmentation is predicted to impact on the search strategies animals use to find habitat. We compared the habitat finding ability between populations of the speckled wood butterfly (Pararge aegeria L.) from landscapes that differ in degree of habitat fragmentation. Naive butterflies reared under standardized laboratory conditions but originating from either fragmented agricultural landscapes or more continuous forested landscapes were released in the field, at fixed distances from a target habitat patch, and their flight paths were recorded. Butterflies originating from fragmented agricultural landscapes were better able to find a woodlot habitat from a distance compared to conspecifics from continuous forested landscapes. To manipulate the access to olfactory information, a subset of individuals from both landscape types were included in an antennae removal experiment. This confirmed the longer perceptual range for butterflies from agricultural landscapes and indicated the significance of both visual and olfactory information for orientation towards habitat. Our results are consistent with selection for increased perceptual range in fragmented landscapes to reduce dispersal costs. An increased perceptual range will alter the functional connectivity and thereby the chances for population persistence for the same level of structural connectivity in a fragmented landscape.	[Ockinger, Erik] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Ockinger, Erik; Van Dyck, Hans] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-3000 Louvain, Belgium	Swedish University of Agricultural Sciences; Universite Catholique Louvain	Ockinger, E (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	hans.vandyck@uclouvain.be	Öckinger, Erik/F-4154-2010	Öckinger, Erik/0000-0001-7517-4505	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); UCL-Academie Louvain (ARC) [10/15-031]; FNRS (FRFC) [2.4595.07]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); UCL-Academie Louvain (ARC); FNRS (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This study was funded by grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to EO and from UCL-Academie Louvain (ARC-grant no. 10/15-031) and FNRS (FRFC grant 2.4595.07) to HVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2003, J CHEM ECOL, V29, P2319, DOI 10.1023/A:1026278531806; [Anonymous], 2006, SAS MIXED MODELS; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Batschelet E, 1981, CIRCULAR STAT BIOL; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forero-Medina G, 2009, J TROP ECOL, V25, P53, DOI 10.1017/S0266467408005543; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Gibbs M, 2009, BEHAV ECOL SOCIOBIOL, V64, P1, DOI 10.1007/s00265-009-0849-8; Goodwin BJ, 1999, OIKOS, V84, P160, DOI 10.2307/3546877; Hein S, 2005, ECOL ENTOMOL, V30, P225, DOI 10.1111/j.0307-6946.2005.00680.x; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kovach WL, 2009, ORIANA CIRCULAR STAT; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Merckx T, 2006, FUNCT ECOL, V20, P436, DOI 10.1111/j.1365-2435.2006.01124.x; Merckx T, 2003, P ROY SOC B-BIOL SCI, V270, P1815, DOI 10.1098/rspb.2003.2459; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Omura H, 2009, CHEMOECOLOGY, V19, P227, DOI 10.1007/s00049-009-0024-8; Palmer SCF, 2011, METHODS ECOL EVOL, V2, P258, DOI 10.1111/j.2041-210X.2010.00073.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schooley RL, 2003, OIKOS, V102, P559, DOI 10.1034/j.1600-0706.2003.12490.x; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Vandewoestijne S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013810; Vuilleumier S, 2006, OIKOS, V113, P139, DOI 10.1111/j.0030-1299.2006.14405.x; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	36	22	23	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41517	10.1371/journal.pone.0041517	http://dx.doi.org/10.1371/journal.pone.0041517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870227	Green Submitted, gold, Green Published			2022-12-25	WOS:000307212800023
J	Pristera, A; Baker, MD; Okuse, K				Pristera, Alessandro; Baker, Mark D.; Okuse, Kenji			Association between Tetrodotoxin Resistant Channels and Lipid Rafts Regulates Sensory Neuron Excitability	PLOS ONE			English	Article							MECHANOSENSITIVE ION CHANNELS; MEMBRANE-PROTEIN FUNCTION; PRIMARY AFFERENT NEURONS; GATED SODIUM-CHANNELS; DRG NEURONS; ANNEXIN-II; IN-VITRO; PAIN; DOMAINS; AXONS	Voltage-gated sodium channels (VGSCs) play a key role in the initiation and propagation of action potentials in neurons. Na(V)1.8 is a tetrodotoxin (TTX) resistant VGSC expressed in nociceptors, peripheral small-diameter neurons able to detect noxious stimuli. Na(V)1.8 underlies the vast majority of sodium currents during action potentials. Many studies have highlighted a key role for Na(V)1.8 in inflammatory and chronic pain models. Lipid rafts are microdomains of the plasma membrane highly enriched in cholesterol and sphingolipids. Lipid rafts tune the spatial and temporal organisation of proteins and lipids on the plasma membrane. They are thought to act as platforms on the membrane where proteins and lipids can be trafficked, compartmentalised and functionally clustered. In the present study we investigated Na(V)1.8 sub-cellular localisation and explored the idea that it is associated with lipid rafts in nociceptors. We found that Na(V)1.8 is distributed in clusters along the axons of DRG neurons in vitro and ex vivo. We also demonstrated, by biochemical and imaging studies, that Na(V)1.8 is associated with lipid rafts along the sciatic nerve ex vivo and in DRG neurons in vitro. Moreover, treatments with methyl-beta-cyclodextrin (M beta CD) and 7-ketocholesterol (7KC) led to the dissociation between rafts and Na(V)1.8. By calcium imaging we demonstrated that the lack of association between rafts and Na(V)1.8 correlated with impaired neuronal excitability, highlighted by a reduction in the number of neurons able to conduct mechanically- and chemically-evoked depolarisations. These findings reveal the sub-cellular localisation of Na(V)1.8 in nociceptors and highlight the importance of the association between Na(V)1.8 and lipid rafts in the control of nociceptor excitability.	[Pristera, Alessandro; Okuse, Kenji] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London, England; [Baker, Mark D.] Univ London, Blizard Inst, Neurosci & Trauma Ctr, Barts, England; [Baker, Mark D.] London Sch Med & Dent, London, England	Imperial College London; University of London; University of London; Queen Mary University London	Pristera, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London, England.	k.okuse@imperial.ac.uk			Wellcome Trust; Wellcome Trust UK [080958/Z/06/Z, 083259/C/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust UK(Wellcome Trust)	This work was supported by the Wellcome Trust. AP and KO are members of the Wellcome Trust London Pain Consortium.; This work was supported by the Wellcome Trust UK (080958/Z/06/Z and 083259/C/07/Z), and AP and KO are members of London Pain Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Black JA, 2002, EXP EYE RES, V75, P193, DOI 10.1006/exer.2002.2014; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2009, EMBO J, V28, P1378, DOI 10.1038/emboj.2009.105; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; ENGLAND JD, 1990, P NATL ACAD SCI USA, V87, P6777, DOI 10.1073/pnas.87.17.6777; Fang X, 2002, J NEUROSCI, V22, P7425; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gold MS, 2003, J NEUROSCI, V23, P158; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Hering H, 2003, J NEUROSCI, V23, P3262; Hille B, 2001, ION CHANNELS EXCITAB, Vxviii, P814; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; KANDEL ER, 2000, PRINCIPLES NEURAL SC, pR41; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MEIRI H, 1985, BRAIN RES, V359, P326, DOI 10.1016/0006-8993(85)91444-1; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Pristera A, 2011, NEUROSCIENTIST; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Rush AM, 2005, EUR J NEUROSCI, V22, P39, DOI 10.1111/j.1460-9568.2005.04186.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SMITH KJ, 1982, J NEUROL SCI, V54, P13, DOI 10.1016/0022-510X(82)90215-5; Swanwick RS, 2010, NEUROSCI LETT, V486, P78, DOI 10.1016/j.neulet.2010.08.074; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Usoskin D, 2010, P NATL ACAD SCI USA, V107, P16336, DOI 10.1073/pnas.0914705107; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Waxman Stephen G., 1995; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	94	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40079	10.1371/journal.pone.0040079	http://dx.doi.org/10.1371/journal.pone.0040079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870192	Green Published, gold			2022-12-25	WOS:000307212800003
J	Schmidt, CM; Hood, WR				Schmidt, Christina M.; Hood, Wendy R.			Calcium Availability Influences Litter Size and Sex Ratio in White-Footed Mice (Peromyscus leucopus)	PLOS ONE			English	Article							COLUMBIAN GROUND-SQUIRRELS; BIG BROWN BATS; MATERNAL DIET; BONE METABOLISM; LIFE-HISTORY; OOCYTE ACTIVATION; BODY-COMPOSITION; SKELETAL MASS; PREGNANCY; LACTATION	The production of offspring typically requires investment of resources derived from both the environment and maternal somatic reserves. As such, the availability of either of these types of resources has the potential to limit the degree to which resources are allocated to reproduction. Theory and empirical studies have argued that mothers modify reproductive performance relative to exogenous resource availability and maternal condition by adjusting size, number or sex of offspring produced. These relationships have classically been defined relative to availability of energy sources; however, in vertebrates, calcium also plays a critical role in offspring production, as a considerable amount of calcium is required to support the development of offspring skeleton(s). We tested whether the availability of calcium influences reproductive output by providing female white-footed mice with a low-calcium or standard diet from reproductive maturity to senescence. We then compared maternal skeletal condition and reproductive output, based on offspring mass, offspring number and litter sex ratio, between dietary treatments. Mothers on the low-calcium diet exhibited diminished skeletal condition at senescence and produced smaller and strongly female-biased litters. We show that skeletal condition and calcium intake can influence sex ratio and reproductive output following general theoretical models of resource partitioning during reproduction.	[Schmidt, Christina M.; Hood, Wendy R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Schmidt, CM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ossavolatus@gmail.com	Schmidt, Christina/A-7711-2013	Schmidt, Christina/0000-0003-4627-8326; Hood, Wendy/0000-0002-8398-3908	American Society of Mammalogists; Society for Integrative and Comparative Biology; Auburn University College of Science and Mathematics	American Society of Mammalogists; Society for Integrative and Comparative Biology; Auburn University College of Science and Mathematics	The project was funded by grants-in-aid of research from the American Society of Mammalogists (http://www.mammalsociety.org) and the Society for Integrative and Comparative Biology (http://www.sicb.org) awarded to CMS as well as through start up funding provided to WRH from the Auburn University College of Science and Mathematics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; BIRD E, 1986, PHYSIOL BEHAV, V36, P307, DOI 10.1016/0031-9384(86)90021-1; Boelter MDD, 1943, J NUTR, V26, P105, DOI 10.1093/jn/26.2.105; Booher CM, 2008, J ZOOL, V274, P38, DOI 10.1111/j.1469-7998.2007.00354.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowman B. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P347; Bowman BM, 1999, BONE, V25, P553, DOI 10.1016/S8756-3282(99)00204-5; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Charnov EL, 2007, AM NAT, V170, pE129, DOI 10.1086/522840; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; COLE FR, 1978, J MAMMAL, V59, P809, DOI 10.2307/1380145; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; CURREY JD, 1969, J BIOMECH, V2, P1, DOI 10.1016/0021-9290(69)90036-0; CUTHBERTSON KSR, 1981, NATURE, V294, P754, DOI 10.1038/294754a0; Dama MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016296; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DOBSON FS, 1985, CAN J ZOOL, V63, P2105, DOI 10.1139/z85-309; DOBSON FS, 1995, ECOLOGY, V76, P851, DOI 10.2307/1939350; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; GOUNDIE TR, 1986, J MAMMAL, V67, P53, DOI 10.2307/1381001; Graveland J, 1996, OECOLOGIA, V105, P351, DOI 10.1007/BF00328738; GRUBER HE, 1994, BONE, V15, P167, DOI 10.1016/8756-3282(94)90704-8; Hanover JA, 2009, J BIOL CHEM, V284, P12593, DOI 10.1074/jbc.R800076200; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Heytens E, 2008, REPROD BIOMED ONLINE, V17, P764, DOI 10.1016/S1472-6483(10)60403-8; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hood WR, 2006, J COMP PHYSIOL B, V176, P807, DOI 10.1007/s00360-006-0102-y; Johnson LE, 2002, J NUTR, V132, P2270, DOI 10.1093/jn/132.8.2270; Jones G, 2000, EUR J CLIN NUTR, V54, P749, DOI 10.1038/sj.ejcn.1601082; Kalkwarf HJ, 2002, ENDOCRINE, V17, P49, DOI 10.1385/ENDO:17:1:49; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; KOJOLA I, 1989, EVOLUTION, V43, P1331, DOI [10.2307/2409370, 10.1111/j.1558-5646.1989.tb02582.x]; Koo WWK, 1999, OBSTET GYNECOL, V94, P577, DOI 10.1016/S0029-7844(99)00371-3; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Liesegang A, 2007, J ANIM PHYSIOL AN N, V91, P217, DOI 10.1111/j.1439-0396.2007.00695.x; Miller SC, 2005, BIOL REPROD, V73, P156, DOI 10.1095/biolreprod.105.039610; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Oftedal O.T., 1984, Symposia of the Zoological Society of London, P33; ONO KA, 1987, BEHAV ECOL SOCIOBIOL, V21, P109, DOI 10.1007/BF02395438; Ott SM, 1999, J BONE MINER RES, V14, P1779, DOI 10.1359/jbmr.1999.14.10.1779; Patten MA, 2007, J AVIAN BIOL, V38, P637, DOI 10.1111/j.2007.0908-8857.04203.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; RAMAN L, 1978, AM J CLIN NUTR, V31, P466, DOI 10.1093/ajcn/31.3.466; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Schmidt CM, 2011, EFFECTS DIETARY SKEL; Skibiel AL, 2009, ECOL MONOGR, V79, P325, DOI 10.1890/08-0718.1; SKOGLAND T, 1986, OIKOS, V46, P417, DOI 10.2307/3565843; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Spiller C, 2009, BIOL CELL, V101, P587, DOI 10.1042/BC20090021; STUDIER EH, 1995, J MAMMAL, V76, P32, DOI 10.2307/1382312; TERMAN CR, 1967, J MAMMAL, V48, P589, DOI 10.2307/1377582; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WAUTERS LA, 1995, BEHAV ECOL SOCIOBIOL, V37, P189, DOI 10.1007/s002650050180; Wysolmerski JJ, 2010, ANN NY ACAD SCI, V1192, P161, DOI 10.1111/j.1749-6632.2009.05249.x; Yin J, 2010, EUR J CLIN NUTR, V64, P131, DOI 10.1038/ejcn.2009.117; Zeni S, 2003, CALCIFIED TISSUE INT, V73, P594, DOI 10.1007/s00223-002-1093-7	66	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41402	10.1371/journal.pone.0041402	http://dx.doi.org/10.1371/journal.pone.0041402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870218	Green Published, Green Submitted			2022-12-25	WOS:000307212800018
J	Harris, CA; Buckley, CL; Nowotny, T; Passaro, PA; Seth, AK; Kemenes, G; O'Shea, M				Harris, Christopher A.; Buckley, Christopher L.; Nowotny, Thomas; Passaro, Peter A.; Seth, Anil K.; Kemenes, Gyoergy; O'Shea, Michael			Multi-Neuronal Refractory Period Adapts Centrally Generated Behaviour to Reward	PLOS ONE			English	Article							CEREBRAL GIANT-CELLS; SNAIL LYMNAEA-STAGNALIS; DEVELOPING SPINAL-CORD; POND SNAIL; FEEDING SYSTEM; MODULATORY ROLE; MOTOR PATTERN; NETWORK; INTERNEURONS; DOPAMINE	Oscillating neuronal circuits, known as central pattern generators (CPGs), are responsible for generating rhythmic behaviours such as walking, breathing and chewing. The CPG model alone however does not account for the ability of animals to adapt their future behaviour to changes in the sensory environment that signal reward. Here, using multi-electrode array (MEA) recording in an established experimental model of centrally generated rhythmic behaviour we show that the feeding CPG of Lymnaea stagnalis is itself associated with another, and hitherto unidentified, oscillating neuronal population. This extra-CPG oscillator is characterised by high population-wide activity alternating with population-wide quiescence. During the quiescent periods the CPG is refractory to activation by food-associated stimuli. Furthermore, the duration of the refractory period predicts the timing of the next activation of the CPG, which may be minutes into the future. Rewarding food stimuli and dopamine accelerate the frequency of the extra-CPG oscillator and reduce the duration of its quiescent periods. These findings indicate that dopamine adapts future feeding behaviour to the availability of food by significantly reducing the refractory period of the brain's feeding circuitry.	[Harris, Christopher A.; Kemenes, Gyoergy; O'Shea, Michael] Univ Sussex, Sussex Ctr Neurosci, Sch Life Sci, Brighton, E Sussex, England; [Buckley, Christopher L.; Nowotny, Thomas; Passaro, Peter A.; Seth, Anil K.] Univ Sussex, Sch Engn & Informat, Brighton, E Sussex, England; [Seth, Anil K.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England	University of Sussex; University of Sussex; University of Sussex	Harris, CA (corresponding author), Univ Sussex, Sussex Ctr Neurosci, Sch Life Sci, Brighton, E Sussex, England.	C.A.Harris@sussex.ac.uk; M.O-Shea@sussex.ac.uk	Seth, Anil/AAE-8499-2019; Kemenes, George/L-4910-2019; Nowotny, Thomas/C-3883-2012	Seth, Anil/0000-0002-1421-6051; Kemenes, George/0000-0003-2004-8725; Nowotny, Thomas/0000-0002-4451-915X; Harris, Christopher/0000-0003-4791-1496; Buckley, Christopher L/0000-0002-8551-9121	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H009906/1]; BBSRC Studentship; Engineering and Physical Sciences Research Council [EP/G007543/1]; BBSRC [BB/H009906/1] Funding Source: UKRI; EPSRC [EP/G007543/1] Funding Source: UKRI; MRC [G0400551] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009906/1] Funding Source: researchfish; Medical Research Council [G0400551] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk) grant BB/H009906/1 and BBSRC Studentship to C.A. Harris and the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant EP/G007543/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1984, J NEUROBIOL, V15, P67, DOI 10.1002/neu.480150107; ASCHER P, 1972, J PHYSIOL-LONDON, V225, P173, DOI 10.1113/jphysiol.1972.sp009933; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; ELEKES K, 1991, J COMP NEUROL, V307, P214, DOI 10.1002/cne.903070205; ELLIOTT CJH, 1985, J NEUROPHYSIOL, V54, P1412, DOI 10.1152/jn.1985.54.6.1412; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; GROSS GW, 1979, IEEE T BIO-MED ENG, V26, P273, DOI 10.1109/TBME.1979.326402; Harris CA, 2010, J NEUROSCI METH, V186, P171, DOI 10.1016/j.jneumeth.2009.11.014; KEMENES G, 1986, J EXP BIOL, V122, P113; KEMENES G, 1989, BEHAV NEURAL BIOL, V52, P260, DOI 10.1016/S0163-1047(89)90383-X; Kemenes G, 2001, J NEUROSCI, V21, P2903, DOI 10.1523/JNEUROSCI.21-08-02903.2001; Kemenes G, 2009, CURR BIOL, V19, pR9, DOI 10.1016/j.cub.2008.10.013; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Kojima S, 2000, NEUROSCIENCE, V100, P893, DOI 10.1016/S0306-4522(00)00338-9; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; KYRIAKIDES MA, 1989, J NEUROBIOL, V20, P635, DOI 10.1002/neu.480200704; LONDON JA, 1987, J NEUROSCI, V7, P649; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marra V, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00161; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; NOVAK JL, 1986, IEEE T BIO-MED ENG, V33, P196, DOI 10.1109/TBME.1986.325891; ROSE RM, 1979, J EXP BIOL, V80, P137; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Staras K, 1998, J NEUROSCI, V18, P3669; Straub VA, 2002, J NEUROPHYSIOL, V88, P1569, DOI 10.1152/jn.2002.88.4.1569; Streit J, 2006, ADV NETWORK ELECTROP, P377, DOI DOI 10.1007/0-387-25858-2_16; Tabak J, 2000, J NEUROSCI, V20, P3041; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; TUERSLEY MD, 1987, BEHAV NEURAL BIOL, V48, P222, DOI 10.1016/S0163-1047(87)90780-1; Vavoulis DV, 2007, EUR J NEUROSCI, V25, P2805, DOI 10.1111/j.1460-9568.2007.05517.x; Vehovszky A, 2001, J NEUROPHYSIOL, V86, P792, DOI 10.1152/jn.2001.86.2.792; WHITE NM, 1989, NEUROSCI BIOBEHAV R, V13, P181, DOI 10.1016/S0149-7634(89)80028-4; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; YEOMAN MS, 1994, J NEUROPHYSIOL, V72, P1372, DOI 10.1152/jn.1994.72.3.1372; Yeoman MS, 1996, J NEUROPHYSIOL, V75, P11, DOI 10.1152/jn.1996.75.1.11; YEOMAN MS, 1994, J NEUROPHYSIOL, V72, P1357, DOI 10.1152/jn.1994.72.3.1357	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42493	10.1371/journal.pone.0042493	http://dx.doi.org/10.1371/journal.pone.0042493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860134	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000307045600106
J	Ponsaerts, R; D'hondt, C; Hertens, F; Parys, JB; Leybaert, L; Vereecke, J; Himpens, B; Bultynck, G				Ponsaerts, Raf; D'hondt, Catheleyne; Hertens, Frederic; Parys, Jan B.; Leybaert, Luc; Vereecke, Johan; Himpens, Bernard; Bultynck, Geert			RhoA GTPase Switch Controls Cx43-Hemichannel Activity through the Contractile System	PLOS ONE			English	Article							INTERCELLULAR CALCIUM WAVE; THROMBIN-INDUCED INHIBITION; VASCULAR ENDOTHELIAL-CELLS; GAP-JUNCTION CHANNELS; ATP RELEASE; MYOSIN-II; MEMBRANE PERMEABILIZATION; CONNEXIN HEMICHANNELS; COMMUNICATION; MODULATION	ATP-dependent paracrine signaling, mediated via the release of ATP through plasma membrane-embedded hemichannels of the connexin family, coordinates a synchronized response between neighboring cells. Connexin 43 (Cx43) hemichannels that are present in the plasma membrane need to be tightly regulated to ensure cell viability. In monolayers of bovine corneal endothelial cells (BCEC),Cx43-mediated ATP release is strongly inhibited when the cells are treated with inflammatory mediators, in particular thrombin and histamine. In this study we investigated the involvement of RhoA activation in the inhibition of hemichannel-mediated ATP release in BCEC. We found that RhoA activation occurs rapidly and transiently upon thrombin treatment of BCEC. The RhoA activity correlated with the onset of actomyosin contractility that is involved in the inhibition of Cx43 hemichannels. RhoA activation and inhibition of Cx43-hemichannel activity were both prevented by pre-treatment of the cells with C3-toxin as well as knock down of RhoA by siRNA. These findings provide evidence that RhoA activation is a key player in thrombin-induced inhibition of Cx43-hemichannel activity. This study demonstrates that RhoA GTPase activity is involved in the acute inhibition of ATP-dependent paracrine signaling, mediated by Cx43 hemichannels, in response to the inflammatory mediator thrombin. Therefore, RhoA appears to be an important molecular switch that controls Cx43 hemichannel openings and hemichannel-mediated ATP-dependent paracrine intercellular communication under (patho) physiological conditions of stress.	[Ponsaerts, Raf; D'hondt, Catheleyne; Hertens, Frederic; Parys, Jan B.; Vereecke, Johan; Himpens, Bernard; Bultynck, Geert] Katholieke Univ Leuven, Fac Med, Campus Gasthuisberg ON 1, Lab Mol & Cellular Signaling,Dept Cellular & Mol, Louvain, Belgium; [Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Physiol Grp, Dept Basic Med Sci, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Ponsaerts, R (corresponding author), Katholieke Univ Leuven, Fac Med, Campus Gasthuisberg ON 1, Lab Mol & Cellular Signaling,Dept Cellular & Mol, Louvain, Belgium.	raf.ponsaerts@med.kuleuven.be; geert.bultynck@med.kuleuven.be	Leybaert, Luc/F-4079-2015	Leybaert, Luc/0000-0001-6452-6982; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Foundation - Flanders [G.0545.08, G.0298.11]; Interuniversity Attraction Poles Program (Belgian Science Policy) [P6/28]	Research Foundation - Flanders(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office)	The work was supported by grants from the Research Foundation - Flanders (G.0545.08 to B.H. and J.V.; G.0298.11 to G. B and L. L.) and the Interuniversity Attraction Poles Program (Belgian Science Policy; P6/28 to G.B., J.B.P. and B. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Blum AE, 2010, AM J PHYSIOL-CELL PH, V298, pC386, DOI 10.1152/ajpcell.00430.2009; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P1518, DOI 10.1167/iovs.06-1062; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Goedecke S, 2011, AM J PHYSL CELL PHYS; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P104, DOI 10.1167/iovs.04-0846; Gomes P, 2006, EXP EYE RES, V83, P1225, DOI 10.1016/j.exer.2006.06.012; Iyer S, 2007, COMPUT METH PROG BIO, V85, P203, DOI 10.1016/j.cmpb.2006.11.004; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2010, J PHYSIOL-LONDON, V588, P2255, DOI 10.1113/jphysiol.2009.186643; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Ponsaerts R, 2012, BIOL CELL; PONSAERTS R, 2010, SPRINGER SCI, P161, DOI DOI 10.1007/978-90-481-3435-9_10; Ponsaerts R, 2008, INVEST OPHTH VIS SCI, V49, P4816, DOI 10.1167/iovs.07-1533; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Satpathy M, 2004, EXP EYE RES, V79, P477, DOI 10.1016/j.exer.2004.06.018; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; Stehberg J, 2012, FASEB J; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x	34	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42074	10.1371/journal.pone.0042074	http://dx.doi.org/10.1371/journal.pone.0042074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860057	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950900064
J	Yang, Q; Liao, L; Deng, X; Chen, R; Gray, NS; Yates, JR; Lee, JD				Yang, Q.; Liao, L.; Deng, X.; Chen, R.; Gray, N. S.; Yates, J. R., III; Lee, J. D.			BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction	ONCOGENE			English	Article						BMK1; PML; p53	HUMAN-PAPILLOMAVIRUS TYPE-16; MAMMALIAN MAP KINASE; PREMATURE SENESCENCE; SIGNAL-TRANSDUCTION; CUTANEOUS MELANOMA; CELL-PROLIFERATION; GENE-EXPRESSION; E6 ONCOPROTEIN; ONCOGENIC RAS; GROWTH-FACTOR	Promyelocytic leukemia protein (PML) modulates the p53 tumor suppressor through its interaction with p53 and MDM2. We found that activated big MAP kinase 1 (BMK1) preferentially associates with PML isoform IV and disrupts PML-MDM2 interaction. Doxorubicin, a common chemotherapeutic agent, is known to promote PML-mediated p53 activation in part by promoting PML-dependent MDM2 nucleolar sequestration. We discovered that BMK1 deactivation coupled with doxorubicin synergistically enhanced MDM2 nucleolar sequestration and, consequently, promoted PML-mediated p53 upregulation leading to tumor cell apoptosis in vitro and tumor regression in vivo. Collectively, these results not only suggest that BMK1 activity has a role in suppressing p53 by blocking the interaction between PML and MDM2, but also implicate that pharmacological BMK1 inhibitor should significantly enhance the anticancer capacity of doxorubicin-based chemotherapy.	[Yang, Q.; Chen, R.; Lee, J. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Liao, L.; Yates, J. R., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Deng, X.; Gray, N. S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jdlee@scripps.edu	Yang, Qingkai/AAK-5111-2021	Yang, Qingkai/0000-0001-6628-5393; Deng, Xianming/0000-0002-9354-5864	National Institutes of Health [CA079871, CA114059]; University of California [19XT-0084]; NATIONAL CANCER INSTITUTE [R01CA114059, R01CA079871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Giovanni Blandino, Dr Myung Kim and Dr Pier Paolo Pandolfi for generously providing the PML null and control cell lines. This work was supported by the National Institutes of Health [CA079871 and CA114059 to JDL] and by the funds from the Tobacco-Related Disease, Research Program of the University of California [19XT-0084 to JDL].	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Beech SJ, 2005, EXP CELL RES, V307, P109, DOI 10.1016/j.yexcr.2005.03.012; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bisht S, 2009, WIRES NANOMED NANOBI, V1, P415, DOI 10.1002/wnan.43; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Ferbeyre G, 2000, GENE DEV, V14, P2015; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Haluska FG, 1998, J CLIN ONCOL, V16, P670, DOI 10.1200/JCO.1998.16.2.670; Hayashi M, 2005, CANCER RES, V65, P7699, DOI 10.1158/0008-5472.CAN-04-4540; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Polsky D, 2001, CANCER RES, V61, P7642; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Weldon CB, 2002, SURGERY, V132, P293, DOI 10.1067/msy.2002.125389; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zhu HY, 2003, J BIOL CHEM, V278, P49286, DOI 10.1074/jbc.M308302200	37	30	33	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3156	3164		10.1038/onc.2012.332	http://dx.doi.org/10.1038/onc.2012.332			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22869143	Green Accepted			2022-12-25	WOS:000321004600006
J	Hulf, T; Sibbritt, T; Wiklund, ED; Patterson, K; Song, JZ; Stirzaker, C; Qu, W; Nair, S; Horvath, LG; Armstrong, NJ; Kench, JG; Sutherland, RL; Clark, SJ				Hulf, T.; Sibbritt, T.; Wiklund, E. D.; Patterson, K.; Song, J. Z.; Stirzaker, C.; Qu, W.; Nair, S.; Horvath, L. G.; Armstrong, N. J.; Kench, J. G.; Sutherland, R. L.; Clark, S. J.			Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer	ONCOGENE			English	Article						microRNA; miR-205; MED1; epigenetics; prostate cancer	ANDROGEN RECEPTOR; EXPRESSION PROFILES; COREGULATORY ROLE; MEDIATOR COMPLEX; LUNG-CANCER; GENE; MIR-205; OVEREXPRESSION; PROLIFERATION; DEREGULATION	Deregulation of microRNA (miRNA) expression can have a critical role in carcinogenesis. Here we show in prostate cancer that miRNA-205 (miR-205) transcription is commonly repressed and the MIR-205 locus is hypermethylated. LOC642587, the MIR-205 host gene of unknown function, is also concordantly inactivated. We show that miR-205 targets mediator 1 (MED1, also called TRAP220 and PPARBP) for transcriptional silencing in normal prostate cells, leading to reduction in MED1 mRNA levels, and in total and active phospho-MED1 protein. Overexpression of miR-205 in prostate cancer cells negatively affects cell viability, consistent with a tumor suppressor function. We found that hypermethylation of the MIR-205 locus was strongly related with a decrease in miR-205 expression and an increase in MED1 expression in primary tumor samples (n = 14), when compared with matched normal prostate (n = 7). An expanded patient cohort (tumor n = 149, matched normal n = 30) also showed significant MIR-205 DNA methylation in tumors compared with normal, and MIR-205 hypermethylation is significantly associated with biochemical recurrence (hazard ratio = 2.005, 95% confidence interval (1.109, 3.625), P = 0.02), in patients with low preoperative prostate specific antigen. In summary, these results suggest that miR-205 is an epigenetically regulated tumor suppressor that targets MED1 and may provide a potential biomarker in prostate cancer management.	[Hulf, T.; Sibbritt, T.; Wiklund, E. D.; Patterson, K.; Song, J. Z.; Stirzaker, C.; Qu, W.; Nair, S.; Horvath, L. G.; Armstrong, N. J.; Kench, J. G.; Sutherland, R. L.; Clark, S. J.] St Vincents Hosp, Garvan Inst Med Res, Epigenet Grp, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Wiklund, E. D.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Horvath, L. G.] Royal Prince Alfred Hosp, Dept Med Oncol, Sydney Canc Ctr, Camperdown, NSW 2050, Australia; [Armstrong, N. J.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Kench, J. G.] Royal Prince Alfred Hosp, Dept Tissue Pathol, Camperdown, NSW 2050, Australia; [Clark, S. J.] Univ NSW, St Vincents Clin Sch, St Vincents Hosp, Darlinghurst, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Aarhus University; University of Sydney; University of New South Wales Sydney; University of Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Clark, SJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Epigenet Grp, Canc Res Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	s.clark@garvan.org.au	Clark, Susan J/U-7365-2019; Armstrong, Nicola J./AAF-3045-2021; Clark, Susan J/B-2272-2008	Clark, Susan J/0000-0001-5925-5030; Armstrong, Nicola J./0000-0002-4477-293X; Clark, Susan J/0000-0001-5925-5030; Stirzaker, Clare/0000-0001-5601-3140; Kench, James Geoffrey/0000-0001-8687-4988; Patterson, Kate/0000-0003-3919-7261; Horvath, Lisa/0000-0001-6842-9223	Cancer Institute NSW (CINSW); Cure Cancer Australia fellowships; National Health and Medical Research Council; CINSW project grants	Cancer Institute NSW (CINSW); Cure Cancer Australia fellowships; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CINSW project grants	We would like to thank Gillian Lehrbach, Ann-Maree Haynes, Ruth Pe Benito and Clarisse Puno for technical assistance. This work is supported by Cancer Institute NSW (CINSW), Cure Cancer Australia fellowships (TH), and National Health and Medical Research Council and CINSW project grants (SJC).	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Devaney J, 2011, CANCER EPIDEM BIOMAR, V20, P148, DOI 10.1158/1055-9965.EPI-10-0719; Dijckmeester WA, 2009, J GASTROINTEST SURG, V13, P846, DOI 10.1007/s11605-009-0799-5; Feber A, 2008, J THORACIC CARDIOVAS, V135, P60; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Jia L, 2005, CANCER RES, V65, P8003, DOI 10.1158/0008-5472.CAN-04-3679; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Platica Micsunica, 1997, In Vitro Cellular and Developmental Biology Animal, V33, P147; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ryan D, 2006, MOL VIS, V12, P1175; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Vijayvargia R, 2007, CANCER RES, V67, P4034, DOI 10.1158/0008-5472.CAN-06-3039; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	55	71	76	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2891	2899		10.1038/onc.2012.300	http://dx.doi.org/10.1038/onc.2012.300			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22869146				2022-12-25	WOS:000320369100009
J	Liang, YJ; Wu, H; Lei, R; Chong, RA; Wei, Y; Lu, X; Tagkopoulos, I; Kung, SY; Yang, QF; Hu, GH; Kang, YB				Liang, Yajun; Wu, Heng; Lei, Rong; Chong, Robert A.; Wei, Yong; Lu, Xin; Tagkopoulos, Ilias; Kung, Sun-Yuan; Yang, Qifeng; Hu, Guohong; Kang, Yibin			Transcriptional Network Analysis Identifies BACH1 as a Master Regulator of Breast Cancer Bone Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; HYPOXIA; GENES; SIGNATURE; DYNAMICS; GROWTH; CELLS; BTB	The application of functional genomic analysis of breast cancer metastasis has led to the identification of a growing number of organ-specific metastasis genes, which often function in concert to facilitate different steps of the metastatic cascade. However, the gene regulatory network that controls the expression of these metastasis genes remains largely unknown. Here, we demonstrate a computational approach for the deconvolution of transcriptional networks to discover master regulators of breast cancer bone metastasis. Several known regulators of breast cancer bone metastasis such as Smad4 and HIF1 were identified in our analysis. Experimental validation of the networks revealed BACH1, a basic leucine zipper transcription factor, as the common regulator of several functional metastasis genes, including MMP1 and CXCR4. Ectopic expression of BACH1 enhanced the malignance of breast cancer cells, and conversely, BACH1 knockdown significantly reduced bone metastasis. The expression of BACH1 and its target genes was linked to the higher risk of breast cancer recurrence in patients. This study established BACH1 as the master regulator of breast cancer bone metastasis and provided a paradigm to identify molecular determinants in complex pathological processes.	[Liang, Yajun; Lei, Rong; Hu, Guohong] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, Shanghai 200025, Peoples R China; [Wu, Heng; Chong, Robert A.; Wei, Yong; Lu, Xin; Hu, Guohong; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Tagkopoulos, Ilias; Kung, Sun-Yuan] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Princeton University; Princeton University; Shandong University	Hu, GH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	ghhu@sibs.ac.cn; ykang@princeton.edu	yang, qiang/GYJ-0971-2022	Kang, Yibin/0000-0002-1626-6730; Hu, Guohong/0000-0002-2980-5166; Yang, Qifeng/0000-0003-0576-8513	New Jersey commission on Cancer Research; Ministry of Science and Technology of China [2011CB510105]; Chinese Academy of Sciences [2009OHTP08, KSCX2-YW-R-192]; National Natural Science Foundation [81071754]; Shanghai Pujiang Plan Grant [10PJ1411600]; National Institutes of Health [R01CA134519, R01CA141062]; Department of Defense; Komen for the Cure; Brewster Foundation; Champalimaud Foundation; NATIONAL CANCER INSTITUTE [R01CA134519, R01CA141062] Funding Source: NIH RePORTER	New Jersey commission on Cancer Research; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Plan Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Brewster Foundation; Champalimaud Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by postdoctoral fellowships from the New Jersey commission on Cancer Research and grants from the Ministry of Science and Technology of China (2011CB510105), the Chinese Academy of Sciences (2009OHTP08, KSCX2-YW-R-192), the National Natural Science Foundation (81071754), and the Shanghai Pujiang Plan Grant (10PJ1411600). To whom correspondence may be addressed. Tel.: 86-21-63846825; E-mail: ghhu@sibs.ac.cn.; Supported by National Institutes of Health Grants R01CA134519 and R01CA141062, the Department of Defense, Komen for the Cure, the Brewster Foundation, and the Champalimaud Foundation. To whom correspondence may be addressed. Tel.: 01-609-258-8834; E-mail: ykang@princeton.edu.	Alvarez A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-243; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Butte A. J., 2000, PAC S BIOC PSB HAW J, P5418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartemink A. J., 2001, PAC S BIOC PSB HAW J, P6422; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lim W. K., 2009, PAC S BIOC PSB HAW J, P14504; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Tagkopoulos I., 2005, 5 IEEE S BIOINF BIOE; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Toki T, 2005, BLOOD, V105, P3100, DOI 10.1182/blood-2004-07-2826; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhong H, 1999, CANCER RES, V59, P5830	45	81	84	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33533	33544		10.1074/jbc.M112.392332	http://dx.doi.org/10.1074/jbc.M112.392332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875853	hybrid, Green Published			2022-12-25	WOS:000309602100039
J	Di Lullo, G; Ieva, F; Longhi, R; Paganoni, AM; Protti, MP				Di Lullo, Giulia; Ieva, Francesca; Longhi, Renato; Paganoni, Anna Maria; Protti, Maria Pia			Estimating Point and Interval Frequency of Antigen-Specific CD4(+) T Cells Based on Short In Vitro Expansion and Improved Poisson Distribution Analysis	PLOS ONE			English	Article							CLASS-II TETRAMERS; GRADE CERVICAL LESIONS; IMMUNE-RESPONSES; MEMORY; VIRUS; IMMUNOTHERAPY; REPERTOIRE; VACCINES; SUBSETS; ROLES	Background: Knowledge of antigen-specific CD4(+) T cells frequencies is pivotal to the choice of the antigen to be used in anti-viral and anti-tumor vaccination procedures and for monitoring of immune responses. Methods that employ small cell numbers from patient samples, are easy to perform and do not require complex techniques/instrumentations and therefore standardization are desirable. Methodology/Principal Findings: Purified blood CD4(+) T cells from healthy donors were cultured with autologous antigen presenting cells in several replicate wells in equal numbers in the absence (un-stimulated wells) or in the presence of synthetic peptides corresponding to viral antigens promiscuous HLA-DR epitopes (antigen-stimulated wells). At day 7 of culture low dose IL-2 was added and at day 14 IFN-gamma and IL-5 release in the supernatant was measured. A statistical analysis approach, based on Poisson distribution, was then implemented to calculate the frequency of viral-specific CD4(+) T cells. We first determined a patient-specific exceptionality threshold of cytokine release in the un-stimulated wells and then, based on this threshold, we counted the inactive/active wells within the antigen-stimulated wells. This number, along with the number of cells per well, allowed the point and interval estimates of frequencies. A ready-to-use Excel worksheet template with automatic calculations for frequencies estimate was developed and is provided as a supplemental file (Table S9). Conclusions/Significance: We report a simple experimental procedure combining short term in vitro cell culture with statistical analysis to calculate the frequency of antigen-specific CD4(+) T cells. The detailed experimental procedure along with the Excel applicative are a valuable tool for monitoring immune responses in the clinical practice.	[Di Lullo, Giulia; Protti, Maria Pia] Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy; [Di Lullo, Giulia; Protti, Maria Pia] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Ieva, Francesca; Paganoni, Anna Maria] Politecn Milan, Dipartimento Matemat, Laboratorty Modeling & Sci Comp MOX, I-20133 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Di Lullo, G (corresponding author), Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy.	m.protti@hsr.it	Di Lullo, Giulia/G-4800-2016; Paganoni, Anna Maria/N-9885-2016; Protti, Maria Pia/J-7899-2016	Di Lullo, Giulia/0000-0002-9358-920X; Paganoni, Anna Maria/0000-0002-8253-3630; Protti, Maria Pia/0000-0001-9079-2336; Ieva, Francesca/0000-0003-0165-1983	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-4510, IG-11353]; Special Program Molecular Clinical Oncology AIRC 5 per mille [9965]; Italian Ministry of Health	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology AIRC 5 per mille(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by: AIRC (Associazione Italiana per la Ricerca sul Cancro, IG-4510, IG-11353), Special Program Molecular Clinical Oncology AIRC 5 per mille (9965), and the Italian Ministry of Health (Programma Straordinario Ricerca Oncologica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Cecconi V, 2008, CYTOM PART A, V73A, P1010, DOI 10.1002/cyto.a.20603; Cecconi V, 2010, EUR J IMMUNOL, V40, P1603, DOI 10.1002/eji.200940123; Curnis F, 2004, CANCER RES, V64, P565, DOI 10.1158/0008-5472.CAN-03-1753; Danke NA, 2003, J IMMUNOL, V171, P3163, DOI 10.4049/jimmunol.171.6.3163; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Heller KN, 2007, BLOOD, V109, P1138, DOI 10.1182/blood-2006-05-023663; Hoos A, 2011, NAT BIOTECHNOL, V29, P867, DOI 10.1038/nbt.2000; Jovanovic BD, 1997, AM STAT, V51, P137, DOI 10.2307/2685405; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Lyerly HK, 2003, SEMIN ONCOL, V30, P9, DOI 10.1016/S0093-7754(03)00230-6; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; MAZZOCCHI A, 1994, INT J CANCER, V58, P330, DOI 10.1002/ijc.2910580304; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Seresini S, 2007, J IMMUNOL, V179, P7176, DOI 10.4049/jimmunol.179.10.7176; Seresini S, 2010, IMMUNOLOGY, V131, P89, DOI 10.1111/j.1365-2567.2010.03277.x; Siota M, 2011, EXPERT REV VACCINES, V10, P299, DOI [10.1586/ERV.10.169, 10.1586/erv.10.169]; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tassi E, 2008, J IMMUNOL, V181, P6595, DOI 10.4049/jimmunol.181.9.6595; van der Burg SH, 2011, PROBABILITY RANDOM P, V3; van der Burg SH, 2008, EXPERT REV VACCINES, V7, P1, DOI 10.1586/14760584.7.1.1; van der Burg SH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002785; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Whitmire JK, 2000, PHILOS T R SOC B, V355, P373, DOI 10.1098/rstb.2000.0577	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42340	10.1371/journal.pone.0042340	http://dx.doi.org/10.1371/journal.pone.0042340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879946	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900030
J	Vey, G; Moreno-Hagelsieb, G				Vey, Gregory; Moreno-Hagelsieb, Gabriel			Metagenomic Annotation Networks: Construction and Applications	PLOS ONE			English	Article							GUT MICROBIOME; FUNCTIONAL MODULES; ESCHERICHIA-COLI; SEQUENCE; DATABASE; GENOMES; ENZYMES; MODELS	The derivation and comparison of biological interaction networks are vital for understanding the functional capacity and hierarchical organization of integrated microbial communities. In the current work we present metagenomic annotation networks as a novel taxonomy-free approach for understanding the functional architecture of metagenomes. Specifically, metagenomic operon predictions are exploited to derive functional interactions that are translated and categorized according to their associated functional annotations. The result is a collection of discrete networks of weighted annotation linkages. These networks are subsequently examined for the occurrence of annotation modules that portray the functional and organizational characteristics of various microbial communities. A variety of network perspectives and annotation categories are applied to recover a diverse range of modules with different degrees of annotative cohesiveness. Applications to biocatalyst discovery and human health issues are discussed, as well as the limitations of the current implementation.	[Vey, Gregory] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	University of Waterloo; Wilfrid Laurier University	Vey, G (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	gmoreno@wlu.ca		Vey, Gregory/0000-0003-1574-1373; Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450	NSERC Strategic Grant; NSERC Discovery Grant	NSERC Strategic Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	GV was supported by an NSERC Strategic Grant; GM-H's research was supported by a NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; CHEN GJ, 1989, APPL ENVIRON MICROB, V55, P2658, DOI 10.1128/AEM.55.10.2658-2663.1989; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hsu JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-281; Janga SC, 2011, METAB ENG, V13, P1, DOI 10.1016/j.ymben.2010.07.001; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kidd P, 2005, ALTERN MED REV, V10, P193; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Konietzny SGA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-141; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Liu Bo, 2011, BMC Proc, V5 Suppl 2, pS9, DOI 10.1186/1753-6561-5-S2-S9; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Pignatelli M, 2008, BIOINFORMATICS, V24, P2124, DOI 10.1093/bioinformatics/btn355; Rende D, 2011, MOL BIOSYST, V7, P2205, DOI 10.1039/c1mb05064h; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vey G, 2010, MOL BIOSYST, V6, P1247, DOI 10.1039/b919263h; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	37	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41283	10.1371/journal.pone.0041283	http://dx.doi.org/10.1371/journal.pone.0041283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879885	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900008
J	Brim, H; Lee, E; Abu-Asab, MS; Chaouchi, M; Razjouyan, H; Namin, H; Goel, A; Schaffer, AA; Ashktorab, H				Brim, Hassan; Lee, Edward; Abu-Asab, Mones S.; Chaouchi, Mohamed; Razjouyan, Hadi; Namin, Hassanzadeh; Goel, Ajay; Schaeffer, Alejandro A.; Ashktorab, Hassan			Genomic Aberrations in an African American Colorectal Cancer Cohort Reveals a MSI-Specific Profile and Chromosome X Amplification in Male Patients	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; SPORADIC COLON-CANCER; MICROSATELLITE INSTABILITY; HUMAN BREAST; EXPRESSION; CARCINOMAS; DISTINCT; HYPERMETHYLATION; HYBRIDIZATION; ABNORMALITIES	Objective: DNA aberrations that cause colorectal cancer (CRC) occur in multiple steps that involve microsatellite instability (MSI) and chromosomal instability (CIN). Herein, we studied CRCs from AA patients for their CIN and MSI status. Experimental Design: Array CGH was performed on 30 AA colon tumors. The MSI status was established. The CGH data from AA were compared to published lists of 41 TSG and oncogenes in Caucasians and 68 cancer genes, proposed via systematic sequencing for somatic mutations in colon and breast tumors. The patient-by-patient CGH profiles were organized into a maximum parsimony cladogram to give insights into the tumors' aberrations lineage. Results: The CGH analysis revealed that CIN was independent of age, gender, stage or location. However, both the number and nature of aberrations seem to depend on the MSI status. MSI-H tumors clustered together in the cladogram. The chromosomes with the highest rates of CGH aberrations were 3, 5, 7, 8, 20 and X. Chromosome X was primarily amplified in male patients. A comparison with Caucasians revealed an overall similar aberration profile with few exceptions for the following genes; THRB, RAF1, LPL, DCC, XIST, PCNT, STS and genes on the 20q12-q13 cytoband. Among the 68 CAN genes, all showed some level of alteration in our cohort. Conclusion: Chromosome X amplification in male patients with CRC merits follow-up. The observed CIN may play a distinctive role in CRC in AAs. The clustering of MSI-H tumors in global CGH data analysis suggests that chromosomal aberrations are not random.	[Brim, Hassan; Lee, Edward; Razjouyan, Hadi; Namin, Hassanzadeh; Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20059 USA; [Brim, Hassan; Lee, Edward; Razjouyan, Hadi; Namin, Hassanzadeh; Ashktorab, Hassan] Howard Univ, Coll Med, Ctr Canc, Dept Pathol, Washington, DC USA; [Abu-Asab, Mones S.] NCI, NIH, DHHS, Bethesda, MD 20892 USA; [Chaouchi, Mohamed] Georgetown Univ, Sch Med, Dept Physiol & Biophys, Washington, DC 20007 USA; [Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA	Howard University; Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; National Institutes of Health (NIH) - USA	Brim, H (corresponding author), Howard Univ, Dept Med, Washington, DC 20059 USA.	hbrim@howard.edu; hashktorab@howard.edu	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Ashktorab, hassan/AAJ-2908-2020	Abu-Asab, Mones/0000-0002-4047-1232; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute (NCI), National Institutes of Health; National Institutes of Health, National Cancer Institute and National Library of Medicine; Research Centers in Minority Institutions (RCMI);  [CA102681]; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute and National Library of Medicine; Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Grant #CA102681, funded by the National Cancer Institute (NCI), National Institutes of Health, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Library of Medicine, and by Research Centers in Minority Institutions (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Arnold CN, 2004, CANCER BIOL THER, V3, P960, DOI 10.4161/cbt.3.10.1113; Arthold S, 2011, HUM GENET; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Cacev T, 2005, GUT, V54, P1129, DOI 10.1136/gut.2004.053348; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Carethers JM, 2011, GASTROENTEROLOGY; Chen G, 2010, PATHOL RES PRACT, V206, P631, DOI 10.1016/j.prp.2010.05.011; Chura JC, 2009, MOL CELL ENDOCRINOL, V301, P51, DOI 10.1016/j.mce.2008.07.015; Copelli SB, 2001, ONCOL REP, V8, P923; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Goel A, 2003, CANCER RES, V63, P1608; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Hu Q, 2011, MOL CELL BIOL; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jian BX, 2009, CELL CYCLE, V8, P3770, DOI 10.4161/cc.8.22.10066; Kelly KM, 2007, AM J HEALTH BEHAV, V31, P502, DOI 10.5993/AJHB.31.5.6; Kibreab A, 2009, GASTEREOENTROLOGY, P136; Kratz CP, 2002, BLOOD, V99, P372, DOI 10.1182/blood.V99.1.372; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lu CX, 2011, AM J CANCER RES, V1, P1; Maliekal TT, 2003, ONCOGENE, V22, P4889, DOI 10.1038/sj.onc.1206806; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rmali KA, 2005, WORLD J GASTROENTERO, V11, P1283, DOI 10.3748/wjg.v11.i9.1283; Salhab M, 2008, BREAST CANCER RES TR, V109, P35, DOI 10.1007/s10549-007-9622-8; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Tominaga E, 2010, GYNECOL ONCOL, V118, P160, DOI 10.1016/j.ygyno.2010.03.010; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Unotoro J, 2006, J INT MED RES, V34, P397, DOI 10.1177/147323000603400409; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Will O, 2007, GASTROENTEROLOGY, V132, P527, DOI 10.1053/j.gastro.2006.11.043; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong JCT, 2011, CLIN CANCER RES, V17, P4167, DOI 10.1158/1078-0432.CCR-10-1224; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40392	10.1371/journal.pone.0040392	http://dx.doi.org/10.1371/journal.pone.0040392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879877	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000004
J	Terazono, H; Kim, H; Hayashi, M; Hattori, A; Nomura, F; Kaneko, T; Yasuda, K				Terazono, Hideyuki; Kim, Hyonchol; Hayashi, Masahito; Hattori, Akihiro; Nomura, Fumimasa; Kaneko, Tomoyuki; Yasuda, Kenji			A Non-Destructive Culturing and Cell Sorting Method for Cardiomyocytes and Neurons Using a Double Alginate Layer	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MICROENCAPSULATION; SCAFFOLDS; DELIVERY; BEHAVIOR; SAFETY; REPAIR; MOUSE; LINES	A non-destructive method of collecting cultured cells after identifying their in situ functional characteristics is proposed. In this method, cells are cultivated on an alginate layer in a culture dish and released by spot application of a calcium chelate buffer that locally melts the alginate layer and enables the collection of cultured cells at the single-cell level. Primary hippocampal neurons, beating human embryonic stem (hES) cell-derived cardiomyocytes, and beating hES cell-derived cardiomyocyte clusters cultivated on an alginate layer were successfully released and collected with a micropipette. The collected cells were recultured while maintaining their physiological function, including beating, and elongated neurites. These results suggest that the proposed method may eventually facilitate the transplantation of ES- or iPS-derived cardiomyocytes and neurons differentiated in culture.	[Terazono, Hideyuki; Kim, Hyonchol; Hayashi, Masahito; Yasuda, Kenji] Kanagawa Acad Sci & Technol, On Chip Cell Project, Kawasaki, Kanagawa, Japan; [Hattori, Akihiro; Nomura, Fumimasa; Kaneko, Tomoyuki; Yasuda, Kenji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Biomed Informat, Div Biosyst, Tokyo, Japan	Kanagawa Academy Science & Technology; Tokyo Medical & Dental University (TMDU)	Terazono, H (corresponding author), Kanagawa Acad Sci & Technol, On Chip Cell Project, Kawasaki, Kanagawa, Japan.	yasuda.bmi@tmd.ac.jp	Kim, Hyonchol/R-9922-2017; Yasuda, Kenji/L-6520-2016	Kim, Hyonchol/0000-0002-1786-648X; Terazono, Hideyuki/0000-0002-2657-4454; Yasuda, Kenji/0000-0002-1433-4509	Kanagawa Academy of Science and Technology	Kanagawa Academy of Science and Technology	This research was supported by Kanagawa Academy of Science and Technology's own research budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018; Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207; Heise M, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-47; Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005; Kaneko T, 2007, ANALYST, V132, P892, DOI 10.1039/b704961g; Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura M, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:6(060201); Pouton CW, 2005, ADV DRUG DELIVER REV, V57, P1918, DOI 10.1016/j.addr.2005.08.003; Raikwar SP, 2011, TRANSPLANTATION, V91, P11, DOI 10.1097/TP.0b013e3181fdd98b; Sams AV, 2009, DRUG METAB REV, V41, P123; Selden C, 1999, ANN NY ACAD SCI, V875, P353, DOI 10.1111/j.1749-6632.1999.tb08517.x; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tostoes RM, 2011, BIOTECHNOL BIOENG, V108, P41, DOI 10.1002/bit.22920; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yan YN, 2005, J BIOACT COMPAT POL, V20, P259, DOI 10.1177/0883911505053658; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yang J, 2006, J DRUG TARGET, V14, P471, DOI 10.1080/10611860600847997; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026	27	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42485	10.1371/journal.pone.0042485	http://dx.doi.org/10.1371/journal.pone.0042485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870332	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100106
J	Lu, TP; Lee, CY; Tsai, MH; Chiu, YC; Hsiao, CK; Lai, LC; Chuang, EY				Lu, Tzu-Pin; Lee, Chien-Yueh; Tsai, Mong-Hsun; Chiu, Yu-Chiao; Hsiao, Chuhsing Kate; Lai, Liang-Chuan; Chuang, Eric Y.			miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets	PLOS ONE			English	Article							MULTIPLE-MYELOMA; GENE-EXPRESSION; CANCER-CELLS; IDENTIFICATION; REGULATORS; THROMBOSIS; CARCINOMA; APOPTOSIS; MIRNAS	Background: Many prediction tools for microRNA (miRNA) targets have been developed, but inconsistent predictions were observed across multiple algorithms, which can make further analysis difficult. Moreover, the nomenclature of human miRNAs changes rapidly. To address these issues, we developed a web-based system, miRSystem, for converting queried miRNAs to the latest annotation and predicting the function of miRNA by integrating miRNA target gene prediction and function/pathway analyses. Results: First, queried miRNA IDs were converted to the latest annotated version to prevent potential conflicts resulting from multiple aliases. Next, by combining seven algorithms and two validated databases, potential gene targets of miRNAs and their functions were predicted based on the consistency across independent algorithms and observed/expected ratios. Lastly, five pathway databases were included to characterize the enriched pathways of target genes through bootstrap approaches. Based on the enriched pathways of target genes, the functions of queried miRNAs could be predicted. Conclusions: MiRSystem is a user-friendly tool for predicting the target genes and their associated pathways for many miRNAs simultaneously. The web server and the documentation are freely available at http://mirsystem.cgm.ntu.edu.tw/.	[Lu, Tzu-Pin; Chuang, Eric Y.] Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan; [Lu, Tzu-Pin; Tsai, Mong-Hsun; Hsiao, Chuhsing Kate; Lai, Liang-Chuan; Chuang, Eric Y.] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan; [Lee, Chien-Yueh; Chiu, Yu-Chiao; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Chien-Yueh; Chiu, Yu-Chiao; Chuang, Eric Y.] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lu, TP (corresponding author), Natl Taiwan Univ, YongLin Biomed Engn Ctr, Taipei 10764, Taiwan.	llai@ntu.edu.tw; chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009; Lu, Tzupin/ABC-2195-2021	Lai, Liang-Chuan/0000-0002-3913-5338; Lu, Tzupin/0000-0003-3697-0386; Lee, Chien-Yueh/0000-0002-4304-974X; TSAI, MONG-HSUN/0000-0001-8777-5818; hsiao, chuhsing kate/0000-0003-4905-8484; Chiu, Yu-Chiao/0000-0003-1647-8634	National Science Council, Taiwan [NSC100-2314-B-002-054-]; National Taiwan University, Taiwan [99R81811]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This research was supported in part by NSC100-2314-B-002-054- from National Science Council, Taiwan and 99R81811 by National Taiwan University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Berthelsen CH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-97; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Harris A, 2010, AM J TRANSPLANT, V10, P713, DOI 10.1111/j.1600-6143.2010.03032.x; Harrison Claire N, 2005, Hematology Am Soc Hematol Educ Program, P409; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Hsu DF, 2010, LECT NOTES ARTIF INT, V6334, P42, DOI 10.1007/978-3-642-15314-3_5; Hsu DF, 2006, COMBINATORIAL FUSION, P32; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kristinsson SY, 2010, HEMATOL-AM SOC HEMAT, P437, DOI 10.1182/asheducation-2010.1.437; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Ma SM, 2010, INT J RADIAT BIOL, V86, P517, DOI 10.3109/09553001003734592; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McCullough DF, 2010, BIOCHEM SOC T, V38, P1565, DOI 10.1042/BST0381565; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Roy AM, 2005, MOL CANCER THER, V4, P81; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwarzer R, 2008, LEUKEMIA, V22, P2273, DOI 10.1038/leu.2008.138; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Zangari M, 2007, EXPERT REV ANTICANC, V7, P307, DOI 10.1586/14737140.7.3.307	49	209	214	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42390	10.1371/journal.pone.0042390	http://dx.doi.org/10.1371/journal.pone.0042390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870325	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800088
J	Barbati, C; Pierdominici, M; Gambardella, L; Albedi, FM; Karas, RH; Rosano, G; Malorni, W; Ortona, E				Barbati, Cristiana; Pierdominici, Marina; Gambardella, Lucrezia; Albedi, Fiorella Malchiodi; Karas, Richard H.; Rosano, Giuseppe; Malorni, Walter; Ortona, Elena			Cell Surface Estrogen Receptor Alpha Is Upregulated during Subchronic Metabolic Stress and Inhibits Neuronal Cell Degeneration	PLOS ONE			English	Article							ER-ALPHA; HIPPOCAMPAL-NEURONS; PROTEIN-DEGRADATION; AUTOPHAGY; BETA; EXPRESSION; HOMEOSTASIS; ESTRADIOL; SURVIVAL; NUCLEAR	In addition to the classical nuclear estrogen receptor, the expression of non-nuclear estrogen receptors localized to the cell surface membrane (mER) has recently been demonstrated. Estrogen and its receptors have been implicated in the development or progression of numerous neurodegenerative disorders. Furthermore, the pathogenesis of these diseases has been associated with disturbances of two key cellular programs: apoptosis and autophagy. An excess of apoptosis or a defect in autophagy has been implicated in neurodegeneration. The aim of this study was to clarify the role of ER in determining neuronal cell fate and the possible implication of these receptors in regulating either apoptosis or autophagy. The human neuronal cell line SH-SY5Y and mouse neuronal cells in primary culture were thus exposed to chronic minimal peroxide treatment (CMP), a form of subcytotoxic minimal chronic stress previously that mimics multiple aspects of long-term cell stress and represents a limited molecular proxy for neurodegenerative processes. We actually found that either E2 or E2-bovine serum albumin construct (E2BSA, i.e. a non-permeant form of E2) was capable of modulating intracellular cell signals and regulating cell survival and death. In particular, under CMP, the up-regulation of mER alpha, but not mER beta, was associated with functional signals (ERK phosphorylation and p38 dephosphorylation) compatible with autophagic cytoprotection triggering and leading to cell survival. The mER alpha trafficking appeared to be independent of the microfilament system cytoskeletal network but was seemingly associated with microtubular apparatus network, i.e., to MAP2 molecular chaperone. Importantly, antioxidant treatments, administration of siRNA to ER alpha, or the presence of antagonist of ER alpha hindered these events. These results support that the surface expression of mER alpha plays a pivotal role in determining cell fate, and that ligand-induced activation of mER signalling exerts a powerful cell-survival signal. These results shed new light on the pathogenetic mechanisms leading to neuronal cell degeneration.	[Barbati, Cristiana; Malorni, Walter; Ortona, Elena] San Raffaele Inst Sulmona, Laquila, Italy; [Barbati, Cristiana; Pierdominici, Marina; Albedi, Fiorella Malchiodi; Ortona, Elena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Gambardella, Lucrezia; Malorni, Walter] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Rosano, Giuseppe] IRCCS San Raffaele Pisana, Dept Med Sci, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Tufts Medical Center; IRCCS San Raffaele Pisana	Barbati, C (corresponding author), San Raffaele Inst Sulmona, Laquila, Italy.	ortona@iss.it	Malorni, Walter/G-5874-2016; Rosano, Giuseppe M. C./K-8718-2018; Malchiodi-Albedi, Fiorella/A-5944-2015; Pierdominici, Marina/J-6436-2016; ortona, elena/J-6395-2016	Rosano, Giuseppe M. C./0000-0003-4023-2263; Malchiodi-Albedi, Fiorella/0000-0001-7202-0391; Pierdominici, Marina/0000-0002-6372-3754; ortona, elena/0000-0001-9845-8105; malorni, walter/0000-0002-1223-7000	Italian Ministry of Health; Italian Association for Cancer Research (AIRC)	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by research grants from the Italian Ministry of Health (to EO and WM) and from the Italian Association for Cancer Research (AIRC) (WM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bodart JF, J CELL BIOCH, V109, P850; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Camacho-Arroyo I, 2011, LIFE SCI, V89, P123, DOI 10.1016/j.lfs.2011.05.008; Carrer HF, 2005, J STEROID BIOCHEM, V93, P319, DOI 10.1016/j.jsbmb.2004.12.007; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Dehmelt L, 2005, GENOME BIOL, V6; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lista P, 2011, J CELL MOL MED, V15, P1443, DOI 10.1111/j.1582-4934.2011.01293.x; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Malchiodi-Albedi F, 2001, GLIA, V34, P68, DOI 10.1002/glia.1041; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mendelsohn ME, 2010, J CLIN INVEST, V120, P2277, DOI 10.1172/JCI43756; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; O'Neill EE, 2008, BRAIN RES, V1222, P1, DOI 10.1016/j.brainres.2008.05.036; Ohtani-Kaneko R, 2010, NEUROSCI RES, V66, P180, DOI 10.1016/j.neures.2009.10.012; Pierdominici M, 2010, IMMUNOL LETT, V132, P79, DOI 10.1016/j.imlet.2010.06.003; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sanchez AM, 2010, STEROIDS, V75, P528, DOI 10.1016/j.steroids.2009.12.003; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Srivastava DP, 2011, J NEUROSCI, V31, P16056, DOI 10.1523/JNEUROSCI.4097-11.2011; Vacirca D, 2012, NEUROBIOL AGING, V33, P753, DOI 10.1016/j.neurobiolaging.2010.05.013; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	46	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42339	10.1371/journal.pone.0042339	http://dx.doi.org/10.1371/journal.pone.0042339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860116	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600092
J	Zhang, TW; Hu, SN; Zhang, GY; Pan, LL; Zhang, XW; Al-Mssallem, IS; Yu, J				Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Al-Mssallem, Ibrahim S.; Yu, Jun			The Organelle Genomes of Hassawi Rice (Oryza sativa L.) and Its Hybrid in Saudi Arabia: Genome Variation, Rearrangement, and Origins	PLOS ONE			English	Article							TRANSFER-RNA GENES; MITOCHONDRIAL GENOMES; SEQUENCE; RECOMBINATION; EVOLUTION; FREQUENCY	Hassawi rice (Oryza sativa L.) is a landrace adapted to the climate of Saudi Arabia, characterized by its strong resistance to soil salinity and drought. Using high quality sequencing reads extracted from raw data of a whole genome sequencing project, we assembled both chloroplast (cp) and mitochondrial (mt) genomes of the wild-type Hassawi rice (Hassawi-1) and its dwarf hybrid (Hassawi-2). We discovered 16 InDels (insertions and deletions) but no SNP (single nucleotide polymorphism) is present between the two Hassawi cp genomes. We identified 48 InDels and 26 SNPs in the two Hassawi mt genomes and a new type of sequence variation, termed reverse complementary variation (RCV) in the rice cp genomes. There are two and four RCVs identified in Hassawi-1 when compared to 93-11 (indica) and Nipponbare (japonica), respectively. Microsatellite sequence analysis showed there are more SSRs in the genic regions of both cp and mt genomes in the Hassawi rice than in the other rice varieties. There are also large repeats in the Hassawi mt genomes, with the longest length of 96,168 bp and 96,165 bp in Hassawi-1 and Hassawi-2, respectively. We believe that frequent DNA rearrangement in the Hassawi mt and cp genomes indicate ongoing dynamic processes to reach genetic stability under strong environmental pressures. Based on sequence variation analysis and the breeding history, we suggest that both Hassawi-1 and Hassawi-2 originated from the Indonesian variety Peta since genetic diversity between the two Hassawi cultivars is very low albeit an unknown historic origin of the wild-type Hassawi rice.	[Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Al-Mssallem, Ibrahim S.; Yu, Jun] King Abdulaziz City Sci & Technol, JCGR, Riyadh, Saudi Arabia; [Zhang, Tongwu; Hu, Songnian; Zhang, Guangyu; Pan, Linlin; Zhang, Xiaowei; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Tongwu; Hu, Songnian; Yu, Jun] Zhejiang Univ, Coll Life Sci, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Coll Agr & Food Sci, Dept Biotechnol, Al Hssa, Hofuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Zhejiang University; King Faisal University	Zhang, TW (corresponding author), King Abdulaziz City Sci & Technol, JCGR, Riyadh, Saudi Arabia.	zhangxw@big.ac.cn; imssallem@kacst.edu.sa; junyu@big.ac.cn	Zhang, Tongwu/M-4975-2015; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST); Chinese Academy of Sciences	Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank the Joint Center of Excellence for Genomics, King Abdulaziz City for Science and Technology (KACST) and Chinese Academy of Sciences. KASCT had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mssallem IS, 1997, ARAB GULF J SCI RES, V15, P633; Al-Mssallem MQ, 2011, EUR J CLIN NUTR, V65, P627, DOI 10.1038/ejcn.2011.4; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Barker GLA, 2009, PLANT BIOTECHNOL J, V7, P318, DOI 10.1111/j.1467-7652.2009.00412.x; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Imelfort M, 2009, PLANT BIOTECHNOL J, V7, P312, DOI 10.1111/j.1467-7652.2009.00406.x; Kato A, 2000, DNA SEQUENCE, V11, P395, DOI 10.3109/10425170009033990; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu HT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-163; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Nishikawa T, 2005, THEOR APPL GENET, V110, P696, DOI 10.1007/s00122-004-1895-2; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Rajendrakumar P, 2007, BIOINFORMATICS, V23, P1, DOI 10.1093/bioinformatics/btl547; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wang XY, 2002, SCI CHINA SER C, V45, P504, DOI 10.1360/02yc9055; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu X, 2011, NAT BIOTECH; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38	40	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42041	10.1371/journal.pone.0042041	http://dx.doi.org/10.1371/journal.pone.0042041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22870184	Green Submitted, gold, Green Published			2022-12-25	WOS:000307045600055
J	Ben-Shmuel, A; Shvab, A; Gavert, N; Brabletz, T; Ben-Ze'ev, A				Ben-Shmuel, A.; Shvab, A.; Gavert, N.; Brabletz, T.; Ben-Ze'ev, A.			Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-kappa B signaling that promotes colon cancer progression	ONCOGENE			English	Article						L1; IGFBP-2; ezrin; NF-kappa B; CRC	FACTOR-BINDING PROTEIN-2; I IGF-I; THERAPEUTIC TARGET; ERM PROTEINS; INSULIN; EXPRESSION; SERUM; L1; BIOMARKER; RECEPTOR	L1, a neuronal cell adhesion receptor of the immunoglobulin-like protein family is expressed in invading colorectal cancer (CRC) cells as a target gene of Wnt/beta-catenin signaling. Overexpression of L1 in CRC cells enhances cell motility and proliferation, and confers liver metastasis. We recently identified ezrin and the I kappa B-NF-kappa B pathway as essential for the biological properties conferred by L1 in CRC cells. Here, we studied the underlying molecular mechanisms and found that L1 enhances ezrin phosphorylation, via Rho-associated protein kinase (ROCK), and is required for L1-ezrin co-localization at the juxtamembrane domain and for enhancing cell motility. Global transcriptomes from L1-expressing CRC cells were compared with transcriptomes from the same cells expressing small hairpin RNA (shRNA) to ezrin. Among the genes whose expression was elevated by L1 and ezrin we identified insulin-like growth factor-binding protein 2 (IGFBP-2) and showed that its increased expression is mediated by an NF-kappa B-mediated transactivation of the IGFBP-2 gene promoter. Expression of a constitutively activated mutant ezrin (Ezrin567D) could also increase IGFBP-2 levels in CRC cells. Overexpression of IGFBP-2 in CRC cells lacking L1-enhanced cell proliferation (in the absence of serum), cell motility, tumorigenesis and induced liver metastasis, similar to L1 overexpression. Suppression of endogenous IGFBP-2 in L1-transfected cells inhibited these properties conferred by L1. We detected IGFBP-2 in a unique organization at the bottom of human colonic crypts in normal mucosa and at increased levels throughout human CRC tissue samples co-localizing with the phosphorylated p65 subunit of NF-kappa B. Finally, we found that IGFBP-2 and L1 can form a molecular complex suggesting that L1-mediated signaling by the L1-ezrin-NF-kappa B pathway, that induces IGFBP-2 expression, has an important role in CRC progression.	[Ben-Shmuel, A.; Shvab, A.; Gavert, N.; Ben-Ze'ev, A.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Brabletz, T.] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany	Weizmann Institute of Science; University of Freiburg	Ben-Ze'ev, A (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	avri.ben-zeev@weizmann.ac.il		Gavert, Nancy/0000-0003-1639-4684; ben-ze'ev, avri/0000-0001-6113-3921	Israel Science Foundation (ISF); Israel Cancer Research Fund (ICRF)	Israel Science Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Fund (ICRF)	We thank Drs M Arpin, M Pollak, W Zhang and V Lemmon for providing reagents. This study was supported by grants from the Israel Science Foundation (ISF) and from Israel Cancer Research Fund (ICRF). AB-Z is the incumbent of the Lunenfeld-Kunin Professorial chair of genetics.	Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Busund LTR, 2004, VIRCHOWS ARCH, V444, P142, DOI 10.1007/s00428-003-0931-y; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; ELATIQ F, 1994, INT J CANCER, V57, P491, DOI 10.1002/ijc.2910570409; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gautreau A, 2002, J CELL BIOL, V10, P193; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; Hoeflich A, 2001, CANCER RES, V61, P8601; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; KARASIK A, 1994, J CLIN ENDOCR METAB, V78, P271, DOI 10.1210/jc.78.2.271; Langsrud O, 2007, J APPL STAT, V34, P1275, DOI 10.1080/02664760701594246; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Mishra L, 1998, GROWTH HORM IGF RES, V8, P473, DOI 10.1016/S1096-6374(98)80300-6; Miyako K, 2009, MOL ENDOCRINOL, V23, P169, DOI 10.1210/me.2008-0168; Moore LM, 2009, P NATL ACAD SCI USA, V106, P16675, DOI 10.1073/pnas.0900807106; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Renehan AG, 2000, J CLIN ENDOCR METAB, V85, P3402, DOI 10.1210/jc.85.9.3402; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200	40	37	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2013	32	27					3220	3230		10.1038/onc.2012.340	http://dx.doi.org/10.1038/onc.2012.340			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22869145				2022-12-25	WOS:000321301600002
J	Tryndyak, V; de Conti, A; Kobets, T; Kutanzi, K; Koturbash, I; Han, T; Fuscoe, JC; Latendresse, JR; Melnyk, S; Shymonyak, S; Collins, L; Ross, SA; Rusyn, I; Beland, FA; Pogribny, IP				Tryndyak, Volodymyr; de Conti, Aline; Kobets, Tetyana; Kutanzi, Kristy; Koturbash, Igor; Han, Tao; Fuscoe, James C.; Latendresse, John R.; Melnyk, Stepan; Shymonyak, Svitlana; Collins, Leonard; Ross, Sharon A.; Rusyn, Ivan; Beland, Frederick A.; Pogribny, Igor P.			Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism	FASEB JOURNAL			English	Article						nonalcoholic fatty liver; interindividual; oxidative stress	ELEMENT-BINDING PROTEIN; PPAR-ALPHA; OXIDATIVE STRESS; HEPATIC STEATOSIS; EXPRESSION; CHREBP; CYTOCHROME-P450; SUSCEPTIBILITY; PROGRESSION; DIVERSITY	Nonalcoholic fatty liver disease (NAFLD) is a major health problem and a leading cause of chronic liver disease in the United States and developed countries. In humans, genetic factors greatly influence individual susceptibility to NAFLD. The goals of this study were to compare the magnitude of interindividual differences in the severity of liver injury induced by methyl-donor deficiency among individual inbred strains of mice and to investigate the underlying mechanisms associated with the variability. Feeding mice a choline-and folate-deficient diet for 12 wk caused liver injury similar to NAFLD. The magnitude of liver injury varied among the strains, with the order of sensitivity being A/J approximate to C57BL/6J approximate to C3H/HeJ < 129S1/SvImJ approximate to CAST/EiJ < PWK/PhJ < WSB/EiJ. The interstrain variability in severity of NAFLD liver damage was associated with dysregulation of genes involved in lipid metabolism, primarily with a down-regulation of the peroxisome proliferator receptor alpha (PPAR alpha)-regulated lipid catabolic pathway genes. Markers of oxidative stress and oxidative stress-induced DNA damage were also elevated in the livers but were not correlated with severity of liver damage. These findings suggest that the PPAR alpha-regulated metabolism network is one of the key mechanisms determining interstrain susceptibility and severity of NAFLD in mice.-Tryndyak, V., de Conti, A., Kobets, T., Kutanzi, K., Koturbash, I., Han, T., Fuscoe, J. C., Latendresse, J. R., Melnyk, S., Shymonyak, S., Collins, L., Ross, S. A., Rusyn, I., Beland, F. A., Pogribny, I. P. Interstrain differences in the severity of liver injury induced by a choline-and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism. FASEB J. 26, 4592-4602 (2012). www.fasebj.org	[Tryndyak, Volodymyr; Kobets, Tetyana; Kutanzi, Kristy; Koturbash, Igor; Beland, Frederick A.; Pogribny, Igor P.] US FDA, NCTR, Div Biochem Toxicol, Jefferson, AR 72079 USA; [Han, Tao; Fuscoe, James C.] US FDA, NCTR, Div Syst Biol, Jefferson, AR 72079 USA; [Latendresse, John R.] US FDA, NCTR, Toxicol Pathol Associates, Jefferson, AR 72079 USA; [de Conti, Aline] Univ Sao Paulo, Lab Diet Nutr & Canc, Sao Paulo, Brazil; [Kobets, Tetyana; Shymonyak, Svitlana; Collins, Leonard; Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Melnyk, Stepan] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Ross, Sharon A.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Universidade de Sao Paulo; University of North Carolina; University of North Carolina Chapel Hill; University of Arkansas System; University of Arkansas Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pogribny, IP (corresponding author), US FDA, NCTR, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov	Rusyn, Ivan/S-2426-2016; de Conti, Aline/I-1666-2013	Kobets, Tetyana/0000-0002-8207-5035; Beland, Frederick/0000-0002-2113-6260; Rusyn, Ivan/0000-0001-9340-7384; Tryndyak, Volodymyr/0000-0002-8319-2954	NIEHS NIH HHS [P30 ES010126] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Daly AK, 2011, EXPERT REV GASTROENT, V5, P253, DOI [10.1586/egh.11.18, 10.1586/EGH.11.18]; Di Rosa M, 2012, J MOL MED, V90, P105, DOI 10.1007/s00109-011-0803-x; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Fischer M, 2003, J BIOL CHEM, V278, P27997, DOI 10.1074/jbc.M302140200; Fisher CD, 2008, ARCH TOXICOL, V82, P959, DOI 10.1007/s00204-008-0312-z; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Harrill AH, 2009, TOXICOL SCI, V110, P235, DOI 10.1093/toxsci/kfp096; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hernaez R, 2012, GASTROENT HEPAT-BARC, V35, P32, DOI 10.1016/j.gastrohep.2011.08.002; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Gomez-Lechon MJ, 2009, CURR DRUG METAB, V10, P692, DOI 10.2174/138920009789895543; Klein K, 2012, CLIN PHARMACOL THER, V91, P1044, DOI 10.1038/clpt.2011.336; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Koh KH, 2011, DRUG METAB DISPOS, V39, P165, DOI 10.1124/dmd.110.035790; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Nakamura J, 2000, J BIOL CHEM, V275, P5323, DOI 10.1074/jbc.275.8.5323; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Powell CL, 2006, TOXICOL SCI, V93, P213, DOI 10.1093/toxsci/kfl030; Powell CL, 2005, CANCER LETT, V229, P1, DOI 10.1016/j.canlet.2004.12.002; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Vluggens A, 2010, LAB INVEST, V90, P696, DOI 10.1038/labinvest.2010.46; Yamazaki Y, 2008, J GASTROEN HEPATOL, V23, P276, DOI 10.1111/j.1440-1746.2007.05150.x; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	45	35	36	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4592	4602		10.1096/fj.12-209569	http://dx.doi.org/10.1096/fj.12-209569			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872676	Green Published			2022-12-25	WOS:000310574200021
J	Winkler, CW; Foster, SC; Matsumoto, SG; Preston, MA; Xing, RB; Bebo, BF; Banine, F; Berny-Lang, MA; Itakura, A; McCarty, OJT; Sherman, LS				Winkler, Clayton W.; Foster, Scott C.; Matsumoto, Steven G.; Preston, Marnie A.; Xing, Rubing; Bebo, Bruce F.; Banine, Fatima; Berny-Lang, Michelle A.; Itakura, Asako; McCarty, Owen J. T.; Sherman, Larry S.			Hyaluronan Anchored to Activated CD44 on Central Nervous System Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; P-SELECTIN; MEDIATED MOTILITY; PRIMARY ADHESION; RECEPTOR; INFLAMMATION; INTEGRIN; PROTEIN	The extravasation of lymphocytes across central nervous system (CNS) vascular endothelium is a key step in inflammatory demyelinating diseases including multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The glycosaminoglycan hyaluronan (HA) and its receptor, CD44, have been implicated in this process but their precise roles are unclear. We find that CD44(-/-) mice have a delayed onset of EAE compared with wild type animals. Using an in vitro lymphocyte rolling assay, we find that fewer slow rolling (<1 mu m/s) wild type (WT) activated lymphocytes interact with CD44(-/-) brain vascular endothelial cells (ECs) than with WTECs. We also find that CD44(-/-) ECs fail to anchor HA to their surfaces, and that slow rolling lymphocyte interactions with WTECs are inhibited when the ECs are treated with a pegylated form of the PH20 hyaluronidase (PEG-PH20). Subcutaneous injection of PEG-PH20 delays the onset of EAE symptoms by similar to 1 day and transiently ameliorates symptoms for 2 days following disease onset. These improved symptoms correspond histologically to degradation of HA in the lumen of CNS blood vessels, decreased demyelination, and impaired CD4(+) T-cell extravasation. Collectively these data suggest that HA tethered to CD44 on CNS ECs is critical for the extravasation of activated T cells into the CNS providing new insight into the mechanisms promoting inflammatory demyelinating disease.	[Winkler, Clayton W.; Foster, Scott C.; Matsumoto, Steven G.; Preston, Marnie A.; Xing, Rubing; Bebo, Bruce F.; Banine, Fatima; Sherman, Larry S.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Berny-Lang, Michelle A.; Itakura, Asako; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Integrat Biosci Dept, Sch Dent, Portland, OR 97239 USA; [Matsumoto, Steven G.] Oregon Hlth & Sci Univ, Sch Med, Dept Biomed Engn, Portland, OR 97239 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University	Sherman, LS (corresponding author), 505 NW 185th Ave, Beaverton, OR 97006 USA.	shermanl@ohsu.edu	Winkler, Clayton/F-8031-2018	Winkler, Clayton/0000-0002-4460-3378; Berny-Lang, Michelle/0000-0001-5889-4295	National Institutes of Health [P51 RR000163, P30 NS061800]; Halozyme Therapeutics Inc.; Laura Fund for Multiple Sclerosis Research; National Multiple Sclerosis Society [CA1055-A-3]; Vertex Pharmaceuticals scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Halozyme Therapeutics Inc.; Laura Fund for Multiple Sclerosis Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Vertex Pharmaceuticals scholar award(Vertex Pharmaceuticals); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P51 RR000163 and P30 NS061800, Halozyme Therapeutics Inc., the Laura Fund for Multiple Sclerosis Research, National Multiple Sclerosis Society Grant CA1055-A-3, and a Vertex Pharmaceuticals scholar award.	ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Brennan FR, 1999, IMMUNOLOGY, V98, P427, DOI 10.1046/j.1365-2567.1999.00894.x; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Campo GM, 2012, J CELL BIOCHEM, V113, P1852, DOI 10.1002/jcb.24054; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Deng X, 2002, J REPROD IMMUNOL, V54, P93, DOI 10.1016/S0165-0378(01)00124-3; Doring A, 2007, J IMMUNOL, V179, P8470, DOI 10.4049/jimmunol.179.12.8470; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; Gares S L, 2000, Dev Immunol, V7, P209, DOI 10.1155/2000/94616; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Hardy CM, 2004, REPRODUCTION, V127, P325, DOI 10.1530/rep.1.00016; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Holmoy T, 2007, ACTA NEUROL SCAND, V115, P39, DOI 10.1111/j.1600-0404.2007.00845.x; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Laman JD, 1998, MULT SCLER, V4, P147, DOI 10.1177/135245859800400312; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; PILARSKI LM, 1993, J IMMUNOL, V150, P4292; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Simpson MA, 2012, INT J CANCER, V131, pE836, DOI 10.1002/ijc.27427; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Sugie K, 2004, P NATL ACAD SCI USA, V101, P14859, DOI 10.1073/pnas.0406168101; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tuohy TMF, 2004, GLIA, V47, P335, DOI 10.1002/glia.20042; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	55	33	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33237	33251		10.1074/jbc.M112.356287	http://dx.doi.org/10.1074/jbc.M112.356287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865853	Green Published, hybrid			2022-12-25	WOS:000309602100014
J	Tran, TH; Shi, XF; Zaia, J; Ai, XB				Tran, Thanh H.; Shi, Xiaofeng; Zaia, Joseph; Ai, Xingbin			Heparan Sulfate 6-O-endosulfatases (Sulfs) Coordinate the Wnt Signaling Pathways to Regulate Myoblast Fusion during Skeletal Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATELLITE STEM-CELLS; BETA-CATENIN; GROWTH; ACTIVATION; EXPRESSION; DIFFERENTIATION; INTERNALIZATION; MYOGENESIS; CAVEOLIN; CANCER	Skeletal muscle regeneration is mediated by satellite cells (SCs). Upon injury, SCs undergo self-renewal, proliferation, and differentiation into myoblasts followed by myoblast fusion to form new myofibers. We previously showed that the heparan sulfate (HS) 6-O-endosulfatases (Sulf1 and -2) repress FGF signaling to induce SC differentiation during muscle regeneration. Here, we identify a novel role of Sulfs in myoblast fusion using a skeletal muscle-specific Sulf double null (Sulf(SK)-DN) mouse. Regenerating Sulf(SK)-DN muscles exhibit reduced canonical Wnt signaling and elevated non-canonical Wnt signaling. In addition, we show that Sulfs are required to repress non-canonical Wnt signaling to promote myoblast fusion. Notably, skeletal muscle-relevant non-canonical Wnt ligands lack HS binding capacity, suggesting that Sulfs indirectly repress this pathway. Mechanistically, we show that Sulfs reduce the canonical Wnt-HS binding and regulate colocalization of the co-receptor LRP5 with caveolin3. Therefore, Sulfs may increase the bioavailability of canonical Wnts for Frizzled receptor and LRP5/6 interaction in lipid raft, which may in turn antagonize non-canonical Wnt signaling. Furthermore, changes in subcellular distribution of active focal adhesion kinase (FAK) are associated with the fusion defect of Sulf-deficient myoblasts and upon noncanonical Wnt treatment. Together, our findings uncover a critical role of Sulfs in myoblast fusion by promoting antagonizing canonical Wnt signaling activities against the noncanonical Wnt pathway during skeletal muscle regeneration.	[Tran, Thanh H.; Ai, Xingbin] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Ai, XB (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 72 E Concord St, Boston, MA 02118 USA.	aix@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Ai, Xingbin/0000-0002-2178-0080	National Institutes of Health [5T32AG000115-24, R01AG034939, R01HL098950, P41RR10888]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000115, R01AG034939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 5T32AG000115-24 (to T. T.) and Grants R01AG034939 (to X. A.) and R01HL098950 and P41RR10888 (to J. Z.).	Ai X., 2005, CHEM BIOL HEPARIN HE, P245; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	39	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32651	32664		10.1074/jbc.M112.353243	http://dx.doi.org/10.1074/jbc.M112.353243			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865881	Green Published, hybrid			2022-12-25	WOS:000309168300033
J	Ranasinghe, JA; Stein, ED; Miller, PE; Weisberg, SB				Ranasinghe, J. Ananda; Stein, Eric D.; Miller, Peter E.; Weisberg, Stephen B.			Performance of Two Southern California Benthic Community Condition Indices Using Species Abundance and Presence-Only Data: Relevance to DNA Barcoding	PLOS ONE			English	Article							MARINE BIOTIC INDEX; CHESAPEAKE BAY; ESTUARINE; QUALITY; AMBI	DNA barcoding, as it is currently employed, enhances use of marine benthic macrofauna as environmental condition indicators by improving the speed and accuracy of the underlying taxonomic identifications. The next generation of barcoding applications, processing bulk environmental samples, will likely only provide presence information. However, macrofauna indices presently used to interpret these data are based on species abundances. To assess the importance of this difference, we evaluated the performance of the Southern California Benthic Response Index (BRI) and the AZTI Marine Biotic Index (AMBI) when species abundance data were removed from their calculation. Presence only versions of these two indices were created by eliminating abundance weighting while preserving species identity. Associations between the presence and abundance BRI, and the presence and abundance AMBI were highly significant, with correlation coefficients of 0.99 and 0.81, respectively. The presence versions validated almost equally to the abundance-based indices when applied to the spatial and the temporal monitoring data used to validate the original indices. Simulations in which taxa were systematically removed from calculation of the indices were also conducted to assess how large the barcode library must be for the indices to be effective. Correlation between the BRI-P and BRI remained above 0.9 with only 370 species in the library and reducing the number of species to 450 had almost no effect on correlation between the presence and abundance versions of the AMBI.	[Ranasinghe, J. Ananda; Stein, Eric D.; Weisberg, Stephen B.] So Calif Coastal Water Res Project, Costa Mesa, CA USA; [Miller, Peter E.] Univ Guelph, Canadian Ctr DNA Barcoding, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Southern California Coastal Water Research Project; University of Guelph	Ranasinghe, JA (corresponding author), So Calif Coastal Water Res Project, Costa Mesa, CA USA.	AnandaR@sccwrp.org	Weisberg, Stephen B/B-2477-2008; Stein, Eric D./A-9362-2008	Weisberg, Stephen B/0000-0002-0655-9425; Stein, Eric D./0000-0002-4729-809X	Southern California Coastal Water Research Project	Southern California Coastal Water Research Project	No external funding. This work was supported by Southern California Coastal Water Research Project internal funds only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden RW, 2002, ENVIRONMETRICS, V13, P473, DOI 10.1002/env.548; Bevilacqua S, 2009, MAR POLLUT BULL, V58, P1850, DOI 10.1016/j.marpolbul.2009.07.018; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Borja A, 2008, ECOL INDIC, V8, P395, DOI 10.1016/j.ecolind.2007.05.003; Borja A, 2009, MAR POLLUT BULL, V59, P1, DOI 10.1016/j.marpolbul.2008.11.006; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; County Sanitation Districts of Orange County (CSDOC), 1991, COUNT SAN DISTR OR C; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Dauvin JC, 2009, MAR POLLUT BULL, V59, P38, DOI 10.1016/j.marpolbul.2008.11.008; Dethier MN, 2005, ESTUAR COAST SHELF S, V62, P253, DOI 10.1016/j.ecss.2004.08.021; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; FERRARO SP, 1995, ENVIRON TOXICOL CHEM, V14, P1031, DOI 10.1002/etc.5620140614; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Pinto R, 2009, ECOL INDIC, V9, P1, DOI 10.1016/j.ecolind.2008.01.005; Ranasinghe JA, 2003, ENVIRON MONIT ASSESS, V81, P199, DOI 10.1023/A:1021333209477; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Stoeckle MY, 2008, SCI AM, V299, P82; Stull Janet K., 1995, Bulletin Southern California Academy of Sciences, V94, P21; STULL JK, 1986, MAR BIOL, V91, P539, DOI 10.1007/BF00392606; Teixeira H, 2012, ECOL INDIC, V12, P84, DOI 10.1016/j.ecolind.2011.05.025; Thompson B, 2012, ECOL INDIC, V12, P167, DOI 10.1016/j.ecolind.2011.03.020; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; Weisberg SB, 1997, ESTUARIES, V20, P149, DOI 10.2307/1352728	29	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40875	10.1371/journal.pone.0040875	http://dx.doi.org/10.1371/journal.pone.0040875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879881	Green Published, gold			2022-12-25	WOS:000307437900005
J	Rizzetto, L; Buschow, SI; Beltrame, L; Figdor, CG; Schierer, S; Schuler, G; Cavalieri, D				Rizzetto, Lisa; Buschow, Sonja I.; Beltrame, Luca; Figdor, Carl G.; Schierer, Stephan; Schuler, Gerold; Cavalieri, Duccio			The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BETA-GLUCAN RECEPTOR; C-TYPE LECTINS; IMMUNE-RESPONSES; DC-SIGN; ASPERGILLUS-FUMIGATUS; RECOGNITION; DECTIN-1; MYCOBACTERIA; INNATE	The type of adaptive immune response following host-fungi interaction is largely determined at the level of the antigen-presenting cells, and in particular by dendritic cells (DCs). The extent to which transcriptional regulatory events determine the decision making process in DCs is still an open question. By applying the highly structured DC-ATLAS pathways to analyze DC responses, we classified the various stimuli by revealing the modular nature of the different transcriptional programs governing the recognition of either pathogenic or commensal fungi. Through comparison of the network parts affected by DC stimulation with fungal cells and purified single agonists, we could determine the contribution of each receptor during the recognition process. We observed that initial recognition of a fungus creates a temporal window during which the simultaneous recruitment of cell surface receptors can intensify, complement and sustain the DC activation process. The breakdown of the response to whole live cells, through the purified components, showed how the response to invading fungi uses a set of specific modules. We find that at the start of fungal recognition, DCs rapidly initiate the activation process. Ligand recognition is further enhanced by over-expression of the receptor genes, with a significant correspondence between gene expression and protein levels and function. Then a marked decrease in the receptor levels follows, suggesting that at this moment the DC commits to a specific fate. Overall our pathway based studies show that the temporal window of the fungal recognition process depends on the availability of ligands and is different for pathogens and commensals. Modular analysis of receptor and signalling-adaptor expression changes, in the early phase of pathogen recognition, is a valuable tool for rapid and efficient dissection of the pathogen derived components that determine the phenotype of the DC and thereby the type of immune response initiated.	[Rizzetto, Lisa; Cavalieri, Duccio] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Buschow, Sonja I.; Figdor, Carl G.] Mario Negri Res Inst, Dept Oncol, Translat Genom Unit, Milan, Italy; [Beltrame, Luca] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Schierer, Stephan; Schuler, Gerold] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Cavalieri, Duccio] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy	University of Florence; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Radboud University Nijmegen; University of Erlangen Nuremberg; Fondazione Edmund Mach	Rizzetto, L (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy.		Figdor, Carl G/A-4232-2010; Rizzetto, Lisa/C-7304-2016; Buschow, Sonja/AAD-3567-2020; Beltrame, Luca/AAB-1998-2020; CAVALIERI, DUCCIO/T-3097-2017; Buschow, Sonja I/F-3777-2010	Figdor, Carl G/0000-0002-2366-9212; Rizzetto, Lisa/0000-0002-2170-9276; Beltrame, Luca/0000-0003-3631-6544; CAVALIERI, DUCCIO/0000-0001-6426-5719; Buschow, Sonja/0000-0002-7907-8315	European Community [242220]; Cariplo Foundation [2010-0744]	European Community(European Commission); Cariplo Foundation(Fondazione Cariplo)	This work was supported by funding from the European Community's Project FP6 DC-THERA EU LSHB-CT-2004-512074 and Project FP7, SYBARIS (Grant Agreement 242220). LB was supported by a grant of the Cariplo Foundation (Grant Number 2010-0744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beltrame L, 2011, BIOINFORMATICS, V27, P2127, DOI 10.1093/bioinformatics/btr339; Beltrame L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004128; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cavalieri Duccio, 2010, Immunome Res, V6, P10, DOI 10.1186/1745-7580-6-10; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Mezger M, 2008, ANTIMICROB AGENTS CH, V52, P2644, DOI 10.1128/AAC.01618-07; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Rizzetto L, 2010, IMMUNOBIOLOGY, V215, P762, DOI 10.1016/j.imbio.2010.05.009; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schorey JS, 2008, CURR DRUG TARGETS, V9, P123, DOI 10.2174/138945008783502430; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tam JM, 2012, INTEGR BIOL-UK, V4, P220, DOI 10.1039/c2ib00089j; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42430	10.1371/journal.pone.0042430	http://dx.doi.org/10.1371/journal.pone.0042430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879980	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100091
J	Li, L; Liu, B; Haversen, L; Lu, E; Magnusson, LU; Stahlman, M; Boren, J; Bergstrom, G; Levin, MC; Hulten, LM				Li, Lu; Liu, Bo; Haversen, Liliana; Lu, Emma; Magnusson, Lisa U.; Stahlman, Marcus; Boren, Jan; Bergstrom, Goran; Levin, Malin C.; Hulten, Lillemor Mattsson			The Importance of GLUT3 for De Novo Lipogenesis in Hypoxia-Induced Lipid Loading of Human Macrophages	PLOS ONE			English	Article							GLUCOSE; INFLAMMATION; EXPRESSION; LIVER	Atherosclerotic lesions are characterized by lipid-loaded macrophages (foam cells) and hypoxic regions. Although it is well established that foam cells are produced by uptake of cholesterol from oxidized LDL, we previously showed that hypoxia also promotes foam cell formation even in the absence of exogenous lipids. The hypoxia-induced lipid accumulation results from increased triglyceride biosynthesis but the exact mechanism is unknown. Our aim was to investigate the importance of glucose in promoting hypoxia-induced de novo lipid synthesis in human macrophages. In the absence of exogenous lipids, extracellular glucose promoted the accumulation of Oil Red O-stained lipid droplets in human monocyte-derived macrophages in a concentration-dependent manner. Lipid droplet accumulation was higher in macrophages exposed to hypoxia at all assessed concentrations of glucose. Importantly, triglyceride synthesis from glucose was increased in hypoxic macrophages. GLUT3 was highly expressed in macrophage-rich and hypoxic regions of human carotid atherosclerotic plaques and in macrophages isolated from these plaques. In human monocyte-derived macrophages, hypoxia increased expression of both GLUT3 mRNA and protein, and knockdown of GLUT3 with siRNA significantly reduced both glucose uptake and lipid droplet accumulation. In conclusion, we have shown that hypoxia-induced increases in glucose uptake through GLUT3 are important for lipid synthesis in macrophages, and may contribute to foam cell formation in hypoxic regions of atherosclerotic lesions.	[Li, Lu; Liu, Bo; Haversen, Liliana; Lu, Emma; Magnusson, Lisa U.; Stahlman, Marcus; Boren, Jan; Bergstrom, Goran; Levin, Malin C.; Hulten, Lillemor Mattsson] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden	University of Gothenburg	Li, L (corresponding author), Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden.	lillemor.mattsson@wlab.gu.se	StÃhlman, Marcus/M-4597-2019	Bergstrom, Goran/0000-0003-4289-5722; Henricsson, Marcus/0000-0002-4202-0339; Levin, Malin/0000-0003-1069-5275	Swedish Research Council; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was provided by the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; ANDERSSON M, 1994, J LIPID RES, V35, P535; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; HOROWICZ P, 1962, J NEUROCHEM, V9, P407, DOI 10.1111/j.1471-4159.1962.tb09468.x; HOWARD CF, 1972, ATHEROSCLEROSIS, V15, P359, DOI 10.1016/0021-9150(72)90025-1; Hulten LM, 2009, CURR OPIN LIPIDOL, V20, P409, DOI 10.1097/MOL.0b013e3283307be8; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Magnusson B, 2006, ARTERIOSCLER THROMB; Martin S, 2006, NAT REV MOL CELL BIO; MATTSSON L, 1991, ATHEROSCLEROSIS, V89, P25, DOI 10.1016/0021-9150(91)90004-M; Na TY, 2011, ARTERIOSCL THROM VAS, V31, P2949, DOI 10.1161/ATVBAHA.111.235788; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oorni K, 2006, CURR OPIN LIPIDOL, V17, P534; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Yu J, 2012, BRAIN RES, V1430, P18, DOI 10.1016/j.brainres.2011.10.046	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42360	10.1371/journal.pone.0042360	http://dx.doi.org/10.1371/journal.pone.0042360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876317	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700045
J	Lopez, MJ; Fernandez, E; Gorini, G; Moshammer, H; Polanska, K; Clancy, L; Dautzenberg, B; Delrieu, A; Invernizzi, G; Munoz, G; Precioso, J; Ruprecht, A; Stansty, P; Hanke, W; Nebot, M				Lopez, Maria J.; Fernandez, Esteve; Gorini, Giuseppe; Moshammer, Hanns; Polanska, Kinga; Clancy, Luke; Dautzenberg, Bertrand; Delrieu, Agnes; Invernizzi, Giovanni; Munoz, Gloria; Precioso, Jose; Ruprecht, Ario; Stansty, Peter; Hanke, Wojciech; Nebot, Manel			Exposure to Secondhand Smoke in Terraces and Other Outdoor Areas of Hospitality Venues in Eight European Countries	PLOS ONE			English	Article							2ND-HAND SMOKE; PUBLIC SPACES; IMPACT; BARS; LAW; RESTAURANTS; WORKERS; HEALTH	Background: Outdoor secondhand smoke (SHS) concentrations are usually lower than indoor concentrations, yet some studies have shown that outdoor SHS levels could be comparable to indoor levels under specific conditions. The main objectives of this study were to assess levels of SHS exposure in terraces and other outdoor areas of hospitality venues and to evaluate their potential displacement to adjacent indoor areas. Methods: Nicotine and respirable particles (PM2.5) were measured in outdoor and indoor areas of hospitality venues of 8 European countries. Hospitality venues of the study included night bars, restaurants and bars. The fieldwork was carried out between March 2009 and March 2011. Results: We gathered 170 nicotine and 142 PM2.5 measurements during the study. The median indoor SHS concentration was significantly higher in venues where smoking was allowed (nicotine 3.69 mu g/m3, PM2.5: 120.51 mu g/m3) than in those where smoking was banned (nicotine: 0.48 mu g/m3, PM2.5: 36.90 mu g/m3). The median outdoor nicotine concentration was higher in places where indoor smoking was banned (1.56 mg/m3) than in venues where smoking was allowed (0.31 mg/m3). Among the different types of outdoor areas, the highest median outdoor SHS levels (nicotine: 4.23 mu g/m3, PM2.5: 43.64 mu g/m3) were found in the semi-closed outdoor areas of venues where indoor smoking was banned. Conclusions: Banning indoor smoking seems to displace SHS exposure to adjacent outdoor areas. Furthermore, indoor settings where smoking is banned but which have a semi-closed outdoor area have higher levels of SHS than those with open outdoor areas, possibly indicating that SHS also drifts from outdoors to indoors. Current legislation restricting indoor SHS levels seems to be insufficient to protect hospitality workers - and patrons - from SHS exposure. Tobacco-free legislation should take these results into account and consider restrictions in the terraces of some hospitality venues to ensure effective protection.	[Lopez, Maria J.; Munoz, Gloria; Nebot, Manel] Publ Hlth Agcy Barcelona, Barcelona, Spain; [Lopez, Maria J.; Munoz, Gloria; Nebot, Manel] Consorcio Invest Biomed Red Especializado Epidemi, Barcelona, Spain; [Lopez, Maria J.; Nebot, Manel] Inst Invest Biomed St Pau, Barcelona, Spain; [Fernandez, Esteve] ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Lhospitalet De Llobregat, Spain; [Fernandez, Esteve] Inst Invest Biomed Bellvitge, Canc Control & Prevent Grp, Lhospitalet De Llobregat, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Spain; [Gorini, Giuseppe] Canc Prevent & Res Inst, Environm & Occupat Epidemiol Unit, Florence, Italy; [Moshammer, Hanns] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Polanska, Kinga; Hanke, Wojciech] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Clancy, Luke] Digital Depot, Tobacco Free Res Inst, Dublin, Ireland; [Dautzenberg, Bertrand; Delrieu, Agnes] Off Francais Prevent Tabagisme, Paris, France; [Precioso, Jose] Univ Minho, Braga, Portugal; [Ruprecht, Ario] Italian Coll Gen Practitioners, Fdn Ist Ric & Cura Carattere Sci IRCCS, Environm Tobacco Smoke Res Lab, SIMG,Ist Nazl Tumori,Tobacco Control Unit, Milan, Italy; [Stansty, Peter] Obcianske Zdruzenie Stop Smoking NGO, Stop Fajceniu, Bratislava, Slovakia; [Nebot, Manel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Public Health Agency of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Medical University of Vienna; Nofer Institute of Occupational Medicine; Universidade do Minho; Fondazione IRCCS Istituto Nazionale Tumori Milan; Pompeu Fabra University	Lopez, MJ (corresponding author), Publ Hlth Agcy Barcelona, Barcelona, Spain.	mjlopez@aspb.cat	Lopez, Maria/HHC-3659-2022; clancy, luke/ABA-1826-2020; Clancy, Luke/O-6597-2019; Fernandez, Esteve/A-9750-2008; Gorini, Giuseppe/O-9560-2017; Polanska, Kinga/F-7599-2010; DAUTZENBERG, Bertrand/F-4104-2017	Clancy, Luke/0000-0003-2407-2263; Fernandez, Esteve/0000-0003-4239-723X; Gorini, Giuseppe/0000-0002-1413-5948; Lopez Medina, Maria Jose/0000-0003-4402-2239; DAUTZENBERG, Bertrand/0000-0001-6937-8907; Hanke, Wojciech/0000-0001-7162-2569; Polanska, Kinga/0000-0002-3212-2307; Precioso, Jose/0000-0002-7889-8290	Executive Agency for Health and Consumers; DG SANCO; European Commission [2007313]	Executive Agency for Health and Consumers; DG SANCO; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Executive Agency for Health and Consumers, DG SANCO, European Commission, grant number 2007313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Apsley A, 2012, TOB CONTROL IN PRESS; Brennan E, 2010, NICOTINE TOB RES, V12, P271, DOI 10.1093/ntr/ntp204; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Cameron M, 2010, TOB CONTROL, V19, P19, DOI 10.1136/tc.2009.030544; Chapman S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2804; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Gorini G, 2008, INDOOR AIR, V18, P328, DOI 10.1111/j.1600-0668.2008.00534.x; Hall JC, 2009, J OCCUP ENVIRON HYG, V6, P698, DOI 10.1080/15459620903249893; HAMMOND SK, 1993, SAMPLING ANAL AIRBOR, P319; IARC, 2009, IARC HDB CANC PREVEN; Kaufman P, 2011, TOB CONTROL, V20, P212, DOI 10.1136/tc.2010.041277; Kennedy RD, 2010, TOB CONTROL, V19, P165, DOI 10.1136/tc.2009.031872; Klepeis NE, 2007, J AIR WASTE MANAGE, V57, P522, DOI 10.3155/1047-3289.57.5.522; Lopez MJ, 2008, ENVIRON HEALTH PERSP, V116, P1469, DOI 10.1289/ehp.11374; Lopez MJ, 2012, TOB CONTROL, V21, P407, DOI 10.1136/tc.2010.042275; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Repace J., 2005, MEASUREMENTS OUTDOOR; Ruprecht AA, 2011, EPIDEMIOLOGY, V22, pS206, DOI 10.1097/01.ede.0000392314.24613.c6; Stafford J, 2010, HEALTH PROMOT J AUST, V21, P99, DOI 10.1071/HE10099; Sureda X, 2011, TOB CONTROL; Thomson G, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2806; Thomson G, 2009, NICOTINE TOB RES, V11, P584, DOI 10.1093/ntr/ntp046; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; World Health Organization, 2009, WHO REP GLOB TOB EP; WorldHealthOrganization, 2000, AIR QUAL GUID EUR, Vsecond	26	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42130	10.1371/journal.pone.0042130	http://dx.doi.org/10.1371/journal.pone.0042130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870289	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800062
J	Ortmann, AC; Anders, J; Shelton, N; Gong, LM; Moss, AG; Condon, RH				Ortmann, Alice C.; Anders, Jennifer; Shelton, Naomi; Gong, Limin; Moss, Anthony G.; Condon, Robert H.			Dispersed Oil Disrupts Microbial Pathways in Pelagic Food Webs	PLOS ONE			English	Article							DEEP-WATER HORIZON; GULF-OF-MEXICO; CRUDE-OIL; BACTERIAL OXIDATION; DEGRADING BACTERIA; MARINE ECOSYSTEM; BIODEGRADATION; COMMUNITY; DYNAMICS; SPILL	Most of the studies of microbial processes in response to the Deepwater Horizon oil spill focused on the deep water plume, and not on the surface communities. The effects of the crude oil and the application of dispersants on the coastal microbial food web in the northern Gulf of Mexico have not been well characterized even though these regions support much of the fisheries production in the Gulf. A mesocosm experiment was carried out to determine how the microbial community off the coast of Alabama may have responded to the influx of surface oil and dispersants. While the addition of glucose or oil alone resulted in an increase in the biomass of ciliates, suggesting transfer of carbon to higher trophic levels was likely; a different effect was seen in the presence of dispersant. The addition of dispersant or dispersed oil resulted in an increase in the biomass of heterotrophic prokaryotes, but a significant inhibition of ciliates, suggesting a reduction in grazing and decrease in transfer of carbon to higher trophic levels. Similar patterns were observed in two separate experiments with different starting nutrient regimes and microbial communities suggesting that the addition of dispersant and dispersed oil to the northern Gulf of Mexico waters in 2010 may have reduced the flow of carbon to higher trophic levels, leading to a decrease in the production of zooplankton and fish on the Alabama shelf.	[Ortmann, Alice C.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Ortmann, Alice C.; Anders, Jennifer; Shelton, Naomi; Condon, Robert H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Gong, Limin; Moss, Anthony G.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University of South Alabama; Dauphin Island Sea Lab; Auburn University System; Auburn University	Ortmann, AC (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	aortmann@disl.org			Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI)	Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI)	Funding was provided by individual grants to ACO, AGM and RHC through the Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OR, 2001, MICROBIAL ECOL, V42, P474, DOI 10.1007/s00248-001-0008-x; [Anonymous], 2010, OIL BUDGET CALCULATO; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Bronk DA, 2000, MAR CHEM, V69, P163, DOI 10.1016/S0304-4203(99)00103-6; Bruheim P, 1999, APPL ENVIRON MICROB, V65, P1658; Bruheim P, 1998, CAN J MICROBIOL, V44, P195, DOI 10.1139/cjm-44-2-195; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carassou L, 2011, MAR COAST FISH, V3, P411, DOI 10.1080/19425120.2011.642492; Echeveste P, 2010, ENVIRON POLLUT, V158, P299, DOI 10.1016/j.envpol.2009.07.006; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Huang YJ, 2011, ENVIRON MONIT ASSESS, V176, P517, DOI 10.1007/s10661-010-1601-6; Jean JS, 2008, BIORESOURCE TECHNOL, V99, P7807, DOI 10.1016/j.biortech.2008.01.064; Jimenez N, 2007, APPL MICROBIOL BIOT, V77, P935, DOI 10.1007/s00253-007-1229-9; Jung SW, 2010, J MICROBIOL, V48, P594, DOI 10.1007/s12275-010-0199-2; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Koshikawa H, 2007, ESTUAR COAST SHELF S, V71, P68, DOI 10.1016/j.ecss.2006.08.008; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; LINDEN O, 1987, ENVIRON SCI TECHNOL, V21, P374, DOI 10.1021/es00158a007; Lindstrom JE, 2002, MAR POLLUT BULL, V44, P739, DOI 10.1016/S0025-326X(02)00050-4; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MULKINSPHILLIPS GJ, 1974, APPL MICROBIOL, V28, P547, DOI 10.1128/AEM.28.4.547-552.1974; Operational Science Advisory Team (OSAT-2), 2011, SUMM REP FAT EFF REM; OSAT, 2010, SUMM REP SUBS SUBS O; PARSONS TR, 1984, MAR ENVIRON RES, V13, P265, DOI 10.1016/0141-1136(84)90033-3; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Sharp JH, 2002, BIOGEOCHEMISTRY MARI, P35, DOI DOI 10.1016/B978-012323841-2/50004-X; Sherr E.B., 1993, HDB METHODS AQUATIC, P207; Sherr EB, 1993, HDB METHODS AQUATIC, p[213, 227]; SIRON R, 1993, MAR ENVIRON RES, V35, P273, DOI 10.1016/0141-1136(93)90098-K; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Yoshida A, 2006, MAR POLLUT BULL, V52, P89, DOI 10.1016/j.marpolbul.2005.08.015	40	47	48	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42548	10.1371/journal.pone.0042548	http://dx.doi.org/10.1371/journal.pone.0042548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860136	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600108
J	Batlle, R; Alba-Castellon, L; Loubat-Casanovas, J; Armenteros, E; Franci, C; Stanisavljevic, J; Barderas, R; Martin-Caballero, J; Bonilla, F; Baulida, J; Casal, JI; Gridley, T; de Herreros, AG				Batlle, R.; Alba-Castellon, L.; Loubat-Casanovas, J.; Armenteros, E.; Franci, C.; Stanisavljevic, J.; Barderas, R.; Martin-Caballero, J.; Bonilla, F.; Baulida, J.; Casal, J. I.; Gridley, T.; Garcia de Herreros, A.			Snail1 controls TGF-beta responsiveness and differentiation of mesenchymal stem cells	ONCOGENE			English	Article						Snail1; mesenchymal stem cells; TGF-beta; Akt	TRANSCRIPTION FACTOR SNAIL; NF-KAPPA-B; EXPRESSION; REPRESSOR; TRANSITIONS; PROTEIN; STROMA; BINDS; PTEN; AKT1	The Snail1 transcriptional repressor plays a key role in triggering epithelial-to-mesenchymal transition. Although Snail1 is widely expressed in early development, in adult animals it is limited to a subset of mesenchymal cells where it has a largely unknown function. Using a mouse model with inducible depletion of Snail1, here we demonstrate that Snail1 is required to maintain mesenchymal stem cells (MSCs). This effect is associated to the responsiveness to transforming growth factor (TGF)-beta 1 that shows a strong Snail1 dependence. Snail1 depletion in conditional knockout adult animals causes a significant decrease in the number of bone marrow-derived MSCs. In culture, Snail1-deficient MSCs prematurely differentiate to osteoblasts or adipocytes and, in contrast to controls, are resistant to the TGF-beta 1-induced differentiation block. These results demonstrate a new role for Snail1 in TGF-beta response and MSC maintenance.	[Batlle, R.; Alba-Castellon, L.; Loubat-Casanovas, J.; Armenteros, E.; Franci, C.; Stanisavljevic, J.; Baulida, J.; Garcia de Herreros, A.] IMIM, Programa Recerca Cancer, Hosp Mar, Barcelona 08003, Spain; [Barderas, R.; Casal, J. I.] CSIC, Dept Med Mol, Ctr Invest Biol, Madrid, Spain; [Martin-Caballero, J.] Parc Recerca Biomed Barcelona, Anim Facil, Barcelona, Spain; [Bonilla, F.] Hosp Puerta Hierro, Serv Oncol Med, Majadahonda, Spain; [Gridley, T.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME USA; [Garcia de Herreros, A.] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda; Maine Medical Center; Pompeu Fabra University	de Herreros, AG (corresponding author), IMIM, Programa Recerca Cancer, C Doctor Aiguader 88, Barcelona 08003, Spain.	agarcia@imim.es	Stanisavljević, Jelena/J-7152-2017; Barderas, Rodrigo/K-3560-2014; de Herreros, A Garcia/H-3104-2014; Casal, Ignacio/M-2312-2014; Stanisavljević, Jelena/ABG-8136-2020	Stanisavljević, Jelena/0000-0002-4880-4513; Barderas, Rodrigo/0000-0003-3539-7469; de Herreros, A Garcia/0000-0001-5270-0808; Casal, Ignacio/0000-0003-1085-2840; Stanisavljević, Jelena/0000-0002-4880-4513; Loubat Casanovas, Jordina/0000-0002-0158-3944; Alba-Castellon, Lorena/0000-0003-3449-7820	la Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Ministerio de Ciencia y Tecnologia [SAF2006-00339, SAF2010-16089]; Fundacio La Marato de TV3; NIH [R01HD034883]; ISCIII/FEDER [RD06/0020/0109, RD06/0020/0040, RD06/0020/0020]; Generalitat de Catalunya [2009SGR867]; FPI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034883] Funding Source: NIH RePORTER	la Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISCIII/FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FPI(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M Massoumi for help in the preparation of MSCs, Td'Altri for assistance in the FACS analysis, N Garcia-Giralt and L Larue for reagents, L diCroce for comments and E Batlle for support and advice. This study was funded by a grant awarded by la Fundacion Cientifica de la Asociacion Espanola contra el Cancer to AGH, JIC and FB. Support from the Ministerio de Ciencia y Tecnologia (SAF2006-00339 and SAF2010-16089) and Fundacio La Marato de TV3 to AGH, and NIH R01HD034883 to TG is also appreciated. We also acknowledge support from ISCIII/FEDER (RD06/0020/0109, RD06/0020/0040, RD06/0020/0020), Generalitat de Catalunya (2009SGR867). RB and LA-C were recipients from FPI predoctoral fellowships.	Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; de Frutos CA, 2009, EMBO J, V28, P686, DOI 10.1038/emboj.2009.23; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Murray SA, 2006, GENESIS, V44, P7, DOI 10.1002/gene.20178; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Ryu JM, 2010, J CELL PHYSIOL, V224, P59, DOI [10.1002/jcp.2209, 10.1002/jcp.22091]; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Villagrasa P, 2011, ONCOGENE, V31, P4064; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wu XH, 2011, J BIOL CHEM, V286, P13512, DOI 10.1074/jbc.M110.187351; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200	36	44	44	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 11	2013	32	28					3381	3389		10.1038/onc.2012.342	http://dx.doi.org/10.1038/onc.2012.342			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22869142	Green Submitted, Green Accepted			2022-12-25	WOS:000321620200008
J	Hayashi, T; Morishita, Y; Khattree, R; Misumi, M; Sasaki, K; Hayashi, I; Yoshida, K; Kajimura, J; Kyoizumi, S; Imai, K; Kusunoki, Y; Nakachi, K				Hayashi, Tomonori; Morishita, Yukari; Khattree, Ravindra; Misumi, Munechika; Sasaki, Keiko; Hayashi, Ikue; Yoshida, Kengo; Kajimura, Junko; Kyoizumi, Seishi; Imai, Kazue; Kusunoki, Yoichiro; Nakachi, Kei			Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects	FASEB JOURNAL			English	Article						reactive oxygen species; cytokines; immunosenescence	NF-KAPPA-B; C-REACTIVE PROTEIN; OXIDATIVE STRESS; CELL-DEATH; T-CELLS; CANCER; INTERLEUKIN-6; MORTALITY; OXYGEN; DYSFUNCTION	Past exposure to atomic bomb (A-bomb) radiation has exerted various long-lasting deleterious effects on the health of survivors. Some of these effects are seen even after >60 yr. In this study, we evaluated the subclinical inflammatory status of 442 A-bomb survivors, in terms of 8 inflammation-related cytokines or markers, comprised of plasma levels of reactive oxygen species (ROS), interleukin (IL)-6, tumor necrosis factor alpha (TNF-alpha), C-reactive protein (CRP), IL-4, IL-10, and immunoglobulins, and erythrocyte sedimentation rate (ESR). The effects of past radiation exposure and natural aging on these markers were individually assessed and compared. Next, to assess the biologically significant relationship between inflammation and radiation exposure or aging, which was masked by the interrelationship of those cytokines/markers, we used multivariate statistical analyses and evaluated the systemic markers of inflammation as scores being calculated by linear combinations of selected cytokines and markers. Our results indicate that a linear combination of ROS, IL-6, CRP, and ESR generated a score that was the most indicative of inflammation and revealed clear dependences on radiation dose and aging that were found to be statistically significant. The results suggest that collectively, radiation exposure, in conjunction with natural aging, may enhance the persistent inflammatory status of A-bomb survivors.-Hayashi, T., Morishita, Y., Khattree, R., Misumi, M., Sasaki, K., Hayashi, I., Yoshida, K., Kajimura, J., Kyoizumi, S., Imai, K., Kusunoki, Y., Nakachi, K. Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J. 26, 4765-4773 (2012). www.fasebj.org	[Hayashi, Tomonori; Morishita, Yukari; Sasaki, Keiko; Yoshida, Kengo; Kajimura, Junko; Kyoizumi, Seishi; Imai, Kazue; Kusunoki, Yoichiro; Nakachi, Kei] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima 7320815, Japan; [Khattree, Ravindra] Radiat Effects Res Fdn, Dept Stat, Hiroshima 7320815, Japan; [Misumi, Munechika] Oakland Univ, Dept Math & Stat, Rochester, MI 48063 USA; [Hayashi, Ikue] Hiroshima Univ, Cent Res Lab, Fac Dent, Hiroshima, Japan	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Oakland University; Hiroshima University	Hayashi, T (corresponding author), Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	tomo@rerf.or.jp		Misumi, Munechika/0000-0003-2698-4880	Japanese Ministry of Health, Labor, and Welfare; U.S. Department of Energy (DOE); DOE [DE-HS0000031]; Japanese Ministry of Education, Culture, Sports Science, and Technology; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Japanese Ministry of Education, Culture, Sports Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Radiation Effects Research Foundation (RERF; Hiroshima and Nagasaki, Japan) is a private, nonprofit foundation funded by the Japanese Ministry of Health, Labor, and Welfare and the U.S. Department of Energy (DOE), the latter in part through DOE award DE-HS0000031 to the National Academy of Sciences. This was based on RERF Research Protocols 1-93, 4-02, and 3-09 and was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Education, Culture, Sports Science, and Technology; the Japanese Ministry of Health, Labor, and Welfare; and the U.S. National Institute of Allergy and Infectious Diseases (NIAID; contract HHSN272200900059C). The views of the authors do not necessarily reflect those of the two governments.	Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224; Bishop Y. M., 2007, DISCRETE MULTIVARIAT; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chung J, 2008, BIOTECHNOL LETT, V30, P1553, DOI 10.1007/s10529-008-9744-z; Cubbon RM, 2009, CLIN SCI, V117, P173, DOI 10.1042/CS20080263; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; DINARELLO CA, 1991, BLOOD, V77, P1627; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Douple EB, 2011, DISASTER MED PUBLIC, V5, pS122, DOI 10.1001/dmp.2011.21; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; FEY GH, 1991, BIOCHIMIE, V73, P47, DOI 10.1016/0300-9084(91)90073-A; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hayashi I, 2007, MUTAT RES-GEN TOX EN, V631, P55, DOI 10.1016/j.mrgentox.2007.04.006; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; Kanayama A, 2007, J LEUKOCYTE BIOL, V82, P1344, DOI 10.1189/jlb.0407259; Khattree R., 2000, MULTIVARIATE DATA RE; Khattree R, 1999, APPL MULTIVARIATE ST; KODAMA K, 1990, JPN CIRC J, V54, P414, DOI 10.1253/jcj.54.414; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kusunoki Y, 1999, RADIAT RES, V152, P539, DOI 10.2307/3580151; Kusunoki Y, 1998, RADIAT RES, V150, P227, DOI 10.2307/3579858; Kusunoki Y, 2002, RADIAT RES, V158, P715, DOI 10.1667/0033-7587(2002)158[0715:TCOABS]2.0.CO;2; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; LU ZY, 1995, BLOOD, V86, P3123; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Mantovani G, 2002, INT J CANCER, V98, P84, DOI 10.1002/ijc.10143; Neriishi K, 2001, INT J RADIAT BIOL, V77, P475, DOI 10.1080/09553000010024911; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pannen B H, 1995, New Horiz, V3, P183; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Papadaki HA, 2001, INT J HEMATOL, V73, P339, DOI 10.1007/BF02981959; Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x; Peters T, 2009, MECH AGEING DEV, V130, P564, DOI 10.1016/j.mad.2009.07.003; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sharp GB, 2003, INT J CANCER, V103, P531, DOI 10.1002/ijc.10862; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; Sone H, 2010, REDOX REP, V15, P98, DOI 10.1179/174329210X12650506623843; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ungvari Z, 2004, HERZ, V29, P733, DOI 10.1007/s00059-004-2625-x; VanderMeide PH, 1996, BIOTHERAPY, V8, P243, DOI 10.1007/BF01877210; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003	57	30	31	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4765	4773		10.1096/fj.12-215228	http://dx.doi.org/10.1096/fj.12-215228			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872680	Green Published			2022-12-25	WOS:000310574200036
J	Kobayashi, Y; Tateno, H; Dohra, H; Moriwaki, K; Miyoshi, E; Hirabayashi, J; Kawagishi, H				Kobayashi, Yuka; Tateno, Hiroaki; Dohra, Hideo; Moriwaki, Kenta; Miyoshi, Eiji; Hirabayashi, Jun; Kawagishi, Hirokazu			A Novel Core Fucose-specific Lectin from the Mushroom Pholiota squarrosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; VICIA-FABA AGGLUTININ; COLON-CANCER CELLS; ALPHA-FETOPROTEIN; HEPATOCELLULAR-CARCINOMA; LENS-CULINARIS; OLIGOSACCHARIDE INTERACTIONS; BINDING-SPECIFICITY; ASPERGILLUS-ORYZAE; PURIFICATION	Fuc alpha 1-6 oligosaccharide has a variety of biological functions and serves as a biomarker for hepatocellular carcinoma because of the elevated presence of fucosylated alpha-fetoprotein ( AFP) in this type of cancer. In this study we purified a novel Fuc alpha 1-6-specific lectin from the mushroom Pholiota squarrosa by ion-exchange chromatography and affinity chromatography on thyroglobulin-agarose. The purified lectin was designated as PhoSL ( P. squarrosa lectin). SDS-PAGE, MALDI-TOF mass spectrometry, and N-terminal amino acid sequencing indicate that PhoSL has a molecular mass of 4.5 kDa and consists of 40 amino acids (NH2-APVPVTKLVCDGDTYKCTAYLDFGDGRWVAQWDTNVFHTG-OH). Isoelectric focusing of the lectin showed bands near pI 4.0. The lectin activity was stable between pH 2.0 and 11.0 and at temperatures ranging from 0 to 100 degrees C for incubation times of 30 min. When PhoSL was investigated with frontal affinity chromatography using 132 pyridylaminated oligosaccharides, it was found that the lectin binds only to core alpha 1-6-fucosylated N-glycans and not to other types of fucosylated oligosaccharides, such as alpha 1-2-, alpha 1-3-, and alpha 1-4-fucosylated glycans. Furthermore, PhoSL bound to alpha 1-6-fucosylated AFP but not to non-fucosylated AFP. In addition, PhoSL was able to demonstrate the differential expression of alpha 1-6fucosylation between primary and metastatic colon cancer tissues. Thus, PhoSL will be a promising tool for analyzing the biological functions of alpha 1-6 fucosylation and evaluating Fuc alpha 1-6 oligosaccharides as cancer biomarkers.	[Kobayashi, Yuka] J Oil Mills Inc, Totsuka Ku, Yokohama, Kanagawa 2450064, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba 3058568, Japan; [Dohra, Hideo] Shizuoka Univ, Fac Agr, Inst Genet Res & Biotechnol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Fac Agr, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Suruga Ku, Shizuoka 4228529, Japan; [Moriwaki, Kenta; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Investigat, Suita, Osaka 5650871, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Shizuoka University; Shizuoka University; Shizuoka University; Osaka University	Kobayashi, Y (corresponding author), J Oil Mills Inc, Totsuka Ku, 11 Kagetoricho, Yokohama, Kanagawa 2450064, Japan.	yuka.kobayashi@j-oil.com; achkawa@ipc.shizuoka.ac.jp	Tateno, Hiroaki/M-2706-2018; Hirabayashi, Jun/M-3998-2018	Tateno, Hiroaki/0000-0003-3006-1659; Hirabayashi, Jun/0000-0002-8571-359X; Moriwaki, Kenta/0000-0002-8724-4715; Dohra, Hideo/0000-0002-3919-3538				ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; ALLEN AK, 1976, BIOCHEM J, V155, P127, DOI 10.1042/bj1550127; Amano J, 2009, GLYCOBIOLOGY, V19, P601, DOI 10.1093/glycob/cwp026; [Anonymous], INT J MED MUSH; AOYAGI Y, 1995, GLYCOCONJUGATE J, V12, P194, DOI 10.1007/BF00731319; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; FORIERS A, 1981, J BIOL CHEM, V256, P5550; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; HARADA H, 1987, ANAL BIOCHEM, V164, P374, DOI 10.1016/0003-2697(87)90507-0; Hirabayashi J, 2000, J CHROMATOGR A, V890, P261, DOI 10.1016/S0021-9673(00)00545-8; Horibe M, 2010, PHYTOCHEMISTRY, V71, P648, DOI 10.1016/j.phytochem.2009.12.003; HOWARD IK, 1971, J BIOL CHEM, V246, P1590; Ichikawa E, 2006, ELECTROPHORESIS, V27, P3480, DOI 10.1002/elps.200600040; Jordinson M, 1999, GUT, V44, P709, DOI 10.1136/gut.44.5.709; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375; KAWAGISHI H, 1995, FOOD REV INT, V11, P63, DOI 10.1080/87559129509541019; KAWAGISHI H, 1988, FEBS LETT, V227, P99, DOI 10.1016/0014-5793(88)80876-7; Kobayashi Y, 2004, J BIOL CHEM, V279, P53048, DOI 10.1074/jbc.M407997200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1; Lundy FT, 1999, MOL BIOTECHNOL, V12, P203, DOI 10.1385/MB:12:2:203; Matsumoto H, 2010, CLIN CHEM LAB MED, V48, P505, DOI 10.1515/CCLM.2010.095; MATSUMOTO I, 1983, J BIOCHEM-TOKYO, V93, P763, DOI 10.1093/jb/93.3.763; Matsumura K, 2009, ANAL BIOCHEM, V386, P217, DOI 10.1016/j.ab.2008.11.044; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; MORINAGA T, 1983, P NATL ACAD SCI-BIOL, V80, P4604, DOI 10.1073/pnas.80.15.4604; Moriwaki K, 2011, J BIOL CHEM, V286, P43123, DOI 10.1074/jbc.M111.262741; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097; Mun JY, 2012, APPL MICROBIOL BIOT, V93, P251, DOI 10.1007/s00253-011-3549-z; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Nakamura-Tsuruta S, 2006, METHOD ENZYMOL, V415, P311, DOI 10.1016/S0076-6879(06)15019-3; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Norton PA, 2008, J CELL BIOCHEM, V104, P136, DOI 10.1002/jcb.21610; Oda Y, 2003, J BIOL CHEM, V278, P32439, DOI 10.1074/jbc.M305181200; Sterling RK, 2007, AM J GASTROENTEROL, V102, P2196, DOI 10.1111/j.1572-0241.2007.01405.x; TAKETA K, 1989, ELECTROPHORESIS, V10, P562, DOI 10.1002/elps.1150100805; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tamura Y, 2010, DIGEST DIS SCI, V55, P3576, DOI 10.1007/s10620-010-1222-5; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Yamagata Y, 2003, CLIN CHIM ACTA, V327, P59, DOI 10.1016/S0009-8981(02)00305-4; Yamamoto K, 2010, J GASTROENTEROL, V45, P1272, DOI 10.1007/s00535-010-0278-5; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688	51	78	82	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33973	33982		10.1074/jbc.M111.327692	http://dx.doi.org/10.1074/jbc.M111.327692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872641	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000309654200005
J	Kristiana, I; Luu, W; Stevenson, J; Cartland, S; Jessup, W; Belani, JD; Rychnovsky, SD; Brown, AJ				Kristiana, Ika; Luu, Winnie; Stevenson, Julian; Cartland, Sian; Jessup, Wendy; Belani, Jitendra D.; Rychnovsky, Scott D.; Brown, Andrew J.			Cholesterol through the Looking Glass ABILITY OF ITS ENANTIOMER ALSO TO ELICIT HOMEOSTATIC RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHOLESTEROL; STEROL-REGULATED TRANSPORT; SCAP PROTEIN; BINDING; SREBPS; GOLGI; 25-HYDROXYCHOLESTEROL; IDENTIFICATION; DEGRADATION; LIPOPROTEIN	How cholesterol is sensed to maintain homeostasis has been explained by direct binding to a specific protein, Scap, or through altering the physical properties of the membrane. The enantiomer of cholesterol (ent-cholesterol) is a valuable tool in distinguishing between these two models because it shares non-specific membrane effects with native cholesterol (nat-cholesterol), but not specific binding interactions. This is the first study to compare ent- and nat-cholesterol directly on major molecular parameters of cholesterol homeostasis. We found that ent- cholesterol suppressed activation of the master transcriptional regulator of cholesterol metabolism, SREBP-2, almost as effectively as nat-cholesterol. Importantly, ent-cholesterol induced a conformational change in the cholesterol-sensing protein Scap in isolated membranes in vitro, even when steps were taken to eliminate potential confounding effects from endogenous cholesterol. Ent-cholesterol also accelerated proteasomal degradation of the key cholesterol biosynthetic enzyme, squalene monooxygenase. Together, these findings provide compelling evidence that cholesterol maintains its own homeostasis not only via direct protein interactions, but also by altering membrane properties.	[Kristiana, Ika; Luu, Winnie; Stevenson, Julian; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Cartland, Sian; Jessup, Wendy] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Belani, Jitendra D.; Rychnovsky, Scott D.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of California System; University of California Irvine	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Belani, Jitendra/W-5561-2019	Cartland, Sian/0000-0003-1723-2679; Rychnovsky, Scott/0000-0002-7223-4389	National Health and Medical Research Council Grant [1008081]; Prostate Cancer Foundation Grant [PG2710]; National Heart Foundation of Australia Grant [G11S 5757]	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation Grant; National Heart Foundation of Australia Grant(National Heart Foundation of Australia)	This work was supported by the National Health and Medical Research Council Grant 1008081, the Prostate Cancer Foundation Grant PG2710, and the National Heart Foundation of Australia Grant G11S 5757 (to the Brown Research Laboratory).	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Belani JD, 2008, J ORG CHEM, V73, P2768, DOI 10.1021/jo702694g; Bielska AA, 2012, TRENDS ENDOCRIN MET, V23, P99, DOI 10.1016/j.tem.2011.12.002; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chaudhuri A, 2011, BBA-BIOMEMBRANES, V1808, P19, DOI 10.1016/j.bbamem.2010.10.013; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Kristiana I, 2010, PHARMACOGENOMICS J, V10, P396, DOI 10.1038/tpj.2009.62; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Luker GD, 2000, BIOCHEMISTRY-US, V39, P7651, DOI 10.1021/bi9928593; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MICKUS DE, 1992, J AM CHEM SOC, V114, P359, DOI 10.1021/ja00027a055; Mitchell CR, 2003, METH MOL B, V243, P61; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	44	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33897	33904		10.1074/jbc.M112.360537	http://dx.doi.org/10.1074/jbc.M112.360537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869373	Green Published, hybrid			2022-12-25	WOS:000309602100070
J	Sugiki, T; Takeuchi, K; Yamaji, T; Takano, T; Tokunaga, Y; Kumagai, K; Hanada, K; Takahashi, H; Shimada, I				Sugiki, Toshihiko; Takeuchi, Koh; Yamaji, Toshiyuki; Takano, Toshiaki; Tokunaga, Yuji; Kumagai, Keigo; Hanada, Kentaro; Takahashi, Hideo; Shimada, Ichio			Structural Basis for the Golgi Association by the Pleckstrin Homology Domain of the Ceramide Trafficking Protein (CERT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13,N-15-LABELED LARGE PROTEINS; CROSS-SATURATION EXPERIMENTS; OXYSTEROL-BINDING-PROTEIN; LIPID-TRANSFER PROTEINS; PH-DOMAIN; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; NONVESICULAR TRAFFICKING; MEMBRANE TRAFFICKING; MOLECULAR-BASIS; CELL-SURFACE	Ceramide transport from the endoplasmic reticulum to the Golgi apparatus is crucial in sphingolipid biosynthesis, and the process relies on the ceramide trafficking protein (CERT), which contains pleckstrin homology (PH) and StAR-related lipid transfer domains. The CERT PH domain specifically recognizes phosphatidylinositol 4-monophosphate (PtdIns(4)P), a characteristic phosphoinositide in the Golgi membrane, and is indispensable for the endoplasmic reticulum-to-Golgi transport of ceramide by CERT. In this study, we determined the three-dimensional structure of the CERT PH domain by using solution NMR techniques. The structure revealed the presence of a characteristic basic groove near the canonical PtdIns(4) P recognition site. An extensive interaction study using NMRand other biophysical techniques revealed that the basic groove coordinates the CERT PH domain for efficient PtdIns(4)P recognition and localization in the Golgi apparatus. The notion was also supported by Golgi mislocalization of the CERT mutants in living cells. The distinctive binding modes reflect the functions of PH domains, as the basic groove is conserved only in thePHdomains involved with the PtdIns(4)P-dependent lipid transport activity but not in those with the signal transduction activity.	[Takahashi, Hideo] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sugiki, Toshihiko; Tokunaga, Yuji; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiki, Toshihiko; Takano, Toshiaki; Tokunaga, Yuji] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan; [Sugiki, Toshihiko; Takeuchi, Koh; Tokunaga, Yuji; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Yamaji, Toshiyuki; Kumagai, Keigo; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Yokohama City University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Infectious Diseases (NIID)	Takahashi, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hid@tsurumi.yokohama-cu.ac.jp; shimada@iw-nmr.f.u-tokyo.ac.jp	Kumagai, Keigo/AAG-1385-2021; Takeuchi, Koh/B-4971-2010; Tokunaga, Yuji/L-6339-2018	Takeuchi, Koh/0000-0002-6227-4627; Tokunaga, Yuji/0000-0002-8774-9780; Hanada, Kentaro/0000-0003-1383-2781; Kumagai, Keigo/0000-0002-1663-2905	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Economy, Trade, and Industry; Japan New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [23790064, 24102524, 24890263] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Economy, Trade, and Industry; Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Ministry of Economy, Trade, and Industry, and the Japan New Energy and Industrial Technology Development Organization.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; CERDAN S, 1986, J BIOL CHEM, V261, P4676; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Meinecke R, 2001, J MED CHEM, V44, P3059, DOI 10.1021/jm0109154; Nakamura T, 2010, J MED CHEM, V53, P1917, DOI 10.1021/jm901099v; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roth M, 2004, NAT CELL BIOL, V6, P384, DOI 10.1038/ncb0504-384; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Sugiki T, 2010, ANAL BIOCHEM, V399, P162, DOI 10.1016/j.ab.2009.12.031; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Xu YQ, 2005, J AM CHEM SOC, V127, P11920, DOI 10.1021/ja053539b; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Zhang L, 2006, BIOINFORMATICS, V22, P2833, DOI 10.1093/bioinformatics/btl477	55	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33706	33718		10.1074/jbc.M112.367730	http://dx.doi.org/10.1074/jbc.M112.367730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869376	Green Published, hybrid			2022-12-25	WOS:000309602100053
J	Mittelstadt, ML; Patel, RC				Mittelstadt, Megan L.; Patel, Rekha C.			AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon beta	PLOS ONE			English	Article							NF-KAPPA-B; REGULATORY FACTOR-I; GENE-EXPRESSION; DOWN-REGULATION; GELATINASE-B; IFN-GAMMA; MMP-9; PTEN; STAT-1-ALPHA; ACETYLATION	Matrix metalloproteinase-9 (MMP-9) is a 92 kDa zinc-dependant endopeptidase that degrades components of the extracellular matrix. Increased expression of MMP-9 is implicated in many pathological conditions including metastatic cancer, multiple sclerosis, and atherosclerosis. Although it has been widely noted that interferon-beta (IFN beta) downregulates both the basal and phorbol 12-myristate 13-acetate (PMA)-induced MMP-9 expression at the transcriptional level, the molecular mechanism of this repression is poorly understood. In the present study we identify a novel mechanism for repression of MMP-9 transcription by IFN beta in HT1080 fibrosarcoma cells. Using reporter assays with promoter deletion constructs we show that IFNb's inhibitory effects require a region of the promoter between -154 and -72, which contains an AP-1 binding site. Chromatin immunoprecipitation (ChIP) studies indicate that IFN beta increases histone deacetylase (HDAC)-1 recruitment to the MMP-9 promoter and reduces histone H3 acetylation, in addition to reduced NF-kappa B recruitment. ChIP analysis shows that IFN beta induced HDAC1 recruitment to the MMP-9 promoter and IFNb mediated transcriptional repression is lost when the AP-1 binding site is inactivated by a point mutation. Altogether, our results establish that the repression of MMP-9 transcription in response to IFN beta occurs by the recruitment of HDAC1 via the proximal AP-1 binding site.	[Mittelstadt, Megan L.; Patel, Rekha C.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mittelstadt, ML (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	patelr@biol.sc.edu	Patel, Rekha/M-7123-2015	Patel, Rekha/0000-0001-9434-4880	University of South Carolina Research Opportunity Pilot Grant	University of South Carolina Research Opportunity Pilot Grant	This work was supported by University of South Carolina Research Opportunity Pilot Grant to RCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Galewska Z, 2008, CLIN CHEM LAB MED, V46, P517, DOI 10.1515/CCLM.2008.083; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Han YJ, 2009, FERTIL STERIL, V91, P2324, DOI 10.1016/j.fertnstert.2008.03.047; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Hartung HP, 2000, LANCET, V356, P1114, DOI 10.1016/S0140-6736(05)74558-X; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Ma ZD, 2005, J LEUKOCYTE BIOL, V78, P515, DOI 10.1189/jlb.0205112; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Zhao XY, 2007, FEBS J, V274, P6456, DOI 10.1111/j.1742-4658.2007.06163.x; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	29	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42152	10.1371/journal.pone.0042152	http://dx.doi.org/10.1371/journal.pone.0042152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879913	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000018
J	Tang, YT; Ho, G; Li, YX; Hall, MA; Hills, RL; Black, SC; Liang, Y; Demarest, KT				Tang, Yuting; Ho, George; Li, Yaxin; Hall, Meghan A.; Hills, Robert L.; Black, Shawn C.; Liang, Yin; Demarest, Keith T.			Beneficial Metabolic Effects of CB1R Anti-Sense Oligonucleotide Treatment in Diet-Induced Obese AKR/J Mice	PLOS ONE			English	Article							RECEPTOR ANTAGONIST SR141716; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; ADIPOSE-TISSUE; INSULIN SENSITIVITY; GLUCOSE-UPTAKE; RIMONABANT; EXPRESSION; CB2; STEATOSIS	An increasing amount of evidence supports pleiotropic metabolic roles of the cannibinoid-1 receptor (CB1R) in peripheral tissues such as adipose, liver, skeletal muscle and pancreas. To further understand the metabolic consequences of specific blockade of CB1R function in peripheral tissues, we performed a 10-week-study with an anti-sense oligonucleotide directed against the CB1R in diet-induced obese (DIO) AKR/J mice. DIO AKR/J mice were treated with CB1R ASO Isis-414930 (6.25, 12.5 and 25 mg/kg/week) or control ASO Isis-141923 (25 mg/kg/week) via intraperitoneal injection for 10 weeks. At the end of the treatment, CB1R mRNA from the 25 mg/kg/week CB1R ASO group in the epididymal fat and kidney was decreased by 81% and 63%, respectively. Body weight gain was decreased in a dose-dependent fashion, significantly different in the 25 mg/kg/week CB1R ASO group (46.1 +/- 1.0 g vs veh, 51.2 +/- 0.9 g, p<0.05). Body fat mass was reduced in parallel with attenuated body weight gain. CB1R ASO treatment led to decreased fed glucose level (at week 8, 25 mg/kg/week group, 145 +/- 4 mg/dL vs veh, 195 +/- 10 mg/dL, p<0.05). Moreover, CB1R ASO treatment dose-dependently improved glucose excursion during an oral glucose tolerance test, whereas control ASO exerted no effect. Liver steatosis was also decreased upon CB1R ASO treatment. At the end of the study, plasma insulin and leptin levels were significantly reduced by 25 mg/kg/week CB1R ASO treatment. SREBP1 mRNA expression was decreased in both epididymal fat and liver. G6PC and fatty acid translocase/CD36 mRNA levels were also reduced in the liver. In summary, CB1R ASO treatment in DIO AKR/J mice led to improved insulin sensitivity and glucose homeostasis. The beneficial effects of CB1R ASO treatment strongly support the notion that selective inhibition of the peripheral CB1R, without blockade of central CB1R, may serve as an effective approach for treating type II diabetes, obesity and the metabolic syndrome.	[Tang, Yuting; Ho, George; Li, Yaxin; Hall, Meghan A.; Hills, Robert L.; Black, Shawn C.; Liang, Yin; Demarest, Keith T.] Janssen Pharmaceut Co, Cardiovasc & Metab Therapeut Area, Johnson & Johnson, Spring House, PA USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Tang, YT (corresponding author), Janssen Pharmaceut Co, Cardiovasc & Metab Therapeut Area, Johnson & Johnson, Spring House, PA USA.	ytang69@yahoo.com			Janssen Pharmaceutical Companies of Johnson and Johnson	Janssen Pharmaceutical Companies of Johnson and Johnson	The study was funded by Janssen Pharmaceutical Companies of Johnson and Johnson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Baldassano S, 2008, EUR J PHARMACOL, V582, P132, DOI 10.1016/j.ejphar.2007.12.016; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Bermudez-Silva FJ, 2009, BEST PRACT RES CL EN, V23, P87, DOI 10.1016/j.beem.2008.10.012; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Chang LC, 2009, J FORMOS MED ASSOC, V108, P353, DOI 10.1016/S0929-6646(09)60079-6; Cigolini M, 1999, ATHEROSCLEROSIS, V143, P81, DOI 10.1016/S0021-9150(98)00281-0; Corbille AG, 2007, J NEUROSCI, V27, P6937, DOI 10.1523/JNEUROSCI.3936-06.2007; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Crespillo A, 2011, BIOCHEM J, V433, P175, DOI 10.1042/BJ20100751; Croci T, 1998, BRIT J PHARMACOL, V125, P1393, DOI 10.1038/sj.bjp.0702190; De Gottardi A, 2010, LIVER INT, V30, P1482, DOI 10.1111/j.1478-3231.2010.02298.x; Despres JP, 2009, CURR PHARM DESIGN, V15, P553, DOI 10.2174/138161209787315666; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Esposito I, 2008, MOL PHARMACOL, V74, P1678, DOI 10.1124/mol.108.049205; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Friedman SL, 2008, CELL METAB, V7, P187, DOI 10.1016/j.cmet.2008.02.002; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Getty-Kaushik L, 2009, OBESITY, V17, P1856, DOI 10.1038/oby.2009.234; Gomez R, 2002, J NEUROSCI, V22, P9612; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Janero DR, 2009, EXPERT OPIN EMERG DR, V14, P43, DOI [10.1517/14728210902736568 , 10.1517/14728210902736568]; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Lobo SM, 2012, CYTOKINE IN PRESS; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mendez-Sanchez N, 2007, LIVER INT, V27, P215, DOI 10.1111/j.1478-3231.2006.01401.x; Migrenne S, 2009, AM J PHYSIOL-REG I, V296, pR929, DOI 10.1152/ajpregu.90824.2008; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moezi L, 2006, BRIT J PHARMACOL, V149, P898, DOI 10.1038/sj.bjp.0706928; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Osei-Hyiaman D, 2005, NEUROENDOCRINOLOGY, V81, P273, DOI 10.1159/000087925; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Scheen AJ, 2009, CURR PROTEIN PEPT SC, V10, P56, DOI 10.2174/138920309787315149; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vemuri VK, 2008, PHYSIOL BEHAV, V93, P671, DOI 10.1016/j.physbeh.2007.11.012; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Wang Q, 2011, OBESITY, V19, P505, DOI 10.1038/oby.2010.213; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	68	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42134	10.1371/journal.pone.0042134	http://dx.doi.org/10.1371/journal.pone.0042134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870290	Green Published, gold			2022-12-25	WOS:000307284100046
J	Blaho, M; Egri, A; Bahidszki, L; Kriska, G; Hegedus, R; Akesson, S; Horvath, G				Blaho, Miklos; Egri, Adam; Bahidszki, Lea; Kriska, Gyorgy; Hegedus, Ramon; Akesson, Susanne; Horvath, Gabor			Spottier Targets Are Less Attractive to Tabanid Flies: On the Tabanid-Repellency of Spotty Fur Patterns	PLOS ONE			English	Article							POLARIZATION VISION; WATER; ADVANTAGE; INSECTS; DIPTERA; HORSE; TRAP	During blood-sucking, female members of the family Tabanidae transmit pathogens of serious diseases and annoy their host animals so strongly that they cannot graze, thus the health of the hosts is drastically reduced. Consequently, a tabanid-resistant coat with appropriate brightness, colour and pattern is advantageous for the host. Spotty coats are widespread among mammals, especially in cattle (Bos primigenius). In field experiments we studied the influence of the size and number of spots on the attractiveness of test surfaces to tabanids that are attracted to linearly polarized light. We measured the reflection-polarization characteristics of living cattle, spotty cattle coats and the used test surfaces. We show here that the smaller and the more numerous the spots, the less attractive the target (host) is to tabanids. We demonstrate that the attractiveness of spotty patterns to tabanids is also reduced if the target exhibits spottiness only in the angle of polarization pattern, while being homogeneous grey with a constant high degree of polarization. Tabanid flies respond strongly to linearly polarized light, and we show that bright and dark parts of cattle coats reflect light with different degrees and angles of polarization that in combination with dark spots on a bright coat surface disrupt the attractiveness to tabanids. This could be one of the possible evolutionary benefits that explains why spotty coat patterns are so widespread in mammals, especially in ungulates, many species of which are tabanid hosts.	[Blaho, Miklos; Egri, Adam; Bahidszki, Lea; Horvath, Gabor] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Kriska, Gyorgy] Eotvos Lorand Univ, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary; [Kriska, Gyorgy] Hungarian Acad Sci, Ctr Ecol Res, Danube Res Inst, Vacratot, Hungary; [Hegedus, Ramon] Univ Girona, Comp Vis & Robot Grp, Girona, Spain; [Akesson, Susanne] Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Universitat de Girona; Lund University	Blaho, M (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	susanne.akesson@biol.lu.se	Kriska, György/B-5723-2019; Akesson, Susanne/F-3175-2015	Akesson, Susanne/0000-0001-9039-2180; Kriska, Gyorgy/0000-0003-4271-3167	Hungarian Science Foundation [OTKA K-68462]; European Commission; Swedish Research Council [349-2007-8690]; Centre for Animal Movement Research (CAnMove); Lund University;  [TabaNOid 232366]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research (CAnMove); Lund University; 	This work was supported by the grant OTKA K-68462 from the Hungarian Science Foundation, and the grant TabaNOid 232366 funded by the European Commission under the 7th Framework Programme received by G. Horvath and G. Kriska. Gabor Horvath thanks the German Alexander von Humboldt Foundation for an equipment donation. Susanne Akesson is supported by a project grant from the Swedish Research Council and the Centre for Animal Movement Research (CAnMove) financed by a Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University. Ramon Hegedus is a Marie Curie IEF fellow and is grateful for the support of the European Commission. The authors are grateful to Dr. Robert Farkas and Monika Gyurkovszky (Department of Parasitology and Zoology, Faculty of Veterinary Science, Szent Istvan University, Budapest) for the taxonomical determination of the captured tabanids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SA, 1991, CAN J ZOOL, V69, P369, DOI 10.1139/z91-057; Allen WL, 2011, P ROY SOC B-BIOL SCI, V278, P1373, DOI 10.1098/rspb.2010.1734; Andersson Malte, 1994; Caro T, 2009, PHILOS T R SOC B, V364, P537, DOI 10.1098/rstb.2008.0221; CLARKE CA, 1966, PROC R SOC SER B-BIO, V165, P424, DOI 10.1098/rspb.1966.0075; CLAYTON DH, 1991, PARASITOL TODAY, V7, P329, DOI 10.1016/0169-4758(91)90211-6; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; FINCH VA, 1984, J AGR SCI-CAMBRIDGE, V102, P141, DOI 10.1017/S0021859600041575; FOIL LD, 1989, PARASITOL TODAY, V5, P88, DOI 10.1016/0169-4758(89)90009-4; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; Grant BS, 1999, EVOLUTION, V53, P980; Hall MJR, 1998, MED VET ENTOMOL, V12, P241, DOI 10.1046/j.1365-2915.1998.00107.x; Horvath G, 1997, J EXP BIOL, V200, P1155; Horvath G, 2004, POLARIZED LIGHT ANIM, P447; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lerner A, 2008, J EXP BIOL, V211, P3536, DOI 10.1242/jeb.022277; Majer J, 1987, FAUNA HUNGARIAE, V14, P1; Mihok S, 2012, MED VET ENTOMOL, V26, P282, DOI 10.1111/j.1365-2915.2011.00999.x; Mihok S, 2002, B ENTOMOL RES, V92, P385, DOI 10.1079/BER2002186; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Ortolani Alessia, 1996, P132; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; SCHWIND R, 1991, J COMP PHYSIOL A, V169, P531; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; WALSBERG GE, 1983, BIOSCIENCE, V33, P88, DOI 10.2307/1309169; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504	30	30	31	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41138	10.1371/journal.pone.0041138	http://dx.doi.org/10.1371/journal.pone.0041138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876282	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700010
J	Li, RM; Song, DS; Zhu, ZB; Xu, HH; Liu, SW				Li, Runming; Song, Deshou; Zhu, Zhibo; Xu, Hanhong; Liu, Shuwen			An Induced Pocket for the Binding of Potent Fusion Inhibitor CL-385319 with H5N1 Influenza Virus Hemagglutinin	PLOS ONE			English	Article							ENERGY SIMULATIONS REVEAL; AIM TOPOLOGICAL ANALYSIS; VIRAL MEMBRANE-FUSION; A VIRUS; CONFORMATIONAL-CHANGE; ELECTRONIC DENSITY; GENERALIZED BORN; RECEPTOR-BINDING; PEPTIDE MUTANTS; HYDROGEN-BONDS	The influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 influenza virus, CL-385319, which specifically inhibits HA-mediated viral entry. Studies presented here identified the critical binding residues for CL-385319, which clustered in the stem region of the HA trimer by site-directed mutagenesis. Extensive computational simulations, including molecular docking, molecular dynamics simulations, molecular mechanics generalized Born surface area (MM_GBSA) calculations, charge density and Laplacian calculations, have been carried out to uncover the detailed molecular mechanism that underlies the binding of CL-385319 to H5N1 influenza virus HA. It was found that the recognition and binding of CL-385319 to HA proceeds by a process of "induced fit" whereby the binding pocket is formed during their interaction. Occupation of this pocket by CL-385319 stabilizes the neutral pH structure of hemagglutinin, thus inhibiting the conformational rearrangements required for membrane fusion. This "induced fit" pocket may be a target for structure-based design of more potent influenza fusion inhibitors.	[Li, Runming; Zhu, Zhibo; Liu, Shuwen] So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Song, Deshou; Xu, Hanhong] S China Agr Univ, Key Lab Nat Pesticides & Chem Biol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; South China Agricultural University	Li, RM (corresponding author), So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	liusw@smu.edu.cn		Liu, Shuwen/0000-0001-6346-5006; Xu, Han-Hong/0000-0001-7841-2396	Natural Science Foundation of China [30772602]; foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes [KLB09007]; Guangdong Pearl River Scholar Funded Scheme	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes; Guangdong Pearl River Scholar Funded Scheme	This work was supported by the Natural Science Foundation of China (30772602), the foundation from Key Laboratory of Prevention and Control of Emerging Infectious Diseases of Guangdong Higher Education Institutes (KLB09007) and the Guangdong Pearl River Scholar Funded Scheme to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Biegler-Konig F., 2002, AIM 2000 VERSION 2 0; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cross KJ, 2001, EMBO J, V20, P4432, DOI 10.1093/emboj/20.16.4432; Das P, 2009, J COMPUT CHEM, V30, P1654, DOI 10.1002/jcc.21274; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim CS, 2011, J BIOL CHEM, V286, P13226, DOI 10.1074/jbc.M110.181297; KOCH U, 1995, J PHYS CHEM-US, V99, P9747, DOI 10.1021/j100024a016; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013; Louit G, 2003, PHYSCHEMCOMM, V6, P1, DOI 10.1039/b210911e; Louit G, 2002, PHYSCHEMCOMM, V5, P94, DOI 10.1039/b204736e; Luo GX, 1997, J VIROL, V71, P4062, DOI 10.1128/JVI.71.5.4062-4070.1997; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; LYBRAND TP, 1986, P NATL ACAD SCI USA, V83, P833, DOI 10.1073/pnas.83.4.833; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Plotch SJ, 1999, J VIROL, V73, P140, DOI 10.1128/JVI.73.1.140-151.1999; Popelier PLA, 1998, J PHYS CHEM A, V102, P1873, DOI 10.1021/jp9805048; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; WEIS WI, 1990, EMBO J, V9, P17, DOI 10.1002/j.1460-2075.1990.tb08075.x; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Xia Z, 2012, BIOPHYS J, V102, P1453, DOI 10.1016/j.bpj.2012.01.043; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Yoshimoto J, 1999, ARCH VIROL, V144, P865, DOI 10.1007/s007050050552; Zhou RH, 2008, J PHYS CHEM B, V112, P15813, DOI 10.1021/jp805529z	48	10	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41956	10.1371/journal.pone.0041956	http://dx.doi.org/10.1371/journal.pone.0041956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876294	Green Published, Green Submitted			2022-12-25	WOS:000307184700022
J	Li, YQ; Low, HQ; Foo, JN; Darabi, H; Einarsdottir, K; Humphreys, K; Spurdle, A; Easton, DF; Thompson, DJ; Dunning, AM; Pharoah, PDP; Czene, K; Chia, KS; Hall, P; Liu, JJ				Li, Yuqing; Low, Hui-Qi; Foo, Jia Nee; Darabi, Hatef; Einarsdottir, Kristjana; Humphreys, Keith; Spurdle, Amanda; Easton, Douglas F.; Thompson, Deborah J.; Dunning, Alison M.; Pharoah, Paul D. P.; Czene, Kamila; Chia, Kee Seng; Hall, Per; Liu, Jianjun		ANECS Grp	Genetic Variants in ER Cofactor Genes and Endometrial Cancer Risk	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREGULATORS; GENOME-WIDE ASSOCIATION; ESTROGEN; COACTIVATOR; EXPRESSION	Given that the transcriptional regulatory activity of estrogen receptor (ER) is modulated by its biochemical cofactors, genetic variation within the ER cofactor genes may alter cellular response to estrogen exposure and consequently modify the risk for endometrial cancer. We genotyped 685 tagging SNPs within 60 ER cofactor genes in 564 endometrial cancer cases and 1,510 controls from Sweden, and tested their associations with the risk of endometrial cancer. We investigated the associations of individual SNPs by using a trend test as well as multiple SNPs within a gene or gene complex by using multi-variant association analysis. No significant association was observed for any individual SNPs or genes, but a marginal association of the cumulative genetic variation of the NCOA2 complex as a whole (NCOA2, CARM1, CREBBP, PRMT1 and EP300) with endometrial cancer risk was observed (P-adjusted = 0.033). However, the association failed to be replicated in an independent European dataset of 1265 cases and 5190 controls (P = 0.71). The results indicate that common genetic variants within ER cofactor genes are unlikely to play a significant role in endometrial cancer risk in European population.	[Li, Yuqing; Low, Hui-Qi; Foo, Jia Nee; Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Darabi, Hatef; Humphreys, Keith; Czene, Kamila; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Einarsdottir, Kristjana] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia; [Spurdle, Amanda] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [ANECS Grp] Queensland Inst Med Res, Australian Natl Endometrial Canc Study ANECS Grp, Brisbane, Qld 4006, Australia; [Easton, Douglas F.; Thompson, Deborah J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Dunning, Alison M.; Pharoah, Paul D. P.] Univ Cambridge, Dept Oncol, Cambridge, England; [Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Telethon Kids Institute; University of Western Australia; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Cambridge; National University of Singapore	Li, YQ (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liuj3@gis.a-star.edu.sg	Einarsdóttir, Kristjana/E-8337-2011; Spurdle, Amanda B/A-4978-2011; Pharoah, Paul/V-6658-2019; Nicklin, James L/F-8035-2013; Foo, Jia Nee/D-6069-2014; Liu, Jianjun/AAK-4989-2020	Einarsdóttir, Kristjana/0000-0003-4931-7650; Spurdle, Amanda B/0000-0003-1337-7897; Pharoah, Paul/0000-0001-8494-732X; Nicklin, James L/0000-0001-5857-3723; Foo, Jia Nee/0000-0001-9899-2308; Liu, Jianjun/0000-0002-3255-3019; Czene, Kamila/0000-0002-3233-5695; Dunning, Alison Margaret/0000-0001-6651-7166	American Cancer Society; National Institutes of Health; Department of Defense; Swedish Cancer Society; Swedish Research Council; Agency for Science, Technology and Research of Singapore (A*STAR); National Health and Medical Research Council of Australia [339435]; Cancer Council Queensland [4196615]; Cancer Council Tasmania [403031, 457636]; Cancer Research UK [C490/A10124]; National Health and Medical Research Council [552402]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02, 085475]; Cancer Research UK [11022, 10118] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Research UK(Cancer Research UK); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This discovery dataset was supported by funding from American Cancer Society, National Institutes of Health, Department of Defense, Swedish Cancer Society, Swedish Research Council and the Agency for Science, Technology and Research of Singapore (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The validation dataset was funded as follows: ANECS recruitment was supported by project grants from the National Health and Medical Research Council of Australia (ID#339435), The Cancer Council Queensland (ID#4196615) and Cancer Council Tasmania (ID#403031 and ID#457636). SEARCH recruitment was funded by a programme grant from Cancer Research UK [C490/A10124]. Case genotyping was supported by the National Health and Medical Research Council (ID#552402). Control data was generated by the Wellcome Trust Case Control Consortium (WTCCC)2, and a full list of the investigators who contributed to the generation of the data is available from the WTCCC website. The authors acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Funding for this project was provided by the Wellcome Trust under award 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Arafa M, 2010, PATHOLOGY, V42, P613, DOI 10.3109/00313025.2010.520307; Balmer NN, 2006, MODERN PATHOL, V19, P1593, DOI 10.1038/modpathol.3800696; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Einarsdottir K, 2007, HUM MOL GENET, V16, P154, DOI 10.1093/hmg/ddl451; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li YQ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2817; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; O'Malley BW, 2006, SCIENCE, V313, P1749, DOI 10.1126/science.1132509; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; ONATE SA, 1995, SCIENCE, V270, P1354; Pathirage N, 2006, FERTIL STERIL, V86, P469, DOI 10.1016/j.fertnstert.2005.12.057; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; Weiderpass E, 1999, LANCET, V353, P1824, DOI 10.1016/S0140-6736(98)10233-7	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42445	10.1371/journal.pone.0042445	http://dx.doi.org/10.1371/journal.pone.0042445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876322	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700050
J	Rawlinson, KA; Stella, JS				Rawlinson, Kate A.; Stella, Jessica S.			Discovery of the Corallivorous Polyclad Flatworm, Amakusaplana acroporae, on the Great Barrier Reef, Australia - the First Report from the Wild	PLOS ONE			English	Article							CORAL-REEFS; BAND DISEASE; STONY CORALS; PREDATORS; DIVERSITY; HEALTH	The role of corallivory is becoming increasingly recognised as an important factor in coral health at a time when coral reefs around the world face a number of other stressors. The polyclad flatworm, Amakusaplana acroporae, is a voracious predator of Indo-Pacific acroporid corals in captivity, and its inadvertent introduction into aquaria has lead to the death of entire coral colonies. While this flatworm has been a pest to the coral aquaculture community for over a decade, it has only been found in aquaria and has never been described from the wild. Understanding its biology and ecology in its natural environment is crucial for identifying viable biological controls for more successful rearing of Acropora colonies in aquaria, and for our understanding of what biotic interactions are important to coral growth and fitness on reefs. Using morphological, histological and molecular techniques we determine that a polyclad found on Acropora valida from Lizard Island, Australia is A. acroporae. The presence of extracellular Symbiodinium in the gut and parenchyma and spirocysts in the gut indicates that it is a corallivore in the wild. The examination of a size-range of individuals shows maturation of the sexual apparatus and increases in the number of eyes with increased body length. Conservative estimates of abundance show that A. acroporae occurred on 7 of the 10 coral colonies collected, with an average of 2.6 +/- 0.65 (mean +/- SE) animals per colony. This represents the first report of A. acroporae in the wild, and sets the stage for future studies of A. acroporae ecology and life history in its natural habitat.	[Rawlinson, Kate A.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Stella, Jessica S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Stella, Jessica S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Stella, Jessica S.] CSIRO, Climate Adaptat Flagship, Hobart, Tas, Australia	Dalhousie University; James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rawlinson, KA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	k.rawlinson@dal.ca			Yugilbar Foundation; Lizard Island Research Station - a facility of the Australian Museum; Great Barrier Reef Marine Park Authority Science for Management Award; Natural Sciences and Engineering Research Council of Canada [A5056]	Yugilbar Foundation; Lizard Island Research Station - a facility of the Australian Museum; Great Barrier Reef Marine Park Authority Science for Management Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Animal collection and field work was funded by the Yugilbar Foundation and Lizard Island Research Station - a facility of the Australian Museum and the Great Barrier Reef Marine Park Authority Science for Management Award awarded to J.S. Stella. Morphological and molecular analysis was funded by the Natural Sciences and Engineering Research Council of Canada grant (A5056) awarded to B. K. Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; CASTRO P, 1988, SYMBIOSIS, V5, P161; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; FAUBEL A, 1984, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V81, P189; Faubel A, 1983, MITTEILUNGEN HAMBURG, V80, P189; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Holleman JJ, 1998, HYDROBIOLOGIA, V383, P61, DOI 10.1023/A:1003488905205; JOKIEL PL, 1974, PAC SCI, V28, P361; Kato K., 1940, Japanese Journal of Zoology, V8, P537; Kato K., 1937, Japanese Journal of Zoology, V7, P347; Laidlaw FF, 1906, P ZOOL SOC LOND, V1906, P705; Lang A, 1884, FAUNA FLORA GOLFES N, P688; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Nosratpour F, 2008, ADV CORAL HUSBANDRY, P37; ORMOND R F G, 1976, Marine Behaviour and Physiology, V4, P93; Ostman C, 2000, SCI MAR, V64, P31; PATTON WK, 1994, B MAR SCI, V55, P193; POULTER JL, 1975, PAC SCI, V29, P317; Prudhoe S, 1985, MONOGRAPH POLYCLAD T; Rawlinson KA, 2011, CORAL REEFS, V30, P693, DOI 10.1007/s00338-011-0745-3; Richards Z, 2008, ACROPORA VALIDA IUCN; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; ROBERTSON R, 1970, PAC SCI, V24, P43; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Stella JS, 2010, CORAL REEFS, V29, P957, DOI 10.1007/s00338-010-0648-8; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; TURNER SJ, 1994, CORAL REEFS, V13, P41, DOI 10.1007/BF00426434; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; WINSOR L, 1990, Memoirs of the Queensland Museum, V28, P785	36	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42240	10.1371/journal.pone.0042240	http://dx.doi.org/10.1371/journal.pone.0042240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870308	Green Accepted, Green Published, gold			2022-12-25	WOS:000307212800071
J	Bose, JL; Lehman, MK; Fey, PD; Bayles, KW				Bose, Jeffrey L.; Lehman, McKenzie K.; Fey, Paul D.; Bayles, Kenneth W.			Contribution of the Staphylococcus aureus Atl AM and GL Murein Hydrolase Activities in Cell Division, Autolysis, and Biofilm Formation	PLOS ONE			English	Article							L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; PENICILLIN TOLERANCE; SEQUENCE-ANALYSIS; DNA RELEASE; ENZYMES; IDENTIFICATION; EPIDERMIDIS; SEPARATION; DOMAINS	The most prominent murein hydrolase of Staphylococcus aureus, AtlA, is a bifunctional enzyme that undergoes proteolytic cleavage to yield two catalytically active proteins, an amidase (AM) and a glucosaminidase (GL). Although the bifunctional nature of AtlA has long been recognized, most studies have focused on the combined functions of this protein in cell wall metabolism and biofilm development. In this study, we generated mutant derivatives of the clinical S. aureus isolate, UAMS-1, in which one or both of the AM and GL domains of AtlA have been deleted. Examination of these strains revealed that each mutant exhibited growth rates comparable to the parental strain, but showed clumping phenotypes and lysis profiles that were distinct from the parental strain and each other, suggesting distinct roles in cell wall metabolism. Given the known function of autolysis in the release of genomic DNA for use as a biofilm matrix molecule, we also tested the mutants in biofilm assays and found both AM and GL necessary for biofilm development. Furthermore, the use of enzymatically inactive point mutations revealed that both AM and GL must be catalytically active for S. aureus to form a biofilm. The results of this study provide insight into the relative contributions of AM and GL in S. aureus and demonstrate the contribution of Atl-mediated lysis in biofilm development.	[Bose, Jeffrey L.; Lehman, McKenzie K.; Fey, Paul D.; Bayles, Kenneth W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Bose, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA.	kbayles@unmc.edu			National Institutes of Health [1F32AI081437, P01AI83211, R01AI038901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, F32AI081437, R01AI038901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants 1F32AI081437 (J.L.B.), P01AI83211 (K.W.B.), and R01AI038901 (K.W.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Wadstrom T, 1970, Biochem J, V120, P735; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	25	128	129	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42244	10.1371/journal.pone.0042244	http://dx.doi.org/10.1371/journal.pone.0042244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860095	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600081
J	Eltschinger, S; Greganova, E; Heller, M; Butikofer, P; Altmann, M				Eltschinger, Sandra; Greganova, Eva; Heller, Manfred; Buetikofer, Peter; Altmann, Michael			Eukaryotic Translation Elongation Factor 1A (eEF1A) Domain I from S. cerevisiae Is Required but Not Sufficient for Inter-Species Complementation	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNA; INITIATION-FACTOR 4G; TRYPANOSOMA-BRUCEI; ETHANOLAMINE-PHOSPHOGLYCEROL; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; PROTEIN-SYNTHESIS; POSTTRANSLATIONAL MODIFICATION; FACTOR 1-ALPHA; YEAST	Ethanolamine phosphoglycerol (EPG) is a protein modification attached exclusively to eukaryotic elongation factor 1A (eEF1A). In mammals and plants, EPG is linked to conserved glutamate residues located in eEF1A domains II and III, whereas in the unicellular eukaryote Trypanosoma brucei, only domain III is modified by a single EPG. A biosynthetic precursor of EPG and structural requirements for EPG attachment to T. brucei eEF1A have been reported, but nothing is known about the EPG modifying enzyme(s). By expressing human eEF1A in T. brucei, we now show that EPG attachment to eEF1A is evolutionarily conserved between T. brucei and Homo sapiens. In contrast, S. cerevisiae eEF1A, which has been shown to lack EPG is not modified in T. brucei. Furthermore, we show that eEF1A cannot functionally complement across species when using T. brucei and S. cerevisiae as model organisms. However, functional complementation in yeast can be obtained using eEF1A chimera containing domains II or III from other species. In contrast, yeast domain I is strictly required for functional complementation in S. cerevisiae.	[Eltschinger, Sandra; Greganova, Eva; Buetikofer, Peter; Altmann, Michael] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Greganova, Eva] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Heller, Manfred] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Bern; University Hospital of Bern	Eltschinger, S (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch; michael.altmann@ibmm.unibe.ch		Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation [31003A-119996, 31003A-130815]; Bern University Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University Research Foundation	This work was supported by Swiss National Science Foundation grants 31003A-119996 M.A. and 31003A-130815 to P.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.B. thanks the Bern University Research Foundation for support and A. Atkins for valuable input. E.G. is grateful to P. Maser for support.	ALTMANN M, 1989, J BIOL CHEM, V264, P12145; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Arcari P, 1999, BIOCHEMISTRY-US, V38, P12288, DOI 10.1021/bi990418d; Barhoumi M, 2006, FEBS J, V273, P5086, DOI 10.1111/j.1742-4658.2006.05506.x; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; Beverley S M, 1993, Methods Mol Biol, V21, P333; Butikofer P, 1997, BIOCHEM J, V326, P415; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DEVER TE, 1989, J BIOL CHEM, V264, P20518; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Greganova E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00254; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Greganova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009486; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; LevyStrumpf N, 1997, MOL CELL BIOL, V17, P1615, DOI 10.1128/MCB.17.3.1615; Li QY, 1999, MOL CELL BIOL, V19, P7336; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; PRAT A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P140, DOI 10.1016/0167-4781(90)90155-U; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; Sasikumar AN, 2012, WILEY INTERDISCIPLIN; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; VANHEMERT FJ, 1984, EMBO J, V3, P1109, DOI 10.1002/j.1460-2075.1984.tb01937.x; vanOostveen I, 1997, ANAL BIOCHEM, V247, P310, DOI 10.1006/abio.1997.2052; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42338	10.1371/journal.pone.0042338	http://dx.doi.org/10.1371/journal.pone.0042338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860115	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000306950900090
J	Fang, X; Fang, Y; Liu, L; Liu, GJ; Wu, JH				Fang, Xiang; Fang, Ying; Liu, Li; Liu, Guangjian; Wu, Jianhua			Mapping Paratope on Antithrombotic Antibody 6B4 to Epitope on Platelet Glycoprotein Ibalpha via Molecular Dynamic Simulations	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; IB-ALPHA; MONOCLONAL-ANTIBODIES; BETA-SWITCH; COMPLEX; DISEASE; TRANSITION; GENERATION; MUTATIONS; PROTEINS	Binding of platelet receptor glycoprotein Ib alpha (GPIb alpha) to the A1 domain of von Willebrand factor (vWF) is a critical step in both physiologic hemostasis and pathologic thrombosis, for initiating platelet adhesion to subendothelium of blood vessels at sites of vascular injury. Gain-of-function mutations in GPIb alpha contribute to an abnormally high-affinity binding of platelets to vWF and can lead to thrombosis, an accurate complication causing heart attack and stroke. Of various antithrombotic monoclonal antibodies (mAbs) targeting human GPIb alpha, 6B4 is a potent one to inhibit the interaction between GPIb alpha and vWF-A1 under static and flow conditions. Mapping paratope to epitope with mutagenesis experiments, a traditional route in researches of these antithrombotic mAbs, is usually expensive and time-consuming. Here, we suggested a novel computational procedure, which combines with homology modeling, rigid body docking, free and steered molecular dynamics (MD) simulations, to identify key paratope residues on 6B4 and their partners on GPIb alpha, with hypothesis that the stable hydrogen bonds and salt bridges are the important linkers between paratope and epitope residues. Based on a best constructed model of 6B4 bound with GPIb alpha, the survival ratios and rupture times of all detected hydrogen bonds and salt bridges in binding site were examined via free and steered MD simulations and regarded as indices of thermal and mechanical stabilizations of the bonds, respectively. Five principal paratope residues with their partners were predicted with their high survival ratios and/or long rupture times of involved hydrogen bonds, or with their hydrogen bond stabilization indices ranked in top 5. Exciting, the present results were in good agreement with previous mutagenesis experiment data, meaning a wide application prospect of our novel computational procedure on researches of molecular of basis of ligand-receptor interactions, various antithrombotic mAbs and other antibodies as well as theoretically design of biomolecular drugs.	[Fang, Xiang; Fang, Ying; Liu, Li; Liu, Guangjian; Wu, Jianhua] S China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Fang, X (corresponding author), S China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	yfang@scut.edu.cn; wujianhua@scut.edu.cn			National Natural Science Foundation of China [10972081, 11072080]; Guangdong Province Natural Science Foundation grant [S2011010005451]; Specialized Research Fund for the Doctoral Program of Higher Education grant [20110172110030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation grant; Specialized Research Fund for the Doctoral Program of Higher Education grant	This work was supported by The National Natural Science Foundation of China grants 10972081 (YF) and 11072080 (JW) and by Guangdong Province Natural Science Foundation grant S2011010005451(JW) and Specialized Research Fund for the Doctoral Program of Higher Education grant 20110172110030 (JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcangeli C, 2008, J STRUCT BIOL, V164, P119, DOI 10.1016/j.jsb.2008.06.013; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Chen ZZ, 2008, BIOPHYS J, V95, P1303, DOI 10.1529/biophysj.108.132324; Dai KS, 2003, THROMB RES, V109, P137, DOI 10.1016/S0049-3848(03)00152-X; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Fontayne A, 2007, J BIOL CHEM, V282, P23517, DOI 10.1074/jbc.M701826200; Huang QS, 2011, CELL MOL BIOENG, V4, P495, DOI 10.1007/s12195-011-0171-1; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Long M, 2011, CELL MOL BIOENG, V4, P327, DOI 10.1007/s12195-011-0183-x; Lou JZ, 2008, P NATL ACAD SCI USA, V105, P13847, DOI 10.1073/pnas.0801965105; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RUSSELL SD, 1993, BLOOD, V81, P1787; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 2002, SCIENCE, V297, P1128, DOI 10.1126/science.1075452; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Wu DM, 2002, ARTERIOSCL THROM VAS, V22, P323, DOI 10.1161/hq0202.102321; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang B, 2010, J MOL MODEL, V16, P1159, DOI 10.1007/s00894-009-0629-4; Zhao Y, 2007, J THROMB HAEMOST, V5, P1963, DOI 10.1111/j.1538-7836.2007.02682.x	38	13	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42263	10.1371/journal.pone.0042263	http://dx.doi.org/10.1371/journal.pone.0042263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860101	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900085
J	Larcombe, L; Orr, P; Turner-Brannen, E; Slivinski, CR; Nickerson, PW; Mookherjee, N				Larcombe, Linda; Orr, Pamela; Turner-Brannen, Emily; Slivinski, Caroline R.; Nickerson, Peter W.; Mookherjee, Neeloffer			Effect of Vitamin D Supplementation on Mycobacterium tuberculosis-Induced Innate Immune Responses in a Canadian Dene First Nations Cohort	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; HOST-DEFENSE; CATHELICIDIN LL-37; INFECTION; SYSTEM; POPULATIONS; EXPRESSION; PROTECTION; INDUCTION; MECHANISM	Canadian First Nations (FN) population experiences a high burden of tuberculosis. Vitamin D is known to enhance the expression of innate immune effectors, including cathelicidin LL-37, for protection against infections. In this study we performed longitudinal analyses to investigate the impact of vitamin D supplementation on macrophage responses to Mycobacterium tuberculosis (Mtb) lipoprotein (TLR2/1L), in Canadian Dene FN participants compared to Caucasian participants. Serum 25(OH) D and LL-37 levels were evaluated by ELISA. Transcriptional responses and protein expression of TLR2/1L-induced LL-37 and other innate immune cytokines were monitored in monocyte-derived macrophages (MDMs) before and after 8 months of vitamin D supplementation. In this study we showed that serum levels of LL-37 decreased after vitamin D supplementation in both Dene and Caucasian participants. There was no difference in TLR2/1L-induced LL-37 expression in MDMs in the two groups, either pre-or post-vitamin D supplementation. However, vitamin D supplementation markedly enhanced TLR2/1L-induced responses in MDMs e. g. IL-6, IL-12 and IL-23 among Caucasians but not in the Dene participants. In contrast, after vitamin D supplementation TLR2/1L-induced responses e. g. IL-1 beta, IL-8 and IL-12 were significantly reduced in the Dene MDMs. These results indicate that vitamin D supplementation enhanced TLR2/1L-induced innate immune macrophage responses in the Caucasian but not in the Dene participants. We hypothesize that cytokines may be differentially regulated in Canadian FN compared to Caucasians, in particular those that influence Th1 and Th-17 responses required for the control of Mtb.	[Larcombe, Linda; Orr, Pamela; Turner-Brannen, Emily; Slivinski, Caroline R.; Nickerson, Peter W.; Mookherjee, Neeloffer] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Turner-Brannen, Emily; Nickerson, Peter W.; Mookherjee, Neeloffer] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Larcombe, L (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	mookherj@cc.umanitoba.ca		Nickerson, Peter/0000-0002-7393-7799; Larcombe, Linda/0000-0002-7828-1290; Mookherjee, Neeloffer/0000-0002-9350-4157	Canadian Institutes for Health Research (CIHR); National Sanitarium Association	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sanitarium Association	This study was supported by funding from the Canadian Institutes for Health Research (CIHR) and the National Sanitarium Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Baeke F, 2008, MOL ASPECTS MED, V29, P376, DOI 10.1016/j.mam.2008.05.004; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Bera A, 2003, MOL BIOCHEM PARASIT, V127, P23, DOI 10.1016/S0166-6851(02)00300-6; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gough M, 1996, INFECT IMMUN, V64, P4922, DOI 10.1128/IAI.64.12.4922-4927.1996; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kanda N, 2010, HUM IMMUNOL, V71, P1161, DOI 10.1016/j.humimm.2010.09.005; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Larcombe L, 2011, INT J CIRCUMPOL HEAL, V70, P141, DOI 10.3402/ijch.v70i2.17806; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; REMPEL JD, 2011, EUR J HUM GENET; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Yamshchikov AV, 2010, AM J CLIN NUTR, V92, P603, DOI 10.3945/ajcn.2010.29411; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388	42	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40692	10.1371/journal.pone.0040692	http://dx.doi.org/10.1371/journal.pone.0040692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22866178	Green Published, gold, Green Submitted			2022-12-25	WOS:000306466100056
J	Walker, WA				Walker, Wade A.			The Repeated Replacement Method: A Pure Lagrangian Meshfree Method for Computational Fluid Dynamics	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; HYPERBOLIC CONSERVATION-LAWS; MOVING FINITE-ELEMENTS; MASS METHOD; SCHEMES; DESIGN	In this paper we describe the repeated replacement method (RRM), a new meshfree method for computational fluid dynamics (CFD). RRM simulates fluid flow by modeling compressible fluids' tendency to evolve towards a state of constant density, velocity, and pressure. To evolve a fluid flow simulation forward in time, RRM repeatedly "chops out'' fluid from active areas and replaces it with new "flattened'' fluid cells with the same mass, momentum, and energy. We call the new cells "flattened'' because we give them constant density, velocity, and pressure, even though the chopped-out fluid may have had gradients in these primitive variables. RRM adaptively chooses the sizes and locations of the areas it chops out and replaces. It creates more and smaller new cells in areas of high gradient, and fewer and larger new cells in areas of lower gradient. This naturally leads to an adaptive level of accuracy, where more computational effort is spent on active areas of the fluid, and less effort is spent on inactive areas. We show that for common test problems, RRM produces results similar to other high-resolution CFD methods, while using a very different mathematical framework. RRM does not use Riemann solvers, flux or slope limiters, a mesh, or a stencil, and it operates in a purely Lagrangian mode. RRM also does not evaluate numerical derivatives, does not integrate equations of motion, and does not solve systems of equations.				wwalker3@austin.rr.com		Walker, Wade/0000-0003-2453-8043				Benz W., 1990, P NATO ADV RES WORKS, P269; BERGER MJ, 1984, J COMPUT PHYS, V53, P484, DOI 10.1016/0021-9991(84)90073-1; Carlson NN, 1998, SIAM J SCI COMPUT, V19, P766, DOI 10.1137/S1064827594269561; Carlson NN, 1998, SIAM J SCI COMPUT, V19, P728, DOI 10.1137/S106482759426955X; Catmull E, 1974, UTECCSC74133 U UT; Chaikin G, 1974, COMPUT VISION GRAPH, V3, P346, DOI DOI 10.1016/0146-664X(74)90028-8; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Clough R.W., P 2 ASCE C EL COMP P, P345; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Crowley WP, 1971, LECT NOTE PHYS, V8, P37; Gauger C, 2000, SIAM J NUMER ANAL, V37, P1768, DOI 10.1137/S0036142999352564; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Godunov S, 1959, MAT SBORNIK, V47, P271; HARTEN A, 1987, J COMPUT PHYS, V71, P231, DOI 10.1006/jcph.1996.5632; HARTEN A, 1983, J COMPUT PHYS, V49, P357, DOI 10.1016/0021-9991(83)90136-5; HIRT CW, 1974, J COMPUT PHYS, V14, P227, DOI 10.1006/jcph.1997.5702; Huerta A, 2004, ENCY COMPUTATIONAL M, V1, P279, DOI DOI 10.1002/0470091355.ECM005; Kitsionas S, 2002, MON NOT R ASTRON SOC, V330, P129, DOI 10.1046/j.1365-8711.2002.05115.x; Klingler M, 2005, SIAM J SCI COMPUT, V26, P1744, DOI 10.1137/S1064827502420483; Koshizuka S, 1996, NUCL SCI ENG, V123, P421, DOI 10.13182/NSE96-A24205; Kuprat AP, 1992, GAX9304972 UMI U CAL; Laney, 1998, COMPUTATIONAL GASDYN; Lastiwka M, 2005, INT J NUMER METH FL, V47, P1403, DOI 10.1002/fld.891; Li S., 2002, APPL MECH REV, V55, P1, DOI DOI 10.1115/1.1431547; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Martin HC, 1968, P 2 C MATR METH STRU, P517; MEGLICKI Z, 1993, MON NOT R ASTRON SOC, V264, P691, DOI 10.1093/mnras/264.3.691; MILLER K, 1981, SIAM J NUMER ANAL, V18, P1019, DOI 10.1137/0718070; MILLER K, 1981, SIAM J NUMER ANAL, V18, P1033, DOI 10.1137/0718071; OSHER S, 1983, MATH COMPUT, V41, P321, DOI 10.2307/2007679; Owen JM, 1998, ASTROPHYS J SUPPL S, V116, P155, DOI 10.1086/313100; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; Toro E.F., 2009, RIEMANN SOLVERS NUME, P456; VAN LEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; WHITEHURST R, 1995, MON NOT R ASTRON SOC, V277, P655, DOI 10.1093/mnras/277.2.655	35	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39999	10.1371/journal.pone.0039999	http://dx.doi.org/10.1371/journal.pone.0039999			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22866175	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800031
J	Chen, DWC; Saha, V; Liu, JZ; Schwartz, JM; Krstic-Demonacos, M				Chen, D. W-C; Saha, V.; Liu, J-Z; Schwartz, J-M; Krstic-Demonacos, M.			Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia	ONCOGENE			English	Article						glucocorticoid receptor; gene expression; systems biology; dynamic model	TRANSCRIPTION FACTOR ERG; FACTOR-KAPPA-B; GENE-EXPRESSION; C-JUN; INDUCED APOPTOSIS; TMPRSS2-ERG FUSION; BH3-ONLY PROTEINS; JNK PATHWAY; RECEPTOR; CELLS	Glucocorticoids (GCs) are among the most widely prescribed medications in clinical practice. The beneficial effects of GCs in acute lymphoblastic leukemia (ALL) are based on their ability to induce apoptosis, but the underlying transcriptional mechanisms remain poorly defined. Computational modeling has enormous potential in the understanding of biological processes such as apoptosis and the discovery of novel regulatory mechanisms. We here present an integrated analysis of gene expression kinetic profiles using microarrays from GC sensitive and resistant ALL cell lines and patients, including newly generated and previously published data sets available from the Gene Expression Omnibus. By applying time-series clustering analysis in the sensitive ALL CEM-C7-14 cells, we identified 358 differentially regulated genes that we classified into 15 kinetic profiles. We identified GC response element (GRE) sequences in 33 of the upregulated known or potential GC receptor (GR) targets. Comparative study of sensitive and resistant ALL showed distinct gene expression patterns and indicated unexpected similarities between sensitivity-restored and resistant ALL. We found that activator protein 1 (AP-1), Ets related gene (Erg) and GR pathways were differentially regulated in sensitive and resistant ALL. Erg protein levels were substantially higher in CEM-C1-15-resistant cells, c-Jun was significantly induced in sensitive cells, whereas c-Fos was expressed at low levels in both. c-Jun was recruited on the AP-1 site on the Bim promoter, whereas a transient Erg occupancy on the GR promoter was detected. Inhibition of Erg and activation of GR lead to increased apoptosis in both sensitive and resistant ALL. These novel findings significantly advance our understanding of GC sensitivity and can be used to improve therapy of leukemia.	[Chen, D. W-C; Schwartz, J-M; Krstic-Demonacos, M.] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Saha, V.; Liu, J-Z] Univ Manchester, Sch Med, Manchester M1 7DN, Lancs, England; [Chen, D. W-C; Schwartz, J-M; Krstic-Demonacos, M.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Schwartz, JM (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	jean-marc.schwartz@manchester.ac.uk; m.k.demonacos@manchester.ac.uk	Schwartz, Jean-Marc/AAS-8274-2020	Schwartz, Jean-Marc/0000-0002-6472-0184; Saha, Vaskar/0000-0002-2916-9649				Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Barrett TJ, 1996, BIOCHEMISTRY-US, V35, P9746, DOI 10.1021/bi960058j; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Cai JA, 2010, TRANSL ONCOL, V3, P195, DOI 10.1593/tlo.09328; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen DWC, 2010, PHARMACOGENOMICS, V11, P1545, DOI [10.2217/pgs.10.125, 10.2217/PGS.10.125]; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Geng CD, 2005, J BIOL CHEM, V280, P43264, DOI 10.1074/jbc.M508245200; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; Kettritz R, 2004, J BIOL CHEM, V279, P2657, DOI 10.1074/jbc.M309778200; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Leung KT, 2008, CARCINOGENESIS, V29, P544, DOI 10.1093/carcin/bgm294; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2004, J BIOL CHEM, V279, P4058, DOI 10.1074/jbc.M310415200; Loffler M, 1999, ONCOGENE, V18, P4626, DOI 10.1038/sj.onc.1202820; Lynch JT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-38; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; Medh RD, 1998, CANCER RES, V58, P3684; Medh RD, 2001, ONCOGENE, V20, P4629, DOI 10.1038/sj.onc.1204680; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-18; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rahim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019343; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Tsuzuki S, 2011, BLOOD, V10, P1182; Verger A, 2001, J BIOL CHEM, V276, P17181, DOI 10.1074/jbc.M010208200; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wen LP, 1997, AM J PHYSIOL-LUNG C, V273, pL921, DOI 10.1152/ajplung.1997.273.5.L921; White RJ, 2010, TRENDS GENET, V26, P214, DOI 10.1016/j.tig.2010.02.004; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yi HK, 1997, ONCOGENE, V14, P1259, DOI 10.1038/sj.onc.1201099; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zhou F, 1996, MOL ENDOCRINOL, V10, P306, DOI 10.1210/me.10.3.306; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	73	26	27	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2013	32	25					3039	3048		10.1038/onc.2012.321	http://dx.doi.org/10.1038/onc.2012.321			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22869147				2022-12-25	WOS:000320705700004
J	Koharudin, LMI; Kollipara, S; Aiken, C; Gronenborn, AM				Koharudin, Leonardus M. I.; Kollipara, Sireesha; Aiken, Christopher; Gronenborn, Angela M.			Structural Insights into the Anti-HIV Activity of the Oscillatoria agardhii Agglutinin Homolog Lectin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CYANOVIRIN-N; IMMUNODEFICIENCY-VIRUS TYPE-1; INACTIVATING PROTEIN; DC-SIGN; CULTURED CYANOBACTERIUM; CRYSTAL-STRUCTURES; BINDING-SITES; CONTAINS 2; POTENT; SPECIFICITY	Oscillatoria agardhii agglutinin homolog (OAAH) proteins belong to a recently discovered lectin family. All members contain a sequence repeat of similar to 66 amino acids, with the number of repeats varying among different family members. Apart from data for the founding member OAA, neither three-dimensional structures, information about carbohydrate binding specificities, nor antiviral activity data have been available up to now for any other members of the OAAH family. To elucidate the structural basis for the antiviral mechanism of OAAHs, we determined the crystal structures of Pseudomonas fluorescens and Myxococcus xanthus lectins. Both proteins exhibit the same fold, resembling the founding family member, OAA, with minor differences in loop conformations. Carbohydrate binding studies by NMR and x-ray structures of glycan-lectin complexes reveal that the number of sugar binding sites corresponds to the number of sequence repeats in each protein. As for OAA, tight and specific binding to alpha 3, alpha 6-mannopentaose was observed. All the OAAH proteins described here exhibit potent anti-HIV activity at comparable levels. Altogether, our results provide structural details of the protein-carbohydrate interaction for this novel lectin family and insights into the molecular basis of their HIV inactivation properties.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kollipara, Sireesha; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3,Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Aiken, Christopher/Y-9252-2019	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080642 (to A. M. G.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koharudin LMI, 2011, STRUCTURE, V19, P1170, DOI 10.1016/j.str.2011.05.010; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Keefe BR, 2000, MOL PHARMACOL, V58, P982, DOI 10.1124/mol.58.5.982; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	40	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33796	33811		10.1074/jbc.M112.388579	http://dx.doi.org/10.1074/jbc.M112.388579			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865886	Green Published, hybrid			2022-12-25	WOS:000309602100061
J	Stura, EA; Le Roux, L; Guitot, K; Garcia, S; Bregant, S; Beau, F; Vera, L; Collet, G; Ptchelkine, D; Bakirci, H; Dive, V				Stura, Enrico A.; Le Roux, Laura; Guitot, Karine; Garcia, Sandra; Bregant, Sarah; Beau, Fabrice; Vera, Laura; Collet, Guillaume; Ptchelkine, Denis; Bakirci, Huseyin; Dive, Vincent			Structural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys(165)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; IRREVERSIBLE INHIBITORS; SUBSTRATE RECOGNITION; ACTIVE-SITE; LIGHT-CHAIN; SEROTYPE; BINDING; IDENTIFICATION; PROTEASE; PROGRAM	Clostridium botulinum neurotoxin type A (BoNT/A) is one of the most potent toxins for humans and a major biothreat agent. Despite intense chemical efforts over the past 10 years to develop inhibitors of its catalytic domain (catBoNT/A), highly potent and selective inhibitors are still lacking. Recently, small inhibitors were reported to covalently modify catBoNT/A by targeting Cys(165), a residue located in the enzyme active site just above the catalytic zinc ion. However, no direct proof of Cys(165) modification was reported, and the poor accessibility of this residue in the x-ray structure of catBoNT/A raises concerns about this proposal. To clarify this issue, the functional role of Cys(165) was first assessed through a combination of site-directed mutagenesis and structural studies. These data suggested that Cys(165) is more involved in enzyme catalysis rather than in structural property. Then by peptide mass fingerprinting and x-ray crystallography, we demonstrated that a small compound containing a sulfonyl group acts as inhibitor of catBoNT/A through covalent modification of Cys(165). The crystal structure of this covalent complex offers a structural framework for developing more potent covalent inhibitors catBoNT/A. Other zinc metalloproteases can be founded in the protein database with a cysteine at a similar location, some expressed by major human pathogens; thus this work should find broader applications for developing covalent inhibitors.	[Stura, Enrico A.; Le Roux, Laura; Guitot, Karine; Garcia, Sandra; Bregant, Sarah; Beau, Fabrice; Vera, Laura; Collet, Guillaume; Ptchelkine, Denis; Bakirci, Huseyin; Dive, Vincent] CE Saclay, Commissariat Energie Atom, IBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Dive, V (corresponding author), CE Saclay, Commissariat Energie Atom, IBiTec S, Serv Ingn Mol Prot, Bat 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Stura, Enrico A./A-2793-2010	Stura, Enrico A./0000-0001-6718-2118	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hale M, 2011, J BIOL CHEM, V286, P1802, DOI 10.1074/jbc.M110.146464; KITZ R, 1962, J BIOL CHEM, V237, P3245; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li B., BIOORG MED CHEM, V19, P7338; Li B, 2011, MOLECULES, V16, P202, DOI 10.3390/molecules16010202; Li B, 2010, J MED CHEM, V53, P2264, DOI 10.1021/jm901852f; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemirowicz G, 2008, MOL MICROBIOL, V70, P853, DOI 10.1111/j.1365-2958.2008.06444.x; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Stura EA., 1999, CRYSTALLIZATION PROT, P113; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Willis B, 2008, ANGEW CHEM INT EDIT, V47, P8360, DOI 10.1002/anie.200705531; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	37	15	15	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33607	33614		10.1074/jbc.M112.396697	http://dx.doi.org/10.1074/jbc.M112.396697			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869371	Green Published, hybrid			2022-12-25	WOS:000309602100045
J	Gross, H; Hennard, C; Masouris, I; Cassel, C; Barth, S; Stober-Grasser, U; Mamiani, A; Moritz, B; Ostareck, D; Ostareck-Lederer, A; Neuenkirchen, N; Fischer, U; Deng, W; Leonhardt, H; Noessner, E; Kremmer, E; Grasser, FA				Gross, Henrik; Hennard, Christine; Masouris, Ilias; Cassel, Christian; Barth, Stephanie; Stober-Graesser, Ute; Mamiani, Alfredo; Moritz, Bodo; Ostareck, Dirk; Ostareck-Lederer, Antje; Neuenkirchen, Nils; Fischer, Utz; Deng, Wen; Leonhardt, Heinrich; Noessner, Elfriede; Kremmer, Elisabeth; Graesser, Friedrich A.			Binding of the Heterogeneous Ribonucleoprotein K (hnRNP K) to the Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Enhances Viral LMP2A Expression	PLOS ONE			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; MOTOR-NEURON PROTEIN; RNA-POLYMERASE-II; MESSENGER-RNA; C-MYC; GENE-EXPRESSION; SPLICING FACTOR; DOWN-REGULATION; LIVING CELLS; SM PROTEINS	The Epstein-Barr Virus (EBV) -encoded EBNA2 protein, which is essential for the in vitro transformation of B-lymphocytes, interferes with cellular processes by binding to proteins via conserved sequence motifs. Its Arginine-Glycine (RG) repeat element contains either symmetrically or asymmetrically di-methylated arginine residues (SDMA and ADMA, respectively). EBNA2 binds via its SDMA-modified RG-repeat to the survival motor neurons protein (SMN) and via the ADMA-RG-repeat to the NP9 protein of the human endogenous retrovirus K (HERV-K (HML-2) Type 1). The hypothesis of this work was that the methylated RG-repeat mimics an epitope shared with cellular proteins that is used for interaction with target structures. With monoclonal antibodies against the modified RG-repeat, we indeed identified cellular homologues that apparently have the same surface structure as methylated EBNA2. With the SDMA-specific antibodies, we precipitated the Sm protein D3 (SmD3) which, like EBNA2, binds via its SDMA-modified RG-repeat to SMN. With the ADMA-specific antibodies, we precipitated the heterogeneous ribonucleoprotein K (hnRNP K). Specific binding of the ADMA-antibody to hnRNP K was demonstrated using E. coli expressed/ADMA-methylated hnRNP K. In addition, we show that EBNA2 and hnRNP K form a complex in EBV-infected B-cells. Finally, hnRNP K, when co-expressed with EBNA2, strongly enhances viral latent membrane protein 2A (LMP2A) expression by an unknown mechanism as we did not detect a direct association of hnRNP K with DNA-bound EBNA2 in gel shift experiments. Our data support the notion that the methylated surface of EBNA2 mimics the surface structure of cellular proteins to interfere with or co-opt their functional properties.	[Gross, Henrik; Cassel, Christian; Barth, Stephanie; Stober-Graesser, Ute; Mamiani, Alfredo; Graesser, Friedrich A.] Univ Saarland, Inst Virol, Sch Med, D-6650 Homburg, Germany; [Hennard, Christine; Masouris, Ilias; Noessner, Elfriede; Kremmer, Elisabeth] German Res Ctr Environm Hlth, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany; [Moritz, Bodo] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Saale, Germany; [Ostareck, Dirk; Ostareck-Lederer, Antje] Rhein Westfal TH Aachen, Expt Res Unit, Dept Intens Care & Intermediate Care, Univ Hosp Aachen, Aachen, Germany; [Neuenkirchen, Nils; Fischer, Utz] Univ Wurzburg, Dept Biochem, Bioctr, Wurzburg, Germany; [Deng, Wen; Leonhardt, Heinrich] Univ Munich, Dept Biol, Ctr Integrated Prot Sci Munich, Planegg Martinsried, Germany	Saarland University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg; RWTH Aachen University; RWTH Aachen University Hospital; University of Wurzburg; University of Munich	Gross, H (corresponding author), Univ Saarland, Inst Virol, Sch Med, D-6650 Homburg, Germany.	graesser@uks.eu	Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016; Leonhardt, Heinrich/B-2791-2014; Deng, Wen/GQH-3160-2022	Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Deng, Wen/0000-0003-3062-7843; Ostareck-Lederer, Antje/0000-0003-0733-7071; Ostareck, Dirk/0000-0001-9406-7190	Deutsche Forschungsgemeinschaft [KR2218/2-1, OS290/3-2, GR950/12-1]; BioImaging Network Munich; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioImaging Network Munich; Chinese Scholarship Council(China Scholarship Council)	This work was supported by Deutsche Forschungsgemeinschaft through grant KR2218/2-1 to EK, OS290/3-2 to AO-L and DHO and GR950/12-1 to FG and the BioImaging Network Munich to HL. WD was supported by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; Barth S, 2003, J VIROL, V77, P5008, DOI 10.1128/JVI.77.8.5008-5013.2003; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Cancian L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002164; Chan JYH, 2009, FEBS LETT, V583, P281, DOI 10.1016/j.febslet.2008.12.025; COHEN JI, 1991, J VIROL, V65, P2545, DOI 10.1128/JVI.65.5.2545-2554.1991; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Dambacher S, 2012, NUCLEUS, V3; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Forsman A, 2008, J PROTEOME RES, V7, P2309, DOI 10.1021/pr700769e; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; Garcia-Jurado G, 2011, HYBRIDOMA, V30, P53, DOI 10.1089/hyb.2010.0081; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GRASSER FA, 1991, J VIROL, V65, P3779; Gross H, 2011, INT J CANCER, V129, P1105, DOI 10.1002/ijc.25760; Gross H, 2010, VIROLOGY, V397, P299, DOI 10.1016/j.virol.2009.11.023; Grundhoff AT, 1999, J BIOL CHEM, V274, P19136, DOI 10.1074/jbc.274.27.19136; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hennard C, 2006, J PATHOL, V209, P430, DOI 10.1002/path.1996; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999; Kieff E, 2007, FIELDS VIROLOGY, P2603; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee Jeongbok, 2004, [Journal of Korean Oral Literature, 구비문학연구], V19, P19; Lee MH, 1996, J BIOL CHEM, V271, P3420; Li H, 2010, J BIOL CHEM, V285, P17789, DOI 10.1074/jbc.M109.082057; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; Marchand V, 2011, RNA BIOL, V8, P325, DOI 10.4161/rna.8.2.13984; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794; SAUDER C, 1994, J GEN VIROL, V75, P3067, DOI 10.1099/0022-1317-75-11-3067; Sauder C, 1996, J GEN VIROL, V77, P991, DOI 10.1099/0022-1317-77-5-991; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; TONG X, 1994, J VIROL, V68, P6188, DOI 10.1128/JVI.68.10.6188-6197.1994; TSUI SL, 1994, J VIROL, V68, P4287, DOI 10.1128/JVI.68.7.4287-4294.1994; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Voss MD, 2001, J VIROL, V75, P11781, DOI 10.1128/JVI.75.23.11781-11790.2001; Wei CC, 2006, J BIOL CHEM, V281, P25344, DOI 10.1074/jbc.M601945200; Wu DY, 2000, J VIROL, V74, P8893, DOI 10.1128/JVI.74.19.8893-8903.2000; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zimber-Strobl U, 2001, SEMIN CANCER BIOL, V11, P423, DOI 10.1006/scbi.2001.0409; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x; ZIMBERSTROBL U, 1994, EMBO J, V13, P4973, DOI 10.1002/j.1460-2075.1994.tb06824.x; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200; Zou T, 2011, CELL MOL NEUROBIOL, V31, P541, DOI 10.1007/s10571-011-9647-8	81	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42106	10.1371/journal.pone.0042106	http://dx.doi.org/10.1371/journal.pone.0042106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879910	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100045
J	Haass, W; Stehle, M; Nittka, S; Giehl, M; Schrotz-King, P; Fabarius, A; Hofmann, WK; Seifarth, W				Haass, Wiltrud; Stehle, Michael; Nittka, Stefanie; Giehl, Michelle; Schrotz-King, Petra; Fabarius, Alice; Hofmann, Wolf-Karsten; Seifarth, Wolfgang			The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; TYROSINE KINASE INHIBITOR; CLONAL EVOLUTION; CENTROSOME AMPLIFICATION; COHESIN; ABNORMALITIES; ABERRATIONS; INSTABILITY; EXPRESSION; LINE	Separase, an endopeptidase required for the separation of sister-chromatides in mitotic anaphase, triggers centriole disengagement during centrosome duplication. In cancer, separase is frequently overexpressed, pointing to a functional role as an aneuploidy promoter associated with centrosomal amplification and genomic instability. Recently, we have shown that centrosomal amplification and subsequent chromosomal aberrations are a hallmark of chronic myeloid leukemia (CML), increasing from chronic phase (CP) toward blast crisis (BC). Moreover, a functional linkage of p210BCR-ABL tyrosine kinase activity with centrosomal amplification and clonal evolution has been established in long-term cell culture experiments. Unexpectedly, therapeutic doses of imatinib (IM) did not counteract; instead induced similar centrosomal alterations in vitro. We investigated the influence of IM and p210BCR-ABL on Separase as a potential driver of centrosomal amplification in CML. Short-term cell cultures of p210BCR-ABL-negative (NHDF, UROtsa, HL-60, U937), positive (K562, LAMA-84) and inducible (U937p210BCR-ABL/c6 (Tet-ON)) human cell lines were treated with therapeutic doses of IM and analyzed by qRT-PCR, Western blot analysis and quantitative Separase activity assays. Decreased Separase protein levels were observed in all cells treated with IM in a dose dependent manner. Accordingly, in all p210BCR-ABL-negative cell lines, decreased proteolytic activity of Separase was found. In contrast, p210BCR-ABL-positive cells showed increased Separase proteolytic activity. This activation of Separase was consistent with changes in the expression levels of Separase regulators (Separase phosphorylation at serine residue 1126, Securin, CyclinB1 and PP2A). Our data suggest that regulation of Separase in IM-treated BCR-ABL-positive cells occurs on both the protein expression and the proteolytic activity levels. Activation of Separase proteolytic activity exclusively in p210BCR-ABL-positive cells during IM treatment may act as a driving force for centrosomal amplification, contributing to genomic instability, clonal evolution and resistance in CML.	[Haass, Wiltrud; Stehle, Michael; Giehl, Michelle; Fabarius, Alice; Hofmann, Wolf-Karsten; Seifarth, Wolfgang] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, D-6800 Mannheim, Germany; [Nittka, Stefanie] Heidelberg Univ, Dept Clin Chem, Mannheim Med Ctr, D-6800 Mannheim, Germany; [Schrotz-King, Petra] German Canc Ctr DKFZ, Natl Ctr Tumor Dis NCT, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Haass, W (corresponding author), Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, D-6800 Mannheim, Germany.	wolfgang.seifarth@medma.uni-heidelberg.de			Deutsche Krebshilfe e.V., Bonn, Germany [108783]; Deutsche Krebshilfe e.V., 53113 Bonn, Germany [108783]	Deutsche Krebshilfe e.V., Bonn, Germany(Deutsche Krebshilfe); Deutsche Krebshilfe e.V., 53113 Bonn, Germany	This work was supported by grant 108783 to WS and AF from the Deutsche Krebshilfe e.V., Bonn, Germany (www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was supported by grant 108783 of the Deutsche Krebshilfe e.V., 53113 Bonn, Germany. We thank Susanne Brendel, Helga Kleiner and Stefanie Sandmann for excellent technical assistance. We are thankful to Anthony Walmsley for critically reading the manuscript.	Bacher U, 2005, CANCER GENET CYTOGEN, V157, P53, DOI 10.1016/j.cancergencyto.2004.06.011; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Basu D, 2009, ANAL BIOCHEM, V392, P133, DOI 10.1016/j.ab.2009.05.046; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Cortes J, 2004, HEMATOL ONCOL CLIN N, V18, P671, DOI 10.1016/j.hoc.2004.03.012; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Di Gion P, 2011, CLIN PHARMACOKINET, V50, P551, DOI 10.2165/11593320-000000000-00000; Diaz-Martinez LA, 2010, CELL CYCLE, V9, P1764, DOI 10.4161/cc.9.9.11525; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fabarius A, 2008, HAEMATOL-HEMATOL J, V93, P1145, DOI 10.3324/haematol.12793; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Giehl M, 2007, LEUKEMIA, V21, P1971, DOI 10.1038/sj.leu.2404834; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Hochhaus A, 2009, BEST PRACT RES CL HA, V22, P367, DOI 10.1016/j.beha.2009.05.004; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Jabbour E, 2006, LEUKEMIA, V20, P1767, DOI 10.1038/sj.leu.2404318; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Kumari A, 2012, BLOOD, V119, P530, DOI 10.1182/blood-2010-08-303495; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nowicki MO, 2003, ONCOGENE, V22, P3952, DOI 10.1038/sj.onc.1206620; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; Park KH, 2005, BREAST CANCER RES, V7, pR238, DOI 10.1186/bcr978; Patel H, 2009, BRIT J HAEMATOL, V146, P408, DOI 10.1111/j.1365-2141.2009.07772.x; Pati D, 2008, CELL CYCLE, V7, P3481, DOI 10.4161/cc.7.22.7048; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pihan GA, 2003, CANCER RES, V63, P1398; Podtcheko A, 2003, J CLIN ENDOCR METAB, V88, P1889, DOI 10.1210/jc.2002-021230; Rosenhahn J, 2007, INT J ONCOL, V31, P121; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schnittger S, 2010, GENE CHROMOSOME CANC, V49, P910, DOI 10.1002/gcc.20801; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Simanovsky M, 2008, DIFFERENTIATION, V76, P908, DOI 10.1111/j.1432-0436.2008.00270.x; Terre C, 2004, LEUKEMIA, V18, P1340, DOI 10.1038/sj.leu.2403399; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Verma D, 2010, CANCER-AM CANCER SOC, V116, P2673, DOI 10.1002/cncr.25015; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Yim H, 2011, CELL CYCLE, V10, P1374, DOI 10.4161/cc.10.9.15489; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42863	10.1371/journal.pone.0042863	http://dx.doi.org/10.1371/journal.pone.0042863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870341	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100177
J	Saini, V; Hose, CD; Monks, A; Nagashima, K; Han, BN; Newton, DL; Millione, A; Shah, J; Hollingshead, MG; Hite, KM; Burkett, MW; Delosh, RM; Silvers, TE; Scudiero, DA; Shoemaker, RH				Saini, Vaibhav; Hose, Curtis D.; Monks, Anne; Nagashima, Kunio; Han, Bingnan; Newton, Dianne L.; Millione, Angelena; Shah, Jalpa; Hollingshead, Melinda G.; Hite, Karen M.; Burkett, Mark W.; Delosh, Rene M.; Silvers, Thomas E.; Scudiero, Dominic A.; Shoemaker, Robert H.			Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; INITIATING CELLS; CANCER CELLS; LINE SAOS-2; EXPRESSION; MARKER; OCT-4; DIFFERENTIATION; INHIBITOR; PROTEIN	Recently, there has been renewed interest in the role of tumor stem cells (TSCs) in tumorigenesis, chemoresistance, and relapse of malignant tumors including osteosarcoma. The potential exists to improve osteosarcoma treatment through characterization of TSCs and identification of therapeutic targets. Using transcriptome, proteome, immunophenotyping for cell-surface markers, and bioinformatic analyses, heterogeneous expression of previously reported TSC or osteosarcoma markers, such as CD133, nestin, POU5F1 (OCT3/4), NANOG, SOX2, and aldehyde dehydrogenase, among others, was observed in vitro. However, consistently significantly lower CD326, CD24, CD44, and higher ABCG2 expression in TSC-enriched as compared with un-enriched osteosarcoma cultures was observed. In addition, consistently higher CBX3 expression in TSC-enriched osteosarcoma cultures was identified. ABCA5 was identified as a putative biomarker of TSCs and/or osteosarcoma. Lastly, in a high-throughput screen we identified epigenetic (5-azacytidine), anti-microtubule (vincristine), and anti-telomerase (3,11-difluoro-6,8,13-trimethyl-8H-quino [4,3,2-kl] acridinium methosulfate; RHPS4)-targeted therapeutic agents as candidates for TSC ablation in osteosarcoma.	[Saini, Vaibhav; Shoemaker, Robert H.] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Hose, Curtis D.; Monks, Anne; Nagashima, Kunio; Han, Bingnan; Newton, Dianne L.; Millione, Angelena; Shah, Jalpa; Hite, Karen M.; Burkett, Mark W.; Delosh, Rene M.; Silvers, Thomas E.; Scudiero, Dominic A.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Hollingshead, Melinda G.] NCI, Biol Testing Branch, Div Canc Treatment & Diag, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Saini, V (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	Shoemakr@mail.nih.gov	Shoemaker, Robert/GPK-1314-2022		National Cancer Institute (NCI); National Institutes of Health (NIH); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute; NCI, NIH [HHSN261200800001E]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	VS was supported by a visiting fellowship, National Cancer Institute (NCI), and National Institutes of Health (NIH). The research was supported in part by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, and in part with federal funds from the NCI, NIH, under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; Fan TM, 2010, EXPERT REV ANTICANC, V10, P1327, DOI 10.1586/ERA.10.107; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; GANGEMI RM, 2008, STEM CELLS; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Hu YJ, 2007, CLIN CANCER RES, V13, P929, DOI 10.1158/1078-0432.CCR-06-1718; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; KAWAI A, 1990, CLIN ORTHOP RELAT R, P256; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Marcato P, 2011, STEM CELLS, P2011; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Mathews LA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-267; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; MURRAY E, 1987, J BONE MINER RES, V2, P231; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajendran G, 2010, J NEUROONCOL; RODAN SB, 1987, CANCER RES, V47, P4961; Saini V, 2010, CANCER SCI, V101, P16, DOI 10.1111/j.1349-7006.2009.01371.x; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Singh SK, 2003, CANCER RES, V63, P5821; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Veselska R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-300; Wagner ER, 2010, PPAR RES, V2010, DOI 10.1155/2010/956427; Wang L, 2009, CANCER BIOL THER, V8; Wang L, 2010, INT J CANC; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	51	71	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41401	10.1371/journal.pone.0041401	http://dx.doi.org/10.1371/journal.pone.0041401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870217	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100017
J	Talley, TS; Nguyen, KC; Nguyen, A				Talley, Theresa Sinicrope; Nguyen, Kim-Chi; Nguyen, Anthony			Testing the Effects of an Introduced Palm on a Riparian Invertebrate Community in Southern California	PLOS ONE			English	Article							LITTER-DWELLING ARTHROPODS; DIVERSITY; HABITATS; ECOLOGY; HETEROGENEITY; COLONIZATION; BIODIVERSITY; ASSEMBLAGES; MANAGEMENT; INVASIONS	Despite the iconic association of palms with semi-arid regions, most are introduced and can invade natural areas. Along the San Diego River (San Diego, California, USA), the introduced Canary Island date palm (Phoenix canariensis) forms dense patches among native riparian shrubs like arroyo willow (Salix lasiolepis). The structural differences between the palm and native shrubs are visually obvious, but little is known about palm's effects on the ecosystem. We tested for the effects of the palm on a riparian invertebrate community in June 2011 by comparing the faunal and environmental variables associated with palm and willow canopies, trunks and ground beneath each species. The palm invertebrate community had lower abundance and diversity, fewer taxa feeding on the host (e.g., specialized hemipterans), and more taxa likely using only the plant's physical structure (e.g., web-builders, oak moths, willow hemipterans). There were no observed effects on the ground-dwelling fauna. Faunal differences were due to the physical and trophic changes associated with palm presence, namely increased canopy density, unpalatable leaves, trunk rugosity, and litter accumulations. Palm presence and resulting community shifts may have further ecosystem-level effects through alteration of physical properties, food, and structural resources. These results were consistent with a recent study of invasive palm effects on desert spring arthropods, illustrating that effects may be relatively generalizable. Since spread of the palm is largely localized, but effects are dramatic where it does occur, we recommend combining our results with several further investigations in order to prioritize management decisions.	[Talley, Theresa Sinicrope; Nguyen, Kim-Chi] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Nguyen, Anthony] Univ Calif San Diego, Dept Biol, San Diego, CA 92103 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Talley, TS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	tstalley@ucsd.edu			NOAA [NA08OAR4170669, NA10OAR4170060]; California Sea Grant Project via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce [R/ENV-209]	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant Project via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce	No external funding was received for this study. Some resources (supplies and research assistance) were donated by Paul Dayton through NOAA Grant nos. NA08OAR4170669 and NA10OAR4170060, California Sea Grant Project R/ENV-209, via NOAA's National Sea Grant College Program, U.S. Dept. of Commerce. The statements, findings, conclusions and recommendations are those of the researchers and do not necessarily reflect the views of the aforementioned organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CIT SAN DIEG; Bent AC, 1950, B US NATL MUSEUM, V197; Buffington ML, 1998, J INSECT CONSERV, V2, P99, DOI 10.1023/A:1009653021706; BULTMAN TL, 1984, AM MIDL NAT, V111, P165, DOI 10.2307/2425555; BURKHART B., 2005, Q NEWS CALIF INVASIV, V23, P4; Cal-IPC, 2006, CAL IPC PUBL; Chapin EA, 1925, USDA B, V1355; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CORNETT JW, 2010, DESERT PALM OASIS; CORNETT JW, 1987, WHITE MOUNTAIN RES S, V2, P167; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Fleishman E, 2006, BIOL INVASIONS, V8, P1091, DOI 10.1007/s10530-005-7564-9; *FLOR EX PEST PLAN, 2009, WILDLAND WEEDS, V12, P13; GAINES DA, 1977, I ECOL PUBL, V15, P57; Gilman EF, 2009, PHOENIX CANARIENSIS; Gomez-Vidal S, 2006, MICRON, V37, P624, DOI 10.1016/j.micron.2006.02.003; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hancock MH, 2012, INSECT CONSERV DIVER, V5, P312, DOI 10.1111/j.1752-4598.2011.00162.x; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hickman J. C., 1993, JEPSON MANUAL HIGHER; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Holmquist JG, 2011, BIOL CONSERV, V144, P518, DOI 10.1016/j.biocon.2010.10.007; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Keer GH, 2002, ECOL APPL, V12, P456, DOI 10.1890/1051-0761(2002)012[0456:SMCADW]2.0.CO;2; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P13; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P4; Kelly M, 2007, CALIFORNIA INVASIVE, V15, P15; Kus B, 2002, IRPARIAN BIRD CONSER; Lopez-Llorca LV, 1999, MICRON, V30, P325, DOI 10.1016/S0968-4328(99)00031-1; MAC ARTHUR ROBERT H., 1967; MINER KL, 1989, THESIS SAN DIEGO STA; NADKARNI NM, 1994, AM ZOOL, V34, P70; OLSON TE, 1989, US FOR SERV T R PSW, V110, P278; Pearson DE, 2009, OECOLOGIA, V159, P549, DOI 10.1007/s00442-008-1241-5; Perla B. S., 2008, ARIDLAND SPRINGS N A, P230; POWELL J. A., 1979, CALIFORNIA INSECTS; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; SAWYER JO, 1995, MANUAL CALIFORNIA VE; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Senior K, 2010, FRONT ECOL ENVIRON, V8, P62; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Strong D.R., 1984, INSECTS PLANTS COMMU; Svenning JC, 2002, PALMS INVASIVE PALMS, V46, P1; Talley T. S., 2001, Biological Invasions, V3, P51, DOI 10.1023/A:1011453003168; Tanji KK, 2007, CHOOSE SALT TOLERANT; Trent H., 2010, J SAN DIEGO HIST, V56, P105; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tuck R, 2012, SUNSET PALMS; UETZ GW, 1979, OECOLOGIA, V40, P29, DOI 10.1007/BF00388808; VITT LJ, 1994, J ZOOL, V234, P463, DOI 10.1111/j.1469-7998.1994.tb04860.x; WARD PS, 1987, HILGARDIA, V55, P1; Whitcraft CR, 2008, OECOLOGIA, V158, P259, DOI 10.1007/s00442-008-1144-5; Work TT, 2002, ENVIRON ENTOMOL, V31, P438, DOI 10.1603/0046-225X-31.3.438; Wu L, 2020, LANDSCAPE PLANT SALT; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zona S., 2008, GARDEN HIST, V36, P301; Zuefle ME, 2008, BIOL INVASIONS, V10, P1159, DOI 10.1007/s10530-007-9193-y	63	12	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42460	10.1371/journal.pone.0042460	http://dx.doi.org/10.1371/journal.pone.0042460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879991	Green Published, gold			2022-12-25	WOS:000307284100099
J	Zinn, PO; Sathyan, P; Mahajan, B; Bruyere, J; Hegi, M; Majumder, S; Colen, RR				Zinn, Pascal O.; Sathyan, Pratheesh; Mahajan, Bhanu; Bruyere, John; Hegi, Monika; Majumder, Sadhan; Colen, Rivka R.			A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature	PLOS ONE			English	Article							RECURSIVE PARTITIONING ANALYSIS; II CLINICAL-TRIALS; RECURRENT GLIOMA; PHASE-III; TUMOR; EXPRESSION; SURVIVAL; MULTIFORME; CANCER; TEMOZOLOMIDE	Background: Several studies have established Glioblastoma Multiforme (GBM) prognostic and predictive models based on age and Karnofsky Performance Status (KPS), while very few studies evaluated the prognostic and predictive significance of preoperative MR-imaging. However, to date, there is no simple preoperative GBM classification that also correlates with a highly prognostic genomic signature. Thus, we present for the first time a biologically relevant, and clinically applicable tumor Volume, patient Age, and KPS (VAK) GBM classification that can easily and non-invasively be determined upon patient admission. Methods: We quantitatively analyzed the volumes of 78 GBM patient MRIs present in The Cancer Imaging Archive (TCIA) corresponding to patients in The Cancer Genome Atlas (TCGA) with VAK annotation. The variables were then combined using a simple 3-point scoring system to form the VAK classification. A validation set (N = 64) from both the TCGA and Rembrandt databases was used to confirm the classification. Transcription factor and genomic correlations were performed using the gene pattern suite and Ingenuity Pathway Analysis. Results: VAK-A and VAK-B classes showed significant median survival differences in discovery (P = 0.007) and validation sets (P = 0.008). VAK-A is significantly associated with P53 activation, while VAK-B shows significant P53 inhibition. Furthermore, a molecular gene signature comprised of a total of 25 genes and microRNAs was significantly associated with the classes and predicted survival in an independent validation set (P = 0.001). A favorable MGMT promoter methylation status resulted in a 10.5 months additional survival benefit for VAK-A compared to VAK-B patients. Conclusions: The non-invasively determined VAK classification with its implication of VAK-specific molecular regulatory networks, can serve as a very robust initial prognostic tool, clinical trial selection criteria, and important step toward the refinement of genomics-based personalized therapy for GBM patients.	[Zinn, Pascal O.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Zinn, Pascal O.; Sathyan, Pratheesh; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Colen, Rivka R.] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Zinn, Pascal O.; Hegi, Monika] Univ Lausanne Hosp, CHUV BH19 110, Dept Clin Neurosci, Lausanne, Switzerland; [Mahajan, Bhanu; Bruyere, John; Colen, Rivka R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zinn, PO (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.	zinn@bcm.edu	Colen, Rivka/Y-4062-2019; Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495	National Institutes of Health [R25 CA089017-06A2]; Cancer Imaging Program, DCTD/NCI/NIH; NATIONAL CANCER INSTITUTE [R25CA089017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Imaging Program, DCTD/NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants: R25 CA089017-06A2 (RRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Image data used in this research were obtained from The Cancer Imaging Archive (http://cancerimagingarchive.net/) sponsored by the Cancer Imaging Program, DCTD/NCI/NIH.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Archip N, 2007, ACAD RADIOL, V14, P1242, DOI 10.1016/j.acra.2007.05.025; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Butowski N, 2007, J NEURO-ONCOL, V85, P87, DOI 10.1007/s11060-007-9388-1; Carson KA, 2007, J CLIN ONCOL, V25, P2601, DOI 10.1200/JCO.2006.08.1661; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; DWEEP H, 2011, J BIOMED INFORM; Etienne MC, 1998, CLIN CANCER RES, V4, P2383; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Iliadis G, 2009, STRAHLENTHER ONKOL, V185, P743, DOI 10.1007/s00066-009-2015-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto FM, 2009, CANCER-AM CANCER SOC, V115, P5534, DOI 10.1002/cncr.24612; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kahle KT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09212; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Li SW, 2009, CHINESE MED J-PEKING, V122, P1245, DOI 10.3760/cma.j.issn.0366-6999.2009.11.002; Luise C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015891; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Marko NF, 2008, GENOMICS, V91, P395, DOI 10.1016/j.ygeno.2008.01.002; Martin NL, 2005, ONCOGENE, V24, P6890, DOI 10.1038/sj.onc.1208840; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pichon E, 2004, MED IMAGE ANAL, V8, P267, DOI 10.1016/j.media.2004.06.006; Pierre Bady DS, 2012, ACTA NEUROP IN PRESS; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Resch U, 2008, BIOCHEM BIOPH RES CO, V375, P156, DOI 10.1016/j.bbrc.2008.07.142; Sanai N, 2011, J NEUROSURG; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Scott J, 2010, INT J RAD ONCOL BIOL; Siker ML, 2011, J NEURO-ONCOL, V104, P351, DOI 10.1007/s11060-010-0500-6; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Wu WT, 2010, NEURO-ONCOLOGY, V12, P164, DOI 10.1093/neuonc/nop019; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	49	66	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41522	10.1371/journal.pone.0041522	http://dx.doi.org/10.1371/journal.pone.0041522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870228	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100021
J	Horita, H; Kobayashi, M; Liu, WC; Oka, K; Jarvis, ED; Wada, K				Horita, Haruhito; Kobayashi, Masahiko; Liu, Wan-chun; Oka, Kotaro; Jarvis, Erich D.; Wada, Kazuhiro			Specialized Motor-Driven dusp1 Expression in the Song Systems of Multiple Lineages of Vocal Learning Birds	PLOS ONE			English	Article							BASAL GANGLIA PATHWAY; GENE-EXPRESSION; ZEBRA FINCH; AUDITORY RESPONSES; SEQUENCE ALIGNMENT; PERINEURONAL NETS; NEURAL PATHWAYS; ZENK GENE; BRAIN; FOREBRAIN	Mechanisms for the evolution of convergent behavioral traits are largely unknown. Vocal learning is one such trait that evolved multiple times and is necessary in humans for the acquisition of spoken language. Among birds, vocal learning is evolved in songbirds, parrots, and hummingbirds. Each time similar forebrain song nuclei specialized for vocal learning and production have evolved. This finding led to the hypothesis that the behavioral and neuroanatomical convergences for vocal learning could be associated with molecular convergence. We previously found that the neural activity-induced gene dual specificity phosphatase 1 (dusp1) was up-regulated in non-vocal circuits, specifically in sensory-input neurons of the thalamus and telencephalon; however, dusp1 was not up-regulated in higher order sensory neurons or motor circuits. Here we show that song motor nuclei are an exception to this pattern. The song nuclei of species from all known vocal learning avian lineages showed motor-driven up-regulation of dusp1 expression induced by singing. There was no detectable motor-driven dusp1 expression throughout the rest of the forebrain after non-vocal motor performance. This pattern contrasts with expression of the commonly studied activity-induced gene egr1, which shows motor-driven expression in song nuclei induced by singing, but also motor-driven expression in adjacent brain regions after non-vocal motor behaviors. In the vocal non-learning avian species, we found no detectable vocalizing-driven dusp1 expression in the forebrain. These findings suggest that independent evolutions of neural systems for vocal learning were accompanied by selection for specialized motor-driven expression of the dusp1 gene in those circuits. This specialized expression of dusp1 could potentially lead to differential regulation of dusp1-modulated molecular cascades in vocal learning circuits.	[Horita, Haruhito; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Horita, Haruhito; Oka, Kotaro] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 223, Japan; [Horita, Haruhito; Wada, Kazuhiro] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan; [Kobayashi, Masahiko; Wada, Kazuhiro] Hokkaido Univ, Sch Life Sci, Sapporo, Hokkaido, Japan; [Liu, Wan-chun] Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA	Duke University; Howard Hughes Medical Institute; Keio University; Hokkaido University; Hokkaido University; Rockefeller University	Horita, H (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	jarvis@neuro.duke.edu; wada@sci.hokudai.ac.jp	Jarvis, Erich D/A-2319-2008; Oka, Kotaro/C-4918-2014	Jarvis, Erich D/0000-0001-8931-5049; Wada, Kazuhiro/0000-0001-8137-9144	National Institutes of Health (NIH) [R01DC7218]; NIH Director's Pioneer Award [DP1OD448]; Howard Hughes Medical Institute; Uehara Memorial Foundation; Inamori Foundation; Japan Student Services Organization fellowship;  [22120513];  [20033017]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007218] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22650089] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Uehara Memorial Foundation(Uehara Memorial Foundation); Inamori Foundation; Japan Student Services Organization fellowship; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Research was supported by National Institutes of Health (NIH) R01DC7218, NIH Director's Pioneer Award DP1OD448, and Howard Hughes Medical Institute grants to EDJ, Grant-in-Aid for Young Scientists (A) and for Scientific Research on Innovative Areas, Uehara Memorial Foundation, and Inamori Foundation to KW, Grants-in-Aid for Scientific Research on Innovative Areas (22120513, 20033017) to KO, and a Japan Student Services Organization fellowship to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bleiweiss R, 1997, MOL BIOL EVOL, V14, P325, DOI 10.1093/oxfordjournals.molbev.a025767; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 2000, J COMP NEUROL, V420, P244; BRAUN K, 1985, CELL TISSUE RES, V240, P101, DOI 10.1007/BF00217563; Brenowitz E.A., 1991, Seminars in the Neurosciences, V3, P399, DOI 10.1016/1044-5765(91)90030-R; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chen CC, 2012, JOVE-J VIS EXP, DOI 10.3791/3764; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gahr M, 2000, J COMP NEUROL, V426, P182; Gale SD, 2008, J COMP NEUROL, V508, P824, DOI 10.1002/cne.21700; Goldberg JH, 2011, J NEUROPHYSIOL, V105, P2729, DOI 10.1152/jn.00823.2010; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hara E, 2009, P ROY SOC B-BIOL SCI, V276, P279, DOI 10.1098/rspb.2008.1138; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; KARTEN HARVEY J., 1967; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Kuenzel WJ, 1988, STEREOTAXIC ATLAS BR, pviii; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2001, J NEUROSCI, V21, P6836, DOI 10.1523/JNEUROSCI.21-17-06836.2001; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Matsunaga E, 2009, DEV GROWTH DIFFER, V51, P45, DOI 10.1111/j.1440-169X.2008.01080.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mundy NI, 2007, PLOS BIOL, V5, P1842, DOI 10.1371/journal.pbio.0050250; Nabholz B, 2010, MOL PHYLOGENET EVOL, V57, P466, DOI 10.1016/j.ympev.2010.06.009; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Nottebohm F., 1980, PROGR PSYCHOBIOLOGY, V9, P85; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; PATON JA, 1981, J NEUROSCI, V1, P1279; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Pinaud R, 2007, J COMP NEUROL, V504, P601, DOI 10.1002/cne.21457; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Poopatanapong A, 2006, J NEUROBIOL, V66, P1613, DOI 10.1002/neu.20329; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reinke H, 1998, J COMP NEUROL, V391, P147; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Soderstrom K, 2006, J COMP NEUROL, V496, P739, DOI 10.1002/cne.20963; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Takaki M, 2001, J NEUROCHEM, V79, P679, DOI 10.1046/j.1471-4159.2001.00615.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Vates GE, 1997, J COMP NEUROL, V380, P275; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vowles DM, 1979, NEURAL ENDOCRINE ASP, P351; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; WILD JM, 1994, BRAIN BEHAV EVOLUT, V44, P192, DOI 10.1159/000113577; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103	108	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42173	10.1371/journal.pone.0042173	http://dx.doi.org/10.1371/journal.pone.0042173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876306	Green Published, gold			2022-12-25	WOS:000307184700034
J	Noike, M; Ono, Y; Araki, Y; Tanio, R; Higuchi, Y; Nitta, H; Hamano, Y; Toyomasu, T; Sassa, T; Kato, N; Dairi, T				Noike, Motoyoshi; Ono, Yusuke; Araki, Yuji; Tanio, Ryo; Higuchi, Yusuke; Nitta, Hajime; Hamano, Yoshimitsu; Toyomasu, Tomonobu; Sassa, Takeshi; Kato, Nobuo; Dairi, Tohru			Molecular Breeding of a Fungus Producing a Precursor Diterpene Suitable for Semi-Synthesis by Dissection of the Biosynthetic Machinery	PLOS ONE			English	Article							DIFFERENTIATION-INDUCING AGENT; PLANT-GROWTH REGULATOR; GENE-CLUSTER; COTYLENIN-A; FUNCTIONAL-ANALYSIS; FUSICOCCIN; IDENTIFICATION; ENZYMES; CLONING; ALPHA	Many clinically useful pharmaceuticals are semi-synthesized from natural products produced by actinobacteria and fungi. The synthetic protocols usually contain many complicated reaction steps and thereby result in low yields and high costs. It is therefore important to breed microorganisms that produce a compound most suitable for chemical synthesis. For a long time, desirable mutants have been obtained by random mutagenesis and mass screening. However, these mutants sometimes show unfavorable phenotypes such as low viability and low productivity of the desired compound. Fusicoccin (FC) A is a diterpene glucoside produced by the fungus Phomopsis amygdali. Both FC and the structurally-related cotylenin A (CN) have phytohormone-like activity. However, only CN exhibits anti-cancer activity. Since the CN producer lost its ability to proliferate during preservation, a study on the relationship between structure and activity was carried out, and elimination of the hydroxyl group at position 12 of FC was essential to mimic the CN-like activity. Based on detailed dissection of the biosynthetic machinery, we constructed a mutant producing a compound without a hydroxyl group at position 12 by gene-disruption. The mutant produced this compound as a sole metabolite, which can be easily and efficiently converted into an anti-cancer drug, and its productivity was equivalent to the sum of FC-related compounds produced by the parental strain. Our strategy would be applicable to development of pharmaceuticals that are semisynthesized from fungal metabolites.	[Noike, Motoyoshi; Ono, Yusuke; Araki, Yuji; Tanio, Ryo; Dairi, Tohru] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan; [Higuchi, Yusuke; Nitta, Hajime; Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Toyomasu, Tomonobu; Sassa, Takeshi] Yamagata Univ, Dept Bioresource Engn, Yamagata 990, Japan	Hokkaido University; Osaka University; Fukui Prefectural University; Yamagata University	Noike, M (corresponding author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan.	noike@eng.hokudai.ac.jp; dairi@eng.hokudai.ac.jp	Higuchi, Yusuke/I-1991-2018	Higuchi, Yusuke/0000-0002-5982-9660; Hamano, Yoshimitsu/0000-0001-5117-5116; Dairi, Tohru/0000-0002-3406-7970	Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; MEXT, Japan [B01]; Naito Foundation; Foundation NAGASE Science Technology Development	Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Foundation NAGASE Science Technology Development	This work was supported in part by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan, a Grant-in-Aid for Scientific Research on Innovative Areas, the Global COE Program (Project no. B01: Catalysis as the Basis for Innovation in Materials Science), MEXT, Japan, the Naito Foundation, and the Foundation NAGASE Science Technology Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asahi K, 1997, BIOCHEM BIOPH RES CO, V238, P758, DOI 10.1006/bbrc.1997.7385; BALLIO A, 1968, EXPERIENTIA, V24, P631, DOI 10.1007/BF02153818; BARROW KD, 1971, J CHEM SOC C, P1259, DOI 10.1039/j39710001259; BARROW KD, 1973, J CHEM SOC PERK T 1, P1590, DOI 10.1039/p19730001590; BARROW KD, 1975, J CHEM SOC PERK T 1, P877, DOI 10.1039/p19750000877; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hashimoto M, 2009, BIOORG MED CHEM LETT, V19, P5640, DOI 10.1016/j.bmcl.2009.08.026; Hayashi Y, 2008, J ANTIBIOT, V61, P164, DOI 10.1038/ja.2008.126; Hayashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3072, DOI 10.1271/bbb.70477; Honma Y, 2005, GYNECOL ONCOL, V99, P680, DOI 10.1016/j.ygyno.2005.07.015; Honma Y, 2003, CANCER RES, V63, P3659; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1169, DOI 10.1080/10428190290026222; Kawakami K, 2012, ANTICANCER IN PRESS; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; MacKinnon SL, 1999, PHYTOCHEMISTRY, V51, P215, DOI 10.1016/S0031-9422(98)00732-8; MARRE E, 1979, ANNU REV PLANT PHYS, V30, P273, DOI 10.1146/annurev.pp.30.060179.001421; Matsunawa M, 2006, LEUKEMIA LYMPHOMA, V47, P733, DOI 10.1080/10428190500375839; Minami A, 2009, BIOORG MED CHEM LETT, V19, P870, DOI 10.1016/j.bmcl.2008.11.108; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Ono Y, 2011, J AM CHEM SOC, V133, P2548, DOI 10.1021/ja107785u; Sassa T, 2002, BIOSCI BIOTECH BIOCH, V66, P2356, DOI 10.1271/bbb.66.2356; SASSA T, 1971, AGR BIOL CHEM TOKYO, V35, P1415, DOI 10.1080/00021369.1971.10860078; Sassa T, 1998, BIOSCI BIOTECH BIOCH, V62, P1815, DOI 10.1271/bbb.62.1815; Tajima N, 2002, J PESTIC SCI, V27, P64; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003	30	17	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42090	10.1371/journal.pone.0042090	http://dx.doi.org/10.1371/journal.pone.0042090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870285	Green Published, gold			2022-12-25	WOS:000307212800058
J	Margolis, EB; Toy, B; Himmels, P; Morales, M; Fields, HL				Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Morales, Marisela; Fields, Howard L.			Identification of Rat Ventral Tegmental Area GABAergic Neurons	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MIDBRAIN DOPAMINE NEURONS; IN-VIVO MICRODIALYSIS; MEDIATING OPIATE REWARD; GABA-CONTAINING NEURONS; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; MORPHINE; RECEPTORS	The canonical two neuron model of opioid reward posits that mu opioid receptor (MOR) activation produces reward by disinhibiting midbrain ventral tegmental area (VTA) dopamine neurons through inhibition of local GABAergic interneurons. Although indirect evidence supports the neural circuit postulated by this model, its validity has been called into question by growing evidence for VTA neuronal heterogeneity and the recent demonstration that MOR agonists inhibit GABAergic terminals in the VTA arising from extrinsic neurons. In addition, VTA MOR reward can be dopamine-independent. To directly test the assumption that MOR activation directly inhibits local GABAergic neurons, we investigated the properties of rat VTA GABA neurons directly identified with either immunocytochemistry for GABA or GAD65/67, or in situ hybridization for GAD65/67 mRNA. Utilizing co-labeling with an antibody for the neural marker NeuN and in situ hybridization against GAD65/67, we found that 23 +/- 3% of VTA neurons are GAD65/67(+). In contrast to the assumptions of the two neuron model, VTA GABAergic neurons are heterogeneous, both physiologically and pharmacologically. Importantly, only 7/13 confirmed VTA GABA neurons were inhibited by the MOR selective agonist DAMGO. Interestingly, all confirmed VTA GABA neurons were insensitive to the GABA(B) receptor agonist baclofen (0/6 inhibited), while all confirmed dopamine neurons were inhibited (19/19). The heterogeneity of opioid responses we found in VTA GABAergic neurons, and the fact that GABA terminals arising from neurons outside the VTA are inhibited by MOR agonists, make further studies essential to determine the local circuit mechanisms underlying VTA MOR reward.	[Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Fields, Howard L.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Fields, Howard L.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA; [Morales, Marisela] Natl Inst Drug Abuse, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Margolis, EB (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.	elyssam@gallo.ucsf.edu	Fields, Howard/ABG-9073-2020	Toy, Brian/0000-0002-9612-5697	National Institute On Drug Abuse [R01DA030529]; Irene and Eric Simon Brain Research Foundation; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030529] Funding Source: NIH RePORTER	National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Irene and Eric Simon Brain Research Foundation; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by Grant Number R01DA030529 from the National Institute On Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute On Drug Abuse or the National Institutes of Health. This project was also supported by the Irene and Eric Simon Brain Research Foundation, funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco, and funds to the Intramural Research Program of the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; BECHARA A, 1992, BEHAV NEUROSCI, V106, P798, DOI 10.1037/0735-7044.106.5.798; Bonci A, 1997, J NEUROSCI, V17, P796; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Cohen JY, 2012, NATURE; CONRAD LCA, 1976, BRAIN RES, V113, P589, DOI 10.1016/0006-8993(76)90060-3; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DEVINE DP, 1993, J PHARMACOL EXP THER, V266, P1236; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kaufling J, 2010, BIOL PSYCHIAT, V67, P88, DOI 10.1016/j.biopsych.2009.08.001; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KELLEY AE, 1980, BEHAV BRAIN RES, V1, P3, DOI 10.1016/S0166-4328(80)80047-7; Kirouac GJ, 2004, J COMP NEUROL, V469, P170, DOI 10.1002/cne.11005; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2008, J NEUROSCI, V28, P12672, DOI 10.1523/JNEUROSCI.4569-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Matsui A, 2011, J NEUROSCI, V31, P17729, DOI 10.1523/JNEUROSCI.4570-11.2011; MATTHEWS RT, 1984, NEUROSCIENCE, V11, P617, DOI 10.1016/0306-4522(84)90048-4; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; NOWYCKY MC, 1978, J NEURAL TRANSM, V42, P99, DOI 10.1007/BF01675349; Numan M, 2009, BEHAV NEUROSCI, V123, P740, DOI 10.1037/a0016204; Olmstead MC, 1997, BEHAV NEUROSCI, V111, P1324, DOI 10.1037/0735-7044.111.6.1324; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Omelchenko N, 2010, J NEUROSCI RES, V88, P981, DOI 10.1002/jnr.22265; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Sahraei H, 2005, EUR J PHARMACOL, V524, P95, DOI 10.1016/j.ejphar.2005.09.012; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shoji Y, 1999, J NEUROSCI, V19, P2347; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2006, EXP NEUROL, V202, P139, DOI 10.1016/j.expneurol.2006.05.023; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; WELZL H, 1989, NEUROPHARMACOLOGY, V28, P1017, DOI 10.1016/0028-3908(89)90112-3; Wirtshafter D, 2001, BRAIN RES BULL, V56, P1, DOI 10.1016/S0361-9230(01)00487-7; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Xia YF, 2010, J PHYSIOL-LONDON, V588, P1541, DOI 10.1113/jphysiol.2010.188367; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; YOSHIDA M, 1993, BRAIN RES, V624, P277, DOI 10.1016/0006-8993(93)90087-4; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zangen A, 2002, J NEUROSCI, V22, P7225; Zhang Y, 2009, NEUROSCIENCE, V158, P474, DOI 10.1016/j.neuroscience.2008.09.039	66	118	118	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42365	10.1371/journal.pone.0042365	http://dx.doi.org/10.1371/journal.pone.0042365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860119	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600095
J	Zarraonaindia, I; Iriondo, M; Albaina, A; Pardo, MA; Manzano, C; Grant, WS; Irigoien, X; Estonba, A				Zarraonaindia, Iratxe; Iriondo, Mikel; Albaina, Aitor; Angel Pardo, Miguel; Manzano, Carmen; Grant, W. Stewart; Irigoien, Xabier; Estonba, Andone			Multiple SNP Markers Reveal Fine-Scale Population and Deep Phylogeographic Structure in European Anchovy (Engraulis encrasicolus L.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MITOCHONDRIAL-DNA; GENETIC-DIFFERENCES; STATISTICAL-METHOD; MEDITERRANEAN SEA; STOCK STRUCTURE; NORTH-SEA; ESTUARY; SOFTWARE; ATLANTIC	Geographic surveys of allozymes, microsatellites, nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) have detected several genetic subdivisions among European anchovy populations. However, these studies have been limited in their power to detect some aspects of population structure by the use of a single or a few molecular markers, or by limited geographic sampling. We use a multi-marker approach, 47 nDNA and 15 mtDNA single nucleotide polymorphisms (SNPs), to analyze 626 European anchovies from the whole range of the species to resolve shallow and deep levels of population structure. Nuclear SNPs define 10 genetic entities within two larger genetically distinctive groups associated with oceanic variables and different life-history traits. MtDNA SNPs define two deep phylogroups that reflect ancient dispersals and colonizations. These markers define two ecological groups. One major group of Iberian-Atlantic populations is associated with upwelling areas on narrow continental shelves and includes populations spawning and overwintering in coastal areas. A second major group includes northern populations in the North East (NE) Atlantic (including the Bay of Biscay) and the Mediterranean and is associated with wide continental shelves with local larval retention currents. This group tends to spawn and overwinter in oceanic areas. These two groups encompass ten populations that differ from previously defined management stocks in the Alboran Sea, Iberian-Atlantic and Bay of Biscay regions. In addition, a new North Sea-English Channel stock is defined. SNPs indicate that some populations in the Bay of Biscay are genetically closer to North Western (NW) Mediterranean populations than to other populations in the NE Atlantic, likely due to colonizations of the Bay of Biscay and NW Mediterranean by migrants from a common ancestral population. Northern NE Atlantic populations were subsequently established by migrants from the Bay of Biscay. Populations along the Iberian-Atlantic coast appear to have been founded by secondary waves of migrants from a southern refuge.	[Zarraonaindia, Iratxe; Iriondo, Mikel; Albaina, Aitor; Manzano, Carmen; Estonba, Andone] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Genet Lab, Leioa, Bizkaia, Spain; [Angel Pardo, Miguel] AZTI Tecnalia, Food Res Unit, Derio, Bizkaia, Spain; [Grant, W. Stewart] Alaska Dept Fish & Game, Commercial Fisheries Div, Anchorage, AK 99518 USA; [Irigoien, Xabier] AZTI Tecnalia, Div Marine Res, Pasaia, Gipuzkoa, Spain	University of Basque Country; AZTI; Alaska Department of Fish & Game; AZTI	Zarraonaindia, I (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Genet Lab, Leioa, Bizkaia, Spain.	iratxe.zarraonaindia@ehu.es	Iriondo, Mikel/AAA-7997-2019; Albaina, Aitor/E-6267-2015; Zarraonaindia, Iratxe/ABF-4618-2020; Irigoien, Xabier/B-8171-2009; Pardo, Miguel Angel/H-5133-2015	Iriondo, Mikel/0000-0001-7835-0041; Albaina, Aitor/0000-0003-3353-6090; Zarraonaindia, Iratxe/0000-0002-0615-0187; Irigoien, Xabier/0000-0002-5411-6741; Manzano, Carmen/0000-0002-8261-0608; Pardo, Miguel Angel/0000-0002-3395-3380; Estonba, Andone/0000-0003-2851-5201	Education, Universities and Investigation Department of the Basque Government; European Commission (FACTS) [FP7-KBBE-2009-3, 244966]; Ministry of Science and Innovation of Spain [RTA2006-00068-C02-02]; Agriculture and Fisheries Department of the Basque Government (ECOANCHOA)	Education, Universities and Investigation Department of the Basque Government; European Commission (FACTS)(European Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agriculture and Fisheries Department of the Basque Government (ECOANCHOA)	This work was supported by a research grant to IZ from the Education, Universities and Investigation Department of the Basque Government, by the European Commission (FACTS, FP7-KBBE-2009-3, grant agreement 244966) and two funded projects from the Ministry of Science and Innovation of Spain (RTA2006-00068-C02-02) and the Agriculture and Fisheries Department of the Basque Government (ECOANCHOA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aldanondo N, 2010, FISH OCEANOGR, V19, P196, DOI 10.1111/j.1365-2419.2010.00537.x; Baldo F, 2002, J FISH BIOL, V61, P21, DOI 10.1006/jfbi.2002.2064; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Bembo DG, 1996, ICES J MAR SCI, V53, P115, DOI 10.1006/jmsc.1996.0011; Bembo DG, 1996, MAR BIOL, V126, P529, DOI 10.1007/BF00354635; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Bouchenak-Khelladi Y, 2008, J SEA RES, V59, P269, DOI 10.1016/j.seares.2008.03.001; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Caneco B, 2004, 2004EE24 ICES CM; Chashchin AK, 1996, SCI MAR, V60, P219; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Drake P, 2007, J FISH BIOL, V70, P1689, DOI 10.1111/j.1095-8649.2007.01433.x; Drake P, 2002, ESTUARIES, V25, P451, DOI 10.1007/BF02695987; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grant WS, 2005, J FISH BIOL, V67, P1242, DOI 10.1111/j.1095-8649.2005.00820.x; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; GRANT WS, 1985, J FISH BIOL, V27, P23, DOI 10.1111/j.1095-8649.1985.tb04006.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hilbish TJ, 1996, J EXP MAR BIOL ECOL, V200, P67, DOI 10.1016/S0022-0981(96)02645-7; ICES, 2007, 2007ACFM31 ICES CM; ICES, 2010, 2010ACOM16 ICES CM; Irigoien X, 2007, PROG OCEANOGR, V74, P132, DOI 10.1016/j.pocean.2007.04.011; Ivanova Petya P., 2006, Acta Adriatica, V47, P13; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones B, 2009, MOL ECOL RESOUR, V9, P487, DOI 10.1111/j.1755-0998.2008.02444.x; Junquera S, 1986, REV TRAV I PECHES, V48, P133; KALNINA OV, 1984, GENETIKA+, V20, P309; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Kristoffersen JB, 2008, FISH RES, V91, P187, DOI 10.1016/j.fishres.2007.11.024; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Langella O., 1999, POPULATIONS 1 2 32; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magoulas A, 1996, MOL BIOL EVOL, V13, P178, DOI 10.1093/oxfordjournals.molbev.a025554; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mesnick SL, 2011, MOL ECOL RESOUR, V11, P278, DOI 10.1111/j.1755-0998.2010.02973.x; Motos L, 1996, SCI MAR, V60, P117; PALOMERA I, 1992, MAR ECOL PROG SER, V79, P215; Palomera I, 1993, SCI MAR, V57, P243; Pasteur N, 1985, STRUCTURE GENETIQUE; Pestana G, 1989, THESIS U LISBOA; Petitgas P, 2012, MAR ECOL PROG SER, V444, P1, DOI 10.3354/meps09451; Pritchard JK, 2000, GENETICS, V155, P945; Re P, 1996, SCI MAR, V60, P141; REYNOLDS J, 1983, GENETICS, V105, P767; Ribeiro R, 1996, ESTUAR COAST SHELF S, V42, P467, DOI 10.1006/ecss.1996.0030; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Ryynanen HJ, 2007, J HERED, V98, P692, DOI 10.1093/jhered/esm093; Sanz N, 2008, ICES J MAR SCI, V65, P1635, DOI 10.1093/icesjms/fsn128; Sinovcic Gorenka, 2000, Acta Adriatica, V41, P3; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SPANAKIS E, 1989, J FISH BIOL, V35, P417, DOI 10.1111/j.1095-8649.1989.tb02993.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; TAJIMA F, 1989, GENETICS, V123, P585; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, GENETIC DATA ANAL; Zardoya R, 2004, MOL ECOL, V13, P1785, DOI 10.1111/j.1365-294X.2004.02198.x; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187	76	59	59	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42201	10.1371/journal.pone.0042201	http://dx.doi.org/10.1371/journal.pone.0042201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860082	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900077
J	Hashimoto, Y; Muramatsu, K; Kunii, M; Yoshimura, S; Yamada, M; Sato, T; Ishida, Y; Harada, R; Harada, A				Hashimoto, Yukiko; Muramatsu, Kazuhiro; Kunii, Masataka; Yoshimura, Shin-ichiro; Yamada, Minami; Sato, Takashi; Ishida, Yasumasa; Harada, Reiko; Harada, Akihiro			Uncovering genes required for neuronal morphology by morphology-based gene trap screening with a revertible retrovirus vector	FASEB JOURNAL			English	Article						PC12; synaptic vesicles	PROTEIN; CELLS; LOCALIZATION; MUTAGENESIS; DISRUPTION; POLARITY	The molecular mechanisms of neuronal morphology and synaptic vesicle transport have been largely elusive, and only a few of the molecules involved in these processes have been identified. Here, we developed a novel morphology-based gene trap method, which is theoretically applicable to all cell lines, to easily and rapidly identify the responsible genes. Using this method, we selected several gene-trapped clones of rat pheochromocytoma PC12 cells, which displayed abnormal morphology and distribution of synaptic vesicle-like microvesicles (SLMVs). We identified several genes responsible for the phenotypes and analyzed three genes in more detail. The first gene was BTB/POZ domain-containing protein 9 (Btbd9), which is associated with restless legs syndrome. The second gene was cytokine receptor-like factor 3 (Crlf3), whose involvement in the nervous system remains unknown. The third gene was single-stranded DNA-binding protein 3 (Ssbp3), a gene known to regulate head morphogenesis. These results suggest that Btbd9, Crlf3, and Ssbp3 regulate neuronal morphology and the biogenesis/transport of synaptic vesicles. Because our novel morphology-based gene trap method is generally applicable, this method is promising for uncovering novel genes involved in the function of interest in any cell lines.-Hashimoto, Y., Muramatsu, K., Kunii, M., Yoshimura, S., Yamada, M., Sato, T., Ishida, Y., Harada, R., Harada, A. Uncovering genes required for neuronal morphology by morphology-based gene trap screening with a revertible retrovirus vector. FASEB J. 26, 4662-4674 (2012). www.fasebj.org	[Kunii, Masataka; Yoshimura, Shin-ichiro; Harada, Reiko; Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka 5650871, Japan; [Hashimoto, Yukiko; Muramatsu, Kazuhiro; Yamada, Minami; Sato, Takashi; Harada, Akihiro] Gunma Univ, Grad Sch Med, Inst Mol & Cellular Regulat, Gunma, Japan; [Hashimoto, Yukiko] Gunma Univ, Grad Sch Med, Dept Neurol, Gunma, Japan; [Muramatsu, Kazuhiro] Gunma Univ, Grad Sch Med, Dept Pediat, Gunma, Japan; [Ishida, Yasumasa] Nara Inst Sci & Technol, Div Gene Funct Anim, Grad Sch Biol Sci, Nara, Japan; [Harada, Reiko] Takarazuka Univ Med & Hlth Care, Dept Judo Therapy, Takarazuka, Hyogo, Japan	Osaka University; Gunma University; Gunma University; Gunma University; Nara Institute of Science & Technology	Harada, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka 5650871, Japan.	aharada@acb.med.osaka-u.ac.jp	Muramatsu, Kazuhiro/AAA-6350-2021	Muramatsu, Kazuhiro/0000-0001-9256-5591	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21390050, 21590210]; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	The authors thank M. Takano, A. Goto, H. Togawa, and A. Watanabe for assistance with cell culture and immunostaining. The funding for the open access charge was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan [Grant-in-Aid for Scientific Research (B) 21390050 to A.H.; Grant-in-Aid for Scientific Research (C) 21590210 to R.H.]; grants from Kato Memorial Bioscience Foundation to T. S.; and grants from the Mishima Kaiun Memorial Foundation to R.H.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Araki K, 1999, CELL MOL BIOL, V45, P737; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; BLACK MM, 1989, TRENDS NEUROSCI, V12, P211, DOI 10.1016/0166-2236(89)90124-0; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chowdhury K, 1997, NUCLEIC ACIDS RES, V25, P1531, DOI 10.1093/nar/25.8.1531; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Ishida Y, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e35; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Nishioka N, 2005, DEVELOPMENT, V132, P2535, DOI 10.1242/dev.01844; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Yamamura K, 2008, CANCER SCI, V99, P1, DOI 10.1111/j.1349-7006.2007.00611.x; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	29	12	12	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4662	4674		10.1096/fj.12-207530	http://dx.doi.org/10.1096/fj.12-207530			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22874834	Green Published, hybrid			2022-12-25	WOS:000310574200027
J	Ramabhadran, V; Gurel, PS; Higgs, HN				Ramabhadran, Vinay; Gurel, Pinar S.; Higgs, Henry N.			Mutations to the Formin Homology 2 Domain of INF2 Protein Have Unexpected Effects on Actin Polymerization and Severing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR FUNCTION; CAPPING PROTEIN; FISSION YEAST; FH2 DOMAIN; ATP-ACTIN; ADP-ACTIN; FILAMENTS; MECHANISM; ELONGATION; NUCLEATION	INF2 (inverted formin 2) is a formin protein with unusual biochemical characteristics. As with other formins, the formin homology 2 (FH2) domain of INF2 accelerates actin filament assembly and remains at the barbed end, modulating elongation. The unique feature of INF2 is its ability to sever filaments and enhance depolymerization, which requires the C-terminal region. Physiologically, INF2 acts in the secretory pathway and is mutated in two human diseases, focal and segmental glomerulosclerosis and Charcot-Marie-Tooth disease. In this study, we investigate the effects of mutating two FH2 residues found to be key in other formins: Ile-643 and Lys-792. Surprisingly, neither mutation abolishes barbed end binding, as judged by pyrene-actin and total internal reflection (TIRF) microscopy elongation assays. The I643A mutation causes tight capping of a subset of filaments, whereas K792A causes slow elongation of all filaments. The I643A mutation has a minor inhibitory effect on polymerization activity but causes almost complete abolition of severing and depolymerization activity. The K792A mutation has relatively small effects on polymerization, severing, and depolymerization. In cells, the K792A mutant causes actin accumulation around the endoplasmic reticulum to a similar extent as wild type, whereas the I643A mutant causes no measurable polymerization. The inability of I643A to induce actin polymerization in cells is explained by its inability to promote robust actin polymerization in the presence of capping protein. These results highlight an important point: it is dangerous to assume that mutation of conserved FH2 residues will have equivalent effects in all formins. The work also suggests that both mutations have effects on the mechanism of processive elongation.	[Ramabhadran, Vinay; Gurel, Pinar S.; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818, R01 DK088826]; Hitchcock Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM069818 and R01 DK088826. This work was also supported by the Hitchcock Foundation.	Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gbadegesin RA, 2012, KIDNEY INT, V81, P94, DOI 10.1038/ki.2011.297; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lee HK, 2011, PEDIATR NEPHROL, V26, P73, DOI 10.1007/s00467-010-1644-5; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	45	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34234	34245		10.1074/jbc.M112.365122	http://dx.doi.org/10.1074/jbc.M112.365122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879592	Green Published, hybrid			2022-12-25	WOS:000309654200028
J	Singh, V; Aballay, A				Singh, Varsha; Aballay, Alejandro			Endoplasmic Reticulum Stress Pathway Required for Immune Homeostasis Is Neurally Controlled by Arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; NEURONS; EXPRESSION; ACTIVATION; INFECTION	In response to pathogen infection, the host innate immune system activates microbial killing pathways and cellular stress pathways that need to be balanced because insufficient or excessive immune responses have deleterious consequences. Recent studies demonstrate that two G protein-coupled receptors (GPCRs) in the nervous system of Caenorhabditis elegans control immune homeostasis. To investigate further how GPCR signaling controls immune homeostasis at the organismal level, we studied arrestin-1 (ARR-1), which is the only GPCR adaptor protein in C. elegans. The results indicate that ARR-1 is required for GPCR signaling in ASH, ASI, AQR, PQR, and URX neurons, which control the unfolded protein response and a p38 mitogen-activated protein kinase signaling pathway required for innate immunity. ARR-1 activity also controlled immunity through ADF chemosensory and AFD thermosensory neurons that regulate longevity. Furthermore, we found that although ARR-1 played a key role in the control of immunity by AFD thermosensory neurons, it did not control longevity through these cells. However, ARR-1 partially controlled longevity through ADF neurons.	[Singh, Varsha; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054, Durham, NC 27710 USA.	a.aballay@duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM070977] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Andersson J, 2005, J INTERN MED, V257, P122, DOI 10.1111/j.1365-2796.2004.01440.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Tracey KJ, 2011, SCIENCE, V332, P673, DOI 10.1126/science.1206353; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	33	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33191	33197		10.1074/jbc.M112.398362	http://dx.doi.org/10.1074/jbc.M112.398362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875856	Green Published, hybrid			2022-12-25	WOS:000309602100010
J	Rong, ZL; Fu, XM; Wang, MY; Xu, Y				Rong, Zhili; Fu, Xuemei; Wang, Meiyan; Xu, Yang			A Scalable Approach to Prevent Teratoma Formation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUICIDE GENE; SELECTIVE ABLATION; CYTOTOXIC ANTIBODY; MOLECULAR-CLONING; NANOG; PLURIPOTENCY; EXPRESSION; DISEASE; THERAPEUTICS; PODOCALYXIN	As the renewable source of all cell types in the body, human embryonic stem cells (hESCs) hold great promise for human cell therapy. However, one major bottleneck that hinders the clinic application of hESCs is that hESCs remaining with their differentiated derivatives pose cancer risk by forming teratomas after transplantation. NANOGis a critical pluripotency factor specifically expressed in hESCs but rarely in their differentiated derivatives. By introducing a hyperactive variant of herpes simplex virus thymidine kinase gene into the 3'-untranslated region of the endogenous NANOG gene of hESCs through homologous recombination, we developed a safe and highly scalable approach to efficiently eliminate the teratoma risk associated with hESCs without apparent negative impact on their differentiated cell types. As thymidine kinase is widely used in human gene therapy trials and is the therapeutic target of U. S. Food and Drug Administration-approved drugs, our strategy could be effectively applied to the clinic development of hESC-based human cell therapy.	[Rong, Zhili; Fu, Xuemei; Wang, Meiyan; Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fu, Xuemei] Chengdu Womens & Childrens Cent Hosp, Chengdu, Sichuan, Peoples R China	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Rong, Zhili/H-7561-2014	Rong, Zhili/0000-0002-1699-7074; Wang, Meiyan/0000-0002-4838-7182; Xu, Yang/0000-0001-5574-921X	National Natural Science Foundation of China [81172828]; California Institute for Regenerative Medicine [ET-01277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by Grant 81172828 from National Natural Science Foundation of China (to X. F.) and Early Translational Grant ET-01277 from California Institute for Regenerative Medicine (to Y. X.).	Arumugam SB, 2011, INDIAN J PATHOL MICR, V54, P501, DOI 10.4103/0377-4929.85082; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Black ME, 2001, CANCER RES, V61, P3022; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/RME.11.18, 10.2217/rme.11.18]; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hara A, 2008, STEM CELLS DEV, V17, P619, DOI 10.1089/scd.2007.0235; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; McGavin JK, 2001, DRUGS, V61, P1153, DOI 10.2165/00003495-200161080-00016; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Potdar PD, 2011, HUM CELL, V24, P51, DOI 10.1007/s13577-011-0011-6; RUBINSTEIN E, 1993, THROMB RES, V71, P377, DOI 10.1016/0049-3848(93)90162-H; Scadden David, 2012, Cell Stem Cell, V10, P149, DOI 10.1016/j.stem.2012.01.010; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shen Y, 2006, CANCER GENE THER, V13, P975, DOI 10.1038/sj.cgt.7700946; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x	36	43	48	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32338	32345		10.1074/jbc.M112.383810	http://dx.doi.org/10.1074/jbc.M112.383810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865887	hybrid, Green Published			2022-12-25	WOS:000309168300005
J	Ding, SP; Jiang, T; He, JQ; Qin, BB; Lin, SY; Li, LJ				Ding, Shiping; Jiang, Tao; He, Jianqin; Qin, Beibei; Lin, Shuangyan; Li, Lanjuan			Tagging Single Nucleotide Polymorphisms in the IRF1 and IRF8 Genes and Tuberculosis Susceptibility	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; FACTOR-I POLYMORPHISMS; TAG SNP SELECTION; IFN-GAMMA; B-CELL; INTERFERON; EXPRESSION; IMMUNITY	Genes encoding IRF1 and IRF8 protein have been proposed as candidate tuberculosis susceptibility genes. In order to elucidate whether the IRF1 and IRF8 variants were associated with tuberculosis susceptibility, we conducted a case-control study consisting of 495 controls and 452 ethnically matched cases with tuberculosis in a Chinese population. Seven haplotype tagging single-nucleotide polymorphisms (tagSNPs) (rs2057656; rs2706381; rs2070724; rs2070721; rs2549008; rs2549007; rs2706386) from HapMap database were analyzed, which provided an almost complete coverage of the genetic variations in the IRF1 gene. Fifteen tagSNPs (rs12924316; rs182511; rs305080; rs2292980; rs925994; rs424971; rs16939967; rs11117415; rs4843860; rs9926411; rs8064189; rs12929551; rs10514611; rs1044873; rs6638) were observed in the IRF8 gene. All these tagSNPs were genotyped by SNPstream genotyping and SNaPshot typing. None of the seven tagSNPs was individually associated with tuberculosis in the IRF1 gene. In the IRF8 gene, interestingly, we found that three tagSNPs (rs925994 and rs11117415 located in the intron region; rs10514611 located in the 3'UTR) were associated with risk of tuberculosis after Bonferroni correction. Per allele OR was 1.75 (95% CI 1.35 similar to 2.27,P = 0.002), 4.75 (95% CI 2.16 similar to 10.43, P = 0.002) and 3.39 (95% CI 1.60 similar to 7.20, P = 0.015) respectively. Luciferase reporter gene assay showed that the construct that contained the non-risk allele C of rs10514611 showed significantly higher luciferase activity than did the risk T allele (P<0.01), which implied rs10514611 was a potential functional SNP site. Our results indicated that the IRF8 gene might participate in genetic susceptibility to tuberculosis in a Chinese population.	[Ding, Shiping; He, Jianqin; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Shiping; Jiang, Tao; Qin, Beibei; Lin, Shuangyan] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ding, SP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			"11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis [2008ZX10003011]; Science and Technology Foundation of Public Welfare Profession of Zhejiang Province [2010C33025]; National Natural Science Foundation of China [81072339]; Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases [2010KF12]; Zhejiang Provincial Natural Science Foundation of China [Y2100347, LR12H26001]	"11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis; Science and Technology Foundation of Public Welfare Profession of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the "11th Five-Year" Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis (2008ZX10003011) and the Science and Technology Foundation of Public Welfare Profession of Zhejiang Province (2010C33025) and the National Natural Science Foundation of China (81072339) and the Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2010KF12) and Zhejiang Provincial Natural Science Foundation of China (Y2100347; LR12H26001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Ding SP, 2008, HUM IMMUNOL, V69, P129, DOI 10.1016/j.humimm.2007.11.006; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Lee YJ, 2007, HUM IMMUNOL, V68, P770, DOI 10.1016/j.humimm.2007.06.002; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Okamoto M, 2005, CHEST, V128, P4030, DOI 10.1378/chest.128.6.4030; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Qiao YM, 2004, J IMMUNOL, V172, P2935, DOI 10.4049/jimmunol.172.5.2935; Remus N, 2003, IMMUNOL RES, V28, P109, DOI 10.1385/IR:28:2:109; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Vollstedt S, 2009, TUBERCULOSIS, V89, P71, DOI 10.1016/j.tube.2008.09.006; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; World Health Organization, 2009, GLOB TUB CONTR EP ST; Xu ZL, 2007, EUR J HUM GENET, V15, P1063, DOI 10.1038/sj.ejhg.5201875; Yamada H, 2002, MICROBIOL IMMUNOL, V46, P751, DOI 10.1111/j.1348-0421.2002.tb02760.x; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42104	10.1371/journal.pone.0042104	http://dx.doi.org/10.1371/journal.pone.0042104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879909	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000016
J	Castilho, AF; Aveleira, CA; Leal, EC; Simoes, NF; Fernandes, CR; Meirinhos, RI; Baptista, FI; Ambrosio, AF				Castilho, Aurea F.; Aveleira, Celia A.; Leal, Ermelindo C.; Simoes, Nuria F.; Fernandes, Carolina R.; Meirinhos, Rita I.; Baptista, Filipa I.; Ambrosio, Antonio F.			Heme Oxygenase-1 Protects Retinal Endothelial Cells against High Glucose- and Oxidative/Nitrosative Stress-Induced Toxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; MITOCHONDRIAL SUPEROXIDE; DIABETIC-RETINOPATHY; CARBON-MONOXIDE; MULLER CELLS; APOPTOSIS; OVEREXPRESSION; INDUCTION; INJURY	Diabetic retinopathy is a leading cause of visual loss and blindness, characterized by microvascular dysfunction. Hyperglycemia is considered the major pathogenic factor for the development of diabetic retinopathy and is associated with increased oxidative/nitrosative stress in the retina. Since heme oxygenase-1 (HO-1) is an enzyme with antioxidant and protective properties, we investigated the potential protective role of HO-1 in retinal endothelial cells exposed to high glucose and oxidative/nitrosative stress conditions. Retinal endothelial cells were exposed to elevated glucose, nitric oxide (NO) and hydrogen peroxide (H2O2). Cell viability and apoptosis were assessed by MTT assay, Hoechst staining, TUNEL assay and Annexin V labeling. The production of reactive oxygen species (ROS) was detected by the oxidation of 2',7'-dichlorodihydrofluorescein diacetate. The content of HO-1 was assessed by immunobloting and immunofluorescence. HO activity was determined by bilirubin production. Long-term exposure (7 days) of retinal endothelial cells to elevated glucose decreased cell viability and had no effect on HO-1 content. However, a short-time exposure (24 h) to elevated glucose did not alter cell viability, but increased both the levels of intracellular ROS and HO-1 content. Moreover, the inhibition of HO with SnPPIX unmasked the toxic effect of high glucose and revealed the protection conferred by HO-1. Oxidative/nitrosative stress conditions increased cell death and HO-1 protein levels. These effects of elevated glucose and HO inhibition on cell death were confirmed in primary endothelial cells (HUVECs). When cells were exposed to oxidative/nitrosative stress conditions there was also an increase in retinal endothelial cell death and HO-1 content. The inhibition of HO enhanced ROS production and the toxic effect induced by exposure to H2O2 and NOC-18 (NO donor). Overexpression of HO-1 prevented the toxic effect induced by H2O2 and NOC-18. In conclusion, HO-1 exerts a protective effect in retinal endothelial cells exposed to hyperglycemic and oxidative/nitrosative stress conditions.	[Castilho, Aurea F.; Aveleira, Celia A.; Leal, Ermelindo C.; Simoes, Nuria F.; Fernandes, Carolina R.; Meirinhos, Rita I.; Baptista, Filipa I.; Ambrosio, Antonio F.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal	Universidade de Coimbra	Castilho, AF (corresponding author), Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Baptista, Filipa/E-2828-2012; Aveleira, Célia/AAI-2455-2021; Aveleira, Célia A/L-1325-2014; Ambrósio, António F/I-3722-2012; Leal, Ermelindo C/G-3051-2010	Baptista, Filipa/0000-0001-7972-640X; Aveleira, Célia/0000-0002-2191-0682; Aveleira, Célia A/0000-0002-2191-0682; Ambrósio, António F/0000-0002-0477-1641; Leal, Ermelindo C/0000-0003-1748-9861; Castilho, Aurea/0000-0001-7012-5915	Faculty of Medicine, University of Coimbra, Portugal	Faculty of Medicine, University of Coimbra, Portugal	This work was supported by the Faculty of Medicine, University of Coimbra, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alizadeh M, 2001, INVEST OPHTH VIS SCI, V42, P2706; [Anonymous], 1995, DIABETES, V44, P968; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Aveleira C, 2010, CYTOKINE, V49, P279, DOI 10.1016/j.cyto.2009.11.014; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Carbajal JM, 1998, BIOCHEM BIOPH RES CO, V249, P461, DOI 10.1006/bbrc.1998.9172; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; Cunha-Vaz JG, 2000, OPHTHALMOLOGICA, V214, P377, DOI 10.1159/000027528; Cunha-Vaz JG, 2001, OPHTHALMOLOGICA, V215, P7, DOI 10.1159/000050927; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Grammas P, 2003, MICROVASC RES, V65, P18, DOI 10.1016/S0026-2862(02)00016-X; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Kowluru RA, 2005, LIFE SCI, V76, P1051, DOI 10.1016/j.lfs.2004.10.017; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; MAINES MD, 1986, J BIOL CHEM, V261, P411; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Nakayama M, 2000, BIOCHEM BIOPH RES CO, V271, P665, DOI 10.1006/bbrc.2000.2683; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Salahudeen AA, 2001, TRANSPLANTATION, V72, P1498, DOI 10.1097/00007890-200111150-00005; Shibahara S, 2003, EXP BIOL MED, V228, P472, DOI 10.1177/15353702-0322805-08; Soares MP, 2002, ANTIOXID REDOX SIGN, V4, P321, DOI 10.1089/152308602753666370; Soares MP, 2001, IMMUNOL REV, V184, P275, DOI 10.1034/j.1600-065x.2001.1840124.x; Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443; Ulyanova T, 2001, INVEST OPHTH VIS SCI, V42, P1370; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118	46	73	78	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42428	10.1371/journal.pone.0042428	http://dx.doi.org/10.1371/journal.pone.0042428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879979	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100090
J	Chafe, SC; Pierce, JB; Mangroo, D				Chafe, Shawn C.; Pierce, Jacqueline B.; Mangroo, Dev			Nuclear-Cytoplasmic Trafficking of NTF2, the Nuclear Import Receptor for the RanGTPase, Is Subjected to Regulation	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; TRANSFER-RNA; PORE COMPLEX; TRANSPORT FACTOR; RAN-GTPASE; NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; EXPORT RECEPTOR; POLY(ADP-RIBOSE) POLYMERASE	NTF2 is a cytosolic protein responsible for nuclear import of Ran, a small Ras-like GTPase involved in a number of critical cellular processes, including cell cycle regulation, chromatin organization during mitosis, reformation of the nuclear envelope following mitosis, and controlling the directionality of nucleocytoplasmic transport. Herein, we provide evidence for the first time that translocation of the mammalian NTF2 from the nucleus to the cytoplasm to collect Ran in the GDP form is subjected to regulation. Treatment of mammalian cells with polysorbitan monolaurate was found to inhibit nuclear export of tRNA and proteins, which are processes dependent on RanGTP in the nucleus, but not nuclear import of proteins. Inhibition of the export processes by polysorbitan monolaurate is specific and reversible, and is caused by accumulation of Ran in the cytoplasm because of a block in translocation of NTF2 to the cytoplasm. Nuclear import of Ran and the nuclear export processes are restored in polysorbitan monolaurate treated cells overproducing NTF2. Moreover, increased phosphorylation of a phospho-tyrosine protein and several phospho-threonine proteins was observed in polysorbitan monolaurate treated cells. Collectively, these findings suggest that nucleocytoplasmic translocation of NTF2 is regulated in mammalian cells, and may involve a tyrosine and/or threonine kinase-dependent signal transduction mechanism(s).	[Chafe, Shawn C.; Pierce, Jacqueline B.; Mangroo, Dev] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Chafe, SC (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	devakanand.mangroo@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). JBP is the recipient of a NSERC Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chafe SC, 2011, NUTR STRESS DOES NOT, V22; Chafe SC, 2010, MOL BIOL CELL, V21, P2483, DOI 10.1091/mbc.E10-03-0176; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; Davis JR, 2007, PHARM RES-DORDR, V24, P17, DOI 10.1007/s11095-006-9133-z; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Eswara MBK, 2009, MOL BIOL CELL, V20, P5007, DOI 10.1091/mbc.E09-06-0490; Feldherr C, 1998, J CELL SCI, V111, P1889; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Haberland J, 1999, BIOCHEM J, V343, P653, DOI 10.1042/0264-6021:3430653; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2010, NUCLEUS-PHILA, V1, P237, DOI 10.4161/nucl.1.3.11444; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pierce JB, 2010, NUCLEUS, V1; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ricour C, 2009, J GEN VIROL, V90, P177, DOI 10.1099/vir.0.005678-0; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Steggerda SM, 2000, MOL BIOL CELL, V11, P703, DOI 10.1091/mbc.11.2.703; Steiner-Mosonyi M, 2004, BIOCHEM J, V378, P809, DOI 10.1042/BJ20031306; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	63	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42501	10.1371/journal.pone.0042501	http://dx.doi.org/10.1371/journal.pone.0042501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880006	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100111
J	Hanke, ML; Angle, A; Kielian, T				Hanke, Mark L.; Angle, Amanda; Kielian, Tammy			MyD88-Dependent Signaling Influences Fibrosis and Alternative Macrophage Activation during Staphylococcus aureus Biofilm Infection	PLOS ONE			English	Article							DNA RELEASE; PATHOGENESIS; INFLAMMATION; RECOGNITION; METABOLISM; MECHANISMS; MONOCYTE; GROWTH	Bacterial biofilms represent a significant therapeutic challenge based on their ability to evade host immune and antibiotic-mediated clearance. Recent studies have implicated IL-1 beta in biofilm containment, whereas Toll-like receptors (TLRs) had no effect. This is intriguing, since both the IL-1 receptor (IL-1R) and most TLRs impinge on MyD88-dependent signaling pathways, yet the role of this key adaptor in modulating the host response to biofilm growth is unknown. Therefore, we examined the course of S. aureus catheter-associated biofilm infection in MyD88 knockout (KO) mice. MyD88 KO animals displayed significantly increased bacterial burdens on catheters and surrounding tissues during early infection, which coincided with enhanced dissemination to the heart and kidney compared to wild type (WT) mice. The expression of several proinflammatory mediators, including IL-6, IFN-gamma, and CXCL1 was significantly reduced in MyD88 KO mice, primarily at the later stages of infection. Interestingly, immunofluorescence staining of biofilm-infected tissues revealed increased fibrosis in MyD88 KO mice concomitant with enhanced recruitment of alternatively activated M2 macrophages. Taken in the context of previous studies with IL-1 beta, TLR2, and TLR9 KO mice, the current report reveals that MyD88 signaling is a major effector pathway regulating fibrosis and macrophage polarization during biofilm formation. Together these findings represent a novel example of the divergence between TLR and MyD88 action in the context of S. aureus biofilm infection.	[Hanke, Mark L.; Angle, Amanda; Kielian, Tammy] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Hanke, ML (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA.	tkielian@unmc.edu	Hanke, Mark/H-7835-2013	Kielian, Tammy/0000-0001-7624-670X	National Insititutes of Health National Institute of Allergy and Infectious Disease [P01 AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211] Funding Source: NIH RePORTER	National Insititutes of Health National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Insititutes of Health National Institute of Allergy and Infectious Disease P01 AI083211 Project 4 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706; Cassat James E., 2007, V391, P127; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Duch JM, 2001, AM J KIDNEY DIS, V37, P149, DOI 10.1016/S0272-6386(01)80069-X; Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Lupher ML, 2006, ADV IMMUNOL, V89, P245, DOI 10.1016/S0065-2776(05)89006-6; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mauviel A, 2005, METH MOLEC MED, V117, P69; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; MURRAY DG, 1995, JAMA-J AM MED ASSOC, V273, P1950, DOI 10.1001/jama.1995.03520480070043; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; PICKERING SJ, 1989, NEPHROL DIAL TRANSPL, V4, P62; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rupp ME, 1999, INFECT IMMUN, V67, P2627, DOI 10.1128/IAI.67.5.2627-2632.1999; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wagner C, 2011, INT J ARTIF ORGANS, V34, P811, DOI 10.5301/ijao.5000061; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	44	49	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42476	10.1371/journal.pone.0042476	http://dx.doi.org/10.1371/journal.pone.0042476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879997	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100103
J	Phillips, KM; Horst, RL; Koszewski, NJ; Simon, RR				Phillips, Katherine M.; Horst, Ronald L.; Koszewski, Nicholas J.; Simon, Ryan R.			Vitamin D-4 in Mushrooms	PLOS ONE			English	Article							AGARICUS-BISPORUS; BUTTON MUSHROOMS; BIOLOGICAL-ACTIVITY; STEROLS; ERGOSTEROL; MAMMARY; BIOAVAILABILITY; CARCINOGENESIS; METABOLITES	An unknown vitamin D compound was observed in the HPLC-UV chromatogram of edible mushrooms in the course of analyzing vitamin D-2 as part of a food composition study and confirmed by liquid chromatography-mass spectrometry to be vitamin D-4 (22-dihydroergocalciferol). Vitamin D-4 was quantified by HPLC with UV detection, with vitamin [H-3] itamin D-3 as an internal standard. White button, crimini, portabella, enoki, shiitake, maitake, oyster, morel, chanterelle, and UV-treated portabella mushrooms were analyzed, as four composites each of a total of 71 samples from U.S. retail suppliers and producers. Vitamin D-4 was present (>0.1 mu g/100 g) in a total of 18 composites and in at least one composite of each mushroom type except white button. The level was highest in samples with known UV exposure: vitamin D enhanced portabella, and maitake mushrooms from one supplier (0.2-7.0 and 22.5-35.4 mu g/100 g, respectively). Other mushrooms had detectable vitamin D-4 in some but not all samples. In one composite of oyster mushrooms the vitamin D-4 content was more than twice that of D-2 (6.29 vs. 2.59 mu g/100 g). Vitamin D-4 exceeded 2 mu g/100 g in the morel and chanterelle mushroom samples that contained D-4, but was undetectable in two morel samples. The vitamin D-4 precursor 22,23-dihydroergosterol was found in all composites (4.49-16.5 mg/100 g). Vitamin D-4 should be expected to occur in mushrooms exposed to UV light, such as commercially produced vitamin D enhanced products, wild grown mushrooms or other mushrooms receiving incidental exposure. Because vitamin D-4 coeluted with D-3 in the routine HPLC analysis of vitamin D-2 and an alternate mobile phase was necessary for resolution, researchers analyzing vitamin D-2 in mushrooms and using D-3 as an internal standard should verify that the system will resolve vitamins D-3 and D-4.	[Phillips, Katherine M.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Horst, Ronald L.] Heartland Assays Inc, Ames, IA USA; [Koszewski, Nicholas J.] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA USA; [Simon, Ryan R.] Cantox Hlth Sci Int, Mississauga, ON, Canada	Virginia Polytechnic Institute & State University; Iowa State University	Phillips, KM (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	kmpvpi@vt.edu		Phillips, Katherine/0000-0002-4586-8538	United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program; USDA Nutrient Data Laboratory [59-1235-7-146]; Virginia Tech [59-1235-7-146]; United States Department of Agriculture; Mushroom Council	United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program; USDA Nutrient Data Laboratory; Virginia Tech; United States Department of Agriculture(United States Department of Agriculture (USDA)); Mushroom Council	This work was supported by the United States Department of Agriculture Agricultural Research Service as part of the National Food and Nutrient Analysis Program, by cooperative agreement 59-1235-7-146 between the USDA Nutrient Data Laboratory and Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Katherine Phillips is a Senior Research Scientist at Virginia Tech and has received funding from the United States Department of Agriculture for this work. She has also received funding from the Mushroom Council but the present study was initiated independently and not commissioned or funded by the Mushroom Council. Ronald Horst is Owner/Director of Heartland Assays LLC. Heartland Assays provides analytical and consulting services to many Academic and Commercial institutions regarding interpreting and application Vitamin D assays. These activities will not interfere with the objective presentation and sharing of information presented in the PLoS ONE manuscript. Nick Koszewski is an employee of Iowa State University, College of Veterinary Medicine and has on occasion acted as a consultant in the identification of vitamin D compounds. His activities will not interfere with the objective presentation and sharing of data presented in the PLoS ONE manuscript. Ryan Simon is an employee of Intertek Cantox a scientific and regulatory consulting company, Intertek Cantox has provided consulting services to the U.S. mushroom industry over the past three years. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aburjai T, 1998, PHYTOCHEMISTRY, V49, P2497, DOI 10.1016/S0031-9422(98)00246-5; Bills CE, 1938, J AMER MED ASSOC, V110, P2150, DOI 10.1001/jama.1938.62790260002009; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Boland R, 2003, PLANT SCI, V164, P357, DOI 10.1016/S0168-9452(02)00420-X; BROOKS CJW, 1968, LIPIDS, V3, P391, DOI 10.1007/BF02531277; Byford V, 2002, BBA-MOL CELL BIOL L, V1583, P151, DOI 10.1016/S1388-1981(02)00195-6; Chen TC, 2010, NUTR HEALTH SER, P35, DOI 10.1007/978-1-60327-303-9_2; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DELUCA HF, 1968, ARCH BIOCHEM BIOPHYS, V124, P122, DOI 10.1016/0003-9861(68)90310-X; Feldman D, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P317; Hirsch A.L., 2011, VITAMIN D, P73, DOI DOI 10.1016/B978-0-12-381978-9.10006-X; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; HORST RL, 1984, ARCH BIOCHEM BIOPHYS, V231, P67, DOI 10.1016/0003-9861(84)90363-1; Horst RL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P15; HORWITZ W, 1980, J ASSOC OFF ANA CHEM, V63, P1344; Jasinghe VJ, 2006, FOOD CHEM, V95, P638, DOI 10.1016/j.foodchem.2005.01.046; Jones G, 2010, ENDOCRIN METAB CLIN, V39, P447, DOI 10.1016/j.ecl.2010.02.003; KARMAKAR T, 1983, PHYTOCHEMISTRY, V22, P608, DOI 10.1016/0031-9422(83)83065-9; KENNY PTM, 1995, EUR MASS SPECTROM, V1, P411, DOI 10.1255/ejms.98; KORN ED, 1969, COMP BIOCHEM PHYSIOL, V30, P601, DOI 10.1016/0010-406X(69)92137-9; Koyyalamudi SR, 2011, J FOOD COMPOS ANAL, V24, P976, DOI 10.1016/j.jfca.2011.02.007; Koyyalamudi SR, 2009, J AGR FOOD CHEM, V57, P3351, DOI 10.1021/jf803908q; MATSUMOTO T, 1984, PHYTOCHEMISTRY, V23, P921, DOI 10.1016/S0031-9422(00)85067-0; Mattila P, 2002, FOOD CHEM, V76, P293, DOI 10.1016/S0308-8146(01)00275-8; Mattila P, 2001, J AGR FOOD CHEM, V49, P2343, DOI 10.1021/jf001525d; MATTILA PH, 1994, J AGR FOOD CHEM, V42, P2449, DOI 10.1021/jf00047a016; MCCORKINDALE NJ, 1969, PHYTOCHEMISTRY, V8, P861, DOI 10.1016/S0031-9422(00)85874-4; Mehta RG, 1997, JNCI-J NATL CANCER I, V89, P212, DOI 10.1093/jnci/89.3.212; Mehta RG, 2004, EUR J CANCER, V40, P2331, DOI 10.1016/j.ejca.2004.05.025; MERCER EI, 1976, PHYTOCHEMISTRY, V15, P283, DOI 10.1016/S0031-9422(00)89004-4; Moss GP, 1989, PURE APPL CHEM, V61, P1783; Murillo G, 2005, J STEROID BIOCHEM, V97, P129, DOI 10.1016/j.jsbmb.2005.06.008; NAPOLI JL, 1979, ARCH BIOCHEM BIOPHYS, V197, P119, DOI 10.1016/0003-9861(79)90226-1; Nasir H, 2003, ARCH INSECT BIOCHEM, V52, P175, DOI 10.1002/arch.10079; Outila TA, 1999, AM J CLIN NUTR, V69, P95; PATTERSON GW, 1969, COMP BIOCHEM PHYSIOL, V31, P391, DOI 10.1016/0010-406X(69)90019-X; Phillips KM, 2011, J AGR FOOD CHEM, V59, P7841, DOI 10.1021/jf104246z; Rangel-Castro JI, 2002, MYCOL RES, V106, P70, DOI 10.1017/S0953756201005299; Roberts JS, 2008, J AGR FOOD CHEM, V56, P4541, DOI 10.1021/jf0732511; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; San Diego Gas & Electric, 2009, PROGR DES        SUM, P2; SECKBACH J, 1972, PLANT PHYSIOL, V49, P457, DOI 10.1104/pp.49.3.457; Shao SQ, 2010, J AGR FOOD CHEM, V58, P11616, DOI 10.1021/jf102285b; Simon RB, 2011, BURLINGTON MAG, V153, P59; Tachibana Y, 2001, STEROIDS, V66, P93, DOI 10.1016/S0039-128X(00)00208-7; Teichmann A, 2007, LWT-FOOD SCI TECHNOL, V40, P815, DOI 10.1016/j.lwt.2006.04.003; THOMPSON MJ, 1972, PHYTOCHEMISTRY, V11, P1781, DOI 10.1016/0031-9422(72)85036-2; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NATL NUTR DAT S; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Urbain P, 2010, CLIN NUTR S, V5, P15; Wang T, 2001, J PHOTOCH PHOTOBIO B, V62, P118, DOI 10.1016/S1011-1344(01)00160-9; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Zhao XY, 2001, STEROIDS, V66, P293, DOI 10.1016/S0039-128X(00)00164-1	53	34	34	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40702	10.1371/journal.pone.0040702	http://dx.doi.org/10.1371/journal.pone.0040702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870201	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100009
J	Rupprecht, A; Brauer, AU; Smorodchenko, A; Goyn, J; Hilse, KE; Shabalina, IG; Infante-Duarte, C; Pohl, EE				Rupprecht, Anne; Braeuer, Anja U.; Smorodchenko, Alina; Goyn, Justus; Hilse, Karolina E.; Shabalina, Irina G.; Infante-Duarte, Carmen; Pohl, Elena E.			Quantification of Uncoupling Protein 2 Reveals Its Main Expression in Immune Cells and Selective Up-Regulation during T-Cell Proliferation	PLOS ONE			English	Article							PREVENTS NEURONAL DEATH; NITRIC-OXIDE; MITOCHONDRIAL HYPERPOLARIZATION; ENERGY-METABOLISM; MESSENGER-RNA; UCP2; BRAIN; GENE; MICE; ACTIVATION	Uncoupling protein 2 (UCP2) is an inner mitochondrial membrane protein. Although the protein was discovered in 1997, its function and even its tissue distribution are still under debate. Here we present a quantitative analysis of mRNA and protein expression in various mice tissues, revealing that UCP2 is mainly expressed in organs and cells associated with the immune system. Although the UCP2 gene is present in the brain, as demonstrated using quantitative RT-PCR, the protein was not detectable in neurons under physiological conditions. Instead, we could detect UCP2 in microglia, which act in the immune defense of the central nervous system. In lymphocytes, activation led to a ten-fold increase of UCP2 protein expression simultaneously to the increase in levels of other mitochondrial proteins, whereas lymphocyte re-stimulation resulted in the selective increase of UCP2. The highest detected level of UCP2 expression in stimulated T-cells (0.54 ng/(mg total cellular protein)) was approximately 200 times lower than the level of UCP1 in brown adipose tissue from room temperature acclimated mice. Both the UCP2 expression pattern and the time course of up-regulation in stimulated T-cells imply UCP2's involvement in the immune response, probably by controlling the metabolism during cell proliferation.	[Rupprecht, Anne; Smorodchenko, Alina; Hilse, Karolina E.; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Braeuer, Anja U.; Goyn, Justus] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Shabalina, Irina G.] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Infante-Duarte, Carmen] Expt & Clin Res Ctr, Berlin, Germany	University of Veterinary Medicine Vienna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stockholm University	Rupprecht, A (corresponding author), Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	elena.pohl@vetmeduni.ac.at	Shabalina, Irina G/A-4225-2011; Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Smorodchenko, Alina/ABB-2411-2020; Pohl, Elena E./A-4025-2009; Shabalina, Irina/AAC-3720-2019; Smorodchenko, Alina/AAU-2854-2020; Smorodchenko, Alina/D-1880-2010	Shabalina, Irina G/0000-0002-2915-6450; Pohl, Elena E./0000-0002-0604-5950; Shabalina, Irina/0000-0002-2915-6450; Infante Duarte, Carmen/0000-0003-3005-351X; Smorodchenko, Alina/0000-0003-1415-1531	Deutsche Forschungsgemeinschaft [Po 524/3, Po 524/5]; Sonnenfeld-Stiftung Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung Berlin	This work was financially supported by Deutsche Forschungsgemeinschaft (Po 524/3, Po 524/5 to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Bettina Brokowski, Rike Dannenberg and Thordis Hohnstein (Charite, Berlin) for the excellent technical assistance, Dr. D. Ricquier (BIOTRAM, Universite Paris Descartes) for generous gift of UCP2 knockout mice, Dr. B. Cannon and Dr. J. Nedergaard (The Wenner-Gren Institute, Stockholm University) for valuable discussion. hUCP2 was kindly provided by Dr. M. Jaburek and Dr. P. Jezek (Department of Membrane Transport Biophysics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic). Some of the technical equipment for AUB was sponsored by the Sonnenfeld-Stiftung Berlin. We thank Graham Tebb for editorial assistance.	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Arsenijevic D, 2007, J NEUROIMMUNOL, V186, P121, DOI 10.1016/j.jneuroim.2007.03.013; Baffy G, 2011, BRIT J CANCER, V105, P469, DOI 10.1038/bjc.2011.245; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Clavel S, 2003, NEUROREPORT, V14, P2015, DOI 10.1097/00001756-200311140-00002; Cortez-Pinto H, 1998, BIOCHEM BIOPH RES CO, V251, P313, DOI 10.1006/bbrc.1998.9473; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; de Bilbao F, 2004, J NEUROCHEM, V89, P1283, DOI 10.1111/j.1471-4159.2004.02432.x; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Elorza A, 2008, J BIOL CHEM, V283, P30461, DOI 10.1074/jbc.M805400200; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Horvath TL, 1999, J NEUROSCI, V19, P10417; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Ledesma A., 2002, GENOME BIOL, V3, p3015.1, DOI DOI 10.1186/gb-2002-3-12-reviews3015; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunemann A, 2006, GLIA, V53, P412, DOI 10.1002/glia.20301; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Nagy G, 2007, FREE RADICAL BIO MED, V42, P1625, DOI 10.1016/j.freeradbiomed.2007.02.026; Nagy TR, 2004, NUTRITION, V20, P139, DOI 10.1016/j.nut.2003.09.024; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Rask-Andersen M, 2010, BRAIN RES REV, V62, P147, DOI 10.1016/j.brainresrev.2009.10.007; Richard D, 1998, J COMP NEUROL, V397, P549; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Urbankova E, 2003, J BIOL CHEM, V278, P32497, DOI 10.1074/jbc.M303721200; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yonezawa T, 2009, IUBMB LIFE, V61, P1123, DOI 10.1002/iub.264; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401	69	41	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41406	10.1371/journal.pone.0041406	http://dx.doi.org/10.1371/journal.pone.0041406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870219	gold, Green Published, Green Accepted			2022-12-25	WOS:000307284100018
J	Wang, K; Zhang, R; Xiang, XH; He, F; Lin, LB; Ping, XJ; Yu, L; Han, JS; Zhao, GP; Zhang, QH; Cui, CL				Wang, Ke; Zhang, Rong; Xiang, Xiaohui; He, Fei; Lin, Libo; Ping, Xingjie; Yu, Lei; Han, Jisheng; Zhao, Guoping; Zhang, Qinghua; Cui, Cailian			Differences in Neural-Immune Gene Expression Response in Rat Spinal Dorsal Horn Correlates with Variations in Electroacupuncture Analgesia	PLOS ONE			English	Article							TAIL-FLICK TEST; NEUROPATHIC PAIN; INDIVIDUAL-DIFFERENCES; ACUPUNCTURE ANALGESIA; APJ RECEPTOR; MECHANISMS; CHOLECYSTOKININ; STIMULATION; APELIN; CORD	Background: Electroacupuncture (EA) has been widely used to alleviate diverse pains. Accumulated clinical experiences and experimental observations indicated that significant differences exist in sensitivity to EA analgesia for individuals of patients and model animals. However, the molecular mechanism accounting for this difference remains obscure. Methodology/Principal Findings: We classified model male rats into high-responder (HR; TFL changes >150) and non-responder (NR; TFL changes <= 0) groups based on changes of their pain threshold detected by tail-flick latency (TFL) before and after 2 Hz or 100 Hz EA treatment. Gene expression analysis of spinal dorsal horn (DH) revealed divergent expression in HR and NR after 2 Hz/100 Hz EA. The expression of the neurotransmitter system related genes was significantly highly regulated in the HR animals while the proinflammation cytokines related genes were up-regulated more significantly in NR than that in HR after 2 Hz and 100 Hz EA stimulation, especially in the case of 2 Hz stimulation. Conclusions/Significance: Our results suggested that differential regulation and coordination of neural-immune related genes might play an important role for individual variations in analgesic effects responding to EA in DH. It also provided new candidate genes related to EA responsiveness for future investigation.	[Wang, Ke; He, Fei; Lin, Libo; Zhao, Guoping; Zhang, Qinghua] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Wang, Ke; Xiang, Xiaohui; He, Fei; Zhao, Guoping; Zhang, Qinghua] Natl Engn Res Ctr Biochip Shanghai, Shanghai, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100871, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Minist Educ, Key Lab Neurosci, Beijing 100871, Peoples R China; [Zhang, Rong; Xiang, Xiaohui; Ping, Xingjie; Han, Jisheng; Cui, Cailian] Peking Univ, Minist Publ Hlth, Beijing 100871, Peoples R China; [Yu, Lei] Dept Genet, Piscataway, NJ USA; [Yu, Lei] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Peking University; Peking University; Peking University; Rutgers State University New Brunswick; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, K (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	gpzhao@sibs.ac.cn; qinghua_zhang@shbiochip.com; clcui@bjmu.edu.cn	ping, xingjie/AAW-4597-2020; Zhang, Rong/O-5078-2017; Xiang, Xiaohui/D-8093-2015	Zhang, Rong/0000-0002-6889-5571; Zhao, Guo-Ping/0000-0002-7621-6620; Xiang, Xiaohui/0000-0002-5762-5007; Cui, Cailian/0000-0002-8638-8258	National Basic Research Program of China [973-2007CB512501]; China Postdoctoral Science Foundation [20100480643]; National Natural Science Foundation of China [30801491]	National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 973-2007CB512501), China Postdoctoral Science Foundation (No. 20100480643), and National Natural Science Foundation of China (No. 30801491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RT, 2008, BRAIN RES, V1188, P54, DOI 10.1016/j.brainres.2007.10.060; [Anonymous], 1998, JAMA, V280, P1518; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Chae Y, 2006, J PHYSIOL SCI, V56, P425, DOI 10.2170/physiolsci.RP010206; Cidral-Filho FJ, 2011, NEUROSCIENCE; DAMORE A, 1992, J PHARMACOL TOXICOL, V27, P197, DOI 10.1016/1056-8719(92)90041-X; Fukazawa Y, 2007, J PHARMACOL SCI, V104, P159, DOI 10.1254/jphs.FP0070475; Gao YZ, 2007, AM J CHINESE MED, V35, P767, DOI 10.1142/S0192415X07005259; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kalea AZ, 2010, CURR OPIN INVEST DR, V11, P273; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kim SK, 2009, GENES BRAIN BEHAV, V8, P174, DOI 10.1111/j.1601-183X.2008.00459.x; Kim SK, 2007, BRAIN RES BULL, V74, P357, DOI 10.1016/j.brainresbull.2007.07.006; Ko ES, 2006, PEPTIDES, V27, P1841, DOI 10.1016/j.peptides.2006.01.002; Koo ST, 2008, PAIN, V135, P11, DOI 10.1016/j.pain.2007.04.034; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lau WK, 2008, NEUROSCIENCE, V155, P463, DOI 10.1016/j.neuroscience.2008.06.016; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee G, 2002, NEUROSCI LETT, V325, P17, DOI 10.1016/S0304-3940(02)00214-8; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; Paola FA, 2003, J SPINAL CORD MED, V26, P12; Park JH, 2010, BRAIN RES, V1322, P24, DOI 10.1016/j.brainres.2010.02.001; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Silva JRT, 2011, J PAIN, V12, P51, DOI 10.1016/j.jpain.2010.04.008; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Somers DL, 2009, J PAIN, V10, P221, DOI 10.1016/j.jpain.2008.08.008; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Sun JB, 2010, J MAGN RESON IMAGING, V32, P298, DOI 10.1002/jmri.22238; Tang NM, 1997, PAIN, V71, P71, DOI 10.1016/S0304-3959(97)03341-1; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tjolsen Arne, 1993, Tidsskrift for den Norske Laegeforening, V113, P2921; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Wan Y, 2001, PAIN, V91, P5, DOI 10.1016/S0304-3959(00)00416-4; Wang K, 2010, J NEUROCHEM, V113, P1436, DOI 10.1111/j.1471-4159.2010.06679.x; Wang LN, 2006, BRAIN RES, V1120, P46, DOI 10.1016/j.brainres.2006.08.077; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xing GG, 2007, EXP NEUROL, V208, P323, DOI 10.1016/j.expneurol.2007.09.004; Xu N, 2009, PEPTIDES, V30, P1153, DOI 10.1016/j.peptides.2009.02.011; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; ZHOU Y, 1993, NEUROPEPTIDES, V24, P139, DOI 10.1016/0143-4179(93)90077-N	55	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42331	10.1371/journal.pone.0042331	http://dx.doi.org/10.1371/journal.pone.0042331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879942	Green Published, gold			2022-12-25	WOS:000307284100069
J	Skedelj, V; Arsovska, E; Tomasic, T; Kroflic, A; Hodnik, V; Hrast, M; Bester-Rogac, M; Anderluh, G; Gobec, S; Bostock, J; Chopra, I; O'Neill, AJ; Randall, C; Zega, A				Skedelj, Veronika; Arsovska, Emilija; Tomasic, Tihomir; Kroflic, Ana; Hodnik, Vesna; Hrast, Martina; Bester-Rogac, Marija; Anderluh, Gregor; Gobec, Stanislav; Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher; Zega, Anamarija			6-Arylpyrido[ 2,3-d]pyrimidines as Novel ATP-Competitive Inhibitors of Bacterial D-Alanine:D-Alanine Ligase	PLOS ONE			English	Article							ALANYL-D-ALANINE; ESCHERICHIA-COLI; IDENTIFICATION; BIOSYNTHESIS; PURIFICATION; RESISTANCE; PHOSPHATE; STRAINS; ENZYMES; DESIGN	Background: ATP-dependent D-alanine: D-alanine ligase (Ddl) is a part of biochemical machinery involved in peptidoglycan biosynthesis, as it catalyzes the formation of the terminal D-ala-D-ala dipeptide of the peptidoglycan precursor UDPMurNAc-pentapeptide. Inhibition of Ddl prevents bacterial growth, which makes this enzyme an attractive and viable target in the urgent search of novel effective antimicrobial drugs. To address the problem of a relentless increase in resistance to known antimicrobial agents we focused our attention to discovery of novel ATP-competitive inhibitors of Ddl. Methodology/Principal Findings: Encouraged by recent successful attempts to find selective ATP-competitive inhibitors of bacterial enzymes we designed, synthesized and evaluated a library of 6-arylpyrido[2,3-d]pyrimidine-based compounds as inhibitors of Escherichia coli DdlB. Inhibitor binding to the target enzyme was subsequently confirmed by surface plasmon resonance and studied with isothermal titration calorimetry. Since kinetic analysis indicated that 6-arylpyrido[2,3-d] pyrimidines compete with the enzyme substrate ATP, inhibitor binding to the ATP-binding site was additionally studied with docking. Some of these inhibitors were found to possess antibacterial activity against membrane-compromised and efflux pump-deficient strains of E. coli. Conclusions/Significance: We discovered new ATP-competitive inhibitors of DdlB, which may serve as a starting point for development of more potent inhibitors of DdlB that could include both, an ATP-competitive and D-Ala competitive moiety.	[Skedelj, Veronika; Arsovska, Emilija; Tomasic, Tihomir; Hrast, Martina; Gobec, Stanislav; Zega, Anamarija] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Kroflic, Ana; Bester-Rogac, Marija] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Infrastruct Ctr Surface Plasmon Resonance, Biotech Fac, Ljubljana, Slovenia; [Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher] Univ Leeds, Antimicrobial Res Ctr, Leeds, W Yorkshire, England; [Bostock, Julieanne; Chopra, Ian; O'Neill, Alex J.; Randall, Christopher] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Ljubljana; University of Ljubljana; University of Ljubljana; University of Leeds; University of Leeds	Skedelj, V (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	anamarija.zega@ffa.uni-lj.si	Tomašič, Tihomir/S-1796-2018; Kroflič, Ana/AAW-9093-2021; Bester-Rogac, Marija/Y-2967-2019; Randall, Christopher/L-8647-2013; Bester-Rogac, Marija/S-3406-2018; Anderluh, Gregor/C-6905-2014; Kroflic, Ana/ABC-5977-2021	Tomašič, Tihomir/0000-0001-5534-209X; Kroflič, Ana/0000-0003-1722-8397; Bester-Rogac, Marija/0000-0003-4284-5987; Randall, Christopher/0000-0002-9565-8387; Bester-Rogac, Marija/0000-0003-4284-5987; Anderluh, Gregor/0000-0002-9916-8465; O'Neill, Alex/0000-0003-3222-5493; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [P1-0208]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (Grant P1-0208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACC DISC STUD 3 0; Bag S, 2010, BIOORGAN MED CHEM, V18, P3187, DOI 10.1016/j.bmc.2010.03.031; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Besong GE, 2005, ANGEW CHEM INT EDIT, V44, P6403, DOI 10.1002/anie.200501662; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; DIXON RA, 1986, ANTIMICROB AGENTS CH, V29, P781, DOI 10.1128/AAC.29.5.781; Fan C, 1997, BIOCHEMISTRY-US, V36, P2531, DOI 10.1021/bi962431t; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gholizadeh Y, 2001, PROTEIN SCI, V10, P836, DOI 10.1110/ps.39101; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hamby JM, 1997, J MED CHEM, V40, P2296, DOI 10.1021/jm970367n; Healy VL, 2000, CHEM BIOL, V7, P505, DOI 10.1016/S1074-5521(00)00135-6; Huber W, 1943, J AM CHEM SOC, V65, P2222, DOI 10.1021/ja01251a060; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kovac A, 2007, BIOORG MED CHEM LETT, V17, P2047, DOI 10.1016/j.bmcl.2007.01.015; Kovac A, 2008, J MED CHEM, V51, P7442, DOI 10.1021/jm800726b; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lu PL, 2008, J CHEMOTHERAPY, V20, P202, DOI 10.1179/joc.2008.20.2.202; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; *NCCLS, 1997, M7A4 NCCLS, V17; NEUHAUS FC, 1962, J BIOL CHEM, V237, P778; NEUHAUS FC, 1981, PHARMACOL THERAPEUT, V14, P265, DOI 10.1016/0163-7258(81)90030-9; NEUHAUS FC, 1962, BIOCHEM BIOPH RES CO, V8, P377, DOI 10.1016/0006-291X(62)90011-6; O'Neill AJ, 2002, J ANTIMICROB CHEMOTH, V50, P839, DOI 10.1093/jac/dkf248; Papahatjis DP, 2003, J MED CHEM, V46, P3221, DOI 10.1021/jm020558c; Press W.H., 1992, NUMERICAL RECIPES, V2, P650; Sakamoto J, 2007, EUR J ORG CHEM, V2007, P2700, DOI 10.1002/ejoc.200700118; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Skedelj V, 2011, J MED CHEM, V54, P915, DOI 10.1021/jm101121s; Sova M, 2009, BIOORG MED CHEM LETT, V19, P1376, DOI 10.1016/j.bmcl.2009.01.034; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Timothy DHB, 1999, 3 10 BACTERIAL PEPTI, P241; Triola G, 2009, BIOORGAN MED CHEM, V17, P1079, DOI 10.1016/j.bmc.2008.02.046; Tytgat I, 2009, CURR MED CHEM, V16, P2566, DOI 10.2174/092986709788682029; van den Hoogenband A, 2006, TETRAHEDRON LETT, V47, P4361, DOI 10.1016/j.tetlet.2006.04.103; Vehar B, 2011, BIOORGAN MED CHEM, V19, P5137, DOI 10.1016/j.bmc.2011.07.020; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wong KK, 1998, ADV EXP MED BIOL, V456, P197; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; ZAWADZKE LE, 1991, BIOCHEMISTRY-US, V30, P1673, DOI 10.1021/bi00220a033	46	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39922	10.1371/journal.pone.0039922	http://dx.doi.org/10.1371/journal.pone.0039922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876277	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700005
J	Cheng, Q; Lu, L; Grafstrom, J; Olofsson, MH; Thorell, JO; Samen, E; Johansson, K; Ahlzen, HS; Stone-Elander, S; Linder, S; Arner, ESJ				Cheng, Qing; Lu, Li; Grafstrom, Jonas; Olofsson, Maria Hagg; Thorell, Jan-Olov; Samen, Erik; Johansson, Katarina; Ahlzen, Hanna-Stina; Stone-Elander, Sharon; Linder, Stig; Arner, Elias S. J.		Sel-tag Imaging Project	Combining [C-11]-AnxA5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts	PLOS ONE			English	Article							RECOMBINANT PROTEINS; GRAPHICAL ANALYSIS; ANNEXIN-V; APOPTOSIS; CYTOKERATIN-18; DRUG; PURIFICATION; CHEMOTHERAPY; CARCINOMAS; FORMS	Background: In vivo imaging using Annexin A5-based radioligands is a powerful technique for visualizing massive cell death, but has been less successful in monitoring the modest cell death typically seen in solid tumors after chemotherapy. Here we combined dynamic positron emission tomography (PET) imaging using Annexin A5 with a serum-based apoptosis marker, for improved sensitivity and specificity in assessment of chemotherapy-induced cell death in a solid tumor model. Methodology/Principal Findings: Modest cell death was induced by doxorubicin in a mouse xenograft model with human FaDu head and neck cancer cells. PET imaging was based on C-11-labeled Sel-tagged Annexin A5 ([C-11]-AnxA5-ST) and a size-matched control. 2-deoxy-2-[F-18] fluoro-D-glucose ([F-18]-FDG) was utilized as a tracer of tissue metabolism. Serum biomarkers for cell death were ccK18 and K18 (M30 Apoptosense (R) and M65). Apoptosis in tissue sections was verified ex vivo for validation. Both PET imaging using [C-11]-AnxA5-ST and serum ccK18/K18 levels revealed treatment-induced cell death, with ccK18 displaying the highest detection sensitivity. [F-18]-FDG uptake was not affected by this treatment in this tumor model. [C-11]-AnxA5-ST gave robust imaging readouts at one hour and its short half-life made it possible to perform paired scans in the same animal in one imaging session. Conclusions/Significance: The combined use of dynamic PET with [C-11]-AnxA5-ST, showing specific increases in tumor binding potential upon therapy, with ccK18/K18 serum measurements, as highly sensitive markers for cell death, enabled effective assessment of modest therapy-induced cell death in this mouse xenograft model of solid human tumors.	[Cheng, Qing; Johansson, Katarina; Ahlzen, Hanna-Stina; Stone-Elander, Sharon; Arner, Elias S. J.] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lu, Li] Karolinska Univ Hosp, Dept Comparat Med, Karolinska Expt Res & Imaging Ctr, Stockholm, Sweden; [Lu, Li; Grafstrom, Jonas; Thorell, Jan-Olov; Samen, Erik; Stone-Elander, Sharon] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Olofsson, Maria Hagg; Linder, Stig] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Thorell, Jan-Olov; Samen, Erik; Stone-Elander, Sharon] Karolinska Univ Hosp, Dept Neuroradiol, PET Radiochem, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Cheng, Q (corresponding author), Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden.	Elias.Arner@ki.se	Johansson, Katarina/C-7654-2014; Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Johansson, Katarina/0000-0003-3735-3611; Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Cheng, Qing/0000-0002-3170-9333	Swedish Foundation for Strategic Research (SSF) [RBa08-0067]; Governmental Agency for Innovation Systems (VINNOVA) [2009-00179]; The Swedish Cancer Society (Cancerfonden) [2009/739]; The Swedish Research Council [2008-2654, 2004-5104, 2008-3186]; Karolinska Institutet	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); The Swedish Cancer Society (Cancerfonden); The Swedish Research Council(Swedish Research Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Foundation for Strategic Research (SSF) (RBa08-0067); Governmental Agency for Innovation Systems (VINNOVA) (2009-00179); The Swedish Cancer Society (Cancerfonden) (2009/739 to E.S.J.A.); The Swedish Research Council (2008-2654 to E.S.J.A., 2004-5104 and 2008-3186 to S. S. E.); and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Blankenberg FG, 2009, APOPTOSIS IMAGING AN; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Blankenberg FG, 2008, J NUCL MED, V49, p81S, DOI 10.2967/jnumed.107.045898; Blankenberg Francis G, 2009, Proc Am Thorac Soc, V6, P469, DOI 10.1513/pats.200901-001AW; Blankenberg FG, 2009, ANTI-CANCER AGENT ME, V9, P944, DOI 10.2174/187152009789377727; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2006, CHEMBIOCHEM, V7, P1976, DOI 10.1002/cbic.200600326; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Kong G, 2000, CANCER RES, V60, P6950; Kramer G, 2006, BRIT J CANCER, V94, P1592, DOI 10.1038/sj.bjc.6603129; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Larsen P, 1997, APPL RADIAT ISOTOPES, V48, P153, DOI 10.1016/S0969-8043(96)00177-7; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 2011, J CEREBR BLOOD F MET, V31, P535, DOI 10.1038/jcbfm.2010.123; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Olofsson MH, 2009, CANCER BIOMARK, V5, P117, DOI 10.3233/CBM-2009-0597; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Samen E, 2009, EUR J NUCL MED MOL I, V36, P1283, DOI 10.1007/s00259-009-1111-3; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012	29	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42151	10.1371/journal.pone.0042151	http://dx.doi.org/10.1371/journal.pone.0042151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870292	gold, Green Published			2022-12-25	WOS:000307212800063
J	Ishiwata, T; Orosz, A; Wang, XH; Mustafi, SB; Pratt, GW; Christians, ES; Boudina, S; Abel, ED; Benjamin, IJ				Ishiwata, Takahiro; Orosz, Andras; Wang, Xiaohui; Mustafi, Soumyajit Banerjee; Pratt, Gregory W.; Christians, Elisabeth S.; Boudina, Sihem; Abel, E. Dale; Benjamin, Ivor J.			HSPB2 Is Dispensable for the Cardiac Hypertrophic Response but Reduces Mitochondrial Energetics following Pressure Overload In Mice	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; MEMBER; GENE; PROTECTION; ISCHEMIA; FAMILY; MUSCLE; TISSUE; CRYAB	Background: CryAB (HspB5) and HspB2, two small heat shock genes located adjacently in the vertebrate genome, are hypothesized to play distinct roles. Mice lacking both cryab and hspb2 (DKO) are viable and exhibit adult-onset degeneration of skeletal muscle but confounding results from independent groups were reported for cardiac responses to different stressful conditions (i.e., ischemia/reperfusion or pressure overload). To determine the specific requirements of HSPB2 in heart, we generated cardiac-specific HSPB2 deficient (HSPB2cKO) mice and examined their cardiac function under basal conditions and following cardiac pressure overload. Methodology/Principal Findings: Transverse aortic constriction (TAC) or sham surgery was performed in HSPB2cKO mice and their littermates (HSPB2wt mice). Eight weeks after TAC, we found that expression of several small HSPs (HSPB2, 5, 6) was not markedly modified in HSPB2wt mice. Both cardiac function and the hypertrophic response remained similar in HSPB2cKO and HSPB2wt hearts. In addition, mitochondrial respiration and ATP production assays demonstrated that the absence of HSPB2 did not change mitochondrial metabolism in basal conditions. However, fatty acid supported state 3 respiration rate (ADP stimulated) in TAC operated HSPB2cKO hearts was significantly reduced in compared with TAC operated HSPB2wt mice (10.5 +/- 2.2 vs. 12.8 +/- 2.5 nmol O-2/min/mg dry fiber weight, P<0.05), and ATP production in HSPB2cKO hearts was significantly reduced in TAC compared with sham operated mice (29.8 +/- 0.2 vs. 21.1 +/- 1.8 nmol ATP/min/mg dry fiber weight, P<0.05). Although HSPB2 was not associated with mitochondria under cardiac stress, absence of HSPB2 led to changes in transcript levels of several metabolic and mitochondrial regulator genes. Conclusions/Significance: The present study indicates that HSPB2 can be replaced by other members of the multigene small HSP family under basal conditions while HSPB2 is implicated in the regulation of metabolic/mitochondrial function under cardiac stress such pressure overload.	[Ishiwata, Takahiro; Orosz, Andras; Wang, Xiaohui; Mustafi, Soumyajit Banerjee; Pratt, Gregory W.; Christians, Elisabeth S.; Benjamin, Ivor J.] Univ Utah, Sch Med, Lab Cardiac Dis Redox Signaling & Cell Regenerat, Div Cardiol, Salt Lake City, UT USA; [Boudina, Sihem; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Boudina, Sihem; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Benjamin, Ivor J.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ishiwata, T (corresponding author), Natl Def Med Coll, Dept Pediat, 3-2 Namiki, Tokorozawa, Saitama 359, Japan.	ivor.benjamin@hsc.utah.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health [1DP1OD006438-02]; VA Merit Review Award; NHLBI [5R01HL074370-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074370] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award(US Department of Veterans Affairs); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	2009 National Institutes of Health Director's Pioneer Award 1DP1OD006438-02, VA Merit Review Award (IJB), and NHLBI 5R01HL074370-03 (IJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Golenhofen N, 2006, PFLUG ARCH EUR J PHY, V451, P518, DOI 10.1007/s00424-005-1488-1; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hu ZP, 2008, J NEUROSCI RES, V86, P2125, DOI 10.1002/jnr.21682; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Kadono T, 2006, J MOL CELL CARDIOL, V40, P783, DOI 10.1016/j.yjmcc.2006.03.003; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; Kumarapeli ARK, 2010, AM J TRANSL RES, V2, P390; Kumarapeli ARK, 2008, CIRC RES, V103, P1473, DOI 10.1161/CIRCRESAHA.108.180117; Martin JL, 1997, CIRCULATION, V96, P4343; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Prabhu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029810; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42118	10.1371/journal.pone.0042118	http://dx.doi.org/10.1371/journal.pone.0042118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870288	Green Submitted, gold, Green Published			2022-12-25	WOS:000307212800061
J	McLaughlin, HP; Caly, DL; McCarthy, Y; Ryan, RP; Dow, JM				McLaughlin, Heather Pearl; Caly, Delphine L.; McCarthy, Yvonne; Ryan, Robert Patrick; Dow, John Maxwell			An Orphan Chemotaxis Sensor Regulates Virulence and Antibiotic Tolerance in the Human Pathogen Pseudomonas aeruginosa	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CATIONIC ANTIMICROBIAL PEPTIDES; RESPONSE REGULATOR; DI-GMP; CHEMOSENSORY SYSTEM; BIOFILM FORMATION; GENE-EXPRESSION; EFFLUX SYSTEM; POLYMYXIN-B; RESISTANCE	The synthesis of virulence factors by pathogenic bacteria is highly regulated and occurs in response to diverse environmental cues. An array of two component systems (TCSs) serves to link perception of different cues to specific changes in gene expression and/or bacterial behaviour. Those TCSs that regulate functions associated with virulence represent attractive targets for interference in anti-infective strategies for disease control. We have previously identified PA2572 as a putative response regulator required for full virulence of Pseudomonas aeruginosa, the opportunistic human pathogen, to Galleria mellonella (Wax moth) larvae. Here we have investigated the involvement of candidate sensors for signal transduction involving PA2572. Mutation of PA2573, encoding a probable methyl-accepting chemotaxis protein, gave rise to alterations in motility, virulence, and antibiotic resistance, functions which are also controlled by PA2572. Comparative transcriptome profiling of mutants revealed that PA2572 and PA2573 regulate expression of a common set of 49 genes that are involved in a range of biological functions including virulence and antibiotic resistance. Bacterial two-hybrid analysis indicated a REC-dependent interaction between PA2572 and PA2573 proteins. Finally expression of PA2572 in the PA2573 mutant background restored virulence to G. mellonella towards wild-type levels. The findings indicate a role for the orphan chemotaxis sensor PA2573 in the regulation of virulence and antibiotic tolerance in P. aeruginosa and indicate that these effects are exerted in part through signal transduction involving PA2572.	[McLaughlin, Heather Pearl; Caly, Delphine L.; McCarthy, Yvonne; Ryan, Robert Patrick; Dow, John Maxwell] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	McLaughlin, HP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	m.dow@ucc.ie		Ryan, Rober/0000-0002-7353-0913; Dow, Max/0000-0001-8245-2294	Science Foundation of Ireland [SFI07/NI.1/B955, SFI09/SSIRG/B1654]; Wellcome Trust [WT093314MA]	Science Foundation of Ireland(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been supported by grants from Science Foundation of Ireland (SFI07/NI.1/B955, SFI09/SSIRG/B1654) through an investigator award (to J.M.D) and by the Wellcome Trust (WT093314MA) through a project grant (to J.M.D and R. P. R), which are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; Dong Yi-Hu, 2008, Commun Integr Biol, V1, P88; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Moskowitz SM, 2004, J BACTERIOL, V186, P575, DOI 10.1128/JB.186.2.575-579.2004; NICAS TI, 1985, J INFECT DIS, V152, P716, DOI 10.1093/infdis/152.4.716; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Romling U, 2011, ENV MICROBIOL; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2012, TRENDS MICROBIOL, P1; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wang WH, 2009, FEMS MICROBIOL LETT, V294, P150, DOI 10.1111/j.1574-6968.2009.01563.x; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011	37	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42205	10.1371/journal.pone.0042205	http://dx.doi.org/10.1371/journal.pone.0042205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870303	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800068
J	Wagenhaus, B; Pohlmann, A; Dieringer, MA; Els, A; Waiczies, H; Waiczies, S; Schulz-Menger, J; Niendorf, T				Wagenhaus, Babette; Pohlmann, Andreas; Dieringer, Matthias Alexander; Els, Antje; Waiczies, Helmar; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf			Functional and Morphological Cardiac Magnetic Resonance Imaging of Mice Using a Cryogenic Quadrature Radiofrequency Coil	PLOS ONE			English	Article							MURINE MODEL; MOUSE HEART; 9.4 TESLA; RF PROBE; MRI; SEGMENTATION; BRAIN	Cardiac morphology and function assessment by magnetic resonance imaging is of increasing interest for a variety of mouse models in pre-clinical cardiac research, such as myocardial infarction models or myocardial injury/remodeling in genetically or pharmacologically induced hypertension. Signal-to-noise ratio (SNR) constraints, however, limit image quality and blood myocardium delineation, which crucially depend on high spatial resolution. Significant gains in SNR with a cryogenically cooled RF probe have been shown for mouse brain MRI, yet the potential of applying cryogenic RF coils for cardiac MR (CMR) in mice is, as of yet, untapped. This study examines the feasibility and potential benefits of CMR in mice employing a 400 MHz cryogenic RF surface coil, compared with a conventional mouse heart coil array operating at room temperature. The cryogenic RF coil affords SNR gains of 3.0 to 5.0 versus the conventional approach and hence enables an enhanced spatial resolution. This markedly improved image quality - by better deliniation of myocardial borders and enhanced depiction of papillary muscles and trabeculae - and facilitated a more accurate cardiac chamber quantification, due to reduced intraobserver variability. In summary the use of a cryogenically cooled RF probe represents a valuable means of enhancing the capabilities of CMR of mice.	[Wagenhaus, Babette; Pohlmann, Andreas; Dieringer, Matthias Alexander; Els, Antje; Waiczies, Helmar; Waiczies, Sonia; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Dieringer, Matthias Alexander; Schulz-Menger, Jeanette] Charite Working Grp Cardiac MRI, Expt & Clin Res Ctr, Berlin, Germany; [Dieringer, Matthias Alexander; Schulz-Menger, Jeanette] HELIOS Clin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Wagenhaus, B (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.	andreas.pohlmann@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013; Pohlmann, Andreas/K-7869-2016; Waiczies, Sonia/H-4181-2012	Niendorf, Thoralf/0000-0001-7584-6527; Pohlmann, Andreas/0000-0002-8572-2568; Waiczies, Sonia/0000-0002-9916-9572; Schulz-Menger, Jeanette/0000-0003-3100-1092; Waiczies, Helmar/0000-0001-6651-4790	Max Delbruck Center for Molecular Medicine	Max Delbruck Center for Molecular Medicine(Helmholtz Association)	This study was funded by the Max Delbruck Center for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOKA S, 1993, MAGN RESON IMAGING, V11, P437, DOI 10.1016/0730-725X(93)90078-R; Azaouagh A, 2011, CLIN RES CARDIOL, V100, P383, DOI 10.1007/s00392-011-0295-2; Baltes C, 2010, NMR BIOMED; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Epstein FH, 2007, NMR BIOMED, V20, P238, DOI 10.1002/nbm.1152; Heijman E, 2008, J MAGN RESON IMAGING, V27, P86, DOI 10.1002/jmri.21236; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; Hiba B, 2007, MAGN RESON MED, V58, P745, DOI 10.1002/mrm.21355; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Ramirez MS, 2010, MAGN RESON MED, V63, P803, DOI 10.1002/mrm.22236; Ratering D, 2008, MAGN RESON MED, V59, P1440, DOI 10.1002/mrm.21629; Ratering D, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-43; Schneider JE, 2011, METHODS MOL BIOL, V771, P387, DOI 10.1007/978-1-61779-219-9_20; Schneider JE, 2011, MAGN RESON MED, V65, P60, DOI 10.1002/mrm.22605; Sosnovik DE, 2007, J MAGN RESON IMAGING, V26, P279, DOI 10.1002/jmri.20966; Urashima T, 2008, AM J PHYSIOL-HEART C, V295, pH1351, DOI 10.1152/ajpheart.91526.2007; Waiczies H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032796; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Young AA, 2009, J MAGN RESON IMAGING, V30, P514, DOI 10.1002/jmri.21873	22	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42383	10.1371/journal.pone.0042383	http://dx.doi.org/10.1371/journal.pone.0042383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870323	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000307212800086
J	Garcia-Fuster, MJ; Flagel, SB; Mahmood, ST; Watson, SJ; Akil, H				Julia Garcia-Fuster, M.; Flagel, Shelly B.; Mahmood, S. Taha; Watson, Stanley J.; Akil, Huda			Cocaine Withdrawal Causes Delayed Dysregulation of Stress Genes in the Hippocampus	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; PLASMA-CORTICOSTERONE; DRUG-ADDICTION; NEURAL SYSTEMS; BETA-ENDORPHIN; ANIMAL-MODEL; RATS; BRAIN; ANXIETY; NEUROGENESIS	Relapse, even following an extended period of withdrawal, is a major challenge in substance abuse management. Delayed neurobiological effects of the drug during prolonged withdrawal likely contribute to sustained vulnerability to relapse. Stress is a major trigger of relapse, and the hippocampus regulates the magnitude and duration of stress responses. Recent work has implicated hippocampal plasticity in various aspects of substance abuse. We asked whether changes in stress regulatory mechanisms in the hippocampus may participate in the neuroadaptations that occur during prolonged withdrawal. We therefore examined changes in the rat stress system during the course of withdrawal from extended daily access (5-hours) of cocaine self-administration, an animal model of addiction. Tissue was collected at 1, 14 and 28 days of withdrawal. Plasma corticosterone levels were determined and corticosteroid receptors (GR, MR, MR/GR mRNA ratios) and expression of other stress-related molecules (HSP90AA1 and HSP90AB1 mRNA) were measured in hippocampal subfields using in situ hybridization. Results showed a delayed emergence of dysregulation of stress genes in the posterior hippocampus following 28 days of cocaine withdrawal. This included increased GR mRNA in DG and CA3, increased MR and HSP90AA1 mRNA in DG, and decreased MR/GR mRNA ratio in DG and CA1. Corticosterone levels progressively decreased during the course of withdrawal, were normalized following 28 days of withdrawal, and were correlated negatively with GR and positively with MR/GR mRNA ratio in DG. These results suggest a role for the posterior hippocampus in the neuroadaptations that occur during prolonged withdrawal, and point to a signaling partner of GR, HSP90AA1, as a novel dysregulated target during cocaine withdrawal. These delayed neurobiological effects of extended cocaine exposure likely contribute to sustained vulnerability to relapse.	[Julia Garcia-Fuster, M.] Univ Balearic Isl, Univ Res Inst Hlth Sci, Palma De Mallorca, Spain; [Flagel, Shelly B.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Mahmood, S. Taha; Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA	Universitat de les Illes Balears; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garcia-Fuster, MJ (corresponding author), Univ Balearic Isl, Univ Res Inst Hlth Sci, Palma De Mallorca, Spain.	j.garcia@uib.es	Flagel, Shelly B/G-5561-2012; Garcia-Fuster, M. Julia/L-8307-2014	Flagel, Shelly B/0000-0002-7309-9908; Garcia-Fuster, M. Julia/0000-0002-9177-3775	NIDA [5P01DA021633-02]; NIMH Conte Center Grant [L99MH60398]; Office of Naval Research (ONR) [N00014-09-1-0598]; Pritzker Neuropsychiatric Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060398] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH Conte Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research (ONR)(Office of Naval Research); Pritzker Neuropsychiatric Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIDA 5P01DA021633-02; NIMH Conte Center Grant #L99MH60398; Office of Naval Research (ONR) N00014-09-1-0598 to HA and SJW; and The Pritzker Neuropsychiatric Research Foundation. MJGF is a 'Ramon y Cajal' Researcher (El Ministerio de Economia y Competitividad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Andersen P., 2007, HIPPOCAMPUS BOOK; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; DALLMAN MF, 1987, ANN NY ACAD SCI, V512, P402, DOI 10.1111/j.1749-6632.1987.tb24976.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Deroche V, 1997, J PHARMACOL EXP THER, V281, P1401; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Erb S, 2010, PROG NEURO-PSYCHOPH, V34, P798, DOI 10.1016/j.pnpbp.2009.11.025; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Galici R, 2000, EUR J PHARMACOL, V387, P59, DOI 10.1016/S0014-2999(99)00780-3; Garcia-Fuster MJ, 2010, EUR J NEUROSCI, V31, P79, DOI 10.1111/j.1460-9568.2009.07045.x; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; GERLACH JL, 1972, SCIENCE, V175, P1133, DOI 10.1126/science.175.4026.1133; Goeders NE, 1996, NEUROENDOCRINOLOGY, V64, P337, DOI 10.1159/000127137; Goeders NE, 1996, BRAIN RES, V722, P145, DOI 10.1016/0006-8993(96)00206-5; Grimm JW, 2003, J NEUROSCI, V23, P742; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; Garcia-Fuster MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2303, DOI 10.1038/npp.2011.119; Kalivas Peter W, 2004, Curr Psychiatry Rep, V6, P347, DOI 10.1007/s11920-004-0021-0; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mantsch JR, 2007, BRAIN RES, V1167, P101, DOI 10.1016/j.brainres.2007.05.080; Mantsch JR, 2000, PROG NEURO-PSYCHOPH, V24, P633, DOI 10.1016/S0278-5846(00)00098-1; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; MCEWEN BS, 1988, NEUROCHEM RES, V13, P663, DOI 10.1007/BF00973285; MOLDOW RL, 1987, PEPTIDES, V8, P819, DOI 10.1016/0196-9781(87)90065-9; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Pascale A, 2011, PSYCHOPHARMACOLOGY, V218, P249, DOI 10.1007/s00213-010-2152-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SAPOLSKY RM, 1990, NEUROENDOCRINOLOGY, V51, P328, DOI 10.1159/000125357; Turner CA, 2011, P NATL ACAD SCI USA, V108, P8021, DOI 10.1073/pnas.1103732108; VESCOVI PP, 1992, HORM RES, V37, P221, DOI 10.1159/000182316; Wei Q, 2012, BIOL PSYCHIAT, V71, P224, DOI 10.1016/j.biopsych.2011.07.009; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; Zhe D, 2008, ACTA HISTOCHEM CYTOC, V41, P89, DOI 10.1267/ahc.08013	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42092	10.1371/journal.pone.0042092	http://dx.doi.org/10.1371/journal.pone.0042092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860061	Green Submitted, gold, Green Published			2022-12-25	WOS:000306950900067
J	Kashyap, T; Rabinovitz, I				Kashyap, Trinayan; Rabinovitz, Isaac			The Calcium/Calcineurin Pathway Promotes Hemidesmosome Stability through Inhibition of beta 4 Integrin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-6-BETA-4 INTEGRIN; CELL-MIGRATION; ALPHA(6)BETA(4) INTEGRIN; CARCINOMA-CELLS; CALCINEURIN; PROTEIN; KINASE; GROWTH; COMPONENTS; RECEPTORS	Cell migration depends on cells being able to create and disassemble adhesive contacts. Hemidesmosomes are multiprotein structures that attach epithelia to basal lamina and disassemble during migration and carcinoma invasion. Phosphorylation of the beta 4 integrin, a hemidesmosome component, induces disassembly. Although kinases involved in beta 4 phosphorylation have been identified, little is known about phosphatases countering kinase action. Here we report that calcineurin, a serine-threonine protein phosphatase, regulates beta 4 phosphorylation. Calcineurin inhibitor cyclosporin A (CsA) and calcineurin-siRNA increase beta 4 phosphorylation, induce hemidesmosome disassembly, and increase migration in HaCat keratinocytes, suggesting that calcineurin negatively regulates beta 4 phosphorylation. We found no direct dephosphorylation of beta 4 by calcineurin or association between beta 4 and calcineurin, suggesting indirect regulation of beta 4 phosphorylation. We therefore assessed calcineurin influence on MAPK and PKC, known to phosphorylate beta 4. CsA increased MAPK activity, whereas MAPK inhibitors reduced CsA-induced beta 4 phosphorylation, suggesting that calcineurin restricts beta 4 phosphorylation by MAPK. Calcineurin is activated by calcium. Increased [Ca2+](i) reduces beta 4 phosphorylation and stabilizes hemidesmosomes, effects that are reversed by CsA, indicating that calcineurin mediates calcium effects on beta 4. However, MAPK activation is increased when [Ca2+](i) is increased, suggesting that calcineurin activates an additional mechanism that counteracts MAPK-induced beta 4 phosphorylation. Interestingly, in some squamous cell carcinoma cells, which have reduced hemidesmosomes and increased beta 4 phosphorylation, an increase in [Ca2+](i) using thapsigargin, bradykinin, or acetylcholine can increase hemidesmosomes and reduce beta 4 phosphorylation in a calcineurin-dependent manner. These findings have implications in calcineurin-inhibitor induced carcinoma, a complication of immunosuppressive therapy.	Beth Israel Deaconess Med Ctr, Dept Pathol, Vasc Biol Res Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rabinovitz, I (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol RN 227D, 330 Brookline Ave, Boston, MA 02215 USA.	irabinov@bidmc.harvard.edu			National Institutes of Health [CA120202]; NATIONAL CANCER INSTITUTE [R01CA120202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120202 (to I. R.).	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Bachelder RE, 1999, J BIOL CHEM, V274, P20733, DOI 10.1074/jbc.274.29.20733; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; HEPLER JR, 1987, J BIOL CHEM, V262, P2951; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; PRICE JE, 1988, J INVEST DERMATOL, V91, P258, DOI 10.1111/1523-1747.ep12470396; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SCHREMMERDANNINGER E, 1995, EUR J PHARMACOL, V283, P207, DOI 10.1016/0014-2999(95)00347-N; TALWAR HS, 1990, J INVEST DERMATOL, V95, P705, DOI 10.1111/1523-1747.ep12514507; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996	40	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32440	32449		10.1074/jbc.M112.385245	http://dx.doi.org/10.1074/jbc.M112.385245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865863	hybrid, Green Published			2022-12-25	WOS:000309168300014
J	Miyamoto, H; Katsuyama, E; Miyauchi, Y; Hoshi, H; Miyamoto, K; Sato, Y; Kobayashi, T; Iwasaki, R; Yoshida, S; Mori, T; Kanagawa, H; Fujie, A; Hao, W; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Miyamoto, Kana; Sato, Yuiko; Kobayashi, Tami; Iwasaki, Ryotaro; Yoshida, Shigeyuki; Mori, Tomoaki; Kanagawa, Hiroya; Fujie, Atsuhiro; Hao, Wu; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			An Essential Role for STAT6-STAT1 Protein Signaling in Promoting Macrophage Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY GIANT-CELLS; DC-STAMP; OSTEOCLASTS; RECEPTOR; INTERLEUKIN-4; STAT6; DIFFERENTIATION; ACTIVATION; LIGAND; PHOSPHORYLATION	Macrophage lineage cells such as osteoclasts and foreign body giant cells (FBGCs) form multinuclear cells by cell-cell fusion of mononuclear cells. Recently, we reported that two seven-transmembrane molecules, osteoclast stimulatory transmembrane protein (OC-STAMP) and dendritic cell-specific transmembrane protein (DC-STAMP), were essential for osteoclast and FBGC cell-cell fusion in vivo and in vitro. However, signaling required to regulate FBGC fusion remained largely unknown. Here, we show that signal transducer and activator of transcription 1 (STAT1) deficiency in macrophages enhanced cell-cell fusion and elevated DC-STAMP expression in FBGCs. By contrast, lack of STAT6 increased STAT1 activation, significantly inhibiting cell-cell fusion and decreasing OC-STAMP and DC-STAMP expression in IL-4-induced FBGCs. Furthermore, either STAT1 loss or co-expression of OC-STAMP/DC-STAMP was sufficient to induce cell-cell fusion of FBGCs without IL-4. We conclude that the STAT6-STAT1 axis regulates OC-STAMP and DC-STAMP expression and governs fusogenic mechanisms in FBGCs.	[Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Miyamoto, Kana; Sato, Yuiko; Kobayashi, Tami; Mori, Tomoaki; Kanagawa, Hiroya; Fujie, Atsuhiro; Hao, Wu; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Yoshida, Shigeyuki; Mori, Tomoaki; Fujie, Atsuhiro; Miyamoto, Takeshi] Keio Univ, Sch Med, Ctr Human Metabol Syst Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Iwasaki, Ryotaro; Yoshida, Shigeyuki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Kana; Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Keio Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Toyama, Yoshiaki/K-5743-2013; Matsumoto, Morio M/L-6227-2013; hao, wu/HDM-1705-2022					Abe E, 1999, CALCIFIED TISSUE INT, V64, P508, DOI 10.1007/s002239900641; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; ARONSON M, 1962, NATURE, V193, P399, DOI 10.1038/193399a0; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; DeFife KM, 1997, J IMMUNOL, V158, P3385; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; MBALAVIELE G, 1995, J CLIN INVEST, V95, P2757, DOI 10.1172/JCI117979; MCNALLY AK, 1995, AM J PATHOL, V147, P1487; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Pesu M, 2000, BLOOD, V95, P494, DOI 10.1182/blood.V95.2.494; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sawatani Y, 2008, INT IMMUNOL, V20, P1259, DOI 10.1093/intimm/dxn082; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205; ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4	31	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32479	32484		10.1074/jbc.M112.358226	http://dx.doi.org/10.1074/jbc.M112.358226			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865856	Green Published, hybrid			2022-12-25	WOS:000309168300018
J	Helyar, SJ; Limborg, MT; Bekkevold, D; Babbucci, M; van Houdt, J; Maes, GE; Bargelloni, L; Nielsen, RO; Taylor, MI; Ogden, R; Cariani, A; Carvalho, GR; Panitz, F				Helyar, Sarah J.; Limborg, Morten T.; Bekkevold, Dorte; Babbucci, Massimiliano; van Houdt, Jeroen; Maes, Gregory E.; Bargelloni, Luca; Nielsen, Rasmus O.; Taylor, Martin I.; Ogden, Rob; Cariani, Alessia; Carvalho, Gary R.; Panitz, Frank		FishPopTrace Consortium	SNP Discovery Using Next Generation Transcriptomic Sequencing in Atlantic Herring (Clupea harengus)	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM DISCOVERY; GENETIC-STRUCTURE; GENOME SEQUENCE; POPULATIONS; MARKERS; DIFFERENTIATION; IDENTIFICATION; CLUPEIFORMES; MANAGEMENT; THOUSANDS	The introduction of Next Generation Sequencing (NGS) has revolutionised population genetics, providing studies of non-model species with unprecedented genomic coverage, allowing evolutionary biologists to address questions previously far beyond the reach of available resources. Furthermore, the simple mutation model of Single Nucleotide Polymorphisms (SNPs) permits cost-effective high-throughput genotyping in thousands of individuals simultaneously. Genomic resources are scarce for the Atlantic herring (Clupea harengus), a small pelagic species that sustains high revenue fisheries. This paper details the development of 578 SNPs using a combined NGS and high-throughput genotyping approach. Eight individuals covering the species distribution in the eastern Atlantic were bar-coded and multiplexed into a single cDNA library and sequenced using the 454 GS FLX platform. SNP discovery was performed by de novo sequence clustering and contig assembly, followed by the mapping of reads against consensus contig sequences. Selection of candidate SNPs for genotyping was conducted using an in silico approach. SNP validation and genotyping were performed simultaneously using an Illumina 1,536 GoldenGate assay. Although the conversion rate of candidate SNPs in the genotyping assay cannot be predicted in advance, this approach has the potential to maximise cost and time efficiencies by avoiding expensive and time-consuming laboratory stages of SNP validation. Additionally, the in silico approach leads to lower ascertainment bias in the resulting SNP panel as marker selection is based only on the ability to design primers and the predicted presence of intron-exon boundaries. Consequently SNPs with a wider spectrum of minor allele frequencies (MAFs) will be genotyped in the final panel. The genomic resources presented here represent a valuable multi-purpose resource for developing informative marker panels for population discrimination, microarray development and for population genomic studies in the wild.	[Helyar, Sarah J.; Taylor, Martin I.; Carvalho, Gary R.; FishPopTrace Consortium] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales; [Helyar, Sarah J.] Matis, Food Safety Environm & Genet, Reykjavik, Iceland; [Limborg, Morten T.; Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Silkeborg, Denmark; [Babbucci, Massimiliano; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy; [van Houdt, Jeroen; Maes, Gregory E.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Louvain, Belgium; [Nielsen, Rasmus O.; Panitz, Frank] Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark; [Ogden, Rob] Royal Zool Soc Scotland, TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland; [Cariani, Alessia] Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy	Bangor University; Technical University of Denmark; University of Padua; KU Leuven; Aarhus University; University of Bologna	Helyar, SJ (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	sarah.helyar@matis.is	Limborg, Morten T/B-9633-2015; Cariani, Alessia/L-3459-2016; Taylor, Martin I/B-4298-2013; Bekkevold, Dorte/AAT-1098-2021; Maes, Gregory/C-5450-2008; Panitz, Frank/A-3281-2017; Maes, Gregory/N-4983-2019; Nielsen, Rasmus/D-4405-2009; Helyar, Sarah/C-4988-2013	Limborg, Morten T/0000-0002-7718-6531; Cariani, Alessia/0000-0002-5513-0086; Maes, Gregory/0000-0002-1531-7321; Panitz, Frank/0000-0002-6909-5162; Maes, Gregory/0000-0002-1531-7321; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728; Nielsen, Rasmus/0000-0003-0513-6591; Helyar, Sarah/0000-0002-1600-997X; Bekkevold, Dorte/0000-0002-5297-032X	European Community [KBBE-212399]; European Commission [022717, 044133]; Scientific Research Fund Flanders (FWO-Flanders)	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Scientific Research Fund Flanders (FWO-Flanders)(FWO)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no KBBE-212399 (FishPopTrace). In addition, MTL received financial support from the European Commission through the FP6 projects UNCOVER (Contract No. 022717) and RECLAIM (Contract No. 044133). GM is a post-doctoral researcher funded by the Scientific Research Fund Flanders (FWO-Flanders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; [Anonymous], 2000, METHODS MOL BIOL; [Anonymous], 2011, 29 SESS COMM FISH; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bai J, 2011, J WORLD AQUACULT SOC, V42, P444, DOI 10.1111/j.1749-7345.2011.00485.x; Bekkevold D, 2005, EVOLUTION, V59, P2656; Benjamini Y, 2001, ANN STAT, V29, P1165; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Corrigendum to Council Regulation, 2008, OFFICIAL J EUROPEA L, pL; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; McPherson AA, 2001, J FISH BIOL, V59, P356, DOI 10.1006/jfbi.2001.1769; Milano I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028008; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Smit A, 1996, REPEATMASKER OPEN 30; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x	53	47	49	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42089	10.1371/journal.pone.0042089	http://dx.doi.org/10.1371/journal.pone.0042089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879907	Green Published, Green Accepted, gold			2022-12-25	WOS:000307437900020
J	Bae, JW; Kim, DB; Choi, JY; Park, HJ; Lee, JD; Hur, DG; Bae, SH; Jung, DJ; Lee, SH; Kim, UK; Lee, KY				Bae, Jae Woong; Kim, Dong-Bin; Choi, Jae Young; Park, Hong-Joon; Lee, Jong Dae; Hur, Dong Gu; Bae, Seung-Hyun; Jung, Da Jung; Lee, Sang Heun; Kim, Un-Kyung; Lee, Kyu Yup			Molecular and Clinical Characterization of the Variable Phenotype in Korean Families with Hearing Loss Associated with the Mitochondrial A1555G Mutation	PLOS ONE			English	Article							12S RIBOSOMAL-RNA; NON-SYNDROMIC DEAFNESS; EXTREMELY LOW PENETRANCE; HAN CHINESE PEDIGREES; AMINOGLYCOSIDE OTOTOXICITY; INHERITED SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; PEDIATRIC SUBJECTS; G7444A MUTATION; HUMAN MTDNA	Hearing loss, which is genetically heterogeneous, can be caused by mutations in the mitochondrial DNA (mtDNA). The A1555G mutation of the 12S ribosomal RNA (rRNA) gene in the mtDNA has been associated with both aminoglycoside-induced and non-syndromic hearing loss in many ethnic populations. Here, we report for the first time the clinical and genetic characterization of nine Korean pedigrees with aminoglycoside-induced and non-syndromic hearing loss. These Korean families carry in the A1555G mutation of 12S rRNA gene and exhibit variable penetrance and expressivity of hearing loss. Specifically, the penetrance of hearing loss in these families ranged between 28.6% and 75%, with an average of 60.8%. These results were higher than the 29.8% penetrance that was previously reported in a Chinese population but similar to the 65.4% and 54.1% penetrance observed in a large Arab-Israeli population and nineteen Spanish pedigrees, respectively. The mutational analysis of the complete mtDNA genome in these families showed that the haplogroups of the Korean population, which belongs to the eastern Asian population, were similar to those of the Chinese population but different from the Spanish population, which belongs to the European-Caucasian population. The mtDNA variants that may act as modifier factors were also found to be similar to the Chinese population. Although the mtDNA haplogroups and variants were similar to the eastern Asian population, we did find some differing phenotypes, although some subjects had the same variants. This result suggests that both the ethnic background and environmental factors lead to a variable phenotype of the A1555G mutation.	[Bae, Jae Woong; Kim, Dong-Bin; Bae, Seung-Hyun; Kim, Un-Kyung] Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu, South Korea; [Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Park, Hong-Joon] Soree Ear Clin, Seoul, South Korea; [Lee, Jong Dae] Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea; [Hur, Dong Gu] Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Jinju, South Korea; [Jung, Da Jung; Lee, Sang Heun; Lee, Kyu Yup] Kyungpook Natl Univ, Dept Otolaryngol, Coll Med, Taegu, South Korea	Kyungpook National University; Yonsei University; Yonsei University Health System; Soonchunhyang University; Gyeongsang National University; Gyeongsang National University Hospital; Kyungpook National University	Bae, JW (corresponding author), Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu, South Korea.	kimuk@knu.ac.kr; kylee@knu.ac.kr			Biomedical Research Institute Grant, Kyungpook National University Hospital	Biomedical Research Institute Grant, Kyungpook National University Hospital	This work was supported by Biomedical Research Institute Grant, Kyungpook National University Hospital (2011) (K.Y. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Casano RAMS, 1999, AM J OTOLARYNG, V20, P151, DOI 10.1016/S0196-0709(99)90062-5; Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Dai P, 2006, BIOCHEM BIOPH RES CO, V340, P194, DOI 10.1016/j.bbrc.2005.11.156; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Ding Y, 2009, J GENET GENOMICS, V36, P241, DOI 10.1016/S1673-8527(08)60111-3; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Tang XW, 2007, GENE, V393, P11, DOI 10.1016/j.gene.2007.01.001; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642; Torroni A, 1997, AM J HUM GENET, V60, P1107; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952; Zhao LD, 2005, BIOCHEM BIOPH RES CO, V336, P967, DOI 10.1016/j.bbrc.2005.08.199; Zhu Y, 2006, BIOCHEM BIOPH RES CO, V342, P843, DOI 10.1016/j.bbrc.2006.02.027	40	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42463	10.1371/journal.pone.0042463	http://dx.doi.org/10.1371/journal.pone.0042463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879993	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000036
J	Yoon, HH; Orrock, JM; Foster, NR; Sargent, DJ; Smyrk, TC; Sinicrope, FA				Yoon, Harry H.; Orrock, Jared M.; Foster, Nathan R.; Sargent, Daniel J.; Smyrk, Thomas C.; Sinicrope, Frank A.			Prognostic Impact of FoxP3+Regulatory T Cells in Relation to CD8+T Lymphocyte Density in Human Colon Carcinomas	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; MISMATCH REPAIR; REGULATORY CELLS; ADJUVANT CHEMOTHERAPY; FAVORABLE PROGNOSIS; OVARIAN-CANCER; FOXP3; SURVIVAL	Background: T-lymphocyte infiltration into colon carcinomas can influence clinical outcome, and interactions among T cell subsets may be more informative than either subset alone. Our objective was to examine the prognostic impact of tumor-infiltrating FoxP3(+) regulatory T cells (Tregs) in relation to cytotoxic CD8(+) T lymphocytes in patients with colon carcinomas characterized by DNA mismatch repair (MMR) status who participated in adjuvant chemotherapy trials. Methods: FoxP3(+) and CD8(+) densities in tumor epithelial and stromal compartments were analyzed by immunohistochemistry and quantified in resected, stage II and III colonic carcinomas (N = 216). Immune marker density was dichotomized at the median and categorized as high vs low. MMR status was classified as MMR deficient (dMMR) or proficient (pMMR). Cox models were adjusted for age, stage, and tumor grade. Results: The density of FoxP3+ infiltration was similar in tumor stroma and epithelia, whereas CD8+ was higher in stroma. The prognostic impact of FoxP3+ and CD8+ T cell infiltration was stronger in stroma vs epithelia, and the density of each marker in stroma was independently associated with improved overall survival (OS). However, the impact of FoxP3+ on survival was dependent upon CD8+ density (P interaction = .040). Among CD8+(low) tumors, FoxP3+(high) cases had significantly improved OS compared to FoxP3+(low) cases after adjustment for covariates (hazard ratio 0.43; 95% confidence interval 0.19 to 0.95; P = .030). In contrast, FoxP3+ was not prognostic among CD8+(high) tumors. FoxP3+ remained prognostic in CD8+(low) tumors after further adjustment for MMR or BRAF (V600E) mutation status. Additionally, these immune markers identified a pMMR subgroup with a similarly favorable OS as for dMMR tumors. Conclusions: The prognostic impact of FoxP3+ and CD8+ T cell density are inter-dependent, whereby FoxP3+ exerts a favorable influence on survival only in colon cancers with low CD8+ infiltration.	[Yoon, Harry H.; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Orrock, Jared M.; Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Foster, Nathan R.; Sargent, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Sinicrope, Frank A.] Mayo Clin, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Yoon, HH (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	Sinicrope.frank@mayo.edu		Sargent, Daniel/0000-0002-2684-4741	National Cancer Institute [K05CA-142885, CA25224-32CM]; NATIONAL CANCER INSTITUTE [K05CA142885, U10CA025224] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Cancer Institute K05CA-142885 (Senior Scientist Award to FAS) and by National Cancer Institute Grant CA25224-32CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2002, J CLIN ONCOL, V20, P1735, DOI 10.1200/JCO.2002.07.080; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Banerjea Ayan, 2005, World J Surg Oncol, V3, P26, DOI 10.1186/1477-7819-3-26; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Boland CR, 1998, CANCER RES, V58, P5248; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Elpek KG, 2007, J IMMUNOL, V178, P6840, DOI 10.4049/jimmunol.178.11.6840; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, CANCER RES, V63, P6042; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goode EL, 2011, CANCER EPIDEM BIOMAR, V20, P1638, DOI 10.1158/1055-9965.EPI-11-0455; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; O'Connell MJ, 2006, CLIN COLORECTAL CANC, V6, P133, DOI 10.3816/CCC.2006.n.030; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Phan V, 2008, CANCER IMMUNOL IMMUN, V57, P281, DOI 10.1007/s00262-007-0356-6; Quinn E, 2003, EUR J CANCER, V39, P469, DOI 10.1016/S0959-8049(02)00633-0; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Sinicrope FA, 2007, INT J CANCER, V120, P1232, DOI 10.1002/ijc.22429; Sinicrope FA, 2010, NAT REV CLIN ONCOL, V7, P174, DOI 10.1038/nrclinonc.2009.235; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Takemoto N, 2004, JPN J CLIN ONCOL, V34, P90, DOI 10.1093/jjco/hyh018; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4	55	79	85	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42274	10.1371/journal.pone.0042274	http://dx.doi.org/10.1371/journal.pone.0042274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879926	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000023
J	Bonomi, M; Somigliana, E; Cacciatore, C; Busnelli, M; Rossetti, R; Bonetti, S; Paffoni, A; Mari, D; Ragni, G; Persani, L				Bonomi, Marco; Somigliana, Edgardo; Cacciatore, Chiara; Busnelli, Marta; Rossetti, Raffaella; Bonetti, Silvia; Paffoni, Alessio; Mari, Daniela; Ragni, Guido; Persani, Luca		Italian Network Study Ovarian	Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COPY NUMBER; POLYMERASE-GAMMA; SKELETAL-MUSCLE; POOR RESPONSE; X-CHROMOSOME; IN-VITRO; FAILURE; OOCYTE; INSUFFICIENCY	Primary ovarian insufficiency (POI) is a critical fertility defect characterized by an anticipated and silent impairment of the follicular reserve, but its pathogenesis is largely unexplained. The frequent maternal inheritance of POI together with a remarkable dependence of ovarian folliculogenesis upon mitochondrial biogenesis and bioenergetics suggested the possible involvement of a generalized mitochondrial defect. Here, we verified the existence of a significant correlation between blood and ovarian mitochondrial DNA (mtDNA) content in a group of women undergoing ovarian hyperstimulation (OH), and then aimed to verify whether mtDNA content was significantly altered in the blood cells of POI women. We recruited 101 women with an impaired ovarian reserve: 59 women with premature ovarian failure (POF) and 42 poor responders (PR) to OH. A Taqman copy number assay revealed a significant mtDNA depletion (P<0.001) in both POF and PR women in comparison with 43 women of similar age and intact ovarian reserve, or 53 very old women with a previous physiological menopause. No pathogenic variations in the mitochondrial DNA polymerase gamma (POLG) gene were detected in 57 POF or PR women with low blood mtDNA content. In conclusion, blood cell mtDNA depletion is a frequent finding among women with premature ovarian aging, suggesting that a still undetermined but generalized mitochondrial defect may frequently predispose to POI which could then be considered a form of anticipated aging in which the ovarian defect may represent the first manifestation. The determination of mtDNA content in blood may become an useful tool for the POI risk prediction.	[Bonomi, Marco; Busnelli, Marta; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy; [Cacciatore, Chiara; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, UO Med Gen Indirizzo Endocrinometab, Milan, Italy; [Somigliana, Edgardo; Bonetti, Silvia; Paffoni, Alessio; Ragni, Guido] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Ctr Sterilita, Milan, Italy; [Cacciatore, Chiara; Rossetti, Raffaella; Mari, Daniela; Persani, Luca] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Bonomi, M (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy.	luca.persani@unimi.it	Somigliana, Edgardo/Z-3749-2019; Petraglia, Felice/D-4373-2019; Tonacchera, Massimo/K-8523-2016; Persani, Luca/B-6543-2008; Mari, Daniela/K-5663-2016; Rossetti, Raffaella/B-4972-2013; Busnelli, Marta/AAR-5513-2021; Ricca, Ivana/AAA-4125-2021; Ricca, Ivana/I-4760-2018; Corbetta, Sabrina/H-5457-2011; Paffoni, Alessio/I-7404-2015; Renieri, Alessandra/K-5950-2016; fusi, franco/K-4637-2013; Cannavo, Salvatore/D-7608-2013; Nappi, Rossella/AAC-1793-2022; MAROZZI, ANNA/Q-7282-2017; Bonomi, Marco/T-6487-2019	Somigliana, Edgardo/0000-0002-0223-0032; Petraglia, Felice/0000-0002-8851-625X; Persani, Luca/0000-0003-2068-9581; Mari, Daniela/0000-0002-6950-0789; Rossetti, Raffaella/0000-0001-9112-6175; Busnelli, Marta/0000-0003-3387-2190; Ricca, Ivana/0000-0001-8939-1447; Ricca, Ivana/0000-0001-8939-1447; Corbetta, Sabrina/0000-0001-8140-3175; Paffoni, Alessio/0000-0003-3112-3161; PALLI, Domenico/0000-0002-5558-2437; cavallo, luciano/0000-0003-4787-8681; Renieri, Alessandra/0000-0002-0846-9220; fusi, franco/0000-0002-4349-0842; s, hema/0000-0002-3440-9475; tumino, rosario/0000-0003-2666-414X; Tonacchera, Massimo/0000-0001-5431-5823; Cannavo, Salvatore/0000-0001-8779-7283; Nappi, Rossella/0000-0003-1713-6396; zuffardi, orsetta/0000-0002-1466-4559; MAROZZI, ANNA/0000-0001-9007-2590; Vegetti, Walter/0000-0003-0422-643X; Bione, Silvia/0000-0002-3924-4606; Bonomi, Marco/0000-0001-5454-6074; Villa, Nicoletta/0000-0002-4439-9880; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Telethon Foundation - Italy [GGP09126A]; Istituto Auxologico Italiano, Italy [05C501]	Telethon Foundation - Italy(Fondazione Telethon); Istituto Auxologico Italiano, Italy	The financial support of Telethon Foundation - Italy (Grant no. GGP09126A) and Istituto Auxologico Italiano, Italy (Ricerca Corrente Funds: 05C501) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLAND NI, 1993, BIOL REPROD, V48, P798, DOI 10.1095/biolreprod48.4.798; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Davis CJ, 2000, HUM REPROD, V15, P2418, DOI 10.1093/humrep/15.11.2418; de Boer EJ, 2003, HUM REPROD, V18, P1544, DOI 10.1093/humrep/deg278; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Farhi J, 1997, HUM REPROD, V12, P241, DOI 10.1093/humrep/12.2.241; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Harris SE, 2009, MOL REPROD DEV, V76, P231, DOI 10.1002/mrd.20945; Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553; HUTCHINSON EW, 1991, GENETICS, V127, P729; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lawson R, 2003, HUM REPROD, V18, P527, DOI 10.1093/humrep/deg101; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957; Perls TT, 1997, NATURE, V389, P133, DOI 10.1038/38148; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rizzolio F, 2009, J MED GENET, V46, P585, DOI 10.1136/jmg.2007.056093; Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Simpson JL, 2008, ANN NY ACAD SCI, V1135, P146, DOI 10.1196/annals.1429.019; Smith KR, 2009, J GERONTOL A-BIOL, V64, P740, DOI 10.1093/gerona/glp055; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Tatone C, 2006, MOL HUM REPROD, V12, P655, DOI 10.1093/molehr/gal080; Tong ZB, 2010, FERTIL STERIL, V94, P2932, DOI 10.1016/j.fertnstert.2010.06.049; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Wycherley G, 2005, HUM REPROD, V20, P2757, DOI 10.1093/humrep/dei132	45	32	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42423	10.1371/journal.pone.0042423	http://dx.doi.org/10.1371/journal.pone.0042423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879975	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100086
J	Dey, N; Ghosh-Choudhury, N; Kasinath, BS; Choudhury, GG				Dey, Nirmalya; Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			TGF beta-Stimulated MicroRNA-21 Utilizes PTEN to Orchestrate AKT/mTORC1 Signaling for Mesangial Cell Hypertrophy and Matrix Expansion	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; SMOOTH-MUSCLE-CELLS; MAMMALIAN TARGET; RENAL FIBROSIS; HIGH GLUCOSE; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; TUMOR SUPPRESSION; GENE-EXPRESSION; HIGH INSULIN	Transforming growth factor-beta (TGF beta) promotes glomerular hypertrophy and matrix expansion, leading to glomerulosclerosis. MicroRNAs are well suited to promote fibrosis because they can repress gene expression, which negatively regulate the fibrotic process. Recent cellular and animal studies have revealed enhanced expression of microRNA, miR-21, in renal cells in response to TGF beta. Specific miR-21 targets downstream of TGF beta receptor activation that control cell hypertrophy and matrix protein expression have not been studied. Using 3'UTR-driven luciferase reporter, we identified the tumor suppressor protein PTEN as a target of TGF beta-stimulated miR-21 in glomerular mesangial cells. Expression of miR-21 Sponge, which quenches endogenous miR-21 levels, reversed TGF beta-induced suppression of PTEN. Additionally, miR-21 Sponge inhibited TGF beta-stimulated phosphorylation of Akt kinase, resulting in attenuation of phosphorylation of its substrate GSK3 beta. Tuberin and PRAS40, two other Akt substrates, and endogenous inhibitors of mTORC1, regulate mesangial cell hypertrophy. Neutralization of endogenous miR-21 abrogated TGF beta-stimulated phosphorylation of tuberin and PRAS40, leading to inhibition of phosphorylation of S6 kinase, mTOR and 4EBP-1. Moreover, downregulation of miR-21 significantly suppressed TGF beta-induced protein synthesis and hypertrophy, which were reversed by siRNA-targeted inhibition of PTEN expression. Similarly, expression of constitutively active Akt kinase reversed the miR-21 Sponge-mediated inhibition of TGF beta-induced protein synthesis and hypertrophy. Furthermore, expression of constitutively active mTORC1 prevented the miR-21 Sponge-induced suppression of mesangial cell protein synthesis and hypertrophy by TGF beta. Finally, we show that miR-21 Sponge inhibited TGF beta-stimulated fibronectin and collagen expression. Suppression of PTEN expression and expression of both constitutively active Akt kinase and mTORC1 independently reversed this miR-21-mediated inhibition of TGF beta-induced fibronectin and collagen expression. Our results uncover an essential role of TGF beta-induced expression of miR-21, which targets PTEN to initiate a non-canonical signaling circuit involving Akt/mTORC1 axis for mesangial cell hypertrophy and matrix protein synthesis.	[Dey, Nirmalya; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Adm Res, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Dey, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health (NIH) [RO1 DK50190, RO1 AR 52425, RO1 DK 077295, RC2A 036613]; VA (Veterans Administration) Research Service Merit Review grant; Juvenile Diabetes Research Foundation [1-2008-185]; VA Senior Research Career Scientist Award; VA Merit Review; Cancer Therapy and Research Center, San Antonio, Texas; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA (Veterans Administration) Research Service Merit Review grant; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Senior Research Career Scientist Award; VA Merit Review(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio, Texas; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) RO1 DK50190 grant to GGC supported this work. Part of this work was also supported by VA (Veterans Administration) Research Service Merit Review grant to GGC. GGC is also supported by Juvenile Diabetes Research Foundation 1-2008-185 grants and is recipient of VA Senior Research Career Scientist Award. NGC is supported by VA Merit Review, NIH RO1 AR 52425 grants and Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio, Texas. BSK is supported by NIH RO1 DK 077295, NIH RC2A 036613 and VA Merit Review Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Badal SS, 2012, J AM SOC NEPHROL, V23, P185, DOI 10.1681/ASN.2011121222; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Border WA, 1998, KIDNEY INT, V54, P1390, DOI 10.1046/j.1523-1755.1998.00127.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iwano M, 1996, KIDNEY INT, V49, P1120, DOI 10.1038/ki.1996.162; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jenkins RH, 2012, BIOCHEM J, V443, P407, DOI 10.1042/BJ20111861; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kopp JB, 1996, LAB INVEST, V74, P991; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhdanova O, 2011, KIDNEY INT, V80, P719, DOI 10.1038/ki.2011.122; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	102	90	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42316	10.1371/journal.pone.0042316	http://dx.doi.org/10.1371/journal.pone.0042316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879939	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100066
J	Hsiao, CC; Lee, CH; Tsao, LY; Lo, HC				Hsiao, Chien-Chou; Lee, Chien-Hsing; Tsao, Lon-Yen; Lo, Hui-Chen			The Dose-Dependent Immunoregulatory Effects of the Nitric Oxide Synthase Inhibitor N-G-Nitro-L-Arginine Methyl Ester in Rats with Sub-Acute Peritonitis	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; IMMUNE-SYSTEM; SEPSIS; METABOLISM; PERMEABILITY; ENDOTOXEMIA; RESPONSES; INJURY	Background: Chronic inflammation accompanied by arginine deficiency, immune dysfunction, and excess nitric oxide (NO) production is a clinical condition found in patients with peritonitis. A previous study showed that the nonselective NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) may facilitate the metabolism of the immune nutrient arginine without altering NO homeostasis in rats with sub-acute peritonitis. Here, we investigated the effects of L-NAME on the immunocytic subpopulation distribution and response. Materials and Methods: Male Wistar rats with cecal puncture-induced peritonitis were administered parenteral nutrition solutions supplemented with 0 (CPP group), 5 (LNA group), 25 (MNA group) or 50 (HNA group) mg.kg(-1).day(-1) of L-NAME for 7 days. Parenteral-fed sham-operated rats (TPN group) and orally-fed healthy rats (R group) were included as controls. Results: The TPN group had significantly increased spleen weights and levels of plasma nitrite/nitrate (NOx), circulating white blood cells (WBC), and splenocytic T cells, as well as significantly decreased levels of cytotoxic T-and B-leukocytes and B-splenocytes compared to the R group. The CPP group had significantly decreased levels of plasma NOx and concanavalin (Con) A-stimulated interferon (IFN)-gamma and interleukin (IL)-2 production by leukocytes and significantly increased production of Con A-stimulated tumor necrosis factor (TNF)-alpha and lipopolysaccharide (LPS)-stimulated IFN-gamma in the leukocytes. In addition, the LNA and MNA groups had significantly decreased spontaneous IL-6 and Con A-stimulated TNF-alpha and IFN-gamma production by the leukocytes while the HNA group had significantly increased LPS-stimulated TNF-alpha and Con A-stimulated IFN-gamma and IL-2 production by the splenocytes compared to the CPP group. Conclusions: Low-dose L-NAME infusion may suppress proinflammatory and T-helper-1 (Th1) response in leukocytes, and high-dose infusion may activate the proinflammatory response in splenic macrophages and Th1 response in T-splenocytes in rats with sub-acute peritonitis.	[Hsiao, Chien-Chou; Tsao, Lon-Yen] Changhua Christian Hosp, Clin Nutr Support Serv Team, Dept Pediat, Changhau, Taiwan; [Lee, Chien-Hsing] Changhua Christian Hosp, Div Pediat Surg, Changhau, Taiwan; [Lee, Chien-Hsing] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan; [Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Chang Jung Christian University; Fu Jen Catholic University	Hsiao, CC (corresponding author), Changhua Christian Hosp, Clin Nutr Support Serv Team, Dept Pediat, Changhau, Taiwan.	041663@mail.fju.edu.tw	Lo, Hui-Chen/AAN-5906-2021		National Science Council of the Republic of China [NSC-90-2320-B-371-001]; Changhua Christian Hospital [CCH-4604]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This work was supported by the National Science Council of the Republic of China (http://web1.nsc.gov.tw/) under grant number NSC-90-2320-B-371-001 and by the Changhua Christian Hospital (http://www.cch.org.tw/) under grant number CCH-4604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chaudhari UP, 2010, INT J PHARMACOL, V6, P183; Chen YH, 2012, JPEN J PARE IN PRESS; Cui L, 2000, NUTRITION, V16, P34, DOI 10.1016/S0899-9007(99)00185-9; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Gabbai FB, 1997, J IMMUNOL, V159, P6266; Gavin TP, 2000, J APPL PHYSIOL, V88, P1192, DOI 10.1152/jappl.2000.88.4.1192; GEROULANOS S, 1992, LANCET, V339, P435; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hallemeesch MM, 2002, CLIN NUTR, V21, P111, DOI 10.1054/clnu.2001.0513; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Hsiao CC, 2011, BIOL PHARM BULL, V34, P177, DOI 10.1248/bpb.34.177; Kobara M, 2003, BASIC RES CARDIOL, V98, P319, DOI 10.1007/s00395-003-0423-x; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Lo HC, 2010, PEDIATR SURG INT, V26, P625, DOI 10.1007/s00383-010-2582-9; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Morris DL, 1997, J PHARMACOL TOXICOL, V37, P37, DOI 10.1016/S1056-8719(96)00146-3; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Nieves C, 2007, JPEN-PARENTER ENTER, V31, P101, DOI 10.1177/0148607107031002101; Ninkovic MB, 2009, GEN PHYSIOL BIOPHYS, V28, P243; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Payen D, 1996, CLIN CHEST MED, V17, P333, DOI 10.1016/S0272-5231(05)70318-X; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Pratt VC, 1996, JPEN-PARENTER ENTER, V20, P264, DOI 10.1177/0148607196020004264; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHOU J, 1994, AM J SURG, V167, P145, DOI 10.1016/0002-9610(94)90065-5; TAO RC, 1979, J NUTR, V109, P904, DOI 10.1093/jn/109.5.904; Wang HH, 2003, NEPHROL DIAL TRANSPL, V18, P1181, DOI 10.1093/ndt/gfg079; Wildhaber BE, 2005, J SURG RES, V123, P8, DOI 10.1016/j.jss.2004.06.015; Xie YW, 1996, CIRCULATION, V94, P2580, DOI 10.1161/01.CIR.94.10.2580; Yeh CL, 2005, BRIT J NUTR, V93, P267, DOI 10.1079/BJN20041326	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42467	10.1371/journal.pone.0042467	http://dx.doi.org/10.1371/journal.pone.0042467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879994	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100100
J	Parker, SJ; Meyerowitz, J; James, JL; Liddell, JR; Nonaka, T; Hasegawa, M; Kanninen, KM; Lim, S; Paterson, BM; Donnelly, PS; Crouch, PJ; White, AR				Parker, Sarah J.; Meyerowitz, Jodi; James, Janine L.; Liddell, Jeffrey R.; Nonaka, Takashi; Hasegawa, Masato; Kanninen, Katja M.; Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.; Crouch, Peter J.; White, Anthony R.			Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; BINDING PROTEIN 43; STRESS GRANULES; COPPER; CU-II(ATSM); PARAQUAT; AGGREGATION; DISEASE; DAMAGE; DEATH	Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, motor neuron disease with no effective long-term treatment options. Recently, TDP-43 has been identified as a key protein in the pathogenesis of some cases of ALS. Although the role of TDP-43 in motor neuron degeneration is not yet known, TDP-43 has been shown to accumulate in RNA stress granules (SGs) in cell models and in spinal cord tissue from ALS patients. The SG association may be an early pathological change to TDP-43 metabolism and as such a potential target for therapeutic intervention. Accumulation of TDP-43 in SGs induced by inhibition of mitochondrial activity can be inhibited by modulation of cellular kinase activity. We have also found that treatment of cells and animal models of neurodegeneration, including an ALS model, with bioavailable bis(thiosemicarbazonato)copper(II) complexes (Cu-II(btsc)s) can modulate kinase activity and induce neuroprotective effects. In this study we examined the effect of diacetylbis(-methylthiosemicarbazonato)copper(II) (Cu-II(atsm)) and glyoxalbis(-methylthiosemicarbazonato)copper(II) (Cu-II(gtsm)) on TDP-43-positive SGs induced in SH-SY5Y cells in culture. We found that the Cu-II(btsc)s blocked formation of TDP-43-and human antigen R (HuR)-positive SGs induced by paraquat. The Cu-II(btsc) s protected neurons from paraquat-mediated cell death. These effects were associated with inhibition of ERK phosphorylation. Co-treatment of cultures with either Cu-II(atsm) or an ERK inhibitor, PD98059 both prevented ERK activation and blocked formation of TDP-43-and HuR-positive SGs. Cu-II(atsm) treatment or ERK inhibition also prevented abnormal ubiquitin accumulation in paraquat-treated cells suggesting a link between prolonged ERK activation and abnormal ubiquitin metabolism in paraquat stress and inhibition by Cu. Moreover, Cu-II(atsm) reduced accumulation of C-terminal (219-414) TDP-43 in transfected SH-SY5Y cells. These results demonstrate that Cu-II(btsc) complexes could potentially be developed as a neuroprotective agent to modulate neuronal kinase function and inhibit TDP-43 aggregation. Further studies in TDP-43 animal models are warranted.	[Parker, Sarah J.; Meyerowitz, Jodi; James, Janine L.; Liddell, Jeffrey R.; Kanninen, Katja M.; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Nonaka, Takashi; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia; [Lim, SinChun; Paterson, Brett M.; Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Crouch, Peter J.; White, Anthony R.] Mental Hlth Res Inst, Parkville, Vic, Australia	University of Melbourne; Tokyo Metropolitan Institute of Medical Science; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Parker, SJ (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	arwhite@unimelb.edu.au	Paterson, Brett M/A-2402-2016; Paterson, Brett Michael/GLS-2845-2022; Liddell, Jeffrey/AAH-3685-2021; Nonaka, Takashi/L-8572-2017; White, Anthony/P-5596-2016	Paterson, Brett M/0000-0002-7768-811X; Liddell, Jeffrey/0000-0002-0798-5338; Crouch, Peter/0000-0002-7777-4747; Nonaka, Takashi/0000-0002-0830-9403; White, Anthony/0000-0003-1802-9891	National Health and Medical Research Council of Australia; Australian Research Council (ARC); ARC; C. R. Roper Fellowship; Sigrid Juselius Foundation, Finland; Rotary Health Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); C. R. Roper Fellowship; Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Rotary Health Scholarship	This work was supported by funding from the National Health and Medical Research Council of Australia and Australian Research Council (ARC). ARW is a recipient of an ARC Future Fellowship Award. PJC is recipient of a C. R. Roper Fellowship. KMK was supported by Sigrid Juselius Foundation, Finland. JLJ was supported by a Rotary Health Scholarship. The authors would also like to thank the Motor Neuron Disease Research Institute of Australia, Bethlehem Griffiths Research Foundation and CASS Foundation for the kind support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Beraldo H, 1998, TRANSIT METAL CHEM, V23, P67; Bica L, 2009, MOL BIOSYST, V5, P134, DOI 10.1039/b816577g; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caragounis A, 2010, FREE RADICAL BIO MED, V48, P1152, DOI 10.1016/j.freeradbiomed.2010.01.035; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Donnelly PS, 2012, P NATL ACAD SCI USA, V109, P47, DOI 10.1073/pnas.1116227108; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fodero-Tavoletti MT, 2010, J ALZHEIMERS DIS, V20, P49, DOI 10.3233/JAD-2010-1359; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; GINGRAS BA, 1962, CAN J CHEM, V40, P1053, DOI 10.1139/v62-161; Hung LW, 2012, J EXP MED, V209, P837, DOI 10.1084/jem.20112285; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Izumi Y, 2011, YAKUGAKU ZASSHI, V131, P21, DOI 10.1248/yakushi.131.21; King AE, 2011, NEUROBIOL AGING, V32, P459, DOI 10.1016/j.neurobiolaging.2009.04.004; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Niso-Santano M, 2010, FREE RADICAL BIO MED, V48, P1370, DOI 10.1016/j.freeradbiomed.2010.02.024; Nonaka T, 2009, HUM MOL GENET; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Paterson BM, 2011, CHEM SOC REV, V40, P3005, DOI 10.1039/c0cs00215a; Price KA, 2011, METALLOMICS, V3, P1280, DOI 10.1039/c1mt00092f; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Schimmer AD, 2011, CURR CANCER DRUG TAR, V11, P325; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Swarup V, 2011, PROG NEURO-PSYCHOPH, V35, P363, DOI 10.1016/j.pnpbp.2010.08.006; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Yang W, 2007, J TOXICOL ENV HEAL A, V70, P1849, DOI 10.1080/15287390701459262; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	48	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42277	10.1371/journal.pone.0042277	http://dx.doi.org/10.1371/journal.pone.0042277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879928	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100061
J	Parera, M; Martrus, G; Franco, S; Clotet, B; Martinez, MA				Parera, Mariona; Martrus, Gloria; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel			Canine Hepacivirus NS3 Serine Protease Can Cleave the Human Adaptor Proteins MAVS and TRIF	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CATALYTIC EFFICIENCY; HIV-1 INFECTION; GENETIC SCREEN; EVASION; INHIBITORS; SEQUENCE; HOMOLOG; CULTURE; SAMHD1	Canine hepacivirus (CHV) was recently identified in domestic dogs and horses. The finding that CHV is genetically the virus most closely related to hepatitis C virus (HCV) has raised the question of whether HCV might have evolved as the result of close contact between dogs and/or horses and humans. The aim of this study was to investigate whether the NS3/4A serine protease of CHV specifically cleaves human mitochondrial antiviral signaling protein (MAVS) and Toll-IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF). The proteolytic activity of CHV NS3/4A was evaluated using a bacteriophage lambda genetic screen. Human MAVS- and TRIF-specific cleavage sites were engineered into the lambda cI repressor. Upon infection of Escherichia coli cells coexpressing these repressors and a CHV NS3/4A construct, lambda phage replicated up to 2000-fold more efficiently than in cells expressing a CHV protease variant carrying the inactivating substitution S139A. Comparable results were obtained when several HCV NS3/4A constructs of genotype 1b were assayed. This indicates that CHV can disrupt the human innate antiviral defense signaling pathway and suggests a possible evolutionary relationship between CHV and HCV.	[Parera, Mariona; Martrus, Gloria; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] UAB, Hosp Univ Germans Trias & Pujol, Fundacio irsiCaixa, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Parera, M (corresponding author), UAB, Hosp Univ Germans Trias & Pujol, Fundacio irsiCaixa, Badalona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/E-6114-2016; Franco, Sandra/S-6843-2019; Martinez, Miguel Angel/K-6435-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; Martrus, Gloria/0000-0003-2879-3201; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministry of Science and Innovation [BFU2010-15194, SAF2010-21617]; GALA CONTRA LA SIDA (Barcelona)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GALA CONTRA LA SIDA (Barcelona)	This study was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-15194 and SAF2010-21617) and by GALA CONTRA LA SIDA (Barcelona 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio E, 2011, J VIROL, V85, P5961, DOI 10.1128/JVI.00308-11; Bukh J, 2011, P NATL ACAD SCI USA, V108, P12563, DOI 10.1073/pnas.1107612108; Burbelo PD, 2012, J VIROL; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Franco S, 2007, HEPATOLOGY, V45, P899, DOI 10.1002/hep.21623; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liverton NJ, 2008, J AM CHEM SOC, V130, P4607, DOI 10.1021/ja711120r; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Martinez MA, 2000, ANTIMICROB AGENTS CH, V44, P1132, DOI 10.1128/AAC.44.5.1132-1139.2000; Martinez MA, 2003, ANTIMICROB AGENTS CH, V47, P1760, DOI 10.1128/AAC.47.5.1760-1765.2003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Parera M, 2004, J VIROL, V78, P14057, DOI 10.1128/JVI.78.24.14057-14061.2004; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Ptashne M, 1986, GENETIC SWITCH; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; SAUER RT, 1978, NATURE, V276, P301, DOI 10.1038/276301a0; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	39	21	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42481	10.1371/journal.pone.0042481	http://dx.doi.org/10.1371/journal.pone.0042481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870331	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800095
J	Zhu, MM; Tong, JL; Xu, Q; Nie, F; Xu, XT; Xiao, SD; Ran, ZH				Zhu, Ming Ming; Tong, Jin Lu; Xu, Qi; Nie, Fang; Xu, Xi Tao; Xiao, Shu Dong; Ran, Zhi Hua			Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; BINDING CASSETTE ABC; N-TERMINAL KINASE; CELL LUNG-CANCER; C-JUN; P-GLYCOPROTEIN; MITOXANTRONE-RESISTANCE; REGULATES EXPRESSION; SIDE POPULATION; STEM-CELL	Multidrug resistance remains a major obstacle to effective chemotherapy of colon cancer. ABCG2, as a half-transporter of the G subfamily of ATP-binding cassette transporter genes (ABC transporters), is known to play a crucial role in multidrug resistance. However, the molecular mechanism of controlling ABCG2 expression in drug resistance of colon cancer is unclear and scarcely reported. In the present study, we systematically investigate the potential role of the c-Jun NH2-terminal kinase (JNK) signal pathway in ABCG2-induced multidrug resistance in colon cancer. In the hydroxycamptothecin (HCPT) resistant cell line SW1116/HCPT from human colon cancer cell line SW1116, ABCG2 is the major factor for multidrug resistance, other than well-studied ABCB1 or ABCC1. Our findings indicate that blocking the JNK pathway by pathway inhibitor SP600125 reduces the expression level and transport function of ABCG2 in drug-resistant cells SW116/HCPT. Notably, the experiments of small interfering RNA directed against JNK1 and JNK2 show that only silence of JNK1 gene has the equal effect as SP600125 on dephosphorylation of transcription factor c-Jun and the expression of ABCG2 protein, while the corresponding phenomena were not observed after silence of JNK2 gene. Meanwhile, SP600125 induces the apoptosis of SW116/HCPT cells by promoting the cleavage of PARP and suppressing the anti-apoptotic protein survivin and bcl-2, and increases the sensitivity of SW1116/HCPT to HCPT. Taken together, our work demonstrated that JNK1/c-jun signaling pathway was involved in ABCG2-mediated multidrug resistance in colon cancer cells. Definitely, inhibition of the JNK1/c-jun pathway is useful for reversing ABCG2-mediated drug resistance in HCPT-resistant colon cancer cells.	[Ran, Zhi Hua] Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol & Hepatol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Minist Hlth, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, MM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol & Hepatol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China.	zhihuaran@vip.163.com		ZHU, Mingming/0000-0002-1319-5199	National Natural Science Foundation of China [30770964]; Key laboratory Program of Science and Technology Commission of Shanghai Municipality [06DZ22027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key laboratory Program of Science and Technology Commission of Shanghai Municipality	This work was supported by the National Natural Science Foundation of China (No. 30770964, http://159.226.244.22/portal/proj_search.asp) and the Key laboratory Program of Science and Technology Commission of Shanghai Municipality (No. 06DZ22027, http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1998, CANCER RES, V58, P5337; Bark H, 2008, FEBS LETT, V582, P2595, DOI 10.1016/j.febslet.2008.06.036; Brangi M, 1999, CANCER RES, V59, P5938; Chen Z, 2010, INT J CANCER, V126, P841, DOI 10.1002/ijc.24796; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Costa-Pereira AP, 2000, BRIT J CANCER, V82, P1827, DOI 10.1054/bjoc.2000.1149; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Gancz D, 2009, MOL IMMUNOL, V47, P310, DOI 10.1016/j.molimm.2009.09.016; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Heasley LE, 2006, MOL CELLS, V21, P167; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Kang CD, 2000, EXP CELL RES, V256, P300, DOI 10.1006/excr.2000.4807; Kim JH, 2009, BIOCHEM BIOPH RES CO, V387, P450, DOI 10.1016/j.bbrc.2009.07.036; Lemos C, 2008, INT J CANCER, V123, P1712, DOI 10.1002/ijc.23677; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Maliepaard M, 1999, CANCER RES, V59, P4559; Maliepaard M, 2001, CANCER RES, V61, P3458; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Rabindran SK, 2000, CANCER RES, V60, P47; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Shinoda C, 2005, INT J CANCER, V117, P21, DOI 10.1002/ijc.21094; Singh A, 2010, MOL CANCER THER, V9, P2365, DOI 10.1158/1535-7163.MCT-10-0108; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tong JL, 2011, FEBS LETT, V585, P3560, DOI 10.1016/j.febslet.2011.10.021; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Yang YM, 2003, CLIN CANCER RES, V9, P391; Zhang G, 2011, CANCER SCI, V102, P1216, DOI 10.1111/j.1349-7006.2011.01930.x; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; Zou J, 2006, CHIN J GASTROENTEROL, V11, P327	41	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41763	10.1371/journal.pone.0041763	http://dx.doi.org/10.1371/journal.pone.0041763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870247	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800033
J	Gutierrez, JS; Abad-Gomez, JM; Sanchez-Guzman, JM; Navedo, JG; Masero, JA				Gutierrez, Jorge S.; Abad-Gomez, Jose M.; Sanchez-Guzman, Juan M.; Navedo, Juan G.; Masero, Jose A.			Avian BMR in Marine and Non-Marine Habitats: A Test Using Shorebirds	PLOS ONE			English	Article							BASAL METABOLIC-RATE; DISTANCE MIGRATORY SHOREBIRD; ENERGY-EXPENDITURE; MESIC ENVIRONMENTS; ARIDITY GRADIENT; TROPICAL BIRDS; DESERT BIRDS; RICE FIELDS; SLOW PACE; RATES	Basal metabolic rate (BMR) is closely linked to different habitats and way of life. In birds, some studies have noted that BMR is higher in marine species compared to those inhabiting terrestrial habitats. However, the extent of such metabolic dichotomy and its underlying mechanisms are largely unknown. Migratory shorebirds (Charadriiformes) offer a particularly interesting opportunity for testing this marine-non-marine difference as they are typically divided into two broad categories in terms of their habitat occupancy outside the breeding season: 'coastal' and 'inland' shorebirds. Here, we measured BMR for 12 species of migratory shorebirds wintering in temperate inland habitats and collected additional BMR values from the literature for coastal and inland shorebirds along their migratory route to make inter- and intraspecific comparisons. We also measured the BMR of inland and coastal dunlins Calidris alpina wintering at a similar latitude to facilitate a more direct intraspecific comparison. Our interspecific analyses showed that BMR was significantly lower in inland shorebirds than in coastal shorebirds after the effects of potentially confounding climatic (latitude, temperature, solar radiation, wind conditions) and organismal (body mass, migratory status, phylogeny) factors were accounted for. This indicates that part of the variation in basal metabolism might be attributed to genotypic divergence. Intraspecific comparisons showed that the mass-specific BMR of dunlins wintering in inland freshwater habitats was 15% lower than in coastal saline habitats, suggesting that phenotypic plasticity also plays an important role in generating these metabolic differences. We propose that the absence of tidally-induced food restrictions, low salinity, and less windy microclimates associated with inland freshwater habitats may reduce the levels of energy expenditure, and hence BMR. Further research including common-garden experiments that eliminate phenotypic plasticity as a source of phenotypic variation is needed to determine to what extent these general patterns are attributable to genotypic adaptation.	[Gutierrez, Jorge S.; Abad-Gomez, Jose M.; Sanchez-Guzman, Juan M.; Navedo, Juan G.; Masero, Jose A.] Univ Extremadura, Dept Anat Cell Biol & Zool, Badajoz, Spain	Universidad de Extremadura	Gutierrez, JS (corresponding author), Univ Extremadura, Dept Anat Cell Biol & Zool, Badajoz, Spain.	jorgesgutierrez@unex.es	Abad-Gómez, José M/R-2479-2019; Gutiérrez, Jorge/M-4869-2017; Masero, Jose A./P-3418-2019; SANCHEZ, JUAN MANUEL/M-1889-2014; Gutiérrez, Jorge S./AAM-6821-2020; Masero, Jose A./A-9478-2008	Abad-Gómez, José M/0000-0002-3757-8856; Gutiérrez, Jorge/0000-0001-8459-3162; Masero, Jose A./0000-0001-5318-4833; Gutiérrez, Jorge S./0000-0001-8459-3162; Masero, Jose A./0000-0001-5318-4833; Sanchez Guzman, Juan Manuel/0000-0002-0484-6308	Spanish Ministry of Education and Science [CGL2006-01227]; European Regional Development Fund [ERDF] [GR10174]; Government of Extremadura [GR10174, PRE07034]	Spanish Ministry of Education and Science(Spanish Government); European Regional Development Fund [ERDF](European Commission); Government of Extremadura	Projects CGL2006-01227 (Spanish Ministry of Education and Science) and GR10174 (Government of Extremadura and the European Regional Development Fund [ERDF]), and a PhD fellowship (PRE07034) to JSG from Government of Extremadura provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SJ, 1988, COMP BIOCHEM PHYS A, V89, P79, DOI 10.1016/0300-9629(88)91142-5; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; ASCHOFF J, 1970, FED PROC, V29, P1541; Aschoff J, 1970, J. Orn., Berl., V111, P38, DOI 10.1007/BF01668180; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bozinovic F, 2010, CURR ZOOL, V56, P759, DOI 10.1093/czoolo/56.6.759; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Broggi J, 2005, EVOLUTION, V59, P1600; BRYANT DM, 1995, IBIS, V137, P219, DOI 10.1111/j.1474-919X.1995.tb03242.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cant JP, 1996, J ANIM SCI, V74, P2541; CASTRO G, 1987, WILSON BULL, V99, P267; Cramp S., 1993, HDB BIRDS EUROPE MID; Dawson WR, 2000, STURKIES AVIAN PHYSL, V5th, P390; Duriez O, 2004, ARDEA, V92, P31; Duriez Olivier, 2010, Wader Study Group Bulletin, V117, P119; Ellis H.I., 1984, P203; Ellis Hugh I., 2002, P359; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Frappell PB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P865, DOI 10.1086/425191; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gutierrez JS, 2012, FUNCT ECOL, V26, P236, DOI 10.1111/j.1365-2435.2011.01929.x; Gutierrez JS, 2011, J AVIAN BIOL, V42, P259, DOI 10.1111/j.1600-048X.2011.05323.x; Gutierrez JS, 2011, J EXP BIOL, V214, P829, DOI 10.1242/jeb.048223; HAILS CJ, 1983, CONDOR, V85, P61, DOI 10.2307/1367889; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Hoyo J, 1996, HOATZIN AUKS; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; Kaseloo PA, 2003, J COMP PHYSIOL B, V173, P207, DOI 10.1007/s00360-002-0321-9; Kendeigh S.C., 1977, GRANIVOROUS BIRDS EC, P127, DOI [10.1515/isspar-2015-0001, DOI 10.1515/ISSPAR-2015-0001]; Kersten M, 1998, ARDEA, V86, P71; KERSTEN M, 1987, ARDEA, V75, P175; Kvist A, 2003, OIKOS, V103, P397, DOI 10.1034/j.1600-0706.2003.12259.x; Kvist A, 2001, FUNCT ECOL, V15, P465, DOI 10.1046/j.0269-8463.2001.00549.x; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lindstrom A, 2003, CONDOR, V105, P420, DOI 10.1650/7222; Lindstrom A, 1997, J AVIAN BIOL, V28, P87, DOI 10.2307/3677098; Maddison WP, 2010, MESQUITE MOL SYSTEM; Masero JA, 2011, BIRD CONSERV INT, V21, P12, DOI 10.1017/S0959270910000092; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; McNab BK, 1997, PHYSIOL ZOOL, V70, P718, DOI 10.1086/515881; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; Meissner W, 2009, J FIELD ORNITHOL, V80, P289, DOI 10.1111/j.1557-9263.2009.00232.x; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Piersma Theunis, 2003, Wader Study Group Bulletin, V100, P5; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; RAHN H., 1984, COMPANION ANIMAL PHY, P124; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Rezende EL, 2002, J EXP BIOL, V205, P101; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sanchez-Guzman JM, 2007, BIODIVERS CONSERV, V16, P3333, DOI 10.1007/s10531-006-9018-9; Speakman JR, 2000, ADV ECOL RES, V30, P177; STAALAND H, 1967, COMP BIOCHEM PHYSIOL, V23, P933, DOI 10.1016/0010-406X(67)90354-4; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Taylor NAS, 2006, J THERM BIOL, V31, P90, DOI 10.1016/j.jtherbio.2005.11.007; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tieleman BI, 2002, PHYSIOL BIOCHEM ZOOL, V75, P305, DOI 10.1086/341998; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; VANDERHAEGEN WM, 1994, WILSON BULL, V106, P338; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; White CR, 2007, P ROY SOC B-BIOL SCI, V274, P287, DOI 10.1098/rspb.2006.3727; WHITLOCK CH, 2002, NASA SURFACE METEORO; WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Wikelski M, 2003, P ROY SOC B-BIOL SCI, V270, P2383, DOI 10.1098/rspb.2003.2500; Williams JB, 2005, BIOSCIENCE, V55, P416, DOI 10.1641/0006-3568(2005)055[0416:PAIDB]2.0.CO;2	82	16	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42206	10.1371/journal.pone.0042206	http://dx.doi.org/10.1371/journal.pone.0042206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860084	gold, Green Submitted, Green Published			2022-12-25	WOS:000307045600073
J	Takeuchi, H; Kantharia, J; Sethi, MK; Bakker, H; Haltiwanger, RS				Takeuchi, Hideyuki; Kantharia, Joshua; Sethi, Maya K.; Bakker, Hans; Haltiwanger, Robert S.			Site-specific O-Glucosylation of the Epidermal Growth Factor-like (EGF) Repeats of Notch EFFICIENCY OF GLYCOSYLATION IS AFFECTED BY PROPER FOLDING AND AMINO ACID SEQUENCE OF INDIVIDUAL EGF REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED-N-ACETYLGLUCOSAMINE; FACTOR-LIKE MODULES; FACTOR-LIKE DOMAIN; MAMMALIAN NOTCH; FUCOSYL-TRANSFERASE; FACTOR-IX; PROTEIN O-FUCOSYL-TRANSFERASE-1; EXTRACELLULAR DOMAIN; MOLECULAR-CLONING; MODIFIES NOTCH	O-Glucosylation of epidermal growth factor-like (EGF) repeats in the extracellular domain of Notch is essential for Notch function. O-Glucose can be elongated by xylose to the trisaccharide, Xyl alpha 1-3Xyl alpha 1-3Glc beta 1-O-Ser, whose synthesis is catalyzed by the consecutive action of three glycosyltransferases. A UDP-glucose: protein O-glucosyltransferase (Poglut/Rumi) transfers O-glucose to serine within the O-glucose consensus. Subsequently, either of two UDP-xylose: glucoside xylosyltransferases (Gxylt1 or Gxylt2) transfers xylose to O-glucose. Finally, a UDP-xylose: xyloside xylosyltransferase (Xxylt1) transfers xylose to Xyl alpha 1-3Glc beta 1-O-EGF. Our prior site-mapping studies demonstrated that O-glucose consensus sites are modified at high but variable stoichiometries in mouse Notch1 and identified a novel glycosylation site with alanine in place of proline, suggesting a revised, broader consensus sequence (CXSX(P/A)C). Here we examined the molecular basis for this site specificity. A panel of EGF repeats from human coagulation factor 9 (FA9), mouse Notch1, and Notch2 were bacterially expressed and purified by reverse phase HPLC for use in in vitro enzyme assays. We demonstrate that proper folding of EGF repeats is essential for glycosylation by Poglut/Rumi, that alanine can substitute for proline in the context of coagulation factor 9 EGF repeat for O-glucose transfer, confirming the new consensus sequence, and that positively charged residues within the O-glucose consensus sequence reduce efficiency of glycosylation by Poglut/Rumi. Moreover, proper folding of EGF repeats is also important for the activities of Gxylt1, Gxylt2, and Xxylt1. These results indicate that protein folding and amino acid sequences of individual EGF repeats fundamentally affect both attachment and elongation of O-glucose glycans.	[Takeuchi, Hideyuki; Kantharia, Joshua; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; [Sethi, Maya K.; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hannover Medical School	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	Robert.Haltiwanger@StonyBrook.edu	Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017; Takeuchi, Hideyuki/AAZ-9210-2020	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; 	National Institutes of Health [GM61126]; Mizutani Foundation for Glycoscience; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61126 (to R. S. H.). This work was also supported by a research grant from Mizutani Foundation for Glycoscience (to H. T.) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (from Regenerative Biology to Reconstructive Therapy) for the work in Hannover.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; GIANNELLI F, 1993, NUCLEIC ACIDS RES, V21, P3075, DOI 10.1093/nar/21.13.3075; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HASE S, 1990, J BIOL CHEM, V265, P1858; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luther KB, 2009, INT J BIOCHEM CELL B, V41, P1011, DOI 10.1016/j.biocel.2008.10.001; Luther KB, 2009, J BIOL CHEM, V284, P3294, DOI 10.1074/jbc.M805502200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Montejo JM, 1999, HUM MUTAT, V13, P160, DOI 10.1002/(SICI)1098-1004(1999)13:2<160::AID-HUMU9>3.3.CO;2-3; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Zhong DG, 2002, J BIOL CHEM, V277, P3622, DOI 10.1074/jbc.M111202200	41	61	62	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33934	33944		10.1074/jbc.M112.401315	http://dx.doi.org/10.1074/jbc.M112.401315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872643	Green Published, hybrid			2022-12-25	WOS:000309654200002
J	Martin, M; Leffler, J; Blom, AM				Martin, Myriam; Leffler, Jonatan; Blom, Anna M.			Annexin A2 and A5 Serve as New Ligands for C1q on Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MANNOSE-BINDING LECTIN; DEPENDENT PROTEIN-S; SERUM AMYLOID-P; C4B-BINDING PROTEIN; FACTOR-H; COMPLEMENT ACTIVATION; NECROTIC CELLS; IN-VITRO; SURFACE	C1q is the initiator of the classical complement pathway and opsonizes apoptotic cells to facilitate phagocytosis. Deficiency of C1q is the strongest known risk factor for development of systemic lupus erythematosus (SLE), which appears to be related to ensuing impaired clearance of apoptotic material. The objective of the current study was to investigate new ligands for C1q on the surface of apoptotic cells. We revealed that the two phospholipid-binding proteins annexin A2 and A5 are, beside DNA, significant C1q ligands. We furthermore, demonstrated that C1q binds directly to histones exposed on the surface of dying cells but we did not detect significant interaction with phosphatidylserine. The complement inhibitors C4b-binding protein and factor H also interact with dying cells, most likely to decrease complement activation beyond the level of C3 to allow noninflammatory clearance. Despite the fact that C4b-binding protein, factor H, and C1q share some ligands on dying cells, we showed that these three proteins did not compete with one another for binding to apoptotic cells. We additionally demonstrated that the way in which apoptosis is induced influenced both the degree of apoptosis and the binding of C1q. The knowledge, that annexin A2 and A5 act as ligands for C1q on apoptotic cells, sheds new light on the pathophysiology of autoimmune diseases.	[Martin, Myriam; Leffler, Jonatan; Blom, Anna M.] Lund Univ, Dept Lab Med Malmo, S-20502 Malmo, Sweden	Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Inga Marie Nilssons Gata 53, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/AFS-7369-2022; Leffler, Jonatan/D-4630-2011; Blom, Anna/B-9607-2009; Leffler, Jonatan/A-8748-2018	Leffler, Jonatan/0000-0001-5674-8462; Blom, Anna/0000-0002-1348-1734; Leffler, Jonatan/0000-0001-5674-8462; Martin, Myriam/0000-0003-1526-8678	Soderberg Foundation; Swedish Research Council Grant [K2009-68X-14928-06-3]; Swedish Foundation for Strategic Research; Swedish Rheumatism Association; National Board of Health and Welfare and Skane University Hospital; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustaf V's 80th Birthday Foundation; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation	Soderberg Foundation; Swedish Research Council Grant(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Rheumatism Association; National Board of Health and Welfare and Skane University Hospital; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustaf V's 80th Birthday Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation	This work was supported in part by the Soderberg Foundation, Swedish Research Council Grant K2009-68X-14928-06-3, the Swedish Foundation for Strategic Research, the Swedish Rheumatism Association, the National Board of Health and Welfare and Skane University Hospital, and the Osterlund, Greta and Johan Kock, King Gustaf V's 80th Birthday, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg Foundations.	Ao W, 2011, RHEUMATOL INT, V31, P865, DOI 10.1007/s00296-010-1379-4; Baroni M, 2010, THROMB RES, V125, pE33, DOI 10.1016/j.thromres.2009.09.015; Baruah P, 2010, EUR J IMMUNOL, V40, P1758, DOI 10.1002/eji.200940158; Bengtsson A, 1999, J AUTOIMMUN, V13, P111, DOI 10.1006/jaut.1999.0300; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chabaud S, 2011, J CELL PHYSIOL, V226, P1907, DOI 10.1002/jcp.22520; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; HICKS PS, 1992, J IMMUNOL, V149, P3689; Hrycek A, 2012, RHEUMATOL INT, V32, P1335, DOI 10.1007/s00296-011-1793-2; Iaccarino L, 2011, AUTOIMMUN REV, V10, P553, DOI 10.1016/j.autrev.2011.04.007; Ji NY, 2009, INT J MOL MED, V24, P765, DOI 10.3892/ijmm_00000290; JIANG HX, 1992, J BIOL CHEM, V267, P25597; Kang YH, 2012, IMMUNOBIOLOGY, V217, P455, DOI 10.1016/j.imbio.2011.10.008; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Korb LC, 1997, J IMMUNOL, V158, P4525; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsuda R, 2003, RESUSCITATION, V57, P171, DOI 10.1016/S0300-9572(03)00034-0; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; PAQUES EP, 1979, H-S Z PHYSIOL CHEM, V360, P177, DOI 10.1515/bchm2.1979.360.1.177; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; STURFELT G, 1985, SCAND J RHEUMATOL, V14, P184, DOI 10.3109/03009748509165503; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tissot B, 2003, EUR J BIOCHEM, V270, P4714, DOI 10.1046/j.1432-1033.2003.03870.x; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2005, EXPERT OPIN BIOL TH, V5, P243, DOI 10.1517/14712598.5.2.243; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580	53	78	82	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33733	33744		10.1074/jbc.M112.341339	http://dx.doi.org/10.1074/jbc.M112.341339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879587	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000309602100056
J	Menning, A; Walter, A; Rudolph, M; Gashaw, I; Fritzemeier, KH; Roese, L				Menning, Astrid; Walter, Alexander; Rudolph, Marion; Gashaw, Isabella; Fritzemeier, Karl-Heinrich; Roese, Lars			Granulocytes and Vascularization Regulate Uterine Bleeding and Tissue Remodeling in a Mouse Menstruation Model	PLOS ONE			English	Article							ENDOMETRIAL REPAIR; PROGESTERONE WITHDRAWAL; EARLY-PREGNANCY; GROWTH-FACTOR; MICE; ANGIOGENESIS; DECIDUALIZATION; NEUTROPHILS; HYPOXIA	Menstruation-associated disorders negatively interfere with the quality of life of many women. However, mechanisms underlying pathogenesis of menstrual disorders remain poorly investigated up to date. Among others, this is based on a lack of appropriate pre-clinical animal models. We here employ a mouse menstruation model induced by priming mice with gonadal hormones and application of a physical stimulus into the uterus followed by progesterone removal. As in women, these events are accompanied by menstrual-like bleeding and tissue remodeling processes, i.e. disintegration of decidualized endometrium, as well as subsequent repair. We demonstrate that the onset of bleeding coincides with strong upregulation of inflammatory mediators and massive granulocyte influx into the uterus. Uterine granulocytes play a central role in regulating local tissue remodeling since depletion of these cells results in dysregulated expression of matrix modifying enzymes. As described here for the first time, uterine blood loss can be quantified by help of tampon-like cotton pads. Using this novel technique, we reveal that blood loss is strongly reduced upon inhibition of endometrial vascularization and thus, is a key regulator of menstrual bleeding. Taken together, we here identify angiogenesis and infiltrating granulocytes as critical determinants of uterine bleeding and tissue remodeling in a mouse menstruation model. Importantly, our study provides a technical and scientific basis allowing quantification of uterine blood loss in mice and thus, assessment of therapeutic intervention, proving great potential for future use in basic research and drug discovery.	[Menning, Astrid; Walter, Alexander; Rudolph, Marion; Gashaw, Isabella; Fritzemeier, Karl-Heinrich; Roese, Lars] Bayer HealthCare Pharmaceut, Therapeut Res Grp Oncol Gynecol Therapy, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals	Menning, A (corresponding author), Bayer HealthCare Pharmaceut, Therapeut Res Grp Oncol Gynecol Therapy, Berlin, Germany.	astridmenning@yahoo.de		Gashaw, Isabella/0000-0001-5984-576X	Bayer HealthCare Pharmaceuticals	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals)	This work has been financed by Bayer HealthCare Pharmaceuticals. All authors are employees of Bayer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NIC CLIN GUID; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Cheng CW, 2007, BIOL REPROD, V76, P871, DOI 10.1095/biolreprod.106.057950; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fraser I, 2009, EXP REV OBSTET GYNEC, V4, P179, DOI [10.1586/17474108.4.2.179, DOI 10.1586/17474108.4.2.179]; HALLBERG L, 1964, SCAND J CLIN LAB INV, V16, P244, DOI 10.3109/00365516409060511; HALLBERG L, 1965, ACTA OBSTET GYN SCAN, VS 43, P57; Heryanto B, 2004, REPRODUCTION, V127, P613, DOI 10.1530/rep.1.00161; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; Kaitu'u-Lino TJ, 2007, CELL TISSUE RES, V328, P197, DOI 10.1007/s00441-006-0358-2; MARKEE JE, 1978, AM J OBSTET GYNECOL, V131, P558; Maybin JA, 2011, J CLIN ENDOCR METAB, V96, P2475, DOI 10.1210/jc.2010-2971; Maybin JA, 2011, AM J PATHOL, V178, P1245, DOI 10.1016/j.ajpath.2010.11.070; Maybin JA, 2011, MOL CELL ENDOCRINOL, V335, P42, DOI 10.1016/j.mce.2010.08.006; Million RP, 2008, NAT REV DRUG DISCOV, V7, P115, DOI 10.1038/nrd2507; Milne SA, 1999, J CLIN ENDOCR METAB, V84, P2563, DOI 10.1210/jc.84.7.2563; RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; Salamonsen LA, 2000, HUM REPROD UPDATE, V6, P16, DOI 10.1093/humupd/6.1.16; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312	31	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41800	10.1371/journal.pone.0041800	http://dx.doi.org/10.1371/journal.pone.0041800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879894	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900013
J	Castello, NA; Green, KN; LaFerla, FM				Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.			Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter A beta or Tau Pathology	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; BDNF MESSENGER-RNA; TRANSGENIC MODEL; NEUROBLASTOMA-CELLS; PROMOTER ACTIVITY; IN-VIVO; POLYMORPHISM; MECHANISM; EXPRESSION; COGNITION	Brain-derived neurotrophic factor (BDNF) is a neurotrophin critically involved in cell survival, synaptic plasticity, and memory. BDNF has recently garnered significant attention as a potential therapeutic target for neurodegenerative diseases such as Alzheimer disease (AD), but emerging evidence suggests that BDNF may also be mechanistically involved in the pathogenesis of AD. AD patients have substantially reduced BDNF levels, which may be a result of A beta and tau pathology. Recent evidence, however, indicates reduced BDNF levels may also serve to drive pathology in neuronal cultures, although this has not yet been established in vivo. To further investigate the mechanistic role of BDNF in AD, we generated 3xTg-AD mice with a heterozygous BDNF knockout (BDNF+/-) and analyzed A beta and tau pathology. Aged 3xTg-AD/BDNF+/- mice have significantly reduced levels of brain BDNF, but have comparable levels of A beta and tau pathology to 3xTg-AD/BDNF+/+ mice. These findings indicate that chronic reduction of BDNF does not exacerbate the development of A beta and tau pathology, and instead suggests the reduced BDNF levels found in AD patients are a consequence of these pathologies.	[Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Castello, Nicholas A.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Castello, NA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	laferla@uci.edu			American Health Assistance Foundation; NIH [F31AG034061]; NATIONAL INSTITUTE ON AGING [F31AG034061, P50AG016573] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a grant from the American Health Assistance Foundation (FML) and NIH F31AG034061 (NAC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu H, 2006, DEMENT GERIATR COGN, V22, P216, DOI 10.1159/000094933; Aliaga E, 2010, NEUROBIOL DIS, V37, P208, DOI 10.1016/j.nbd.2009.10.004; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bodner SM, 2005, AM J MED GENET B, V134B, P1, DOI 10.1002/ajmg.b.30154; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Elliott E, 2005, EUR J NEUROSCI, V22, P1081, DOI 10.1111/j.1460-9568.2005.04290.x; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Green K, 2008, J NEUROSCI; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Green KN, 2011, ANN NEUROL, V69, P831, DOI 10.1002/ana.22325; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Olin D, 2005, NEUROSCI LETT, V381, P275, DOI 10.1016/j.neulet.2005.02.017; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pitts AF, 2000, J COMP NEUROL, V418, P241, DOI 10.1002/(SICI)1096-9861(20000313)418:3<241::AID-CNE1>3.0.CO;2-M; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Ruiz-Leon Y, 2001, J NEUROCHEM, V79, P278, DOI 10.1046/j.1471-4159.2001.00547.x; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Zheng ZQ, 2010, J BIOL CHEM, V285, P34708, DOI 10.1074/jbc.M110.150821	38	27	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39566	10.1371/journal.pone.0039566	http://dx.doi.org/10.1371/journal.pone.0039566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870188	Green Published, gold			2022-12-25	WOS:000307284100002
J	Chaffin, DO; Taylor, D; Skerrett, SJ; Rubens, CE				Chaffin, Donald O.; Taylor, Destry; Skerrett, Shawn J.; Rubens, Craig E.			Changes in the Staphylococcus aureus Transcriptome during Early Adaptation to the Lung	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; STATIONARY-PHASE SURVIVAL; DEVICE-RELATED INFECTION; GRAM-POSITIVE BACTERIA; SMALL-COLONY-VARIANT; METHICILLIN-RESISTANT; IN-VIVO; STRESS-RESPONSE; GLYCOPEPTIDE RESISTANCE; DETERMINANT PRODUCTION	Staphylococcus aureus is a common inhabitant of the human nasopharynx. It is also a cause of life-threatening illness, producing a potent array of virulence factors that enable survival in normally sterile sites. The transformation of S. aureus from commensal to pathogen is poorly understood. We analyzed S. aureus gene expression during adaptation to the lung using a mouse model of S. aureus pneumonia. Bacteria were isolated by bronchoalveolar lavage after residence in vivo for up to 6 hours. S. aureus in vivo RNA transcription was compared by microarray to that of shake flask grown stationary phase and early exponential phase cells. Compared to in vitro conditions, the in vivo transcriptome was dramatically altered within 30 minutes. Expression of central metabolic pathways changed significantly in response to the lung environment. Gluconeogenesis (fbs, pckA) was down regulated, as was TCA cycle and fermentation pathway gene expression. Genes associated with amino acid synthesis, RNA translation and nitrate respiration were upregulated, indicative of a highly active metabolic state during the first 6 hours in the lung. Virulence factors regulated by agr were down regulated in vivo and in early exponential phase compared to stationary phase cells. Over time in vivo, expression of ahpCF, involved in H2O2 scavenging, and uspA, which encodes a universal stress regulator, increased. Transcription of leukotoxic alpha and beta-type phenol-soluble modulins psm alpha 1-4 and psm beta 1-2 increased 13 and 8-fold respectively; hld mRNA, encoding delta-hemolysin, was increased 9-fold. These were the only toxins to be significantly upregulated in vivo. These data provide the first complete survey of the S. aureus transcriptome response to the mammalian airway. The results present intriguing contrasts with previous work in other in vitro and in vivo models and provide novel insights into the adaptive and temporal response of S. aureus early in the pathogenesis of pneumonia.	[Chaffin, Donald O.; Rubens, Craig E.] Seattle Childrens Hosp, Res Inst, Seattle, WA USA; [Taylor, Destry; Skerrett, Shawn J.; Rubens, Craig E.] Univ Washington, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Chaffin, DO (corresponding author), Seattle Childrens Hosp, Res Inst, Seattle, WA USA.	craig.rubens@seattlechildrens.org			National Institutes of Health [P50 HL073996]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded under National Institutes of Health grant award number P50 HL073996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Andrews WW, 2008, OBSTET GYNECOL, V111, P113, DOI 10.1097/01.AOG.0000298344.04916.11; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Boyce JM, 2005, J CLIN MICROBIOL, V43, P5992, DOI 10.1128/JCM.43.12.5992-5995.2005; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Choudhry AE, 2003, ANTIMICROB AGENTS CH, V47, P2051, DOI 10.1128/AAC.47.6.2051-2055.2003; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; CROSSLEY K, 1979, J INFECT DIS, V139, P280, DOI 10.1093/infdis/139.3.280; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dunman PM, 2004, J CLIN MICROBIOL, V42, P4275, DOI 10.1128/JCM.42.9.4275-4283.2004; EMMETT M, 1975, CAN J MICROBIOL, V21, P729, DOI 10.1139/m75-107; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kahl BC, 2005, INFECT IMMUN, V73, P4119, DOI 10.1128/IAI.73.7.4119-4126.2005; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kumari DNP, 1998, J HOSP INFECT, V39, P127, DOI 10.1016/S0195-6701(98)90326-7; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; O'Connell NH, 2000, J HOSP INFECT, V45, P255, DOI 10.1053/jhin.2000.0768; Oie S, 1996, J HOSP INFECT, V34, P145, DOI 10.1016/S0195-6701(96)90140-1; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; PATTEE PA, 1975, J BACTERIOL, V124, P201, DOI 10.1128/JB.124.1.201-211.1975; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pragman AA, 2004, FEMS IMMUNOL MED MIC, V42, P147, DOI 10.1016/j.femsim.2004.05.005; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ray B, 2009, MICROB PATHOGENESIS, V47, P94, DOI 10.1016/j.micpath.2009.05.001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rezacova P, 2008, MOL MICROBIOL, V69, P895, DOI 10.1111/j.1365-2958.2008.06318.x; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Schlag S, 2008, J BACTERIOL, V190, P7847, DOI 10.1128/JB.00905-08; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sieradzki K, 1998, MICROB DRUG RESIST, V4, P159, DOI 10.1089/mdr.1998.4.159; Singh VK, 2003, INT J ANTIMICROB AG, V21, P256, DOI 10.1016/S0924-8579(02)00359-X; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; Suzuki M, 2009, J APPL MICROBIOL, V107, P1367, DOI 10.1111/j.1365-2672.2009.04321.x; ten Broeke-Smits NJP, 2010, J HOSP INFECT, V76, P211, DOI 10.1016/j.jhin.2010.07.011; ten Broeke-Smits NJP, 2010, NUCLEIC ACIDS RES, V38, P3263, DOI 10.1093/nar/gkq058; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; van Wamel W, 2002, MICROB PATHOGENESIS, V33, P73, DOI 10.1006/mpat.2002.0513; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09; Ziebuhr W, 1997, INFECT IMMUN, V65, P890, DOI 10.1128/IAI.65.3.890-896.1997	100	66	66	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41329	10.1371/journal.pone.0041329	http://dx.doi.org/10.1371/journal.pone.0041329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876285	gold, Green Submitted, Green Published			2022-12-25	WOS:000307184700013
J	Ohmayer, U; Perez-Fernandez, J; Hierlmeier, T; Poll, G; Williams, L; Griesenbeck, J; Tschochner, H; Milkereit, P				Ohmayer, Uli; Perez-Fernandez, Jorge; Hierlmeier, Thomas; Poell, Gisela; Williams, Lydia; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Local Tertiary Structure Probing of Ribonucleoprotein Particles by Nuclease Fusion Proteins	PLOS ONE			English	Article							RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CELLS; MATURATION; COMPLEX; DESIGN; SITES	Analyses of the conformational dynamics of the numerous cellular ribonucleoprotein particles (RNP) significantly contribute to the understanding of their modes of action. Here, we tested whether ribonuclease fusion proteins incorporated into RNPs can be used as molecular probes to characterize the local RNA environment of these proteins. Fusion proteins of micrococcal nuclease (MNase) with ribosomal proteins were expressed in S. cerevisae to produce in vivo recombinant ribosomes which have a ribonuclease tethered to specific sites. Activation of the MNase activity by addition of calcium led to specific rRNA cleavage events in proximity to the ribosomal binding sites of the fusion proteins. The dimensions of the RNP environment which could be probed by this approach varied with the size of the linker sequence between MNase and the fused protein. Advantages and disadvantages of the use of MNase fusion proteins for local tertiary structure probing of RNPs as well as alternative applications for this type of approach in RNP research are discussed.	[Ohmayer, Uli; Perez-Fernandez, Jorge; Hierlmeier, Thomas; Poell, Gisela; Williams, Lydia; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany	University of Regensburg	Ohmayer, U (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	Joachim.Griesenbeck@vkl.uni-regensburg.de; Herbert.Tschochner@vkl.uni-regensburg.de; Philipp.Milkereit@vkl.uni-regensburg.de	Perez-Fernandez, Jorge/F-6937-2010	Perez-Fernandez, Jorge/0000-0002-0018-5493; Griesenbeck, Joachim/0000-0002-7817-6095	DFG [SFB 960]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant SFB 960 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfinsen C.B., 1971, ENZYMES, V4; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Ben-Shem A, 2011, STRUCTURE EUKARYOTIC; Burke D., 2000, METHODS YEAST GENETI; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Das SR, 2005, CURR OPIN CHEM BIOL, V9, P585, DOI 10.1016/j.cbpa.2005.10.009; Dast R, 2008, P NATL ACAD SCI USA, V105, P4144, DOI 10.1073/pnas.0709032105; Felden B, 2007, CURR OPIN MICROBIOL, V10, P286, DOI 10.1016/j.mib.2007.05.001; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Herschlag Dan, 2009, Methods Enzymol, V469, pxvii, DOI 10.1016/S0076-6879(09)69028-5; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; Lomax JE, 2012, METHOD ENZYMOL, V502, P273, DOI 10.1016/B978-0-12-416039-2.00014-8; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Venema J, 1998, METH MOL B, V77, P257; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42449	10.1371/journal.pone.0042449	http://dx.doi.org/10.1371/journal.pone.0042449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876323	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700051
J	Wang, JB; Fan, JH; Liang, H; Li, J; Xiao, HJ; Wei, WQ; Dawsey, SM; Qiao, YL; Boffetta, P				Wang, Jian-Bing; Fan, Jin-Hu; Liang, Hao; Li, Jing; Xiao, Hui-Juan; Wei, Wen-Qiang; Dawsey, Sanford M.; Qiao, You-Lin; Boffetta, Paolo			Attributable Causes of Esophageal Cancer Incidence and Mortality in China	PLOS ONE			English	Article							RISK-FACTORS; ALCOHOL-DRINKING; GASTRIC CANCERS; CIGARETTE-SMOKING; BRITISH DOCTORS; LIFE-STYLE; TOOTH LOSS; DISEASE; COHORT; FRUIT	Background: To estimate the contribution of tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake to esophageal cancer mortality and incidence in China. Methodology/Principal Findings: We calculated the proportion of esophageal cancer attributable to four known modifiable risk factors [population attributable fraction (PAF)]. Exposure data was taken from meta-analyses and large-scale national surveys of representative samples of the Chinese population. Data on relative risks were also from meta-analyses and large-scale prospective studies. Esophageal cancer mortality and incidence came from the 3rd national death cause survey and population-based cancer registries in China. We estimated that 87,065 esophageal cancer deaths (men 67,686; women: 19,379) and 108,206 cases (men: 83,968, women: 24,238) were attributable to tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake in China in 2005. About 17.9% of esophageal cancer deaths among men and 1.9% among women were attributable to tobacco smoking. About 15.2% of esophageal cancer deaths in men and 1.3% in women were caused by alcohol drinking. Low vegetable intake was responsible for 4.3% esophageal cancer deaths in men and 4.1% in women. The fraction of esophageal cancer deaths attributable to low fruit intake was 27.1% in men and 28.0% in women. Overall, 46% of esophageal cancers (51% in men and 33% in women) were attributable to these four modifiable risk factors. Conclusions/Significance: Tobacco smoking, alcohol drinking, low vegetable intake and low fruit intake were responsible for 46% of esophageal cancer mortality and incidence in China in 2005. These findings provide useful data for developing guidelines for esophageal cancer prevention and control in China.	[Wang, Jian-Bing; Fan, Jin-Hu; Liang, Hao; Li, Jing; Wei, Wen-Qiang; Qiao, You-Lin] Chinese Acad Med Sci, Dept Canc Epidemiol, Peking Union Med Coll, Canc Inst Hosp, Beijing 100730, Peoples R China; [Wang, Jian-Bing; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Bethesda, MD 20892 USA; [Xiao, Hui-Juan] Tianjin Third Cent Hosp, Dept Nutr, Tianjin, Peoples R China; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai	Wang, JB (corresponding author), Chinese Acad Med Sci, Dept Canc Epidemiol, Peking Union Med Coll, Canc Inst Hosp, Beijing 100730, Peoples R China.	qiaoy@cicams.ac.cn; paolo.boffetta@i-pri.org	Qiao, You-Lin/B-4139-2012; Boffetta, Paolo/AAI-7767-2021	Qiao, You-Lin/0000-0001-6380-0871; Boffetta, Paolo/0000-0002-3811-2791; fan, jinhu/0000-0003-3159-7893	International Agency for Research on Cancer (Lyon, France) [GEE/08/19]; National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	International Agency for Research on Cancer (Lyon, France); National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the International Agency for Research on Cancer (Lyon, France), Grant number: CRA No GEE/08/19. It was also supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Chen Wan-qing, 2009, Zhonghua Zhong Liu Za Zhi, V31, P664; Chen Z, 2007, CHINESE HLTH, V12, P15; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; International Agency for Research on Cancer Academie des Sciences-Institut de France Academie de Medecine Federation Nationale des Centres de Lutte contre le Cancer, 2007, IARC WORK GROUP REP, V3; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Liang H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-730; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Ministry of Health of the People's Republic of China, 2008, REP 3 NAT RETR SURV; Olsen JH, 1997, APMIS, V105, P141; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENSION, V3, P50; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Schneider M, 2007, SAMJ S AFR MED J, V97, P717; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wei Wen-qiang, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P398; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu M, 2011, CANCER LETT, V308, P189, DOI 10.1016/j.canlet.2011.05.003; Wu M, 2011, CANCER CAUSE CONTROL, V22, P649, DOI 10.1007/s10552-011-9737-4; Xiang W, 2011, CANCER CAUSE CONTROL, V22, P1153, DOI 10.1007/s10552-011-9791-y; Xiao HJ, 2011, CHINESE J CANCER RES, V23, P171, DOI 10.1007/s11670-011-0171-7; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yu H., 2003, CHIN J PUBLIC HLTH, V19, P763	40	52	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42281	10.1371/journal.pone.0042281	http://dx.doi.org/10.1371/journal.pone.0042281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876312	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700040
J	Planaguma, J; Minsaas, L; Pons, M; Myhren, L; Garrido, G; Aragay, AM				Planaguma, Jesus; Minsaas, Laura; Pons, Monica; Myhren, Lene; Garrido, Georgina; Aragay, Anna M.			Filamin A-Hinge Region 1-EGFP: A Novel Tool for Tracking the Cellular Functions of Filamin A in Real-Time	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; ACTIN-BINDING PROTEIN; STRUCTURAL BASIS; TARGETS FILAMIN; DOMAIN; IDENTIFICATION; ACTIVATION; FILGAP; RHO; ACCUMULATION	Background: Filamin A (FLNa) is an actin-crosslinking protein necessary for stabilizing the cell surface, organizing protrusive activity and for promoting efficient cellular translocation. Recently, our group demonstrated the requirement of FLNa for the internalization of the chemokine receptor CCR2B. Methodology and Principal Findings: In order to study the role of FLNa in vitro and in real-time, we have developed a fluorescent FLNa-EGFP construct. In this novel imaging tool, we introduced the EGFP-tag inside the flexible hinge 1 region of FLNa between two calpain cleavage sites. Our findings indicate that the FLNa-EGFP construct was correctly expressed, cleaved by calpain and colocalized with actin filaments as shown by immunostaining experiments in the human melanoma cell lines A7 (FLNa-repleted) and M2 (FLNa-deficient). In addition, scanning-electron microscopy (SEM) and micropatterning studies also provided clear evidence that the cell rigidity was restored. FLNa-EGFP allowed us to demonstrate the interaction of FLNa with the chemokine receptor CCR2B in endocytic vesicles after CCL2 ligand stimulation. Through live-cell imaging studies we show that the CCR2B receptor in Rab5-positive vesicles moves along filamin A-positive fibers. Significance: Taken together, these results outline the functionality of the FLNa-EGFP and the importance of filamin A for receptor internalization and movement into endocytic vesicles.	[Planaguma, Jesus; Minsaas, Laura; Myhren, Lene; Aragay, Anna M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Pons, Monica; Garrido, Georgina; Aragay, Anna M.] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain	University of Bergen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Planaguma, J (corresponding author), IDIBAPS, Barcelona, Spain.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Pons, Monica/AAB-5309-2019; Garrido Antequera, Georgina/H-3469-2015	Aragay, Anna M/0000-0002-8240-4126; Garrido Antequera, Georgina/0000-0001-7702-7998	Ministerio de Ciencia e Innovacion [BFU2008-04262]; Helse Vest Norway	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Helse Vest Norway	The "Ministerio de Ciencia e Innovacion" (BFU2008-04262) and Helse Vest Norway supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; BRESNICK AR, 1991, J BIOL CHEM, V266, P12989; BYERS HR, 1991, AM J PATHOL, V139, P423; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; FOX JEB, 1985, J BIOL CHEM, V260, P1060; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Ikonen E, 1997, J CELL SCI, V110, P2155; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Minsaas L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012212; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40864	10.1371/journal.pone.0040864	http://dx.doi.org/10.1371/journal.pone.0040864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870205	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800011
J	Sadamoto, H; Takahashi, H; Okada, T; Kenmoku, H; Toyota, M; Asakawa, Y				Sadamoto, Hisayo; Takahashi, Hironobu; Okada, Taketo; Kenmoku, Hiromichi; Toyota, Masao; Asakawa, Yoshinori			De Novo Sequencing and Transcriptome Analysis of the Central Nervous System of Mollusc Lymnaea stagnalis by Deep RNA Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; ANNOTATION; ASSEMBLER; BLAST2GO; APLYSIA; GENOME; MEMORY	The pond snail Lymnaea stagnalis is among several mollusc species that have been well investigated due to the simplicity of their nervous systems and large identifiable neurons. Nonetheless, despite the continued attention given to the physiological characteristics of its nervous system, the genetic information of the Lymnaea central nervous system (CNS) has not yet been fully explored. The absence of genetic information is a large disadvantage for transcriptome sequencing because it makes transcriptome assembly difficult. We here performed transcriptome sequencing for Lymnaea CNS using an Illumina Genome Analyzer IIx platform and obtained 81.9 M of 100 base pair (bp) single end reads. For de novo assembly, five programs were used: ABySS, Velvet, OASES, Trinity and Rnnotator. Based on a comparison of the assemblies, we chose the Rnnotator dataset for the following blast searches and gene ontology analyses. The present dataset, 116,355 contigs of Lymnaea transcriptome shotgun assembly (TSA), contained longer sequences and was much larger compared to the previously reported Lymnaea expression sequence tag (EST) established by classical Sanger sequencing. The TSA sequences were subjected to blast analyses against several protein databases and Aplysia EST data. The results demonstrated that about 20,000 sequences had significant similarity to the reported sequences using a cutoff value of 1e-6, and showed the lack of molluscan sequences in the public databases. The richness of the present TSA data allowed us to identify a large number of new transcripts in Lymnaea and molluscan species.	[Sadamoto, Hisayo; Okada, Taketo] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki City, Kagawa, Japan; [Takahashi, Hironobu; Kenmoku, Hiromichi; Toyota, Masao; Asakawa, Yoshinori] Tokushima Bunri Univ, Inst Pharmacognosy, Tokushima, Japan	Tokushima Bunri University; Tokushima Bunri University	Sadamoto, H (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus, Sanuki City, Kagawa, Japan.	sadamotoh@kph.bunri-u.ac.jp		Takahashi, Hironobu/0000-0003-0045-7716	Japan Society for the Promotion of Science [21770081, 24570091]; Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [24651247] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (21770081 and 24570091 to HS) and Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dames Shale, 2010, J Biomol Tech, V21, P73; Davison A, 2005, PARASITOLOGY, V130, P539, DOI 10.1017/S0031182004006791; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Filla A, 2004, ACTA BIOL HUNG, V55, P315, DOI 10.1556/ABiol.55.2004.1-4.37; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026509; Kawahara Miki R, 2011, PLOS ONE, V6; Kemenes G, 2009, CURR BIOL, V19, pR9, DOI 10.1016/j.cub.2008.10.013; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kojima S, 1997, NEUROSCI LETT, V230, P179, DOI 10.1016/S0304-3940(97)00507-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Ribeiro M, 2010, NEUROSCIENCE, V165, P794, DOI 10.1016/j.neuroscience.2009.11.008; Sadamoto B, 2004, ACTA BIOL HUNG, V55, P163, DOI 10.1556/ABiol.55.2004.1-4.20; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; Vehovszky A, 2002, NEUROSCIENCE, V115, P483, DOI 10.1016/S0306-4522(02)00414-1; Vehovszky A, 2000, BRAIN RES, V867, P188, DOI 10.1016/S0006-8993(00)02315-5; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	72	74	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42546	10.1371/journal.pone.0042546	http://dx.doi.org/10.1371/journal.pone.0042546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870333	gold, Green Submitted, Green Published			2022-12-25	WOS:000307212800096
J	Sweet, M; Kirkham, N; Bendall, M; Currey, L; Bythell, J; Heupel, M				Sweet, Michael; Kirkham, Nigel; Bendall, Mark; Currey, Leanne; Bythell, John; Heupel, Michelle			Evidence of Melanoma in Wild Marine Fish Populations	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; REEF; COMMUNITIES; XIPHOPHORUS; DISEASE; HYBRIDIZATION; GRADIENT; CANCER; ECOLOGY; CORALS	The increase in reports of novel diseases in a wide range of ecosystems, both terrestrial and marine, has been linked to many factors including exposure to novel pathogens and changes in the global climate. Prevalence of skin cancer in particular has been found to be increasing in humans, but has not been reported in wild fish before. Here we report extensive melanosis and melanoma (skin cancer) in wild populations of an iconic, commercially-important marine fish, the coral trout Plectropomus leopardus. The syndrome reported here has strong similarities to previous studies associated with UV induced melanomas in the well-established laboratory fish model Xiphophorus. Relatively high prevalence rates of this syndrome (15%) were recorded at two offshore sites in the Great Barrier Reef Marine Park (GBRMP). In the absence of microbial pathogens and given the strong similarities to the UV-induced melanomas, we conclude that the likely cause was environmental exposure to UV radiation. Further studies are needed to establish the large scale distribution of the syndrome and confirm that the lesions reported here are the same as the melanoma in Xiphophorus, by assessing mutation of the EGFR gene, Xmrk. Furthermore, research on the potential links of this syndrome to increases in UV radiation from stratospheric ozone depletion needs to be completed.	[Sweet, Michael; Bendall, Mark; Bythell, John] Newcastle Univ, Coral Hlth & Dis Lab, Sch Biol, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kirkham, Nigel] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Currey, Leanne] James Cook Univ, Australian Inst Marine Sci, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld 4811, Australia; [Bythell, John] Univ S Pacific, Res Off, Suva, Fiji	Newcastle University - UK; Newcastle University - UK; Australian Institute of Marine Science; James Cook University; University of the South Pacific	Sweet, M (corresponding author), Newcastle Univ, Coral Hlth & Dis Lab, Sch Biol, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.sweet@ncl.ac.uk	Sweet, Michael J/E-9661-2012; Bythell, John/ABE-6138-2021; Currey-Randall, Leanne/AAS-8975-2020; Bythell, John C/E-7962-2010	Sweet, Michael J/0000-0003-4983-8333; Bythell, John/0000-0003-2416-9786; Currey-Randall, Leanne/0000-0002-3772-1288; Bythell, John C/0000-0003-2416-9786; Heupel, Michelle/0000-0002-8245-7332	Natural Environment Research Council grant [NE/E006949]; Natural Environment Research Council [NE/H020616/1] Funding Source: researchfish; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a Natural Environment Research Council grant (NE/E006949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Altinok Ilhan, 2003, Turkish Journal of Fisheries and Aquatic Sciences, V3, P131; ANDERS F, 1980, LINNEAN SOC S SERIES, V9, P211; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dahms HU, 2010, AQUAT TOXICOL, V97, P3, DOI 10.1016/j.aquatox.2009.12.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ebrahimzadeh Mousavi HA, 2005, IRAN J FISH SCI, V5, P105; Fernandez AA, 2008, J FISH BIOL, V72, P292, DOI 10.1111/j.1095-8649.2007.01691.x; Fernandez A.A., 2011, COMP BIOCH PHYSL C; Frisch A, 2006, J FISH BIOL, V68, P1013, DOI 10.1111/j.0022-1112.2006.00977.x; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gimenez-Conti I, 2001, MAR BIOTECHNOL, V3, pS100; Haeder DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI DOI 10.1039/C0PP90036B; Huang AH, 2006, J CLIN MICROBIOL, V44, P3299, DOI 10.1128/JCM.00417-06; Huang PH, 2009, NATURE, V459, P336, DOI 10.1038/459336a; Hubbard Karen, 2008, Ethn Dis, V18, pS2; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kohout J, 2012, FISHERIES MANAG ECOL, V19, P252, DOI 10.1111/j.1365-2400.2011.00828.x; Lewis TJ, 2010, INTEGR CANCER THER, V9, P84, DOI 10.1177/1534735409355171; Lowe C, 1996, NATURE, V383, P677, DOI 10.1038/383677a0; Marie AD, 2012, CAN J FISH AQUAT SCI, V69, P884, DOI 10.1139/F2012-027; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Patton EE, 2010, J INVEST DERMATOL, V130, P14, DOI 10.1038/jid.2009.293; PORCHETHENNERE E, 1992, CELL TISSUE RES, V269, P167, DOI 10.1007/BF00384737; Ramaiah N, 2006, INDIAN J MAR SCI, V35, P380; Regneri J, 2012, COMP BIOCHEM PHYS C, V155, P71, DOI 10.1016/j.cbpc.2011.04.003; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; SCHARTL A, 1995, CANCER RES, V55, P159; SETLOW RB, 1989, P NATL ACAD SCI USA, V86, P8922, DOI 10.1073/pnas.86.22.8922; SMITH RC, 1992, SCIENCE, V255, P952, DOI 10.1126/science.1546292; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Sweet MJ, 2012, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2012.02746, DOI 10.1111/J.1462-2920.2012.02746]; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Vancov T, 2009, FEMS MICROBIOL LETT, V296, P91, DOI 10.1111/j.1574-6968.2009.01621.x; Vielkind J., 1978, Verhandlungen der Deutschen Zoologischen Gesellschaft, V71, P228; Wu Jia-bing, 2009, Journal of Forestry Research (Harbin), V20, P383, DOI 10.1007/s11676-009-0066-3	41	44	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41989	10.1371/journal.pone.0041989	http://dx.doi.org/10.1371/journal.pone.0041989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870273	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000307212800049
J	Ju, CQ; Zhang, K; Wu, XY				Ju, Chengqun; Zhang, Kai; Wu, Xinyi			Derivation of Corneal Endothelial Cell-Like Cells from Rat Neural Crest Cells In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ANTERIOR SEGMENT DYSGENESIS; ADULT SKIN; DIFFERENTIATION; TRANSPLANTATION; RABBIT; MODEL; GENE; CAT	The aim of this study was to investigate the feasibility of inducing rat neural crest cells (NCC) to differentiate to functional corneal endothelial cell (CEC)-like cells in vitro. Rat NCC were induced with adult CEC-derived conditioned medium. Immunofluorescence, flow cytometry and real time RT-PCR assay were used to detect expression of the corneal endothelium differentiation marker N-cadherin and transcription factors FoxC1 and Pitx2. CFDA SE-labeled CEC-like cells were transplanted to the corneal endothelium of a rat corneal endothelium deficiency model, and an eye-down position was maintained for 24 hours to allow cell attachment. The animals were observed for as long as 2 months after surgery and underwent clinical and histological examination. Spindle-like NCC turned to polygonal CEC-like after induction and expressed N-cadherin, FoxC1, Pitx2, zonula occludens-1 and sodium-potassium pump Na+/K+ ATPase. The corneas of the experimental group were much clearer than those of the control group and the mean corneal thickness in the experimental group was significantly less than in the control group7, 14, 21 and 28 days after surgery. Confocal microscopy through focusing and histological analysis confirmed that green fluorescence-positive CEC-like cells formed a monolayer covering the Descemet's membrane in the experimental group. In conclusion, CEC-like cells derived from NCCs displayed characters of native CEC, and the induction protocol provides guidance for future human CEC induction from NCC.	[Ju, Chengqun; Zhang, Kai; Wu, Xinyi] Shandong Univ, Dept Ophthalmol, Qilu Hosp, Jinan 250100, Peoples R China; [Ju, Chengqun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Chinese Minist Educ, Jinan 250100, Peoples R China; [Ju, Chengqun] Shandong Univ, Chinese Minist Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ju, CQ (corresponding author), Shandong Univ, Dept Ophthalmol, Qilu Hosp, Jinan 250100, Peoples R China.	xywu8868@163.com			Key Scientific and Technological Project of Shandong Province, People's Republic of China [2008GGB02111]	Key Scientific and Technological Project of Shandong Province, People's Republic of China	The work is supported by the Key Scientific and Technological Project of Shandong Province, People's Republic of China (grant number:2008GGB02111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Churchill A, 1996, BRIT J OPHTHALMOL, V80, P669, DOI 10.1136/bjo.80.7.669; Cook C S, 1988, J Pediatr Ophthalmol Strabismus, V25, P60; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539; DUBLIN I, 1970, ACTA ANAT, V76, P381; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; GOSPODAROWICZ D, 1979, P NATL ACAD SCI USA, V76, P464, DOI 10.1073/pnas.76.1.464; GOSPODAROWICZ D, 1979, ARCH OPHTHALMOL-CHIC, V97, P2163, DOI 10.1001/archopht.1979.01020020481016; INSLER MS, 1986, CURR EYE RES, V5, P967, DOI 10.3109/02713688608995178; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; KENYON KR, 1975, EXP EYE RES, V21, P125, DOI 10.1016/0014-4835(75)90077-9; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Koh SWM, 2008, INVEST OPHTH VIS SCI, V49, P3491, DOI 10.1167/iovs.07-1543; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; MCCULLEY JP, 1980, OPHTHALMOLOGY, V87, P194; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; MINKOWSKI JS, 1984, INVEST OPHTH VIS SCI, V25, P1416; Miron RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023375; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Reneker LW, 2000, DEVELOPMENT, V127, P533; SIEBERBLUM M, 1985, EXP CELL RES, V158, P267, DOI 10.1016/0014-4827(85)90450-1; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Zhou Y, 2008, BIOCHEM BIOPH RES CO, V376, P542, DOI 10.1016/j.bbrc.2008.09.032; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	34	32	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42378	10.1371/journal.pone.0042378	http://dx.doi.org/10.1371/journal.pone.0042378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860120	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600096
J	Quinto-Alemany, D; Canerina-Amaro, A; Hernandez-Abad, LG; Machin, F; Romesberg, FE; Gil-Lamaignere, C				Quinto-Alemany, David; Canerina-Amaro, Ana; Hernandez-Abad, Luis G.; Machin, Felix; Romesberg, Floyd E.; Gil-Lamaignere, Cristina			Yeasts Acquire Resistance Secondary to Antifungal Drug Treatment by Adaptive Mutagenesis	PLOS ONE			English	Article							SOS RESPONSE; SACCHAROMYCES-CEREVISIAE; MUTATIONS; FLUCYTOSINE; MECHANISMS; BACTERIA	Acquisition of resistance secondary to treatment both by microorganisms and by tumor cells is a major public health concern. Several species of bacteria acquire resistance to various antibiotics through stress-induced responses that have an adaptive mutagenesis effect. So far, adaptive mutagenesis in yeast has only been described when the stress is nutrient deprivation. Here, we hypothesized that adaptive mutagenesis in yeast (Saccharomyces cerevisiae and Candida albicans as model organisms) would also take place in response to antifungal agents (5-fluorocytosine or flucytosine, 5-FC, and caspofungin, CSP), giving rise to resistance secondary to treatment with these agents. We have developed a clinically relevant model where both yeasts acquire resistance when exposed to these agents. Stressful lifestyle associated mutation (SLAM) experiments show that the adaptive mutation frequencies are 20 (S. cerevisiae -5-FC), 600 (C. albicans -5-FC) or 1000 (S. cerevisiae - CSP) fold higher than the spontaneous mutation frequency, the experimental data for C. albicans -5-FC being in agreement with the clinical data of acquisition of resistance secondary to treatment. The spectrum of mutations in the S. cerevisiae -5-FC model differs between spontaneous and acquired, indicating that the molecular mechanisms that generate them are different. Remarkably, in the acquired mutations, an ectopic intrachromosomal recombination with an 87% homologous gene takes place with a high frequency. In conclusion, we present here a clinically relevant adaptive mutation model that fulfils the conditions reported previously.	[Quinto-Alemany, David; Canerina-Amaro, Ana; Hernandez-Abad, Luis G.; Machin, Felix; Gil-Lamaignere, Cristina] Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain; [Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Quinto-Alemany, D (corresponding author), Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain.	eukares@yahoo.com	Machín, Félix/K-6569-2017; Romesberg, Floyd/M-2821-2017; Amaro, Ana Canerina Luis/U-3741-2019; Canerina-Amaro, Ana/K-5763-2017; Gil-Lamaignere, Cristina/A-3866-2013	Machín, Félix/0000-0003-4559-7798; Romesberg, Floyd/0000-0001-6317-1315; Amaro, Ana Canerina Luis/0000-0001-6970-7942; Canerina-Amaro, Ana/0000-0001-6970-7942; Quinto Alemany, David/0000-0001-7167-9303; Garcia Hernandez-Abad, Luis/0000-0001-6012-3553	Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant [EX2004-1241]; "Ramon y Cajal" tenure track programs [RYC07/1263, RYC05/1354]; Instituto de Salud Carlos III [FIS PI08/1624, FIS PI09/00106]; European Regional Development Funds (ERDF)	Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant; "Ramon y Cajal" tenure track programs; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Funds (ERDF)(European Commission)	CGL was supported by the Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant (EX2004-1241), the "Ramon y Cajal" tenure track programs (RYC07/1263 to CGL and RYC05/1354 to FM) and by the Research Project Funding by the Instituto de Salud Carlos III (FIS PI08/1624 to CGL and FIS PI09/00106 to FM). All financial support was co-financed by the European Regional Development Funds (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke D., 2000, METHODS YEAST GENETI; Correia I, 2010, FUTURE MICROBIOL, V5, P1125, DOI 10.2217/FMB.10.72; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HALL BG, 1992, P NATL ACAD SCI USA, V89, P4300, DOI 10.1073/pnas.89.10.4300; Hara T, 2005, PROSTATE, V65, P268, DOI 10.1002/pros.20282; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Heidenreich E, 2007, CRIT REV BIOCHEM MOL, V42, P285, DOI 10.1080/10409230701507773; Hospenthal DR, 1998, CLIN INFECT DIS, V27, P260, DOI 10.1086/514669; Huff CA, 2006, BLOOD, V107, P431, DOI 10.1182/blood-2005-06-2517; Kang NH, 2012, REPROD FERT DEVELOP, V24, P216, DOI 10.1071/RDv24n1Ab207; Lee BF, 2012, CANCER GENE THER, V19, P255, DOI 10.1038/cgt.2011.87; LEWIN CS, 1991, J MED MICROBIOL, V34, P329, DOI 10.1099/00222615-34-6-329; Luria SE, 1943, GENETICS, V28, P491; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; MALAVASIC MJ, 1992, J MED VET MYCOL, V30, P421; Menacho-Marquez M, 2007, CLIN TRANSL ONCOL, V9, P221, DOI 10.1007/s12094-007-0043-2; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Rosenberg SM, 1998, GENETICS, V148, P1559; STEELE DF, 1992, GENETICS, V132, P9; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; WALDORF AR, 1983, ANTIMICROB AGENTS CH, V23, P79, DOI 10.1128/AAC.23.1.79	27	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42279	10.1371/journal.pone.0042279	http://dx.doi.org/10.1371/journal.pone.0042279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860105	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600085
J	Yaddanapudi, K; Mitchell, RA; Putty, K; Willer, S; Sharma, RK; Yan, J; Bodduluri, H; Eaton, JW				Yaddanapudi, Kavitha; Mitchell, Robert A.; Putty, Kalyani; Willer, Sharon; Sharma, Rajesh K.; Yan, Jun; Bodduluri, Haribabu; Eaton, John W.			Vaccination with Embryonic Stem Cells Protects against Lung Cancer: Is a Broad-Spectrum Prophylactic Vaccine against Cancer Possible?	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; ANTITUMOR IMMUNITY; ANTIGEN-EXPRESSION; SUPPRESSOR-CELLS; TUMOR; IDENTIFICATION; DIFFERENTIATION; DYSFUNCTION; TOLERANCE	The antigenic similarity between tumors and embryos has been appreciated for many years and reflects the expression of embryonic gene products by cancer cells and/or cancer-initiating stem cells. Taking advantage of this similarity, we have tested a prophylactic lung cancer vaccine composed of allogeneic murine embryonic stem cells (ESC). Naive C57BL/6 mice were vaccinated with ESC along with a source of granulocyte macrophage-colony stimulating factor (GM-CSF) in order to provide immunostimulatory adjuvant activity. Vaccinated mice were protected against subsequent challenge with implantable Lewis lung carcinoma (LLC). ESC-induced anti-tumor immunity was not due to a non-specific "allo-response" as vaccination with allogeneic murine embryonic fibroblasts did not protect against tumor outgrowth. Vaccine efficacy was associated with robust tumor-reactive primary and memory CD8(+) T effector responses, Th1 cytokine response, higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio, and reduced myeloid derived suppressor cells in the spleen. Prevention of tumorigenesis was found to require a CD8-mediated cytotoxic T lymphocyte (CTL) response because in vivo depletion of CD8(+) T lymphocytes completely abrogated the protective effect of vaccination. Importantly, this vaccination strategy also suppressed the development of lung cancer induced by the combination of carcinogen administration and chronic pulmonary inflammation. Further refinement of this novel vaccine strategy and identification of shared ESC/tumor antigens may lead to immunotherapeutic options for lung cancer patients and, perhaps more importantly, could represent a first step toward the development of prophylactic cancer vaccines.	[Yaddanapudi, Kavitha; Mitchell, Robert A.; Putty, Kalyani; Willer, Sharon; Eaton, John W.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Sharma, Rajesh K.; Yan, Jun; Bodduluri, Haribabu] Univ Louisville, James Graham Brown Canc Ctr, Tumor Immunobiol Program, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Yaddanapudi, K (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA.	EatonRedox@aol.com	Yan, Jun/A-8988-2008; Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NIH/NCRR [P20RR018733]; American Lung Association; Kentucky Lung Cancer Research Program; Commonwealth of Kentucky Research Challenge Trust Fund	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Lung Association; Kentucky Lung Cancer Research Program; Commonwealth of Kentucky Research Challenge Trust Fund	This work was supported by NIH/NCRR P20RR018733 (KY), the American Lung Association (JWE, RAM) and the Kentucky Lung Cancer Research Program (RAM). JWE is supported by the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bai XF, 2003, J CLIN INVEST, V111, P1487, DOI 10.1172/JCI200317656; BALDWIN RW, 1972, ANN I PASTEUR PARIS, V122, P715; BALDWIN RW, 1972, INT J CANCER, V10, P233, DOI 10.1002/ijc.2910100202; Borrello I, 2002, CYTOKINE GROWTH F R, V13, P185, DOI 10.1016/S1359-6101(01)00034-X; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; BUTTLE GAH, 1967, NATURE, V215, P1495, DOI 10.1038/2151495a0; Cohen Jon, 2005, Science, V308, P619, DOI 10.1126/science.308.5722.619; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dong W, 2010, CANCER IMMUNOL IMMUN, V59, P1697, DOI 10.1007/s00262-010-0899-9; Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Errington F, 2006, CLIN CANCER RES, V12, P1333, DOI 10.1158/1078-0432.CCR-05-1113; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hill HC, 2002, CANCER RES, V62, P7254; Horna P, 2007, CURR CANCER DRUG TAR, V7, P41, DOI 10.2174/156800907780006940; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kisley LR, 2002, CARCINOGENESIS, V23, P1653, DOI 10.1093/carcin/23.10.1653; KLAVINS JV, 1971, NATURE-NEW BIOL, V234, P153, DOI 10.1038/newbio234153a0; Kumaraguru U, 2005, J LEUKOCYTE BIOL, V78, P879, DOI 10.1189/jlb.0105007; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li Y, 2009, STEM CELLS, V27, P3103, DOI 10.1002/stem.234; Malkinson AM, 1997, CANCER RES, V57, P2832; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Melief CJM, 2002, IMMUNOL REV, V188, P177, DOI 10.1034/j.1600-065X.2002.18816.x; Nemunaitis J, 2004, J NATL CANCER I, V96, P326, DOI 10.1093/jnci/djh028; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schone G, 1906, MUNCHEN MED WOCHEN, V51, P2517; Schubert C, 2006, NATURE NEWS, DOI [10.1038/news061106-17, DOI 10.1038/NEWS061106-17]; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soiffer R, 2003, J CLIN ONCOL, V21, P3343, DOI 10.1200/JCO.2003.07.005; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; STONEHILL EH, 1970, NATURE, V228, P370, DOI 10.1038/228370a0; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; TRIOLO VA, 1965, CANCER RES, V25, P75; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	38	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42289	10.1371/journal.pone.0042289	http://dx.doi.org/10.1371/journal.pone.0042289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860107	gold, Green Submitted, Green Published			2022-12-25	WOS:000307045600087
J	Fong, MY; Jin, SY; Rane, M; Singh, RK; Gupta, R; Kakar, SS				Fong, Miranda Y.; Jin, Shunying; Rane, Madhavi; Singh, Raj K.; Gupta, Ramesh; Kakar, Sham S.			Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer	PLOS ONE			English	Article							INDUCED CELL-DEATH; HEPATOCELLULAR-CARCINOMA; LIPOSOMAL DOXORUBICIN; PROSTATE-CANCER; DOWN-REGULATION; UP-REGULATION; APOPTOSIS; CYTOTOXICITY; DYSFUNCTION; INHIBITION	Application of doxorubicin (Dox) for the treatment of cancer is restricted due to its severe side effects. We used combination strategy by combining doxorubicin (Dox) with withaferin A (WFA) to minimize the ill effects of Dox. Treatment of various epithelial ovarian cancer cell lines (A2780, A2780/CP70 and CaOV3) with combination of WFA and Dox (WFA/DOX) showed a time- and dose-dependent synergistic effect on inhibition of cell proliferation and induction of cell death, thus reducing the dosage requirement of Dox. Combination treatment resulted in a significant enhancement of ROS production resulting in immense DNA damage, induction of autophagy analyzed by transmission electron microscope and increase in expression of autophagy marker LC3B, and culminated in cell death analyzed by cleaved caspase 3. We validated combination therapy on tumor growth using an in vitro 3Dimension (3D) tumor model and the more classic in vivo xenograft model of ovarian cancer. Both tumor models showed a 70 to 80% reduction in tumor growth compared to control or animals treated with WFA or Dox alone. Immunohistochemical analysis of the tumor tissues from animals treated with WFA/Dox combination showed a significant reduction in cell proliferation and formation of microvessels accompanied by increased in LC3B level, cleaved caspase 3, and DNA damage. Taken together, our data suggest that combining WFA with Dox decreases the dosage requirement of Dox, therefore, minimizing/eliminating the severe side effects associated with high doses of DOX, suggesting the application of this combination strategy for the treatment of ovarian and other cancers with no or minimum side effects.	[Fong, Miranda Y.; Kakar, Sham S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Jin, Shunying; Rane, Madhavi] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Singh, Raj K.] Vivo Biosci Inc, Birmingham, AL USA; [Gupta, Ramesh] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Gupta, Ramesh; Kakar, Sham S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Fong, MY (corresponding author), Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA.	sskaka01@louisville.edu		Singh, Raj/0000-0002-6331-9196	National Institutes of Health/National Cancer Institute [CA124630]; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from National Institutes of Health/National Cancer Institute CA124630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achari C, 2011, MED CHEM, V7, P432, DOI 10.2174/157340611796799087; BEHRENS BC, 1987, CANCER RES, V47, P414; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Campos SM, 2001, GYNECOL ONCOL, V81, P206, DOI 10.1006/gyno.2000.5980; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Cosse JP, 2010, BIOCHEM PHARMACOL, V80, P1160, DOI 10.1016/j.bcp.2010.07.009; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; Dayton A, 2011, J PHARMACOL EXP THER, V339, P350, DOI 10.1124/jpet.111.183681; Donadelli M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.36; El-Naggar SM, 2007, J ENDOCRINOL, V194, P179, DOI 10.1677/JOE-06-0036; El-Naggar SM, 2007, INT J ONCOL, V31, P137; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Hatchi E, 2011, AUTOPHAGY, V7, P1566, DOI 10.4161/auto.7.12.17991; KAUR K, 2007, TISS CULT RES COMMUN, V26, P193; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kudoh K, 2011, GYNECOL ONCOL, V122, P233, DOI 10.1016/j.ygyno.2011.04.046; Kuo CC, 2011, FREE RADICAL BIO MED, V51, P2195, DOI 10.1016/j.freeradbiomed.2011.09.023; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lee SB, 2007, DNA CELL BIOL, V26, P713, DOI 10.1089/dna.2007.0577; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Lin CI, 2010, MOL CANCER RES, V8, P1217, DOI 10.1158/1541-7786.MCR-10-0162; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Manov I, 2011, FEBS J, V278, P3494, DOI 10.1111/j.1742-4658.2011.08271.x; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsuo K, 2010, EXPERT OPIN INV DRUG, V19, P1339, DOI 10.1517/13543784.2010.515585; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Oh JH, 2009, INT IMMUNOPHARMACOL, V9, P614, DOI 10.1016/j.intimp.2009.02.002; Pfisterer J, 2006, SEMIN ONCOL, V33, pS12, DOI 10.1053/j.seminoncol.2006.03.012; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Seales EC, 2007, DRUG DISCOVERY INT, P16; Shah PP, 2011, ONCOGENE; SIEGAL GP, 1993, CANCER LETT, V69, P123, DOI 10.1016/0304-3835(93)90164-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Thaiparambil JT, 2011, INT J CANC; Tomuleasa Ciprian, 2011, Hematol Oncol Stem Cell Ther, V4, P60; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	53	73	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42265	10.1371/journal.pone.0042265	http://dx.doi.org/10.1371/journal.pone.0042265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860102	gold, Green Published, Green Submitted			2022-12-25	WOS:000306950900086
J	Herrera, VLM; Pasion, KA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Dahl (S x R) Congenic Strain Analysis Confirms and Defines a Chromosome 5 Female-Specific Blood Pressure Quantitative Trait Locus to < 7 Mbp	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ESSENTIAL-HYPERTENSION; RAT MODEL; VARIANTS; MAP; GENES	The detection of multiple sex-specific blood pressure (BP) quantitative trait loci (QTLs) in independent total genome analyses of F2 (Dahl S x R)-intercross male and female rat cohorts confirms clinical observations of sex-specific disease cause and response to treatment among hypertensive patients, and mandate the identification of sex-specific hypertension genes/mechanisms. We developed and studied two congenic strains, S.R5A and S.R5B introgressing Dahl R-chromosome 5 segments into Dahl S chromosome 5 region spanning putative BP-f1 and BP-f2 QTLs. Radiotelemetric non-stressed 24-hour BP analysis at four weeks post-high salt diet (8% NaCl) challenge, identified only S.R5B congenic rats with lower SBP (-26.5 mmHg, P= 0.002), DBP (-23.7 mmHg, P= 0.004) and MAP (-25.1 mmHg, P= 0.002) compared with Dahl S female controls at four months of age confirming BP-f1 but not BP-f2 QTL on rat chromosome 5. The S.R5B congenic segment did not affect pulse pressure and relative heart weight indicating that the gene underlying BP-f1 does not influence arterial stiffness and cardiac hypertrophy. The results of our congenic analysis narrowed BP-f1 to chromosome 5 coordinates 134.9-141.5 Mbp setting up the basis for further fine mapping of BP-f1 and eventual identification of the specific gene variant accounting for BP-f1 effect on blood pressure.	[Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Herrera, VLM (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	National Heart, Lung and Blood Institute [HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung and Blood Institute HL086532 (to N.R-O). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MJ, 2000, J CARDIOVASC PHARM, V35, pS41, DOI 10.1097/00005344-200000002-00010; Charchar FJ, 2008, J HUM HYPERTENS, V22, P821, DOI 10.1038/jhh.2008.67; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Deng AY, 2008, CLIN EXP HYPERTENS, V30, P511, DOI 10.1080/10641960802251933; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Deng AY, 2001, MAMM GENOME, V12, P612, DOI 10.1007/s00335-001-2054-6; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Garrett MR, 2002, PHYSIOL GENOMICS, V8, P81, DOI 10.1152/physiolgenomics.00080.2001; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Guimaraes CL, 1992, HYPERTENSION, V19, pII79; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P1126, DOI 10.1006/bbrc.2001.5091; Lee NH, 2007, HYPERTENSION, V50, P1126, DOI 10.1161/HYPERTENSIONAHA.107.093138; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Roman RJ, 2006, AM J PHYSIOL-RENAL, V290, pF1463, DOI 10.1152/ajprenal.00360.2005; Yagil C, 1998, HYPERTENSION, V31, P119, DOI 10.1161/01.HYP.31.1.119	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42214	10.1371/journal.pone.0042214	http://dx.doi.org/10.1371/journal.pone.0042214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860086	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950900078
J	Gandhi, AK; Desai, JV; Ghatge, MS; di Salvo, ML; Di Biase, S; Danso-Danquah, R; Musayev, FN; Contestabile, R; Schirch, V; Safo, MK				Gandhi, Amit K.; Desai, Jigar V.; Ghatge, Mohini S.; di Salvo, Martino L.; Di Biase, Stefano; Danso-Danquah, Richmond; Musayev, Faik N.; Contestabile, Roberto; Schirch, Verne; Safo, Martin K.			Crystal Structures of Human Pyridoxal Kinase in Complex with the Neurotoxins, Ginkgotoxin and Theophylline: Insights into Pyridoxal Kinase Inhibition	PLOS ONE			English	Article							VITAMIN-B6 LEVELS; THERAPY; COCOA; PYRIDOXAL-5'-PHOSPHATE; GENOTOXICITY; ROSCOVITINE; DEFICIENCY; DEPRESSION; PROTEIN; BILOBA	Several drugs and natural compounds are known to be highly neurotoxic, triggering epileptic convulsions or seizures, and causing headaches, agitations, as well as other neuronal symptoms. The neurotoxic effects of some of these compounds, including theophylline and ginkgotoxin, have been traced to their inhibitory activity against human pyridoxal kinase (hPL kinase), resulting in deficiency of the active cofactor form of vitamin B-6, pyridoxal 5'-phosphate (PLP). Pyridoxal (PL), an inactive form of vitamin B-6 is converted to PLP by PL kinase. PLP is the B-6 vitamer required as a cofactor for over 160 enzymatic activities essential in primary and secondary metabolism. We have performed structural and kinetic studies on hPL kinase with several potential inhibitors, including ginkgotoxin and theophylline. The structural studies show ginkgotoxin and theophylline bound at the substrate site, and are involved in similar protein interactions as the natural substrate, PL. Interestingly, the phosphorylated product of ginkgotoxin is also observed bound at the active site. This work provides insights into the molecular basis of hPL kinase inhibition and may provide a working hypothesis to quickly screen or identify neurotoxic drugs as potential hPL kinase inhibitors. Such adverse effects may be prevented by administration of an appropriate form of vitamin B-6, or provide clues of how to modify these drugs to help reduce their hPL kinase inhibitory effects.	[Gandhi, Amit K.; Desai, Jigar V.; Ghatge, Mohini S.; Danso-Danquah, Richmond; Musayev, Faik N.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [di Salvo, Martino L.; Di Biase, Stefano; Contestabile, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [di Salvo, Martino L.; Di Biase, Stefano; Contestabile, Roberto] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Virginia Commonwealth University; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Gandhi, AK (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA.	msafo@vcu.edu	Desai, Jigar V/I-3109-2019; Contestabile, Roberto/J-3467-2019; Musayev, Faik/AAY-2010-2020; Safo, Martin/AAJ-9833-2020; Ghatge, Mohini/AAY-3381-2020	Contestabile, Roberto/0000-0002-5235-9993; Desai, Jigar/0000-0002-8823-0796; di Salvo, Martino Luigi/0000-0003-1233-9338	AD Williams Fund; Jeffress Research Award; Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti; National Cancer Institute of the National Institutes of Health [CA 16059-28]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	AD Williams Fund; Jeffress Research Award; Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants from the AD Williams Fund and Jeffress Research Award (to MKS), and grants from Progetti di Ricerca di Interesse Nazionale and Istituto Pasteur - Fondazione Cenci Bolognetti (to MLdS and RC). The structural biology resources used in this study were also provided in-part by the National Cancer Institute of the National Institutes of Health to the VCU Massey Cancer Center [Grant CA 16059-28]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao AO, 1998, ANN PHARMACOTHER, V32, P889, DOI 10.1345/aph.17377; Apgar JL, 1998, CAFFEINE, P171; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; BARTEL PR, 1994, AM J CLIN NUTR, V60, P93, DOI 10.1093/ajcn/60.1.93; Bonner AB, 1999, VET HUM TOXICOL, V41, P175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUSICK D, 1986, MUTAT RES, V169, P115, DOI 10.1016/0165-1218(86)90090-X; BRUSICK D, 1986, MUTAT RES, V169, P105, DOI 10.1016/0165-1218(86)90089-3; Cao P, 2006, J STRUCT BIOL, V154, P327, DOI 10.1016/j.jsb.2006.02.008; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; DELPORT R, 1993, RES COMMUN CHEM PATH, V79, P325; DELPORT R, 1988, INT J VITAM NUTR RES, V58, P67; DELPORT R, 1990, INT J VITAM NUTR RES, V60, P35; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiehe K, 2000, J NAT PROD, V63, P185, DOI 10.1021/np990414+; Gandhi AK, 2009, BIOCHEM BIOPH RES CO, V381, P12, DOI 10.1016/j.bbrc.2009.01.170; GLENN GM, 1995, VET HUM TOXICOL, V37, P342; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Kastner U, 2007, FEBS J, V274, P1036, DOI 10.1111/j.1742-4658.2007.05654.x; Kajiyama Y, 2002, PEDIATRICS, V109, P325, DOI 10.1542/peds.109.2.325; Kuwahara Hiroya, 2008, Rinsho Shinkeigaku, V48, P125; LaineCessac P, 1997, BIOCHEM PHARMACOL, V54, P863, DOI 10.1016/S0006-2952(97)00252-9; Leistner E, 2010, J NAT PROD, V73, P86, DOI 10.1021/np9005019; Li MH, 2004, J BIOL CHEM, V279, P17459, DOI 10.1074/jbc.M312380200; Li MH, 2002, J BIOL CHEM, V277, P46385, DOI 10.1074/jbc.M208600200; McCormick DB, 1999, J NUTR, V129, P325; Musayev FN, 2007, PROTEIN SCI, V16, P2184, DOI 10.1110/ps.073022107; Newman JA, 2006, J MOL BIOL, V363, P520, DOI 10.1016/j.jmb.2006.08.013; NITSCH C, 1976, BRAIN RES, V105, P173, DOI 10.1016/0006-8993(76)90934-3; Safo MK, 2006, J BACTERIOL, V188, P4542, DOI 10.1128/JB.00122-06; Safo MK, 2004, J BACTERIOL, V186, P8074, DOI 10.1128/JB.186.23.8074-8082.2004; Seto Toshiyuki, 2000, No To Hattatsu, V32, P295; Spinneker A, 2007, NUTR HOSP, V22, P7; Steichen O, 2006, REV MAL RESPIR, V23, P157, DOI 10.1016/S0761-8425(06)71480-2; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495; TARKA SM, 1991, FOOD CHEM TOXICOL, V29, P7, DOI 10.1016/0278-6915(91)90057-E; Tutor-Crespo MJ, 2004, CLIN BIOCHEM, V37, P714, DOI 10.1016/j.clinbiochem.2004.03.007; UBBINK JB, 1990, ENZYME, V43, P72, DOI 10.1159/000468709; UBBINK JB, 1990, ANN NY ACAD SCI, V585, P285, DOI 10.1111/j.1749-6632.1990.tb28061.x; UBBINK JB, 1990, J NUTR, V120, P1352, DOI 10.1093/jn/120.11.1352; UBBINK JB, 1989, J LAB CLIN MED, V113, P15; WADA K, 1985, CHEM PHARM BULL, V33, P3555; Wada Keiji, 2005, Chudoku Kenkyu, V18, P11; WEIR MR, 1990, ANN ALLERGY, V65, P59; WEIR MR, 1991, VET HUM TOXICOL, V33, P118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40954	10.1371/journal.pone.0040954	http://dx.doi.org/10.1371/journal.pone.0040954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22879864	gold, Green Published, Green Submitted			2022-12-25	WOS:000306548900062
J	Bayer, H; Essig, K; Stanzel, S; Frank, M; Gildersleeve, JC; Berger, MR; Voss, C				Bayer, Helene; Essig, Katharina; Stanzel, Sven; Frank, Martin; Gildersleeve, Jeffrey C.; Berger, Martin R.; Voss, Cristina			Evaluation of Riproximin Binding Properties Reveals a Novel Mechanism for Cellular Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; PROSTATE-SPECIFIC ANTIGEN; BREAST-CANCER PATIENTS; HUMAN COLON; SUBMAXILLARY MUCIN; GLYCAN STRUCTURES; GLYCOSYLATION; CARCINOMA; SERUM; BOVINE	Riproximin is a cytotoxic type II ribosome-inactivating protein showing high selectivity for tumor cell lines. Its binding to cell surface glycans is crucial for subsequent internalization and cytotoxicity. In this paper, we describe a unique mechanism of interaction and discuss its implications for the cellular targeting and cytotoxicity of riproximin. On a carbohydrate microarray, riproximin specifically bound to two types of asialo-glycans, namely to bi- and triantennary complex N-glycan structures (NA2/NA3) and to repetitive N-acetyl-D-galactosamine (GalNAc), the so-called clustered Tn antigen, a cancer-specific O-glycan on mucins. Two glycoproteins showing high riproximin binding, the NA3-presenting asialofetuin and the clustered Tn-rich asialo-bovine submaxillary mucin, were subsequently chosen as model glycoproteins to mimic the binding interactions of riproximin with the two types of glycans. ELISA analyses were used to relate the two binding specificities of riproximin to its two sugar binding sites. The ability of riproximin to cross-link the two model proteins revealed that binding of the two types of glycoconjugates occurs within different binding sites. The biological implications of these binding properties were analyzed in cellular assays. The cytotoxicity of riproximin was found to depend on its specific and concomitant interaction with the two glycoconjugates as well as on dynamic avidity effects typical for lectins binding to multivalent glycoproteins. The presence of definite, cancer-related structures on the cells to be targeted determines the therapeutic potency of riproximin. Due to its cross-linking ability, riproximin is expected to show a high degree of specificity for cells exposing both NA2/NA3 and clustered Tn structures.	[Voss, Cristina] Heidelberg Pharma GmbH, Dept Biochem, D-68526 Ladenburg, Germany; [Bayer, Helene; Essig, Katharina; Berger, Martin R.] German Canc Res Ctr, Toxicol & Chemotherapy Unit, D-69120 Heidelberg, Germany; [Stanzel, Sven] German Canc Res Ctr, Dept Biostat, D-69120 Heidelberg, Germany; [Frank, Martin] BIOGNOS AB, S-41705 Gothenburg, Sweden; [Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, Frederick, MD 21702 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Voss, C (corresponding author), Heidelberg Pharma GmbH, Dept Biochem, Schriesheimer Str 101, D-68526 Ladenburg, Germany.	c.voss@hdpharma.com	Gildersleeve, Jeffrey/N-3392-2014	Essig, Katharina/0000-0001-5928-6013; Frank, Martin/0000-0002-1006-6746; Gildersleeve, Jeffrey/0000-0002-3744-6423	National Institutes of Health, NCI, Intramural Research Program; German Federal Ministry of Economics and Technology [Pro Inno II KF0425101UL6, ZIM KF2301002AJ0]; NATIONAL CANCER INSTITUTE [ZIABC010740] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Intramural Research Program.; Supported by German Federal Ministry of Economics and Technology Grants Pro Inno II KF0425101UL6 and ZIM KF2301002AJ0.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Bayer H, 2012, PROTEIN EXPRES PURIF, V82, P97, DOI 10.1016/j.pep.2011.11.018; BHATTACHARYYA L, 1988, ARCH BIOCHEM BIOPHYS, V262, P605, DOI 10.1016/0003-9861(88)90412-2; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; CHANDRASEKARAN EV, 1983, J BIOL CHEM, V258, P7213; Dam TK, 2007, J BIOL CHEM, V282, P28256, DOI 10.1074/jbc.M704677200; Dam TK, 2010, ADV CARBOHYD CHEM BI, V63, P139, DOI 10.1016/S0065-2318(10)63005-3; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DOWNS F, 1969, BIOCHEMISTRY-US, V8, P1760, DOI 10.1021/bi00832a060; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; FODSTAD O, 1984, CANCER RES, V44, P862; Freire T, 2005, CANCER RES, V65, P7880, DOI 10.1158/0008-5472.CAN-04-3746; Girbes T, 2003, CELL MOL BIOL, V49, P537; GREEN ED, 1988, J BIOL CHEM, V263, P18253; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Horrix C, 2011, CELL MOL LIFE SCI, V68, P1269, DOI 10.1007/s00018-010-0524-2; Inoue M, 2001, CANCER RES, V61, P950; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Karg SR, 2009, PLANT PHYSIOL BIOCH, V47, P160, DOI 10.1016/j.plaphy.2008.10.005; Kumar SR, 2005, CLIN CANCER RES, V11, P6868, DOI 10.1158/1078-0432.CCR-05-0146; Lattova E, 2010, J PROTEOME RES, V9, P1533, DOI 10.1021/pr9010266; Lee JJ, 2009, STAT BIOPHARM RES, V1, P4, DOI 10.1198/sbr.2009.0001; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; LIN JY, 1970, NATURE, V227, P292, DOI 10.1038/227292a0; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Nan BC, 1998, GLYCOCONJUGATE J, V15, P1033, DOI 10.1023/A:1006950311937; NILSSON B, 1979, J BIOL CHEM, V254, P4545; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Peracaula R, 2003, GLYCOBIOLOGY, V13, P457, DOI 10.1093/glycob/cwg041; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Saldova R, 2011, ANN ONCOL, V22, P1113, DOI 10.1093/annonc/mdq570; Sarrats A, 2010, OMICS, V14, P465, DOI 10.1089/omi.2010.0050; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Strafors P., 2012, ADV EXP MED BIOL, V729, P111; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Tabares G, 2006, GLYCOBIOLOGY, V16, P132, DOI 10.1093/glycob/cwj042; Telford JE, 2011, BIOCHEM SOC T, V39, P327, DOI 10.1042/BST0390327; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Vercoutter-Edouart AS, 2008, PROTEOMICS, V8, P3236, DOI 10.1002/pmic.200800151; Voss C, 2006, TOXICOL APPL PHARM, V211, P177, DOI 10.1016/j.taap.2005.05.016; Voss C, 2006, FASEB J, V20, P1194, DOI 10.1096/fj.05-5231fje; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007	61	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35873	35886		10.1074/jbc.M112.368548	http://dx.doi.org/10.1074/jbc.M112.368548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22872642	Green Published, hybrid			2022-12-25	WOS:000310364000010
J	Larue, R; Gupta, K; Wuensch, C; Shkriabai, N; Kessl, JJ; Danhart, E; Feng, L; Taltynov, O; Christ, F; Van Duyne, GD; Debyser, Z; Foster, MP; Kvaratskhelia, M				Larue, Ross; Gupta, Kushol; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Danhart, Eric; Feng, Lei; Taltynov, Oliver; Christ, Frauke; Van Duyne, Gregory D.; Debyser, Zeger; Foster, Mark P.; Kvaratskhelia, Mamuka			Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE TRANSCRIPTION COMPLEXES; NUCLEAR-LOCALIZATION SIGNAL; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; DNA-BINDING DOMAIN; IMPORTIN-BETA; MOLECULAR-DYNAMICS; NONDIVIDING CELLS; CATALYTIC DOMAIN	Transportin 3 (TNPO3 or TRN-SR2) has been shown to be an important cellular factor for early steps of lentiviral replication. However, separate studies have implicated distinct mechanisms for TNPO3 either through its interaction with HIV-1 integrase or capsid. Here we have carried out a detailed biophysical characterization of TNPO3 and investigated its interactions with viral proteins. Biophysical analyses including circular dichroism, analytical ultracentrifugation, small-angle x-ray scattering, and homology modeling provide insight into TNPO3 architecture and indicate that it is highly structured and exists in a mon-omer-dimer equilibrium in solution. In vitro biochemical binding assays argued against meaningful direct interaction between TNPO3 and the capsid cores. Instead, TNPO3 effectively bound to the functional intasome but not to naked viral DNA, suggesting that TNPO3 can directly engage the HIV-1 IN tetramer pre-bound to the cognate DNA. Mass spectrometry-based protein footprinting and site-directed mutagenesis studies have enabled us to map several interacting amino acids in the HIV-1 IN C-terminal domain and the cargo binding domain of TNPO3. Our findings provide important information for future genetic analysis to better understand the role of TNPO3 and its interacting partners for HIV-1 replication.	[Larue, Ross; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA; [Larue, Ross; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Comprehens Canc, Coll Pharm, Columbus, OH 43210 USA; [Danhart, Eric; Foster, Mark P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Taltynov, Oliver; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Flanders, Belgium	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; KU Leuven	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Foster, Mark P/F-6332-2012; Kessl, Jacques/J-6073-2015; Kessl, Jacques/AAV-2526-2021; Gupta, Kushol/GOE-5620-2022; Christ, Frauke/H-7513-2018; debyser, zeger/H-1310-2013	Foster, Mark P/0000-0001-9645-7491; Gupta, Kushol/0000-0002-7006-2667; Larue, Ross/0000-0002-0170-7345; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	National Institutes of Health [AI062520, AI097044, GM077234]; EU; FWO; IWT SBO CellCoVir; BOF of the KULeuven; Department of Energy (DOE) program Integrated Diffraction Analysis Technologies; DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097044, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077234, R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); FWO(FWO); IWT SBO CellCoVir; BOF of the KULeuven; Department of Energy (DOE) program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI062520 (to M. K.), AI097044 (to J. J. K.), and GM077234 (to M. P. F). This work was also supported by the FP7 EU project THINC, the FWO, the IWT SBO CellCoVir, and the BOF of the KULeuven.; We thank Gregory Hura, Jane Tanamachi, Kevin Dyer, and Michal Hammel (Advanced Light Source) for assistance with data collection. X-ray scattering and diffraction technologies and their applications to the determination of macromolecular shapes and conformations at the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, were supported in part by the Department of Energy (DOE) program Integrated Diffraction Analysis Technologies and the DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under contract DE-AC02-05CH11231 with the United States Department of Energy. HIV-1 IN monoclonal antibody (8G4) was obtained from National Institutes of Health AIDS Research and Reference Reagent Program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bhardwaj A, 2010, BIOCHEMISTRY-US, V49, P5042, DOI 10.1021/bi100292y; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown P. O., 1997, P161; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Grunwald M, 2011, EMBO J, V30, P427, DOI 10.1038/emboj.2010.320; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Jayappa KD, 2011, J MOL BIOL, V410, P847, DOI 10.1016/j.jmb.2011.04.011; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kobbi L, 2011, J MOL BIOL, V410, P875, DOI 10.1016/j.jmb.2011.03.005; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mckee CJ, 2009, METHODS, V47, P304, DOI 10.1016/j.ymeth.2008.10.023; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V77, P2896; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	83	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34044	34058		10.1074/jbc.M112.384669	http://dx.doi.org/10.1074/jbc.M112.384669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872640	hybrid, Green Published			2022-12-25	WOS:000309654200011
J	Castagnini, M; Picchianti, M; Talluri, E; Biagini, M; Del Vecchio, M; Di Procolo, P; Norais, N; Nardi-Dei, V; Balducci, E				Castagnini, Marta; Picchianti, Monica; Talluri, Eleonora; Biagini, Massimiliano; Del Vecchio, Mariangela; Di Procolo, Paolo; Norais, Nathalie; Nardi-Dei, Vincenzo; Balducci, Enrico			Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins	PLOS ONE			English	Article							ENZYMATIC-ACTIVITY; CHOLERA-TOXIN; DEFENSINS; RIBOSYLTRANSFERASE; MECHANISM; PROTEINS; FAMILY; FORMS; ARG	Among the several toxins used by pathogenic bacteria to target eukaryotic host cells, proteins that exert ADP-ribosylation activity represent a large and studied family of dangerous and potentially lethal toxins. These proteins alter cell physiology catalyzing the transfer of the ADP-ribose unit from NAD to cellular proteins involved in key metabolic pathways. In the present study, we tested the capability of four of these toxins, to ADP-ribosylate alpha- and beta-defensins. Cholera toxin (CT) from Vibrio cholerae and heat labile enterotoxin (LT) from Escherichia coli both modified the human alpha-defensin (HNP-1) and beta-defensin-1 (HBD1), as efficiently as the mammalian mono-ADP-ribosyltransferase-1. Pseudomonas aeruginosa exoenzyme S was inactive on both HNP-1 and HBD1. Neisseria meningitidis NarE poorly recognized HNP-1 as a substrate but it was completely inactive on HBD1. On the other hand, HNP-1 strongly influenced NarE inhibiting its transferase activity while enhancing auto-ADP-ribosylation. We conclude that only some arginine-specific ADP-ribosylating toxins recognize defensins as substrates in vitro. Modifications that alter the biological activities of antimicrobial peptides may be relevant for the innate immune response. In particular, ADP-ribosylation of antimicrobial peptides may represent a novel escape mechanism adopted by pathogens to facilitate colonization of host tissues.	[Castagnini, Marta; Picchianti, Monica; Talluri, Eleonora; Biagini, Massimiliano; Del Vecchio, Mariangela; Di Procolo, Paolo; Norais, Nathalie; Nardi-Dei, Vincenzo] Novartis Vaccines & Diagnost, Siena, Italy; [Balducci, Enrico] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy; [Picchianti, Monica] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Novartis; University of Camerino; University of Siena	Castagnini, M (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	enrico.balducci@unicam.it		Balducci, Enrico/0000-0001-6147-9033	Novartis Vaccines Diagnostics; Province of Siena; Monte dei Paschi di Siena Foundation	Novartis Vaccines Diagnostics; Province of Siena; Monte dei Paschi di Siena Foundation	This study was supported by Novartis Vaccines & Diagnostics and by the Province of Siena and the Monte dei Paschi di Siena Foundation, which granted a fellowship to Marta Castagnini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; KHARADIA SV, 1987, J BIOL CHEM, V262, P17379; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; KochNolte F, 1997, GENOMICS, V39, P370, DOI 10.1006/geno.1996.4520; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MATSUURA R, 1988, BIOCHEM J, V253, P923, DOI 10.1042/bj2530923; MCDONALD LJ, 1994, MOL CELL BIOCHEM, V138, P201, DOI 10.1007/BF00928462; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5849; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1979, J BIOL CHEM, V254, P6270; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yadollahi-Farsani M, 1999, EUR J BIOCHEM, V262, P342, DOI 10.1046/j.1432-1327.1999.00368.x; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41417	10.1371/journal.pone.0041417	http://dx.doi.org/10.1371/journal.pone.0041417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879887	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900010
J	Cooper, N; Kamilar, JM; Nunn, CL				Cooper, Natalie; Kamilar, Jason M.; Nunn, Charles L.			Host Longevity and Parasite Species Richness in Mammals	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DISEASE; EVOLUTION; PATTERNS; RISK; CARNIVORES; DATABASE; DENSITY; RECORDS; RANGE	Hosts and parasites co-evolve, with each lineage exerting selective pressures on the other. Thus, parasites may influence host life-history characteristics, such as longevity, and simultaneously host life-history may influence parasite diversity. If parasite burden causes increased mortality, we expect a negative association between host longevity and parasite species richness. Alternatively, if long-lived species represent a more stable environment for parasite establishment, host longevity and parasite species richness may show a positive association. We tested these two opposing predictions in carnivores, primates and terrestrial ungulates using phylogenetic comparative methods and controlling for the potentially confounding effects of sampling effort and body mass. We also tested whether increased host longevity is associated with increased immunity, using white blood cell counts as a proxy for immune investment. Our analyses revealed weak relationships between parasite species richness and longevity. We found a significant negative relationship between longevity and parasite species richness for ungulates, but no significant associations in carnivores or primates. We also found no evidence for a relationship between immune investment and host longevity in any of our three groups. Our results suggest that greater parasite burden is linked to higher host mortality in ungulates. Thus, shorter-lived ungulates may be more vulnerable to disease outbreaks, which has implications for ungulate conservation, and may be applicable to other shortlived mammals.	[Cooper, Natalie; Nunn, Charles L.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Cooper, Natalie] Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Cooper, Natalie] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Kamilar, Jason M.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Kamilar, Jason M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	Harvard University; Trinity College Dublin; Trinity College Dublin; Midwestern University; Arizona State University; Arizona State University-Tempe	Cooper, N (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	ncooper@tcd.ie	Cooper, Natalie/I-7976-2012	Cooper, Natalie/0000-0003-4919-8655; Kamilar, Jason/0000-0001-6082-9396	Harvard University	Harvard University	This work was funded by Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; ANDERSON R M, 1991; [Anonymous], 1999, WALKERS MAMMALS WORL; BELL G, 1991, J ANIM ECOL, V60, P1047, DOI 10.2307/5430; Belsey DA, 1980, REGRESSION DIAGNOSTI; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blumstein DT, 2008, BIOL LETTERS, V4, P146, DOI 10.1098/rsbl.2007.0606; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Garamszegi LZ, 2011, J EVOLUTION BIOL, V24, P184, DOI 10.1111/j.1420-9101.2010.02156.x; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gregory RD, 1996, BIODIVERS CONSERV, V5, P985, DOI 10.1007/BF00054416; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Huffman M.A., 2007, PRIMATES PERSPECTIVE, P677; *INT SPEC INF SYST, 2002, PHYS REF VAL CD ROM; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; McCallum H, 2006, PLOS BIOL, V4, P1671, DOI 10.1371/journal.pbio.0040342; Moore J., 2002, PARASITES BEHAV ANIM; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morand S, 2000, P ROY SOC B-BIOL SCI, V267, P1999, DOI 10.1098/rspb.2000.1241; Musser G G, 1993, MAMMAL SPECIES WORLD; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Nunn CL, 2005, EVOL ANTHROPOL, V14, P1, DOI 10.1002/evan.20041; Nunn CL, 2003, AM NAT, V162, P597, DOI 10.1086/378721; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2006, INFECT DIS PRIMATES; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Samuel W.M., 2001, PARASITIC DIS WILD M; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thomas F, 2004, J EVOLUTION BIOL, V17, P542, DOI 10.1111/j.1420-9101.2004.00705.x; Torres J, 2006, BIODIVERS CONSERV, V15, P4619, DOI 10.1007/s10531-005-5824-8; Williams E. S., 2001, INFECT DIS WILD MAMM; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	60	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42190	10.1371/journal.pone.0042190	http://dx.doi.org/10.1371/journal.pone.0042190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879916	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000020
J	Steinstraesser, L; Hirsch, T; Schulte, M; Kueckelhaus, M; Jacobsen, F; Mersch, EA; Stricker, I; Afacan, N; Jenssen, H; Hancock, REW; Kindrachuk, J				Steinstraesser, Lars; Hirsch, Tobias; Schulte, Matthias; Kueckelhaus, Maximilian; Jacobsen, Frank; Mersch, Evgenija A.; Stricker, Ingo; Afacan, Nicole; Jenssen, Havard; Hancock, Robert E. W.; Kindrachuk, Jason			Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; ANTIBACTERIAL PEPTIDE; ANTIINFECTIVE PEPTIDE; LL-37; IMMUNITY; RECEPTOR; ANGIOGENESIS; CHEMOTAXIS; RELEASE; SURFACE	Innate defense regulators (IDRs) are synthetic immunomodulatory versions of natural host defense peptides (HDP). IDRs mediate protection against bacterial challenge in the absence of direct antimicrobial activity, representing a novel approach to anti-infective and anti-inflammatory therapy. Previously, we reported that IDR-1018 selectively induced chemokine responses and suppressed pro-inflammatory responses. As there has been an increasing appreciation for the ability of HDPs to modulate complex immune processes, including wound healing, we characterized the wound healing activities of IDR-1018 in vitro. Further, we investigated the efficacy of IDR-1018 in diabetic and non-diabetic wound healing models. In all experiments, IDR-1018 was compared to the human HDP LL-37 and HDP-derived wound healing peptide HB-107. IDR-1018 was significantly less cytotoxic in vitro as compared to either LL-37 or HB-107. Furthermore, administration of IDR-1018 resulted in a dose-dependent increase in fibroblast cellular respiration. In vivo, IDR-1018 demonstrated significantly accelerated wound healing in S. aureus infected porcine and non-diabetic but not in diabetic murine wounds. However, no significant differences in bacterial colonization were observed. Our investigation demonstrates that in addition to previously reported immunomodulatory activities IDR-1018 promotes wound healing independent of direct antibacterial activity. Interestingly, these effects were not observed in diabetic wounds. It is anticipated that the wound healing activities of IDR-1018 can be attributed to modulation of host immune pathways that are suppressed in diabetic wounds and provide further evidence of the multiple immunomodulatory activities of IDR-1018.	[Steinstraesser, Lars; Hirsch, Tobias; Schulte, Matthias; Kueckelhaus, Maximilian; Jacobsen, Frank; Mersch, Evgenija A.] Ruhr Univ Bochum, Dept Plast Surg, BG Univ Hosp Bergmannsheil, Bochum, Germany; [Stricker, Ingo] Ruhr Univ Bochum, Inst Pathol, BG Univ Hosp Bergmannsheil, Bochum, Germany; [Afacan, Nicole; Hancock, Robert E. W.; Kindrachuk, Jason] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Jenssen, Havard] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark	Ruhr University Bochum; Ruhr University Bochum; University of British Columbia; Roskilde University	Steinstraesser, L (corresponding author), Ruhr Univ Bochum, Dept Plast Surg, BG Univ Hosp Bergmannsheil, Univ Str 150, Bochum, Germany.	lars.steinstraesser@ruhr-uni-bochum.de	Hirsch, Tobias/AAS-6707-2021; Hancock, Robert E. W./E-1145-2013	Hirsch, Tobias/0000-0002-3641-2707; Hancock, Robert E. W./0000-0001-5989-8503; Jenssen, Havard/0000-0003-0007-0335; Kindrachuk, Jason/0000-0002-3305-7084	Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative; Canadian Cystic Fibrosis Foundation; Deutsche Forschungsgemeinschaft [Ste1099, HI1279/4-1]	Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative; Canadian Cystic Fibrosis Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial Support to REWH from the Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative is gratefully acknowledged. REWH is the recipient of a Canada Research Chair. JK was supported by a fellowship from the Canadian Cystic Fibrosis Foundation. The work was additionally supported by the Deutsche Forschungsgemeinschaft (Ste1099 to LS and HI1279/4-1 to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; COLEMAN DL, 1982, DIABETES, V31, P1; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hirsch T, 2008, PROTEIN PEPTIDE LETT, V15, P238; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; Jacobsen F, 2005, J ANTIMICROB CHEMOTH, V55, P735, DOI 10.1093/jac/dki067; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Lee HY, 2008, BIOCHEM BIOPH RES CO, V369, P573, DOI 10.1016/j.bbrc.2008.02.046; Lee PHA, 2004, WOUND REPAIR REGEN, V12, P351, DOI 10.1111/j.1067-1927.2004.012303.x; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Oono T, 2002, ARCH DERMATOL RES, V294, P185, DOI 10.1007/s00403-002-0310-6; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Steinstraesser L, 2004, BURNS, V30, P619, DOI 10.1016/j.burns.2004.05.013; Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang LJ, 2009, CURR OPIN INVEST DR, V10, P164	38	100	108	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e39373	10.1371/journal.pone.0039373	http://dx.doi.org/10.1371/journal.pone.0039373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879874	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000002
J	Rieger, G; Savin-Williams, RC				Rieger, Gerulf; Savin-Williams, Ritch C.			The Eyes Have It: Sex and Sexual Orientation Differences in Pupil Dilation Patterns	PLOS ONE			English	Article							AROUSAL PATTERNS; VIEWING TIME; SIZE CHANGES; GENDER; RAPE; MEN; WOMEN; SPECIFICITY; IDENTITY; BEHAVIOR	Recent research suggests profound sex and sexual orientation differences in sexual response. These results, however, are based on measures of genital arousal, which have potential limitations such as volunteer bias and differential measures for the sexes. The present study introduces a measure less affected by these limitations. We assessed the' pupil dilation of 325 men and women of various sexual orientations to male and female erotic stimuli. Results supported hypotheses. In general, self-reported sexual orientation corresponded with pupil dilation to men and women. Among men, substantial dilation to both sexes was most common in bisexual-identified men. In contrast, among women, substantial dilation to both sexes was most common in heterosexual-identified women. Possible reasons for these differences are discussed. Because the measure of pupil dilation is less invasive than previous measures of sexual response, it allows for studying diverse age and cultural populations, usually not included in sexuality research.	[Rieger, Gerulf; Savin-Williams, Ritch C.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	Cornell University	Rieger, G (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	Gerulf@cornell.edu		Rieger, Gerulf/0000-0002-4875-2629	American Institutes of Bisexuality; United States Department of Agruculture's Federal Formula Funds [NYC-321421]	American Institutes of Bisexuality; United States Department of Agruculture's Federal Formula Funds	This research was funded by the American Institutes of Bisexuality (http://www.bisexual.org/home.html) and the United States Department of Agruculture's Federal Formula Funds (http://cuaes.cornell.edu/support/index.cfm) given to Cornell University for project NYC-321421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2011, ARCH SEX BEHAV, V40, P1293, DOI 10.1007/s10508-011-9778-5; Bailey JM, 2009, NEBR SYM MOTIV, V54, P43; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bartlett NH, 2006, ARCH SEX BEHAV, V35, P659, DOI 10.1007/s10508-006-9055-1; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Blanchard R, 2001, PSYCHOL ASSESSMENT, V13, P118, DOI 10.1037/1040-3590.13.1.118; Blanchard R, 2012, ARCH SEX BEHAV, V41, P13, DOI 10.1007/s10508-010-9675-3; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Burri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021982; Card RD, 1990, ANN SEX RES, V3, P381, DOI DOI 10.1177/107906329000300401; Cardoso FL, 2010, SEX CULT, V14, P306, DOI 10.1007/s12119-010-9076-8; Cardoso FL, 2008, SEX CULT, V12, P21, DOI 10.1007/s12119-007-9014-6; Cerny JA, 2011, ARCH SEX BEHAV, V40, P687, DOI 10.1007/s10508-011-9746-0; Chivers ML, 2007, J PERS SOC PSYCHOL, V93, P1108, DOI 10.1037/0022-3514.93.6.1108; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Diamond L. M., 2008, SEXUAL FLUIDITY UNDE; Dixson A.F., 2010, ANIMAL HOMOSEXUALITY, P381; Drummond KD, 2008, DEV PSYCHOL, V44, P34, DOI 10.1037/0012-1649.44.1.34; ELLIS L, 1987, PSYCHOL BULL, V101, P233, DOI 10.1037/0033-2909.101.2.233; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; Golde JA, 2000, J SEX RES, V37, P53, DOI 10.1080/00224490009552020; Goldinger SD, 2012, CURR DIR PSYCHOL SCI, V21, P90, DOI 10.1177/0963721412436811; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; HESS ECKHARD H., 1965, J ABNORM PSYCHOL, V70, P165, DOI 10.1037/h0021978; Hines M, 2010, HDB LIFE SPAN DEV; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Imhoff R, 2010, ARCH SEX BEHAV, V39, P1275, DOI 10.1007/s10508-009-9595-2; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Janssen E., 2002, HDB CONDUCTING RES H, P139; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Johnson KL, 2007, J PERS SOC PSYCHOL, V93, P321, DOI 10.1037/0022-3514.93.3.321; JOHNSON MH, 1995, DEV PSYCHOBIOL, V28, P281, DOI 10.1002/dev.420280504; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; KINSMAN G, 1995, LABOUR-TRAVAIL, P133; Kinsman G, 2001, WHOSE NATL SECURITY, P143; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lippa RA, 2008, ARCH SEX BEHAV, V37, P173, DOI 10.1007/s10508-007-9267-z; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Otero SC, 2011, PSYCHOPHYSIOLOGY, V48, P1346, DOI 10.1111/j.1469-8986.2011.01217.x; PALMER C, 1989, ETHNOLOGY, V28, P1, DOI 10.2307/3773639; Peplau LA, 2003, CURR DIR PSYCHOL SCI, V12, P37, DOI 10.1111/1467-8721.01221; Peplau LA, 2001, PERS RELATIONSHIP, V8, P1, DOI 10.1111/j.1475-6811.2001.tb00025.x; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Quinsey VL, 1996, ETHOL SOCIOBIOL, V17, P341, DOI 10.1016/S0162-3095(96)00060-X; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2012, 2 ROUTES BISEXUALITY; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; Rieger G, 2012, ARCH SEX BEHAV, V41, P529, DOI 10.1007/s10508-012-9942-6; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rosenthal AM, 2011, BIOL PSYCHOL, V88, P112, DOI 10.1016/j.biopsycho.2011.06.015; Rupp HA, 2008, ARCH SEX BEHAV, V37, P206, DOI 10.1007/s10508-007-9217-9; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; SANDAY PR, 1981, J SOC ISSUES, V37, P5, DOI 10.1111/j.1540-4560.1981.tb01068.x; Savin-Williams R C, 2005, NEW GAY TEENAGER; Savin-Williams RC, 2012, ARCH SEX BEHAV, V41, P103, DOI 10.1007/s10508-012-9913-y; Sawatsky John, 1980, MEN SHADOWS RCMP SEC; Slaughter L, 1997, AM J OBSTET GYNECOL, V176, P609, DOI 10.1016/S0002-9378(97)70556-8; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stief M, 2012, PERSONLAITY BISEXUAL; ten Donkelaar HJ, 2011, CLIN NEUROANATOMY, DOI [10.1007/1978-1003-1642-19134-19133_19112, DOI 10.1007/1978-1003-1642-19134-19133_19112]; THORNHILL R, 1983, ETHOL SOCIOBIOL, V4, P137, DOI 10.1016/0162-3095(83)90027-4; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; WALLEN K, 1995, CHIC SEX HIST SOC, P57; Wilson G., 2005, BORN GAY PSYCHOBIOLO; WOLCHIK SA, 1985, ARCH SEX BEHAV, V14, P93, DOI 10.1007/BF01541656	74	108	108	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40256	10.1371/journal.pone.0040256	http://dx.doi.org/10.1371/journal.pone.0040256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22870196	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100007
J	Stump, MR; Gong, QM; Zhou, ZF				Stump, Matthew R.; Gong, Qiuming; Zhou, Zhengfeng			Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome	PLOS ONE			English	Article							SPLICE-SITE MUTATION; RECTIFIER K+ CURRENT; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; PHARMACOLOGICAL RESCUE; ENDOPLASMIC-RETICULUM; TUMOR-CELLS; EXPRESSION; TRAFFICKING; DOMAIN	Background: Mutations in the human ether-a-go-go-related gene 1 (hERG1) cause type 2 long QT syndrome (LQT2). The hERG1 gene encodes a K+ channel with properties similar to the rapidly activating delayed rectifying K+ current in the heart. Several hERG1 isoforms with unique structural and functional properties have been identified. To date, the pathogenic mechanisms of LQT2 mutations have been predominantly described in the context of the hERG1a isoform. In the present study, we investigated the functional consequences of the LQT2 mutation G628S in the hERG1b and hERG1a(USO) isoforms. Methods: A double-stable, mammalian expression system was developed to characterize isoform-specific dominant-negative effects of G628S-containing channels when co-expressed at equivalent levels with wild-type hERG1a. Western blot and co-immunoprecipitation studies were performed to study the trafficking and co-assembly of wild-type and mutant hERG1 isoforms. Patch-clamp electrophysiology was performed to characterize hERG1 channel function and the isoform-specific dominant-negative effects associated with the G628S mutation. Conclusions: The non-functional hERG1a-G628S and hERG1b-G628S channels co-assembled with wild-type hERG1a and dominantly suppressed hERG1 current. In contrast, G628S-induced dominant-negative effects were absent in the context of the hERG1a(USO) isoform. hERG1a(USO)-G628S channels did not appreciably associate with hERG1a and did not significantly suppress hERG1 current when co-expressed at equivalent ratios or at ratios that approximate those found in cardiac tissue. These results suggest that the dominant-negative effects of LQT2 mutations may primarily occur in the context of the hERG1a and hERG1b isoforms.	[Stump, Matthew R.; Gong, Qiuming; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97201 USA	Oregon Health & Science University	Stump, MR (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97201 USA.	zhouzh@ohsu.edu			National Institutes of Health [HL-68854]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the National Institutes of Health grant HL-68854 to ZZ (www.nhlbi.nih.gov/). MRS was supported by an American Heart Association postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Crotti L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-18; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Gong QM, 2008, J MOL CELL CARDIOL, V44, P502, DOI 10.1016/j.yjmcc.2008.01.002; Gong QM, 2010, J BIOL CHEM, V285, P32233, DOI 10.1074/jbc.M109.095695; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gong QM, 2004, AM J PHYSIOL-HEART C, V287, pH652, DOI 10.1152/ajpheart.00052.2004; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hou L, 2010, CIRC RES; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sanguinetti MC, 2010, PFLUG ARCH EUR J PHY, V460, P265, DOI 10.1007/s00424-009-0758-8; SAUER B, 1990, New Biologist, V2, P441; Stump MR, 2011, AM J PHYSIOL-HEART C, V300, pH312, DOI 10.1152/ajpheart.00818.2010; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42552	10.1371/journal.pone.0042552	http://dx.doi.org/10.1371/journal.pone.0042552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876326	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700054
J	Weigand, JE; Boeckel, JN; Gellert, P; Dimmeler, S				Weigand, Julia E.; Boeckel, Jes-Niels; Gellert, Pascal; Dimmeler, Stefanie			Hypoxia-Induced Alternative Splicing in Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; DOWN-REGULATION; ROBO3 ISOFORMS; PROTEIN; RNA; TRANSCRIPTION; ANGIOGENESIS; SYNDECAN-2; PROMOTER; CUGBP1	Background: Adaptation to low oxygen by changing gene expression is vitally important for cell survival and tissue development. The sprouting of new blood vessels, initiated from endothelial cells, restores the oxygen supply of ischemic tissues. In contrast to the transcriptional response induced by hypoxia, which is mainly mediated by members of the HIF family, there are only few studies investigating alternative splicing events. Therefore, we performed an exon array for the genome-wide analysis of hypoxia-related changes of alternative splicing in endothelial cells. Methodology/Principal findings: Human umbilical vein endothelial cells (HUVECs) were incubated under hypoxic conditions (1% O-2) for 48 h. Genome-wide transcript and exon expression levels were assessed using the Affymetrix GeneChip Human Exon 1.0 ST Array. We found altered expression of 294 genes after hypoxia treatment. Upregulated genes are highly enriched in glucose metabolism and angiogenesis related processes, whereas downregulated genes are mainly connected to cell cycle and DNA repair. Thus, gene expression patterns recapitulate known adaptations to low oxygen supply. Alternative splicing events, until now not related to hypoxia, are shown for nine genes: six which are implicated in angiogenesis-mediated cytoskeleton remodeling (cask, itsn1, larp6, sptan1, tpm1 and robo1); one, which is involved in the synthesis of membrane-anchors (pign) and two universal regulators of gene expression (cugbp1 and max). Conclusions/Significance: For the first time, this study investigates changes in splicing in the physiological response to hypoxia on a genome-wide scale. Nine alternative splicing events, until now not related to hypoxia, are reported, considerably expanding the information on splicing changes due to low oxygen supply. Therefore, this study provides further knowledge on hypoxia induced gene expression changes and presents new starting points to study the hypoxia adaptation of endothelial cells.	[Weigand, Julia E.; Boeckel, Jes-Niels; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany; [Gellert, Pascal] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Goethe University Frankfurt; Max Planck Society	Weigand, JE (corresponding author), Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany.	weigand@bio.tu-darmstadt.de		Dimmeler, Stefanie/0000-0002-1045-2436; Weigand, Julia/0000-0003-4247-1348; Gellert, Pascal/0000-0001-9325-025X	DFG [Exc 147-1]	DFG(German Research Foundation (DFG))	The study was supported by the DFG (Exc 147-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Camurri L, 2005, MOL CELL NEUROSCI, V30, P485, DOI 10.1016/j.mcn.2005.07.014; Challa AK, 2005, MECH DEVELOP, V122, P1073, DOI 10.1016/j.mod.2005.06.006; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Clark K, 2002, FEBS LETT, V523, P12, DOI 10.1016/S0014-5793(02)02904-6; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gang HY, 2011, CIRC RES, V108, P1084, DOI 10.1161/CIRCRESAHA.110.238709; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Glenn HL, 2010, AM J PHYSIOL-CELL PH, V298, pC46, DOI 10.1152/ajpcell.00387.2009; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Granes F, 1999, EXP CELL RES, V248, P439, DOI 10.1006/excr.1999.4437; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Hsueh YP, 2009, ANN NEUROL, V66, P438, DOI 10.1002/ana.21755; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huichalaf CH, 2007, GENE, V396, P391, DOI 10.1016/j.gene.2007.04.022; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Matsushita S, 2006, J HISTOCHEM CYTOCHEM, V54, P343, DOI 10.1369/jhc.4A6611.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mills JD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.030; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Mykhalchenko V G, 2008, Ukr Biokhim Zh (1999), V80, P19; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Nural HF, 2007, GENE EXPR PATTERNS, V7, P837, DOI 10.1016/j.modgep.2007.07.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qi J, 2005, BIOCHEM BIOPH RES CO, V328, P517, DOI 10.1016/j.bbrc.2005.01.014; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shichiri M, 1999, MOL ENDOCRINOL, V13, P1353, DOI 10.1210/me.13.8.1353; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; Sugnet C W, 2004, Pac Symp Biocomput, P66; Sun QZ, 2010, INT J BIOCHEM CELL B, V42, P90, DOI 10.1016/j.biocel.2009.09.011; Sun Rong-ju, 2011, Zhonghua Shao Shang Za Zhi, V27, P156; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ursitti JA, 2007, J MOL CELL CARDIOL, V42, P572, DOI 10.1016/j.yjmcc.2006.11.018; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Weng HF, 2009, CELL MOL BIOL LETT, V14, P273, DOI 10.2478/s11658-008-0046-1; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Yue Y, 2006, GENOMICS, V88, P772, DOI 10.1016/j.ygeno.2006.05.011; Zeevi-Levin N, 2005, CARDIOVASC RES, V66, P64, DOI 10.1016/j.cardiores.2005.01.014; Zhu LL, 2011, CELL REPROGRAM, V13, P113, DOI 10.1089/cell.2010.0043	79	58	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42697	10.1371/journal.pone.0042697	http://dx.doi.org/10.1371/journal.pone.0042697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876330	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700058
J	Gong, SQ; Epasinghe, J; Rueggeberg, FA; Niu, LN; Mettenberg, D; Yiu, CKY; Blizzard, JD; Wu, CD; Mao, J; Drisko, CL; Pashley, DH; Tay, FR				Gong, Shi-qiang; Epasinghe, Jeevani; Rueggeberg, Frederick A.; Niu, Li-na; Mettenberg, Donald; Yiu, Cynthia K. Y.; Blizzard, John D.; Wu, Christine D.; Mao, Jing; Drisko, Connie L.; Pashley, David H.; Tay, Franklin R.			An ORMOSIL-Containing Orthodontic Acrylic Resin with Concomitant Improvements in Antimicrobial and Fracture Toughness Properties	PLOS ONE			English	Article							QUATERNARY AMMONIUM-SALTS; DENTURE BASE RESIN; CANDIDA-ALBICANS; BACTERIAL ADHESION; BIOFILM FORMATION; ORAL COLONIZATION; CALCIUM-PHOSPHATE; SILANE COATINGS; IN-VITRO; TEMPERATURE	Global increase in patients seeking orthodontic treatment creates a demand for the use of acrylic resins in removable appliances and retainers. Orthodontic removable appliance wearers have a higher risk of oral infections that are caused by the formation of bacterial and fungal biofilms on the appliance surface. Here, we present the synthetic route for an antibacterial and antifungal organically-modified silicate (ORMOSIL) that has multiple methacryloloxy functionalities attached to a siloxane backbone (quaternary ammonium methacryloxy silicate, or QAMS). By dissolving the water-insoluble, rubbery ORMOSIL in methyl methacrylate, QAMS may be copolymerized with polymethyl methacrylate, and covalently incorporated in the pressure-processed acrylic resin. The latter demonstrated a predominantly contact-killing effect on Streptococcus mutans ATCC 36558 and Actinomyces naselundii ATCC 12104 biofilms, while inhibiting adhesion of Candida albicans ATCC 90028 on the acrylic surface. Apart from its favorable antimicrobial activities, QAMS-containing acrylic resins exhibited decreased water wettability and improved toughness, without adversely affecting the flexural strength and modulus, water sorption and solubility, when compared with QAMS-free acrylic resin. The covalently bound, antimicrobial orthodontic acrylic resin with improved toughness represents advancement over other experimental antimicrobial acrylic resin formulations, in its potential to simultaneously prevent oral infections during appliance wear, and improve the fracture resistance of those appliances.	[Gong, Shi-qiang; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China; [Epasinghe, Jeevani; Yiu, Cynthia K. Y.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Rueggeberg, Frederick A.; Mettenberg, Donald; Drisko, Connie L.; Pashley, David H.; Tay, Franklin R.] Georgia Hlth Sci Univ, Coll Dent Med, Augusta, GA USA; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Blizzard, John D.] Quadsil Inc, Midland, MI USA; [Wu, Christine D.] Univ Illinois, Coll Dent, Chicago, IL USA	Huazhong University of Science & Technology; University of Hong Kong; University System of Georgia; Augusta University; Air Force Military Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gong, SQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China.	maojing1999@yahoo.com; ftay@georgiahealth.edu	Yiu, Cynthia/B-2183-2009; niu, lina/GWR-3585-2022; Rueggeberg, Frederick/N-8182-2017; Gong, Shi-qiang/HGB-7742-2022	Gong, Shi-qiang/0000-0001-9796-4081; Rueggeberg, Frederick/0000-0003-1947-3337; /0000-0003-4090-6205	NIDCR [R01 DE015306-06]; Georgia Health Sciences University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015306] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Georgia Health Sciences University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant R01 DE015306-06 from NIDCR (PI. David Pashley) and the ERA award from Georgia Health Sciences University (PI. Franklin Tay). The authors thank David Lang, Lang Dental Manufacturing Co. Inc., for supplying the Ortho-Jet acrylic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; ARENDORF T, 1985, J CLIN PERIODONTOL, V12, P360, DOI 10.1111/j.1600-051X.1985.tb00926.x; Batoni G, 2001, EUR J ORAL SCI, V109, P388, DOI 10.1034/j.1600-0722.2001.00089.x; Bjerklin K, 1983, Br J Orthod, V10, P21; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Cheng L, 2012, J DENT RES, V91, P460, DOI 10.1177/0022034512440579; Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08; Gong SQ, 2012, ACTA BIOMATER, V8, P3270, DOI 10.1016/j.actbio.2012.05.031; Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0; Grave A M, 1985, Dent Mater, V1, P185, DOI 10.1016/S0109-5641(85)80015-4; HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hibino K, 2009, INT J PAEDIATR DENT, V19, P301, DOI 10.1111/j.1365-263X.2009.00988.x; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; International Organization for Standardization, 2010, 207952 ISO; Ishida H, 1998, ANTIMICROB AGENTS CH, V42, P1641, DOI 10.1128/AAC.42.7.1641; ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859, DOI 10.1128/AEM.24.6.859-863.1972; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Kanie T, 2000, DENT MATER, V16, P150, DOI 10.1016/S0109-5641(99)00097-4; Kassaee MZ, 2008, J APPL POLYM SCI, V110, P1699, DOI 10.1002/app.28762; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; King G, ACCESS ORTHODONTIC S; Kopecky F, 1996, PHARMAZIE, V51, P135; Leggat PA, 2003, INT DENT J, V53, P126, DOI 10.1111/j.1875-595X.2003.tb00736.x; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MINAGI S, 1985, INFECT IMMUN, V47, P11, DOI 10.1128/IAI.47.1.11-14.1985; Monteiro DR, 2012, J PROSTHODONT, V21, P7, DOI 10.1111/j.1532-849X.2011.00772.x; Monticello RA, 2010, APPLIED BIOMEDICAL MICROBIOLOGY: A BIOFILMS APPROACH, P45; Morgan TD, 2000, J APPL MICROBIOL, V89, P617, DOI 10.1046/j.1365-2672.2000.01158.x; Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963; Oosterhof JJH, 2006, APPL ENVIRON MICROB, V72, P3673, DOI 10.1128/AEM.72.5.3673-3677.2006; OWEN MJ, 1980, IND ENG CHEM PROD RD, V19, P97, DOI 10.1021/i360073a023; Ozer RR, 2010, J APPL POLYM SCI, V118, P2397, DOI 10.1002/app.32221; PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501; Rantala LI, 2003, J ORAL REHABIL, V30, P501, DOI 10.1046/j.1365-2842.2003.01108.x; Regis RR, 2012, J PROSTHODONT, V21, P283, DOI 10.1111/j.1532-849X.2011.00815.x; Regis RR, 2011, J PROSTHODONT, V20, P372, DOI 10.1111/j.1532-849X.2011.00719.x; Lessa FCR, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.09.042; Shinonaga Y, 2012, ACTA BIOMATER, V8, P1388, DOI 10.1016/j.actbio.2011.09.017; Sodagar A, 2012, J PROSTHODONT RES, V56, P120, DOI 10.1016/j.jpor.2011.06.002; Song J, 2011, COLLOID SURFACE B, V82, P651, DOI 10.1016/j.colsurfb.2010.10.027; Song L, 2011, TEXT RES J, V81, P504, DOI 10.1177/0040517510380776; Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061; Tamura K, 2005, PEDIATR DENT J, V15, P212, DOI 10.1016/S0917-2394(05)70056-2; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; Vahdat N, 2001, J APPL POLYM SCI, V79, P1265, DOI 10.1002/1097-4628(20010214)79:7<1265::AID-APP140>3.0.CO;2-H; Vento-Zahra E, 2011, QUINTESSENCE INT, V42, P37; Wady AF, 2012, J APPL MICROBIOL, V112, P1163, DOI 10.1111/j.1365-2672.2012.05293.x; YAMAMOTO K, 1995, ANAL CHIM ACTA, V302, P75, DOI 10.1016/0003-2670(94)00428-O; Yiu CKY, 2006, BIOMATERIALS, V27, P1695, DOI 10.1016/j.biomaterials.2005.09.037; Zappini G, 2003, J PROSTHET DENT, V90, P578, DOI 10.1016/j.prosdent.2003.09.008	58	37	39	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42355	10.1371/journal.pone.0042355	http://dx.doi.org/10.1371/journal.pone.0042355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870322	Green Published, gold			2022-12-25	WOS:000307212800085
J	Cortez, C; Yoshida, N; Bahia, D; Sobreira, TJP				Cortez, Cristian; Yoshida, Nobuko; Bahia, Diana; Sobreira, Tiago J. P.			Structural Basis of the Interaction of a Trypanosoma cruzi Surface Molecule Implicated in Oral Infection with Host Cells and Gastric Mucin	PLOS ONE			English	Article							ACUTE CHAGAS-DISEASE; METACYCLIC TRYPOMASTIGOTES; ESCHERICHIA-COLI; TRANS-SIALIDASE; HELA-CELLS; INVASION; BINDING; ADHESION; TRANSMISSION; PROTEIN	Host cell invasion and dissemination within the host are hallmarks of virulence for many pathogenic microorganisms. As concerns Trypanosoma cruzi, which causes Chagas disease, the insect vector-derived metacyclic trypomastigotes (MT) initiate infection by invading host cells, and later blood trypomastigotes disseminate to diverse organs and tissues. Studies with MT generated in vitro and tissue culture-derived trypomastigotes (TCT), as counterparts of insect-borne and bloodstream parasites, have implicated members of the gp85/trans-sialidase superfamily, MT gp82 and TCT Tc85-11, in cell invasion and interaction with host factors. Here we analyzed the gp82 structure/function characteristics and compared them with those previously reported for Tc85-11. One of the gp82 sequences identified as a cell binding site consisted of an a-helix, which connects the N-terminal beta-propeller domain to the C-terminal beta-sandwich domain where the second binding site is nested. In the gp82 structure model, both sites were exposed at the surface. Unlike gp82, the Tc85-11 cell adhesion sites are located in the N-terminal beta-propeller region. The gp82 sequence corresponding to the epitope for a monoclonal antibody that inhibits MT entry into target cells was exposed on the surface, upstream and contiguous to the alpha-helix. Located downstream and close to the alpha-helix was the gp82 gastric mucin binding site, which plays a central role in oral T. cruzi infection. The sequences equivalent to Tc85-11 laminin-binding sites, which have been associated with the parasite ability to overcome extracellular matrices and basal laminae, was poorly conserved in gp82, compatible with its reduced capacity to bind laminin. Our study indicates that gp82 is structurally suited for MT to initiate infection by the oral route, whereas Tc85-11, with its affinity for laminin, would facilitate the parasite dissemination through diverse organs and tissues.	[Cortez, Cristian; Yoshida, Nobuko; Bahia, Diana] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Sobreira, Tiago J. P.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Cortez, C (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	nyoshida@unifesp.br	Yoshida, Nobuko/AAL-6082-2020; Sobreira, Tiago/C-1276-2008; Bahia, Diana/W-3974-2019; cortez, cristian/GLT-4441-2022	Yoshida, Nobuko/0000-0002-3925-8557; Sobreira, Tiago/0000-0002-0217-0084; Cortez, Cristian/0000-0003-1887-0808	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61450-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300578/2010-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2006/61450-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #300578/2010-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Alves MJM, 2007, IUBMB LIFE, V59, P274, DOI 10.1080/15216540701200084; Alves Maria Julia M., 2008, V47, P58; Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; ARAYA JE, 1994, MOL BIOCHEM PARASIT, V65, P161, DOI 10.1016/0166-6851(94)90124-4; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; Cortez M, 2006, MICROBES INFECT, V8, P36, DOI 10.1016/j.micinf.2005.05.016; Cortez M, 2006, MICROBES INFECT, V8, P1502, DOI 10.1016/j.micinf.2006.01.007; Covarrubias C, 2007, INT J PARASITOL, V37, P1609, DOI 10.1016/j.ijpara.2007.05.013; de Goes Cavalcanti LP, 2009, CAD SAUDE COLET, V17, P911; Dias JP, 2008, REV SOC BRAS MED TRO, V41, P296, DOI 10.1590/S0037-86822008000300014; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; Hoft DF, 1996, INFECT IMMUN, V64, P3800, DOI 10.1128/IAI.64.9.3800-3810.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Maeda FY, 2011, ACTA TROP, V120, P231, DOI 10.1016/j.actatropica.2011.09.001; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; Marroquin-Quelopana M, 2004, BIOCHEM BIOPH RES CO, V325, P612, DOI 10.1016/j.bbrc.2004.10.068; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Beltrao HDM, 2009, TROP DOCT, V39, P231, DOI 10.1258/td.2009.090035; MORTARA RA, 1992, INFECT IMMUN, V60, P4673, DOI 10.1128/IAI.60.11.4673-4678.1992; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Neira I, 2003, INFECT IMMUN, V71, P557, DOI 10.1128/IAI.71.1.557-561.2003; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; Pereira CM, 1999, INFECT IMMUN, V67, P4908, DOI 10.1128/IAI.67.9.4908-4911.1999; Rajkumar R, 1998, MOL CELL BIOCHEM, V178, P261, DOI 10.1023/A:1006844125976; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Staquicini DI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000613; Steindel M, 2008, DIAGN MICR INFEC DIS, V60, P25, DOI 10.1016/j.diagmicrobio.2007.07.016; Sudha PS, 2001, CURR MICROBIOL, V42, P381; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; VALKONEN KH, 1991, MOL MICROBIOL, V5, P2133, DOI 10.1111/j.1365-2958.1991.tb02143.x; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	44	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42153	10.1371/journal.pone.0042153	http://dx.doi.org/10.1371/journal.pone.0042153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860068	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600060
J	Hendrie, CA; Brewer, G				Hendrie, Colin A.; Brewer, Gayle			Evidence to Suggest That Teeth Act as Human Ornament Displays Signalling Mate Quality	PLOS ONE			English	Article							TOOTH COLOR; BIRTH-WEIGHT; CARDIOVASCULAR-DISEASE; DENTAL-HEALTH; HEART-DISEASE; FETAL-GROWTH; SKIN COLOR; WOMEN; AGE; DISCOLORATION	Ornament displays seen in animals convey information about genetic quality, developmental history and current disease state to both prospective sexual partners and potential rivals. In this context, showing of teeth through smiles etc is a characteristic feature of human social interaction. Tooth development is influenced by genetic and environmental factors. Adult teeth record environmental and traumatic events, as well as the effects of disease and ageing. Teeth are therefore a rich source of information about individuals and their histories. This study examined the effects of digital manipulations of tooth colour and spacing. Results showed that deviation away from normal spacing and/or the presence of yellowed colouration had negative effects on ratings of attractiveness and that these effects were markedly stronger in female models. Whitening had no effect beyond that produced by natural colouration. This indicates that these colour induced alterations in ratings of attractiveness are mediated by increased/decreased yellowing rather than whitening per se. Teeth become yellower and darker with age. Therefore it is suggested that whilst the teeth of both sexes act as human ornament displays, the female display is more complex because it additionally signals residual reproductive value.	[Hendrie, Colin A.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Brewer, Gayle] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England	University of Leeds; University of Central Lancashire	Hendrie, CA (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	c.a.hendrie@leeds.ac.uk		Brewer, Gayle/0000-0003-0690-4548				Alkhatib MN, 2004, J DENT, V32, P561, DOI 10.1016/j.jdent.2004.06.002; ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1996, LANCET, V334, P577; Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Baydas B, 2005, EUR J ORTHODONT, V27, P98, DOI 10.1093/ejo/cjh088; BENDICH A, 1993, ANN NY ACAD SCI, V691, P61, DOI 10.1111/j.1749-6632.1993.tb26157.x; Bonato M, 2009, ANIM BEHAV, V77, P1033, DOI 10.1016/j.anbehav.2009.02.008; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Brook AH, 2009, ARCH ORAL BIOL, V54, pS3, DOI 10.1016/j.archoralbio.2009.09.005; BROOK AH, 1984, ARCH ORAL BIOL, V29, P373, DOI 10.1016/0003-9969(84)90163-8; Cerqueira DF, 2008, ORAL SURG ORAL MED O, V105, P353, DOI 10.1016/j.tripleo.2007.05.032; Chatrchaiwiwatana S, 2007, PUBLIC HEALTH, V121, P106, DOI 10.1016/j.puhe.2006.06.010; Clarke LH, 2009, J WOMEN AGING, V21, P198, DOI 10.1080/08952840903054757; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeSantis M, 2000, PSYCHOLOGY, V37, P21; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; FEARNE JM, 1993, EARLY HUM DEV, V33, P81, DOI 10.1016/0378-3782(93)90203-7; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fink Bernhard, 2008, J Cosmet Dermatol, V7, P155, DOI 10.1111/j.1473-2165.2008.00382.x; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gangestad SW., 1997, EVOLUTIONARY SOCIAL, P169; GARN SM, 1965, J DENT RES, V44, P439, DOI 10.1177/00220345650440022201; Godoy R, 2005, J ECON PSYCHOL, V26, P469, DOI 10.1016/j.joep.2004.10.004; GOODKIND RJ, 1987, J PROSTHET DENT, V58, P535, DOI 10.1016/0022-3913(87)90380-5; GORANSSON G, 1990, ANIM BEHAV, V40, P89, DOI 10.1016/S0003-3472(05)80668-2; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hall JA., 1986, PSYCHOL GENDER ADV M, P136; Hamalainen P, 2003, EUR J ORAL SCI, V111, P291, DOI 10.1034/j.1600-0722.2003.00055.x; Hassan A K, 2000, East Mediterr Health J, V6, P511; Hess U., 2002, EMPIRICAL REFLECTION, P187; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; Hofel L, 2007, INT J PERIODONT REST, V27, P349; Houser M. L., 2007, HUMAN COMMUNICATION, V10, P69; Jahangiri L, 2002, J PROSTHET DENT, V87, P149, DOI 10.1067/mpr.2002.121109; Jansson L, 2001, J CLIN PERIODONTOL, V28, P762, DOI 10.1034/j.1600-051X.2001.280807.x; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kim JM, 2007, INT J GERIATR PSYCH, V22, P850, DOI 10.1002/gps.1750; Koeppel LB., 1993, INTERPERSONAL COMMUN, P13; Kotsomitis N, 1996, Aust Orthod J, V14, P172; KOWALSKI RM, 1993, SEX ROLES, V29, P13, DOI 10.1007/BF00289994; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Krumhuber E, 2009, J NONVERBAL BEHAV, V33, P1, DOI 10.1007/s10919-008-0056-8; Lee HK, 2010, ARCH GERONTOL GERIAT, V50, P30, DOI 10.1016/j.archger.2009.01.005; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Marlowe FW, 1998, HUM NATURE-INT BIOS, V9, P263, DOI 10.1007/s12110-998-1005-2; Massaro M, 2003, BEHAV ECOL SOCIOBIOL, V55, P169, DOI 10.1007/s00265-003-0683-3; Mehu M, 2008, BEHAVIOUR, V145, P1747, DOI 10.1163/156853908786279619; Mitsuyoshi Y, 2011, JPN DENT SCI REV, V47, P157, DOI 10.1016/j.jdsr.2011.01.001; MOLLER AP, 1994, J PARASITOL, V80, P850, DOI 10.2307/3283433; MOORE MM, 1985, ETHOL SOCIOBIOL, V6, P237, DOI 10.1016/0162-3095(85)90016-0; Morley J, 1997, CURR OPIN COSMET D, V4, P35; MORSE C, 1982, J PSYCHOL, V110, P3, DOI 10.1080/00223980.1982.9915318; NAVEH Y, 1976, J MED GENET, V13, P277, DOI 10.1136/jmg.13.4.277; Newton JT, 2003, INT J PROSTHODONT, V16, P429; Odioso L L, 2000, Compend Contin Educ Dent Suppl, pS35; Okamoto N, 2010, BRAIN RES, V1349, P68, DOI 10.1016/j.brainres.2010.06.054; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Penin X, 2002, AM J PHYS ANTHROPOL, V118, P50, DOI 10.1002/ajpa.10044; Pfeiffer RA, 1964, Z KINDERHEILKD, V90, P301; Preuschoft S., 1997, NONVERBAL COMMUNICAT, P171; Qualtrough A J, 1994, Quintessence Int, V25, P7; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; Schmidt Christopher J, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P254, DOI 10.1097/01.moo.0000233596.68928.39; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Sulieman M, 2005, Dent Update, V32, P463; TENBOSCH JJ, 1995, J DENT RES, V74, P374, DOI 10.1177/00220345950740011401; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Thornton GR, 1943, J SOC PSYCHOL, V18, P127, DOI 10.1080/00224545.1943.9921704; Tosun G, 2009, J CLIN PEDIATR DENT, V34, P71, DOI 10.17796/jcpd.34.1.kr015833p1qg6873; Vallittu PK, 1996, J DENT, V24, P335, DOI 10.1016/0300-5712(95)00079-8; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; Verhaegen M., 2007, ECOLOGY RES PROGR, P155; Watts A, 2001, BRIT DENT J, V190, P309, DOI 10.1038/sj.bdj.4800959a; Xiao J, 2007, J ORAL REHABIL, V34, P351, DOI 10.1111/j.1365-2842.2007.01729.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	89	18	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42178	10.1371/journal.pone.0042178	http://dx.doi.org/10.1371/journal.pone.0042178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860076	Green Published, gold, Green Accepted			2022-12-25	WOS:000307045600067
J	Kasson, TMD; Rexroth, S; Barry, BA				Kasson, Tina M. Dreaden; Rexroth, Sascha; Barry, Bridgette A.			Light-Induced Oxidative Stress, N-Formylkynurenine, and Oxygenic Photosynthesis	PLOS ONE			English	Article							EVOLVING PHOTOSYSTEM-II; SPINACH THYLAKOID MEMBRANES; BINDING PROTEIN CP43; CRYSTAL-STRUCTURE; TRYPTOPHAN OXIDATION; OXIDIZED TRYPTOPHAN; MEDIATED DAMAGE; D1 PROTEIN; IN-VIVO; PHOTOINHIBITION	Light stress in plants results in damage to the water oxidizing reaction center, photosystem II (PSII). Redox signaling, through oxidative modification of amino acid side chains, has been proposed to participate in this process, but the oxidative signals have not yet been identified. Previously, we described an oxidative modification, N-formylkynurenine (NFK), of W365 in the CP43 subunit. The yield of this modification increases under light stress conditions, in parallel with the decrease in oxygen evolving activity. In this work, we show that this modification, NFK365-CP43, is present in thylakoid membranes and may be formed by reactive oxygen species produced at the Mn4CaO5 cluster in the oxygen-evolving complex. NFK accumulation correlates with the extent of photoinhibition in PSII and thylakoid membranes. A modest increase in ionic strength inhibits NFK365-CP43 formation, and leads to accumulation of a new, light-induced NFK modification (NFK317) in the D1 polypeptide. Western analysis shows that D1 degradation and oligomerization occur under both sets of conditions. The NFK modifications in CP43 and D1 are found 17 and 14 Angstrom from the Mn4CaO5 cluster, respectively. Based on these results, we propose that NFK is an oxidative modification that signals for damage and repair in PSII. The data suggest a two pathway model for light stress responses. These pathways involve differential, specific, oxidative modification of the CP43 or D1 polypeptides.	[Kasson, Tina M. Dreaden; Barry, Bridgette A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kasson, Tina M. Dreaden; Barry, Bridgette A.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Rexroth, Sascha] Ruhr Univ Bochum, Dept Biol, Bochum, Germany	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Ruhr University Bochum	Kasson, TMD (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu	Rexroth, Sascha/H-3702-2011	Rexroth, Sascha/0000-0003-3819-2127	National Science Foundation [MCB 08-42246]; Direct For Biological Sciences [0842246] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Grant from National Science Foundation: MCB 08-42246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ANDERSON JM, 1994, PHOTOSYNTH RES, V41, P315, DOI 10.1007/BF00019409; Anderson LB, 2000, J BIOL CHEM, V275, P4920, DOI 10.1074/jbc.275.7.4920; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boda D, 2007, BIOPHYS J, V93, P1960, DOI 10.1529/biophysj.107.105478; Bollag DM, 1991, PROTEIN METHODS; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Fedorova M, 2010, PROTEOMICS, V10, P2692, DOI 10.1002/pmic.201000147; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Giessauf A, 1996, FEBS LETT, V389, P136; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HILLIER W, 1993, PHOTOSYNTH RES, V38, P417, DOI 10.1007/BF00046769; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Huesgen PF, 2006, FEBS LETT, V580, P6929, DOI 10.1016/j.febslet.2006.11.058; Hunzinger C, 2006, J PROTEOME RES, V5, P625, DOI 10.1021/pr050377+; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Johnson PE, 1998, BIOCHEMISTRY-US, V37, P12772, DOI 10.1021/bi980978x; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MACDONALD GM, 1995, J BIOL CHEM, V270, P8420, DOI 10.1074/jbc.270.15.8420; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mizusawa N, 2003, BIOCHEMISTRY-US, V42, P10034, DOI 10.1021/bi0300534; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; MORI H, 1995, BBA-BIOENERGETICS, V1228, P37, DOI 10.1016/0005-2728(94)00156-Y; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Ouellette AJA, 1998, P NATL ACAD SCI USA, V95, P2204, DOI 10.1073/pnas.95.5.2204; Patsikka E, 2002, PLANT PHYSIOL, V129, P1359, DOI 10.1104/pp.004788; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; Rexroth S, 2012, BBA-BIOENERGETICS, V1817, P381, DOI 10.1016/j.bbabio.2011.11.006; Rinalducci S, 2005, J PROTEOME RES, V4, P2327, DOI 10.1021/pr0502368; Rochu D, 2004, BIOCHEM J, V380, P627, DOI 10.1042/BJ20031861; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Rozak PR, 2002, PLANT CELL ENVIRON, V25, P421, DOI 10.1046/j.0016-8025.2001.00823.x; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; SIMAT T, 1994, J CHROMATOGR A, V661, P93, DOI 10.1016/0021-9673(94)85180-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIRGIN I, 1988, FEBS LETT, V233, P408, DOI 10.1016/0014-5793(88)80472-1; WAGGONER CM, 1989, FEBS LETT, V244, P237, DOI 10.1016/0014-5793(89)81200-1; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	68	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42220	10.1371/journal.pone.0042220	http://dx.doi.org/10.1371/journal.pone.0042220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860088	gold, Green Submitted, Green Published			2022-12-25	WOS:000307045600075
J	Panter, J; Griffin, S; Ogilvie, D				Panter, Jenna; Griffin, Simon; Ogilvie, David			Correlates of Reported and Recorded Time Spent in Physical Activity in Working Adults: Results from the Commuting and Health in Cambridge Study	PLOS ONE			English	Article							ACCELEROMETRY; PEDOMETER; VALIDITY; WALKING	Background: The correlates of physical activity in adults are relatively well studied. However, many studies use self-reported ('reported') measures of activity and we know little about the possible differences between the correlates of reported and objective ('recorded') measures of physical activity. We compared the correlates of reported and recorded time spent in moderate-to-vigorous physical activity (MVPA) in a sample of working adults. Methods: In 2009, participants in the Commuting and Health in Cambridge study completed questionnaires assessing individual, socio-demographic, health and contextual characteristics. Recorded time spent in MVPA over seven days was ascertained using accelerometers and reported time spent in MVPA was assessed using the Recent Physical Activity Questionnaire (RPAQ). Correlates of MVPA were investigated using sex-specific linear regression models. Results: 486 participants (70% women) provided both reported and recorded physical activity data. 89% recorded at least 30 minutes of MVPA per day. In men, none of the potential explanatory variables were associated with both reported and recorded time spent in MVPA. In women, of all the potential explanatory variables only that of having a standing or manual occupation was associated with both reported (+42 min/day; 95% CI 16.4 to 68.4, p = 0.001) and recorded (+9 min/day; 95% CI: 3.5 to 15.7, p = 0.002) time spent in MVPA. Discussion: The use of an objective measure of physical activity may influence the correlates which are observed. Researchers may wish to consider using and analysing recorded and reported measures in combination to gain a more complete view of the correlates of physical activity.	[Panter, Jenna] MRC, Epidemiol Unit, Cambridge, England; UKCRC Ctr Diet & Act Res CEDAR, Inst Publ Hlth, Cambridge, England	University of Cambridge	Panter, J (corresponding author), MRC, Epidemiol Unit, Cambridge, England.	jenna.panter@mrc-epid.cam.ac.uk	Griffin, Simon/K-3106-2013	Griffin, Simon/0000-0002-2157-4797; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme [09/3001/06]; Medical Research Council [U106179474]; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); National Institute for Health Research Public Health Research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Commuting and Health in Cambridge study was developed by David Ogilvie, Simon Griffin, Andy Jones and Roger Mackett and initially funded under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The study is now funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: see http://www.phr.nihr.ac.uk/funded_projects). David Ogilvie and Simon Griffin are supported by the Medical Research Council [Unit Programme number U106179474]. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Bibby P., 2004, DEV NEW CLASSIFICATI; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cleland VJ, 2011, J SCI MED SPORT, V14, P496, DOI 10.1016/j.jsams.2011.04.006; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; Department for Communities and Local Government, 2005, GEN LAND US DAT STAT; Department of Health, 2011, START ACT STAY ACT R; Duncan MJ, 2005, INT J BEHAV NUTR PHY, V2; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Ishii K, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-61; Janz KF, 2006, BRIT J SPORT MED, V40, P191, DOI 10.1136/bjsm.2005.023036; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Ogilvie D, 2010, J PHYS ACT HEALTH, V7, pS341, DOI 10.1123/jpah.7.s3.s341; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis J.F., 2002, ECOLOGICAL MODELS HL; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; Ware JE Jr, 2001, SCORE INTERPRET SING; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42202	10.1371/journal.pone.0042202	http://dx.doi.org/10.1371/journal.pone.0042202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860083	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600072
J	Larsen, M; Sauce, D; Arnaud, L; Fastenackels, S; Appay, V; Gorochov, G				Larsen, Martin; Sauce, Delphine; Arnaud, Laurent; Fastenackels, Solene; Appay, Victor; Gorochov, Guy			Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index	PLOS ONE			English	Article							CD8(+) T-CELLS; HIV; RESPONSES; VACCINE; IMMUNIZATION; PROGRESSION; PROTECTION; INDUCTION; CORRELATE; POLLEN	Functional evaluation of naturally occurring or vaccination-induced T cell responses in mice, men and monkeys has in recent years advanced from single-parameter (e.g. IFN-gamma-secretion) to much more complex multidimensional measurements. Co-secretion of multiple functional molecules (such as cytokines and chemokines) at the single-cell level is now measurable due primarily to major advances in multiparametric flow cytometry. The very extensive and complex datasets generated by this technology raise the demand for proper analytical tools that enable the analysis of combinatorial functional properties of T cells, hence polyfunctionality. Presently, multidimensional functional measures are analysed either by evaluating all combinations of parameters individually or by summing frequencies of combinations that include the same number of simultaneous functions. Often these evaluations are visualized as pie charts. Whereas pie charts effectively represent and compare average polyfunctionality profiles of particular T cell subsets or patient groups, they do not document the degree or variation of polyfunctionality within a group nor does it allow more sophisticated statistical analysis. Here we propose a novel polyfunctionality index that numerically evaluates the degree and variation of polyfuntionality, and enable comparative and correlative parametric and non-parametric statistical tests. Moreover, it allows the usage of more advanced statistical approaches, such as cluster analysis. We believe that the polyfunctionality index will render polyfunctionality an appropriate end-point measure in future studies of T cell responsiveness.	[Larsen, Martin; Sauce, Delphine; Arnaud, Laurent; Fastenackels, Solene; Appay, Victor; Gorochov, Guy] INSERM, UMR S 945, Paris, France; [Larsen, Martin; Sauce, Delphine; Fastenackels, Solene; Appay, Victor; Gorochov, Guy] Univ Paris 06, Paris, France; [Arnaud, Laurent] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, Paris, France; [Appay, Victor; Gorochov, Guy] Lab AP HP Immunol Cellulaire & Tissulaire, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Larsen, M (corresponding author), INSERM, UMR S 945, Paris, France.	Martin.Larsen@upmc.fr	Appay, Victor/M-4830-2017; Appay, Victor/AAM-7701-2021; Gorochov, Guy/P-2911-2017; sauce, delphine/H-1990-2014; Larsen, Martin/A-7316-2014; SAUCE, Delphine/ABE-5975-2020	sauce, delphine/0000-0003-4596-7373; Larsen, Martin/0000-0003-1375-4816; SAUCE, Delphine/0000-0003-4596-7373; Appay, Victor/0000-0001-5434-3963; ARNAUD, Laurent/0000-0002-8077-8394; Gorochov, Guy/0000-0003-2097-9677	Inserm; Universite Pierre et Marie Curie "EMERGENCE'' program; European FP6 "ATTACK'' program [LSHC-CT-2005-018914]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie "EMERGENCE'' program; European FP6 "ATTACK'' program	The study was supported by Inserm, the Universite Pierre et Marie Curie "EMERGENCE'' program and by the European FP6 "ATTACK'' program (Contract: LSHC-CT-2005-018914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Appay Victor, 2008, P59, DOI 10.1007/978-3-7643-8334-3_6; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Boulet S, 2007, J IMMUNOL METHODS, V320, P18, DOI 10.1016/j.jim.2006.11.010; Crack LR, 2011, CLIN EXP ALLERGY; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Ferrando-Martinez S, 2012, J VIROL; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Frey O, 2010, ANN RHEUM DIS, V69, P1495, DOI 10.1136/ard.2009.119164; Gasser O, 2009, AM J TRANSPLANT, V9, P794, DOI 10.1111/j.1600-6143.2008.02539.x; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Larsen M, 2011, EUR J IMMUNOL, V41, P2596, DOI 10.1002/eji.201041131; Lindstedt M, 2005, INT IMMUNOL, V17, P401, DOI 10.1093/intimm/dxh220; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Mittag D, 2010, J IMMUNOL, V184, P4708, DOI 10.4049/jimmunol.0901036; Mkhwanazi N, 2010, VIROLOGY, V405, P483, DOI 10.1016/j.virol.2010.06.002; Newell EW, 2012, IMMUNITY; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Papagno L, 2007, J IMMUNOL METHODS, V328, P182, DOI 10.1016/j.jim.2007.09.001; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Sauce D, 2009, J VIROL, V83, P9068, DOI 10.1128/JVI.00141-09; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Smith C, 2009, J VIROL, V83, P6192, DOI 10.1128/JVI.00239-09; Streeck H, 2011, BLOOD, V117, P5112, DOI 10.1182/blood-2010-12-321588; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	43	61	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42403	10.1371/journal.pone.0042403	http://dx.doi.org/10.1371/journal.pone.0042403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860124	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900091
J	Chong, HH; Yao, X; Sun, JP; Qiu, ZL; Zhang, M; Waltersperger, S; Wang, MT; Cui, S; He, YX				Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Waltersperger, Sandro; Wang, Meitian; Cui, Sheng; He, Yuxian			The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSMEMBRANE PROTEIN GP41; VIRAL MEMBRANE-FUSION; COILED-COIL DOMAIN; ENVELOPE GLYCOPROTEIN; CORE STRUCTURE; ATOMIC-STRUCTURE; RESISTANT HIV-1; PEPTIDE; ENFUVIRTIDE	CP621-652 is a potent HIV-1 fusion inhibitor peptide derived from the C-terminal heptad repeat of gp41. We recently identified that its N-terminal residues Met-626 and Thr-627 adopt a unique hook-like structure (termed M-T hook) thus stabilizing the interaction of the inhibitor with the deep pocket on the N-terminal heptad repeat. In this study, we further demonstrated that the M-T hook structure is a key determinant of CP621-652 in terms of its thermostability and anti-HIV activity. To directly define the structure and function of the M-T hook, we generated the peptide MT-C34 by incorporating Met-626 and Thr-627 into the N terminus of the C-terminal heptad repeat-derived peptide C34. The high resolution crystal structure (1.9 angstrom) of MT-C34 complexed by an N-terminal heptad repeat-derived peptide reveals that the M-T hook conformation is well preserved at the N-terminal extreme of the inhibitor. Strikingly, addition of two hook residues could dramatically enhance the binding affinity and thermostability of 6-helix bundle core. Compared with C34, MT-C34 exhibited significantly increased activity to inhibit HIV-1 envelope-mediated cell fusion (6.6-fold), virus entry (4.5-fold), and replication (6-fold). Mechanistically, MT-C34 had a 10.5-fold higher increase than C34 in blocking 6-helix bundle formation. We further showed that MT-C34 possessed higher potency against T20 (Enfuvirtide, Fuzeon)-resistant HIV-1 variants. Therefore, this study provides convincing data for our proposed concept that the M-T hook structure is critical for designing HIV-1 fusion inhibitors.	[Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Cui, S (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cui.sheng@ipb.pumc.edu.cn; yhe@ipb.pumc.edu.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	Natural Science Foundation of China [81025009, 81271830]; National 973 Program of China [2010CB530100]; Beijing Natural Science Foundation [7122116]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Outstanding Youth Award of Natural Science Foundation of China Grant 81025009, National 973 Program of China Grant 2010CB530100, Natural Science Foundation of China Grant 81271830, and Beijing Natural Science Foundation Grant 7122116.	Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Li J, 2009, IMMUNOBIOLOGY, V214, P51, DOI 10.1016/j.imbio.2008.04.005; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000; Wexler-Cohen Y, 2006, J BIOL CHEM, V281, P9005, DOI 10.1074/jbc.M512475200; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao X, 2012, J BIOL CHEM, V287, P26618, DOI 10.1074/jbc.M112.381079; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	44	49	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34558	34568		10.1074/jbc.M112.390393	http://dx.doi.org/10.1074/jbc.M112.390393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879603	Green Published, hybrid			2022-12-25	WOS:000309654200059
J	Woloszynek, JC; Hu, Y; Pham, CTN				Woloszynek, Josh C.; Hu, Ying; Pham, Christine T. N.			Cathepsin G-regulated Release of Formyl Peptide Receptor Agonists Modulate Neutrophil Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; N-TERMINAL PEPTIDE; ANNEXIN-I; CATHELICIDIN PEPTIDE; HOST-DEFENSE; ANTIMICROBIAL PEPTIDES; INSULIN-SECRETION; SERINE PROTEASES; LAVAGE FLUID; LIPOCORTIN 1	Neutrophil serine proteases play an important role in inflammation by modulating neutrophil effector functions. We have previously shown that neutrophils deficient in the serine proteases cathepsin G and neutrophil elastase (CG/NE neutrophils) exhibit severe defects in chemokine CXCL2 release and reactive oxygen species (ROS) production when activated on immobilized immune complex. Exogenously added active CG rescues these defects, but the mechanism remains undefined. Using a protease-based proteomic approach, we found that, in vitro, the addition of exogenous CG to immune complex-stimulated CG/NE neutrophils led to a decrease in the level of cell-associated annexin A1 (AnxA1) and cathelin-related antimicrobial peptide (CRAMP), both known inflammatory mediators. We further confirmed that, in vivo, CG was required for the extracellular release of AnxA1 and CRAMP in a subcutaneous air pouch model. In vitro, CG efficiently cleaved AnxA1, releasing the active N-terminal peptide Ac2-26, and processed CRAMP in limited fashion. Ac2-26 and CRAMP peptides enhanced the release of CXCL2 by CG/NE neutrophils in a dose-dependent manner via formyl peptide receptor (FPR) stimulation. Blockade of FPRs by an antagonist, Boc2 (t-Boc-Phe-D-Leu-Phe-D-Leu-Phe), abrogates CXCL2 release, whereas addition of FPR agonists, fMLF and F2L, relieves Boc2 inhibition. Furthermore, the addition of active CG, but not inactive CG, also relieves Boc2 inhibition. These findings suggest that CG modulates neutrophil effector functions partly by controlling the release (and proteolysis) of FPR agonists. Unexpectedly, we found that mature CRAMP, but not Ac2-26, induced ROS production through an FPR-independent pathway.	[Woloszynek, Josh C.; Hu, Ying; Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pham, CTN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, 660 S Euclid Ave,Bx 8045, St Louis, MO 63110 USA.	cpham@dom.wustl.edu			Arthritis Foundation; National Institutes of Health [AR007279, AI049261, AI049261-08S2, P30AR048335]; National Institutes of Health, NCI Cancer Center [P30 CA91842]; National Center for Research Resources, a component of the National Institutes of Health [UL1 RR024992]; National Institutes of Health Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049261, R01AI049261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335, T32AR007279] Funding Source: NIH RePORTER	Arthritis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a postdoctoral fellowship from the Arthritis Foundation (to J. C. W.), National Institutes of Health T32 Training Grant AR007279 (to J. C. W.), and the National Institutes of Health Grants AI049261 and supplemental AI049261-08S2 (to C. T. N. P.). The Siteman Cancer Center is supported in part by National Institutes of Health, NCI Cancer Center Support Grant P30 CA91842. The Speed Congenics Facility of the Rheumatic Diseases Core Center is supported by National Institutes of Health Grant P30AR048335. This work was also supported by Grant UL1 RR024992 from the National Center for Research Resources, a component of the National Institutes of Health and the National Institutes of Health Roadmap for Medical Research.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bjerknes R, 1997, EUR J ENDOCRINOL, V136, P92, DOI 10.1530/eje.0.1360092; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Bylund J, 2001, ANTIMICROB AGENTS CH, V45, P1700, DOI 10.1128/AAC.45.6.1700-1704.2001; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CIRINO G, 1993, BRIT J PHARMACOL, V108, P573, DOI 10.1111/j.1476-5381.1993.tb12843.x; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Hong SH, 2002, FEBS LETT, V532, P17, DOI 10.1016/S0014-5793(02)03613-X; HUANG KS, 1987, J BIOL CHEM, V262, P7639; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PEPINSKY RB, 1986, J BIOL CHEM, V261, P4239; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rafiq K, 2008, CIRC RES, V102, P32, DOI 10.1161/CIRCRESAHA.107.150573; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rescher U, 2006, BBA-MOL CELL RES, V1763, P1320, DOI 10.1016/j.bbamcr.2006.08.041; SMITH SF, 1990, ENVIRON HEALTH PERSP, V85, P135, DOI 10.2307/3430676; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stie J, 2007, J LEUKOCYTE BIOL, V82, P161, DOI 10.1189/jlb.0906586; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tsao FHC, 1998, AM J RESP CELL MOL, V18, P120, DOI 10.1165/ajrcmb.18.1.2808; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; VERBANAC D, 1993, FEBS LETT, V317, P255, DOI 10.1016/0014-5793(93)81287-A; Vishwanatha JK, 1998, CLIN CANCER RES, V4, P2559; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Won JH, 2003, BIOCHEM BIOPH RES CO, V307, P389, DOI 10.1016/S0006-291X(03)01197-5; Xu LM, 2009, INFLAMM RES, V58, P921, DOI 10.1007/s00011-009-0066-y; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang YH, 1997, INFLAMMATION, V21, P583, DOI 10.1023/A:1027330021479; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; Zarember KA, 2002, INFECT IMMUN, V70, P569, DOI 10.1128/IAI.70.2.569-576.2002; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zheng Y, 2007, BRIT J DERMATOL, V157, P1124, DOI 10.1111/j.1365-2133.2007.08196.x; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zuyderduyn S, 2006, J ALLERGY CLIN IMMUN, V117, P1328, DOI 10.1016/j.jaci.2006.03.022	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34101	34109		10.1074/jbc.M112.394452	http://dx.doi.org/10.1074/jbc.M112.394452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879591	Green Published, hybrid			2022-12-25	WOS:000309654200016
J	Guo, J; Wang, TZ; Li, X; Shallow, H; Yang, TH; Li, WT; Xu, JM; Fridman, MD; Yang, XL; Zhang, ST				Guo, Jun; Wang, Tingzhong; Li, Xian; Shallow, Heidi; Yang, Tonghua; Li, Wentao; Xu, Jianmin; Fridman, Michael D.; Yang, Xiaolong; Zhang, Shetuan			Cell Surface Expression of Human Ether-a-go-go-related Gene (hERG) Channels Is Regulated by Caveolin-3 Protein via the Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; SHORT-QT SYNDROME; I-KR; POTASSIUM CHANNEL; MEMBRANE-PROTEINS; EXTRACELLULAR K+; FAMILY; IDENTIFICATION; DEGRADATION; ENDOCYTOSIS	The human ether-a-go-go-related gene (hERG) encodes the rapidly activating delayed rectifier potassium channel (I-Kr) which plays an important role in cardiac repolarization. A reduction or increase in hERG current can cause long or short QT syndrome, respectively, leading to fatal cardiac arrhythmias. The channel density in the plasma membrane is a key determinant of the whole cell current amplitude. To gain insight into the molecular mechanisms for the regulation of hERG density at the plasma membrane, we used whole cell voltage clamp, Western blotting, and immunocytochemical methods to investigate the effects of an integral membrane protein, caveolin-3 (Cav3) on hERG expression levels. Our data demonstrate that Cav3, hERG, and ubiquitin-ligase Nedd4-2 interact with each other and form a complex. Expression of Cav3 thus enhances the hERG-Nedd4-2 interaction, leading to an increased ubiquitination and degradation of mature, plasma-membrane localized hERG channels. Disrupting Nedd4-2 interaction with hERG by mutations eliminates the effects of Cav3 on hERG channels. Knockdown of endogenous Cav3 or Nedd4-2 in cultured neonatal rat ventricular myocytes using siRNA led to an increase in native I-Kr. Our data demonstrate that hERG expression in the plasma membrane is regulated by Cav3 via Nedd4-2. These findings extend our understanding of the regulation of hERG channels and cardiac electrophysiology.	[Guo, Jun; Wang, Tingzhong; Li, Xian; Shallow, Heidi; Yang, Tonghua; Li, Wentao; Xu, Jianmin; Fridman, Michael D.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall,Rm 429, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Wang, Tingzhong/0000-0002-6390-7967; Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research Grant [MOP 72911]; Heart and Stroke Foundation of Ontario Grant [T 6612]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Grant	This work was supported by the Canadian Institutes of Health Research Grant MOP 72911 and the Heart and Stroke Foundation of Ontario Grant T 6612 (to S. Z.).	Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2011, J BIOL CHEM, V286, P34664, DOI 10.1074/jbc.M111.253351; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shallow H, 2011, BIOPHYS J, V100, P102; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	46	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33132	33141		10.1074/jbc.M112.389643	http://dx.doi.org/10.1074/jbc.M112.389643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879586	Green Published, hybrid			2022-12-25	WOS:000309602100005
J	Jung, HI; Gayomba, SR; Rutzke, MA; Craft, E; Kochian, LV; Vatamaniuk, OK				Jung, Ha-il; Gayomba, Sheena R.; Rutzke, Michael A.; Craft, Eric; Kochian, Leon V.; Vatamaniuk, Olena K.			COPT6 Is a Plasma Membrane Transporter That Functions in Copper Homeostasis in Arabidopsis and Is a Novel Target of SQUAMOSA Promoter-binding Protein-like 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; MOLECULAR CHARACTERIZATION; OXIDATIVE STRESS; DOWN-REGULATION; GENE; YEAST; EXPRESSION; DEGRADATION; ELEMENTS	Among the mechanisms controlling copper homeostasis in plants is the regulation of its uptake and tissue partitioning. Here we characterized a newly identified member of the conserved CTR/COPT family of copper transporters in Arabidopsis thaliana, COPT6. We showed that COPT6 resides at the plasma membrane and mediates copper accumulation when expressed in the Saccharomyces cerevisiae copper uptake mutant. Although the primary sequence of COPT6 contains the family conserved domains, including methionine-rich motifs in the extracellular N-terminal domain and a second transmembrane helix (TM2), it is different from the founding family member, S. cerevisiae Ctr1p. This conclusion was based on the finding that although the positionally conserved Met(106) residue in the TM2 of COPT6 is functionally essential, the conserved Met(27) in the N-terminal domain is not. Structure-function studies revealed that the N-terminal domain is dispensable for COPT6 function in copper-replete conditions but is important under copper-limiting conditions. In addition, COPT6 interacts with itself and with its homolog, COPT1, unlike Ctr1p, which interacts only with itself. Analyses of the expression pattern showed that although COPT6 is expressed in different cell types of different plant organs, the bulk of its expression is located in the vasculature. We also show that COPT6 expression is regulated by copper availability that, in part, is controlled by a master regulator of copper homeostasis, SPL7. Finally, studies using the A. thaliana copt6-1 mutant and plants overexpressing COPT6 revealed its essential role during copper limitation and excess.	[Jung, Ha-il; Gayomba, Sheena R.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Rutzke, Michael A.; Craft, Eric; Kochian, Leon V.] Cornell Univ, Robert W Holley Ctr Agr & Hlth, USDA ARS, Ithaca, NY 14853 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA)	Vatamaniuk, OK (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Kochian, Leon/ABH-6148-2020	Kochian, Leon/0000-0003-3416-089X	Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch [125433]; USDA-CSREES NYC-MRF [S1041 125853]; Cornell start-up grant	Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch; USDA-CSREES NYC-MRF(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Cornell start-up grant	This work was supported by the Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch 125433, USDA-CSREES NYC-MRF S1041 125853, and a Cornell start-up grant (to O. K. V).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andres-Colas N, 2010, PLANT PHYSIOL, V153, P170, DOI 10.1104/pp.110.153676; Arteca RN, 2000, PHYSIOL PLANTARUM, V108, P188, DOI 10.1034/j.1399-3054.2000.108002188.x; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohu CM, 2007, PHYSIOL PLANTARUM, V129, P747, DOI 10.1111/j.1399-3054.2007.00879.x; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2007, BIOMETALS, V20, P705, DOI 10.1007/s10534-006-9054-7; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Garcia-Molina A, 2011, PLANT J, V65, P848, DOI 10.1111/j.1365-313X.2010.04472.x; Gavnholt B, 2002, PHYSIOL PLANTARUM, V116, P273, DOI 10.1034/j.1399-3054.2002.1160301.x; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jung HI, 2011, METHODS MOL BIOL, V744, P109, DOI 10.1007/978-1-61779-123-9_8; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Kim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012938; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Klaumann S, 2011, NEW PHYTOL, V192, P393, DOI 10.1111/j.1469-8137.2011.03798.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lequeux H, 2010, PLANT PHYSIOL BIOCH, V48, P673, DOI 10.1016/j.plaphy.2010.05.005; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; MURPHY A, 1995, PLANT PHYSIOL, V108, P29, DOI 10.1104/pp.108.1.29; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sancenon V, 2004, J BIOL CHEM, V279, P15348, DOI 10.1074/jbc.M313321200; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Xiao ZG, 2002, CHEM COMMUN, P588, DOI 10.1039/b111180a; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yonkovich J, 2002, J BIOL CHEM, V277, P23981, DOI 10.1074/jbc.C200203200; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhai Zhiyang, 2009, J Vis Exp, DOI 10.3791/1149; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	73	60	68	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33252	33267		10.1074/jbc.M112.397810	http://dx.doi.org/10.1074/jbc.M112.397810			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865877	hybrid, Green Published			2022-12-25	WOS:000309602100015
J	Nishimura, R; Wakabayashi, M; Hata, K; Matsubara, T; Honma, S; Wakisaka, S; Kiyonari, H; Shioi, G; Yamaguchi, A; Tsumaki, N; Akiyama, H; Yoneda, T				Nishimura, Riko; Wakabayashi, Makoto; Hata, Kenji; Matsubara, Takuma; Honma, Shiho; Wakisaka, Satoshi; Kiyonari, Hiroshi; Shioi, Go; Yamaguchi, Akira; Tsumaki, Noriyuki; Akiyama, Haruhiko; Yoneda, Toshiyuki			Osterix Regulates Calcification and Degradation of Chondrogenic Matrices through Matrix Metalloproteinase 13 (MMP13) Expression in Association with Transcription Factor Runx2 during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CHONDROCYTE DIFFERENTIATION; COLLAGEN GENE; OSTEOBLAST DIFFERENTIATION; CAMPOMELIC DYSPLASIA; BONE-DEVELOPMENT; GROWTH-PLATE; II COLLAGEN; CARTILAGE	Endochondral ossification is temporally and spatially regulated by several critical transcription factors, including Sox9, Runx2, and Runx3. Although the molecular mechanisms that control the late stages of endochondral ossification (e.g. calcification) are physiologically and pathologically important, these precise regulatory mechanisms remain unclear. Here, we demonstrate that Osterix is an essential transcription factor for endochondral ossification that functions downstream of Runx2. The global and conditional Osterix-deficient mice studied here exhibited a defect of cartilage-matrix ossification and matrix vesicle formation. Importantly, Osterix deficiencies caused the arrest of endochondral ossification at the hypertrophic stage. Microarray analysis revealed that matrix metallopeptidase 13 (MMP13) is an important target of Osterix. We also showed that there exists a physical interaction between Osterix and Runx2 and that these proteins function cooperatively to induce MMP13 during chondrocyte differentiation. Most interestingly, the introduction of MMP13 stimulated the calcification of matrices in Osterix-deficient mouse limb bud cells. Our results demonstrated that Osterix was essential to endochondral ossification and revealed that the physical and functional interaction between Osterix and Runx2 were necessary for the induction of MMP13 during endochondral ossification.	[Nishimura, Riko; Wakabayashi, Makoto; Hata, Kenji; Matsubara, Takuma; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Honma, Shiho; Wakisaka, Satoshi] Osaka Univ, Dept Oral Anat, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kiyonari, Hiroshi; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Yamaguchi, Akira] Tokyo Med Dent Sch, Dept Oral Pathol, Bunkyo Ku, Tokyo 1138549, Japan; [Tsumaki, Noriyuki] Osaka Univ, Dept Orthoped, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthoped, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Kyoto University	Nishimura, R (corresponding author), Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Matsubara, Takuma/B-5031-2019; Yamaguchi, Akira/AAX-9286-2020; Kiyonari, Hiroshi/N-7936-2015	Matsubara, Takuma/0000-0002-8505-0431; Tsumaki, Noriyuki/0000-0002-0520-3654; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research; 21st Century COE Program; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research; 21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research (to T. Y. and R. N.); the 21st Century COE Program (to T. Y. and R. N.); the Uehara Memorial Foundation (to R. N.); and the Astellas Foundation for Research on Metabolic Disorders (to R. N.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kawaguchi H, 2008, MOL CELLS, V25, P1; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu Y, 2000, J BIOL CHEM, V275, P12712, DOI 10.1074/jbc.275.17.12712; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Takahashi I, 1998, J CELL SCI, V111, P2067; Takigawa Y, 2010, J CELL SCI, V123, P3780, DOI 10.1242/jcs.071373; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	38	114	122	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33179	33190		10.1074/jbc.M111.337063	http://dx.doi.org/10.1074/jbc.M111.337063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869368	Green Published, hybrid			2022-12-25	WOS:000309602100009
J	Su, WM; Han, GS; Casciano, J; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Casciano, Jessica; Carman, George M.			Protein Kinase A-mediated Phosphorylation of Pah1p Phosphatidate Phosphatase Functions in Conjunction with the Pho85p-Pho80p and Cdc28p-Cyclin B Kinases to Regulate Lipid Synthesis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CTP SYNTHETASE; PHOSPHOLIPID-SYNTHESIS; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; MEMBRANE-PROTEINS; ORTHOLOGUE PAH1P; CHOLINE KINASE; METABOLISM; IDENTIFICATION	Pah1p, which functions as phosphatidate phosphatase (PAP) in the yeast Saccharomyces cerevisiae, plays a crucial role in lipid homeostasis by controlling the relative proportions of its substrate phosphatidate and its product diacylglycerol. The diacylglycerol produced by PAP is used for the synthesis of triacylglycerol as well as for the synthesis of phospholipids via the Kennedy pathway. Pah1p is a highly phosphorylated protein in vivo and has been previously shown to be phosphorylated by the protein kinases Pho85p-Pho80p and Cdc28p-cyclin B. In this work, we showed that Pah1p was a bona fide substrate for protein kinase A, and we identified by mass spectrometry and mutagenesis that Ser-10, Ser-677, Ser-773, Ser-774, and Ser-788 were the target sites of phosphorylation. Protein kinase A-mediated phosphorylation of Pah1p inhibited its PAP activity by decreasing catalytic efficiency, and the inhibitory effect was primarily conferred by phosphorylation at Ser-10. Analysis of the S10A and S10D mutations (mimicking dephosphorylation and phosphorylation, respectively), alone or in combination with the seven alanine (7A) mutations of the sites phosphorylated by Pho85p-Pho80p and Cdc28p-cyclin B, indicated that phosphorylation at Ser-10 stabilized Pah1p abundance and inhibited its association with membranes, PAP activity, and triacylglycerol synthesis. The S10A mutation enhanced the physiological effects imparted by the 7A mutations, whereas the S10D mutations attenuated the effects of the 7A mutations. These data indicated that the protein kinase A-mediated phosphorylation of Ser-10 functions in conjunction with the phosphorylations mediated by Pho85p-Pho80p and Cdc28p-cyclin B and that phospho-Ser-10 should be dephosphorylated for proper PAP function.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from the USPHS [GM-50679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 from the USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; CULBERTSON MR, 1975, GENETICS, V80, P23; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	85	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33364	33376		10.1074/jbc.M112.402339	http://dx.doi.org/10.1074/jbc.M112.402339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865862	Green Published, hybrid			2022-12-25	WOS:000309602100024
J	Huang, CD; Bhaskaran, R; Mohanty, S				Huang, Chengdong; Bhaskaran, Rajagopalan; Mohanty, Smita			Eukaryotic N-Glycosylation Occurs via the Membrane-anchored C-terminal Domain of the Stt3p Subunit of Oligosaccharyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OLIGOSACCHARYLTRANSFERASE; YEAST OLIGOSACCHARYLTRANSFERASE; TRANSFERASE COMPLEX; NMR-SPECTROSCOPY; LEISHMANIA-MAJOR; PROTEIN; RECOGNITION; SEQUENCE; SYNTHASE; BIOLOGY	N-Glycosylation is an essential and highly conserved protein modification. In eukaryotes, it is catalyzed by a multisubunit membrane-associated enzyme, oligosaccharyltransferase (OT). We report the high resolution structure of the C-terminal domain of eukaryotic Stt3p. Unlike its soluble beta-sheet-rich prokaryotic counterparts, our model reveals that the C-terminal domain of yeast Stt3p is highly helical and has an overall oblate spheroid-shaped structure containing a membrane-embedded region. Anchoring of this protein segment to the endoplasmic reticulum membrane is likely to bring the membrane-embedded donor substrate closer, thus facilitating glycosylation efficiency. Structural comparison of the region near the WWDYG signature motif revealed that the acceptor substrate-binding site of yeast OT strikingly resembles its prokaryotic counterparts, suggesting a conserved mechanism of N-glycosylation from prokaryotes to eukaryotes. Furthermore, comparison of the NMR and cryo-EM structures of yeast OT revealed that the molecular architecture of this acceptor substrate-recognizing domain has interesting spatial specificity for interactions with other essential OT subunits.	[Huang, Chengdong; Bhaskaran, Rajagopalan; Mohanty, Smita] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Auburn University System; Auburn University	Mohanty, S (corresponding author), Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg,Mell St, Auburn, AL 36849 USA.	mohansm@auburn.edu	Mohanty, Smita/AAP-2969-2021; Huang, Chengdong/G-8454-2018	Huang, Chengdong/0000-0002-8997-9459; Bhaskaran, Raj/0000-0001-8008-9962	National Institutes of Health [GM66340, DK082397]; United States Department of Agriculture PECASE [2003-35302-12930, 2011-65503-20030]; National Science Foundation [IBN-0628064]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture PECASE; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The 900-MHz NMR data were collected at the NMR Facility of the University of Georgia, funded by National Institutes of Health Grant GM66340. We thank Dr. Uma V. Katre for critical reading of the manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grant DK082397 (to S. M.). This work was also supported by United States Department of Agriculture PECASE Award 2003-35302-12930 and Grant 2011-65503-20030 and by National Science Foundation Grant IBN-0628064 (to S. M.).	Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Gayen S, 2011, BIOCHEM BIOPH RES CO, V409, P572, DOI 10.1016/j.bbrc.2011.05.050; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Huang CD, 2010, J AM CHEM SOC, V132, P3662, DOI 10.1021/ja100078z; Huang CD, 2010, BIOCHEMISTRY-US, V49, P1115, DOI 10.1021/bi902181v; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lennarz WJ, 2007, ACTA BIOCHIM POL, V54, P673, DOI 10.18388/abp.2007_3131; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Yan Q, 1999, J BIOL CHEM, V274, P5021, DOI 10.1074/jbc.274.8.5021; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Zubkov S, 2004, P NATL ACAD SCI USA, V101, P3821, DOI 10.1073/pnas.0400512101	43	7	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32450	32458		10.1074/jbc.M112.342253	http://dx.doi.org/10.1074/jbc.M112.342253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865878	hybrid, Green Published			2022-12-25	WOS:000309168300015
J	Qi, RS; Singh, D; Kao, CC				Qi, Rongsu; Singh, Divyendu; Kao, C. Cheng			Proteolytic Processing Regulates Toll-like Receptor 3 Stability and Endosomal Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; NUCLEIC-ACID; BINDING-SITE; TLR3; RECOGNITION; ACTIVATION; UNC93B1; DNA	Toll-like receptors (TLRs) 3, 7, and 9 are innate immune receptors that recognize nucleic acids from pathogens in endosomes and initiate signaling transductions that lead to cytokine production. Activation of TLR9 for signaling requires proteolytic processing within the ectodomain by endosome-associated proteases. Whether TLR3 requires similar proteolytic processing to become competent for signaling remains unclear. Herein we report that human TLR3 is proteolytically processed to form two fragments in endosomes. Unc93b1 is required for processing by transporting TLR3 through the Golgi complex and to the endosomes. Proteolytic cleavage requires the eight-amino acid Loop1 within leucine-rich repeat 12 of the TLR3 ectodomain. Proteolytic cleavage is not required for TLR3 signaling in response to poly(I:C), although processing could modulate the degree of response toward viral double-stranded RNAs, especially in mouse cells. Both the full-length and cleaved fragments of TLR3 can bind poly(I:C) and are present in endosomes. However, although the full-length TLR3 has a half-life in HEK293T cells of 3 h, the cleaved fragments have half-lives in excess of 7 h. Inhibition of TLR3 cleavage by either treatment with cathepsin inhibitor or by a mutation in Loop1 decreased the abundance of TLR3 in endosomes targeted for lysosomal degradation.	[Qi, Rongsu; Singh, Divyendu; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA	Indiana University System; Indiana University Bloomington	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA.	ckao@indiana.edu			Indiana Economic Development Corp.	Indiana Economic Development Corp.	This work was supported in part by a grant from the Indiana Economic Development Corp. (to C. C. K.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Avalos AM, 2011, EUR J IMMUNOL, V41, P2820, DOI 10.1002/eji.201141563; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2006, J ENDOTOXIN RES, V12, P375, DOI 10.1179/096805106X118780; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; CHEN JW, 1986, BIOCHEM SOC SYMP, P97; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fukuda K, 2008, J BIOL CHEM, V283, P22787, DOI 10.1074/jbc.M802284200; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Stenmark H, 2001, GENOME BIOL, V2; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tokisue Takashi, 2008, Nucleic Acids Symp Ser (Oxf), P203, DOI 10.1093/nass/nrn103; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Weber C, 2012, IMMUNOLOGY, V136, P64, DOI 10.1111/j.1365-2567.2012.03559.x; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186	50	69	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32617	32629		10.1074/jbc.M112.387803	http://dx.doi.org/10.1074/jbc.M112.387803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865861	Green Published, hybrid			2022-12-25	WOS:000309168300030
J	Kolotilin, I; Kaldis, A; Devriendt, B; Joensuu, J; Cox, E; Menassa, R				Kolotilin, Igor; Kaldis, Angelo; Devriendt, Bert; Joensuu, Jussi; Cox, Eric; Menassa, Rima			Production of a Subunit Vaccine Candidate against Porcine Post-Weaning Diarrhea in High-Biomass Transplastomic Tobacco	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; PSBA MESSENGER-RNA; HIGH-LEVEL EXPRESSION; F4 K88 FIMBRIAE; TRANSGENIC TOBACCO; ORAL IMMUNIZATION; MAJOR SUBUNIT; CHLOROPLAST TRANSFORMATION; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION	Post-weaning diarrhea (PWD) in piglets is a major problem in piggeries worldwide and results in severe economic losses. Infection with Enterotoxigenic Escherichia coli (ETEC) is the key culprit for the PWD disease. F4 fimbriae of ETEC are highly stable proteinaceous polymers, mainly composed of the major structural subunit FaeG, with a capacity to evoke mucosal immune responses, thus demonstrating a potential to act as an oral vaccine against ETEC-induced porcine PWD. In this study we used a transplastomic approach in tobacco to produce a recombinant variant of the FaeG protein, rFaeG(ntd/dsc), engineered for expression as a stable monomer by N-terminal deletion and donor strand-complementation (ntd/dsc). The generated transplastomic tobacco plants accumulated up to 2.0 g rFaeG(ntd/dsc) per 1 kg fresh leaf tissue (more than 1% of dry leaf tissue) and showed normal phenotype indistinguishable from wild type untransformed plants. We determined that chloroplast-produced rFaeG(ntd/dsc) protein retained the key properties of an oral vaccine, i.e. binding to porcine intestinal F4 receptors (F4R), and inhibition of the F4-possessing (F4+) ETEC attachment to F4R. Additionally, the plant biomass matrix was shown to delay degradation of the chloroplast-produced rFaeG(ntd/dsc) in gastrointestinal conditions, demonstrating a potential to function as a shelter-vehicle for vaccine delivery. These results suggest that transplastomic plants expressing the rFaeG(ntd/dsc) protein could be used for production and, possibly, delivery of an oral vaccine against porcine F4+ ETEC infections. Our findings therefore present a feasible approach for developing an oral vaccination strategy against porcine PWD.	[Kolotilin, Igor; Kaldis, Angelo; Menassa, Rima] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada; [Devriendt, Bert; Cox, Eric] Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium; [Joensuu, Jussi] VTT Tech Res Ctr Finland, Espoo, Finland	Agriculture & Agri Food Canada; Ghent University; VTT Technical Research Center Finland	Kolotilin, I (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada.	rima.menassa@agr.gc.ca	Devriendt, Bert/AAM-6666-2021	Devriendt, Bert/0000-0002-3222-8769; Menassa, Rima/0000-0003-3536-0332; Cox, Eric/0000-0003-4281-2990	A-base; Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada	A-base; Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada	This study was supported by A-base funding and the Cellulosic Biofuels Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Adil, 2010, Recent Pat Biotechnol, DOI 10.2174/187220810793611464; Arlen PA, 2007, PLANT BIOTECHNOL J, V5, P511, DOI 10.1111/j.1467-7652.2007.00258.x; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; BERTSCHINGER HU, 1999, DIS SWINE, P431; Bock R, 2007, CURR OPIN BIOTECH, V18, P100, DOI 10.1016/j.copbio.2006.12.001; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calinescu C, 2007, INT J PHARMACEUT, V343, P18, DOI 10.1016/j.ijpharm.2007.04.017; Caloca MJ, 2007, COMP IMMUNOL MICROB, V30, P187, DOI 10.1016/j.cimid.2006.12.003; Caloca MJ, 2006, COMP IMMUNOL MICROB, V29, P225, DOI 10.1016/j.cimid.2006.06.001; CIOSEK D, 1983, COMP IMMUNOL MICROB, V6, P313, DOI 10.1016/0147-9571(83)90024-3; Clarke JL, 2011, PLANT MOL BIOL, V76, P211, DOI 10.1007/s11103-011-9767-z; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; Daniell H, 2005, VACCINE, V23, P1779, DOI 10.1016/j.vaccine.2004.11.004; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Drechsel O, 2011, NUCLEIC ACIDS RES, V39, P1427, DOI 10.1093/nar/gkq978; Eibl C, 1999, PLANT J, V19, P333, DOI 10.1046/j.1365-313X.1999.00543.x; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Farran I, 2008, PLANT BIOTECHNOL J, V6, P516, DOI 10.1111/j.1467-7652.2008.00334.x; Fernandez-San Millan A, 2003, PLANT BIOTECHNOL J, V1, P71, DOI 10.1046/j.1467-7652.2003.00008.x; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; GAASTRA W, 1983, FEMS MICROBIOL LETT, V18, P177, DOI 10.1111/j.1574-6968.1983.tb00474.x; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Hampson D. J., 1994, P171; Harris LJ, 2001, PHYSIOL MOL PLANT P, V58, P173, DOI 10.1006/pmpp.2001.0326; Huang YH, 2006, J MICROBIOL, V44, P548; Huang YH, 2003, INFECT IMMUN, V71, P5436, DOI 10.1128/IAI.71.9.5436-5439.2003; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; Joensuu JJ, 2004, TRANSGENIC RES, V13, P295, DOI 10.1023/B:TRAG.0000034621.55404.70; Joensuu JJ, 2006, TRANSGENIC RES, V15, P359, DOI 10.1007/s11248-006-0010-7; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; JONES GW, 1972, INFECT IMMUN, V6, P918, DOI 10.1128/IAI.6.6.918-927.1972; JOSEPHSEN J, 1984, FEMS MICROBIOL LETT, V25, P301, DOI 10.1111/j.1574-6968.1984.tb01476.x; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; KLEMM P, 1981, EUR J BIOCHEM, V117, P617; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Lee MYT, 2006, BIOTECHNOL BIOENG, V94, P1129, DOI 10.1002/bit.20948; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maliga P, 2003, TRENDS BIOTECHNOL, V21, P20, DOI 10.1016/S0167-7799(02)00007-0; Matoba N, 2011, METHODS MOL BIOL, V701, P199, DOI 10.1007/978-1-61737-957-4_11; McCabe MS, 2008, PLANT BIOTECHNOL J, V6, P914, DOI 10.1111/j.1467-7652.2008.00365.x; McGhee J. R., 1999, MUCOSAL IMMUNOLOGY, P485; Melkebeek V, 2007, VET IMMUNOL IMMUNOP, V116, P199, DOI 10.1016/j.vetimm.2007.01.021; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Menassa R, 2007, PLANT BIOTECHNOL J, V5, P50, DOI 10.1111/j.1467-7652.2006.00214.x; Merchant HA, 2011, EUR J PHARM SCI, V42, P3, DOI 10.1016/j.ejps.2010.09.019; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Molina A, 2004, PLANT BIOTECHNOL J, V2, P141, DOI 10.1046/j.1467-7652.2004.00057.x; Nadai M, 2009, TRANSGENIC RES, V18, P173, DOI 10.1007/s11248-008-9209-0; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; ORSKOV I, 1964, ACTA PATHOL MIC SC, V62, P439, DOI 10.1111/apm.1964.62.3.439; Rasschaert K, 2007, VET MICROBIOL, V123, P249, DOI 10.1016/j.vetmic.2007.02.017; Rice J., 2005, Animal Health Research Reviews, V6, P199, DOI 10.1079/AHR2005110; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; RUSSELL TL, 1993, PHARMACEUT RES, V10, P187, DOI 10.1023/A:1018970323716; Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5; Shen HF, 2010, ACTA BIOCH BIOPH SIN, V42, P558, DOI 10.1093/abbs/gmq060; Snoeck V, 2004, J CONTROL RELEASE, V94, P143, DOI 10.1016/j.jconrel.2003.09.015; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; STAUB JM, 1993, EMBO J, V12, P601, DOI 10.1002/j.1460-2075.1993.tb05692.x; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Svab Z, 2007, P NATL ACAD SCI USA, V104, P7003, DOI 10.1073/pnas.0700063104; The United States Pharmacopeia, 2011, GASTR FLUID SIM TS, V1, P968; The United States Pharmacopeia, 1990, GASTR FLUID SIM TS; The United States Pharmacopeia, 2011, PANCR, V3, P3803; The United States Pharmacopeia, 2011, INT FLUID SIM TS, V1, P969; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Tregoning JS, 2003, NUCLEIC ACIDS RES, V31, P1174, DOI 10.1093/nar/gkg221; Van den Broeck W, 2002, VET IMMUNOL IMMUNOP, V85, P171, DOI 10.1016/S0165-2427(01)00429-9; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; Van den Broeck W, 2000, VET MICROBIOL, V71, P223, DOI 10.1016/S0378-1135(99)00174-1; Van Molle I, 2007, J MOL BIOL, V368, P791, DOI 10.1016/j.jmb.2007.02.051; Van Molle I, 2009, J MOL BIOL, V394, P957, DOI 10.1016/j.jmb.2009.09.059; VERA A, 1995, CURR GENET, V27, P280, DOI 10.1007/BF00326161; Verdonck F, 2004, VACCINE, V22, P4291, DOI 10.1016/j.vaccine.2004.04.016; Verdonck F, 2004, VET MICROBIOL, V102, P215, DOI 10.1016/j.vetmic.2004.06.002; Verdonck F, 2008, VACCINE, V26, P5728, DOI 10.1016/j.vaccine.2008.08.017; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wirth S, 2006, J BIOTECHNOL, V125, P159, DOI 10.1016/j.jbiotec.2006.02.012; Yu LX, 2007, J BIOTECHNOL, V131, P362, DOI 10.1016/j.jbiotec.2007.07.942; Zhou F, 2008, PLANT BIOTECHNOL J, V6, P897, DOI 10.1111/j.1467-7652.2008.00356.x; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x	92	30	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42405	10.1371/journal.pone.0042405	http://dx.doi.org/10.1371/journal.pone.0042405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879967	Green Published, gold			2022-12-25	WOS:000307284100081
J	Nair, NU; Das Sahu, A; Bucher, P; Moret, BME				Nair, Nishanth Ulhas; Das Sahu, Avinash; Bucher, Philipp; Moret, Bernard M. E.			ChIPnorm: A Statistical Method for Normalizing and Identifying Differential Regions in Histone Modification ChIP-seq Libraries	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENES; IDENTIFICATION; PROFILES; SITES	The advent of high-throughput technologies such as ChIP-seq has made possible the study of histone modifications. A problem of particular interest is the identification of regions of the genome where different cell types from the same organism exhibit different patterns of histone enrichment. This problem turns out to be surprisingly difficult, even in simple pairwise comparisons, because of the significant level of noise in ChIP-seq data. In this paper we propose a two-stage statistical method, called ChIPnorm, to normalize ChIP-seq data, and to find differential regions in the genome, given two libraries of histone modifications of different cell types. We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods. We correlate the histone marks with gene expression data and confirm that histone modifications H3K27me3 and H3K4me3 act as respectively a repressor and an activator of genes. Compared to what was previously reported in the literature, we find that a substantially higher fraction of bivalent marks in ES cells for H3K27me3 and H3K4me3 move into a K27-only state. We find that most of the promoter regions in protein-coding genes have differential histone-modification sites. The software for this work can be downloaded from http://lcbb.epfl.ch/software.html.	[Nair, Nishanth Ulhas; Moret, Bernard M. E.] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lab Computat Biol & Bioinformat, Lausanne, Switzerland; [Das Sahu, Avinash] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Bucher, Philipp] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Bucher, Philipp; Moret, Bernard M. E.] Swiss Inst Bioinformat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University System of Maryland; University of Maryland College Park; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Nair, NU (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lab Computat Biol & Bioinformat, Lausanne, Switzerland.	philipp.bucher@isb-sib.ch; bernard.moret@epfl.ch	Nair, Nishanth Ulhas/AFZ-7133-2022	Nair, Nishanth Ulhas/0000-0002-8832-0329; Sahu, Avinash/0000-0002-2193-6276; Moret, Bernard/0000-0003-1549-4544	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NUN's work was supported by a grant from the Swiss National Science Foundation. The authors would like to thank the reviewers and the editor for their helpful comments.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brusslan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033151; Buske OJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-415; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dudoit S, 2002, STAT SINICA, V12, P111; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Lehninger A., 2005, LEHNINGER PRINCIPLES; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	31	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e39573	10.1371/journal.pone.0039573	http://dx.doi.org/10.1371/journal.pone.0039573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870189	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100003
J	Nodehi, SM; Repp, R; Kellner, C; Brautigam, J; Staudinger, M; Schub, N; Peipp, M; Gramatzki, M; Humpe, A				Nodehi, Sahar Mohseni; Repp, Roland; Kellner, Christian; Braeutigam, Joachim; Staudinger, Matthias; Schub, Natalie; Peipp, Matthias; Gramatzki, Martin; Humpe, Andreas			Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed against the AML Stem Cell Antigen CD96	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; LECTIN-LIKE MOLECULE-1; SINGLE-CHAIN FV; HUMAN IGG1; GAMMA-RIII; RECEPTOR; CYTOTOXICITY; EXPRESSION; BINDING	CD96, a cell surface antigen recently described to be preferentially expressed on acute myeloid leukemia (AML) leukemic stem cells (LSC) may represent an interesting target structure for the development of antibody-based therapeutic approaches. The v-regions from the CD96-specific hybridoma TH-111 were isolated and used to generate a CD96-specific single chain fragment of the variable regions (scFv). An affinity maturated variant resulting in 4-fold enhanced CD96-binding was generated by random mutagenesis and stringent selection using phage display. The affinity maturated scFv CD96-S32F was used to generate bivalent mini-antibodies by genetically fusing an IgG1 wild type Fc region or a variant with enhanced CD16a binding. Antibody dependent cell-mediated cytotoxicity (ADCC) experiments revealed that Fc engineering was essential to trigger significant effector cell-mediated lysis when the wild type scFv was used. The mini-antibody variant generated by fusing the affinity-maturated scFv with the optimized Fc variant demonstrated the highest ADCC activity (2.3-fold enhancement in efficacy). In conclusion, our data provide proof of concept that CD96 could serve as a target structure for effector cell-mediated lysis and demonstrate that both enhancing affinity for CD96 and for CD16a resulted in mini-antibodies with the highest cytolytic potential.	[Nodehi, Sahar Mohseni; Repp, Roland; Kellner, Christian; Staudinger, Matthias; Schub, Natalie; Peipp, Matthias; Gramatzki, Martin; Humpe, Andreas] Univ Kiel, Inst Zool, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, D-24098 Kiel, Germany; [Braeutigam, Joachim] Univ Kiel, Inst Zool, Dept Biol Struct, D-24098 Kiel, Germany	University of Kiel; University of Kiel	Nodehi, SM (corresponding author), Univ Kiel, Inst Zool, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, D-24098 Kiel, Germany.	a.humpe@med2.uni-kiel.de	Peipp, Matthias/A-8775-2013; Kellner, Christian/G-4238-2015	Kellner, Christian/0000-0002-2562-6902; Peipp, Matthias/0000-0002-5088-3804	Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany) [DJCLS R 08/01]; Wilhelm Sander-Stiftung (Neustadt, Germany) [2007.065.1]; FAZIT-Stiftung (Frankfurt am Main, Germany)	Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany); Wilhelm Sander-Stiftung (Neustadt, Germany); FAZIT-Stiftung (Frankfurt am Main, Germany)	This study was supported by research grant DJCLS R 08/01 from the Deutsche Jose Carreras Leukaemie Stiftung e.V. (Munich, Germany;http://www.carreras-stiftung.de/) and research grant 2007.065.1 from the Wilhelm Sander-Stiftung (Neustadt, Germany; http://www.sanst.de/cms/front_content.php), SMN was supported by the FAZIT-Stiftung (Frankfurt am Main, Germany; http://www.fazit-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GP, 1993, CANCER RES, V53, P4026; Bakker ABH, 2004, CANCER RES, V64, P8443, DOI 10.1158/0008-5472.CAN-04-1659; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; CARROLL WL, 1988, MOL IMMUNOL, V25, P991, DOI 10.1016/0161-5890(88)90005-3; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Desjarlais JR, 2007, DRUG DISCOV TODAY, V12, P898, DOI 10.1016/j.drudis.2007.08.009; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gramatzki M, 1998, EXP HEMATOL, V26, P1209; Guan Y, 2000, LEUKEMIA, V14, P2135, DOI 10.1038/sj.leu.2401975; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hayden-Ledbetter MS, 2009, CLIN CANCER RES, V15, P2739, DOI 10.1158/1078-0432.CCR-08-1694; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kabat EA, 1991, SEQUENCES PROTEINS I; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kugler M, 2010, BRIT J HAEMATOL, V150, P574, DOI 10.1111/j.1365-2141.2010.08300.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafrenie RM, 2007, EXPERT OPIN THER TAR, V11, P727, DOI 10.1517/14728222.11.6.727; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Majeti R, 2011, ONCOGENE, V30, P1009, DOI 10.1038/onc.2010.511; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; McCall AM, 2001, J IMMUNOL, V166, P6112, DOI 10.4049/jimmunol.166.10.6112; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Repp R, 2011, J IMMUNOL METHODS; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Toleikis Lars, 2004, Methods Mol Med, V94, P447; Vercauteren SM, 2007, CYTOTHERAPY, V9, P194, DOI 10.1080/14653240601164042; Vidarsson G, 2001, J IMMUNOL METHODS, V249, P245, DOI 10.1016/S0022-1759(00)00337-9; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JH, 2009, J BIOL CHEM, V284, P595, DOI 10.1074/jbc.M804089200; WANG PL, 1992, J IMMUNOL, V148, P2600; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zhao XB, 2007, BLOOD, V110, P2569, DOI 10.1182/blood-2006-12-062927; Zhao XX, 2010, HAEMATOL-HEMATOL J, V95, P71, DOI 10.3324/haematol.2009.009811	53	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42426	10.1371/journal.pone.0042426	http://dx.doi.org/10.1371/journal.pone.0042426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879978	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100088
J	Callander, GE; Ma, S; Ganella, DE; Wimmer, VC; Gundlach, AL; Thomas, WG; Bathgate, RAD				Callander, Gabrielle E.; Ma, Sherie; Ganella, Despina E.; Wimmer, Verena C.; Gundlach, Andrew L.; Thomas, Walter G.; Bathgate, Ross A. D.			Silencing Relaxin-3 in Nucleus Incertus of Adult Rodents: A Viral Vector-based Approach to Investigate Neuropeptide Function	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; SPONTANEOUS-ALTERNATION; PEPTIDE FAMILY; MODULATION; STRESS; GENE; OPTIMIZATION; EXPRESSION; NEURONS; BRAIN	Relaxin-3, the most recently identified member of the relaxin peptide family, is produced by GABAergic projection neurons in the nucleus incertus (NI), in the pontine periventricular gray. Previous studies suggest relaxin-3 is a modulator of stress responses, metabolism, arousal and behavioural activation. Knockout mice and peptide infusions in vivo have significantly contributed to understanding the function of this conserved neuropeptide. Yet, a definitive role remains elusive due to discrepancies between models and a propensity to investigate pharmacological effects over endogenous function. To investigate the endogenous function of relaxin-3, we generated a recombinant adeno-associated viral (rAAV) vector expressing microRNA against relaxin-3 and validated its use to knock down relaxin-3 in adult rats. Bilateral stereotaxic infusion of rAAV1/2 EmGFP miR499 into the NI resulted in significant reductions in relaxin-3 expression as demonstrated by ablation of relaxin-3-like immunoreactivity at 3, 6 and 9 weeks and by qRT-PCR at 12 weeks. Neuronal health was unaffected as transduced neurons in all groups retained expression of NeuN and stained for Nissl bodies. Importantly, qRT-PCR confirmed that relaxin-3 receptor expression levels were not altered to compensate for reduced relaxin-3. Behavioural experiments confirmed no detrimental effects on general health or well-being and therefore several behavioural modalities previously associated with relaxin-3 function were investigated. The validation of this viral vector-based model provides a valuable alternative to existing in vivo approaches and promotes a shift towards more physiologically relevant investigations of endogenous neuropeptide function.	[Callander, Gabrielle E.; Ganella, Despina E.; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Callander, Gabrielle E.; Ma, Sherie; Ganella, Despina E.; Wimmer, Verena C.; Gundlach, Andrew L.; Bathgate, Ross A. D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Ma, Sherie] Univ Melbourne, Dept Med Austin Hlth, Melbourne, Vic 3010, Australia; [Gundlach, Andrew L.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Thomas, Walter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; University of Melbourne; University of Melbourne; University of Queensland	Callander, GE (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	Gabrielle.Callander@florey.edu.au; bathgate@unimelb.edu.au	Gundlach, Andrew L/X-6421-2018; Bathgate, Ross/ABE-6471-2020; Thomas, Walter/I-2208-2015	Gundlach, Andrew L/0000-0002-6066-9692; Bathgate, Ross/0000-0001-6301-861X; Thomas, Walter/0000-0003-0685-2952; Ma, Sherie/0000-0003-3597-9522; Wimmer, Verena/0000-0002-9931-8179	National Health and Medical Research Council of Australia (NHMRC) [1005988, 520299]; Victorian Government Operational Infrastructure Support Program; University of Melbourne; Australian Postgraduate Award; Senior Research Fellowships; NHMRC, Australia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; University of Melbourne(University of Melbourne); Australian Postgraduate Award(Australian Government); Senior Research Fellowships; NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by National Health and Medical Research Council of Australia (NHMRC, www.nhmrc.gov.au http://www.nhmrc.gov.au) project grants 1005988 (Andrew L. Gundlach, Ross A. D. Bathgate) and 520299 (Sherie Ma), and by the Victorian Government Operational Infrastructure Support Program (www.business.vic.gov.au http://www.business.vic.gov.au). Gabrielle E. Callander was a recipient of a Melbourne Research Scholarship from The University of Melbourne. Despina E. Ganella is a recipient of an Australian Postgraduate Award, Andrew L. Gundlach and Ross A. D. Bathgate were recipients of Senior Research Fellowships and Sherie Ma was the recipient of a Biomedical Postdoctoral Fellowship from NHMRC, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Callander GE, 2009, ANN NY ACAD SCI, V1160, P261, DOI 10.1111/j.1749-6632.2008.03816.x; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Cisse RS, 2008, BEHAV NEUROSCI, V122, P549, DOI 10.1037/0735-7044.122.3.549; DeGroot A, 2003, NEUROSCIENCE, V117, P493, DOI 10.1016/S0306-4522(02)00651-6; Donizetti A, 2008, DEV DYNAM, V237, P3864, DOI 10.1002/dvdy.21786; During Matthew J, 2003, Methods Mol Med, V76, P221; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hida T, 2006, J RECEPT SIG TRANSD, V26, P147, DOI 10.1080/10799890600623373; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; McGowan BM, 2007, AM J PHYSIOL-ENDOC M, V292, pE913, DOI 10.1152/ajpendo.00346.2006; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Miyanioto Y, 2008, REGUL PEPTIDES, V145, P54, DOI 10.1016/j.regpep.2007.08.010; Olucha-Bordonau FE, 2003, J COMP NEUROL, V464, P62, DOI 10.1002/cne.10774; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silvertown JD, 2010, REGUL PEPTIDES, V159, P44, DOI 10.1016/j.regpep.2009.09.007; Smith CM, 2012, GENES BRAIN BEHAV, V11, P94, DOI 10.1111/j.1601-183X.2011.00730.x; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Smith CM, 2009, ANN NY ACAD SCI, V1160, P259, DOI 10.1111/j.1749-6632.2009.03952.x; Smith CM, 2009, ANN NY ACAD SCI, V1160, P236, DOI 10.1111/j.1749-6632.2009.03953.x; Stefani MR, 1998, BRAIN RES, V813, P50, DOI 10.1016/S0006-8993(98)00876-2; Sutton SW, 2009, ANN NY ACAD SCI, V1160, P242, DOI 10.1111/j.1749-6632.2008.03812.x; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Tanaka M, 2010, FEBS J, V277, P4990, DOI 10.1111/j.1742-4658.2010.07931.x; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Watanabe Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00050; Watanabe Y, 2011, J MOL NEUROSCI, V43, P169, DOI 10.1007/s12031-010-9468-0; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42300	10.1371/journal.pone.0042300	http://dx.doi.org/10.1371/journal.pone.0042300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876314	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700042
J	Lassen, LB; Ballarin-Gonzalez, B; Schmitz, A; Fuchtbauer, A; Pedersen, FS; Fuchtbauer, EM				Lassen, Louise Berkhoudt; Ballarin-Gonzalez, Borja; Schmitz, Alexander; Fuchtbauer, Annette; Pedersen, Finn Skou; Fuchtbauer, Ernst-Martin			Nras Overexpression Results in Granulocytosis, T-Cell Expansion and Early Lethality in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; N-RAS; ONCOGENIC NRAS; H-RAS; K-RAS; ACTIVATION; EXPRESSION; GENE; CSF; IDENTIFICATION	NRAS is a proto-oncogene involved in numerous myeloid malignancies. Here, we report on a mouse line bearing a single retroviral long terminal repeat inserted into Nras. This genetic modification resulted in an increased level of wild type Nras mRNA giving the possibility of studying the function and activation of wild type NRAS. Flow cytometry was used to show a variable but significant increase of immature myeloid cells in spleen and thymus, and of T-cells in the spleen. At an age of one week, homozygous mice began to retard compared to their wild type and heterozygous littermates. Two weeks after birth, animals started to progressively lose weight and die before weaning. Heterozygous mice showed a moderate increase of T-cells and granulocytes but survived to adulthood and were fertile. In homozygous and heterozygous mice Gfi1 and Gcsf mRNA levels were upregulated, possibly explaining the increment in immature myeloid cells detected in these mice. The short latency period indicates that Nras overexpression alone is sufficient to cause dose-dependent granulocytosis and T-cell expansion.	[Lassen, Louise Berkhoudt; Ballarin-Gonzalez, Borja; Schmitz, Alexander; Fuchtbauer, Annette; Pedersen, Finn Skou; Fuchtbauer, Ernst-Martin] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Schmitz, Alexander] Aarhus Univ Hosp, Aalborg Hosp, Dept Haematol, DK-8000 Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Lassen, LB (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	emf@mb.au.dk			Danish Cancer Society; Danish Medical Research Council; Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	This study was supported in part by grants from the Danish Cancer Society, the Danish Medical Research Council and the Danish Genetically Modified Animal Resource (DAGMAR) funded by the Danish Agency for Science, Technology, and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; BOS JL, 1989, CANCER RES, V49, P4682; Byrne JL, 1998, BRIT J HAEMATOL, V100, P256; DEMETRI GD, 1990, J CLIN INVEST, V86, P1261, DOI 10.1172/JCI114833; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; GOUGH NM, 1985, EMBO J, V4, P645, DOI 10.1002/j.1460-2075.1985.tb03678.x; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lovmand J, 1998, J VIROL, V72, P5745, DOI 10.1128/JVI.72.7.5745-5756.1998; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MANGUES R, 1992, ONCOGENE, V7, P2073; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Martin-Hernandez J, 2001, J VIROL, V75, P11907, DOI 10.1128/JVI.75.23.11907-11912.2001; Morris ES, 2009, NAT MED, V15, P436, DOI 10.1038/nm.1948; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Perez de Castro I, 2003, CANCER RES, V63, P1615; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sierra MD, 2010, BLOOD, V115, P3970, DOI 10.1182/blood-2009-10-246967; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; VELLENGA E, 1988, BLOOD, V71, P1529; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang JY, 2011, CELL CYCLE, V10, P2836, DOI 10.4161/cc.10.17.17195; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; WERTZ K, 1994, TRANSGENICS, V1, P277; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102	38	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42216	10.1371/journal.pone.0042216	http://dx.doi.org/10.1371/journal.pone.0042216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876308	Green Published, gold			2022-12-25	WOS:000307184700036
J	Gea-Sorli, S; Bonjoch, L; Closa, D				Gea-Sorli, Sabrina; Bonjoch, Laia; Closa, Daniel			Differences in the Inflammatory Response Induced by Acute Pancreatitis in Different White Adipose Tissue Sites in the Rat	PLOS ONE			English	Article							FATTY-ACID COMPOSITION; LIPIDS; MACROPHAGES; SEVERITY; OBESITY	Background: There is increasing evidence of the role of adipose tissue on the systemic effects of acute pancreatitis. Patients with higher body mass index have increased risk of local and systemic complications and patients with android fat distribution and higher waist circumference are at greater risk for developing the severe form of the disease. Here we evaluated the changes on different areas of adipose tissue and its involvement on the inflammatory response in an experimental model of acute pancreatitis. Methods: Pancreatitis was induced in male Wistar rats by intraductal administration of sodium taurocholate. Orlistat was administered to inhibit lipase activity. Activation of peritoneal macrophages was evaluated by measuring IL1 beta and TNF alpha expression. Inflammation was evaluated by measuring myeloperoxidase activity in mesenteric, epididymal and retroperitoneal areas of adipose tissue. Changes in the expression of inflammatory mediator in these areas of adipose tissue were also evaluated by RT-PCR. Results: Pancreatitis induces the activation of peritoneal macrophages and a strong inflammatory response in mesenteric and epididymal sites of adipose tissue. By contrast, no changes were found in retroperitoneal adipose tissue. Inhibition of lipase prevented the activation of macrophages and the local inflammation in adipose tissue. Conclusions: Our results confirm the involvement of adipose tissue on the progression of systemic inflammatory response during acute pancreatitis. However, there is a considerable diversity in different adipose tissue sites. These differences need to be taken into account in order to understand the progression from local pancreatic damage to systemic inflammation during acute pancreatitis.	[Gea-Sorli, Sabrina] IIBB CSIC, IDIBAPS, Dept Expt Pathol, Barcelona, Spain; CIBEREHD, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Gea-Sorli, S (corresponding author), IIBB CSIC, IDIBAPS, Dept Expt Pathol, Barcelona, Spain.	daniel.closa@iibb.csic.es	Closa, Daniel/Y-3848-2019	Closa Autet, Daniel/0000-0003-3797-3095; Bonjoch, Laia/0000-0002-3351-0037	Ministerio de Ciencia e Innovacion [SAF 2009-07605]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was supported by the project SAF 2009-07605 and from Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Romero MD, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-42; DETTELBACH MA, 1990, J BONE MINER RES, V5, P1249; Franco-Pons N, 2012, ANN SURG IN PRESS; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Gea-Sorl S, 2011, J PATHOL, V223, P417, DOI 10.1002/path.2814; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gutierrez PT, 2008, GUT, V57, P642, DOI 10.1136/gut.2007.127472; Hilal MA, 2008, OBES SURG, V18, P326, DOI 10.1007/s11695-007-9298-5; Hussain N, 1998, AM J RESP CELL MOL, V19, P867, DOI 10.1165/ajrcmb.19.6.3118; KLOPPEL G, 1993, PANCREAS, V8, P659; MALCOM GT, 1989, AM J CLIN NUTR, V50, P288, DOI 10.1093/ajcn/50.2.288; Martinez J, 2006, PANCREATOLOGY, V6, P206, DOI 10.1159/000092104; Mery CM, 2002, PANCREATOLOGY, V2, P543, DOI 10.1159/000066099; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Sempere L, 2008, PANCREATOLOGY, V8, P257, DOI 10.1159/000134273; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Villena JA, 2001, INT J OBESITY, V25, P1275, DOI 10.1038/sj.ijo.0801680; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828	19	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41933	10.1371/journal.pone.0041933	http://dx.doi.org/10.1371/journal.pone.0041933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870264	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800044
J	Liu, YX; Tai, JL; Li, GQ; Zhang, ZW; Xue, JH; Liu, HS; Zhu, H; Cheng, JD; Liu, YL; Li, AM; Zhang, Y				Liu, Yu-xiao; Tai, Jun-li; Li, Guo-qing; Zhang, Zhi-wen; Xue, Jing-hui; Liu, Hong-sheng; Zhu, Heng; Cheng, Ji-de; Liu, Yuan-ling; Li, An-ming; Zhang, Yi			Exposure to 1950-MHz TD-SCDMA Electromagnetic Fields Affects the Apoptosis of Astrocytes via Caspase-3-Dependent Pathway	PLOS ONE			English	Article							RADIOFREQUENCY RADIATION; CELL-PROLIFERATION; OXIDATIVE STRESS; GENE-EXPRESSION; MHZ; INDUCTION; TUMORS; BCL-2; DNA	The usage of mobile phone increases globally. However, there is still a paucity of data about the impact of electromagnetic fields (EMF) on human health. This study investigated whether EMF radiation would alter the biology of glial cells and act as a tumor-promoting agent. We exposed rat astrocytes and C6 glioma cells to 1950-MHz TD-SCDMA for 12, 24 and 48 h respectively, and found that EMF exposure had differential effects on rat astroctyes and C6 glioma cells. A 48 h of exposure damaged the mitochondria and induced significant apoptosis of astrocytes. Moreover, caspase-3, a hallmark of apoptosis, was highlighted in astrocytes after 48 h of EMF exposure, accompanied by a significantly increased expression of bax and reduced level of bcl-2. The tumorigenicity assays demonstrated that astrocytes did not form tumors in both control and exposure groups. In contrast, the unexposed and exposed C6 glioma cells show no significant differences in both biological feature and tumor formation ability. Therefore, our results implied that exposure to the EMF of 1950-MHz TD-SCDMA may not promote the tumor formation, but continuous exposure damaged the mitochondria of astrocytes and induce apoptosis through a caspase-3-dependent pathway with the involvement of bax and bcl-2.	[Liu, Yu-xiao; Zhang, Zhi-wen; Xue, Jing-hui; Liu, Hong-sheng; Li, An-ming] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing, Peoples R China; [Zhu, Heng; Cheng, Ji-de; Liu, Yuan-ling; Zhang, Yi] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Beijing 100730, Peoples R China; [Li, Guo-qing] China Telecommun Technol Labs, Beijing, Peoples R China; [Tai, Jun-li] Jian Gong Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, YX (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing, Peoples R China.	anmingli301@163.com; zhangyi612@hotmail.com	zhu, dingdingabc/AAZ-7892-2020		National Key Basic Research Program of China [2010CB833604]; National Natural Sciences Foundation of China [31070996, 31171084]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Basic Research Program of China (Grant number 2010CB833604), the National Natural Sciences Foundation of China (Grant numbers 31070996, 31171084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WR, 2000, CANCER RES, V60, P1857; Ammari M, 2008, TOXICOLOGY, V250, P70, DOI 10.1016/j.tox.2008.05.019; Ammari M, 2008, BIOMED PHARMACOTHER, V62, P273, DOI 10.1016/j.biopha.2008.03.002; Buttiglione M, 2007, J CELL PHYSIOL, V213, P759, DOI 10.1002/jcp.21146; Capri M, 2004, INT J RADIAT BIOL, V80, P389, DOI 10.1080/09553000410001702346; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cleary SF, 1996, FASEB J, V10, P913; Dasdag S, 2009, ELECTROMAGN BIOL MED, V28, P342, DOI 10.3109/15368370903206556; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; Gerner C, 2010, INT ARCH OCC ENV HEA, V83, P691, DOI 10.1007/s00420-010-0513-7; Goodman R, 2002, J CELL PHYSIOL, V192, P16, DOI 10.1002/jcp.10098; Hirose H, 2010, BIOELECTROMAGNETICS, V31, P104, DOI 10.1002/bem.20532; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Joubert V, 2007, BIOELECTROMAGNETICS, V28, P115, DOI 10.1002/bem.20274; Karaca E, 2011, J NEUROONCOL; Kismali G, 2012, INT J RADIAT BIOL, V88, P414, DOI 10.3109/09553002.2012.661517; La Regina M, 2003, RADIAT RES, V160, P143, DOI 10.1667/RR3028; Liu YX, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-85; Lonn S, 2005, AM J EPIDEMIOL, V161, P526, DOI 10.1093/aje/kwi091; Miyakoshi J, 2005, BIOELECTROMAGNETICS, V26, P251, DOI 10.1002/bem.20077; Narita K, 1997, IN VIVO, V11, P329; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; O'Connor RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011828; Perez-Bruzon RN, 2011, HISTOL HISTOPATHOL, V26, P1187, DOI 10.14670/HH-26.1187; Pinon LGP, 1997, DEVELOPMENT, V124, P4173; Sannino A, 2011, INT J RADIAT BIOL, V87, P993, DOI 10.3109/09553002.2011.574779; Sekijima M, 2010, J RADIAT RES, V51, P277, DOI 10.1269/jrr.09126; Stagg RB, 2001, RADIAT RES, V155, P584, DOI 10.1667/0033-7587(2001)155[0584:EOIACE]2.0.CO;2; Trillo MA, 2011, BIOELECTROMAGNETICS, V32, P340, DOI 10.1002/bem.20643; Trosic I, 2009, ARH HIG RADA TOKSIKO, V60, P109, DOI 10.2478/10004-1254-60-2009-1891; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Warren HG, 2003, LARYNGOSCOPE, V113, P663, DOI 10.1097/00005537-200304000-00015; Xu SC, 2010, BRAIN RES, V1311, P189, DOI 10.1016/j.brainres.2009.10.062; Yan JG, 2009, ELECTROMAGN BIOL MED, V28, P383, DOI 10.3109/15368370903287614; Zeni O, 2012, BIOELECTROMAGETICS	35	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42332	10.1371/journal.pone.0042332	http://dx.doi.org/10.1371/journal.pone.0042332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870319	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800082
J	Shi, Y; Sheng, R; Zhong, TT; Xu, Y; Chen, XP; Yang, D; Sun, Y; Yang, FY; Hu, YZ; Zhou, NM				Shi, Ying; Sheng, Rong; Zhong, Tingting; Xu, Yu; Chen, Xiaopan; Yang, Dong; Sun, Yi; Yang, Fenyan; Hu, Yongzhou; Zhou, Naiming			Identification and Characterization of ZEL-H16 as a Novel Agonist of the Histamine H-3 Receptor	PLOS ONE			English	Article							G-PROTEIN; ACETYLCHOLINE-RELEASE; NORADRENALINE-RELEASE; MOLECULAR-CLONING; SEROTONIN RELEASE; SUBSTANTIA-NIGRA; H3 RECEPTORS; IN-VITRO; BP 2-94; BRAIN	The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases. In this study, a non-imidazole compound, ZEL-H16, was identified as a novel histamine H3 receptor agonist. ZEL-H16 was found to bind to human H3R with a Ki value of approximately 2.07 nM and 4.36 nM to rat H3R. Further characterization indicated that ZEL-H16 behaved as a partial agonist on the inhibition of forskolin-stimulated cAMP accumulation (the efficacy was 60% of that of histamine) and activation of ERK1/2 signaling (the efficacy was 50% of that of histamine) at H3 receptors, but acted as a full agonist just like histamin in the guinea-pig ileum contraction assay. These effects were blocked by pertussis toxin and H3 receptor specific antagonist thioperamide. ZEL-H16 showed no agonist or antagonist activities at the cloned human histamine H1, H2, and H4 receptors and other biogenic amine GPCRs in the CRE-driven reporter assay. Furthermore, our present data demonstrated that treatment of ZEL-H16 resulted in intensive H3 receptor internalization and delayed recycling to the cell surface as compared to that of control with treatment of histamine. Thus, ZEL-H16 is a novel and potent nonimidazole agonist of H3R, which might serve as a pharmacological tool for future investigations or as possible therapeutic agent of H3R.	[Shi, Ying; Zhong, Tingting; Chen, Xiaopan; Yang, Dong; Sun, Yi; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Rong; Xu, Yu; Yang, Fenyan; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Shi, Y (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	huyz@zju.edu.cn; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022; yang, dongxiao/GWM-8493-2022	Chen, Xiaopan/0000-0003-4289-7541	National Natural Science Foundation of China [30670425]; Ministry of Science and Technology [2008AA02Z138]; National Key Tech Project for Major Creation of New drugs [2009ZX09501-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Key Tech Project for Major Creation of New drugs	This work was supported by grants from the National Natural Science Foundation of China (No. 30670425), the Ministry of Science and Technology (No. 2008AA02Z138) and the National Key Tech Project for Major Creation of New drugs (No. 2009ZX09501-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ares JJ, 1998, CURR PHARM DESIGN, V4, P17; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bonaventure P, 2007, BIOCHEM PHARMACOL, V73, P1084, DOI 10.1016/j.bcp.2006.10.031; Bongers G, 2007, BIOCHEM PHARMACOL, V73, P1195, DOI 10.1016/j.bcp.2007.01.008; Cecchi M, 1998, INFLAMM RES, V47, pS32; Celanire S, 2005, DRUG DISCOV TODAY, V10, P1613, DOI 10.1016/S1359-6446(05)03625-1; CIPRANDI G, 1992, DRUGS, V43, P154, DOI 10.2165/00003495-199243020-00003; CORUZZI G, 1991, N-S ARCH PHARMACOL, V343, P225, DOI 10.1007/BF00168615; Drutel G, 2001, MOL PHARMACOL, V59, P1; Esbenshade TA, 2006, MOL INTERV, V6, P77, DOI 10.1124/mi.6.2.5; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; FINK K, 1990, N-S ARCH PHARMACOL, V342, P513; Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; GARBARG M, 1992, J PHARMACOL EXP THER, V263, P304; Garduno-Torres B, 2007, NEUROPHARMACOLOGY, V52, P527, DOI 10.1016/j.neuropharm.2006.08.001; Gbahou F, 2010, J PHARMACOL EXP THER, V334, P945, DOI 10.1124/jpet.110.168633; Hough LB, 2001, MOL PHARMACOL, V59, P415, DOI 10.1124/mol.59.3.415; Kitbunnadaj R, 2003, J MED CHEM, V46, P5445, DOI 10.1021/jm030905y; Korotkova TM, 2005, NEUROPHARMACOLOGY, V49, P129, DOI 10.1016/j.neuropharm.2005.03.001; Korotkova TM, 2002, NEUROSCI LETT, V320, P133, DOI 10.1016/S0304-3940(02)00050-2; KORTE A, 1990, BIOCHEM BIOPH RES CO, V168, P979, DOI 10.1016/0006-291X(90)91125-C; Kraus MM, 2001, INFLAMM RES, V50, pS74; Krueger KM, 2005, J PHARMACOL EXP THER, V314, P271, DOI 10.1124/jpet.104.078865; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Ligneau X, 1998, J PHARMACOL EXP THER, V287, P658; Lim HD, 2006, CURR TOP MED CHEM, V6, P1365, DOI 10.2174/15680266106061365; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; MARTINEZMIR MI, 1990, BRAIN RES, V526, P322, DOI 10.1016/0006-8993(90)91240-H; Millan-Guerrero RO, 2006, CAN J NEUROL SCI, V33, P195, DOI 10.1017/S0317167100004960; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; OHKUBO T, 1995, EUR J PHARMACOL, V273, P83, DOI 10.1016/0014-2999(94)00668-W; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Rouleau A, 2000, J PHARMACOL EXP THER, V295, P219; Rouleau A, 1997, J PHARMACOL EXP THER, V281, P1085; Sasse A, 1999, J MED CHEM, V42, P4269, DOI 10.1021/jm991068w; Sasse A, 2000, BIOORGAN MED CHEM, V8, P1139, DOI 10.1016/S0968-0896(00)00050-X; Schlicker E, 1996, N-S ARCH PHARMACOL, V353, P482; SCHLICKER E, 1993, PHARMACOLOGY, V47, P111, DOI 10.1159/000139085; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; SCHLICKER E, 1994, N-S ARCH PHARMACOL, V350, P34; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Threlfell S, 2004, J NEUROSCI, V24, P8704, DOI 10.1523/JNEUROSCI.2690-04.2004; VOLLINGA RC, 1994, J MED CHEM, V37, P332, DOI 10.1021/jm00029a002; Wijtmans M, 2007, EXPERT OPIN INV DRUG, V16, P967, DOI 10.1517/13543784.16.7.967; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yoshimoto R, 2006, P NATL ACAD SCI USA, V103, P13866, DOI 10.1073/pnas.0506104103	54	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42185	10.1371/journal.pone.0042185	http://dx.doi.org/10.1371/journal.pone.0042185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870296	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800065
J	Leal, MF; Chung, J; Calcagno, DQ; Assumpcao, PP; Demachki, S; da Silva, IDCG; Chammas, R; Burbano, RR; Smith, MDC				Leal, Mariana Ferreira; Chung, Janete; Calcagno, Danielle Queiroz; Assumpcao, Paulo Pimentel; Demachki, Samia; Cotrim Guerreiro da Silva, Ismael Dale; Chammas, Roger; Burbano, Rommel Rodriguez; Cardoso Smith, Marilia de Arruda			Differential Proteomic Analysis of Noncardia Gastric Cancer from Individuals of Northern Brazil	PLOS ONE			English	Article							2-DIMENSIONAL ELECTROPHORESIS; INTESTINAL METAPLASIA; INCREASED EXPRESSION; GEL-ELECTROPHORESIS; HELICOBACTER-PYLORI; PROTEIN EXPRESSION; GENE-EXPRESSION; TP53 GENE; MYC; IDENTIFICATION	Gastric cancer is the second leading cause of cancer-related death worldwide. The identification of new cancer biomarkers is necessary to reduce the mortality rates through the development of new screening assays and early diagnosis, as well as new target therapies. In this study, we performed a proteomic analysis of noncardia gastric neoplasias of individuals from Northern Brazil. The proteins were analyzed by two-dimensional electrophoresis and mass spectrometry. For the identification of differentially expressed proteins, we used statistical tests with bootstrapping resampling to control the type I error in the multiple comparison analyses. We identified 111 proteins involved in gastric carcinogenesis. The computational analysis revealed several proteins involved in the energy production processes and reinforced the Warburg effect in gastric cancer. ENO1 and HSPB1 expression were further evaluated. ENO1 was selected due to its role in aerobic glycolysis that may contribute to the Warburg effect. Although we observed two up-regulated spots of ENO1 in the proteomic analysis, the mean expression of ENO1 was reduced in gastric tumors by western blot. However, mean ENO1 expression seems to increase in more invasive tumors. This lack of correlation between proteomic and western blot analyses may be due to the presence of other ENO1 spots that present a slightly reduced expression, but with a high impact in the mean protein expression. In neoplasias, HSPB1 is induced by cellular stress to protect cells against apoptosis. In the present study, HSPB1 presented an elevated protein and mRNA expression in a subset of gastric cancer samples. However, no association was observed between HSPB1 expression and clinicopathological characteristics. Here, we identified several possible biomarkers of gastric cancer in individuals from Northern Brazil. These biomarkers may be useful for the assessment of prognosis and stratification for therapy if validated in larger clinical study sets.	[Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Cardoso Smith, Marilia de Arruda] Univ Fed Sao Paulo, Div Genet, Dept Morphol & Genet, Sao Paulo, Brazil; [Chung, Janete] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Assumpcao, Paulo Pimentel] Fed Univ Para, Joao de Barros Barreto Univ Hosp, Surg Serv, BR-66059 Belem, Para, Brazil; [Demachki, Samia] Fed Univ Para, Joao de Barros Barreto Univ Hosp, Pathol Serv, BR-66059 Belem, Para, Brazil; [Cotrim Guerreiro da Silva, Ismael Dale] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, Brazil; [Chammas, Roger] Univ Sao Paulo, Sch Med, Expt Oncol Lab, Sao Paulo, Brazil; [Burbano, Rommel Rodriguez] Fed Univ Para, Human Cytogenet Lab, Inst Biol Sci, BR-66059 Belem, Para, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Para	Leal, MF (corresponding author), Univ Fed Sao Paulo, Div Genet, Dept Morphol & Genet, Sao Paulo, Brazil.	mariana.morf@epm.br	de A. C. Smith, Marilia/C-4397-2012; Chammas, Roger/A-8004-2011; Leal, Mariana/C-4010-2012; Chung, Janete/E-9176-2015; Burbano, Rommel R/C-4149-2012	de A. C. Smith, Marilia/0000-0002-1441-1033; Chammas, Roger/0000-0003-0342-8726; Leal, Mariana/0000-0003-4375-2563; Chung, Janete/0000-0001-8335-9323; Burbano, Rommel R/0000-0002-4872-234X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Dr. Chammas, Dr. Smith and Dr. Burbano) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Dr. Leal, Dr. Chung and Dr. Calcagno) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2010, CANCER GENET CYTOGEN, V202, P63, DOI 10.1016/j.cancergencyto.2010.05.020; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cesar ACG, 2004, CANCER GENET CYTOGEN, V153, P127, DOI 10.1016/j.cancergencyto.2004.01.017; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; Cheng Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-191; CLAYTON CL, 1992, J CLIN MICROBIOL, V30, P192, DOI 10.1128/JCM.30.1.192-200.1992; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Ebert MR, 2006, EUR J GASTROEN HEPAT, V18, P847, DOI 10.1097/00042737-200608000-00007; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; El-Serag HB, 2002, GUT, V50, P368, DOI 10.1136/gut.50.3.368; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatti LL, 2003, CLIN EXP MED, V3, P166, DOI 10.1007/s10238-003-0021-0; Giaginis C, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-14; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; INCA, 2009, EST 2010 INC CANC BR, P98; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kapranos N, 2002, J CANCER RES CLIN, V128, P426, DOI 10.1007/s00432-002-0357-y; Khayat AS, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-55; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Li N, 2007, J PROTEOME RES, V6, P3304, DOI 10.1021/pr0702363; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Lin LL, 2012, J PROTEOMICS; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meuwissen THE, 2004, GENET SEL EVOL, V36, P191, DOI 10.1051/gse:2003058; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nam NH, 2003, CURR DRUG TARGETS, V4, P159, DOI 10.2174/1389450033346966; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; Raiol LCC, 2008, CANCER GENET CYTOGEN, V181, P31, DOI 10.1016/j.cancergencyto.2007.10.011; Resende ALS, 2006, ARQUIVOS GASTROENTER, V43, P6; Ryu JW, 2003, J KOREAN MED SCI, V18, P505, DOI 10.3346/jkms.2003.18.4.505; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; Sobin LH, 2002, TNM CLASSIFICATION M, V6th; Takeno S, 2001, ANN SURG ONCOL, V8, P215, DOI 10.1245/aso.2001.8.3.215; Takeno SS, 2009, CANCER GENET CYTOGEN, V190, P1, DOI 10.1016/j.cancergencyto.2008.09.007; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179; WARBURG O, 1956, SCIENCE, V124, P269; Werner M, 2001, J CANCER RES CLIN, V127, P207, DOI 10.1007/s004320000195; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Whelan SL, 1993, TRENDS CANC INCIDENC; Wu C, 2009, ONCOL REP, V21, P1429, DOI 10.3892/or_00000371; Yan GR, 2011, PROTEOMICS, V11, P3657, DOI 10.1002/pmic.201100215; Yang YX, 2009, J CANCER RES CLIN, V135, P181, DOI 10.1007/s00432-008-0460-9; Yoshihara T, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-75; Zhang J, 2007, J PROTEOME RES, V6, P4423, DOI 10.1021/pr0703425; Zoubeidi A, 2012, INT J BIOCH CELL BIO	74	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42255	10.1371/journal.pone.0042255	http://dx.doi.org/10.1371/journal.pone.0042255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860099	Green Submitted, gold, Green Published			2022-12-25	WOS:000306950900084
J	Mockel, A; Obringer, C; Hakvoort, TBM; Seeliger, M; Lamers, WH; Stoetzel, C; Dollfus, H; Marion, V				Mockel, Anais; Obringer, Cathy; Hakvoort, Theodorus B. M.; Seeliger, Mathias; Lamers, Wouter H.; Stoetzel, Corinne; Dollfus, Helene; Marion, Vincent			Pharmacological Modulation of the Retinal Unfolded Protein Response in Bardet-Biedl Syndrome Reduces Apoptosis and Preserves Light Detection Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INITIATION-FACTOR 2-ALPHA; RETINITIS-PIGMENTOSA; VALPROIC ACID; MOUSE MODEL; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; CILIA DEFECTS; CELL FATE	Ciliopathies, a class of rare genetic disorders, present often with retinal degeneration caused by protein transport defects between the inner segment and the outer segment of the photoreceptors. Bardet-Biedl syndrome is one such ciliopathy, genetically heterogeneous with 17 BBS genes identified to date, presenting early onset retinitis pigmentosa. By investigating BBS12-deprived retinal explants and the Bbs12(-/-) murine model, we show that the impaired intraciliary transport results in protein retention in the endoplasmic reticulum. The protein overload activates a proapoptotic unfolded protein response leading to a specific Caspase12-mediated death of the photoreceptors. Having identified a therapeutic window in the early postnatal retinal development and through optimized pharmacological modulation of the unfolded protein response, combining three specific compounds, namely valproic acid, guanabenz, and a specific Caspase12 inhibitor, achieved efficient photoreceptor protection, thereby maintaining light detection ability in vivo.	[Marion, Vincent] Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res INSERM,EA 3949, Lab Physiopathol Syndromes Rares Hereditaires,AVE, F-67085 Strasbourg, France; [Hakvoort, Theodorus B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1100 DD Amsterdam, Netherlands; [Seeliger, Mathias; Stoetzel, Corinne] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, D-72076 Tubingen, Germany; [Dollfus, Helene] Hop Univ Strasbourg, Serv Genet Med, F-67200 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Marion, V (corresponding author), Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res INSERM,EA 3949, Lab Physiopathol Syndromes Rares Hereditaires,AVE, 9th Floor,Bldg 3,11 Rue Humann, F-67085 Strasbourg, France.	vincent.marion@unistra.fr	Lamers, Wouter H./D-2965-2012; Marion, Vincent/H-9730-2016	Marion, Vincent/0000-0002-8271-7376; Dollfus, Helene/0000-0002-2249-895X; obringer, cathy/0000-0002-7349-8749	Agence Nationale pour la Recherche (ANR Call for Rare Diseases); INSERM Avenir Program; RETINA France; UNADEV; Fondation de France	Agence Nationale pour la Recherche (ANR Call for Rare Diseases)(French National Research Agency (ANR)); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); RETINA France; UNADEV; Fondation de France(Fondation de France)	This work was supported by the Agence Nationale pour la Recherche (ANR Call for Rare Diseases 2009) and the INSERM Avenir Program.; We thank RETINA France, UNADEV, Fondation de France, and the patient associations for support. We thank the Institut Clinique de la Souris for the generation of the Bbs12 mouse model, Michel Roux for the lending of the ERG device, and UMR748 employees for the mice breeding.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balan AG, 2010, ALCOHOL, V44, P553, DOI 10.1016/j.alcohol.2010.07.003; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Clemson CM, 2011, BRIT J OPHTHALMOL, V95, P89, DOI 10.1136/bjo.2009.175356; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sandberg MA, 2011, BRIT J OPHTHALMOL, V95, P744, DOI 10.1136/bjo.2010.198176; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Schooneveld MJ, 2011, BRIT J OPHTHALMOL, V95, P153, DOI 10.1136/bjo.2010.194373; Wang JF, 1999, MOL PHARMACOL, V55, P521; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhang ZZ, 2011, NEUROSCI LETT, V504, P88, DOI 10.1016/j.neulet.2011.09.003	59	35	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37483	37494		10.1074/jbc.M112.386821	http://dx.doi.org/10.1074/jbc.M112.386821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22869374	hybrid, Green Published			2022-12-25	WOS:000310588500077
J	Saito, K; Kandori, H; Ishikita, H				Saito, Keisuke; Kandori, Hideki; Ishikita, Hiroshi			Factors That Differentiate the H-bond Strengths of Water Near the Schiff Bases in Bacteriorhodopsin and Anabaena Sensory Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER HYDROGEN-BOND; PROTON-TRANSFER; ELECTROSTATIC CALCULATIONS; DISSOCIATION-CONSTANTS; HISTIDINE-RESIDUES; IONIZABLE GROUPS; IMIDAZOLE RING; PK(A); RELEASE; ASPARTATE-85	Bacteriorhodopsin (BR) functions as a light-driven proton pump, whereas Anabaena sensory rhodopsin (ASR) is believed to function as a photosensor despite the high similarity in their protein sequences. In Fourier transform infrared (FTIR) spectroscopic studies, the lowest O-D stretch for D2O was observed at similar to 2200 cm(-1) in BR but was significantly higher in ASR (>2500 cm(-1)), which was previously attributed to a water molecule near the Schiff base (W402) that is H-bonded to Asp-85 in BR and Asp-75 in ASR. We investigated the factors that differentiate the lowest O-D stretches of W402 in BR and ASR. Quantum mechanical/molecular mechanical calculations reproduced the H-bond geometries of the crystal structures, and the calculated O-D stretching frequencies were corroborated by the FTIR band assignments. The potential energy profiles indicate that the smaller O-D stretching frequency in BR originates from the significantly higher pK(a)(Asp-85) in BR relative to the pK(a)(Asp-75) in ASR, which were calculated to be 1.5 and -5.1, respectively. The difference is mostly due to the influences of Ala-53, Arg-82, Glu-194-Glu-204, and Asp-212 on pK(a)(Asp-85) in BR and the corresponding residues Ser-47, Arg-72, Ser-188-Asp-198, and Pro-206 on pK(a)(Asp-75) in ASR. Because these residues participate in proton transfer pathways in BR but not in ASR, the presence of a strongly H-bonded water molecule near the Schiff base ultimately results from the proton-pumping activity in BR.	[Saito, Keisuke; Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Nagoya Institute of Technology; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Sakyo Ku, 202 Bldg E,Yoshida Konoe Cho, Kyoto 6068501, Japan.	hiro@cp.kyoto-u.ac.jp	Saito, Keisuke/D-2528-2009; Ishikita, Hiroshi/G-9864-2018	Saito, Keisuke/0000-0002-2293-9743; Ishikita, Hiroshi/0000-0002-5849-8150	JST PRESTO program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22740276, 20108014]; MEXT; Takeda Science Foundation; Kyoto University; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22740276] Funding Source: KAKEN	JST PRESTO program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kyoto University; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JST PRESTO program (to H. I.), Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan 22740276 (to K. S.) and 20108014 (to H. K.), Special Coordination Fund for Promoting Science and Technology of MEXT (to H. I.), Takeda Science Foundation (to H. I.), Kyoto University Step-up Grant-in-aid for Young Scientists (to H. I.), and Grant for Basic Science Research Projects from the Sumitomo Foundation (to H. I.).	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; BAASOV T, 1986, BIOCHEMISTRY-US, V25, P5249, DOI 10.1021/bi00366a040; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; BALASHOV SP, 1995, BIOCHEMISTRY-US, V34, P8820, DOI 10.1021/bi00027a034; Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; Bombarda E, 2006, J AM CHEM SOC, V128, P12129, DOI 10.1021/ja0619657; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN LS, 1993, BIOPHYS J, V65, P124, DOI 10.1016/S0006-3495(93)81064-6; Calimet N, 2004, J MOL BIOL, V339, P571, DOI 10.1016/j.jmb.2004.03.075; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Frey PA, 2006, ISOTOPE EFFECTS CHEM, P975; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Gerencser L, 2001, BIOCHEMISTRY-US, V40, P1850, DOI 10.1021/bi0021636; Goyal P, 2011, J AM CHEM SOC, V133, P14981, DOI 10.1021/ja201568s; Han K-L, 2010, HYDROGEN BONDING TRA, P377; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Hayashi S, 2004, J AM CHEM SOC, V126, P10516, DOI 10.1021/ja047506s; Ishikita H, 2003, BIOCHEMISTRY-US, V42, P3882, DOI 10.1021/bi026781t; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; KANDORI H, 1995, J AM CHEM SOC, V117, P2118, DOI 10.1021/ja00112a036; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Lanyi JK, 2007, J MOL BIOL, V365, P1379, DOI 10.1016/j.jmb.2006.11.016; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; METZ G, 1992, FEBS LETT, V303, P237, DOI 10.1016/0014-5793(92)80528-O; MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; ROUSSO I, 1995, BIOCHEMISTRY-US, V34, P12059, DOI 10.1021/bi00037a049; Saito K, 2012, P NATL ACAD SCI USA, V109, P167, DOI 10.1073/pnas.1113599108; Saito K, 2011, J AM CHEM SOC, V133, P14379, DOI 10.1021/ja203947k; SAMPOGNA RV, 1994, BIOPHYS J, V66, P1341, DOI 10.1016/S0006-3495(94)80925-7; Schutz CN, 2004, PROTEINS, V55, P711, DOI 10.1002/prot.20096; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Shibata N, 2005, BIOCHEMISTRY-US, V44, P7406, DOI 10.1021/bi050122+; Song YF, 2003, BIOCHEMISTRY-US, V42, P9875, DOI 10.1021/bi034482d; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943	51	18	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34009	34018		10.1074/jbc.M112.388348	http://dx.doi.org/10.1074/jbc.M112.388348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865888	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000309654200008
J	Benjannet, S; Hamelin, J; Chretien, M; Seidah, NG				Benjannet, Suzanne; Hamelin, Josee; Chretien, Michel; Seidah, Nabil G.			Loss- and Gain-of-function PCSK9 Variants CLEAVAGE SPECIFICITY, DOMINANT NEGATIVE EFFECTS, AND LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PCSK9; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; HEPG2 CELLS; CHOLESTEROL; MUTATIONS; PROTEIN; FURIN; PH; PROSEGMENT	The proprotein convertase PCSK9 is a major target in the treatment of hypercholesterolemia because of its ability bind the LDL receptor (LDLR) and enhance its degradation in endosomes/lysosomes. In the endoplasmic reticulum, the zymogen pro-PCSK9 is first autocatalytically cleaved at its internal Gln(152)down arrow, resulting in a secreted enzymatically inactive complex of PCSK9 with its inhibitory prosegment (prosegment.PCSK9), which is the active form of PCSK9 on the LDLR. We mutagenized the P1 cleavage site Gln(152) into all other residues except Cys and analyzed the expression and secretion of the resulting mutants. The data demonstrated the following. 1) The only P1 residues recognized by PCSK9 are Gln > Met > Ala > Ser > Thr approximate to Asn, revealing an unsuspected specificity. 2) All other mutations led to the formation of an unprocessed zymogen that acted as a dominant negative retaining the native protein in the endoplasmic reticulum. Analysis of a large panoply of known natural and artificial point mutants revealed that this general dominant negative observation applies to all PCSK9 mutations that result in the inability of the protein to exit the endoplasmic reticulum. Such a tight quality control property of the endoplasmic reticulum may lead to the development of specific PCSK9 small molecule inhibitors that block its autocatalytic processing. Finally, inspired by the most active gain-of-function mutant, D374Y, we evaluated the LDLR degradation activity of 18 Asp(374) variants of PCSK9. All Asp374 mutations resulted in similar gain-of-function activity on the LDLR except that D374E was as active as native PCSK9, D374G was relatively less active, and D374N and D374P were completely inactive.	[Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Chretien, Michel] Ottawa Hosp, Res Inst, Ottawa, ON K1Y 4E9, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Seidah, NG (corresponding author), Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; CHRETIEN, Michel/0000-0002-8588-4460	Canadian Institutes of Health Research (CIHR) Grant [MOP-102741]; CIHR [MOP-102618, 211351]; Strauss Foundation	Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-102741, Team Grant MOP-44363, and Canada Chair Grant 216684 (to N. G. S.), CIHR Grants MOP-102618 and 211351 (to M. C.), and Strauss Foundation grants (to N. G. S. and M. C.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Akram ON, 2010, ARTERIOSCL THROM VAS, V30, P1279, DOI 10.1161/ATVBAHA.110.209007; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Cariou B, 2009, ARTERIOSCL THROM VAS, V29, P2191, DOI 10.1161/ATVBAHA.109.194191; Chretien M., 2012, BIOCH CELL IN PRESS; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Geoghegan KF, 2009, BIOCHEMISTRY-US, V48, P2941, DOI 10.1021/bi802232m; Gutierrez-Cirlos C, 2011, ANN HEPATOL, V10, P155, DOI 10.1016/S1665-2681(19)31564-9; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Y., 2012, J MOL BIOL IN PRESS; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	53	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33745	33755		10.1074/jbc.M112.399725	http://dx.doi.org/10.1074/jbc.M112.399725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875854	Green Published, hybrid			2022-12-25	WOS:000309602100057
J	Mechaly, A; Levy, H; Epstein, E; Rosenfeld, R; Marcus, H; Ben-Arie, E; Shafferman, A; Ordentlich, A; Mazor, O				Mechaly, Adva; Levy, Haim; Epstein, Eyal; Rosenfeld, Ronit; Marcus, Hadar; Ben-Arie, Einat; Shafferman, Avigdor; Ordentlich, Arie; Mazor, Ohad			A Novel Mechanism for Antibody-based Anthrax Toxin Neutralization INHIBITION OF PREPORE-TO-PORE CONVERSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; LETHAL FACTOR; RECEPTOR; INFECTION; BINDING; CLOSTRIDIUM; VACCINES; IMMUNITY	Protective antigen (PA), a key component of anthrax toxin, mediates the entry of lethal factor (LF) or edema factor (EF) through a membranal pore into target cells. We have previously reported the isolation and chimerization of cAb29, an anti-PA monoclonal antibody that effectively neutralizes anthrax toxin in an unknown mechanism. The aim of this study was to elucidate the neutralizing mechanism of this antibody in vitro and to test its ability to confer post-exposure protection against anthrax in vivo. By systematic evaluation of the steps taking place during the PA-based intoxication process, we found that cAb29 did not interfere with the initial steps of intoxication, namely its ability to bind to the anthrax receptor, the consecutive proteolytic cleavage to PA(63), oligomerization, prepore formation, or LF binding. However, the binding of cAb29 to the prepore prevented its pH-triggered transition to the transmembranal pore, thus preventing the last step of intoxication, i.e. the translocation of LF/EF into the cell. Epitope mapping, using a phage display peptide library, revealed that cAb29 binds the 2 alpha(1) loop in domain 2 of PA, a loop that undergoes major conformational changes during pore formation. In vivo, we found that 100% of anthrax-infected rabbits survived when treated with cAb29 12 h after exposure. In conclusion, these experiments demonstrate that cAb29 exerts its potent neutralizing activity in a unique manner by blocking the prepore-to-pore conversion process.	[Rosenfeld, Ronit; Ben-Arie, Einat; Shafferman, Avigdor; Ordentlich, Arie; Mazor, Ohad] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel; Israel Inst Biol Res, Dept Infect Dis, IL-74100 Ness Ziona, Israel; [Epstein, Eyal; Marcus, Hadar] Israel Inst Biol Res, Dept Biotechnol, IL-74100 Ness Ziona, Israel		Ordentlich, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel.	arieo@iibr.gov.il						Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Bann JG, 2012, PROTEIN SCI, V21, P1, DOI 10.1002/pro.752; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Crowe SR, 2010, J INFECT DIS, V202, P251, DOI 10.1086/653495; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; Grabenstein JD, 2008, CLIN INFECT DIS, V46, P129, DOI 10.1086/523578; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Mazor O, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P275, DOI 10.1007/978-90-481-9054-6_30; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Rosenfeld R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006351; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Williams AS, 2009, PROTEIN SCI, V18, P2277, DOI 10.1002/pro.238; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zarebski LM, 2008, EXPERT REV VACCINES, V7, P55, DOI 10.1586/14760584.7.1.55	26	20	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32665	32673		10.1074/jbc.M112.400473	http://dx.doi.org/10.1074/jbc.M112.400473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22869370	Green Published, hybrid			2022-12-25	WOS:000309168300034
J	Fischer, S; Bayersdorfer, F; Harant, E; Reng, R; Arndt, S; Bosserhoff, AK; Schneuwly, S				Fischer, Susanne; Bayersdorfer, Florian; Harant, Eva; Reng, Renate; Arndt, Stephanie; Bosserhoff, Anja-Katrin; Schneuwly, Stephan			fussel (fuss) - A Negative Regulator of BMP Signaling in Drosophila melanogaster	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR; TUMOR-SUPPRESSOR; CO-REPRESSOR; BETA; GENE; SKI; DPP; GROWTH; SMAD; RECEPTOR	The TGF-beta/BMP signaling cascades control a wide range of developmental and physiological functions in vertebrates and invertebrates. In Drosophila melanogaster, members of this pathway can be divided into a Bone Morphogenic Protein (BMP) and an Activin-beta (Act-beta) branch, where Decapentaplegic (Dpp), a member of the BMP family has been most intensively studied. They differ in ligands, receptors and transmitting proteins, but also share some components, such as the Co-Smad Medea (Med). The essential role of Med is to form a complex with one of the two activating Smads, mothers against decapentaplegic (Mad) or dSmad, and to translocate together to the nucleus where they can function as transcriptional regulators of downstream target genes. This signaling cascade underlies different mechanisms of negative regulation, which can be exerted by inhibitory Smads, such as daughters against decapentaplegic (dad), but also by the Ski-Sno family. In this work we identified and functionally analyzed a new member of the Ski/Sno-family, fussel (fuss), the Drosophila homolog of the human functional suppressing element 15 (fussel-15). fuss codes for two differentially spliced transcripts with a neuronal expression pattern. The proteins are characterized by a Ski-Sno and a SAND homology domain. Overexpression studies and genetic interaction experiments clearly reveal an interaction of fuss with members of the BMP pathway, leading to a strong repression of BMP-signaling. The protein interacts directly with Medea and seems to reprogram the Smad pathway through its influence upon the formation of functional Mad/Medea complexes. This leads amongst others to a repression of downstream target genes of the Dpp pathway, such as optomotor blind (omb). Taken together we could show that fuss exerts a pivotal role as an antagonist of BMP signaling in Drosophila melanogaster.	[Fischer, Susanne; Bayersdorfer, Florian; Harant, Eva; Reng, Renate; Schneuwly, Stephan] Univ Regensburg, Inst Zool, D-8400 Regensburg, Germany; [Arndt, Stephanie; Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, Regensburg, Germany	University of Regensburg; University of Regensburg	Fischer, S (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-8400 Regensburg, Germany.	stephan.schneuwly@biologie.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X; Schneuwly, Stephan/0000-0001-7711-8902	University of Regensburg	University of Regensburg	This work was funded by the University of Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arguello JR, 2010, MOL BIOL EVOL, V27, P848, DOI 10.1093/molbev/msp291; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Cao J, 2006, DROS INFORM SERV, V89, P131; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; DIAZBENJUMEA J, 1989, GENOME, V31, P612, DOI 10.1139/g89-114; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Minaki Y, 2008, GENE EXPR PATTERNS, V8, P418, DOI 10.1016/j.gep.2008.04.004; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Montagne J, 1996, DEVELOPMENT, V122, P2589; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; O'Connor MB, 2006, DEVELOPMENT, V133, P183; OKANO H, 1994, GENE, V148, P203; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Parker L, 2004, PROG MOLEC, V34, P73; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ramel MC, 2007, MECH DEVELOP, V124, P304, DOI 10.1016/j.mod.2006.12.006; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Twombly V, 1996, DEVELOPMENT, V122, P1555; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	69	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42349	10.1371/journal.pone.0042349	http://dx.doi.org/10.1371/journal.pone.0042349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879948	Green Published, gold			2022-12-25	WOS:000307437900031
J	An, JY; Liew, AWC; Nelson, CC				An, Jiyuan; Liew, Alan Wee-Chung; Nelson, Colleen C.			Seed-Based Biclustering of Gene Expression Data	PLOS ONE			English	Article							ALGORITHM	Background: Accumulated biological research outcomes show that biological functions do not depend on individual genes, but on complex gene networks. Microarray data are widely used to cluster genes according to their expression levels across experimental conditions. However, functionally related genes generally do not show coherent expression across all conditions since any given cellular process is active only under a subset of conditions. Biclustering finds gene clusters that have similar expression levels across a subset of conditions. This paper proposes a seed-based algorithm that identifies coherent genes in an exhaustive, but efficient manner. Methods: In order to find the biclusters in a gene expression dataset, we exhaustively select combinations of genes and conditions as seeds to create candidate bicluster tables. The tables have two columns (a) a gene set, and (b) the conditions on which the gene set have dissimilar expression levels to the seed. First, the genes with less than the maximum number of dissimilar conditions are identified and a table of these genes is created. Second, the rows that have the same dissimilar conditions are grouped together. Third, the table is sorted in ascending order based on the number of dissimilar conditions. Finally, beginning with the first row of the table, a test is run repeatedly to determine whether the cardinality of the gene set in the row is greater than the minimum threshold number of genes in a bicluster. If so, a bicluster is outputted and the corresponding row is removed from the table. Repeating this process, all biclusters in the table are systematically identified until the table becomes empty. Conclusions: This paper presents a novel biclustering algorithm for the identification of additive biclusters. Since it involves exhaustively testing combinations of genes and conditions, the additive biclusters can be found more readily.	[An, Jiyuan; Nelson, Colleen C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Liew, Alan Wee-Chung] Griffith Univ, Sch Informat & Commun Technol, Griffith, Qld, Australia	Queensland University of Technology (QUT); Griffith University	An, JY (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	j.an@qut.edu.au	An, Jiyuan/ABD-2471-2020; Liew, Alan Wee-Chung/F-6988-2011	Liew, Alan Wee-Chung/0000-0001-6718-7584; An, Jiyuan/0000-0002-8183-8248	Queensland Smart Futures Premier's Fellowship; Prostate Cancer Foundation of Australia [PCFA PG25]	Queensland Smart Futures Premier's Fellowship; Prostate Cancer Foundation of Australia	Funding provided by the Queensland Smart Futures Premier's Fellowship and the Prostate Cancer Foundation of Australia (PCFA PG25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; An JY, 2009, INT J INNOV COMPUT I, V5, P1419; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Cheng Y, BICLUSTERING EXPRESS; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Dharan S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S27; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Kriegel HP, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1497577.1497578; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Wang H, CLUSTERING PATTERN S; Yoon S, 2005, IEEE ACM T COMPUT BI, V2, P339, DOI 10.1109/TCBB.2005.55; Yoon S, 2004, ENHANCED PCLUSTERING; Zhao HY, 2008, J THEOR BIOL, V251, P264, DOI 10.1016/j.jtbi.2007.11.030; Zhao HY, 2012, CURR BIOINFORM, V7, P43, DOI 10.2174/157489312799304413	22	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42431	10.1371/journal.pone.0042431	http://dx.doi.org/10.1371/journal.pone.0042431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879981	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100092
J	Clerc, P; Carey, GB; Mehrabian, Z; Wei, M; Hwang, HH; Girnun, GD; Chen, HG; Martin, SS; Polster, BM				Clerc, Pascaline; Carey, Gregory B.; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Girnun, Geoffrey D.; Chen, Hegang; Martin, Stuart S.; Polster, Brian M.			Rapid Detection of an ABT-737-Sensitive Primed for Death State in Cells Using Microplate-Based Respirometry	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; BH3 MIMETIC ABT-737; CHRONIC LYMPHOCYTIC-LEUKEMIA; OUTER-MEMBRANE PERMEABILITY; CYTOCHROME-C RELEASE; BRAIN MITOCHONDRIA; CHROMOSOME-TRANSLOCATION; CANCER-CELLS; NEURAL CELL; APOPTOSIS	Cells that exhibit an absolute dependence on the anti-apoptotic BCL-2 protein for survival are termed "primed for death" and are killed by the BCL-2 antagonist ABT-737. Many cancers exhibit a primed phenotype, including some that are resistant to conventional chemotherapy due to high BCL-2 expression. We show here that 1) stable BCL-2 overexpression alone can induce a primed for death state and 2) that an ABT-737-induced loss of functional cytochrome c from the electron transport chain causes a reduction in maximal respiration that is readily detectable by microplate-based respirometry. Stable BCL-2 overexpression sensitized non-tumorigenic MCF10A mammary epithelial cells to ABT-737-induced caspase-dependent apoptosis. Mitochondria within permeabilized BCL-2 overexpressing cells were selectively vulnerable to ABT-737-induced cytochrome c release compared to those from control-transfected cells, consistent with a primed state. ABT-737 treatment caused a dose-dependent impairment of maximal O-2 consumption in MCF10A BCL-2 overexpressing cells but not in control-transfected cells or in immortalized mouse embryonic fibroblasts lacking both BAX and BAK. This impairment was rescued by delivering exogenous cytochrome c to mitochondria via saponin-mediated plasma membrane permeabilization. An ABT-737-induced reduction in maximal O-2 consumption was also detectable in SP53, JeKo-1, and WEHI-231 B-cell lymphoma cell lines, with sensitivity correlating with BCL-2: MCL-1 ratio and with susceptibility (SP53 and JeKo-1) or resistance (WEHI-231) to ABT-737-induced apoptosis. Multiplexing respirometry assays to ELISA-based determination of cytochrome c redistribution confirmed that respiratory inhibition was associated with cytochrome c release. In summary, cell-based respiration assays were able to rapidly identify a primed for death state in cells with either artificially overexpressed or high endogenous BCL-2. Rapid detection of a primed for death state in individual cancers by "bioenergetics-based profiling" may eventually help identify the subset of patients with chemoresistant but primed tumors who can benefit from treatment that incorporates a BCL-2 antagonist.	[Clerc, Pascaline; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Polster, Brian M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Clerc, Pascaline; Mehrabian, Zara; Wei, Michael; Hwang, Hyehyun; Polster, Brian M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Carey, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Girnun, Geoffrey D.; Polster, Brian M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Martin, Stuart S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Clerc, P (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institutes of Health [NS064978]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BMP received support from National Institutes of Health grant NS064978. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bodet L, 2011, BLOOD, V118, P3901, DOI 10.1182/blood-2010-11-317438; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Buron N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009924; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; High LM, 2010, MOL PHARMACOL, V77, P483, DOI 10.1124/mol.109.060780; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martin S, 2001, TELECONNECT, V19, P10; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Merlo GR, 1997, CELL GROWTH DIFFER, V8, P251; Milanesi E, 2006, J BIOL CHEM, V281, P10066, DOI 10.1074/jbc.M513708200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nicholls DG, 2010, J VIS EXP, P2511; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Polster BM, 2003, J NEUROSCI, V23, P2735; Polster BM, 2001, J BIOL CHEM, V276, P37887; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Schuh RA, 2011, J NEUROSCI RES; Sears KT, 2008, INT J CANCER, V122, P1496, DOI 10.1002/ijc.23207; SOULE HD, 1990, CANCER RES, V50, P6075; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Touzeau C, 2011, CLIN CANCER RES, V17, P5973, DOI 10.1158/1078-0432.CCR-11-0955; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42487	10.1371/journal.pone.0042487	http://dx.doi.org/10.1371/journal.pone.0042487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880001	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100108
J	Majewski, T; Spiess, PE; Bondaruk, J; Black, P; Clarke, C; Benedict, W; Dinney, CP; Grossman, HB; Tang, KS; Czerniak, B				Majewski, Tadeusz; Spiess, Philippe E.; Bondaruk, Jolanta; Black, Peter; Clarke, Charlotte; Benedict, William; Dinney, Colin P.; Grossman, Herbert Barton; Tang, Kuang S.; Czerniak, Bogdan			Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; ENHANCED LASER-DESORPTION; MASS-SPECTROMETRY; PROTEIN EXPRESSION; TREE ANALYSIS; SERUM; REPRODUCIBILITY; PATTERNS; QUANTIFICATION; IDENTIFICATION	We used protein expression profiles to develop a classification rule for the detection and prognostic assessment of bladder cancer in voided urine samples. Using the Ciphergen PBS II ProteinChip Reader, we analyzed the protein profiles of 18 pairs of samples of bladder tumor and adjacent urothelium tissue, a training set of 85 voided urine samples (32 controls and 53 bladder cancer), and a blinded testing set of 68 voided urine samples (33 controls and 35 bladder cancer). Using t-tests, we identified 473 peaks showing significant differential expression across different categories of paired bladder tumor and adjacent urothelial samples compared to normal urothelium. Then the intensities of those 473 peaks were examined in a training set of voided urine samples. Using this approach, we identified 41 protein peaks that were differentially expressed in both sets of samples. The expression pattern of the 41 protein peaks was used to classify the voided urine samples as malignant or benign. This approach yielded a sensitivity and specificity of 59% and 90%, respectively, on the training set and 80% and 100%, respectively, on the testing set. The proteomic classification rule performed with similar accuracy in low- and high-grade bladder carcinomas. In addition, we used hierarchical clustering with all 473 protein peaks on 65 benign voided urine samples, 88 samples from patients with clinically evident bladder cancer, and 127 samples from patients with a history of bladder cancer to classify the samples into Cluster A or B. The tumors in Cluster B were characterized by clinically aggressive behavior with significantly shorter metastasis-free and disease-specific survival.	[Majewski, Tadeusz; Bondaruk, Jolanta; Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Spiess, Philippe E.; Black, Peter; Dinney, Colin P.; Grossman, Herbert Barton] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Clarke, Charlotte] Ciphergen Biosyst Inc, Fremont, CA USA; [Benedict, William] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Tang, Kuang S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Majewski, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	bczernia@mdanderson.org	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Dinney, Colin/0000-0002-8969-711X	National Institute of Health [R01 CA 151489, P50 CA91846]; NATIONAL CANCER INSTITUTE [R01CA151489, P50CA091846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants R01 CA 151489 (BC) and GU SPORE Grant P50 CA91846 (Project 1, BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbod MF, 2005, ARTIF INTELL, P109; Albrethsen J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-8; Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Baggerly KA, 2004, ENDOCR-RELAT CANCER, V11, P583, DOI 10.1677/erc.1.00868; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Catto JWF, 2003, CLIN CANCER RES, V9, P4172; Cho WCS, 2007, EXPERT REV PROTEOMIC, V4, P401, DOI 10.1586/14789450.4.3.401; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cleverley S, 2005, NAT METHODS, V2, P393, DOI DOI 10.1038/NMETH0505-393; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Conrad DH, 2008, J GEN INTERN MED, V23, P78, DOI 10.1007/s11606-007-0411-1; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Diao L, 2011, CANCER INFORM, V10, P45, DOI 10.4137/CIN.S6438; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002; FK M IA S, 1999, HISTOLOGICAL TYPING; Gaston KE, 2010, METHODS MOL BIOL, V641, P303, DOI 10.1007/978-1-60761-711-2_17; Gazdar AF, 2001, JNCI-J NATL CANCER I, V93, P413, DOI 10.1093/jnci/93.6.413; Goodison S, 2009, EXPERT REV PROTEOMIC, V6, P507, DOI 10.1586/EPR.09.70; Holterman DA, 2006, UROL ONCOL-SEMIN ORI, V24, P97, DOI 10.1016/j.urolonc.2005.07.010; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Kehinde EO, 2011, SCAND J UROL NEPHROL, V45, P113, DOI 10.3109/00365599.2010.533694; Khwaja FW, 2006, PROTEOMICS, V6, P6277, DOI 10.1002/pmic.200600135; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; Liu WW, 2005, EUR UROL, V47, P456, DOI 10.1016/j.eururo.2004.10.006; Lu M, 2007, BIOMARK INSIGHTS, V2, P347; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Mueller J, 2005, EUR UROL, V47, P885, DOI 10.1016/j.eururo.2005.02.016; Muller CA, 2002, AM J PATHOL, V160, P1311, DOI 10.1016/S0002-9440(10)62558-8; Pan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027574; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2003, J NUTR, V133, p2476S, DOI 10.1093/jn/133.7.2476S; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Pollard C, 2009, AM J PATHOL, V175, P1824, DOI 10.2353/ajpath.2009.090155; Qu YS, 2002, CLIN CHEM, V48, P1835; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Rogers MA, 2003, CANCER RES, V63, P6971; Sanchez-Carbayo M, 2004, CLIN BIOCHEM, V37, P562, DOI 10.1016/j.clinbiochem.2004.05.014; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Schwamborn K, 2010, EXPERT REV PROTEOMIC, V7, P897, DOI 10.1586/EPR.10.82; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sobin OH, 1999, TNM CLASSIFICATION M; Spiess PE, 2006, ARCH PATHOL LAB MED, V130, P844; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Thulasiraman V, 2001, BIOTECHNIQUES, V30, P428, DOI 10.2144/01302pf02; Van Que N, 2011, Curr Urol Rep, V12, P34, DOI 10.1007/s11934-010-0151-3; Vlahou A, 2001, AM J PATHOL, V158, P1491, DOI 10.1016/S0002-9440(10)64100-4; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhu W, 2003, P NATL ACAD SCI USA, V100, P14666, DOI 10.1073/pnas.2532248100	50	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42452	10.1371/journal.pone.0042452	http://dx.doi.org/10.1371/journal.pone.0042452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879988	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100097
J	Ou, XL; Gao, J; Wang, H; Wang, HS; Lu, HL; Sun, HY				Ou, Xue-ling; Gao, Jun; Wang, Huan; Wang, Hong-sheng; Lu, Hui-ling; Sun, Hong-yu			Predicting Human Age with Bloodstains by sjTREC Quantification	PLOS ONE			English	Article							RECENT THYMIC EMIGRANTS; PERIPHERAL-BLOOD; EXCISION CIRCLES; HIV-INFECTION; OUTPUT; PCR; INDIVIDUALS; GUIDELINES; DELETION; DNA	The age-related decline of signal joint T-cell receptor rearrangement excision circles (sjTRECs) in human peripheral blood has been demonstrated in our previous study and other reports. Until now, only a few studies on sjTREC detection in bloodstain samples were reported, which were based on a small sample of subjects of a limited age range, although bloodstains are much more frequently encountered in forensic practice. In this present study, we adopted the sensitive Taqman real-time quantitative polymerase chain reaction (qPCR) method to perform sjTREC quantification in bloodstains from individuals ranging from 0-86 years old (n = 264). The results revealed that sjTREC contents in human bloodstains were declined in an age-dependent manner (r = -0.8712). The formula of age estimation was Age = -7.1815Y-42.458 +/- 9.42 (Y dCt(TBP-sjTREC); 9.42 standard error). Furthermore, we tested for the influence of short-or long-storage time by analyzing fresh and stored bloodstains from the same individuals. Remarkably, no statistically significant difference in sjTREC contents was found between the fresh and old DNA samples over a 4-week of storage time. However, significant loss (0.16-1.93 dCt) in sjTREC contents was detected after 1.5 years of storage in 31 samples. Moreover, preliminary sjTREC quantification from up to 20-year-old bloodstains showed that though the sjTREC contents were detectable in all samples and highly correlated with donor age, a time-dependent decrease in the correlation coefficient r was found, suggesting the predicting accuracy of this described assay would be deteriorated in aged samples. Our findings show that sjTREC quantification might be also suitable for age prediction in bloodstains, and future researches into the time-dependent or other potential impacts on sjTREC quantification might allow further improvement of the predicting accuracy.	[Ou, Xue-ling; Lu, Hui-ling; Sun, Hong-yu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gynaecol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Hong-sheng] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ou, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China.	sunhongyu2002@163.com	Ou, Xueling/W-9964-2019; Wang, Hongsheng/N-1940-2019; Sun, 宏钰/H-7885-2018	Ou, Xueling/0000-0003-2345-4980; Wang, Hongsheng/0000-0002-0054-4820; Sun, 宏钰/0000-0002-5926-4495	National Natural Science Foundation of China [81001352]; China Postdoctoral Science Foundation [20100470957]; Natural Science Foundation of Guangdong Province of China [10451008901004242]; Fundamental Research Funds for the Central Universities [09YKPY78]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	These studies are supported by the National Natural Science Foundation of China (grant no. 81001352), China Postdoctoral Science Foundation (grant no. 20100470957), Natural Science Foundation of Guangdong Province of China (grant no. 10451008901004242) and the Fundamental Research Funds for the Central Universities (09YKPY78). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Breit TM, 1997, J IMMUNOL, V159, P4341; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ferrando-Martinez S, 2010, J IMMUNOL METHODS, V352, P111, DOI 10.1016/j.jim.2009.11.007; Ferrando-Martinez S, 2009, AGE, V31, P87, DOI 10.1007/s11357-008-9084-x; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Lang PO, 2011, J IMMUNOL METHODS, V369, P133, DOI 10.1016/j.jim.2011.05.002; Lorenzi AR, 2008, J IMMUNOL METHODS, V339, P185, DOI 10.1016/j.jim.2008.09.013; Meissner C, 1997, INT J LEGAL MED, V110, P288, DOI 10.1007/s004140050089; Meissner C, 2010, FORENSIC SCI INT, V203, P34, DOI 10.1016/j.forsciint.2010.07.010; Ou XL, 2011, INT J LEGAL MED, V125, P603, DOI 10.1007/s00414-010-0528-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pido-Lopez J, 2001, CLIN EXP IMMUNOL, V125, P409, DOI 10.1046/j.1365-2249.2001.01640.x; Ren F, 2009, AM J FOREN MED PATH, V30, P252, DOI 10.1097/PAF.0b013e318187df8e; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; Schmeling A, 2008, INT J LEGAL MED, V122, P457, DOI 10.1007/s00414-008-0254-2; Schmeling A, 2007, FORENSIC SCI INT, V165, P178, DOI 10.1016/j.forsciint.2006.05.016; Tsuji A, 2002, FORENSIC SCI INT, V126, P197, DOI 10.1016/S0379-0738(02)00086-5; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zubakov D, 2010, CURR BIOL, V20, pR970, DOI 10.1016/j.cub.2010.10.022	23	42	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42412	10.1371/journal.pone.0042412	http://dx.doi.org/10.1371/journal.pone.0042412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879970	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100083
J	Kwee, RM; Truijman, MTB; van Oostenbrugge, RJ; Mess, WH; Prins, MH; Franke, CL; Korten, AGGC; Wildberger, JE; Kooi, ME				Kwee, Robert M.; Truijman, Martine T. B.; van Oostenbrugge, Robert J.; Mess, Werner H.; Prins, Martin H.; Franke, Cees L.; Korten, Arthur G. G. C.; Wildberger, Joachim E.; Kooi, M. Eline			Longitudinal MRI Study on the Natural History of Carotid Artery Plaques in Symptomatic Patients	PLOS ONE			English	Article							NECROTIC CORE SIZE; ATHEROSCLEROTIC PLAQUE; HIGH-RESOLUTION; FIBROUS CAP; STENOSIS; ENDARTERECTOMY; FEATURES; STROKE	Purpose: To investigate the natural history of carotid atherosclerosis in patients who experienced a TIA or ischemic stroke. Patients and Methods: Ninety-two TIA/stroke patients (57 men, mean age 67.7 +/- 9.8 years) with ipsilateral <70% carotid stenosis underwent multisequence MRI of the plaque ipsilateral to the symptomatic side at baseline and after one year. For each plaque, several parameters were assessed at both time points. Results: Carotid lumen, wall and total vessel (= carotid lumen and wall) volume did not significantly change. Forty-four patients had a plaque with a lipid-rich necrotic core (LRNC) at baseline, of which 34 also had a LRNC after one year. In three patients a LRNC appeared after one year. Thirty patients had a plaque with a thin and/or ruptured fibrous cap (FC) at both time points. In seven patients, FC status changed from thin and/or ruptured into thick and intact. In three patients, FC status changed from thick and intact into thin and/or ruptured. Twenty patients had intraplaque hemorrhage (IPH) at both time points. In four patients, IPH disappeared, whereas in three patients, new IPH appeared at follow-up. Conclusion: In TIA/stroke patients, carotid plaque morphology does not significantly change over a one-year period. IPH and FC status change in a minority of patients.	[Kwee, Robert M.; Truijman, Martine T. B.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Kwee, Robert M.; Truijman, Martine T. B.; van Oostenbrugge, Robert J.; Mess, Werner H.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Truijman, Martine T. B.; Mess, Werner H.] Maastricht Univ Med Ctr, Dept Clin Neurophysiol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Prins, Martin H.] Maastricht Univ Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Franke, Cees L.] Atrium Med Ctr Parkstad, Dept Neurol, Heerlen, Netherlands; [Korten, Arthur G. G. C.] Laurentius Hosp, Dept Neurol, Roermond, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Atrium Medical Center	Kwee, RM (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	rmkwee@gmail.com	Mess, Werner/AAB-9527-2020; Kooi, M. Eline/D-3848-2016	Kooi, M. Eline/0000-0001-7562-5724; Wildberger, Joachim/0000-0002-4810-6854	Netherlands Heart Foundation [2006B61]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Netherlands Heart Foundation (grant 2006B61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussel L, 2009, RADIOLOGY, V252, P789, DOI 10.1148/radiol.2523081798; Cai JM, 2005, CIRCULATION, V112, P3437, DOI 10.1161/CIRCULATIONAHA.104.528174; Cappendijk VC, 2004, J MAGN RESON IMAGING, V20, P105, DOI 10.1002/jmri.20060; Cappendijk VC, 2008, J MAGN RESON IMAGING, V27, P1356, DOI 10.1002/jmri.21359; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Kwee RM, 2010, INVEST RADIOL, V45, P803, DOI 10.1097/RLI.0b013e3181ed15ff; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Oikawa M, 2009, CIRC J, V73, P1765, DOI 10.1253/circj.CJ-09-0617; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2007, ATHEROSCLEROSIS, V194, pE34, DOI 10.1016/j.atherosclerosis.2006.08.016; Saam T, 2006, RADIOLOGY, V240, P464, DOI 10.1148/radiol.2402050390; Shaalan WE, 2008, J VASC SURG, V48, P104, DOI 10.1016/j.jvs.2008.02.068; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Underhill HR, 2009, JACC-CARDIOVASC IMAG, V2, P1381, DOI 10.1016/j.jcmg.2009.08.007; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Zhao XQ, 2011, JACC-CARDIOVASC IMAG, V4, P977, DOI 10.1016/j.jcmg.2011.06.013	20	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42472	10.1371/journal.pone.0042472	http://dx.doi.org/10.1371/journal.pone.0042472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860130	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600104
J	Hulleman, JD; Balch, WE; Kelly, JW				Hulleman, John D.; Balch, William E.; Kelly, Jeffery W.			Translational attenuation differentially alters the fate of disease-associated fibulin proteins	FASEB JOURNAL			English	Article						eIF2 alpha; age-related macular degeneration; cutis laxa; malattia leventinese; proteostasis	ELASTIC FIBER HOMEOSTASIS; FACTOR 2-ALPHA KINASE; ENDOPLASMIC-RETICULUM; MACULAR DEGENERATION; ABERRANT ACCUMULATION; MALATTIA LEVENTINESE; VISUAL IMPAIRMENT; GENE-EXPRESSION; STRESS; MUTATION	Mutations in fibulin proteins that cause cellular secretion deficiencies are linked to a variety of diseases, ranging from retinopathies to cutis laxa (CL). One secretion-deficient fibulin mutant, R345W fibulin-3, causes the macular dystrophy malattia leventinese by increased endoplasmic reticulum retention and/or extracellular misfolding. Herein, we report that small-molecule activation of the PERK arm of the unfolded protein response partially rescues R345W secretion deficiencies through translational attenuation mediated by eIF2 alpha phosphorylation. Enhanced mutant fibulin-3 secretion can also be achieved by activation of a PERK-independent eIF2 alpha kinase through arsenite treatment and is independent of activating transcription factor 4 signaling and protein translation. However, this translational attenuation strategy was unsuccessful for enhancing the secretion deficiencies of fibulin-5 mutants associated with age-related macular degeneration or CL. While lowered growth temperature enhanced the secretion of mutants associated with CL (C217R and S227P), these effects were not mediated through translational attenuation. In stark contrast to the situation with fibulin-3, protein translation was required for efficient wild-type and mutant fibulin-5 secretion. These data suggest that alteration of specific cellular signaling pathways and proteostasis network components can differentially influence fibulin fate, a hypothesis that could be exploited as a therapy for fibulin-related diseases.-Hulleman, J. D., Balch, W. E., Kelly, J. W. Translational attenuation differentially alters the fate of disease-associated fibulin proteins. FASEB J. 26, 4548-4560 (2012). www.fasebj.org	[Hulleman, John D.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hulleman, John D.; Balch, William E.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hulleman, John D.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hulleman, JD (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hulleman@scripps.edu; jkelly@scripps.edu	Hulleman, John D./AAV-8242-2020	Hulleman, John/0000-0001-8149-656X	Lita Annenberg Hazen Foundation; Skaggs Institute for Chemical Biology; Scripps Translational Science Institute [UL1 RR025774]; U.S. National Institutes of Health [AG018917]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018917] Funding Source: NIH RePORTER	Lita Annenberg Hazen Foundation; Skaggs Institute for Chemical Biology; Scripps Translational Science Institute; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank R. Luke Wiseman for his insightful review of the manuscript. This work was supported by the Lita Annenberg Hazen Foundation, the Skaggs Institute for Chemical Biology, grant UL1 RR025774 from the Scripps Translational Science Institute (J. W. K.), and grant AG018917 from the U.S. National Institutes of Health (J. W. K.).	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; GALISTEO ML, 1995, J BIOL CHEM, V270, P16595, DOI 10.1074/jbc.270.28.16595; Greene B, 1999, J BIOL CHEM, V274, P16141, DOI 10.1074/jbc.274.23.16141; Gupta R, 2010, FEBS LETT, V584, P3620, DOI 10.1016/j.febslet.2010.07.036; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; Jones RPO, 2010, INVEST OPHTH VIS SCI, V51, P2356, DOI 10.1167/iovs.09-4620; Jones RPO, 2009, J BIOL CHEM, V284, P25938, DOI 10.1074/jbc.M109.011627; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Kojima C, 2009, JNCI-J NATL CANCER I, V101, P1670, DOI 10.1093/jnci/djp414; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; McLaughlin PJ, 2007, HUM MOL GENET, V16, P3059, DOI 10.1093/hmg/ddm264; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Schneider R, 2010, J MOL BIOL, V401, P605, DOI 10.1016/j.jmb.2010.06.039; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; TIELSCH JM, 1995, NEW ENGL J MED, V332, P1205, DOI 10.1056/NEJM199505043321806; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weigell-Weber M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1184, DOI 10.1001/archopht.121.8.1184; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018	59	19	20	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4548	4560		10.1096/fj.11-202861	http://dx.doi.org/10.1096/fj.11-202861			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872678	Green Published			2022-12-25	WOS:000310574200017
J	Vermeer, LS; Lan, Y; Abbate, V; Ruh, E; Bui, TT; Wilkinson, LJ; Kanno, T; Jumagulova, E; Kozlowska, J; Patel, J; McIntyre, CA; Yam, WC; Siu, G; Atkinson, RA; Lam, JKW; Bansal, SS; Drake, AF; Mitchell, GH; Mason, AJ				Vermeer, Louic S.; Lan, Yun; Abbate, Vincenzo; Ruh, Emrah; Bui, Tam T.; Wilkinson, Louise J.; Kanno, Tokuwa; Jumagulova, Elmira; Kozlowska, Justyna; Patel, Jayneil; McIntyre, Caitlin A.; Yam, W. C.; Siu, Gilman; Atkinson, R. Andrew; Lam, Jenny K. W.; Bansal, Sukhvinder S.; Drake, Alex F.; Mitchell, Graham H.; Mason, A. James			Conformational Flexibility Determines Selectivity and Antibacterial, Antiplasmodial, and Anticancer Potency of Cationic alpha-Helical Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-VESICLES; SECONDARY STRUCTURE; ESCHERICHIA-COLI; CELL SELECTIVITY; HEPARAN-SULFATE; MODEL MEMBRANES; LYTIC PEPTIDES; LIPID-BILAYERS; BUFORIN II	We used a combination of fluorescence, circular dichroism (CD), and NMR spectroscopies in conjunction with size exclusion chromatography to help rationalize the relative antibacterial, antiplasmodial, and cytotoxic activities of a series of proline-free and proline-containing model antimicrobial peptides (AMPs) in terms of their structural properties. When compared with proline-free analogs, proline-containing peptides had greater activity against Gram-negative bacteria, two mammalian cancer cell lines, and intraerythrocytic Plasmodium falciparum, which they were capable of killing without causing hemolysis. In contrast, incorporation of proline did not have a consistent effect on peptide activity against Mycobacterium tuberculosis. In membrane-mimicking environments, structures with high alpha-helix content were adopted by both proline-free and proline-containing peptides. In solution, AMPs generally adopted disordered structures unless their sequences comprised more hydrophobic amino acids or until coordinating phosphate ions were added. Proline-containing peptides resisted ordering induced by either method. The roles of the angle subtended by positively charged amino acids and the positioning of the proline residues were also investigated. Careful positioning of proline residues in AMP sequences is required to enable the peptide to resist ordering and maintain optimal antibacterial activity, whereas varying the angle subtended by positively charged amino acids can attenuate hemolytic potential albeit with a modest reduction in potency. Maintaining conformational flexibility improves AMP potency and selectivity toward bacterial, plasmodial, and cancerous cells while enabling the targeting of intracellular pathogens.	[Vermeer, Louic S.; Lan, Yun; Abbate, Vincenzo; Bui, Tam T.; Wilkinson, Louise J.; Kanno, Tokuwa; Jumagulova, Elmira; Kozlowska, Justyna; Patel, Jayneil; McIntyre, Caitlin A.; Bansal, Sukhvinder S.; Drake, Alex F.; Mason, A. James] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Lan, Yun; Lam, Jenny K. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Lan, Yun; Ruh, Emrah; Mitchell, Graham H.] Kings Coll London, Dept Immunobiol, Malaria Lab, London SE1 9RT, England; [Lan, Yun; Ruh, Emrah; Mitchell, Graham H.] Guys Hosp, St Thomas Hosp, Sch Med, London SE1 9RT, England; [Yam, W. C.; Siu, Gilman] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Atkinson, R. Andrew] Kings Coll London, Ctr Biomol Spect, London SE1 1UL, England; [Atkinson, R. Andrew] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; University of Hong Kong; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Hong Kong; University of London; King's College London; University of London; King's College London	Mason, AJ (corresponding author), Kings Coll London, Inst Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England.	james.mason@kcl.ac.uk	Lam, Jenny/A-4842-2010; Vermeer, Louic S/I-4883-2012; Mason, James/J-2273-2012; Abbate, Vincenzo/K-6204-2019; SIU, Kit Hang/L-7796-2017; Mitchell, Graham/AAA-5654-2020; Atkinson, Robert Andrew/ABE-8068-2020	Lam, Jenny/0000-0003-2997-010X; Mason, James/0000-0003-0411-602X; SIU, Kit Hang/0000-0002-4354-3393; Atkinson, Robert Andrew/0000-0002-3645-9492; Mitchell, G.H./0000-0002-4922-8044; Abbate, Vincenzo/0000-0002-3300-0520; Vermeer, Louic/0000-0003-1815-7412; Bui, Tam Thu Thi/0000-0002-8074-4928	Medical Research Council [NIRG G0801072/87482]; Wellcome Trust; University of London Central Research Fund Grant AR/CRF/B; Applied Photophysics Ltd.; Research Fund for Control of Infectious Diseases [RFCID 11100682]; Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme; Medical Research Council [G0801072] Funding Source: researchfish; MRC [G0801072] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of London Central Research Fund Grant AR/CRF/B; Applied Photophysics Ltd.; Research Fund for Control of Infectious Diseases; Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant NIRG G0801072/87482 (to A. J. M.), The Wellcome Trust Value in People Award (to A. J. M.) and Capital Award (to the King's College London Centre for Biomolecular Spectroscopy), University of London Central Research Fund Grant AR/CRF/B, Applied Photophysics Ltd., Research Fund for Control of Infectious Diseases Grant RFCID 11100682 (to J. K. W. L. and A. J. M.), and the Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme (to J. K. W. L.).	ALLEY MC, 1988, CANCER RES, V48, P589; ANDREU D, 1985, BIOCHEMISTRY-US, V24, P1683, DOI 10.1021/bi00328a017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Avrahami D, 2001, BIOCHEMISTRY-US, V40, P12591, DOI 10.1021/bi0105330; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; Chen Y, 1996, J AM CHEM SOC, V118, P9271, DOI 10.1021/ja961307u; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DRAKE AF, 1988, BIOPHYS CHEM, V31, P143, DOI 10.1016/0301-4622(88)80019-X; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Epand RF, 2010, BIOPHYS J, V98, P2564, DOI 10.1016/j.bpj.2010.03.002; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Fadnes B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-116; Fadnes B, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-183; Fossi M, 2005, J MAGN RESON, V175, P92, DOI 10.1016/j.jmr.2005.03.020; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; Goddard T. D., 2008, SPARKY 3; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hong SY, 1999, BIOCHEM PHARMACOL, V58, P1775, DOI 10.1016/S0006-2952(99)00259-2; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026; Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lan Y, 2010, BBA-BIOMEMBRANES, V1798, P1934, DOI 10.1016/j.bbamem.2010.07.003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; Mason AJ, 2009, J BIOL CHEM, V284, P119, DOI 10.1074/jbc.M806201200; Nishikawa M, 2004, FEMS MICROBIOL LETT, V239, P255, DOI 10.1016/j.femsle.2004.08.043; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Pukala TL, 2004, BIOCHEMISTRY-US, V43, P937, DOI 10.1021/bi035760b; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Song YM, 2004, BIOCHEM BIOPH RES CO, V314, P615, DOI 10.1016/j.bbrc.2003.12.142; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TATHAM AS, 1983, BIOCHEM J, V211, P683, DOI 10.1042/bj2110683; Unger T, 2001, BIOCHEMISTRY-US, V40, P6388, DOI 10.1021/bi0026066; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Yang ST, 2006, FEBS J, V273, P4040, DOI 10.1111/j.1742-4658.2006.05407.x; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	58	63	67	0	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34120	34133		10.1074/jbc.M112.359067	http://dx.doi.org/10.1074/jbc.M112.359067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22869378	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000309654200018
J	Arriola, DJ; Mayo, SL; Skarra, DV; Benson, CA; Thackray, VG				Arriola, David J.; Mayo, Susan L.; Skarra, Danalea V.; Benson, Courtney A.; Thackray, Varykina G.			FOXO1 Transcription Factor Inhibits Luteinizing Hormone beta Gene Expression in Pituitary Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; GROWTH-FACTOR-I; GNRH PULSE FREQUENCY; PROTEIN-KINASE-C; OXIDATIVE STRESS; NEGATIVE REGULATION; RESPONSE ELEMENT; GRANULOSA-CELLS; L-BETA-T2 CELLS; DISCRETE STAGES	Synthesis of luteinizing hormone (LH) is tightly controlled by a complex network of hormonal signaling pathways that can be modulated by metabolic cues, such as insulin. One group of candidate genes that may be regulated by insulin signaling in pituitary gonadotrope cells is the FOXO subfamily of forkhead transcription factors. In this study we investigated whether FOXO1 is expressed in gonadotropes and if it can modulate LH beta-subunit (Lhb) gene expression. We demonstrated that FOXO1 is expressed in murine gonadotrope cells and that insulin signaling increased FOXO1 phosphorylation and cytoplasmic localization in a PI3K-dependent manner. We also showed that FOXO1 repressed basal transcription and gonadotropin-releasing hormone ( GnRH) induction of both the murine and human LHB genes in L beta T2 cells, suggesting that FOXO1 regulation of LHB transcription may be conserved between rodents and humans. Although we did not detect FOXO1 binding to the proximal Lhb promoter, the FOXO1 DNA binding domain was necessary for the suppression, suggesting that FOXO1 exerts its effect through protein-protein interactions with transcription factors/cofactors required for Lhb gene expression. FOXO1 repression mapped to the proximal Lhb promoter containing steroidogenic factor 1 (SF1), pituitary homeobox 1 (PTX1), and early growth response protein 1 (EGR1) binding elements. Additionally, FOXO1 blocked induction of the Lhb promoter with overexpressed SF1, PTX1, and EGR1, indicating that FOXO1 repression occurs via these transcription factors but not through regulation of their promoters. In summary, we demonstrate that FOXO1 phosphorylation and cellular localization is regulated by insulin signaling in gonadotropes and that FOXO1 inhibits Lhb transcription. Our study also suggests that FOXO1 may play an important role in controlling LH levels in response to metabolic cues.	[Thackray, Varykina G.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Reprod Med, 9500 Gilman Dr,MC0674, La Jolla, CA 92093 USA.	vthackray@ucsd.edu			National Institutes of Health [K01 DK080467, R01 HD067448, T32 HD007203]; UCSD/UCLA Diabetes and Endocrinology Research Center [P30 DK063491]; NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; UCSD Academic Senate Health Sciences Research Grant; NCI Cancer Support Grant [P30 CA023100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, T32HD007203, R01HD067448, U54HD012303, F32HD074414] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, K01DK080467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD/UCLA Diabetes and Endocrinology Research Center; NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; UCSD Academic Senate Health Sciences Research Grant; NCI Cancer Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK080467 and R01 HD067448 (to V. G. T.) as well as T32 HD007203 (to D. V. S.). This work was also supported by a pilot and feasibility grant from the UCSD/UCLA Diabetes and Endocrinology Research Center (P30 DK063491) by NICHD, National Institutes of Health through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and by a UCSD Academic Senate Health Sciences Research Grant.; We thank Djurdjica Coss, Kellie Breen, and Pamela Mellon for helpful discussions and comments. We also thank Scott Kelley for suggestions and critical reading of the manuscript. We acknowledge using the UCSD Cancer Center DNA Sequencing Shared Resource funded in part by the NCI Cancer Support Grant P30 CA023100 for DNA sequencing.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Alarid ET, 1998, MOL CELL ENDOCRINOL, V140, P25; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Armstrong J, 1997, ENDOCRINOLOGY, V138, P1903, DOI 10.1210/en.138.5.1903; ATTARDI B, 1990, MOL ENDOCRINOL, V4, P721, DOI 10.1210/mend-4-5-721; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brosens JJ, 2009, ADV EXP MED BIOL, V665, P227; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Charles MA, 2008, GENESIS, V46, P507, DOI 10.1002/dvg.20398; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; Cunningham MA, 2003, ENDOCRINOLOGY, V144, P5585, DOI 10.1210/en.2003-0678; Dorn C, 2004, AM J OBSTET GYNECOL, V191, P132, DOI 10.1016/j.ajog.2004.01.054; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Dunaif A, 2001, ANNU REV MED, V52, P401, DOI 10.1146/annurev.med.52.1.401; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; Harris D, 2002, ENDOCRINOLOGY, V143, P1018, DOI 10.1210/en.143.3.1018; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V254, P84, DOI 10.1016/j.mce.2006.04.015; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V252, P126, DOI 10.1016/j.mce.2006.03.026; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jiang QR, 2005, J MOL ENDOCRINOL, V35, P145, DOI 10.1677/jme.1.01754; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2009, DEV BIOL, V331, P292, DOI 10.1016/j.ydbio.2009.05.546; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Leblanc P, 1997, ENDOCRINOLOGY, V138, P574, DOI 10.1210/en.138.2.574; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Mann RJ, 2003, RECENT PROG HORM RES, V58, P343, DOI 10.1210/rp.58.1.343; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Navratil AM, 2009, MOL CELL ENDOCRINOL, V311, P47, DOI 10.1016/j.mce.2009.07.014; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rose A, 2004, J BIOL CHEM, V279, P52500, DOI 10.1074/jbc.M404571200; Rosenberg SB, 2002, MOL ENDOCRINOL, V16, P1280, DOI 10.1210/me.16.6.1280; Salisbury TB, 2007, MOL ENDOCRINOL, V21, P963, DOI 10.1210/me.2006-0383; Schweizer-Groyer G, 2006, ANN NY ACAD SCI, V1091, P296, DOI 10.1196/annals.1378.075; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SOLDANI R, 1994, EUR J ENDOCRINOL, V131, P641, DOI 10.1530/eje.0.1310641; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thackray VG, 2009, ENDOCRINOLOGY, V150, P2395, DOI 10.1210/en.2008-1027; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vasilyev VV, 2002, ENDOCRINOLOGY, V143, P3414, DOI 10.1210/en.2001-211215; Weck J, 2000, MOL ENDOCRINOL, V14, P472, DOI 10.1210/me.14.4.472; Xia YX, 2001, EUR J ENDOCRINOL, V144, P73, DOI 10.1530/eje.0.1440073; Yoo RY, 2006, FERTIL STERIL, V85, P1049, DOI 10.1016/j.fertnstert.2005.09.037; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	83	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33424	33435		10.1074/jbc.M112.362103	http://dx.doi.org/10.1074/jbc.M112.362103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865884	Green Published, hybrid			2022-12-25	WOS:000309602100029
J	Cai, CX; Teng, L; Vu, D; He, JQ; Guo, YR; Li, QH; Tang, XL; Rokosh, G; Bhatnagar, A; Bolli, R				Cai, Chuanxi; Teng, Lei; Duc Vu; He, Jia-Qiang; Guo, Yiru; Li, Qianghong; Tang, Xian-Liang; Rokosh, Gregg; Bhatnagar, Aruni; Bolli, Roberto			The Heme Oxygenase 1 Inducer (CoPP) Protects Human Cardiac Stem Cells against Apoptosis through Activation of the Extracellular Signal-regulated Kinase (ERK)/NRF2 Signaling Pathway and Cytokine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES INSULIN SENSITIVITY; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CARBON-MONOXIDE; PARACRINE MECHANISMS; VENTRICULAR-FUNCTION; TRANSCRIPTION FACTOR; PROGENITOR CELLS; GROWTH-FACTOR; GENE	Intracoronary delivery of c-kit-positive human cardiac stem cells (hCSCs) is a promising approach to repair the infarcted heart, but it is severely limited by the poor survival of donor cells. Cobalt protoporphyrin (CoPP), a well known heme oxygenase 1 inducer, has been used to promote endogenous CO generation and protect against ischemia/reperfusion injury. Therefore, we determined whether preconditioning hCSCs with CoPP promotes CSC survival. c-kit-positive, lineage-negative hCSCs were isolated from human heart biopsies. Lactate dehydrogenase release assays demonstrated that preconditioning CSCs with CoPP markedly enhanced cell survival after oxidative stress induced by H2O2, concomitant with up-regulation of heme oxygenase 1, COX-2, and anti-apoptotic proteins (BCL2, BCL2-A1, and MCL-1) and increased phosphorylation of NRF2. Apoptotic cytometric assays showed that pretreatment of CSCs with CoPP enhanced the cells' resistance to apoptosis induced by oxidative stress. Conversely, knocking down HO-1, COX-2, or NRF2 by shRNA gene silencing abrogated the cytoprotective effects of CoPP. Further, preconditioning CSCs with CoPP led to a global increase in release of cytokines, such as EGF, FGFs, colony-stimulating factors, and chemokine ligand. Conditioned medium from cells pretreated with CoPP conferred naive CSCs remarkable resistance to apoptosis, demonstrating that cytokines released by preconditioned cells play a key role in the anti-apoptotic effects of CoPP. Preconditioning CSCs with CoPP also induced an increase in the phosphorylation of Erk1/2, which are known to modulate multiple pro-survival genes. These results potentially provide a simple and effective strategy to enhance survival of CSCs after transplantation and, therefore, their efficacy in repairing infarcted myocardium.	[Cai, Chuanxi; Teng, Lei; Duc Vu; He, Jia-Qiang; Guo, Yiru; Li, Qianghong; Tang, Xian-Liang; Rokosh, Gregg; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, 550 S Jackson St, Louisville, KY 40292 USA.	rbolli@louisville.edu	Teng, Lei/G-3562-2012; Guo, Yiru/L-2618-2015; Cai, Chuanxi/AAW-1488-2020; Tang, Xian-Liang/L-5703-2015; Rokosh, Gregg/J-2730-2013; Bolli, Roberto/A-6870-2010	Teng, Lei/0000-0001-9213-4054; Guo, Yiru/0000-0002-0614-9899; Rokosh, Gregg/0000-0002-9214-2254	National Institutes of Health [R21 HL104315, R01 HL114951, P20 RR024489, R01 HL55757, HL-70897, HL-76794, P01HL78825]; American Heart Association Grant [12BGIA9090005]; Kentucky Science and Engineering Foundation Grant [2134-RDE-013]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114951, P01HL078825, R01HL076794, R21HL104315, R01HL070897, R01HL055757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); Kentucky Science and Engineering Foundation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL104315 and R01 HL114951 (to C. C.); P20 RR024489 (to A. B.); and R01 HL55757, HL-70897, HL-76794, and P01HL78825 (to R. B.). This work was also supported by American Heart Association Grant 12BGIA9090005 (to C. C.) and Kentucky Science and Engineering Foundation Grant 2134-RDE-013 (to C. C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dawn B, 2005, Minerva Cardioangiol, V53, P549; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dzau VJ, 2005, J AM COLL CARDIOL, V46, P1351, DOI 10.1016/j.jacc.2005.07.023; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2010, J CARDIOVASC TRANSL, V3, P89, DOI 10.1007/s12265-009-9161-2; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Kawamoto S, 2011, TISSUE ENG PT A, V17, P1605, DOI 10.1089/ten.tea.2010.0447; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Liu XL, 2007, AM J PHYSIOL-HEART C, V293, pH48, DOI 10.1152/ajpheart.00741.2006; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mohri T, 2006, J BIOL CHEM, V281, P6442, DOI 10.1074/jbc.M508969200; Morita T, 1995, J CLIN INVEST, V96, P2676, DOI 10.1172/JCI118334; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Orozco-Ibarra M, 2009, INT J BIOCHEM CELL B, V41, P1304, DOI 10.1016/j.biocel.2008.11.003; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Piantadosi CA, 2002, NEW ENGL J MED, V347, P1054, DOI 10.1056/NEJMp020104; Rani KGA, 2010, GROWTH FACTORS, V28, P157, DOI 10.3109/08977190903512628; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Schuh A, 2009, BASIC RES CARDIOL, V104, P403, DOI 10.1007/s00395-008-0763-7; Shintani Satoshi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS123, DOI 10.1038/ncpcardio0430; Shirai T, 1998, J THORAC CARDIOV SUR, V115, P210, DOI 10.1016/S0022-5223(98)70459-3; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Smith H, 2012, STEM CELLS DEV, V21, P476, DOI 10.1089/scd.2011.0025; Stastna M, 2010, PROTEOMICS, V10, P245, DOI 10.1002/pmic.200900515; Stastna M, 2009, FEBS LETT, V583, P1800, DOI 10.1016/j.febslet.2009.03.026; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sun BW, 2008, INT J BIOL SCI, V4, P176; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Yau TM, 2005, ANN THORAC SURG, V80, P1779, DOI 10.1016/j.athoracsur.2005.04.079; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695; Zhou P, 2009, SEMIN IMMUNOPATHOL, V31, P411, DOI 10.1007/s00281-009-0166-3; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	66	80	87	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33720	33732		10.1074/jbc.M112.385542	http://dx.doi.org/10.1074/jbc.M112.385542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879597	Green Published, hybrid			2022-12-25	WOS:000309602100055
J	Padilla-Meier, GP; Gilcrease, EB; Weigele, PR; Cortines, JR; Siegel, M; Leavitt, JC; Teschke, CM; Casjens, SR				Padilla-Meier, G. Pauline; Gilcrease, Eddie B.; Weigele, Peter R.; Cortines, Juliana R.; Siegel, Molly; Leavitt, Justin C.; Teschke, Carolyn M.; Casjens, Sherwood R.			Unraveling the Role of the C-terminal Helix Turn Helix of the Coat-binding Domain of Bacteriophage P22 Scaffolding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PHAGE-P22 PROCAPSIDS; FUNCTIONAL DOMAINS; ELECTRON CRYOMICROSCOPY; MATURATION TRANSITION; SALMONELLA PHAGE-P22; STRUCTURAL PROTEINS; NUCLEOTIDE-SEQUENCE; CIRCULAR-DICHROISM; DNA ENCAPSULATION	Many viruses encode scaffolding and coat proteins that co-assemble to form procapsids, which are transient precursor structures leading to progeny virions. In bacteriophage P22, the association of scaffolding and coat proteins is mediated mainly by ionic interactions. The coat protein-binding domain of scaffolding protein is a helix turn helix structure near the C terminus with a high number of charged surface residues. Residues Arg-293 and Lys-296 are particularly important for coat protein binding. The two helices contact each other through hydrophobic side chains. In this study, substitution of the residues of the interface between the helices, and the residues in the beta-turn, by aspartic acid was used examine the importance of the conformation of the domain in coat binding. These replacements strongly affected the ability of the scaffolding protein to interact with coat protein. The severity of the defect in the association of scaffolding protein to coat protein was dependent on location, with substitutions at residues in the turn and helix 2 causing the most significant effects. Substituting aspartic acid for hydrophobic interface residues dramatically perturbs the stability of the structure, but similar substitutions in the turn had much less effect on the integrity of this domain, as determined by circular dichroism. We propose that the binding of scaffolding protein to coat protein is dependent on angle of the beta-turn and the orientation of the charged surface on helix 2. Surprisingly, formation of the highly complex procapsid structure depends on a relatively simple interaction.	[Padilla-Meier, G. Pauline; Cortines, Juliana R.; Siegel, Molly; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Gilcrease, Eddie B.; Weigele, Peter R.; Leavitt, Justin C.; Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	University of Connecticut; University of Connecticut; Utah System of Higher Education; University of Utah	Teschke, CM (corresponding author), Rm 2200,Emma Eccles Jones Med Res Bldg,15 N Med D, Salt Lake City, UT 84112 USA.	teschke@uconn.edu; sherwood.casjens@path.utah.edu	Weigele, Peter/AIE-8230-2022; Cortines, Juliana/V-3997-2019	Weigele, Peter/0000-0003-3696-4541; Cortines, Juliana/0000-0003-2481-9267; Leavitt, Justin/0000-0003-4544-0483	National Institutes of Health [R01 GM076661, R01 AI074825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076661 (to C. M. T.) and R01 AI074825 ( to S. R. C.).	ADAMS MB, 1985, J VIROL, V53, P180, DOI 10.1128/JVI.53.1.180-184.1985; Aramli LA, 1999, J BIOL CHEM, V274, P22217, DOI 10.1074/jbc.274.32.22217; Baines J., 2003, VIRAL GENOME PACKAGI, P135; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Black Lindsay W., 1994, P218; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; CASJENS S, 1979, J MOL BIOL, V131, P1, DOI 10.1016/0022-2836(79)90298-5; Cerritelli ME, 1996, J MOL BIOL, V258, P299, DOI 10.1006/jmbi.1996.0251; Chang JR, 2009, VIROLOGY, V384, P144, DOI 10.1016/j.virol.2008.11.016; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Cherwa JE, 2008, J VIROL, V82, P5774, DOI 10.1128/JVI.02758-07; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; Dokland T, 1999, CELL MOL LIFE SCI, V56, P580, DOI 10.1007/s000180050455; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; EARNSHAW W, 1978, J MOL BIOL, V126, P721, DOI 10.1016/0022-2836(78)90017-7; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; FULLER MT, 1982, J MOL BIOL, V156, P633, DOI 10.1016/0022-2836(82)90270-4; Gibson W, 2008, CURR TOP MICROBIOL, V325, P187; GOPE R, 1983, J VIROL, V47, P96, DOI 10.1128/JVI.47.1.96-105.1983; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1993, J BIOL CHEM, V268, P9358; Greene B, 1996, VIROLOGY, V225, P82, DOI 10.1006/viro.1996.0577; Greene B, 1999, J BIOL CHEM, V274, P16135, DOI 10.1074/jbc.274.23.16135; Greene B, 1999, J BIOL CHEM, V274, P16141, DOI 10.1074/jbc.274.23.16141; GREENE B, 1994, VIROLOGY, V205, P188, DOI 10.1006/viro.1994.1634; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; Huet A, 2010, J VIROL, V84, P9350, DOI 10.1128/JVI.00942-10; ISRAEL V, 1967, VIROLOGY, V33, P317, DOI 10.1016/0042-6822(67)90150-X; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENK E, 1975, VIROLOGY, V68, P182, DOI 10.1016/0042-6822(75)90160-9; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; Luque I, 1996, BIOCHEMISTRY-US, V35, P13681, DOI 10.1021/bi961319s; Medina E, 2010, J MOL BIOL, V401, P813, DOI 10.1016/j.jmb.2010.06.060; Morais MC, 2004, MOL CELL, V15, P991, DOI 10.1016/j.molcel.2004.08.023; Padilla-Meier GP, 2011, J MOL BIOL, V410, P226, DOI 10.1016/j.jmb.2011.05.006; Parent KN, 2005, VIROLOGY, V340, P33, DOI 10.1016/j.virol.2005.06.018; Parent KN, 2004, MOL MICROBIOL, V54, P1036, DOI 10.1111/j.1365-2958.2004.04326.x; Parent KN, 2007, J MOL BIOL, V365, P513, DOI 10.1016/j.jmb.2006.09.088; Parent KN, 2006, J MOL BIOL, V359, P1097, DOI 10.1016/j.jmb.2006.03.068; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Parker MH, 1997, PROTEIN SCI, V6, P1583, DOI 10.1002/pro.5560060722; Parker MH, 1998, J MOL BIOL, V281, P69, DOI 10.1006/jmbi.1998.1917; Parker MH, 1998, VIROLOGY, V250, P337, DOI 10.1006/viro.1998.9386; Parker MH, 2001, BIOCHEMISTRY-US, V40, P8962, DOI 10.1021/bi0026167; Parker MH, 1997, J MOL BIOL, V268, P655, DOI 10.1006/jmbi.1997.0995; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1990, BIOCHEMISTRY-US, V29, P5626, DOI 10.1021/bi00475a030; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Prevelige PE, 2012, ADV EXP MED BIOL, V726, P325, DOI 10.1007/978-1-4614-0980-9_14; RAY P, 1975, VIROLOGY, V64, P247, DOI 10.1016/0042-6822(75)90096-3; RISHOVD S, 1994, VIROLOGY, V200, P744, DOI 10.1006/viro.1994.1238; SCHWARZ JJ, 1989, GENETICS, V121, P635; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Suhanovsky MM, 2011, VIROLOGY, V417, P418, DOI 10.1016/j.virol.2011.06.025; Sun YH, 2000, J MOL BIOL, V297, P1195, DOI 10.1006/jmbi.2000.3620; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Teschke CM, 1999, BIOCHEMISTRY-US, V38, P2873, DOI 10.1021/bi982739f; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; Thuman-Commike PA, 2000, J VIROL, V74, P3871, DOI 10.1128/JVI.74.8.3871-3873.2000; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Tuma R, 1998, J MOL BIOL, V281, P81, DOI 10.1006/jmbi.1998.1916; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weigele PR, 2005, J MOL BIOL, V348, P831, DOI 10.1016/j.jmb.2005.03.004; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601; Zlotnick A, 2012, VIROLOGY, V428, P64, DOI 10.1016/j.virol.2012.03.017	82	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33766	33780		10.1074/jbc.M112.393132	http://dx.doi.org/10.1074/jbc.M112.393132			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879595	Green Published, hybrid			2022-12-25	WOS:000309602100059
J	Zhang, Y; Xiao, X; Zhang, XM; Zhao, ZQ; Zhang, YQ				Zhang, Yan; Xiao, Xiao; Zhang, Xiao-Meng; Zhao, Zhi-Qi; Zhang, Yu-Qiu			Estrogen Facilitates Spinal Cord Synaptic Transmission via Membrane-bound Estrogen Receptors IMPLICATIONS FOR PAIN HYPERSENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CINGULATE CORTEX CONTRIBUTES; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EVOKED FIELD POTENTIALS; NMDA RECEPTOR; DORSAL-HORN; HYPOTHALAMIC NEURONS; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS	Recent evidence suggests that estrogen is synthesized in the spinal dorsal horn and plays a role in nociceptive processes. However, the cellular and molecular mechanisms underlying these effects remain unclear. Using electrophysiological, biochemical, and morphological techniques, we here demonstrate that 17 beta-estradiol (E2), a major form of estrogen, can directly modulate spinal cord synaptic transmission by 1) enhancing NMDA receptor-mediated synaptic transmission in dorsal horn neurons, 2) increasing glutamate release from primary afferent terminals, 3) increasing dendritic spine density in cultured spinal cord dorsal horn neurons, and 4) potentiating spinal cord long term potentiation (LTP) evoked by high frequency stimulation (HFS) of Lissauer's tract. Notably, E2-BSA, a ligand that acts only on membrane estrogen receptors, can mimic E2-induced facilitation of HFS-LTP, suggesting a nongenomic action of this neurosteroid. Consistently, cell surface biotinylation demonstrated that three types of ERs (ER alpha, ER beta, and GPER1) are localized on the plasma membrane of dorsal horn neurons. Furthermore, the ER alpha and ER beta antagonist ICI 182,780 completely abrogates the E2-induced facilitation of LTP. ER beta (but not ER alpha) activation can recapitulate E2-induced persistent increases in synaptic transmission (NMDA-dependent) and dendritic spine density, indicating a critical role of ER beta in spinal synaptic plasticity. E2 also increases the phosphorylation of ERK, PKA, and NR2B, and spinal HFS-LTP is prevented by blockade of PKA, ERK, or NR2B activation. Finally, HFS increases E2 release in spinal cord slices, which can be prevented by aromatase inhibitor androstatrienedione, suggesting activity-dependent local synthesis and release of endogenous E2.	Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200032, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Zhang, Yan] Wannan Med Coll, Cell Electrophysiol Lab, Wuhu 241002, Peoples R China	Fudan University; Fudan University; Wannan Medical College		yuqiuzhang@fudan.edu.cn	Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020		National Natural Science Foundation of China [31271183, 31121061, 31070973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271183, 31121061, and 31070973.	Adams MM, 2004, J COMP NEUROL, V474, P419, DOI 10.1002/cne.20148; ARAI A, 1992, BRAIN RES, V598, P173, DOI 10.1016/0006-8993(92)90181-8; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Cao H, 2009, NEUROSCI BULL, V25, P301, DOI 10.1007/s12264-009-0904-5; Cao H, 2009, J NEUROSCI, V29, P3307, DOI 10.1523/JNEUROSCI.4300-08.2009; Cheng LZ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-1; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Evrard H, 2000, J COMP NEUROL, V423, P552, DOI 10.1002/1096-9861(20000807)423:4<552::AID-CNE2>3.0.CO;2-S; Evrard HC, 2004, J NEUROSCI, V24, P7225, DOI 10.1523/JNEUROSCI.1638-04.2004; Evrard HC, 2006, AM J PHYSIOL-REG I, V291, pR291, DOI 10.1152/ajpregu.00930.2005; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Fu Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-26; Gu Q, 1996, J NEUROSCI, V16, P3620; Ji R R, 2007, Handb Exp Pharmacol, P359; Ji R. R., 2005, NEUROSCI B, V21, P3; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji YP, 2011, PAIN, V152, P1182, DOI 10.1016/j.pain.2011.01.046; Jiang P, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-2; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lagrange AH, 1997, MOL PHARMACOL, V51, P605, DOI 10.1124/mol.51.4.605; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu NJ, 2011, J NEUROSCI, V31, P11836, DOI 10.1523/JNEUROSCI.1901-11.2011; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Mermelstein PG, 2009, J NEUROENDOCRINOL, V21, P257, DOI 10.1111/j.1365-2826.2009.01838.x; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Murphy DD, 1998, J NEUROSCI, V18, P2550; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Peng GD, 2009, J BIOL CHEM, V284, P30138, DOI 10.1074/jbc.M109.036756; Peng HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE416, DOI 10.1152/ajpendo.00129.2009; PETERSON ER, 1982, SCIENCE, V217, P377, DOI 10.1126/science.6124041; Qiu J, 2003, J NEUROSCI, V23, P9529; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Singh M, 1999, J NEUROSCI, V19, P1179; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2010, J NEUROSCI, V30, P13454, DOI 10.1523/JNEUROSCI.3264-10.2010; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tang B, 2008, PAIN, V137, P540, DOI 10.1016/j.pain.2007.10.017; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Xin WJ, 2006, J NEUROSCI RES, V84, P934, DOI 10.1002/jnr.21013; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Ying B, 2006, BIOCHEM BIOPH RES CO, V340, P1264, DOI 10.1016/j.bbrc.2005.12.139; Zadran S, 2009, P NATL ACAD SCI USA, V106, P21936, DOI 10.1073/pnas.0912558106; Zamani MR, 2004, NEUROSCIENCE, V129, P243, DOI 10.1016/j.neuroscience.2004.06.082; Zhong YQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-92; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	66	39	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33268	33281		10.1074/jbc.M112.368142	http://dx.doi.org/10.1074/jbc.M112.368142			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869379	Green Published, hybrid			2022-12-25	WOS:000309602100016
J	Bhat, P; Yang, HX; Bogre, L; Devoto, A; Paccanaro, A				Bhat, Prajwal; Yang, Haixuan; Boegre, Laszlo; Devoto, Alessandra; Paccanaro, Alberto			Computational Selection of Transcriptomics Experiments Improves Guilt-by-Association Analyses	PLOS ONE			English	Article							MICROARRAY DATA; ARABIDOPSIS; NETWORKS; PLANT	The Guilt-by-Association (GBA) principle, according to which genes with similar expression profiles are functionally associated, is widely applied for functional analyses using large heterogeneous collections of transcriptomics data. However, the use of such large collections could hamper GBA functional analysis for genes whose expression is condition specific. In these cases a smaller set of condition related experiments should instead be used, but identifying such functionally relevant experiments from large collections based on literature knowledge alone is an impractical task. We begin this paper by analyzing, both from a mathematical and a biological point of view, why only condition specific experiments should be used in GBA functional analysis. We are able to show that this phenomenon is independent of the functional categorization scheme and of the organisms being analyzed. We then present a semi-supervised algorithm that can select functionally relevant experiments from large collections of transcriptomics experiments. Our algorithm is able to select experiments relevant to a given GO term, MIPS FunCat term or even KEGG pathways. We extensively test our algorithm on large dataset collections for yeast and Arabidopsis. We demonstrate that: using the selected experiments there is a statistically significant improvement in correlation between genes in the functional category of interest; the selected experiments improve GBA-based gene function prediction; the effectiveness of the selected experiments increases with annotation specificity; our algorithm can be successfully applied to GBA-based pathway reconstruction. Importantly, the set of experiments selected by the algorithm reflects the existing literature knowledge about the experiments. [A MATLAB implementation of the algorithm and all the data used in this paper can be downloaded from the paper website: http://www.paccanarolab.org/papers/CorrGene/].	[Bhat, Prajwal; Boegre, Laszlo; Devoto, Alessandra] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Bhat, Prajwal; Yang, Haixuan; Paccanaro, Alberto] Royal Holloway Univ London, Dept Comp Sci, Egham, Surrey, England; [Bhat, Prajwal; Yang, Haixuan; Boegre, Laszlo; Devoto, Alessandra; Paccanaro, Alberto] Royal Holloway Univ London, Ctr Syst & Synthet Biol, Egham, Surrey, England	University of London; Royal Holloway University London; University of London; Royal Holloway University London; University of London; Royal Holloway University London	Bhat, P (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England.	alessandra.devoto@rhul.ac.uk; alberto@cs.rhul.ac.uk	Paccanaro, Alberto/AAW-5625-2020		United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00964X/1]; Agnes Grace Allen Endowment; School of Biological Sciences at Royal Holloway, University of London; BBSRC [BB/E003486/1, FP7-PEOPLE-ITN-2009-PIEF-GA-2009-255035]; Biotechnology and Biological Sciences Research Council [BB/E003486/1, BBS/B/13314, BB/F00964X/1, BB/K004131/1] Funding Source: researchfish; BBSRC [BB/K004131/1, BB/F00964X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agnes Grace Allen Endowment; School of Biological Sciences at Royal Holloway, University of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HY and AP were supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant BB/F00964X/1 (http://www.bbsrc.ac.uk/). PB was supported by the Agnes Grace Allen Endowment and the School of Biological Sciences at Royal Holloway, University of London (http://www.rhul.ac.uk/home.aspx). AD was supported by the BBSRC New Investigator Grant BB/E003486/1 (http://www.bbsrc.ac.uk/). LB was supported by BBSRC grant FP7-PEOPLE-ITN-2009-PIEF-GA-2009-255035 (http://cordis.europa.eu/fp7/people/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Avanci NC, 2010, GENET MOL RES, V9, P484, DOI 10.4238/vol9-1gmr754; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barber C, 2004, PLANT J CELL MOL BIO, V39, P70, DOI [10.1111/j.1365-313X.2004.02104.x, DOI 10.1111/J.1365-313X.2004.02104.X]; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hastie T., 2009, UNSUPERVISED LEARNIN; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906	17	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e39681	10.1371/journal.pone.0039681	http://dx.doi.org/10.1371/journal.pone.0039681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879875	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900002
J	Oda, M; Kanoh, Y; Watanabe, Y; Masai, H				Oda, Masako; Kanoh, Yutaka; Watanabe, Yoshihisa; Masai, Hisao			Regulation of DNA Replication Timing on Human Chromosome by a Cell-Type Specific DNA Binding Protein SATB1	PLOS ONE			English	Article							MATRIX-ATTACHMENT REGION; GLOBAL GENE REGULATOR; S-PHASE CHECKPOINT; FISSION YEAST; HUMAN GENOME; T-CELLS; IN-VIVO; DEPENDENT REGULATION; TH2 DIFFERENTIATION; CYCLE PROGRESSION	Background: Replication timing of metazoan DNA during S-phase may be determined by many factors including chromosome structures, nuclear positioning, patterns of histone modifications, and transcriptional activity. It may be determined by Mb-domain structures, termed as "replication domains", and recent findings indicate that replication timing is under developmental and cell type-specific regulation. Methodology/Principal Findings: We examined replication timing on the human 5q23/31 3.5-Mb segment in T cells and non-T cells. We used two independent methods to determine replication timing. One is quantification of nascent replicating DNA in cell cycle-fractionated stage-specific S phase populations. The other is FISH analyses of replication foci. Although the locations of early-and late-replicating domains were common between the two cell lines, the timing transition region (TTR) between early and late domains were offset by 200-kb. We show that Special AT-rich sequence Binding protein 1 (SATB1), specifically expressed in T-cells, binds to the early domain immediately adjacent to TTR and delays the replication timing of the TTR. Measurement of the chromosome copy number along the TTR during synchronized S phase suggests that the fork movement may be slowed down by SATB1. Conclusions: Our results reveal a novel role of SATB1 in cell type-specific regulation of replication timing along the chromosome.	[Oda, Masako; Kanoh, Yutaka; Watanabe, Yoshihisa; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science	Oda, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Bunkyo Ku, Tokyo 113, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (A) (to HM) and Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to HM). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2010, EMBO MOL MED, V2, P6, DOI 10.1002/emmm.200900053; Agrelo R, 2009, EPIGENETICS-US, V4, P568, DOI 10.4161/epi.4.8.10186; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Chastain PD, 2006, CELL CYCLE, V5, P2160, DOI 10.4161/cc.5.18.3236; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Farkash-Amar S, 2010, CHROMOSOME RES, V18, P115, DOI 10.1007/s10577-009-9091-5; Forbes E, 2010, IMMUNOL CELL BIOL, V88, P240, DOI 10.1038/icb.2009.101; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Guan ZQ, 2009, J CELL BIOL, V187, P623, DOI 10.1083/jcb.200905144; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hayashida T, 2006, J IMMUNOL, V176, P5446, DOI 10.4049/jimmunol.176.9.5446; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; Kumar PP, 2007, J VIROL, V81, P5617, DOI 10.1128/JVI.01405-06; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Kumar S, 2009, MOL CELL BIOL, V29, P602, DOI 10.1128/MCB.01319-08; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsumoto S, 2011, J CELL BIOL, V195, P387, DOI 10.1083/jcb.201107025; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nakayama Y, 2005, CELL CYCLE, V4, P1099; Nogami M, 2000, CHROMOSOMA, V108, P514, DOI 10.1007/s004120050403; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schultz SS, 2010, MOL CELL BIOL, V30, P4521, DOI 10.1128/MCB.00380-10; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Strehl S, 1997, MOL CELL BIOL, V17, P6157, DOI 10.1128/MCB.17.10.6157; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004629; Watanabe Y, 2000, GENE, V252, P163, DOI 10.1016/S0378-1119(00)00208-0; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	74	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42375	10.1371/journal.pone.0042375	http://dx.doi.org/10.1371/journal.pone.0042375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879953	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900034
J	Favier, RP; Spee, B; Schotanus, BA; van den Ingh, TSGAM; Fieten, H; Brinkhof, B; Viebahn, CS; Penning, LC; Rothuizen, J				Favier, Robert P.; Spee, Bart; Schotanus, Baukje A.; van den Ingh, Ted S. G. A. M.; Fieten, Hille; Brinkhof, Bas; Viebahn, Cornelia S.; Penning, Louis C.; Rothuizen, Jan			COMMD1-Deficient Dogs Accumulate Copper in Hepatocytes and Provide a Good Model for Chronic Hepatitis and Fibrosis	PLOS ONE			English	Article							WILSON-DISEASE GENE; LIVER-REGENERATION; PROGENITOR CELLS; TOXICOSIS; MURR1; CONSEQUENCES; LOCALIZATION; REPOPULATION; ACTIVATION; EXPRESSION	New therapeutic concepts developed in rodent models should ideally be evaluated in large animal models prior to human clinical application. COMMD1-deficiency in dogs leads to hepatic copper accumulation and chronic hepatitis representing a Wilson's disease like phenotype. Detailed understanding of the pathogenesis and time course of this animal model is required to test its feasibility as a large animal model for chronic hepatitis. In addition to mouse models, true longitudinal studies are possible due to the size of these dogs permitting detailed analysis of the sequence of events from initial insult to final cirrhosis. Therefore, liver biopsies were taken each half year from five new born COMMD1-deficient dogs over a period of 42 months. Biopsies were used for H&E, reticulin, and rubeanic acid (copper) staining. Immunohistochemistry was performed on hepatic stellate cell (HSC) activation marker (alpha-smooth muscle actin, alpha-SMA), proliferation (Ki67), apoptosis (caspase-3), and bile duct and liver progenitor cell (LPC) markers keratin (K) 19 and 7. Quantitative RT-PCR and Western Blots were performed on gene products involved in the regenerative and fibrotic pathways. Maximum copper accumulation was reached at 12 months of age, which coincided with the first signs of hepatitis. HSCs were activated (alpha-MA) from 18 months onwards, with increasing reticulin deposition and hepatocytic proliferation in later stages. Hepatitis and caspase-3 activity (first noticed at 18 months) increased over time. Both HGF and TGF-beta 1 gene expression peaked at 24 months, and thereafter decreased gradually. Both STAT3 and c-MET showed an increased time-dependent activation. Smad2/3 phosphorylation, indicative for fibrogenesis, was present at all time-points. COMMD1-deficient dogs develop chronic liver disease and cirrhosis comparable to human chronic hepatitis, although at much higher pace. Therefore they represent a genetically-defined large animal model to test clinical applicability of new therapeutics developed in rodent models.	[Favier, Robert P.; Spee, Bart; Schotanus, Baukje A.; Fieten, Hille; Brinkhof, Bas; Viebahn, Cornelia S.; Penning, Louis C.; Rothuizen, Jan] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [van den Ingh, Ted S. G. A. M.] TCCI Consultancy BV, Utrecht, Netherlands	Utrecht University	Favier, RP (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	r.p.favier@uu.nl	Penning, Louis/AAC-7524-2019; Brinkhof, Bas/S-8687-2017	Brinkhof, Bas/0000-0003-3617-0709				[Anonymous], 2010, R LANG ENV STAT COMP; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Bird TG, 2008, CELL TISSUE RES, V331, P283, DOI 10.1007/s00441-007-0542-z; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Favier RP, 2005, MAMM GENOME, V16, P460, DOI 10.1007/s00335-004-2457-2; Ferenci P, 1996, HEPATOLOGY, V24, P952; Henderson NC, 2008, TOXICOLOGY, V254, P130, DOI 10.1016/j.tox.2008.08.017; Hoffmann G, 2006, J VET INTERN MED, V20, P856, DOI 10.1892/0891-6640(2006)20[856:CCHILR]2.0.CO;2; Hoogenraad TU, 1986, LANCET, V19, P170; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Lovicu M, 2006, J GASTROENTEROL, V41, P582, DOI 10.1007/s00535-006-1807-0; Mekonnen GA, 2007, VET PATHOL, V44, P803, DOI 10.1354/vp.44-6-803; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sarkar B, 2011, METALLOMICS, V3, P20, DOI 10.1039/c0mt00031k; Schotanus BA, 2009, LIVER INT, V29, P1241, DOI 10.1111/j.1478-3231.2009.02024.x; Shibata C, 2006, LIVER TRANSPLANT, V12, P78, DOI 10.1002/lt.20558; Spee B, 2007, ANIM GENET, V38, P168, DOI 10.1111/j.1365-2052.2007.01580.x; Spee B, 2006, LIVER INT, V26, P716, DOI 10.1111/j.1478-3231.2006.01277.x; Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588; SU LC, 1982, AM J PHYSIOL, V243, pG226, DOI 10.1152/ajpgi.1982.243.3.G226; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; Van den Ingh TSGAM, 2006, WSAVA STANDARDS CLIN, P85; van Sprundel RG, 2010, COMP HEPATOL, V18, P4; VANDENINGH TSGAM, 1988, VET QUART, V10, P84, DOI 10.1080/01652176.1988.9694154; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183	40	32	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42158	10.1371/journal.pone.0042158	http://dx.doi.org/10.1371/journal.pone.0042158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879914	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000307810000019
J	Kalinina, OV; Oberwinkler, H; Glass, B; Krausslich, HG; Russell, RB; Briggs, JAG				Kalinina, Olga V.; Oberwinkler, Heike; Glass, Baerbel; Kraeusslich, Hans-Georg; Russell, Robert B.; Briggs, John A. G.			Computational Identification of Novel Amino-Acid Interactions in HIV Gag via Correlated Evolution	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; CONTACT PREDICTION; PROTEIN EVOLUTION; INFORMATION; COVARIANCE; CONSERVATION; MUTATIONS; POSITIONS; MODELS	Pairs of amino acid positions that evolve in a correlated manner are proposed to play important roles in protein structure or function. Methods to detect them might fare better with families for which sequences of thousands of closely related homologs are available than families with only a few distant relatives. We applied co-evolution analysis to thousands of sequences of HIV Gag, finding that the most significantly co-evolving positions are proximal in the quaternary structures of the viral capsid. A reduction in infectivity caused by mutating one member of a significant pair could be rescued by a compensatory mutation of the other.	[Kalinina, Olga V.; Kraeusslich, Hans-Georg; Russell, Robert B.] Univ Heidelberg, Bioquant, CellNetworks, Heidelberg, Germany; [Oberwinkler, Heike; Glass, Baerbel; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Infect Dis, Heidelberg, Germany; [Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Kalinina, OV (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	robert.russell@bioquant.uni-heidelberg.de; briggs@embl.de	Russell, Rob/AAH-9145-2019; Briggs, John/J-3096-2012; Russell, Robert/GWU-6389-2022; Kalinina, Olga V/M-8482-2016	Russell, Rob/0000-0002-1905-4717; Russell, Robert/0000-0002-7213-1398; Kalinina, Olga V/0000-0002-9445-477X; Krausslich, Hans-Georg/0000-0002-8756-329X; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SPP 1175]; EMBO Long Term Fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO))	H-GK and JAGB and were supported by a grant from the Deutsche Forschungsgemeinschaft within SPP 1175. OVK was partially supported by an EMBO Long Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42468	10.1371/journal.pone.0042468	http://dx.doi.org/10.1371/journal.pone.0042468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879995	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100101
J	Lam, V; Bigley, T; Terhune, SS; Wakatsuki, T				Lam, Vy; Bigley, Tarin; Terhune, Scott S.; Wakatsuki, Tetsuro			A Method for Quantifying Mechanical Properties of Tissue following Viral Infection	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; GROWTH-FACTOR RECEPTOR; MUSCLE-CELL MIGRATION; GENE-EXPRESSION; UL131-128 GENES; CYTOCHALASIN-D; FIBROBLASTS; ADHESION; MYOFIBROBLASTS; ACTIN	Viral infection and replication involves the reorganization of the actin network within the host cell. Actin plays a central role in the mechanical properties of cells. We have demonstrated a method to quantify changes in mechanical properties of fabricated model three-dimensional (3D) connective tissue following viral infection. Using this method, we have characterized the impact of infection by the human herpesvirus, cytomegalovirus (HCMV). HCMV is a member of the herpesvirus family and infects a variety of cell types including fibroblasts. In the body, fibroblasts are necessary for maintaining connective tissue and function by creating mechanical force. Using this 3D connective tissue model, we observed that infection disrupted the cell's ability to generate force and reduced the cumulative contractile force of the tissue. The addition of HCMV viral particles in the absence of both viral gene expression and DNA replication was sufficient to disrupt tissue function. We observed that alterations of the mechanical properties are, in part, due to a disruption of the underlying complex actin microfilament network established by the embedded fibroblasts. Finally, we were able to prevent HCMV-mediated disruption of tissue function by the addition of human immune globulin against HCMV. This study demonstrates a method to quantify the impact of viral infection on mechanical properties which are not evident using conventional cell culture systems.	[Lam, Vy; Bigley, Tarin; Terhune, Scott S.; Wakatsuki, Tetsuro] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Bigley, Tarin; Terhune, Scott S.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Wakatsuki, Tetsuro] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Wakatsuki, Tetsuro] InvivoSci LLC, Madison, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Lam, V (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	sterhune@mcw.edu		Bigley, Tarin/0000-0001-7443-9436; Wakatsuki, Tetsuro/0000-0002-2175-1132	MCW Research Development funds; NIH [R44 GM087784]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM087784] Funding Source: NIH RePORTER	MCW Research Development funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by MCW Research Development funds to S. T. and NIH R44 GM087784 to T. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele-Ohl S, 2012, AM J TRANSPLANT; Andreoni K A, 2001, Transpl Infect Dis, V3 Suppl 2, P25, DOI 10.1034/j.1399-3062.2001.00005.x; Arcangeletti MC, 2000, MICROBIOLOGICA, V23, P241; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Kalejta RF, 2008, MICROBIOL MOL BIOL R, V72, P249, DOI 10.1128/MMBR.00040-07; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; Lam VY, 2011, J BIOMOL SCREEN, V16, P120, DOI 10.1177/1087057110388269; LOSSE D, 1982, ARCH VIROL, V71, P353, DOI 10.1007/BF01315066; Marquez JP, 2009, TISSUE ENG PART C-ME, V15, P181, DOI 10.1089/ten.tec.2008.0347; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Melnychuk RM, 2004, J VIROL, V78, P8382, DOI 10.1128/jvi.78.15.8382-8391.2004; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Michelson S, 2001, MICROBES INFECT, V3, P1005, DOI 10.1016/S1286-4579(01)01464-2; Miller MS, 2009, J VIROL, V83, P7015, DOI 10.1128/JVI.00398-09; Miron-Mendoza M, 2008, MOL BIOL CELL, V19, P2051, DOI 10.1091/mbc.E07-09-0930; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Penfold MET, 2003, J VIROL, V77, P10404, DOI 10.1128/JVI.77.19.10404-10413.2003; Rhee S, 2009, EXP MOL MED; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sivakumar P, 2008, INFLAMM RES, V57, P410, DOI 10.1007/s00011-008-7166-y; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06; Terhune SS, 2004, J VIROL, V78, P10390, DOI 10.1128/JVI.78.19.10390-10398.2004; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ujihara Y, 2008, J PHYSIOL SCI, V58, P499, DOI 10.2170/physiolsci.RP007708; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42197	10.1371/journal.pone.0042197	http://dx.doi.org/10.1371/journal.pone.0042197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870300	Green Published, gold			2022-12-25	WOS:000307284100053
J	Lin, IT; Yang, HC; Chen, JH				Lin, In-Tsang; Yang, Hong-Chang; Chen, Jyh-Horng			Enlargement of the Field of View and Maintenance of a High Signal-to-Noise Ratio Using a Two-Element High-T-c Superconducting Array in a 3T MRI	PLOS ONE			English	Article							RF COIL; NMR; MICROSCOPY; RECEIVER; QUALITY; PROBE	This study examines the enlargement of the field of view (FOV) and the maintenance of a high signal-to-noise ratio (SNR) through the use of two high-temperature superconducting (HTS) resonators in a 3T MRI. Two Bi2Sr2Ca2Cu3Ox (Bi-2223) surface resonators, each of 4-cm diameter, were used in a 3T MRI. Professionally made copper resonators operate at 300 K, but each Bi-2223 resonator, operated at 77 K and demonstrated a 3.75 fold increase in SNR gain. For the same scanning time, the SNR of the images of a rat's brain and back, obtained using two small Bi-2223 surface resonators, was higher than that obtained using a single 8-cm surface resonator.	[Lin, In-Tsang; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Yang, Hong-Chang] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University	Lin, IT (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan.	hcyang@phys.ntu.edu.tw; jhchen@ntu.edu.tw			National Health Research Institutes [NHRI-EX101- 10038EI]; National Science Council [NSC 100-2120-M002-015]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	The study is funded by National Health Research Institutes (http://www.nhri.org.tw), grant number NHRI-EX101- 10038EI and National Science Council (http://web1.nsc.gov.tw), grant number NSC 100-2120-M002-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RD, 1993, SCIENCE, V259, P793, DOI 10.1126/science.8430331; Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016; Ginefri JC, 1999, REV SCI INSTRUM, V70, P4730, DOI 10.1063/1.1150142; Ginefri JC, 2007, METHODS, V43, P54, DOI 10.1016/j.ymeth.2007.03.011; Grasso G, 2000, SUPERCOND SCI TECH, V13, pL15, DOI 10.1088/0953-2048/13/10/102; Hoult DI, 2002, CONCEPT MAGNETIC RES, V15, P262, DOI 10.1002/cmr.10047; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hurlston SE, 1999, MAGNET RESON MED, V41, P1032, DOI 10.1002/(SICI)1522-2594(199905)41:5<1032::AID-MRM23>3.3.CO;2-O; HYDE JS, 1986, J MAGN RESON, V70, P512, DOI 10.1016/0022-2364(86)90146-0; Keinan-Adamsky K, 2006, MAGN RESON MED, V55, P532, DOI 10.1002/mrm.20775; Kuo R, 2007, J MAGN RESON IMAGING, V25, P245, DOI 10.1002/jmri.20815; Lin IT, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573600; Ma QY, 1999, IEEE T APPL SUPERCON, V9, P3565, DOI 10.1109/77.783800; Miller J, 1999, MAGNETIC RESONANCE M, V41; Neuberger T, 2008, NMR BIOMED; OKADA H, 1995, J MAGN RESON SER B, V107, P158, DOI 10.1006/jmrb.1995.1072; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Wosik J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801384; Wright AC, 2000, MAGNET RESON MED, V43, P163, DOI 10.1002/(SICI)1522-2594(200002)43:2<163::AID-MRM1>3.0.CO;2-K; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; WRIGHT SM, 1991, MAGNET RESON MED, V17, P252, DOI 10.1002/mrm.1910170128; Yang HC, 2007, SUPERCOND SCI TECH, V20, P777, DOI 10.1088/0953-2048/20/8/009; Yoshioka H, 2003, SKELETAL RADIOL, V32, P575, DOI 10.1007/s00256-003-0672-7; Yuan J, 2004, SUPERCOND SCI TECH, V17, P333, DOI 10.1088/0953-2048/17/3/006; Zhang XL, 2005, MAGN RESON MED, V53, P1234, DOI 10.1002/mrm.20462	26	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42509	10.1371/journal.pone.0042509	http://dx.doi.org/10.1371/journal.pone.0042509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880009	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100114
J	Menge, DNL; Hedin, LO; Pacala, SW				Menge, Duncan N. L.; Hedin, Lars O.; Pacala, Stephen W.			Nitrogen and Phosphorus Limitation over Long-Term Ecosystem Development in Terrestrial Ecosystems	PLOS ONE			English	Article							HYDROLOGIC CONTROLS; PRIMARY SUCCESSION; TEMPERATE FOREST; SOIL DEVELOPMENT; GLACIER BAY; NUTRIENT LIMITATION; INORGANIC NITROGEN; FIXATION; DYNAMICS; CYCLES	Nutrient limitation to net primary production (NPP) displays a diversity of patterns as ecosystems develop over a range of timescales. For example, some ecosystems transition from N limitation on young soils to P limitation on geologically old soils, whereas others appear to remain N limited. Under what conditions should N limitation and P limitation prevail? When do transitions between N and P limitation occur? We analyzed transient dynamics of multiple timescales in an ecosystem model to investigate these questions. Post-disturbance dynamics in our model are controlled by a cascade of rates, from plant uptake (very fast) to litter turnover (fast) to plant mortality (intermediate) to plant-unavailable nutrient loss (slow) to weathering (very slow). Young ecosystems are N limited when symbiotic N fixation (SNF) is constrained and P weathering inputs are high relative to atmospheric N deposition and plant N: P demand, but P limited under opposite conditions. In the absence of SNF, N limitation is likely to worsen through succession (decades to centuries) because P is mineralized faster than N. Over long timescales (centuries and longer) this preferential P mineralization increases the N: P ratio of soil organic matter, leading to greater losses of plant-unavailable N versus P relative to plant N: P demand. These loss dynamics favor N limitation on older soils despite the rising organic matter N: P ratio. However, weathering depletion favors P limitation on older soils when continual P inputs (e. g., dust deposition) are low, so nutrient limitation at the terminal equilibrium depends on the balance of these input and loss effects. If NPP switches from N to P limitation over long time periods, the transition time depends most strongly on the P weathering rate. At all timescales SNF has the capacity to overcome N limitation, so nutrient limitation depends critically on limits to SNF.	[Menge, Duncan N. L.; Hedin, Lars O.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Menge, Duncan N. L.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Menge, Duncan N. L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Princeton University; National Center for Ecological Analysis & Synthesis; Stanford University	Menge, DNL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dmenge@princeton.edu		Menge, Duncan/0000-0003-4736-9844	National Science Foundation (NSF) [EF-0553768]; University of California, Santa Barbara; State of California; Carbon Mitigation Initiative; NSF [0614116]; Mellon Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Carbon Mitigation Initiative; NSF(National Science Foundation (NSF)); Mellon Foundation	This work was conducted in part while D.N.L.M. was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by the National Science Foundation (NSF) (www.nsf.gov; Grant #EF-0553768), the University of California, Santa Barbara (www.ucsb.edu), and the State of California (www.ca.gov). D.N.L.M. was also supported by the Carbon Mitigation Initiative (cmi.princeton.edu). L.O.H. was supported by a grant from the NSF (DEB #0614116) and the A. W. Mellon Foundation (www.mellon.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; ABRAMS P, 1987, THEOR POPUL BIOL, V32, P262, DOI 10.1016/0040-5809(87)90050-5; Adair EC, 2008, GLOBAL CHANGE BIOL, V14, P2636, DOI 10.1111/j.1365-2486.2008.01674.x; Agren GI, 1996, THEORETICAL ECOSYSTE; ARNONE JA, 1990, NEW PHYTOL, V116, P55, DOI 10.1111/j.1469-8137.1990.tb00510.x; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001822; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; BINKLEY D, 1992, ECOLOGY, V73, P2022, DOI 10.2307/1941452; Binkley D., 1994, BIOL MANAGEMENT RED, P57; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; Buendia C, 2010, BIOGEOSCIENCES, V7, P2025, DOI 10.5194/bg-7-2025-2010; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Compton JE, 2003, ECOSYSTEMS, V6, P773, DOI 10.1007/s10021-002-0207-4; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; D'Odorico P, 2003, ADV WATER RESOUR, V26, P59, DOI 10.1016/S0309-1708(02)00095-7; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; DeAngelis D. L., 1992, DYNAMICS NUTR CYCLIN; FIELD CB, 1992, ANNU REV ECOL SYST, V23, P201, DOI 10.1146/annurev.es.23.110192.001221; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2000, ECOSYSTEMS, V3, P433, DOI 10.1007/s100210000039; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Hall SJ, 1999, NATURE, V400, P152, DOI 10.1038/22094; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Holloway JM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001862; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Knops JMH, 2000, ECOSCIENCE, V7, P166, DOI 10.1080/11956860.2000.11682585; Lambers H., 2008, PLANT PHYSL ECOLOGY; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Manzoni S, 2004, NONLINEAR PROC GEOPH, V11, P589, DOI 10.5194/npg-11-589-2004; McGroddy ME, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003005; McMurtrie RE, 1996, GLOBAL CHANGE BIOL, V2, P49, DOI 10.1111/j.1365-2486.1996.tb00048.x; Menge DNL, 2008, P NATL ACAD SCI USA, V105, P1573, DOI 10.1073/pnas.0711411105; Menge DNL, 2007, GLOBAL CHANGE BIOL, V13, P2582, DOI 10.1111/j.1365-2486.2007.01456.x; Menge DNL, 2011, ECOSYSTEMS, V14, P519, DOI 10.1007/s10021-011-9426-x; Menge DNL, 2011, THEOR ECOL-NETH, V4, P163, DOI 10.1007/s12080-010-0110-0; Menge DNL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012056; Menge DNL, 2009, AM NAT, V174, P465, DOI 10.1086/605377; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Menge DNL, 2009, J THEOR BIOL, V257, P104, DOI 10.1016/j.jtbi.2008.10.032; Menge DNL, 2009, AM NAT, V173, P164, DOI 10.1086/595749; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pearson HL, 2002, ECOSYSTEMS, V5, P587, DOI 10.1007/s10021-002-0172-y; Pearson HL, 2001, ECOL APPL, V11, P1381, DOI 10.2307/3060927; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Perakis SS, 2005, ECOLOGY, V86, P96, DOI 10.1890/04-0415; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Porder S, 2007, ECOSYSTEMS, V10, P158, DOI 10.1007/s10021-006-9011-x; Porder S, 2011, BIOGEOCHEMISTRY, V102, P153, DOI 10.1007/s10533-010-9428-3; Porporato A, 2003, ADV WATER RESOUR, V26, P45, DOI 10.1016/S0309-1708(02)00094-5; Providoli I, 2006, SOIL BIOL BIOCHEM, V38, P1645, DOI 10.1016/j.soilbio.2005.11.019; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; RASTETTER EB, 1992, ECOLOGY, V73, P1157, DOI 10.2307/1940666; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Ruess RW, 2009, ECOSYSTEMS, V12, P489, DOI 10.1007/s10021-009-9237-5; Runyan CW, 2012, ADV WATER RESOUR, V35, P94, DOI 10.1016/j.advwatres.2011.10.004; SCHIMEL JP, 1989, SOIL BIOL BIOCHEM, V21, P1059, DOI 10.1016/0038-0717(89)90044-8; Selmants PC, 2010, ECOLOGY, V91, P474, DOI 10.1890/09-0243.1; Selmants PC, 2008, GLOBAL BIOGEOCHEMICA, V22, P13; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Stevens P. R, 1968, CHRONOSEQUENCE SOILS; SWAP R, 1992, TELLUS B, V44, P133, DOI 10.1034/j.1600-0889.1992.t01-1-00005.x; Tilman D., 1982, Monographs in Population Biology, pi; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; van den Berg HA, 2002, J MATH BIOL, V44, P276, DOI 10.1007/s002850100123; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P432; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; von Liebig J, 1840, ORGANIC CHEM ITS APP; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Walker L. R., 1993, PRIMARY SUCCESSION L, P249; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319	103	84	90	0	206	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42045	10.1371/journal.pone.0042045	http://dx.doi.org/10.1371/journal.pone.0042045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870281	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100043
J	Ward, SE; Kim, HS; Komurov, K; Mendiratta, S; Tsai, PL; Schmolke, M; Satterly, N; Manicassamy, B; Forst, CV; Roth, MG; Garcia-Sastre, A; Blazewska, KM; McKenna, CE; Fontoura, BM; White, MA				Ward, Samuel E.; Kim, Hyun Seok; Komurov, Kakajan; Mendiratta, Saurabh; Tsai, Pei-Ling; Schmolke, Mirco; Satterly, Neal; Manicassamy, Balaji; Forst, Christian V.; Roth, Michael G.; Garcia-Sastre, Adolfo; Blazewska, Katarzyna M.; McKenna, Charles E.; Fontoura, Beatriz M.; White, Michael A.			Host Modulators of H1N1 Cytopathogenicity	PLOS ONE			English	Article							NS1 PROTEIN; VIRUS; IDENTIFICATION; CONTRIBUTES; INHIBITION; ACTIVATION; RESISTANCE; INDUCTION; INFECTION; COMPLEX	Influenza A virus infects 5-20% of the population annually, resulting in similar to 35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolution of viral proteins gives rise to drug resistance. In consequence additional intervention strategies, that target host factors required for the viral life cycle, are under investigation. Here we employed arrayed whole-genome siRNA screening strategies to identify cell-autonomous molecular components that are subverted to support H1N1 influenza A virus infection of human bronchial epithelial cells. Integration across relevant public data sets exposed druggable gene products required for epithelial cell infection or required for viral proteins to deflect host cell suicide checkpoint activation. Pharmacological inhibition of representative targets, RGGT and CHEK1, resulted in significant protection against infection of human epithelial cells by the A/WS/33 virus. In addition, chemical inhibition of RGGT partially protected against H5N1 and the 2009 H1N1 pandemic strain. The observations reported here thus contribute to an expanding body of studies directed at decoding vulnerabilities in the command and control networks specified by influenza virulence factors.	[Ward, Samuel E.; Kim, Hyun Seok; Mendiratta, Saurabh; Tsai, Pei-Ling; Satterly, Neal; Fontoura, Beatriz M.; White, Michael A.] Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA; [Komurov, Kakajan] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Komurov, Kakajan] Cincinnati Childrens Hosp, Med Ctr, Div Canc Biol Human Genet & Biomed Informat, Cincinnati, OH USA; [Schmolke, Mirco; Manicassamy, Balaji; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Forst, Christian V.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Blazewska, Katarzyna M.] Tech Univ Lodz, Inst Organ Chem, PL-90924 Lodz, Poland; [Blazewska, Katarzyna M.; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Lodz University of Technology; University of Southern California	Ward, SE (corresponding author), Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA.	Michael.White@utsouthwestern.edu	Schmolke, Mirco/AAI-9081-2020; Błażewska, Katarzyna/M-3722-2018	Schmolke, Mirco/0000-0002-2491-3029; Błażewska, Katarzyna/0000-0002-1218-7111; Roth, Michael/0000-0002-9056-332X; Manicassamy, Balaji/0000-0003-1964-0967; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Forst, Christian/0000-0003-0229-9459	National Institutes of Health [AI083614, CA071443, CA129451, HHSN266200700010C, AI095320]; Robert Welch Foundation [I-1414]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA071443, R01CA129451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089539, R00AI095320, R21AI083614, R01AI079110, K99AI095320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (AI083614, CA071443, CA129451, HHSN266200700010C and AI095320) and the Robert Welch Foundation (I-1414, www.welch1.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Baron RA, 2009, J BIOL CHEM, V284, P6861, DOI 10.1074/jbc.M806952200; Blazewska KM, 2011, CHEM COMMUN, V47, P6395, DOI 10.1039/c1cc10876j; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jackson JR, 2000, CANCER RES, V60, P566; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knipe DM, 2001, FIELDS VIROLOGY, V1, P1487; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; McKenna CE, 2010, J MED CHEM, V53, P3454, DOI 10.1021/jm900232u; Meunier I, 2011, J GEN VIROL, V92, P1635, DOI 10.1099/vir.0.032193-0; Micillo E, 2000, ALLERGY, V55, P42; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; Tisoncik JR, 2011, J GEN VIROL, V92, P2093, DOI 10.1099/vir.0.032060-0; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vreede FT, 2010, VIRULENCE, V1, P436, DOI 10.4161/viru.1.5.12967; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39284	10.1371/journal.pone.0039284	http://dx.doi.org/10.1371/journal.pone.0039284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876275	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700003
J	Blanchette, C; Lacayo, CI; Fischer, NO; Hwang, M; Thelen, MP				Blanchette, Craig; Lacayo, Catherine I.; Fischer, Nicholas O.; Hwang, Mona; Thelen, Michael P.			Enhanced Cellulose Degradation Using Cellulase-Nanosphere Complexes	PLOS ONE			English	Article							TRACHEARY ELEMENTS; CELL; LIGNIN; BINDING; HYDROLYSIS; CULTURES; ENZYMES	Enzyme catalyzed conversion of plant biomass to sugars is an inherently inefficient process, and one of the major factors limiting economical biofuel production. This is due to the physical barrier presented by polymers in plant cell walls, including semi-crystalline cellulose, to soluble enzyme accessibility. In contrast to the enzymes currently used in industry, bacterial cellulosomes organize cellulases and other proteins in a scaffold structure, and are highly efficient in degrading cellulose. To mimic this clustered assembly of enzymes, we conjugated cellulase obtained from Trichoderma viride to polystyrene nanospheres (cellulase: NS) and tested the hydrolytic activity of this complex on cellulose substrates from purified and natural sources. Cellulase: NS and free cellulase were equally active on soluble carboxymethyl cellulose (CMC); however, the complexed enzyme displayed a higher affinity in its action on microcrystalline cellulose. Similarly, we found that the cellulase: NS complex was more efficient in degrading natural cellulose structures in the thickened walls of cultured wood cells. These results suggest that nanoparticle-bound enzymes can improve catalytic efficiency on physically intractable substrates. We discuss the potential for further enhancement of cellulose degradation by physically clustering combinations of different glycosyl hydrolase enzymes, and applications for using cellulase: NS complexes in biofuel production.	[Blanchette, Craig; Lacayo, Catherine I.; Fischer, Nicholas O.; Hwang, Mona; Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Blanchette, C (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci, Livermore, CA 94550 USA.	blanchette2@llnl.gov; mthelen@llnl.gov	Thelen, Michael/C-6834-2008; Fischer, Nicholas/AAE-2409-2019; Thelen, Michael P/G-2032-2014	Thelen, Michael/0000-0002-2479-5480; Fischer, Nicholas/0000-0001-7575-4390; Thelen, Michael P/0000-0002-2479-5480	Department of Energy/Basic Energy Research BR [KP1601010]	Department of Energy/Basic Energy Research BR(United States Department of Energy (DOE))	This work was supported by Department of Energy/Basic Energy Research B&R#: KP1601010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benova-Kakosova A, 2006, PLANT PHYSIOL, V142, P696, DOI 10.1104/pp.106.085712; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g; BREUIL C, 1985, ENZYME MICROB TECH, V7, P327, DOI 10.1016/0141-0229(85)90111-5; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Dashtban M, 2010, CRIT REV BIOTECHNOL, V30, P302, DOI 10.3109/07388551.2010.490938; Dincer A, 2007, J MOL CATAL B-ENZYM, V45, P10, DOI 10.1016/j.molcatb.2006.10.005; Ding SY, 2008, CURR OPIN BIOTECH, V19, P218, DOI 10.1016/j.copbio.2008.04.008; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Imai M, 2004, BIOCHEM ENG J, V17, P79, DOI 10.1016/S1369-703X(03)00141-4; Jordan J, 2011, J MOL CATAL B-ENZYM, V68, P139, DOI 10.1016/j.molcatb.2010.09.010; Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Lacayo CI, 2010, PLANT PHYSIOL, V154, P121, DOI 10.1104/pp.110.155242; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; LAMED R, 1983, ISRAEL J MED SCI, V19, P674; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; Liu J, 2006, BIOCHEM ENG J, V30, P82, DOI 10.1016/j.bej.2006.02.005; Milioni D, 2001, PLANT MOL BIOL, V47, P221, DOI 10.1023/A:1010647902487; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; Oda Y, 2012, CURR OPIN PLANT BIOL, V15, P38, DOI 10.1016/j.pbi.2011.10.005; ROBERTS AW, 1994, PLANT PHYSIOL, V105, P699, DOI 10.1104/pp.105.2.699; Tassa C, 2010, BIOCONJUGATE CHEM, V21, P14, DOI 10.1021/bc900438a; TAYLOR JG, 1992, PLANT J, V2, P959, DOI 10.1111/j.1365-313X.1992.00959.x; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	33	29	33	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42116	10.1371/journal.pone.0042116	http://dx.doi.org/10.1371/journal.pone.0042116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870287	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800060
J	Burgess, A; Huang, YX; Waspe, AC; Ganguly, M; Goertz, DE; Hynynen, K				Burgess, Alison; Huang, Yuexi; Waspe, Adam C.; Ganguly, Milan; Goertz, David E.; Hynynen, Kullervo			High-Intensity Focused Ultrasound (HIFU) for Dissolution of Clots in a Rabbit Model of Embolic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; IN-VITRO; PHASED-ARRAY; THROMBOLYSIS; SURGERY; SONOTHROMBOLYSIS; DISRUPTION; THERAPY	It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke suggesting that alternative therapies are necessary. In this study, we investigate the potential for high intensity focused ultrasound (HIFU) to initiate thrombolysis in an embolic model of stroke. Iron-loaded blood clots were injected into the middle cerebral artery (MCA) of New Zealand White rabbits, through the internal carotid artery and blockages were confirmed by angiography. MRI was used to localize the iron-loaded clot and target the HIFU beam for treatment. HIFU pulses (1.5 MHz, 1 ms bursts, 1 Hz pulse repetition frequency, 20 s duration) were applied to initiate thrombolysis. Repeat angiograms and histology were used to assess reperfusion and vessel damage. Using 275 W of acoustic power, there was no evidence of reperfusion in post-treatment angiograms of 3 rabbits tested. In a separate group of animals, 415 W of acoustic power was applied and reperfusion was observed in 2 of the 4 (50%) animals treated. In the last group of animals, acoustic power was further increased to 550 W, which led to the reperfusion in 5 of 7 (similar to 70%) animals tested. Histological analysis confirmed thatthe sonicated vessels remained intact after HIFU treatment. Hemorrhage was detected outside of the sonication site, likely due to the proximity of the target vessel with the base of the rabbit skull. These results demonstrate the feasibility of using HIFU, as a stand-alone method, to cause effective thrombolysis without immediate damage to the targeted vessels. HIFU, combined with imaging modalities used to identify and assess stroke patients, could dramatically reduce the time to achieve flow restoration in patients thereby significantly increasing the number of patients which benefit from thrombolysis treatments.	[Burgess, Alison; Huang, Yuexi; Waspe, Adam C.; Ganguly, Milan; Goertz, David E.; Hynynen, Kullervo] Sunnybrook Res Inst, Toronto, ON, Canada; [Waspe, Adam C.; Goertz, David E.; Hynynen, Kullervo] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Burgess, A (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	aburgess@sri.utoronto.ca			National Institute of Health [R01 EB009032]; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009032] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institute of Health grant # R01 EB009032 (Kullervo Hynynen). Alison Burgess was partially funded by a fellowship awarded by the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexandrov AV, 2008, STROKE, V39, P1464, DOI 10.1161/STROKEAHA.107.505727; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014; BLINC A, 1993, BLOOD, V81, P2636; Brown AT, 2011, INVEST RADIOL, V46, P202, DOI 10.1097/RLI.0b013e318200757a; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; Clement GT, 2005, J ULTRAS MED, V24, P1117, DOI 10.7863/jum.2005.24.8.1117; Connor CW, 2004, IEEE T BIO-MED ENG, V51, P1693, DOI 10.1109/TBME.2004.831516; Culp BC, 2007, J VASC INTERV RADIOL, V18, P187, DOI 10.1016/j.jvir.2006.12.720; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Datta S, 2008, ULTRASOUND MED BIOL, V34, P1421, DOI 10.1016/j.ultrasmedbio.2008.01.016; Datta S, 2006, ULTRASOUND MED BIOL, V32, P1257, DOI 10.1016/j.ultrasmedbio.2006.04.008; Duck F.A., 1990, MED PHYS, V18; Elias JW, 2011, C NEUR SURG 2011 ANN; Fagan SC, 1998, EXP NEUROL, V150, P153, DOI 10.1006/exnr.1997.6756; Flores R, 2011, INVEST RADIOL, V46, P419, DOI 10.1097/RLI.0b013e31820e143a; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Holscher T, 2011, J NEUROL NEUROPHYS S, pS1; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 1997, RADIOLOGY, V204, P247, DOI 10.1148/radiology.204.1.9205255; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; Maxwell AD, 2011, J VASC INTERV RADIOL, V22, P369, DOI 10.1016/j.jvir.2010.10.007; Maxwell AD, 2009, ULTRASOUND MED BIOL, V35, P1982, DOI 10.1016/j.ultrasmedbio.2009.07.001; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001; OLERUD JE, 1987, J INVEST DERMATOL, V88, P615, DOI 10.1111/1523-1747.ep12470221; Rosenschein U, 2000, CIRCULATION, V102, P238, DOI 10.1161/01.CIR.102.2.238; Song JH, 2012, IEEE T BIO-MED ENG, V59, P435, DOI 10.1109/TBME.2011.2174057; Song JH, 2010, IEEE T BIO-MED ENG, V57, P124, DOI 10.1109/TBME.2009.2028739; Westermark S, 1999, CLIN SCI, V97, P67, DOI 10.1042/CS19980379; Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c	37	65	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42311	10.1371/journal.pone.0042311	http://dx.doi.org/10.1371/journal.pone.0042311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870315	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800078
J	Hughes, AD; Brunner, L; Cook, EJ; Kelly, MS; Wilson, B				Hughes, Adam D.; Brunner, Lars; Cook, Elizabeth J.; Kelly, Maeve S.; Wilson, Ben			Echinoderms Display Morphological and Behavioural Phenotypic Plasticity in Response to Their Trophic Environment	PLOS ONE			English	Article							ECHINOID PSAMMECHINUS-MILIARIS; URCHIN PARACENTROTUS-LIVIDUS; KELP FOREST ECOSYSTEMS; SEA-URCHIN; RESOURCE-ALLOCATION; REPRODUCTIVE-CYCLE; COVERING BEHAVIOR; FOOD AVAILABILITY; FIELD CONDITIONS; GROWTH ZONES	The trophic interactions of sea urchins are known to be the agents of phase shifts in benthic marine habitats such as tropical and temperate reefs. In temperate reefs, the grazing activity of sea urchins has been responsible for the destruction of kelp forests and the formation of 'urchin barrens', a rocky habitat dominated by crustose algae and encrusting invertebrates. Once formed, these urchin barrens can persist for decades. Trophic plasticity in the sea urchin may contribute to the stability and resilience of this alternate stable state by increasing diet breadth in sea urchins. This plasticity promotes ecological connectivity and weakens species interactions and so increases ecosystem stability. We test the hypothesis that sea urchins exhibit trophic plasticity using an approach that controls for other typically confounding environmental and genetic factors. To do this, we exposed a genetically homogenous population of sea urchins to two very different trophic environments over a period of two years. The sea urchins exhibited a wide degree of phenotypic trophic plasticity when exposed to contrasting trophic environments. The two populations developed differences in their gross morphology and the test microstructure. In addition, when challenged with unfamiliar prey, the response of each group was different. We show that sea urchins exhibit significant morphological and behavioural phenotypic plasticity independent of their environment or their nutritional status.	[Hughes, Adam D.; Brunner, Lars; Cook, Elizabeth J.; Kelly, Maeve S.; Wilson, Ben] Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland	UHI Millennium Institute	Hughes, AD (corresponding author), Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland.	adam.hughes@sams.ac.uk	Hughes, Adam D/J-7867-2013; Hughes, Adam D/L-1088-2016	Cottier-Cook, Elizabeth/0000-0002-1466-6802; Wilson, Ben/0000-0002-1546-4962	Natural Environment Research Council, UK; NERC [dml010002] Funding Source: UKRI; Natural Environment Research Council [dml010002] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (http://www.nerc.ac.uk/) UK, under the Oceans 2025 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allardyce BJ, 2010, J MORPHOL, V271, P61, DOI 10.1002/jmor.10781; Balch T, 2000, MAR ECOL PROG SER, V205, P139, DOI 10.3354/meps205139; Barnes DKA, 2001, MAR BIOL, V138, P1205, DOI 10.1007/s002270100543; BLACK R, 1982, MAR BIOL, V71, P101, DOI 10.1007/BF00396997; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Crook AC, 1999, J MAR BIOL ASSOC UK, V79, P1117, DOI 10.1017/S002531549900137X; Crook AC, 2001, MAR ECOL-P S Z N I, V22, P231, DOI 10.1046/j.1439-0485.2001.01727.x; Crook AC, 2000, J MAR BIOL ASSOC UK, V80, P177, DOI 10.1017/S0025315499001721; Urriago JD, 2011, J EXP MAR BIOL ECOL, V399, P17, DOI 10.1016/j.jembe.2011.01.004; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ebert TA, 1996, OCEANOL ACTA, V19, P347; Ebert TA, 2003, FISH B-NOAA, V101, P915; EBERT TA, 1980, B MAR SCI, V30, P467; EDWARDS PB, 1991, J EXP MAR BIOL ECOL, V145, P205, DOI 10.1016/0022-0981(91)90176-W; Estes JA, 2004, B MAR SCI, V74, P621; GAGE JD, 1991, MAR BIOL, V110, P217, DOI 10.1007/BF01313707; Gagnon P, 2003, J EXP MAR BIOL ECOL, V290, P179, DOI 10.1016/S0022-0981(03)00077-7; Guillou M, 2000, J EXP MAR BIOL ECOL, V245, P183, DOI 10.1016/S0022-0981(99)00162-8; Hagen NT, 2008, MAR BIOL, V153, P907, DOI 10.1007/s00227-007-0863-1; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hernandez JC, 2010, J EXP BIOL, V213, P520, DOI 10.1242/jeb.029959; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes AD, 2006, MAR BIOL, V148, P789, DOI 10.1007/s00227-005-0124-0; Hughes AD, 2005, MAR ECOL PROG SER, V305, P101, DOI 10.3354/meps305101; Kelly M, 2007, DEV AQUACULTURE FISH, P287; Kelly MS, 2000, J MAR BIOL ASSOC UK, V80, P909, DOI 10.1017/S0025315400002897; LANG C, 1976, MAR BIOL, V36, P321, DOI 10.1007/BF00389193; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; LINDAHL PER ERIC, 1929, ACTA ZOOL [STOCKHOLM], V10, P401; Ling SD, 2009, MAR ECOL PROG SER, V374, P113, DOI 10.3354/meps07729; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McClanahan TR, 1999, ECOSYSTEMS, V2, P511, DOI 10.1007/s100219900099; Moore H. B., 1935, Journal of the Marine Biological Association Plymouth NS, V20, P109; Moya-Larano J, 2011, PHILOS T R SOC B, V366, P1425, DOI 10.1098/rstb.2010.0241; NORTH WJ, 1970, SCIENCE, V167, P209, DOI 10.1126/science.167.3915.209-a; Otero-Villanueva MDM, 2006, J MAR BIOL ASSOC UK, V86, P773, DOI 10.1017/S0025315406013695; PEARSE JS, 1975, AM ZOOL, V15, P731; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Russell MP, 1998, J EXP MAR BIOL ECOL, V220, P1, DOI 10.1016/S0022-0981(97)00079-8; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Selden R, 2009, MAR BIOL, V156, P1057, DOI 10.1007/s00227-009-1150-0; Sivertsen K, 2006, J APPL PHYCOL, V18, P599, DOI 10.1007/s10811-006-9064-4; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Verling E, 2002, MAR BIOL, V140, P391, DOI 10.1007/s002270100689	50	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41243	10.1371/journal.pone.0041243	http://dx.doi.org/10.1371/journal.pone.0041243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870211	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800014
J	Jensen, H; Folkersen, L; Skov, S				Jensen, Helle; Folkersen, Lasse; Skov, Soren			Regulation and Gene Expression Profiling of NKG2D Positive Human Cytomegalovirus-Primed CD4(+) T-Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RHEUMATOID-ARTHRITIS; INTRACELLULAR SEQUESTRATION; SURFACE EXPRESSION; FUNCTIONAL SUBSETS; EFFECTOR FUNCTIONS; GLYCOPROTEIN UL16; HUMAN CD94; FACTOR TOX; IFN-GAMMA	NKG2D is a stimulatory receptor expressed by natural killer (NK) cells, CD8(+) T-cells, and gamma delta T-cells. NKG2D expression is normally absent from CD4(+) T-cells, however recently a subset of NKG2D(+) CD4(+) T-cells has been found, which is specific for human cytomegalovirus (HCMV). This particular subset of HCMV-specific NKG2D(+) CD4(+) T-cells possesses effector-like functions, thus resembling the subsets of NKG2D(+) CD4(+) T-cells found in other chronic inflammations. However, the precise mechanism leading to NKG2D expression on HCMV-specific CD4(+) T-cells is currently not known. In this study we used genome-wide analysis of individual genes and gene set enrichment analysis (GSEA) to investigate the gene expression profile of NKG2D(+) CD4(+) T-cells, generated from HCMV-primed CD4(+) T-cells. We show that the HCMV-primed NKG2D(+) CD4(+) T-cells possess a higher differentiated phenotype than the NKG2D(-) CD4(+) T-cells, both at the gene expression profile and cytokine profile. The ability to express NKG2D at the cell surface was primarily determined by the activation or differentiation status of the CD4(+) T-cells and not by the antigen presenting cells. We observed a correlation between CD94 and NKG2D expression in the CD4(+) T-cells following HCMV stimulation. However, knock-down of CD94 did not affect NKG2D cell surface expression or signaling. In addition, we show that NKG2D is recycled at the cell surface of activated CD4(+) T-cells, whereas it is produced de novo in resting CD4(+) T-cells. These findings provide novel information about the gene expression profile of HCMV-primed NKG2D(+) CD4(+) T-cells, as well as the mechanisms regulating NKG2D cell surface expression.	[Jensen, Helle; Skov, Soren] Univ Copenhagen, Sect Biomed, Immunol Lab, Fac Life Sci, Copenhagen, Denmark; [Folkersen, Lasse] Karolinska Inst, Atherosclerosis Res Unit, Dept Med, Stockholm, Sweden	University of Copenhagen; Karolinska Institutet	Jensen, H (corresponding author), Univ Copenhagen, Sect Biomed, Immunol Lab, Fac Life Sci, Copenhagen, Denmark.	hellejensen@fastmail.fm; sosk@life.ku.dk		Skov, Soren/0000-0003-0732-0026; Folkersen, Lasse/0000-0003-0708-9530	Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond; Beckett-Fonden	Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond; Beckett-Fonden	This study was supported by: Gigtforeningen; Mogens Svarre Mogensens Fond; Frimodt-Heineke Fonden; Ekspeditionssekretaer cand.jur. Torkil Steenbecks legat; Augustinus Fonden; Grosserer LF Foghts Fond; Oldermand, slagtermester Peter Ryholts Legat; Grosserer Valdemar Foersom og hustru Thyra Foersom, fodt Ottos Fond; Direktor Jacob Madsen og hustru Olga Madsens Fond and Beckett-Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; ARAMBURU J, 1991, J IMMUNOL, V147, P714; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Capraru D, 2008, CLIN IMMUNOL, V127, P144, DOI 10.1016/j.clim.2007.12.004; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; Chen HW, 2006, CLIN IMMUNOL, V119, P21, DOI 10.1016/j.clim.2005.11.003; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Kobayashi T, 2007, INFLAMM BOWEL DIS, V13, P837, DOI 10.1002/ibd.20113; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lieto LD, 2003, J IMMUNOL, V171, P5277, DOI 10.4049/jimmunol.171.10.5277; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Meyers JH, 2002, J IMMUNOL, V169, P5382, DOI 10.4049/jimmunol.169.10.5382; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Ogawa K, 2001, J IMMUNOL, V166, P6404, DOI 10.4049/jimmunol.166.10.6404; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pena SV, 1997, J IMMUNOL, V158, P2680; Pingiotti E, 2007, ANN NY ACAD SCI, V1107, P32, DOI 10.1196/annals.1381.004; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Roda-Navarro P, 2009, J BIOL CHEM, V284, P16463, DOI 10.1074/jbc.M808561200; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2000, CURR TOP MICROBIOL, V251, P167; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Spies T, 2008, NAT IMMUNOL, V9, P1013, DOI 10.1038/ni0908-1013; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Vetter CS, 2004, BRIT J CANCER, V91, P1495, DOI 10.1038/sj.bjc.6602123; Yang D, 2009, MOL IMMUNOL, V46, P1432, DOI 10.1016/j.molimm.2008.12.010; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	54	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41577	10.1371/journal.pone.0041577	http://dx.doi.org/10.1371/journal.pone.0041577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870231	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800025
J	Weingartner, A; Kemmer, G; Muller, FD; Zampieri, RA; dos Santos, MG; Schiller, J; Pomorski, TG				Weingaertner, Adrien; Kemmer, Gerdi; Mueller, Frederic D.; Zampieri, Ricardo Andrade; dos Santos, Marcos Gonzaga; Schiller, Juergen; Pomorski, Thomas Guenther			Leishmania Promastigotes Lack Phosphatidylserine but Bind Annexin V upon Permeabilization or Miltefosine Treatment	PLOS ONE			English	Article							MALDI-TOF MS; MASS-SPECTROMETRY; DONOVANI PROMASTIGOTES; TRYPANOSOMA-BRUCEI; APOPTOTIC MIMICRY; KENNEDY PATHWAY; BLOOD-STREAM; CELL-DEATH; PHOSPHOLIPIDS; ASYMMETRY	The protozoan parasite Leishmania is an intracellular pathogen infecting and replicating inside vertebrate host macrophages. A recent model suggests that promastigote and amastigote forms of the parasite mimic mammalian apoptotic cells by exposing phosphatidylserine (PS) at the cell surface to trigger their phagocytic uptake into host macrophages. PS presentation at the cell surface is typically analyzed using fluorescence-labeled annexin V. Here we show that Leishmania promastigotes can be stained by fluorescence-labeled annexin V upon permeabilization or miltefosine treatment. However, combined lipid analysis by thin-layer chromatography, mass spectrometry and 31 P nuclear magnetic resonance (NMR) spectroscopy revealed that Leishmania promastigotes lack any detectable amount of PS. Instead, we identified several other phospholipid classes such phosphatidic acid, phosphatidylethanolamine; phosphatidylglycerol and phosphatidylinositol as candidate lipids enabling annexin V staining.	[Weingaertner, Adrien] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Kemmer, Gerdi; Pomorski, Thomas Guenther] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen C, Denmark; [Mueller, Frederic D.] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Zampieri, Ricardo Andrade; dos Santos, Marcos Gonzaga] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil; [Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany; [Weingaertner, Adrien] Helmholtz Ctr Infekt Res, Braunschweig, Germany	Humboldt University of Berlin; University of Copenhagen; Humboldt University of Berlin; Universidade de Sao Paulo; Leipzig University	Weingartner, A (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	tgp@life.ku.dk	Pomorski, Thomas Günther/G-4804-2014; Santos, Marcos/E-1993-2013; Kemmer, Gerdi Christine/C-1691-2015; Zampieri, Ricardo/D-3706-2018	Pomorski, Thomas Günther/0000-0002-4889-0829; Kemmer, Gerdi Christine/0000-0002-4686-5531; 	FAZIT (AW); Research Training Group 1121 of the German Research Foundation; Carlsberg Foundation; "Center for Synthetic Biology" at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology and Innovation	FAZIT (AW); Research Training Group 1121 of the German Research Foundation; Carlsberg Foundation(Carlsberg Foundation); "Center for Synthetic Biology" at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology and Innovation	This work was supported by FAZIT (AW), Research Training Group 1121 of the German Research Foundation (AW, TGP), and the Carlsberg Foundation (TGP). TGP and GK gratefully acknowledge financial support from "Center for Synthetic Biology" at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Eibisch M, 2011, RAPID COMMUN MASS SP, V25, P2619, DOI 10.1002/rcm.5161; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; ESKO JD, 1983, J BIOL CHEM, V258, P3051; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fuchs B, 2008, ANAL BIOANAL CHEM, V392, P849, DOI 10.1007/s00216-008-2301-8; Fuchs B, 2011, PROG LIPID RES, V50, P132, DOI 10.1016/j.plipres.2010.10.001; Gellermann GP, 2006, BIOL CHEM, V387, P1267, DOI 10.1515/BC.2006.157; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Hein EM, 2010, RAPID COMMUN MASS SP, V24, P2083, DOI 10.1002/rcm.4614; Hein EM, 2009, RAPID COMMUN MASS SP, V23, P1636, DOI 10.1002/rcm.4042; Henriques C, 2003, PARASITOL RES, V89, P123, DOI 10.1007/s00436-002-0728-y; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P1591, DOI 10.1016/j.jasms.2007.05.017; Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Khademvatan S, 2011, KOREAN J PARASITOL, V49, P17, DOI 10.3347/kjp.2011.49.1.17; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Murphy R. C, 2002, MASS SPECTROMETRY PH; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Petkovic M, 2001, ANALYST, V126, P1042, DOI 10.1039/b101921j; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Rohlfing A, 2007, ANAL CHEM, V79, P5793, DOI 10.1021/ac070633x; Schiller J, 1999, ANAL BIOCHEM, V267, P46, DOI 10.1006/abio.1998.3001; Schiller J, 2007, CURR ANAL CHEM, V3, P283, DOI 10.2174/157341107782109635; Schiller J, 2007, EUR BIOPHYS J BIOPHY, V36, P517, DOI 10.1007/s00249-006-0090-6; Schiller J, 2007, FRONT BIOSCI-LANDMRK, V12, P2568, DOI 10.2741/2255; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Singh N, 2009, PARASITOL RES, V105, P1317, DOI 10.1007/s00436-009-1557-z; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yoneyama KAG, 2006, J LIPID RES, V47, P2171, DOI 10.1194/jlr.M600285-JLR200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	55	60	60	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42070	10.1371/journal.pone.0042070	http://dx.doi.org/10.1371/journal.pone.0042070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870283	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800056
J	Lailson-Brito, J; Cruz, R; Dorneles, PR; Andrade, L; Azevedo, AD; Fragoso, AB; Vidal, LG; Costa, MB; Bisi, TL; Almeida, R; Carvalho, DP; Bastos, WR; Malm, O				Lailson-Brito, Jose; Cruz, Renato; Dorneles, Paulo Renato; Andrade, Leonardo; Azevedo, Alexandre de Freitas; Fragoso, Ana Bernadete; Vidal, Lara Gama; Costa, Marianna Badini; Bisi, Tatiana Lemos; Almeida, Ronaldo; Carvalho, Dario Pires; Bastos, Wanderley Rodrigues; Malm, Olaf			Mercury-Selenium Relationships in Liver of Guiana Dolphin: The Possible Role of Kupffer Cells in the Detoxification Process by Tiemannite Formation	PLOS ONE			English	Article							WHALES DELPHINAPTERUS-LEUCAS; HEAVY-METALS; MARINE MAMMALS; BRAZILIAN COAST; STENELLA-COERULEOALBA; METHYL-MERCURY; SOTALIA-GUIANENSIS; ORGANIC MERCURY; TRACE-ELEMENTS; RINGED SEALS	Top marine predators present high mercury concentrations in their tissues as consequence of biomagnification of the most toxic form of this metal, methylmercury (MeHg). The present study concerns mercury accumulation by Guiana dolphins (Sotalia guianensis), highlighting the selenium-mediated methylmercury detoxification process. Liver samples from 19 dolphins incidentally captured within Guanabara Bay (Rio de Janeiro State, Brazil) from 1994 to 2006 were analyzed for total mercury (THg), methylmercury (MeHg), total organic mercury (TOrgHg) and selenium (Se). X-ray microanalyses were also performed. The specimens, including from fetuses to 30-year-old dolphins, comprising 8 females and 11 males, presented high THg (0.53-132 mg/g wet wt.) and Se concentrations (0.17-74.8 mg/g wet wt.). Correlations between THg, MeHg, TOrgHg and Se were verified with age (p < 0.05), as well as a high and positive correlation was observed between molar concentrations of Hg and Se (p < 0.05). Negative correlations were observed between THg and the percentage of MeHg contribution to THg (p < 0.05), which represents a consequence of the selenium-mediated methylmercury detoxification process. Accumulation of Se-Hg amorphous crystals in Kupffer Cells was demonstrated through ultra-structural analysis, which shows that Guiana dolphin is capable of carrying out the demethylation process via mercury selenide formation.	[Lailson-Brito, Jose; Dorneles, Paulo Renato; Azevedo, Alexandre de Freitas; Fragoso, Ana Bernadete; Vidal, Lara Gama; Bisi, Tatiana Lemos] Univ Estado Rio De Janeiro, Fac Oceanog, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Rio De Janeiro, Brazil; [Lailson-Brito, Jose; Dorneles, Paulo Renato; Costa, Marianna Badini; Malm, Olaf] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Radioisotopos Eduardo Penna Franca, Rio de Janeiro, Brazil; [Cruz, Renato] UFF, Dept Biol Celular & Mol, Rio De Janeiro, Brazil; [Andrade, Leonardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Fragoso, Ana Bernadete] Univ Estado Rio Grande do Norte UERN, Inst Ciencias Exatas & Nat, Mossoro, RN, Brazil; [Almeida, Ronaldo; Carvalho, Dario Pires; Bastos, Wanderley Rodrigues] Univ Fed Rondonia UNIR, Lab Biogeoquim Ambiental, Porto Velho, Rondonia, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal de Rondonia	Lailson-Brito, J (corresponding author), Univ Estado Rio De Janeiro, Fac Oceanog, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Rio De Janeiro, Brazil.	lailson@uerj.br	Almeida, ronaldo/AFN-6168-2022; Malm, Olaf/H-1724-2012; Bastos, Wanderley/AAQ-5875-2020; AZEVEDO, ALEXANDRE/HII-5648-2022; Bisi, Tatiana L/B-1330-2014; de Almeida, Ronaldo/K-7658-2012; Brito, Jose Lailson/B-3572-2013; Azevedo, Alexandre/B-9660-2013; Andrade, Leonardo/C-9554-2011; Dorneles, Paulo R/M-2049-2013; Bastos, Wanderley R/E-9856-2013	Almeida, ronaldo/0000-0001-5666-2909; Bisi, Tatiana L/0000-0003-3480-6697; Brito, Jose Lailson/0000-0001-8366-458X; Azevedo, Alexandre/0000-0002-3754-9035; Andrade, Leonardo/0000-0002-0004-5677; Malm, Olaf/0000-0002-4116-7160; Bastos, Wanderley/0000-0002-2105-9947; Dorneles, Paulo/0000-0003-0296-739X	Brazilian Research Council - CNPq [482938/2007-2]; Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program) [E-26/110.371/2007]; Ministry of Education of Brazil - CAPES (Ciencias do Mar) [09/2009]; Society for Marine Mammalogy; CAPES; FAPERJ/UERJ ("Prociencia'' Program); FAPERJ/UERJ (JCNE) [E- 26/103.247/2011]; CNPq [305303/2010-4, 304826/2008-1]; FAPERJ (JCNE) [101.449/2010]; FAPERJ (CNE)	Brazilian Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Education of Brazil - CAPES (Ciencias do Mar); Society for Marine Mammalogy; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ/UERJ ("Prociencia'' Program); FAPERJ/UERJ (JCNE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (JCNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ (CNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by Brazilian Research Council - CNPq (Edital Universal - grant #482938/2007-2), by Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program, grant #E-26/110.371/2007), by the Ministry of Education of Brazil - CAPES (Ciencias do Mar no 09/2009) and by Society for Marine Mammalogy. LB-J had a scholarship from CAPES and has a research grant from FAPERJ/UERJ ("Prociencia'' Program and JCNE # E- 26/103.247/2011) and from CNPq (grant # 305303/2010-4). AFA has a research grant from CNPq (grant # 304826/2008-1) and from FAPERJ (JCNE # 101.449/2010). OM has a research grant from CNPq and from FAPERJ (CNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE JM, 1990, MAR ENVIRON RES, V30, P43, DOI 10.1016/0141-1136(90)90010-L; [Anonymous], 2001, 1630 EPA; AUGIER H, 1993, CELL MOL BIOL, V39, P621; Azevedo A.F., 2004, J CETACEAN RES MANAG, V6, P265; Azevedo Alexandre F., 2009, Marine Biodiversity Records, V2, pe22, DOI 10.1017/S1755267208000262; Bennett PM, 2001, ENVIRON POLLUT, V112, P33, DOI 10.1016/S0269-7491(00)00105-6; Betti C, 1996, MAR POLLUT BULL, V32, P545, DOI 10.1016/0025-326X(96)84573-5; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BORN EW, 1981, ARCTIC, V34, P255; Cardellicchio N, 2002, ENVIRON POLLUT, V116, P265, DOI 10.1016/S0269-7491(01)00127-0; Caurant F, 1996, SCI TOTAL ENVIRON, V186, P95, DOI 10.1016/0048-9697(96)05087-5; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; Das K, 2003, N P TOX ENV, P135; DeGuise S, 1996, ENVIRON TOXICOL CHEM, V15, P1357, DOI 10.1002/etc.5620150815; DIETZ R, 1991, SARSIA, V76, P17, DOI 10.1080/00364827.1991.10413461; DIETZ R, 1990, SCI TOTAL ENVIRON, V95, P41, DOI 10.1016/0048-9697(90)90051-U; Dorneles PR, 2008, ENVIRON SCI TECHNOL, V42, P5368, DOI 10.1021/es800702k; Dorneles PR, 2010, ENVIRON INT, V36, P60, DOI 10.1016/j.envint.2009.10.001; Dorneles PR, 2008, ENVIRON POLLUT, V156, P1268, DOI 10.1016/j.envpol.2008.03.007; Dufresne MM, 2010, MAR POLLUT BULL, V60, P344, DOI 10.1016/j.marpolbul.2009.10.019; Flanagan PR, 1978, GASTROENTEROLOGY, P74; Flores PAC, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1188; Frouin H, 2012, AQUAT TOXICOL, V109, P185, DOI 10.1016/j.aquatox.2011.09.021; Habran S, 2011, ENVIRON POLLUT, V159, P2523, DOI 10.1016/j.envpol.2011.06.019; HONDA K, 1982, AGR BIOL CHEM TOKYO, V46, P3011, DOI 10.1080/00021369.1982.10865534; ITANO K, 1984, AGR BIOL CHEM TOKYO, V48, P1109, DOI 10.1080/00021369.1984.10866282; JICA, 1992, STUD REC GUAN BAY EC; JULSHAMN K, 1987, SCI TOTAL ENVIRON, V65, P53, DOI 10.1016/0048-9697(87)90160-4; Khan MAK, 2010, CHEM RES TOXICOL, V23, P1202, DOI 10.1021/tx100080s; KOEMAN J H, 1975, Science of the Total Environment, V3, P279, DOI 10.1016/0048-9697(75)90052-2; Koeman J. H., 1972, TNO-Nieuws, V27, P570; KOEMAN JH, 1973, NATURE, V245, P385, DOI 10.1038/245385a0; Kunito T, 2004, MAR POLLUT BULL, V49, P574, DOI 10.1016/j.marpolbul.2004.03.009; Lacerda L.D., 1983, TROPICAL ECOLOGY, V24, P162; Lacerda LD, 1994, BIBLIOGRAFIA CONTAMI; Lailson-Brito J, 2010, ENVIRON POLLUT, V158, P1800, DOI 10.1016/j.envpol.2009.11.002; Lemes M, 2011, ENVIRON TOXICOL CHEM, V30, P2732, DOI 10.1002/etc.684; LEONZIO C, 1992, SCI TOTAL ENVIRON, V119, P77, DOI 10.1016/0048-9697(92)90257-S; LIANG L, 1994, CLIN CHEM, V40, P602; Lockhart WL, 2005, SCI TOTAL ENVIRON, V351, P391, DOI 10.1016/j.scitotenv.2005.01.050; Marins RV, 2004, QUIM NOVA, V27, P763, DOI 10.1590/S0100-40422004000500016; MARTOJA R, 1977, CR ACAD SCI D NAT, V285, P109; Martoja R., 1980, VIE MILIEU LIFE ENV, V30, P7; Mason A. Z., 1995, METAL SPECIATION BIO, P479; Monteiro-Neto C, 2003, ENVIRON POLLUT, V123, P319, DOI 10.1016/S0269-7491(02)00371-8; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; O'Shea Thomas J., 1999, P485; PALMISANO F, 1995, MAR ENVIRON RES, V40, P109, DOI 10.1016/0141-1136(94)00142-C; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Pfeiffer WC, 1987, HEAVY METALS POLLUTI; RAWSON AJ, 1993, ECOTOX ENVIRON SAFE, V25, P41, DOI 10.1006/eesa.1993.1005; RAWSON AJ, 1995, ECOTOX ENVIRON SAFE, V30, P309, DOI 10.1006/eesa.1995.1035; REBELLO A D L, 1988, Anais da Academia Brasileira de Ciencias, V60, P419; Renzoni A, 1998, ENVIRON RES, V77, P68, DOI 10.1006/enrs.1998.3832; RONALD K, 1977, Science of the Total Environment, V8, P1, DOI 10.1016/0048-9697(77)90057-2; Seixas TG, 2006, J BRAZILIAN SOC ECOT, V1, P21; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Taylor VF, 2011, ANAL METHODS-UK, V3, P1143, DOI 10.1039/c0ay00528b; UTHE JF, 1972, J ASSOC OFF ANA CHEM, V55, P583; VANDEVEN WSM, 1979, CHEMOSPHERE, V8, P539, DOI 10.1016/0045-6535(79)90101-2; Wagemann R, 2000, SCI TOTAL ENVIRON, V261, P21, DOI 10.1016/S0048-9697(00)00592-1; Wagemann R, 1998, SCI TOTAL ENVIRON, V218, P19, DOI 10.1016/S0048-9697(98)00192-2; Wagemann R, 1996, SCI TOTAL ENVIRON, V186, P41, DOI 10.1016/0048-9697(96)05085-1; WAGEMANN R, 1988, MAR MAMMAL SCI, V4, P339, DOI 10.1111/j.1748-7692.1988.tb00542.x; Wagemann R, 1997, ENVIRON TOXICOL CHEM, V16, P1859, DOI 10.1002/etc.5620160914; Wagemann R., 1984, CAN TECH REP FISH AQ, V1279, P1	67	74	76	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42162	10.1371/journal.pone.0042162	http://dx.doi.org/10.1371/journal.pone.0042162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860072	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600065
J	Laksanalamai, P; Joseph, LA; Silk, BJ; Burall, LS; Tarr, CL; Gerner-Smidt, P; Datta, AR				Laksanalamai, Pongpan; Joseph, Lavin A.; Silk, Benjamin J.; Burall, Laurel S.; Tarr, Cheryl L.; Gerner-Smidt, Peter; Datta, Atin R.			Genomic Characterization of Listeria monocytogenes Strains Involved in a Multistate Listeriosis Outbreak Associated with Cantaloupe in US	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; UNITED-STATES; ESCHERICHIA-COLI; PULSENET; MEAT; DIVERSITY; ENVIRONMENT; EVOLUTION; INFECTION; PROTOCOL	A multistate listeriosis outbreak associated with cantaloupe consumption was reported in the United States in September, 2011. The outbreak investigation recorded a total of 146 invasive illnesses, 30 deaths and one miscarriage. Subtyping of the outbreak associated clinical, food and environmental isolates revealed two serotypes (1/2a and 1/2b) and four pulsed-field gel electrophoresis two-enzyme pattern combinations I, II, III, and IV, including one rarely seen before this outbreak. A DNA-microarray, Listeria GeneChip (R), developed by FDA from 24 Listeria monocytogenes genome sequences, was used to further characterize a representative sample of the outbreak isolates. The microarray data ( in the form of present or absent calls of specific DNA sequences) separated the isolates into two distinct groups as per their serotypes. The gene content of the outbreak-associated isolates was distinct from that of the previously-reported outbreak strains belonging to the same serotypes. Although the 1/2b outbreak associated isolates are closely related to each other, the 1/2a isolates could be further divided into two distinct genomic groups, one represented by pattern combination I strains and the other represented by highly similar pattern combinations III and IV strains. Gene content analysis of these groups revealed unique genomic sequences associated with these two 1/2a genovars. This work underscores the utility of multiple approaches, such as serotyping, PFGE and DNA microarray analysis to characterize the composition of complex polyclonal listeriosis outbreaks.	[Laksanalamai, Pongpan; Burall, Laurel S.; Datta, Atin R.] FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Joseph, Lavin A.; Silk, Benjamin J.; Tarr, Cheryl L.; Gerner-Smidt, Peter] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Laksanalamai, P (corresponding author), FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA.	Atin.datta@fda.hhs.gov						Abu-Ali GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-296; Affymetrix, 2005, AFF GENECHIP EXPR AN; Affymetrix, 2002, STAT ALG DESCR DOC; [Anonymous], 2011, INFORM RECALLED JENS; [Anonymous], 2011, LISTERIOSIS LISTERIA; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruno JC, 2011, FEMS MICROBIOL LETT, V323, P171, DOI 10.1111/j.1574-6968.2011.02373.x; Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Cheng Ying, 2008, P337, DOI 10.1201/9781420051414.ch11; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Datta A. R., 2003, International handbook of foodborne pathogens, P105; FLEMING DW, 1985, NEW ENGL J MED, V312, P404, DOI 10.1056/NEJM198502143120704; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8; Halpin JL, 2010, FOODBORNE PATHOG DIS, V7, P293, DOI 10.1089/fpd.2009.0394; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iturriaga MH, 2002, J FOOD PROTECT, V65, P1745, DOI 10.4315/0362-028X-65.11.1745; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Kathariou S, 2006, FOODBORNE PATHOG DIS, V3, P292, DOI 10.1089/fpd.2006.3.292; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032896; Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mellin JR, 2012, RNA BIOL, V9, P372, DOI 10.4161/rna.19235; Norton D. M., 2007, LISTERIA LISTERIOSIS, P305; O'Connor L, 2010, LETT APPL MICROBIOL, V51, P490, DOI 10.1111/j.1472-765X.2010.02928.x; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Reina LD, 2002, J FOOD PROTECT, V65, P1881, DOI 10.4315/0362-028X-65.12.1881; Revazishvili T, 2004, J CLIN MICROBIOL, V42, P276, DOI 10.1128/JCM.42.1.276-285.2004; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schuppler M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/704321; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Voidarou C, 2011, ANAEROBE, V17, P341, DOI 10.1016/j.anaerobe.2011.05.018; Wagner Martin, 2008, P3, DOI 10.1201/9781420051414.ch1	48	95	98	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42448	10.1371/journal.pone.0042448	http://dx.doi.org/10.1371/journal.pone.0042448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860127	Green Submitted, Green Published, gold			2022-12-25	WOS:000307045600101
J	Miralles, M; Segura, MM; Puig, M; Bosch, A; Chillon, M				Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel			Efficient Amplification of Chimeric Adenovirus 5/40S Vectors Carrying the Short Fiber Protein of Ad40 in Suspension Cell Cultures	PLOS ONE			English	Article							GENE-TRANSFER; ENTERIC ADENOVIRUS-40; IN-VITRO; TYPE-40; TRANSDUCTION; RECEPTOR; POLYCATIONS; TROPISM; GROWTH; VIRUS	The human adenovirus 40 (Ad40) is a promising tool for gene therapy of intestinal diseases. Since the production of Ad40 in vitro is extremely inefficient, chimeric Adenovirus 5/40S vectors carrying the Ad40 short fiber on the Ad5 capsid have been developed. However, Ad5/40S productivity is low. We hypothesized that low productivity was a result of inefficient viral entry into producer cells during amplification. To this end, we have developed a production strategy based on using 211B cells (expressing Ad5 fiber) during amplification steps, while Ad5/40S infectivity is further improved by adding polybrene during infections. In addition, the optimal harvesting time was determined by evaluating the Ad5/40S viral cycle. The developed production strategy significantly reduces the number of amplification cycles and duration of the process. Finally, to further facilitate Ad5/40S production, 211B cells were adapted to suspension thus allowing to easily upscale the production process in bioreactors.	[Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain; [Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Miralles, M (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain.	miguel.chillon@uab.es	Bosch, Assumpcio/C-7593-2015; Chillon, Miguel/A-2466-2009	Bosch, Assumpcio/0000-0002-7205-2796; Chillon, Miguel/0000-0003-0840-2111	Association Francaise contre les Myopathies (AFM) [12277]; FPU fellowship from Ministerio de Educacion de Espana [AP2007-01563];  [ISCIII-PI081162];  [ISCIII-PI10-00561];  [SGR2009-1300]; ICREA Funding Source: Custom	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FPU fellowship from Ministerio de Educacion de Espana; ; ; ; ICREA(ICREA)	This work was supported by ISCIII-PI081162 and ISCIII-PI10-00561, SGR2009-1300 and Association Francaise contre les Myopathies (AFM#12277). M. M. is a recipient of an FPU fellowship from the Ministerio de Educacion de Espana (AP2007-01563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2007, VIROLOGY, V367, P51, DOI 10.1016/j.virol.2007.05.014; Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BROWN M, 1984, J CLIN MICROBIOL, V20, P334, DOI 10.1128/JCM.20.3.334-338.1984; BROWN M, 1992, J VIROL, V66, P3198, DOI 10.1128/JVI.66.5.3198-3205.1992; Chillon M, 2011, METHODS MOL BIOL, V737, P117, DOI 10.1007/978-1-61779-095-9_5; Clark PR, 1999, CANCER GENE THER, V6, P437, DOI 10.1038/sj.cgt.7700074; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Doronin K, 2003, VIROLOGY, V305, P378, DOI 10.1006/viro.2002.1772; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Geisse S, 2005, ANIMAL CELL TECHNOLOGY MEETS GENOMICS, P373; HASHIMOTO S, 1991, J VIROL, V65, P2429, DOI 10.1128/JVI.65.5.2429-2435.1991; Jacobsen F, 2006, J GENE MED, V8, P138, DOI 10.1002/jgm.843; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Kaplan JM, 1998, HUM GENE THER, V9, P1469, DOI 10.1089/hum.1998.9.10-1469; Kesisoglou F, 2005, MOL PHARMACEUT, V2, P500, DOI 10.1021/mp0498897; KIDD AH, 1993, VIROLOGY, V192, P73, DOI 10.1006/viro.1993.1009; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Lu ZZ, 2009, J GENE MED, V11, P128, DOI 10.1002/jgm.1284; Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Rodriguez E, 2006, MOL THER, V13, pS5, DOI 10.1016/j.ymthe.2006.08.023; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07; Schoggins JW, 2005, J VIROL, V79, P11627, DOI 10.1128/JVI.79.18.11627-11637.2005; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Seiradake E, 2005, J VIROL, V79, P14088, DOI 10.1128/JVI.79.22.14088-14094.2005; Sherwood V, 2007, J GEN VIROL, V88, P71, DOI 10.1099/vir.0.82445-0; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; TIEMESSEN CT, 1995, J GEN VIROL, V76, P481, DOI 10.1099/0022-1317-76-3-481; TIEMESSEN CT, 1994, J VIROL, V68, P1239, DOI 10.1128/JVI.68.2.1239-1244.1994; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Von Seggern DJ, 1998, J GEN VIROL, V79, P1461, DOI 10.1099/0022-1317-79-6-1461; Von Seggern DJ, 2000, J VIROL, V74, P354, DOI 10.1128/JVI.74.1.354-362.2000; Wang C, 2008, EXPERT OPIN DRUG DEL, V5, P385, DOI 10.1517/17425247.5.4.385 ; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zabner J, 1999, J VIROL, V73, P8689, DOI 10.1128/JVI.73.10.8689-8695.1999	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42073	10.1371/journal.pone.0042073	http://dx.doi.org/10.1371/journal.pone.0042073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860056	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600058
J	Cameron, TA; Roper, M; Zambryski, PC				Cameron, Todd A.; Roper, Marcus; Zambryski, Patricia C.			Quantitative Image Analysis and Modeling Indicate the Agrobacterium tumefaciens Type IV Secretion System Is Organized in a Periodic Pattern of Foci	PLOS ONE			English	Article							PROTEIN TRANSLOCATION; DNA TRANSFER; MEMBRANE; FILAMENTS; GROWTH; IDENTIFICATION; MORPHOGENESIS; LOCALIZATION; DIVERSITY; SEQUENCE	The Gram negative plant pathogen Agrobacterium tumefaciens is uniquely capable of genetically transforming eukaryotic host cells during the infection process. DNA and protein substrates are transferred into plant cells via a type IV secretion system (T4SS), which forms large cell-envelope spanning complexes at multiple sites around the bacterial circumference. To gain a detailed understanding of T4SS positioning, the spatial distribution of fluorescently labeled T4SS components was quantitatively assessed to distinguish between random and structured localization processes. Through deconvolution microscopy followed by Fourier analysis and modeling, T4SS foci were found to localize in a non-random periodic pattern. These results indicate that T4SS complexes are dependent on an underlying scaffold or assembly process to obtain an organized distribution suitable for effective delivery of substrates into host cells.	[Cameron, Todd A.; Zambryski, Patricia C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Roper, Marcus] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Cameron, TA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	zambrysk@berkeley.edu		Roper, Marcus/0000-0001-8756-0112; Cameron, Todd/0000-0002-6608-6551	NSF [MCB-0343566]; Miller Institute for Basic Research in Sciences; Div Of Molecular and Cellular Bioscience [0923840] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Sciences; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	TC and PZ were supported by NSF (http://www.nsf.gov) grant MCB-0343566. MR was supported by a fellowship from the Miller Institute for Basic Research in Sciences (http://millerinstitute.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AKIYOSHI DE, 1983, P NATL ACAD SCI-BIOL, V80, P407, DOI 10.1073/pnas.80.2.407; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Brown PJB, 2011, SEMIN CELL DEV BIOL, V22, P790, DOI 10.1016/j.semcdb.2011.06.006; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Chandran V, 2009, NATURE; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Foulquier E, 2011, MOL MICROBIOL, V80, P309, DOI 10.1111/j.1365-2958.2011.07587.x; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Perez-Nunez D, 2011, MOL MICROBIOL, V79, P759, DOI 10.1111/j.1365-2958.2010.07483.x; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Rasband W., 2006, IMAGEJ; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; STACHEL SE, 1986, P NATL ACAD SCI USA, V83, P379, DOI 10.1073/pnas.83.2.379; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; THOMASHOW MF, 1986, SCIENCE, V231, P616, DOI 10.1126/science.3511528; THOMPSON J, 1992, RES MICROBIOL, V143, P127, DOI 10.1016/0923-2508(92)90001-5; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; VERNADE D, 1988, J BACTERIOL, V170, P5822, DOI 10.1128/jb.170.12.5822-5829.1988; Wang S, 2012, P NATL ACAD SCI USA, V109, pE595, DOI 10.1073/pnas.1117132109; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	50	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42219	10.1371/journal.pone.0042219	http://dx.doi.org/10.1371/journal.pone.0042219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860087	gold, Green Published, Green Submitted			2022-12-25	WOS:000306950900079
J	Johannesson, TG; Sogaard, OS; Tolstrup, M; Petersen, MS; Bernth-Jensen, JM; Ostergaard, L; Erikstrup, C				Johannesson, Thomas G.; Sogaard, Ole S.; Tolstrup, Martin; Petersen, Mikkel S.; Bernth-Jensen, Jens M.; Ostergaard, Lars; Erikstrup, Christian			The Impact of B-Cell Perturbations on Pneumococcal Conjugate Vaccine Response in HIV-Infected Adults	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; STREPTOCOCCUS-PNEUMONIAE; RISK-FACTORS; DISEASE; MEMORY; IMMUNODEFICIENCY; INDIVIDUALS; ANTIBODIES; COHORT; ASSAYS	Untreated HIV infection results in severe perturbations of the B-cell population and hyporesponsiveness to vaccination. We studied associations between circulating B-cell subsets and antibody response to pneumococcal conjugate vaccine in treated and untreated HIV patients. Ninety-five HIV-infected adults were grouped according to antiretroviral therapy (ART) and CD4+ cell count as follows: 20 ART-naive (no prior ART), 62 ART-responders (received ART, and CD4 count >500 cells/mu l), and 13 impaired responders (received ART for more than 3 years, and CD4 count <500 cells/mu l). All subjects were immunized twice with double-dose 7-valent pneumococcal conjugate vaccine with or without 1 mg CPG 7909 (toll-like receptor 9 agonist) at baseline and after three months. Pre-vaccination B-cell subpopulations were assessed by flow cytometry. Serum IgG concentrations for vaccine serotypes were quantified by ELISA at baseline and 3, 4, and 9 months post-vaccination. ART responders had more isotype-switched memory B cells and more marginal-zone (MZ)-like B cells compared with impaired responders. Furthermore, ART-naive patients had higher concentration of transitional B cells and plasmablasts compared with B cells of other patient groups. The concentration of MZ-like, isotype switched memory cells and plasmablasts correlated positively with post-vaccination IgG concentration at 3, 4, and 9 months. Low concentrations of isotype-switched memory B cells was the strongest independent predictor of poor pneumococcal conjugate vaccine responsiveness, emphasizing that B-cell subset disturbances are associated with poor vaccine response among HIV-infected patients	[Johannesson, Thomas G.; Sogaard, Ole S.; Tolstrup, Martin; Ostergaard, Lars] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Johannesson, Thomas G.; Petersen, Mikkel S.; Bernth-Jensen, Jens M.; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Johannesson, TG (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.	tgjohannesson@gmail.com	Ostergaard, Lars/AAA-3020-2020; Hjelholt, Thomas/AAL-2056-2021; Søgaard, Ole S/P-6058-2016; Hjelholt, Thomas Johannesson/AAQ-3614-2020; Bernth-Jensen, Jens Magnus/H-6694-2019; Søgaard, Ole Schmeltz/AEP-7968-2022	Ostergaard, Lars/0000-0003-2459-0511; Hjelholt, Thomas/0000-0003-0112-5801; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Tolstrup, Martin/0000-0001-7020-5173; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Erikstrup, Christian/0000-0001-6551-6647; Ostergaard, Lars/0000-0002-7619-605X	Aarhus University; Danish Council for Independent Research \ Medical Sciences; Scandinavian Society for Antimicrobial Chemotherapy; Aase and Ejnar Danielsen's Foundation	Aarhus University; Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF)); Scandinavian Society for Antimicrobial Chemotherapy; Aase and Ejnar Danielsen's Foundation	Grant support was provided by Aarhus University, The Danish Council for Independent Research vertical bar Medical Sciences, Scandinavian Society for Antimicrobial Chemotherapy, and Aase and Ejnar Danielsen's Foundation. Coley Pharmaceutical Group (now part of Pfizer) provided CPG 7909 for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry PM, 2006, AIDS, V20, P437, DOI 10.1097/01.aids.0000206507.54901.84; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Crum-Cianflone NF, 2010, J INFECT DIS, V202, P1114, DOI 10.1086/656147; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Fournier AM, 2002, AIDS, V16, P1755, DOI 10.1097/00002030-200209060-00007; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Madhi SA, 2009, J INFECT DIS, V199, P1168, DOI 10.1086/597388; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Martinez JE, 2006, CLIN VACCINE IMMUNOL, V13, P459, DOI 10.1128/CVI.13.4.459-466.2006; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Rabian C, 2010, CLIN INFECT DIS, V50, P1174, DOI 10.1086/651418; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Shen X, 2010, CURR HIV AIDS REP; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sogaard OS, 2010, AIDS, V24, P1315, DOI 10.1097/QAD.0b013e328339fe0b; Subramaniam KS, 2003, J INFECT DIS, V187, P758, DOI 10.1086/368331; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42307	10.1371/journal.pone.0042307	http://dx.doi.org/10.1371/journal.pone.0042307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860110	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950900088
J	Zeng, XY; Wang, YP; Cantley, J; Iseli, TJ; Molero, JC; Hegarty, BD; Kraegen, EW; Ye, Y; Ye, JM				Zeng, Xiao-Yi; Wang, Yi-Ping; Cantley, James; Iseli, Tristan J.; Molero, Juan Carlos; Hegarty, Bronwyn D.; Kraegen, Edward W.; Ye, Yang; Ye, Ji-Ming			Oleanolic Acid Reduces Hyperglycemia beyond Treatment Period with Akt/FoxO1-Induced Suppression of Hepatic Gluconeogenesis in Type-2 Diabetic Mice	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; FAT-FED RATS; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; SMALL-MOLECULE; URSOLIC ACID; BETA-CELLS; OBESITY; DIET	The present study investigated the chronic efficacy of oleanolic acid (OA), a triterpenoid selected from our recent screening, on hyperglycemia in type-2 diabetic mice. C57BL/6J mice were fed a high-fat diet followed by low doses of streptozotocin to generate a type-2 diabetic model. OA (100 mg/kg/day) was administered orally for 2 weeks with its effects monitored for 6 weeks. High-fat feeding and streptozotocin generated a steady hyperglycemia (21.2 +/- 1.1 mM) but OA administration reversed the hyperglycemia by similar to 60%. Interestingly, after the cessation of OA administration, the reversed hyperglycemia was sustained for the entire post-treatment period of the study (4 weeks) despite the reoccurrence of dyslipidemia. Examination of insulin secretion and pancreas morphology did not indicate improved beta-cell function as a likely mechanism. Urine glucose loss was decreased with substantial improvement of diabetic nephropathy after the OA treatment. Pair-feeding the OA-treated mice to an untreated group ruled out food intake as a main factor attributable for this sustained reduction in hyperglycemia. Studies with the use of glucose tracers revealed no increase in glucose influx into muscle, adipose tissue or liver in the OA-treated mice. Finally, we analyzed key regulators of gluconeogenesis in the liver and found significant increases in the phosphorylation of both Akt and FoxO1 after treatment with OA. Importantly, these increases were significantly correlated with a down-regulation of glucose-6-phosphatase expression. Our findings suggest triterpenoids are a potential source of new efficacious drugs for sustained control of hyperglycemia. The liver appears to be a major site of action, possibly by the suppression of hepatic glucose production via the Akt/FoxO1 axis.	[Zeng, Xiao-Yi; Wang, Yi-Ping; Molero, Juan Carlos; Ye, Ji-Ming] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Zeng, Xiao-Yi; Wang, Yi-Ping; Molero, Juan Carlos; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Cantley, James; Iseli, Tristan J.; Hegarty, Bronwyn D.; Kraegen, Edward W.; Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia; [Ye, Yang; Ye, Ji-Ming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Garvan Institute of Medical Research; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zeng, XY (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au		Zeng, Xiaoyi/0000-0002-0102-0367; Cantley, James/0000-0003-2509-1271	National Health and Medical Research Council [NHMRC Project Grant] [535930]; International Scientific Linkage Program Grant of Australia [CH 080212]	National Health and Medical Research Council [NHMRC Project Grant]; International Scientific Linkage Program Grant of Australia	This work was supported by the National Health and Medical Research Council [NHMRC Project Grant 535930 to JMY and YY] and the International Scientific Linkage Program Grant [CH 080212 to YJM and EWK] of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chalkley SM, 2002, AM J PHYSIOL-ENDOC M, V282, pE1231, DOI 10.1152/ajpendo.00173.2001; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Cleasby ME, 2004, DIABETES, V53, P3258, DOI 10.2337/diabetes.53.12.3258; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Huang THW, 2005, BRIT J PHARMACOL, V145, P767, DOI 10.1038/sj.bjp.0706245; Ji HY, 2009, ARCH PHARM RES, V32, P251, DOI 10.1007/s12272-009-1230-1; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nataraju A, 2009, TRANSPLANTATION, V88, P987, DOI 10.1097/TP.0b013e3181b9cbc4; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Teodoro T, 2008, FEBS LETT, V582, P1375, DOI 10.1016/j.febslet.2008.03.026; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Wang ZH, 2010, EUR J PHARMACOL, V628, P255, DOI 10.1016/j.ejphar.2009.11.019; World Health Organization, 2011, DIAB FACT SHEET; Ye JM, 2011, BRIT J PHARMACOL, V163, P556, DOI 10.1111/j.1476-5381.2011.01240.x; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	43	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42115	10.1371/journal.pone.0042115	http://dx.doi.org/10.1371/journal.pone.0042115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860063	gold, Green Published, Green Submitted			2022-12-25	WOS:000306950900069
J	Ross, CL; Liang, XW; Liu, Q; Murray, BE; Hook, M; Ganesh, VK				Ross, Cana L.; Liang, Xiaowen; Liu, Qing; Murray, Barbara E.; Hoeoek, Magnus; Ganesh, Vannakambadi K.			Targeted Protein Engineering Provides Insights into Binding Mechanism and Affinities of Bacterial Collagen Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; BIOCHEMICAL-CHARACTERIZATION; SURFACE-PROTEINS; VIRULENCE FACTOR; IV COLLAGENS; HUG MODEL; CELL-WALL; MSCRAMM; ACE	The collagen-binding bacterial proteins, Ace and Cna, are well characterized on the biochemical and structural level. Despite overall structural similarity, recombinant forms of the Ace and Cna ligand-binding domains exhibit significantly different affinities and binding kinetics for collagen type I (CI) in vitro. In this study, we sought to understand, in submolecular detail, the bases for these differences. Using a structure-based approach, we engineered Cna and Ace variants by altering specific structural elements within the ligand-binding domains. Surface plasmon resonance-based binding analysis demonstrated that mutations that are predicted to alter the orientation of the Ace and Cna N-1 and N-2 subdomains significantly affect the interaction between the MSCRAMM (microbial surface components recognizing adhesive matrix molecule) and CI in vitro, including affinity, association/dissociation rates and binding ratio. Moreover, we utilized this information to engineer an Ace variant with an 11,000-fold higher CI affinity than the parent protein. Finally, we noted that several engineered proteins that exhibited a weak interaction with CI recognized more sites on CI, suggesting an inverse correlation between affinity and specificity.	[Ross, Cana L.; Liang, Xiaowen; Liu, Qing; Hoeoek, Magnus; Ganesh, Vannakambadi K.] Texas A&M Hlth Sci Ctr, Ctr Inflammatory & Infect Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Murray, Barbara E.] Univ Texas Med Sch, Div Infect Dis, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Ganesh, VK (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Inflammatory & Infect Dis, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	vganesh@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951	National Institutes of Health from the NIAID [R01AI047923]; American Heart Association [10POST4160090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047923] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI047923 from the NIAID (to B. E. M. and M. H.). This work was also supported by American Heart Association Fellowship 10POST4160090 (to C. L. R.). A patent (pending) application has been filed based on some results in the manuscript.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Biacore Life Sciences, 2004, BIAEVALUATION SOFTW; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Mamo W, 2000, MICROBIOL IMMUNOL, V44, P381, DOI 10.1111/j.1348-0421.2000.tb02509.x; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Sato Y, 2004, J DENT RES, V83, P534, DOI 10.1177/154405910408300705; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Xu Y, 2004, J BIOL CHEM, V279, P51760, DOI 10.1074/jbc.M406417200; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	34	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34856	34865		10.1074/jbc.M112.371054	http://dx.doi.org/10.1074/jbc.M112.371054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865854	Green Published, hybrid			2022-12-25	WOS:000309654200084
J	Currier, RB; Calvete, JJ; Sanz, L; Harrison, RA; Rowley, PD; Wagstaff, SC				Currier, Rachel B.; Calvete, Juan J.; Sanz, Libia; Harrison, Robert A.; Rowley, Paul D.; Wagstaff, Simon C.			Unusual Stability of Messenger RNA in Snake Venom Reveals Gene Expression Dynamics of Venom Replenishment	PLOS ONE			English	Article							VIPERA-PALAESTINAE; BOMBINA-ORIENTALIS; MOLECULAR-CLONING; PRECURSOR CDNAS; GLAND; PROTEINS; ENZYMES; TOAD; IDENTIFICATION; EUKARYOTES	Venom is a critical evolutionary innovation enabling venomous snakes to become successful limbless predators; it is therefore vital that venomous snakes possess a highly efficient venom production and delivery system to maintain their predatory arsenal. Here, we exploit the unusual stability of messenger RNA in venom to conduct, for the first time, quantitative PCR to characterise the dynamics of gene expression of newly synthesised venom proteins following venom depletion. Quantitative PCR directly from venom enables real-time dynamic studies of gene expression in the same animals because it circumvents the conventional requirement to sacrifice snakes to extract mRNA from dissected venom glands. Using qPCR and proteomic analysis, we show that gene expression and protein re-synthesis triggered by venom expulsion peaks between days 3-7 of the cycle of venom replenishment, with different protein families expressed in parallel. We demonstrate that venom re-synthesis occurs very rapidly following depletion of venom stores, presumably to ensure venomous snakes retain their ability to efficiently predate and remain defended from predators. The stability of mRNA in venom is biologically fascinating, and could significantly empower venom research by expanding opportunities to produce transcriptomes from historical venom stocks and rare or endangered venomous species, for new therapeutic, diagnostic and evolutionary studies.	[Currier, Rachel B.; Harrison, Robert A.; Rowley, Paul D.; Wagstaff, Simon C.] Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool, Merseyside, England; [Calvete, Juan J.; Sanz, Libia] Inst Biomed Valencia, Lab Prot Estruct, Valencia, Spain	Liverpool School of Tropical Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Currier, RB (corresponding author), Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool, Merseyside, England.	r.harrison@liverpool.ac.uk	Calvete, Juan/P-2555-2019; Calvete, Juan J/K-9619-2014	Calvete, Juan/0000-0001-5026-3122; Calvete, Juan J/0000-0001-5026-3122; Wagstaff, Simon/0000-0003-0577-5537; Currier, Rachel/0000-0002-0381-3029; Sanz, Libia/0000-0003-4991-9598	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F012675/1]; Biotechnology and Biological Sciences Research Council [BB/F012675/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship awarded to RB Currier and BBSRC research grant awarded to Dr. RA Harrison and Dr. SC Wagstaff (BB/F012675/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BROWN RS, 1975, AM J PHYSIOL, V229, P1675, DOI 10.1152/ajplegacy.1975.229.6.1675; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvete JJ, 2011, EXPERT REV PROTEOMIC, V8, P739, DOI [10.1586/EPR.11.61, 10.1586/epr.11.61]; Carneiro SM, 2007, TOXICON, V49, P106, DOI 10.1016/j.toxicon.2006.04.020; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Casewell NR, 2011, MOL BIOL EVOL, V28, P1157, DOI 10.1093/molbev/msq302; Chen TB, 2006, TOXICON, V47, P288, DOI 10.1016/j.toxicon.2005.11.004; Chen TB, 2005, PEPTIDES, V26, P377, DOI 10.1016/j.peptides.2004.10.021; Chen TB, 2003, REGUL PEPTIDES, V115, P115, DOI 10.1016/S0167-0115(03)00146-0; Chen TB, 2003, PEPTIDES, V24, P873, DOI 10.1016/S0196-9781(03)00165-7; Chen TB, 2003, PEPTIDES, V24, P853, DOI 10.1016/S0196-9781(03)00167-0; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Currier RB, 2010, TOXICON, V55, P864, DOI 10.1016/j.toxicon.2009.12.009; Dhananjaya BL, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1, DOI 10.1134/S0006297910010013; Fasoli E, 2010, J PROTEOMICS, V73, P932, DOI 10.1016/j.jprot.2009.12.006; FRANCIS B, 1992, TOXICON, V30, P1239, DOI 10.1016/0041-0101(92)90440-G; FREITAS MA, 1992, TOXICON, V30, P461, DOI 10.1016/0041-0101(92)90542-D; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; IBM, 2009, PAWS STAT COMM SYNT; Juaez P, 2006, J MOL EVOL, V63, P142, DOI 10.1007/s00239-005-0268-z; Kordis D, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P401; MACKESSY SP, 1991, J MORPHOL, V208, P109, DOI 10.1002/jmor.1052080106; Mackessy SP, 2006, ZOOL ANZ, V245, P147, DOI 10.1016/j.jcz.2006.01.003; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Odell GV, 1998, TOXICON, V36, P1801, DOI 10.1016/S0041-0101(98)00084-1; ORON U, 1973, J CELL BIOL, V56, P177, DOI 10.1083/jcb.56.1.177; ORON U, 1978, BIOCHEM J, V174, P733, DOI 10.1042/bj1740733; ORON U, 1978, J CELL BIOL, V78, P488, DOI 10.1083/jcb.78.2.488; PAINE MJI, 1992, TOXICON, V30, P379, DOI 10.1016/0041-0101(92)90534-C; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sousa JRF, 2001, TOXICON, V39, P787, DOI 10.1016/S0041-0101(00)00208-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VILJOEN CC, 1979, TOXICON, V17, P77, DOI 10.1016/0041-0101(79)90258-7; Wagstaff SC, 2008, BIOCHEM BIOPH RES CO, V365, P650, DOI 10.1016/j.bbrc.2007.11.027; Wagstaff SC, 2006, GENE, V377, P21, DOI 10.1016/j.gene.2006.03.008	39	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41888	10.1371/journal.pone.0041888	http://dx.doi.org/10.1371/journal.pone.0041888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879897	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000307437900014
J	Natarajan, K; Senapati, S				Natarajan, Kathiresan; Senapati, Sanjib			Understanding the Basis of Drug Resistance of the Mutants of alpha beta-Tubulin Dimer via Molecular Dynamics Simulations	PLOS ONE			English	Article							COMMON PHARMACOPHORE; FREE-ENERGIES; EPOTHILONE; MUTATIONS; BINDING; TAXOL; MECHANISMS; STABILITY; TAXANES; TARGET	The vital role of tubulin dimer in cell division makes it an attractive drug target. Drugs that target tubulin showed significant clinical success in treating various cancers. However, the efficacy of these drugs is attenuated by the emergence of tubulin mutants that are unsusceptible to several classes of tubulin binding drugs. The molecular basis of drug resistance of the tubulin mutants is yet to be unraveled. Here, we employ molecular dynamics simulations, protein-ligand docking, and MMPB(GB) SA analyses to examine the binding of anticancer drugs, taxol and epothilone to the reported point mutants of tubulin - T274I, R282Q, and Q292E. Results suggest that the mutations significantly alter the tubulin structure and dynamics, thereby weaken the interactions and binding of the drugs, primarily by modifying the M loop conformation and enlarging the pocket volume. Interestingly, these mutations also affect the tubulin distal sites that are associated with microtubule building processes.	[Natarajan, Kathiresan; Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Natarajan, K (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	sanjibs@iitm.ac.in	Natarajan, Dr.Kathiresan/GRX-7735-2022; Natarajan, Kathiresan/D-8656-2014	Natarajan, Kathiresan/0000-0003-2255-5966	Council of Scientific and Industrial Research (CSIR), Govt. of India; CSIR	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Council of Scientific and Industrial Research (CSIR), Govt. of India. KN acknowledges CSIR for the research fellowship. The computer resources of Computer Centre, IIT Madras are gratefully acknowledged. The funders had no role in study, design, data collection, and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1996, INS 2; BOLLAG DM, 1995, CANCER RES, V55, P2325; Case D.A., 2022, AMBER 2020; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forli S, 2010, CHEMMEDCHEM, V5, P35, DOI 10.1002/cmdc.200900303; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Goodin S, 2004, J CLIN ONCOL, V22, P2015, DOI 10.1200/JCO.2004.12.001; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hasegawa S, 2002, INT J CANCER, V101, P46, DOI 10.1002/ijc.10575; He LF, 2000, BIOCHEMISTRY-US, V39, P3972, DOI 10.1021/bi992518p; He LF, 2001, MOL CANCER THER, V1, P3; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kingston DGI, 2005, CELL CYCLE, V4, P279, DOI 10.4161/cc.4.2.1408; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kowalski J, 1997, TAXOL R, V272, P2534; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li YK, 2000, BIOCHEMISTRY-US, V39, P616, DOI 10.1021/bi992044u; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Perakyla M, 2001, PROTEIN ENG, V14, P753, DOI 10.1093/protein/14.10.753; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264; Yang CPH, 2005, MOL CANCER THER, V4, P987, DOI 10.1158/1535-7163.MCT-05-0024	43	32	32	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42351	10.1371/journal.pone.0042351	http://dx.doi.org/10.1371/journal.pone.0042351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879949	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900032
J	Fink, AE; Bender, KJ; Trussell, LO; Otis, TS; DiGregorio, DA				Fink, Ann E.; Bender, Kevin J.; Trussell, Laurence O.; Otis, Thomas S.; DiGregorio, David A.			Two-Photon Compatibility and Single-Voxel, Single-Trial Detection of Subthreshold Neuronal Activity by a Two-Component Optical Voltage Sensor	PLOS ONE			English	Article							MEMBRANE-POTENTIAL CHANGES; GABA(A) RECEPTOR FUNCTION; RESONANCE ENERGY-TRANSFER; SENSITIVE DYES; CEREBELLAR SYNAPSE; DENDRITIC SPINES; PYRAMIDAL NEURONS; IN-SITU; CELLS; EXCITATION	Minimally invasive measurements of neuronal activity are essential for understanding how signal processing is performed by neuronal networks. While optical strategies for making such measurements hold great promise, optical sensors generally lack the speed and sensitivity necessary to record neuronal activity on a single-trial, single-neuron basis. Here we present additional biophysical characterization and practical improvements of a two-component optical voltage sensor (2cVoS), comprised of the neuronal tracer dye, DiO, and dipicrylamine (DiO/DPA). Using laser spot illumination we demonstrate that membrane potential-dependent fluorescence changes can be obtained in a wide variety of cell types within brain slices. We show a correlation between membrane labeling and the sensitivity of the magnitude of fluorescence signal, such that neurons with the brightest membrane labeling yield the largest Delta F/F values per action potential (AP; similar to 40%). By substituting a blue-shifted donor for DiO we confirm that DiO/DPA works, at least in part, via a Forster resonance energy transfer (FRET) mechanism. We also describe a straightforward iontophoretic method for labeling multiple neurons with DiO and show that DiO/DPA is compatible with two-photon (2P) imaging. Finally, exploiting the high sensitivity of DiO/DPA, we demonstrate AP-induced fluorescence transients (fAPs) recorded from single spines of hippocampal pyramidal neurons and single-trial measurements of subthreshold synaptic inputs to granule cell dendrites. Our findings suggest that the 2cVoS, DiO/DPA, enables optical measurements of trial-to-trial voltage fluctuations with very high spatial and temporal resolution, properties well suited for monitoring electrical signals from multiple neurons within intact neuronal networks.	[Fink, Ann E.; DiGregorio, David A.] Dept Neurosci, Unit Dynam Neuronal Imaging, Paris, France; [Fink, Ann E.; DiGregorio, David A.] Inst Pasteur, CNRS, URA 2182, Paris, France; [Bender, Kevin J.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Bender, Kevin J.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Otis, Thomas S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fink, AE (corresponding author), Dept Neurosci, Unit Dynam Neuronal Imaging, Paris, France.	david.digregorio@pasteur.fr		Fink, Ann/0000-0002-9380-8644	Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche [ANR-07-NEUR-008, ANR-2010-BLANC-1411]; Ecole des Neurosciences de Paris; NIH [NS 68408, NS028901, K99/R00: DC011080]; McKnight Foundation; European Community [237644]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028901, R01NS068408, R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC011080] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme; Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ecole des Neurosciences de Paris; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme, Fondation Fyssen, Fondation pour la Recherche Medicale, Federation pour la Recherche sur le Cerveau, Agence Nationale de la Recherche (ANR-07-NEUR-008 and ANR-2010-BLANC-1411), Ecole des Neurosciences de Paris to DD and by NIH grant NS 68408 and the McKnight Foundation to TSO. AF was also supported by Marie Curie Individual Fellowship 237644 within the 7th European Community Framework Program (FP7-PEOPLE-IIF-2008). LT was supported by NIH grant NS028901. KB was supported by NIH grant K99/R00: DC011080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CD, 2011, BIOPHYS J, V101, pL11, DOI 10.1016/j.bpj.2011.06.021; Antic S, 1999, J NEUROPHYSIOL, V82, P1615, DOI 10.1152/jn.1999.82.3.1615; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Bender KJ, 2003, J NEUROSCI, V23, P8759; Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chisari M, 2011, BRIT J PHARMACOL, V164, P667, DOI 10.1111/j.1476-5381.2011.01396.x; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35, DOI 10.1007/3-540-08907-1_2; DiFranco M, 2007, J GEN PHYSIOL, V130, P581, DOI 10.1085/jgp.200709831; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005; Fisher JAN, 2005, J NEUROSCI METH, V148, P94, DOI 10.1016/j.jneumeth.2005.06.027; Fisher JAN, 2008, J NEUROPHYSIOL, V99, P1545, DOI 10.1152/jn.00929.2007; Fromherz P, 2007, EUR BIOPHYS J; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; HAUGLAND RP, 1969, P NATL ACAD SCI USA, V63, P23, DOI 10.1073/pnas.63.1.23; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Otsu Y, 2008, J NEUROSCI METH, V173, P259, DOI 10.1016/j.jneumeth.2008.06.015; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; Wang DS, 2010, BIOPHYS J, V99, P2355, DOI 10.1016/j.bpj.2010.07.037; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	43	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41434	10.1371/journal.pone.0041434	http://dx.doi.org/10.1371/journal.pone.0041434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870221	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100020
J	Hu, XP; Wu, JQ; Zhu, LP; Wang, X; Xu, B; Wang, RY; Ou, XT; Weng, XH				Hu, Xiu-Ping; Wu, Ji-Qin; Zhu, Li-Ping; Wang, Xuan; Xu, Bin; Wang, Rui-Ying; Ou, Xue-Ting; Weng, Xin-Hua			Association of Fc gamma Receptor IIB Polymorphism with Cryptococcal Meningitis in HIV-Uninfected Chinese Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RIIA CD32; IIIB POLYMORPHISMS; GENE POLYMORPHISMS; SUSCEPTIBILITY; DISEASE; FCGR2B; GENOTYPE; BINDING; PHAGOCYTOSIS	Background: As important regulators of the immune system, the human Fc gamma receptors (Fc gamma Rs) have been demonstrated to play important roles in the pathogenesis of various infectious diseases. The aim of the present study was to identify the association between FCGR polymorphisms and cryptococcal meningitis. Methodology/Principal Findings: In this case control genetic association study, we genotyped four functional polymorphisms in low-affinity Fc gamma Rs, including FCGR2A 131H/R, FCGR3A 158F/V, FCGR3B NA1/NA2, and FCGR2B 232I/T, in 117 patients with cryptococcal meningitis and 190 healthy controls by multiplex SNaPshot technology. Among the 117 patients with cryptococcal meningitis, 59 had predisposing factors. In patients with cryptococcal meningitis, the FCGR2B 232I/I genotype was over-presented (OR = 1.652, 95% CI [1.02-2.67]; P = 0.039) and the FCGR2B 232I/T genotype was under-presented (OR = 0.542, 95% CI [0.33-0.90]; P = 0.016) in comparison with control group. In cryptococcal meningitis patients without predisposing factors, FCGR2B 232I/I genotype was also more frequently detected (OR = 1.958, 95% CI [1.05-3.66]; P = 0.033), and the FCGR2B 232I/T genotype was also less frequently detected (OR = 0.467, 95% CI [0.24-0.91]; P = 0.023) than in controls. No significant difference was found among FCGR2A 131H/R, FCGR3A 158F/V, and FCGR3B NA1/NA2 genotype frequencies between patients and controls. Conclusion/Significance: We found for the first time associations between cryptococcal meningitis and FCGR2B 232I/T genotypes, which suggested that Fc gamma RIIB might play an important role in the central nervous system infection by Cryptococcus in HIV-uninfected individuals.	[Hu, Xiu-Ping; Wu, Ji-Qin; Zhu, Li-Ping; Wang, Xuan; Xu, Bin; Wang, Rui-Ying; Ou, Xue-Ting; Weng, Xin-Hua] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University	Hu, XP (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	zhulp@fudan.edu.cn		Wang, Ruiying/0000-0002-3638-4582	National Natural Science Foundation of China [81071333]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [No. 81071333]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson R, 2006, NUCLEIC ACIDS RES, V34, pW651, DOI 10.1093/nar/gkl125; BREDIUS RGM, 1994, IMMUNOLOGY, V83, P624; Bruin M, 2004, BRIT J HAEMATOL, V127, P561, DOI 10.1111/j.1365-2141.2004.05235.x; Chai L, 2010, J DENT RES, V89, P705, DOI 10.1177/0022034510365444; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Chiapello LS, 2008, INT IMMUNOL, V20, P1527, DOI 10.1093/intimm/dxn112; Chu ZT, 2004, TISSUE ANTIGENS, V63, P21, DOI 10.1111/j.1399-0039.2004.00142.x; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Endeman H, 2009, CLIN VACCINE IMMUNOL, V16, P1087, DOI 10.1128/CVI.00037-09; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Hessner MJ, 1996, TRANSFUSION, V36, P895, DOI 10.1046/j.1537-2995.1996.361097017176.x; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Kyogoku C, 2002, GENES IMMUN, V3, P488, DOI 10.1038/sj.gene.6363921; Li XL, 2003, ARTHRITIS RHEUM, V48, P3242, DOI 10.1002/art.11313; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; Magnusson V, 2004, ARTHRITIS RHEUM, V50, P1348, DOI 10.1002/art.20151; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Meletiadis J, 2007, MED MYCOL, V45, P513, DOI 10.1080/13693780701390140; Molle I, 2008, LEUKEMIA LYMPHOMA, V49, P1116, DOI 10.1080/10428190802074585; Monari C, 2006, J IMMUNOL, V177, P6842, DOI 10.4049/jimmunol.177.10.6842; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Nasr A, 2007, SCAND J IMMUNOL, V66, P87, DOI 10.1111/j.1365-3083.2007.01947.x; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Platonov AE, 1998, CLIN INFECT DIS, V27, P746, DOI 10.1086/514935; REILLY AF, 1994, CLIN DIAGN LAB IMMUN, V1, P640, DOI 10.1128/CDLI.1.6.640-644.1994; Sadki K, 2010, J GENET GENOMICS, V37, P257, DOI 10.1016/S1673-8527(09)60044-8; Siriboonrit U, 2003, TISSUE ANTIGENS, V61, P374, DOI 10.1034/j.1399-0039.2003.00047.x; Sole-Violan J, 2011, CRIT CARE MED, V39, P1388, DOI 10.1097/CCM.0b013e31820eda74; van der Pol WL, 2003, IMMUNOGENETICS, V55, P240, DOI 10.1007/s00251-003-0574-9; van Schie RCAA, 2000, CLIN DIAGN LAB IMMUN, V7, P676, DOI 10.1128/CDLI.7.4.676-681.2000; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034400; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Xu G, 2007, J CLIN LAB ANAL, V21, P298, DOI 10.1002/jcla.20189; Yuan FF, 2005, TISSUE ANTIGENS, V66, P291, DOI 10.1111/j.1399-0039.2005.00476.x; Zhou XJ, 2010, NEPHROL DIAL TRANSPL, V25, P97, DOI 10.1093/ndt/gfp374; Zhu LP, 2010, MED MYCOL, V48, P570, DOI 10.3109/13693780903437876; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	49	37	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42439	10.1371/journal.pone.0042439	http://dx.doi.org/10.1371/journal.pone.0042439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879986	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100095
J	Jednorog, K; Altarelli, I; Monzalvo, K; Fluss, J; Dubois, J; Billard, C; Dehaene-Lambertz, G; Ramus, F				Jednorog, Katarzyna; Altarelli, Irene; Monzalvo, Karla; Fluss, Joel; Dubois, Jessica; Billard, Catherine; Dehaene-Lambertz, Ghislaine; Ramus, Franck			The Influence of Socioeconomic Status on Children's Brain Structure	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; COGNITIVE-DEVELOPMENT; NEURAL MECHANISMS; CHILDHOOD POVERTY; CORTICAL NETWORKS; MATERNAL-CARE; GYRIFICATION; HIPPOCAMPUS; ATTENTION; PRESCHOOL	Children's cognitive abilities and school achievements are deeply affected by parental socioeconomic status (SES). Numerous studies have reported lower cognitive performance in relation to unfavorable environments, but little is known about the effects of SES on the child's neural structures. Here, we systematically explore the association between SES and brain anatomy through MRI in a group of 23 healthy 10-year-old children with a wide range of parental SES. We confirm behaviorally that language is one of the cognitive domains most affected by SES. Furthermore, we observe widespread modifications in children's brain structure. A lower SES is associated with smaller volumes of gray matter in bilateral hippocampi, middle temporal gyri, left fusiform and right inferior occipito-temporal gyri, according to both volume-and surface-based morphometry. Moreover, we identify local gyrification effects in anterior frontal regions, supportive of a potential developmental lag in lower SES children. In contrast, we found no significant association between SES and white matter architecture. These findings point to the potential neural mediators of the link between unfavourable environmental conditions and cognitive skills.	[Jednorog, Katarzyna; Altarelli, Irene; Ramus, Franck] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Jednorog, Katarzyna] Nencki Inst Expt Biol, Warsaw, Poland; [Monzalvo, Karla; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] Inst Natl Sante & Rech Med, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Monzalvo, Karla; Dubois, Jessica; Dehaene-Lambertz, Ghislaine] Inst BioImaging, Div Life Sci, Comissariat Energie Atom, Gif Sur Yvette, France; [Monzalvo, Karla; Fluss, Joel; Dubois, Jessica; Billard, Catherine; Dehaene-Lambertz, Ghislaine] Univ Paris 11, Orsay, France; [Fluss, Joel; Billard, Catherine] AP HP, Paris, France; [Fluss, Joel] Hop Univ Geneve, Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); University of Geneva	Jednorog, K (corresponding author), Ecole Normale Super, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	k.jednorog@nencki.gov.pl; irene.altarelli@ens.fr	Jednoróg, Katarzyna/AFO-8052-2022; Ramus, Franck/A-1755-2009; Dubois, Jessica/P-2461-2014; Dehaene, Ghislaine/O-3633-2017	Jednoróg, Katarzyna/0000-0003-3072-6956; Ramus, Franck/0000-0002-1122-5913; Dubois, Jessica/0000-0003-4865-8111; Dehaene, Ghislaine/0000-0003-2221-9081	Ecole des Neurosciences de Paris; Fyssen Foundation; Agence Nationale de la Recherche	Ecole des Neurosciences de Paris; Fyssen Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR))	Research was supported by Ecole des Neurosciences de Paris, Fyssen Foundation, and grants from Agence Nationale de la Recherche (Genedys and Socodev). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bredy TW, 2004, EUR J NEUROSCI, V20, P1355, DOI 10.1111/j.1460-9568.2004.03599.x; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dickinson D., 1987, EARLY CHILD RES Q, V2, P1, DOI [DOI 10.1016/0885-2006(87)90010-X, 10.1016/0885-2006(87)90010-X]; Dodd B, 2003, CLIN LINGUIST PHONET, V17, P617, DOI 10.1080/0269920031000111348; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Farah MJ, 2008, DEVELOPMENTAL SCI, V11, P793, DOI 10.1111/j.1467-7687.2008.00688.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fluss J, 2009, J DEV BEHAV PEDIATR, V30, P206, DOI 10.1097/DBP.0b013e3181a7ed6c; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; GORMAN KS, 1995, J NUTR, V125, pS2239, DOI 10.1093/jn/125.suppl_8.2239S; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hawley DF, 2012, HIPPOCAMPUS, V22, P1338, DOI 10.1002/hipo.20970; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kesler SR, 2006, NEUROPSYCHOLOGIA, V44, P445, DOI 10.1016/j.neuropsychologia.2005.05.015; Khomsi A, 1999, LECT MOTS COMPREHENS; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Lefavrais P, 1965, REV PSYCHOL APPL, V15; Lege M, 1976, TEST VOCABULAIRE DEN; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Mezzacappa E, 2004, CHILD DEV, V75, P1373, DOI 10.1111/j.1467-8624.2004.00746.x; Molfese VJ, 2003, J LEARN DISABIL-US, V36, P59, DOI 10.1177/00222194030360010701; Monzalvo K, 2012, NEUROIMAGE, V61, P258, DOI 10.1016/j.neuroimage.2012.02.035; Noble KG, 2005, J DEV BEHAV PEDIATR, V26, P370, DOI 10.1097/00004703-200510000-00006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Otero GA, 1997, ELECTROEN CLIN NEURO, V102, P512, DOI 10.1016/S0013-4694(97)95213-9; Otero GA, 2003, CLIN NEUROPHYSIOL, V114, P1918, DOI 10.1016/S1388-2457(03)00173-1; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Ritsher JEB, 2001, BRIT J PSYCHIAT, V178, pS84, DOI 10.1192/bjp.178.40.s84; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sprenger-Charolles L., 2005, EUR REV APPL PSYCHOL, V55, P157, DOI DOI 10.1016/J.ERAP.2004.11.002; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Tomalski P, 2010, CURR OPIN PSYCHIATR, V23, P233, DOI 10.1097/YCO.0b013e3283387a8c; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; WALLACH L, 1977, J EDUC PSYCHOL, V69, P36, DOI 10.1037/0022-0663.69.1.36; Wechsler D., 2005, WISC 4 ECHELLE INTEL; White T, 2011, DEV PSYCHOPATHOL, V23, P339, DOI 10.1017/S0954579410000842	53	170	172	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42486	10.1371/journal.pone.0042486	http://dx.doi.org/10.1371/journal.pone.0042486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22880000	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100107
J	Sornom, P; Gismondi, E; Vellinger, C; Devin, S; Ferard, JF; Beisel, JN				Sornom, Pascal; Gismondi, Eric; Vellinger, Celine; Devin, Simon; Ferard, Jean-Francois; Beisel, Jean-Nicolas			Effects of Sublethal Cadmium Exposure on Antipredator Behavioural and Antitoxic Responses in the Invasive Amphipod Dikerogammarus villosus	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITIES; RELEASED CHEMICAL CUES; GAMMARUS-PULEX L; LIPID-PEROXIDATION; PREDATOR AVOIDANCE; CRUSTACEA; PREY; COMMUNICATION; TOXICITY; SUSCEPTIBILITY	Amphipods are recognised as an important component of freshwater ecosystems and are frequently used as an ecotoxicological test species. Despite this double interest, there is still a lack of information concerning toxic impacts on ecologically relevant behaviours. The present study investigated the influence of cadmium (Cd), a non-essential heavy metal, on both antipredator behaviours and antitoxic responses in the invasive amphipod Dikerogammarus villosus under laboratory conditions. Amphipod behaviour (i.e. refuge use, aggregation with conspecifics, exploration and mobility) was recorded following a 4-min test-exposure to 500 mu g Cd/L with or without a 24-h Cd pre-exposure and in the presence or absence of a high perceived risk of predation (i.e. water scented by fish predators and injured conspecifics). Following behavioural tests, malondialdehyde (MDA) levels, a biomarker for toxic effect, and energy reserves (i.e. lipid and glycogen contents) were assessed. Cd exposures induced (1) cell damage reflected by high MDA levels, (2) erratic behaviour quantified by decreasing refuge use and exploration, and increasing mobility, and (3) a depletion in energy reserves. No significant differences were observed between 4-min test-exposed and 24-h pre-exposed individuals. Gammarids exposed to Cd had a disturbed perception of the alarm stimuli, reflected by increased time spent outside of refuges and higher mobility compared to gammarids exposed to unpolluted water. Our results suggest that Cd exposure rapidly disrupts the normal behavioural responses of gammarids to alarm substances and alters predator-avoidance strategies, which could have potential impacts on aquatic communities.	[Sornom, Pascal; Gismondi, Eric; Vellinger, Celine; Devin, Simon; Ferard, Jean-Francois; Beisel, Jean-Nicolas] Univ Lorraine, CNRS UMR 7146, Lab Interact, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Sornom, P (corresponding author), Univ Lorraine, CNRS UMR 7146, Lab Interact, Metz, France.	pascal.sornom@umail.univ-metz.fr	Beisel, Jean-Nicolas/H-4392-2011; Gismondi, Eric/ABC-4356-2020	Beisel, Jean-Nicolas/0000-0002-1935-7689; VELLINGER, Celine/0000-0002-5448-8705; Gismondi, Eric/0000-0003-3102-3443; Devin, Simon/0000-0003-4431-4987				Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Abjornsson Kajsa, 2000, Aquatic Ecology, V34, P379, DOI 10.1023/A:1011442331229; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; Baumgartner D, 2002, ARCH HYDROBIOL, V155, P353; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Bronmark C, 2000, OIKOS, V88, P103, DOI 10.1034/j.1600-0706.2000.880112.x; CAMPBELL JI, 1974, EXPERIENTIA, V30, P1396, DOI 10.1007/BF01919655; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Chivers DP, 1996, ANIM BEHAV, V52, P315, DOI 10.1006/anbe.1996.0177; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dahl J, 1998, P ROY SOC B-BIOL SCI, V265, P1339, DOI 10.1098/rspb.1998.0439; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DEMEESTER L, 1993, ECOLOGY, V74, P1467; Devin S, 2001, ANN LIMNOL-INT J LIM, V37, P21, DOI 10.1051/limn/2001001; Durou C, 2008, BIOMARQUEURS EVALUAT, P273; Dutra BK, 2009, COMP BIOCHEM PHYS C, V149, P640, DOI 10.1016/j.cbpc.2009.01.005; Eckmann Reiner, 2008, Aquatic Invasions, V3, P184, DOI 10.3391/ai.2008.3.2.9; Endler J.A., 1991, P169; Felten V, 2008, AQUAT TOXICOL, V86, P413, DOI 10.1016/j.aquatox.2007.12.002; Geret F, 2002, AQUAT LIVING RESOUR, V15, P61, DOI 10.1016/S0990-7440(01)01147-0; Geret F, 2002, BIOMARKERS, V7, P242, DOI 10.1080/13547500210125040; Gerhardt A, 1995, ENVIRON SCI POLLUT R, V2, P15, DOI 10.1007/BF02987506; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Gonzalo C, 2010, B ENVIRON CONTAM TOX, V85, P472, DOI 10.1007/s00128-010-0132-8; Guerlet E, 2008, CHEMOSPHERE, V72, P697, DOI 10.1016/j.chemosphere.2008.04.013; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2; Honda RT, 2008, AQUAT TOXICOL, V89, P204, DOI 10.1016/j.aquatox.2008.07.001; HOWELL R, 1985, HYDROBIOLOGIA, V123, P245, DOI 10.1007/BF00034386; Hunter K, 2004, ENVIRON TOXICOL CHEM, V23, P1311, DOI 10.1897/03-369; Kaldonski N, 2008, NATURWISSENSCHAFTEN, V95, P839, DOI 10.1007/s00114-008-0392-x; Kalmijn A.J., 1988, P83; Kelleher B, 1998, ARCH HYDROBIOL, V143, P363; Khan FR, 2010, AQUAT TOXICOL, V96, P124, DOI 10.1016/j.aquatox.2009.10.010; Kinzler W, 2009, AQUAT ECOL, V43, P457, DOI 10.1007/s10452-008-9206-7; Kusch RC, 2008, ENVIRON TOXICOL CHEM, V27, P705, DOI 10.1897/07-273.1; Lefcort H, 1998, ARCH ENVIRON CON TOX, V35, P447, DOI 10.1007/s002449900401; Lefcort H, 2000, ARCH ENVIRON CON TOX, V38, P311, DOI 10.1007/s002449910041; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Maazouzi C, 2008, ENVIRON POLLUT, V156, P221, DOI 10.1016/j.envpol.2007.12.010; MacNeil C, 1999, ECOGRAPHY, V22, P686, DOI 10.1111/j.1600-0587.1999.tb00518.x; Mathis A, 1997, ETHOLOGY, V103, P33; MCCAHON CP, 1988, AQUAT TOXICOL, V13, P183, DOI 10.1016/0166-445X(88)90051-3; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Pennuto C, 2008, AQUAT ECOL, V42, P629, DOI 10.1007/s10452-007-9139-6; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Platvoet D, 2009, BIOL INVASIONS, V11, P2085, DOI 10.1007/s10530-009-9488-2; Pockl M, 2007, FRESHWATER BIOL, V52, P50, DOI 10.1111/j.1365-2427.2006.01671.x; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Roast SD, 2001, AQUAT TOXICOL, V52, P217, DOI 10.1016/S0166-445X(00)00153-3; Sancho E, 1998, ECOTOX ENVIRON SAFE, V41, P168, DOI 10.1006/eesa.1998.1689; Scott GR, 2003, J EXP BIOL, V206, P1779, DOI 10.1242/jeb.00353; Sih A., 1987, P203; Sornom P, 2010, ENVIRON POLLUT, V158, P1288, DOI 10.1016/j.envpol.2010.01.022; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; STUHLBACHER A, 1992, ARCH ENVIRON CON TOX, V22, P319; SULLIVAN BK, 1983, MAR BIOL, V77, P299, DOI 10.1007/BF00395819; Vellinger C, 2012, ENVIRON POLLUT, V160, P66, DOI 10.1016/j.envpol.2011.09.002; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wallace WG, 2000, ENVIRON TOXICOL CHEM, V19, P962, DOI 10.1002/etc.5620190425; Wallace WG, 2004, AQUAT TOXICOL, V69, P289, DOI 10.1016/j.aquatox.2004.05.010; WILLIAMS DD, 1985, OIKOS, V44, P280, DOI 10.2307/3544701; WILLIAMS KA, 1985, ARCH HYDROBIOL, V102, P461; Wisenden BD, 1999, ETHOLOGY, V105, P407, DOI 10.1046/j.1439-0310.1999.00399.x; Wisenden BD, 2001, J CHEM ECOL, V27, P1249, DOI 10.1023/A:1010376215052; Wright D. A., 1994, Environmental Reviews, V2, P187	68	19	19	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42435	10.1371/journal.pone.0042435	http://dx.doi.org/10.1371/journal.pone.0042435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879985	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100094
J	Chen, Y; Siewers, V; Nielsen, J				Chen, Yun; Siewers, Verena; Nielsen, Jens			Profiling of Cytosolic and Peroxisomal Acetyl-CoA Metabolism in Saccharomyces cerevisiae	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; CITRATE SYNTHASES; BUDDING YEAST; LOCALIZATION; GROWTH; GENE; MITOCHONDRIA; DISRUPTION; TRANSPORT; MEMBRANE	As a key intracellular metabolite, acetyl-coenzyme A (acetyl-CoA) plays a major role in various metabolic pathways that link anabolism and catabolism. In the yeast Saccharomyces cerevisiae, acetyl-CoA involving metabolism is compartmentalized, and may vary with the nutrient supply of a cell. Membranes separating intracellular compartments are impermeable to acetyl-CoA and no direct transport between the compartments occurs. Thus, without carnitine supply the glyoxylate shunt is the sole possible route for transferring acetyl-CoA from the cytosol or the peroxisomes into the mitochondria. Here, we investigate the physiological profiling of different deletion mutants of ACS1, ACS2, CIT2 and MLS1 individually or in combination under alternative carbon sources, and study how various mutations alter carbon distribution. Based on our results a detailed model of carbon distribution about cytosolic and peroxisomal acetyl-CoA metabolism in yeast is suggested. This will be useful to further develop yeast as a cell factory for the biosynthesis of acetyl-CoA-derived products.	[Chen, Yun; Siewers, Verena; Nielsen, Jens] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Chen, Y (corresponding author), Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Chen, Yun/G-6645-2017; Siewers, Verena/AAV-4902-2020; Nielsen, Jens/Q-1347-2017	Chen, Yun/0000-0002-2146-6008; Siewers, Verena/0000-0002-9502-9804; Nielsen, Jens/0000-0002-9955-6003	Firmenich; Knut and Alice Wallenberg Foundation; Chalmers Foundation	Firmenich; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation	The authors thank Firmenich, the Knut and Alice Wallenberg Foundation and the Chalmers Foundation for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, FEMS YEAST RES, V12, P598, DOI 10.1111/j.1567-1364.2012.00809.x; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HARTIG A, 1992, NUCLEIC ACIDS RES, V20, P5677, DOI 10.1093/nar/20.21.5677; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KIM KS, 1986, MOL CELL BIOL, V6, P1936, DOI 10.1128/MCB.6.6.1936; KISPAL G, 1988, J BIOL CHEM, V263, P11145; KLEIN HP, 1979, J BACTERIOL, V137, P179, DOI 10.1128/JB.137.1.179-184.1979; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; Lee JG, 2006, J BIOCHEM, V140, P121, DOI 10.1093/jb/mvj136; Lee YJ, 2011, YEAST, V28, P153, DOI 10.1002/yea.1828; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; PRONK JT, 1994, MICROBIOL-SGM, V140, P601, DOI 10.1099/00221287-140-3-601; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Regev-Rudzki N, 2009, MOL MICROBIOL, V72, P297, DOI 10.1111/j.1365-2958.2009.06659.x; RICKEY TM, 1986, MOL CELL BIOL, V6, P488, DOI 10.1128/MCB.6.2.488; ROSENKRANTZ M, 1986, MOL CELL BIOL, V6, P4509, DOI 10.1128/MCB.6.12.4509; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; WEINHOUSE S, 1951, J BIOL CHEM, V191, P707	32	86	89	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42475	10.1371/journal.pone.0042475	http://dx.doi.org/10.1371/journal.pone.0042475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876324	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700052
J	De Meester, N; Derycke, S; Moens, T				De Meester, Nele; Derycke, Sofie; Moens, Tom			Differences in Time until Dispersal between Cryptic Species of a Marine Nematode Species Complex	PLOS ONE			English	Article							FREE-LIVING MARINE; MEIOFAUNAL COLONIZATION; FOOD AVAILABILITY; GENETIC-STRUCTURE; ACTIVE EMERGENCE; TRADE-OFFS; ESTUARINE; COEXISTENCE; REPRODUCTION; MIGRATION	Co-occurrence of closely related species may be achieved in environments with fluctuating dynamics, where competitively inferior species can avoid competition through dispersal. Here we present an experiment in which we compared active dispersal abilities (time until first dispersal, number and gender of dispersive adults, and nematode densities at time of dispersal) in Litoditis marina, a common bacterivorous nematode species complex comprising four often co-occurring cryptic species, Pm I, II, III, and IV, as a function of salinity and food distribution. The experiment was conducted in microcosms consisting of an inoculation plate, connection tube, and dispersal plate. Results show species-specific dispersal abilities with Pm I dispersing almost one week later than Pm III. The number of dispersive adults at time of first dispersal was species-specific, with one dispersive female in Pm I and Pm III and a higher, gender-balanced, number in Pm II and Pm IV. Food distribution affected dispersal: in absence of food in the inoculation plate, all species dispersed after ca four days. When food was available Pm I dispersed later, and at the same time and densities irrespective of food conditions in the dispersal plate (food vs no food), suggesting density-dependent dispersal. Pm III dispersed faster and at a lower population density. Salinity affected dispersal, with slower dispersal at higher salinity. These results suggest that active dispersal in Litoditis marina is common, density-dependent, and with species, gender-and environment-specific dispersal abilities. These differences can lead to differential responses under suboptimal conditions and may help to explain temporary coexistence at local scales.	[De Meester, Nele; Derycke, Sofie; Moens, Tom] Univ Ghent, Marine Biol Unit, Dept Biol, B-9000 Ghent, Belgium; [De Meester, Nele; Derycke, Sofie] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium	Ghent University; Ghent University	De Meester, N (corresponding author), Univ Ghent, Marine Biol Unit, Dept Biol, B-9000 Ghent, Belgium.	nele.demeester@ugent.be	Moens, Tom/AAB-8701-2019		Ghent University [B/09941, B/11644]; FWO [B/07715]	Ghent University(Ghent University); FWO(FWO)	SD is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO. Financial support for this study came from the special research fund (BOF) of Ghent University through projects B/09941and B/11644 and from the FWO through project B/07715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; ARMONIES W, 1988, MAR ECOL PROG SER, V43, P151, DOI 10.3354/meps043151; Begon M, 1996, INTERSPECIFIC COMPET, P265; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Darwin C., 1859, ORIGIN SPECIES MEANS; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Dietrich G., 1957, ALLGEMEINE MEERESKUN; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gerhardt HC, 2005, ANIM BEHAV, V70, P39, DOI 10.1016/j.anbehav.2004.09.021; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Guilini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018912; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Ims R, 2001, DISPERSAL; INGLIS WILLIAM G., 1961, BULL BRIT MUS [NAT HIST] ZOOL, V7, P320; Kaiser M, 2005, PETROLEUM ACCOUN JUL, P1; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; LEE JJ, 1977, HELGOLAND WISS MEER, V30, P272, DOI 10.1007/BF02207841; Lurz PWW, 1997, ANIM BEHAV, V54, P427, DOI 10.1006/anbe.1996.0486; Mare M. F., 1942, Journal of the Marine Biological Association Plymouth, V25, P517; Moens T, 2000, MAR ECOL PROG SER, V205, P185, DOI 10.3354/meps205185; Moens T, 1999, MAR ECOL PROG SER, V184; Moens T, 2005, AQUAT MICROB ECOL, V40, P77, DOI 10.3354/ame040077; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Moens T, 1996, J EXP MAR BIOL ECOL, V197, P177, DOI 10.1016/0022-0981(95)00163-8; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P115, DOI 10.1016/S0022-0981(99)00113-6; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; Neira C, 2001, DEEP-SEA RES PT I, V48, P2453, DOI 10.1016/S0967-0637(01)00018-8; OLAFSSON E, 1990, MAR ECOL PROG SER, V65, P241, DOI 10.3354/meps065241; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; Perrin Nicolas, 2001, P123; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; R Core Team, 2022, R LANG ENV STAT COMP; RALIN D B, 1968, Southwestern Naturalist, V13, P283, DOI 10.2307/3669222; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; SUDHAUS W, 1974, Faunistisch-Oekologische Mitteilungen, V4, P365; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thomas CFG, 1999, J ARACHNOL, V27, P294; Thomas MC, 2011, ZOOLOGIA-CURITIBA, V28, P449, DOI 10.1590/S1984-46702011000400006; TIETJEN JH, 1972, OECOLOGIA, V10, P167, DOI 10.1007/BF00347988; Ullberg J, 2003, MAR BIOL, V143, P867, DOI 10.1007/s00227-003-1139-z; Ullberg J, 2004, THESIS STOCKHOLM U S; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; VRANKEN G, 1983, NEMATOLOGICA, V29, P468, DOI 10.1163/187529283X00348; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wetzel MA, 2002, MAR BIOL, V141, P679, DOI 10.1007/s00227-002-0863-0; Wiens John A., 2001, P96; WINSTON MR, 1995, AM NAT, V145, P527, DOI 10.1086/285754; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhou H, 2001, J EXP MAR BIOL ECOL, V256, P99, DOI 10.1016/S0022-0981(00)00310-5	79	19	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42674	10.1371/journal.pone.0042674	http://dx.doi.org/10.1371/journal.pone.0042674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876328	gold, Green Published			2022-12-25	WOS:000307184700056
J	Isemura, T; Kaga, A; Tabata, S; Somta, P; Srinives, P; Shimizu, T; Jo, U; Vaughan, DA; Tomooka, N				Isemura, Takehisa; Kaga, Akito; Tabata, Satoshi; Somta, Prakit; Srinives, Peerasak; Shimizu, Takehiko; Jo, Uken; Vaughan, Duncan A.; Tomooka, Norihiko			Construction of a Genetic Linkage Map and Genetic Analysis of Domestication Related Traits in Mungbean (Vigna radiata)	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; BRUCHID RESISTANCE GENE; ANGULARIS WILLD. OHWI; SSR MARKERS; L. WILCZEK; MICROSATELLITE MARKERS; POWDERY MILDEW; QTL ANALYSIS; SEED WEIGHT; GENOME	The genetic differences between mungbean and its presumed wild ancestor were analyzed for domestication related traits by QTL mapping. A genetic linkage map of mungbean was constructed using 430 SSR and EST-SSR markers from mungbean and its related species, and all these markers were mapped onto 11 linkage groups spanning a total of 727.6 cM. The present mungbean map is the first map where the number of linkage groups coincided with the haploid chromosome number of mungbean. In total 105 QTLs and genes for 38 domestication related traits were identified. Compared with the situation in other Vigna crops, many linkage groups have played an important role in the domestication of mungbean. In particular the QTLs with high contribution were distributed on seven out of 11 linkage groups. In addition, a large number of QTLs with small contribution were found. The accumulation of many mutations with large and/or small contribution has contributed to the differentiation between wild and cultivated mungbean. The useful QTLs for seed size, pod dehiscence and pod maturity that have not been found in other Asian Vigna species were identified in mungbean, and these QTLs may play the important role as new gene resources for other Asian Vigna species. The results provide the foundation that will be useful for improvement of mungbean and related legumes.	[Isemura, Takehisa; Kaga, Akito; Jo, Uken; Vaughan, Duncan A.; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Biodivers Res Unit, Tsukuba, Ibaraki, Japan; [Tabata, Satoshi] Kazusa DNA Res Inst, Dept Plant Genome Res, Kisarazu, Chiba, Japan; [Somta, Prakit; Srinives, Peerasak] Kasetsart Univ, Dept Agron, Fac Agr Kamphaeng Saen, Nakhon Pathom, Thailand; [Shimizu, Takehiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Res Div Plants 1, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute; Kasetsart University	Isemura, T (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Biodivers Res Unit, Tsukuba, Ibaraki, Japan.	tomooka@affrc.go.jp			Japanese Ministry of the Education, Culture, Sports, Science and Technology [18390009]	Japanese Ministry of the Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in Aid for Scientific Research of the Japanese Ministry of the Education, Culture, Sports, Science and Technology (No. 18390009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Chaitieng B, 2002, PLANT BREEDING, V121, P521, DOI 10.1046/j.1439-0523.2002.00751.x; Chankaew S, 2011, MOL BREEDING, V28, P255, DOI 10.1007/s11032-010-9478-1; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Chen XF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-129; Cheng Z, 2011, 14 NIAS INT WORKSH G, P83; DOEBLEY J, 1995, GENETICS, V141, P333; FATOKUN CA, 1992, GENETICS, V132, P841; Fernandez GCJ, 1988, AVRDC MUNGBEAN IMPRO, P58; Fukuoka H, 2005, BIOTECHNIQUES, V39, P472, DOI 10.2144/000112025; Fuller DQ, 2006, ENVIRON ARCHAEOL, V11, P219, DOI 10.1179/174963106x123232; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; GOPINATHAN MC, 1985, ANN BOT-LONDON, V56, P723; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Humphry ME, 2005, PLANT BREEDING, V124, P292, DOI 10.1111/j.1439-0523.2005.01084.x; Humphry ME, 2003, GENOME, V46, P738, DOI 10.1139/G03-057; Humphry ME, 2002, THEOR APPL GENET, V105, P160, DOI 10.1007/s00122-002-0909-1; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Isemura T, 2007, ANN BOT-LONDON, V100, P1053, DOI 10.1093/aob/mcm155; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; James AT, 1999, AUST J BOT, V47, P601, DOI 10.1071/BT97068; Kaga A, 1998, MOL GEN GENET, V258, P378, DOI 10.1007/s004380050744; Kaga A, 1996, THEOR APPL GENET, V93, P658, DOI 10.1007/BF00224059; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Kasettranan W., 2010, Journal of Crop Science and Biotechnology, V13, P155, DOI 10.1007/s12892-010-0052-z; Kikuchi K, 2006, ANN BOT-LONDON, V98, P545, DOI 10.1093/aob/mcl145; KITAMURA K, 1988, JPN J BREED, V38, P459; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lambrides C.J., 2007, PULSES SUGAR TUBER C, P69, DOI [10.1007/978-3-540-34516-9_4, DOI 10.1007/978-3-540-34516-9_4]; Lambrides CJ, 2004, J HERED, V95, P532, DOI 10.1093/jhered/esh078; Lambrides CJ, 2000, AUST J AGR RES, V51, P415, DOI 10.1071/AR99052; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Mei L, 2009, GENOME, V52, P589, DOI 10.1139/G09-031; Menancio-Hautea D., 1993, GENETIC MAPS 1992 CO; MENANCIOHAUTEA D, 1993, THEOR APPL GENET, V86, P797, DOI 10.1007/BF00212605; Miyagi M, 2004, THEOR APPL GENET, V110, P151, DOI 10.1007/s00122-004-1821-7; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Sangiri C, 2007, AUST J BOT, V55, P837, DOI 10.1071/BT07105; Saravanakumar P, 2004, AUST J BOT, V52, P417, DOI 10.1071/BT03091; Sato S, 2005, DNA RES, V12, P301, DOI 10.1093/dnares/dsi018; Senthil N., 2011, 14 NIAS INT WORKSH G, P53; Somta P, 2008, MOL ECOL RESOUR, V8, P1155, DOI 10.1111/j.1755-0998.2008.02219.x; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; Somta P, 2009, BREEDING SCI, V59, P149, DOI 10.1270/jsbbs.59.149; Srinives P., 2011, 14 NIAS INT WORKSH G, P63; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Ullah H, 2011, PAK J BOT, V43, P301; Van Ooijien JW., 2006, JOIN MAP 4 0 SOFTWAR; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Weeden NF, 2007, ANN BOT-LONDON, V100, P1017, DOI 10.1093/aob/mcm122; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; YOUNG ND, 1993, THEOR APPL GENET, V87, P243, DOI 10.1007/BF00223772; YOUNG ND, 1992, THEOR APPL GENET, V84, P839, DOI 10.1007/BF00227394; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	58	97	106	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41304	10.1371/journal.pone.0041304	http://dx.doi.org/10.1371/journal.pone.0041304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876284	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700012
J	Hahn, T; Kettle, CJ; Ghazoul, J; Frei, ER; Matter, P; Pluess, AR				Hahn, Thomas; Kettle, Chris J.; Ghazoul, Jaboury; Frei, Esther R.; Matter, Philippe; Pluess, Andrea R.			Patterns of Genetic Variation across Altitude in Three Plant Species of Semi-Dry Grasslands	PLOS ONE			English	Article							CLIMATE-CHANGE; CENTRAL POPULATIONS; COMPUTER-PROGRAM; WIND POLLINATION; DIVERSITY; ALPINE; EXTINCTION; DIFFERENTIATION; FRAGMENTATION; CONSERVATION	Background: Environmental gradients caused by altitudinal gradients may affect genetic variation within and among plant populations and inbreeding within populations. Populations in the upper range periphery of a species may be important source populations for range shifts to higher altitude in response to climate change. In this study we investigate patterns of population genetic variation at upper peripheral and lower more central altitudes in three common plant species of semi-dry grasslands in montane landscapes. Methodology/Principal Findings: In Briza media, Trifolium montanum and Ranunculus bulbosus genetic diversity, inbreeding and genetic relatedness of individuals within populations and genetic differentiation among populations was characterized using AFLP markers. Populations were sampled in the Swiss Alps at 1800 (upper periphery of the study organisms) and at 1200 m a.s.l. Genetic diversity was not affected by altitude and only in B. media inbreeding was greater at higher altitudes. Genetic differentiation was slightly greater among populations at higher altitudes in B. media and individuals within populations were more related to each other compared to individuals in lower altitude populations. A similar but less strong pattern of differentiation and relatedness was observed in T. montanum, while in R. bulbosus there was no effect of altitude. Estimations of population size and isolation of populations were similar, both at higher and lower altitudes. Conclusions/Significance: Our results suggest that altitude does not affect genetic diversity in the grassland species under study. Genetic differentiation of populations increased only slightly at higher elevation, probably due to extensive (historic) gene flow among altitudes. Potentially pre-adapted genes might therefore spread easily across altitudes. Our study indicates that populations at the upper periphery are not genetically depauperate or isolated and thus may be important source populations for migration under climate change.	[Hahn, Thomas; Kettle, Chris J.; Ghazoul, Jaboury; Frei, Esther R.; Matter, Philippe; Pluess, Andrea R.] ETH, Inst Terr Ecosyst, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hahn, T (corresponding author), ETH, Inst Terr Ecosyst, Zurich, Switzerland.	thomas.hahn@env.ethz.ch	Ghazoul, Jaboury/B-2121-2018; Kettle, Chris/A-6160-2011	Frei, Esther R./0000-0003-1910-7900	Swiss National Science Foundation (SNF) [3100A0-116277]; Competence Center Environment and Sustainability (CCES) BioChange	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Competence Center Environment and Sustainability (CCES) BioChange	This project was financially supported by Swiss National Science Foundation (SNF) No. 3100A0-116277 (http://www.snf.ch/E/Pages/default.aspx), and Competence Center Environment and Sustainability (CCES) BioChange (http://www.cces.ethz.ch/projects/clench/BioChange). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, PFLANZENSOZIOLOGISCH; [Anonymous], 2004, FLORA ALPINA; [Anonymous], TWW BUND TROCK WEID; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; [Anonymous], LANDNUTZUNG BIOL VIE; [Anonymous], 1999, LEBENSRAUME SCHWEIZ; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Auffret AG, 2011, APPL VEG SCI, V14, P291, DOI 10.1111/j.1654-109X.2011.01124.x; Bingham RA, 2000, INT J PLANT SCI, V161, P403, DOI 10.1086/314272; Brundli U.-B., 2010, SCHWEIZERISCHES LAND; Bruun HH, 2002, AMBIO, V31, P425, DOI 10.1639/0044-7447(2002)031[0425:TPIOLH]2.0.CO;2; Burel F., 2003, LANDSCAPE ECOLOGY CO; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dasmahapatra KK, 2008, HEREDITY, V100, P286, DOI 10.1038/sj.hdy.6801075; Dixon JM, 2002, J ECOL, V90, P737, DOI 10.1046/j.1365-2745.2002.00684.x; Duan YW, 2009, PLANT BIOLOGY, V11, P796, DOI 10.1111/j.1438-8677.2009.00195.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goodell K, 1997, AM J BOT, V84, P1362, DOI 10.2307/2446134; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hannah L, 2011, CONSERV BIOL, V25, P1139, DOI 10.1111/j.1523-1739.2011.01788.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARPER JOHN L., 1957, JOUR ECOL, V45, P287; Hautier Y, 2009, J PLANT ECOL, V2, P125, DOI 10.1093/jpe/rtp011; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Heywood John S., 1993, American Journal of Botany, V80, P545, DOI [10.1002/j.1537-2197.1993.tb13838.x, 10.2307/2445370]; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Jacquemyn H, 2009, ANN BOT-LONDON, V103, P777, DOI 10.1093/aob/mcn253; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Larcher W, 2006, SITZUNGBERICHTE ANZE, V212, P3; Lauber K., 2001, FLORA HELVETICA; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lopez PG, 2010, AM J BOT, V97, P423, DOI 10.3732/ajb.0900208; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; MANTEL N, 1967, CANCER RES, V27, P209; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; MURRAY BG, 1974, HEREDITY, V33, P285, DOI 10.1038/hdy.1974.94; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; OUBORG NJ, 1991, OECOLOGIA, V86, P359, DOI 10.1007/BF00317601; OYAMA K, 1993, J PLANT RES, V106, P143, DOI 10.1007/BF02344418; Pannell JR, 1999, EVOLUTION, V53, P664, DOI 10.1111/j.1558-5646.1999.tb05362.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Plank, 1981, DRY GRASSLANDS EUROP; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Pluess AR, 2004, AM J BOT, V91, P2013, DOI 10.3732/ajb.91.12.2013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Richards CM, 1999, EVOLUTION, V53, P63, DOI [10.2307/2640920, 10.1111/j.1558-5646.1999.tb05333.x]; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Shi MM, 2011, PLOS ONE, V6; STEINBACH K, 1994, PHYTON-ANN REI BOT A, V34, P203; Tamura S, 2000, PLANT ECOL, V147, P185, DOI 10.1023/A:1009870521175; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wagner V, 2011, AM J BOT, V98, P1173, DOI 10.3732/ajb.1000385; Weber JJ, 2012, AM J BOT; WEIMARCK A, 1968, HEREDITAS-GENETISK A, V60, P157; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Yakimowski SB, 2008, NEW PHYTOL, V180, P534, DOI 10.1111/j.1469-8137.2008.02582.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Ziello C, 2009, CLIM RES, V39, P227, DOI 10.3354/cr00822	82	36	39	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41608	10.1371/journal.pone.0041608	http://dx.doi.org/10.1371/journal.pone.0041608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870236	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800029
J	Yoon, CH; Rho, SB; Kim, ST; Kho, S; Park, J; Jang, IS; Woo, S; Kim, SS; Lee, JH; Lee, SH				Yoon, Cheol-Hee; Rho, Seung Bae; Kim, Seong-Tae; Kho, Seongho; Park, Junsoo; Jang, Ik-Soon; Woo, Seonock; Kim, Sung Soon; Lee, Je-Ho; Lee, Seung-Hoon			Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical Cancer	PLOS ONE			English	Article							BETA-STIMULATED CLONE-22; SALIVARY-GLAND CANCER; GROWTH-FACTOR-BETA; DOWN-REGULATION; CELL LINE; IN-VIVO; MDM2; SUPPRESSOR; GENE; PROTEIN	The p53 tumor suppressor function can be compromised in many tumors by the cellular antagonist HDM2 and human papillomavirus oncogene E6 that induce p53 degradation. Restoration of p53 activity has strong therapeutic potential. Here, we identified TSC-22 as a novel p53-interacting protein and show its novel function as a positive regulator of p53. We found that TSC-22 level was significantly down-regulated in cervical cancer tissues. Moreover, over-expression of TSC-22 was sufficient to inhibit cell proliferation, promote cellular apoptosis in cervical cancer cells and suppress growth of xenograft tumors in mice. Expression of also TSC-22 enhanced the protein level of p53 by protecting it from poly-ubiquitination. When bound to the motif between amino acids 100 and 200 of p53, TSC-22 inhibited the HDM2- and E6-mediated p53 polyubiquitination and degradation. Consequently, ectopic over-expression of TSC-22 activated the function of p53, followed by increased expression of p21(Waf1/Cip1) and PUMA in human cervical cancer cell lines. Interestingly, TSC-22 did not affect the interaction between p53 and HDM2. Knock-down of TSC-22 by small interfering RNA clearly enhanced the polyubiquitination of p53, leading to the degradation of p53. These results suggest that TSC-22 acts as a tumor suppressor by safeguarding p53 from poly-ubiquitination mediated-degradation.	[Yoon, Cheol-Hee] Natl Inst Hlth, Div Aids, Ctr Immunol & Pathol, Chungbuk, South Korea; [Kim, Seong-Tae; Kho, Seongho; Lee, Seung-Hoon] Yongin Univ, Dept Life Sci, Yongin, Gyeonggi Do, South Korea; [Rho, Seung Bae] Natl Canc Ctr, Res Inst, Goyang Si, Gyeonggi Do, San Marino; [Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Jang, Ik-Soon] Daegeon Ctr, Korea Basic Sci Inst, Daegion, South Korea; [Woo, Seonock] Korea Ocean Res & Dev Inst, S Sea Environm Res Dept, Geoje, South Korea; [Lee, Je-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Yongin University; Yonsei University; Korea Basic Science Institute (KBSI); Korea Institute of Ocean Science & Technology (KIOST); Sungkyunkwan University (SKKU); Samsung Medical Center	Yoon, CH (corresponding author), Natl Inst Hlth, Div Aids, Ctr Immunol & Pathol, Chungbuk, South Korea.	jeholee@gmail.com; shlee@yongin.ac.kr		Jang, Ik Soon/0000-0003-2092-6372	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20110026217]; Korea Basic Science Institute NAP grant [T3278B]; Korea National Institute of Health	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Basic Science Institute NAP grant; Korea National Institute of Health	This research was mainly supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110026217) and partially assisted by the Korea Basic Science Institute NAP grant (T3278B) and the internal grant from Korea National Institute of Health. The funders had no role in study design, data collection and analysis, dicision to publish, or preparation of the manuscript.	Ahn H, 2011, MOL CELL BIOCH; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dobens LL, 1997, MECH DEVELOP, V65, P197, DOI 10.1016/S0925-4773(97)00080-4; Hashiguchi A, 2004, DEV GROWTH DIFFER, V46, P535; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Iida M, 2007, TOXICOL SCI, V99, P43, DOI 10.1093/toxsci/kfm138; Kawamata H, 1998, BRIT J CANCER, V77, P71, DOI 10.1038/bjc.1998.11; Kawamata H, 2004, CURR CANCER DRUG TAR, V4, P521, DOI 10.2174/1568009043332844; Kester HA, 1999, J BIOL CHEM, V274, P27439, DOI 10.1074/jbc.274.39.27439; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Lee JH, 2008, FEBS LETT, V582, P1210, DOI 10.1016/j.febslet.2008.01.066; Lee SH, 2005, CANCER RES, V65, P137; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Nakamura M, 2011, CANC SCI; Nakashiro K, 1998, CANCER RES, V58, P549; Ohta S, 1997, BIOCHEM J, V324, P777, DOI 10.1042/bj3240777; Omotehara F, 2000, ONCOL REP, V7, P737; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; Shostak KO, 2005, EXP ONCOL, V27, P314; Shostak KO, 2003, J SURG ONCOL, V82, P57, DOI 10.1002/jso.10180; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Uchida D, 2000, LAB INVEST, V80, P955, DOI 10.1038/labinvest.3780098; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yan XH, 2011, MOL CELL BIOL, V31, P3700, DOI 10.1128/MCB.05448-11; Yoon CH, EMBO REP, V11, P393; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu JH, 2009, BLOOD, V113, P5558, DOI 10.1182/blood-2009-02-205732; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	37	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42006	10.1371/journal.pone.0042006	http://dx.doi.org/10.1371/journal.pone.0042006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870275	gold, Green Submitted, Green Published			2022-12-25	WOS:000307212800051
J	Bi, MJ; Tong, J; Chang, F; Wang, J; Wei, HX; Dai, YP; Chu, MX; Zhao, YF; Li, N				Bi, Mingjun; Tong, Jia; Chang, Fei; Wang, Jing; Wei, Hengxi; Dai, Yunping; Chu, Mingxing; Zhao, Yaofeng; Li, Ning			Pituitary-Specific Overexpression of Porcine Follicle-Stimulating Hormone Leads to Improvement of Female Fecundity in BAC Transgenic Mice	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; BETA-SUBUNIT GENE; TIME QUANTITATIVE PCR; COPY-NUMBER; ESCHERICHIA-COLI; EXPRESSION; DNA; GONADOTROPINS; CLONING; MODELS	Follicle-stimulating hormone (FSH) is a pituitary glycoprotein that, together with luteinizing hormone, plays a crucial role in ovarian folliculogenesis and female fertility. We previously found that FSH beta is a major gene controlling high prolificacy of Chinese Erhualian pigs. To directly study the biological effects on reproductive function of porcine FSH (pFSH) for polyovulatory species, we generated a novel gain-of-function mouse model using a bacterial artificial chromosome (BAC) system to jointly introduce 92 kb and 165 kb genomic fragments comprising the pFSH alpha- and beta-subunit genes. These directed the physiological expression of pFSH with the same temporal and spatial pattern as endogenous FSH in female transgenic (TG) mice. Serum levels of biologically active pFSH heterodimers in independent TG lines ranged from 6.36 to 19.83 IU/L. High basal pFSH activity led to a significant reduction of serum LH and testosterone levels in TG females compared to wild-type (WT) littermates, yet endogenous FSH and estradiol levels were significantly elevated. Interestingly, ovarian histology showed that the number of corpora lutea was significantly higher at 14 and 28 weeks of age in TG females and breeding curves revealed that mean litter sizes of TG females were obviously larger than for WT littermates before 52 weeks of age. These findings indicate that pituitary-specific overexpression of pFSH within physiological boundaries can increase ovulation rate and litter size, but it does not cause reproductive defects. Therefore, our TG mouse model provides exciting insights for investigating the actions of pFSH in vivo.	[Bi, Mingjun; Tong, Jia; Chang, Fei; Wang, Jing; Dai, Yunping; Zhao, Yaofeng; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wei, Hengxi] S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Chu, Mingxing] Chinese Acad Agr Sci, Key Lab Farm Anim Genet Resources & Germplasm Inn, Minist Agr, Inst Anim Sci, Beijing 100193, Peoples R China	China Agricultural University; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Bi, MJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	nlicau@hotmail.com			National Transgenic Breeding Program of China [2008ZX08006-005, 2011ZX08006-005, 2011ZX08010-006]	National Transgenic Breeding Program of China	This work was supported by National Transgenic Breeding Program of China (2008ZX08006-005, 2011ZX08006-005 and 2011ZX08010-006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2006, J ENDOCRINOL, V188, P549, DOI 10.1677/joe.1.06614; Allan CM, 2001, ENDOCRINOLOGY, V142, P2213, DOI 10.1210/en.142.6.2213; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Campbell BK, 2006, ENDOCRINOLOGY, V147, P1608, DOI 10.1210/en.2005-0604; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chrast R, 1999, TRANSGENIC RES, V8, P147, DOI 10.1023/A:1008858014473; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Du Li-Xin, 2002, Yi Chuan Xue Bao, V29, P977; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; He ZY, 2008, FREE RADICAL BIO MED, V45, P1135, DOI 10.1016/j.freeradbiomed.2008.07.019; HIRAI T, 1990, J MOL ENDOCRINOL, V5, P147, DOI 10.1677/jme.0.0050147; KATO Y, 1989, MOL CELL ENDOCRINOL, V62, P135, DOI 10.1016/0303-7207(89)90122-6; KATO Y, 1991, J MOL ENDOCRINOL, V7, P27, DOI 10.1677/jme.0.0070027; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kumar TR, 2007, MOL CELL ENDOCRINOL, V260, P249, DOI 10.1016/j.mce.2006.09.002; Kumar TR, 1999, MOL ENDOCRINOL, V13, P851, DOI 10.1210/me.13.6.851; KUMAR TR, 1992, MOL ENDOCRINOL, V6, P81, DOI 10.1210/me.6.1.81; Kumar TR, 2006, MOL CELL ENDOCRINOL, V247, P103, DOI 10.1016/j.mce.2005.12.006; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 1998, ENDOCRINOLOGY, V139, P3289, DOI 10.1210/en.139.7.3289; KUMAR TR, 1995, NEUROENDOCRINOLOGY, V61, P628, DOI 10.1159/000126889; KUMAR TR, 1993, MOL ENDOCRINOL, V7, P898, DOI 10.1210/me.7.7.898; LAMB BT, 1995, CURR OPIN GENET DEV, V5, P342, DOI 10.1016/0959-437X(95)80049-2; Liu W, 2006, PROG NAT SCI-MATER, V16, P889; LIU YX, 1986, BIOL REPROD, V35, P27, DOI 10.1095/biolreprod35.1.27; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matzuk MM, 2003, BIOL REPROD, V69, P338, DOI 10.1095/biolreprod.102.013953; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McTavish KJ, 2007, ENDOCRINOLOGY, V148, P4432, DOI 10.1210/en.2007-0046; MONACO AP, 1994, TRENDS BIOTECHNOL, V12, P280, DOI 10.1016/0167-7799(94)90140-6; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Nielsen LB, 1997, J BIOL CHEM, V272, P29752, DOI 10.1074/jbc.272.47.29752; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Rulli SB, 2005, REPRODUCTION, V130, P283, DOI 10.1530/rep.1.00661; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Stinnakre MG, 1999, BIOCHEM J, V339, P33, DOI 10.1042/0264-6021:3390033; Strong SJ, 1997, NUCLEIC ACIDS RES, V25, P3959, DOI 10.1093/nar/25.19.3959; Su P, 2005, BIOL REPROD, V73, P681, DOI 10.1095/biolreprod.104.039164; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Tomic D, 2007, REPROD TOXICOL, V23, P317, DOI 10.1016/j.reprotox.2006.08.004; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Zhao YF, 1998, SCI CHINA SER C, V41, P664, DOI 10.1007/BF02882910	49	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42335	10.1371/journal.pone.0042335	http://dx.doi.org/10.1371/journal.pone.0042335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860114	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600091
J	Xie, W; Feng, Q; Su, YH; Dong, B; Wu, J; Meng, L; Qu, LK; Shou, CC				Xie, Wei; Feng, Qin; Su, Yahui; Dong, Bin; Wu, Jian; Meng, Lin; Qu, Like; Shou, Chengchao			Transcriptional Regulation of PES1 Expression by c-Jun in Colon Cancer	PLOS ONE			English	Article							60S RIBOSOMAL-SUBUNIT; CELL-PROLIFERATION; NUCLEOLAR LOCALIZATION; PEBOW-COMPLEX; BRCT DOMAIN; PESCADILLO; BIOGENESIS; PROTEIN; GENE; BOP1	Pescadillo is a nucleolar protein that has been suggested to be involved in embryonic development and ribosome biogenesis. Deregulated expression of human pescadillo (PES1) was described in some tumors, but its precise roles in tumorigenesis remains unclear. In this study, we generated three monoclonal antibodies recognizing PES1 with high specificity and sensitivity, with which PES1 expression in human colon cancer was analyzed immunohistochemically. Out of 265 colon cancer tissues, 89 (33.6%) showed positive PES1 expression, which was significantly higher than in non-cancerous tissues (P<0.001). Silencing of PES1 in colon cancer cells resulted in decreased proliferation, reduced growth of xenografts, and cell cycle arrest in G1 phase, indicating PES1 functions as an oncogene. We then explored the mechanism by which PES1 expression is controlled in human colon cancers and demonstrated that c-Jun, but not JunB, JunD, c-Fos, or mutant c-Jun, positively regulated PES1 promoter transcription activity. In addition, we mapped -274/-264 region of PES1 promoter as the c-Jun binding sequence, which was validated by chromatin immunoprecipitation and electrophoretic mobility shift assays. Moreover, we demonstrated a positive correlation between c-Jun and PES1 expression in colon cancer cells and colon cancer tissues. Upstream of c-Jun, it was revealed that c-Jun NH2-terminal kinases (JNK) is essential for controlling PES1 expression. Our study, in the first place, uncovers the oncogenic role of PES1 in colon cancer and elucidates the molecular mechanism directing PES1 expression.	[Xie, Wei; Feng, Qin; Su, Yahui; Wu, Jian; Meng, Lin; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Dong, Bin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Xie, W (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	scc@bjcancer.org			National 973 Program of China [2009CB521805]; National Nature Science Foundation of China [81172367]	National 973 Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National 973 Program of China (2009CB521805) and the National Nature Science Foundation of China (81172367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Charpentier AH, 2000, CANCER RES, V60, P5977; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Haque J, 2000, GENOMICS, V70, P201, DOI 10.1006/geno.2000.6375; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; Holzel M, 2007, NUCLEIC ACIDS RES, V35, P789, DOI 10.1093/nar/gkl1058; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Killian A, 2004, ONCOGENE, V23, P8597, DOI 10.1038/sj.onc.1207845; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kim B, 2003, CANCER RES, V63, P8248; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kondoh N, 2001, ANTICANCER RES, V21, P2429; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022; Prisco M, 2004, MOL CELL BIOL, V24, P5421, DOI 10.1128/MCB.24.12.5421-5433.2004; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Sikorski EM, 2006, J BIOL CHEM, V281, P24423, DOI 10.1074/jbc.M602287200; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Szabo E, 1996, CANCER RES, V56, P305; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Weber A, 2007, HUM PATHOL, V38, P228, DOI 10.1016/j.humpath.2006.07.012; Zhang H, 2005, SCI CHINA SER C, V48, P270, DOI 10.1360/062004-86; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096	35	28	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42253	10.1371/journal.pone.0042253	http://dx.doi.org/10.1371/journal.pone.0042253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860098	gold, Green Published, Green Submitted			2022-12-25	WOS:000306950900083
J	Chell, V; Balmanno, K; Little, AS; Wilson, M; Andrews, S; Blockley, L; Hampson, M; Gavine, PR; Cook, SJ				Chell, V.; Balmanno, K.; Little, A. S.; Wilson, M.; Andrews, S.; Blockley, L.; Hampson, M.; Gavine, P. R.; Cook, S. J.			Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance	ONCOGENE			English	Article						acquired resistance; ERK1/2; FGFR; PKB; tyrosine kinase inhibitors	MULTIPLE-MYELOMA; BLADDER-CANCER; STOMACH-CANCER; GASTRIC-CANCER; PROTEIN-KINASE; C/EBP-ALPHA; LINES; GENE; PHOSPHORYLATION; AMPLIFICATION	Fibroblast growth factor receptors (FGFRs) can act as driving oncoproteins in certain cancers, making them attractive drug targets. Here we have characterized tumour cell responses to two new inhibitors of FGFR1-3, AZ12908010 and the clinical candidate AZD4547, making comparisons with the well-characterized FGFR inhibitor PD173074. In a panel of 16 human tumour cell lines, the anti-proliferative activity of AZ12908010 or AZD4547 was strongly linked to the presence of deregulated FGFR signalling, indicating that addiction to deregulated FGFRs provides a therapeutic opportunity for selective intervention. Acquired resistance to targeted tyrosine kinase inhibitors is a growing problem in the clinic but has not yet been explored for FGFR inhibitors. To assess how FGFR-dependent tumour cells adapt to long-term FGFR inhibition, we generated a derivative of the KMS-11 myeloma cell line (FGFR(Y373C)) with acquired resistance to AZ12908010 (KMS-11R cells). Basal phosphorylated FGFR and FGFR-dependent downstream signalling were constitutively elevated and refractory to drug in KMS-11R cells. Sequencing of FGFR3 in KMS-11R cells revealed the presence of a heterozygous mutation at the gatekeeper residue, encoding FGFR3(V555M); consistent with this, KMS-11R cells were cross-resistant to AZD4547 and PD173074. These results define the selectivity and efficacy of two new FGFR inhibitors and identify a secondary gatekeeper mutation as a mechanism of acquired resistance to FGFR inhibitors that should be anticipated as clinical evaluation proceeds.	[Chell, V.; Balmanno, K.; Little, A. S.; Wilson, M.; Cook, S. J.] Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England; [Andrews, S.] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Blockley, L.; Hampson, M.] AstraZeneca, R&D Genet, Macclesfield, Cheshire, England; [Gavine, P. R.] AstraZeneca R&D, Innovat Ctr China, Shanghai, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca; AstraZeneca	Cook, SJ (corresponding author), Babraham Inst, Signalling Lab, Babraham Res Campus, Cambridge CB22 3AT, England.	simon.cook@babraham.ac.uk		Cook, Simon/0000-0001-9087-1616; Balmanno, Kathryn/0000-0002-6417-3889	CASE PhD studentship (nee Victoria Knights); Biotechnology and Biological Sciences Research Council (BBSRC); AstraZeneca; Babraham Institute; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C199, BBS/E/B/0000C235, BBS/E/B/000C0417, BBS/E/B/000C0419] Funding Source: researchfish; Worldwide Cancer Research [12-1259] Funding Source: researchfish; BBSRC [BBS/E/B/000C0417, BBS/E/B/0000C235, BBS/E/B/000C0419] Funding Source: UKRI	CASE PhD studentship (nee Victoria Knights); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank Anne Segonds-Pichon (Babraham Bioinformatics Group) for statistical analysis of qRT-PCR data and Jonathan Keats, Janet Nutt, Margaret Knowles, Matthias Ebert and Andrew Garner for provision of some of the cell lines used in this study. We would especially like to thank Andrew Garner for initiating this project, and for discussions and encouragement in its early stages. We are grateful to Teresa Klinowska, Nigel Brooks, Elaine Kilgour and Paul Smith for many useful discussions and suggestions throughout. This work was supported by a CASE PhD studentship (VC, nee Victoria Knights) funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and AstraZeneca, and a sponsored research agreement between AstraZeneca and the Babraham Institute.	Al-Ahmadie HA, 2011, J PATHOL, V224, P270, DOI 10.1002/path.2892; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Azam M, 2006, MOL DIAGN THER, V10, P67, DOI 10.1007/BF03256446; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Binato R, 2009, MOL MED REP, V2, P657, DOI 10.3892/mmr_00000153; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Hammerman PS, 2009, CLIN CANCER RES, V15, P7502, DOI 10.1158/1078-0432.CCR-09-0189; HATTORI Y, 1990, P NATL ACAD SCI USA, V87, P5983, DOI 10.1073/pnas.87.15.5983; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Jang JH, 2001, CANCER RES, V61, P3541; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Klinowska T, 2008, GORD RES C 2 7 MARCH; Klint Peter, 1999, Frontiers in Bioscience, V4, pD165, DOI 10.2741/Klint; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Lombardi L, 2007, GENE CHROMOSOME CANC, V46, P226, DOI 10.1002/gcc.20404; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Moffa AB, 2004, MOL CANCER RES, V2, P643; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MOR O, 1993, CANCER GENET CYTOGEN, V65, P111, DOI 10.1016/0165-4608(93)90217-A; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Squires M, 2011, MOL CANCER THER, V10, P1542, DOI 10.1158/1535-7163.MCT-11-0426; Sun SS, 2012, J SURG ONCOL, V105, P773, DOI 10.1002/jso.22120; Tannheimer SL, 2000, BREAST CANCER RES, V2, P311, DOI 10.1186/bcr73; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; Tsujimoto H, 1997, VIRCHOWS ARCH, V431, P383, DOI 10.1007/s004280050115; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007	60	102	108	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 20	2013	32	25					3059	3070		10.1038/onc.2012.319	http://dx.doi.org/10.1038/onc.2012.319			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	168KX	22869148				2022-12-25	WOS:000320705700006
J	King, JD; Lee, J; Riemen, CE; Neumann, D; Xiong, S; Foskett, JK; Mehta, A; Muimo, R; Hallows, KR				King, J. Darwin, Jr.; Lee, Jeffrey; Riemen, Claudia E.; Neumann, Dietbert; Xiong, Sheng; Foskett, J. Kevin; Mehta, Anil; Muimo, Richmond; Hallows, Kenneth R.			Role of Binding and Nucleoside Diphosphate Kinase A in the Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; IN-VITRO; HISTIDINE PHOSPHORYLATION; CHLORIDE CHANNEL; FLUID SECRETION; R-DOMAIN; CFTR; INHIBITION; TRANSPORT; ATP	Cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel mutations cause cystic fibrosis lung disease. A better understanding of CFTR regulatory mechanisms could suggest new therapeutic strategies. AMP-activated protein kinase (AMPK) binds to and phosphorylates CFTR, attenuating PKA-activated CFTR gating. However, the requirement for AMPK binding to CFTR and the potential role of other proteins in this regulation are unclear. We report that nucleoside diphosphate kinaseA(NDPK-A) interacts with both AMPK and CFTR in overlay blots of airway epithelial cell lysates. Binding studies in Xenopus oocytes and transfected HEK-293 cells revealed that a CFTR peptide fragment that binds AMPK (CFTR-1420-57) disrupted the AMPK-CFTR interaction. Introduction of CFTR-1420-57 into human bronchial Calu-3 cells enhanced forskolin-stimulated whole cell conductance in patch clamp measurements. Similarly, injection of CFTR-1420-57 into Xenopus oocytes blocked the inhibition of cAMP-stimulated CFTR conductance by AMPK in two-electrode voltage clamp studies. AMPK also inhibited CFTR conductance with co-expression of WT NDPK-A in two-electrode voltage clamp studies, but co-expression of a catalytically inactive H118F mutant or various Ser-120 NDPK-A mutants prevented this inhibition. In vitro phosphorylation of WT NDPK-A was enhanced by purified active AMPK, but phosphorylation was prevented in H118F and phosphomimic Ser-120 NDPK-A mutants. AMPK does not appear to phosphorylate NDPK-A directly but rather promotes an NDPK-A autophosphorylation event that involves His-118 and Ser-120. Taken together, these results suggest that NDPK-A exists in a functional cellular complex with AMPK and CFTR in airway epithelia, and NDPK-A catalytic function is required for the AMPK-dependent regulation of CFTR.	[King, J. Darwin, Jr.; Lee, Jeffrey; Xiong, Sheng; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Riemen, Claudia E.; Mehta, Anil] Univ Dundee, Div Med Sci, Dundee DD1 9SY, Scotland; [Neumann, Dietbert] Cardiovasc Res Inst, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Xiong, Sheng] Jinan Univ, Coll Life Sci & Technol, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China; [Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Muimo, Richmond] Univ Sheffield, Sch Med, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Dundee; Maastricht University; Jinan University; University of Pennsylvania; University of Sheffield	Hallows, KR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu	Foskett, Kevin/R-2549-2019; Hallows, Kenneth/A-8477-2013	Foskett, J. Kevin/0000-0002-8854-0268; Neumann, Dietbert/0000-0002-4316-684X; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [P30 DK079307, R01 DK075048, T32 HL007563]; Cystic Fibrosis Foundation [KING10F0, HALLOW06P0]; Wellcome Trust [086370/Z/08/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK075048 (to K. R. H.), and T32 HL007563 (to J. D. K.). This work was also supported by Cystic Fibrosis Foundation Grants KING10F0 (to J. D. K.) and HALLOW06P0 (to K. R. H.).; Supported by Wellcome Trust Grant 086370/Z/08/Z.	Annesley SJ, 2011, N-S ARCH PHARMACOL, V384, P341, DOI 10.1007/s00210-011-0615-0; BELL CL, 1993, AM J PHYSIOL, V264, pC925, DOI 10.1152/ajpcell.1993.264.4.C925; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; Biondi RM, 1996, ANAL BIOCHEM, V242, P165, DOI 10.1006/abio.1996.0449; Biondi RM, 1996, FEBS LETT, V399, P183, DOI 10.1016/S0014-5793(96)01299-9; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dar HH, 2010, BIOCHEM J, V430, P539, DOI 10.1042/BJ20100026; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Guerrant R. L., 1990, REV INFECT DIS, V12, P41; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kowluru A, 2003, AM J PHYSIOL-ENDOC M, V285, pE498, DOI 10.1152/ajpendo.00121.2003; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Muimo R, 2000, J BIOL CHEM, V275, P36632, DOI 10.1074/jbc.M000829200; Muimo R, 2006, J BIOENERG BIOMEMBR, V38, P181, DOI 10.1007/s10863-006-9033-2; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Onyenwoke RU, 2012, MOL BIOL CELL, V23, P381, DOI 10.1091/mbc.E11-08-0699; Pastor-Soler NM, 2012, CURR OPIN NEPHROL HY, V21, P523, DOI 10.1097/MNH.0b013e3283562390; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Treharne KJ, 2009, MOL CELL BIOCHEM, V329, P107, DOI 10.1007/s11010-009-0118-1; TREHARNE KJ, 1994, AM J PHYSIOL-LUNG C, V267, pL592, DOI 10.1152/ajplung.1994.267.5.L592; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	51	25	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33389	33400		10.1074/jbc.M112.396036	http://dx.doi.org/10.1074/jbc.M112.396036			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869372	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000309602100026
J	Wu, CY; Yeh, YC; Chan, JT; Yang, YC; Yang, JR; Liu, MT; Wu, HS; Hsiao, PW				Wu, Chia-Ying; Yeh, Yi-Chun; Chan, Jia-Tsrong; Yang, Yu-Chih; Yang, Ji-Rong; Liu, Ming-Tsan; Wu, Ho-Sheng; Hsiao, Pei-Wen			A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus	PLOS ONE			English	Article							HELPER T-CELLS; HA2 GLYCOPOLYPEPTIDE; FUSION PEPTIDE; HEMAGGLUTININ; NEURAMINIDASE; MICE; PARTICLES; INFECTION; BINDING; ORIGIN	The recent threats of influenza epidemics and pandemics have prioritized the development of a universal vaccine that offers protection against a wider variety of influenza infections. Here, we demonstrate a genetically modified virus-like particle (VLP) vaccine, referred to as H5M2eN1-VLP, that increased the antigenic content of NA and induced rapid recall of antibody against HA(2) after viral infection. As a result, H5M2eN1-VLP vaccination elicited a broad humoral immune response against multiple viral proteins and caused significant protection against homologous RG-14 (H5N1) and heterologous A/California/07/2009 H1N1 (CA/07) and A/PR/8/34 H1N1 (PR8) viral lethal challenges. Moreover, the N1-VLP (lacking HA) induced production of a strong NA antibody that also conferred significant cross protection against H5N1 and heterologous CA/07 but not PR8, suggesting the protection against N1-serotyped viruses can be extended from avian-origin to CA/07 strain isolated in humans, but not to evolutionally distant strains of human-derived. By comparative vaccine study of an HA-based VLP (H5N1-VLP) and NA-based VLPs, we found that H5N1-VLP vaccination induced specific and strong protective antibodies against the HA(1) subunit of H5, thus restricting the breadth of cross-protection. In summary, we present a feasible example of direction of VLP vaccine immunity toward NA and HA(2), which resulted in cross protection against both seasonal and pandemic influenza strains, that could form the basis for future design of a better universal vaccine.	[Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Yang, Ji-Rong; Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Yang, Ji-Rong; Hsiao, Pei-Wen] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Yang, Ji-Rong; Liu, Ming-Tsan; Wu, Ho-Sheng] Ctr Dis Control, Dept Hlth, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Centers For Disease Control - Taiwan	Wu, CY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	pwhsiao@gate.sinica.edu.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	Genome Summit Project-III of Academia Sinica; National Science Council [NSC 95-2745-B-001-003]; Academia Sinica Postdoctoral Fellows Program	Genome Summit Project-III of Academia Sinica; National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica Postdoctoral Fellows Program	This study was financially supported by the Genome Summit Project-III of Academia Sinica (P. W. Hsiao), the National Science Council (NSC 95-2745-B-001-003), and the Academia Sinica Postdoctoral Fellows Program (C.Y. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Bright RA, 2009, VACCINE, V27, P6366, DOI 10.1016/j.vaccine.2009.02.084; Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cohen FS, 2001, NAT STRUCT BIOL, V8, P653, DOI 10.1038/90341; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Horvath A, 1998, IMMUNOL LETT, V60, P127, DOI 10.1016/S0165-2478(97)00137-5; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1987, J IMMUNOL, V139, P2015; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kilbourne E D, 1976, Hosp Pract, V11, P15; Kilbourne ED, 1976, HOSP PRACT, V11, P21; Lai JCC, 2010, J GEN VIROL, V91, P2322, DOI 10.1099/vir.0.019935-0; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Takahashi Y, 2009, J INFECT DIS, V199, P1629, DOI 10.1086/598954; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009784	35	36	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42363	10.1371/journal.pone.0042363	http://dx.doi.org/10.1371/journal.pone.0042363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879951	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900033
J	Wan, X; Kim, MI; Kim, MJ; Kim, I				Wan, Xinlong; Kim, Man Il; Kim, Min Jee; Kim, Iksoo			Complete Mitochondrial Genome of the Free-Living Earwig, Challia fletcheri (Dermaptera: Pygidicranidae) and Phylogeny of Polyneoptera	PLOS ONE			English	Article							DNA-SEQUENCE; NUCLEOTIDE-SEQUENCE; GENE REARRANGEMENTS; CONTROL REGION; RICH REGION; ALIGNED 18S; ORGANIZATION; MODEL; HEXAPODA; INSECTA	The insect order Dermaptera, belonging to Polyneoptera, includes similar to 2,000 extant species, but no dermapteran mitochondrial genome has been sequenced. We sequenced the complete mitochondrial genome of the free-living earwig, Challia fletcheri, compared its genomic features to other available mitochondrial sequences from polyneopterous insects. In addition, the Dermaptera, together with the other known polyneopteran mitochondrial genome sequences (protein coding, ribosomal RNA, and transfer RNA genes), were employed to understand the phylogeny of Polyneoptera, one of the least resolved insect phylogenies, with emphasis on the placement of Dermaptera. The complete mitochondrial genome of C. fletcheri presents the following several unusual features: the longest size in insects is 20,456 bp; it harbors the largest tandem repeat units (TRU) among insects; it displays T- and G-skewness on the major strand and A- and C-skewness on the minor strand, which is a reversal of the general pattern found in most insect mitochondrial genomes, and it possesses a unique gene arrangement characterized by a series of gene translocations and/or inversions. The reversal pattern of skewness is explained in terms of inversion of replication origin. All phylogenetic analyses consistently placed Dermaptera as the sister to Plecoptera, leaving them as the most basal lineage of Polyneoptera or sister to Ephemeroptera, and placed Odonata consistently as the most basal lineage of the Pterygota.	[Wan, Xinlong; Kim, Man Il; Kim, Min Jee; Kim, Iksoo] Chonnam Natl Univ, Coll Agr & Life Sci, Kwangju, South Korea; [Kim, Man Il] Natl Forens Serv, Western Dist Off, Jangseong Gun, Jeonnam Do Prov, South Korea	Chonnam National University; National Forensic Service	Wan, X (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Kwangju, South Korea.	ikkim81@chonnam.ac.kr			National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources"	National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources"	This work was supported by research grants from the National Institute of Biological Resources - "The Genetic Evaluation of Important Biological Resources" awarded to Iksoo Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, SHIN TSUKUSHI KONCHU, V7, P41; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; BOYCE TM, 1989, GENETICS, V123, P825; BROWN WM, 1985, MOL EVOLUTION GENETI; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Carapelli A, 2005, CRUSTACEAN ISS, V16, P295, DOI 10.1201/9781420037548.ch12; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Carpenter F. M., 1992, TREATISE INVERTEBRAT, V4; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cedric G, 2005, ENTOMOLOGY; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Comandi S, 2009, GENE, V439, P25, DOI 10.1016/j.gene.2009.02.020; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Doston EM, 2001, INSECT MOL BIOL, V10, P205; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; FAURON CMR, 1980, NUCLEIC ACIDS RES, V8, P2439, DOI 10.1093/nar/8.11.2439; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Giles E. T., 1963, Transactions of the Royal Entomological Society of London, V115, P95; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gullan PJ, 2010, INSECT OUTLINE ENTOM, V4th; Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inohira K, 1997, MOL BIOL EVOL, V14, P814, DOI 10.1093/oxfordjournals.molbev.a025822; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Komoto N, 2012, GENOME, V55, P222, DOI [10.1139/g2012-007, 10.1139/G2012-007]; Kristensen N.P., 1991, P125; Kukalova-Peck J., 1991, P141; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lin CP, 2010, GENE, V468, P20, DOI 10.1016/j.gene.2010.08.001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2006, GENE, V381, P49, DOI 10.1016/j.gene.2006.06.009; Podsiadlowski L, 2006, INSECT MOL BIOL, V15, P253, DOI 10.1111/j.1365-2583.2006.00640.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvestre D, 2006, GENET MOL BIOL, V29, P572, DOI 10.1590/S1415-47572006000300030; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thompson J.D., 1997, NUCLEIC ACIDS RES, V24, P173; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Willmann R, 2004, ASSEMBLING THE TREE OF LIFE, P330; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yoon Il-Byong, 1996, Korean Journal of Entomology, V26, P403; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang JY, 2008, ANN ENTOMOL SOC AM, V101, P1131, DOI 10.1603/0013-8746-101.6.1131; Zhang YY, 2010, MOL BIOL REP, V37, P3509, DOI 10.1007/s11033-009-9944-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	89	40	44	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42056	10.1371/journal.pone.0042056	http://dx.doi.org/10.1371/journal.pone.0042056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879905	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000013
J	Meyer, JP; Qiu, JJ; Chen, NE; Larkin, GL; Altice, FL				Meyer, Jaimie P.; Qiu, Jingjun; Chen, Nadine E.; Larkin, Gregory L.; Altice, Frederick L.			Emergency Department Use by Released Prisoners with HIV: An Observational Longitudinal Study	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-SERVICES UTILIZATION; SUBSTANCE-ABUSE TREATMENT; ADDICTION SEVERITY INDEX; ANTIRETROVIRAL THERAPY; INFECTED PRISONERS; VULNERABLE POPULATIONS; BEHAVIORAL-MODEL; PHYSICIAN SCALE	Background: Many people living with HIV access healthcare systems through the emergency department (ED), and increased ED use may be indicative of disenfranchisement with primary HIV care, under-managed comorbid disease, or coincide with use of other healthcare resources. The goal of this study was to investigate ED use by HIV-infected prisoners transitioning to communities. Methods: We evaluated ED use by 151 HIV-infected released prisoners who were enrolled in a randomized controlled trial of directly administered versus self-administered antiretroviral therapy in Connecticut. Primary outcomes were quantity and type of ED visits and correlates of ED use were evaluated with multivariate models by Poisson regression. Results: In the 12 months post-release, there were 227 unique ED contacts made by 85/151 (56%) subjects. ED visits were primarily for acute febrile syndromes (32.6%) or pain (20.3%), followed by substance use issues (19.4%), trauma (18%), mental illness (11%), and social access issues (4.4%). Compared to those not utilizing the ED, users were more likely to be white, older, and unmarried, with less trust in their physician and poorer perceived physical health but greater social support. In multivariate models, ED use was correlated with moderate to severe depression (IRR = 1.80), being temporarily housed (IRR = 0.54), and alcohol addiction severity (IRR = 0.21) but not any surrogates of HIV severity. Conclusions: EDs are frequent sources of care after prison-release with visits often reflective of social and psychiatric instability. Future interventions should attempt to fill resource gaps, engage released prisoners in continuous HIV care, and address these substantial needs.	[Meyer, Jaimie P.; Qiu, Jingjun; Chen, Nadine E.; Altice, Frederick L.] Yale Univ, Sch Med, Dept Med, AIDS Program, New Haven, CT 06510 USA; [Larkin, Gregory L.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Larkin, Gregory L.] Univ Auckland, Sch Med, Dept Surg, Div Emergency Med, Auckland, New Zealand; [Chen, Nadine E.] Univ Calif San Diego, Sch Med, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Yale University; University of Auckland; University of California System; University of California San Diego; Yale University	Meyer, JP (corresponding author), Yale Univ, Sch Med, Dept Med, AIDS Program, New Haven, CT 06510 USA.	jaimie.meyer@yale.edu	Meyer, Jaimie/U-1582-2019	Meyer, Jaimie/0000-0001-5735-385X; LARKIN, GREGORY LUKE/0000-0002-8655-7824	National Institute on Drug Abuse [R01 DA017059, K24 DA017072, K23 DA033858]; National Institutes of Allergy and Infectious Diseases [T32 AI007517]; National Institute of Mental Health [T32 MH020031]; American Foundation for Suicide Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007517, R01AI041440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, K23DA033858, R01DA017059] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Foundation for Suicide Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Primary funding for this research was provided by the National Institute on Drug Abuse (R01 DA017059, FLA). The authors would also like to acknowledge career development funding from the National Institutes of Allergy and Infectious Diseases (T32 AI007517 for JPM), the National Institute of Mental Health (T32 MH020031 for JPM), the National Institute on Drug Abuse (K24 DA017072 for FLA and K23 DA033858 for JPM) and the American Foundation for Suicide Prevention (Distinguished Investigator Award for GLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Aday LA, 1997, HDB HLTH BEHAV RES; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altice F, 2011, DAART SUPERIOR SELF; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Andersen R, 1968, BEHAV MODELS FAMILIE; ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; Baillargeon J, 2008, JAMA-J AM MED ASSOC, V98, P661; Baillargeon J, 2010, AIDS PATIENT CARE ST, V24, P389, DOI 10.1089/apc.2009.0303; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; Chen NE, 2011, AIDS BEHAV; Connecticut Department of Correction, 2011, STATISTICS; Cunningham WE, 2006, MED CARE, V44, P1038, DOI 10.1097/01.mlr.0000242942.17968.69; D'Amore J, 2001, ACAD EMERG MED, V8, P1051, DOI 10.1111/j.1553-2712.2001.tb01114.x; Frank J, 2012, C EM DEP UT MENT HLT; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Huba G, 1996, MODULE 46 SOCIAL SUP; James D, 2005, SUBSTANCE DEPENDENCE; James D. J., 2006, HIGHLIGHTS MENTAL HL; Josephs JS, 2010, HIV MED, V11, P74, DOI 10.1111/j.1468-1293.2009.00748.x; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; Masson CL, 2004, AIDS CARE, V16, P744, DOI 10.1080/09540120412331269585; MAUSKOPF J, 1994, HEALTH SERV RES, V29, P489; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Meade CS, 2009, AIDS PATIENT CARE ST, V23, P259, DOI 10.1089/apc.2008.0210; Najavits LM, 1998, J STUD ALCOHOL, V59, P56, DOI 10.15288/jsa.1998.59.56; Niska R, 2010, NATL HOSP AMBULATORY; Palepu A, 2004, ANTIVIR THER, V9, P713; Palepu A, 2003, J SUBST ABUSE TREAT, V25, P37, DOI 10.1016/S0740-5472(03)00064-3; Pollock HA, 2002, J GEN INTERN MED, V17, P341, DOI 10.1046/j.1525-1497.2002.10663.x; Prekker ME, 2009, J TRAUMA, V66, P1688, DOI 10.1097/TA.0b013e31817db0f1; Qualitymetric, 2010, SF36V2 HLTH SURV; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Ruger JP, 2004, ACAD EMERG MED, V11, P1311, DOI 10.1197/j.aem.2004.07.008; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Saber-Tehrani AS, 2012, CONTEMP CLIN TRIALS, V33, P436, DOI 10.1016/j.cct.2011.11.002; Schwarz R, 2012, J SUBSTANCE ABUSE TR; Shults RA, 2009, J SAFETY RES, V40, P329, DOI 10.1016/j.jsr.2009.06.001; Sohler NL, 2007, AIDS PATIENT CARE ST, V21, pS68, DOI 10.1089/apc.2007.9985; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038335; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wohl D, 2010, AIDS BEHAV S1, V125; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Wyatt GE, 2005, J HEALTH CARE POOR U, V16, P9, DOI 10.1353/hpu.2005.0120	62	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42416	10.1371/journal.pone.0042416	http://dx.doi.org/10.1371/journal.pone.0042416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22879972	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100085
J	Wu, B; Li, Y; Wang, CS; Vigneron, DB; Zhang, XL				Wu, Bing; Li, Ye; Wang, Chunsheng; Vigneron, Daniel B.; Zhang, Xiaoliang			Multi-Reception Strategy with Improved SNR for Multichannel MR Imaging	PLOS ONE			English	Article							TO-NOISE RATIO; COIL DESIGN; VOLUME COIL; RADIOFREQUENCY COIL; ARRAY; RECONSTRUCTION; SMASH; ACQUISITION; PERFORMANCE; HARMONICS	A multi-reception strategy with extended GRAPPA is proposed in this work to improve MR imaging performance at ultra-high field MR systems with limited receiver channels. In this method, coil elements are separated to two or more groups under appropriate grouping criteria. Those groups are enabled in sequence for imaging first, and then parallel acquisition is performed to compensate for the redundant scan time caused by the multiple receptions. To efficiently reconstruct the data acquired from elements of each group, a specific extended GRAPPA was developed. This approach was evaluated by using a 16-element head array on a 7 Tesla whole-body MRI scanner with 8 receive channels. The in-vivo experiments demonstrate that with the same scan time, the 16-element array with twice receptions and acceleration rate of 2 can achieve significant SNR gain in the periphery area of the brain and keep nearly the same SNR in the center area over an eight-element array, which indicates the proposed multi-reception strategy and extended GRAPPA are feasible to improve image quality for MRI systems with limited receive channels. This study also suggests that it is advantageous for a MR system with N receiver channels to utilize a coil array with more than N elements if an appropriate acquisition strategy is applied.	[Wu, Bing; Li, Ye; Wang, Chunsheng; Vigneron, Daniel B.; Zhang, Xiaoliang] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Vigneron, Daniel B.; Zhang, Xiaoliang] Univ Calif Berkeley, Univ Calif San Francisco Univ Calif Berkeley Join, Berkeley, CA 94720 USA; [Vigneron, Daniel B.; Zhang, Xiaoliang] Calif Inst Quantitat Biosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Wu, B (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	xiaoliang.zhang@ucsf.edu			National Institutes of Health [EB004453, EB008699, P41EB013598]; QB3; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008699, P41EB013598, R01EB004453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding provided by National Institutes of Health grants EB004453, EB008699 and P41EB013598, www.nih.gov, and QB3, qb3.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Banerjee S, 2006, MAGN RESON MED, V56, P1075, DOI 10.1002/mrm.21059; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Bydder M, 2002, MAGNET RESON MED, V47, P160, DOI 10.1002/mrm.10044; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Gilbert KM, 2010, MAGN RESON MED, V64, P1640, DOI 10.1002/mrm.22574; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Jakob PM, 1998, MAGN RESON MATER PHY, V7, P42; King SB, 2010, MAGN RESON MED, V63, P1346, DOI 10.1002/mrm.22295; Ledden PJ, 2005, P 13 ISMRM ANN M MIA, P322; Li Y, 2011, QUANT IMAGING MED SU, V1, P24, DOI 10.3978/j.issn.2223-4292.2011.11.04; Li Y, 2011, MED PHYS, V38, P4086, DOI 10.1118/1.3598112; Liang ZP, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P1204; Lin FH, 1999, IEEE T MED IMAGING, V18, P1129, DOI 10.1109/42.819323; McKenzie CA, 2004, RADIOLOGY, V230, P589, DOI 10.1148/radiol.2302021230; McKenzie CA, 2002, MAGNET RESON MED, V47, P529, DOI 10.1002/mrm.10087; McKenzie CA, 2001, MAGNET RESON MED, V46, P619, DOI 10.1002/mrm.1236; Ohliger MA, 2004, MAGNET RESON MED, V52, P628, DOI 10.1002/mrm.20195; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pang Y, 2011, QUANT IMAGING MED SU, V1, P4, DOI 10.3978/j.issn.2223-4292.2011.11.02; Pang Y, 2012, MAGN RESON MED, V67, P965, DOI 10.1002/mrm.23073; Pang Y, 2011, CONCEPT MAGN RESON B, V39B, P206, DOI 10.1002/cmr.b.20209; Pang Y, 2012, MAGN RESON IMAGING, V30, P290, DOI 10.1016/j.mri.2011.09.022; Pang Y, 2011, IEEE T MED IMAGING, V30, P1965, DOI 10.1109/TMI.2011.2160192; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Qu P, 2005, J MAGN RESON, V174, P60, DOI 10.1016/j.jmr.2005.01.015; Reykowski A., 2004, P 12 ANN M ISMRM KYO, P1587; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Spence DK, 2005, P ANN INT IEEE EMBS, P4286, DOI 10.1109/IEMBS.2005.1615412; Traficante D.D., 1991, CONCEPT MAGNETIC RES, V3, P83, DOI [10.1002/cmr.1820030203, DOI 10.1002/CMR.1820030203]; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Vossen M, 2011, J MAGN RESON, V208, P291, DOI 10.1016/j.jmr.2010.11.004; WALD LL, 1995, MAGNET RESON MED, V34, P433, DOI 10.1002/mrm.1910340321; Wang CS, 2012, MAGN RESON IMAGING, V30, P78, DOI 10.1016/j.mri.2011.08.007; Wang Z, 2005, MAGN RESON MED, V54, P738, DOI 10.1002/mrm.20601; Weiger M, 2001, MAGNET RESON MED, V45, P495, DOI 10.1002/1522-2594(200103)45:3<495::AID-MRM1065>3.0.CO;2-V; Wiesinger F, 2004, MAGNET RESON MED, V52, P376, DOI 10.1002/mrm.20183; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wu B, 2010, P 18 ANN M ISMRM STO, P3860; Wu B, 2012, MAGN RESON MED, V68, P1332, DOI 10.1002/mrm.24121; Wu B, 2012, IEEE T MED IMAGING, V31, P183, DOI 10.1109/TMI.2011.2166273; Wu B, 2010, IEEE T BIO-MED ENG, V57, P397, DOI 10.1109/TBME.2009.2030170; Wu B, 2010, IEEE T MED IMAGING, V29, P179, DOI 10.1109/TMI.2009.2033597; Zhang Xiaoliang, 2012, OMICS J Radiol, V1, pe110; Zhang XL, 2005, MAGN RESON MED, V53, P1234, DOI 10.1002/mrm.20462; Zhang XL, 2005, IEEE T BIO-MED ENG, V52, P495, DOI 10.1109/TBME.2004.842968; Zhang XL, 2003, J MAGN RESON, V161, P242, DOI 10.1016/S1090-7807(03)00004-1; Zhang XL, 2001, MAGNET RESON MED, V46, P443, DOI 10.1002/mrm.1212	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42237	10.1371/journal.pone.0042237	http://dx.doi.org/10.1371/journal.pone.0042237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879921	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100057
J	Jacobs, JH; Archer, BN; Baker, MG; Cowling, BJ; Heffernan, RT; Mercer, G; Uez, O; Hanshaoworakul, W; Viboud, C; Schwartz, J; Tchetgen, ET; Lipsitch, M				Jacobs, Jessica Hartman; Archer, Brett Nicholas; Baker, Michael G.; Cowling, Benjamin J.; Heffernan, Richard T.; Mercer, Geoff; Uez, Osvaldo; Hanshaoworakul, Wanna; Viboud, Cecile; Schwartz, Joel; Tchetgen, Eric Tchetgen; Lipsitch, Marc			Searching for Sharp Drops in the Incidence of Pandemic A/H1N1 Influenza by Single Year of Age	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; A H1N1 VIRUS; PREEXISTING IMMUNITY; ANTIBODY; INFECTION; RESPONSES; HUMANS	Background: During the 2009 H1N1 pandemic (pH1N1), morbidity and mortality sparing was observed among the elderly population; it was hypothesized that this age group benefited from immunity to pH1N1 due to cross-reactive antibodies generated from prior infection with antigenically similar influenza viruses. Evidence from serologic studies and genetic similarities between pH1N1 and historical influenza viruses suggest that the incidence of pH1N1 cases should drop markedly in age cohorts born prior to the disappearance of H1N1 in 1957, namely those at least 52-53 years old in 2009, but the precise range of ages affected has not been delineated. Methods and Findings: To test for any age-associated discontinuities in pH1N1 incidence, we aggregated laboratory-confirmed pH1N1 case data from 8 jurisdictions in 7 countries, stratified by single year of age, sex (when available), and hospitalization status. Using single year of age population denominators, we generated smoothed curves of the weighted risk ratio of pH1N1 incidence, and looked for sharp drops at varying age bandwidths, defined as a significantly negative second derivative. Analyses stratified by hospitalization status and sex were used to test alternative explanations for observed discontinuities. We found that the risk of laboratory-confirmed infection with pH1N1 declines with age, but that there was a statistically significant leveling off or increase in risk from about 45 to 50 years of age, after which a sharp drop in risk occurs until the late fifties. This trend was more pronounced in hospitalized cases and in women and was independent of the choice in smoothing parameters. The age range at which the decline in risk accelerates corresponds to the cohort born between 1951-1959 (hospitalized) and 1953-1960 (not hospitalized). Conclusions: The reduced incidence of pH1N1 disease in older individuals shows a detailed age-specific pattern consistent with protection conferred by exposure to influenza A/H1N1 viruses circulating before 1957.	[Jacobs, Jessica Hartman; Schwartz, Joel; Tchetgen, Eric Tchetgen; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Archer, Brett Nicholas] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Baker, Michael G.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Heffernan, Richard T.] Wisconsin Dept Hlth Serv, Div Publ Hlth, Madison, WI USA; [Mercer, Geoff] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Uez, Osvaldo] Minist Publ Hlth, Natl Inst Epidemiol, ANLIS, Buenos Aires, DF, Argentina; [Hanshaoworakul, Wanna] Minist Publ Hlth, Dept Dis Control, Tiwanond, Nonthaburi, Thailand; [Viboud, Cecile] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Tchetgen, Eric Tchetgen] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Otago; University of Hong Kong; Australian National University; Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jacobs, JH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jhartman44@gmail.com	Archer, Brett Nicholas/A-5610-2012; Tchetgen, Eric Tchetgen/AAF-6160-2021; Cowling, Benjamin John/C-4263-2009	Archer, Brett Nicholas/0000-0002-4144-1094; Cowling, Benjamin John/0000-0002-6297-7154; Lipsitch, Marc/0000-0003-1504-9213	National Institute Of General Medical Sciences [U54GM088558]; MedImmune Inc.; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MedImmune Inc.(AstraZenecaMedimmune); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by the National Institute Of General Medical Sciences [Award Number U54GM088558], http://www.nigms.nih.gov/. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BJC has received research funding from MedImmune Inc. and consults for Crucell MV. ML declares consulting income/honoraria from Pfizer, Novartis, Avian/Pandemic Flu Registry (Outcome Sciences, supported by Roche), and AIR Worldwide. The following co-authors are editors: Benjamin J Cowling and Cecile Viboud. This does not alter the authors` adherence to all the PLoS ONE policies on sharing data and materials.	Adalja AA, 2010, EMERG INFECT DIS, V16, P1028, DOI [10.3201/eid1606.091563, 10.3201/eid1606.091653]; Balter S, 2010, EMERG INFECT DIS, V16, P1259, DOI 10.3201/eid1608.091847; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Booy R, 2011, MED J AUSTRALIA, V194, P19, DOI 10.5694/j.1326-5377.2011.tb04139.x; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EURO SURVEILL, V15; Instituto Nacional de Estadistica y Censos, 2010, CUADR P2 TOT PAIS PO; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Klein SL, 2010, BIOL SEX DIFFER, V1, P5; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Prachayangprecha S, 2010, J HEALTH POPUL NUTR, V28, P537, DOI 10.3329/jhpn.v28i6.6601; R Development Core Team, 2009, R FDN STAT COMP; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Siegel, 2004, METHODS MAT DEMOGRAP; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sonderegger D., 2008, SIZER SIGNIFICANT ZE; Statistics South Africa, 2009, MID POP EST 2009; VAILLANT L, 2009, EURO SURVEILL, V14; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viboud C, 2010, PLOS CURR; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	40	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42328	10.1371/journal.pone.0042328	http://dx.doi.org/10.1371/journal.pone.0042328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876316	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700044
J	Johnson, SE; Barrick, D				Johnson, Scott E.; Barrick, Douglas			Dissecting and Circumventing the Requirement for RAM in CSL-Dependent Notch Signaling	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; RBP-J; HUMAN HOMOLOG; TRANSCRIPTION COMPLEXES; DROSOPHILA SUPPRESSOR; INTRACELLULAR DOMAIN; BINDING-PROTEIN; ANKYRIN REPEATS; MOUSE NOTCH1	The Notch signaling pathway is an intercellular communication network vital to metazoan development. Notch activation leads to the nuclear localization of the intracellular portion (NICD) of the Notch receptor. Once in the nucleus, NICD binds the transcription factor CSL through a bivalent interaction involving the high-affinity RAM region and the lower affinity ANK domain, converting CSL from a transcriptionally-repressed to an active state. This interaction is believed to directly displace co-repressor proteins from CSL and recruit co-activator proteins. Here we investigate the consequences of this bivalent organization in converting CSL from the repressed to active form. One proposed function of RAM is to promote the weak ANK: CSL interaction; thus, fusion of CSL-ANK should bypass this function of RAM. We find that a CSL-ANK fusion protein is transcriptionally active in reporter assays, but that the addition of RAM in trans further increases transcriptional activity, suggesting another role of RAM in activation. A single F235L point substitution, which disrupts co-repressor binding to CSL, renders the CSL-ANK fusion fully active and refractory to further stimulation by RAM in trans. These results suggest that in the context of a mammalian CSL-ANK fusion protein, the main role of RAM is to displace co-repressor proteins from CSL.	[Johnson, Scott E.; Barrick, Douglas] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Johnson, SE (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	barrick@jhu.edu			National Institutes of Health [GM060001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant GM060001 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Engel ME, 2010, MOL CELL BIOL, V30, P1852, DOI 10.1128/MCB.01342-09; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; Salat D, 2008, MOL CELL BIOL, V28, P3502, DOI 10.1128/MCB.01966-07; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e39093	10.1371/journal.pone.0039093	http://dx.doi.org/10.1371/journal.pone.0039093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876274	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700002
J	Sun, JF; Najafzadeh, MJ; van den Ende, AHGG; Vicente, VA; Feng, PY; Xi, LY; De Hoog, GS				Sun, Jiufeng; Najafzadeh, Mohammed J.; van den Ende, Albertus H. G. Gerrits; Vicente, Vania A.; Feng, Peiying; Xi, Liyan; De Hoog, Gerrit S.			Molecular Characterization of Pathogenic Members of the Genus Fonsecaea Using Multilocus Analysis	PLOS ONE			English	Article							MELANIN-LIKE PIGMENTS; YEAST-LIKE FUNGI; IN-VITRO; INFECTION; CHROMOBLASTOMYCOSIS; DERMATITIDIS; DIVERSITY; LACCASE; CDC42; POLYMORPHISM	Members of the fungal genus Fonsecaea causing human chromoblastomycosis show substantial geographic structuring. Genetic identity of clinical and environmental strains suggests transmission from plant debris, while the evolutionary processes that have led to spatially separated populations have remained unexplained. Sequences of ITS, BT2, ACT1, Cdc42, Lac and HmgA were analyzed, either by direct sequencing or by cloning. Thirty-seven clinical and environmental Fonsecaea strains from Central and South America, Asia, Africa and Europe were sequenced and possible recombination events were calculated. Phylogenetic trees of Cdc42, Lac and HmgA were statistically supported, but ITS, BT2 and ACT1 trees were not. The Standardized Index of Association (I-A(S)) did not detect recombination (I-A(S) = 0.4778), neither did the Phi-test for separate genes. In Fonsecaea nubica non-synonymous mutations causing functional changes were observed in Lac gene, even though no selection pressures were detected with the neutrality test (Tajima D test, p>0.05). Genetic differentiation of populations for each gene showed separation of American, African and Asian populations. Strains of clinical vs. environmental origin showed genetic distances that were comparable or lower than found in geographic differentiation. In conclusion, here we demonstrated clonality of sibling species using multilocus data, geographic structuring of populations, and a low functional and structural selective constraint during evolution of the genus Fonsecaea.	[Sun, Jiufeng; Xi, Liyan; De Hoog, Gerrit S.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Dept Parasitol,Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng; Najafzadeh, Mohammed J.; van den Ende, Albertus H. G. Gerrits; Feng, Peiying; De Hoog, Gerrit S.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Najafzadeh, Mohammed J.; De Hoog, Gerrit S.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1012 WX Amsterdam, Netherlands; [Najafzadeh, Mohammed J.] Mashhad Univ Med Sci, Sch Med, Ghaem Hosp, Canc Mol Pathol Res Ctr, Mashhad, Iran; [Najafzadeh, Mohammed J.] Mashhad Univ Med Sci, Dept Parasitol & Mycol, Mashhad, Iran; [Vicente, Vania A.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil; [Feng, Peiying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [De Hoog, Gerrit S.] Peking Univ, Hlth Sci Ctr, Res Ctr Med Mycol, Beijing 100871, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Amsterdam; Mashhad University Medical Science; Mashhad University Medical Science; Universidade Federal do Parana; Sun Yat Sen University; Peking University	Sun, JF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China.	xiliyan@mail.sysu.edu.cn; de.hoog@cbs.knaw.nl	Najafzadeh, M. J./M-9910-2019; sun, Jiufeng/CAG-6546-2022; vicente, vania/AAF-3464-2020; Najafzadeh, Mohammad Javad/F-9986-2017	Najafzadeh, M. J./0000-0002-0590-1073; vicente, vania/0000-0002-2953-4861; sun, jiufeng/0000-0003-1047-929X	National Natural Science Foundation of China [U0932009]; Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships [CEVF-00007]; International Program of Project 985 at Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships; International Program of Project 985 at Sun Yat-sen University	This work was supported by National Natural Science Foundation of China (No.U0932009) and The Federation of European Biochemical Societies (FEBS) Chinese European Visiting Fellowships (No. CEVF-00007), and was partly supported by the International Program of Project 985 at Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Attapattu MC, 1997, MYCOPATHOLOGIA, V137, P145, DOI 10.1023/A:1006819530825; Badali H, 2008, STUD MYCOL, P175, DOI 10.3114/sim.2008.61.18; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CHASKES S, 1978, J CLIN MICROBIOL, V7, P146; COOPER CR, 1993, INFECT IMMUN, V61, P2069, DOI 10.1128/IAI.61.5.2069-2081.1993; de Hoog GS, 2003, J CLIN MICROBIOL, V41, P4767, DOI 10.1128/JCM.41.10.4767-4778.2003; de Hoog GS, 2004, MED MYCOL, V42, P405, DOI 10.1080/13693780410001661464; Deng S, 2008, STUD MYCOL, P121, DOI 10.3114/sim.2008.61.12; Dong F, 2005, INFECT IMMUN, V73, P1868, DOI 10.1128/IAI.73.3.1868-1872.2005; Esterre P, 1996, AM J TROP MED HYG, V55, P45, DOI 10.4269/ajtmh.1996.55.45; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Henikoff JG, 1996, COMPUT APPL BIOSCI, V12, P135; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kawasaki M, 1999, MED MYCOL, V37, P435, DOI 10.1046/j.1365-280X.1999.00210.x; Kombila M, 1995, Sante, V5, P235; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Mander GJ, 2006, APPL ENVIRON MICROB, V72, P5020, DOI 10.1128/AEM.00060-06; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Morris-Jones R, 2005, INFECT IMMUN, V73, P6147, DOI 10.1128/IAI.73.9.6147-6150.2005; Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; Najafzadeh MJ, 2009, MED MYCOL, V47, P17, DOI 10.1080/13693780802527178; Najafzadeh MJ, 2011, EMERG INFECT DIS, V17, P464, DOI [10.3201/1703.100555, 10.3201/eid1703.100555]; Nosanchuk JD, 2004, FEMS MICROBIOL LETT, V239, P187, DOI 10.1016/j.femsle.2004.08.040; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Queiroz-Telles F, 2009, MED MYCOL, V47, P3, DOI 10.1080/13693780802538001; Salgado Claudio Guedes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P33, DOI 10.1590/S0036-46652004000100006; Silva JP, 1998, MYCOPATHOLOGIA, V143, P171, DOI 10.1023/A:1006957415346; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Sun JF, 2011, MYCOPATHOLOGIA, V172, P373, DOI 10.1007/s11046-011-9439-1; Sun J, 2010, J MICROBIOL METH, V80, P19, DOI 10.1016/j.mimet.2009.10.002; Szaniszlo P J, 1993, Arch Med Res, V24, P251; TAJIMA F, 1989, GENETICS, V123, P585; Tanabe Hiroshi, 2004, Nihon Ishinkin Gakkai Zasshi, V45, P105, DOI 10.3314/jjmm.45.105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Vicente VA, 2008, STUD MYCOL, P137, DOI 10.3114/sim.2008.61.14; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; Xi LY, 2009, MED MYCOL, V47, P27, DOI 10.1080/13693780802468209; Xie Z, 2012, MOL BIOL REP, V39, P839, DOI 10.1007/s11033-011-0806-2; Ye XC, 2000, J BACTERIOL, V182, P4941, DOI 10.1128/JB.182.17.4941-4950.2000	47	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41512	10.1371/journal.pone.0041512	http://dx.doi.org/10.1371/journal.pone.0041512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876287	gold, Green Published			2022-12-25	WOS:000307184700015
J	Jian, HH; Xu, J; Xiao, X; Wang, FP				Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping			Dynamic Modulation of DNA Replication and Gene Transcription in Deep-Sea Filamentous Phage SW1 in Response to Changes of Host Growth and Temperature	PLOS ONE			English	Article							SHEWANELLA-PIEZOTOLERANS WP3; PLASMID COPY NUMBER; COLD-SHOCK RESPONSE; MINUS-STRAND ORIGIN; ESCHERICHIA-COLI; MESSENGER-RNA; ESCAPE SYNTHESIS; WEST PACIFIC; BACTERIOPHAGE; LAMBDA	Little is known about the response of deep-sea virus and their relationship with their host towards environmental change. Although viruses are thought to play key roles in the deep-sea ecological evolution and biogeochemical cycling, these roles are yet to be defined. This study aims to delineate the relationship between a deep-sea filamentous phage SW1 and its host Shewanella piezotolerans (S. piezotolerans) WP3, and their response towards temperature change. The copy number of SW1's replicative form (RF-) DNA and single-stranded (ss-) DNA along the different growth phases of WP3 were quantified at 20 degrees C and 4 degrees C, respectively. The copy number of SW1 RF-DNA was found to be temperature and growth phase-dependent, while the ssDNA of SW1 was only produced at 4 degrees C. This is the first report showing low-temperature dependence of phage DNA replication. The transcription of SW1 key genes fpsA and fpsR were also found to be induced at low temperature during all the monitored growth periods of WP3. Additionally, the transcription of SW1 was found to be induced by cold-shock while its DNA replication was not changed. Our data demonstrates a dynamic change of virus DNA replication and transcription in accordance with host growth, and the low temperature adapted mechanisms for SW1 activities in the deep sea. This low temperature adapted deep-sea virus-bacterium system could serve as an ideal model to further study the mechanism and relationship of deep-sea virus-bacteria ecosystems.	[Jian, Huahua] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Jian, Huahua; Xu, Jun; Xiao, Xiang; Wang, Fengping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Wang, Fengping] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Xiamen University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, FP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	fengpingw@sjtu.edu.cn	Jian, Huahua/E-6732-2016; xiao, xiang/GWU-6035-2022	Jian, Huahua/0000-0001-5507-497X	National Science Foundation of China [40830213, 41076078]; Science and Technology Commission of Shanghai Municipality [10JC1406700]; State Key Laboratory of Ocean Engineering in China [GKZD010053-1]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key Laboratory of Ocean Engineering in China	This work was supported by National Science Foundation of China (grant No. 40830213, 41076078); a grant from the Science and Technology Commission of Shanghai Municipality (grant No. 10JC1406700), and a grant from the State Key Laboratory of Ocean Engineering in China (grant No. GKZD010053-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X; Fang L, 1999, FEMS MICROBIOL LETT, V176, P39, DOI 10.1016/S0378-1097(99)00216-5; Fang L, 1997, MOL MICROBIOL, V23, P355, DOI 10.1046/j.1365-2958.1997.2351592.x; Frye JG, 2005, J BACTERIOL, V187, P1485, DOI 10.1128/JB.187.4.1485-1492.2005; FUKASAWA T, 1978, MOL GEN GENET, V167, P83, DOI 10.1007/BF00270324; Gabig M, 1998, MOL GEN GENET, V258, P494, DOI 10.1007/s004380050760; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; GILADI H, 1995, P NATL ACAD SCI USA, V92, P2184, DOI 10.1073/pnas.92.6.2184; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Higashitani A, 1997, P NATL ACAD SCI USA, V94, P2909, DOI 10.1073/pnas.94.7.2909; Higashitani N, 1996, GENES CELLS, V1, P829, DOI 10.1046/j.1365-2443.1996.d01-279.x; Horiuchi K, 1997, GENES CELLS, V2, P425, DOI 10.1046/j.1365-2443.1997.1360334.x; Johnson RM, 1968, J ARIZONA ACAD SCI, V5, p28 , DOI 10.2307/40022820; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Li SK, 2008, ARCH MICROBIOL, V189, P549, DOI 10.1007/s00203-007-0347-1; Li SK, 2006, EXTREMOPHILES, V10, P97, DOI 10.1007/s00792-005-0476-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Obuchowski M, 1997, J BACTERIOL, V179, P5987, DOI 10.1128/jb.179.19.5987-5991.1997; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Sambrook J, 2001, MOL CLONING LAB MANU; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; TAYLOR K, 1995, FEMS MICROBIOL REV, V17, P109; Wang F, 2007, J BACTERIOL, V189, P7151, DOI 10.1128/JB.00569-07; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wang FP, 2004, EXTREMOPHILES, V8, P165, DOI 10.1007/s00792-003-0365-0; Wegrzyn A, 2001, ARCH MICROBIOL, V175, P86, DOI 10.1007/s002030000245; WEGRZYN G, 1995, J BIOTECHNOL, V43, P139; WEGRZYN G, 2001, RRD VIROLOGY I, V3, P375; Wegrzyn G, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-2; Wells LE, 2006, AQUAT MICROB ECOL, V45, P15, DOI 10.3354/ame045015; WIEBE WJ, 1968, MAR BIOL, V1, P244, DOI 10.1007/BF00347117; WILLARD M, 1968, J MOL BIOL, V32, P37, DOI 10.1016/0022-2836(68)90143-5; Xiao X, 2007, INT J SYST EVOL MICR, V57, P60, DOI 10.1099/ijs.0.64500-0; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x	42	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41578	10.1371/journal.pone.0041578	http://dx.doi.org/10.1371/journal.pone.0041578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870232	Green Published, Green Submitted, gold			2022-12-25	WOS:000307212800026
J	Lescarbeau, RM; Seib, FP; Prewitz, M; Werner, C; Kaplan, DL				Lescarbeau, Reynald M.; Seib, F. Philipp; Prewitz, Marina; Werner, Carsten; Kaplan, David L.			In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors	PLOS ONE			English	Article							LNCAP CELLS; ANDROGEN RECEPTOR; NEUROENDOCRINE DIFFERENTIATION; FACTORS INDUCE; PROGRESSION; DEPRIVATION; PHOSPHORYLATION; OSTEOBLASTS; EXPRESSION; SIGNATURE	The spread of prostate cancer cells to the bone marrow microenvironment and castration resistant growth are key steps in disease progression and significant sources of morbidity. However, the biological significance of mesenchymal stem cells (MSCs) and bone marrow derived extracellular matrix (BM-ECM) in this process is not fully understood. We therefore established an in vitro engineered bone marrow tissue model that incorporates hMSCs and BM-ECM to facilitate mechanistic studies of prostate cancer cell survival in androgen-depleted media in response to paracrine factors and BM-ECM. hMSC-derived paracrine factors increased LNCaP cell survival, which was in part attributed to IGFR and IL6 signaling. In addition, BM-ECM increased LNCaP and MDA-PCa-2b cell survival in androgen-depleted conditions, and induced chemoresistance and morphological changes in LNCaPs. To determine the effect of BM-ECM on cell signaling, the phosphorylation status of 46 kinases was examined. Increases in the phosphorylation of MAPK pathway-related proteins as well as sustained Akt phosphorylation were observed in BM-ECM cultures when compared to cultures grown on plasma-treated polystyrene. Blocking MEK1/2 or the PI3K pathway led to a significant reduction in LNCaP survival when cultured on BM-ECM in androgen-depleted conditions. The clinical relevance of these observations was determined by analyzing Erk phosphorylation in human bone metastatic prostate cancer versus non-metastatic prostate cancer, and increased phosphorylation was seen in the metastatic samples. Here we describe an engineered bone marrow model that mimics many features observed in patients and provides a platform for mechanistic in vitro studies.	[Lescarbeau, Reynald M.; Seib, F. Philipp; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Prewitz, Marina; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Dresden, Germany	Tufts University; Leibniz Institut fur Polymerforschung Dresden	Lescarbeau, RM (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Werner, Carsten/F-8127-2010; Prewitz, Marina/G-4482-2013; Werner, Carsten/AAF-1510-2019	Werner, Carsten/0000-0003-0189-3448; Reinsch, Marina/0000-0003-1054-6456; Seib, Philipp/0000-0002-1955-1975	National Institutes of Health (Tissue Engineering Resource Center) [P41 EB002520-05]; Mildred Scheel Postdoctoral fellowship from the German Cancer Aid; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health (Tissue Engineering Resource Center); Mildred Scheel Postdoctoral fellowship from the German Cancer Aid; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant P41 EB002520-05 (Tissue Engineering Resource Center) (DL Kaplan). FP Seib is supported by a Mildred Scheel Postdoctoral fellowship from the German Cancer Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Andresen C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P148; Blaszczyk N, 2004, CLIN CANCER RES, V10, P1860, DOI 10.1158/1078-0432.CCR-0974-3; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Lee JT, 2005, INT J ONCOL, V26, P1637; Lee SO, 2004, PROSTATE, V60, P178, DOI 10.1002/pros.20045; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Martin-Orozco RM, 2007, NEOPLASIA, V9, P614, DOI 10.1593/neo.07337; Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483; Mostaghel EA, 2008, BEST PRACT RES CL EN, V22, P243, DOI 10.1016/j.beem.2008.01.003; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Pathi SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008849; Reichert JC, 2010, BIOMATERIALS, V31, P7928, DOI 10.1016/j.biomaterials.2010.06.055; Seib FP, 2009, TISSUE ENG PT A, V15, P3161, DOI 10.1089/ten.TEA.2008.0600; Seib FP, 2009, EUR J CELL BIOL, V88, P257, DOI 10.1016/j.ejcb.2009.01.003; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Thomas F, 2010, PROSTATE, V70, P856, DOI 10.1002/pros.21119; Vincent T, 2005, LEUKEMIA LYMPHOMA, V46, P803, DOI 10.1080/10428190500051448; Wang G, 2009, CANCER RES, V69, P3433, DOI 10.1158/0008-5472.CAN-08-3506; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Yang J, 2001, CANCER RES, V61, P5652; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	27	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40372	10.1371/journal.pone.0040372	http://dx.doi.org/10.1371/journal.pone.0040372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870197	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800006
J	Eng, D; Ma, HY; Xu, J; Shih, HP; Gross, MK; Kiouss, C				Eng, Diana; Ma, Hsiao-Yen; Xu, Jun; Shih, Hung-Ping; Gross, Michael K.; Kiouss, Chrissa			Loss of Abdominal Muscle in Pitx2 Mutants Associated with Altered Axial Specification of Lateral Plate Mesoderm	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HOX GENES; RIEGER-SYNDROME; TRANSCRIPTIONAL NETWORK; REGULATORY NETWORKS; EXPRESSION ANALYSIS; MOUSE DEVELOPMENT; VERTEBRATE BODY; SKELETAL-MUSCLE; RETINOIC ACID	Sequence specific transcription factors (SSTFs) combinatorially define cell types during development by forming recursively linked network kernels. Pitx2 expression begins during gastrulation, together with Hox genes, and becomes localized to the abdominal lateral plate mesoderm (LPM) before the onset of myogenesis in somites. The somatopleure of Pitx2 null embryos begins to grow abnormally outward before muscle regulatory factors (MRFs) or Pitx2 begin expression in the dermomyotome/myotome. Abdominal somites become deformed and stunted as they elongate into the mutant body wall, but maintain normal MRF expression domains. Subsequent loss of abdominal muscles is therefore not due to defects in specification, determination, or commitment of the myogenic lineage. Microarray analysis was used to identify SSTF families whose expression levels change in E10.5 interlimb body wall biopsies. All Hox9-11 paralogs had lower RNA levels in mutants, whereas genes expressed selectively in the hypaxial dermomyotome/myotome and sclerotome had higher RNA levels in mutants. In situ hybridization analyses indicate that Hox gene expression was reduced in parts of the LPM and intermediate mesoderm of mutants. Chromatin occupancy studies conducted on E10.5 interlimb body wall biopsies showed that Pitx2 protein occupied chromatin sites containing conserved bicoid core motifs in the vicinity of Hox 9-11 and MRF genes. Taken together, the data indicate that Pitx2 protein in LPM cells acts, presumably in combination with other SSTFs, to repress gene expression, that are normally expressed in physically adjoining cell types. Pitx2 thereby prevents cells in the interlimb LPM from adopting the stable network kernels that define sclerotomal, dermomyotomal, or myotomal mesenchymal cell types. This mechanism may be viewed either as lineage restriction or specification.	[Eng, Diana; Ma, Hsiao-Yen; Xu, Jun; Gross, Michael K.; Kiouss, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Shih, Hung-Ping] Univ Calif San Diego, Dept Pediat, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Oregon State University; University of California System; University of California San Diego	Eng, D (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	michael.gross@oregonstate.edu; chrissa.kioussi@oregonstate.edu	Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563	NIH-NIAMS [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by NIH-NIAMS grant AR054406 to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2002, MECH DEVELOP, V110, P187, DOI 10.1016/S0925-4773(01)00560-3; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; BOBER E, 1994, DEVELOPMENT, V120, P3073; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Campione M, 1999, DEVELOPMENT, V126, P1225; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Christ B, 1998, ANAT EMBRYOL, V197, P1; COATES MI, 1995, CURR BIOL, V5, P844, DOI 10.1016/S0960-9822(95)00169-2; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Daston G, 1996, DEVELOPMENT, V122, P1017; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deries M, 2010, DEV DYNAM, V239, P2898, DOI 10.1002/dvdy.22425; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Eng D, 2010, GENE, V469, P1, DOI 10.1016/j.gene.2010.08.008; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Gage PJ, 1999, DEVELOPMENT, V126, P4643; GOULDING M, 1994, DEVELOPMENT, V120, P957; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Schubert M, 2004, P NATL ACAD SCI USA, V101, P10320, DOI 10.1073/pnas.0403216101; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Sporle R, 1996, DEVELOPMENT, V122, P79; SUEMORI H, 1995, MECH DEVELOP, V51, P265, DOI 10.1016/0925-4773(95)00371-1; Summerbell D, 2002, MECH DEVELOP, V117, P331, DOI 10.1016/S0925-4773(02)00208-3; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	68	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42228	10.1371/journal.pone.0042228	http://dx.doi.org/10.1371/journal.pone.0042228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860089	gold, Green Published			2022-12-25	WOS:000307045600076
J	Franzen, CA; Todorovic, V; Desai, BV; Mirzoeva, S; Yang, XMJ; Green, KJ; Pelling, JC				Franzen, Carrie A.; Todorovic, Viktor; Desai, Bhushan V.; Mirzoeva, Salida; Yang, Ximing J.; Green, Kathleen J.; Pelling, Jill C.			The Desmosomal Armadillo Protein Plakoglobin Regulates Prostate Cancer Cell Adhesion and Motility through Vitronectin-Dependent Src Signaling	PLOS ONE			English	Article							GAMMA-CATENIN; BETA-CATENIN; E-CADHERIN; N-CADHERIN; P-CADHERIN; MESENCHYMAL TRANSITION; ALPHA-CATENIN; LNCAP MODEL; EXPRESSION; PATHWAY	Plakoglobin (PG) is an armadillo protein that associates with both classic and desmosomal cadherins, but is primarily concentrated in mature desmosomes in epithelia. While reduced levels of PG have been reported in localized and hormone refractory prostate tumors, the functional significance of these changes is unknown. Here we report that PG expression is reduced in samples of a prostate tumor tissue array and inversely correlated with advancing tumor potential in 7 PCa cell lines. Ectopically expressed PG enhanced intercellular adhesive strength, and attenuated the motility and invasion of aggressive cell lines, whereas silencing PG in less tumorigenic cells had the opposite effect. PG also regulated cell-substrate adhesion and motility through extracellular matrix (ECM)-dependent inhibition of Src kinase, suggesting that PG's effects were not due solely to increased intercellular adhesion. PG silencing resulted in elevated levels of the ECM protein vitronectin (VN), and exposing PG-expressing cells to VN induced Src activity. Furthermore, increased VN levels and Src activation correlated with diminished expression of PG in patient tissues. Thus, PG may inhibit Src by keeping VN low. Our results suggest that loss of intercellular adhesion due to reduced PG expression might be exacerbated by activation of Src through a PG-dependent mechanism. Furthermore, PG down-regulation during PCa progression could contribute to the known VN-dependent promotion of PCa invasion and metastasis, demonstrating a novel functional interaction between desmosomal cell-cell adhesion and cell-substrate adhesion signaling axes in prostate cancer.	[Franzen, Carrie A.; Todorovic, Viktor; Desai, Bhushan V.; Mirzoeva, Salida; Yang, Ximing J.; Green, Kathleen J.; Pelling, Jill C.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	Northwestern University	Franzen, CA (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	j-pelling@northwestern.edu		Todorovic, Viktor/0000-0002-1428-6973; Franzen, Carrie/0000-0002-1127-8599	National Cancer Institute (NCI) Prostate SPORE grant, Zell Foundation [P50 CA90386]; Rosenberg Seed Grant; J. L. Mayberry endowment; National Institutes of Health (NIH) training grants [T32 CA070085, F32 AR055444]; American Cancer Society (ACS) postdoctoral grant [PF-10-235-01-CSM];  [R01s CA122151];  [AR041836]; NATIONAL CANCER INSTITUTE [T32CA070085, P50CA090386, R01CA122151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041836, F32AR055444] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Prostate SPORE grant, Zell Foundation; Rosenberg Seed Grant; J. L. Mayberry endowment; National Institutes of Health (NIH) training grants; American Cancer Society (ACS) postdoctoral grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Cancer Institute (NCI) Prostate SPORE grant P50 CA90386, Zell Foundation, support from Rosenberg Seed Grant (to J.C.P.), R01s CA122151, AR041836 and the J. L. Mayberry endowment (to K.J.G.), National Institutes of Health (NIH) training grants T32 CA070085 (to C.A.F. and V.T.) and F32 AR055444 (to V.T.) and an American Cancer Society (ACS) postdoctoral grant PF-10-235-01-CSM (C.A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Arenas MI, 2000, HISTOCHEM J, V32, P659, DOI 10.1023/A:1004111331752; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; COWIN P, 1994, P NATL ACAD SCI USA, V91, P10759, DOI 10.1073/pnas.91.23.10759; Denk C, 1997, CANCER LETT, V120, P185, DOI 10.1016/S0304-3835(97)00308-X; Dusek RL, 2007, J INVEST DERMATOL, V127, P792, DOI 10.1038/sj.jid.5700615; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Franzen CA, 2009, CANCER PREV RES, V2, P830, DOI 10.1158/1940-6207.CAPR-09-0066; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Giroldi LA, 1999, INT J CANCER, V82, P70, DOI 10.1002/(SICI)1097-0215(19990702)82:1<70::AID-IJC13>3.0.CO;2-#; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzfeld M, 2006, BIOCHIM BIOPHYS ACTA, V1773, P69; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Levenberg S, 1998, J CELL SCI, V111, P347; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; MonierGavelle F, 1997, J CELL BIOL, V137, P1663, DOI 10.1083/jcb.137.7.1663; Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ojakian GK, 2001, J CELL SCI, V114, P941; Palka HL, 1997, J CELL SCI, V110, P2359; Park SI, 2007, EXPERT OPIN THER TAR, V11, P1207, DOI 10.1517/14728222.11.9.1207; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Paul R, 1997, BRIT J UROL, V79, P37, DOI 10.1111/j.1464-410X.1997.tb00799.x; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pontes-Junior Jose, 2009, J Carcinog, V8, P3; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Seiffert D, 1996, J BIOL CHEM, V271, P5474, DOI 10.1074/jbc.271.10.5474; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Sobin L, 2009, TNM CLASSIFICATION M; Society AC, 2010, CANC FACTS FIG 2010; Soler AP, 1997, AM J PATHOL, V151, P471; SOMMERS CL, 1994, CANCER RES, V54, P3544; Stewart D, 2004, NATION, V279, P2; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; THALMANN GN, 1994, CANCER RES, V54, P2577; Todorovic V, 2010, J CELL SCI; Todorovic V, 2010, MOL CELL PROTEOMICS, V9, P351, DOI 10.1074/mcp.M900358-MCP200; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; You XK, 2003, EXP CELL RES, V288, P246, DOI 10.1016/S0014-4827(03)00204-0; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	85	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42132	10.1371/journal.pone.0042132	http://dx.doi.org/10.1371/journal.pone.0042132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860065	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950900071
J	Shao, HJ; Lee, S; Gae-Scott, S; Nakata, C; Chen, SJ; Hamad, AR; Chakravarti, S				Shao, HanJuan; Lee, Seakwoo; Gae-Scott, Sherri; Nakata, Chiaki; Chen, Shoujun; Hamad, Abdel R.; Chakravarti, Shukti			Extracellular Matrix Lumican Promotes Bacterial Phagocytosis, and Lum(-/-) Mice Show Increased Pseudomonas aeruginosa Lung Infection Severity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEINS; GRAM-NEGATIVE BACTERIA; COLLAGEN FIBRILLOGENESIS; PHAGOSOME MATURATION; CORNEAL OPACITY; EXPRESSION; PROTEOGLYCAN; FIBROMODULIN; DECORIN; LPS	Phagocytosis is central to bacterial clearance, but the exact mechanism is incompletely understood. Here, we show a novel and critical role for lumican, the connective tissue extracellular matrix small leucine-rich repeat proteoglycan, in CD14-mediated bacterial phagocytosis. In Psuedomonas aeruginosa lung infections, lumican-deficient (Lum(-/-)) mice failed to clear the bacterium from lungs, tissues, and showed a dramatic increase in mortality. In vitro, phagocytosis of nonopsonized Gram-negative Escherichia coli and P. aeruginosa was inhibited in Lum(-/-) peritoneal macrophages (M Phi s). Lumican co-localized with CD14, CD18, and bacteria on Lum(+/+) M Phi surfaces. Using two different P. aeruginosa strains that require host CD14 (808) or CD18/CR3 (P1) for phagocytosis, we showed that lumican has a larger role in CD14-mediated phagocytosis. Recombinant lumican (rLum) restored phagocytosis in Lum(-/-) M Phi s. Surface plasmon resonance showed specific binding of rLum to CD14 (K-A = 2.15 x 10(6) M-1), whereas rLumY20A, and not rLumY21A, where a tyrosine in each was replaced with an alanine, showed 60-fold decreased binding. The rLumY20A variant also failed to restore phagocytosis in Lum(-/-) M Phi s, indicating Tyr-20 to be functionally important. Thus, in addition to a structural role in connective tissues, lumican has a major protective role in Gram-negative bacterial infections, a novel function for small leucine-rich repeat proteoglycans.	[Shao, HanJuan; Lee, Seakwoo; Gae-Scott, Sherri; Chakravarti, Shukti] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Nakata, Chiaki; Hamad, Abdel R.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Dept Ophthalmol, Sch Med, Baltimore, MD 21205 USA; [Chen, Shoujun] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL 33612 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of South Florida	Chakravarti, S (corresponding author), Johns Hopkins Univ, Dept Med, Sch Med, 720 Rutland Ave, Baltimore, MD 21205 USA.	schakra1@jhmi.edu			National Institutes of Health [NEI EY11654]; NATIONAL EYE INSTITUTE [R01EY011654, R56EY011654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant NEI EY11654 (to S. C).	Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; Grunwald U, 1996, J IMMUNOL, V157, P4119; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Heale JP, 2001, J INFECT DIS, V183, P1214, DOI 10.1086/319685; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; Lambiase A, 2009, NEW MICROBIOL, V32, P277; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Leygue E, 2000, J PATHOL, V192, P313; Lu YP, 2002, PATHOL INT, V52, P519, DOI 10.1046/j.1440-1827.2002.01384.x; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Naito Z, 2002, INT J ONCOL, V20, P943; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pagani L, 2005, J CLIN MICROBIOL, V43, P3824, DOI 10.1128/JCM.43.8.3824-3828.2005; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROUGHLEY PJ, 1994, MICROSC RES TECHNIQ, V28, P385, DOI 10.1002/jemt.1070280505; Safdar A, 2009, EXPERT OPIN DRUG SAF, V8, P435, DOI 10.1517/14740330903036083; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Sztrolovics R, 1999, SPINE, V24, P1765, DOI 10.1097/00007632-199909010-00003; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Troup S, 2003, CLIN CANCER RES, V9, P207; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056	50	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35860	35872		10.1074/jbc.M112.380550	http://dx.doi.org/10.1074/jbc.M112.380550			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22865855	Green Published, hybrid			2022-12-25	WOS:000310364000009
J	Cohen, L; Asraf, H; Sekler, I; Hershfinkel, M				Cohen, Limor; Asraf, Hila; Sekler, Israel; Hershfinkel, Michal			Extracellular pH Regulates Zinc Signaling via an Asp Residue of the Zinc-sensing Receptor (ZnR/GPR39)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; COORDINATION ENVIRONMENTS; MOLECULAR-MECHANISM; INTRACELLULAR CA2+; NA+/H+ EXCHANGE; COLONIC CRYPTS; ION CHANNELS; MUCOSAL PH; CELLS; CALCIUM	Zinc activates a specific Zn2+ -sensing receptor, ZnR/GPR39, and thereby triggers cellular signaling leading to epithelial cell proliferation and survival. Epithelial cells that express ZnR, particularly colonocytes, face frequent changes in extracellular pH that are of physiological and pathological implication. Here we show that the ZnR/GPR39-dependent Ca2+ responses in HT29 colonocytes were maximal at pH 7.4 but were reduced by about 50% at pH 7.7 and by about 62% at pH 7.1 and were completely abolished at pH 6.5. Intracellular acidification did not attenuate ZnR/GPR39 activity, indicating that the pH sensor of this protein is located on an extracellular domain. ZnR/GPR39-dependent activation of extracellular-regulated kinase (ERK) 1/2 or AKT pathways was abolished at acidic extracellular pH of 6.5. A similar inhibitory effect was monitored for the ZnR/GPR39-dependent up-regulation of Na+/H+ exchange activity at pH 6.5. Focusing on residues putatively facing the extracellular domain, we sought to identify the pH sensor of ZnR/GPR39. Replacing the histidine residues forming the Zn2+ binding site, His(17) or His(19), or other extracellular-facing histidines to alanine residues did not abolish the pH dependence of ZnR/GPR39. In contrast, replacing Asp(313) with alanine resulted in similar Ca2+ responses triggered by ZnR/GPR39 at pH 7.4 or 6.5. This mutant also showed similar activation of ERK1/2 and AKT pathways, and ZnR-dependent up-regulation of Na+/H+ exchange at pH 7.4 and pH 6.5. Substitution of Asp(313) to His or Glu residues restored pH sensitivity of the receptor. This indicates that Asp(313), which was shown to modulate Zn2+ binding, is an essential residue of the pH sensor of GPR39. In conclusion, ZnR/GPR39 is tuned to sense physiologically relevant changes in extracellular pH that thus regulate ZnR-dependent signaling and ion transport activity.	[Cohen, Limor; Asraf, Hila; Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hershfinkel, M (corresponding author), Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, POB 653, IL-84105 Beer Sheva, Israel.	hmichal@bgu.ac.il	Hershfinkel, Michal/F-1548-2012	Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [513/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 513/09 (to M. H.).	Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Arena EA, 2012, AM J PHYSIOL-CELL PH, V302, pC412, DOI 10.1152/ajpcell.00163.2011; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Bachmann O, 2011, BIOL PHARM BULL, V34, P794, DOI 10.1248/bpb.34.794; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; CHU SY, 1995, P NATL ACAD SCI USA, V92, P3303, DOI 10.1073/pnas.92.8.3303; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; Cohen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035482; Dong X, 2011, ACTA PHYSIOL, V201, P97, DOI 10.1111/j.1748-1716.2010.02207.x; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Gent AK, 1999, J PHYSIOL-LONDON, V517, P507, DOI 10.1111/j.1469-7793.1999.0507t.x; Goo Tyralee, 2010, Curr Gastroenterol Rep, V12, P465, DOI 10.1007/s11894-010-0147-7; Gore A, 2004, J BIOL CHEM, V279, P11106, DOI 10.1074/jbc.M400005200; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; Hargitai D, 2010, RESP PHYSIOL NEUROBI, V170, P67, DOI 10.1016/j.resp.2009.12.001; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holzer P, 2011, ACTA PHYSIOL, V201, P63, DOI 10.1111/j.1748-1716.2010.02143.x; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Levinthal C, 2009, PHARMACOLOGY, V83, P88, DOI 10.1159/000180124; Liu JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019638; Luk HH, 2002, EUR J PHARMACOL, V443, P197, DOI 10.1016/S0014-2999(02)01592-3; Lukin JA, 2004, CHEM REV, V104, P1219, DOI 10.1021/cr940325w; Malin SA, 2009, J NEUROSCI, V29, P743, DOI 10.1523/JNEUROSCI.3791-08.2009; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; MCDOUGALL CJ, 1993, DIGEST DIS SCI, V38, P542, DOI 10.1007/BF01316512; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Perdikis DA, 1998, DIGEST DIS SCI, V43, P1537, DOI 10.1023/A:1018871016691; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Quinn SJ, 2004, J BIOL CHEM, V279, P37241, DOI 10.1074/jbc.M404520200; Sandoval M, 2011, BIOL PHARM BULL, V34, P803, DOI 10.1248/bpb.34.803; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; Segal D, 2004, BIOCHEM BIOPH RES CO, V323, P1145, DOI 10.1016/j.bbrc.2004.08.211; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; Sharma M, 2005, J PHOTOCH PHOTOBIO B, V81, P107, DOI 10.1016/j.jphotobiol.2005.07.001; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; THORNTON JR, 1981, LANCET, V1, P1081; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Umemura T, 2002, J BIOL CHEM, V277, P1593, DOI 10.1074/jbc.M109930200; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WALKER ARP, 1992, GUT, V33, P572, DOI 10.1136/gut.33.4.572; Walsh BM, 2007, AM J PHYSIOL-CELL PH, V293, pC1687, DOI 10.1152/ajpcell.00189.2006; Wilson M, 2012, J BIOL CHEM, V287, P9322, DOI 10.1074/jbc.C111.320796	57	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33339	33350		10.1074/jbc.M112.372441	http://dx.doi.org/10.1074/jbc.M112.372441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879599	Green Published, hybrid			2022-12-25	WOS:000309602100022
J	Takahata, Y; Hinoi, E; Takarada, T; Nakamura, Y; Ogawa, S; Yoneda, Y				Takahata, Yoshifumi; Hinoi, Eiichi; Takarada, Takeshi; Nakamura, Yukari; Ogawa, Shinya; Yoneda, Yukio			Positive Regulation by gamma-Aminobutyric Acid B Receptor Subunit-1 of Chondrogenesis through Acceleration of Nuclear Translocation of Activating Transcription Factor-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GABA(B) RECEPTOR; EXPRESSION CLONING; INDIAN-HEDGEHOG; PROTEIN; GROWTH; BRAIN; DIFFERENTIATION; MINERALIZATION; CHONDROCYTES	A view that signaling machineries for the neurotransmitter gamma-aminobutyric acid (GABA) are functionally expressed by cells outside the central nervous system is now prevailing. In this study, we attempted to demonstrate functional expression of GABAergic signaling molecules by chondrocytes. In cultured murine costal chondrocytes, mRNA was constitutively expressed for metabotropic GABA(B) receptor subunit-1 (GABA(B)R1), but not for GABA(B)R2. Immunohistochemical analysis revealed the predominant expression of GABABR1 by prehypertrophic to hypertrophic chondrocytes in tibial sections of newborn mice. The GABA(B)R agonist baclofen failed to significantly affect chondrocytic differentiation determined by Alcian blue staining and alkaline phosphatase activity in cultured chondrocytes, whereas newborn mice knocked out of GABA(B)R1 (KO) showed a decreased body size and delayed calcification in hyoid bone and forelimb and hindlimb digits. Delayed calcification was also seen in cultured metatarsals from KO mice with a marked reduction of Indian hedgehog gene (Ihh) expression. Introduction of GABABR1 led to synergistic promotion of the transcriptional activity of activating transcription factor-4 (ATF4) essential for normal chondrogenesis, in addition to facilitating ATF4-dependent Ihh promoter activation. Although immunoreactive ATF4 was negligibly detected in the nucleus of chondrocytes from KO mice, ATF4 expression was again seen in the nucleus and cytoplasm after the retroviral introduction of GABABR1 into cultured chondrocytes from KO mice. In nuclear extracts of KO chondrocytes, a marked decrease was seen in ATF4 DNA binding. These results suggest that GABABR1 positively regulates chondrogenesis through a mechanism relevant to the acceleration of nuclear translocation of ATF4 for Ihh expression in chondrocytes.	[Takahata, Yoshifumi; Hinoi, Eiichi; Takarada, Takeshi; Nakamura, Yukari; Ogawa, Shinya; Yoneda, Yukio] Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021; Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22659065]; Ono Medical Research Foundation; Mishima Kaiun Memorial Foundation, Japan; Grants-in-Aid for Scientific Research [24650196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Mishima Kaiun Memorial Foundation, Japan(Mishima Kaiun Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 22659065 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to E. H.) and in part by research grants from the Ono Medical Research Foundation and the Mishima Kaiun Memorial Foundation, Japan (to E. H.).	Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Long FX, 2006, DEV BIOL, V298, P327, DOI 10.1016/j.ydbio.2006.06.042; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020167; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SCHERFT JP, 1984, METAB BONE DIS RELAT, V5, P195, DOI 10.1016/0221-8747(84)90030-4; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; Takahata Y, 2011, J BIOL CHEM, V286, P32906, DOI 10.1074/jbc.M111.253526; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; Wang LY, 2006, J BIOL CHEM, V281, P24553, DOI 10.1074/jbc.M600939200; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33293	33303		10.1074/jbc.M112.344051	http://dx.doi.org/10.1074/jbc.M112.344051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879594	hybrid, Green Published			2022-12-25	WOS:000309602100018
J	Irieda, H; Morita, T; Maki, K; Homma, M; Aiba, H; Sudo, Y				Irieda, Hiroki; Morita, Teppei; Maki, Kimika; Homma, Michio; Aiba, Hiroji; Sudo, Yuki			Photo-induced Regulation of the Chromatic Adaptive Gene Expression by Anabaena Sensory Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-2 SIGMA-FACTORS; RNA-POLYMERASE; SCHIFF-BASE; HYDROGEN-BOND; FTIR; TRANSCRIPTION; PROTEINS; COMPLEX; ROLES; WATER	Rhodopsin molecules are photochemically reactive membrane-embedded proteins, with seven transmembrane alpha-helices, which bind the chromophore retinal (vitamin A aldehyde). They are roughly divided into two groups according to their basic functions: (i) ion transporters such as proton pumps, chloride pumps, and cation channels; and (ii) photo-sensors such as sensory rhodopsin from microbes and visual pigments from animals. Anabaena sensory rhodopsin (ASR), found in 2003 in the cyanobacterium Anabaena PCC7120, is categorized as a microbial sensory rhodopsin. To investigate the function of ASR in vivo, ASR and the promoter sequence of the pigment protein phycocyanin were co-introduced into Escherichia coli cells with the reporter gene crp. The result clearly showed that ASR functions as a repressor of the CRP protein expression and that this is fully inhibited by the light activation of ASR, suggesting that ASR would directly regulate the transcription of crp. The repression is also clearly inhibited by the truncation of the C-terminal region of ASR, or mutations on the C-terminal Arg residues, indicating the functional importance of the C-terminal region. Thus, our results demonstrate a novel function of rhodopsin molecules and raise the possibility that the membrane-spanning protein ASR could work as a transcriptional factor. In the future, the ASR activity could be utilized as a tool for arbitrary protein expression in vivo regulated by visible light.	[Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Morita, Teppei; Aiba, Hiroji] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Irieda, Hiroki/N-8455-2015; Sudo, Yuki/AGY-0493-2022	Irieda, Hiroki/0000-0002-4545-9187; Sudo, Yuki/0000-0001-8155-9356	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22018010, 23687019]; Grants-in-Aid for Scientific Research [23657100] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 22018010 and 23687019 (to Y. S.).	AIBA H, 1981, J BIOL CHEM, V256, P1905; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; Brown LS, 2006, PHOTOCH PHOTOBIO SCI, V5, P538, DOI 10.1039/b514537f; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Imamura S, 2004, GENES CELLS, V9, P1175, DOI 10.1111/j.1365-2443.2004.00808.x; JOHNSON TR, 1988, J BACTERIOL, V170, P1858, DOI 10.1128/jb.170.4.1858-1865.1988; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kawanabe A, 2006, BIOCHEMISTRY-US, V45, P4362, DOI 10.1021/bi052324b; Kawanabe A, 2008, BIOCHEMISTRY-US, V47, P10033, DOI 10.1021/bi800941a; Kawanabe A, 2007, J AM CHEM SOC, V129, P8644, DOI 10.1021/ja072085a; Kehoe DM, 2010, P NATL ACAD SCI USA, V107, P9029, DOI 10.1073/pnas.1004510107; Klare JP, 2011, EUR J CELL BIOL, V90, P731, DOI 10.1016/j.ejcb.2011.04.013; Koksharova OA, 2002, APPL MICROBIOL BIOT, V58, P123, DOI 10.1007/s00253-001-0864-9; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; SCHNEIDER GJ, 1991, GENE, V105, P51, DOI 10.1016/0378-1119(91)90513-B; SCHNEIDER GJ, 1987, J BIOL CHEM, V262, P14633; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Shi LC, 2006, J MOL BIOL, V358, P686, DOI 10.1016/j.jmb.2006.02.036; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Shibato J, 2002, MOL GENET GENOMICS, V267, P684, DOI 10.1007/s00438-002-0704-3; Sineshchekov OA, 2006, BIOPHYS J, V91, P4519, DOI 10.1529/biophysj.106.093641; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Singh B, 2001, CURR MICROBIOL, V43, P265, DOI 10.1007/s002840010299; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Stowe-Evans EL, 2004, PHOTOCH PHOTOBIO SCI, V3, P495, DOI 10.1039/b316952a; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y., 2012, CRC HDB ORGANIC PHOT, P1173; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Vogeley L, 2007, J MOL BIOL, V367, P741, DOI 10.1016/j.jmb.2006.11.074; Yoshimura T, 2007, FEBS LETT, V581, P1495, DOI 10.1016/j.febslet.2007.03.010	41	35	36	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32485	32493		10.1074/jbc.M112.390864	http://dx.doi.org/10.1074/jbc.M112.390864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22872645	hybrid, Green Published			2022-12-25	WOS:000309168300019
J	Zha, YH; Ding, E; Yang, LQ; Mao, L; Wang, XW; McCarthy, BA; Huang, S; Ding, HF				Zha, Yunhong; Ding, Emily; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Huang, Shuang; Ding, Han-Fei			Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; HIGH-RISK NEUROBLASTOMA; RETINOIC ACID; HOMEOBOX GENES; NEURONAL DIFFERENTIATION; 13-CIS-RETINOIC ACID; NERVOUS-SYSTEM; STEM-CELLS; EXPRESSION; ACTIVATION	Retinoic acid (RA) can induce growth arrest and neuronal differentiation of neuroblastoma cells and has been used in clinic for treatment of neuroblastoma. It has been reported that RA induces the expression of several HOXD genes in human neuroblastoma cell lines, but their roles in RA action are largely unknown. The HOXD cluster contains nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) that are positioned sequentially from 39 to 59, with HOXD1 at the 39 end and HOXD13 the 59 end. Here we show that all HOXD genes are induced by RA in the human neuroblastoma BE(2)-C cells, with the genes located at the 39 end being activated generally earlier than those positioned more 59 within the cluster. Individual induction of HOXD8, HOXD9, HOXD10 or HOXD12 is sufficient to induce both growth arrest and neuronal differentiation, which is associated with downregulation of cell cycle-promoting genes and upregulation of neuronal differentiation genes. However, induction of other HOXD genes either has no effect (HOXD1) or has partial effects (HOXD3, HOXD4, HOXD11 and HOXD13) on BE(2)-C cell proliferation or differentiation. We further show that knockdown of HOXD8 expression, but not that of HOXD9 expression, significantly inhibits the differentiation-inducing activity of RA. HOXD8 directly activates the transcription of HOXC9, a key effector of RA action in neuroblastoma cells. These findings highlight the distinct functions of HOXD genes in RA induction of neuroblastoma cell differentiation.	[Zha, Yunhong; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Ding, Han-Fei] Georgia Hlth Sci Univ, Med Coll Georgia, Ctr Canc, Augusta, GA USA; [Zha, Yunhong; Yang, Liqun; Mao, Ling; Wang, Xiangwei; McCarthy, Brian A.; Ding, Han-Fei] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA; [Huang, Shuang] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Ding, Emily] Lakeside High Sch, Evans, GA USA; [Zha, Yunhong] Three Gorges Univ, First Peoples Hosp Yichang, Coll Med, Dept Neurol, Yichang, Hubei, Peoples R China; [Mao, Ling] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Wang, Xiangwei] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; China Three Gorges University; Huazhong University of Science & Technology; Army Medical University	Zha, YH (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Ctr Canc, Augusta, GA USA.	hding@georgiahealth.edu	Wu, Yuqi/AAL-9861-2020	Ding, Han-Fei/0000-0001-5702-3439	National Institutes of Health [CA124982]; Georgia Cancer Coalition Distinguished Scholar Award; National Science Foundation of China [NSFC 81101905]; National Natural Science Foundation of China [81172443]; NATIONAL CANCER INSTITUTE [R01CA124982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Scholar Award; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA124982 and a Georgia Cancer Coalition Distinguished Scholar Award to HD. LM was supported in part by the National Science Foundation of China (NSFC 81101905) and XW by the National Natural Science Foundation of China (No. 81172443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Ambros IM, 2002, CANCER, V94, P1574, DOI 10.1002/cncr.10359; Beckwith J B, 1968, J Pediatr Surg, V3, P106; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; GAETANO C, 1991, CELL GROWTH DIFFER, V2, P487; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; HUGHES M, 1974, CANCER, V34, P1706, DOI 10.1002/1097-0142(197411)34:5<1706::AID-CNCR2820340519>3.0.CO;2-J; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lufkin T, 1996, CURR OPIN GENET DEV, V6, P575, DOI 10.1016/S0959-437X(96)80086-4; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PEVERALI FA, 1990, DIFFERENTIATION, V45, P61, DOI 10.1111/j.1432-0436.1990.tb00458.x; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; SAWHNEY N, 1992, J PATHOL, V168, P161, DOI 10.1002/path.1711680202; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SIDELL N, 1982, J NATL CANCER I, V68, P589; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Volchenboum SL, 2009, J CLIN ONCOL, V27, P1003, DOI 10.1200/JCO.2008.20.2739; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595	50	30	33	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e40728	10.1371/journal.pone.0040728	http://dx.doi.org/10.1371/journal.pone.0040728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879880	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900004
J	Luo, J; Chen, YC; Wu, YH; Shi, PL; She, J; Zhou, P				Luo, Ji; Chen, Youchao; Wu, Yanhong; Shi, Peili; She, Jia; Zhou, Peng			Temporal-Spatial Variation and Controls of Soil Respiration in Different Primary Succession Stages on Glacier Forehead in Gongga Mountain, China	PLOS ONE			English	Article							MICROBIAL BIOMASS; CO2 EFFLUX; STAND AGE; CARBON; TEMPERATURE; FOREST; VEGETATION; NITROGEN; VARIABILITY; PATTERNS	Soil respiration (SR) is an important process in the global carbon cycle. It is difficult to estimate SR emission accurately because of its temporal and spatial variability. Primary forest succession on Glacier forehead provides the ideal environment for examining the temporal-spatial variation and controlling factors of SR. However, relevant studies on SR are relatively scarce, and variations, as well as controlling factors, remain uncertain in this kind of region. In this study, we used a static chamber system to measure SR in six sites which represent different stages of forest succession on forehead of a temperate glacier in Gongga Mountain, China. Our results showed that there was substantial temporal (coefficient of variation (CV) ranged from 39.3% to 73.9%) and spatial (CV ranged from 12.3% to 88.6%) variation in SR. Soil temperature (ST) at 5 cm depth was the major controlling factor of temporal variation in all six sites. Spatial variation in SR was mainly caused by differences in plant biomass and Total N among the six sites. Moreover, soil moisture (SM), microbial biomass carbon (MBC), soil organic carbon (SOC), pH and bulk density could influence SR by directly or indirectly affecting plant biomass and Total N. Q(10) values (ranged from 2.1 to 4.7) increased along the forest succession, and the mean value (3.3) was larger than that of temperate ecosystems, which indicated a general tendency towards higher-Q(10) in colder ecosystems than in warmer ecosystems. Our findings provided valuable information for understanding temporal-spatial variation and controlling factors of SR.	[Luo, Ji; Chen, Youchao; Wu, Yanhong; She, Jia; Zhou, Peng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Chen, Youchao; She, Jia; Zhou, Peng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Shi, Peili] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Luo, J (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	whchenyouchao@yahoo.com.cn	Peili, SHi/AAT-6450-2021	shi, pei li/0000-0002-1120-0003	Chinese Academy of Science [KZCX2-YW-BR-21, KZCX2-EW-309]; National Natural Science Foundation of China [40871042]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Knowledge Innovation Project of the Chinese Academy of Science (Grants KZCX2-YW-BR-21 and KZCX2-EW-309) and the National Natural Science Foundation of China (Grant 40871042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekku Y.S., 2004, POLAR BIOSCI, V17, P36; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Bremner DJ, 1996, METHOD SOIL ANAL, P539; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Chen ZJ, 2002, J SOIL WATER CONSERV, V16, P119; [程根伟 Cheng Genwei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1049; Cote L, 2000, SOIL BIOL BIOCHEM, V32, P1079, DOI 10.1016/S0038-0717(00)00017-1; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; De Kovel CGF, 2000, PLANT ECOL, V149, P43, DOI 10.1023/A:1009898622773; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Epron D, 2004, FOREST ECOL MANAG, V202, P149, DOI 10.1016/j.foreco.2004.07.019; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Franzluebbers K, 2002, SOIL SCI SOC AM J, V66, P254, DOI 10.2136/sssaj2002.0254; HANSON PJ, 1993, TREE PHYSIOL, V13, P1, DOI 10.1093/treephys/13.1.1; Jackson RB, 2000, METHODS IN ECOSYSTEM SCIENCE, P199; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P189, DOI 10.1016/0038-0717(76)90003-1; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Li X., 1995, MOUNTAIN RES, V13, P109; Li ZX, 2010, QUATERN INT, V218, P166, DOI 10.1016/j.quaint.2008.09.005; Liu Ying, 2005, Yingyong Shengtai Xuebao, V16, P1581; Longdoz B, 2000, GLOB CHANGE BIOL, V6, P907, DOI 10.1046/j.1365-2486.2000.00369.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Robbins JA, 2010, ARCT ANTARCT ALP RES, V42, P351, DOI 10.1657/1938-4246-42.3.351; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Shen RenFang, 1997, Pedosphere, V7, P297; SMITH JL, 1985, SOIL BIOL BIOCHEM, V17, P11, DOI 10.1016/0038-0717(85)90083-5; Soe ARB, 2005, TREE PHYSIOL, V25, P1427, DOI 10.1093/treephys/25.11.1427; Su Z, 2002, QUATERN INT, V97-8, P123, DOI 10.1016/S1040-6182(02)00057-5; Thuille A, 2000, TREE PHYSIOL, V20, P849; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Wang X, 2010, CAN J FOREST RES, V40, P788, DOI 10.1139/X10-010; Yan JH, 2006, GLOBAL CHANGE BIOL, V12, P810, DOI 10.1111/j.1365-2486.2006.01141.x; Yan JH, 2007, PEDOSPHERE, V17, P397, DOI 10.1016/S1002-0160(07)60048-4; Yan JH, 2009, SOIL BIOL BIOCHEM, V41, P991, DOI 10.1016/j.soilbio.2008.12.018; [易志刚 Yi Zhigang], 2003, [生态学报, Acta Ecologica Sinica], V23, P1673; Yu X, 2011, PLSO ONE, P6; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; [张金波 ZHANG Jinbo], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P1537; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	49	32	38	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42354	10.1371/journal.pone.0042354	http://dx.doi.org/10.1371/journal.pone.0042354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879950	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000028
J	Marten, F; Tsaneva-Atanasova, K; Giuggioli, L				Marten, Frank; Tsaneva-Atanasova, Krasimira; Giuggioli, Luca			Bacterial Secretion and the Role of Diffusive and Subdiffusive First Passage Processes	PLOS ONE			English	Article							III SECRETION; PROTEIN-TRANSPORT; HOST-CELLS; SALMONELLA; EFFECTORS; DYNAMICS; ESCAPE; IPAC	By funneling protein effectors through needle complexes located on the cellular membrane, bacteria are able to infect host cells during type III secretion events. The spatio-temporal mechanisms through which these events occur are however not fully understood, due in part to the inherent challenges in tracking single molecules moving within an intracellular medium. As a result, theoretical predictions of secretion times are still lacking. Here we provide a model that quantifies, depending on the transport characteristics within bacterial cytoplasm, the amount of time for a protein effector to reach either of the available needle complexes. Using parameters from Shigella flexneri we are able to test the role that translocators might have to activate the needle complexes and offer semi-quantitative explanations of recent experimental observations.	[Marten, Frank; Tsaneva-Atanasova, Krasimira; Giuggioli, Luca] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Giuggioli, Luca] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Giuggioli, Luca] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Marten, F (corresponding author), Univ Bristol, Dept Engn Math, Bristol, Avon, England.	Luca.Giuggioli@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Giuggioli, Luca/J-2881-2012	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Giuggioli, Luca/0000-0002-2325-4682	Engineering and Physical Sciences Research Council (EPSRC) [EP/E501214/1, EP/E032249/1, EP/H024786/1]; Medical Research Council (MRC) [MR/J002097/1]; MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [MR/J002097/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding of this work has come from different sources, namely the Engineering and Physical Sciences Research Council (EPSRC) grants EP/E501214/1, EP/E032249/1, EP/H024786/1 and the Medical Research Council (MRC) grant MR/J002097/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton G., 1989, ELEMENTS GREENS FUNC; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Chevalier C, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/2/025002; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Enninga J, 2009, CELL MICROBIOL, V11, P1462, DOI 10.1111/j.1462-5822.2009.01360.x; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; Germano G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066102; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Giuggioli L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002008; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Innocenti B, 2008, J NEUROPHYSIOL, V99, P25, DOI 10.1152/jn.00737.2007; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kenkre VM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051907; Loverdo C, 2008, NAT PHYS, V4, P134, DOI 10.1038/nphys830; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3; Redner S, 2007, GUIDE 1 PASSAGE PROC; Rudner DZ, 2002, COLD SPRING HARB PER, V2, P1; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schuss Z, 2007, P NATL ACAD SCI USA, V104, P16098, DOI 10.1073/pnas.0706599104; Simpson N, 2010, METHODS MOL BIOL, V619, P241, DOI 10.1007/978-1-60327-412-8_14; Tamano K, 2002, METHOD ENZYMOL, V358, P385; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; Van Engelenburg SB, 2010, NAT METHODS, V7, P325, DOI [10.1038/NMETH.1437, 10.1038/nmeth.1437]; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41421	10.1371/journal.pone.0041421	http://dx.doi.org/10.1371/journal.pone.0041421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879888	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000006
J	Rushmore, J; Leonhardt, SD; Drea, CM				Rushmore, Julie; Leonhardt, Sara D.; Drea, Christine M.			Sight or Scent: Lemur Sensory Reliance in Detecting Food Quality Varies with Feeding Ecology	PLOS ONE			English	Article							RED COLOBUS MONKEYS; TRICHROMATIC VISION; OLFACTORY SENSITIVITY; RINGTAILED LEMUR; SQUIRREL-MONKEYS; SCRAMBLE COMPETITION; EVOLUTION; CUES; SELECTION; VOLATILE	Visual and olfactory cues provide important information to foragers, yet we know little about species differences in sensory reliance during food selection. In a series of experimental foraging studies, we examined the relative reliance on vision versus olfaction in three diurnal, primate species with diverse feeding ecologies, including folivorous Coquerel's sifakas (Propithecus coquereli), frugivorous ruffed lemurs (Varecia variegata spp), and generalist ring-tailed lemurs (Lemur catta). We used animals with known color-vision status and foods for which different maturation stages (and hence quality) produce distinct visual and olfactory cues (the latter determined chemically). We first showed that lemurs preferentially selected high-quality foods over low-quality foods when visual and olfactory cues were simultaneously available for both food types. Next, using a novel apparatus in a series of discrimination trials, we either manipulated food quality (while holding sensory cues constant) or manipulated sensory cues (while holding food quality constant). Among our study subjects that showed relatively strong preferences for high-quality foods, folivores required both sensory cues combined to reliably identify their preferred foods, whereas generalists could identify their preferred foods using either cue alone, and frugivores could identify their preferred foods using olfactory, but not visual, cues alone. Moreover, when only high-quality foods were available, folivores and generalists used visual rather than olfactory cues to select food, whereas frugivores used both cue types equally. Lastly, individuals in all three of the study species predominantly relied on sight when choosing between low-quality foods, but species differed in the strength of their sensory biases. Our results generally emphasize visual over olfactory reliance in foraging lemurs, but we suggest that the relative sensory reliance of animals may vary with their feeding ecology.	[Rushmore, Julie; Leonhardt, Sara D.; Drea, Christine M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA; [Rushmore, Julie] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Leonhardt, Sara D.] Leuphana Univ, Dept Ecol, Luneburg, Germany; [Leonhardt, Sara D.; Drea, Christine M.] Duke Univ, Dept Biol, Durham, NC USA	Duke University; University System of Georgia; University of Georgia; Leuphana University Luneburg; Duke University	Rushmore, J (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA.	cdrea@duke.edu	Leonhardt, Sara/AAI-6901-2020	Leonhardt, Sara/0000-0002-8154-9569	National Science Foundation [BCS-0409367, IOS-0719003]; Duke University's Molly Glander Awards; Undergraduate Research Support grants; German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium	National Science Foundation(National Science Foundation (NSF)); Duke University's Molly Glander Awards; Undergraduate Research Support grants; German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was provided by National Science Foundation grants (BCS-0409367 and IOS-0719003), Duke University's Molly Glander Awards (http://lemur.duke.edu/research/funding-opportunities/) and Undergraduate Research Support grants (http://undergraduateresearch.duke.edu/), and a German Academic Exchange Program (DAAD), Nordamerika Vollzeitstipendium (http://www.daad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET IN PRESS; Albone E.S., 1984, J WILEY; Allman J.M., 1999, EVOLVING BRAINS; Aujard F, 1997, PHYSIOL BEHAV, V62, P1003, DOI 10.1016/S0031-9384(97)00206-0; Azodanlou R, 2004, EUR FOOD RES TECHNOL, V218, P167, DOI 10.1007/s00217-003-0822-0; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Bolen RH, 1997, J COMP PSYCHOL, V111, P152; Bosque C, 2003, COMP BIOCHEM PHYS A, V135, P321, DOI 10.1016/S1095-6433(03)00080-1; Boulet M, 2010, J EVOLUTION BIOL, V23, P1558, DOI 10.1111/j.1420-9101.2010.02007.x; Boulet M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-281; Britt A, 2000, FOLIA PRIMATOL, V71, P133, DOI 10.1159/000021741; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2002, COMP BIOCHEM PHYS A, V133, P861, DOI 10.1016/S1095-6433(02)00209-X; CHAPMAN GW, 1991, J AGR FOOD CHEM, V39, P867, DOI 10.1021/jf00005a010; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Church SC, 1998, P ROY SOC B-BIOL SCI, V265, P1509, DOI 10.1098/rspb.1998.0465; CHYAU CC, 1992, J AGR FOOD CHEM, V40, P846, DOI 10.1021/jf00017a028; Crawford JC, 2011, P ROY SOC B-BIOL SCI, V278, P122, DOI 10.1098/rspb.2010.1203; Dearing MD, 2005, ANNU REV ECOL EVOL S, V36, P169, DOI 10.1146/annurev.ecolsys.36.102003.152617; Delbarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P82, DOI 10.1111/j.1420-9101.2010.02145.x; delBarco-Trillo J, 2012, PHILOS T R SOC B, V367, P1909, DOI 10.1098/rstb.2011.0225; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dominy NJ, 2004, AM J PRIMATOL, V62, P189, DOI 10.1002/ajp.20015; Dominy NJ, 2001, EVOL ANTHROPOL, V10, P171, DOI 10.1002/evan.1031; DOUCET CM, 1993, OIKOS, V67, P201, DOI 10.2307/3545464; Drapier M, 2003, INT J PRIMATOL, V24, P295, DOI 10.1023/A:1023097116080; DREA CM, 1995, ANIM LEARN BEHAV, V23, P1, DOI 10.3758/BF03198009; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dudley R, 2000, Q REV BIOL, V75, P3, DOI 10.1086/393255; Early DM, 1998, J ANIM SCI, V76, P728; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fobes JL, 1982, PRIMATE BEHAV, P220; Glew RH, 2005, EUR FOOD RES TECHNOL, V221, P113, DOI 10.1007/s00217-005-1201-9; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Heth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P53, DOI 10.1007/s00265-002-0476-0; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; Hiramatsu C, 2009, ANIM BEHAV, V77, P1421, DOI 10.1016/j.anbehav.2009.02.012; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Irwin MT, 2007, AM J PRIMATOL, V69, P471, DOI 10.1002/ajp.20353; Isbell LA, 1991, BEHAV ECOL, V2, P143, DOI 10.1093/beheco/2.2.143; Jetz W, 2001, BEHAV ECOL, V12, P134, DOI 10.1093/beheco/12.2.134; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; Kappeler PM, 1984, LESSER APES EVOLUTIO, P228; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kirk E. Christopher, 2004, P539; Koivula M, 1997, ANIM BEHAV, V54, P873, DOI 10.1006/anbe.1996.0513; Kuhn U, 2004, PLANT CELL ENVIRON, V27, P1469, DOI 10.1111/j.1365-3040.2004.01252.x; Kuhn U, 2004, GLOBAL CHANGE BIOL, V10, P663, DOI 10.1111/j.1529-8817.2003.00771.x; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; KYRIAZAKIS I, 1993, BRIT J NUTR, V69, P617, DOI 10.1079/BJN19930064; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2003, PHYSIOL BEHAV, V78, P321, DOI 10.1016/S0031-9384(02)00976-9; Laska M, 2002, BEHAV BRAIN RES, V134, P165, DOI 10.1016/S0166-4328(01)00464-8; Laska M, 2002, J EXP BIOL, V205, P1633; Laska M, 2007, AM J PRIMATOL, V69, P282, DOI 10.1002/ajp.20345; Leonhardt SD, 2009, BEHAV ECOL, V20, P1, DOI 10.1093/beheco/arn106; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; LOUGHRIN JH, 1992, PHYTOCHEMISTRY, V31, P1537, DOI 10.1016/0031-9422(92)83101-4; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; MAISELS F, 1994, INT J PRIMATOL, V15, P681, DOI 10.1007/BF02737427; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; MERTL AS, 1976, FOLIA PRIMATOL, V26, P151, DOI 10.1159/000155736; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; New JG, 2000, BRAIN BEHAV EVOLUT, V59, P177; Odeen A, 2010, J COMP PHYSIOL A, V196, P91, DOI 10.1007/s00359-009-0474-z; Osbourn AE, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P1, DOI 10.1007/978-0-387-85498-4; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Piep M, 2008, ANIM BEHAV, V75, P871, DOI 10.1016/j.anbehav.2007.07.008; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; RICHARD A, 1974, FOLIA PRIMATOL, V22, P178, DOI 10.1159/000155624; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Schilling A., 1979, P461; Scordato ES, 2007, CHEM SENSES, V32, P493, DOI 10.1093/chemse/bjm018; Scordato ES, 2007, ANIM BEHAV, V73, P301, DOI 10.1016/j.anbehav.2006.08.006; Siemers BM, 2007, INT J PRIMATOL, V28, P291, DOI 10.1007/s10764-007-9135-7; Siitari H, 1999, P ROY SOC B-BIOL SCI, V266, P2125, DOI 10.1098/rspb.1999.0897; Smith C, 2004, P ROY SOC B-BIOL SCI, V271, P949, DOI 10.1098/rspb.2004.2690; Smith T, 2006, OLFACTION AND THE BRAIN, P135, DOI 10.1017/CBO9780511543623.010; Snaith TV, 2005, BEHAV ECOL SOCIOBIOL, V59, P185, DOI 10.1007/s00265-005-0023-x; Sokal R. R., 1981, BIOMETRY; Stephens D.W., 1986, pi; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Vasey N, 2000, AM J PHYS ANTHROPOL, V112, P411, DOI 10.1002/1096-8644(200007)112:3<411::AID-AJPA10>3.0.CO;2-R; Vasey N., 2003, NAT HIST MADAG, P1332; Wrangham R. W., 1977, P503; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; YEAGER CP, 1989, INT J PRIMATOL, V10, P497, DOI 10.1007/BF02739363	102	31	31	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41558	10.1371/journal.pone.0041558	http://dx.doi.org/10.1371/journal.pone.0041558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870229	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100022
J	Yadav, G; Babu, S				Yadav, Gitanjali; Babu, Suresh			NEXCADE: Perturbation Analysis for Complex Networks	PLOS ONE			English	Article							POLLINATION NETWORKS; SYSTEMS; CENTRALITY; COEXTINCTIONS; ROBUSTNESS; COMMUNITY; TOLERANCE; LETHALITY	Recent advances in network theory have led to considerable progress in our understanding of complex real world systems and their behavior in response to external threats or fluctuations. Much of this research has been invigorated by demonstration of the 'robust, yet fragile' nature of cellular and large-scale systems transcending biology, sociology, and ecology, through application of the network theory to diverse interactions observed in nature such as plant-pollinator, seed-dispersal agent and host-parasite relationships. In this work, we report the development of NEXCADE, an automated and interactive program for inducing disturbances into complex systems defined by networks, focusing on the changes in global network topology and connectivity as a function of the perturbation. NEXCADE uses a graph theoretical approach to simulate perturbations in a user-defined manner, singly, in clusters, or sequentially. To demonstrate the promise it holds for broader adoption by the research community, we provide pre-simulated examples from diverse real-world networks including eukaryotic protein-protein interaction networks, fungal biochemical networks, a variety of ecological food webs in nature as well as social networks. NEXCADE not only enables network visualization at every step of the targeted attacks, but also allows risk assessment, i.e. identification of nodes critical for the robustness of the system of interest, in order to devise and implement context-based strategies for restructuring a network, or to achieve resilience against link or node failures. Source code and license for the software, designed to work on a Linux-based operating system (OS) can be downloaded at http://www.nipgr.res.in/nexcade_download.html. In addition, we have developed NEXCADE as an OS-independent online web server freely available to the scientific community without any login requirement at http://www.nipgr.res.in/nexcade.html.	[Yadav, Gitanjali] Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi, India; [Babu, Suresh] Ambedkar Univ, Sch Human Ecol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Ambedkar University Delhi	Yadav, G (corresponding author), Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi, India.	gy@nipgr.res.in		Yadav, Gitanjali/0000-0001-6591-9964; Babu, Suresh/0000-0002-3004-3066	Department of Biotechnology, Government of India; Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India; BTIS grant of DBT, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India; BTIS grant of DBT, India	This work was funded by an Innovative Young Biotechnologist Award grant from the Department of Biotechnology, Government of India, awarded to Gitanjali Yadav. Financial support to Suresh Babu was provided by the Man & Biosphere Programme of the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G.Y thanks Director, NIPGR for support. Laboratory resources provided under BTIS grant of DBT, India, are gratefully acknowledged.	Albert R, 2000, PHYS REV LETT, V84, P5660, DOI 10.1103/PhysRevLett.84.5660; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bao G, 2010, CELL MOL BIOENG, V3, P91, DOI 10.1007/s12195-010-0109-z; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Chia NY, 2011, WILEY INTERDISCIPLIN; Csardi N., 2006, INT J COMP SYST, V1695, P1; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2009, PHILOS T R SOC B, V364, P1711, DOI 10.1098/rstb.2008.0219; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fruchterman TMJ, 1990, GRAPH DRAWING FORCE; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harary F, 1994, GRAPH THEORY; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaneko K, 2006, LIFE INTRO COMPLEX S; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nussinov R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/030301; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X	43	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41827	10.1371/journal.pone.0041827	http://dx.doi.org/10.1371/journal.pone.0041827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870252	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100033
J	Asakura, K; Izumi, Y; Yamauchi, Y; Nakatsuka, S; Inoue, M; Yashiro, H; Abe, T; Sato, Y; Nomori, H				Asakura, Keisuke; Izumi, Yotaro; Yamauchi, Yoshikane; Nakatsuka, Seishi; Inoue, Masanori; Yashiro, Hideki; Abe, Takayuki; Sato, Yuji; Nomori, Hiroaki			Incidence of Pleural Recurrence after Computed Tomography-Guided Needle Biopsy in Stage I Lung Cancer	PLOS ONE			English	Article							CHEST-WALL IMPLANTATION; GROUND-GLASS OPACITY; TIME CT FLUOROSCOPY; ASPIRATION BIOPSY; RISK; METASTASIS; EXPERIENCE; GUIDANCE	Objective: A risk of tumor seeding after percutaneous needle biopsy has been reported in various organs, including the lung. This study retrospectively evaluated the proportion of ipsilateral pleural recurrence after computed tomography-guided needle biopsy (CTNB) in p-stage I lung cancer patients. Methods: Of the 321 patients diagnosed with p-stage I lung cancer, 124 underwent CTNB before surgery, while 197 underwent non-CTNB procedures, including bronchoscopic biopsy in 188 patients and thoracoscopic wedge resection in 9. These patients were retrospectively analyzed. Results: While the tumor size was significantly larger in the non-CTNB group (25 +/- 9 mm) in comparison to the CTNB group (19 +/- 9 mm) (p<0.001), percentage of pleural, vascular, or lymphatic invasions were comparable between the two groups. Eight patients developed ipsilateral pleural recurrences, one (1%) in the CTNB group, and 7 (4%) in the non-CTNB group. Of these, 3 patients developed pleural recurrence only at first, 1 (1%) in the CTNB group, and 2 (1%) in the non-CTNB group. The differences in the proportions of these pleural recurrences between the 2 groups were not significant. Subgroup analyses by baseline characteristics such as tumor size, pT stage, or microscopic pleural invasion, showed that proportions of pleural recurrences in CTNB group were not high compared with non-CTNB group in each subgroup. Analysis of progression-free survival showed that recurrences in CTNB were not high compared with non-CTNB. Conclusions: The pleural recurrence was not significantly increased after CTNB in p-stage I lung cancer patients in this particular study.	[Asakura, Keisuke; Izumi, Yotaro; Yamauchi, Yoshikane; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan; [Nakatsuka, Seishi; Inoue, Masanori; Yashiro, Hideki] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 160, Japan; [Abe, Takayuki; Sato, Yuji] Keio Univ, Sch Med, Clin Res Ctr, Tokyo 160, Japan	Keio University; Keio University; Keio University	Asakura, K (corresponding author), Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan.	yotaroizumi@a2.keio.jp	Yamauchi, Yoshikane/I-1952-2019	Yamauchi, Yoshikane/0000-0002-3374-2399; Asakura, Keisuke/0000-0002-4491-3456				Daly B, 1999, RADIOLOGY, V211, P309, DOI 10.1148/radiology.211.2.r99ma51309; Gianfelice D, 2000, J VASC INTERV RADIOL, V11, P879, DOI 10.1016/S1051-0443(07)61805-3; Goldstraw P, 2009, IASLC STAGING MANUAL, P113; Ibukuro K, 2009, AM J ROENTGENOL, V193, pW430, DOI 10.2214/AJR.08.2214; Inoue M, 2011, ANN THORAC SURG, V91, P1066, DOI 10.1016/j.athoracsur.2010.12.032; Kara M, 2001, EUR J CARDIO-THORAC, V20, P868, DOI 10.1016/S1010-7940(01)00866-1; Katada K, 1996, RADIOLOGY, V200, P851, DOI 10.1148/radiology.200.3.8756943; Kim JH, 2003, EUR J CARDIO-THORAC, V23, P828, DOI 10.1016/S1010-7940(03)00095-2; Matsuguma H, 2005, ANN THORAC SURG, V80, P2026, DOI 10.1016/j.athoracsur.2005.06.074; Raftopoulos Y, 2000, J THORAC CARDIOV SUR, V119, P1288, DOI 10.1067/mtc.2000.105888; REDWOOD N, 1989, THORAX, V44, P826, DOI 10.1136/thx.44.10.826; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; SEYFER AE, 1989, ANN THORAC SURG, V48, P284, DOI 10.1016/0003-4975(89)90091-X; Shimizu K, 2006, LUNG CANCER-J IASLC, V51, P173, DOI 10.1016/j.lungcan.2005.10.019; Tsukada H, 2000, AM J ROENTGENOL, V175, P239, DOI 10.2214/ajr.175.1.1750239; VORAVUD N, 1992, CHEST, V102, P313, DOI 10.1378/chest.102.1.313; Wisnivesky JP, 2006, AM J RESP CRIT CARE, V174, P684, DOI 10.1164/rccm.200602-160OC; Yamauchi Y, 2011, EUR J RADIOL, V79, pE85, DOI 10.1016/j.ejrad.2011.03.088; Yoshikawa T, 2000, JPN J CLIN ONCOL, V30, P450, DOI 10.1093/jjco/hyd120	19	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42043	10.1371/journal.pone.0042043	http://dx.doi.org/10.1371/journal.pone.0042043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876299	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700027
J	He, LH; Linden, DJ; Sapirstein, A				He, Lihua; Linden, David J.; Sapirstein, Adam			Astrocyte Inositol Triphosphate Receptor Type 2 and Cytosolic Phospholipase A(2) Alpha Regulate Arteriole Responses in Mouse Neocortical Brain Slices	PLOS ONE			English	Article							ARACHIDONIC-ACID EPOXYGENASE; PROSTANOID RECEPTORS; NITRIC-OXIDE; FUNCTIONAL HYPEREMIA; VASCULAR-RESPONSES; PROSTAGLANDIN E-2; BLOOD-FLOW; RAT-BRAIN; 20-HETE; NEURONS	Functional hyperemia of the cerebral vascular system matches regional blood flow to the metabolic demands of the brain. One current model of neurovascular control holds that glutamate released by neurons activates group I metabotropic glutamate receptors (mGluRs) on astrocytes, resulting in the production of diffusible messengers that act to regulate smooth muscle cells surrounding cerebral arterioles. The acute mouse brain slice is an experimental system in which changes in arteriole diameter can precisely measured with light microscopy. Stimulation of the brain slice triggers specific cellular responses that can be correlated to changes in arteriole diameter. Here we used inositol trisphosphate receptor type 2 (IP(3)R2) and cytosolic phospholipase A(2) alpha (cPLA(2)alpha) deficient mice to determine if astrocyte mGluR activation coupled to IP(3)R2-mediated Ca2+ release and subsequent cPLA(2)alpha activation is required for arteriole regulation. We measured changes in astrocyte cytosolic free Ca2+ and arteriole diameters in response to mGluR agonist or electrical field stimulation in acute neocortical mouse brain slices maintained in 95% or 20% O-2. Astrocyte Ca2+ and arteriole responses to mGluR activation were absent in IP(3)R2(-/-) slices. Astrocyte Ca2+ responses to mGluR activation were unchanged by deletion of cPLA(2)alpha but arteriole responses to either mGluR agonist or electrical stimulation were ablated. The valence of changes in arteriole diameter (dilation/constriction) was dependent upon both stimulus and O-2 concentration. Neuron-derived NO and activation of the group I mGluRs are required for responses to electrical stimulation. These findings indicate that an mGluR/IP(3)R2/cPLA(2)alpha signaling cascade in astrocytes is required to transduce neuronal glutamate release into arteriole responses.	[He, Lihua; Sapirstein, Adam] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Linden, David J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	He, LH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	Asapirs1@JHMI.edu			Anesthesia Departmental Grant (Johns Hopkins University School of Medicine); American Heart Association; National Institutes of Health [NS048978]; Johns Hopkins University Brain Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048978] Funding Source: NIH RePORTER	Anesthesia Departmental Grant (Johns Hopkins University School of Medicine); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Brain Sciences Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Anesthesia Departmental Grant (Johns Hopkins University School of Medicine), an American Heart Association Grant in Aid (AS), and grants from the National Institutes of Health: NS048978 (AS) and the Johns Hopkins University Brain Sciences Institute (DJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Alkayed NJ, 1996, STROKE, V27, P971, DOI 10.1161/01.STR.27.5.971; Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; Alonso-Galicia M, 1999, STROKE, V30, P2727, DOI 10.1161/01.STR.30.12.2727; AlonsoGalicia M, 1997, HYPERTENSION, V29, P320, DOI 10.1161/01.HYP.29.1.320; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Balboa MA, 2002, FEBS LETT, V531, P12, DOI 10.1016/S0014-5793(02)03481-6; Barkoudah E, 2004, AM J PHYSIOL-HEART C, V287, pH1459, DOI 10.1152/ajpheart.00369.2004; Bingham CO, 1999, P ASSOC AM PHYSICIAN, V111, P516, DOI 10.1046/j.1525-1381.1999.99321.x; Blanco VM, 2008, AM J PHYSIOL-HEART C, V294, pH2855, DOI 10.1152/ajpheart.91451.2007; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BORG C, 1994, J BIOL CHEM, V269, P6109; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DORN GW, 1992, J BIOL CHEM, V267, P24897; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; FERGUS A, 1995, BRAIN RES, V694, P78, DOI 10.1016/0006-8993(95)00768-L; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Harder DR, 2000, ACTA PHYSIOL SCAND, V168, P543, DOI 10.1046/j.1365-201x.2000.00707.x; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; Kitaura H, 2007, NEUROSCI RES, V59, P160, DOI 10.1016/j.neures.2007.06.1469; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lautens LL, 1998, BRAIN RES, V809, P18, DOI 10.1016/S0006-8993(98)00806-3; Leis HJ, 2008, BRIT J PHARMACOL, V155, P731, DOI 10.1038/bjp.2008.304; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Liu XG, 2008, AM J PHYSIOL-HEART C, V295, pH619, DOI 10.1152/ajpheart.01211.2007; Ma JY, 1996, AM J PHYSIOL-HEART C, V270, pH1085, DOI 10.1152/ajpheart.1996.270.3.H1085; Mashimo M, 2008, J CELL SCI, V121, P3015, DOI 10.1242/jcs.032987; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Sharp AH, 1999, J COMP NEUROL, V406, P207; Shen Y, 2007, P NATL ACAD SCI USA, V104, P6078, DOI 10.1073/pnas.0605427104; Shibata N, 2010, ACTA NEUROPATHOL, V119, P345, DOI 10.1007/s00401-009-0636-7; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42194	10.1371/journal.pone.0042194	http://dx.doi.org/10.1371/journal.pone.0042194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876307	Green Submitted, gold, Green Published			2022-12-25	WOS:000307184700035
J	Connell, S; Meade, KG; Allan, B; Lloyd, AT; Kenny, E; Cormican, P; Morris, DW; Bradley, DG; O'Farrelly, C				Connell, Sarah; Meade, Kieran G.; Allan, Brenda; Lloyd, Andrew T.; Kenny, Elaine; Cormican, Paul; Morris, Derek W.; Bradley, Daniel G.; O'Farrelly, Cliona			Avian Resistance to Campylobacter jejuni Colonization Is Associated with an Intestinal Immunogene Expression Signature Identified by mRNA Sequencing	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; TOLL-LIKE RECEPTORS; GUILLAIN-BARRE-SYNDROME; 2 GENETIC LINES; EPITHELIAL-CELLS; CYTOKINE RESPONSES; CECAL COLONIZATION; IN-VITRO; DIFFERENTIAL EXPRESSION; MATERNAL ANTIBODIES	Campylobacter jejuni is the most common cause of human bacterial gastroenteritis and is associated with several post-infectious manifestations, including onset of the autoimmune neuropathy Guillain-Barre syndrome, causing significant morbidity and mortality. Poorly-cooked chicken meat is the most frequent source of infection as C. jejuni colonizes the avian intestine in a commensal relationship. However, not all chickens are equally colonized and resistance seems to be genetically determined. We hypothesize that differences in immune response may contribute to variation in colonization levels between susceptible and resistant birds. Using high-throughput sequencing in an avian infection model, we investigate gene expression associated with resistance or susceptibility to colonization of the gastrointestinal tract with C. jejuni and find that gut related immune mechanisms are critical for regulating colonization. Amongst a single population of 300 4-week old chickens, there was clear segregation in levels of C. jejuni colonization 48 hours post-exposure. RNAseq analysis of caecal tissue from 14 C. jejuni-susceptible and 14 C. jejuni-resistant birds generated over 363 million short mRNA sequences which were investigated to identify 219 differentially expressed genes. Significantly higher expression of genes involved in the innate immune response, cytokine signaling, B cell and T cell activation and immunoglobulin production, as well as the renin-angiotensin system was observed in resistant birds, suggesting an early active immune response to C. jejuni. Lower expression of these genes in colonized birds suggests suppression or inhibition of a clearing immune response thus facilitating commensal colonization and generating vectors for zoonotic transmission. This study describes biological processes regulating C. jejuni colonization of the avian intestine and gives insight into the differential immune mechanisms incited in response to commensal bacteria in general within vertebrate populations. The results reported here illustrate how an exaggerated immune response may be elicited in a subset of the population, which alters host-microbe interactions and inhibits the commensal state, therefore having wider relevance with regard to inflammatory and autoimmune disease.	[Connell, Sarah; Bradley, Daniel G.] Univ Dublin, Smurfit Inst Genet, Trinity Coll, Dublin, Ireland; [Allan, Brenda] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Lloyd, Andrew T.; O'Farrelly, Cliona] Univ Dublin, Sch Biochem & Immunol, Trinity Coll, Dublin, Ireland; [Kenny, Elaine; Cormican, Paul; Morris, Derek W.] Univ Dublin, Trinity Genome Sequencing Lab, Inst Mol Med, Trinity Coll, Dublin, Ireland; [Kenny, Elaine; Cormican, Paul; Morris, Derek W.] Univ Dublin, Dept Psychiat, Trinity Coll, Dublin, Ireland	Trinity College Dublin; University of Saskatchewan; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Connell, S (corresponding author), Univ Dublin, Smurfit Inst Genet, Trinity Coll, Dublin, Ireland.	saconnel@tcd.ie	Meade, Kieran/K-7562-2015; Meade, Kieran G/HDN-5926-2022; Morris, Derek/AAW-8343-2021; Kenny, Elaine/D-1644-2014	Meade, Kieran G/0000-0002-3051-8586; Morris, Derek/0000-0002-3413-570X; Bradley, Daniel G/0000-0001-7335-7092; Connell, Sarah/0000-0003-4431-1364; O'Farrelly, Cliona/0000-0002-0616-2874; Lloyd, Andrew/0000-0001-9989-7652; Kenny, Elaine/0000-0003-4676-3436	Irish Department of Agriculture and Food's Food Institutional Research Measure [06_RDD_486]; Trinity Centre for High Performance Computing; Science Foundation Ireland	Irish Department of Agriculture and Food's Food Institutional Research Measure; Trinity Centre for High Performance Computing; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This research was funded by the The Irish Department of Agriculture and Food's Food Institutional Research Measure (http://www.agriculture.gov.ie/research/foodinstitutionalresearchmeasurefirm) - Grant No: 06_RDD_486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all staff who assisted with animal infection experiments in the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Next generation sequencing was performed in the Trinity Genome Sequencing Laboratory supported by the Trinity Centre for High Performance Computing, core facilities funded by Science Foundation Ireland.	Alemka A, 2010, J MED MICROBIOL, V59, P898, DOI 10.1099/jmm.0.019315-0; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang CW, 2007, CLIN MICROBIOL INFEC, V13, P915, DOI 10.1111/j.1469-0691.2007.01765.x; Bakhiet M, 2004, J INFECTION, V48, P236, DOI 10.1016/j.jinf.2003.11.006; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berer K, 2011, NATURE; Borrmann E, 2007, VET MICROBIOL, V124, P115, DOI 10.1016/j.vetmic.2007.04.041; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Byrne CM, 2007, MICROBIOL-SGM, V153, P561, DOI 10.1099/mic.0.2006/000711-0; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; CAWTHRAW S, 1994, AVIAN DIS, V38, P341, DOI 10.2307/1591960; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Cox NA, 2006, AVIAN DIS, V50, P450, DOI 10.1637/7481-120205R.1; Cox NA, 2009, POULTRY SCI, V88, P2449, DOI 10.3382/ps.2009-00195; Cox NA, 2005, AVIAN DIS, V49, P155, DOI 10.1637/7234-070704R; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dhillon AS, 2006, AVIAN DIS, V50, P55, DOI 10.1637/7411-071405R.1; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Hanel I, 2004, VET MICROBIOL, V101, P75, DOI 10.1016/j.vetmic.2004.04.004; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hu L, 2006, MICROB PATHOGENESIS, V40, P91, DOI 10.1016/j.micpath.2005.11.004; Johanesen PA, 2006, INFECT IMMUN, V74, P3437, DOI 10.1128/IAI.01740-05; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Koskinen R, 1998, J IMMUNOL, V160, P4943; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson CL, 2008, MICROBIOL-SGM, V154, P3835, DOI 10.1099/mic.0.2008/021279-0; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li X, 2008, POULTRY SCI, V87, P1742, DOI 10.3382/ps.2008-00136; Li XY, 2011, ANIM GENET, V42, P491, DOI 10.1111/j.1365-2052.2010.02168.x; Li XY, 2012, IMMUNOGENETICS, V64, P59, DOI 10.1007/s00251-011-0557-1; Li XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011827; Li YP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-107; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; LOWENTHAL JW, 1994, IMMUNOL CELL BIOL, V72, P115, DOI 10.1038/icb.1994.18; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Meade KG, 2009, IMMUNOGENETICS, V61, P101, DOI 10.1007/s00251-008-0346-7; MINGARI MC, 1984, NATURE, V312, P641, DOI 10.1038/312641a0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MYSZEWSKI MA, 1990, AVIAN DIS, V34, P588, DOI 10.2307/1591249; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Okwan-Duodu D, 2010, J BIOL CHEM, V285, P39051, DOI 10.1074/jbc.M110.163782; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; RALPH P, 1984, J IMMUNOL, V133, P2442; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Richardson LJ, 2011, AVIAN DIS, V55, P375, DOI 10.1637/9613-121310-Reg.1; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Scharfstein J, 2008, BIOL CHEM, V389, P1015, DOI 10.1515/BC.2008.126; Shaughnessy RG, 2011, VET IMMUNOL IMMUNOP, V142, P64, DOI 10.1016/j.vetimm.2011.04.010; Shaughnessy RG, 2009, VET IMMUNOL IMMUNOP, V132, P191, DOI 10.1016/j.vetimm.2009.06.007; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Smith CK, 2005, INFECT IMMUN, V73, P2094, DOI 10.1128/IAI.73.4.2094-2100.2005; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; Wassenaar TM, 1999, MICROBES INFECT, V1, P1023, DOI 10.1016/S1286-4579(99)80520-6; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yin CG, 2010, POULTRY SCI, V89, P2259, DOI 10.3382/ps.2010-00826; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	99	37	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40409	10.1371/journal.pone.0040409	http://dx.doi.org/10.1371/journal.pone.0040409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870198	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800007
J	Fischer, M; Snajder, R; Pabinger, S; Dander, A; Schossig, A; Zschocke, J; Trajanoski, Z; Stocker, G				Fischer, Maria; Snajder, Rene; Pabinger, Stephan; Dander, Andreas; Schossig, Anna; Zschocke, Johannes; Trajanoski, Zlatko; Stocker, Gernot			SIMPLEX: Cloud-Enabled Pipeline for the Comprehensive Analysis of Exome Sequencing Data	PLOS ONE			English	Article							HUMAN GENOME; DNA; ALIGNMENT; VARIANTS; MUTATIONS; SOFTWARE; GENE; ALGORITHMS; CAPTURE; FORMAT	In recent studies, exome sequencing has proven to be a successful screening tool for the identification of candidate genes causing rare genetic diseases. Although underlying targeted sequencing methods are well established, necessary data handling and focused, structured analysis still remain demanding tasks. Here, we present a cloud-enabled autonomous analysis pipeline, which comprises the complete exome analysis workflow. The pipeline combines several in-house developed and published applications to perform the following steps: (a) initial quality control, (b) intelligent data filtering and pre-processing, (c) sequence alignment to a reference genome, (d) SNP and DIP detection, (e) functional annotation of variants using different approaches, and (f) detailed report generation during various stages of the workflow. The pipeline connects the selected analysis steps, exposes all available parameters for customized usage, performs required data handling, and distributes computationally expensive tasks either on a dedicated high-performance computing infrastructure or on the Amazon cloud environment (EC2). The presented application has already been used in several research projects including studies to elucidate the role of rare genetic diseases. The pipeline is continuously tested and is publicly available under the GPL as a VirtualBox or Cloud image at http://simplex.i-med.ac.at; additional supplementary data is provided at http://www.icbi.at/exome.	[Fischer, Maria; Snajder, Rene; Pabinger, Stephan; Dander, Andreas; Trajanoski, Zlatko; Stocker, Gernot] Innsbruck Med Univ, Div Bioinformat, Bioctr, Innsbruck, Austria; [Snajder, Rene; Dander, Andreas] Ctr Personalized Canc Med, Innsbruck, Austria; [Schossig, Anna; Zschocke, Johannes] Innsbruck Med Univ, Div Human Genet, Bioctr, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Fischer, M (corresponding author), Innsbruck Med Univ, Div Bioinformat, Bioctr, Innsbruck, Austria.	maria.fischer@i-med.ac.at; gernot@stocker.bz	Trajanoski, Zlatko/AAT-6703-2021; Stocker, Gernot/Q-2461-2019; Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Pabinger, Stephan/0000-0001-9876-5965; Snajder, Rene/0000-0002-7318-976X; Stocker, Gernot/0000-0001-8326-1852	GENAU Bioinformatics Network (BIN III); "Bioinformatics Tyrol" project of the "Standortagentur Tyrol"; COMET Center ONCOTYROL	GENAU Bioinformatics Network (BIN III); "Bioinformatics Tyrol" project of the "Standortagentur Tyrol"; COMET Center ONCOTYROL	This work was funded by GENAU Bioinformatics Network (BIN III), by the "Bioinformatics Tyrol" project of the "Standortagentur Tyrol," and by the COMET Center ONCOTYROL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S4; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asmann YW, 2012, BIOINFORMATICS, V28, P277, DOI 10.1093/bioinformatics/btr612; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Cavallo A, 2005, BIOINFORMATICS, V21, P1443, DOI 10.1093/bioinformatics/bti220; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chapman B, NEXT GENERATION SEQU; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolan PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-250; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Durbin R, 2009, BIOINFORMATICS; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Alcantara A, 2009, BIOINFORMATICS; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Metzker ML, 2009, NAT REV GENET; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Schossig A, 2012, AM J HUM GENET, V90, P701, DOI 10.1016/j.ajhg.2012.02.012; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wetterstrand K.A., DNA SEQUENCING COSTS; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	52	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41948	10.1371/journal.pone.0041948	http://dx.doi.org/10.1371/journal.pone.0041948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870267	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800046
J	Horvath, DM; Stall, RE; Jones, JB; Pauly, MH; Vallad, GE; Dahlbeck, D; Staskawicz, BJ; Scott, JW				Horvath, Diana M.; Stall, Robert E.; Jones, Jeffrey B.; Pauly, Michael H.; Vallad, Gary E.; Dahlbeck, Doug; Staskawicz, Brian J.; Scott, John W.			Transgenic Resistance Confers Effective Field Level Control of Bacterial Spot Disease in Tomato	PLOS ONE			English	Article							CAMPESTRIS PV-VESICATORIA; RACE T3; GENE AVRBS2; AVIRULENCE; PATHOGEN; COPPER; VIRUS; INHERITANCE; PERFORMANCE; QUALITY	We investigated whether lines of transgenic tomato (Solanum lycopersicum) expressing the Bs2 resistance gene from pepper, a close relative of tomato, demonstrate improved resistance to bacterial spot disease caused by Xanthomonas species in replicated multi-year field trials under commercial type growing conditions. We report that the presence of the Bs2 gene in the highly susceptible VF 36 background reduced disease to extremely low levels, and VF 36-Bs2 plants displayed the lowest disease severity amongst all tomato varieties tested, including commercial and breeding lines with host resistance. Yields of marketable fruit from transgenic lines were typically 2.5 times that of the non-transformed parent line, but varied between 1.5 and 11.5 fold depending on weather conditions and disease pressure. Trials were conducted without application of any copper-based bactericides, presently in wide use despite negative impacts on the environment. This is the first demonstration of effective field resistance in a transgenic genotype based on a plant R gene and provides an opportunity for control of a devastating pathogen while eliminating ineffective copper pesticides.	[Horvath, Diana M.; Pauly, Michael H.] Two Blades Fdn, Evanston, IL USA; [Stall, Robert E.; Jones, Jeffrey B.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Vallad, Gary E.; Scott, John W.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Dahlbeck, Doug; Staskawicz, Brian J.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Berkeley	Horvath, DM (corresponding author), Two Blades Fdn, Evanston, IL USA.	dmh@2blades.org			Two Blades Foundation; Florida Tomato Committee	Two Blades Foundation; Florida Tomato Committee	Project support was provided in part by the Two Blades Foundation (2blades.org) and the Florida Tomato Committee. The funders had no role in study design, data collection and analysis, or decision to publish. 2Blades staff participated in the drafting of the manuscript.	Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P1346, DOI 10.1094/MPMI.2000.13.12.1346; Biffen RH, 1905, J AGR SCI, V1, P4, DOI 10.1017/S0021859600000137; Bravo-Almonacid F, 2012, TRANSGENIC RES, V21, P967, DOI 10.1007/s11248-011-9584-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Fan JH, 2011, J SOIL SEDIMENT, V11, P639, DOI 10.1007/s11368-011-0349-0; Ferreira SA, 2002, PLANT DIS, V86, P101, DOI 10.1094/PDIS.2002.86.2.101; Fuchs M, 2007, ANNU REV PHYTOPATHOL, V45, P173, DOI 10.1146/annurev.phyto.45.062806.094434; Glades Crop Care, 1999, CROP PROF S FLOR TOM; Green J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030973; GROENEWEGEN C, 1994, HORTSCIENCE, V29, P1088, DOI 10.21273/HORTSCI.29.9.1088; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Horsfall J, 1945, PHYTOPATHOLOGY, V36, P655; Huang CH, 2011, PLANT DIS MANAGEMENT, V5, pV066; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Krens FA, 2011, TRANSGENIC RES, V20, P1113, DOI 10.1007/s11248-011-9484-z; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; MARCO GM, 1983, PLANT DIS, V67, P779, DOI 10.1094/PD-67-779; Olson SM, 2007, VEGETABLE PRODUCTION, P409; POHRONEZNY K, 1983, HORTSCIENCE, V18, P69; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Rowell B., 1999, HortTechnology, V9, P641; Rowell B, 2001, HORTTECHNOLOGY, V11, P648, DOI 10.21273/HORTTECH.11.4.648; Sasu MA, 2009, P NATL ACAD SCI USA, V106, P19067, DOI 10.1073/pnas.0905106106; Scott JW, 2001, J AM SOC HORTIC SCI, V126, P436, DOI 10.21273/JASHS.126.4.436; Scott JW, 1996, RPT TOMATO GENT COOP, V46; STALL R. E., 1962, PLANT DIS REPTR, V46, P389; STALL RE, 1986, PHYTOPATHOLOGY, V76, P240, DOI 10.1094/Phyto-76-240; Swords KMM, 1996, J BACTERIOL, V178, P4661, DOI 10.1128/jb.178.15.4661-4669.1996; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Thayer PL, 1962, FLORIDA AGR EXPT STA, V1523, P163; Toor GS, 2010, P FLORIDA TOMATO I, P8; Vallad GE, 2011, PLANT DIS MANAGEMENT, V5, pV061; Vallad GE, 2011, PLANT DIS MANAGEMENT, V5, pV067; Vishnevetsky J, 2011, TRANSGENIC RES, V20, P61, DOI 10.1007/s11248-010-9392-7; WANG JF, 1994, PHYTOPATHOLOGY, V84, P702, DOI 10.1094/Phyto-84-702; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524; Zhang S, 2011, PLANT DIS MANAGEMENT, V5, pV016; Zhao BY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002408	39	108	110	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42036	10.1371/journal.pone.0042036	http://dx.doi.org/10.1371/journal.pone.0042036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870280	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800055
J	Khamduang, W; Gaudy-Graffin, C; Ngo-Giang-Huong, N; Jourdain, G; Moreau, A; Luekamlung, N; Halue, G; Buranawanitchakorn, Y; Kunkongkapan, S; Buranabanjasatean, S; Lallemant, M; Sirirungsi, W; Goudeau, A				Khamduang, Woottichai; Gaudy-Graffin, Catherine; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Moreau, Alain; Luekamlung, Nuananong; Halue, Guttiga; Buranawanitchakorn, Yuwadee; Kunkongkapan, Sura; Buranabanjasatean, Sudanee; Lallemant, Marc; Sirirungsi, Wasna; Goudeau, Alain		Program HIV Prevention Treatment	Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand	PLOS ONE			English	Article							PATIENTS RECEIVING LAMIVUDINE; HIV-1-INFECTED ADULTS; INDIVIDUALS; RESISTANT; EFFICACY; ADOLESCENTS; GUIDELINES; MORTALITY; IMPACT; COHORT	Background: Approximately 4 million of people are co-infected with HIV and Hepatitis B virus (HBV). In resource-limited settings, the majority of HIV-infected patients initiate first-line highly active antiretroviral therapy containing lamivudine (3TC-containing-HAART) and long-term virological response of HBV to lamivudine-containing HAART in co-infected patients is not well known. Methodology/Principal Finding: HIV-HBV co-infected patients enrolled in the PHPT cohort (ClinicalTrials. gov NCT00433030) and initiating a 3TC-containing-HAART regimen were included. HBV-DNA, HIV-RNA, CD4+ T-cell counts and alanine transaminase were measured at baseline, 3 months, 12 months and then every 6 months up to 5 years. Kaplan-Meier analysis was used to estimate the cumulative rates of patients who achieved and maintained HBV-DNA suppression. Of 30 co-infected patients, 19 were positive for HBe antigen (HBeAg). At initiation of 3TC-containing-HAART, median HBV DNA and HIV RNA levels were 7.35 log10 IU/mL and 4.47 log10 copies/mL, respectively. At 12 months, 67% of patients achieved HBV DNA suppression: 100% of HBeAg-negative patients and 47% of HBeAg-positive. Seventy-three percent of patients had HIV RNA below 50 copies/mL. The cumulative rates of maintained HBV-DNA suppression among the 23 patients who achieved HBV-DNA suppression were 91%, 87%, and 80% at 1, 2, and 4 years respectively. Of 17 patients who maintained HBV-DNA suppression while still on 3TC, 4 (24%) lost HBsAg and 7 of 8 (88%) HBeAg-positive patients lost HBeAg at their last visit (median duration, 59 months). HBV breakthrough was observed only in HBeAg-positive patients and 6 of 7 patients presenting HBV breakthrough had the rtM204I/V mutations associated with 3TC resistance along with rtL180M and/or rtV173L. Conclusions: All HBeAg-negative patients and 63% of HBeAg-positive HIV-HBV co-infected patients achieved long-term HBV DNA suppression while on 3TC-containing-HAART. This study provides information useful for the management of co-infected patients in resource-limited countries where the vast majority of co-infected patients are currently receiving 3TC.	[Khamduang, Woottichai; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc; Sirirungsi, Wasna] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Khamduang, Woottichai; Gaudy-Graffin, Catherine; Moreau, Alain; Goudeau, Alain] Univ Tours, Fac Med, INSERM, U966,CHRU Tours, Tours, France; [Khamduang, Woottichai; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] IRD, UMI Programs HIV Prevent & Treatment PHPT 174, Chiang Mai, Thailand; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Luekamlung, Nuananong] Lamphun Hosp, Lamphun, Thailand; [Halue, Guttiga] Phayao Hosp, Phayao, Thailand; [Buranawanitchakorn, Yuwadee] Chiang Kham Hosp, Phayao, Thailand; [Kunkongkapan, Sura] Mae Sai Hosp, Chiangrai, Thailand; [Buranabanjasatean, Sudanee] Mae Chan Hosp, Chiangrai, Thailand	Chiang Mai University; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard T.H. Chan School of Public Health	Khamduang, W (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand.	kwoottichai@gmail.com; goudeau@med.univ-tours.fr	Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017; Khamduang, Woottichai/AFG-2454-2022	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Khamduang, Woottichai/0000-0003-0196-5691	Agence Nationale de Recherches sur le Sida et les hepatites virales [ANRS 12-179]; Global Fund to fight AIDS, TB and Malaria; Institut de Recherche pour le Developpement (IRD), France; Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs; IRD; Franco-Thai cooperation program in Higher Education and Research; Faculty of Associated Medical Sciences, Chiang Mai University; French Ministry of Foreign Affairs	Agence Nationale de Recherches sur le Sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Global Fund to fight AIDS, TB and Malaria(United States Agency for International Development (USAID)); Institut de Recherche pour le Developpement (IRD), France; Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs; IRD; Franco-Thai cooperation program in Higher Education and Research; Faculty of Associated Medical Sciences, Chiang Mai University; French Ministry of Foreign Affairs	This work was supported by Agence Nationale de Recherches sur le Sida et les hepatites virales (grant number ANRS 12-179); the Global Fund to fight AIDS, TB and Malaria; the Institut de Recherche pour le Developpement (IRD), France; and Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs. WK received scholarships from the IRD, the Franco-Thai cooperation program in Higher Education and Research, the Faculty of Associated Medical Sciences, Chiang Mai University, and the French Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2011, GUID US ANT AG HIV 1, P111; Benhamou Y, 2006, HEPATOLOGY, V43, P548, DOI 10.1002/hep.21055; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; da Silva Luiz Caetano, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P189; de Vries-Sluijs TEMS, 2006, J CLIN VIROL, V36, P60, DOI 10.1016/j.jcv.2005.12.004; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Ford N, 2008, S AFR J HIV MED, P8; Hoff J, 2001, CLIN INFECT DIS, V32, P963, DOI 10.1086/319368; Kiertiburanakul Sasisopin, 2007, Journal of the Medical Association of Thailand, V90, P237; Kim HN, 2011, J VIRAL HEPATITIS, V18, pE447, DOI 10.1111/j.1365-2893.2011.01466.x; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Nishizaki Y, 2006, TOKAI J EXP CLIN MED, V31, P111; Phanuphak P, 2004, AIDS, V18, pS33, DOI 10.1097/00002030-200406003-00007; Pillay D, 2000, AIDS, V14, P1111, DOI 10.1097/00002030-200006160-00007; Sheng WH, 2012, CLIN INFECT DIS, V54, P548, DOI 10.1093/cid/cir851; Snow-Lampart A, 2011, HEPATOLOGY, V53, P763, DOI 10.1002/hep.24078; Sungkanuparph Somnuek, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P863; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Sungkanuparph Somnuek, 2008, Journal of the Medical Association of Thailand, V91, P1925; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Villeneuve JP, 2003, J HEPATOL, V39, P1085, DOI 10.1016/j.jhep.2003.09.022; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2009, RAP ADV ANT THER HIV, V3, P11	31	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42184	10.1371/journal.pone.0042184	http://dx.doi.org/10.1371/journal.pone.0042184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860080	Green Published, gold			2022-12-25	WOS:000307045600071
J	Naylor, RJ; Livesey, L; Schumacher, J; Henke, N; Massey, C; Brock, KV; Fernandez-Fuente, M; Piercy, RJ				Naylor, Rosie J.; Livesey, Leanda; Schumacher, John; Henke, Nicole; Massey, Claire; Brock, Kenny V.; Fernandez-Fuente, Marta; Piercy, Richard J.			Allele Copy Number and Underlying Pathology Are Associated with Subclinical Severity in Equine Type 1 Polysaccharide Storage Myopathy (PSSM1)	PLOS ONE			English	Article							SKELETAL-MUSCLE; POMPE DISEASE; PHOSPHOFRUCTOKINASE DEFICIENCY; EXERTIONAL RHABDOMYOLYSIS; INSULIN SENSITIVITY; MCARDLES DISEASE; QUARTER HORSES; GYS1 MUTATION; EXERCISE; GLUCOSE	Equine type 1 polysaccharide storage myopathy (PSSM1), a common glycogenosis associated with an R309H founder mutation in the glycogen synthase 1 gene (GYS1), shares pathological features with several human myopathies. In common with related human disorders, the pathogenesis remains unclear in particular, the marked phenotypic variability between affected animals. Given that affected animals accumulate glycogen and alpha-crystalline polysaccharide within their muscles, it is possible that physical disruption associated with the presence of this material could exacerbate the phenotype. The aim of this study was to compare the histopathological changes in horses with PSSM1, and specifically, to investigate the hypothesis that the severity of underlying pathology, (e.g. vacuolation and inclusion formation) would (1) be higher in homozygotes than heterozygotes and (2) correlate with clinical severity. Resting and post-exercise plasma creatine kinase (CK) and aspartate aminotransferase (AST) enzyme activity measurements and muscle pathology were assessed in matched cohorts of PSSM1 homozygotes, heterozygotes or control horses. Median (interquartile range (IR)) resting CK activities were 364 (332-764) U/L for homozygotes, 301 (222-377) U/L for heterozygotes and 260 (216-320) U/L for controls, and mean (+/- SD) AST activity for homozygotes were 502 (+/116) U/L, for heterozygotes, 357 (+/-92) U/L and for controls, 311 (+/-64) U/L and were significantly different between groups (P = 0.04 and P = 0.01 respectively). Resting plasma AST activity was significantly associated with the severity of subsarcolemmal vacuolation (rho = 0.816; P = 0.01) and cytoplasmic inclusions (rho = 0.766; P = 0.01). There were fewer type 2x and more type 2a muscle fibres in PSSM1-affected horses. Our results indicate that PSSM1 has incomplete dominance. Furthermore, the association between plasma muscle enzyme activity and severity of underlying pathology suggests that physical disruption of myofibres may contribute to the myopathic phenotype. This work provides insight into PSSM1 pathogenesis and has implications for related human glycogenoses.	[Naylor, Rosie J.; Massey, Claire; Fernandez-Fuente, Marta; Piercy, Richard J.] Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Livesey, Leanda; Schumacher, John; Henke, Nicole; Brock, Kenny V.] Auburn Univ, Auburn, AL 36849 USA	University of London; University of London Royal Veterinary College; Auburn University System; Auburn University	Naylor, RJ (corresponding author), Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England.	rpiercy@rvc.ac.uk	Fernandez-Fuente, Marta/A-1761-2014					Annandale EJ, 2005, AM J VET RES, V66, P839, DOI 10.2460/ajvr.2005.66.839; Annandale EJ, 2004, NEUROMUSCULAR DISORD, V14, P666, DOI 10.1016/j.nmd.2004.05.007; ARGOV Z, 1987, ANN NEUROL, V22, P46, DOI 10.1002/ana.410220112; Art T, 2006, Equine Vet J Suppl, P298; Brojer JT, 2006, AM J VET RES, V67, P1589, DOI 10.2460/ajvr.67.9.1589; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; Byrne E, 2000, COMP CONT EDUC PRACT, V22, P503; De La Corte FD, 2002, J VET INTERN MED, V16, P581, DOI 10.1892/0891-6640(2002)016&lt;0581:DOOPSM&gt;2.3.CO;2; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; DiMauro S, 2011, OFFICIAL J MEDITERRA, V30, P96; Dranchak PK, 2007, AM J VET RES, V68, P1079, DOI 10.2460/ajvr.68.10.1079; Dubowitz V, 2007, MUSCLE BIOPSY PRACTC; Duran J, 2012, EMBO MOL MED; Eto D, 2003, EQUINE VET J, V35, P676, DOI 10.2746/042516403775696276; Firshman AM, 2005, JAVMA-J AM VET MED A, V227, P1958, DOI 10.2460/javma.2005.227.1958; Firshman AM, 2003, AM J VET RES, V64, P1319, DOI 10.2460/ajvr.2003.64.1319; Firshman AM, 2008, AM J VET RES, V69, P818, DOI 10.2460/ajvr.69.6.818; HAYS AP, 1981, NEUROLOGY, V31, P1077, DOI 10.1212/WNL.31.9.1077; Hicks J, 2011, ULTRASTRUCT PATHOL, V35, P183, DOI 10.3109/01913123.2011.601404; JENSEN M, 1990, ACTA VET SCAND, V31, P129; LEWIS SF, 1985, J APPL PHYSIOL, V59, P1991, DOI 10.1152/jappl.1985.59.6.1991; LEWIS SF, 1986, J APPL PHYSIOL, V61, P391, DOI 10.1152/jappl.1986.61.2.391; McCue ME, 2008, J VET INTERN MED, V22, P1228, DOI 10.1111/j.1939-1676.2008.0167.x; McCue ME, 2009, VET PATHOL, V46, P1281, DOI 10.1354/vp.08-VP-0177-M-FL; Mccue ME, 2009, NEUROMUSCULAR DISORD, V19, P37, DOI 10.1016/j.nmd.2008.10.001; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Naylor RJ, 2012, J VET INTER IN PRESS; Papadimas GK, 2011, CLIN NEUROL NEUROSUR, V113, P303, DOI 10.1016/j.clineuro.2010.12.005; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rivero JLL, 1996, ANAT RECORD, V246, P185, DOI 10.1002/(SICI)1097-0185(199610)246:2<185::AID-AR5>3.0.CO;2-0; Schwarz B, 2011, VET REC, V169, P583, DOI 10.1136/vr.d5438; Serrano AL, 2000, J MUSCLE RES CELL M, V21, P235, DOI 10.1023/A:1005642632711; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Stanley RL, 2009, EQUINE VET J, V41, P597, DOI 10.2746/042516409X407611; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Valberg SJ, 1999, EQUINE VET J, V31, P43, DOI 10.1111/j.2042-3306.1999.tb03789.x; VALBERG SJ, 1992, NEUROMUSCULAR DISORD, V2, P351, DOI 10.1016/S0960-8966(06)80006-4; Valentine BA, 2006, VET PATHOL, V43, P270, DOI 10.1354/vp.43-3-270; Valentine BA, 2005, VET PATHOL, V42, P823, DOI 10.1354/vp.42-6-823; Valentine BA, 2000, VET PATHOL, V37, P193, DOI 10.1354/vp.37-2-193; Valentine BA, 2006, NEUROMUSCULAR DISORD, V16, P603, DOI 10.1016/j.nmd.2006.05.259; Vucic S, 2007, MUSCLE NERVE, V35, P536, DOI 10.1002/mus.20720; Xu S, 2010, J APPL PHYSIOL, V108, P1383, DOI 10.1152/japplphysiol.01253.2009; Yamano S, 2002, AM J VET RES, V63, P1408, DOI 10.2460/ajvr.2002.63.1408	45	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42317	10.1371/journal.pone.0042317	http://dx.doi.org/10.1371/journal.pone.0042317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860112	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600090
J	Haraguchi, R; Matsumaru, D; Nakagata, N; Miyagawa, S; Suzuki, K; Kitazawa, S; Yamada, G				Haraguchi, Ryuma; Matsumaru, Daisuke; Nakagata, Naomi; Miyagawa, Shinichi; Suzuki, Kentaro; Kitazawa, Sohei; Yamada, Gen			The Hedgehog Signal Induced Modulation of Bone Morphogenetic Protein Signaling: An Essential Signaling Relay for Urinary Tract Morphogenesis	PLOS ONE			English	Article							EXTERNAL GENITALIA FORMATION; TAMOXIFEN-INDUCIBLE FORM; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; VACTERL ASSOCIATION; MOLECULAR ANALYSIS; MOUSE MODEL; KIDNEY; EXPRESSION; GENE	Background: Congenital diseases of the urinary tract are frequently observed in infants. Such diseases present a number of developmental anomalies such as hydroureter and hydronephrosis. Although some genetically-modified mouse models of growth factor signaling genes reproduce urinary phenotypes, the pathogenic mechanisms remain obscure. Previous studies suggest that a portion of the cells in the external genitalia and bladder are derived from peri-cloacal mesenchymal cells that receive Hedgehog (Hh) signaling in the early developmental stages. We hypothesized that defects in such progenitor cells, which give rise to urinary tract tissues, may be a cause of such diseases. Methodology/Principal Findings: To elucidate the pathogenic mechanisms of upper urinary tract malformations, we analyzed a series of Sonic hedgehog (Shh) deficient mice. Shh(-/-) displayed hydroureter and hydronephrosis phenotypes and reduced expression of several developmental markers. In addition, we suggested that Shh modulation at an early embryonic stage is responsible for such phenotypes by analyzing the Shh conditional mutants. Tissue contribution assays of Hh-responsive cells revealed that peri-cloacal mesenchymal cells, which received Hh signal secreted from cloacal epithelium, could contribute to the ureteral mesenchyme. Gain- and loss-of-functional mutants for Hh signaling revealed a correlation between Hh signaling and Bone morphogenetic protein (Bmp) signaling. Finally, a conditional ablation of Bmp receptor type IA (BmprIA) gene was examined in Hh-responsive cell lineages. This system thus made it possible to analyze the primary functions of the growth factor signaling relay. The defective Hh-to-Bmp signaling relay resulted in severe urinary tract phenotypes with a decrease in the number of Hh-responsive cells. Conclusions/Significance: This study identified the essential embryonic stages for the pathogenesis of urinary tract phenotypes. These results suggested that Hh-responsive mesenchymal Bmp signaling maintains the population of peri-cloacal mesenchyme cells, which is essential for the development of the ureter and the upper urinary tract.	[Haraguchi, Ryuma; Matsumaru, Daisuke; Suzuki, Kentaro; Yamada, Gen] Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama, Japan; [Haraguchi, Ryuma; Matsumaru, Daisuke; Miyagawa, Shinichi; Suzuki, Kentaro; Yamada, Gen] Kumamoto Univ, Dept Organ Format, Inst Mol Embryol & Genet, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Haraguchi, Ryuma; Kitazawa, Sohei] Ehime Univ, Dept Mol Pathol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan; [Miyagawa, Shinichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Aichi, Japan	Wakayama Medical University; Kumamoto University; Ehime University; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Haraguchi, R (corresponding author), Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama, Japan.	transg8@wakayama-med.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356; Matsumaru, Daisuke/0000-0002-1832-624X; Nakagata, Naomi/0000-0002-5737-9993; Yamada, Gen/0000-0001-6160-2660	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23790228, 24790292, 22132006]; Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institutes of Health Grant [R01ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Grant-in-Aid for Young Scientists B (23790228 and 24790292), for Scientific Research on Innovative Areas: Molecular mechanisms for establishment of sex differences (22132006), and the Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work is also supported by National Institutes of Health Grant R01ES016597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaga M, 2010, AM J MED GENET A, V152A, P781, DOI 10.1002/ajmg.a.33293; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Cain JE, 2006, J ANAT, V209, P745, DOI 10.1111/j.1469-7580.2006.00655.x; Cain JE, 2011, PEDIATR NEPHROL, V26, P1365, DOI 10.1007/s00467-010-1704-x; Cain JE, 2005, KIDNEY INT, V67, P420, DOI 10.1111/j.1523-1755.2005.67098.x; Chan KT, 2010, BIOCHEM BIOPH RES CO, V398, P153, DOI 10.1016/j.bbrc.2010.05.150; Chevalier RL, 1998, SEMIN NEPHROL, V18, P585; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DANEMAN A, 1991, RADIOL CLIN N AM, V29, P351; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Di Giovanni V, 2011, DEVELOPMENT, V138, P2717, DOI 10.1242/dev.059030; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Dudley AT, 1997, DEV DYNAM, V208, P349; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Godin RE, 1998, DEVELOPMENT, V125, P3473; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensley MR, 2012, ZEBRAFISH, V9, P44, DOI 10.1089/zeb.2011.0730; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Kim JH, 2001, CLIN GENET, V59, P306, DOI 10.1034/j.1399-0004.2001.590503.x; Kim PCW, 2001, J PEDIATR SURG, V36, P381, DOI 10.1053/jpsu.2001.20722; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Li MM, 2008, AM J MED GENET A, V146A, P368, DOI 10.1002/ajmg.a.32116; Li MM, 2009, J PEDIATR-US, V155, P311, DOI 10.1016/j.jpeds.2009.04.001; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Martinez-Frias M, 2001, CLIN GENET, V60, P397, DOI 10.1034/j.1399-0004.2001.600515.x; Matsumaru D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016260; McGlinn E, 2006, CURR OPIN GENET DEV, V16, P426, DOI 10.1016/j.gde.2006.06.013; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Omori A, 2011, CONGENIT ANOM, V51, P102, DOI 10.1111/j.1741-4520.2011.00318.x; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Seifert AW, 2009, DEVELOPMENT, V136, P3949, DOI 10.1242/dev.042291; Song RF, 2011, PEDIATR NEPHROL, V26, P353, DOI 10.1007/s00467-010-1629-4; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Tripathi P, 2010, DEV BIOL, V340, P518, DOI 10.1016/j.ydbio.2010.02.007; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wong EYM, 2011, DEV BIOL, V352, P382, DOI 10.1016/j.ydbio.2011.02.003; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yao Y, 2011, BJU INT, V107, P1002, DOI 10.1111/j.1464-410X.2010.09520.x; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	81	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42245	10.1371/journal.pone.0042245	http://dx.doi.org/10.1371/journal.pone.0042245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860096	Green Submitted, Green Published, gold			2022-12-25	WOS:000306950900081
J	Lonnell, N; Hylander, K; Jonsson, BG; Sundberg, S				Lonnell, Niklas; Hylander, Kristoffer; Jonsson, Bengt Gunnar; Sundberg, Sebastian			The Fate of the Missing Spores - Patterns of Realized Dispersal beyond the Closest Vicinity of a Sporulating Moss	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; WOOD-DECAYING FUNGI; SEED DISPERSAL; COLONIZATION; BRYOPHYTES; WIND; DEPOSITION; MECHANISMS; SPHAGNUM; ISLANDS	It is well-known that many species with small diaspores can disperse far during extended temporal scales (many years). However, studies on short temporal scales usually only cover short distances (in, e.g., bryophytes up to 15 m). By using a novel experimental design, studying the realized dispersal, we extend this range by almost two orders of magnitude. We recorded establishment of the fast-growing moss Discelium nudum on introduced suitable substrates, placed around a translocated, sporulating mother colony. Around 2,000 pots with acidic clay were placed at different distances between 5 m and 600 m, in four directions, on a raised bog, with increased pot numbers with distance. The experiment was set up in April-May and the realized dispersal (number of colonized pots) was recorded in September. Close to the mother colony (up to 10 m), the mean colonization rates (ratio of colonized pots) exceeded 50%. At distances between 10 and 50 m colonization dropped sharply, but beyond 50 m the mean colonization rates stabilized and hardly changed (1-3%). The estimated density of spores causing establishments at the further distances (2-6 spores/m(2)) was realistic when compared to the estimated spore output from the central colonies. Our study supports calculations from earlier studies, limited to short distances, that a majority of the spores disperse beyond the nearest vicinity of a source. The even colonization pattern at further distances raises interesting questions about under what conditions spores are transported and deposited. However, it is clear that regular establishment is likely at the km-scale for this and many other species with similar spore output and dispersal mechanism.	[Lonnell, Niklas; Hylander, Kristoffer] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Jonsson, Bengt Gunnar] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden; [Sundberg, Sebastian] Uppsala Univ, Evolutionary Biol Ctr, Dept Plant Ecol & Evolut, Uppsala, Sweden; [Sundberg, Sebastian] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden	Stockholm University; Mid-Sweden University; Uppsala University; Swedish University of Agricultural Sciences	Lonnell, N (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	niklas.lonnell@botan.su.se		Sundberg, Sebastian/0000-0001-7966-9097	Swedish research council Formas [217-2008-1193]	Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This research was funded by a grant from the Swedish research council Formas (217-2008-1193, www.formas.se) to Kristoffer Hylander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell H.W., 1875, SKANDINAVISKA LOFMOS; Aune K, 2005, BIOL CONSERV, V124, P89, DOI 10.1016/j.biocon.2005.01.015; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; AYLOR DE, 1985, ATMOS ENVIRON, V19, P803, DOI 10.1016/0004-6981(85)90069-1; AYLOR DE, 1987, PHYTOPATHOLOGY, V77, P1442, DOI 10.1094/Phyto-77-1442; Boros A., 1993, ATLAS RECENT EUROPEA; BREMER P, 1990, LINDBERGIA, V16, P3; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Cronberg N, 2002, J ECOL, V90, P925, DOI 10.1046/j.1365-2745.2002.00723.x; D Fontaneto, 2011, BIOGEOGRAPHY MICROSC; DURING HJ, 1979, LINDBERGIA, V5, P2; Edman M, 2004, ECOL APPL, V14, P893, DOI 10.1890/03-5103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gjerde I, 2012, ECOLOGY, V93, P749, DOI 10.1890/11-1018.1; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hill MO., 2007, BRYOATT ATTRIBUTES B; Hutsemekers V, 2008, DIVERS DISTRIB, V14, P483, DOI 10.1111/j.1472-4642.2007.00454.x; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Lonnell N, 2011, PLANT ECOL, V3, P1; MILES CJ, 1992, J BRYOL, V17, P355, DOI 10.1179/jbr.1992.17.2.355; Miller NG, 2004, AM J BOT, V91, P1173, DOI 10.3732/ajb.91.8.1173; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nichols J., 2001, DISPERSAL; Norros V, 2012, OIKOS, V121, P961, DOI 10.1111/j.1600-0706.2012.20052.x; NYHOLM E, 1989, ILLUSTRATED FLORA NO; Okland RH, 2003, ECOLOGY, V84, P1909; Pohjamo M, 2006, EVOL ECOL, V20, P415, DOI 10.1007/s10682-006-0011-2; Pounden E, 2008, J ECOL, V96, P591, DOI 10.1111/j.1365-2745.2008.01380.x; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Roads E, 2003, J HATTORI BOT LAB, P305; SHAW J, 1985, BRYOLOGIST, V88, P263, DOI 10.2307/3243035; Smith A.J.E., 2004, MOSS FLORA BRITAIN I, DOI [10.1017/cbo9780511541858, DOI 10.1017/CBO9780511541858]; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; SODERSTROM L, 1989, J BRYOL, V15, P793; Sundberg S, 2006, J BIOGEOGR, V33, P1479, DOI 10.1111/j.1365-2699.2006.01520.x; Sundberg S, 2005, OIKOS, V108, P115, DOI 10.1111/j.0030-1299.2005.12916.x; Sundberg S, ECOGRAPHY IN PRESS, DOI [10.1111/j.1600-0587.2012.07664.x, DOI 10.1111/J.1600-0587.2012.07664.X]; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Wilkinson DM, 2012, J BIOGEOGR, V39, P89, DOI 10.1111/j.1365-2699.2011.02569.x	51	47	50	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41987	10.1371/journal.pone.0041987	http://dx.doi.org/10.1371/journal.pone.0041987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22870183	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306950200143
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			Transfer-messenger RNA-SmpB Protein Regulates Ribonuclease R Turnover by Promoting Binding of HsIUV and Lon Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TMRNA-MEDIATED SURVEILLANCE; END RULE PATHWAY; ESCHERICHIA-COLI; SUBSTRATE RECOGNITION; RIBOSOME RESCUE; NUCLEASE DOMAIN; HSLUV PROTEASE; STRUCTURED RNA; STABLE RNA; DEGRADATION	RNase R, an important exoribonuclease involved in degradation of structured RNA, is subject to a novel mechanism of regulation. The enzyme is extremely unstable in rapidly growing cells but becomes stabilized under conditions of stress, such as stationary phase or cold shock. RNase R instability results from acetylation which promotes binding of tmRNA-SmpB, two trans-translation factors, to its C-terminal region. Here, we examine how binding of tmRNA-SmpB leads to proteolysis of RNase R. We show that RNase R degradation is due to two proteases, HsIUV and Lon. In their absence, RNase R is stable. We also show, using an in vitro system that accurately replicates the in vivo process, that tmRNA-SmpB is not essential, but it stimulates binding of the protease to the N-terminal region of RNase R and that it does so by a direct interaction between the protease and SmpB which stabilizes protease binding. Thus, a sequence of events, initiated by acetylation of a single Lys residue, results in proteolysis of RNase R in exponential phase cells. RNase R in stationary phase or in cold-shocked cells is not acetylated, and thereby remains stable. Such a regulatory mechanism, dependent on protein acetylation, has not been observed previously in bacterial cells.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Liang, Wenxing/E-7133-2012		National Institutes of Health Grant [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dougan DA, 2010, MOL MICROBIOL, V76, P545, DOI 10.1111/j.1365-2958.2010.07120.x; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	34	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33472	33479		10.1074/jbc.M112.375287	http://dx.doi.org/10.1074/jbc.M112.375287			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879590	Green Published, hybrid			2022-12-25	WOS:000309602100033
J	Nishi, M; Aoyama, F; Kisa, F; Zhu, H; Sun, MZ; Lin, PH; Ohta, H; Van, B; Yamamoto, S; Kakizawa, S; Sakai, H; Ma, JJ; Sawaguchi, A; Takeshima, H				Nishi, Miyuki; Aoyama, Fumiyo; Kisa, Fumihiko; Zhu, Hua; Sun, Mingzhai; Lin, Peihui; Ohta, Hiroya; Van, Bo; Yamamoto, Shinichiro; Kakizawa, Sho; Sakai, Hideki; Ma, Jianjie; Sawaguchi, Akira; Takeshima, Hiroshi			TRIM50 Protein Regulates Vesicular Trafficking for Acid Secretion in Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; PHOSPHOINOSITIDE 3-KINASE; SKELETAL-MUSCLE; OXYNTIC CELLS; IN-VITRO; LOCALIZATION; RECEPTOR; TRANSFORMATION; MAINTENANCE; CHANNELS	Of the TRIM/RBCC family proteins taking part in a variety of cellular processes, TRIM50 is a stomach-specific member with no defined biological function. Our biochemical data demonstrated that TRIM50 is specifically expressed in gastric parietal cells and is predominantly localized in the tubulovesicular and canalicular membranes. In cultured cells ectopically expressing GFP-TRIM50, confocal microscopic imaging revealed dynamic movement of TRIM50-associated vesicles in a phosphoinositide 3-kinase-dependent manner. A protein overlay assay detected preferential binding of the PRY-SPRY domain from the TRIM50 C-terminal region to phosphatidylinositol species, suggesting that TRIM50 is involved in vesicular dynamics by sensing the phosphorylated state of phosphoinositol lipids. Trim50 knockout mice retained normal histology in the gastric mucosa but exhibited impaired secretion of gastric acid. In response to histamine, Trim50 knock-out parietal cells generated deranged canaliculi, swollen microvilli lacking actin filaments, and excess multilamellar membrane complexes. Therefore, TRIM50 seems to play an essential role in tubulovesicular dynamics, promoting the formation of sophisticated canaliculi and microvilli during acid secretion in parietal cells.	[Aoyama, Fumiyo; Sawaguchi, Akira] Miyazaki Univ, Fac Med, Miyazaki 8891692, Japan; [Nishi, Miyuki; Kisa, Fumihiko; Ohta, Hiroya; Van, Bo; Yamamoto, Shinichiro; Kakizawa, Sho; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Zhu, Hua; Sun, Mingzhai; Lin, Peihui; Ma, Jianjie] Univ Med & Dent New Jersey, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Sakai, Hideki] Toyama Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan	University of Miyazaki; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toyama	Sawaguchi, A (corresponding author), Miyazaki Univ, Fac Med, Miyazaki 8891692, Japan.	sawa@fc.miyazaki-u.ac.jp; takeshim@pharm.kyoto-u.ac.jp	Sun, Mingzhai/B-4945-2012; Lin, Pei-Hui/I-3011-2015; Zhu, Hua/G-4409-2010	Lin, Pei-Hui/0000-0002-3894-5099; Takeshima, Hiroshi/0000-0003-4525-3725; Zhu, Hua/0000-0001-7136-7326	National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Ministry of Health and Welfare; Takeda Science Foundation; UBE Foundation; Japan Foundation for Applied Enzymology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24790073, 23240055] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); UBE Foundation(UBE Foundation); Japan Foundation for Applied Enzymology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science, the Ministry of Health and Welfare, the Takeda Science Foundation, the UBE Foundation, and the Japan Foundation for Applied Enzymology.	BLACK JA, 1982, GASTROENTEROLOGY, V83, P595; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CHEW CS, 1990, METHOD ENZYMOL, V191, P640; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; Fujii T, 2009, J BIOL CHEM, V284, P619, DOI 10.1074/jbc.M806562200; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Ko G, 2010, P NATL ACAD SCI USA, V107, P21511, DOI 10.1073/pnas.1016390107; Lang PA, 2007, CELL PHYSIOL BIOCHEM, V20, P527, DOI 10.1159/000107536; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Masumiya H, 2009, CHANNELS, V3, P6, DOI 10.4161/chan.3.1.7571; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sawaguchi A, 2005, ARCH HISTOL CYTOL, V68, P151, DOI 10.1679/aohc.68.151; Sawaguchi A, 2004, J HISTOCHEM CYTOCHEM, V52, P77, DOI 10.1177/002215540405200108; Sawaguchi A, 2006, J ELECTRON MICROSC, V55, P97, DOI 10.1093/jmicro/dfl004; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	40	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33523	33532		10.1074/jbc.M112.370551	http://dx.doi.org/10.1074/jbc.M112.370551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872646	hybrid, Green Published			2022-12-25	WOS:000309602100038
J	Ildefonso, CJ; Bond, WS; Al-Tawashi, AR; Hurwitz, MY; Hurwitz, RL				Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.			The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; TUMOR-CELL MIGRATION; GAMMA-SECRETASE; GENE-THERAPY; CONGENITAL AMAUROSIS; HYALURONAN FRAGMENTS; MURINE NEUROBLASTOMA; IMMUNE-RESPONSE; CANCER CELLS; PROMOTES	The success of gene therapy in the ocular environment is partly due to the presence of hyaluronan in vitreous. Here we explore the mechanism of hyaluronan-mediated enhancement of adenoviral vector transgene expression. Introduction of hyaluronan receptor CD44 into CD44-negative cells followed by transduction in the presence of vitreous with an adenoviral vector containing an IL-12-coding transgene increases IL-12 secretion. We demonstrate that sequential CD44 proteolysis is responsible for hyaluronan-mediated enhancement. Metalloproteinase or gamma-secretase inhibitors decrease adenoviral-mediated transgene expression. Deletion of these proteolytic sites in CD44 also inhibits transgene expression. Expression of CD44 with a mutation to prevent phosphorylation of serine 325 inhibits the response to vitreous. Expression of the CD44 intracellular domain enhances transgene expression in the absence of vitreous. CD44-mediated enhancement of gene expression was observed with vectors using different promoters and appears because of an increase in mRNA production, not because of an increase in vector transduction as determined by quantitative RT-PCR and quantitative PCR, respectively. These data fit a model where the interaction of hyaluronan in vitreous and CD44 modulates transgene expression by initiating CD44 proteolysis and release of the cytoplasmic domain, resulting in increased transgene transcription.	[Ildefonso, Cristhian J.; Bond, Wesley S.; Hurwitz, Richard L.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Texas Children Canc Ctr, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Texas Children Hematol Ctr, Houston, TX 77030 USA; [Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hurwitz, RL (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, 1102 Bates St,Suite 1025, Houston, TX 77030 USA.	rlhurwit@txch.org	Ildefonso, Cristhian/AAC-3576-2021	Ildefonso, Cristhian/0000-0001-6179-720X	National Institutes of Health [GM085793, CA103698, CA97762]; Clayton Foundation for Research; Retina Research Foundation; Golfers Against Cancer; Howard Hughes Medical Institute's Med-Into-Grad Initiative; NATIONAL CANCER INSTITUTE [P20CA103698, R21CA097762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Retina Research Foundation; Golfers Against Cancer; Howard Hughes Medical Institute's Med-Into-Grad Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085793 (to C. J. I.), CA103698 (to R. L. H.), and CA97762 (to R. L. H.). This work was also supported by the Clayton Foundation for Research, the Retina Research Foundation, and Golfers Against Cancer and in part by a grant from the Howard Hughes Medical Institute's Med-Into-Grad Initiative.	Bennett J, 2003, GENE THER, V10, P977, DOI 10.1038/sj.gt.3302030; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brenner M, 2010, MOL THER, V18, P451, DOI 10.1038/mt.2010.12; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chaudhuri SR, 2007, MOL THER, V15, P566, DOI 10.1038/sj.mt.6300044; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cichy J, 2005, BBA-MOL CELL RES, V1745, P59, DOI 10.1016/j.bbamcr.2005.02.006; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Iinuma H, 2006, J IMMUNOL, V176, P3461, DOI 10.4049/jimmunol.176.6.3461; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khan T, 2006, JNCI-J NATL CANCER I, V98, P190, DOI 10.1093/jnci/djj021; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; Lewis CA, 2001, BIOCHEM J, V357, P843, DOI 10.1042/0264-6021:3570843; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Murai S, 2004, VIRCHOWS ARCH, V445, P271, DOI 10.1007/s00428-004-1029-x; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; PURE E, 1995, J EXP MED, V181, P55, DOI 10.1084/jem.181.1.55; Ryu CH, 2011, HUM GENE THER, V22, P733, DOI 10.1089/hum.2010.187; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; TAYLOR KA, 1992, ANAL BIOCHEM, V201, P190, DOI 10.1016/0003-2697(92)90194-C; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32697	32707		10.1074/jbc.M112.347369	http://dx.doi.org/10.1074/jbc.M112.347369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865879	Green Published, hybrid			2022-12-25	WOS:000309168300037
J	Stiegler, AL; Draheim, KM; Li, XF; Chayen, NE; Calderwood, DA; Boggon, TJ				Stiegler, Amy L.; Draheim, Kyle M.; Li, Xiaofeng; Chayen, Naomi E.; Calderwood, David A.; Boggon, Titus J.			Structural Basis for Paxillin Binding and Focal Adhesion Targeting of beta-Parvin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; LD MOTIFS; ALPHA-PARVIN; SECONDARY-STRUCTURE; ANKYRIN REPEAT; CELL-ADHESION; PROTEIN; COMPLEX; LOCALIZATION; RECOGNITION	beta-Parvin is a cytoplasmic adaptor protein that localizes to focal adhesions where it interacts with integrin-linked kinase and is involved in linking integrin receptors to the cytoskeleton. It has been reported that despite high sequence similarity to beta-parvin, beta-parvin does not bind paxillin, suggesting distinct interactions and cellular functions for these two closely related parvins. Here, we reveal that beta-parvin binds directly and specifically to leucine-aspartic acid repeat (LD) motifs in paxillin via its C-terminal calponin homology (CH2) domain. We present the co-crystal structure of beta-parvin CH2 domain in complex with paxillin LD1 motif to 2.9 angstrom resolution and find that the interaction is similar to that previously observed between beta-parvin and paxillin LD1. We also present crystal structures of unbound beta-parvin CH2 domain at 2.1 angstrom and 2.0 angstrom resolution that show significant conformational flexibility in the N-terminal alpha-helix, suggesting an induced fit upon paxillin binding. We find that beta-parvin has specificity for the LD1, LD2, and LD4 motifs of paxillin, with K-D values determined to 27, 42, and 73 mu M, respectively, by surface plasmon resonance. Furthermore, we show that proper localization of beta-parvin to focal adhesions requires both the paxillin and integrin-linked kinase binding sites and that paxillin is important for early targeting of beta-parvin. These studies provide the first molecular details of beta-parvin binding to paxillin and help define the requirements for beta-parvin localization to focal adhesions.	[Stiegler, Amy L.; Draheim, Kyle M.; Li, Xiaofeng; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Chayen, Naomi E.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW7 2AZ, England	Yale University; Yale University; Yale University; Imperial College London	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [R01GM088240, RR026992]; American Cancer Society; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM088240 and RR026992.; Supported by an American Cancer Society postdoctoral fellowship.; Supported by an American Heart Association postdoctoral fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chayen NE, 2005, PROG BIOPHYS MOL BIO, V88, P329, DOI 10.1016/j.pbiomolbio.2004.07.007; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korenbaum E, 2001, GENE, V279, P69, DOI 10.1016/S0378-1119(01)00743-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev A. A., 2012, CCP4 NEWSLETTER, V48; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li XF, 2011, J BIOL CHEM, V286, P26138, DOI 10.1074/jbc.M110.211250; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Olski TM, 2001, J CELL SCI, V114, P525; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1994, J CELL SCI, V107, P1583; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	54	25	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32566	32577		10.1074/jbc.M112.367342	http://dx.doi.org/10.1074/jbc.M112.367342			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22869380	Green Published, hybrid			2022-12-25	WOS:000309168300026
J	Frank, E; Wu, YZ; Piyaratna, N; Body, WJ; Snikeris, P; South, T; Gerdin, AK; Bjursell, M; Bohlooly-Y, M; Storlien, L; Huang, XF				Frank, Elisabeth; Wu, Yizhen; Piyaratna, Naomi; Body, William James; Snikeris, Peta; South, Timothy; Gerdin, Anna-Karin; Bjursell, Mikael; Bohlooly-Y, Mohammad; Storlien, Leonard; Huang, Xu-Feng			Metabolic Parameters and Emotionality Are Little Affected in G-Protein Coupled Receptor 12 (Gpr12) Mutant Mice	PLOS ONE			English	Article							MOUSE MODELS; DEFICIENT MICE; MESSENGER-RNA; ANIMAL-MODELS; EXPRESSION; DIET; IDENTIFICATION; RESISTANT; SEVERITY; C57BL/6J	Background: G-protein coupled receptors (GPR) bear the potential to serve as yet unidentified drug targets for psychiatric and metabolic disorders. GPR12 is of major interest given its putative role in metabolic function and its unique brain distribution, which suggests a role in emotionality and affect. We tested Gpr12 deficient mice in a series of metabolic and behavioural tests and subjected them to a well-established high-fat diet feeding protocol. Methodology/Principal Findings: Comparing the mutant mice with wild type littermates, no significant differences were seen in body weight, fatness or weight gain induced by a high-fat diet. The Gpr12 mutant mice displayed a modest but significant lowering of energy expenditure and a trend to lower food intake on a chow diet, but no other metabolic parameters, including respiratory rate, were altered. No emotionality-related behaviours (assessed by light-dark box, tail suspension, and open field tests) were affected by the Gpr12 gene mutation. Conclusions/Significance: Studying metabolic and emotionality parameters in Gpr12 mutant mice did not reveal a major phenotypic impact of the gene mutation. Compared to previous results showing a metabolic phenotype in Gpr12 mice with a mixed 129 and C57Bl6 background, we suggest that a more pure C57Bl/6 background due to further backcrossing might have reduced the phenotypic penetrance.	[Frank, Elisabeth; Snikeris, Peta; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Frank, Elisabeth; Wu, Yizhen; Piyaratna, Naomi; Body, William James; Snikeris, Peta; South, Timothy; Huang, Xu-Feng] Univ Wollongong, Sch Hlth Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Gerdin, Anna-Karin; Bjursell, Mikael; Bohlooly-Y, Mohammad] AstraZeneca R&D, Molndal, Sweden; [Storlien, Leonard] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia	University of Wollongong; AstraZeneca; University of Sydney	Frank, E (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	efrank@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Snikeris, Peta/L-9082-2017; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Snikeris, Peta/0000-0002-2334-1102; Huang, Xu-Feng/0000-0002-5895-2253	Schizophrenia Research Institute, Australia; NSW Ministry of Health; AstraZeneca, Sweden; Schizophrenia Research Institute; AstraZeneca	Schizophrenia Research Institute, Australia; NSW Ministry of Health; AstraZeneca, Sweden(AstraZeneca); Schizophrenia Research Institute; AstraZeneca(AstraZeneca)	This work was supported by the Schizophrenia Research Institute, Australia, (www.schizophreniaresearch.org.au) utilising infrastructure funding from NSW Ministry of Health, and by AstraZeneca, Sweden. The Schizophrenia Research Institute supported the project by salary and budget for EF and PS. AstraZeneca (www.astrazeneca.com) employs AKG, MB and MBY, and financially supported the studies. The funding bodies had, however, no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; Bjursell M, 2006, DIABETES, V55, P725, DOI 10.2337/diabetes.55.03.06.db05-1302; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2006, BIOCHEM BIOPH RES CO, V348, P359, DOI 10.1016/j.bbrc.2006.07.090; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bresnick JN, 2003, ASSAY DRUG DEV TECHN, V1, P239, DOI 10.1089/15406580360545053; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; EIDNE KA, 1991, FEBS LETT, V292, P243, DOI 10.1016/0014-5793(91)80876-5; Flint J, 2008, CURR OPIN GENET DEV, V18, P235, DOI 10.1016/j.gde.2008.07.002; Frank E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007821; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Girirajan S, 2009, EUR J MED GENET, V52, P224, DOI 10.1016/j.ejmg.2008.12.002; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; Ignatov A, 2003, J NEUROSCI, V23, P907; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Joost P, 2002, GENOME BIOL, V3; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lee AWS, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001729; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Lin ZJ, 2008, ARCH PHARM RES, V31, P1108, DOI 10.1007/s12272-001-1276-4; Lu Xiaoming, 2012, Mol Cell Biochem, V366, P101, DOI 10.1007/s11010-012-1287-x; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; McCutcheon JE, 2008, EUR J NEUROSCI, V27, P683, DOI 10.1111/j.1460-9568.2008.06043.x; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; SONG ZH, 1994, FEBS LETT, V351, P375, DOI 10.1016/0014-5793(94)00888-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Wotjak CT, 2005, MINI-REV MED CHEM, V5, P659, DOI 10.2174/1389557054368763; Yagi H, 2009, NEUROSCI LETT, V461, P190, DOI 10.1016/j.neulet.2009.06.012	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42395	10.1371/journal.pone.0042395	http://dx.doi.org/10.1371/journal.pone.0042395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879962	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900037
J	Nelson, JL; Zavaleta, ES				Nelson, Joanna L.; Zavaleta, Erika S.			Salt Marsh as a Coastal Filter for the Oceans: Changes in Function with Experimental Increases in Nitrogen Loading and Sea-Level Rise	PLOS ONE			English	Article							NUTRIENT OVER-ENRICHMENT; SALICORNIA-VIRGINICA; SPARTINA-FOLIOSA; BIOGEOCHEMICAL CYCLES; SOUTHERN CALIFORNIA; ELEVATED CO2; RIVER-BASIN; EUTROPHICATION; ECOSYSTEM; CONSEQUENCES	Coastal salt marshes are among Earth's most productive ecosystems and provide a number of ecosystem services, including interception of watershed-derived nitrogen (N) before it reaches nearshore oceans. Nitrogen pollution and climate change are two dominant drivers of global-change impacts on ecosystems, yet their interacting effects at the land-sea interface are poorly understood. We addressed how sea-level rise and anthropogenic N additions affect the salt marsh ecosystem process of nitrogen uptake using a field-based, manipulative experiment. We crossed simulated sea-level change and ammonium-nitrate (NH4NO3)-addition treatments in a fully factorial design to examine their potentially interacting effects on emergent marsh plants in a central California estuary. We measured above-and belowground biomass and tissue nutrient concentrations seasonally and found that N-addition had a significant, positive effect on a) aboveground biomass, b) plant tissue N concentrations, c) N stock sequestered in plants, and d) shoot: root ratios in summer. Relative sea-level rise did not significantly affect biomass, with the exception of the most extreme sea-level-rise simulation, in which all plants died by the summer of the second year. Although there was a strong response to N-addition treatments, salt marsh responses varied by season. Our results suggest that in our site at Coyote Marsh, Elkhorn Slough, coastal salt marsh plants serve as a robust N trap and coastal filter; this function is not saturated by high background annual N inputs from upstream agriculture. However, if the marsh is drowned by rising seas, as in our most extreme sea-level rise treatment, marsh plants will no longer provide the ecosystem service of buffering the coastal ocean from eutrophication.	[Nelson, Joanna L.; Zavaleta, Erika S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Nelson, JL (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	jnelson@stanfordalumni.org			National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship [NA08NOS4200268]; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz); University of California Santa Cruz, STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz); Marilyn C. Davis Scholarship; Center for Dynamics at the Land-Sea Interface; Environmental Studies department	National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz); University of California Santa Cruz, STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz); Marilyn C. Davis Scholarship; Center for Dynamics at the Land-Sea Interface; Environmental Studies department	The following sources of funding awarded to J.L. Nelson supported the research: National Oceanic and Atmospheric Administration/National Estuarine Research Reserve Graduate Research Fellowship (grant number NA08NOS4200268); Phi Beta Kappa; CA Environmental Quality Initiative; Garden Club of America Coastal Wetlands scholarship; and from the University of California Santa Cruz: STEPS (Science, Technology, Engineering, Policy and Society "Institute, at University of California, Santa Cruz), STARS (Services for Transfer and Re-entry Students'' at University of California, Santa Cruz), the Marilyn C. Davis Scholarship, the Center for Dynamics at the Land-Sea Interface, and the Environmental Studies department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; Ahrens TD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006661; [Anonymous], 2007, BIOGEOCHEMISTRY ESTU; Boesch DF, 2002, ESTUARIES, V25, P886, DOI 10.1007/BF02804914; Boyer KE, 1999, RESTOR ECOL, V7, P74, DOI 10.1046/j.1526-100X.1999.07109.x; Boyer KE, 2001, WETLANDS, V21, P315, DOI 10.1672/0277-5212(2001)021[0315:SVIASC]2.0.CO;2; Brand A, 2012, ECOLOGICAL IN PRESS; Breschini SJ, 2002, HORTSCIENCE, V37, P1061, DOI 10.21273/HORTSCI.37.7.1061; Brew DS, 2010, J COASTAL RES, V26, P912, DOI 10.2112/08-1174.1; Bricker, 2007, EFFECTS NUTR ENRICHM; Brin LD, 2010, MAR ECOL PROG SER, V400, P3, DOI 10.3354/meps08460; Caffrey J.M., 2002, CHANGES CALIFORNIA E; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; COVIN JD, 1988, WETLANDS, V8, P51, DOI 10.1007/BF03160808; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Day JW, 2004, OCEAN COAST MANAGE, V47, P671, DOI 10.1016/j.ocecoaman.2004.12.007; Deegan Linda A., 2007, Ecological Applications, V17, pS42, DOI 10.1890/06-0452.1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Drake DC, 2009, ECOLOGY, V90, P2535, DOI 10.1890/08-1051.1; Elkorn_Slough_National_Estuarine_Research_Reserve, 2011, TID WETL PROJ; Elsey-Quirk T, 2011, ESTUAR COAST, V34, P470, DOI 10.1007/s12237-011-9379-5; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Faeth P, 2002, ESTUARIES, V25, P869, DOI 10.1007/BF02804912; FIELD CB, 1999, CONFRONTING CLIMATE; Fogel BN, 2004, J ECOL, V92, P589, DOI 10.1111/j.0022-0477.2004.00903.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gillespie A, 2011, MORRO BAY SEDIMENT L; Griffith KA, 2008, ECOLOGY PARASITIC PL; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Haines B., 1985, PHYSL ECOLOGY N AM P, P323; Hopkinson CS, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P991, DOI 10.1016/B978-0-12-372522-6.00022-0; HOPKINSON CS, 1984, ECOLOGY, V65, P961, DOI 10.2307/1938068; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Howes B.L., 1996, ESTUARINE SHORES EVO, P287; Jannasch HW, 2008, LIMNOL OCEANOGR-METH, V6, P263, DOI 10.4319/lom.2008.6.263; Johnson KS, 2004, LAND OCEAN BIOGEOCHE; Kennedy V.S, 1984, ESTUARY FILTER; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lindig-Cisneros R, 2002, ESTUARIES, V25, P1174, DOI 10.1007/BF02692214; Little C., 2009, BIOL ROCKY SHORES, Patent No. [1711.11065, 171111065]; Los Huertos MW, 1999, THESIS U CALIFORNIA; Lowe PB, 1999, MARSH LOSS ELKHORN S; MAHALL BE, 1976, J ECOL, V64, P793, DOI 10.2307/2258809; Martone RG, 2008, OECOLOGIA, V158, P151, DOI 10.1007/s00442-008-1129-4; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Mitsch W., 2000, WETLANDS, V3rd; Mitsch WJ, 2001, BIOSCIENCE, V51, P373, DOI 10.1641/0006-3568(2001)051[0373:RNLTTG]2.0.CO;2; Mitsch WJ, 2006, ECOL ENG, V26, P55, DOI 10.1016/j.ecoleng.2005.09.005; Mitsch WJ, 2005, ECOL ENG, V24, P267, DOI 10.1016/j.ecoleng.2005.02.005; MORRIS JT, 1991, ANNU REV ECOL SYST, V22, P257, DOI 10.1146/annurev.es.22.110191.001353; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; National Research Council, 2000, CLEAN COAST WAT UND; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI 10.1098/rsta.2010.029; Nidzieko NJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005864; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Phillips B, 2002, CHANGES CALIFORNIA E, P237; Plant JN, 2009, COASTAL ESTUARINE RE; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Schile LM, 2011, WETLANDS, V31, P1165, DOI 10.1007/s13157-011-0227-y; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Short F.T., 1984, ESTUARY FILTER, P395, DOI 10.1016/b978-0-12-405070-9.50024-4; Simoes MP, 2011, AQUAT BOT, V94, P119, DOI 10.1016/j.aquabot.2011.01.001; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sousa AI, 2008, ENVIRON POLLUT, V156, P628, DOI 10.1016/j.envpol.2008.06.022; Stevenson J.C., 2009, HUMAN IMPACTS SALT M, P171; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Turner RE, 2011, ESTUAR COAST, V34, P1084, DOI 10.1007/s12237-010-9341-y; Turner RE, 2009, LIMNOL OCEANOGR, V54, P1634, DOI 10.4319/lo.2009.54.5.1634; VALIELA I, 1973, Estuarine and Coastal Marine Science, V1, P261, DOI 10.1016/0302-3524(73)90039-X; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward KM, 2003, ESTUARIES, V26, P116, DOI 10.1007/BF02691699; Watson EB, 2011, RESTOR ECOL, V19, P765, DOI 10.1111/j.1526-100X.2010.00722.x; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 1996, ECOL APPL, V6, P84, DOI 10.2307/2269555	83	69	69	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e38558	10.1371/journal.pone.0038558	http://dx.doi.org/10.1371/journal.pone.0038558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879873	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900001
J	Lopman, BA; Pitzer, VE; Sarkar, R; Gladstone, B; Patel, M; Glasser, J; Gambhir, M; Atchison, C; Grenfell, BT; Edmunds, WJ; Kang, G; Parashar, UD				Lopman, Benjamin A.; Pitzer, Virginia E.; Sarkar, Rajiv; Gladstone, Beryl; Patel, Manish; Glasser, John; Gambhir, Manoj; Atchison, Christina; Grenfell, Bryan T.; Edmunds, W. John; Kang, Gagandeep; Parashar, Umesh D.			Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic Settings	PLOS ONE			English	Article							DOUBLE-BLIND; CHILDREN; SAFETY; GASTROENTERITIS; IMMUNOGENICITY; DIARRHEA; INFANTS; MORTALITY; INFECTION; DISEASE	Introduction: Rotavirus vaccine efficacy ranges from >90% in high socio-economic settings (SES) to 50% in low SES. With the imminent introduction of rotavirus vaccine in low SES countries, understanding reasons for reduced efficacy in these settings could identify strategies to improve vaccine performance. Methods: We developed a mathematical model to predict rotavirus vaccine efficacy in high, middle and low SES based on data specific for each setting on incidence, protection conferred by natural infection and immune response to vaccination. We then examined factors affecting efficacy. Results: Vaccination was predicted to prevent 93%, 86% and 51% of severe rotavirus gastroenteritis in high, middle and low SES, respectively. Also predicted was that vaccines are most effective against severe disease and efficacy declines with age in low but not high SES. Reduced immunogenicity of vaccination and reduced protection conferred by natural infection are the main factors that compromise efficacy in low SES. Discussion: The continued risk of severe disease in non-primary natural infections in low SES is a key factor underpinning reduced efficacy of rotavirus vaccines. Predicted efficacy was remarkably consistent with observed clinical trial results from different SES, validating the model. The phenomenon of reduced vaccine efficacy can be predicted by intrinsic immunological and epidemiological factors of low SES populations. Modifying aspects of the vaccine (e. g. improving immunogenicity in low SES) and vaccination program (e. g. additional doses) may bring improvements.	[Lopman, Benjamin A.; Patel, Manish; Glasser, John; Gambhir, Manoj; Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Pitzer, Virginia E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pitzer, Virginia E.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Sarkar, Rajiv; Gladstone, Beryl] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Gambhir, Manoj; Kang, Gagandeep] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreaks Anal & Modelling, London, England; [Atchison, Christina; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Centers for Disease Control & Prevention - USA; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Christian Medical College & Hospital (CMCH) Vellore; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Lopman, BA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	blopman@cdc.gov	Sarkar, Rajiv/AAU-7203-2021	Sarkar, Rajiv/0000-0003-0616-3129; Atchison, Christina/0000-0001-8304-7389; Gambhir, Manoj/0000-0002-4831-6261; Pitzer, Virginia/0000-0003-1015-2289	National Institutes of Health [R01 GM083983-01]; Bill and Melinda Gates Foundation; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Global Alliance for Vaccines and Immunisation (GAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Global Alliance for Vaccines and Immunisation (GAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 GM083983-01), the Bill and Melinda Gates Foundation, the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, the Fogarty International Center, National Institutes of Health (V. E. P and B. G.). Additional Support for this project was provided by Program for Appropriate Technology in Health (PATH) through funding from the Global Alliance for Vaccines and Immunisation (GAVI). The views expressed by the authors do not necessarily reflect the views of GAVI and/or PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2009, VACCINE, V28, P422, DOI 10.1016/j.vaccine.2009.10.032; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Bhandari N, 2009, J INFECT DIS, V200, P421, DOI 10.1086/600104; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Braeckman T, 2011, PEDIATR INFECT DIS J, V30, pS21, DOI 10.1097/INF.0b013e3181fefc51; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; FARRINGTON CP, 1992, INT J EPIDEMIOL, V21, P1014, DOI 10.1093/ije/21.5.1014; Field EJ, 2010, PEDIATRICS, V126, pE506, DOI 10.1542/peds.2010-0443; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Justino MC, 2011, PEDIAT INFECT DIS J; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Phillips G, 2010, AM J EPIDEM IN PRESS; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sahni LC, 2010, VACCINE, V28, P6314, DOI 10.1016/j.vaccine.2010.06.109; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	38	97	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e41720	10.1371/journal.pone.0041720	http://dx.doi.org/10.1371/journal.pone.0041720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879893	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000307810000009
J	Yu, G; Yao, WM; Wang, J; Ma, X; Xiao, W; Li, H; Xia, D; Yang, Y; Deng, KL; Xiao, HB; Wang, BH; Guo, XL; Guan, W; Hu, ZQ; Bai, YQ; Xu, H; Liu, JH; Zhang, X; Ye, ZQ				Yu, Gan; Yao, Weimin; Wang, Ji; Ma, Xin; Xiao, Wei; Li, Heng; Xia, Ding; Yang, Yang; Deng, Kangli; Xiao, Haibing; Wang, Bohan; Guo, Xiaolin; Guan, Wei; Hu, Zhiquan; Bai, Yinqi; Xu, Hua; Liu, Jihong; Zhang, Xu; Ye, Zhangqun			LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray	PLOS ONE			English	Article							LONG NONCODING RNAS; TUMOR SUPPRESSION; GENE-EXPRESSION; KIDNEY CANCER; CHROMATIN; IDENTIFICATION; TRANSCRIPTION; INACTIVATION; PROSTATE; DISEASE	Background: Long noncoding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of cancers. In this study, we described lncRNAs profiles in 6 pairs of human renal clear cell carcinoma (RCCC) and the corresponding adjacent nontumorous tissues (NT) by microarray. Methodology/Principal Findings: With abundant and varied probes accounting 33,045 LncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 17157. From the data we found there were thousands of lncRNAs that differentially expressed (>= 2 fold-change) in RCCC tissues compared with NT and 916 lncRNAs differentially expressed in five or more of six RCCC samples. Compared with NT, many lncRNAs were significantly up-regulated or down-regulated in RCCC. Our data showed that down-regulated lncRNAs were more common than up-regulated ones. ENST00000456816, X91348, BC029135, NR_024418 were evaluated by qPCR in sixty-three pairs of RCCC and NT samples. The four lncRNAs were aberrantly expressed in RCCC compared with matched histologically normal renal tissues. Conclusions/Significance: Our study is the first one to determine genome-wide lncRNAs expression patterns in RCCC by microarray. The results displayed that clusters of lncRNAs were aberrantly expressed in RCCC compared with NT samples, which revealed that lncRNAs differentially expressed in tumor tissues and normal tissues may exert a partial or key role in tumor development. Taken together, this study may provide potential targets for future treatment of RCCC and novel insights into cancer biology.	[Yu, Gan; Yao, Weimin; Xiao, Wei; Li, Heng; Xia, Ding; Yang, Yang; Deng, Kangli; Xiao, Haibing; Wang, Bohan; Guo, Xiaolin; Guan, Wei; Hu, Zhiquan; Xu, Hua; Liu, Jihong; Ye, Zhangqun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Wang, Ji] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Wang, Ji] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Ma, Xin; Zhang, Xu] Peoples Liberat Army Gen Hosp, Mil Postgrad Med Coll, Dept Urol, Beijing, Peoples R China; [Bai, Yinqi] BGI Shenzhen, Shenzhen, Peoples R China	Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI)	Yu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China.	xuhua@mail.hust.edu.cn	Wang, Ji/I-5795-2012		National Natural Science Foundation of China [31072238, 31172441, 81170650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31072238, 31172441, 81170650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeem K, 2011, BIOMED PAP, V155, P231, DOI 10.5507/bp.2011.029; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dall'Oglio MF, 2010, INT BRAZ J UROL, V36, P410, DOI 10.1590/S1677-55382010000400004; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ifere Godwin O, 2009, Recent Pat DNA Gene Seq, V3, P151; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oosterwijk E, 2011, EUR UROL, V60, P622, DOI 10.1016/j.eururo.2011.06.048; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren S., 2012, CELL RES; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SHUIN T, 1994, CANCER RES, V54, P2852; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Sutherland HF, 1996, AM J HUM GENET, V59, P23; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; van Rooijen E, 2010, DIS MODEL MECH, V3, P343, DOI 10.1242/dmm.004036; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	42	90	96	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42377	10.1371/journal.pone.0042377	http://dx.doi.org/10.1371/journal.pone.0042377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879955	gold, Green Submitted, Green Published			2022-12-25	WOS:000307810000029
J	Achilli, A; Iommarini, L; Olivieri, A; Pala, M; Kashani, BH; Reynier, P; La Morgia, C; Valentino, ML; Liguori, R; Pizza, F; Barboni, P; Sadun, F; De Negri, AM; Zeviani, M; Dollfus, H; Moulignier, A; Ducos, G; Orssaud, C; Bonneau, D; Procaccio, V; Leo-Kottler, B; Fauser, S; Wissinger, B; Amati-Bonneau, P; Torroni, A; Carelli, V				Achilli, Alessandro; Iommarini, Luisa; Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Reynier, Pascal; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Sadun, Federico; De Negri, Anna Maria; Zeviani, Massimo; Dollfus, Helene; Moulignier, Antoine; Ducos, Ghislaine; Orssaud, Christophe; Bonneau, Dominique; Procaccio, Vincent; Leo-Kottler, Beate; Fauser, Sascha; Wissinger, Bernd; Amati-Bonneau, Patrizia; Torroni, Antonio; Carelli, Valerio			Rare Primary Mitochondrial DNA Mutations and Probable Synergistic Variants in Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							RESPIRATORY COMPLEX-I; PRIMARY LHON MUTATION; ND6 GENE; MTDNA MUTATIONS; HOT-SPOT; CLINICAL-FEATURES; SEQUENCE-ANALYSIS; G14459A MUTATION; DISEASE; FAMILIES	Background: Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disorder, which in over 90% of cases is due to one of three primary mitochondrial DNA (mtDNA) point mutations (m. 11778G>A, m. 3460G>A and m. 14484T>C, respectively in MT-ND4, MT-ND1 and MT-ND6 genes). However, the spectrum of mtDNA mutations causing the remaining 10% of cases is only partially and often poorly defined. Methodology/Principal Findings: In order to improve such a list of pathological variants, we completely sequenced the mitochondrial genomes of suspected LHON patients from Italy, France and Germany, lacking the three primary common mutations. Phylogenetic and conservation analyses were performed. Sixteen mitochondrial genomes were found to harbor at least one of the following nine rare LHON pathogenic mutations in genes MT-ND1 (m.3700G>A/p.A132T, m>3733G>A-C/p.E143K-Q, m.4171C>A/p.L289M), MT-ND4L (m.10663T>C/p.V65A) and MT-ND6 (m.14459G>A/p.A72V, m.14495A>G/p.M64I, m.14482C>A/p.L60S, and m.14568C>T/p.G36S). Phylogenetic analyses revealed that these substitutions were due to independent events on different haplogroups, whereas interspecies comparisons showed that they affected conserved amino acid residues or domains in the ND subunit genes of complex I. Conclusions/Significance: Our findings indicate that these nine substitutions are all primary LHON mutations. Therefore, despite their relative low frequency, they should be routinely tested for in all LHON patients lacking the three common mutations. Moreover, our sequence analysis confirms the major role of haplogroups J1c and J2b (over 35% in our probands versus 6% in the general population of Western Europe) and other putative synergistic mtDNA variants in LHON expression.	[Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Iommarini, Luisa; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Carelli, Valerio] Univ Bologna, IRCCS Ist Sci Neurol Bologna, Bologna, Italy; [Iommarini, Luisa; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Pizza, Fabio; Barboni, Piero; Carelli, Valerio] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent; Amati-Bonneau, Patrizia] U1083 CNRS6214, UMR INSERM, Angers, France; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent] Univ Angers, Sch Med, Angers, France; [Reynier, Pascal; Bonneau, Dominique; Procaccio, Vincent; Amati-Bonneau, Patrizia] Univ Hosp Angers, Dept Biochem & Genet, Angers, France; [Barboni, Piero] Studio Oculist DAzeglio, Bologna, Italy; [Sadun, Federico] Osped San Giovanni Evangelista, Tivoli, Italy; [De Negri, Anna Maria] Azienda San Camillo Forlanini, Rome, Italy; [Zeviani, Massimo] Fdn C Besta Neurol Inst IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Affect Rares Genet Ophtalmol, Strasbourg, France; [Moulignier, Antoine] Fdn Ophtalmol Adolphe de Rothschild, Serv Neurol, Paris, France; [Ducos, Ghislaine] St Jean Languedoc Clin, Dept Ophthalmol, Toulouse, France; [Orssaud, Christophe] AP HP, HEGP, Ctr Reference Malad Rares Ophtalmol, Paris, France; [Wissinger, Bernd] Univ Clin Tuebingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany; [Fauser, Sascha] Univ Cologne, Ctr Ophthalmol, Dept Vitreoretinal Surg, D-50931 Cologne, Germany	University of Perugia; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Azienda Ospedaliera San Camillo-Forlanini; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Cologne	Achilli, A (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy.	valerio.carelli@unibo.it	Pizza, Fabio/AAC-1794-2020; Zeviani, Massimo/K-2891-2014; Bonneau, Dominique/K-6110-2015; Torroni, Antonio/E-1557-2011; Orssaud, Christophe/ACM-6549-2022; sadun, federico/AAF-6588-2019; Liguori, Rocco/AAB-7860-2020; OLIVIERI, ANNA/I-9235-2012; Reynier, Pascal/K-3677-2015; amati-bonneau, patrizia/K-6198-2015; Barboni, Piero/AAA-9936-2020; Zeviani, Massimo/AAU-2632-2021; Iommarini, Luisa/J-2328-2018; Achilli, Alessandro/I-9236-2012; La Morgia, Chiara/H-6765-2012	Torroni, Antonio/0000-0002-4163-4478; OLIVIERI, ANNA/0000-0002-3941-8098; Barboni, Piero/0000-0002-0118-4177; Zeviani, Massimo/0000-0002-9067-5508; Iommarini, Luisa/0000-0002-6804-7302; Achilli, Alessandro/0000-0001-6871-3451; Liguori, Rocco/0000-0002-1815-1013; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Pala, Maria/0000-0001-9202-8331; MOULIGNIER, Antoine/0000-0001-7566-0175; Bonneau, Dominique/0000-0002-6886-0969; Dollfus, Helene/0000-0002-2249-895X; LA MORGIA, Chiara/0000-0002-4639-8929; procaccio, Vincent/0000-0002-1537-4684; Reynier, Pascal/0000-0003-0802-4608; CARELLI, VALERIO/0000-0003-4923-6404; PIZZA, FABIO/0000-0003-2294-9551	Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Telethon-Italy [1005, 1015, GGP06233]; ERARE European consortium on optic atrophies	Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Telethon-Italy(Fondazione Telethon); ERARE European consortium on optic atrophies	This study was supported by Progetti Ricerca Interesse Nazionale 2009 (Italian Ministry of the University) (to AA and AT); FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO); Fondazione Alma Mater Ticinensis (to AT); Telethon-Italy grants 1005 (to MZ and VC), 1015 (to MZ), GGP06233 (to VC); and ERARE European consortium on optic atrophies (to DB and BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Besch D, 1999, GRAEF ARCH CLIN EXP, V237, P745, DOI 10.1007/s004170050307; Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; CUI S, 2007, OPHTHALMOLOGY, V16, P382; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Fauser Sascha, 2002, Ophthalmic Genet, V23, P191, DOI 10.1076/opge.23.3.191.7881; Ferre M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.107; Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jia XY, 2010, BIOCHEM BIOPH RES CO, V403, P237, DOI 10.1016/j.bbrc.2010.11.017; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177; Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0; LERTRIT P, 1992, AM J HUM GENET, V51, P457; Luberichs J, 2002, GRAEF ARCH CLIN EXP, V240, P96, DOI 10.1007/s00417-001-0423-1; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MITOMAP, HUM MIT GEN DAT; Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473; Newman NJ, 2005, WALSH HOYTS CLIN NEU, P482; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449; Torroni A, 1997, AM J HUM GENET, V60, P1107; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740; Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P693, DOI 10.1016/j.bbrc.2009.06.102; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051; Zhang JJ, 2010, BIOCHEM BIOPH RES CO, V399, P647, DOI 10.1016/j.bbrc.2010.07.135; Zhang SR, 2008, MITOCHONDRION, V8, P205, DOI 10.1016/j.mito.2008.02.003; Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168	61	64	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42242	10.1371/journal.pone.0042242	http://dx.doi.org/10.1371/journal.pone.0042242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879922	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000307284100058
J	Jobse, BN; Rhem, RG; McCurry, CAJR; Wang, IQ; Labiris, NR				Jobse, Brian N.; Rhem, Rod G.; McCurry, Cory A. J. R.; Wang, Iris Q.; Labiris, N. Renee			Imaging Lung Function in Mice Using SPECT/CT and Per-Voxel Analysis	PLOS ONE			English	Article							GAS ELIMINATION TECHNIQUE; SMALL-ANIMAL SPECT; BLOOD-FLOW; PULMONARY VENTILATION; COMPUTED-TOMOGRAPHY; RAT MODEL; PERFUSION; AGE; GRAVITY	Chronic lung disease is a major worldwide health concern but better tools are required to understand the underlying pathologies. Ventilation/perfusion (V/Q) single photon emission computed tomography (SPECT) with per-voxel analysis allows for non-invasive measurement of regional lung function. A clinically adapted V/Q methodology was used in healthy mice to investigate V/Q relationships. Twelve week-old mice were imaged to describe normal lung function while 36 week-old mice were imaged to determine how age affects V/Q. Mice were ventilated with Technegas (TM) and injected with Tc-99m-macroaggregated albumin to trace ventilation and perfusion, respectively. For both processes, SPECT and CT images were acquired, co-registered, and quantitatively analyzed. On a per-voxel basis, ventilation and perfusion were moderately correlated (R = 0.58 +/- 0.03) in 12 week old animals and a mean log(V/Q) ratio of -0.07 +/- 0.01 and standard deviation of 0.36 +/- 0.02 were found, defining the extent of V/Q matching. In contrast, 36 week old animals had significantly increased levels of V/Q mismatching throughout the periphery of the lung. Measures of V/Q were consistent across healthy animals and differences were observed with age demonstrating the capability of this technique in quantifying lung function. Per-voxel analysis and the ability to non-invasively assess lung function will aid in the investigation of chronic lung disease models and drug efficacy studies.	[Jobse, Brian N.; Rhem, Rod G.; McCurry, Cory A. J. R.; Wang, Iris Q.; Labiris, N. Renee] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada; [Jobse, Brian N.] McMaster Univ, Dept Pathol & Mol Med, Div Resp Dis & Allergy, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Jobse, Brian N.; Labiris, N. Renee] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Jobse, BN (corresponding author), McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada.	labir@mcmaster.ca			Firestone Institute of Respiratory Health-AstraZeneca; Department of Medicine Career Award; AstraZeneca	Firestone Institute of Respiratory Health-AstraZeneca; Department of Medicine Career Award; AstraZeneca(AstraZeneca)	Funding provided by Firestone Institute of Respiratory Health-AstraZeneca Collaboration Unrestricted Grant; NRL holds an internal Department of Medicine Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by an AstraZeneca Collaboration Unrestricted Grant. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alfaro V, 2001, CLIN EXP PHARMACOL P, V28, P419, DOI 10.1046/j.1440-1681.2001.3455.x; Cardus J, 1997, AM J RESP CRIT CARE, V156, P648, DOI 10.1164/ajrccm.156.2.9606016; Dolovich Myrna, 2004, Proc Am Thorac Soc, V1, P329, DOI 10.1513/pats.200404-030MS; Fain SB, 2005, ACAD RADIOL, V12, P1385, DOI 10.1016/j.acra.2005.08.005; Farncombe TH, 2008, MED PHYS, V35, P1785, DOI 10.1118/1.2905031; Franc BL, 2008, J NUCL MED, V49, P1651, DOI 10.2967/jnumed.108.055442; Froese AR, 2007, EUR RESPIR J, V30, P1082, DOI 10.1183/09031936.00000507; Funk T, 2004, MED PHYS, V31, P2680, DOI 10.1118/1.1781553; Galvin I, 2007, BRIT J ANAESTH, V98, P420, DOI 10.1093/bja/aem036; GLENNY RW, 1991, J APPL PHYSIOL, V71, P620, DOI 10.1152/jappl.1991.71.2.620; HOLLAND J, 1968, J CLIN INVEST, V47, P81, DOI 10.1172/JCI105717; Jobse BN, 2009, EUR RESPIR J, V33, P1437, DOI 10.1183/09031936.00087508; Jogi J, 2011, EUR J NUCL MED MOL I, V38, P1344, DOI 10.1007/s00259-011-1757-5; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Khaltaev N, 2007, GLOBAL SURVEILLANCE; King GG, 2010, SEMIN NUCL MED, V40, P467, DOI 10.1053/j.semnuclmed.2010.07.006; Koba W, 2011, SEMIN NUCL MED, V41, P151, DOI 10.1053/j.semnuclmed.2010.12.003; Kreck TC, 2001, J APPL PHYSIOL, V91, P1741, DOI 10.1152/jappl.2001.91.4.1741; Levitski MG, 2007, PULMONARY PHYSL, P113; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Marsh S, 2011, AUSTRALAS PHYS ENG S, V34, P63, DOI 10.1007/s13246-011-0059-3; Miller MR, 2011, CHEST, V139, P52, DOI 10.1378/chest.10-0189; Mistry NN, 2010, MAGN RESON MED, V63, P728, DOI 10.1002/mrm.22221; Petersson J, 2012, J APPL PHYSL; Press W, 2007, POWELLS METHODS MULT, P509; Senden TJ, 1997, J NUCL MED, V38, P1327; Sprung J, 2006, CAN J ANAESTH, V53, P1244, DOI 10.1007/BF03021586; Suga K, 2010, ANN NUCL MED, V24, P269, DOI 10.1007/s12149-010-0369-7; Togao O, 2011, J MAGN RESON IMAGING; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; Wagner PD, 2008, INTENS CARE MED, V34, P994, DOI 10.1007/s00134-008-1108-6; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405	33	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42187	10.1371/journal.pone.0042187	http://dx.doi.org/10.1371/journal.pone.0042187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870297	gold, Green Published			2022-12-25	WOS:000307284100050
J	Suzuki, M; Ohsaki, Y; Tatematsu, T; Shinohara, Y; Maeda, T; Cheng, JL; Fujimoto, T				Suzuki, Michitaka; Ohsaki, Yuki; Tatematsu, Tsuyako; Shinohara, Yuki; Maeda, Takashi; Cheng, Jinglei; Fujimoto, Toyoshi			Translation Inhibitors Induce Formation of Cholesterol Ester-Rich Lipid Droplets	PLOS ONE			English	Article							MACROPHAGE FOAM CELLS; LYSOSOMAL ACID LIPASE; CAENORHABDITIS-ELEGANS; AUTOPHAGY; TIP47; FAT; CYCLOHEXIMIDE; RECRUITMENT; METABOLISM; EXPRESSION	Lipid droplets (LDs) in non-adipocytes contain triglycerides (TG) and cholesterol esters (CE) in variable ratios. TG-rich LDs are generated when unsaturated fatty acids are administered, but the conditions that induce CE-rich LD formation are less well characterized. In the present study, we found that protein translation inhibitors such as cycloheximide (CHX) induced generation of CE-rich LDs and that TIP47 (perilipin 3) was recruited to the LDs, although the expression of this protein was reduced drastically. Electron microscopy revealed that LDs formed in CHX-treated cells possess a distinct electron-dense rim that is not found in TG-rich LDs, whose formation is induced by oleic acid. CHX treatment caused upregulation of mTORC1, but the CHX-induced increase in CE-rich LDs occurred even when rapamycin or Torin1 was given along with CHX. Moreover, the increase in CE was seen in both wild-type and autophagy-deficient Atg5-null mouse embryonic fibroblasts, indicating that mTORC1 activation and suppression of autophagy are not necessary to induce the observed phenomenon. The results showed that translation inhibitors cause a significant change in the lipid ester composition of LDs by a mechanism independent of mTORC1 signaling and autophagy.	[Suzuki, Michitaka; Ohsaki, Yuki; Tatematsu, Tsuyako; Shinohara, Yuki; Maeda, Takashi; Cheng, Jinglei; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan	Nagoya University	Suzuki, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan.	tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020	Fujimoto, Toyoshi/0000-0002-3601-7977	Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [21390053, 23113711]; Kazato Research Foundation; Takeda Science Foundation	Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Kazato Research Foundation(Kazato Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grants-in-Aid for Scientific Research (21390053, 23113711) and the Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (http://www.mext.go.jp/english/) (to MS, TF) and by grants from the Kazato Research Foundation (http://www.kazato.org/english/index.html) and the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html) (to YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Aslanidis C, 1996, GENOMICS, V33, P85, DOI 10.1006/geno.1996.0162; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; FEWSTER ME, 1969, J CHROMATOGR, V43, P120, DOI 10.1016/S0021-9673(00)99173-8; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Han JH, 1999, J LIPID RES, V40, P830; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Murphy D.J., 2011, PROTOPLASMA; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ohsaki Y, 2006, BIOCHEM BIOPH RES CO, V347, P279, DOI 10.1016/j.bbrc.2006.06.074; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; REZ G, 1973, VIRCHOWS ARCH B, V12, P123; RUMPELT HJ, 1978, AM J PATHOL, V91, P49; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Zechner R, 2009, NATURE, V458, P1118, DOI 10.1038/4581118a	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42379	10.1371/journal.pone.0042379	http://dx.doi.org/10.1371/journal.pone.0042379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879956	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100075
J	Joshi, J; Karanth, KP				Joshi, Jahnavi; Karanth, K. Praveen			Coalescent Method in Conjunction with Niche Modeling Reveals Cryptic Diversity among Centipedes in the Western Ghats of South India	PLOS ONE			English	Article							SPECIES DELIMITATION; SCOLOPENDRID CENTIPEDES; BOUNDARIES; COMPLEX; DNA; TAXONOMY; DISTRIBUTIONS; SYSTEMATICS; MORPHOLOGY; PHYLOGENY	Background: There has been growing interest in integrative taxonomy that uses data from multiple disciplines for species delimitation. Typically, in such studies, monophyly is taken as a proxy for taxonomic distinctiveness and these units are treated as potential species. However, monophyly could arise due to stochastic processes. Thus here, we have employed a recently developed tool based on coalescent approach to ascertain the taxonomic distinctiveness of various monophyletic units. Subsequently, the species status of these taxonomic units was further tested using corroborative evidence from morphology and ecology. This inter-disciplinary approach was implemented on endemic centipedes of the genus Digitipes (Attems 1930) from the Western Ghats (WG) biodiversity hotspot of India. The species of the genus Digitipes are morphologically conserved, despite their ancient late Cretaceous origin. Principal Findings: Our coalescent analysis based on mitochondrial dataset indicated the presence of nine putative species. The integrative approach, which includes nuclear, morphology, and climate datasets supported distinctiveness of eight putative species, of which three represent described species and five were new species. Among the five new species, three were morphologically cryptic species, emphasizing the effectiveness of this approach in discovering cryptic diversity in less explored areas of the tropics like the WG. In addition, species pairs showed variable divergence along the molecular, morphological and climate axes. Conclusions: A multidisciplinary approach illustrated here is successful in discovering cryptic diversity with an indication that the current estimates of invertebrate species richness for the WG might have been underestimated. Additionally, the importance of measuring multiple secondary properties of species while defining species boundaries was highlighted given variable divergence of each species pair across the disciplines.	[Joshi, Jahnavi; Karanth, K. Praveen] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Joshi, J (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	karanth@ces.iisc.ernet.in	Joshi, Jahnavi/AAX-2434-2020	Joshi, Jahnavi/0000-0002-6015-4138				Attems C., 1930, Das Tierreich Lieferung, V54, P1; Balakrishnan R, 2005, SYST BIOL, V54, P689, DOI 10.1080/10635150590950308; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Biju SD, 2005, COPEIA, P29, DOI 10.1643/CH-04-194R1; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, EVOLUTION, V56, P1123; Cadena CD, 2010, BIOL J LINN SOC, V99, P152, DOI 10.1111/j.1095-8312.2009.01333.x; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Edgecombe GD, 2002, SYST ENTOMOL, V27, P31, DOI 10.1046/j.0307-6970.2001.00163.x; Edgecombe GD, 2007, ANNU REV ENTOMOL, V52, P151, DOI 10.1146/annurev.ento.52.110405.091326; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; Giri VB, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2164.1.5; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irfan-Ullah M, 2007, BIODIVERS CONSERV, V16, P1917, DOI 10.1007/s10531-006-9110-1; JANGI BS, 1984, J SCI IND RES INDIA, V43, P27; Joshi J, 2011, MOL PHYLOGENET EVOL, V60, P287, DOI 10.1016/j.ympev.2011.04.024; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kumara Honnavalli N., 2009, Endangered Species Research, V7, P29, DOI 10.3354/esr00185; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lewis J. G. E., 2003, African Invertebrates, V44, P61; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon KC, 1999, WINCLADA BETA VER 09; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Ruiz-Sanchez E, 2010, MOL PHYLOGENET EVOL, V54, P344, DOI 10.1016/j.ympev.2009.10.035; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders KL, 2006, BIOL J LINN SOC, V87, P343, DOI 10.1111/j.1095-8312.2006.00568.x; Schlick-Steiner BC, 2006, MOL PHYLOGENET EVOL, V40, P259, DOI 10.1016/j.ympev.2006.03.005; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Sureshan P. M., 2006, Zoos Print Journal, V21, P2285; Sureshan PM, 2003, ZOOS PRINT J, V19, P1401; Swofford DL, 2001, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506	55	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42225	10.1371/journal.pone.0042225	http://dx.doi.org/10.1371/journal.pone.0042225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876311	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000307184700039
J	Ritlop, C; Monat, C; Cousineau, B				Ritlop, Christine; Monat, Caroline; Cousineau, Benoit			Isolation and Characterization of Functional Tripartite Group II Introns Using a Tn5-Based Genetic Screen	PLOS ONE			English	Article							BASE-PAIRING INTERACTIONS; LACTOCOCCUS-LACTIS; REVERSE-TRANSCRIPTASE; CONJUGATIVE TRANSFER; RNA; MITOCHONDRIA; ELEMENTS; PRS01; PLANT	Background: Group II introns are RNA enzymes that splice themselves from pre-mRNA transcripts. Most bacterial group II introns harbour an open reading frame (ORF), coding for a protein with reverse transcriptase, maturase and occasionally DNA binding and endonuclease activities. Some ORF-containing group II introns were shown to be mobile retroelements that invade new DNA target sites. From an evolutionary perspective, group II introns are hypothesized to be the ancestors of the spliceosome-dependent nuclear introns and the small nuclear RNAs (snRNAs - U1, U2, U4, U5 and U6) that are important functional elements of the spliceosome machinery. The ability of some group II introns fragmented in two or three pieces to assemble and undergo splicing in trans supports the theory that spliceosomal snRNAs evolved from portions of group II introns. Methodology/Principal Findings: We used a transposon-based genetic screen to explore the ability of the Ll.LtrB group II intron from the Gram-positive bacterium Lactococcus lactis to be fragmented into three pieces in vivo. Trans-splicing tripartite variants of Ll. LtrB were selected using a highly efficient and sensitive trans-splicing/conjugation screen. We report that numerous fragmentation sites located throughout Ll. LtrB support tripartite trans-splicing, showing that this intron is remarkably tolerant to fragmentation. Conclusions/Significance: This work unveils the great versatility of group II intron fragments to assemble and accurately trans-splice their flanking exons in vivo. The selected introns represent the first evidence of functional tripartite group II introns in bacteria and provide experimental support for the proposed evolutionary relationship between group II introns and snRNAs.	[Ritlop, Christine; Monat, Caroline; Cousineau, Benoit] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	McGill University	Ritlop, C (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	benoit.cousineau@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to B. C. B. C. is a FRSQ Chercheur-Boursier Junior 2 and a McGill University William Dawson Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhocine K, 2004, MOL MICROBIOL, V51, P1459, DOI 10.1111/j.1365-2958.2004.03923.x; Belhocine K, 2008, RNA, V14, P1782, DOI 10.1261/rna.1083508; Belhocine K, 2007, NUCLEIC ACIDS RES, V35, P2257, DOI 10.1093/nar/gkl1146; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2008, MOL CELL, V30, P472, DOI 10.1016/j.molcel.2008.04.001; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Fedorova O, 2007, BIOL CHEM, V388, P665, DOI 10.1515/BC.2007.090; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JACQUIER A, 1990, TRENDS BIOCHEM SCI, V15, P351, DOI 10.1016/0968-0004(90)90075-M; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Klein JR, 2004, J BACTERIOL, V186, P1991, DOI 10.1128/JB.186.7.1991-1998.2004; Knoop V, 1997, MOL GEN GENET, V255, P269, DOI 10.1007/s004380050497; LAMBOWITZ AM, 2010, COLD SPRING HARB PER; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; MILLS DA, 1994, APPL ENVIRON MICROB, V60, P4413, DOI 10.1128/AEM.60.12.4413-4420.1994; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Quiroga C, 2011, RNA, V17, P2212, DOI 10.1261/rna.028886.111; Reznikoff WS, 2004, METH MOL B, V260, P83, DOI 10.1385/1-59259-755-6:083; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shearman C, 1996, MOL MICROBIOL, V21, P45, DOI 10.1046/j.1365-2958.1996.00610.x; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Valadlkhan S, 2007, BIOL CHEM, V388, P693, DOI 10.1515/BC.2007.080	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41589	10.1371/journal.pone.0041589	http://dx.doi.org/10.1371/journal.pone.0041589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876289	Green Submitted, gold, Green Published			2022-12-25	WOS:000307184700017
J	Bruno, A; Costantino, G; de Fabritiis, G; Pastor, M; Selent, J				Bruno, Agostino; Costantino, Gabriele; de Fabritiis, Gianni; Pastor, Manuel; Selent, Jana			Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR-DYNAMICS SIMULATIONS; A(2A) ADENOSINE RECEPTOR; GLUTAMATE-RECEPTOR; HEPTAHELICAL DOMAIN; CRYSTAL-STRUCTURE; ACTIVATION MECHANISM; ALLOSTERIC MODULATOR; BINDING-SITE; RHODOPSIN	The recent elucidation of the X-ray structure of several class A GPCRs clearly indicates that the amphipathic helix 8 (H8) is a conserved structural domain in most crystallized GPCRs. Very little is known about the presence and the possible role of an analogous H8 domain in the distantly related class C GPCRs. In this study, we investigated the structural properties for the H8 domain of the mGluR2 receptor, a class C GPCR, by applying extended molecular dynamics simulations. Our study indicates that the amphipathic H8 adopts membrane-sensitive conformational states, which depend on the membrane composition. Cholesterol-rich membranes stabilize the helical structure of H8 whereas cholesterol-depleted membranes induce a disruption of H8. The observed link between membrane cholesterol levels and H8 conformational states suggests that H8 behaves as a sensor of cholesterol concentration.	[Bruno, Agostino; Pastor, Manuel; Selent, Jana] Univ Pompeu Fabra, Comp Assisted Drug Design Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Bruno, Agostino; Costantino, Gabriele] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [de Fabritiis, Gianni] Univ Pompeu Fabra, Computat Biochem & Biophys Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain	Pompeu Fabra University; University of Parma; Pompeu Fabra University	Bruno, A (corresponding author), Univ Pompeu Fabra, Comp Assisted Drug Design Lab, Res Programme Biomed Informat GRIB, Barcelona, Spain.	gabriele.costantino@unipr.it; jana.selent@upf.edu	Selent, Jana/E-6912-2015; Gasull, Martina/J-4076-2019; Bruno, Agostino/F-3929-2014; Pastor, Manuel/A-1566-2010	Selent, Jana/0000-0002-1844-4449; Bruno, Agostino/0000-0002-2731-980X; Pastor, Manuel/0000-0001-8850-1341; De Fabritiis, Gianni/0000-0003-3913-4877	La MARATO de TV3 Foundation [091010]; Spanish Ministerio de Educacion y Ciencia [SAF2009-13609-C04-04]; CINECA consortium	La MARATO de TV3 Foundation; Spanish Ministerio de Educacion y Ciencia(Spanish Government); CINECA consortium(CINECA, Italy)	The authors gratefully acknowledge financial support from La MARATO de TV3 Foundation (Ref.-No. 091010) and the Spanish Ministerio de Educacion y Ciencia (SAF2009-13609-C04-04). GC and AB gratefully acknowledge the CINECA consortium for the support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Binder H, 2001, J PHYS CHEM B, V105, P12378, DOI 10.1021/jp010118h; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bruno A, 2011, FUTURE MED CHEM, V3, P665, DOI [10.4155/fmc.11.27, 10.4155/FMC.11.27]; Bruno A, 2009, J CHEM INF MODEL, V49, P1602, DOI 10.1021/ci900067g; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Costanzi S, 2010, CHIM OGGI, V28, P26; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gamba Z, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026662; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Khelashvili G, 2009, PROTEINS, V76, P403, DOI 10.1002/prot.22355; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Kuwasako K, 2011, PEPTIDES, V32, P144, DOI 10.1016/j.peptides.2010.10.005; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lundstrom L, 2011, BRIT J PHARMACOL, V164, P521, DOI 10.1111/j.1476-5381.2011.01409.x; Lyman E, 2009, STRUCTURE, V17, P1660, DOI 10.1016/j.str.2009.10.010; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mihailescu M, 2011, J MEMBRANE BIOL, V239, P63, DOI 10.1007/s00232-010-9326-6; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Obiol-Pardo C, 2011, PROTEINS, V79, P1695, DOI 10.1002/prot.23021; Olausson BES, 2012, J AM CHEM SOC, V134, P4324, DOI 10.1021/ja2108382; Park PSH, 2009, BIOCHEMISTRY-US, V48, P4294, DOI 10.1021/bi900417b; Parker MS, 2010, AMINO ACIDS, V38, P1, DOI 10.1007/s00726-009-0316-x; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rondard P, 2011, NEUROPHARMACOLOGY, V60, P82, DOI 10.1016/j.neuropharm.2010.08.009; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Spooren W, 2010, CURR TOP BEHAV NEURO, V2, P391, DOI 10.1007/7854_2010_36; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tiburu EK, 2011, AAPS J, V13, P92, DOI 10.1208/s12248-010-9244-7; Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012; Vanejevs M, 2008, J MED CHEM, V51, P634, DOI 10.1021/jm0611298; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	69	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42023	10.1371/journal.pone.0042023	http://dx.doi.org/10.1371/journal.pone.0042023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870276	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800052
J	Jiang, L; Cheng, TC; Zhao, P; Yang, Q; Wang, GH; Jin, SK; Lin, P; Xiao, Y; Xia, QY				Jiang, Liang; Cheng, Tingcai; Zhao, Ping; Yang, Qiong; Wang, Genhong; Jin, Shengkai; Lin, Ping; Xiao, Yang; Xia, Qingyou			Resistance to BmNPV via Overexpression of an Exogenous Gene Controlled by an Inducible Promoter and Enhancer in Transgenic Silkworm, Bombyx mori	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; DELAYED-EARLY GENE; OVER-EXPRESSION; DNA-REPLICATION; HOMOLOGOUS DNA; CELL-LINES; BACULOVIRUS; INSECT; NUCLEOPOLYHEDROVIRUS; IDENTIFICATION	The hycu-ep32 gene of Hyphantria cunea NPV can inhibit Bombyx mori nucleopolyhedrovirus (BmNPV) multiplication in co-infected cells, but it is not known whether the overexpression of the hycu-ep32 gene has an antiviral effect in the silkworm, Bombyx mori. Thus, we constructed four transgenic vectors, which were under the control of the 39 K promoter of BmNPV (39 KP), Bombyx mori A4 promoter (A4P), hr3 enhancer of BmNPV combined with 39 KP, and hr3 combined with A4P. Transgenic lines were created via embryo microinjection using practical diapause silkworm. qPCR revealed that the expression level of hycu-ep32 could be induced effectively after BmNPV infection in transgenic lines where hycu-ep32 was controlled by hr3 combined with 39 KP (i.e., HEKG). After oral inoculation of BmNPV with 3 x 10(5) occlusion bodies per third instar, the mortality with HEKG-B was approximately 30% lower compared with the non-transgenic line. The economic characteristics of the transgenic lines remained unchanged. These results suggest that overexpression of an exogenous antiviral gene controlled by an inducible promoter and enhancer is a feasible method for breeding silkworms with a high antiviral capacity.	[Jiang, Liang; Cheng, Tingcai; Zhao, Ping; Wang, Genhong; Jin, Shengkai; Lin, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Yang, Qiong; Xiao, Yang] Guangdong Acad Agr Sci, Sericulture & Farm Prod Proc Res Inst, Guangzhou, Guangdong, Peoples R China	Southwest University - China; Guangdong Academy of Agricultural Sciences	Jiang, L (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Genhong/AAC-3055-2019	Wang, Genhong/0000-0002-5598-7282; Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Foundation for Sci & Tech Research Project of Chongqing [CSTC2009AA1024]; National Natural Science Foundation of China [30901054]; Production, Education & Research of Guangdong and Ministry of Education [2010A090200079]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Foundation for Sci & Tech Research Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Production, Education & Research of Guangdong and Ministry of Education	This work was funded by the National Basic Research Program of China (No. 2012CB114600), http://www.973.gov.cn/Default_3.aspx; the National Hi-Tech Research and Development Program of China (No. 2011AA100306), http://www.863.gov.cn/; the Foundation for Sci & Tech Research Project of Chongqing (CSTC2009AA1024), http://www.cstc.gov.cn/; the National Natural Science Foundation of China (No. 30901054), http://www.nsfc.gov.cn/Portal0/default152.htm; and the Production, Education & Research of Guangdong and Ministry of Education (No. 2010A090200079), http://cxy.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; CARSON DD, 1991, J VIROL, V65, P945, DOI 10.1128/JVI.65.2.945-951.1991; de Bilbao F, 2009, J NEUROCHEM, V110, P12, DOI 10.1111/j.1471-4159.2009.06098.x; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; GONG M, 1994, VIROLOGY, V204, P38, DOI 10.1006/viro.1994.1508; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; GUARINO LA, 1994, VIROLOGY, V200, P328, DOI 10.1006/viro.1994.1197; HUH NE, 1990, J GEN VIROL, V71, P2195, DOI 10.1099/0022-1317-71-9-2195; Isobe R, 2004, ARCH VIROL, V149, P1931, DOI 10.1007/s00705-004-0349-0; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Lin X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-32; LU A, 1993, VIROLOGY, V195, P710, DOI 10.1006/viro.1993.1422; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; MORRIS TD, 1992, J VIROL, V66, P7397, DOI 10.1128/JVI.66.12.7397-7405.1992; Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143; NISSEN MS, 1989, J VIROL, V63, P493, DOI 10.1128/JVI.63.2.493-503.1989; Ohshima M, 1999, J BIOCHEM-TOKYO, V125, P431, DOI 10.1093/oxfordjournals.jbchem.a022304; PULLEN SS, 1995, J VIROL, V69, P156, DOI 10.1128/JVI.69.1.156-165.1995; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rodems SM, 1997, J VIROL, V71, P9270, DOI 10.1128/JVI.71.12.9270-9277.1997; RODEMS SM, 1993, J VIROL, V67, P5776, DOI 10.1128/JVI.67.10.5776-5785.1993; Shirata N, 2010, VIROLOGY, V398, P149, DOI 10.1016/j.virol.2009.11.049; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; TJIA ST, 1979, VIROLOGY, V99, P399, DOI 10.1016/0042-6822(79)90018-7; Viswanathan P, 2003, J BIOL CHEM, V278, P52564, DOI 10.1074/jbc.M309351200; Wally O, 2010, PLANTA, V232, P1229, DOI 10.1007/s00425-010-1252-4; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	36	46	54	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41838	10.1371/journal.pone.0041838	http://dx.doi.org/10.1371/journal.pone.0041838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870254	Green Published, gold, Green Submitted			2022-12-25	WOS:000307212800037
J	Lancel, S; Montaigne, D; Marechal, X; Marciniak, C; Hassoun, SM; Decoster, B; Ballot, C; Blazejewski, C; Corseaux, D; Lescure, B; Motterlini, R; Neviere, R				Lancel, Steve; Montaigne, David; Marechal, Xavier; Marciniak, Camille; Hassoun, Sidi Mohamed; Decoster, Brigitte; Ballot, Caroline; Blazejewski, Caroline; Corseaux, Delphine; Lescure, Bernadette; Motterlini, Roberto; Neviere, Remi			Carbon Monoxide Improves Cardiac Function and Mitochondrial Population Quality in a Mouse Model of Metabolic Syndrome	PLOS ONE			English	Article							IN-VIVO; OXIDATIVE STRESS; HEME OXYGENASE-1; PROTEIN-KINASE; BIOGENESIS; MICE; AUTOPHAGY; EXPRESSION; MOLECULE; RESPIRATION	Aims: Metabolic syndrome induces cardiac dysfunction associated with mitochondria abnormalities. As low levels of carbon monoxide (CO) may improve myocardial and mitochondrial activities, we tested whether a CO-releasing molecule (CORM-3) reverses metabolic syndrome-induced cardiac alteration through changes in mitochondrial biogenesis, dynamics and autophagy. Methods and Results: Mice were fed with normal diet (ND) or high-fat diet (HFD) for twelve weeks. Then, mice received two intraperitoneal injections of CORM-3 (10 mg.kg(-1)), with the second one given 16 hours after the first. Contractile function in isolated hearts and mitochondrial parameters were evaluated 24 hours after the last injection. Mitochondrial population was explored by electron microscopy. Changes in mitochondrial dynamics, biogenesis and autophagy were assessed by western-blot and RT-qPCR. Left ventricular developed pressure was reduced in HFD hearts. Mitochondria from HFD hearts presented reduced membrane potential and diminished ADP-coupled respiration. CORM-3 restored both cardiac and mitochondrial functions. Size and number of mitochondria increased in the HFD hearts but not in the CORM-3-treated HFD group. CORM-3 modulated HFD-activated mitochondrial fusion and biogenesis signalling. While autophagy was not activated in the HFD group, CORM-3 increased the autophagy marker LC3-II. Finally, ex vivo experiments demonstrated that autophagy inhibition by 3-methyladenine abolished the cardioprotective effects of CORM-3. Conclusion: CORM-3 may modulate pathways controlling mitochondrial quality, thus leading to improvements of mitochondrial efficiency and HFD-induced cardiac dysfunction.	[Lancel, Steve; Montaigne, David; Marechal, Xavier; Marciniak, Camille; Hassoun, Sidi Mohamed; Decoster, Brigitte; Ballot, Caroline; Blazejewski, Caroline; Neviere, Remi] Univ Lille 2, EA4484, Dept Physiol, Lille, France; [Corseaux, Delphine] Univ Lille 2, EA2693, Lille, France; [Lescure, Bernadette] Univ Paris 06, INSERM, IFR65, Irssa, Paris, France; [Motterlini, Roberto] Paris Est Univ, INSERM, U955, Fac Med, Creteil, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Lancel, S (corresponding author), Univ Lille 2, EA4484, Dept Physiol, Lille, France.	steve.lancel@univ-lille2.fr	Montaigne, David/R-6066-2018; Corseaux, Delphine/R-4360-2018; Motterlini, Roberto/Q-1890-2019; Lancel, Steve/C-4387-2012; , Lancel/H-9047-2019; Marechal, Xavier/R-5762-2018; Motterlini, Roberto/G-2489-2013; Corseaux, Delphine/P-4821-2019	Montaigne, David/0000-0002-2346-863X; Corseaux, Delphine/0000-0001-8642-1508; Motterlini, Roberto/0000-0003-2684-2612; , Lancel/0000-0002-3292-5433; Marechal, Xavier/0000-0001-6399-7811; Motterlini, Roberto/0000-0003-2684-2612; Corseaux, Delphine/0000-0001-8642-1508; Neviere, Remi/0000-0002-7966-0110	Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche [EA4484]; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais [08480265]; Fondation de France [2009002501]; Fondation Coeur et Arteres [FCA09T6]	Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais(Region Hauts-de-France); Fondation de France(Fondation de France); Fondation Coeur et Arteres	This work was supported by EA4484- Universite Lille 2- Ministere de l'Enseignement Superieur et de la Recherche; CPER "cardiodiabete 2008'' - FEDER Region Nord Pas-de-Calais 08480265; Fondation de France 2009002501 and Fondation Coeur et Arteres FCA09T6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Grilli A, 2003, ANN CLIN LAB SCI, V33, P208; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Loennechen JP, 1999, PHARMACOL TOXICOL, V85, P192, DOI 10.1111/j.1600-0773.1999.tb00091.x; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Neviere R, 2010, CRIT CARE MED, V38, P2031, DOI 10.1097/CCM.0b013e3181eedafb; Nicholls D., 2002, BIOENERGETICS, V3; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; PACE N, 1950, SCIENCE, V111, P652, DOI 10.1126/science.111.2894.652; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Rhodes MA, 2009, AM J PHYSIOL-HEART C, V297, pH392, DOI 10.1152/ajpheart.00164.2009; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Soni H, 2011, TOXICOL APPL PHARM, V253, P70, DOI 10.1016/j.taap.2011.03.013; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Urquhart P, 2007, J PHARMACOL EXP THER, V321, P656, DOI 10.1124/jpet.106.117218; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314	32	49	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41836	10.1371/journal.pone.0041836	http://dx.doi.org/10.1371/journal.pone.0041836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870253	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800036
J	Li, L; Wang, M; Zhao, QJ; Fogelson, N				Li, Ling; Wang, Meng; Zhao, Qian-Jing; Fogelson, Noa			Neural Mechanisms Underlying the Cost of Task Switching: An ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; EXECUTIVE CONTROL; SET; COMPONENTS; CONFLICT	Background: When switching from one task to a new one, reaction times are prolonged. This phenomenon is called switch cost (SC). Researchers have recently used several kinds of task-switching paradigms to uncover neural mechanisms underlying the SC. Task-set reconfiguration and passive dissipation of a previously relevant task-set have been reported to contribute to the cost of task switching. Methodology/Principal Findings: An unpredictable cued task-switching paradigm was used, during which subjects were instructed to switch between a color and an orientation discrimination task. Electroencephalography (EEG) and behavioral measures were recorded in 14 subjects. Response-stimulus interval (RSI) and cue-stimulus interval (CSI) were manipulated with short and long intervals, respectively. Switch trials delayed reaction times (RTs) and increased error rates compared with repeat trials. The SC of RTs was smaller in the long CSI condition. For cue-locked waveforms, switch trials generated a larger parietal positive event-related potential (ERP), and a larger slow parietal positivity compared with repeat trials in the short and long CSI condition. Neural SC of cue-related ERP positivity was smaller in the long RSI condition. For stimulus-locked waveforms, a larger switch-related central negative ERP component was observed, and the neural SC of the ERP negativity was smaller in the long CSI. Results of standardized low resolution electromagnetic tomography (sLORETA) for both ERP positivity and negativity showed that switch trials evoked larger activation than repeat trials in dorsolateral prefrontal cortex (DLPFC) and posterior parietal cortex (PPC). Conclusions/Significance: The results provide evidence that both RSI and CSI modulate the neural activities in the process of task-switching, but that these have a differential role during task-set reconfiguration and passive dissipation of a previously relevant task-set.	[Li, Ling; Wang, Meng; Zhao, Qian-Jing] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Fogelson, Noa] Univ A Coruna, Dept Psychol, La Coruna, Spain	University of Electronic Science & Technology of China; Universidade da Coruna	Li, L (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	liling@uestc.edu.cn	Li, Ling/F-3433-2015	Fogelson, Noa/0000-0003-2239-2212	Natural Science Foundation of China [30800242, 91120016]; Program for Changjiang Scholars and Innovative Research Team in University; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Natural Science Foundation of China (Grant Nos. 30800242 and 91120016), by the Program for Changjiang Scholars and Innovative Research Team in University, by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; De Baene W, 2012, HUM BRAIN MAPP, V33, P639, DOI 10.1002/hbm.21234; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Friedman D, 1997, EVOKED POTENTIAL, V104, P498, DOI 10.1016/S0168-5597(97)00036-1; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Goffaux P, 2006, BIOL PSYCHOL, V72, P278, DOI 10.1016/j.biopsycho.2005.11.009; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; Jersild A. T., 1927, ARCH PSYCHOL, V89; JODO E, 1990, ELECTROEN CLIN NEURO, V76, P249, DOI 10.1016/0013-4694(90)90019-G; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nicholson R, 2005, PSYCHOPHYSIOLOGY, V42, P540, DOI 10.1111/j.1469-8986.2005.00350.x; Nicholson R, 2006, BRAIN RES, V1121, P160, DOI 10.1016/j.brainres.2006.08.101; Nicholson R, 2006, BRAIN RES, V1095, P107, DOI 10.1016/j.brainres.2006.04.016; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Poulsen C, 2005, COGNITIVE BRAIN RES, V24, P133, DOI 10.1016/j.cogbrainres.2005.01.008; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2002, J COGNITIVE NEUROSCI, V14, P1139, DOI 10.1162/089892902760807159; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stoet G, 2009, TRENDS COGN SCI, V13, P228, DOI 10.1016/j.tics.2009.02.002; Swainson R, 2006, BRAIN RES, V1105, P61, DOI 10.1016/j.brainres.2006.02.027; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; VERLEGER R, 1991, PSYCHOPHYSIOLOGY, V28, P468, DOI 10.1111/j.1469-8986.1991.tb00733.x; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	50	26	26	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42233	10.1371/journal.pone.0042233	http://dx.doi.org/10.1371/journal.pone.0042233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860090	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900080
J	Chicca, A; Marazzi, J; Nicolussi, S; Gertsch, J				Chicca, Andrea; Marazzi, Janine; Nicolussi, Simon; Gertsch, Juerg			Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOID ANANDAMIDE; N-ARACHIDONOYLETHANOLAMINE ANANDAMIDE; VANILLOID VR1 RECEPTORS; HUMAN ENDOTHELIAL-CELLS; DOSE-RESPONSE CURVES; INHIBITOR AM404; MONOACYLGLYCEROL LIPASE; QUANTITATIVE ESTIMATION; ENZYMATIC-HYDROLYSIS	Despite extensive research on the trafficking of anandamide (AEA) across cell membranes, little is known about the membrane transport of other endocannabinoids, such as 2-arachidonoylglycerol (2-AG). Previous studies have provided data both in favor and against a cell membrane carrier-mediated transport of endocannabinoids, using different methodological approaches. Because AEA and 2-AG undergo rapid and almost complete intracellular hydrolysis, we employed a combination of radioligand assays and absolute quantification of cellular and extracellular endocannabinoid levels. In human U937 leukemia cells, 100 nM AEA and 1 mu M 2-AG were taken up through a fast and saturable process, reaching a plateau after 5 min. Employing differential pharmacological blockage of endocannabinoid uptake, breakdown, and interaction with intracellular binding proteins, we show that eicosanoid endocannabinoids harboring an arachidonoyl chain compete for a common membrane target that regulates their transport, whereas other N-acylethanolamines did not interfere with AEA and 2-AG uptake. By combining fatty acid amide hydrolase or monoacyl glycerol lipase inhibitors with hydrolase-inactive concentrations of the AEA transport inhibitors UCM707 (1 mu M) and OMDM-2 (5 mu M), a functional synergism on cellular AEA and 2-AG uptake was observed. Intriguingly, structurally unrelated AEA uptake inhibitors also blocked the cellular release of AEA and 2-AG. We show, for the first time, that UCM707 and OMDM-2 inhibit the bidirectional movement of AEA and 2-AG across cell membranes. Our findings suggest that a putative endocannabinoid cell membrane transporter controls the cellular AEA and 2-AG trafficking and metabolism.	[Chicca, Andrea; Marazzi, Janine; Nicolussi, Simon; Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland	University of Bern	Gertsch, J (corresponding author), Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland.	gertsch@ibmm.unibe.ch	Chicca, Andrea/AAP-7156-2020	Chicca, Andrea/0000-0001-9593-636X; Gertsch, Jurg/0000-0003-0978-1555; Nicolussi, Simon/0000-0003-1260-3282	Swiss National Science Foundation National Centre of Competence in Research TransCure; University of Bern Foundation; Novartis Research Foundation [10B48]	Swiss National Science Foundation National Centre of Competence in Research TransCure; University of Bern Foundation; Novartis Research Foundation	This work was supported by the Swiss National Science Foundation National Centre of Competence in Research TransCure, the University of Bern Foundation, and Novartis Research Foundation Grant 10B48.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Alptekin A, 2010, EUR J PHARMACOL, V634, P10, DOI 10.1016/j.ejphar.2010.02.013; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Battista N, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00009; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blom T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004713; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Centonze D, 2004, NEUROPSYCHOPHARMACOL, V29, P1488, DOI 10.1038/sj.npp.1300458; Chicca A, 2009, INT IMMUNOPHARMACOL, V9, P850, DOI 10.1016/j.intimp.2009.03.006; CHU AJ, 1993, CELL BIOCHEM FUNCT, V11, P201, DOI 10.1002/cbf.290110308; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 1998, BIOCHEM J, V331, P15; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fasia L, 2003, EUR J BIOCHEM, V270, P3498, DOI 10.1046/j.1432-1033.2003.03724.x; Felder CC, 2006, MOL INTERV, V6, P149, DOI 10.1124/mi.6.3.6; Fezza F, 2002, FEBS LETT, V513, P294, DOI 10.1016/S0014-5793(02)02341-4; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Fogli S, 2006, FEBS LETT, V580, P1733, DOI 10.1016/j.febslet.2006.02.024; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Hajos N, 2004, EUR J NEUROSCI, V19, P2991, DOI 10.1111/j.0953-816X.2004.03433.x; Hamtiaux L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026823; Hermann A, 2006, AAPS J, V8, pE409, DOI 10.1007/BF02854913; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Hillard CJ, 2000, CHEM PHYS LIPIDS, V108, P123, DOI 10.1016/S0009-3084(00)00191-2; Izeboud CA, 2000, N-S ARCH PHARMACOL, V362, P184, DOI 10.1007/s002100000281; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Jarrahian A, 2000, J NEUROCHEM, V74, P2597, DOI 10.1046/j.1471-4159.2000.0742597.x; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kelley BG, 2004, EUR J PHARMACOL, V496, P33, DOI 10.1016/j.ejphar.2004.06.011; La Rana G, 2008, NEUROPHARMACOLOGY, V54, P521, DOI 10.1016/j.neuropharm.2007.10.021; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Ligresti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010239; Liu YJ, 2009, BIOL CELL, V101, P133, DOI 10.1042/BC20080083; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lopez-Rodriguez ML, 2003, EUR J MED CHEM, V38, P403, DOI 10.1016/S0223-5234(03)00045-X; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; Maccarrone M, 2002, BIOCHEM J, V366, P137, DOI 10.1042/BJ20020438; Maccarrone M, 2002, BLOOD, V100, P4040, DOI 10.1182/blood-2002-05-1444; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Marazzi J, 2011, J IMMUNOL METHODS, V373, P219, DOI 10.1016/j.jim.2011.08.021; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; McFarland MJ, 2008, MOL PHARMACOL, V74, P101, DOI 10.1124/mol.108.044834; McFarland MJ, 2004, J BIOL CHEM, V279, P41991, DOI 10.1074/jbc.M407250200; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; Moore SA, 2005, P NATL ACAD SCI USA, V102, P17852, DOI 10.1073/pnas.0507470102; Muthian S, 2000, J PHARMACOL EXP THER, V293, P289; Nicholson RA, 2003, BRAIN RES, V978, P194, DOI 10.1016/S0006-8993(03)02808-7; Nievergelt A, 2011, J IMMUNOL, V187, P4140, DOI 10.4049/jimmunol.1100880; Obata T, 2003, J CHROMATOGR B, V792, P131, DOI 10.1016/S1570-0232(03)00311-8; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2010, J LIPID RES, V51, P2435, DOI 10.1194/jlr.D004176; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; POCH G, 1990, J PHARMACOL METHOD, V24, P311, DOI 10.1016/0160-5402(90)90015-D; POCH G, 1990, CAN J PHYSIOL PHARM, V68, P1338; POCH G, 1995, J PHARMACOL TOXICOL, V33, P197, DOI 10.1016/1056-8719(95)00016-B; POCH G, 1980, J PHARMACOL METHOD, V4, P179, DOI 10.1016/0160-5402(80)90036-4; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schmid PC, 2000, CHEM PHYS LIPIDS, V104, P185, DOI 10.1016/S0009-3084(99)00124-3; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; Ueda N, 1999, FEBS LETT, V454, P267, DOI 10.1016/S0014-5793(99)00820-0; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P656, DOI 10.1016/j.intimp.2005.10.002; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	113	92	95	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34660	34682		10.1074/jbc.M112.373241	http://dx.doi.org/10.1074/jbc.M112.373241			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879589	hybrid, Green Published			2022-12-25	WOS:000309654200068
J	Price, GA; Holmes, RK				Price, Gregory A.; Holmes, Randall K.			Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera	PLOS ONE			English	Article							TOXIN-B-SUBUNIT; SOLUBLE COLONIZATION FACTOR; OUTER-MEMBRANE VESICLES; VIBRIO-CHOLERAE; INTRANASAL IMMUNIZATION; COREGULATED PILUS; EL-TOR; MUCOSAL IMMUNIZATION; ANTIBODY-RESPONSES; CLASSICAL BIOTYPE	The secreted colonization factor, TcpF, which is produced by Vibrio cholerae 01 and 0139, has generated interest as a potential protective antigen in the development of a subunit vaccine against cholera. This study evaluated immunogenicity/protective efficacy of a TcpF holotoxin-like chimera (TcpF-A2-CTB) following intraperitoneal immunization compared to TcpF alone, a TcpF+CTB mixture, or CTB alone. Immunization with the TcpF-A2-CTB chimera elicited significantly greater amounts of anti-TcpF IgG than immunization with the other antigens (P<0.05). Protective efficacy was measured using 6-day-old pups reared from immunized dams and orogastrically challenged with a lethal dose of El Tor V. cholerae 01 Inaba strain N16961. Protection from death, and weight loss analysis at 24 and 48 hours post-infection demonstrated that immunization with TcpF alone was poorly protective. However, immunization with TcpF+CTB was highly protective and showed a trend toward greater protection than immunization with CTB alone (82% vs 64% survival). Immunization with the TcpF-A2-CTB chimera demonstrated less protection (50% survival) than immunization with the TcpF+CTB mixture. The TcpF-A2-CTB chimera used for this study contained the heterologous classical CTB variant whereas the El Tor CTB variant (expressed by the challenge strain) was used in the other immunization groups. For all immunization groups that received CTB, quantitative ELISA data demonstrated that the amounts of serum IgG directed against the homologous immunizing CTB antigen was statistically greater than the amount to the heterologous CTB antigen (P <= 0.003). This finding provides a likely explanation for the poorer protection observed following immunization with the TcpF-A2-CTB chimera and the relatively high level of protection seen after immunization with homologous CTB alone. Though immunization with TcpF alone provided no protection, the additive protective effect when TcpF was combined with CTB demonstrates its possible value as a component of a multivalent subunit vaccine against Vibrio cholerae 01 and 0139.	[Price, Gregory A.; Holmes, Randall K.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Price, GA (corresponding author), Miriam Hosp, Dept Infect Dis, Providence, RI 02906 USA.	randall.holmes@ucdenver.edu			National Institutes of Health [R01-AI31940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant R01-AI31940. No other grants contributed to support of this work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bergquist C, 1997, INFECT IMMUN, V65, P2676, DOI 10.1128/IAI.65.7.2676-2684.1997; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Curlin GT, 1975, P 11 JOINT C CHOL US, P314; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; DERTZBAUGH MT, 1993, INFECT IMMUN, V61, P384, DOI 10.1128/IAI.61.2.384-390.1993; Fazil MH, 2011, J MOL MODEL; Goel AK, 2010, INFECT GENET EVOL, V10, P815, DOI 10.1016/j.meegid.2009.06.022; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; HAJISHENGALLIS G, 1995, J IMMUNOL, V154, P4322; Hang L, 2003, P NATL ACAD SCI USA, V100, P8508, DOI 10.1073/pnas.1431769100; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HOLMGREN J, 1973, Scandinavian Journal of Infectious Diseases, V5, P77, DOI 10.3109/inf.1973.5.issue-1.15; HOLMGREN J, 1977, NATURE, V269, P602, DOI 10.1038/269602a0; Isaka M, 1998, VACCINE, V16, P1620, DOI 10.1016/S0264-410X(98)00066-8; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; JOBLING MG, 1992, INFECT IMMUN, V60, P4915, DOI 10.1128/IAI.60.11.4915-4924.1992; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Kundu J, 2009, FEMS IMMUNOL MED MIC, V56, P179, DOI 10.1111/j.1574-695X.2009.00563.x; LEVINE MM, 1979, T ROY SOC TROP MED H, V73, P3, DOI 10.1016/0035-9203(79)90119-6; Li X, 2004, INFECT IMMUN, V72, P7306, DOI 10.1128/IAI.72.12.7306-7310.2004; Manning PA, 1997, GENE, V192, P63, DOI 10.1016/S0378-1119(97)00036-X; MARCHLEWICZ BA, 1983, DIAGN MICR INFEC DIS, V1, P129, DOI 10.1016/0732-8893(83)90042-1; MCKENZIE SJ, 1984, J IMMUNOL, V133, P1818; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Noriki H, 1976, P 12 JOINT C CHOL US, P302; PIERCE NF, 1982, INFECT IMMUN, V37, P687, DOI 10.1128/IAI.37.2.687-694.1982; Plotkin SA, 2008, VACCINES, pxvii; Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005; Rask C, 2000, APMIS, V108, P178, DOI 10.1034/j.1600-0463.2000.d01-42.x; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008603.pub2; SRIVASTAVA R, 1979, INDIAN J MED RES, V70, P369; Sultan F, 1998, INFECT IMMUN, V66, P462, DOI 10.1128/IAI.66.2.462-468.1998; TAMPLIN ML, 1989, J GEN MICROBIOL, V135, P1195; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; UJIIYE A, 1968, Tropical Medicine, V10, P65; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; Wu HY, 1998, VACCINE, V16, P286, DOI 10.1016/S0264-410X(97)00168-0; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	50	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42434	10.1371/journal.pone.0042434	http://dx.doi.org/10.1371/journal.pone.0042434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879984	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900039
J	Schlafer, S; Raarup, MK; Wejse, PL; Nyvad, B; Stadler, BM; Sutherland, DS; Birkedal, H; Meyer, RL				Schlafer, Sebastian; Raarup, Merete K.; Wejse, Peter L.; Nyvad, Bente; Stadler, Brigitte M.; Sutherland, Duncan S.; Birkedal, Henrik; Meyer, Rikke L.			Osteopontin Reduces Biofilm Formation in a Multi-Species Model of Dental Biofilm	PLOS ONE			English	Article							PLAQUE; LACTOFERRIN; STREPTOCOCCI; REMOVAL	Background: Combating dental biofilm formation is the most effective means for the prevention of caries, one of the most widespread human diseases. Among the chemical supplements to mechanical tooth cleaning procedures, non-bactericidal adjuncts that target the mechanisms of bacterial biofilm formation have gained increasing interest in recent years. Milk proteins, such as lactoferrin, have been shown to interfere with bacterial colonization of saliva-coated surfaces. We here study the effect of bovine milk osteopontin (OPN), a highly phosphorylated whey glycoprotein, on a multispecies in vitro model of dental biofilm. While considerable research effort focuses on the interaction of OPN with mammalian cells, there are no data investigating the influence of OPN on bacterial biofilms. Methodology/Principal Findings: Biofilms consisting of Streptococcus oralis, Actinomyces naeslundii, Streptococcus mitis, Streptococcus downei and Streptococcus sanguinis were grown in a flow cell system that permitted in situ microscopic analysis. Crystal violet staining showed significantly less biofilm formation in the presence of OPN, as compared to biofilms grown without OPN or biofilms grown in the presence of caseinoglycomacropeptide, another phosphorylated milk protein. Confocal microscopy revealed that OPN bound to the surface of bacterial cells and reduced mechanical stability of the biofilms without affecting cell viability. The bacterial composition of the biofilms, determined by fluorescence in situ hybridization, changed considerably in the presence of OPN. In particular, colonization of S. mitis, the best biofilm former in the model, was reduced dramatically. Conclusions/Significance: OPN strongly reduces the amount of biofilm formed in a well-defined laboratory model of acidogenic dental biofilm. If a similar effect can be observed in vivo, OPN might serve as a valuable adjunct to mechanical tooth cleaning procedures.	[Schlafer, Sebastian; Stadler, Brigitte M.; Sutherland, Duncan S.; Meyer, Rikke L.] Aarhus Univ, Fac Sci & Technol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Schlafer, Sebastian; Nyvad, Bente] Aarhus Univ, Fac Hlth, Dept Dent, Aarhus, Denmark; [Schlafer, Sebastian; Meyer, Rikke L.] Aarhus Univ, Fac Sci & Technol, Dept Biosci, Aarhus, Denmark; [Raarup, Merete K.] Aarhus Univ, Stereol & Elect Microscopy Res Lab, Aarhus, Denmark; [Raarup, Merete K.] Aarhus Univ, MIND Ctr, Aarhus, Denmark; [Wejse, Peter L.] Arla Foods Amba, Viby J, Denmark; [Birkedal, Henrik] Aarhus Univ, Fac Sci & Technol, Dept Chem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schlafer, S (corresponding author), Aarhus Univ, Fac Sci & Technol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark.	sebastian.schlafer@hotmail.de; rikke.meyer@biology.au.dk	Stadler, Brigitte/I-2661-2013; Sutherland, Duncan S/E-4385-2010; Birkedal, Henrik/AAD-3128-2020; Meyer, Rikke Louise/AAB-5377-2021; Schlafer, Sebastian/I-8788-2018	Sutherland, Duncan S/0000-0002-5045-9915; Birkedal, Henrik/0000-0002-4201-2179; Meyer, Rikke Louise/0000-0002-6485-5134; Stadler, Brigitte/0000-0002-7335-3945; Nyvad, Bente/0000-0002-9545-0447; Schlafer, Sebastian/0000-0003-2463-1926	Danish National Advanced Technology Foundation through ProSURF platform project (Protein-Based Functionalisation of Surfaces); Carlsberg Foundation	Danish National Advanced Technology Foundation through ProSURF platform project (Protein-Based Functionalisation of Surfaces); Carlsberg Foundation(Carlsberg Foundation)	This work was funded by the Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk) through the ProSURF platform project (Protein-Based Functionalisation of Surfaces) and by the Carlsberg Foundation (http://www.carlsbergfondet.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair Steven M., 1998, Pediatric Dentistry, V20, P101; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Arslan SY, 2009, ORAL MICROBIOL IMMUN, V24, P411, DOI 10.1111/j.1399-302X.2009.00537.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Gaffar A, 1997, EUR J ORAL SCI, V105, P502, DOI 10.1111/j.1600-0722.1997.tb00237.x; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Guggenheim B, 1999, CARIES RES, V33, P446, DOI 10.1159/000016550; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hirota K, 2011, J DENT RES, V90, P900, DOI 10.1177/0022034511402996; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Niemi LD, 2009, CARIES RES, V43, P171, DOI 10.1159/000213888; Oho T, 2002, INFECT IMMUN, V70, P5279, DOI 10.1128/IAI.70.9.5279-5282.2002; ONG G, 1990, J CLIN PERIODONTOL, V17, P463, DOI 10.1111/j.1600-051X.1990.tb02345.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Prasad KVV, 2011, AM J DENT, V24, P60; Schlafer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025299; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sodek J, 2006, J DENT RES, V85, P404, DOI 10.1177/154405910608500503; van der Weijden GA, 2005, J CLIN PERIODONTOL, V32, P214, DOI 10.1111/j.1600-051X.2005.00795.x; Wakabayashi H, 2009, ANTIMICROB AGENTS CH, V53, P3308, DOI 10.1128/AAC.01688-08; Younson J, 2004, MOL DIVERS, V8, P121, DOI 10.1023/B:MODI.0000025655.93643.fa	25	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41534	10.1371/journal.pone.0041534	http://dx.doi.org/10.1371/journal.pone.0041534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879891	Green Published, gold			2022-12-25	WOS:000307437900012
J	Harel, S; Tu, EY; Weisberg, S; Esquilin, M; Chambers, SM; Liu, B; Carson, CT; Studer, L; Reizis, B; Tomishima, MJ				Harel, Sivan; Tu, Edmund Y.; Weisberg, Stuart; Esquilin, Manuel; Chambers, Stuart M.; Liu, Becky; Carson, Christian T.; Studer, Lorenz; Reizis, Boris; Tomishima, Mark J.			ZFX Controls the Self-Renewal of Human Embryonic Stem Cells	PLOS ONE			English	Article							DERIVATION; LINES	Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) offer great promise in regenerative medicine and disease modeling due to their unlimited self-renewal and broad differentiation capacity. There is evidence that the growth properties and critical signaling pathways differ between murine and human ESCs; therefore, it is essential to perform functional studies to test the putatively conserved mechanisms of pluripotent stem cell self-renewal between species. Previously, we identified the transcription factor Zfx as a key regulator of self-renewal in murine ESCs. Here we extend those findings to human ESCs. ZFX knockdown in hESCs hindered clonal growth and decreased colony size after serial replating. ZFX overexpression enhanced clone formation in the presence of Y-27632, increased colony size at low density and decreased expression of differentiation-related genes in human ESCs. ZFX-overexpressing hESCs resisted spontaneous differentiation but could be directed to differentiate into endodermal and neural cell fates when provided with the appropriate cues. Thus, ZFX acts as a molecular rheostat regulating the balance between self-renewal and differentiation in hESCs, revealing the close evolutionary conservation of the self-renewal mechanisms in murine and human ESCs.	[Harel, Sivan; Weisberg, Stuart; Esquilin, Manuel; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA; [Tu, Edmund Y.; Chambers, Stuart M.; Liu, Becky; Studer, Lorenz; Tomishima, Mark J.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Carson, Christian T.] BD Biosci, La Jolla, CA USA	Columbia University; Memorial Sloan Kettering Cancer Center	Harel, S (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA.	bvr2101@columbia.edu; tomishim@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Reizis, Boris/0000-0003-1140-7853; Weisberg, Stuart/0000-0002-8698-5976	The Starr Foundation; NYSTEM [C024175-01]; National Institutes of Health [HL084353]; Becton, Dickinson and Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084353] Funding Source: NIH RePORTER	The Starr Foundation; NYSTEM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Becton, Dickinson and Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The Starr Foundation (MJT and LS; www.starrfoundation.org), NYSTEM grant C024175-01 (MJT and LS; www.nystem.ny.org), National Institutes of Health grant HL084353 (to BR) and Becton, Dickinson and Company (CTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang ZD, 2001, GENOME RES, V11, P137, DOI 10.1101/gr.159001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42302	10.1371/journal.pone.0042302	http://dx.doi.org/10.1371/journal.pone.0042302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879936	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100063
J	Labbe, J; Murat, C; Morin, E; Tuskan, GA; Le Tacon, F; Martin, F				Labbe, Jessy; Murat, Claude; Morin, Emmanuelle; Tuskan, Gerald A.; Le Tacon, Francois; Martin, Francis			Characterization of Transposable Elements in the Ectomycorrhizal Fungus Laccaria bicolor	PLOS ONE			English	Article							INVERTED-REPEAT ELEMENTS; GENOME SEQUENCE; MAIZE; EVOLUTION; GENES; RETROTRANSPOSONS; ORGANIZATION; FAMILY; IDENTIFICATION; SUBSTITUTIONS	Background: The publicly available Laccaria bicolor genome sequence has provided a considerable genomic resource allowing systematic identification of transposable elements (TEs) in this symbiotic ectomycorrhizal fungus. Using a TE-specific annotation pipeline we have characterized and analyzed TEs in the L. bicolor S238N-H82 genome. Methodology/Principal Findings: TEs occupy 24% of the 60 Mb L. bicolor genome and represent 25,787 full-length and partial copy elements distributed within 171 families. The most abundant elements were the Copia-like. TEs are not randomly distributed across the genome, but are tightly nested or clustered. The majority of TEs exhibits signs of ancient transposition except some intact copies of terminal inverted repeats (TIRS), long terminal repeats (LTRs) and a large retrotransposon derivative (LARD) element. There were three main periods of TE expansion in L. bicolor: the first from 57 to 10 Mya, the second from 5 to 1 Mya and the most recent from 0.5 Mya ago until now. LTR retrotransposons are closely related to retrotransposons found in another basidiomycete, Coprinopsis cinerea. Conclusions: This analysis 1) represents an initial characterization of TEs in the L. bicolor genome, 2) contributes to improve genome annotation and a greater understanding of the role TEs played in genome organization and evolution and 3) provides a valuable resource for future research on the genome evolution within the Laccaria genus.	[Labbe, Jessy; Murat, Claude; Morin, Emmanuelle; Le Tacon, Francois; Martin, Francis] Lorraine Univ Interact Arbres Microorganismes, INRA, UMR, Ctr Nancy Champenoux, Nancy, France; [Labbe, Jessy; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioSci Div, Oak Ridge, TN USA	INRAE; United States Department of Energy (DOE); Oak Ridge National Laboratory	Labbe, J (corresponding author), Lorraine Univ Interact Arbres Microorganismes, INRA, UMR, Ctr Nancy Champenoux, Nancy, France.	labbejj@ornl.gov	Murat, Claude/AAA-5226-2020; morin, emmanuelle/AAA-1246-2019; Labbe, Jessy/G-9532-2011; Tuskan, Gerald/A-6225-2011	Murat, Claude/0000-0003-0685-7307; morin, emmanuelle/0000-0002-7268-972X; Labbe, Jessy/0000-0003-0368-2054; Tuskan, Gerald/0000-0003-0106-1289	INRA; Region Lorraine Research Council; Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL); Office of Biological and Environmental Research at the United States Department of Energy Office of Science; UT-Battelle, LLC [DE-AC05-00OR22725]	INRA; Region Lorraine Research Council(Region Grand-Est); Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL); Office of Biological and Environmental Research at the United States Department of Energy Office of Science(United States Department of Energy (DOE)); UT-Battelle, LLC	This work was supported by INRA, the Region Lorraine Research Council and by the Plant-Microbe Interfaces Scientific Focus Area project at Oak Ridge National Laboratory (ORNL) sponsored by Office of Biological and Environmental Research at the United States Department of Energy Office of Science. ORNL is managed by UT-Battelle, LLC, under contract DE-AC05-00OR22725 for the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2001, MOL GENET GENOMICS, V266, P471, DOI 10.1007/s004380100563; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Baker Scott E., 2008, Fungal Biology Reviews, V22, P1, DOI 10.1016/j.fbr.2008.03.001; Barabaschi D, 2012, MOL BIOTECHNOL, V50, P250, DOI 10.1007/s12033-011-9443-1; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Boeke J. D., 1997, P343; Boeke JD, 1989, MOBILE DNA, P335; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DECARIS B, 1978, MOL GEN GENET, V162, P69, DOI 10.1007/BF00333852; Deninger PL, 1989, ASM, V19, P619; Diez J, 2003, CURR GENET, V43, P34, DOI 10.1007/s00294-002-0363-2; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Fu HH, 2001, P NATL ACAD SCI USA, V98, P8903, DOI 10.1073/pnas.141221898; Halling RE, 2001, ANN MO BOT GARD, V88, P5, DOI 10.2307/2666128; Harley J.L., 1983, MYCORRHIZAL SYMBIOSI; Hu JP, 2000, PLANT MOL BIOL, V42, P667, DOI 10.1023/A:1006355510883; Iwamoto M, 2003, MOL GENET GENOMICS, V268, P771, DOI 10.1007/s00438-002-0797-8; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Johnson LJ, 2007, EVOL BIOL, V34, P121, DOI 10.1007/s11692-007-9012-5; Kempken F, 1998, FUNGAL GENET BIOL, V25, P110, DOI 10.1006/fgbi.1998.1091; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Labbe J, 2008, NEW PHYTOL, V180, P316, DOI 10.1111/j.1469-8137.2008.02614.x; Labbe J, 2011, CURR GENET, V57, P75, DOI 10.1007/s00294-010-0328-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Metzgar D, 2000, GENOME RES, V10, P72; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Miller WJ, 1999, GENETICA, V107, P197, DOI 10.1023/A:1004070603792; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Niculita-Hirzel H, 2008, NEW PHYTOL, V180, P329, DOI 10.1111/j.1469-8137.2008.02525.x; Novikova O, 2009, FUNCT INTEGR GENOMIC, V9, P27, DOI 10.1007/s10142-008-0093-8; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandmeyer S, 1998, GENOME RES, V8, P416, DOI 10.1101/gr.8.5.416; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tikhonov AP, 1999, P NATL ACAD SCI USA, V96, P7409, DOI 10.1073/pnas.96.13.7409; Walbot V, 2001, P NATL ACAD SCI USA, V98, P8163, DOI 10.1073/pnas.161278798; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Zhu Y, 2000, GENET RES, V76, P227, DOI 10.1017/S001667230000478X	60	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40197	10.1371/journal.pone.0040197	http://dx.doi.org/10.1371/journal.pone.0040197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870194	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100006
J	Talens, S; Leebeek, FWG; Demmers, JAA; Rijken, DC				Talens, Simone; Leebeek, Frank W. G.; Demmers, Jeroen A. A.; Rijken, Dingeman C.			Identification of Fibrin Clot-Bound Plasma Proteins	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; VENOUS THROMBOEMBOLISM; CROSS-LINKING; RISK; DISEASE; PROTEOMICS; COMPONENT; ARTERIAL; THROMBIN; INHIBITION	Several proteins are known to bind to a fibrin network and to change clot properties or function. In this study we aimed to get an overview of fibrin clot-bound plasma proteins. A plasma clot was formed by adding thrombin, CaCl2 and aprotinin to citrated platelet-poor plasma and unbound proteins were washed away with Tris-buffered saline. Non-covalently bound proteins were extracted, separated with 2D gel electrophoresis and visualized with Sypro Ruby. Excised protein spots were analyzed with mass spectrometry. The identity of the proteins was verified by checking the mass of the protein, and, if necessary, by Western blot analysis. Next to established fibrin-binding proteins we identified several novel fibrin clot-bound plasma proteins, including alpha(2)-macroglobulin, carboxypeptidase N, alpha(1)-antitrypsin, haptoglobin, serum amyloid P, and the apolipoproteins A-I, E, J, and A-IV. The latter six proteins are associated with high-density lipoprotein particles. In addition we showed that high-density lipoprotein associated proteins were also present in fibrinogen preparations purified from plasma. Most plasma proteins in a fibrin clot can be classified into three groups according to either blood coagulation, protease inhibition or high-density lipoprotein metabolism. The presence of high-density lipoprotein in clots might point to a role in hemostasis.	[Talens, Simone; Leebeek, Frank W. G.; Rijken, Dingeman C.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Demmers, Jeroen A. A.] Erasmus Univ, Prote Ctr, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Talens, S (corresponding author), Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands.	d.rijken@erasmusmc.nl	Demmers, Jeroen/F-4046-2016	Demmers, Jeroen/0000-0002-8757-9611				Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; CHU CT, 1994, ANN NY ACAD SCI, V737, P291, DOI 10.1111/j.1749-6632.1994.tb44319.x; de Haas CJC, 2000, INFECT IMMUN, V68, P4954, DOI 10.1128/IAI.68.9.4954-4960.2000; Eichinger S, 2007, CIRCULATION, V115, P1609, DOI 10.1161/CIRCULATIONAHA.106.649954; Flinterman LE, 2010, BRIT J HAEMATOL, V149, P118, DOI 10.1111/j.1365-2141.2009.08074.x; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Henderson RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-27; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Howes JM, 2012, DIABETES VASC DIS RE, V9, P216, DOI 10.1177/1479164111432788; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUH MM, 1988, BLOOD, V71, P1693; IINO M, 1995, EUR J BIOCHEM, V232, P90, DOI 10.1111/j.1432-1033.1995.tb20785.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KOOPMAN J, 1992, J CLIN INVEST, V90, P238, DOI 10.1172/JCI115841; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Mahmoodi BK, 2008, CIRCULATION, V118, P1659, DOI 10.1161/CIRCULATIONAHA.108.780759; MUI PTK, 1977, AM J PHYSIOL, V233, pH346, DOI 10.1152/ajpheart.1977.233.3.H346; NAIR CH, 1991, THROMB RES, V61, P315, DOI 10.1016/0049-3848(91)90109-A; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; Oslakovic C, 2010, J CLIN INVEST, V120, P1396, DOI 10.1172/JCI42260; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; Park CT, 2000, BLOOD, V95, P198, DOI 10.1182/blood.V95.1.198.001k31_198_204; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Reiner AP, 2001, THROMB HAEMOSTASIS, V85, P584; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Smalberg JH, 2011, ARTERIOSCL THROM VAS, V31, P485, DOI 10.1161/ATVBAHA.110.213371; TAKEBE M, 1995, THROMB HAEMOSTASIS, V73, P662; Talens S, 2011, J HEPATOL, V54, P908, DOI 10.1016/j.jhep.2010.08.026; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wolberg AS, 2010, HAEMOPHILIA, V16, P7, DOI 10.1111/j.1365-2516.2010.02253.x	45	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41966	10.1371/journal.pone.0041966	http://dx.doi.org/10.1371/journal.pone.0041966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870270	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100041
J	Lennartsson, J; Hakansson, N; Wennergren, U; Jonsson, A				Lennartsson, Jenny; Hakansson, Nina; Wennergren, Uno; Jonsson, Annie			SpecNet: A Spatial Network Algorithm that Generates a Wide Range of Specific Structures	PLOS ONE			English	Article							OUTBREAKS; COMPONENT; GRAPHS; POINT	Network measures are used to predict the behavior of different systems. To be able to investigate how various structures behave and interact we need a wide range of theoretical networks to explore. Both spatial and non-spatial methods exist for generating networks but they are limited in the ability of producing wide range of network structures. We extend an earlier version of a spatial spectral network algorithm to generate a large variety of networks across almost all the theoretical spectra of the following network measures: average clustering coefficient, degree assortativity, fragmentation index, and mean degree. We compare this extended spatial spectral network-generating algorithm with a non-spatial algorithm regarding their ability to create networks with different structures and network measures. The spatial spectral network-generating algorithm can generate networks over a much broader scale than the non-spatial and other known network algorithms. To exemplify the ability to regenerate real networks, we regenerate networks with structures similar to two real Swedish swine transport networks. Results show that the spatial algorithm is an appropriate model with correlation coefficients at 0.99. This novel algorithm can even create negative assortativity and managed to achieve assortativity values that spans over almost the entire theoretical range.	[Lennartsson, Jenny; Hakansson, Nina; Jonsson, Annie] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden; [Hakansson, Nina; Wennergren, Uno] Linkoping Univ, Dept Phys & Measurement Technol, S-58183 Linkoping, Sweden	University of Skovde; Linkoping University	Lennartsson, J (corresponding author), Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden.	annie.jonsson@his.se		Hakansson, Nina/0000-0003-2929-1617	Swedish Civil Contingencies Agency (MSB); Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security [ST-108-000017]	Swedish Civil Contingencies Agency (MSB); Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security	This work was partially funded by the Swedish Civil Contingencies Agency (MSB), and the authors also received support from the Foreign Animal Disease Modeling program of the Science and Technology Directorate, Department of Homeland Security (grant ST-108-000017). No additional external funding received for this study. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Ames GM, 2011, P ROY SOC B-BIOL SCI, V278, P3544, DOI 10.1098/rspb.2011.0290; Asano T, 1995, J COMPUT SYST SCI, V51, P503, DOI 10.1006/jcss.1995.1086; Badham J, 2008, THEOR POPUL BIOL, V74, P161, DOI 10.1016/j.tpb.2008.06.002; Badham J, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1501; Badham J, 2010, THEOR POPUL BIOL, V77, P71, DOI 10.1016/j.tpb.2009.11.003; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Boily MC, 2007, MATH POPUL STUD, V14, P237, DOI 10.1080/08898480701612873; Borgatti S, 2003, KEY PLAYER PROBLEM D; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hakansson N, 2010, ADV COMPLEX SYST, V13, P239, DOI 10.1142/S0219525910002517; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Mugglestone MA, 2001, ENVIRON ECOL STAT, V8, P237, DOI 10.1023/A:1011339607376; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pusch A, 2008, PHYS REV E, V77; Serrano MA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036133; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Webb CR, 2005, PREV VET MED, V68, P3, DOI 10.1016/j.prevetmed.2005.01.003; Weber S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046111; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	41	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42679	10.1371/journal.pone.0042679	http://dx.doi.org/10.1371/journal.pone.0042679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876329	Green Submitted, Green Published, gold			2022-12-25	WOS:000307184700057
J	Stumpf, RP; Wynne, TT; Baker, DB; Fahnenstiel, GL				Stumpf, Richard P.; Wynne, Timothy T.; Baker, David B.; Fahnenstiel, Gary L.			Interannual Variability of Cyanobacterial Blooms in Lake Erie	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; MICROCYSTIS-AERUGINOSA; SATELLITE DETECTION; SAGINAW BAY; MERIS; ECOSYSTEM; CHLOROPHYLL; QUALITY; MUSSELS; BIOMASS	After a 20-year absence, severe cyanobacterial blooms have returned to Lake Erie in the last decade, in spite of negligible change in the annual load of total phosphorus (TP). Medium-spectral Resolution Imaging Spectrometer (MERIS) imagery was used to quantify intensity of the cyanobacterial bloom for each year from 2002 to 2011. The blooms peaked in August or later, yet correlate to discharge (Q) and TP loads only for March through June. The influence of the spring TP load appears to have started in the late 1990 s, after Dreissenid mussels colonized the lake, as hindcasts prior to 1998 are inconsistent with the observed blooms. The total spring Q or TP load appears sufficient to predict bloom magnitude, permitting a seasonal forecast prior to the start of the bloom.	[Stumpf, Richard P.; Wynne, Timothy T.] NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Baker, David B.] Univ Heidelberg, Natl Ctr Water Qual Res, Tiffin, OH USA; [Fahnenstiel, Gary L.] NOAA, Great Lakes Environm Res Lab, Muskegon, MI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Heidelberg University USA; National Oceanic Atmospheric Admin (NOAA) - USA	Stumpf, RP (corresponding author), NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA.	Richard.stumpf@noaa.gov	Fahnenstiel, Gary/ABD-6133-2020; Stumpf, Richard/L-5237-2019	Stumpf, Richard/0000-0001-5531-6860	NASA [NNH08ZDA001N]; NOAA Oceans and Human Health Initiative;  [NNH09AL53I]	NASA(National Aeronautics & Space Administration (NASA)); NOAA Oceans and Human Health Initiative(National Oceanic Atmospheric Admin (NOAA) - USA); 	This study was partially funded by NASA Applied Science Program announcement NNH08ZDA001N, contract NNH09AL53I, and the NOAA Oceans and Human Health Initiative. MERIS imagery was provided by the European Space Agency (Category-1 Proposal C1P.9975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LAKELINES; Binding CE, 2012, J PLANKTON RES, V34, P569, DOI 10.1093/plankt/fbs021; Binding CE, 2011, J PLANKTON RES, V33, P1847, DOI 10.1093/plankt/fbr079; Bridgeman TB, 2012, J GREAT LAKES RES, V38, P90, DOI 10.1016/j.jglr.2011.09.010; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Budd J.W., 2001, VERH INT VEREIN LIMN, V27, P3787; Budd JW, 2001, LIMNOL OCEANOGR, V46, P213, DOI 10.4319/lo.2001.46.2.0213; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Conroy JD, 2005, J GREAT LAKES RES, V31, P89, DOI 10.1016/S0380-1330(05)70307-5; Culver DA, 1999, TOXICITY ECOLOGICAL; European Space Agency, 2012, MERIS PROD ALG; Evans MA, 2010, ENVIRON RES LETT, V6, P1; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower JFR, 1999, INT J REMOTE SENS, V20, P1771, DOI 10.1080/014311699212470; Graham JL, 2010, ENVIRON SCI TECHNOL, V44, P7361, DOI 10.1021/es1008938; Hunter PD, 2008, LIMNOL OCEANOGR, V53, P2391, DOI 10.4319/lo.2008.53.6.2391; Joosse PJ, 2011, CAN J SOIL SCI, V91, P317, DOI [10.4141/CJSS10005, 10.4141/cjss10005]; KAHRU M, 1994, AMBIO, V23, P469; Kutovaya OA, 2012, HARMFUL ALGAE, V15, P71, DOI 10.1016/j.hal.2011.11.007; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179, DOI 10.4319/lo.2004.49.6.2179; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; MAKAREWICZ JC, 1991, BIOSCIENCE, V41, P216, DOI 10.2307/1311411; McGillicuddy DJ, 2011, LIMNOL OCEANOGR, V56, P2411, DOI 10.4319/lo.2011.56.6.2411; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; Mocko D., 2012, NASAGSFCHSL NLDAS PR, DOI [10.5067/Z62LT6J96R4F, DOI 10.5067/Z62LT6J96R4F]; Nalepa TF, 1995, J GREAT LAKES RES, V21, P411, DOI 10.1016/S0380-1330(95)71055-3; NOAA, 2012, HARMF ALG BLOOMS LAK; O'Dell J, 1993, 600R93100 EPA ENV MO; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards RP, 2010, J SOIL WATER CONSERV, V65, P450, DOI 10.2489/jswc.65.6.450; Richards RP, 2002, J ENVIRON QUAL, V31, P6, DOI 10.2134/jeq2002.0006; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Ruiz-Verdu A, 2008, REMOTE SENS ENVIRON, V112, P3996, DOI 10.1016/j.rse.2007.11.019; Twiss MR, 2012, J GREAT LAKES RES, V38, P18, DOI 10.1016/j.jglr.2011.12.008; US Environmental Protection Agency, 1986, PHOSPH DIET LOW LAK; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Wang J, 2012, J CLIMATE, V25, P1318, DOI 10.1175/2011JCLI4066.1; Wynne TT, 2008, INT J REMOTE SENS, V29, P3665, DOI 10.1080/01431160802007640; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025	41	286	290	8	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42444	10.1371/journal.pone.0042444	http://dx.doi.org/10.1371/journal.pone.0042444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870327	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800091
J	Mak, GWY; Lai, WL; Zhou, Y; Li, MT; Ng, IOL; Ching, YP				Mak, Grace Wing-Yan; Lai, Wai-Lung; Zhou, Yuan; Li, Mingtao; Ng, Irene Oi-Lin; Ching, Yick-Pang			CDK5RAP3 Is a Novel Repressor of p14(ARF) in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							ACTIVATOR-BINDING-PROTEIN; TUMOR-SUPPRESSOR; EXPRESSION; INVASION; KINASE; LZAP; C53; P53	CDK5 regulatory subunit associated protein 3 (CDK5RAP3) is a novel activator of PAK4 and processes important prometastatic function in hepatocarcinogenesis. However, it remains unclear if there are other mechanisms by which CDK5RAP3 promotes HCC metastasis. Here, we showed that in CDK5RAP3 stable knockdown SMMC-7721 HCC cells, p14(ARF) tumor suppressor was upregulated at protein and mRNA levels, and ectopic expression of CDK5RAP3 was found to repress the transcription of p14(ARF). Using chromatin immunoprecipitation assay, we demonstrated that CDK5RAP3 bound to p14(ARF) promoter in vivo. Furthermore, knockdown of p14(ARF) in CDK5RAP3 stable knockdown HCC cells reversed the suppression of HCC cell invasiveness mediated by knockdown of CDK5RAP3. Taken together, our findings provide the new evidence that overexpression of CDK5RAP3 promotes HCC metastasis via downregulation of p14(ARF).	[Mak, Grace Wing-Yan; Lai, Wai-Lung; Zhou, Yuan; Ching, Yick-Pang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin; Ching, Yick-Pang] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University	Mak, GWY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	ypching@hku.hk		CHING, Yick Pang/0000-0002-6461-8358; Ng, Irene Oi-lin/0000-0001-7532-2029; Mak, Grace Wing-Yan/0000-0003-2861-6221	The Hong Kong Research Grant Council [N_HKU715/08, 7/CRF/09]	The Hong Kong Research Grant Council(Hong Kong Research Grants Council)	Our research is financially supported by The Hong Kong Research Grant Council (N_HKU715/08 and 7/CRF/09) (webpage: http://www.ugc.edu.hk/eng/rgc/about/about.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2005, J NEUROPATH EXP NEUR, V64, P74, DOI 10.1093/jnen/64.1.74; Anzola M, 2004, EUR J GASTROEN HEPAT, V16, P19, DOI 10.1097/00042737-200401000-00004; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Mak GWY, 2011, CANCER RES, V71, P2949, DOI 10.1158/0008-5472.CAN-10-4046; Moll UM, 2003, MOL CANCER RES, V1, P1001; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Yin XL, 2005, INT J MOL MED, V16, P251; Zhou DP, 1996, BIOCHEM J, V320, P623, DOI 10.1042/bj3200623	20	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42210	10.1371/journal.pone.0042210	http://dx.doi.org/10.1371/journal.pone.0042210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860085	Green Published, gold, Green Submitted			2022-12-25	WOS:000307045600074
J	Xu, XM; Wang, J; Aron, A; Lei, W; Westmaas, JL; Weng, XC				Xu, Xiaomeng; Wang, Jin; Aron, Arthur; Lei, Wei; Westmaas, J. Lee; Weng, Xuchu			Intense Passionate Love Attenuates Cigarette Cue-Reactivity in Nicotine-Deprived Smokers: An fMRI Study	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SMOKING CUES; SELF-EXPANSION; WITHDRAWAL SYMPTOMS; DOPAMINE RELEASE; NEURAL BASIS; DRUG REWARD; ABSTINENCE; MINDFULNESS; ACTIVATION	Self-expanding experiences like falling in love or engaging in novel, exciting and interesting activities activate the same brain reward mechanism (mesolimbic dopamine pathway) that reinforces drug use and abuse, including tobacco smoking. This suggests the possibility that reward from smoking is substitutable by self-expansion (through competition with the same neural system), potentially aiding cessation efforts. Using a model of self-expansion in the context of romantic love, the present fMRI experiment examined whether, among nicotine-deprived smokers, relationship self-expansion is associated with deactivation of cigarette cue-reactivity regions. Results indicated that among participants who were experiencing moderate levels of craving, cigarette cue-reactivity regions (e.g., cuneus and posterior cingulate cortex) showed significantly less activation during self-expansion conditions compared with control conditions. These results provide evidence that rewards from one domain (self-expansion) can act as a substitute for reward from another domain (nicotine) to attenuate cigarette cue reactivity.	[Xu, Xiaomeng; Aron, Arthur] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Wang, Jin; Lei, Wei; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China; [Wang, Jin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Xiaomeng] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA; [Lei, Wei] Sichuan Univ, W China Hosp, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Westmaas, J. Lee] Amer Canc Soc, Behav Res Ctr, Atlanta, GA 30329 USA; [Weng, Xuchu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Sichuan University; American Cancer Society; Hangzhou Normal University	Xu, XM (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	Xiaomeng_Xu@Brown.edu	Xu, Xiaomeng/H-3308-2019	Xu, Xiaomeng/0000-0003-3695-4845	National Institute on Drug Abuse [F31DA024941-01A2]; National Science Foundation [BCS-0937559]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024941] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study came from award F31DA024941-01A2 from the National Institute on Drug Abuse to XX and award BCS-0937559 from the National Science Foundation to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and do not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.	Acevedo B, 2011, SOC COG AFFECT NEURO; Alter RJ, 2006, J DRUG EDUC, V36, P335, DOI 10.2190/2780-G96W-J17N-R3H1; Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; Aron A., 2001, BLACKWELL HDB SOCIAL, P478, DOI DOI 10.1002/9780470998557.CH19; Aron AP, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P27; Baker TB, 2011, ANN BEHAV MED, V41, P192, DOI 10.1007/s12160-010-9252-y; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bowen S, 2009, PSYCHOL ADDICT BEHAV, V23, P666, DOI 10.1037/a0017127; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brewer JA, 2011, DRUG ALCOHOL DEPEN, V119, P72, DOI 10.1016/j.drugalcdep.2011.05.027; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Carr KD, 2007, PHYSIOL BEHAV, V91, P459, DOI 10.1016/j.physbeh.2006.09.021; Carson JW, 2007, J MARITAL FAM THER, V33, P517, DOI 10.1111/j.1752-0606.2007.00035.x; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Cunningham WA, 2012, CURR DIR PSYCHOL SCI, V21, P54, DOI 10.1177/0963721411430832; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; David V, 2004, PSYCHOPHARMACOLOGY, V174, P367, DOI 10.1007/s00213-003-1767-5; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; DONOVAN DM, 1988, ASSESSMENT ADDICTIVE, P3; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Fiore MC, 2008, TREATING TOBACCO USE; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Forget B, 2010, BIOL PSYCHIAT, V68, P265, DOI 10.1016/j.biopsych.2010.01.029; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Haylett SA, 2004, ADDICT BEHAV, V29, P61, DOI 10.1016/S0306-4603(03)00083-2; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; Kalivas PW, 1998, J NEUROCHEM, V70, P1497; Kellogg SH, 2005, INT J DRUG POLICY, V16, P369, DOI 10.1016/j.drugpo.2005.08.001; Lambert C, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen074; Lee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z; Lim HK, 2005, J PSYCHIATR RES, V39, P333, DOI 10.1016/j.jpsychires.2004.08.004; Liu Y, 2011, J NEUROSCI, V31, P7960, DOI 10.1523/JNEUROSCI.1006-11.2011; MARKS I, 1990, BRIT J ADDICT, V85, P1389; McBride D, 2006, NEUROPSYCHOPHARMACOL, V31, P2728, DOI 10.1038/sj.npp.1301075; McClernon FJ, 2009, PSYCHOPHARMACOLOGY, V204, P25, DOI 10.1007/s00213-008-1436-9; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Meeusen Romain, 2005, Ann Transplant, V10, P49; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Ortigue S, 2010, J SEX MED, V7, P3541, DOI 10.1111/j.1743-6109.2010.01999.x; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qian J., 2010, B WORLD HEALTH ORGAN, P717; REISSMAN C, 1993, J SOC PERS RELAT, V10, P243, DOI 10.1177/026540759301000205; ROSE JE, 1985, CLIN PHARMACOL THER, V38, P450, DOI 10.1038/clpt.1985.203; Salvy SJ, 2009, ANN BEHAV MED, V38, P205, DOI 10.1007/s12160-009-9145-0; Shiffman S, 2006, PSYCHOPHARMACOLOGY, V184, P608, DOI 10.1007/s00213-005-0175-4; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Strong G., 2006, SELF RELATIONSHIPS C, P342; Sziraki I, 2002, NEUROCHEM RES, V27, P253, DOI 10.1023/A:1014844823534; Taylor AH, 2007, ADDICTION, V102, P534, DOI 10.1111/j.1360-0443.2006.01739.x; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Vaillant G.E., 1995, WISDOM EGO; Vidrine JI, 2009, SUBST ABUS, V30, P318, DOI 10.1080/08897070903252973; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wilson SJ, 2005, NICOTINE TOB RES, V7, P637, DOI 10.1080/14622200500185520; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; WOOLVERTON WL, 1984, J PHARMACOL EXP THER, V230, P678; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Xu XM, 2010, ADDICT BEHAV, V35, P295, DOI 10.1016/j.addbeh.2009.10.019; Yan XD, 2009, ADDICT BIOL, V14, P478, DOI 10.1111/j.1369-1600.2009.00172.x; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	74	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42235	10.1371/journal.pone.0042235	http://dx.doi.org/10.1371/journal.pone.0042235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860092	Green Published, gold			2022-12-25	WOS:000307045600078
J	Pust, S; Klokk, TI; Musa, N; Jenstad, M; Risberg, B; Erikstein, B; Tcatchoff, L; Liestol, K; Danielsen, HE; van Deurs, B; Sandvig, K				Pust, S.; Klokk, T. I.; Musa, N.; Jenstad, M.; Risberg, B.; Erikstein, B.; Tcatchoff, L.; Liestol, K.; Danielsen, H. E.; van Deurs, B.; Sandvig, K.			Flotillins as regulators of ErbB2 levels in breast cancer	ONCOGENE			English	Article						ErbB2 receptor tyrosine kinase; flotillin; breast cancer; endocytosis; downregulation	SIGNALING NETWORK; EPITHELIAL-CELLS; MAMMALIAN-CELLS; UP-REGULATION; IN-SITU; PHASE-I; RECEPTOR; KINASE; PROTEINS; GELDANAMYCIN	Amplification and overexpression of the receptor tyrosine kinase ErbB2 occur in up to 30% of human breast cancers, and high ErbB2 levels are correlated with poor prognosis for breast cancer patients. In contrast to the epithelial growth factor receptor (ErbB1), ErbB2 is not downregulated by ligand-induced mechanisms. Here we show that flotillins are involved in the stabilization of ErbB2 at the plasma membrane. In SKBR3 breast cancer cells and breast cancer tissue, a positive correlation between flotillin and ErbB2 expression levels could be demonstrated. Moreover, the tissue microarray analyses of biopsies from 194 patients diagnosed with carcinomas of the breast showed that flotillin-2 emerged as a potential predictor of prognosis in breast cancer. Depletion of flotillin-1 and flotillin-2 leads to internalization and degradation of ErbB2. Furthermore, flotillin-1 and -2 were found to be in a molecular complex with ErbB2 and Hsp90. The depletion of one of these proteins results in disruption of this complex, followed by destabilization of ErbB2 at the membrane, and its internalization and degradation. As a consequence, ErbB2-triggered downstream signalling is inhibited. Our data demonstrate a novel mechanism for interfering with ErbB2 signalling, which potentially can have clinical impact.	[Pust, S.; Klokk, T. I.; Musa, N.; Tcatchoff, L.; Sandvig, K.] Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway; [Pust, S.; Klokk, T. I.; Musa, N.; Jenstad, M.; Risberg, B.; Tcatchoff, L.; Liestol, K.; Danielsen, H. E.; Sandvig, K.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Jenstad, M.; Risberg, B.; Danielsen, H. E.] Oslo Univ Hosp, Inst Med Informat, N-0379 Oslo, Norway; [Risberg, B.] Oslo Univ Hosp, Dept Pathol, N-0379 Oslo, Norway; [Erikstein, B.] Oslo Univ Hosp, N-0379 Oslo, Norway; [van Deurs, B.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Sandvig, K.] Univ Oslo, Fac Math & Nat Sci, Dept Mol Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Copenhagen; University of Oslo	Sandvig, K (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway.	ksandvig@radium.uio.no	Danielsen, Havard e/A-7540-2014; Danielsen, Havard/AAK-8489-2020; Pust, Sascha/M-3201-2013	Pust, Sascha/0000-0002-0178-2206; Asp, Nagham Theres/0000-0002-2143-1470	South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Research Council; Norwegian Cancer Society	South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	We thank Wanja Kildal, Anne-Mari Gjestvang Pedersen and Anne Engen for their expert technical assistance. We thank Gisou van der Goot (EPFL, Lausanne, Switzerland) for providing the polyclonal flotillin-1 antibody used in confocal microscopy. We thank Ornulf Borgan for assistance with the analysis of the results from the breast tissue samples. We thank the South-Eastern Norway Regional Health Authority (Helse Sor-Ost), the Norwegian Research Council and the Norwegian Cancer Society for financial support.	Allred DC, 1998, MODERN PATHOL, V11, P155; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baulida J, 1996, J BIOL CHEM, V271, P5251; Cicenas J, 2006, EUR J CANCER, V42, P636, DOI 10.1016/j.ejca.2005.11.012; Citri A, 2004, CELL CYCLE, V3, P51; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Jones KL, 2009, LANCET ONCOL, V10, P1179, DOI 10.1016/S1470-2045(09)70315-8; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Modi S, 2006, CLIN BREAST CANCER, V7, P270, DOI 10.3816/CBC.2006.n.040; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pauletti G, 2000, J CLIN ONCOL, V18, P3651, DOI 10.1200/JCO.2000.18.21.3651; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schulte T, 1997, DEVELOPMENT, V124, P577; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spears M, 2012, BREAST CANCER RES TR, V132, P463, DOI 10.1007/s10549-011-1606-z; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Vassilieva EV, 2009, BIOCHEM BIOPH RES CO, V379, P460, DOI 10.1016/j.bbrc.2008.12.118; Wu YY, 2010, CANCER RES, V70, P5475, DOI 10.1158/0008-5472.CAN-10-0176; Wu YY, 1999, INT J ONCOL, V14, P1021; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	43	50	52	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 18	2013	32	29					3443	3451		10.1038/onc.2012.357	http://dx.doi.org/10.1038/onc.2012.357			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22869152				2022-12-25	WOS:000322014900005
J	de Sio, FRS; Barde, I; Offner, S; Kapopoulou, A; Corsinotti, A; Bojkowska, K; Genolet, R; Thomas, JH; Luescher, IF; Pinschewer, D; Harris, N; Trono, D				de Sio, Francesca R. Santoni; Barde, Isabelle; Offner, Sandra; Kapopoulou, Adamandia; Corsinotti, Andrea; Bojkowska, Karolina; Genolet, Raphael; Thomas, James H.; Luescher, Immanuel F.; Pinschewer, Daniel; Harris, Nicola; Trono, Didier			KAP1 regulates gene networks controlling T-cell development and responsiveness	FASEB JOURNAL			English	Article						epigenetics; adaptive immune cells; Kruppelassociated box zinc finger proteins; KRAB-ZFP; KRAB-ZFPassociated protein 1; KAP1	FINGER GENES; CHROMATIN; EXPRESSION; PROTEINS; DIFFERENTIATION; COREPRESSOR; CONTRIBUTES; REPRESSION; THYMOCYTES; PROMOTERS	Chromatin remodeling at specific genomic loci controls lymphoid differentiation. Here, we investigated the role played in this process by Kruppel-associated box (KRAB)-associated protein 1 (KAP1), the universal cofactor of KRAB-zinc finger proteins (ZFPs), a tetrapod-restricted family of transcriptional repressors. T-cell-specific Kap1-deleted mice displayed a significant expansion of immature thymocytes, imbalances in CD4(+)/CD8(+) cell ratios, and altered responses to TCR and TGF(+) stimulation when compared to littermate KAP1 control mice. Transcriptome and chromatin studies revealed that KAP1 binds T-cell-specific cis-acting regulatory elements marked by the H3K9me3 repressive mark and enriched in Ikaros/NuRD complexes. Also, KAP1 directly controls the expression of several genes involved in TCR and cytokine signaling. Among these, regulation of FoxO1 seems to play a major role in this system. Likely responsible for tethering KAP1 to at least part of its genomic targets, a small number of KRAB-ZFPs are selectively expressed in T-lymphoid cells. These results reveal the so far unsuspected yet important role of KAP1-mediated epigenetic regulation in T-lymphocyte differentiation and activation.-Santoni de Sio, F. R., Barde, I., Offner, S., Kapopoulou, A., Corsinotti, A., Bojkowska, K., Genolet, R., Thomas, J. H., Luescher, I. F., Pinschewer, D., Harris, N., Trono, D. KAP1 regulates gene networks controlling T-cell development and responsiveness. FASEB J. 26, 4561-4575 (2012). www.fasebj.org	[de Sio, Francesca R. Santoni; Barde, Isabelle; Offner, Sandra; Kapopoulou, Adamandia; Corsinotti, Andrea; Bojkowska, Karolina; Harris, Nicola; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [de Sio, Francesca R. Santoni; Barde, Isabelle; Offner, Sandra; Kapopoulou, Adamandia; Corsinotti, Andrea; Bojkowska, Karolina; Harris, Nicola; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, CH-1015 Lausanne, Switzerland; [Harris, Nicola] Ecole Polytech Fed Lausanne, Swiss Vaccine Res Inst, CH-1015 Lausanne, Switzerland; [Kapopoulou, Adamandia] SIB, Lausanne, Switzerland; [Genolet, Raphael; Luescher, Immanuel F.] Ludwig Inst Canc Res, Lausanne, Switzerland; [Thomas, James H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pinschewer, Daniel] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Washington; University of Washington Seattle; University of Geneva	Trono, D (corresponding author), EPFL SV DO, Stn 19, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	de Sio, Francesca Santoni/AAF-3432-2020; harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; Santoni de Sio, Francesca Romana/0000-0002-6522-0499; Bojkowska, Karolina/0000-0002-7961-8676; Pinschewer, Daniel/0000-0002-1594-3189	Swiss National Science Foundation; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	The authors thank Andrea Annoni for great help with Treg experiments; Fabio Aloisio for histological analyses; Sonia Verp for technical help; Ute Koch, Frederic Radtke, Anna Groner, Helen Rowe, and Corinne Schar for fruitful discussion; Giovanna Ambrosini, Jacques Rougemont, Patrick Descombes, and the Genomics Platform of the Frontiers in Genetics program for help in high-throughput analyses; Jessica Dessimoz and the EPFL Histology Core Facility; and Miguel Garcia and the EPFL Flow Cytometry Core Facility. Part of the computation was performed on the Swiss Institute of Bioinformatics Vital-IT facility (http://www.vital-it.ch). This work was supported by grants from the Swiss National Science Foundation and the European Research Council to D. T. Author contributions: F. R. S. D. S designed and performed experiments, analyzed data, and wrote the paper; A. C., I. B., K. B., N.H., D. P., and I. L. helped in designing experiments and provided reagents; I. B., S. O., A. A., and R. G. performed experiments; J. H. T. and A. K. analyzed data; D. T. designed experiments, analyzed data, and wrote the paper. The authors declare no conflicts of interest.	Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cammas F, 2000, DEVELOPMENT, V127, P2955; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Cuddapah S, 2010, CURR OPIN IMMUNOL, V22, P341, DOI 10.1016/j.coi.2010.02.007; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fayard E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135re5; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Genolet R, 2012, EMBO J, V31, P1666, DOI 10.1038/emboj.2012.48; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kioussis D, 2007, SCIENCE, V317, P620, DOI 10.1126/science.1143777; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Marsland BJ, 2005, P NATL ACAD SCI USA, V102, P14374, DOI 10.1073/pnas.0506250102; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Morrow Michael, 2011, PDA J Pharm Sci Technol, V65, P692, DOI 10.5731/pdajpst.2011.00841; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	55	32	32	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4561	4575		10.1096/fj.12-206177	http://dx.doi.org/10.1096/fj.12-206177			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22872677	Green Accepted, Bronze			2022-12-25	WOS:000310574200018
J	Holmborn, K; Habicher, J; Kasza, Z; Eriksson, AS; Filipek-Gorniok, B; Gopal, S; Couchman, JR; Ahlberg, PE; Wiweger, M; Spillmann, D; Kreuger, J; Ledin, J				Holmborn, Katarina; Habicher, Judith; Kasza, Zsolt; Eriksson, Anna S.; Filipek-Gorniok, Beata; Gopal, Sandeep; Couchman, John R.; Ahlberg, Per E.; Wiweger, Malgorzata; Spillmann, Dorothe; Kreuger, Johan; Ledin, Johan			On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; MOLECULAR-CLONING; HSPG SYNTHESIS; CELL POLARITY; GROWTH-PLATE; EXPRESSION; EXT2; PROTEOGLYCANS; GLYPICAN; XYLOSE	The present study addresses the roles of heparan sulfate (HS) proteoglycans and chondroitin sulfate (CS) proteoglycans in the development of zebrafish pharyngeal cartilage structures. uxs1 and b3gat3 mutants, predicted to have impaired biosynthesis of both HS and CS because of defective formation of the common proteoglycan linkage tetrasaccharide were analyzed along with ext2 and extl3 mutants, predicted to have defective HS polymerization. Notably, the effects on HS and CS biosynthesis in the respective mutant strains were shown to differ from what had been hypothesized. In uxs1 and b3gat3 mutant larvae, biosynthesis of CS was shown to be virtually abolished, whereas these mutants still were capable of synthesizing 50% of the HS produced in control larvae. extl3 and ext2 mutants on the other hand were shown to synthesize reduced amounts of hypersulfated HS. Further, extl3 mutants produced higher levels of CS than control larvae, whereas morpholino-mediated suppression of csgalnact1/csgalnact2 resulted in increased HS biosynthesis. Thus, the balance of the Extl3 and Csgalnact1/Csgalnact2 proteins influences the HS/CS ratio. A characterization of the pharyngeal cartilage element morphologies in the single mutant strains, as well as in ext2;uxs1 double mutants, was conducted. A correlation between HS and CS production and phenotypes was found, such that impaired HS biosynthesis was shown to affect chondrocyte intercalation, whereas impaired CS biosynthesis inhibited formation of the extracellular matrix surrounding chondrocytes.	[Holmborn, Katarina; Kasza, Zsolt; Eriksson, Anna S.; Filipek-Gorniok, Beata; Ahlberg, Per E.; Spillmann, Dorothe; Kreuger, Johan] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Habicher, Judith; Ledin, Johan] Uppsala Univ, Sci Life Lab, Dept Organism Biol, SE-75236 Uppsala, Sweden; [Gopal, Sandeep; Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Wiweger, Malgorzata] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands	Uppsala University; Uppsala University; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kreuger, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se; Johan.Ledin@ebc.uu.se	Kreuger, Johan/HDM-1503-2022; Ahlberg, Per/E-8086-2013; Korzeniowska, Małgorzata Irena/AFS-1696-2022; Wiweger, Małgorzata/AAX-6584-2021	Wiweger, Małgorzata/0000-0002-9537-9257; Ledin, Johan/0000-0002-7319-7735; Gopal, Sandeep/0000-0002-6706-6747; Ahlberg, Per/0000-0001-9054-2900	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Foundation for Strategic Research Project [A3 05:207g]; Foundation for Proteoglycan Research at Uppsala University; Knut and Alice Wallenberg Foundation; Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Foundation for Strategic Research Project; Foundation for Proteoglycan Research at Uppsala University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"	The work was supported by funds from the Swedish Research Council (to J. K., P. A., and J. L.), the Swedish Cancer Society (to J. K., D. S., and A. E.), the Swedish Childhood Cancer Foundation (to J. K.), Swedish Foundation for Strategic Research Project A3 05:207g (to J. K.), the Foundation for Proteoglycan Research at Uppsala University (J. K., D. S., A. E.), the Knut and Alice Wallenberg Foundation (J. L., P. A.), and the Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations" (J. L., P. A.).	Ahrens MJ, 2009, DEVELOPMENT, V136, P3463, DOI 10.1242/dev.040592; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Edgren G, 1997, GLYCOBIOLOGY, V7, P103, DOI 10.1093/glycob/7.1.103; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; Grandel H, 2000, DEVELOPMENT, V127, P4169; Gulberti S, 2005, THESCIENTIFICWORLDJO, V5, P510, DOI 10.1100/tsw.2005.65; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Janvier P, 2007, GEODIVERSITAS, V29, P143; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Roehl H. H., 2000, DEV DYNAM, V239, P1901; Schilling TF, 1996, DEVELOPMENT, V123, P329; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yao T, 2008, ZOOL SCI, V25, P976, DOI 10.2108/zsj.25.976; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	47	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33905	33916		10.1074/jbc.M112.401646	http://dx.doi.org/10.1074/jbc.M112.401646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869369	Green Published, hybrid			2022-12-25	WOS:000309602100071
J	Anikeeva, N; Gakamsky, D; Scholler, J; Sykulev, Y				Anikeeva, Nadia; Gakamsky, Dimitry; Scholler, Jorgen; Sykulev, Yuri			Evidence that the Density of Self Peptide-MHC Ligands Regulates T-Cell Receptor Signaling	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; ANTIGEN RECOGNITION; IMMUNOLOGICAL SYNAPSE; TETRASPAN MICRODOMAINS; CYTOLYTIC ACTIVITY; QUANTUM DOTS; CD8; ACTIVATION; COMPLEX; TCR	Noncognate or self peptide-MHC (pMHC) ligands productively interact with T-cell receptor (TCR) and are always in a large access over the cognate pMHC on the surface of antigen presenting cells. We assembled soluble cognate and noncognate pMHC class I (pMHC-I) ligands at designated ratios on various scaffolds into oligomers that mimic pMHC clustering and examined how multivalency and density of the pMHCs in model clusters influences the binding to live CD8 T cells and the kinetics of TCR signaling. Our data demonstrate that the density of self pMHC-I proteins promotes their interaction with CD8 co-receptor, which plays a critical role in recognition of a small number of cognate pMHC-I ligands. This suggests that MHC clustering on live target cells could be utilized as a sensitive mechanism to regulate T cell responsiveness.	[Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; [Gakamsky, Dimitry] Edinburgh Instruments Ltd, Livingston, Scotland; [Scholler, Jorgen] Immudex Inc, Copenhagen, Denmark	Jefferson University; Jefferson University	Anikeeva, N (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	ysykulev@lac.jci.tju.edu	Gakamsky, Dmitry/H-6947-2013		National Institute of Health [AI52812, CA131973]; Royal Society Industry Fellowship; NATIONAL CANCER INSTITUTE [R21CA131973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052812, R56AI052812] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society Industry Fellowship(Royal Society of London); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by National Institute of Health AI52812, CA131973 grants to YS and a Royal Society Industry Fellowship to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2003, J IMMUNOL METHODS, V277, P75, DOI 10.1016/S0022-1759(03)00179-0; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2011, NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, NSTI-NANOTECH 2011, VOL 3, P443; Anikeeva N, 2011, IMMUNOL RES, V51, P183, DOI 10.1007/s12026-011-8252-8; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Capps GG, 2004, BIOPHYS J, V86, P2896, DOI 10.1016/S0006-3495(04)74341-6; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; Edidin M, 2010, IMMUNOL RES, V47, P265, DOI 10.1007/s12026-009-8159-9; ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Gakamsky DM, 2000, BIOCHEMISTRY-US, V39, P11163, DOI 10.1021/bi000763z; Gakamsky DM, 2005, BIOPHYS J, V89, P2121, DOI 10.1529/biophysj.105.061671; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Gascoigne NRJ, 2010, CURR TOP MICROBIOL, V340, P171, DOI 10.1007/978-3-642-03858-7_9; Gaspar R, 2001, J IMMUNOL, V166, P5078, DOI 10.4049/jimmunol.166.8.5078; Germain RN, 2002, ADV EXP MED BIOL, V512, P97; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Kundu SK, 1998, AIDS RES HUM RETROV, V14, P1669, DOI 10.1089/aid.1998.14.1669; Lebedeva T, 2004, IMMUNOLOGY, V113, P460, DOI 10.1111/j.1365-2567.2004.01985.x; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maeurer M, 2001, TRENDS IMMUNOL, V22, P599, DOI 10.1016/S1471-4906(01)02061-0; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; MATKO J, 1994, J IMMUNOL, V152, P3353; Nagy P, 2006, BIOCHEM BIOPH RES CO, V347, P758, DOI 10.1016/j.bbrc.2006.06.157; Pecht I, 2005, FEBS LETT, V579, P3336, DOI 10.1016/j.febslet.2005.04.025; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Sapsford KE, 2007, J PHYS CHEM C, V111, P11528, DOI 10.1021/jp073550t; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Scholler J, 2010, J IMMUNOL METHODS, V360, P1, DOI 10.1016/j.jim.2010.05.008; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Valmori D, 1998, J IMMUNOL, V160, P1750; Vogt AB, 2002, IMMUNOL REV, V189, P136, DOI 10.1034/j.1600-065X.2002.18912.x; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhong LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005945	68	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41466	10.1371/journal.pone.0041466	http://dx.doi.org/10.1371/journal.pone.0041466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22870225	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500005
J	Nischalke, HD; Schmitz, V; Luda, C; Aldenhoff, K; Berger, C; Feldmann, G; Sauerbruch, T; Spengler, U; Nattermann, J				Nischalke, Hans Dieter; Schmitz, Volker; Luda, Carolin; Aldenhoff, Katharina; Berger, Cordula; Feldmann, Georg; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob			Detection of IGF2BP3, HOXB7, and NEK2 mRNA Expression in Brush Cytology Specimens as a New Diagnostic Tool in Patients with Biliary Strictures	PLOS ONE			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; IN-SITU HYBRIDIZATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PANCREATICOBILIARY MALIGNANCIES; KINESIN OVEREXPRESSION; PREOPERATIVE DIAGNOSIS; COLORECTAL-CANCER; BIOPSY SPECIMENS; FORCEPS BIOPSY	Introduction: It is a challenging task to distinguish between benign and malignant lesions in patients with biliary strictures. Here we analyze whether determination of target gene mRNA levels in intraductal brush cytology specimens may be used to improve the diagnosis of bile duct carcinoma. Materials and Methods: Brush cytology specimens from 119 patients with biliary strictures (malignant: n = 72; benign: n = 47) were analyzed in a retrospective cohort study. mRNA of IGF-II mRNA-binding protein 3 (IGF2BP3), homeobox B7 (HOXB7), Forkhead box M1 (FOXM1), kinesin family member 2C (KIF2C) and serine/threonine kinase NEK2 was determined by semi-quantitative RT-PCR using the Delta Ct method. Results: IGF2BP3 (p < 0.0001), HOXB7 (p < 0.0001), and NEK2 (p < 0.0001) mRNA expression levels were significantly increased in patients with cholangiocarcinoma or pancreatic cancer. Median DCt values differed by 3.5 cycles (IGF2BP3), 2.8 cycles (HOXB7) and 1.3 cycles (NEK2) corresponding to 11-fold, 7-fold and 2.5-fold increased mRNA levels in malignant versus benign samples. Sensitivity to detect biliary cancer was 76.4% for IGF2BP3 (80.9% specificity); 72.2% for HOXB7 (78.7% specificity) and 65.3% for NEK2 (72.3% specificity), whereas routine cytology reached only 43.1% sensitivity (85.4% specificity). Diagnostic precision was further improved, when all three molecular markers were assessed in combination (77.8% sensitivity, 87.2% specificity) and achieved 87.5% sensitivity and 87.2% specificity when molecular markers were combined with routine cytology. Conclusions: Our data suggest that measuring IGF2BP3, HOXB7 and NEK2 mRNA levels by RT-PCR in addition to cytology has the potential to improve detection of malignant biliary disorders from brush cytology specimens.	[Nischalke, Hans Dieter; Schmitz, Volker; Luda, Carolin; Aldenhoff, Katharina; Berger, Cordula; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Feldmann, Georg] Univ Bonn, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 3, Bonn, Germany	University of Bonn; University of Bonn	Nischalke, HD (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	nischalke@ukb.uni-bonn.de		Nischalke, Hans Dieter/0000-0002-3457-0023	Deutsche Krebshilfe (German Cancer Aid) [107865]; Deutsche Forschungsgemeinschaft [SFB TR57 TP12]; H.W. & J. Hector Foundation [M42]; German Cancer Foundation (Deutsche Krebshilfe) [109215, 109929]; European Community [HEALTH-F2-2011-256986]	Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H.W. & J. Hector Foundation; German Cancer Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); European Community(European Commission)	This study was funded by the Deutsche Krebshilfe (German Cancer Aid) (http://www.krebshilfe.de/english.html) grant 107865 to Hans Dieter Nischalke and Ulrich Spengler, the SFB TR57 TP12 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to Jacob Nattermann and Ulrich Spengler and the H.W. & J. Hector Foundation (http://www.hector-stiftung.de/) M42 to Jacob Nattermann. GF was supported by the German Cancer Foundation (Deutsche Krebshilfe) grants number 109215 and 109929 as well as by the European Community's Seventh Framework Program [FP7-2007-2013] under grant agreement HEALTH-F2-2011-256986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2011, AM J HEMATOL, V86, pE64, DOI 10.1002/ajh.22164; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chapman MH, 2012, J HEPATOL; de Bellis M, 2002, GASTROINTEST ENDOSC, V56, P720, DOI 10.1067/mge.2002.129219; de Bellis M, 2002, GASTROINTEST ENDOSC, V56, P552, DOI 10.1067/mge.2002.128132; Feldmann G, 2006, ENDOSCOPY, V38, P604, DOI 10.1055/s-2006-925065; Fishman DS, 2009, WORLD J GASTROENTERO, V15, P1353, DOI 10.3748/wjg.15.1353; Fraser MM, 2005, CANCER RES, V65, P6228, DOI 10.1158/0008-5472.CAN-05-0650; Fritcher EGB, 2010, CURR OPIN GASTROEN, V26, P259, DOI 10.1097/MOG.0b013e3283383bd0; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Glasbrenner B, 1999, ENDOSCOPY, V31, P712; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gray S, 2011, J PANCREAS, V12, P216; Hann LE, 2000, SEMIN SURG ONCOL, V19, P94, DOI 10.1002/1098-2388(200009)19:2<94::AID-SSU3>3.0.CO;2-X; Hansel DE, 2003, AM J PATHOL, V163, P217, DOI 10.1016/S0002-9440(10)63645-0; Itoi T, 2000, GASTROINTEST ENDOSC, V52, P380, DOI 10.1067/mge.2000.108303; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kipp BR, 2010, J MOL DIAGN; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Levy MJ, 2007, GASTROINTEST ENDOSC, V66, P483, DOI 10.1016/j.gie.2007.03.1053; Ligato S, 2008, DIAGN CYTOPATHOL, V36, P561, DOI 10.1002/dc.20836; Menias CO, 2008, RADIOGRAPHICS, V28, P1115, DOI 10.1148/rg.284075148; Morales CP, 1998, GASTROINTEST ENDOSC, V48, P402, DOI 10.1016/S0016-5107(98)70011-2; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; Nehls O, 2004, SEMIN LIVER DIS, V24, P139, DOI 10.1055/s-2004-828891; Niiyama H, 1999, CANCER, V85, P2138, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2138::AID-CNCR7>3.0.CO;2-8; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Ponsioen CY, 1999, ENDOSCOPY, V31, P305; Principe A, 2003, HEPATO-GASTROENTEROL, V50, P1246; PUGLIESE V, 1995, GASTROINTEST ENDOSC, V42, P520, DOI 10.1016/S0016-5107(95)70004-8; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; RUPP M, 1990, ACTA CYTOL, V34, P221; RYAN ME, 1991, GASTROINTEST ENDOSC, V37, P139, DOI 10.1016/S0016-5107(91)70671-8; RYAN ME, 1994, GASTROINTEST ENDOSC, V40, P133, DOI 10.1016/S0016-5107(94)70154-7; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Schoefl R, 1997, SCAND J GASTROENTERO, V32, P363, DOI 10.3109/00365529709007685; Shi CJ, 2009, J MOL DIAGN, V11, P583, DOI 10.2353/jmoldx.2009.090061; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Siddiqui AA, 2012, CLIN GASTROENTEROL H, V10, P466, DOI 10.1016/j.cgh.2011.12.021; Stewart CJR, 2000, DIAGN CYTOPATHOL, V23, P308, DOI 10.1002/1097-0339(200011)23:5<308::AID-DC4>3.0.CO;2-H; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Takano T, 1999, J CLIN ENDOCR METAB, V84, P951, DOI 10.1210/jc.84.3.951; Takano T, 1999, CANCER RES, V59, P4542; Wang SL, 2011, HISTOPATHOLOGY, V59, P631, DOI 10.1111/j.1365-2559.2011.03941.x; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2010, PHARM RES-DORDR, V27, P1159, DOI 10.1007/s11095-010-0106-x; Weglarz L, 2006, ACTA BIOCHIM POL, V53, P349; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Zhao H, 2007, DIAGN CYTOPATHOL, V35, P700, DOI 10.1002/dc.20739	54	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42141	10.1371/journal.pone.0042141	http://dx.doi.org/10.1371/journal.pone.0042141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879911	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900021
J	Johnson, LDS; Jameson, SC				Johnson, Lisa D. S.; Jameson, Stephen C.			TGF-beta Sensitivity Restrains CD8+T Cell Homeostatic Proliferation by Enforcing Sensitivity to IL-7 and IL-15	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD8(+) T-CELLS; VERSUS-HOST-DISEASE; IN-VIVO; C-MYC; RECEPTOR; SURVIVAL; EXPRESSION; NAIVE; MICE	The pleiotropic cytokine TGF-beta has been implicated in the regulation of numerous aspects of the immune response, including naive T cell homeostasis. Previous studies found that impairing TGF-beta responsiveness (through expression of a dominant-negative TGF-beta RII [DNRII] transgene) leads to accumulation of memory phenotype CD8 T cells, and it was proposed that this resulted from enhanced IL-15 sensitivity. Here we show naive DNRII CD8 T cells exhibit enhanced lymphopenia-driven proliferation and generation of "homeostatic'' memory cells. However, this enhanced response occurred in the absence of IL-15 and, unexpectedly, even in the combined absence of IL-7 and IL-15, which were thought essential for CD8 T cell homeostatic expansion. DNRII transgenic CD8 T cells still require access to self Class I MHC for homeostatic proliferation, arguing against generalized dysregulation of homeostatic cues. These findings suggest TGF-beta responsiveness is critical for enforcing sensitivity to homeostatic cytokines that limit maintenance and composition of the CD8 T cell pool. (154 words).	[Johnson, Lisa D. S.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Johnson, LDS (corresponding author), Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013; Johnson, Lisa DS/E-4218-2013	Jameson, Stephen C/0000-0001-9137-1146; Johnson, Lisa DS/0000-0002-2019-6560	NIH [R01AI075168, R37AI38903]; UMN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903, R01AI075168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the NIH (R01AI075168 and R37AI38903, to S.C.J.) and by UMN departmental support (to SCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; CAPOCASALE RJ, 1995, P NATL ACAD SCI USA, V92, P5501, DOI 10.1073/pnas.92.12.5501; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chung B, 2008, BIOL BLOOD MARROW TR, V14, P16, DOI 10.1016/j.bbmt.2007.07.015; Coomes SM, 2010, TRANSPLANTATION, V90, P1139, DOI 10.1097/TP.0b013e3181efd018; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kieper WC, 2001, J IMMUNOL, V166, P5515, DOI 10.4049/jimmunol.166.9.5515; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li WQ, 2010, MOL CELL BIOL, V30, P590, DOI 10.1128/MCB.01006-09; Lucas PJ, 2006, BLOOD, V108, P2789, DOI 10.1182/blood-2006-05-025676; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Mehal WZ, 2005, INT IMMUNOL, V17, P531, DOI 10.1093/intimm/dxh233; Modiano JF, 2008, IMMUNOL RES; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sinha ML, 2002, BLOOD, V100, P2642, DOI 10.1182/blood-2002-04-1082; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Zhang N, 2012, NATURE IMMUNOLOGY	42	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42268	10.1371/journal.pone.0042268	http://dx.doi.org/10.1371/journal.pone.0042268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879925	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000022
J	Lagomarcino, AJ; Miller, AI				Lagomarcino, Anne J.; Miller, Arnold I.			The Relationship between Genus Richness and Geographic Area in Late Cretaceous Marine Biotas: Epicontinental Sea versus Open-Ocean-Facing Settings	PLOS ONE			English	Article							PHANEROZOIC TRENDS; DIVERSITY; EXTINCTION; CURVES; ISLAND	For present-day biotas, close relationships have been documented between the number of species in a given region and the area of the region. To date, however, there have been only limited studies of these relationships in the geologic record, particularly for ancient marine biotas. The recent development of large-scale marine paleontological databases, in conjunction with enhanced geographical mapping tools, now allow for their investigation. At the same time, there has been renewed interest in comparing the environmental and paleobiological properties of two broad-scale marine settings: epicontinental seas, broad expanses of shallow water covering continental areas, and open-ocean-facing settings, shallow shelves and coastlines that rim ocean basins. Recent studies indicate that spatial distributions of taxa and the kinetics of taxon origination and extinction may have differed in these two settings. Against this backdrop, we analyze regional Genus-Area Relationships (GARs) of Late Cretaceous marine invertebrates in epicontinental sea and open-ocean settings using data from the Paleobiology Database. We present a new method for assessing GARs that is particularly appropriate for fossil data when the geographic distribution of these data is patchy and uneven. Results demonstrate clear relationships between genus richness and area for regions worldwide, but indicate that as area increases, genus richness increases more per unit area in epicontinental seas than in open-ocean settings. This difference implies a greater degree of compositional heterogeneity as a function of geographic area in epicontinental sea settings, a finding that is consistent with the emerging understanding of physical differences in the nature of water masses between the two marine settings.	[Lagomarcino, Anne J.; Miller, Arnold I.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Lagomarcino, AJ (corresponding author), Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA.	anne.lagomarcino@gmail.com	Lagomarcino, Anne J/Q-6060-2018	Lagomarcino, Anne J/0000-0002-3893-5771	Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Geological Society of America Graduate Student Research Grant; Paleontological Society Student Research Grant; Mid-American Paleontology Society (MAPS) Outstanding Research Awards; University of Cincinnati, Department of Geology, Caster Award; National Aeronautics and Space Administration (NASA) grant [NNX10AQ44G]	Theodore Roosevelt Memorial Fund of the American Museum of Natural History; Geological Society of America Graduate Student Research Grant; Paleontological Society Student Research Grant; Mid-American Paleontology Society (MAPS) Outstanding Research Awards; University of Cincinnati, Department of Geology, Caster Award; National Aeronautics and Space Administration (NASA) grant	This work was supported by the following: Theodore Roosevelt Memorial Fund of the American Museum of Natural History 2009 (http://www.amnh.org/); Geological Society of America Graduate Student Research Grant 2009 (http://www.geosociety.org/); Paleontological Society Student Research Grant, Mid-American Paleontology Society (MAPS) Outstanding Research Awards 2009 (http://www.paleosoc.org/index.html); University of Cincinnati, Department of Geology, Caster Award 2010 (http://www.artsci.uc.edu/geology/); and National Aeronautics and Space Administration (NASA) grant number NNX10AQ44G (Program in Exobiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PA, 2005, SEDIMENT GEOL, V179, P175, DOI 10.1016/j.sedgeo.2005.05.004; Allison PA, 2006, PALAIOS, V21, P513, DOI 10.2110/palo.2006.S06; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; [Anonymous], 2010, R LANG ENV STAT COMP; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BABINOT JF, 1992, PALAEOGEOGR PALAEOCL, V92, P283, DOI 10.1016/0031-0182(92)90088-M; BAMBACH R K, 1977, Paleobiology, V3, P152; Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Blakey R, 2010, COLORADO PLATEAU STR; Braden B., 1986, COLL MATH J, V17, P326, DOI [10.2307/2686282, DOI 10.1080/07468342.1986.11972974]; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marui Y, 2004, PALEOBIOLOGY, V30, P222, DOI 10.1666/0094-8373(2004)030<0222:SCFLSO>2.0.CO;2; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Miller AI, 2009, SCIENCE, V326, P1106, DOI 10.1126/science.1180061; Miller AI, 2009, PALEOBIOLOGY, V35, P612, DOI 10.1666/0094-8373-35.4.612; Mitchell AJ, 2010, SEDIMENT GEOL, V228, P81, DOI 10.1016/j.sedgeo.2010.03.008; Mitchell AJ, 2010, SEDIMENTOLOGY, V57, P359, DOI 10.1111/j.1365-3091.2009.01082.x; Panchuk KM, 2006, J SEDIMENT RES, V76, P200, DOI 10.2110/jsr.2006.017; Peters SE, 2007, PALEOBIOLOGY, V33, P165, DOI 10.1666/06067.1; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rosenzweig ML, 1999, ECOGRAPHY, V22, P614, DOI 10.1111/j.1600-0587.1999.tb00510.x; Scheiner SM, 2004, GLOBAL ECOL BIOGEOGR, V13, P479, DOI 10.1111/j.1466-822X.2004.00127.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; SEPKOSKI J J JR, 1976, Paleobiology, V2, P298; Smith KT, 2008, EVOL ECOL RES, V10, P987; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Wells MR, 2005, SEDIMENTOLOGY, V52, P715, DOI 10.1111/j.1365-3091.2005.00718.x; [No title captured]	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e40472	10.1371/journal.pone.0040472	http://dx.doi.org/10.1371/journal.pone.0040472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870199	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100008
J	Logotheti, S; Papaevangeliou, D; Michalopoulos, I; Sideridou, M; Tsimaratou, K; Christodoulou, I; Pyrillou, K; Gorgoulis, V; Vlahopoulos, S; Zoumpourlis, V				Logotheti, Stella; Papaevangeliou, Dimitra; Michalopoulos, Ioannis; Sideridou, Maria; Tsimaratou, Katerina; Christodoulou, Ioannis; Pyrillou, Katerina; Gorgoulis, Vassilis; Vlahopoulos, Spiros; Zoumpourlis, Vassilis			Progression of Mouse Skin Carcinogenesis Is Associated with Increased Er alpha Levels and Is Repressed by a Dominant Negative Form of Er alpha	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ORGAN TRANSPLANT RECIPIENTS; FACTOR-BINDING SITES; BREAST-CANCER CELLS; ENDOGENOUS ESTROGEN; SIGNALING PROTECTS; TUMOR-GROWTH; EXPRESSION; GENE; MECHANISMS	Estrogen receptors (ER), namely ER alpha and ER beta, are hormone-activated transcription factors with an important role in carcinogenesis. In the present study, we aimed at elucidating the implication of ER alpha in skin cancer, using chemicallyinduced mouse skin tumours, as well as cell lines representing distinct stages of mouse skin oncogenesis. First, using immunohistochemical staining we showed that ER alpha is markedly increased in aggressive mouse skin tumours in vivo as compared to the papilloma tumours, whereas ER beta levels are low and become even lower in the aggressive spindle tumours of carcinogen-treated mice. Then, using the multistage mouse skin carcinogenesis model, we showed that ER alpha gradually increases during promotion and progression stages of mouse skin carcinogenesis, peaking at the most aggressive stage, whereas ER beta levels only slightly change throughout skin carcinogenesis. Stable transfection of the aggressive, spindle CarB cells with a dominant negative form of ER alpha (dnER alpha) resulted in reduced ER alpha levels and reduced binding to estrogen responsive elements (ERE)-containing sequences. We characterized two highly conserved EREs on the mouse ER alpha promoter through which dnER alpha decreased endogenous ER alpha levels. The dnER alpha-transfected CarB cells presented altered protein levels of cytoskeletal and cell adhesion molecules, slower growth rate and impaired anchorage-independent growth in vitro, whereas they gave smaller tumours with extended latency period of tumour onset in vivo. Our findings suggest an implication of ER alpha in the aggressiveness of spindle mouse skin cancer cells, possibly through regulation of genes affecting cell shape and adhesion, and they also provide hints for the effective targeting of spindle cancer cells by dnER alpha .	[Logotheti, Stella; Papaevangeliou, Dimitra; Christodoulou, Ioannis; Pyrillou, Katerina; Vlahopoulos, Spiros; Zoumpourlis, Vassilis] Natl Hellen Res Fdn, Biomed Applicat Unit, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Michalopoulos, Ioannis] Acad Athens, Ctr Immunol & Transplantat, Biomed Res Fdn, Athens, Greece; [Sideridou, Maria; Tsimaratou, Katerina; Gorgoulis, Vassilis] Univ Athens, Sch Med, Mol Carcinogenesis Grp, Dept Histol & Embryol, GR-11527 Athens, Greece	National Hellenic Research Foundation; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens	Logotheti, S (corresponding author), Natl Hellen Res Fdn, Biomed Applicat Unit, Inst Biol Med Chem & Biotechnol, Athens, Greece.	vzub@eie.gr	Gorgoulis, Vassilis/AAD-3630-2019; , 0000-0001-8991-8712/S-4398-2016; Vlahopoulos, Spiros A/A-1186-2014; Vlahopoulos, Spiros/AAK-6362-2020	Gorgoulis, Vassilis/0000-0001-9001-4112; , 0000-0001-8991-8712/0000-0001-8991-8712; Vlahopoulos, Spiros A/0000-0001-6245-3863; Vlahopoulos, Spiros/0000-0001-6245-3863; Pyrillou, Katerina/0000-0003-0375-7810; Logotheti, Stella/0000-0001-8249-2202	USA - Greek bilateral cooperation grant [05NON-EU-3]; GSRT	USA - Greek bilateral cooperation grant; GSRT(Greek Ministry of Development-GSRT)	This work was supported by a USA - Greek bilateral cooperation grant (05NON-EU-3) funded by the GSRT (http://www.startupgreece.gov.gr/content/general-secretariat-research-and-technology-gsrt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2004, AM J OBSTET GYNECOL, V191, P1621, DOI 10.1016/j.ajog.2004.04.022; Bakas P, 2008, FERTIL STERIL, V90, P1878, DOI 10.1016/j.fertnstert.2007.09.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chantzi NI, 2011, STEROIDS, V76, P974, DOI 10.1016/j.steroids.2011.05.010; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen K, 2005, BRIT J DERMATOL, V152, P518, DOI 10.1111/J.1365-2133.2005.06347.X; Cho JL, 2008, PHOTOCH PHOTOBIO SCI, V7, P120, DOI 10.1039/b709856a; Cho JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P608, DOI 10.1039/b9pp00168a; Copland JA, 2009, BIOESSAYS, V31, P629, DOI 10.1002/bies.200800138; Covaleda AMS, 2008, TOXICOL SCI, V105, P303, DOI 10.1093/toxsci/kfn141; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; INCE BA, 1995, ENDOCRINOLOGY, V136, P3194, DOI 10.1210/en.136.8.3194; INCE BA, 1993, J BIOL CHEM, V268, P14026; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lazennec G, 1999, MOL ENDOCRINOL, V13, P969, DOI 10.1210/me.13.6.969; Lee EJ, 2001, MOL MED, V7, P773, DOI 10.1007/BF03401968; Lindberg K, 2010, J CELL PHYSIOL, V222, P156, DOI 10.1002/jcp.21932; Liu MM, 2002, J BIOL CHEM, V277, P24353, DOI 10.1074/jbc.M201829200; Logotheti S, 2010, FEBS J, V277, P3014, DOI 10.1111/j.1742-4658.2010.07710.x; Mancuso M, 2009, CARCINOGENESIS, V30, P340, DOI 10.1093/carcin/bgn243; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Papassava P, 2004, CANCER RES, V64, P8573, DOI 10.1158/0008-5472.CAN-03-0955; Pozzi M, 1998, J CELL BIOL, V142, P587; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; SAPINO A, 1986, CANCER RES, V46, P2526; Schodin DJ, 1995, J BIOL CHEM, V270, P31163, DOI 10.1074/jbc.270.52.31163; Shaaban AM, 2005, AM J SURG PATHOL, V29, P1593, DOI 10.1097/01.pas.0000184807.38037.75; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; STOLER AB, 1993, J CELL BIOL, V122, P1103, DOI 10.1083/jcb.122.5.1103; Terhorst D, 2009, BRIT J DERMATOL, V161, P85, DOI 10.1111/j.1365-2133.2009.09454.x; Widyarini S, 2006, P NATL ACAD SCI USA, V103, P12837, DOI 10.1073/pnas.0603642103; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZACHOS G, 1995, INT J ONCOL, V6, P595; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41957	10.1371/journal.pone.0041957	http://dx.doi.org/10.1371/journal.pone.0041957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870269	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100040
J	Lucas, G; Lluis-Ganella, C; Subirana, I; Musameh, MD; Gonzalez, JR; Nelson, CP; Senti, M; Schwartz, SM; Siscovick, D; O'Donnell, CJ; Melander, O; Salomaa, V; Purcell, S; Altshuler, D; Samani, NJ; Kathiresan, S; Elosua, R				Lucas, Gavin; Lluis-Ganella, Carla; Subirana, Isaac; Musameh, Muntaser D.; Ramon Gonzalez, Juan; Nelson, Christopher P.; Senti, Mariano; Schwartz, Stephen M.; Siscovick, David; O'Donnell, Christopher J.; Melander, Olle; Salomaa, Veikko; Purcell, Shaun; Altshuler, David; Samani, Nilesh J.; Kathiresan, Sekar; Elosua, Roberto		Myocardial Infarction Genetics Con; Wellcome Trust Case Control Consor	Hypothesis-Based Analysis of Gene-Gene Interactions and Risk of Myocardial Infarction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; EPISTASIS; LOCI; POLYMORPHISMS; HERITABILITY; CHOLESTEROL; STRATEGIES	The genetic loci that have been found by genome-wide association studies to modulate risk of coronary heart disease explain only a fraction of its total variance, and gene-gene interactions have been proposed as a potential source of the remaining heritability. Given the potentially large testing burden, we sought to enrich our search space with real interactions by analyzing variants that may be more likely to interact on the basis of two distinct hypotheses: a biological hypothesis, under which MI risk is modulated by interactions between variants that are known to be relevant for its risk factors; and a statistical hypothesis, under which interacting variants individually show weak marginal association with MI. In a discovery sample of 2,967 cases of early-onset myocardial infarction (MI) and 3,075 controls from the MIGen study, we performed pair-wise SNP interaction testing using a logistic regression framework. Despite having reasonable power to detect interaction effects of plausible magnitudes, we observed no statistically significant evidence of interaction under these hypotheses, and no clear consistency between the top results in our discovery sample and those in a large validation sample of 1,766 cases of coronary heart disease and 2,938 controls from the Wellcome Trust Case-Control Consortium. Our results do not support the existence of strong interaction effects as a common risk factor for MI. Within the scope of the hypotheses we have explored, this study places a modest upper limit on the magnitude that epistatic risk effects are likely to have at the population level (odds ratio for MI risk 1.3-2.0, depending on allele frequency and interaction model).	[Lucas, Gavin; Lluis-Ganella, Carla; Subirana, Isaac; Senti, Mariano; Elosua, Roberto] IMIM, Barcelona, Spain; [Lluis-Ganella, Carla; Ramon Gonzalez, Juan; Elosua, Roberto] Epidemiol & Publ Hlth Network CIBERESP, Barcelona, Spain; [Musameh, Muntaser D.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Musameh, Muntaser D.; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Ramon Gonzalez, Juan] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Ramon Gonzalez, Juan] IMIM Hosp Mar Res Inst, Barcelona, Spain; [Senti, Mariano] Pompeu Fabra Univ, Barcelona, Spain; [Schwartz, Stephen M.; Siscovick, David] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Schwartz, Stephen M.; Siscovick, David] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [O'Donnell, Christopher J.] NHLBI, Framingham, MA USA; [O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Purcell, Shaun] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Altshuler, David; Kathiresan, Sekar] Broad Inst MIT & Harvard, Cambridge, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lucas, G (corresponding author), IMIM, Barcelona, Spain.	glucas@imim.es	Lluís-Ganella, Carla/G-5998-2012; Erdmann, Jeanette/A-4417-2009; Senti, M/D-4309-2014; Altshuler, David M/A-4476-2009; Ramos, Rafel/D-9627-2016; Ramos, Rafel/P-2083-2019; Erdmann, Jeanette/P-7513-2014; Gonzalez, Juan R/B-7860-2018	Lluís-Ganella, Carla/0000-0001-7609-5497; Altshuler, David M/0000-0002-7250-4107; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Erdmann, Jeanette/0000-0002-4486-6231; Gonzalez, Juan R/0000-0003-3267-2146; Piazza, Alberto/0000-0002-2355-4183; Berzuini, Carlo/0000-0001-6056-0489; Lucas, Gavin/0000-0003-4166-9416; Marrugat, Jaume/0000-0003-3320-554X; Schwartz, Stephen/0000-0001-7499-8502; Iles, Mark/0000-0002-2603-6509; Ouwehand, Willem/0000-0002-7744-1790; Hattersley, Andrew/0000-0001-5620-473X; Melander, Olle/0000-0002-2581-484X; Nelson, Christopher/0000-0001-8025-2897; Senti, Mariano/0000-0002-6983-3831; ELOSUA, ROBERTO/0000-0001-8235-0095	National Institutes of Health, USA [R01 HL087676]; Wellcome Trust [085475]; ACC1O [RD08-1-0024]; European Regional Development Fund (ERDF-FEDER); Spanish Ministry of Science and Innovation through Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES and GENOMet network) [RD06/0009, PI061254, PI09/90506, MTM2010-09526-E]; Catalan Research and Technology Innovation Interdepartmental Commission [SGR 1195]; Fundacio La Marato de TV3 [1081810, 080431]; Academy of Finland [129494, 139635]; Juan de la Cierva Program, Ministerio de Educacion [JCI-2009-04684]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098938, ZIAHL006173, ZIAHL006175, R01HL056931, ZIAHL006002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; National Institute for Health Research [CL-2010-11-001, NF-SI-0611-10219] Funding Source: researchfish	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); ACC1O; European Regional Development Fund (ERDF-FEDER)(European Commission); Spanish Ministry of Science and Innovation through Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES and GENOMet network); Catalan Research and Technology Innovation Interdepartmental Commission; Fundacio La Marato de TV3; Academy of Finland(Academy of Finland); Juan de la Cierva Program, Ministerio de Educacion; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Myocardial Infarction Genetics Consortium (MIGen) was funded by grant R01 HL087676 from the National Institutes of Health, USA. The Wellcome Trust Case-Control Consortium 2 was funded by the Wellcome Trust under award 085475. This work was supported by a grant from ACC1O (RD08-1-0024), the European Regional Development Fund (ERDF-FEDER), the Spanish Ministry of Science and Innovation through the Carlos III Health Institute (CIBER Epidemiologia y Salud Publica, Red HERACLES RD06/0009, PI061254, PI09/90506 and the GENOMet network, MTM2010-09526-E), the Catalan Research and Technology Innovation Interdepartmental Commission (SGR 1195) and Fundacio La Marato de TV3 (1081810; 080431). VS was supported by the Academy of Finland (grants # 129494 and 139635). GL was funded by the Juan de la Cierva Program, Ministerio de Educacion (JCI-2009-04684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bell JT, 2011, ANN HUM GENET, V75, P10, DOI 10.1111/j.1469-1809.2010.00629.x; Bhattacharya K, 2011, GENET EPIDEMIOL, V35, P800, DOI 10.1002/gepi.20629; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moskvina V, 2011, BIOL PSYCHIAT, V70, P198, DOI 10.1016/j.biopsych.2011.01.034; Okser S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001146; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Segurado R, 2011, EUR J HUM GENET, V19, P577, DOI 10.1038/ejhg.2010.250; Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; World Health Organization, 2009, GOOD CLIN LAB PRACT, P28; Yang C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S26; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e41730	10.1371/journal.pone.0041730	http://dx.doi.org/10.1371/journal.pone.0041730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876292	Green Published, Green Submitted, gold			2022-12-25	WOS:000307184700020
J	Sykaras, AG; Demenis, C; Case, RM; McLaughlin, JT; Smith, CP				Sykaras, Alexandros G.; Demenis, Claire; Case, R. Maynard; McLaughlin, John T.; Smith, Craig P.			Duodenal Enteroendocrine I-Cells Contain mRNA Transcripts Encoding Key Endocannabinoid and Fatty Acid Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; VAGAL AFFERENT NEURONS; CHOLECYSTOKININ SECRETION; GLYCEMIC CONTROL; ENDOCRINE CELL; EXPRESSION; GUT; RELEASE; GPR119	Enteroendocrine cells have a critical role in regulation of appetite and energy balance. I-cells are a subtype of enteroendocrine cells localized in duodenum that release cholecystokinin in response to ingested fat and amino-acids. Despite their potentially pivotal role in nutrient sensing and feeding behaviour, native I-cells have previously been difficult to isolate and study. Here we describe a robust protocol for the isolation and characterization of native duodenal I-cells and additionally, using semi-quantitative RT-PCR we determined that mouse duodenal I-cells contain mRNA transcripts encoding key fatty acid and endocannabinoid receptors including the long chain fatty acid receptors GPR40/FFAR1, GPR120/O3FAR1; short chain fatty acid receptors GPR41/FFAR3 and GPR43/FFAR2; the oleoylethanolamide receptor GPR119 and the classic endocannabinoid receptor CB1. These data suggest that I-cells sense a wide range of gut lumen nutrients and also have the capacity to respond to signals of fatty-acid derivatives or endocannabinoid peptides.	[Sykaras, Alexandros G.; Demenis, Claire; Case, R. Maynard; Smith, Craig P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Sykaras, Alexandros G.] Univ Crete, Fac Med, Grad Programme Mol Basis Human Dis, Iraklion, Crete, Greece; [McLaughlin, John T.] Univ Manchester, Sch Med, Sch Translat Med, Manchester, Lancs, England	University of Manchester; University of Crete; University of Manchester	Sykaras, AG (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Craig.smith@manchester.ac.uk	Sykaras, Alexandros/AAO-1565-2020	Sykaras, Alexandros/0000-0002-2972-0138; McLaughlin, John/0000-0001-6158-5135	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank members of the BSF (University of Manchester) for animal husbandry, Mr Michael Smiga and Dr Andy Hayes (University of Manchester, Genomic Technologies Core Facility) for PicoChip analysis and their advice about RNA amplification, and Mr Michael Jackson (University of Manchester, Flow Cytometry facility) for help with FACS analysis. We would like to thank Ms Xiaoxing Huang for excellent technical assistance in genotyping and animal experiments. We are indebted to Professor Graham Dockray (University of Liverpool, UK) for his donation of anti-CCK antibody. CD holds a BBSRC studentship.	Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; BUCHAN AMJ, 1978, GUT, V19, P403, DOI 10.1136/gut.19.5.403; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2006, AM J PHYSIOL-GASTR L, V290, pG1289, DOI 10.1152/ajpgi.00543.2005; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; D'Argenio G, 2007, J MOL MED, V85, P523, DOI 10.1007/s00109-007-0192-3; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Diakogiannaki E, 2011, PSYSL BEHAV, V106, P387; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Flock G, 2011, ENDOCRINOLOGY, V152, P374, DOI 10.1210/en.2010-1047; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; McLaughlin J, 1999, GASTROENTEROLOGY, V116, P46, DOI 10.1016/S0016-5085(99)70227-1; McLaughlin JT, 1998, J PHYSIOL-LONDON, V513, P11, DOI 10.1111/j.1469-7793.1998.011by.x; Moran Gordon W, 2008, Therap Adv Gastroenterol, V1, P51, DOI 10.1177/1756283X08093943; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; POLAK JM, 1975, LANCET, V2, P1016; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; SMITH GP, 1985, AM J PHYSIOL, V249, pR638, DOI 10.1152/ajpregu.1985.249.5.R638; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tolhurst G, 2012, DIABETES; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Wang Y, 2011, AM J PHYSIOL-GASTR L, V300, pG528, DOI 10.1152/ajpgi.00387.2010; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	50	94	95	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42373	10.1371/journal.pone.0042373	http://dx.doi.org/10.1371/journal.pone.0042373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876318	Green Published, gold, Green Submitted			2022-12-25	WOS:000307184700046
J	Takaoka, Y; Shimizu, Y; Hasegawa, H; Ouchi, Y; Qiao, SL; Nagahara, M; Ichihara, M; Lee, JD; Adachi, K; Hamaguchi, M; Iwamoto, T				Takaoka, Yuji; Shimizu, Yuko; Hasegawa, Hitoki; Ouchi, Yasuo; Qiao, Shanlou; Nagahara, Miki; Ichihara, Masatoshi; Lee, Jiing-Dwan; Adachi, Koichi; Hamaguchi, Michinari; Iwamoto, Takashi			Forced Expression of miR-143 Represses ERK5/c-Myc and p68/p72 Signaling in Concert with miR-145 in Gut Tumors of Apc(Min) Mice	PLOS ONE			English	Article							DEAD-BOX; C-MYC; MICRORNA; P68; RNA; MICROPROCESSOR; PROGRESSION; COMPLEX; COLON; GENE	Recently, miR-143 and miR-145 have been shown to belong to a subset of microRNAs whose expression is controlled by a complex of a tumor suppressor p53 and DEAD-box RNA helicase subunits p68/p72. While accumulating studies have acknowledged that both miRNAs function as tumor suppressors and are similarly regulated, evidence of their coordinated action against tumorigenesis has been poorly presented. Herein, we establish transgenic mice that express miR-143 under the control of the CAG regulatory unit. When crossbred with Apc(Min/+) mice, the development of tumors in the small intestines is significantly attenuated. In the transgenic small intestine tumors, the endogenous miR-145 is also enhanced and the expression of c-Myc and p68/p72, both of which have been reported to be pivotal for gut tumor development, is suppressed, corresponding to the downregulation of ERK5. We demonstrate that the combination of miR-143 and miR-145 inhibits the expression of c-Myc in human colon cancer cells, whereas miR-145 retards that of p72. Moreover, we show the possibilities that miR-145 modulates p72 expression through its 39 untranslated region and that c-Myc downregulation is involved in both p68 suppression and miR-145 induction. These findings suggest that forced expression of miR-143, probably interacting with endogenous miR-145, inhibits ERK5/c-Myc and p68/p72/beta-catenin signaling and hampers small intestine tumor development in Apc(Min/+) mice. This unique cascade, in turn, may prevent overproduction of a subset of tumor suppressive miRNAs by repressing their own modulators, p68/p72.	[Takaoka, Yuji; Shimizu, Yuko; Qiao, Shanlou; Ichihara, Masatoshi; Iwamoto, Takashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Hasegawa, Hitoki; Ouchi, Yasuo; Nagahara, Miki; Iwamoto, Takashi] Chubu Univ, Ctr Educ Lab Anim Res, Kasugai, Aichi 487, Japan; [Hasegawa, Hitoki; Hamaguchi, Michinari] Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Adachi, Koichi] Nagoya Univ, Grad Sch Med, Radioisotope Res Ctr Med Div, Nagoya, Aichi 4648601, Japan	Chubu University; Chubu University; Nagoya University; Scripps Research Institute; Nagoya University	Takaoka, Y (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan.	iwamoto@isc.chubu.ac.jp			Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology [S0801055];  [19590408]	Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology; 	This study was supported in part by Grants-in-Aid for Scientific Research (C) (no 19590408) and Center of Excellence Project for Private Universities (no. S0801055) from the Ministry of Education, Culture, Sports, Science, and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bommer GT, 2007, CANCER CELL, V11, P391, DOI 10.1016/j.ccr.2007.04.015; Bui Thi V, 2010, Genes Cancer, V1, P568; Buzzi N, 2009, MOL CELL BIOCHEM, V328, P201, DOI 10.1007/s11010-009-0090-9; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Heinlein UAO, 1998, J PATHOL, V184, P345, DOI 10.1002/(SICI)1096-9896(199804)184:4<345::AID-PATH1243>3.0.CO;2-6; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; IWAMOTO T, 1990, ONCOGENE, V5, P535; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Mendell JT, 2009, NAT GENET, V41, P768, DOI 10.1038/ng0709-768; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036	39	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42137	10.1371/journal.pone.0042137	http://dx.doi.org/10.1371/journal.pone.0042137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876303	Green Submitted, gold, Green Published			2022-12-25	WOS:000307184700031
J	Verheggen, FJ; Diez, L; Sablon, L; Fischer, C; Bartram, S; Haubruge, E; Detrain, C				Verheggen, Francois J.; Diez, Lise; Sablon, Ludovic; Fischer, Christophe; Bartram, Stefan; Haubruge, Eric; Detrain, Claire			Aphid Alarm Pheromone as a Cue for Ants to Locate Aphid Partners	PLOS ONE			English	Article							LADY BEETLE; (E)-BETA-FARNESENE; MUTUALISM; PLANT	The mutualistic relationships that occur between myrmecophilous aphids and ants are based on the rich food supply that honeydew represents for ants and on the protection they provide against aphid natural enemies. While aphid predators and parasitoids actively forage for oviposition sites by using aphid semiochemicals, scouts of aphid-tending ant species would also benefit from locating honeydew resources by orienting toward aphid pheromone sources. The present study aims to provide additional information on the use of Aphis fabae alarm pheromone, i.e. (E)-beta-farnesene (E beta F), by ant scouts. The perception and behavioral impact of E beta F on Lasius niger were investigated using electroantennography and two bio-assays measuring their attraction and orientation towards aphid semiochemicals. Pronounced electrical depolarizations were observed from L. niger scout antennae to stimulations of A. fabae alarm pheromone, while other sesquiterpenes elicited weak or no responses. L. niger scouts were significantly attracted toward E beta F in a four-arm olfactometer, as well as in an two-choice bioassay. These laboratory results suggest for the first time that low amounts of aphid alarm pheromone can be used by L. niger scouts as a cue indicating the presence of aphid colonies and could therefore mediate the aphid-ant partnership in the field.	[Verheggen, Francois J.; Sablon, Ludovic; Haubruge, Eric] Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux Agrobio Tech, Gembloux, Belgium; [Diez, Lise; Detrain, Claire] Univ Brussels, Dept Social Ecol, Brussels, Belgium; [Fischer, Christophe] Univ Liege, Dept Analyt Chem, Gembloux Agrobio Tech, Gembloux, Belgium; [Bartram, Stefan] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany	University of Liege; University of Liege; Max Planck Society	Verheggen, FJ (corresponding author), Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux Agrobio Tech, Gembloux, Belgium.	entomologie.gembloux@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476; Bartram, Stefan/0000-0002-8574-2817; Verheggen, Francois/0000-0002-5849-1661	FNRS (Fonds National de la Recherche Scientifique) [2.4600.09]; CURAGx PhD grant; F.R.I.A. grants	FNRS (Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); CURAGx PhD grant; F.R.I.A. grants(Fonds de la Recherche Scientifique - FNRS)	Dr. Detrain is senior research assistant at Belgian foundation for scientific research (FNRS). The authors work has been funded by a FNRS (Fonds National de la Recherche Scientifique) grant (no2.4600.09). Dr. Sablon is financially supported by a CURAGx PhD grant. Dr. Fischer and Dr. Diez are financially supported by F.R.I.A. grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Almohamad R, 2008, J APPL ENTOMOL, V132, P601, DOI 10.1111/j.1439-0418.2008.01309.x; Detrain C, 2010, PHYSIOL ENTOMOL, V35, P168, DOI 10.1111/j.1365-3032.2010.00730.x; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; Holldobler B., 1990, pi; Leroy PD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1347; Lohman DJ, 2006, ECOL ENTOMOL, V31, P41, DOI 10.1111/j.0307-6946.2006.00758.x; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Micha SG, 1996, CHEMOECOLOGY, V7, P132, DOI 10.1007/BF01245965; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; Outreman Y, 2010, APHID BIODIVERSITY UNDER ENVIRONMENTAL CHANGE: PATTERNS AND PROCESSES, P171, DOI 10.1007/978-90-481-8601-3_10; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; Sakata H, 1995, RES POPUL ECOL, V37, P159, DOI 10.1007/BF02515816; Verheggen FJ, 2008, J CHEM ECOL, V34, P301, DOI 10.1007/s10886-008-9434-2; Verheggen FJ, 2007, J CHEM ECOL, V33, P2148, DOI 10.1007/s10886-007-9370-6; Verheggen FJ, 2009, BEHAV ECOL, V20, P283, DOI 10.1093/beheco/arp009; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	20	24	26	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e41841	10.1371/journal.pone.0041841	http://dx.doi.org/10.1371/journal.pone.0041841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870255	gold, Green Published			2022-12-25	WOS:000307212800038
J	Carafoli, F; Hussain, SA; Hohenester, E				Carafoli, Federico; Hussain, Sadaf-Ahmahni; Hohenester, Erhard			Crystal Structures of the Network-Forming Short-Arm Tips of the Laminin beta 1 and gamma 1 Chains	PLOS ONE			English	Article							N-TERMINAL DOMAINS; CONGENITAL NEPHROSIS; MESANGIAL SCLEROSIS; MUSCULAR-DYSTROPHY; LE MODULES; BINDING; MUTATION; ANATOMY; COMPLEX; SYSTEM	The heterotrimeric laminins are a defining component of basement membranes and essential for tissue formation and function in all animals. The three short arms of the cross-shaped laminin molecule are composed of one chain each and their tips mediate the formation of a polymeric network. The structural basis for laminin polymerisation is unknown. We have determined crystal structures of the short-arm tips of the mouse laminin beta 1 and gamma 1 chains, which are grossly similar to the previously determined structure of the corresponding alpha 5 chain region. The short-arm tips consist of a laminin N-terminal (LN) domain that is attached like the head of a flower to a rod-like stem formed by tandem laminin-type epidermal growth factor-like (LE) domains. The LN domain is a beta-sandwich with elaborate loop regions that differ between chains. The gamma 1 LN domain uniquely contains a calcium binding site. The LE domains have little regular structure and are stabilised by cysteines that are disulphide-linked 1-3, 2-4, 5-6 and 7-8 in all chains. The LN surface is not conserved across the alpha, beta and gamma chains, but within each chain subfamily there is a striking concentration of conserved residues on one face of the beta-sandwich, while the opposite face invariably is shielded by glycans. We propose that the extensive conserved patches on the beta and gamma LN domains mediate the binding of these two chains to each other, and that the alpha chain LN domain subsequently binds to the composite beta-gamma surface. Mutations in the laminin beta 2 LN domain causing Pierson syndrome are likely to impair the folding of the beta 2 chain or its ability to form network interactions.	[Carafoli, Federico; Hussain, Sadaf-Ahmahni; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London	Carafoli, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	e.hohenester@imperial.ac.uk			Wellcome Trust Senior Research Fellowship in Basic Biomedical Science [083942/Z/07/Z]; BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524840/1] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science awarded to EH (083942/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Kalkhof S, 2010, BIOCHEMISTRY-US, V49, P8359, DOI 10.1021/bi101187f; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; PAULSSON M, 1988, J BIOL CHEM, V263, P5425; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suh JH, 2011, P NATL ACAD SCI USA, V108, P15348, DOI 10.1073/pnas.1108269108; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zenker M, 2004, AM J MED GENET A, V130A, P138, DOI 10.1002/ajmg.a.30310	44	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42473	10.1371/journal.pone.0042473	http://dx.doi.org/10.1371/journal.pone.0042473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860131	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600105
J	Griffin, PE; Roddam, LF; Belessis, YC; Strachan, R; Beggs, S; Jaffe, A; Cooley, MA				Griffin, Phoebe E.; Roddam, Louise F.; Belessis, Yvonne C.; Strachan, Roxanne; Beggs, Sean; Jaffe, Adam; Cooley, Margaret A.			Expression of PPAR gamma and Paraoxonase 2 Correlated with Pseudomonas aeruginosa Infection in Cystic Fibrosis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; MESSENGER-RNA EXPRESSION; LUNG INFLAMMATION; IMMUNE-RESPONSE; YOUNG-CHILDREN; CELLS; MODEL; IDENTIFICATION; MACROPHAGES	The Pseudomonas aeruginosa quorum sensing signal molecule N-3-oxododecanoyl-L-homoserine lactone (3OC(12)HSL) can inhibit function of the mammalian anti-inflammatory transcription factor peroxisome proliferator activated receptor (PPAR)gamma, and can be degraded by human paraoxonase (PON)2. Because 3OC(12)HSL is detected in lungs of cystic fibrosis (CF) patients infected with P. aeruginosa, we investigated the relationship between P. aeruginosa infection and gene expression of PPAR gamma and PON2 in bronchoalveolar lavage fluid (BALF) of children with CF. Total RNA was extracted from cell pellets of BALF from 43 children aged 6 months-5 years and analyzed by reverse transcription-quantitative real time PCR for gene expression of PPAR gamma, PON2, and P. aeruginosa lasI, the 3OC12HSL synthase. Patients with culture-confirmed P. aeruginosa infection had significantly lower gene expression of PPAR gamma and PON2 than patients without P. aeruginosa infection. All samples that were culture-positive for P. aeruginosa were also positive for lasI expression. There was no significant difference in PPAR gamma or PON2 expression between patients without culture-detectable infection and those with non-Pseudomonal bacterial infection, so reduced expression was specifically associated with P. aeruginosa infection. Expression of both PPAR gamma and PON2 was inversely correlated with neutrophil counts in BALF, but showed no correlation with other variables evaluated. Thus, lower PPAR gamma and PON2 gene expression in the BALF of children with CF is associated specifically with P. aeruginosa infection and neutrophilia. We cannot differentiate whether this is a cause or the effect of P. aeruginosa infection, but propose that the level of expression of these genes may be a marker for susceptibility to early acquisition of P. aeruginosa in children with CF.	[Griffin, Phoebe E.] Menzies Res Inst, Hobart, Tas, Australia; [Griffin, Phoebe E.; Roddam, Louise F.; Beggs, Sean; Cooley, Margaret A.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Belessis, Yvonne C.; Strachan, Roxanne; Jaffe, Adam] Sydney Childrens Hosp, Dept Resp Med, Randwick, NSW, Australia; [Beggs, Sean] Royal Hobart Hosp, Dept Pediat, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; Royal Hobart Hospital	Griffin, PE (corresponding author), Menzies Res Inst, Hobart, Tas, Australia.	Margaret.Cooley@utas.edu.au	Beggs, Sean/J-5621-2013; Roddam, Louise/J-7348-2014; Roddam, Louise F/C-2408-2019	Roddam, Louise F/0000-0002-4152-0681; Griffin, Phoebe/0000-0001-8208-5818; Jaffe, Adam/0000-0002-1963-5415	Australian Cystic Fibrosis Research Trust; Royal Hobart Hospital Research Foundation	Australian Cystic Fibrosis Research Trust; Royal Hobart Hospital Research Foundation	This study was funded by grants from the Australian Cystic Fibrosis Research Trust (www.cysticfibrosis.org.au) and the Royal Hobart Hospital Research Foundation (www.rhhresearchfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2008, J CYST FIBROS, V7, P68, DOI 10.1016/j.jcf.2007.05.004; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Becker J, 2006, FUND CLIN PHARMACOL, V20, P429, DOI 10.1111/j.1472-8206.2006.00425.x; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Chambers CE, 2005, FEMS MICROBIOL LETT, V244, P297, DOI 10.1016/j.femsle.2005.01.055; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Greene M. E., 1995, Gene Expression, V4, P281; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; Hameed S, 2011, PEDIATR PULM, V46, P747, DOI 10.1002/ppul.21495; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Hotta K, 1999, J GERONTOL A-BIOL, V54, pB183, DOI 10.1093/gerona/54.5.B183; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Jarad N A, 2005, Chron Respir Dis, V2, P133, DOI 10.1191/1479972305cd065oa; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mackness B, 2005, J INTERN MED, V258, P363, DOI 10.1111/j.1365-2796.2005.01554.x; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Pascual G, 2007, NOVART FDN SYMP, V286, P196; Pascual Gabriel, 2007, Novartis Found Symp, V286, P183; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Ritchie AJ, 2007, IMMUNOL CELL BIOL, V85, P596, DOI 10.1038/sj.icb.7100090; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; STOLTZ DA, 2006, AM J PHYSL LUNG CELL; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Takamura T, 2001, EUR J PHARMACOL, V422, P23, DOI 10.1016/S0014-2999(01)01053-6; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Wargo MJ, 2007, FEMS MICROBIOL LETT, V273, P38, DOI 10.1111/j.1574-6968.2007.00773.x; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09	52	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42241	10.1371/journal.pone.0042241	http://dx.doi.org/10.1371/journal.pone.0042241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860094	gold, Green Published, Green Submitted			2022-12-25	WOS:000307045600080
J	Spulber, S; Edoff, K; Hong, L; Morisawa, S; Shirahata, S; Ceccatelli, S				Spulber, Stefan; Edoff, Karin; Hong, Lie; Morisawa, Shinkatsu; Shirahata, Sanetaka; Ceccatelli, Sandra			Molecular Hydrogen Reduces LPS-Induced Neuroinflammation and Promotes Recovery from Sickness Behaviour in Mice	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED SICKNESS; DIFFERENT BRAIN-REGIONS; RICH SALINE PROTECTS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MICROGLIAL CELLS; ALPHA-TOCOPHEROL; INTESTINAL ISCHEMIA/REPERFUSION	Molecular hydrogen has been shown to have neuroprotective effects in mouse models of acute neurodegeneration. The effect was suggested to be mediated by its free-radical scavenger properties. However, it has been shown recently that molecular hydrogen alters gene expression and protein phosphorylation. The aim of this study was to test whether chronic ad libitum consumption of molecular hydrogen-enriched electrochemically reduced water (H-ERW) improves the outcome of lipopolysaccharide (LPS)-induced neuroinflammation. Seven days after the initiation of H-ERW treatment, C57Bl/6 mice received a single injection of LPS (0.33 mg/kg i.p.) or an equivalent volume of vehicle. The LPS-induced sickness behaviour was assessed 2 h after the injection, and recovery was assessed by monitoring the spontaneous locomotor activity in the homecage for 72 h after the administration of LPS. The mice were killed in the acute or recovery phase, and the expression of pro-and antiinflammatory cytokines in the hippocampus was assessed by real-time PCR. We found that molecular hydrogen reduces the LPS-induced sickness behaviour and promotes recovery. These effects are associated with a shift towards anti-inflammatory gene expression profile at baseline (downregulation of TNF-alpha and upregulation of IL-10). In addition, molecular hydrogen increases the amplitude, but shortens the duration and promotes the extinction of neuroinflammation. Consistently, molecular hydrogen modulates the activation and gene expression in a similar fashion in immortalized murine microglia (BV-2 cell line), suggesting that the effects observed in vivo may involve the modulation of microglial activation. Taken together, our data point to the regulation of cytokine expression being an additional critical mechanism underlying the beneficial effects of molecular hydrogen.	[Spulber, Stefan; Edoff, Karin; Hong, Lie; Ceccatelli, Sandra] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Morisawa, Shinkatsu] Nihon Trim Co Ltd, Osaka, Japan; [Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Kyushu, Japan	Karolinska Institutet; Kyushu University	Spulber, S (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	stefan.spulber@ki.se	Spulber, Stefan/J-2989-2012	Spulber, Stefan/0000-0001-8122-6738; Ceccatelli, Sandra/0000-0002-9367-8480	Nihon-Trim CO., Ltd.	Nihon-Trim CO., Ltd.	This work was funded by a research grant provided by Nihon-Trim CO., Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal-Price A, 2001, J NEUROSCI, V21, P6480; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Berg BM, 2005, J NUTR, V135, P1157, DOI 10.1093/jn/135.5.1157; Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DISANTO E, 1995, NEUROIMMUNOMODULAT, V2, P149, DOI 10.1159/000096885; Fishkin RJ, 1997, PSYCHOPHARMACOLOGY, V132, P335, DOI 10.1007/s002130050353; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Godbout JP, 2005, J NEUROIMMUNOL, V169, P97, DOI 10.1016/j.jneuroim.2005.08.003; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hennigan A, 2007, BRAIN RES, V1130, P158, DOI 10.1016/j.brainres.2006.10.066; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Itoh T, 2011, BIOCHEM BIOPH RES CO, V411, P143, DOI 10.1016/j.bbrc.2011.06.116; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Laurenzi MA, 2001, NEUROCHEM RES, V26, P1209, DOI 10.1023/A:1013911205494; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Lisak RP, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-30; Liu Q, 2010, LIVER INT, V30, P958, DOI 10.1111/j.1478-3231.2010.02254.x; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Lundkvist GB, 2002, NEUROBIOL DIS, V11, P20, DOI 10.1006/nbdi.2002.0536; Mao YF, 2009, BIOCHEM BIOPH RES CO, V381, P602, DOI 10.1016/j.bbrc.2009.02.105; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Nakao A, 2010, J HEART LUNG TRANSPL, V29, P544, DOI 10.1016/j.healun.2009.10.011; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2011, BIOCH BIOPHYS ACTA; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ren LQ, 1999, MOL BRAIN RES, V65, P198, DOI 10.1016/S0169-328X(99)00016-9; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Richwine AF, 2008, PSYCHONEUROENDOCRINO, V33, P1369, DOI 10.1016/j.psyneuen.2008.08.003; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shirahata S, 2011, TRENDS FOOD SCI TECH; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sun HM, 2010, CURR NEUROVASC RES, V7, P268, DOI 10.2174/156720210793180819; Thibeault I, 2001, J COMP NEUROL, V434, P461, DOI 10.1002/cne.1187; Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109; Wolff S, 2009, INTENS CARE MED, V35, P730, DOI 10.1007/s00134-009-1394-7; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu TY, 2011, AAPS J, V13, P1, DOI 10.1208/s12248-010-9239-4; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	69	50	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42078	10.1371/journal.pone.0042078	http://dx.doi.org/10.1371/journal.pone.0042078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860058	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600059
J	Nayak, BK; Feliers, D; Sudarshan, S; Friedrichs, WE; Day, RT; New, DD; Fitzgerald, JP; Eid, A; DeNapoli, T; Parekh, DJ; Gorin, Y; Block, K				Nayak, B. K.; Feliers, D.; Sudarshan, S.; Friedrichs, W. E.; Day, R. T.; New, D. D.; Fitzgerald, J. P.; Eid, A.; DeNapoli, T.; Parekh, D. J.; Gorin, Y.; Block, K.			Stabilization of HIF-2 alpha through redox regulation of mTORC2 activation and initiation of mRNA translation	ONCOGENE			English	Article						mTOR; Nox oxidase; Rictor; p22(phox); HIF-2 alpha; renal cancer	TUMOR-SUPPRESSOR PROTEIN; CANCER; PHOSPHORYLATION; EXPRESSION; CARCINOMA; COMPLEX; EIF4E; AKT; TRANSFORMATION; CONTRIBUTES	Hypoxia inducible factor-2 alpha (HIF-2 alpha) has a critical role in renal tumorigenesis. HIF-2 alpha is stabilized in von Hippel-Lindau (VHL)-deficient renal cell carcinoma through mechanisms that require ongoing mRNA translation. Mammalian target of rapamycin (mTOR) functions in two distinct complexes: Raptor-associated mTORC1 and Rictor-associated mTORC2. Rictor-associated mTORC2 complex has been linked to maintaining HIF-2 alpha protein in the absence of VHL; however, the mechanisms remain to be elucidated. Although Raptor-associated mTORC1 is a known key upstream regulator of mRNA translation, initiation and elongation, the role of mTORC2 in regulating mRNA translation is not clear. Complex assembly of the mRNA cap protein, eukaryotic translation initiation factor 4 (eIF4)E, with activators (eIF4 gamma (eIF4G)) and inhibitors (eIF4E-binding protein 1 (4E-BP1)) are rate-limiting determinants of mRNA translation. Our laboratory has previously demonstrated that reactive oxygen species, mediated by p22(phox)-based Nox oxidases, are enhanced in VHL-deficient cells and have a role in the activation of Akt on S473, a site phosphorylated by the mTORC2 complex. In this study, we examined the role of Rictor-dependent regulation of HIF-2 alpha through eIF4E-dependent mRNA translation and examined the effects of p22(phox)-based Nox oxidases on TORC2 regulation. We demonstrate for the first time that mTORC2 complex stability and activation is redox sensitive, and further defined a novel role for p22(phox)-based Nox oxidases in eIF4E-dependent mRNA translation through mTORC2. Furthermore, we provide the first evidence that silencing of p22(phox) reduces HIF-2 alpha-dependent gene targeting in vitro and tumor formation in vivo. The clinical relevance of these studies is demonstrated.	[Nayak, B. K.; Feliers, D.; Friedrichs, W. E.; Day, R. T.; New, D. D.; Eid, A.; Gorin, Y.; Block, K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Sudarshan, S.; Fitzgerald, J. P.; Parekh, D. J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [DeNapoli, T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Block, K.] South Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Block, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, MC 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	block@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	Veterans Administration; NIH [R01 NCI CA131272, K08 CA138774]; Voelcker Fund Young Investigator Award; Cancer Center Support Grant, National Cancer Institute [5 P30 CA054174-18]; NATIONAL CANCER INSTITUTE [K08CA138774, P30CA054174, R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033665] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; Cancer Center Support Grant, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge Dr Goutam Gosh-Choudhury for the HRE responsive element, Cynthia Galindo for technical contributions and Dr Hanna E. Abboud for helpful discussions and critical reading of the manuscript. This study was supported by the Veterans Administration Career Development Award and NIH R01 NCI CA131272 (KB), and NIH K08 CA138774 and Voelcker Fund Young Investigator Award (SS). This study was also supported in part by the Cancer Center Support Grant, National Cancer Institute, 5 P30 CA054174-18 (DJP).	Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Foster H, 2010, ANTICANCER RES, V30, P3529; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee HJ, 2009, UROLOGY, V73, P394, DOI 10.1016/j.urology.2008.08.472; Pandolfi PP, 2004, ONCOGENE, V23, P3134, DOI 10.1038/sj.onc.1207618; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	28	39	40	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 27	2013	32	26					3147	3155		10.1038/onc.2012.333	http://dx.doi.org/10.1038/onc.2012.333			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22869144	Green Accepted			2022-12-25	WOS:000321004600005
J	Muller, MP; Shkumatov, AV; Oesterlin, LK; Schoebel, S; Goody, PR; Goody, RS; Itzen, A				Mueller, Matthias P.; Shkumatov, Alexander V.; Oesterlin, Lena K.; Schoebel, Stefan; Goody, Philip R.; Goody, Roger S.; Itzen, Aymelt			Characterization of Enzymes from Legionella pneumophila Involved in Reversible Adenylylation of Rab1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; SMALL GTPASE RAB1; NUCLEOTIDE-EXCHANGE; BIOLOGICAL MACROMOLECULES; STRUCTURAL INSIGHTS; GDI DISPLACEMENT; KINETIC-DATA; FIC DOMAIN; AMPYLATION	After the pathogenic bacterium Legionella pneumophila is phagocytosed, it injects more than 250 different proteins into the cytoplasm of host cells to evade lysosomal digestion and to replicate inside the host cell. Among these secreted proteins is the protein DrrA/SidM, which has been shown to modify Rab1b, a main regulator of vesicular trafficking in eukaryotic cells, by transfer of adenosine monophosphate(AMP) to Tyr(77). In addition, Legionella provides the protein SidD that hydrolytically reverses the covalent modification, suggesting a tight spatial and temporal control of Rab1 function by Legionella during infection. Small angle x-ray scattering experiments of DrrA allowed us to validate a tentative complex model built by combining available crystallographic data. We have established the effects of adenylylation on Rab1 interactions and properties in a quantitative way. In addition, we have characterized the kinetics of DrrA-catalyzed adenylylation as well as SidD-catalyzed deadenylylation toward Rab1 and have determined the nucleotide specificities of both enzymes. This study enhances our knowledge of proteins subverting Rab1 function at the Legionella-containing vacuole.	[Itzen, Aymelt] Tech Univ Munich, Dept Chem, CIPSM, D-85747 Garching, Germany; [Mueller, Matthias P.; Oesterlin, Lena K.; Schoebel, Stefan; Goody, Philip R.; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Shkumatov, Alexander V.] DESY, European Mol Biol Lab, Hamburg Outstat, D-22603 Hamburg, Germany	Technical University of Munich; Max Planck Society; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Itzen, A (corresponding author), Tech Univ Munich, Dept Chem, CIPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	aymelt.itzen@tum.de	Itzen, Aymelt/F-5157-2014; Goody, Roger S/J-8845-2014	Itzen, Aymelt/0000-0002-4249-5617; Goody, Roger S/0000-0002-0772-0444; Muller, Matthias/0000-0002-1529-8933; Goody, Philip Roger/0000-0002-1485-4221	Max-Planck-Society; Deutsche Forschungsgemeinschaft [SFB642, A4]; International Max Planck Research School in Chemical Biology (Dortmund, Germany)	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology (Dortmund, Germany)	This work was supported by grants from the Max-Planck-Society and the Deutsche Forschungsgemeinschaft (SFB642, Grant A4).; Supported by the International Max Planck Research School in Chemical Biology (Dortmund, Germany).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chavas LMG, 2007, ACTA CRYSTALLOGR D, V63, P769, DOI 10.1107/S0907444907019725; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; Goody Roger S, 2011, Commun Integr Biol, V4, P72, DOI 10.4161/cib.4.1.13857; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Itzen A, 2011, SEMIN CELL DEV BIOL, V22, P48, DOI 10.1016/j.semcdb.2010.10.003; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Oesterlin LK, 2012, P NATL ACAD SCI USA, V109, P5621, DOI 10.1073/pnas.1121161109; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rigden DJ, 2011, FEBS LETT, V585, P2749, DOI 10.1016/j.febslet.2011.08.006; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P1, DOI 10.1016/j.semcdb.2010.12.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Tilney LG, 2001, J CELL SCI, V114, P4637; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wittmann JG, 2004, FEBS LETT, V568, P23, DOI 10.1016/j.febslet.2004.05.004; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu YB, 2004, STRUCTURE, V12, P861, DOI 10.1016/S0969-2126(04)00111-X; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	60	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35036	35046		10.1074/jbc.M112.396861	http://dx.doi.org/10.1074/jbc.M112.396861			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22872634	Green Published, hybrid			2022-12-25	WOS:000309968000015
J	Montgomery, C; Pei, ZT; Watkins, PA; Miziorko, HM				Montgomery, Christa; Pei, Zhengtong; Watkins, Paul A.; Miziorko, Henry M.			Identification and Characterization of an Extramitochondrial Human 3-Hydroxy-3-methylglutaryl-CoA Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-METHYLGLUTARYL COENZYME; HMG-COA LYASE; ENZYME-ACTIVITY; KETONE-BODIES; EXPRESSION; CELLS; LIVER; DEHYDROGENASE; DEFICIENCY; METABOLISM	3-Hydroxy-3-methylglutaryl-CoA lyase-like protein (HMGCLL1) has been annotated in the Mammalian Genome Collection as a previously unidentified human HMG-CoA lyase (HMGCL). To test the validity of this annotation and evaluate the physiological role of the protein, plasmids were constructed for protein expression in Escherichia coli and Pichia pastoris. Protein expression in E. coli produced insoluble material. In contrast, active HMGCLL1 could be recovered upon expression in P. pastoris. Antibodies were prepared against a unique peptide sequence found in the N terminus of the protein. In immunodetection experiments, the antibodies discriminated between HMGCLL1 and mitochondrial HMGCL. Purified enzyme was characterized and demonstrated to cleave HMG-CoA to acetoacetate and acetyl-CoA with catalytic and affinity properties comparable with human mitochondrial HMGCL. The deduced HMGCLL1 sequence contains an N-terminal myristoylation motif; the putative modification site was eliminated by construction of a G2A HMGCLL1. Modification of both proteins was attempted using human N-myristoyltransferase and [H-3] myristoyl-CoA. Wild-type protein was clearly modified, whereas G2A protein was not labeled. Myristoylation of HMGCLL1 affects its cellular localization. Upon transfection of appropriate expression plasmids into COS1 cells, immunofluorescence detection indicates that G2A HMGCLL1 exhibits a diffuse pattern, suggesting a cytosolic location. In contrast, wildtype HMGCLL1 exhibits a punctate as well as a perinuclear immunostaining pattern, indicating myristoylation dependent association with nonmitochondrial membrane compartments. In control experiments with the HMGCL expression plasmid, protein is localized in the mitochondria, as anticipated. The available results for COS1 cell expression, as well as endogenous expression in U87 cells, indicate that HMGCLL1 is an extramitochondrial hydroxymethylglutaryl-CoA lyase.	[Montgomery, Christa; Miziorko, Henry M.] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Pei, Zhengtong; Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Pei, Zhengtong; Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	University of Missouri System; University of Missouri Kansas City; Johns Hopkins University; Johns Hopkins University	Miziorko, HM (corresponding author), Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	miziorkoh@umkc.edu		Watkins, Paul A./0000-0002-3246-1405	National Institutes of Health [DK21491, HD020461]; Marion-Merrell-Dow foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021491, R37DK021491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marion-Merrell-Dow foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK21491 and HD020461 and the Marion-Merrell-Dow foundation.	BACHHAWAT BK, 1955, J BIOL CHEM, V216, P727; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Fu ZJ, 2010, J BIOL CHEM, V285, P26341, DOI 10.1074/jbc.M110.139931; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; GOLDFARB S, 1971, J LIPID RES, V12, P512; Green D, 1996, BIOCHEMISTRY-US, V35, P8158, DOI 10.1021/bi952807n; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; HILDEBRANDT LA, 1995, AM J PHYSIOL-CELL PH, V269, pC22, DOI 10.1152/ajpcell.1995.269.1.C22; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Linder S, 1996, BIOTECHNIQUES, V20, P980; Montgomery C, 2011, FASEB J, V25; Montgomery C, 2011, ARCH BIOCHEM BIOPHYS, V511, P48, DOI 10.1016/j.abb.2011.04.004; PATEL MS, 1981, P NATL ACAD SCI-BIOL, V78, P7214, DOI 10.1073/pnas.78.11.7214; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; Pie J, 2007, MOL GENET METAB, V92, P198, DOI 10.1016/j.ymgme.2007.06.020; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057	25	13	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33227	33236		10.1074/jbc.M112.393231	http://dx.doi.org/10.1074/jbc.M112.393231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865860	hybrid, Green Published			2022-12-25	WOS:000309602100013
J	Wu, L; Pan, LF; Zhang, CC; Zhang, MJ				Wu, Lin; Pan, Lifeng; Zhang, Chuchu; Zhang, Mingjie			Large Protein Assemblies Formed by Multivalent Interactions between Cadherin23 and Harmonin Suggest a Stable Anchorage Structure at the Tip Link of Stereocilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY HAIR-CELLS; USHER-SYNDROME PROTEINS; DOMAIN-CONTAINING PROTEIN; MYOSIN VIIA; CROSS-LINKS; COMPLEX; TRANSDUCTION; REVEALS; EAR; MECHANOTRANSDUCTION	Stereocilia tip links of inner ear hair cells are subjected to constant stretching during hair-bundle deflection, and accordingly are well designed to prevent from being broken by mechanical tensions. The roots of tip links, which couple tip links with the cytoskeleton, supposedly play important roles in withstanding large forces under stimulated conditions. The upper root of the tip link is mainly formed by the cytoplasmic tail of cadherin23 and its actin-anchoring protein harmonin. However, the detailed organization mode of the two proteins that gives rise to a strong upper root remains unclear. Here we show that the exon68-encoded peptide of cadherin23 can either interact with the N-terminal domain (NTD) of harmonin or form a homodimer. We demonstrate that the three harmonin binding sites of cadherin23, namely the NTD-binding motif, the exon68 peptide, and the C-terminal PDZ binding motif, do not synergize with each other in binding to harmonin, instead they facilitate formation of polymeric cadherin23/harmonin complexes. The exon68 peptide can promote the cadherin23/harmonin polymer formation via either binding to harmonin NTD or self-dimerization. We propose that the polymeric cadherin23/harmonin complex formed beneath the upper tip link membranes may serve as part of the stable rootlet structure for anchoring the tip links of stereocilia.	[Wu, Lin; Pan, Lifeng; Zhang, Chuchu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Inst Adv Study, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk		Zhang, Mingjie/0000-0001-9404-0190; Zhang, Chuchu/0000-0001-9234-6073	Research Grants Council of Hong Kong [664009, 660709, 663610, 663811, HKUST6/CRF/10, SEG_HKUST06]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Grants 664009, 660709, 663610, 663811, HKUST6/CRF/10, and SEG_HKUST06 from the Research Grants Council of Hong Kong (to M. Z.).	Afrin R, 2006, BIOCHEM BIOPH RES CO, V348, P238, DOI 10.1016/j.bbrc.2006.07.050; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; JARAMILLO F, 1992, FASEB J, V6, pA516; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAMOO Y, 1994, BIOCHEMISTRY-US, V33, P8272, DOI 10.1021/bi00193a014; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010	41	22	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33460	33471		10.1074/jbc.M112.378505	http://dx.doi.org/10.1074/jbc.M112.378505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879593	Green Published, hybrid			2022-12-25	WOS:000309602100032
J	Zorn, JA; Wolan, DW; Agard, NJ; Wells, JA				Zorn, Julie A.; Wolan, Dennis W.; Agard, Nicholas J.; Wells, James A.			Fibrils Colocalize Caspase-3 with Procaspase-3 to Foster Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; INDUCED-PROXIMITY MODEL; ZYMOGEN ACTIVATION; PROTEOLYTIC-ENZYMES; ALLOSTERIC SITE; CELL-DEATH; IN-VITRO; INTERMEDIATE-FILAMENTS; HUNTINGTONS-DISEASE; DIMER INTERFACE	Most proteases are expressed as inactive precursors, or zymogens, that become activated by limited proteolysis. We previously identified a small molecule, termed 1541, that dramatically promotes the maturation of the zymogen, procaspase-3, to its mature form, caspase-3. Surprisingly, compound 1541 self-assembles into nanofibrils, and localization of procaspase- 3 to the fibrils promotes activation. Here, we interrogate the biochemical mechanism of procaspase- 3 activation on 1541 fibrils in addition to proteogenic amyloid-beta(1-40) fibrils. In contrast to previous reports, we find no evidence that procaspase- 3 alone is capable of self-activation, consistent with its fate-determining role in executing apoptosis. In fact, mature caspase-3 is > 10(7)-fold more active than procaspase-3, making this proenzyme a remarkably inactive zymogen. However, we also show that fibril-induced colocalization of trace amounts of caspase-3 or other initiator proteases with procaspase- 3 dramatically stimulates maturation of the proenzyme in vitro. Thus, similar to known cellular signaling complexes, these synthetic or natural fibrils can serve as platforms to concentrate procaspase- 3 for trans-activation by upstream proteases.	[Zorn, Julie A.; Wolan, Dennis W.; Agard, Nicholas J.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016; Agard, Nicholas/AAU-6495-2020	Agard, Nicholas/0000-0003-4916-2484; Wolan, Dennis/0000-0001-9879-8353	National Institutes of Health Grant [R01 CA136779]; NCI [F32 CA119641-03]; Achievement Rewards for College Scientists (ARCS) Foundation Award; Scleroderma Research Foundation Evnin-Wright Fellowship; Multiple Myeloma Translational Initiative (MMTI) at UCSF;  [F32 AI077177]; NATIONAL CANCER INSTITUTE [F32CA119641, R01CA136779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077177] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Achievement Rewards for College Scientists (ARCS) Foundation Award; Scleroderma Research Foundation Evnin-Wright Fellowship; Multiple Myeloma Translational Initiative (MMTI) at UCSF; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136779, Grant F32 CA119641-03 from NCI (to D. W. W.), and Grant F32 AI077177 (to N. J. A.). This work was also supported by an Achievement Rewards for College Scientists (ARCS) Foundation Award (to J. A. Z.), a Scleroderma Research Foundation Evnin-Wright Fellowship (to J. A. Z.), and the Multiple Myeloma Translational Initiative (MMTI) at UCSF.	Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Ganesan R, 2006, J MOL BIOL, V359, P1378, DOI 10.1016/j.jmb.2006.04.051; GERTLER A, 1974, BIOCHEMISTRY-US, V13, P1302, DOI 10.1021/bi00703a038; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; GRAYBILL TL, 1995, BIOORG MED CHEM LETT, V5, P1197, DOI 10.1016/0960-894X(95)00194-X; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Karki P, 2005, ARCH BIOCHEM BIOPHYS, V442, P125, DOI 10.1016/j.abb.2005.07.023; KASSELL B, 1973, SCIENCE, V180, P1022, DOI 10.1126/science.180.4090.1022; KAY J, 1971, J BIOL CHEM, V246, P6661; Khan AR, 1998, PROTEIN SCI, V7, P815; KINGSTON IB, 1995, NAT MED, V1, P138; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; LONSDALEECCLES JD, 1978, BIOCHEMISTRY-US, V17, P2805, DOI 10.1021/bi00607a016; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; MADISON EL, 1993, METHOD ENZYMOL, V223, P249; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2003, BIOCHEMISTRY-US, V42, P12311, DOI 10.1021/bi034999p; Pop C, 2001, BIOCHEMISTRY-US, V40, P14224, DOI 10.1021/bi011037e; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; ROBINSON NC, 1973, BIOCHEMISTRY-US, V12, P420, DOI 10.1021/bi00727a010; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schipper JL, 2011, BIOPHYS CHEM, V159, P100, DOI 10.1016/j.bpc.2011.05.013; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen A, 2010, MOL BIOSYST, V6, P1431, DOI 10.1039/c003913f; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; SILVERBERG M, 1982, BLOOD, V60, P64; Smith TJ, 2006, J AM CHEM SOC, V128, P14456, DOI 10.1021/ja065557e; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Twiddy D, 2006, J BIOL CHEM, V281, P3876, DOI 10.1074/jbc.M507393200; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Wu JW, 2001, EUR J BIOCHEM, V268, P1547, DOI 10.1046/j.1432-1033.2001.01914.x; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yuan RT, 2012, APOPTOSIS, V17, P229, DOI 10.1007/s10495-011-0677-y; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	86	39	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33781	33795		10.1074/jbc.M112.386128	http://dx.doi.org/10.1074/jbc.M112.386128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872644	Green Published, hybrid			2022-12-25	WOS:000309602100060
J	Davison, J; Opik, M; Zobel, M; Vasar, M; Metsis, M; Moora, M				Davison, John; Oepik, Maarja; Zobel, Martin; Vasar, Martti; Metsis, Madis; Moora, Mari			Communities of Arbuscular Mycorrhizal Fungi Detected in Forest Soil Are Spatially Heterogeneous but Do Not Vary throughout the Growing Season	PLOS ONE			English	Article							HYACINTHOIDES-NON-SCRIPTA; SPECIES RICHNESS; MOLECULAR DIVERSITY; PLANT; SCALE; BIODIVERSITY; DYNAMICS; GLOMEROMYCOTA; AMPLIFICATION; ASSEMBLAGES	Despite the important ecosystem role played by arbuscular mycorrhizal fungi (AMF), little is known about spatial and temporal variation in soil AMF communities. We used pyrosequencing to characterise AMF communities in soil samples (n = 44) from a natural forest ecosystem. Fungal taxa were identified by BLAST matching of reads against the MaarjAM database of AMF SSU rRNA gene diversity. Sub-sampling within our dataset and experimental shortening of a set of long reads indicated that our approaches to taxonomic identification and diversity analysis were robust to variations in pyrosequencing read length and numbers of reads per sample. Different forest plots (each 10610 m and separated from one another by 30 m) contained significantly different soil AMF communities, and the pairwise similarity of communities decreased with distance up to 50 m. However, there were no significant changes in community composition between different time points in the growing season (May-September). Spatial structure in soil AMF communities may be related to the heterogeneous vegetation of the natural forest study system, while the temporal stability of communities suggests that AMF in soil represent a fairly constant local species pool from which mycorrhizae form and disband during the season.	[Davison, John; Oepik, Maarja; Zobel, Martin; Vasar, Martti; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Metsis, Madis] Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Tallinn University of Technology	Davison, J (corresponding author), Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	john.davison@ut.ee	Öpik, Maarja/A-1765-2008; Metsis, Madis/F-7080-2016; Zobel, Martin/H-1336-2015; Moora, Mari/D-1961-2009	Öpik, Maarja/0000-0001-8025-7460; Metsis, Madis/0000-0003-1667-677X; Zobel, Martin/0000-0001-7957-6704; Moora, Mari/0000-0002-4819-7506	Estonian Science Foundation [9050, 9157, 7738]; EU LIFE Programme [LIFE08 ENV/EE/000258]; European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research);  [SF0180098s08]	Estonian Science Foundation; EU LIFE Programme; European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research); 	This research was funded by grants from the Estonian Science Foundation (9050, 9157, 7738), targeted financing (SF0180098s08), the EU LIFE Programme (LIFE08 ENV/EE/000258), and the European Regional Development Fund (Center of Excellence FIBIR - Frontiers In Biodiversity Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P1498, DOI 10.1016/j.soilbio.2011.03.026; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Bainard LD, 2011, AGR ECOSYST ENVIRON, V144, P13, DOI 10.1016/j.agee.2011.07.014; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Boerner REJ, 1996, MYCORRHIZA, V6, P79, DOI 10.1007/s005720050111; Carvalho LM, 2003, PLANT SOIL, V251, P227, DOI 10.1023/A:1023016317269; Chelius MK, 1999, MYCORRHIZA, V9, P61, DOI 10.1007/s005720050264; CLAPP JP, 1995, NEW PHYTOL, V130, P259, DOI 10.1111/j.1469-8137.1995.tb03047.x; Dai ML, 2012, CAN J MICROBIOL, V58, P81, DOI [10.1139/W11-111, 10.1139/w11-111]; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hassan SED, 2011, MOL ECOL, V20, P3469, DOI 10.1111/j.1365-294X.2011.05142.x; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 1999, MOL ECOL, V8, P659, DOI 10.1046/j.1365-294x.1999.00604.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; Jumpponen A, 2011, MYCORRHIZA, V21, P453, DOI 10.1007/s00572-010-0358-7; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lankau RA, 2011, NEW PHYTOL, V189, P536, DOI 10.1111/j.1469-8137.2010.03481.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Liu RJ, 2003, MYCORRHIZA, V13, P123, DOI 10.1007/s00572-002-0207-4; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Ma WK, 2005, SOIL BIOL BIOCHEM, V37, P1589, DOI 10.1016/j.soilbio.2005.01.020; Mangan SA, 2010, ECOLOGY, V91, P2594, DOI 10.1890/09-0396.1; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; MORTON JB, 1993, MYCOTAXON, V48, P491; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J, 2010, R PACKAGE VERSION 1; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pellegrino E, 2012, NEW PHYTOL, V194, P810, DOI 10.1111/j.1469-8137.2012.04090.x; Pivato B, 2007, NEW PHYTOL, V176, P197, DOI 10.1111/j.1469-8137.2007.02151.x; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; Robinson-Boyer L, 2009, FUNGAL ECOL, V2, P1, DOI 10.1016/j.funeco.2008.11.001; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schwartz MW, 2006, ECOL LETT, V9, P501, DOI 10.1111/j.1461-0248.2006.00910.x; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Wolfe BE, 2007, MYCORRHIZA, V17, P175, DOI 10.1007/s00572-006-0089-y; Wu FS, 2011, PLANT SOIL, V342, P233, DOI 10.1007/s11104-010-0688-4; Yang C, 2010, MICROB ECOL, V59, P724, DOI 10.1007/s00248-009-9629-2; ZOBEL K, 1993, J VEG SCI, V4, P489, DOI 10.2307/3236076; ZOBEL M, 1989, ANN BOT FENN, V26, P171	74	120	127	2	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e41938	10.1371/journal.pone.0041938	http://dx.doi.org/10.1371/journal.pone.0041938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22879900	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900016
J	Florian, RV				Florian, Razvan V.			The Chronotron: A Neuron That Learns to Fire Temporally Precise Spike Patterns	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SPINY STELLATE NEURONS; SYNAPTIC PLASTICITY; ERROR-BACKPROPAGATION; RECURRENT NETWORKS; THETA OSCILLATIONS; DISTAL DENDRITES; PHASE PRECESSION; VISUAL-CORTEX; FINITE MEMORY	In many cases, neurons process information carried by the precise timings of spikes. Here we show how neurons can learn to generate specific temporally precise output spikes in response to input patterns of spikes having precise timings, thus processing and memorizing information that is entirely temporally coded, both as input and as output. We introduce two new supervised learning rules for spiking neurons with temporal coding of information (chronotrons), one that provides high memory capacity (E-learning), and one that has a higher biological plausibility (I-learning). With I-learning, the neuron learns to fire the target spike trains through synaptic changes that are proportional to the synaptic currents at the timings of real and target output spikes. We study these learning rules in computer simulations where we train integrate-and-fire neurons. Both learning rules allow neurons to fire at the desired timings, with sub-millisecond precision. We show how chronotrons can learn to classify their inputs, by firing identical, temporally precise spike trains for different inputs belonging to the same class. When the input is noisy, the classification also leads to noise reduction. We compute lower bounds for the memory capacity of chronotrons and explore the influence of various parameters on chronotrons' performance. The chronotrons can model neurons that encode information in the time of the first spike relative to the onset of salient stimuli or neurons in oscillatory networks that encode information in the phases of spikes relative to the background oscillation. Our results show that firing one spike per cycle optimizes memory capacity in neurons encoding information in the phase of firing relative to a background rhythm.	Romanian Inst Sci & Technol, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania	Romanian Institute of Science & Technology	Florian, RV (corresponding author), Romanian Inst Sci & Technol, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania.	florian@rist.ro	Florian, Răzvan Valentin/A-1033-2010; Florian, Răzvan Valentin/I-7321-2019	Florian, Răzvan Valentin/0000-0002-4181-4727; Florian, Răzvan Valentin/0000-0002-4181-4727	Romanian National Authority for Scientific Research (PNCDI II, Parteneriate) [11-039/2007]; Max Planck - Coneural Partner Group	Romanian National Authority for Scientific Research (PNCDI II, Parteneriate); Max Planck - Coneural Partner Group(Max Planck Society)	This work has been sponsored by a grant of the Romanian National Authority for Scientific Research (PNCDI II, Parteneriate, contract no. 11-039/2007) and by the Max Planck - Coneural Partner Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HH, 2004, ESAAN 2004 P EUR S A, P355; Andersen P., 2007, HIPPOCAMPUS BOOK; [Anonymous], 1998, NEURAL NETWORKS COMP; Ariav G, 2003, J NEUROSCI, V23, P7750; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barak O, 2006, NEURAL COMPUT, V18, P2343, DOI 10.1162/neco.2006.18.10.2343; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry SD, 2001, NEUROBIOL LEARN MEM, V76, P298, DOI 10.1006/nlme.2001.4025; Bohte S. M., 2000, SPIKEPROP ERROR BACK, P419; Bohte Sander M., 2004, Natural Computing, V3, P195, DOI 10.1023/B:NACO.0000027755.02868.60; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Booij O, 2004, THESIS U AMSTERDAM N; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Carey MR, 2009, NEURON, V62, P112, DOI 10.1016/j.neuron.2009.02.022; Carnell A, 2005, P EUR S ART NEUR NET; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; D'Haene M, 2009, NEURAL COMPUT, V21, P1068, DOI 10.1162/neco.2008.02-08-707; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; ECCLES J, 1976, NOTES REC ROY SOC, V30, P219, DOI 10.1098/rsnr.1976.0015; Edelmann E, 2011, FRONTIERS SYNAPTIC N, V3; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Fang HJ, 2010, NEURAL COMPUT, V22, P1060, DOI 10.1162/neco.2009.10-08-885; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Florian RV, 2008, LECT NOTES COMPUT SC, V5164, P368, DOI 10.1007/978-3-540-87559-8_38; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Florian RV, 2006, LECT NOTES COMPUT SC, V4131, P718; Florian RV, 2005, Seventh International Symposium on Symbolic and Numeric Algorithms for Scientific Computing, Proceedings, P299; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gers FA, 2003, J MACH LEARN RES, V3, P115, DOI 10.1162/153244303768966139; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W., 2002, SPIKING NEURON MODEL; Gerstner W, 2010, FRONTIERS SYNAPTIC N, V2; Gerstner W., 2001, HDB BIOL PHYS, P469; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; Havenith MN, 2011, J NEUROSCI, V31, P8570, DOI 10.1523/JNEUROSCI.2817-10.2011; Hertz JA, 2018, INTRO THEORY NEURAL; Huang YY, 2004, P NATL ACAD SCI USA, V101, P859, DOI 10.1073/pnas.2237201100; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jaeger H., 2001, 148 GMD; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jin DZ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015010; Jin DZ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021905; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kaiser F, 2007, LECT NOTES COMPUT SC, V4668, P380; Kasinski A., 2006, International Journal of Applied Mathematics and Computer Science, V16, P101; Kasinski A, 2005, LECT NOTES COMPUT SC, V3696, P145, DOI 10.1007/11550822_24; La Camera G, 2004, NEURAL COMPUT, V16, P2101, DOI 10.1162/0899766041732468; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Legenstein RA, 2006, ADV NEURAL INFORM PR, V17, P865; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McKennoch S, 2006, IEEE IJCNN, P3970; McKennoch S, 2009, NEURAL COMPUT, V21, P9, DOI 10.1162/neco.2008.09-07-610; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Moore SC, 2002, THESIS U BATH UK; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakama T, 2009, NEUROCOMPUTING, V73, P151, DOI 10.1016/j.neucom.2009.05.017; Paugam-Moisy H, 2007, EUR S ART NEUR NETW; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2006, P EUR S ART NEUR NET; Ponulak F., 2006, PHD POZN U TECHNOL, V46, P47; Ponulak F, 2006, D91 SECURESCM; Ponulak F, 2005, D91 SECURESCM; Ponulak F, 2008, INT J APPL MATH COMP, V18, P117, DOI 10.2478/v10006-008-0011-1; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; Ruf B, 1997, NEURAL PROCESS LETT, V5, P9, DOI 10.1023/A:1009697008681; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schrauwen B, 2004, IEEE IJCNN, P471, DOI 10.1109/IJCNN.2004.1379954; Schrauwen B, 2006, P 2006 INT JOINT C N, P3463; Schrauwen Benjamin, 2007, PROC EUR S ARTIF NEU, P471; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sugisaki E, 2011, NEUROSCIENCE, V192, P91, DOI 10.1016/j.neuroscience.2011.06.064; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tino P, 2006, NEURAL COMPUT, V18, P591, DOI 10.1162/089976606775623360; Tino P, 2005, LECT NOTES COMPUT SC, V3611, P666; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Urbanczik R, 2009, NEURAL COMPUT, V21, P340, DOI 10.1162/neco.2008.09-07-605; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Voegtlin T., 2007, ADV NEURAL INFORM PR, V19, P1457; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xin JG, 2001, IEEE IJCNN, P1772, DOI 10.1109/IJCNN.2001.938430; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	116	122	130	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e40233	10.1371/journal.pone.0040233	http://dx.doi.org/10.1371/journal.pone.0040233			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879876	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000003
J	Kapoor, SK; Raman, AV; Sachdeva, KS; Satyanarayana, S				Kapoor, Sunil K.; Raman, A. Venkat; Sachdeva, Kuldeep Singh; Satyanarayana, Srinath			How Did the TB Patients Reach DOTS Services in Delhi? A Study of Patient Treatment Seeking Behavior	PLOS ONE			English	Article							INDIA; CARE; HIV/AIDS	Setting: Revised National Tuberculosis Control Programme (RNTCP), Delhi, India. Objective: To ascertain the number and sequence of providers visited by TB patients before availing treatment services from DOTS; to describe the duration between onset of symptoms to treatment. Study design: A cross sectional, qualitative study. Information was gathered through in-depth interviews of TB patients registered during the month of Oct, 2012 for availing TB treatment under the Revised National TB Control Programme from four tuberculosis diagnosis and treatment centers in Delhi. Results: Out of the 114 patients who registered, 108 participated in the study. The study showed that informal providers and retail chemists were the first point of contact and source of clinical advice for two-third of the patients, while the rest sought medical care from qualified providers directly. Most patients sought medical care from more than two providers, before being diagnosed as TB. Female TB patients and patients with extra-pulmonary TB had long mean duration between onset of symptoms to initiation of treatment (6.3 months and 8.4 months respectively). Conclusion: The pathways followed by TB patients, illustrated in this study, provide valuable lessons on the importance of different types of providers (both formal and informal) in the health system in a society like India and the delays in the diagnosis and treatment of tuberculosis.	[Kapoor, Sunil K.] Harrow Med Ctr, Noida, India; [Raman, A. Venkat] Univ Delhi, Fac Management Studies, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Satyanarayana, Srinath] SE Asia Reg Off, New Delhi, India	University of Delhi	Kapoor, SK (corresponding author), Harrow Med Ctr, Noida, India.	sunil_kapoor96@yahoo.com; drsrinaths@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551				Bajpai V, 2010, NATL MED J INDIA, V23, P231; Central TB Division, 2010, UN ACC TB CAR PRACT; Central Tuberculosis Division, 2011, ANN REP REV NAT TUB; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Chavali Annapurna, 2010, INFORMAL PROVISION H; Delhi State TB Cell, 2011, DOTS SERV DELH; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; Mignone J, 2007, AIDS CARE, V19, P152, DOI 10.1080/09540120600780542; Price Waterhouse Coopers, 2007, HLTH CAR IND EM MARK; Raman A. Venkat, 2008, PUBLIC PRIVATE PRATN; Sheikh K, 2006, T ROY SOC TROP MED H, V100, P312, DOI 10.1016/j.trstmh.2005.04.023; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Stop TB Department, 2011, GLOB PLAN STOP TB 20; The Union South-East Asia Regional Office New Delhi, 2010, PROJ AXSH GLOB FUND; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar MW, 2003, INT J TUBERC LUNG D, V7, P1113; World Health Organisation Geneva, 2012, GLOB TUB CONTR 2011; Yesudian CAK, 2011, HLTH SEEKING BEHAV U	18	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42458	10.1371/journal.pone.0042458	http://dx.doi.org/10.1371/journal.pone.0042458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22879990	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000035
J	De Vlaminck, I; Henighan, T; van Loenhout, MTJ; Burnham, DR; Dekker, C				De Vlaminck, Iwijn; Henighan, Thomas; van Loenhout, Marijn T. J.; Burnham, Daniel R.; Dekker, Cees			Magnetic Forces and DNA Mechanics in Multiplexed Magnetic Tweezers	PLOS ONE			English	Article							PERSISTENCE LENGTH; MOLECULE; ELASTICITY	Magnetic tweezers (MT) are a powerful tool for the study of DNA-enzyme interactions. Both the magnet-based manipulation and the camera-based detection used in MT are well suited for multiplexed measurements. Here, we systematically address challenges related to scaling of multiplexed magnetic tweezers (MMT) towards high levels of parallelization where large numbers of molecules (say 10 3) are addressed in the same amount of time required by a single-molecule measurement. We apply offline analysis of recorded images and show that this approach provides a scalable solution for parallel tracking of the xyz-positions of many beads simultaneously. We employ a large field-of-view imaging system to address many DNA-bead tethers in parallel. We model the 3D magnetic field generated by the magnets and derive the magnetic force experienced by DNA-bead tethers across the large field of view from first principles. We furthermore experimentally demonstrate that a DNA-bead tether subject to a rotating magnetic field describes a bicircular, Limac, on rotation pattern and that an analysis of this pattern simultaneously yields information about the force angle and the position of attachment of the DNA on the bead. Finally, we apply MMT in the high-throughput investigation of the distribution of the induced magnetic moment, the position of attachment of DNA on the beads, and DNA flexibility. The methods described herein pave the way to kilo-molecule level magnetic tweezers experiments.	[De Vlaminck, Iwijn; Henighan, Thomas; van Loenhout, Marijn T. J.; Burnham, Daniel R.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands	Delft University of Technology	De Vlaminck, I (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	c.dekker@tudelft.nl	Burnham, Daniel/A-3261-2014; De Vlaminck, Iwijn/P-6479-2015	De Vlaminck, Iwijn/0000-0001-6085-7311; Burnham, Daniel/0000-0002-3017-8964; Dekker, Cees/0000-0001-6273-071X	Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Netherlands America Fulbright Foundation	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands America Fulbright Foundation	This work was supported by a 'DNA-in-action' grant from the "Stichting voor Fundamenteel Onderzoek der Materie (FOM)'', which is financially supported by the "Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)''. Thomas Henighan thanks the Netherlands America Fulbright Foundation for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Danilowicz C, 2005, ANAL CHEM, V77, P3023, DOI 10.1021/ac050057+; De Vlaminck I, 2011, NANO LETT; De Vlaminck I, 2012, MOL CELL; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Hall LM, 1992, COLL MATH J, V23, P20, DOI DOI 10.1080/07468342.1992.11973429; Halvorsen K, 2010, BIOPHYS J, V98, pL53, DOI 10.1016/j.bpj.2010.03.012; Holthausen JT, 2011, NUCL ACIDS RES; Jackson JD, 1999, AM J PHYS, V67, P107, DOI 10.1119/1.19203; Klaue D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.028302; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Kruithof M, 2008, BIOPHYS J, V94, P2343, DOI 10.1529/biophysj.107.121673; Leach J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026301; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Ribeck N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2981687; Segall DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088306; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; Severin PMD, 2011, LAB CHIP, V11, P856, DOI [10.1039/c0lc00302f, 10.1039/c01c00302f]; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; te Velthuis AJW, 2010, BIOPHYS J, V100, p481a; van Aelst K, 2010, P NATL ACAD SCI USA, V107, P9123, DOI 10.1073/pnas.1001637107; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; Xiao BT, 2010, NUCLEIC ACIDS RES, V38, P6176, DOI 10.1093/nar/gkq435	31	51	53	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e41432	10.1371/journal.pone.0041432	http://dx.doi.org/10.1371/journal.pone.0041432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22870220	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100019
J	Liu, CC; Mauk, MG; Hart, R; Bonizzoni, M; Yan, GY; Bau, HH				Liu, Changchun; Mauk, Michael G.; Hart, Robert; Bonizzoni, Mariangela; Yan, Guiyun; Bau, Haim H.			A Low-Cost Microfluidic Chip for Rapid Genotyping of Malaria-Transmitting Mosquitoes	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE-CHAIN-REACTION; ANOPHELES-GAMBIAE; SAMPLE PREPARATION; IDENTIFICATION; DNA; DIFFERENTIATION; POLYMORPHISM; MICROARRAY; ARABIENSIS	Background: Vector control is one of the most effective measures to prevent the transmission of malaria, a disease that causes over 600,000 deaths annually. Around 30-40 Anopheles mosquito species are natural vectors of malaria parasites. Some of these species cannot be morphologically distinguished, but have behavioral and ecological differences. Emblematic of this is the Anopheles gambiae species complex. The correct identification of vector species is fundamental to the development of control strategies and epidemiological studies of disease transmission. Methodology/Principal Findings: An inexpensive, disposable, field-deployable, sample-to-answer, microfluidic chip was designed, constructed, and tested for rapid molecular identification of Anopheles gambiae and Anopheles arabiensis. The chip contains three isothermal amplification reactors. One test reactor operates with specific primers to amplify Anopheles gambiae DNA, another with specific primers for Anopheles arabiensis DNA, and the third serves as a negative control. A mosquito leg was crushed on an isolation membrane. Two discs, laden with mosquito tissue, were punched out of the membrane and inserted into the two test chambers. The isolated, disc-bound DNA served as a template in the amplification processes. The amplification products were detected with intercalating fluorescent dye that was excited with a blue light-emitting diode. The emitted light was observed by eye and recorded with a cell-phone camera. When the target consisted of Anopheles gambiae, the reactor containing primers specific to An. gambiae lit up while the other two reactors remained dark. When the target consisted of Anopheles arabiensis, the reactor containing primers specific to An. arabiensis lit up while the other two reactors remained dark. Conclusions/Significance: The microfluidic chip provides a means to identify mosquito type through molecular analysis. It is suitable for field work, allowing one to track the geographical distribution of mosquito populations and community structure alterations due to environmental changes and malaria intervention measures.	[Liu, Changchun; Mauk, Michael G.; Hart, Robert; Bau, Haim H.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Bonizzoni, Mariangela; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Irvine, CA USA	University of Pennsylvania; University of California System; University of California Irvine	Liu, CC (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	bau@seas.upenn.edu	Bau, Haim H/D-1161-2009; bonizzoni, mariangela/AAM-9035-2021	bonizzoni, mariangela/0000-0003-0568-8564	National Institutes of Health/National Institute of Dental and Craniofacial Research [U01DE017855]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [1K25AI099160-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI099160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE017855] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant U01DE017855 and National Institutes of Health/National Institute of Allergy and Infectious Diseases grant 1K25AI099160-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 2008, BIOCHEM BIOPH RES CO, V376, P671, DOI 10.1016/j.bbrc.2008.09.061; Bonizzoni M, 2009, AM J TROP MED HYG, V81, P1030, DOI 10.4269/ajtmh.2009.09-0333; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bynum WF, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P49; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033176; CARLSON DA, 1979, ANN TROP MED PARASIT, V73, P589, DOI 10.1080/00034983.1979.11687301; Chen DF, 2010, BIOMED MICRODEVICES, V12, P705, DOI 10.1007/s10544-010-9423-4; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coosemans M, 1998, AM J TROP MED HYG, V58, P70, DOI 10.4269/ajtmh.1998.58.70; Cortes AL, 2009, AVIAN DIS, V53, P510, DOI 10.1637/8871-041009-Reg.1; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a; Djogbenou L, 2010, ACTA TROP, V114, P116, DOI 10.1016/j.actatropica.2010.02.001; Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103; FAVIA G, 1994, P NATL ACAD SCI USA, V91, P10315, DOI 10.1073/pnas.91.22.10315; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Jamjoom Manal, 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P227; Kim J, 2009, LAB CHIP, V9, P606, DOI 10.1039/b807915c; Liu CC, 2011, MICROFLUID NANOFLUID, V11, P209, DOI 10.1007/s10404-011-0788-3; Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Liu CC, 2011, LAB CHIP, V11, P1688, DOI 10.1039/c1lc20089e; Liu CC, 2009, LAB CHIP, V9, P768, DOI 10.1039/b814322f; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Lui C, 2009, SENSORS-BASEL, V9, P3713, DOI 10.3390/s90503713; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Qiu XB, 2011, BIOMED MICRODEVICES, V13, P809, DOI 10.1007/s10544-011-9551-5; Rajendram D, 2006, J MICROBIOL METH, V67, P582, DOI 10.1016/j.mimet.2006.05.010; Ramirez JL, 2009, CURR MOL MED, V9, P116, DOI 10.2174/156652409787581600; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Walker ED, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-23; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066	41	41	45	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42222	10.1371/journal.pone.0042222	http://dx.doi.org/10.1371/journal.pone.0042222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879919	gold, Green Published			2022-12-25	WOS:000307284100056
J	Ren, XH; Xu, JY; Cooper, JP; Kang, MH; Erdreich-Epstein, A				Ren, Xiuhai; Xu, Jingying; Cooper, Jason P.; Kang, Min H.; Erdreich-Epstein, Anat			c-Abl Is an Upstream Regulator of Acid Sphingomyelinase in Apoptosis Induced by Inhibition of Integrins alpha v beta 3 and alpha v beta 5	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; TYROSINE KINASE; DNA-DAMAGE; CERAMIDE GENERATION; CARCINOMA-CELLS; BRAIN-TUMORS; PHASE-I; MODULATION; ACTIN; ALPHA(V)BETA(3)	Inhibition of integrins alpha v beta 3/alpha v beta 5 by the cyclic function-blocking peptide, RGDfV (Arg-Gly-Asp-Phe-Val) can induce apoptosis in both normal cells and tumor cells. We show that RGDfV induced apoptosis in ECV-304 carcinoma cells, increased activity and mRNA expression of acid sphingomyelinase (ASM), and increased ceramides C-16, C-18:0, C-24:0 and C-24:1 while decreasing the corresponding sphingomyelins. siRNA to ASM decreased RGDfV-induced apoptosis as measured by TUNEL, PARP cleavage, mitochondrial depolarization, and caspase-3 and caspase-8 activities, as well as by annexinV in a 3D collagen model. These findings indicate a causal role for ASM in RGDfV-induced apoptosis in ECV-304. We have shown that c-Abl, a non-receptor tyrosine kinase, also mediates RGDfV-induced apoptosis. However, c-Abl, has not been previously linked to ASM in any system. Here we show that STI-571 (imatinib, inhibitor of c-Abl) inhibited RGDfV-induced ASM activity. Furthermore, STI-571 and c-Abl-siRNA both inhibited RGDfV-induced increase in ASM mRNA, but ASM-siRNA did not affect c-Abl phosphorylation or expression, supporting that c-Abl regulates the RGDfV-induced increase in ASM expression. These studies implicate ASM as a mediator of apoptosis induced by inhibition of integrins avb3/avb5, and for the first time place c-Abl as an upstream regulator of ASM expression and activity.	[Ren, Xiuhai; Xu, Jingying; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90033 USA; [Ren, Xiuhai; Xu, Jingying; Erdreich-Epstein, Anat] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Cooper, Jason P.; Kang, Min H.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; Children's Hospital Los Angeles; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Southern California	Ren, XH (corresponding author), Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90033 USA.	epstein@usc.edu	Xu, Jingying/G-2036-2010	Cooper, Jason P/0000-0003-0023-8054; Kang, Min H/0000-0003-3603-7035; Erdreich-Epstein, Anat/0000-0003-4269-4373	National Institutes of Health [CA98568]; Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award; Grayson's Gift; Nautica Malibu Triathlon Fund; Rachel Ann Hage Neuro-Oncology Fund; Bogart Pediatric Cancer Research Program; T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research; NATIONAL CANCER INSTITUTE [R01CA098568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award; Grayson's Gift; Nautica Malibu Triathlon Fund; Rachel Ann Hage Neuro-Oncology Fund; Bogart Pediatric Cancer Research Program; T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA98568 from the National Institutes of Health to AE. JX was supported in part by a Children's Hospital Los Angeles Saban Research Institute Pre-doctoral Fellowship Award. The work was also supported in part by Grayson's Gift and by support from the Nautica Malibu Triathlon Fund, the Rachel Ann Hage Neuro-Oncology Fund, the Bogart Pediatric Cancer Research Program, and the T. J. Martell Foundation for Leukemia, Cancer, and AIDS Research (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2007, METHOD ENZYMOL, V426, P85, DOI 10.1016/S0076-6879(07)26005-7; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Bello L, 2001, NEUROSURGERY, V49, P380, DOI 10.1097/00006123-200108000-00022; BHATTACHARYA S, 1995, J BIOL CHEM, V270, P16781, DOI 10.1074/jbc.270.28.16781; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Erdreich-Epstein A, 2005, BLOOD, V105, P4353, DOI 10.1182/blood-2004-08-3098; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Erdreich-Epstein A, 2000, CANCER RES, V60, P712; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Genersch E, 2003, EUR J CELL BIOL, V82, P105, DOI 10.1078/0171-9335-00297; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong JG, 1999, NATURE, V399, P806; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Gulbins Erich, 2002, Subcell Biochem, V36, P229; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Koos B, 2010, CANCER-AM CANCER SOC, V116, P5075, DOI 10.1002/cncr.25420; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Lewis JM, 2002, P NATL ACAD SCI USA, V99, P3627, DOI 10.1073/pnas.062698499; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; MacDonald TJ, 2008, J CLIN ONCOL, V26, P919, DOI 10.1200/JCO.2007.14.1812; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Maupas-Schwalm F, 2009, CELL SIGNAL, V21, P1925, DOI 10.1016/j.cellsig.2009.08.010; MCGAHON AJ, 1995, J BIOL CHEM, V270, P22625, DOI 10.1074/jbc.270.38.22625; Meltser V, 2011, CELL DEATH DIFFER, V18, P2, DOI 10.1038/cdd.2010.132; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Rebillard A, 2008, ONCOGENE, V27, P6590, DOI 10.1038/onc.2008.257; Rebillard A, 2010, EUR J CANCER, V46, P1445, DOI 10.1016/j.ejca.2010.01.034; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; Schlieben S, 1996, LEUKEMIA, V10, P957; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Taga T, 2002, INT J CANCER, V98, P690, DOI 10.1002/ijc.10265; Truong T, 2003, P NATL ACAD SCI USA, V100, P10281, DOI 10.1073/pnas.1635435100; van Bokhoven A, 2001, CANCER RES, V61, P6340; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	58	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42291	10.1371/journal.pone.0042291	http://dx.doi.org/10.1371/journal.pone.0042291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22879933	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100062
J	Cvirn, G; Schlagenhauf, A; Leschnik, B; Koestenberger, M; Roessler, A; Jantscher, A; Vrecko, K; Juergens, G; Hinghofer-Szalkay, H; Goswami, N				Cvirn, Gerhard; Schlagenhauf, Axel; Leschnik, Bettina; Koestenberger, Martin; Roessler, Andreas; Jantscher, Andreas; Vrecko, Karoline; Juergens, Guenther; Hinghofer-Szalkay, Helmut; Goswami, Nandu			Coagulation Changes during Presyncope and Recovery	PLOS ONE			English	Article							PLASMA-VOLUME CHANGES; BLOOD-COAGULATION; PSYCHOLOGICAL STRESS; FIBRINOLYSIS; AGGREGATION; MECHANISM; PRESSURE; PARADOX	Orthostatic stress activates the coagulation system. The extent of coagulation activation with full orthostatic load leading to presyncope is unknown. We examined in 7 healthy males whether presyncope, using a combination of head up tilt (HUT) and lower body negative pressure (LBNP), leads to coagulation changes as well as in the return to baseline during recovery. Coagulation responses (whole blood thrombelastometry, whole blood platelet aggregation, endogenous thrombin potential, markers of endothelial activation and thrombin generation), blood cell counts and plasma mass density (for volume changes) were measured before, during, and 20 min after the orthostatic stress. Maximum orthostatic load led to a 25% plasma volume loss. Blood cell counts, prothrombin levels, thrombin peak, endogenous thrombin potential, and tissue factor pathway inhibitor levels increased during the protocol, commensurable with hemoconcentration. The markers of endothelial activation (tissue factor, tissue plasminogen activator), and thrombin generation (F1+2, prothrombin fragments 1 and 2, and TAT, thrombin-antithrombin complex) increased to an extent far beyond the hemoconcentration effect. During recovery, the markers of endothelial activation returned to initial supine values, but F1+2 and TAT remained elevated, suggestive of increased coagulability. Our findings of increased coagulability at 20 min of recovery from presyncope may have greater clinical significance than short-term procoagulant changes observed during standing. While our experiments were conducted in healthy subjects, the observed hypercoagulability during graded orthostatic challenge, at presyncope and in recovery may be an important risk factor particularly for patients already at high risk for thromboembolic events (e. g. those with coronary heart disease, atherosclerosis or hypertensives).	[Cvirn, Gerhard; Vrecko, Karoline; Juergens, Guenther] Med Univ Graz, Inst Physiol Chem, Graz, Austria; [Schlagenhauf, Axel; Leschnik, Bettina; Koestenberger, Martin] Med Univ Graz, Dept Paediat, Graz, Austria; [Roessler, Andreas; Jantscher, Andreas; Hinghofer-Szalkay, Helmut; Goswami, Nandu] Med Univ Graz, Inst Physiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Cvirn, G (corresponding author), Med Univ Graz, Inst Physiol Chem, Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008; Schlagenhauf, Axel/AAK-9598-2021; Koestenberger, Martin/J-5008-2019; Goswami, Nandu/B-4021-2011	Roessler, Andreas/0000-0001-9543-8870; Schlagenhauf, Axel/0000-0003-3408-6415; Koestenberger, Martin/0000-0003-1766-7859; 				Bassenge E, 1996, PROG CARDIOVASC DIS, V39, P209, DOI 10.1016/S0033-0620(96)80002-8; BAUER KA, 2001, HEMOSTASIS THROMBOSI, P1113; Cvirn G, 2007, BLOOD COAGUL FIBRIN, V18, P585, DOI 10.1097/MBC.0b013e328285d832; Dielis AWJH, 2005, HYPERTENSION, V46, P1236, DOI 10.1161/01.HYP.0000193538.20705.23; FILEP J, 1987, THROMB RES, V45, P7, DOI 10.1016/0049-3848(87)90252-0; Goswami N, 2009, PHYSIOL RES, V58, P311, DOI 10.33549/physiolres.931431; Goswami N, 2012, PHYSIOL BEHAV, V106, P569, DOI 10.1016/j.physbeh.2012.02.022; Goswami N, 2010, INT J PSYCHOPHYSIOL, V75, P54, DOI 10.1016/j.ijpsycho.2009.11.005; HAGAN RD, 1978, J APPL PHYSIOL, V45, P414, DOI 10.1152/jappl.1978.45.3.414; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; HINGHOFERSZALKAY H, 1986, AM J PHYSIOL, V250, pH68, DOI 10.1152/ajpheart.1986.250.1.H68; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Hitosugi M, 2000, THROMB RES, V100, P409, DOI 10.1016/S0049-3848(00)00348-0; Jacob G, 1998, J APPL PHYSIOL, V84, P914; Jacob G, 2005, MAYO CLIN PROC, V80, P611, DOI 10.4065/80.5.611; JEN CYJ, 1984, J LAB CLIN MED, V103, P115; Laszlo Z, 2001, PHYSIOL RES, V50, P71; Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219; Masoud M, 2008, HYPERTENSION, V51, P1545, DOI 10.1161/HYPERTENSIONAHA.108.112003; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P589, DOI 10.1055/s-2006-949664; Papousek I, 2010, BIOL PSYCHOL, V83, P108, DOI 10.1016/j.biopsycho.2009.11.008; Rossler A, 1999, HYPERTENSION, V34, P1147, DOI 10.1161/01.HYP.34.5.1147; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Thrall G, 2007, THROMB RES, V120, P819, DOI 10.1016/j.thromres.2007.01.004; Trementino L, 2010, NEUROENDOCRINOLOGY, V92, P55, DOI 10.1159/000314349; von Kanel R, 2003, J APPL PHYSIOL, V94, P1455, DOI 10.1152/japplphysiol.00892.2002; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Wirtz PH, 2006, J HYPERTENS, V24, P2409, DOI 10.1097/HJH.0b013e32801098e5	32	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42221	10.1371/journal.pone.0042221	http://dx.doi.org/10.1371/journal.pone.0042221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876309	gold, Green Published			2022-12-25	WOS:000307184700037
J	Frick, WF; Stepanian, PM; Kelly, JF; Howard, KW; Kuster, CM; Kunz, TH; Chilson, PB				Frick, Winifred F.; Stepanian, Phillip M.; Kelly, Jeffrey F.; Howard, Kenneth W.; Kuster, Charles M.; Kunz, Thomas H.; Chilson, Phillip B.			Climate and Weather Impact Timing of Emergence of Bats	PLOS ONE			English	Article							FREE-TAILED BATS; TADARIDA-BRASILIENSIS; ECOLOGICAL RESPONSES; PHENOLOGY; DECLINES; QPE	Interest in forecasting impacts of climate change have heightened attention in recent decades to how animals respond to variation in climate and weather patterns. One difficulty in determining animal response to climate variation is lack of long-term datasets that record animal behaviors over decadal scales. We used radar observations from the national NEXRAD network of Doppler weather radars to measure how group behavior in a colonially-roosting bat species responded to annual variation in climate and daily variation in weather over the past 11 years. Brazilian free-tailed bats (Tadarida brasiliensis) form dense aggregations in cave roosts in Texas. These bats emerge from caves daily to forage at high altitudes, which makes them detectable with Doppler weather radars. Timing of emergence in bats is often viewed as an adaptive trade-off between emerging early and risking predation or increased competition and emerging late which restricts foraging opportunities. We used timing of emergence from five maternity colonies of Brazilian free-tailed bats in south-central Texas during the peak lactation period (15 June-15 July) to determine whether emergence behavior was associated with summer drought conditions and daily temperatures. Bats emerged significantly earlier during years with extreme drought conditions than during moist years. Bats emerged later on days with high surface temperatures in both dry and moist years, but there was no relationship between surface temperatures and timing of emergence in summers with normal moisture levels. We conclude that emergence behavior is a flexible animal response to climate and weather conditions and may be a useful indicator for monitoring animal response to long-term shifts in climate.	[Frick, Winifred F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Stepanian, Phillip M.; Kuster, Charles M.; Chilson, Phillip B.] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Stepanian, Phillip M.; Kuster, Charles M.; Chilson, Phillip B.] Univ Oklahoma, Atmospher Radar Res Ctr, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Howard, Kenneth W.] NOAA, Natl Severe Storms Lab, Norman, OK 73069 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of California System; University of California Santa Cruz; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; National Oceanic Atmospheric Admin (NOAA) - USA; Boston University	Frick, WF (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	wfrick@ucsc.edu	Frick, Winifred F/G-3501-2012; Kelly, Jeffrey F/B-2029-2015; Frick, Winifred/ABA-3519-2020; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Chilson, Phillip B./C-8491-2012	Kelly, Jeffrey F/0000-0002-8255-7990; Frick, Winifred/0000-0002-9469-1839; 	NSF [DBI-0905881, EPS 0919466]; National Oceanic and Atmospheric Administration National Severe Storms Laboratory [NA08OAR4320904]; University of Oklahoma	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration National Severe Storms Laboratory(National Oceanic Atmospheric Admin (NOAA) - USA); University of Oklahoma	WFF was supported by NSF DBI-0905881. JFK was supported by NSF EPS 0919466. PBC was funded in part through the National Oceanic and Atmospheric Administration National Severe Storms Laboratory Grant NA08OAR4320904. PBC and PMS were partially supported through internal funding from the University of Oklahoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Buler JJ, 2009, IEEE T GEOSCI REMOTE, V47, P2741, DOI 10.1109/TGRS.2009.2014463; BULLOCK DJ, 1987, J ZOOL, V211, P267, DOI 10.1111/j.1469-7998.1987.tb01533.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chilson PB, ECOSPHERE; Chilson PB, 2012, B AM METEOROLOGICAL, V93, P1; Diehl RH, 2002, BIRD CONSERVATION IM, P876; Duverge PL, 2000, ECOGRAPHY, V23, P32, DOI 10.1034/j.1600-0587.2000.230104.x; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gauthreaux SA, 2008, INTEGR COMP BIOL, V48, P12, DOI 10.1093/icb/icn021; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hawkins BA, 1998, AM NAT, V152, P480, DOI 10.1086/286184; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Horn JW, 2008, INTEGR COMP BIOL, V48, P24, DOI 10.1093/icb/icn051; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; JONES G, 1994, PHILOS T R SOC B, V346, P445, DOI 10.1098/rstb.1994.0161; Kelly JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00257.1; Langston C, 2007, J ATMOS OCEAN TECH, V24, P776, DOI 10.1175/JTECH2001.1; Lee YF, 2001, ZOOL STUD, V40, P309; McCracken GF, 2008, INTEGR COMP BIOL, V48, P107, DOI 10.1093/icb/icn033; PALMER WC, 1965, 45 WEATH BUR RES; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Reichard JD, 2009, J MAMMAL, V90, P1478, DOI 10.1644/08-MAMM-A-266R1.1; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Sarkar D., 2019, NLME LINEAR NONLINEA; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Team RDC, 2012, R LANG ENV STAT COMP; Vasiloff SV, 2007, B AM METEOROL SOC, V88, P1899, DOI 10.1175/BAMS-88-12-1899; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whickam H, 2009, GGPLOT2 ELEGANT GRAP; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283; Zhang J, 2005, J ATMOS OCEAN TECH, V22, P30, DOI 10.1175/JTECH-1689.1; Zhang J, 2004, ERAD PUBLICATION SER, V2, P105; Zhang J, 2011, B AM METEOROL SOC, V92, P1321, DOI 10.1175/2011BAMS-D-11-00047.1; Zuur Alain F., 2009, P1	39	40	43	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42737	10.1371/journal.pone.0042737	http://dx.doi.org/10.1371/journal.pone.0042737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876331	Green Published, gold			2022-12-25	WOS:000307184700059
J	Worley, B; Richard, G; Harbison, GS; Powers, R				Worley, Bradley; Richard, Georgia; Harbison, Gerard S.; Powers, Robert			C-13 NMR Reveals No Evidence of n-pi* Interactions in Proteins	PLOS ONE			English	Article							CHEMICAL-SHIFTS; ENERGETICS; SECONDARY; DATABASE; AMIDE; STATE	An n-pi* interaction between neighboring carbonyl groups has been postulated to stabilize protein structures. Such an interaction would affect the C-13 chemical shielding of the carbonyl groups, whose paramagnetic component is dominated by n-pi* and pi-pi* excitations. Model compound calculations indicate that both the interaction energetics and the chemical shielding of the carbonyl group are instead dominated by a classical dipole-dipole interaction. A set of high-resolution protein structures with associated carbonyl C-13 chemical shift assignments verifies this correlation and provides no evidence for an inter-carbonyl n-pi* interaction.	[Worley, Bradley; Richard, Georgia; Harbison, Gerard S.; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Worley, B (corresponding author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.	rpowers3@unl.edu	Powers, Robert/AAK-3431-2020	Powers, Robert/0000-0001-9948-6837; Richard, Georgia/0000-0002-7803-621X	National Institute of Allergy and Infectious Diseases [R21AI081154]; National Institutes of Health [RR015468-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081154] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part from the National Institute of Allergy and Infectious Diseases (grant number R21AI081154) to RP. The research was performed in facilities renovated with support from the National Institutes of Health (grant number RR015468-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; ASAKAWA N, 1992, J AM CHEM SOC, V114, P3261, DOI 10.1021/ja00035a016; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Cisnetti F, 2004, CHEMPHYSCHEM, V5, P807, DOI 10.1002/cphc.200301041; De JWH, 1970, MOL PHYS, V18, P31; DEDIOS AC, 1993, SCIENCE, V260, P1491, DOI 10.1126/science.8502992; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Knudsen Michael, 2010, Human Genomics, V4, P207; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Markwick PRL, 2004, J AM CHEM SOC, V126, P11424, DOI 10.1021/ja047859r; Mera H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125109; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Pearson W R, 2000, Methods Mol Biol, V132, P185; RAMSEY NF, 1950, PHYS REV, V78, P699, DOI 10.1103/PhysRev.78.699; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SAVITSKY GB, 1965, J PHYS CHEM-US, V69, P3105, DOI 10.1021/j100893a048; Shakhnovich E, 2009, P NATL ACAD SCI USA, V106, P11823, DOI 10.1073/pnas.0906228106; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wylie BJ, 2007, J AM CHEM SOC, V129, P5318, DOI 10.1021/ja0701199; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	32	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2012	7	8							e42075	10.1371/journal.pone.0042075	http://dx.doi.org/10.1371/journal.pone.0042075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JA	22876300	Green Submitted, gold, Green Published			2022-12-25	WOS:000307184700028
J	Mandke, P; Wyatt, N; Fraser, J; Bates, B; Berberich, SJ; Markey, MP				Mandke, Pooja; Wyatt, Nicholas; Fraser, Jillian; Bates, Benjamin; Berberich, Steven J.; Markey, Michael P.			MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame	PLOS ONE			English	Article							MALIGNANT GLIOMAS; DOWN-REGULATION; SPLICE VARIANT; HDMX GENE; P53; AMPLIFICATION; OVEREXPRESSION; MIR-34A; ACTIVATION; DEGRADATION	Background: MDM4, also called MDMX or HDMX in humans, is an important negative regulator of the p53 tumor suppressor. MDM4 is overexpressed in about 17% of all cancers and more frequently in some types, such as colon cancer or retinoblastoma. MDM4 is known to be post-translationally regulated by MDM2-mediated ubiquitination to decrease its protein levels in response to genotoxic stress, resulting in accumulation and activation of p53. At the transcriptional level, MDM4 gene regulation has been less clearly understood. We have reported that DNA damage triggers loss of MDM4 mRNA and a concurrent increase in p53 activity. These experiments attempt to determine a mechanism for down-regulation of MDM4 mRNA. Methodology/Principal Findings: Here we report that MDM4 mRNA is a target of hsa-mir-34a (miR-34a). MDM4 mRNA contains a lengthy 39 untranslated region; however, we find that it is a miR-34a site within the open reading frame (ORF) of exon 11 that is responsible for the repression. Overexpression of miR-34a, but not a mutant miR-34a, is sufficient to decrease MDM4 mRNA levels to an extent identical to those of known miR-34a target genes. Likewise, MDM4 protein levels are decreased by miR-34a overexpression. Inhibition of endogenous miR-34a increased expression of miR-34a target genes and MDM4. A portion of MDM4 exon 11 containing this 8mer-A1 miR-34a site fused to a luciferase reporter gene is sufficient to confer responsiveness, being inhibited by additional expression of exogenous mir-34a and activated by inhibition of miR34a. Conclusions/Significance: These data establish a mechanism for the observed DNA damage-induced negative regulation of MDM4 and potentially provide a novel means to manipulate MDM4 expression without introducing DNA damage.	[Mandke, Pooja; Wyatt, Nicholas; Fraser, Jillian; Bates, Benjamin; Berberich, Steven J.; Markey, Michael P.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Mandke, P (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	michael.markey@wright.edu	Mandke, Pooja/AAX-6329-2021	Mandke, Pooja/0000-0001-5410-6968; Markey, Michael/0000-0002-8593-2290	American Cancer Society, Ohio Division	American Cancer Society, Ohio Division(American Cancer Society)	Expression plasmids for miR-34a and mutant miR-34a were kindly provided by Dr. Moshe Oren. This work was supported in part by a grant from the American Cancer Society, Ohio Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Allende-Vega N., 2012, ONCOGENE, P53; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bartel F, 2004, VERH DEUT G, V88, P199; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Giglio S, 2005, CANCER RES, V65, P9687, DOI 10.1158/0008-5472.CAN-05-0450; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Lal A, 2012, PLOS GENET, V7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Li MY, 2011, MOL CELL, V43, P1023, DOI 10.1016/j.molcel.2011.08.020; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; Markey MP, 2011, FRONT BIOSCI-LANDMRK, V16, P1144, DOI 10.2741/3780; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Rasband W.S., 1997, IMAGEJ; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rickman DS, 2001, CANCER RES, V61, P6885; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753	54	70	76	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e42034	10.1371/journal.pone.0042034	http://dx.doi.org/10.1371/journal.pone.0042034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870278	gold, Green Published, Green Submitted			2022-12-25	WOS:000307212800054
J	Zarie, ES; Kaidas, V; Gedamu, D; Mishra, YK; Adelung, R; Furkert, FH; Scherliess, R; Steckel, H; Groessner-Schreiber, B				Zarie, Eman S.; Kaidas, Viktor; Gedamu, Dawit; Mishra, Yogendra K.; Adelung, Rainer; Furkert, Franz H.; Scherliess, Regina; Steckel, Hartwig; Groessner-Schreiber, Birte			Solvent Free Fabrication of Micro and Nanostructured Drug Coatings by Thermal Evaporation for Controlled Release and Increased Effects	PLOS ONE			English	Article							DELIVERY; NANOPARTICLES; SOLUBILITY; DEVICES; DESIGN; WATER	Nanostructuring of drug delivery systems offers many promising applications like precise control of dissolution and release kinetics, enhanced activities, flexibility in terms of surface coatings, integration into implants, designing the appropriate scaffolds or even integrating into microelectronic chips etc. for different desired applications. In general such kind of structuring is difficult due to unintentional mixing of chemical solvents used during drug formulations. We demonstrate here the successful solvent-free fabrication of micro-nanostructured pharmaceutical molecules by simple thermal evaporation (TE). The evaporation of drug molecules and their emission to a specific surface under vacuum led to controlled assembling of the molecules from vapour phase to solid phase. The most important aspects of thermal evaporation technique are: solvent-free, precise control of size, possibility of fabricating multilayer/hybrid, and free choice of substrates. This could be shown for twenty eight pharmaceutical substances of different chemical structures which were evaporated on surfaces of titanium and glass discs. Structural investigations of different TE fabricated drugs were performed by atomic force microscopy, scanning electron microscopy and Raman spectroscopy which revealed that these drug substances preserve their structurality after evaporation. Titanium discs coated with antimicrobial substances by thermal evaporation were subjected to tests for antibacterial or antifungal activities, respectively. A significant increase in their antimicrobial activity was observed in zones of inhibition tests compared to controls of the diluted substances on the discs made of paper for filtration. With thermal evaporation, we have successfully synthesized solvent-free nanostructured drug delivery systems in form of multilayer structures and in hybrid drug complexes respectively. Analyses of these substances consolidated that thermal evaporation opens up the possibility to convert dissoluble drug substances into the active forms by their transfer onto a specific surface without the need of their prior dissolution.	[Zarie, Eman S.; Kaidas, Viktor; Gedamu, Dawit; Mishra, Yogendra K.; Adelung, Rainer] Univ Kiel, Inst Mat Sci, D-24098 Kiel, Germany; [Furkert, Franz H.; Scherliess, Regina; Steckel, Hartwig] Univ Kiel, Dept Pharmaceut & Biopharmaceut, Kiel, Germany; [Groessner-Schreiber, Birte] Univ Kiel, Dept Operat Dent & Periodontol, Arnold Heller Kiel, Germany	University of Kiel; University of Kiel; University of Kiel	Zarie, ES (corresponding author), Univ Kiel, Inst Mat Sci, Kaiserstr, D-24098 Kiel, Germany.	ra@tf.uni-kiel.de	Adelung, Rainer/AAU-1027-2021; Mishra, Yogendra Kumar/G-6241-2010	Adelung, Rainer/0000-0002-2617-678X; Mishra, Yogendra Kumar/0000-0002-8786-9379; Scherliess, Regina/0000-0001-8685-5672	Egyptian government; Alexander von Humboldt foundation; Deutsche Forschungsgemeinschaft (DFG); DFG founded Inflammation at Interfaces cluster	Egyptian government; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG founded Inflammation at Interfaces cluster	The authors gratefully acknowledge several grants: E. S. Z. a Ph. D. grant from Egyptian government, Y. K. M. a postdoctoral grant from Alexander von Humboldt foundation and R. A. a Heisenberg Professorship by the Deutsche Forschungsgemeinschaft (DFG). Furthermore, R. A. wants to thank the DFG founded Inflammation at Interfaces cluster for its support.	Bergstrom CAS, 2007, J MED CHEM, V50, P5858, DOI 10.1021/jm0706416; Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Derle D, 2010, INT J CURRENT PHARM, V2, P10; Ginty PJ, 2005, MATER TODAY, V8, P42, DOI 10.1016/S1369-7021(05)71036-1; Good DJ, 2009, CRYST GROWTH DES, V9, P2252, DOI 10.1021/cg801039j; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0; Katz HE, 2009, ANNU REV MATER RES, V39, P71, DOI 10.1146/annurev-matsci-082908-145433; Kreuter J, 2008, TUMORI J, V94, P271; Kulkarni AP, 2004, CHEM MATER, V16, P4556, DOI 10.1021/cm0494731; Langer R, 1998, NATURE, V392, P5; Lipinski CA, 2004, BIOTECH PHARM ASPECT, V1, P93; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mattox D. M., 2003, FDN VACUUM COATING T; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Mishima K, 2008, ADV DRUG DELIVER REV, V60, P411, DOI 10.1016/j.addr.2007.02.003; Montali A, 2006, INJURY, V37, P81, DOI 10.1016/j.injury.2006.04.013; Nakazawa G, 2008, NAT CLIN PRACT CARD, V5, P1, DOI 10.1038/ncpcardio1093; Patel R.P., 2009, INDIAN J SCI TECHNOL, V2, P44, DOI 10.17485/ijst/2009/v2i10.3; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pierige F, 2008, ADV DRUG DELIVER REV, V60, P286, DOI 10.1016/j.addr.2007.08.029; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/s0168-3659(00)00339-4; Takagi T, 2006, MOL PHARMACEUT, V3, P631, DOI 10.1021/mp0600182; Urban GA, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/012001; Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1; Venables J A, 2000, INTRO SURFACE THIN F; Wang WC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225504; Weszka J., 2009, J ACHIEVEMENTS MAT M, V35, P29; Xinming Li, 2008, Cont Lens Anterior Eye, V31, P57, DOI 10.1016/j.clae.2007.09.002; Yang YZ, 2008, VACUUM, V83, P569, DOI 10.1016/j.vacuum.2008.04.062; Zaporojtchenko V, 2006, NANOTECHNOLOGY, V17, P4904, DOI 10.1088/0957-4484/17/19/020; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463	33	17	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e40746	10.1371/journal.pone.0040746	http://dx.doi.org/10.1371/journal.pone.0040746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	22870203	Green Submitted, Green Published, gold			2022-12-25	WOS:000307212800009
J	Choi, JY; Roh, JY; Wang, Y; Zhen, Z; Tao, XY; Lee, JH; Liu, Q; Kim, JS; Shin, SW; Je, YH				Choi, Jae Young; Roh, Jong Yul; Wang, Yong; Zhen, Zou; Tao, Xue Ying; Lee, Joo Hyun; Liu, Qin; Kim, Jae Su; Shin, Sang Woon; Je, Yeon Ho			Analysis of Genes Expression of Spodoptera exigua Larvae upon AcMNPV Infection	PLOS ONE			English	Article							AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; HORMONE-BINDING-PROTEIN; GLYCOPROTEIN E2; MESSENGER-RNA; VIRUS; HEMOLYMPH; GLOVERIN; CELLS; BACULOVIRUSES; TRANSCRIPTION	Background: The impact of Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) infection on host gene expression in Spodoptera exigua 4th instar larvae was investigated through the use of 454 sequencing-based RNA-seq of cDNA libraries developed from insects challenged with active AcMNPV or heat-inactivated AcMNPV. Methodology/Principal Findings: By comparing the two cDNA libraries, we show that 201 host genes are significantly up-regulated and 234 genes are significantly down-regulated by active AcMNPV infection. Down-regulated host genes included genes encoding antimicrobial peptides, namely three gloverin isoforms and an attacin, indicating that the viral infection actively repressed the expression of a portion of the host immune gene repertoire. Another interesting group of down-regulated host genes included genes encoding two juvenile hormone binding proteins and a hexamerin, all of which are involved in juvenile hormone regulation. The expression of these genes was enhanced by the topical application of Juvenile Hormone III (JHIII) in the insects challenged with heat-inactivated AcMNPV. However, infection with the active virus strongly suppresses the expression of these three genes, regardless of the absence or presence of JHIII. Conclusions/Significance: Using RNA-seq, we have identified groups of immune-regulated and juvenile hormone-regulated genes that are suppressed by infection with active AcMNPV. This information and further studies on the regulation of host gene expression by AcMNPV will provide the tools needed to enhance the utility of the virus as an effective protein expression system and as an insecticide.	[Choi, Jae Young; Tao, Xue Ying; Lee, Joo Hyun; Liu, Qin; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Roh, Jong Yul] Korea Natl Inst Hlth, Div Med Entomol, Chungbuk, South Korea; [Wang, Yong] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhen, Zou] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Kim, Jae Su] Chonbuk Natl Univ, Coll Agr Life Sci, Dept Agr Biol, Jeonju, South Korea; [Shin, Sang Woon] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Shin, Sang Woon] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Je, Yeon Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Lanzhou University; Chinese Academy of Sciences; Institute of Zoology, CAS; Jeonbuk National University; University of California System; University of California Riverside; University of California System; University of California Riverside; Seoul National University (SNU)	Choi, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea.	shinwoongg@gmail.com; btrus@snu.ac.kr	zou, zhen/C-6134-2016; Tao, XueYing/ABG-6993-2021; Kim, Jae Su/L-2194-2013; Choi, Jae Young/G-1731-2010	zou, zhen/0000-0003-3550-7656; Tao, XueYing/0000-0002-6539-4659; 	Next-Generation BioGreen 21 Program [PJ008036]; Rural Development Administration, Republic of Korea; 2nd stage of the Brain Korea 21 project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); 2nd stage of the Brain Korea 21 project	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008036), Rural Development Administration, Republic of Korea. HJS, YW, XYT, and QL were supported by the 2nd stage of the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Bangels Eva, 2008, Commun Agric Appl Biol Sci, V73, P655; Bouma A, 1999, VET MICROBIOL, V66, P101, DOI 10.1016/S0378-1135(99)00003-6; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Choudary P V, 1995, Methods Mol Biol, V39, P243; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; GUARINO LA, 1992, J VIROL, V66, P7113, DOI 10.1128/JVI.66.12.7113-7120.1992; Guo TQ, 2005, VIROLOGY, V341, P231, DOI 10.1016/j.virol.2005.06.045; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Kawaoka S, 2008, ARCH INSECT BIOCHEM, V67, P87, DOI 10.1002/arch.20223; KRAMER KJ, 1974, P NATL ACAD SCI USA, V71, P493, DOI 10.1073/pnas.71.2.493; Landais I, 2003, BIOINFORMATICS, V19, P2343, DOI 10.1093/bioinformatics/btg324; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Pearson MN, 2001, VIROLOGY, V291, P22, DOI 10.1006/viro.2001.1191; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Sun XL, 2002, J INVERTEBR PATHOL, V81, P63, DOI 10.1016/S0022-2011(02)00144-1; Tawfik AI, 2006, J INSECT PHYSIOL, V52, P255, DOI 10.1016/j.jinsphys.2005.11.005; van Oers MM, 1999, J GEN VIROL, V80, P2253, DOI 10.1099/0022-1317-80-8-2253; van Oers MM, 2001, INSECT MOL BIOL, V10, P255, DOI 10.1046/j.1365-2583.2001.00263.x; van Rijn PA, 1999, VACCINE, V17, P433, DOI 10.1016/S0264-410X(98)00215-1; Vanarsdall AL, 2007, VIROLOGY, V364, P475, DOI 10.1016/j.virol.2007.03.024; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; YOUNG KKY, 1993, J CLIN MICROBIOL, V31, P882, DOI 10.1128/JCM.31.4.882-886.1993; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42462	10.1371/journal.pone.0042462	http://dx.doi.org/10.1371/journal.pone.0042462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860129	Green Submitted, Green Published, gold			2022-12-25	WOS:000307045600103
J	Joseph, S; Deneke, VE; Dahl, KDC				Joseph, Stancy; Deneke, Victoria E.; Dahl, Karen D. Cowden			ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA-BINDING PROTEINS; EPITHELIAL OVARIAN-CARCINOMA; CANCER-THERAPY; EXPRESSION; FAMILY; PHOSPHORYLATION; DIFFERENTIATION; INHIBITION; ACTIVATION	Alternative splicing is a common occurrence in many cancers. Alternative splicing is linked with decreased apoptosis and chemoresistance in cancer cells. We previously demonstrated that ARID3B, a member of the AT-rich interactive domain (ARID) family of DNA binding proteins, is overexpressed in ovarian cancer. Therefore we wanted to assess the effect of ARID3B splice forms on cell viability. We identified a novel splice form of the ARID3B gene (designated as ARID3B Sh), which lacks the C-terminal exons 5-9 present in the full-length isoform (ARID3B Fl). ARID3B Fl is expressed in a variety of cancer cell lines. Expression of ARID3B Sh varied by cell type, but was highly expressed in most ovarian cancer lines. ARID3B is modestly transcriptionally activated by epidermal growth factor receptor (EGFR) signaling through the PEA3 transcription factor. We further found that ARID3B Fl is predominantly nuclear but is also present at the plasma membrane and in the cytosol. Endogenous ARID3B Sh is present in nuclear fractions, yet, when overexpressed ARID3B Sh accumulates in the cytosol and membrane fractions. The differential localization of these isoforms suggests they have different functions. Importantly, ARID3B Fl overexpression results in upregulation of pro-apoptotic BIM and induces Tumor Necrosis Factor alpha (TNF alpha) and TNF-related apoptosis inducing ligand (TRAIL) induced cell death. The ARID3B Fl-induced genes include TNF alpha, TRAIL, TRADD, TNF-R2, Caspase 10 and Caspase 7. Interestingly, ARID3B Sh does not induce apoptosis or expression of these genes. ARID3B Fl induces death receptor mediated apoptosis while the novel splice form ARID3B Sh does not induce cell death. Therefore alternative splice forms of ARID3B may play different roles in ovarian cancer progression.	[Joseph, Stancy; Dahl, Karen D. Cowden] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN USA; [Dahl, Karen D. Cowden] Notre Dame Univ, Dept Chem & Biochem, Notre Dame, IN USA; [Dahl, Karen D. Cowden] Notre Dame Univ, Eck Inst Global Hlth, Notre Dame, IN USA; [Dahl, Karen D. Cowden] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Deneke, Victoria E.] Univ Notre Dame, Dept Engn, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University-Purdue University Indianapolis; University of Notre Dame	Joseph, S (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN USA.	kcowdend@iupui.edu		Deneke, Victoria/0000-0002-4404-8706	National Institutes of Health (NIH) [R00CA133190]; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R00CA133190] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) R00CA133190. This research was supported in part by a grant from the Marsha Rivkin Center for Ovarian Cancer Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American CancerSociety, 2010, GLOB CANC FACTS FIG; BERKOWITZ R, 1983, AM J OBSTET GYNECOL, V146, P607, DOI 10.1016/0002-9378(83)90999-7; Bevis KS, 2010, GYNECOL ONCOL, V119, P157, DOI 10.1016/j.ygyno.2010.05.034; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cretney E, 2006, IMMUNOL CELL BIOL, V84, P87, DOI 10.1111/j.1440-1711.2005.01413.x; Dahl KDC, 2007, MOL CANCER RES, V5, P413, DOI 10.1158/1541-7786.MCR-07-0019; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Ellerbroek SM, 1998, INT J CANCER, V78, P331, DOI 10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Kovalenko A, 2006, MOL CELL, V22, P433, DOI 10.1016/j.molcel.2006.05.002; MOSER TL, 1994, INT J CANCER, V56, P552, DOI 10.1002/ijc.2910560415; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Numata S, 1999, CANCER RES, V59, P3741; Sayers TJ, 2006, CANCER IMMUNOL IMMUN, V55, P76, DOI 10.1007/s00262-005-0676-3; SCAMBIA G, 1992, J CLIN ONCOL, V10, P529, DOI 10.1200/JCO.1992.10.4.529; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; STEWART CJR, 1992, INT J GYNECOL PATHOL, V11, P266, DOI 10.1097/00004347-199210000-00004; Syed V, 2007, J CELL BIOCHEM, V102, P442, DOI 10.1002/jcb.21304; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Tanaka Y, 2011, CANCER BIOL THER, V11, P50, DOI 10.4161/cbt.11.1.13877; Tidwell JA, 2011, MOL IMMUNOL, V49, P260, DOI 10.1016/j.molimm.2011.08.025; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; Webb CF, 1998, J IMMUNOL, V160, P4747; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95	40	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42159	10.1371/journal.pone.0042159	http://dx.doi.org/10.1371/journal.pone.0042159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860069	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600062
J	Matias, I; Gatta-Cherifi, B; Tabarin, A; Clark, S; Leste-Lasserre, T; Marsicano, G; Piazza, PV; Cota, D				Matias, Isabelle; Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Leste-Lasserre, Thierry; Marsicano, Giovanni; Piazza, Pier Vincenzo; Cota, Daniela			Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity	PLOS ONE			English	Article							ENERGY-BALANCE; LIFE-STYLE; CB1 RECEPTOR; FOOD-INTAKE; ANANDAMIDE; SYSTEM; ACTIVATION; PLASMA; ACYLETHANOLAMIDES; INHIBITION	Background: The discovery of the endocannabinoid system and of its role in the regulation of energy balance has significantly advanced our understanding of the physiopathological mechanisms leading to obesity and type 2 diabetes. New knowledge on the role of this system in humans has been acquired by measuring blood endocannabinoids. Here we explored endocannabinoids and related N-acylethanolamines in saliva and verified their changes in relation to body weight status and in response to a meal or to body weight loss. Methodology/Principal Findings: Fasting plasma and salivary endocannabinoids and N-acylethanolamines were measured through liquid mass spectrometry in 12 normal weight and 12 obese, insulin-resistant subjects. Salivary endocannabinoids and N-acylethanolamines were evaluated in the same cohort before and after the consumption of a meal. Changes in salivary endocannabinoids and N-acylethanolamines after body weight loss were investigated in a second group of 12 obese subjects following a 12-weeks lifestyle intervention program. The levels of mRNAs coding for enzymes regulating the metabolism of endocannabinoids, N-acylethanolamines and of cannabinoid type 1 (CB1) receptor, alongside endocannabinoids and N-acylethanolamines content, were assessed in human salivary glands. The endocannabinoids 2-arachidonoylglycerol (2-AG), N-arachidonoylethanolamide (anandamide, AEA), and the N-acylethanolamines (oleoylethanolamide, OEA and palmitoylethanolamide, PEA) were quantifiable in saliva and their levels were significantly higher in obese than in normal weight subjects. Fasting salivary AEA and OEA directly correlated with BMI, waist circumference and fasting insulin. Salivary endocannabinoids and N-acylethanolamines did not change in response to a meal. CB1 receptors, ligands and enzymes were expressed in the salivary glands. Finally, a body weight loss of 5.3% obtained after a 12-weeks lifestyle program significantly decreased salivary AEA levels. Conclusions/Significance: Endocannabinoids and N-acylethanolamines are quantifiable in saliva and their levels correlate with obesity but not with feeding status. Body weight loss significantly decreases salivary AEA, which might represent a useful biomarker in obesity.	[Matias, Isabelle; Marsicano, Giovanni] INSERM, Grp Endocannabinoids & Neuroadaptat, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Cota, Daniela] INSERM, Grp Energy Balance & Obes, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Leste-Lasserre, Thierry; Piazza, Pier Vincenzo] INSERM, Grp Physiopathol Addict, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Matias, Isabelle; Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Leste-Lasserre, Thierry; Marsicano, Giovanni; Piazza, Pier Vincenzo; Cota, Daniela] Univ Bordeaux, Neuroctr Magendie Physiopathol Plasticite Neurona, Bordeaux, France; [Gatta-Cherifi, Blandine; Tabarin, Antoine] Haut Leveque Hosp, Dept Endocrinol, Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Matias, I (corresponding author), INSERM, Grp Endocannabinoids & Neuroadaptat, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France.	daniela.cota@inserm.fr	Marsicano, Giovanni/I-9603-2016	Cota, Daniela/0000-0002-6909-2156; Marsicano, Giovanni/0000-0003-3804-1951; Cherifi, Blandine/0000-0002-7399-1330	INSERM/AVENIR; INSERM/ interface; Aquitaine Region; French Society of Endocrinology; Fondation Recherche Medicale; EU-FP7 [HEALTH-F2-2008-223713]; EU-FP7 ENDOFOOD [ERC-2010-StG]	INSERM/AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM/ interface; Aquitaine Region(Region Nouvelle-Aquitaine); French Society of Endocrinology; Fondation Recherche Medicale; EU-FP7(European Commission); EU-FP7 ENDOFOOD	This work was supported by INSERM/AVENIR (DC and GM), INSERM/ interface (DC), Aquitaine Region (DC and GM), French Society of Endocrinology (BGC), Fondation Recherche Medicale, EU-FP7 HEALTH-F2-2008-223713 and EU-FP7 ENDOFOOD ERC-2010-StG (GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Benedix F, 2011, OBES SURG, V21, P616, DOI 10.1007/s11695-011-0374-5; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Dall'Aglio C, 2010, VET RES COMMUN, V34, pS9, DOI 10.1007/s11259-010-9379-0; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Epstein LH, 1996, PSYCHOSOM MED, V58, P160, DOI 10.1097/00006842-199603000-00011; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Fernandez-Solari J, 2010, ARCH ORAL BIOL, V55, P583, DOI 10.1016/j.archoralbio.2010.05.006; Fezza F, 2003, BBA-MOL CELL BIOL L, V1633, P61, DOI 10.1016/S1388-1981(03)00087-8; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Joosten MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-49; Jumpertz R, 2010, EXP CLIN ENDOCR DIAB, V118, P591, DOI 10.1055/s-0030-1253344; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Lam PMW, 2010, ANAL BIOANAL CHEM, V398, P2089, DOI 10.1007/s00216-010-4103-z; Lawrence Herenia P, 2002, J Can Dent Assoc, V68, P170; Li BB, 2011, ARCH ORAL BIOL, V56, P389, DOI 10.1016/j.archoralbio.2010.10.014; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Marczylo TH, 2009, ANAL BIOCHEM, V384, P106, DOI 10.1016/j.ab.2008.08.040; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Modeer T, 2010, OBESITY, V18, P2367, DOI 10.1038/oby.2010.63; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Prestifilippo JP, 2009, ALCOHOL ALCOHOLISM, V44, P443, DOI 10.1093/alcalc/agp040; POWERS PS, 1982, INT J OBESITY, V6, P267; Prestifilippo JP, 2006, EXP BIOL MED, V231, P1421, DOI 10.1177/153537020623100816; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schwartz GJ, 2011, PHYSIOL BEHAV, V104, P621, DOI 10.1016/j.physbeh.2011.05.003; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Unick JL, 2011, DIABETES CARE, V34, P2152, DOI 10.2337/dc11-0874; Ware MA, 2003, PAIN, V102, P211, DOI 10.1016/S0304-3959(02)00400-1; WOOLEY OW, 1976, PHYSIOL BEHAV, V17, P187, DOI 10.1016/0031-9384(76)90062-7; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107	44	84	88	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42399	10.1371/journal.pone.0042399	http://dx.doi.org/10.1371/journal.pone.0042399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860123	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600099
J	Ellertsdottir, E; Berthold, PR; Bouzaffour, M; Dufourcq, P; Trayer, V; Gauron, C; Vriz, S; Affolter, M; Rampon, C				Ellertsdottir, Elin; Berthold, Peter R.; Bouzaffour, Mohamed; Dufourcq, Pascale; Trayer, Vincent; Gauron, Carole; Vriz, Sophie; Affolter, Markus; Rampon, Christine			Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System	PLOS ONE			English	Article							THROMBIN-RECEPTOR; VASCULAR DEVELOPMENT; DESENSITIZATION; HEMATOPOIESIS; INHIBITION; KINASE	Thrombin receptor, F2R or PAR1 is a G-protein coupled receptor, located in the membrane of endothelial cells. It has been initially found to transduce signals in hemostasis, but recently also known to act in cancer and in vascular development. Mouse embryos lacking PAR1 function die from hemorrhages with varying frequency at midgestation. We have performed a survey of potential PAR1 homologs in the zebrafish genome and identified a teleost ortholog of mammalian PAR1. Knockdown of par1 function in zebrafish embryos demonstrates a requirement for Par1 in cardio-vascular development. Furthermore, we show that function of Par1 requires the presence of a phylogenetically conserved proteolytic cleavage site and a second intracellular domain. Altogether our results demonstrate a high degree of conservation of PAR1 proteins in the vertebrate lineage in respect to amino acid sequence as well as protein function.	[Ellertsdottir, Elin; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland; [Berthold, Peter R.; Bouzaffour, Mohamed; Dufourcq, Pascale; Trayer, Vincent; Vriz, Sophie; Rampon, Christine] Univ Paris Diderot, Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] CNRS, UMR 7241, Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] INSERM, Paris, France	University of Basel; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Ellertsdottir, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	christine.rampon@college-de-france.fr		Affolter, Markus/0000-0002-5171-0016; /0000-0002-9058-9378; rampon, christine/0000-0002-1444-3166; /0000-0003-2029-5750	Swiss National Science Foundation; Network of Excellence grant "Cells into Organs" from the FP6 of the European Community; ANR Proteophane; Canton Basel-Stadt; Canton Basel-Land	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Network of Excellence grant "Cells into Organs" from the FP6 of the European Community; ANR Proteophane(French National Research Agency (ANR)); Canton Basel-Stadt; Canton Basel-Land	This work has been supported by the Cantons Basel-Stadt and Basel-Land, the Swiss National Science Foundation, and by a Network of Excellence grant "Cells into Organs" from the FP6 of the European Community. Carole Gauron is supported by ANR Proteophane 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211; Iida A, 2010, CURR BIOL, V20, P1110, DOI 10.1016/j.cub.2010.04.052; ISHII K, 1994, J BIOL CHEM, V269, P1125; Jiang TR, 1998, J MOL CELL CARDIOL, V30, P2193, DOI 10.1006/jmcc.1998.0779; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kwan TT, 2006, EXP HEMATOL, V34, P27, DOI 10.1016/j.exphem.2005.09.017; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McKinney MC, 2008, METHOD ENZYMOL, V444, P65, DOI 10.1016/S0076-6879(08)02804-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Song M, 2007, BIOCHEM BIOPH RES CO, V357, P924, DOI 10.1016/j.bbrc.2007.04.033; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xu H, 2011, DEV DYNAM, V240, P278, DOI 10.1002/dvdy.22517; Yasutake M, 1996, CIRC RES, V79, P705, DOI 10.1161/01.RES.79.4.705; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025	38	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42131	10.1371/journal.pone.0042131	http://dx.doi.org/10.1371/journal.pone.0042131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860064	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950900070
J	Lin, S; Gu, HP; Xu, M; Cui, XJ; Zhang, YY; Gao, W; Yuan, G				Lin, Sen; Gu, Huiping; Xu, Ming; Cui, Xiaojie; Zhang, Youyi; Gao, Wei; Yuan, Gu			The Formation and Stabilization of a Novel G-Quadruplex in the 5 '-Flanking Region of the Relaxin Gene	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RELEVANT G-QUADRUPLEX; AUTOMATED DOCKING; BERBERINE DERIVATIVES; CIRCULAR-DICHROISM; DNA; BINDING; RECOGNITION; PROMOTER; TARGET	It has been reported that binding of STAT3 protein to the 5'-flanking region of the relaxin gene may result in downregulation of the relaxin expression. There is a Guanine(G)-rich segment located in about 3.8 Kb upstream of the relaxin gene and very close to the STAT3's binding site. In our study, NMR spectroscopy revealed the formation of G-quadruplex by this G-rich strand, and the result was confirmed by ESI mass spectrometry and CD spectroscopy. The theoretical structure of RLX G-quadruplex was constructed and refined by molecular modeling. When this relaxin G-quadruplex was stabilized by berberine(Delta Tm=10 degrees C), a natural alkaloid from a Chinese herb, the gene expression could be up-regulated in a dose-dependent manner which was proved by luciferase assay. This result is different from the general G-quadruplex function that inhibiting the telomere replication or down-regulating many oncogenes expression. Therefore, our study reported a novel G- quadruplex in the relaxin gene and complemented the regulation mechanism about gene expression by G- quadruplexes.	[Lin, Sen; Cui, Xiaojie; Yuan, Gu] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Gu, Huiping; Xu, Ming; Zhang, Youyi; Gao, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth,Hosp 3,Minist Educ,Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lin, S (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; guyuan@pku.edu.cn			National Natural Science Foundation of China [90913004, 81070196]; Program for New Century Excellent Talents in University; Beijing Talents Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Talents Foundation	This work was supported by the National Natural Science Foundation of China (no. 90913004 and 81070196) and Program for New Century Excellent Talents in University and Beijing Talents Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Arora A, 2008, FEBS J, V275, P3971, DOI 10.1111/j.1742-4658.2008.06541.x; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bishop GR, 2007, BIOPHYS CHEM, V126, P165, DOI 10.1016/j.bpc.2006.07.009; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cosconati S, 2009, J AM CHEM SOC, V131, P16336, DOI 10.1021/ja9063662; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Grand CL, 2002, EUR J CANCER, V38, pS106; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li HH, 2009, CHEM-EUR J, V15, P2445, DOI 10.1002/chem.200801922; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu XH, 2010, CARDIOVASC RES, V88, P150, DOI 10.1093/cvr/cvq181; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Negri AL, 2004, J NEPHROL, V17, P496; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sherwood O. David, 1994, P861; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zhou J, 2007, CHEM-EUR J, V13, P945, DOI 10.1002/chem.200600424	45	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31201	10.1371/journal.pone.0031201	http://dx.doi.org/10.1371/journal.pone.0031201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22876305	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700031
J	Jin, HY; Song, B; Oudit, GY; Davidge, ST; Yu, HM; Jiang, YY; Gao, PJ; Zhu, DL; Ning, G; Kassiri, Z; Penninger, JM; Zhong, JC				Jin, Hai-Yan; Song, Bei; Oudit, Gavin Y.; Davidge, Sandra T.; Yu, Hui-Min; Jiang, Yan-Yan; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Kassiri, Zamaneh; Penninger, Josef M.; Zhong, Jiu-Chang			ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONVERTING ENZYME 2; SPONTANEOUSLY HYPERTENSIVE-RATS; VASCULAR INFLAMMATION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NULL MICE; OVEREXPRESSION; HYPERTROPHY; DYSFUNCTION	Inflammation and oxidative stress play a crucial role in angiotensin (Ang) II-mediated vascular injury. Angiotensin-converting enzyme 2 (ACE2) has recently been identified as a specific Ang II-degrading enzyme but its role in vascular biology remains elusive. We hypothesized that loss of ACE2 would facilitate Ang II-mediated vascular inflammation and peroxynitrite production. 10-week wildtype (WT, Ace2(+/y)) and ACE2 knockout (ACE2KO, Ace2(-/y)) mice received with mini-osmotic pumps with Ang II (1.5 mg.kg(-1).d(-1)) or saline for 2 weeks. Aortic ACE2 protein was obviously reduced in WT mice in response to Ang II related to increases in profilin-1 protein and plasma levels of Ang II and Ang-(1-7). Loss of ACE2 resulted in greater increases in Ang II-induced mRNA expressions of inflammatory cytokines monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-1 beta, and IL-6 without affecting tumor necrosis factor-alpha in aortas of ACE2KO mice. Furthermore, ACE2 deficiency led to greater increases in Ang II-mediated profilin-1 expression, NADPH oxidase activity, and superoxide and peroxynitrite production in the aortas of ACE2KO mice associated with enhanced phosphorylated levels of Akt, p70S6 kinase, extracellular signal-regulated kinases (ERK1/2) and endothelial nitric oxide synthase (eNOS). Interestingly, daily treatment with AT1 receptor blocker irbesartan (50 mg/kg) significantly prevented Ang II-mediated aortic profilin-1 expression, inflammation, and peroxynitrite production in WT mice with enhanced ACE2 levels and the suppression of the Akt-ERK-eNOS signaling pathways. Our findings reveal that ACE2 deficiency worsens Ang II-mediated aortic inflammation and peroxynitrite production associated with the augmentation of profilin-1 expression and the activation of the Akt-ERK-eNOS signaling, suggesting potential therapeutic approaches by enhancing ACE2 action for patients with vascular diseases.	[Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Zhong, Jiu-Chang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Zhong, Jiu-Chang] Shanghai Res Inst Hypertens, Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Oudit, Gavin Y.; Davidge, Sandra T.; Jiang, Yan-Yan; Kassiri, Zamaneh] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Obstet, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Gynecol, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Yu, Hui-Min] Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yu, Hui-Min] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Alberta; University of Alberta; University of Alberta; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Jin, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jiuchangzhong@yahoo.com.cn	Penninger, Josef M/I-6860-2013; Buchko, Garry/G-6173-2015	Penninger, Josef M/0000-0002-8194-3777; Davidge, Sandra/0000-0002-5559-4905; Buchko, Garry/0000-0002-3639-1061	National Natural Science Foundation of China [30973522, 81170246]; Shanghai Pujiang Talents Program [11PJ1408300]; Health Bureau of Shanghai [2011347]; Canadian Institute for Health Research [86602, 84279]; Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Program(Shanghai Pujiang Program); Health Bureau of Shanghai; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grants. 30973522 & 81170246 to JCZ), Shanghai Pujiang Talents Program (11PJ1408300 to JCZ), Scientific Research Project of Health Bureau of Shanghai (2011347 to HYJ), the Canadian Institute for Health Research (Grants 86602 to GYO, 84279 to ZK), the Alberta Innovates-Health Solutions (JCZ and GYO), and "New Hundred Talents Program" of Shanghai Jiao Tong University School of Medicine to JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Batlle D, 2010, CIRC RES, V107, P822, DOI 10.1161/CIRCRESAHA.110.229831; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Cheng JF, 2011, VASC PHARMACOL, V55, P34, DOI 10.1016/j.vph.2011.04.003; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Ebrahimian T, 2011, HYPERTENSION, V57, P245, DOI 10.1161/HYPERTENSIONAHA.110.159889; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Guo YJ, 2008, ARCH MED RES, V39, P149, DOI 10.1016/j.arcmed.2007.07.010; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Horrevoets AJG, 2007, CIRC RES, V101, P328, DOI 10.1161/CIRCRESAHA.107.158881; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kagota S, 2009, J PHARMACOL SCI, V109, P556, DOI 10.1254/jphs.08273FP; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	35	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38502	10.1371/journal.pone.0038502	http://dx.doi.org/10.1371/journal.pone.0038502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22879982	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900051
J	Xu, D; Gao, ZQ; Zhang, XW; Fan, X; Wang, YT; Li, DM; Wang, W; Zhuang, ZM; Ye, NH				Xu, Dong; Gao, Zhengquan; Zhang, Xiaowen; Fan, Xiao; Wang, Yitao; Li, Demao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao			Allelopathic Interactions between the Opportunistic Species Ulva prolifera and the Native Macroalga Gracilaria lichvoides	PLOS ONE			English	Article							RED SEAWEED; GROWTH; EPIPHYTES; CONFERTA; CHLOROPHYTA; RHODOPHYTA; INVASION; LACTUCA	Allelopathy, one type of direct plant competition, can be a potent mechanism through which plant communities are structured. The aim of this study was to determine whether allelopathic interactions occur between the opportunistic green tide-forming species Ulva prolifera and the native macroalga Gracilaria lichvoides, both of which were collected from the coastline of East China sea. In laboratory experiments, the presence of G. lichvoides at 1.25 g wet weight L-1 significantly inhibited growth and photosynthesis of U. prolifera at concentrations of 1.25, 2.50, and 3.75 g wet weight L-1 (p < 0.05) in both semi-continuous co-culture assays and in co-culture assays without nutrient supplementation. In contrast, although U. prolifera had a density effect on G. lichvoides, the differences among treatments were not significant (p > 0.05). Culture medium experiments further confirmed that some allelochemicals may be released by both of the tested macroalgae, and these could account for the observed physiological inhibition of growth and photosynthesis. Moreover, the native macroalgae G. lichvoides was a stronger competitor than the opportunistic species U. prolifera. Collectively, the results of the present study represent a significant advance in exploring ecological questions about the effects of green tide blooms on the macroalgal community.	[Xu, Dong; Zhang, Xiaowen; Fan, Xiao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Gao, Zhengquan] Shandong Univ Technol, Sch Life Sci, Zibo, Peoples R China; [Wang, Yitao] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Li, Demao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Key Lab Ind Biol Syst & Bioproce Engn, Tianjin, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shandong University of Technology; Qingdao Agricultural University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Xu, D (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			Shandong Science and Technology plan project [2011GHY11528]; Hi-Tech Research and Development Program (863) of China [2012AA052103]; Specialized Fund for the Basic Research Operating expenses Program [20603022012004, 2010-ts-03]; National Natural Science Foundation of China [41176153]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology plan project [11-3-1-5-hy]; National Marine Public Welfare Research Project [200805069]; National Science & Technology Pillar Program [2008BAD95B11, 2010BAC68B03]	Shandong Science and Technology plan project; Hi-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Specialized Fund for the Basic Research Operating expenses Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology plan project; National Marine Public Welfare Research Project; National Science & Technology Pillar Program	This work was supported by Shandong Science and Technology plan project (2011GHY11528), the Hi-Tech Research and Development Program (863) of China (2012AA052103), the Specialized Fund for the Basic Research Operating expenses Program (20603022012004, 2010-ts-03), National Natural Science Foundation of China (41176153), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (11-3-1-5-hy), National Marine Public Welfare Research Project (200805069), and the National Science & Technology Pillar Program, (2008BAD95B11, 2010BAC68B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Frankenstein G., 2000, BLOOMS ULVOIDS PUGET; Friedlander M, 1996, J APPL PHYCOL, V8, P21, DOI 10.1007/BF02186217; FRIEDLANDER M, 1991, BOT MAR, V34, P161, DOI 10.1515/botm.1991.34.3.161; Huo YZ, 2011, HARMFUL ALGAE, V10, P411, DOI 10.1016/j.hal.2011.02.003; Jarchow ME, 2009, PLANT ECOL, V204, P113, DOI 10.1007/s11258-009-9573-8; Ji XQ, 2011, CHIN J OCEANOL LIMN, V29, P840, DOI 10.1007/s00343-011-0512-x; Klein J, 2005, MAR ECOL PROG SER, V290, P79, DOI 10.3354/meps290079; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Leliaert F, 2008, MARINE POLLUTION B, V56, P15; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; Lundholm N, 2005, MAR ECOL PROG SER, V288, P21, DOI 10.3354/meps288021; Macias Francisco A., 2008, Phytochemistry Reviews, V7, P155, DOI 10.1007/s11101-007-9065-1; Mineur F, 2008, J MAR BIOL ASSOC UK, V88, P693, DOI 10.1017/S0025315408001409; Nan CR, 2008, AQUAT BOT, V89, P9, DOI 10.1016/j.aquabot.2008.01.005; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Schmidt LE, 2001, MAR ECOL PROG SER, V216, P67, DOI 10.3354/meps216067; SVIRSKI E, 1993, HYDROBIOLOGIA, V261, P391; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tang YZ, 2011, HARMFUL ALGAE, V10, P480, DOI 10.1016/j.hal.2011.03.003; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Walters LJ, 2006, FRONT ECOL ENVIRON, V4, P75, DOI 10.1890/1540-9295(2006)004[0075:EACUDO]2.0.CO;2; Wang RJ, 2007, J SEA RES, V58, P189, DOI 10.1016/j.seares.2007.03.002; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; Wang Y, 2009, J APPL PHYCOL, V21, P375, DOI 10.1007/s10811-008-9380-y; Wasson K, 2005, BIOL INVASIONS, V7, P935, DOI 10.1007/s10530-004-2995-2; White LF, 2011, J EXP MAR BIOL ECOL, V405, P111, DOI 10.1016/j.jembe.2011.05.024; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Wonham MJ, 2006, ECOL LETT, V9, P663, DOI 10.1111/j.1461-0248.2006.00913.x; Worm B, 2001, OECOLOGIA, V128, P281, DOI 10.1007/s004420100648; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	41	66	68	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33648	10.1371/journal.pone.0033648	http://dx.doi.org/10.1371/journal.pone.0033648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496758	gold, Green Published, Green Submitted			2022-12-25	WOS:000305014500014
J	Strode, C; de Melo-Santos, M; Magalhaes, T; Araujo, A; Ayres, C				Strode, Clare; de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia			Expression Profile of Genes during Resistance Reversal in a Temephos Selected Strain of the Dengue Vector, Aedes aegypti	PLOS ONE			English	Article							INSECTICIDE-RESISTANCE; ANOPHELES-GAMBIAE; DETOXIFICATION GENES; CULEX-QUINQUEFASCIATUS; LARVAL TOLERANCE; FIELD-EVALUATION; MALARIA VECTORS; MOSQUITO; CULICIDAE; DIPTERA	Background: The mosquito Aedes aegypti is one of the most important disease vectors because it transmits two major arboviruses, dengue and yellow fever, which cause significant global morbidity and mortality. Chemical insecticides form the cornerstone of vector control. The organophosphate temephos a larvicide recommended by WHO for controlling Ae. aegypti, however, resistance to this compound has been reported in many countries, including Brazil. Methodology/Principal Findings: The aim of this study was to identify genes implicated in metabolic resistance in an Ae. aegypti temephos resistant strain, named RecR, through microarray analysis. We utilized a custom 'Ae. aegypti detox chip' and validated microarray data through RT-PCR comparing susceptible and resistant individuals. In addition, we analyzed gene expression in 4th instar larvae from a reversed susceptible strain (RecRev), exposed and unexposed to temephos. The results obtained revealed a set of 13 and 6 genes significantly over expressed in resistant adult mosquitoes and larvae, respectively. One of these genes, the cytochrome P450 CYP6N12, was up-regulated in both stages. RT-PCR confirmed the microarray results and, additionally, showed no difference in gene expression between temephos exposed and unexposed RecRev mosquitoes. This suggested that the differences in the transcript profiles among the strains are heritable due to a selection process and are not caused by immediate insecticide exposure. Reversal of temephos resistance was demonstrated and, importantly, there was a positive correlation between a decrease in the resistance ratio and an accompanying decrease in the expression levels of previously over expressed genes. Some of the genes identified here have also been implicated in metabolic resistance in other mosquito species and insecticide resistant populations of Ae. aegypti. Conclusions/Significance: The identification of gene expression signatures associated to insecticide resistance and their suppression could greatly aid the development of improved strategies of vector control.	[Strode, Clare] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, Dept Entomol, Recife, PE, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Strode, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	c.strode@liv.ac.uk	Magalhaes, Tereza/V-6632-2019; Ball, Becky/E-6573-2011; Magalhaes, Catarina/A-6836-2016	Strode, Clare/0000-0003-2833-8073; Cary, Stephen/0000-0002-2876-2387; Ball, Becky/0000-0001-8592-1316; Magalhaes, Catarina/0000-0001-9576-2398; Ruprecht, Ulrike/0000-0002-0898-7677	National Council for Scientific and Technological Development 384 (CNPq Pronex grant) [550116/2010-9]; Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE) [APQ 1361-4.00/08]	National Council for Scientific and Technological Development 384 (CNPq Pronex grant); Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE)	This work was funded by National Council for Scientific and Technological Development 384 (CNPq Pronex grant 550116/2010-9) and Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE, Grant ID: APQ 1361-4.00/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Lan Q., 1992, Insect Molecular Biology, V1, P71, DOI 10.1111/j.1365-2583.1993.tb00107.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu N, 1996, BIOCHEM GENET, V34, P133, DOI 10.1007/BF02396246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020; Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Peixoto CA, 2008, PARASITOL RES, V103, P717, DOI 10.1007/s00436-008-1020-6; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Raghavendra K, 2011, ACTA TROP, V118, P50, DOI 10.1016/j.actatropica.2011.02.001; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Raghavendra K, 2010, INDIAN J MED RES, V132, P260; Raghavendra K, 2010, PARASITOL RES, V107, P1291, DOI 10.1007/s00436-010-2001-0; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Saude Md, 2006, QUANTIFICATION METHO, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang JF, 1998, J MED ENTOMOL, V35, P716, DOI 10.1093/jmedent/35.5.716; WHO, 2021, DENGUE DENGUE HAEMOR; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	43	57	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e39439	10.1371/journal.pone.0039439	http://dx.doi.org/10.1371/journal.pone.0039439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	23028563	Green Published, Green Accepted, gold			2022-12-25	WOS:000307212800002
J	Kong, XB; Liu, KW; Wang, HB; Zhang, SF; Zhang, Z				Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen			Identification and Behavioral Evaluation of Sex Pheromone Components of the Chinese Pine Caterpillar Moth, Dendrolimus tabulaeformis	PLOS ONE			English	Article							MASS-SPECTROMETRY; ATTRACTANT; ACETATES; SUPERANS	Background: The Chinese pine caterpillar moth, Dendrolimus tabulaeformis Tsai and Liu (Lepidoptera: Lasiocampidae) is the most important defoliator of coniferous trees in northern China. Outbreaks occur over enormous areas and often lead to the death of forests during 2-3 successive years of defoliation. The sex pheromone of D. tabulaeformis was investigated to define its chemistry and behavioral activity. Methodology/Principal Findings: Sex pheromone was collected from calling female D. tabulaeformis by headspace solid phase microextraction (SPME) and by solvent extraction of pheromone glands. Extracts were analyzed by coupled gas chromatography/mass spectrometry (GC-MS) and coupled GC-electroantennographic detection (GC-EAD), using antennae from male moths. Five components from the extracts elicited antennal responses. These compounds were identified by a combination of retention indices, electron impact mass spectral matches, and derivatization as (Z)-5-dodecenyl acetate (Z5-12:OAc), (Z)-5-dodecenyl alcohol (Z5-12:OH), (5Z,7E)-5,7-dodecadien-1-yl acetate (Z5,E7-12:OAc), (5Z,7E)-5,7-dodecadien-1-yl propionate (Z5,E7-12:OPr), and (5Z,7E)-5,7-dodecadien-1-ol (Z5,E7-12:OH). Behavioral assays showed that male D. tabulaeformis strongly discriminated against incomplete and aberrant blend ratios. The correct ratio of Z5,E7-12:OAc, Z5,E7-12:OH, and Z5,E7-12:OPr was essential for optimal upwind flight and source contact. The two monoenes, Z5-12:OAc and Z5-12:OH, alone or binary mixtures, had no effect on behavioral responses when added to the optimal three-component blend. Conclusions/Significance: The fact that deviations from the optimal ratio of 100:100:4.5 of Z5,E7-12:OAc, Z5,EZ7-12:OH, and Z5,E7-12:OPr resulted in marked decreases in male responses suggests that biosynthesis of the pheromone components is precisely controlled. The optimal blend of the sex pheromone components of D. tabulaeformis worked out in this study should find immediate use in monitoring this pest in Chinese forests.	[Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen] Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China; [Liu, Kui-Wei] Shandong Agr Univ, Inst Plant Protect, Tai An, Shandong, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Shandong Agricultural University	Kong, XB (corresponding author), Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China.	zhangzhen@caf.ac.cn	Wang, Hongbin/N-5851-2018	Wang, Hongbin/0000-0002-3355-2448; Zhang, Weijie/0000-0002-6462-6067	CAF [CAFRIFEEP201002]; National Natural Science Foundation of China [30771737]	CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nonprofit Institute Research Grant of CAF (CAFRIFEEP201002), and partially supported from the National Natural Science Foundation of China (Grant No. 30771737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1982, AGR BIOL CHEM TOKYO, V46, P709, DOI 10.1080/00021369.1982.10865117; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Klun JA, 2000, J ENTOMOL SCI, V35, P158, DOI 10.18474/0749-8004-35.2.158; Kong XB, 2001, CHINESE SCI BULL, V46, P2077; Kong XB, 2007, J CHEM ECOL, V33, P1316, DOI 10.1007/s10886-007-9313-2; Kong Xiang-Bo, 2003, Acta Entomologica Sinica, V46, P131; Kong XB, 2007, ENTOMOL EXP APPL, V124, P37, DOI 10.1111/j.1570-7458.2007.00562.x; Kong XB, 2011, J CHEM ECOL, V37, P412, DOI 10.1007/s10886-011-9932-5; Kovalev B. G., 1993, Chemistry of Natural Compounds, V29, P135, DOI 10.1007/BF00631042; LINN CE, 1986, J CHEM ECOL, V12, P659, DOI 10.1007/BF01012100; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; McElfresh JS, 1999, J CHEM ECOL, V25, P687, DOI 10.1023/A:1020876229787; Meng X.-z., 1983, Scientia Silvae Sinicae, V19, P137; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; PRIESNER E, 1984, Z NATURFORSCH C, V39, P1192; Yan JJ, 1991, FOREST INSECTS CHINA, P961; YOUNG DC, 1990, J CHROMATOGR, V522, P295, DOI 10.1016/0021-9673(90)85199-6; Zhao Cheng-Hua, 1993, Acta Entomologica Sinica, V36, P247	18	136	145	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33381	10.1371/journal.pone.0033381	http://dx.doi.org/10.1371/journal.pone.0033381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22876288	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700057
